Citrus Sinensis ID: 042634
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 427 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGP4 | 1010 | Probable LRR receptor-lik | no | no | 0.929 | 0.393 | 0.374 | 1e-68 | |
| Q9SD62 | 1025 | Putative receptor-like pr | no | no | 0.545 | 0.227 | 0.483 | 9e-65 | |
| C0LGT6 | 1031 | LRR receptor-like serine/ | no | no | 0.906 | 0.375 | 0.338 | 3e-57 | |
| Q9ZUI0 | 980 | Putative leucine-rich rep | no | no | 0.519 | 0.226 | 0.387 | 6e-43 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.918 | 0.313 | 0.300 | 1e-40 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.899 | 0.348 | 0.294 | 6e-35 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.512 | 0.175 | 0.353 | 1e-33 | |
| P47735 | 999 | Receptor-like protein kin | no | no | 0.491 | 0.210 | 0.364 | 2e-32 | |
| C0LGX3 | 993 | LRR receptor-like serine/ | no | no | 0.889 | 0.382 | 0.295 | 6e-32 | |
| Q9LYN8 | 1192 | Leucine-rich repeat recep | no | no | 0.494 | 0.177 | 0.340 | 3e-31 |
| >sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 260 bits (665), Expect = 1e-68, Method: Compositional matrix adjust.
Identities = 184/491 (37%), Positives = 250/491 (50%), Gaps = 94/491 (19%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS 63
L GN F G IP G L ++ + L N G IP + + L LN + N LEG +P
Sbjct: 536 LEGNLFYGDIPDLKG-LVGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVPV 594
Query: 64 SLGKCQNLILLDL-SNNNLTG------------TTPTEV-----------IGLS-SLSIY 98
G +N + + NN+L G P+ V IG+S +++
Sbjct: 595 K-GIFENATTVSIVGNNDLCGGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLL 653
Query: 99 LDL--------------SQNQLNGPLPS---------NFGILKNLGAIDISENKL-SGQI 134
L L + N P PS ++G L+N S N + SG
Sbjct: 654 LLLFMASVTLIWLRKRKKNKETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGSF 713
Query: 135 PSSIGSCIRLEQLVMNGNFF----RGNIPSSLSSLRGIENLDLSRNNFIRHRNLVKIITS 190
+ + + E+ V+ RG + S ++ +++ IRHRNLVK++T+
Sbjct: 714 GTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECESLKD--------IRHRNLVKLLTA 765
Query: 191 CASVDFQGNDSEALVYEFMVNGSLEEWLHPN-----REALKNLNLLQRLSIAVDVASALD 245
C+S+DFQGN+ AL+YEFM NGSL+ WLHP + L LL+RL+IA+DVAS LD
Sbjct: 766 CSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEVEEIHRPSRTLTLLERLNIAIDVASVLD 825
Query: 246 YLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPE-ATNNFFN----------- 293
YLH +C PI HCDLKPSNVLLD +LTAHV DFGLA+ L + +FFN
Sbjct: 826 YLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFDEESFFNQLSSAGVRGTI 885
Query: 294 -FQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEALPERLAE 352
+ EYG+G + S +GDVYSFGILLLE FTGKRPTNE+F GN TL+++ K ALPER+ +
Sbjct: 886 GYAAPEYGVGGQPSINGDVYSFGILLLEMFTGKRPTNELFGGNFTLNSYTKSALPERILD 945
Query: 353 IVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412
IVD +L H F V ECL V +G+ C E P R+ V
Sbjct: 946 IVDESIL-------------HIGLRVGFPVVECLTMVFEVGLRCCEESPMNRLATSIVVK 992
Query: 413 QLLSFRNKLVK 423
+L+S R + K
Sbjct: 993 ELISIRERFFK 1003
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 248 bits (632), Expect = 9e-65, Method: Compositional matrix adjust.
Identities = 128/265 (48%), Positives = 166/265 (62%), Gaps = 32/265 (12%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNR-----EALKNLNLLQR 233
IRHRNLVK++T C+S DF+GND ALVYEFM NG+L+ WLHP+ + L L R
Sbjct: 771 IRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHPDEIEETGNPSRTLGLFAR 830
Query: 234 LSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFN 293
L+IA+DVASAL YLH YC PI HCD+KPSN+LLD +LTAHV DFGLA+ L + + F+
Sbjct: 831 LNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLLKFDRDTFH 890
Query: 294 FQIA-------------EYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHN 340
Q + EYGMG S GDVYSFGI+LLE FTGKRPTN++F LTLH+
Sbjct: 891 IQFSSAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGIVLLEIFTGKRPTNKLFVDGLTLHS 950
Query: 341 FVKEALPERLA-EIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSE 399
F K AL +R A +I D +L + + F++ ECL V +GV+CS E
Sbjct: 951 FTKSALQKRQALDITDETIL-------------RGAYAQHFNMVECLTLVFRVGVSCSEE 997
Query: 400 LPRERMNMEEVAAQLLSFRNKLVKN 424
P R++M E ++L+S R ++
Sbjct: 998 SPVNRISMAEAISKLVSIRESFFRD 1022
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 223 bits (567), Expect = 3e-57, Method: Compositional matrix adjust.
Identities = 165/488 (33%), Positives = 236/488 (48%), Gaps = 101/488 (20%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS 63
+ GN F G IP I L L+ + N G IP + +L L LN + N EG +P+
Sbjct: 544 MQGNSFDGAIP-DISRLVSLKNVDFSNNNLSGRIPRYLASLPSLRNLNLSMNKFEGRVPT 602
Query: 64 SLGKCQNLILLDL-SNNNLTG-------------TTPTE--------------VIGLSSL 95
+ G +N + + N N+ G +P + IG++SL
Sbjct: 603 T-GVFRNATAVSVFGNTNICGGVREMQLKPCIVQASPRKRKPLSVRKKVVSGICIGIASL 661
Query: 96 -------SIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLV 148
S+ + + + N N LG K+S + S S L+
Sbjct: 662 LLIIIVASLCWFMKRKKKNNASDGNPSDSTTLGMF---HEKVSYEELHSATSRFSSTNLI 718
Query: 149 MNGNFFRGNIPSSL----SSLRGIENLDLSRNNF-------------IRHRNLVKIITSC 191
+GNF GN+ L + L ++ L+L ++ IRHRNLVK+IT C
Sbjct: 719 GSGNF--GNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRHRNLVKLITVC 776
Query: 192 ASVDFQGNDSEALVYEFMVNGSLEEWLHPN-----REALKNLNLLQRLSIAVDVASALDY 246
+S+D +GND ALVYEFM GSL+ WL + ++L ++L+IA+DVASAL+Y
Sbjct: 777 SSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRSLTPAEKLNIAIDVASALEY 836
Query: 247 LHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFF-------------N 293
LH +C P+ HCD+KPSN+LLD +LTAHV DFGLA+ L + F
Sbjct: 837 LHVHCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRESFLNQFSSAGVRGTIG 896
Query: 294 FQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEALPERLAEI 353
+ EYGMG + S GDVYSFGILLLE F+GK+PT+E F G+ LH++ K L
Sbjct: 897 YAAPEYGMGGQPSIQGDVYSFGILLLEMFSGKKPTDESFAGDYNLHSYTKSIL------- 949
Query: 354 VDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAAQ 413
G TS ++ ++ E L VL +G+ CS E PR+RM +E +
Sbjct: 950 ----------SGCTSSGGSN-------AIDEGLRLVLQVGIKCSEEYPRDRMRTDEAVRE 992
Query: 414 LLSFRNKL 421
L+S R+K
Sbjct: 993 LISIRSKF 1000
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 175 bits (444), Expect = 6e-43, Method: Compositional matrix adjust.
Identities = 98/253 (38%), Positives = 145/253 (57%), Gaps = 31/253 (12%)
Query: 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVD 239
RHRNL++IIT+C+ F ALV M NGSLE L+P + KNL+L+Q ++I D
Sbjct: 714 RHRNLIRIITTCSKPGFN-----ALVLPLMPNGSLERHLYPGEYSSKNLDLIQLVNICSD 768
Query: 240 VASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPE-----ATNNFFNF 294
VA + YLHHY +VHCDLKPSN+LLD E+TA V DFG+++ + +T++ +F
Sbjct: 769 VAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVEETVSTDDSVSF 828
Query: 295 ------------QIA-EYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNF 341
IA EYGMG ST GDVYSFG+LLLE +G+RPT+ + +LH F
Sbjct: 829 GSTDGLLCGSVGYIAPEYGMGKRASTHGDVYSFGVLLLEIVSGRRPTDVLVNEGSSLHEF 888
Query: 342 VKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELP 401
+K P+ L I++ L + +G+ K +E ++ ++ +G+ C+ P
Sbjct: 889 MKSHYPDSLEGIIEQALSRWKPQGKPEKCEK--------LWREVILEMIELGLVCTQYNP 940
Query: 402 RERMNMEEVAAQL 414
R +M +VA ++
Sbjct: 941 STRPDMLDVAHEM 953
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 167 bits (424), Expect = 1e-40, Method: Compositional matrix adjust.
Identities = 148/492 (30%), Positives = 219/492 (44%), Gaps = 100/492 (20%)
Query: 1 AFTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGS 60
A L N FTGRIP +I L KL+ L L N+ GE+P IG++ L LN + N LEG
Sbjct: 773 ALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGK 832
Query: 61 IPSSLGKCQ--------NLILLDLSNNNLTGT------TPTEVIGLSSLS---------- 96
+ + Q L LS+ N G+ +P V+ +S++S
Sbjct: 833 LKKQFSRWQADAFVGNAGLCGSPLSHCNRAGSKNQRSLSPKTVVIISAISSLAAIALMVL 892
Query: 97 -IYLDLSQNQ-------------------LNGPLPSNFGILKNLGAIDISE--NKLSGQI 134
I L QN PL SN G ++ DI E + L+ +
Sbjct: 893 VIILFFKQNHDLFKKVRGGNSAFSSNSSSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEF 952
Query: 135 PSSIGSCIRL--------EQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNFIRHRNLVK 186
G ++ E + + ++ ++ S+ S R ++ L IRHR+LVK
Sbjct: 953 MIGSGGSGKVYKAELKNGETIAVKKILWKDDLMSNKSFNREVKTL-----GTIRHRHLVK 1007
Query: 187 IITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKN--LNLLQRLSIAVDVASAL 244
++ C+S + + L+YE+M NGS+ +WLH N K L RL IA+ +A +
Sbjct: 1008 LMGYCSS---KADGLNLLIYEYMANGSVWDWLHANENTKKKEVLGWETRLKIALGLAQGV 1064
Query: 245 DYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL-------PEATNNF---FNF 294
+YLH+ C PIVH D+K SNVLLD + AH+GDFGLAK L E+ F + +
Sbjct: 1065 EYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGNYDTNTESNTMFAGSYGY 1124
Query: 295 QIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEAL-----PER 349
EY + + DVYS GI+L+E TGK PT MF + +V+ L E
Sbjct: 1125 IAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTEAMFDEETDMVRWVETVLDTPPGSEA 1184
Query: 350 LAEIVDPVL--LVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM 407
+++D L L+ EE E VL I + C+ P+ER +
Sbjct: 1185 REKLIDSELKSLLPCEE-------------------EAAYQVLEIALQCTKSYPQERPSS 1225
Query: 408 EEVAAQLLSFRN 419
+ + LL+ N
Sbjct: 1226 RQASEYLLNVFN 1237
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 148 bits (374), Expect = 6e-35, Method: Compositional matrix adjust.
Identities = 140/475 (29%), Positives = 202/475 (42%), Gaps = 91/475 (19%)
Query: 7 NQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIP---- 62
N +G IP S+G+L L+ L L NK GEIP+SIGNL L+ N + N L G++P
Sbjct: 630 NNLSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGNLMSLLICNISNNNLVGTVPDTAV 689
Query: 63 -----------------SSLGKCQNLI---------LLDLSNNNLTGTTPTEVIGLSSLS 96
S CQ L+ L++ S T VIG L
Sbjct: 690 FQRMDSSNFAGNHGLCNSQRSHCQPLVPHSDSKLNWLINGSQRQKILTITCIVIGSVFLI 749
Query: 97 IYLDLS-------------QNQLNGPLPSNFGILKN----LGAIDISENKLSGQIPSSIG 139
+L L ++Q + ++ K G +D + N S + G
Sbjct: 750 TFLGLCWTIKRREPAFVALEDQTKPDVMDSYYFPKKGFTYQGLVDATRN-FSEDVVLGRG 808
Query: 140 SCIRLEQLVMNGNFF--------RGNIPSSLSSLRGIENLDLSRNNFIRHRNLVKIITSC 191
+C + + M+G RG SS +S R ++S IRHRN+VK+ C
Sbjct: 809 ACGTVYKAEMSGGEVIAVKKLNSRGEGASSDNSFRA----EISTLGKIRHRNIVKLYGFC 864
Query: 192 ASVDFQGNDSEALVYEFMVNGSLEEWLHPN-REALKNLNLLQRLSIAVDVASALDYLHHY 250
+S L+YE+M GSL E L + L + N R IA+ A L YLHH
Sbjct: 865 YH-----QNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWN--ARYRIALGAAEGLCYLHHD 917
Query: 251 CETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLP-------EATNNFFNFQIAEYGMGS 303
C IVH D+K +N+LLD AHVGDFGLAK + A + + EY
Sbjct: 918 CRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSMSAVAGSYGYIAPEYAYTM 977
Query: 304 EVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVERE 363
+V+ D+YSFG++LLE TGK P + G L N+V+ + + ++ + + +
Sbjct: 978 KVTEKCDIYSFGVVLLELITGKPPVQPLEQGG-DLVNWVRRS----IRNMIPTIEMFDAR 1032
Query: 364 EGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAAQLLSFR 418
K H+ + VL I + C+S P R M EV A + R
Sbjct: 1033 LDTNDKRTVHE-----------MSLVLKIALFCTSNSPASRPTMREVVAMITEAR 1076
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 144 bits (364), Expect = 1e-33, Method: Compositional matrix adjust.
Identities = 92/260 (35%), Positives = 133/260 (51%), Gaps = 41/260 (15%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREAL----KNLNLLQRL 234
IRHR+LVK++ C+S + L+YE+M NGS+ +WLH ++ L K L+ RL
Sbjct: 1003 IRHRHLVKLMGYCSS---KSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARL 1059
Query: 235 SIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPE------AT 288
IAV +A ++YLHH C PIVH D+K SNVLLD + AH+GDFGLAK L E +
Sbjct: 1060 RIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDS 1119
Query: 289 NNFF----NFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVK- 343
N +F + EY + + DVYS GI+L+E TGK PT+ +F + + +V+
Sbjct: 1120 NTWFACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMDMVRWVET 1179
Query: 344 --EALPERLAEIVDPVL--LVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSE 399
E +++DP L L+ EE + VL I + C+
Sbjct: 1180 HLEVAGSARDKLIDPKLKPLLPFEE-------------------DAACQVLEIALQCTKT 1220
Query: 400 LPRERMNMEEVAAQLLSFRN 419
P+ER + + LL N
Sbjct: 1221 SPQERPSSRQACDSLLHVYN 1240
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P47735|RLK5_ARATH Receptor-like protein kinase 5 OS=Arabidopsis thaliana GN=RLK5 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 140 bits (353), Expect = 2e-32, Method: Compositional matrix adjust.
Identities = 90/247 (36%), Positives = 127/247 (51%), Gaps = 37/247 (14%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
IRH+++V++ C+S D + LVYE+M NGSL + LH +R+ L +RL IA+
Sbjct: 744 IRHKSIVRLWCCCSS-----GDCKLLVYEYMPNGSLADVLHGDRKGGVVLGWPERLRIAL 798
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKF-------LPEATNNF 291
D A L YLHH C PIVH D+K SN+LLD + A V DFG+AK PEA +
Sbjct: 799 DAAEGLSYLHHDCVPPIVHRDVKSSNILLDSDYGAKVADFGIAKVGQMSGSKTPEAMSGI 858
Query: 292 F---NFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEALPE 348
+ EY V+ D+YSFG++LLE TGK+PT+ G+ + +V AL +
Sbjct: 859 AGSCGYIAPEYVYTLRVNEKSDIYSFGVVLLELVTGKQPTDSEL-GDKDMAKWVCTALDK 917
Query: 349 -RLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM 407
L ++DP L KE + V+ IG+ C+S LP R +M
Sbjct: 918 CGLEPVIDPKL--------------------DLKFKEEISKVIHIGLLCTSPLPLNRPSM 957
Query: 408 EEVAAQL 414
+V L
Sbjct: 958 RKVVIML 964
|
Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates that controls floral organ abscission. May interact with the 'INFLORESCENCE DEFICIENT IN ABSCISSION' (IDA) ligands family. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGX3|HSL2_ARATH LRR receptor-like serine/threonine-protein kinase HSL2 OS=Arabidopsis thaliana GN=HSL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 139 bits (349), Expect = 6e-32, Method: Compositional matrix adjust.
Identities = 142/480 (29%), Positives = 197/480 (41%), Gaps = 100/480 (20%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS 63
L N+ G IP +GDL L L L N+ GEIP+ + L L N ++N L G IPS
Sbjct: 538 LSNNRLRGGIPPELGDLPVLNYLDLSNNQLTGEIPAELLRLK-LNQFNVSDNKLYGKIPS 596
Query: 64 SLGKCQNLILLDLSNN------NLTGTTPTE---------------VIGLSSLSIYLDLS 102
G Q++ N NL P ++ L+ ++L +
Sbjct: 597 --GFQQDIFRPSFLGNPNLCAPNLDPIRPCRSKRETRYILPISILCIVALTGALVWLFIK 654
Query: 103 QNQLNGPLPSNFGILKNLGAIDISENKLSGQ-----IPSSIGSCIRLEQLVMNGNFF--- 154
L P + + +E + Q I S GS + + +G
Sbjct: 655 TKPLFKRKPKRTNKITIFQRVGFTEEDIYPQLTEDNIIGSGGSGLVYRVKLKSGQTLAVK 714
Query: 155 -----RGNIPSSLSSLRG-IENLDLSRNNFIRHRNLVKIITSCASVDFQGNDSEALVYEF 208
G S S R +E L R+ I VK++ C +F+ LVYEF
Sbjct: 715 KLWGETGQKTESESVFRSEVETLGRVRHGNI-----VKLLMCCNGEEFR-----FLVYEF 764
Query: 209 MVNGSLEEWLHPNRE--ALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVL 266
M NGSL + LH +E A+ L+ R SIAV A L YLHH PIVH D+K +N+L
Sbjct: 765 MENGSLGDVLHSEKEHRAVSPLDWTTRFSIAVGAAQGLSYLHHDSVPPIVHRDVKSNNIL 824
Query: 267 LDGELTAHVGDFGLAKFLPEATNN------------FFNFQIAEYGMGSEVSTSGDVYSF 314
LD E+ V DFGLAK L N+ + + EYG S+V+ DVYSF
Sbjct: 825 LDHEMKPRVADFGLAKPLKREDNDGVSDVSMSCVAGSYGYIAPEYGYTSKVNEKSDVYSF 884
Query: 315 GILLLETFTGKRPTNEMFTGNLTLHNFVKEA---LP-----------------ERLAEIV 354
G++LLE TGKRP + F N + F EA P L+++V
Sbjct: 885 GVVLLELITGKRPNDSSFGENKDIVKFAMEAALCYPSPSAEDGAMNQDSLGNYRDLSKLV 944
Query: 355 DPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAAQL 414
DP + K TR + E + VL + + C+S P R M +V L
Sbjct: 945 DPKM---------------KLSTREY---EEIEKVLDVALLCTSSFPINRPTMRKVVELL 986
|
Receptor-like serine/threonine-kinase acting on substrates that controls floral organ abscission. Regulated by the 'INFLORESCENCE DEFICIENT IN ABSCISSION' (IDA) family of ligands. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1 | Back alignment and function description |
|---|
Score = 136 bits (342), Expect = 3e-31, Method: Compositional matrix adjust.
Identities = 84/247 (34%), Positives = 129/247 (52%), Gaps = 36/247 (14%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
++H NLV ++ C+ ++ + LVYE+MVNGSL+ WL L+ L+ +RL IAV
Sbjct: 968 VKHPNLVSLLGYCSF-----SEEKLLVYEYMVNGSLDHWLRNQTGMLEVLDWSKRLKIAV 1022
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNF------- 291
A L +LHH I+H D+K SN+LLDG+ V DFGLA+ + ++
Sbjct: 1023 GAARGLAFLHHGFIPHIIHRDIKASNILLDGDFEPKVADFGLARLISACESHVSTVIAGT 1082
Query: 292 FNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFT----GNLTLHNFVKEALP 347
F + EYG + +T GDVYSFG++LLE TGK PT F GNL + +++
Sbjct: 1083 FGYIPPEYGQSARATTKGDVYSFGVILLELVTGKEPTGPDFKESEGGNL-VGWAIQKINQ 1141
Query: 348 ERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM 407
+ +++DP+L+ S ++K + +L I + C +E P +R NM
Sbjct: 1142 GKAVDVIDPLLV-------------------SVALKNSQLRLLQIAMLCLAETPAKRPNM 1182
Query: 408 EEVAAQL 414
+V L
Sbjct: 1183 LDVLKAL 1189
|
Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 427 | ||||||
| 359486510 | 965 | PREDICTED: probable LRR receptor-like se | 0.559 | 0.247 | 0.6 | 2e-86 | |
| 255576770 | 851 | serine-threonine protein kinase, plant-t | 0.943 | 0.473 | 0.412 | 3e-84 | |
| 255586722 | 936 | serine-threonine protein kinase, plant-t | 0.569 | 0.259 | 0.604 | 1e-83 | |
| 224121660 | 774 | predicted protein [Populus trichocarpa] | 0.953 | 0.525 | 0.399 | 1e-82 | |
| 297736629 | 1195 | unnamed protein product [Vitis vinifera] | 0.864 | 0.308 | 0.405 | 4e-82 | |
| 297819322 | 919 | hypothetical protein ARALYDRAFT_347815 [ | 0.948 | 0.440 | 0.377 | 2e-80 | |
| 125581304 | 1077 | hypothetical protein OsJ_05889 [Oryza sa | 0.950 | 0.376 | 0.416 | 3e-80 | |
| 302142240 | 869 | unnamed protein product [Vitis vinifera] | 0.967 | 0.475 | 0.386 | 2e-79 | |
| 224097752 | 1025 | predicted protein [Populus trichocarpa] | 0.564 | 0.235 | 0.553 | 2e-79 | |
| 224097750 | 1023 | predicted protein [Populus trichocarpa] | 0.564 | 0.235 | 0.545 | 6e-79 |
| >gi|359486510|ref|XP_002271317.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like, partial [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 325 bits (834), Expect = 2e-86, Method: Compositional matrix adjust.
Identities = 156/260 (60%), Positives = 189/260 (72%), Gaps = 21/260 (8%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREAL------KNLNLLQ 232
IRHRNLVK++T+C+ VD+QGND +A+VYEFMVNGSLE+WLHP + LN LQ
Sbjct: 690 IRHRNLVKVLTACSGVDYQGNDFKAVVYEFMVNGSLEQWLHPTPTTAEASAPPRKLNFLQ 749
Query: 233 RLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNF- 291
RL+IA+DVA ALDYLHH C+TPIVHCDLKPSNVLLD E+T HVGDFG+AKFLPEA
Sbjct: 750 RLNIAIDVACALDYLHHQCQTPIVHCDLKPSNVLLDTEMTGHVGDFGIAKFLPEAATRVP 809
Query: 292 ------------FNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLH 339
+ EYGMGSEVSTSGDVYSFGILLLE FTGKRPT +MF +L +H
Sbjct: 810 EIQSSSIGIRGTIGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKRPTEDMFKDSLNIH 869
Query: 340 NFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSE 399
NFVK A+PER+AEI DPVLL +E E + ++ S +ECL+S+ GIG+ CS+E
Sbjct: 870 NFVKTAVPERVAEIADPVLL--QEGVEMDNTTSQRRMASSHDAQECLISIFGIGLACSAE 927
Query: 400 LPRERMNMEEVAAQLLSFRN 419
LPRER N+ + AA+L S R+
Sbjct: 928 LPRERKNITDAAAELNSVRD 947
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255576770|ref|XP_002529272.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223531261|gb|EEF33104.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 318 bits (815), Expect = 3e-84, Method: Compositional matrix adjust.
Identities = 185/449 (41%), Positives = 264/449 (58%), Gaps = 46/449 (10%)
Query: 7 NQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLG 66
NQ TG IP +G L L + + N+ G IPSSIGNL+ L L+ +N L G+IPSSLG
Sbjct: 412 NQITGSIPSDMGKLQNLYSMFFDHNRLTGIIPSSIGNLSFLNLLHLNDNNLHGTIPSSLG 471
Query: 67 KCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDI- 125
C L+ +DLS NNL G+ ++ L + Y + + S+ +LK+L +
Sbjct: 472 NCHELVFIDLSQNNLNGSISDQLFALPTF-FYCWFQHPKTE--VVSDTLVLKSLEEVSYK 528
Query: 126 ----SENKLSGQIPSSIGSCIRLEQLVMNGNF-----------FRGNIPSSLSSLRGIEN 170
+ N S + GS + +++++ + RG S ++ +++
Sbjct: 529 SILKATNGFSAESLIGAGSFGSVYKVILDEDGPALAIKVLNLQHRGASKSFMAECEALKS 588
Query: 171 LDLSRNNFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNRE------A 224
IRHRNLVKIITSC S+DFQGND +ALVYE+M NG+LE WLH
Sbjct: 589 --------IRHRNLVKIITSCTSIDFQGNDFKALVYEYMPNGNLENWLHLGSGIGVAPFE 640
Query: 225 LKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL 284
+L+LLQR+ IA+D+ +ALDYLHH CE PI+HCDLKPSNVLLD ++ AH+GDFGLAKFL
Sbjct: 641 TNSLSLLQRIDIAIDIGNALDYLHHQCERPIIHCDLKPSNVLLDIDMVAHIGDFGLAKFL 700
Query: 285 PEATN----------NFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTG 334
P+ N + EYG+GSEVSTSGDVYS+GILLLE TGK+PT++ FTG
Sbjct: 701 PQLANPAQSSSMGVRGTIGYAPPEYGLGSEVSTSGDVYSYGILLLEMMTGKKPTDDNFTG 760
Query: 335 NLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGV 394
N LH+ + ALP+ ++EIVDP+LL + ET+ + + S +CL+S++ +G+
Sbjct: 761 NHNLHSICRMALPDEVSEIVDPILL---QGDETNNNQGSMEPKAADSKVKCLISMIKVGI 817
Query: 395 TCSSELPRERMNMEEVAAQLLSFRNKLVK 423
CS E P++RM++ L ++ ++
Sbjct: 818 ACSMESPQDRMDISNALTNLHYIKSNYIR 846
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255586722|ref|XP_002533985.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223526036|gb|EEF28405.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 316 bits (810), Expect = 1e-83, Method: Compositional matrix adjust.
Identities = 156/258 (60%), Positives = 196/258 (75%), Gaps = 15/258 (5%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREA----LKNLNLLQRL 234
IRHRNLVK++T+C+SVD+QGN+ +ALVYEFMVNGSLEEWLHP EA NLN+LQRL
Sbjct: 682 IRHRNLVKVLTACSSVDYQGNEFKALVYEFMVNGSLEEWLHPPDEAKAIPRNNLNILQRL 741
Query: 235 SIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNF 294
+IAVDVA ALDYLH++CETPI+HCDLKPSN+LLD E+T HVGDFGLAKF E ++ +
Sbjct: 742 NIAVDVACALDYLHNHCETPIIHCDLKPSNILLDNEMTGHVGDFGLAKFYRERSHQSSSI 801
Query: 295 QI--------AEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEAL 346
I AEYG G+EVSTSGDVYS+GILLLE FTGKRP ++ F +++LHN+VK AL
Sbjct: 802 GIRGSLGYAPAEYGTGNEVSTSGDVYSYGILLLEIFTGKRPMDDWFNEDVSLHNYVKNAL 861
Query: 347 PERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMN 406
PE++ EI+DP L E E G + ++ R+ ECL+S+ IGV CS+E P ERMN
Sbjct: 862 PEQVVEILDPTLFQEGEGGISLIRRSNASINRTM---ECLISICEIGVACSAETPGERMN 918
Query: 407 MEEVAAQLLSFRNKLVKN 424
+ +VA QL+S RNKL++N
Sbjct: 919 ICDVAGQLVSIRNKLLRN 936
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224121660|ref|XP_002330621.1| predicted protein [Populus trichocarpa] gi|222872225|gb|EEF09356.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 313 bits (802), Expect = 1e-82, Method: Compositional matrix adjust.
Identities = 195/488 (39%), Positives = 276/488 (56%), Gaps = 81/488 (16%)
Query: 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSI 61
+L GN F G IP S+ L L+ L L N G+IP +G+L LL +L+ + N LEG +
Sbjct: 282 LSLKGNFFKGSIPESLSSLRALKVLDLSYNNLSGQIPKFLGDLKLLESLDLSFNDLEGQV 341
Query: 62 PSSLGKCQNLILLDLSNN----------NLTGTTPTE----------------------V 89
P G N ++ ++ N NL+ T E +
Sbjct: 342 PVQ-GVFGNTSVISIAGNKKLCGGIPQLNLSRCTTNESAKLKSSTKILIVAMSGGLLVVI 400
Query: 90 IGLSSLSIYLDLSQNQLNGPLPSNFGI-LKNLGAIDI--SENKLSGQIPSSIGSCIRLEQ 146
+ +SS+ Y + S +GI + + D+ + N+ S +GS
Sbjct: 401 LLVSSMLFYFFRKTKDMQASSTSTWGIPFRRVAYQDLLLATNEFSSANSIGVGSF----- 455
Query: 147 LVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF-------------IRHRNLVKIITSCAS 193
G+ +RG +P ++ ++ L+L R IRHRNLV+++++C+S
Sbjct: 456 ----GSVYRGILPPDGMAV-AVKVLNLLRKGASRSFMAECAALVNIRHRNLVRVVSACSS 510
Query: 194 VDFQGNDSEALVYEFMVNGSLEEWLHP-----NREALKNLNLLQRLSIAVDVASALDYLH 248
+DFQGND +A+VYE MVNGSLEEWLHP N + L++LNL+QRL+I++DVA+AL+YLH
Sbjct: 511 IDFQGNDFKAIVYELMVNGSLEEWLHPIHQPNNAQELRSLNLIQRLNISIDVANALNYLH 570
Query: 249 HYC-ETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNF-------------FNF 294
+C TPIVHCDLKPSNVLL+ E+TA VGDFGLA+ PE ++ +
Sbjct: 571 QHCGSTPIVHCDLKPSNVLLNAEMTACVGDFGLARLRPEVSHQLSSGQTSSVGLKGTIGY 630
Query: 295 QIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEALPERLAEIV 354
EYG+GS+VST GDVYSFGILLLE FTGKRPT MF L LHN+ + AL R++E+V
Sbjct: 631 AAPEYGVGSDVSTYGDVYSFGILLLEMFTGKRPTEGMFKDGLNLHNYAEMALHGRVSEVV 690
Query: 355 DPVLLVEREEGETSKANAHKQ-FTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAAQ 413
+P+LL RE+ E S ++H+ + + ECL+S++ IGV CS ELPRERM+M V A+
Sbjct: 691 EPILL--REDVERSIHSSHRMNHIETGKILECLISIIKIGVACSVELPRERMDMSIVVAE 748
Query: 414 LLSFRNKL 421
L R+ L
Sbjct: 749 LHRIRDIL 756
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297736629|emb|CBI25500.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 311 bits (797), Expect = 4e-82, Method: Compositional matrix adjust.
Identities = 218/537 (40%), Positives = 268/537 (49%), Gaps = 168/537 (31%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIP------------------------- 38
L GN+ G IP IG+L L+RL + N+ G IP
Sbjct: 435 LDGNKIGGSIPAGIGNLVSLERLEMWENQLSGSIPVDIGKLQNLRKENSIQGGEFKKVHE 494
Query: 39 --------SSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEVI 90
SS+GNL LI L N +G IPSSLGKCQNL+ LDLS NNL+GT P +V+
Sbjct: 495 PSFNRILPSSLGNLENLIQLVLGRNYFQGKIPSSLGKCQNLLFLDLSLNNLSGTIPPQVV 554
Query: 91 GLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMN 150
LSSLSI LD+S N+L G LP G LKNLG +D+S N LSG IPSS+GSC LE L M
Sbjct: 555 SLSSLSISLDISDNRLTGALPIEVGNLKNLGVLDVSNNMLSGGIPSSVGSCTSLEYLSMK 614
Query: 151 GNFFR------------------------GNIPSSLSSLRGIENLDLSRNNF-------- 178
GNFF+ G IP L + + ++LS N+F
Sbjct: 615 GNFFQGSIPSSFSSLRGIRILDLSHNNLSGKIPEFLQDIH-FQLVNLSYNDFEGILPTEG 673
Query: 179 ----IRHRNL---VKIITSCAS--------------VDFQ----------------GNDS 201
+ R L +KII + V +Q GND
Sbjct: 674 VFKNPKKRGLSLALKIIIATKKGEPASSSSEKSLLKVSYQSLLRATDGFSSSNLIGGNDF 733
Query: 202 EALVYEFMVNGSLEEWLHPNREAL------KNLNLLQRLSIAVDVASALDYLHHYCETPI 255
+A+VYEFMVNGSLE+WLHP + LN LQRL+IA+D
Sbjct: 734 KAVVYEFMVNGSLEQWLHPTPTTAEASAPPRKLNFLQRLNIAID---------------- 777
Query: 256 VHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNF-------------FNFQIAEYGMG 302
PSNVLLD E+T HVGDFG+AKFLPEA + EYGMG
Sbjct: 778 ------PSNVLLDTEMTGHVGDFGIAKFLPEAATRVPEIQSSSIGIRGTIGYAAPEYGMG 831
Query: 303 SEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVER 362
SEVSTSGDVYSFGILLLE FTGKRPT +MF +L +HNFVK A+PER
Sbjct: 832 SEVSTSGDVYSFGILLLEMFTGKRPTEDMFKDSLNIHNFVKTAVPER------------- 878
Query: 363 EEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAAQLLSFRN 419
++ S +ECL+S+ GIG+ CS+ELPRER N+ + AA+L S R+
Sbjct: 879 -----------RRMASSHDAQECLISIFGIGLACSAELPRERKNITDAAAELNSVRD 924
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297819322|ref|XP_002877544.1| hypothetical protein ARALYDRAFT_347815 [Arabidopsis lyrata subsp. lyrata] gi|297323382|gb|EFH53803.1| hypothetical protein ARALYDRAFT_347815 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 306 bits (783), Expect = 2e-80, Method: Compositional matrix adjust.
Identities = 192/509 (37%), Positives = 270/509 (53%), Gaps = 104/509 (20%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS 63
L N+ +G IP +IG+L +LQ+L L N F G IP S+ N + L+ L N L G+IP
Sbjct: 419 LSSNKLSGVIPSTIGNLTRLQKLRLSNNIFEGTIPPSLSNCSELLHLEIGYNKLNGTIPK 478
Query: 64 SLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFG-------- 115
+ + +L+ L + +N+++GT P +V L +L + L +S N+L+G L G
Sbjct: 479 EIMQLSHLLTLSMPSNSISGTLPNDVGRLQNL-VLLSVSDNKLSGELSQTLGNCLSMEEI 537
Query: 116 ---------ILKNLGAI------DISENKLSG-------------QIPSSIGSCIRL--- 144
I+ N+ + D+S N LSG + +S S + +
Sbjct: 538 YLQGNSFDGIIPNIKGLVGVKRDDMSNNNLSGISLRWLRKRKKNQKTNNSAASTLEIFHE 597
Query: 145 ----------------EQLVMNGNF---FRGNIPSSLSSLRGIENLDLSRNNF------- 178
+V +G+F F+ +P + + ++ L++ R
Sbjct: 598 KISYGDLRNATDGFSASNMVGSGSFGTVFKALLPEE-NKIVAVKVLNMERRGAMKSFMAE 656
Query: 179 ------IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPN-----REALKN 227
IRHRNLVK++T+CAS+DFQGN+ AL+YEFM NGSL+ WLHP R +
Sbjct: 657 CESLKDIRHRNLVKLLTACASIDFQGNEFRALIYEFMPNGSLDMWLHPEEIEEIRRPSRT 716
Query: 228 LNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPE- 286
L L +RL+IAVDVAS LDYLH +C PI HCDLKPSNVLLD +LTAHV DFGLA+ L +
Sbjct: 717 LTLRERLNIAVDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKF 776
Query: 287 ATNNFFN------------FQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTG 334
+FFN + EYGMG + S GDVYSFG+L+LE FTGKRPTNE+F G
Sbjct: 777 DQESFFNQLSSAGVRGTIGYAAPEYGMGGQPSIHGDVYSFGVLVLEMFTGKRPTNELFEG 836
Query: 335 NLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGV 394
+ TLH++ + ALPER+ +I D +L H F V ECL +L +G+
Sbjct: 837 SFTLHSYTRSALPERVLDIADKSIL-------------HSGLRVGFPVVECLKVILDVGL 883
Query: 395 TCSSELPRERMNMEEVAAQLLSFRNKLVK 423
C E P R+ E A +L+S R + K
Sbjct: 884 RCCEESPMNRLATSEAAKELISIRERFFK 912
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|125581304|gb|EAZ22235.1| hypothetical protein OsJ_05889 [Oryza sativa Japonica Group] | Back alignment and taxonomy information |
|---|
Score = 305 bits (781), Expect = 3e-80, Method: Compositional matrix adjust.
Identities = 181/435 (41%), Positives = 255/435 (58%), Gaps = 29/435 (6%)
Query: 7 NQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLG 66
N F+G +P I +L + + N+ GEIP SIG+ L N L+G IP+S+
Sbjct: 647 NMFSGSLPLEISNLKNIADIDFSNNQISGEIPPSIGDCQSLQYFKIQGNFLQGPIPASVS 706
Query: 67 KCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDIS 126
+ + L +LDLS+NN +G P + ++ L+ L+LS N GP+P N GI N+ I
Sbjct: 707 RLKGLQVLDLSHNNFSGDIPQFLASMNGLA-SLNLSFNHFEGPVP-NDGIFLNINETAIE 764
Query: 127 ENKLSGQIPSSIGSCIRLEQLVMNGNFFRG----NIPSSLSSLRGIENLDLSRNNFIRHR 182
N+ G S GS + + + N+ +S I + R +RHR
Sbjct: 765 GNE--GLCGGSFGSVYKGRMTIQDQEVTVAVKVLNLQQRGASQSFIAECEALR--CVRHR 820
Query: 183 NLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREA---LKNLNLLQRLSIAVD 239
NLVKI+T C+S+D QG+D +ALVYEFM NG+L++WLH + E K LN+++RL IA+D
Sbjct: 821 NLVKILTVCSSIDIQGHDFKALVYEFMPNGNLDQWLHQHLEENGEDKVLNIIKRLDIAID 880
Query: 240 VASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFF------- 292
V SALDYLH + PI+HCDLKPSN+LLD E+ AHVGDFGLA+ L + ++
Sbjct: 881 VVSALDYLHQHRPLPIIHCDLKPSNILLDSEMVAHVGDFGLARVLHQDHSDMLEKSSGWA 940
Query: 293 ------NFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEAL 346
+ EYG+G+EVS GDVYS+GILLLE FTGKRPT F L+LHN+VK AL
Sbjct: 941 TMRGTIGYAAPEYGLGNEVSILGDVYSYGILLLEMFTGKRPTGTEFREALSLHNYVKMAL 1000
Query: 347 PERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMN 406
P+ + +I D LL E +GE + N+ + TR + C+ S+L IGV+CS E P +RM+
Sbjct: 1001 PDNVIDIADQHLLSENNDGE--EINSDGKRTRDTRIA-CITSILQIGVSCSKESPADRMH 1057
Query: 407 MEEVAAQLLSFRNKL 421
+ E +L ++K
Sbjct: 1058 IGEALKELQRTKDKF 1072
|
Source: Oryza sativa Japonica Group Species: Oryza sativa Genus: Oryza Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302142240|emb|CBI19443.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 302 bits (774), Expect = 2e-79, Method: Compositional matrix adjust.
Identities = 197/510 (38%), Positives = 275/510 (53%), Gaps = 97/510 (19%)
Query: 7 NQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLG 66
N +G IP IG+L ++Q L L N G IPSS+GNL L L+ + N L G IP++
Sbjct: 352 NLISGEIPPEIGELGEMQELYLASNNISGRIPSSLGNLRQLSQLDLSSNRLVGGIPTNFS 411
Query: 67 KCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLP--------------- 111
Q L+ +DLSNN L + P E++GL LS L+LS+N L GPLP
Sbjct: 412 NFQRLLSMDLSNNRLNESIPKEILGLPGLSTLLNLSKNSLTGPLPQEVEALESSLEELFM 471
Query: 112 ----------SNFGILKNLGAIDISENKLSGQIPSSIG------------------SCIR 143
G ++ L +D+S N+L+G IPS IG S
Sbjct: 472 ANNKFSGSIPDTLGEVRGLEILDLSTNQLTGSIPS-IGVLAYLKKSKAKKLPITSDSFKV 530
Query: 144 LEQLV-------MNGNFFRGNI--PSSLSSLR----------GIENLDLSRN-------- 176
L Q+V GNF + N+ S S+ I+ LD+ RN
Sbjct: 531 LHQVVSYDDLRMATGNFNQQNLIGKGSFGSVYKGYLTEGTAVAIKVLDIQRNGSWKSFFA 590
Query: 177 -----NFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKN--LN 229
+RHRNLVK+ITSC+S+DF+ + AL+Y+FM NGSLE+W+ R LN
Sbjct: 591 ECEALRTVRHRNLVKLITSCSSLDFKNVEFLALIYDFMHNGSLEDWIKGTRRHASGCALN 650
Query: 230 LLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPE--- 286
L++RL IA+DVA A+DYLHH ETPI HCDLKPSNVLLD ++TA VGDFGLA+ L +
Sbjct: 651 LVERLKIAIDVACAMDYLHHDSETPIAHCDLKPSNVLLDKDMTAKVGDFGLARLLMDRAA 710
Query: 287 -----ATNNFFNFQIA----EYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLT 337
A+ + I EYG+G + +TSGDVYS+G++LLE FTGK PT+E F G LT
Sbjct: 711 DQQSIASTHGLRGSIGYIPPEYGLGGKPTTSGDVYSYGVMLLEMFTGKSPTHESFLGGLT 770
Query: 338 LHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVK-ECLVSVLGIGVTC 396
L +V+ A P + ++VDP LL+ + A H+ S V+ ECL++V+G+ ++C
Sbjct: 771 LAQWVQSAFPTNVRQVVDPELLLP------TGALQHEGHPISEEVQHECLIAVIGVALSC 824
Query: 397 SSELPRERMNMEEVAAQLLSFRNKLVKNIL 426
+ + R++ + +QL + L+K L
Sbjct: 825 TVDSSDRRISSRDALSQLKTAAKALLKPTL 854
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224097752|ref|XP_002311067.1| predicted protein [Populus trichocarpa] gi|222850887|gb|EEE88434.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 302 bits (773), Expect = 2e-79, Method: Compositional matrix adjust.
Identities = 145/262 (55%), Positives = 190/262 (72%), Gaps = 21/262 (8%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNR-----EALKNLNLLQR 233
IRHRNLVK++T+C+ +DFQGND +ALVYEFMVNGSLEEWLHP + ++L+LLQR
Sbjct: 759 IRHRNLVKVLTACSGIDFQGNDFKALVYEFMVNGSLEEWLHPAQISDEAHRRRDLSLLQR 818
Query: 234 LSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNF-- 291
L+IA+DVASALDYLH++C+ IVHCDLKPSNVLLDG+LTAHVGDFGLA+ LP+A++
Sbjct: 819 LNIAIDVASALDYLHNHCQIAIVHCDLKPSNVLLDGDLTAHVGDFGLARLLPQASHQLCL 878
Query: 292 -----------FNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHN 340
+ EYG+GSEVS GDVYS+GILLLE FTG+RPT+ +F L LHN
Sbjct: 879 DQTSSIGLKGTIGYAAPEYGLGSEVSPYGDVYSYGILLLEVFTGRRPTDGLFKDGLNLHN 938
Query: 341 FVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSEL 400
F K ALP +AE++DPVL+ E EE + +A ++ + + ECL +++ +GV CS+E
Sbjct: 939 FAKTALPISVAEVLDPVLVTEAEE---TSGDASRRMSHIGNHMECLAAIVKVGVACSAEF 995
Query: 401 PRERMNMEEVAAQLLSFRNKLV 422
PRERM + VA +L R+ L+
Sbjct: 996 PRERMEISSVAVELRRIRHILL 1017
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224097750|ref|XP_002311066.1| predicted protein [Populus trichocarpa] gi|222850886|gb|EEE88433.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 301 bits (770), Expect = 6e-79, Method: Compositional matrix adjust.
Identities = 143/262 (54%), Positives = 189/262 (72%), Gaps = 21/262 (8%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNR-----EALKNLNLLQR 233
IRHRNLVK++T+C+ +DFQGND +ALVYEFMVNGSLEEWLHP + ++L+LLQR
Sbjct: 757 IRHRNLVKVLTACSGIDFQGNDFKALVYEFMVNGSLEEWLHPVQISDEAHVRRDLSLLQR 816
Query: 234 LSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNF-- 291
L+IA+DVASALDYLH++C+ + HCDLKPSNVLLDG++TAHVGDFGLA+ LP+A++
Sbjct: 817 LNIAIDVASALDYLHNHCQIAVAHCDLKPSNVLLDGDMTAHVGDFGLARLLPQASHQLCL 876
Query: 292 -----------FNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHN 340
+ EYG+GSEVS GDVYS+GILLLE FTG+RPTN +F L LHN
Sbjct: 877 DQTSSIGLKGTIGYAAPEYGLGSEVSPYGDVYSYGILLLEVFTGRRPTNGLFKDGLNLHN 936
Query: 341 FVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSEL 400
F K ALP +AE++DPVL+ E EE + +A ++ + + ECL +++ +GV CS+E
Sbjct: 937 FAKTALPISVAEVLDPVLVTEAEE---TSGDASRRMSHIGNHMECLAAIVKVGVACSAEF 993
Query: 401 PRERMNMEEVAAQLLSFRNKLV 422
PRERM + VA +L R+ L+
Sbjct: 994 PRERMEISSVAVELRRIRHILL 1015
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 427 | ||||||
| TAIR|locus:2079142 | 1010 | AT3G47570 [Arabidopsis thalian | 0.543 | 0.229 | 0.509 | 1.6e-94 | |
| TAIR|locus:2075631 | 1009 | AT3G47090 [Arabidopsis thalian | 0.543 | 0.229 | 0.505 | 2.1e-94 | |
| TAIR|locus:2079157 | 1011 | AT3G47580 [Arabidopsis thalian | 0.540 | 0.228 | 0.496 | 1.1e-91 | |
| TAIR|locus:2075661 | 1025 | AT3G47110 [Arabidopsis thalian | 0.545 | 0.227 | 0.501 | 4.1e-91 | |
| UNIPROTKB|Q40640 | 1025 | Xa21 "Receptor kinase-like pro | 0.594 | 0.247 | 0.428 | 6.2e-81 | |
| TAIR|locus:2149922 | 1031 | EFR "EF-TU receptor" [Arabidop | 0.393 | 0.162 | 0.532 | 6.3e-74 | |
| TAIR|locus:2169975 | 993 | HSL2 "HAESA-like 2" [Arabidops | 0.548 | 0.235 | 0.366 | 1.4e-56 | |
| TAIR|locus:2120362 | 1249 | GSO1 "GASSHO1" [Arabidopsis th | 0.414 | 0.141 | 0.416 | 1.4e-56 | |
| TAIR|locus:2175703 | 502 | AT5G39390 [Arabidopsis thalian | 0.510 | 0.434 | 0.473 | 4.8e-56 | |
| TAIR|locus:2047525 | 980 | AT2G24130 [Arabidopsis thalian | 0.405 | 0.176 | 0.413 | 5e-55 |
| TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 627 (225.8 bits), Expect = 1.6e-94, Sum P(2) = 1.6e-94
Identities = 134/263 (50%), Positives = 169/263 (64%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNR-EAL----KNLNLLQR 233
IRHRNLVK++T+C+S+DFQGN+ AL+YEFM NGSL+ WLHP E + + L LL+R
Sbjct: 754 IRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEVEEIHRPSRTLTLLER 813
Query: 234 LSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATN-NFF 292
L+IA+DVAS LDYLH +C PI HCDLKPSNVLLD +LTAHV DFGLA+ L + +FF
Sbjct: 814 LNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFDEESFF 873
Query: 293 N------------FQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHN 340
N + EYG+G + S +GDVYSFGILLLE FTGKRPTNE+F GN TL++
Sbjct: 874 NQLSSAGVRGTIGYAAPEYGVGGQPSINGDVYSFGILLLEMFTGKRPTNELFGGNFTLNS 933
Query: 341 FVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSEL 400
+ K ALPER+ +IVD +L H F V ECL V +G+ C E
Sbjct: 934 YTKSALPERILDIVDESIL-------------HIGLRVGFPVVECLTMVFEVGLRCCEES 980
Query: 401 PRERMNMEEVAAQLLSFRNKLVK 423
P R+ V +L+S R + K
Sbjct: 981 PMNRLATSIVVKELISIRERFFK 1003
|
|
| TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 637 (229.3 bits), Expect = 2.1e-94, Sum P(2) = 2.1e-94
Identities = 133/263 (50%), Positives = 170/263 (64%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNR-EAL----KNLNLLQR 233
IRHRNLVK++T+CAS+DFQGN+ AL+YEFM NGSL++WLHP E + + L LL+R
Sbjct: 753 IRHRNLVKLLTACASIDFQGNEFRALIYEFMPNGSLDKWLHPEEVEEIHRPSRTLTLLER 812
Query: 234 LSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATN-NFF 292
L+IA+DVAS LDYLH +C PI HCDLKPSN+LLD +LTAHV DFGLA+ L + +FF
Sbjct: 813 LNIAIDVASVLDYLHVHCHEPIAHCDLKPSNILLDDDLTAHVSDFGLARLLLKFDQESFF 872
Query: 293 N------------FQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHN 340
N + EYGMG + S GDVYSFG+L+LE FTGKRPTNE+F GN TL++
Sbjct: 873 NQLSSAGVRGTIGYAAPEYGMGGQPSIHGDVYSFGVLVLEMFTGKRPTNELFGGNFTLNS 932
Query: 341 FVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSEL 400
+ K ALPER+ +I D +L H F V ECL +L +G+ C E
Sbjct: 933 YTKAALPERVLDIADKSIL-------------HSGLRVGFPVLECLKGILDVGLRCCEES 979
Query: 401 PRERMNMEEVAAQLLSFRNKLVK 423
P R+ E A +L+S R + K
Sbjct: 980 PLNRLATSEAAKELISIRERFFK 1002
|
|
| TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 615 (221.5 bits), Expect = 1.1e-91, Sum P(2) = 1.1e-91
Identities = 130/262 (49%), Positives = 165/262 (62%)
Query: 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPN-----REALKNLNLLQRL 234
RHRNLVK++T+CAS DFQGN+ AL+YE++ NGS++ WLHP R + L LL+RL
Sbjct: 756 RHRNLVKLLTACASTDFQGNEFRALIYEYLPNGSVDMWLHPEEVEEIRRPPRTLTLLERL 815
Query: 235 SIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNF 294
+I +DVAS LDYLH +C PI HCDLKPSNVLL+ +LTAHV DFGLA+ L + F
Sbjct: 816 NIVIDVASVLDYLHVHCHEPIAHCDLKPSNVLLEDDLTAHVSDFGLARLLLKFDKESFLN 875
Query: 295 QIA-------------EYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNF 341
Q++ EYGMG + S GDVYSFG+LLLE FTGKRPT+E+F GNLTLH++
Sbjct: 876 QLSSAGVRGTIGYAAPEYGMGGQPSIHGDVYSFGVLLLEMFTGKRPTDELFGGNLTLHSY 935
Query: 342 VKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELP 401
K ALPE++ EI D +L H F ECL VL +G+ C E P
Sbjct: 936 TKLALPEKVFEIADKAIL-------------HIGLRVGFRTAECLTLVLEVGLRCCEEYP 982
Query: 402 RERMNMEEVAAQLLSFRNKLVK 423
R+ EVA +L+S R + K
Sbjct: 983 TNRLATSEVAKELISIRERFFK 1004
|
|
| TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 598 (215.6 bits), Expect = 4.1e-91, Sum P(2) = 4.1e-91
Identities = 133/265 (50%), Positives = 168/265 (63%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNR-EALKN----LNLLQR 233
IRHRNLVK++T C+S DF+GND ALVYEFM NG+L+ WLHP+ E N L L R
Sbjct: 771 IRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHPDEIEETGNPSRTLGLFAR 830
Query: 234 LSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFN 293
L+IA+DVASAL YLH YC PI HCD+KPSN+LLD +LTAHV DFGLA+ L + + F+
Sbjct: 831 LNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLLKFDRDTFH 890
Query: 294 FQIA-------------EYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHN 340
Q + EYGMG S GDVYSFGI+LLE FTGKRPTN++F LTLH+
Sbjct: 891 IQFSSAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGIVLLEIFTGKRPTNKLFVDGLTLHS 950
Query: 341 FVKEALPERLA-EIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSE 399
F K AL +R A +I D ET A+ Q F++ ECL V +GV+CS E
Sbjct: 951 FTKSALQKRQALDITD----------ETILRGAYAQH---FNMVECLTLVFRVGVSCSEE 997
Query: 400 LPRERMNMEEVAAQLLSFRNKLVKN 424
P R++M E ++L+S R ++
Sbjct: 998 SPVNRISMAEAISKLVSIRESFFRD 1022
|
|
| UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 541 (195.5 bits), Expect = 6.2e-81, Sum P(2) = 6.2e-81
Identities = 119/278 (42%), Positives = 174/278 (62%)
Query: 159 PSSLSSLRGIENLDLSRNNFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWL 218
P +L S + RN +RHRNLVKI+T C+S+D +GND +A+VY+FM NGSLE+W+
Sbjct: 743 PKALKSFTA--ECEALRN--MRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWI 798
Query: 219 HP--NREA-LKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHV 275
HP N +A ++LNL +R++I +DVA ALDYLH + P+VHCD+K SNVLLD ++ AHV
Sbjct: 799 HPETNDQADQRHLNLHRRVTILLDVACALDYLHRHGPEPVVHCDIKSSNVLLDSDMVAHV 858
Query: 276 GDFGLAKFLPEATN---------NFFN---FQIAEYGMGSEVSTSGDVYSFGILLLETFT 323
GDFGLA+ L + T+ F + EYG+G ST GD+YS+GIL+LE T
Sbjct: 859 GDFGLARILVDGTSLIQQSTSSMGFIGTIGYAAPEYGVGLIASTHGDIYSYGILVLEIVT 918
Query: 324 GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVK 383
GKRPT+ F +L L +V+ L R+ ++VD L+++ E S N+ + +
Sbjct: 919 GKRPTDSTFRPDLGLRQYVELGLHGRVTDVVDTKLILDSENWLNSTNNSPCR-----RIT 973
Query: 384 ECLVSVLGIGVTCSSELPRERMNMEEVAAQLLSFRNKL 421
EC+V +L +G++CS ELP R ++ +L + + L
Sbjct: 974 ECIVWLLRLGLSCSQELPSSRTPTGDIIDELNAIKQNL 1011
|
|
| TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 469 (170.2 bits), Expect = 6.3e-74, Sum P(2) = 6.3e-74
Identities = 99/186 (53%), Positives = 128/186 (68%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLH-PNREAL----KNLNLLQR 233
IRHRNLVK+IT C+S+D +GND ALVYEFM GSL+ WL + E + ++L ++
Sbjct: 764 IRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRSLTPAEK 823
Query: 234 LSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATN-NFF 292
L+IA+DVASAL+YLH +C P+ HCD+KPSN+LLD +LTAHV DFGLA+ L + +F
Sbjct: 824 LNIAIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRESFL 883
Query: 293 N-FQIA-----------EYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHN 340
N F A EYGMG + S GDVYSFGILLLE F+GK+PT+E F G+ LH+
Sbjct: 884 NQFSSAGVRGTIGYAAPEYGMGGQPSIQGDVYSFGILLLEMFSGKKPTDESFAGDYNLHS 943
Query: 341 FVKEAL 346
+ K L
Sbjct: 944 YTKSIL 949
|
|
| TAIR|locus:2169975 HSL2 "HAESA-like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 333 (122.3 bits), Expect = 1.4e-56, Sum P(2) = 1.4e-56
Identities = 96/262 (36%), Positives = 130/262 (49%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNRE--ALKNLNLLQRLSI 236
+RH N+VK++ C G + LVYEFM NGSL + LH +E A+ L+ R SI
Sbjct: 740 VRHGNIVKLLMCC-----NGEEFRFLVYEFMENGSLGDVLHSEKEHRAVSPLDWTTRFSI 794
Query: 237 AVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNN------ 290
AV A L YLHH PIVH D+K +N+LLD E+ V DFGLAK L N+
Sbjct: 795 AVGAAQGLSYLHHDSVPPIVHRDVKSNNILLDHEMKPRVADFGLAKPLKREDNDGVSDVS 854
Query: 291 ------FFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKE 344
+ + EYG S+V+ DVYSFG++LLE TGKRP + F N + F E
Sbjct: 855 MSCVAGSYGYIAPEYGYTSKVNEKSDVYSFGVVLLELITGKRPNDSSFGENKDIVKFAME 914
Query: 345 AL---PERLAEIVDPVLLVER--EEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSE 399
A P AE D + + + SK K + +E + VL + + C+S
Sbjct: 915 AALCYPSPSAE--DGAMNQDSLGNYRDLSKLVDPKMKLSTREYEE-IEKVLDVALLCTSS 971
Query: 400 LPRERMNMEEVAAQLLSFRNKL 421
P R M +V +LL + L
Sbjct: 972 FPINRPTMRKVV-ELLKEKKSL 992
|
|
| TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 338 (124.0 bits), Expect = 1.4e-56, Sum P(2) = 1.4e-56
Identities = 82/197 (41%), Positives = 112/197 (56%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREAL-KNLNLLQ---RL 234
IRHR+LVK++ C+S + L+YE+M NGS+ +WLH ++ L K LL RL
Sbjct: 1003 IRHRHLVKLMGYCSS---KSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARL 1059
Query: 235 SIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA--TNNFF 292
IAV +A ++YLHH C PIVH D+K SNVLLD + AH+GDFGLAK L E TN
Sbjct: 1060 RIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDS 1119
Query: 293 NFQIA--------EYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVK- 343
N A EY + + DVYS GI+L+E TGK PT+ +F + + +V+
Sbjct: 1120 NTWFACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMDMVRWVET 1179
Query: 344 --EALPERLAEIVDPVL 358
E +++DP L
Sbjct: 1180 HLEVAGSARDKLIDPKL 1196
|
|
| TAIR|locus:2175703 AT5G39390 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 523 (189.2 bits), Expect = 4.8e-56, Sum P(2) = 4.8e-56
Identities = 123/260 (47%), Positives = 154/260 (59%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHP-NREALKN----LNLLQR 233
IRHRNL K+IT C+S+D QGND ALVYEFM GSL+ WL P + E+ N L ++
Sbjct: 261 IRHRNLAKLITVCSSLDSQGNDFRALVYEFMPKGSLDMWLQPEDLESANNHSRSLTFAEK 320
Query: 234 LSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL---PEAT-- 288
++IA+DVASAL+YLH YC P+ HCD+KPSNVLLD +LTAHV DFGLA+ L E T
Sbjct: 321 VNIAIDVASALEYLHVYCHDPVAHCDIKPSNVLLDDDLTAHVSDFGLARLLYNFDEKTFL 380
Query: 289 NNF--------FNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHN 340
N F + EYGMGS+ S GDVYSFG+LLLE FTGK+PT+ F G LH
Sbjct: 381 NQFSSAGVRGTIGYAAPEYGMGSKPSIQGDVYSFGVLLLEMFTGKKPTDNSFGGGYNLHG 440
Query: 341 FVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSEL 400
+ K L TS+ R+ V E L VL +G+ CS E
Sbjct: 441 YTKSVL-----------------SCSTSRGG------RTM-VDEWLRLVLEVGIKCSEEY 476
Query: 401 PRERMNMEEVAAQLLSFRNK 420
PR+RM M E +L+S ++K
Sbjct: 477 PRDRMGMAEAVRELVSIKSK 496
|
|
| TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 332 (121.9 bits), Expect = 5.0e-55, Sum P(2) = 5.0e-55
Identities = 72/174 (41%), Positives = 99/174 (56%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS 63
L N TG IP +GD+ +L L + N G IP S GNL+ L L N L G++P
Sbjct: 352 LSNNHLTGEIPMELGDIPRLGLLDVSRNNLSGSIPDSFGNLSQLRRLLLYGNHLSGTVPQ 411
Query: 64 SLGKCQXXXXXXXXXXXXTGTTPTEVIG-LSSLSIYLDLSQNQLNGPLPSNFGILKNLGA 122
SLGKC TGT P EV+ L +L +YL+LS N L+GP+P + + +
Sbjct: 412 SLGKCINLEILDLSHNNLTGTIPVEVVSNLRNLKLYLNLSSNHLSGPIPLELSKMDMVLS 471
Query: 123 IDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRN 176
+D+S N+LSG+IP +GSCI LE L ++ N F +PSSL L ++ LD+S N
Sbjct: 472 VDLSSNELSGKIPPQLGSCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFN 525
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | eugene3.01420001 | hypothetical protein (774 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 427 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-33 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-33 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-29 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-28 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-26 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-26 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-25 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 9e-24 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-23 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-23 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-22 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-21 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 6e-21 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-19 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-19 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-18 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-17 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-17 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 6e-16 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 8e-16 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-16 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-15 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-15 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-14 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-14 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-14 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-14 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-14 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-13 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-13 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-12 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-12 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-12 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-12 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-12 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-12 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-12 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-12 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 9e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-11 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-11 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-11 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-11 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-11 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 9e-11 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-10 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-10 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-10 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-10 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-10 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-10 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-10 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-10 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-10 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-10 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-10 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 8e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-09 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-09 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-09 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-09 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-09 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 6e-09 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-09 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-09 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 7e-09 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 7e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-08 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-08 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-08 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-08 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-08 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-08 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-08 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-08 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-08 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-08 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-08 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-08 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-08 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-08 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-08 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-08 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 7e-08 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 8e-08 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-07 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-07 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-07 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-07 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-07 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-07 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-07 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-07 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-07 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-07 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-07 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-07 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-07 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-07 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-07 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-07 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-07 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-07 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-07 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-07 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-07 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-07 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-07 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-07 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 7e-07 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 7e-07 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 8e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-06 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-06 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-06 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-06 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-06 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-06 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-06 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-06 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-06 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-06 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-06 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 5e-06 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-06 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-06 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-06 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-06 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 7e-06 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 7e-06 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 7e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 8e-06 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 8e-06 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-06 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 9e-06 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 9e-06 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-05 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-05 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-05 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-05 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-05 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-05 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-05 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-05 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-05 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-05 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-05 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-05 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-05 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-05 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-05 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-05 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-05 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-05 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-05 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-05 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-05 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-05 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-05 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-05 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-05 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-05 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-05 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-05 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-05 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-05 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-05 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-05 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 7e-05 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 8e-05 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 8e-05 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-05 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 8e-05 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 9e-05 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 1e-04 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-04 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-04 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-04 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-04 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-04 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-04 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-04 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-04 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-04 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-04 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-04 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-04 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-04 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 2e-04 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-04 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-04 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-04 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-04 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-04 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-04 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-04 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-04 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-04 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-04 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-04 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-04 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-04 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-04 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 5e-04 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-04 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 7e-04 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 7e-04 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 7e-04 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 7e-04 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-04 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 8e-04 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 9e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.001 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 0.001 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 0.001 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 0.001 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 0.001 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 0.001 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 0.001 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 0.001 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 0.001 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 0.001 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 0.002 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.002 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 0.002 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 0.002 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 0.002 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 0.002 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 0.002 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 0.002 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 0.002 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 0.002 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 0.003 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 0.003 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 0.003 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 0.003 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 0.003 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 0.003 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 0.003 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 0.003 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 0.004 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 0.004 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 0.004 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 1e-33
Identities = 71/175 (40%), Positives = 99/175 (56%), Gaps = 1/175 (0%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS 63
LV N TG IP S+G+L LQ L L NK G IP SI +L LI+L+ ++N L G IP
Sbjct: 243 LVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPE 302
Query: 64 SLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAI 123
+ + QNL +L L +NN TG P + L L + L L N+ +G +P N G NL +
Sbjct: 303 LVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQV-LQLWSNKFSGEIPKNLGKHNNLTVL 361
Query: 124 DISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178
D+S N L+G+IP + S L +L++ N G IP SL + R + + L N+F
Sbjct: 362 DLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSF 416
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 5e-33
Identities = 77/175 (44%), Positives = 102/175 (58%), Gaps = 1/175 (0%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS 63
L N +G IP IG L+ L L N G+IP+S+ NLT L L A N L G IP
Sbjct: 147 LSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPR 206
Query: 64 SLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAI 123
LG+ ++L + L NNL+G P E+ GL+SL+ +LDL N L GP+PS+ G LKNL +
Sbjct: 207 ELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLN-HLDLVYNNLTGPIPSSLGNLKNLQYL 265
Query: 124 DISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178
+ +NKLSG IP SI S +L L ++ N G IP + L+ +E L L NNF
Sbjct: 266 FLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNF 320
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 8e-29
Identities = 72/176 (40%), Positives = 94/176 (53%), Gaps = 1/176 (0%)
Query: 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSI 61
TL NQ G+IP +G + L+ + L N GEIP IG LT L L+ N L G I
Sbjct: 193 LTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPI 252
Query: 62 PSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLG 121
PSSLG +NL L L N L+G P + L L I LDLS N L+G +P L+NL
Sbjct: 253 PSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKL-ISLDLSDNSLSGEIPELVIQLQNLE 311
Query: 122 AIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNN 177
+ + N +G+IP ++ S RL+ L + N F G IP +L + LDLS NN
Sbjct: 312 ILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNN 367
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 7e-28
Identities = 79/223 (35%), Positives = 106/223 (47%), Gaps = 50/223 (22%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIG---NLTLL------------- 47
L N FTG+IP ++ L +LQ L L NKF GEIP ++G NLT+L
Sbjct: 315 LFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPE 374
Query: 48 --------ITLNFAENMLEGSIPSSLGKCQNL------------------------ILLD 75
L N LEG IP SLG C++L LD
Sbjct: 375 GLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLD 434
Query: 76 LSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIP 135
+SNNNL G + + SL + L L++N+ G LP +FG K L +D+S N+ SG +P
Sbjct: 435 ISNNNLQGRINSRKWDMPSLQM-LSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVP 492
Query: 136 SSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178
+GS L QL ++ N G IP LSS + + +LDLS N
Sbjct: 493 RKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQL 535
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 4e-26
Identities = 43/150 (28%), Positives = 65/150 (43%), Gaps = 19/150 (12%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+ H N+VK+ F+ + LV E+ GSL++ L N L+ + L I +
Sbjct: 48 LNHPNIVKLYGV-----FEDENHLYLVMEYCEGGSLKDLLKENE---GKLSEDEILRILL 99
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLD-GELTAHVGDFGLAKFLPEATNNFFNFQIA 297
+ L+YLH I+H DLKP N+LLD + DFGL+K L +
Sbjct: 100 QILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGT 156
Query: 298 EYGM-------GSEVSTSGDVYSFGILLLE 320
M S D++S G++L E
Sbjct: 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 6e-26
Identities = 67/173 (38%), Positives = 94/173 (54%), Gaps = 2/173 (1%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS 63
L N G IP S+G L+R+ L+ N F GE+PS L L+ L+ + N L+G I S
Sbjct: 387 LFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINS 446
Query: 64 SLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAI 123
+L +L L+ N G P + G L LDLS+NQ +G +P G L L +
Sbjct: 447 RKWDMPSLQMLSLARNKFFGGLP-DSFGSKRLE-NLDLSRNQFSGAVPRKLGSLSELMQL 504
Query: 124 DISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRN 176
+SENKLSG+IP + SC +L L ++ N G IP+S S + + LDLS+N
Sbjct: 505 KLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQN 557
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-25
Identities = 59/155 (38%), Positives = 91/155 (58%), Gaps = 2/155 (1%)
Query: 7 NQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLG 66
N GRI D+ LQ L+L NKF+G +P S G+ L L+ + N G++P LG
Sbjct: 438 NNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLG 496
Query: 67 KCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDIS 126
L+ L LS N L+G P E+ L + LDLS NQL+G +P++F + L +D+S
Sbjct: 497 SLSELMQLKLSENKLSGEIPDELSSCKKL-VSLDLSHNQLSGQIPASFSEMPVLSQLDLS 555
Query: 127 ENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSS 161
+N+LSG+IP ++G+ L Q+ ++ N G++PS+
Sbjct: 556 QNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPST 590
|
Length = 968 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 99.1 bits (248), Expect = 9e-24
Identities = 49/186 (26%), Positives = 80/186 (43%), Gaps = 45/186 (24%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+ H N+VK++ C + +V E+M G L +L NR L+L LS A+
Sbjct: 58 LDHPNVVKLLGVCTE-----EEPLYIVMEYMEGGDLLSYLRKNRP---KLSLSDLLSFAL 109
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL-------------- 284
+A ++YL +H DL N L+ L + DFGL++ L
Sbjct: 110 QIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLP 166
Query: 285 -----PEATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNEMFTGNLTL 338
PE+ + ++ ++ DV+SFG+LL E FT G++P M N +
Sbjct: 167 IRWMAPES------LKEGKF------TSKSDVWSFGVLLWEIFTLGEQPYPGM--SNEEV 212
Query: 339 HNFVKE 344
++K
Sbjct: 213 LEYLKN 218
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 98.4 bits (246), Expect = 2e-23
Identities = 50/186 (26%), Positives = 82/186 (44%), Gaps = 44/186 (23%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+ H N+VK++ C + +V E+M G L ++L NR K L+L LS A+
Sbjct: 58 LDHPNIVKLLGVCTE-----EEPLMIVMEYMPGGDLLDYLRKNRP--KELSLSDLLSFAL 110
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL-------------- 284
+A ++YL +H DL N L+ L + DFGL++ L
Sbjct: 111 QIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLP 167
Query: 285 -----PEATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNEMFTGNLTL 338
PE+ + ++ ++ DV+SFG+LL E FT G+ P M N +
Sbjct: 168 IRWMAPES------LKEGKF------TSKSDVWSFGVLLWEIFTLGEEPYPGM--SNAEV 213
Query: 339 HNFVKE 344
++K+
Sbjct: 214 LEYLKK 219
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 2e-23
Identities = 48/157 (30%), Positives = 70/157 (44%), Gaps = 23/157 (14%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
++H N+V++ F+ D LV E+ G L + L L+ +
Sbjct: 54 LKHPNIVRLYDV-----FEDEDKLYLVMEYCEGGDLFDLLKKR----GRLSEDEARFYLR 104
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQI-- 296
+ SAL+YLH IVH DLKP N+LLD + + DFGLA+ L +
Sbjct: 105 QILSALEYLHSKG---IVHRDLKPENILLDEDGHVKLADFGLARQLDP--GEKLTTFVGT 159
Query: 297 AEYGM------GSEVSTSGDVYSFGILLLETFTGKRP 327
EY M G + D++S G++L E TGK P
Sbjct: 160 PEY-MAPEVLLGKGYGKAVDIWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 4e-22
Identities = 50/156 (32%), Positives = 76/156 (48%), Gaps = 19/156 (12%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+ H N+V++I + F+ D LV E+ G L ++L L+ + IA+
Sbjct: 55 LSHPNIVRLIDA-----FEDKDHLYLVMEYCEGGDLFDYLSRG----GPLSEDEAKKIAL 105
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIAE 298
+ L+YLH I+H DLKP N+LLD + DFGLAK L +++++ F
Sbjct: 106 QILRGLEYLHSN---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTP 162
Query: 299 YGMGSEV-------STSGDVYSFGILLLETFTGKRP 327
+ M EV DV+S G++L E TGK P
Sbjct: 163 WYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (228), Expect = 5e-21
Identities = 47/192 (24%), Positives = 80/192 (41%), Gaps = 48/192 (25%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREAL-----KNLNLLQR 233
+ H N+V+++ C + LV E+M G L ++L +R L+L
Sbjct: 53 LGHPNVVRLLGVCTE-----EEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDL 107
Query: 234 LSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL--------- 284
LS A+ +A ++YL VH DL N L+ +L + DFGL++ +
Sbjct: 108 LSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK 164
Query: 285 -----------PEATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNEMF 332
PE+ I + ++ DV+SFG+LL E FT G P +
Sbjct: 165 TGGKLPIRWMAPES----LKDGI--F------TSKSDVWSFGVLLWEIFTLGATPYPGLS 212
Query: 333 TGNLTLHNFVKE 344
N + ++++
Sbjct: 213 --NEEVLEYLRK 222
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 91.0 bits (227), Expect = 6e-21
Identities = 43/170 (25%), Positives = 73/170 (42%), Gaps = 44/170 (25%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+ H N+V+++ C + +V E+M G L ++L + E L L L +A+
Sbjct: 58 LSHPNIVRLLGVCT-----QGEPLYIVTEYMPGGDLLDFLRKHGE---KLTLKDLLQMAL 109
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL-------------- 284
+A ++YL VH DL N L+ L + DFGL++ +
Sbjct: 110 QIAKGMEYLE---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKL 166
Query: 285 ------PEATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRP 327
PE+ + + ++ DV+SFG+LL E FT G++P
Sbjct: 167 PIKWMAPESLKD------------GKFTSKSDVWSFGVLLWEIFTLGEQP 204
|
Length = 258 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 3e-19
Identities = 58/165 (35%), Positives = 79/165 (47%), Gaps = 38/165 (23%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+RH NLV+++ V QGN +V E+M GSL ++L A+ + L Q+L A+
Sbjct: 57 LRHPNLVQLL----GVVLQGN-PLYIVTEYMAKGSLVDYLRSRGRAV--ITLAQQLGFAL 109
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAK---------------F 283
DV ++YL E VH DL NVL+ +L A V DFGLAK
Sbjct: 110 DVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT 166
Query: 284 LPEATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRP 327
PEA + ST DV+SFGILL E ++ G+ P
Sbjct: 167 APEALRE------------KKFSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 5e-19
Identities = 63/177 (35%), Positives = 90/177 (50%), Gaps = 4/177 (2%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTL-LITLNFAENMLEGSIP 62
L G +G+I +I L +Q + L N+ G IP I + L LN + N GSIP
Sbjct: 76 LSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIP 135
Query: 63 SSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGA 122
G NL LDLSNN L+G P ++ SSL + LDL N L G +P++ L +L
Sbjct: 136 R--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKV-LDLGGNVLVGKIPNSLTNLTSLEF 192
Query: 123 IDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNFI 179
+ ++ N+L GQIP +G L+ + + N G IP + L + +LDL NN
Sbjct: 193 LTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLT 249
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 4e-18
Identities = 48/137 (35%), Positives = 80/137 (58%), Gaps = 2/137 (1%)
Query: 43 NLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLS 102
N + +++++ + + G I S++ + + ++LSNN L+G P ++ SS YL+LS
Sbjct: 67 NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLS 126
Query: 103 QNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSL 162
N G +P G + NL +D+S N LSG+IP+ IGS L+ L + GN G IP+SL
Sbjct: 127 NNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSL 184
Query: 163 SSLRGIENLDLSRNNFI 179
++L +E L L+ N +
Sbjct: 185 TNLTSLEFLTLASNQLV 201
|
Length = 968 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 1e-17
Identities = 49/159 (30%), Positives = 75/159 (47%), Gaps = 18/159 (11%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+ H N+VK C G S L+ E++ +GSL ++L +R+ +NL + L +
Sbjct: 63 LDHENIVKYKGVCEK---PGGRSLRLIMEYLPSGSLRDYLQRHRD---QINLKRLLLFSS 116
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA-----TNNFFN 293
+ +DYL +H DL N+L++ E + DFGLAK LPE
Sbjct: 117 QICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGE 173
Query: 294 FQIAEYG----MGSEVSTSGDVYSFGILLLETFTGKRPT 328
I Y S+ S++ DV+SFG+ L E FT P+
Sbjct: 174 SPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPS 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 4e-17
Identities = 45/191 (23%), Positives = 79/191 (41%), Gaps = 32/191 (16%)
Query: 154 FRGNIPSSLSSLRGIENLDLSRNNFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGS 213
G+ L +L + LS ++H N+V+ S + ++ + E++ GS
Sbjct: 35 LSGDSEEELEALEREIRI-LSS---LQHPNIVRYYGSERDEE---KNTLNIFLEYVSGGS 87
Query: 214 LEEWLHPNREALKNL-----NLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLD 268
L LK ++++ + + L YLH IVH D+K +N+L+D
Sbjct: 88 L-------SSLLKKFGKLPEPVIRKYTR--QILEGLAYLH---SNGIVHRDIKGANILVD 135
Query: 269 GELTAHVGDFGLAKFLPEATNNFFNFQIA--------EYGMGSEVSTSGDVYSFGILLLE 320
+ + DFG AK L + + E G E + D++S G ++E
Sbjct: 136 SDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIE 195
Query: 321 TFTGKRPTNEM 331
TGK P +E+
Sbjct: 196 MATGKPPWSEL 206
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 78.6 bits (192), Expect = 6e-16
Identities = 52/167 (31%), Positives = 75/167 (44%), Gaps = 25/167 (14%)
Query: 177 NFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSI 236
+ N+VK+ FQ S LV E++ GSLE+ L L+ + L I
Sbjct: 53 SLNHPPNIVKLYDF-----FQDEGSLYLVMEYVDGGSLEDLLK-KIGRKGPLSESEALFI 106
Query: 237 AVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELT-AHVGDFGLAKFLPEATNNFFNFQ 295
+ SAL+YLH I+H D+KP N+LLD + + DFGLAK LP+ +
Sbjct: 107 LAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPA 163
Query: 296 IAEYGMGSE---------------VSTSGDVYSFGILLLETFTGKRP 327
+ +G+ S+S D++S GI L E TG P
Sbjct: 164 LPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPP 210
|
Length = 384 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 8e-16
Identities = 51/178 (28%), Positives = 84/178 (47%), Gaps = 28/178 (15%)
Query: 159 PSSLSSLRGIENLDLSRNNFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWL 218
+L S+ + +DL +N ++H N+VK I S + +DS ++ E+ NGSL
Sbjct: 40 EEALKSIM--QEIDLLKN--LKHPNIVKYIGS-----IETSDSLYIILEYAENGSL---- 86
Query: 219 HPNREALKNLNLLQRLSIAVDVA---SALDYLHHYCETPIVHCDLKPSNVLLDGELTAHV 275
R+ +K +AV V L YLH E ++H D+K +N+L + +
Sbjct: 87 ---RQIIKKFGPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKL 140
Query: 276 GDFGLAKFLPEATNNFFNFQIAEYGMGSEV------STSGDVYSFGILLLETFTGKRP 327
DFG+A L + + + + Y M EV ST+ D++S G ++E TG P
Sbjct: 141 ADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 9e-16
Identities = 49/141 (34%), Positives = 76/141 (53%), Gaps = 2/141 (1%)
Query: 7 NQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLG 66
NQF+G +P +G L +L +L L NK GEIP + + L++L+ + N L G IP+S
Sbjct: 485 NQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFS 544
Query: 67 KCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILK-NLGAIDI 125
+ L LDLS N L+G P + + SL + +++S N L+G LPS L N A+
Sbjct: 545 EMPVLSQLDLSQNQLSGEIPKNLGNVESL-VQVNISHNHLHGSLPSTGAFLAINASAVAG 603
Query: 126 SENKLSGQIPSSIGSCIRLEQ 146
+ + G S + C R+ +
Sbjct: 604 NIDLCGGDTTSGLPPCKRVRK 624
|
Length = 968 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 1e-15
Identities = 53/166 (31%), Positives = 75/166 (45%), Gaps = 28/166 (16%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+RH L+++ C + +V E M GSL E+L A + L L Q + +A
Sbjct: 58 LRHPKLIQLYAVCTL-----EEPIYIVTELMKYGSLLEYLQ--GGAGRALKLPQLIDMAA 110
Query: 239 DVASALDYL--HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFN--- 293
VAS + YL +Y +H DL NVL+ V DFGLA+ + E + +
Sbjct: 111 QVASGMAYLEAQNY-----IHRDLAARNVLVGENNICKVADFGLARVIKE---DIYEARE 162
Query: 294 ---FQIA----EYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNEM 331
F I E + + S DV+SFGILL E T G+ P M
Sbjct: 163 GAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGM 208
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 3e-15
Identities = 46/156 (29%), Positives = 71/156 (45%), Gaps = 17/156 (10%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+RH++L+ + C+ + ++ E M GSL +L + L + + +A
Sbjct: 59 LRHKHLISLFAVCS-----VGEPVYIITELMEKGSLLAFLRSPEG--QVLPVASLIDMAC 111
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAK------FLPEATNNFF 292
VA + YL E +H DL N+L+ +L V DFGLA+ +L +
Sbjct: 112 QVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPY 168
Query: 293 NFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRP 327
+ E ST DV+SFGILL E FT G+ P
Sbjct: 169 KWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVP 204
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 3e-14
Identities = 52/157 (33%), Positives = 74/157 (47%), Gaps = 30/157 (19%)
Query: 181 HRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDV 240
H N+VK C+ QG L+ E++ GSL ++L + LNL Q L A +
Sbjct: 65 HENIVKYKGCCSE---QGGKGLQLIMEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQI 116
Query: 241 ASALDYLH--HYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIAE 298
+ YLH HY +H DL NVLLD + +GDFGLAK +PE +++ E
Sbjct: 117 CEGMAYLHSQHY-----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE---YYRVRE 168
Query: 299 YGMG------------SEVSTSGDVYSFGILLLETFT 323
G ++ S + DV+SFG+ L E T
Sbjct: 169 DGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 4e-14
Identities = 50/162 (30%), Positives = 70/162 (43%), Gaps = 30/162 (18%)
Query: 178 FIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNL-LQRLSI 236
+H N+VK S + D +V EF GSL ++ LK+ N L I
Sbjct: 53 KCKHPNIVKYYGS-----YLKKDELWIVMEFCSGGSL-------KDLLKSTNQTLTESQI 100
Query: 237 AV---DVASALDYLHHYCETPIVHCDLKPSNVLL--DGELTAHVGDFGLAKFLPEATNNF 291
A ++ L+YLH I+H D+K +N+LL DGE+ + DFGL+ L T
Sbjct: 101 AYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEV--KLIDFGLSAQL-SDTKAR 154
Query: 292 FNFQIAEYGMGSEV------STSGDVYSFGILLLETFTGKRP 327
Y M EV D++S GI +E GK P
Sbjct: 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 5e-14
Identities = 47/157 (29%), Positives = 79/157 (50%), Gaps = 15/157 (9%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+ H+NLV+++ + G +V E M G+L +L AL ++++Q L ++
Sbjct: 56 LHHKNLVRLL---GVILHNG---LYIVMELMSKGNLVNFLRTRGRAL--VSVIQLLQFSL 107
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNF---FNFQ 295
DVA ++YL +VH DL N+L+ + A V DFGLA+ +N +
Sbjct: 108 DVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT 164
Query: 296 IAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNEM 331
E + S+ DV+S+G+LL E F+ G+ P +M
Sbjct: 165 APEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM 201
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (175), Expect = 5e-14
Identities = 53/177 (29%), Positives = 72/177 (40%), Gaps = 47/177 (26%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLS--- 235
I H +VK A FQ + LV E+ G L + H ++E R S
Sbjct: 50 INHPFIVK--LHYA---FQTEEKLYLVLEYAPGGEL--FSHLSKEG--------RFSEER 94
Query: 236 ---IAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGE----LTAHVGDFGLAKFLPEAT 288
A ++ AL+YLH I++ DLKP N+LLD + LT DFGLAK L
Sbjct: 95 ARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLT----DFGLAKELSS-- 145
Query: 289 NNFFNFQIA--------EYGMGSEVSTSGDVYSFGILLLETFTGKRP-----TNEMF 332
E +G + D +S G+LL E TGK P E++
Sbjct: 146 EGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIY 202
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 5e-14
Identities = 49/169 (28%), Positives = 71/169 (42%), Gaps = 42/169 (24%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+RH LV++ C+ + +V E+M GSL ++L K L L Q + +A
Sbjct: 58 LRHDKLVQLYAVCS-----EEEPIYIVTEYMSKGSLLDFLK--SGEGKKLRLPQLVDMAA 110
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL-------------- 284
+A + YL +H DL N+L+ L + DFGLA+ +
Sbjct: 111 QIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFP 167
Query: 285 -----PEATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRP 327
PEA N+ F I DV+SFGILL E T G+ P
Sbjct: 168 IKWTAPEAA-NYGRFTI-----------KSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 1e-13
Identities = 49/159 (30%), Positives = 72/159 (45%), Gaps = 25/159 (15%)
Query: 185 VKIITSCAS---VDFQG----NDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIA 237
+K + SC S V G ++V E+M GSL + L + + + IA
Sbjct: 50 LKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLL----KKVGKIPEPVLAYIA 105
Query: 238 VDVASALDYLHHYCETPIVHCDLKPSNVLL--DGELTAHVGDFGLAKFLPEATNNFFNFQ 295
+ LDYLH + I+H D+KPSN+L+ GE + DFG++K L + F
Sbjct: 106 RQILKGLDYLHT--KRHIIHRDIKPSNLLINSKGE--VKIADFGISKVLENTLDQCNTFV 161
Query: 296 -IAEYGM------GSEVSTSGDVYSFGILLLETFTGKRP 327
Y M G S + D++S G+ LLE GK P
Sbjct: 162 GTVTY-MSPERIQGESYSYAADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 33/82 (40%), Positives = 47/82 (57%)
Query: 11 GRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQN 70
G IP I L LQ + L N G IP S+G++T L L+ + N GSIP SLG+ +
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 71 LILLDLSNNNLTGTTPTEVIGL 92
L +L+L+ N+L+G P + G
Sbjct: 492 LRILNLNGNSLSGRVPAALGGR 513
|
Length = 623 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 3e-13
Identities = 47/155 (30%), Positives = 71/155 (45%), Gaps = 19/155 (12%)
Query: 181 HRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDV 240
H NLV++ C +V E+M NG L +L + L LL + DV
Sbjct: 58 HPNLVQLYGVCTK-----QRPIFIVTEYMANGCLLNYLRERKGKLGTEWLL---DMCSDV 109
Query: 241 ASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL--PEATNNF-FNFQI- 296
A++YL +H DL N L+ + V DFGLA+++ + T++ F +
Sbjct: 110 CEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVK 166
Query: 297 ---AEYGMGSEVSTSGDVYSFGILLLETFT-GKRP 327
E S S+ DV+SFG+L+ E F+ GK P
Sbjct: 167 WAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 58/223 (26%), Positives = 98/223 (43%), Gaps = 45/223 (20%)
Query: 140 SCIRLEQLVMNGNF---FRG--NIPSSLSSLRGIENL-----DLSRNNFIR--------- 180
S + +E+++ G F RG +P I+ L D R +F+
Sbjct: 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFD 63
Query: 181 HRNLVK---IITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIA 237
H N+++ ++T V ++ E+M NGSL+++L N + Q + +
Sbjct: 64 HPNIIRLEGVVTKSRPV--------MIITEYMENGSLDKFLRENDGKFT---VGQLVGML 112
Query: 238 VDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL--PEATNNFFNFQ 295
+AS + YL VH DL N+L++ L V DFGL++ L EAT +
Sbjct: 113 RGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGK 169
Query: 296 IAEYGMGSEV------STSGDVYSFGILLLETFT-GKRPTNEM 331
I E +++ DV+SFGI++ E + G+RP +M
Sbjct: 170 IPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDM 212
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 2e-12
Identities = 52/172 (30%), Positives = 83/172 (48%), Gaps = 35/172 (20%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPN----------REALKNL 228
+H N+VK C +G D +V+E+M +G L ++L + + L
Sbjct: 65 FQHENIVKFYGVCT----EG-DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGEL 119
Query: 229 NLLQRLSIAVDVASALDYL--HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPE 286
L Q L IAV +AS + YL H+ VH DL N L+ +L +GDFG+++ +
Sbjct: 120 TLSQLLQIAVQIASGMVYLASQHF-----VHRDLATRNCLVGYDLVVKIGDFGMSRDV-- 172
Query: 287 ATNNFFN----------FQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRP 327
T +++ + E M + +T DV+SFG++L E FT GK+P
Sbjct: 173 YTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 3e-12
Identities = 50/155 (32%), Positives = 74/155 (47%), Gaps = 24/155 (15%)
Query: 181 HRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDV 240
H N+VK C G + L+ EF+ +GSL+E+L N+ +NL Q+L AV +
Sbjct: 65 HENIVKYKGICTE---DGGNGIKLIMEFLPSGSLKEYLPRNK---NKINLKQQLKYAVQI 118
Query: 241 ASALDYL--HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQ--- 295
+DYL Y VH DL NVL++ E +GDFGL K + E ++ +
Sbjct: 119 CKGMDYLGSRQY-----VHRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEYYTVKDDL 172
Query: 296 -------IAEYGMGSEVSTSGDVYSFGILLLETFT 323
E + S+ + DV+SFG+ L E T
Sbjct: 173 DSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 3e-12
Identities = 45/171 (26%), Positives = 73/171 (42%), Gaps = 23/171 (13%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+ H LV++ C +V E+M NG L +L RE K Q L +
Sbjct: 56 LSHEKLVQLYGVCTK-----QRPIYIVTEYMSNGCLLNYL---REHGKRFQPSQLLEMCK 107
Query: 239 DVASALDYL--HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL--PEATNNF--- 291
DV + YL + +H DL N L+D + V DFGL++++ E T++
Sbjct: 108 DVCEGMAYLESKQF-----IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSK 162
Query: 292 --FNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNEMFTGNLTLH 339
+ E + S+ S+ DV++FG+L+ E ++ GK P
Sbjct: 163 FPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEK 213
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 3e-12
Identities = 50/157 (31%), Positives = 76/157 (48%), Gaps = 24/157 (15%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
++H N+VK C S G + LV E++ GSL ++L +RE L + LL S
Sbjct: 62 LQHDNIVKYKGVCYSA---GRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYAS--- 115
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIAE 298
+ ++YL VH DL N+L++ E +GDFGL K LP+ +++ E
Sbjct: 116 QICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKE---YYKVRE 169
Query: 299 YGMG------------SEVSTSGDVYSFGILLLETFT 323
G S+ S + DV+SFG++L E FT
Sbjct: 170 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 4e-12
Identities = 58/225 (25%), Positives = 102/225 (45%), Gaps = 48/225 (21%)
Query: 140 SCIRLEQLVMNGNF-----------FRGNIPSSLSSLRGIENLDLSRNNFIR-------- 180
SCI++E+++ G F + IP ++ +L+ + R +F+
Sbjct: 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKA-GYTEKQRRDFLSEASIMGQF 62
Query: 181 -HRNLVK---IITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSI 236
H N++ ++T V +V E+M NGSL+ +L R+ ++Q + +
Sbjct: 63 DHPNIIHLEGVVTKSKPV--------MIVTEYMENGSLDAFL---RKHDGQFTVIQLVGM 111
Query: 237 AVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL---PEATNNFFN 293
+AS + YL + VH DL N+L++ L V DFGL++ L PEA
Sbjct: 112 LRGIASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRG 168
Query: 294 FQIAEYGMGSEV------STSGDVYSFGILLLETFT-GKRPTNEM 331
+I E +++ DV+S+GI++ E + G+RP EM
Sbjct: 169 GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEM 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 4e-12
Identities = 32/98 (32%), Positives = 45/98 (45%), Gaps = 10/98 (10%)
Query: 236 IAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQ 295
++ AL+YLH I+H D+KP N+LLD + H+ DF +A + T
Sbjct: 105 WICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSG 161
Query: 296 IAEYGMGSEV------STSGDVYSFGILLLETFTGKRP 327
Y M EV S + D +S G+ E GKRP
Sbjct: 162 TPGY-MAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 4e-12
Identities = 41/160 (25%), Positives = 69/160 (43%), Gaps = 29/160 (18%)
Query: 181 HRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDV 240
H ++V+++ C S Q L+ + M G L +++ +++ + + LL + V +
Sbjct: 68 HPHVVRLLGICLSSQVQ------LITQLMPLGCLLDYVRNHKDNIGSQYLL---NWCVQI 118
Query: 241 ASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIAEYG 300
A + YL E +VH DL NVL+ + DFGLAK L + AE G
Sbjct: 119 AKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEY----HAEGG 171
Query: 301 M------------GSEVSTSGDVYSFGILLLETFT-GKRP 327
+ DV+S+G+ + E T G +P
Sbjct: 172 KVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 65.7 bits (161), Expect = 6e-12
Identities = 50/215 (23%), Positives = 87/215 (40%), Gaps = 47/215 (21%)
Query: 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVD 239
H ++K+ + FQ ++ V E+ NG L +++ +L+ A +
Sbjct: 60 GHPGIIKLYYT-----FQDEENLYFVLEYAPNGELLQYIRKY----GSLDEKCTRFYAAE 110
Query: 240 VASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPE----------ATN 289
+ AL+YLH I+H DLKP N+LLD ++ + DFG AK L ATN
Sbjct: 111 ILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATN 167
Query: 290 NFFNFQI-----------AEYGM------GSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332
+ AEY + S D+++ G ++ + TGK P
Sbjct: 168 IDSQIEKNRRRFASFVGTAEY-VSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGS- 225
Query: 333 TGNLTLHNFVKEAL------PERLAEIVDPVLLVE 361
LT +K P ++++ +L+++
Sbjct: 226 NEYLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLD 260
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (158), Expect = 9e-12
Identities = 44/164 (26%), Positives = 70/164 (42%), Gaps = 20/164 (12%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+ H N++K S F+ +V E+ G L + + ++ K Q L V
Sbjct: 56 LNHPNIIKYYES-----FEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFV 110
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIAE 298
+ AL YLH I+H D+KP N+ L +GDFG++K L +T + +
Sbjct: 111 QLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVL-SSTVDLAKTVVGT 166
Query: 299 -YGMGSEV------STSGDVYSFGILLLETFTGKRPTNEMFTGN 335
Y + E+ + D++S G +L E T K P F G
Sbjct: 167 PYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHP----FEGE 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 30/83 (36%), Positives = 54/83 (65%), Gaps = 1/83 (1%)
Query: 57 LEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGI 116
L G IP+ + K ++L ++LS N++ G P + ++SL + LDLS N NG +P + G
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEV-LDLSYNSFNGSIPESLGQ 488
Query: 117 LKNLGAIDISENKLSGQIPSSIG 139
L +L ++++ N LSG++P+++G
Sbjct: 489 LTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 31/89 (34%), Positives = 48/89 (53%), Gaps = 1/89 (1%)
Query: 74 LDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQ 133
L L N L G P ++ L L ++LS N + G +P + G + +L +D+S N +G
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQ-SINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 134 IPSSIGSCIRLEQLVMNGNFFRGNIPSSL 162
IP S+G L L +NGN G +P++L
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 45/159 (28%), Positives = 78/159 (49%), Gaps = 15/159 (9%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
++H N+VK+I C S L++E++ +L E L+NL+ +R IA+
Sbjct: 740 LQHPNIVKLIGLCRS-----EKGAYLIHEYIEGKNLSE-------VLRNLSWERRRKIAI 787
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFN--FQI 296
+A AL +LH C +V +L P +++DG+ H+ L L T F + +
Sbjct: 788 GIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL-RLSLPGLLCTDTKCFISSAYVA 846
Query: 297 AEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGN 335
E +++ D+Y FG++L+E TGK P + F +
Sbjct: 847 PETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVH 885
|
Length = 968 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 50/156 (32%), Positives = 76/156 (48%), Gaps = 19/156 (12%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+RH NLV+++ V + +V E+M GSL ++L ++ + L L ++
Sbjct: 56 LRHSNLVQLL----GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL--LKFSL 109
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIAE 298
DV A++YL VH DL NVL+ + A V DFGL K EA++ ++
Sbjct: 110 DVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPV 163
Query: 299 YGMGSEV------STSGDVYSFGILLLETFT-GKRP 327
E ST DV+SFGILL E ++ G+ P
Sbjct: 164 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 50/174 (28%), Positives = 82/174 (47%), Gaps = 37/174 (21%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPN------------REALK 226
++H ++VK C D +V+E+M +G L ++L + R+A
Sbjct: 64 LQHEHIVKFYGVCGD-----GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKG 118
Query: 227 NLNLLQRLSIAVDVASALDYL--HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL 284
L L Q L IA +AS + YL H+ VH DL N L+ L +GDFG+++ +
Sbjct: 119 ELGLSQMLHIASQIASGMVYLASQHF-----VHRDLATRNCLVGANLLVKIGDFGMSRDV 173
Query: 285 PEATNNFFN----------FQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRP 327
+ +++ + E M + +T DV+SFG++L E FT GK+P
Sbjct: 174 --YSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 5e-11
Identities = 46/156 (29%), Positives = 73/156 (46%), Gaps = 25/156 (16%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVY---EFMVNGSLEEWLHP-NREALKNLNLLQRL 234
I+H NLV+++ C E Y EFM G+L ++L NR+ + + LL
Sbjct: 59 IKHPNLVQLLGVCTR--------EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY-- 108
Query: 235 SIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFF-- 292
+A ++SA++YL + +H DL N L+ V DFGL++ + T
Sbjct: 109 -MATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 164
Query: 293 -NFQI---AEYGMG-SEVSTSGDVYSFGILLLETFT 323
F I A + ++ S DV++FG+LL E T
Sbjct: 165 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 6e-11
Identities = 53/169 (31%), Positives = 77/169 (45%), Gaps = 31/169 (18%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFM---VNGSLEEWLHPNREALKNLNLLQRLS 235
++H NLVK V+ VY FM G+LEE L R + + ++++ +
Sbjct: 56 LKHPNLVK----YYGVEVHREK----VYIFMEYCSGGTLEELLEHGR--ILDEHVIRVYT 105
Query: 236 IAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQ 295
+ + L YLH IVH D+KP+N+ LD +GDFG A L T
Sbjct: 106 L--QLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEV 160
Query: 296 IAEYG----MGSEVSTSG---------DVYSFGILLLETFTGKRPTNEM 331
+ G M EV T G D++S G ++LE TGKRP +E+
Sbjct: 161 QSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 7e-11
Identities = 47/165 (28%), Positives = 73/165 (44%), Gaps = 31/165 (18%)
Query: 181 HRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDV 240
H +V++I C + LV E G L ++L RE + +L + +A V
Sbjct: 55 HPCIVRLIGVCKG------EPLMLVMELAPLGPLLKYLKKRRE-IPVSDLKE---LAHQV 104
Query: 241 ASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIA--- 297
A + YL VH DL NVLL A + DFG+++ L A ++++ A
Sbjct: 105 AMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRAL-GAGSDYYRATTAGRW 160
Query: 298 ----------EYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNEM 331
YG + S+ DV+S+G+ L E F+ G +P EM
Sbjct: 161 PLKWYAPECINYG---KFSSKSDVWSYGVTLWEAFSYGAKPYGEM 202
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 9e-11
Identities = 33/81 (40%), Positives = 50/81 (61%), Gaps = 1/81 (1%)
Query: 35 GEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSS 94
G IP+ I L L ++N + N + G+IP SLG +L +LDLS N+ G+ P + L+S
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 95 LSIYLDLSQNQLNGPLPSNFG 115
L I L+L+ N L+G +P+ G
Sbjct: 492 LRI-LNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (151), Expect = 1e-10
Identities = 49/166 (29%), Positives = 70/166 (42%), Gaps = 43/166 (25%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSI-- 236
IRH LV + S FQ + + LV E++ G L L + R
Sbjct: 58 IRHPFLVNLYGS-----FQDDSNLYLVMEYVPGGELFSHLRKSG----------RFPEPV 102
Query: 237 ----AVDVASALDYLHHYCETPIVHCDLKPSNVLLD--GELTAHVGDFGLAKFLPEATNN 290
A V AL+YLH + IV+ DLKP N+LLD G + + DFG AK + T
Sbjct: 103 ARFYAAQVVLALEYLHS-LD--IVYRDLKPENLLLDSDGYIK--ITDFGFAKRVKGRT-- 155
Query: 291 FFNFQI---AEYGMGSEV------STSGDVYSFGILLLETFTGKRP 327
+ + EY + E+ + D ++ GIL+ E G P
Sbjct: 156 ---YTLCGTPEY-LAPEIILSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 52/181 (28%), Positives = 87/181 (48%), Gaps = 33/181 (18%)
Query: 174 SRNNFIRHRNLVKIITSCASVDFQGNDSE----ALVYEFMVNGSLEEWLH---PNRE--- 223
+R +F R L+ ++ V F G +E +V+E+M +G L +L P+ +
Sbjct: 50 ARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILA 109
Query: 224 -----ALKNLNLLQRLSIAVDVASALDYLH--HYCETPIVHCDLKPSNVLLDGELTAHVG 276
A L L Q L+IA +AS + YL H+ VH DL N L+ L +G
Sbjct: 110 GGEDVAPGQLTLGQMLAIASQIASGMVYLASLHF-----VHRDLATRNCLVGQGLVVKIG 164
Query: 277 DFGLAKFLPEATNNF---------FNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKR 326
DFG+++ + +T+ + + E + + +T D++SFG++L E FT GK+
Sbjct: 165 DFGMSRDI-YSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQ 223
Query: 327 P 327
P
Sbjct: 224 P 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 29/84 (34%), Positives = 51/84 (60%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS 63
L N+ +G IP + KL L L N+ G+IP+S + +L L+ ++N L G IP
Sbjct: 506 LSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPK 565
Query: 64 SLGKCQNLILLDLSNNNLTGTTPT 87
+LG ++L+ +++S+N+L G+ P+
Sbjct: 566 NLGNVESLVQVNISHNHLHGSLPS 589
|
Length = 968 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 61.8 bits (151), Expect = 2e-10
Identities = 57/175 (32%), Positives = 85/175 (48%), Gaps = 36/175 (20%)
Query: 181 HRNLVKIITSCASVDFQGNDSEA-LVYEFMVNGSLEEWLHPNREALKNLNLLQRL---SI 236
H N+VK++ +V ND + LV+E+M E LH A+ N+L+ + I
Sbjct: 66 HPNIVKLL----NVIKAENDKDIYLVFEYM-----ETDLH----AVIRANILEDVHKRYI 112
Query: 237 AVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQI 296
+ AL Y+H ++H DLKPSN+LL+ + + DFGLA+ L E N N +
Sbjct: 113 MYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVL 169
Query: 297 AEYG-----------MGSEVSTSG-DVYSFGILLLETFTGKRPTNEMFTGNLTLH 339
+Y +GS T G D++S G +L E GK P +F G TL+
Sbjct: 170 TDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK-P---LFPGTSTLN 220
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 53/216 (24%), Positives = 100/216 (46%), Gaps = 30/216 (13%)
Query: 140 SCIRLEQLVMNGNF---FRG--NIPSSLSSLRGIENL-----DLSRNNFIRHRNLVKIIT 189
S I ++++ G F FRG +P I+ L + R +F+ +++ +
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64
Query: 190 SCASVDFQGNDSE----ALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALD 245
+ +G ++ ++ E+M NG+L+++L R+ + Q + + +A+ +
Sbjct: 65 HHNIIRLEGVVTKFKPAMIITEYMENGALDKYL---RDHDGEFSSYQLVGMLRGIAAGMK 121
Query: 246 YLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL---PEATNNFFNFQIAEYGMG 302
YL + VH DL N+L++ L V DFGL++ L PE T +I
Sbjct: 122 YL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTA 178
Query: 303 SEV------STSGDVYSFGILLLETFT-GKRPTNEM 331
E +++ DV+SFGI++ E + G+RP +M
Sbjct: 179 PEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDM 214
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 2e-10
Identities = 44/140 (31%), Positives = 63/140 (45%), Gaps = 30/140 (21%)
Query: 204 LVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPS 263
+V EFM NG L +L + L LL S+ DV ++YL +H DL
Sbjct: 76 IVTEFMENGCLLNYLRQRQGKLSKDMLL---SMCQDVCEGMEYLE---RNSFIHRDLAAR 129
Query: 264 NVLLDGELTAHVGDFGLAKFL--PEATNNF-------------FNFQIAEYGMGSEVSTS 308
N L+ V DFG+ +++ E T++ FNF S+ S+
Sbjct: 130 NCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNF--------SKYSSK 181
Query: 309 GDVYSFGILLLETFT-GKRP 327
DV+SFG+L+ E FT GK P
Sbjct: 182 SDVWSFGVLMWEVFTEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 3e-10
Identities = 55/226 (24%), Positives = 102/226 (45%), Gaps = 48/226 (21%)
Query: 140 SCIRLEQLVMNGNF---FRGNI--PSSLSSLRGIENL-----DLSRNNFI---------R 180
SC+++E+++ G F RG + P I+ L + R +F+
Sbjct: 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD 63
Query: 181 HRNLVK---IITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIA 237
H N++ ++T V ++ EFM NG+L+ +L N ++Q + +
Sbjct: 64 HPNIIHLEGVVTKSRPV--------MIITEFMENGALDSFLRQND---GQFTVIQLVGML 112
Query: 238 VDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNF------ 291
+A+ + YL E VH DL N+L++ L V DFGL++FL + T++
Sbjct: 113 RGIAAGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSL 169
Query: 292 -----FNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNEM 331
+ E + +++ DV+S+GI++ E + G+RP +M
Sbjct: 170 GGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 215
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 3e-10
Identities = 46/153 (30%), Positives = 73/153 (47%), Gaps = 16/153 (10%)
Query: 186 KIITSCAS---VDFQG----NDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
I+ C S V F G N ++ E+M GSL++ L +E + IAV
Sbjct: 51 DILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKIL---KEVQGRIPERILGKIAV 107
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFF----NF 294
V L YLH + I+H D+KPSN+L++ + DFG++ L + F ++
Sbjct: 108 AVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSY 165
Query: 295 QIAEYGMGSEVSTSGDVYSFGILLLETFTGKRP 327
E G++ S D++S G+ L+E TG+ P
Sbjct: 166 MAPERIQGNDYSVKSDIWSLGLSLIELATGRFP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 4e-10
Identities = 41/132 (31%), Positives = 63/132 (47%), Gaps = 14/132 (10%)
Query: 204 LVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPS 263
LV+EFM +G L ++L R LL + +DV + YL ++H DL
Sbjct: 76 LVFEFMEHGCLSDYLRAQRGKFSQETLLG---MCLDVCEGMAYLESSN---VIHRDLAAR 129
Query: 264 NVLLDGELTAHVGDFGLAKFL-----PEATNNFFNFQIA--EYGMGSEVSTSGDVYSFGI 316
N L+ V DFG+ +F+ +T F + + E S+ S+ DV+SFG+
Sbjct: 130 NCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGV 189
Query: 317 LLLETFT-GKRP 327
L+ E F+ GK P
Sbjct: 190 LMWEVFSEGKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 4e-10
Identities = 47/157 (29%), Positives = 74/157 (47%), Gaps = 22/157 (14%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+RH LV++ + + +V E+M GSL ++L E K L L Q + +A
Sbjct: 58 LRHEKLVQLYAVVSE------EPIYIVTEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAA 109
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIAE 298
+AS + Y+ VH DL+ +N+L+ L V DFGLA+ + + N + Q A+
Sbjct: 110 QIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED--NEYTARQGAK 164
Query: 299 Y---------GMGSEVSTSGDVYSFGILLLETFTGKR 326
+ + + DV+SFGILL E T R
Sbjct: 165 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 5e-10
Identities = 44/167 (26%), Positives = 68/167 (40%), Gaps = 47/167 (28%)
Query: 180 RHRNLVKIITSCASVDFQGNDSEAL--VYEFMVNGSLEEWLHPNREALKNLNLLQRLSIA 237
H N+VK+I C + + V E + GSL +L + L LLQ ++
Sbjct: 50 DHPNIVKLIGVCV-------QKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQ---MS 99
Query: 238 VDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAK--------------- 282
+D A+ ++YL +H DL N L+ + DFG+++
Sbjct: 100 LDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156
Query: 283 -----FLPEATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTG 324
PEA N YG ++ DV+S+GILL ETF+
Sbjct: 157 IPIKWTAPEALN---------YG---RYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 6e-10
Identities = 43/177 (24%), Positives = 69/177 (38%), Gaps = 41/177 (23%)
Query: 175 RNNFIRHRNLVKIITSCASVDFQGNDSEA----LVYEFMVNGSLEEWLHPNREALKNLN- 229
R F+ +++K V G S +V E M G L+ +L R +N
Sbjct: 53 RIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPG 112
Query: 230 -----LLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL 284
L + + +A ++A + YL VH DL N ++ +LT +GDFG+ + +
Sbjct: 113 LGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDI 169
Query: 285 PEATNNFFNFQIAEY------------GMGSE------VSTSGDVYSFGILLLETFT 323
E +Y M E +T DV+SFG++L E T
Sbjct: 170 YE----------TDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 8e-10
Identities = 45/163 (27%), Positives = 66/163 (40%), Gaps = 26/163 (15%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
H N+VK TS F D LV ++ GSL L + + L IA
Sbjct: 56 CNHPNVVKYYTS-----FVVGDELWLVMPYLSGGSL---LDIMKSSYPR-GGLDEAIIAT 106
Query: 239 ---DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNF---- 291
+V L+YLH + +H D+K N+LL + + + DFG++ L + +
Sbjct: 107 VLKEVLKGLEYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVR 163
Query: 292 FNFQIAEYGMGSEVSTSG-------DVYSFGILLLETFTGKRP 327
F M EV D++SFGI +E TG P
Sbjct: 164 KTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 29/66 (43%), Positives = 37/66 (56%)
Query: 1 AFTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGS 60
+ L GN G IP S+G + L+ L L N F G IP S+G LT L LN N L G
Sbjct: 446 SINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGR 505
Query: 61 IPSSLG 66
+P++LG
Sbjct: 506 VPAALG 511
|
Length = 623 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 46/138 (33%), Positives = 66/138 (47%), Gaps = 16/138 (11%)
Query: 196 FQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPI 255
FQ + + EF+V G L L R+A + N + + A ++ A +YLH I
Sbjct: 87 FQDENRVYFLLEFVVGGELFTHL---RKAGRFPNDVAKFYHA-ELVLAFEYLH---SKDI 139
Query: 256 VHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIAEYGMGSEVSTSG------ 309
++ DLKP N+LLD + V DFG AK +P+ T F EY + EV S
Sbjct: 140 IYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT--FTLCGTPEY-LAPEVIQSKGHGKAV 196
Query: 310 DVYSFGILLLETFTGKRP 327
D ++ G+LL E G P
Sbjct: 197 DWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 30/78 (38%), Positives = 46/78 (58%)
Query: 99 LDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNI 158
L L L G +P++ L++L +I++S N + G IP S+GS LE L ++ N F G+I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 159 PSSLSSLRGIENLDLSRN 176
P SL L + L+L+ N
Sbjct: 483 PESLGQLTSLRILNLNGN 500
|
Length = 623 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 38/142 (26%), Positives = 61/142 (42%), Gaps = 36/142 (25%)
Query: 204 LVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPS 263
++ E+M NGSL ++L L + + + +A +A + ++ +H DL+ +
Sbjct: 77 IITEYMENGSLVDFL--KTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAA 131
Query: 264 NVLLDGELTAHVGDFGLAKFL-------------------PEATNNFFNFQIAEYGMGSE 304
N+L+ L + DFGLA+ + PEA N YG
Sbjct: 132 NILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN---------YGT--- 179
Query: 305 VSTSGDVYSFGILLLETFTGKR 326
+ DV+SFGILL E T R
Sbjct: 180 FTIKSDVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 49/143 (34%), Positives = 67/143 (46%), Gaps = 27/143 (18%)
Query: 204 LVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV------------DVASALDYLHHYC 251
L Y F G L L + L+ +L RLS V ++A ALD+LH
Sbjct: 63 LHYAFQTEGKLYLIL----DFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH--- 115
Query: 252 ETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNF-QIAEYGMGSEV----- 305
I++ DLKP N+LLD E + DFGL+K + ++F EY M EV
Sbjct: 116 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEY-MAPEVVNRRG 174
Query: 306 -STSGDVYSFGILLLETFTGKRP 327
+ S D +SFG+L+ E TG P
Sbjct: 175 HTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 46/165 (27%), Positives = 70/165 (42%), Gaps = 41/165 (24%)
Query: 181 HRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDV 240
H N+VK C + + + L+ EFM GSLE H E +A +
Sbjct: 131 HPNVVK----CHDMFDHNGEIQVLL-EFMDGGSLEG-THIADEQ-------FLADVARQI 177
Query: 241 ASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL---------------- 284
S + YLH IVH D+KPSN+L++ + DFG+++ L
Sbjct: 178 LSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAY 234
Query: 285 --PEATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRP 327
PE N N G+ +GD++S G+ +LE + G+ P
Sbjct: 235 MSPERINTDLN-------HGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 53/180 (29%), Positives = 88/180 (48%), Gaps = 17/180 (9%)
Query: 159 PSSLSSLRGIENLDLS---RNNFIRHRNLVKIITSCASVDFQG---NDSE-ALVYEFMVN 211
PS L R + +L++ RN IR ++ S V F G +D E ++ E M
Sbjct: 28 PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 87
Query: 212 GSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGEL 271
GSL++ L + + + L ++SIAV L YL + I+H D+KPSN+L++
Sbjct: 88 GSLDQVLKEAKRIPEEI--LGKVSIAV--LRGLAYLRE--KHQIMHRDVKPSNILVNSRG 141
Query: 272 TAHVGDFGLAKFLPEATNNFF----NFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRP 327
+ DFG++ L ++ N F ++ E G+ S D++S G+ L+E G+ P
Sbjct: 142 EIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 3e-09
Identities = 42/161 (26%), Positives = 69/161 (42%), Gaps = 30/161 (18%)
Query: 179 IRHRNLVK---IITSCASVDFQGNDSEALVYEFM---VNGSLEEWLHPNREALKNLNLLQ 232
+RH N+V+ I+TS +V+E+M + G L+ P + Q
Sbjct: 55 LRHPNIVRLKEIVTSKGKGSI------YMVFEYMDHDLTGLLD---SPEVK----FTESQ 101
Query: 233 RLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL-PEATNNF 291
+ L YLH I+H D+K SN+L++ + + DFGLA+ + ++
Sbjct: 102 IKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY 158
Query: 292 FNFQIA------EYGMGSEVSTSG-DVYSFGILLLETFTGK 325
N I E +G+ D++S G +L E F GK
Sbjct: 159 TNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 3e-09
Identities = 44/176 (25%), Positives = 83/176 (47%), Gaps = 41/176 (23%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSE--ALVYEFMVNGSLEEWL---HPN---------REA 224
++H N+V ++ C + +++E++ +G L E+L P+
Sbjct: 65 LQHPNIVCLLGVC-------TKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETV 117
Query: 225 LKNLNLLQRLSIAVDVASALDYL--HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAK 282
+L+ L IA+ +A+ ++YL HH+ VH DL N L+ LT + DFGL++
Sbjct: 118 KSSLDCSDFLHIAIQIAAGMEYLSSHHF-----VHRDLAARNCLVGEGLTVKISDFGLSR 172
Query: 283 FLPEATNNFFNFQ----------IAEYGMGSEVSTSGDVYSFGILLLETFT-GKRP 327
+ A +++ Q E + + +T D++SFG++L E F+ G +P
Sbjct: 173 DIYSA--DYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 6e-09
Identities = 49/184 (26%), Positives = 75/184 (40%), Gaps = 55/184 (29%)
Query: 181 HRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWL------------HPNREALK-- 226
H N+VK++ CA L++E+M G L E+L H A K
Sbjct: 67 HPNIVKLLGVCAV-----GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCG 121
Query: 227 ----NLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAK 282
L+ ++L IA VA+ + YL E VH DL N L+ + + DFGL++
Sbjct: 122 LNPLPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR 178
Query: 283 FLPEATNNFFNFQIAEYGMGSE------------------VSTSGDVYSFGILLLETFT- 323
N A+Y SE +T DV+++G++L E F+
Sbjct: 179 ----------NIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 228
Query: 324 GKRP 327
G +P
Sbjct: 229 GMQP 232
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 6e-09
Identities = 49/187 (26%), Positives = 81/187 (43%), Gaps = 32/187 (17%)
Query: 177 NFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKN---LNLLQR 233
NF H N+VK++ C N+ + ++ E M G L +L R L L +
Sbjct: 55 NF-NHPNIVKLLGVCLL-----NEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKEL 108
Query: 234 LSIAVDVASALDYLHHYCETPIVHCDLKPSNVLL-----DGELTAHVGDFGLAKFLPEAT 288
L I +DVA YL + +H DL N L+ D + +GDFGLA+ +
Sbjct: 109 LDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDI--YK 163
Query: 289 NNFFN----------FQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNEMFTGNLT 337
++++ + E + + +T DV+SFG+L+ E T G++P + N
Sbjct: 164 SDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL--NNQE 221
Query: 338 LHNFVKE 344
+ V
Sbjct: 222 VLQHVTA 228
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 6e-09
Identities = 30/97 (30%), Positives = 45/97 (46%), Gaps = 9/97 (9%)
Query: 237 AVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAK--FLPEATNNFF-- 292
A ++ L +LH E I++ DLK NVLLD E + DFG+ K L T + F
Sbjct: 102 AAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCG 158
Query: 293 --NFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRP 327
++ E + D ++ G+LL E G+ P
Sbjct: 159 TPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 7e-09
Identities = 52/205 (25%), Positives = 92/205 (44%), Gaps = 31/205 (15%)
Query: 142 IRLEQLVMNGNF-------FRGNIPSSLSSLR-GIENLDLSRNNFIRHRNLVKIITSCAS 193
++L + + NG F + GN ++ +L+ G +S +F+ ++K +
Sbjct: 8 LQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT----MSPESFLEEAQIMKKLRHDKL 63
Query: 194 VDFQGNDSEALVY---EFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHY 250
V SE +Y E+M GSL ++L + L L + +A VA+ + Y+
Sbjct: 64 VQLYAVVSEEPIYIVTEYMSKGSLLDFLKDGEG--RALKLPNLVDMAAQVAAGMAYIE-- 119
Query: 251 CETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIAEY---------GM 301
+H DL+ +N+L+ L + DFGLA+ + + N + Q A++ +
Sbjct: 120 -RMNYIHRDLRSANILVGDGLVCKIADFGLARLIED--NEYTARQGAKFPIKWTAPEAAL 176
Query: 302 GSEVSTSGDVYSFGILLLETFTGKR 326
+ DV+SFGILL E T R
Sbjct: 177 YGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 7e-09
Identities = 39/131 (29%), Positives = 60/131 (45%), Gaps = 13/131 (9%)
Query: 204 LVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPS 263
+V E+ NG L + L R + + R I + + L +LH I+H D+K
Sbjct: 76 IVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG--LAHLH---SKKILHRDIKSL 130
Query: 264 NVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIAE-YGMGSEV------STSGDVYSFGI 316
N+ LD +GD G+AK L NF N + Y + E+ + DV++ G+
Sbjct: 131 NLFLDAYDNVKIGDLGVAKLL-SDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGV 189
Query: 317 LLLETFTGKRP 327
+L E TGK P
Sbjct: 190 VLYECCTGKHP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 35/109 (32%), Positives = 58/109 (53%), Gaps = 4/109 (3%)
Query: 74 LDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSN-FGILKNLGAIDISENKLSG 132
+DLS N++G + + L + ++LS NQL+GP+P + F +L +++S N +G
Sbjct: 74 IDLSGKNISGKISSAIFRLPYIQT-INLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTG 132
Query: 133 QIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNFIRH 181
IP GS LE L ++ N G IP+ + S ++ LDL N +
Sbjct: 133 SIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGK 179
|
Length = 968 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 45/174 (25%), Positives = 73/174 (41%), Gaps = 25/174 (14%)
Query: 173 LSRNNFIRHRNLV---KIITSCAS---VDFQG---NDSEALVY---EFMVNGSLEEWLHP 220
+ N + ++ +I SC S V + G ++S + + E+ GSL+
Sbjct: 35 TTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKK 94
Query: 221 NREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGL 280
++ + IA V L YLH I+H D+KPSN+LL + + DFG+
Sbjct: 95 VKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGV 151
Query: 281 AKFLPEATNNF-FNFQIAEYGM------GSEVSTSGDVYSFGILLLETFTGKRP 327
+ E N+ F + M G S + DV+S G+ LLE + P
Sbjct: 152 SG---ELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 1e-08
Identities = 40/168 (23%), Positives = 73/168 (43%), Gaps = 29/168 (17%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNL---NLLQRLS 235
+ H N+++ + C LV EF G L+ +L NR + + ++LQR+
Sbjct: 52 LNHPNVLQCLGQCIESI-----PYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM- 105
Query: 236 IAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLA------KFLPEATN 289
A +VAS L +LH + +H DL N L +L+ +GD+GLA +
Sbjct: 106 -ACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDC 161
Query: 290 NFFNFQ------IAEYG---MGSEVSTSGDVYSFGILLLETFT-GKRP 327
+ + + G + + + +++S G+ + E FT +P
Sbjct: 162 HAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 53/180 (29%), Positives = 87/180 (48%), Gaps = 17/180 (9%)
Query: 159 PSSLSSLRGIENLDLS---RNNFIRHRNLVKIITSCASVDFQG---NDSE-ALVYEFMVN 211
PS L R + +L++ RN IR ++ S V F G +D E ++ E M
Sbjct: 28 PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 87
Query: 212 GSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGEL 271
GSL++ L + + L ++SIAV L YL + I+H D+KPSN+L++
Sbjct: 88 GSLDQVLKKAGRIPEQI--LGKVSIAV--IKGLTYLRE--KHKIMHRDVKPSNILVNSRG 141
Query: 272 TAHVGDFGLAKFLPEATNNFF----NFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRP 327
+ DFG++ L ++ N F ++ E G+ S D++S G+ L+E G+ P
Sbjct: 142 EIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 47/182 (25%), Positives = 79/182 (43%), Gaps = 24/182 (13%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+ H NL+++ + +V E GSL + L + ++ L AV
Sbjct: 53 LDHENLIRLYGVVLT------HPLMMVTELAPLGSLLDRLRKDALGHFLISTL--CDYAV 104
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNF---FNFQ 295
+A+ + YL +H DL N+LL + +GDFGL + LP+ +++ + +
Sbjct: 105 QIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLK 161
Query: 296 IAEYGMGSE------VSTSGDVYSFGILLLETFT-GKRPTNEMFTGNLTLHNFVKEALPE 348
+ E S + DV+ FG+ L E FT G+ P + +G+ L KE E
Sbjct: 162 VPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL-SGSQILKKIDKEG--E 218
Query: 349 RL 350
RL
Sbjct: 219 RL 220
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 2e-08
Identities = 40/132 (30%), Positives = 63/132 (47%), Gaps = 16/132 (12%)
Query: 204 LVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPS 263
+V EFM GSL ++L K L L Q + +A +A + Y+ +H DL+ +
Sbjct: 77 IVTEFMGKGSLLDFLKEGDG--KYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAA 131
Query: 264 NVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIAEY---------GMGSEVSTSGDVYSF 314
N+L+ L + DFGLA+ + + N + Q A++ + + DV+SF
Sbjct: 132 NILVGDNLVCKIADFGLARLIED--NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF 189
Query: 315 GILLLETFTGKR 326
GILL E T R
Sbjct: 190 GILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-08
Identities = 41/140 (29%), Positives = 70/140 (50%), Gaps = 20/140 (14%)
Query: 204 LVYEFMVNGSLEEWL--HPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLK 261
LV+E+M + L++++ H R AL N ++ S + + + H E ++H DLK
Sbjct: 75 LVFEYM-DKDLKKYMDTHGVRGALD-PNTVK--SFTYQLLKGIAFCH---ENRVLHRDLK 127
Query: 262 PSNVLLDGELTAHVGDFGLAKFLPEATNNFFN------FQIAEYGMGSEV-STSGDVYSF 314
P N+L++ + DFGLA+ N F N ++ + +GS STS D++S
Sbjct: 128 PQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSV 187
Query: 315 GILLLETFTGKRPTNEMFTG 334
G ++ E TG+ +F G
Sbjct: 188 GCIMAEMITGR----PLFPG 203
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 42/152 (27%), Positives = 64/152 (42%), Gaps = 14/152 (9%)
Query: 204 LVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPS 263
L+ E+ G L E L K+L+ +L +A+D L L+ Y P + +L
Sbjct: 99 LILEYCTRGYLREVLDKE----KDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSV 152
Query: 264 NVLLDGELTAHVGDFGLAKFLPEATNNFFNFQI-AEYGM----GSEVSTSGDVYSFGILL 318
+ L+ + GL K L NF + Y M SE + D+YS G++L
Sbjct: 153 SFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVL 212
Query: 319 LETFTGKRPTNEMFTG---NLTLHNFVKEALP 347
E FTGK P + T +L ++ LP
Sbjct: 213 WEIFTGKIPFENLTTKEIYDLIINKNNSLKLP 244
|
Length = 283 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 41/164 (25%), Positives = 74/164 (45%), Gaps = 28/164 (17%)
Query: 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWL------------HPNREALKN 227
+H+N++ ++ +C + ++ E+ G+L E+L +P + +
Sbjct: 82 KHKNIINLLGACTQ-----DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQ 136
Query: 228 LNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAK----- 282
L+ +S A VA ++YL +H DL NVL+ + + DFGLA+
Sbjct: 137 LSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 193
Query: 283 -FLPEATNNFFNFQ-IAEYGMGSEVST-SGDVYSFGILLLETFT 323
+ + TN + +A + + T DV+SFG+LL E FT
Sbjct: 194 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 3e-08
Identities = 39/160 (24%), Positives = 70/160 (43%), Gaps = 21/160 (13%)
Query: 181 HRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDV 240
H +V+++ C Q LV + GSL + + +R++L LL + V +
Sbjct: 68 HAYIVRLLGICPGASLQ------LVTQLSPLGSLLDHVRQHRDSLDPQRLL---NWCVQI 118
Query: 241 ASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL-PEATNNFFN------ 293
A + YL + +VH +L N+LL + + DFG+A L P+ F++
Sbjct: 119 AKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPI 175
Query: 294 -FQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNEM 331
+ E + + DV+S+G+ + E + G P M
Sbjct: 176 KWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM 215
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.0 bits (131), Expect = 3e-08
Identities = 50/184 (27%), Positives = 83/184 (45%), Gaps = 44/184 (23%)
Query: 158 IPSSLSSLRGIENL-DLSRNNFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEE 216
IPS+ +LR I L +L N ++ L+ +I + LV+E+ + L++
Sbjct: 41 IPST--ALREISLLKELKHPNIVK---LLDVIHT--------ERKLYLVFEYC-DMDLKK 86
Query: 217 WLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVG 276
+L L + NL++ SI + L Y H + I+H DLKP N+L++ + +
Sbjct: 87 YLDKRPGPL-SPNLIK--SIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLA 140
Query: 277 DFGLAKFLPEATNNFFNFQIAEYG--------------MGSEV-STSGDVYSFGILLLET 321
DFGLA+ F + Y +GS+ ST+ D++S G + E
Sbjct: 141 DFGLAR--------AFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEM 192
Query: 322 FTGK 325
TGK
Sbjct: 193 ITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 4e-08
Identities = 60/233 (25%), Positives = 97/233 (41%), Gaps = 50/233 (21%)
Query: 162 LSSLRGIENLDLSRNNFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLH-- 219
LS++R E L R H N+V+++ CA+ LV+E V+ L +L
Sbjct: 44 LSTVR--EVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEH-VDQDLRTYLDKV 100
Query: 220 --PNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGD 277
P A +L+++ LD+LH C IVH DLKP N+L+ + D
Sbjct: 101 PPPGLPAETIKDLMRQF------LRGLDFLHANC---IVHRDLKPENILVTSGGQVKLAD 151
Query: 278 FGLAKFLPEATNNFFNFQIA-------------EYGMGSEVSTSGDVYSFGILLLETFTG 324
FGLA+ ++ Q+A E + S +T D++S G + E F
Sbjct: 152 FGLAR--------IYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR- 202
Query: 325 KRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFT 377
++P +F GN EA ++L +I D + L ++ F+
Sbjct: 203 RKP---LFCGN-------SEA--DQLGKIFDLIGLPPEDDWPRDVTLPRGAFS 243
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 4e-08
Identities = 36/131 (27%), Positives = 61/131 (46%), Gaps = 15/131 (11%)
Query: 204 LVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPS 263
++ E+ GS+ + A K ++++ R +V AL Y+H ++H D+K +
Sbjct: 79 IIMEYAEGGSVRTLMKAGPIAEKYISVIIR-----EVLVALKYIHK---VGVIHRDIKAA 130
Query: 264 NVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIAEYGMGSEVSTSG-------DVYSFGI 316
N+L+ + DFG+A L + ++ F Y M EV T G D++S GI
Sbjct: 131 NILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGI 190
Query: 317 LLLETFTGKRP 327
+ E TG P
Sbjct: 191 TIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 4e-08
Identities = 33/102 (32%), Positives = 51/102 (50%), Gaps = 13/102 (12%)
Query: 240 VASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFN--FQIA 297
V L YLH I+H DLK N+L+D + + DFG++K + +N N Q +
Sbjct: 117 VLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGS 173
Query: 298 EYGMGSEV--------STSGDVYSFGILLLETFTGKRPTNEM 331
+ M EV S D++S G ++LE F G+RP ++
Sbjct: 174 VFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE 215
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 5e-08
Identities = 29/102 (28%), Positives = 42/102 (41%), Gaps = 8/102 (7%)
Query: 234 LSIAVDVASALDYLHH--YCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNF 291
I + AL H+ ++H DLKP+N+ LD +GDFGLAK L ++
Sbjct: 108 WRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA 167
Query: 292 FNFQIAEYGMGSEV------STSGDVYSFGILLLETFTGKRP 327
+ Y M E D++S G L+ E P
Sbjct: 168 KTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 5e-08
Identities = 48/188 (25%), Positives = 81/188 (43%), Gaps = 51/188 (27%)
Query: 158 IPSS----LSSLRGIENLDLSRNNFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGS 213
IP S ++ L+ +E+ + H N+V+++ C LV+E V+
Sbjct: 41 IPLSTLREIALLKQLESFE--------HPNIVRLLDVCHGPRTDRELKLTLVFEH-VDQD 91
Query: 214 LEEWL--HPNR----EALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLL 267
L +L P E +K+L + Q L +D+LH + IVH DLKP N+L+
Sbjct: 92 LATYLSKCPKPGLPPETIKDL-MRQLLR-------GVDFLHSHR---IVHRDLKPQNILV 140
Query: 268 DGELTAHVGDFGLAKFLPEATNNFFNFQIA-------------EYGMGSEVSTSGDVYSF 314
+ + DFGLA+ ++F++A E + S +T D++S
Sbjct: 141 TSDGQVKIADFGLAR--------IYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSV 192
Query: 315 GILLLETF 322
G + E F
Sbjct: 193 GCIFAELF 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 6e-08
Identities = 39/105 (37%), Positives = 54/105 (51%), Gaps = 15/105 (14%)
Query: 233 RLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAK-FLPEATNNF 291
R+ IA ++ ALD+LH + I++ D+K N+LLD E + DFGL+K FL E
Sbjct: 108 RVYIA-EIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERA 163
Query: 292 FNF-QIAEYGMGSEVSTSG--------DVYSFGILLLETFTGKRP 327
++F EY M EV G D +S G+L E TG P
Sbjct: 164 YSFCGTIEY-MAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 7e-08
Identities = 46/156 (29%), Positives = 67/156 (42%), Gaps = 24/156 (15%)
Query: 236 IAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFF--- 292
IAV V L YL Y I+H D+KPSN+L++ + DFG++ L + + F
Sbjct: 108 IAVAVVEGLTYL--YNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGT 165
Query: 293 -NFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRP---TNEMFTGNLT-------LHNF 341
+ E G + + DV+S GI ++E GK P +N G L
Sbjct: 166 STYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQI 225
Query: 342 VKE--------ALPERLAEIVDPVLLVEREEGETSK 369
V+E PE L + VD LL + E T +
Sbjct: 226 VQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQ 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 8e-08
Identities = 48/175 (27%), Positives = 75/175 (42%), Gaps = 45/175 (25%)
Query: 184 LVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASA 243
+V++I C + +S LV E G L ++L N+ + N+ + + V+
Sbjct: 58 IVRMIGICEA------ESWMLVMELAELGPLNKFLQKNKH-VTEKNITE---LVHQVSMG 107
Query: 244 LDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATN-------------- 289
+ YL ET VH DL NVLL + A + DFGL+K L N
Sbjct: 108 MKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKW 164
Query: 290 ------NFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNEMFTGNLT 337
N++ F S+ DV+SFG+L+ E F+ G++P M +T
Sbjct: 165 YAPECMNYYKF-----------SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVT 208
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 52.6 bits (127), Expect = 1e-07
Identities = 45/153 (29%), Positives = 64/153 (41%), Gaps = 29/153 (18%)
Query: 196 FQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQ----RLSIAVDVASALDYLHHYC 251
FQG + LV E++ G L L+N+ L R+ IA ++ AL+YLH
Sbjct: 62 FQGKKNLYLVMEYLPGGDL-------ASLLENVGSLDEDVARIYIA-EIVLALEYLHSN- 112
Query: 252 ETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIAE--------YGMGS 303
I+H DLKP N+L+D + DFGL+K N E +
Sbjct: 113 --GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170
Query: 304 EV------STSGDVYSFGILLLETFTGKRPTNE 330
EV S + D +S G +L E G P +
Sbjct: 171 EVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG 203
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 43/196 (21%), Positives = 76/196 (38%), Gaps = 25/196 (12%)
Query: 144 LEQLVMNGNFFRGNI--PSSLSSLRGIENLDLSRNNFIRHR---NLVKIITSCASVDFQG 198
L + G++F + S + + + N+ R + + K+ S FQ
Sbjct: 14 LAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS-----FQS 68
Query: 199 NDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258
D LV E++ G + + L L +V ++ LH + I+H
Sbjct: 69 KDYLYLVMEYLNGGDCASLI----KTLGGLPEDWAKQYIAEVVLGVEDLH---QRGIIHR 121
Query: 259 DLKPSNVLLDGELTAHV--GDFGLAKFLPEATNNFF---NFQIAEYGMGSEVSTSGDVYS 313
D+KP N+L+D T H+ DFGL++ F ++ E +G D +S
Sbjct: 122 DIKPENLLIDQ--TGHLKLTDFGLSR-NGLENKKFVGTPDYLAPETILGVGDDKMSDWWS 178
Query: 314 FGILLLETFTGKRPTN 329
G ++ E G P +
Sbjct: 179 LGCVIFEFLFGYPPFH 194
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 42/151 (27%), Positives = 65/151 (43%), Gaps = 18/151 (11%)
Query: 181 HRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDV 240
H N+V ++ +C ++ E+ G L +L RE+ L L LS + V
Sbjct: 98 HENIVNLLGACTI-----GGPILVITEYCCYGDLLNFLRRKRESFLTLEDL--LSFSYQV 150
Query: 241 ASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFF--NFQIAE 298
A + +L +H DL NVLL + DFGLA+ + +N N ++
Sbjct: 151 AKGMAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPV 207
Query: 299 YGMGSE------VSTSGDVYSFGILLLETFT 323
M E + DV+S+GILL E F+
Sbjct: 208 KWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 1e-07
Identities = 40/134 (29%), Positives = 58/134 (43%), Gaps = 15/134 (11%)
Query: 204 LVYEFMVNGSLEEWLHPNREALKNLNLLQRL-SIAVDVASALDYLHHYCETPIVHCDLKP 262
+V E+ G L + + R+ + L Q + I + + L LH E I+H DLK
Sbjct: 76 IVMEYAPFGDLSKAIS-KRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKS 131
Query: 263 SNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIAE-YGMGSEV------STSGDVYSFG 315
+N+LL +GD G++K L N QI + M EV S D++S G
Sbjct: 132 ANILLVANDLVKIGDLGISKVL---KKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLG 188
Query: 316 ILLLETFTGKRPTN 329
LL E T P
Sbjct: 189 CLLYEMATFAPPFE 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 36/123 (29%), Positives = 54/123 (43%), Gaps = 13/123 (10%)
Query: 236 IAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQ 295
+ V + AL YL + ++H D+KPSN+LLD + DFG++ L ++ +
Sbjct: 119 MTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAG 176
Query: 296 IAEYGMGSE----------VSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEA 345
A Y M E DV+S GI L+E TG+ P T L ++E
Sbjct: 177 CAAY-MAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE 235
Query: 346 LPE 348
P
Sbjct: 236 PPS 238
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.2 bits (126), Expect = 1e-07
Identities = 36/136 (26%), Positives = 58/136 (42%), Gaps = 20/136 (14%)
Query: 205 VYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV---DVASALDYLHHYCETPIVHCDLK 261
+ E+ GS + L P + L IA +V L+YLH E +H D+K
Sbjct: 77 IMEYCGGGSCLDLLKPGK--------LDETYIAFILREVLLGLEYLH---EEGKIHRDIK 125
Query: 262 PSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIAEYGMGSEV------STSGDVYSFG 315
+N+LL E + DFG++ L + F + M EV D++S G
Sbjct: 126 AANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLG 185
Query: 316 ILLLETFTGKRPTNEM 331
I +E G+ P +++
Sbjct: 186 ITAIELAKGEPPLSDL 201
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 2e-07
Identities = 51/181 (28%), Positives = 83/181 (45%), Gaps = 31/181 (17%)
Query: 172 DLSRNNFIRHRNLVKIITSCASVDFQG----NDSEALVYEFMVNGSLEEWLH---PNREA 224
D +R +F R L+ + V F G D +V+E+M +G L ++L P+
Sbjct: 48 DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVL 107
Query: 225 L------KNLNLLQRLSIAVDVASALDYL--HHYCETPIVHCDLKPSNVLLDGELTAHVG 276
+ L Q L IA +A+ + YL H+ VH DL N L+ L +G
Sbjct: 108 MAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHF-----VHRDLATRNCLVGENLLVKIG 162
Query: 277 DFGLAKFLPEATNNF---------FNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKR 326
DFG+++ + +T+ + + E M + +T DV+S G++L E FT GK+
Sbjct: 163 DFGMSRDV-YSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ 221
Query: 327 P 327
P
Sbjct: 222 P 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 44/178 (24%), Positives = 84/178 (47%), Gaps = 39/178 (21%)
Query: 174 SRNNFIR---------HRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREA 224
+RN+F++ + N+++++ C S +D ++ E+M NG L ++L RE
Sbjct: 60 ARNDFLKEIKIMSRLKNPNIIRLLGVCVS-----DDPLCMITEYMENGDLNQFL-SQREI 113
Query: 225 ---------LKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHV 275
+ ++++ L +AV +AS + YL VH DL N L+ T +
Sbjct: 114 ESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKI 170
Query: 276 GDFGLAKFLPEATNNFFNFQ----------IAEYGMGSEVSTSGDVYSFGILLLETFT 323
DFG+++ L + +++ Q E + + +T+ DV++FG+ L E FT
Sbjct: 171 ADFGMSRNL--YSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 40/138 (28%), Positives = 66/138 (47%), Gaps = 13/138 (9%)
Query: 196 FQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPI 255
FQ ++ V E++ G L + ++ +L + A ++ L +LH I
Sbjct: 65 FQTKENLFFVMEYLNGGDLMFHI----QSCHKFDLPRATFYAAEIICGLQFLH---SKGI 117
Query: 256 VHCDLKPSNVLLDGELTAHVGDFGLAK--FLPEATNNFF----NFQIAEYGMGSEVSTSG 309
V+ DLK N+LLD + + DFG+ K L +A F ++ E +G + +TS
Sbjct: 118 VYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSV 177
Query: 310 DVYSFGILLLETFTGKRP 327
D +SFG+LL E G+ P
Sbjct: 178 DWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 2e-07
Identities = 52/166 (31%), Positives = 84/166 (50%), Gaps = 24/166 (14%)
Query: 175 RNNFIRHRNLVKIITSCAS---VDFQG---NDSE-ALVYEFMVNGSLEEWLHPNREALKN 227
RN IR +K++ C S V F G +D E ++ E M GSL++ L +N
Sbjct: 43 RNQIIRE---LKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEN 99
Query: 228 LNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLL--DGELTAHVGDFGLAKFLP 285
+ L ++SIAV L YL + I+H D+KPSN+L+ GE+ + DFG++ L
Sbjct: 100 I--LGKISIAV--LRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIK--LCDFGVSGQLI 151
Query: 286 EATNNFF----NFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRP 327
++ N F ++ E G+ + D++S G+ L+E G+ P
Sbjct: 152 DSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 41/164 (25%), Positives = 70/164 (42%), Gaps = 28/164 (17%)
Query: 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNR------------EALKN 227
+H+N++ ++ C +V E+ +G+L ++L R +
Sbjct: 74 KHKNIINLLGVCT-----QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEET 128
Query: 228 LNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAK----- 282
L +S A VA +++L +H DL NVL+ + + DFGLA+
Sbjct: 129 LTQKDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHI 185
Query: 283 -FLPEATNNFFNFQ-IAEYGMGSEVST-SGDVYSFGILLLETFT 323
+ + TN + +A + V T DV+SFG+LL E FT
Sbjct: 186 DYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 46/164 (28%), Positives = 72/164 (43%), Gaps = 28/164 (17%)
Query: 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNR--------EALK----N 227
+H+N++ ++ +C Q LV E+ G+L E+L R + K
Sbjct: 76 KHKNIINLLGACT----QDGPLYVLV-EYASKGNLREYLRARRPPGMDYSFDTCKLPEEQ 130
Query: 228 LNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAK----- 282
L +S A VA ++YL +H DL NVL+ + + DFGLA+
Sbjct: 131 LTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNI 187
Query: 283 -FLPEATNNFFNFQ-IAEYGMGSEVST-SGDVYSFGILLLETFT 323
+ + TN + +A + V T DV+SFG+LL E FT
Sbjct: 188 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 44/166 (26%), Positives = 80/166 (48%), Gaps = 20/166 (12%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKN----LNLLQRL 234
+ H+N++ I+ C + + ++Y +M G+L+ +L R N L+ Q +
Sbjct: 65 LSHQNILPILHVC----IEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120
Query: 235 SIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAK--F------LPE 286
+A+ +A + YLH ++H D+ N ++D EL + D L++ F L +
Sbjct: 121 HMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD 177
Query: 287 ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNEM 331
N + E + E S++ DV+SFG+LL E T G+ P E+
Sbjct: 178 NENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI 223
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 3e-07
Identities = 28/89 (31%), Positives = 43/89 (48%), Gaps = 9/89 (10%)
Query: 238 VDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIA 297
V + SAL+++H I+H D+KP+NV + +GD GL +F T +
Sbjct: 113 VQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGT 169
Query: 298 EYGMGSE-VSTSG-----DVYSFGILLLE 320
Y M E + +G D++S G LL E
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYE 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 41/144 (28%), Positives = 63/144 (43%), Gaps = 37/144 (25%)
Query: 204 LVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPS 263
++ E+M GSL ++L + + L + + + +A + Y+ +H DL+ +
Sbjct: 78 IITEYMAKGSLLDFL--KSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAA 132
Query: 264 NVLLDGELTAHVGDFGLAKFL-------------------PEATNNFFNFQIAEYGMGSE 304
NVL+ L + DFGLA+ + PEA NF +F I
Sbjct: 133 NVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAI-NFGSFTI-------- 183
Query: 305 VSTSGDVYSFGILLLETFT-GKRP 327
DV+SFGILL E T GK P
Sbjct: 184 ---KSDVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 37/109 (33%), Positives = 47/109 (43%), Gaps = 28/109 (25%)
Query: 236 IAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL----------- 284
IAV AL+YL E I+H D+KPSN+LLD + DFG++ L
Sbjct: 112 IAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAG 169
Query: 285 ------PEATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRP 327
PE + Y + S DV+S GI L E TGK P
Sbjct: 170 CRPYMAPERID---PSARDGYDVRS------DVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 3e-07
Identities = 35/97 (36%), Positives = 46/97 (47%), Gaps = 10/97 (10%)
Query: 240 VASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIAEY 299
V A +YLH+ I++ DLKP N+LLD + DFG AK L + EY
Sbjct: 102 VVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEY 158
Query: 300 GMGSEV------STSGDVYSFGILLLETFTGKRPTNE 330
+ E+ S D +S GILL E TG+ P E
Sbjct: 159 -VAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGE 194
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 3e-07
Identities = 46/162 (28%), Positives = 74/162 (45%), Gaps = 21/162 (12%)
Query: 181 HRNLVKIITSC-ASVDFQGNDSEALVYEFMVNGSLEEWLHPNR--EALKNLNLLQRLSIA 237
H N++K+I C + Q ++ FM +G L +L +R + L L L
Sbjct: 60 HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFM 119
Query: 238 VDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQ-- 295
VD+A ++YL + +H DL N +L ++T V DFGL+K + + + Q
Sbjct: 120 VDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSK---KIYSGDYYRQGR 173
Query: 296 --------IAEYGMGSEVSTS-GDVYSFGILLLETFT-GKRP 327
IA + V TS DV++FG+ + E T G+ P
Sbjct: 174 IAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 4e-07
Identities = 42/159 (26%), Positives = 76/159 (47%), Gaps = 24/159 (15%)
Query: 184 LVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASA 243
+V++I C + ++ LV E G L ++L ++ + N+++ + V+
Sbjct: 57 IVRMIGVCEA------EALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMH---QVSMG 107
Query: 244 LDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIA------ 297
+ YL VH DL NVLL + A + DFGL+K L A ++++ + A
Sbjct: 108 MKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKAL-GADDSYYKARSAGKWPLK 163
Query: 298 ----EYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNEM 331
E + S+ DV+S+GI + E F+ G++P +M
Sbjct: 164 WYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM 202
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 4e-07
Identities = 45/199 (22%), Positives = 84/199 (42%), Gaps = 36/199 (18%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREAL-----KNLNLLQR 233
+ H+N+V+++ C + + ++ E+ G L+++L + L+ Q+
Sbjct: 65 LSHKNVVRLLGLC-----REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQK 119
Query: 234 LSIAVDVASALDYL--HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNF 291
+++ +A +D+L + VH DL N L+ + V L+K + +
Sbjct: 120 VALCTQIALGMDHLSNARF-----VHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYK 174
Query: 292 FNFQIA-------EYGMGSEVSTSGDVYSFGILLLETFT-GKRP----TNEMF-----TG 334
+ E + ST DV+SFG+L+ E FT G+ P ++E G
Sbjct: 175 LRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG 234
Query: 335 NLTLHNFVKEALPERLAEI 353
L L V E P RL ++
Sbjct: 235 KLELP--VPEGCPSRLYKL 251
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 5e-07
Identities = 25/61 (40%), Positives = 39/61 (63%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS 63
L NQ +G+IP S ++ L +L L N+ GEIP ++GN+ L+ +N + N L GS+PS
Sbjct: 530 LSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPS 589
Query: 64 S 64
+
Sbjct: 590 T 590
|
Length = 968 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 6e-07
Identities = 44/181 (24%), Positives = 77/181 (42%), Gaps = 46/181 (25%)
Query: 173 LSRNNFIRHRNLVKIITSCASVDFQGNDSEALVY---EFMVNGSLEEWLHP---NREALK 226
+S F+ N++K + V ++ +Y EFM GSL ++L +++ L
Sbjct: 43 MSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP 102
Query: 227 NLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL-- 284
L + + +A + ++ + +H DL+ +N+L+ L + DFGLA+ +
Sbjct: 103 KL-----IDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIED 154
Query: 285 -----------------PEATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKR 326
PEA N +G + DV+SFGILL+E T G+
Sbjct: 155 NEYTAREGAKFPIKWTAPEAIN---------FG---SFTIKSDVWSFGILLMEIVTYGRI 202
Query: 327 P 327
P
Sbjct: 203 P 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 6e-07
Identities = 38/130 (29%), Positives = 59/130 (45%), Gaps = 33/130 (25%)
Query: 212 GSLEEWLHPN--REALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDG 269
G+ EE L N R+ LK LN YLH+ I+H D+K +N+L+D
Sbjct: 101 GAFEETLVRNFVRQILKGLN----------------YLHN---RGIIHRDIKGANILVDN 141
Query: 270 ELTAHVGDFGLAKFLPEATNNFFN------FQIAEYGMGSEV------STSGDVYSFGIL 317
+ + DFG++K L + + Q + + M EV + D++S G L
Sbjct: 142 KGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCL 201
Query: 318 LLETFTGKRP 327
++E TGK P
Sbjct: 202 VVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 6e-07
Identities = 41/149 (27%), Positives = 65/149 (43%), Gaps = 21/149 (14%)
Query: 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVD 239
+H N+V S + D +V E+M GSL + + N +N Q + +
Sbjct: 73 KHPNIVDYYDS-----YLVGDELWVVMEYMDGGSLTDIITQNF---VRMNEPQIAYVCRE 124
Query: 240 VASALDYLHHYCETPIVHCDLKPSNVLL--DGELTAHVGDFGLAKFLPEATNNFFNFQIA 297
V L+YLH ++H D+K N+LL DG + + DFG A L + + +
Sbjct: 125 VLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVK--LADFGFAAQLTKEKSKRNSVVGT 179
Query: 298 EYGMGSEV------STSGDVYSFGILLLE 320
Y M EV D++S GI+ +E
Sbjct: 180 PYWMAPEVIKRKDYGPKVDIWSLGIMCIE 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 6e-07
Identities = 35/109 (32%), Positives = 54/109 (49%), Gaps = 27/109 (24%)
Query: 236 IAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL----------- 284
IAV + AL+YLH + ++H D+KPSNVL++ + DFG++ +L
Sbjct: 108 IAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAG 165
Query: 285 ------PEATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRP 327
PE N N + G +V + DV+S GI ++E TG+ P
Sbjct: 166 CKPYMAPERINPELNQK------GYDVKS--DVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 7e-07
Identities = 34/102 (33%), Positives = 54/102 (52%), Gaps = 11/102 (10%)
Query: 228 LNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA 287
L L Q ++A + SA+DY+H E I+H D+K NVL++G +GDFG A F +
Sbjct: 257 LGLAQVTAVARQLLSAIDYIH--GEG-IIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313
Query: 288 TNNFFNFQIA--------EYGMGSEVSTSGDVYSFGILLLET 321
+ F++ IA E G + S D++S G+++ E
Sbjct: 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEA 355
|
Length = 461 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 7e-07
Identities = 47/166 (28%), Positives = 76/166 (45%), Gaps = 28/166 (16%)
Query: 181 HRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDV 240
H +LV+++ C S Q LV + M +G L +++H +++ N+ L+ V +
Sbjct: 68 HPHLVRLLGVCLSPTIQ------LVTQLMPHGCLLDYVHEHKD---NIGSQLLLNWCVQI 118
Query: 241 ASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFN------- 293
A + YL E +VH DL NVL+ + DFGLA+ L E +N
Sbjct: 119 AKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLL-EGDEKEYNADGGKMP 174
Query: 294 --FQIAEYGMGSEVSTSGDVYSFGILLLE--TFTGKR----PTNEM 331
+ E + + DV+S+G+ + E TF GK PT E+
Sbjct: 175 IKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI 220
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 8e-07
Identities = 37/138 (26%), Positives = 63/138 (45%), Gaps = 13/138 (9%)
Query: 196 FQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPI 255
FQ + V E++ G L + + + + + + A ++ L +LH + I
Sbjct: 65 FQTKEHLFFVMEYLNGGDL---MFHIQSSGR-FDEARARFYAAEIICGLQFLH---KKGI 117
Query: 256 VHCDLKPSNVLLDGELTAHVGDFGLAK--FLPEATNNFF----NFQIAEYGMGSEVSTSG 309
++ DLK NVLLD + + DFG+ K E + F ++ E G + + S
Sbjct: 118 IYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESV 177
Query: 310 DVYSFGILLLETFTGKRP 327
D +SFG+LL E G+ P
Sbjct: 178 DWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 1e-06
Identities = 32/97 (32%), Positives = 50/97 (51%), Gaps = 9/97 (9%)
Query: 237 AVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAK--FLPEATNNFF-- 292
+ +++ AL+YLH E I++ DLK NVLLD E + D+G+ K P T + F
Sbjct: 102 SAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCG 158
Query: 293 --NFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRP 327
N+ E G + S D ++ G+L+ E G+ P
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 36/98 (36%), Positives = 51/98 (52%), Gaps = 13/98 (13%)
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAK-FLPEATNNFFNF-QI 296
++ AL++LH + IV+ D+K N+LLD E + DFGL+K FL E ++F
Sbjct: 113 EIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGT 169
Query: 297 AEYGMGSEV--STSG-----DVYSFGILLLETFTGKRP 327
EY M E+ G D +S GIL+ E TG P
Sbjct: 170 IEY-MAPEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 23/57 (40%), Positives = 33/57 (57%)
Query: 122 AIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178
+ + L G IP+ I L+ + ++GN RGNIP SL S+ +E LDLS N+F
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478
|
Length = 623 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 34/106 (32%), Positives = 53/106 (50%), Gaps = 13/106 (12%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREA---LKNLNLLQRLS 235
++H NL++ + C V LV EF G L+ +L R+A + LQR+
Sbjct: 52 LQHSNLLQCLGQCTEVT-----PYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRM- 105
Query: 236 IAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLA 281
A ++A L +LH + +H DL N LL +LT +GD+GL+
Sbjct: 106 -ACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 43/162 (26%), Positives = 65/162 (40%), Gaps = 42/162 (25%)
Query: 181 HRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDV 240
H N+VK+I C +V E + G +L ++ LK L++ A+D
Sbjct: 51 HPNIVKLIGVCTQ-----RQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVK---FALDA 102
Query: 241 ASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAK------------------ 282
A+ + YL +H DL N L+ + DFG+++
Sbjct: 103 AAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK 159
Query: 283 -FLPEATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT 323
PEA N YG S+ DV+S+GILL ETF+
Sbjct: 160 WTAPEALN---------YG---RYSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 45/180 (25%), Positives = 79/180 (43%), Gaps = 23/180 (12%)
Query: 181 HRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDV 240
H N+V + S + D +V EF+ G+L + + R +N Q ++ + V
Sbjct: 78 HENVVDMYNS-----YLVGDELWVVMEFLEGGALTDIVTHTR-----MNEEQIATVCLSV 127
Query: 241 ASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIAEYG 300
AL YLH+ ++H D+K ++LL + + DFG + + + Y
Sbjct: 128 LRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYW 184
Query: 301 MGSEV------STSGDVYSFGILLLETFTGKRPT-NEMFTGNLTLHNFVKEALPERLAEI 353
M EV T D++S GI+++E G+ P NE L +++ LP R+ +
Sbjct: 185 MAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE---PPLQAMRRIRDNLPPRVKDS 241
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 61/198 (30%), Positives = 97/198 (48%), Gaps = 8/198 (4%)
Query: 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSI 61
L N+ I + +L L L L+ N +IP IG L + + S+
Sbjct: 98 LDLNLNRLRSNIS-ELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIESL 155
Query: 62 PSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLG 121
PS L NL LDLS N+L+ P + LS+L+ LDLS N+++ LP +L L
Sbjct: 156 PSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNN-LDLSGNKIS-DLPPEIELLSALE 212
Query: 122 AIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNFIRH 181
+D+S N + ++ SS+ + L L ++ N ++P S+ +L +E LDLS NN I
Sbjct: 213 ELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLS-NNQISS 269
Query: 182 RNLVKIITSCASVDFQGN 199
+ + +T+ +D GN
Sbjct: 270 ISSLGSLTNLRELDLSGN 287
|
Length = 394 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 39/157 (24%), Positives = 70/157 (44%), Gaps = 25/157 (15%)
Query: 181 HRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNR------------EALKNL 228
H N++ ++ +C + L E+ +G+L ++L +R L
Sbjct: 67 HPNIINLLGACEHRGYL-----YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 121
Query: 229 NLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAK----FL 284
+ Q L A DVA +DYL + +H DL N+L+ A + DFGL++ ++
Sbjct: 122 SSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 178
Query: 285 PEATNNFFNFQIAEYGMGSEV-STSGDVYSFGILLLE 320
+ +A + V +T+ DV+S+G+LL E
Sbjct: 179 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWE 215
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 39/164 (23%), Positives = 63/164 (38%), Gaps = 27/164 (16%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+ H N+V ++ S + V+E++ +L RE L L
Sbjct: 35 LYHPNIVALLDSGEA----PPGLLFAVFEYVPGRTL-------REVLAADGALPAGETGR 83
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLL---DGELTAHVGDFGLAKFLPEATNNFFNFQ 295
+ LD L IVH DLKP N+++ A V DFG+ LP +
Sbjct: 84 LMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATL 143
Query: 296 IAEYGM-------------GSEVSTSGDVYSFGILLLETFTGKR 326
+ G V+ + D+Y++G++ LE TG+R
Sbjct: 144 TRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 3e-06
Identities = 48/180 (26%), Positives = 76/180 (42%), Gaps = 16/180 (8%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+RH N+V+ + F ND +V + + L E + +E + + +I V
Sbjct: 66 LRHPNIVRYYKT-----FLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAK------FLPEATNNFF 292
+ AL YLH E IVH DL P+N++L + + DFGLAK L
Sbjct: 121 QMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTIL 178
Query: 293 NFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRP--TNEMFTGNLTLHNFVKEALPERL 350
+ E DV++FG +L + T + P + M + + V E LPE +
Sbjct: 179 -YSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGM 237
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 3e-06
Identities = 35/106 (33%), Positives = 44/106 (41%), Gaps = 30/106 (28%)
Query: 237 AVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL------------ 284
A ++ AL+YLH IV+ DLKP N+LLD E + DFG AK L
Sbjct: 107 ASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCGTPE 163
Query: 285 ---PEATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRP 327
PE I G V D ++ GIL+ E G P
Sbjct: 164 YLAPEV--------IQSKGHNKAV----DWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 42/138 (30%), Positives = 63/138 (45%), Gaps = 13/138 (9%)
Query: 196 FQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPI 255
FQ LV E++ G L H R+ + L A ++ AL++LH E I
Sbjct: 65 FQTTSRLFLVIEYVNGGDL--MFHMQRQ--RKLPEEHARFYAAEICIALNFLH---ERGI 117
Query: 256 VHCDLKPSNVLLDGELTAHVGDFGLAK--FLPEATNNFF----NFQIAEYGMGSEVSTSG 309
++ DLK NVLLD + + D+G+ K P T + F N+ E G E S
Sbjct: 118 IYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSV 177
Query: 310 DVYSFGILLLETFTGKRP 327
D ++ G+L+ E G+ P
Sbjct: 178 DWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 4e-06
Identities = 44/164 (26%), Positives = 68/164 (41%), Gaps = 34/164 (20%)
Query: 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKN---LNLLQRLSI 236
H+N+V++I V F+ ++ E M G L+ +L NR + L + L
Sbjct: 67 NHQNIVRLI----GVSFERL-PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121
Query: 237 AVDVASALDYLHHYCETPIVHCDLKPSNVLLDGE---LTAHVGDFGLAK----------- 282
A DVA YL E +H D+ N LL + A + DFG+A+
Sbjct: 122 ARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG 178
Query: 283 ---FLPEATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT 323
LP + E + ++ DV+SFG+LL E F+
Sbjct: 179 GRAMLP------IKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 4e-06
Identities = 37/134 (27%), Positives = 60/134 (44%), Gaps = 14/134 (10%)
Query: 204 LVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPS 263
++ E++ GS + L P L+ Q +I ++ LDYLH +H D+K +
Sbjct: 79 IIMEYLGGGSALDLLEPG-----PLDETQIATILREILKGLDYLH---SEKKIHRDIKAA 130
Query: 264 NVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIAEYGMGSEV------STSGDVYSFGIL 317
NVLL + DFG+A L + F + M EV + D++S GI
Sbjct: 131 NVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGIT 190
Query: 318 LLETFTGKRPTNEM 331
+E G+ P +E+
Sbjct: 191 AIELAKGEPPHSEL 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 4e-06
Identities = 49/155 (31%), Positives = 72/155 (46%), Gaps = 22/155 (14%)
Query: 196 FQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPI 255
FQ + LV F +NG E + H RE +L+ R A ++ AL+ LH + +
Sbjct: 62 FQSPEKLYLVLAF-INGG-ELFHHLQREGRFDLSR-ARFYTA-ELLCALENLHKF---NV 114
Query: 256 VHCDLKPSNVLLDGELTAHVG--DFGLAKF---LPEATNNFF---NFQIAEYGMGSEVST 307
++ DLKP N+LLD H+ DFGL K + TN F + E +G +
Sbjct: 115 IYRDLKPENILLD--YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTK 172
Query: 308 SGDVYSFGILLLETFTGKRP-----TNEMFTGNLT 337
+ D ++ G+LL E TG P NEM+ L
Sbjct: 173 AVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ 207
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 4e-06
Identities = 38/153 (24%), Positives = 69/153 (45%), Gaps = 19/153 (12%)
Query: 181 HRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDV 240
H N+V++ +S + D +V EF+ G+L + + R +N Q ++ + V
Sbjct: 75 HPNIVEMYSS-----YLVGDELWVVMEFLEGGALTDIVTHTR-----MNEEQIATVCLAV 124
Query: 241 ASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIAEYG 300
AL +LH ++H D+K ++LL + + DFG + + + Y
Sbjct: 125 LKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYW 181
Query: 301 MGSEV------STSGDVYSFGILLLETFTGKRP 327
M EV T D++S GI+++E G+ P
Sbjct: 182 MAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 5e-06
Identities = 40/190 (21%), Positives = 75/190 (39%), Gaps = 41/190 (21%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEA----LVYEFMVNGSLEEWLHPNREALKNLNLLQRL 234
++H N+++ + C EA LV+E+ G L+ +L + +N LL
Sbjct: 52 LQHPNILQCLGQCV---------EAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ 102
Query: 235 SIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKF----------- 283
+A ++A+ + ++H + +H DL N L +LT VGD+G+
Sbjct: 103 RMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETED 159
Query: 284 ---------LPEATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTG 334
PE F I +E + +V++ G+ L E F +
Sbjct: 160 DKCVPLRWLAPELVGEFHGGLIT-----AEQTKPSNVWALGVTLWELFENAAQPYSHLSD 214
Query: 335 NLTLHNFVKE 344
L++ +K+
Sbjct: 215 REVLNHVIKD 224
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 5e-06
Identities = 29/96 (30%), Positives = 39/96 (40%), Gaps = 8/96 (8%)
Query: 237 AVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATN-----NF 291
A + L++LH + IV+ DLKP NVLLD + D GLA L
Sbjct: 101 AAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGT 157
Query: 292 FNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRP 327
+ E G S D ++ G L E G+ P
Sbjct: 158 PGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 6e-06
Identities = 40/158 (25%), Positives = 69/158 (43%), Gaps = 25/158 (15%)
Query: 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNR------------EALKN 227
H N++ ++ +C + + + E+ G+L ++L +R
Sbjct: 61 HHPNIINLLGACENRGYL-----YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAST 115
Query: 228 LNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAK----F 283
L Q L A DVA+ + YL E +H DL NVL+ L + + DFGL++ +
Sbjct: 116 LTSQQLLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVY 172
Query: 284 LPEATNNFFNFQIAEYGMGSEV-STSGDVYSFGILLLE 320
+ + +A + V +T DV+SFG+LL E
Sbjct: 173 VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWE 210
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 6e-06
Identities = 52/178 (29%), Positives = 82/178 (46%), Gaps = 34/178 (19%)
Query: 179 IRHRNLVK----IITSCASVDFQGNDSEA--LVYEFM---VNGSLEEWL-HPNREALKNL 228
+ HRN+V + ++DF+ D A LV+E+M + G LE L H + + +K
Sbjct: 63 LNHRNIVNLKEIVTDKQDALDFK-KDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK-- 119
Query: 229 NLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA- 287
S + L+Y H + +H D+K SN+LL+ + + DFGLA+
Sbjct: 120 ------SFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEE 170
Query: 288 ----TNNFFN--FQIAEYGMGSEVST-SGDVYSFGILLLETFTGKRPTNEMFTGNLTL 338
TN ++ E +G E + DV+S G +L E FT K+P +F N L
Sbjct: 171 SRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKP---IFQANQEL 224
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 6e-06
Identities = 34/155 (21%), Positives = 63/155 (40%), Gaps = 21/155 (13%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+ H N++K++ F+ LV+EFM + R L S
Sbjct: 55 LNHPNIIKLLDV-----FRHKGDLYLVFEFMDTDLYKLIKDRQRG----LPESLIKSYLY 105
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIA- 297
+ L + H + I+H DLKP N+L++ E + DFGLA+ + + +
Sbjct: 106 QLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSF-GSPVRPYTHYVVT 161
Query: 298 ------EYGMGSEVSTSG-DVYSFGILLLETFTGK 325
E +G + ++ D++S G + E + +
Sbjct: 162 RWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (114), Expect = 6e-06
Identities = 31/111 (27%), Positives = 46/111 (41%), Gaps = 25/111 (22%)
Query: 243 ALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL--PEATNNFFNFQIAEY- 299
L YLH ++H DLKPSN+L++ + DFGLA+ + E F EY
Sbjct: 115 GLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFL----TEYV 167
Query: 300 -----------GMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLH 339
S + + D++S G + E T K P +F G +
Sbjct: 168 VTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK-P---LFPGRDYID 214
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 7e-06
Identities = 32/115 (27%), Positives = 51/115 (44%), Gaps = 22/115 (19%)
Query: 224 ALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKF 283
A +N+ + L+I V A+ YLH E I+H D+K N+ ++ +GDFG A F
Sbjct: 175 AKRNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACF 231
Query: 284 LPEATNNFFNFQIAEYGMGSEVSTSG-------------DVYSFGILLLETFTGK 325
+ N + YG ++T+ D++S GI+L E T
Sbjct: 232 PVDINANKY------YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 7e-06
Identities = 50/182 (27%), Positives = 82/182 (45%), Gaps = 22/182 (12%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
++H N+V S FQ N +V E+ G L + ++ R L + + Q LS V
Sbjct: 56 MKHPNIVTFFAS-----FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSED--QILSWFV 108
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGE-LTAHVGDFGLAKFLPEATNNFFNFQIA 297
++ L ++H + I+H D+K N+ L + A +GDFG+A+ L ++ +
Sbjct: 109 QISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGT 165
Query: 298 EYGMGSEV------STSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEALPERLA 351
Y + E+ + D++S G +L E T K P F GN LH V + A
Sbjct: 166 PYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP----FEGN-NLHQLVLKICQGYFA 220
Query: 352 EI 353
I
Sbjct: 221 PI 222
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 7e-06
Identities = 41/164 (25%), Positives = 69/164 (42%), Gaps = 28/164 (17%)
Query: 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHP------------NREALKN 227
+H+N++ ++ +C Q +V E+ G+L E+L R +
Sbjct: 79 KHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLRARRPPGMEYSYDIARVPDEQ 133
Query: 228 LNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAK----- 282
+ +S VA ++YL +H DL NVL+ + DFGLA+
Sbjct: 134 MTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNI 190
Query: 283 -FLPEATNNFFNFQ-IAEYGMGSEVST-SGDVYSFGILLLETFT 323
+ + TN + +A + V T DV+SFG+L+ E FT
Sbjct: 191 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 8e-06
Identities = 39/117 (33%), Positives = 58/117 (49%), Gaps = 27/117 (23%)
Query: 171 LDLSRNNFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLH-----PNREAL 225
L LS++ FI H L + S +V LV E+++ G ++ LH A+
Sbjct: 58 LALSKSPFIVH--LYYSLQSANNV--------YLVMEYLIGGDVKSLLHIYGYFDEEMAV 107
Query: 226 KNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAK 282
K ++ +VA ALDYLH + I+H DLKP N+L+ E + DFGL+K
Sbjct: 108 KYIS---------EVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 8e-06
Identities = 40/157 (25%), Positives = 69/157 (43%), Gaps = 35/157 (22%)
Query: 179 IRHRNLVKIITSCASVD-FQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIA 237
++H N++ + +D F + LV+EFM LE+ +K+ ++ L+ A
Sbjct: 59 LKHPNIIGL------LDVFGHKSNINLVFEFM-ETDLEK-------VIKDKSI--VLTPA 102
Query: 238 VDVAS-------ALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNN 290
D+ S L+YLH I+H DLKP+N+L+ + + DFGLA+
Sbjct: 103 -DIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK 158
Query: 291 FFNFQIA------EYGMGSEVSTSG-DVYSFGILLLE 320
+ + E G+ G D++S G + E
Sbjct: 159 MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAE 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 8e-06
Identities = 46/170 (27%), Positives = 69/170 (40%), Gaps = 35/170 (20%)
Query: 177 NFIRHRNLVKII-TSCASVDFQGNDSEALVYEFMVNGSLEEWLH---PNREALKNLNLLQ 232
+ H ++++++ +C F L E+M GS+ L +EA+ Q
Sbjct: 58 ARLNHPHIIRMLGATCEDSHFN------LFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQ 111
Query: 233 RLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAH---VGDFGLAKFLPEATN 289
+ L YLH E I+H D+K +N+L+D T + DFG A L
Sbjct: 112 -------LLRGLSYLH---ENQIIHRDVKGANLLIDS--TGQRLRIADFGAAARLAAKGT 159
Query: 290 NFFNFQIAEYG----MGSEV------STSGDVYSFGILLLETFTGKRPTN 329
FQ G M EV S DV+S G +++E T K P N
Sbjct: 160 GAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWN 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 9e-06
Identities = 41/164 (25%), Positives = 70/164 (42%), Gaps = 28/164 (17%)
Query: 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKN------------ 227
+H+N++ ++ C ++ E+ G+L E+L R +
Sbjct: 76 KHKNIINLLGVCTQ-----EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQ 130
Query: 228 LNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAK----- 282
L+ +S A VA ++YL +H DL NVL+ + + DFGLA+
Sbjct: 131 LSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDI 187
Query: 283 -FLPEATNNFFNFQ-IAEYGMGSEVST-SGDVYSFGILLLETFT 323
+ + +N + +A + V T DV+SFGIL+ E FT
Sbjct: 188 DYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 9e-06
Identities = 50/205 (24%), Positives = 78/205 (38%), Gaps = 53/205 (25%)
Query: 148 VMNGNFFRGNIPSSLSSLRGIENLDLSRNNFIR---------HRNLVKIITSCASVDFQG 198
V +G N P ++ S R DL + F++ H N+V++I C
Sbjct: 11 VFSGRLRADNTPVAVKSCRETLPPDL-KAKFLQEARILKQYSHPNIVRLIGVCTQ----- 64
Query: 199 NDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258
+V E + G +L LK L+Q + + A+ ++YL +H
Sbjct: 65 KQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQ---MVENAAAGMEYLESKH---CIHR 118
Query: 259 DLKPSNVLLDGELTAHVGDFGLAK--------------------FLPEATNNFFNFQIAE 298
DL N L+ + + DFG+++ PEA N
Sbjct: 119 DLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALN--------- 169
Query: 299 YGMGSEVSTSGDVYSFGILLLETFT 323
YG S+ DV+SFGILL E F+
Sbjct: 170 YG---RYSSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 45/162 (27%), Positives = 76/162 (46%), Gaps = 21/162 (12%)
Query: 181 HRNLVKIITSC-ASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIA-- 237
H N++++I C +V+ +G S ++ FM +G L +L +R L ++ +
Sbjct: 59 HPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFM 118
Query: 238 VDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQ-- 295
D+AS ++YL +H DL N +L+ + V DFGL+K + N + Q
Sbjct: 119 TDIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSK---KIYNGDYYRQGR 172
Query: 296 --------IAEYGMGSEVSTS-GDVYSFGILLLETFT-GKRP 327
IA + V T+ DV+SFG+ + E T G+ P
Sbjct: 173 IAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 39/138 (28%), Positives = 61/138 (44%), Gaps = 13/138 (9%)
Query: 196 FQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPI 255
FQ + V EF+ G L H + +L + A ++ L +LH I
Sbjct: 65 FQTKEHLFFVMEFLNGGDL--MFHIQDKG--RFDLYRATFYAAEIVCGLQFLH---SKGI 117
Query: 256 VHCDLKPSNVLLDGELTAHVGDFGLAK---FLPEATNNFF---NFQIAEYGMGSEVSTSG 309
++ DLK NV+LD + + DFG+ K F + F ++ E G + + S
Sbjct: 118 IYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSV 177
Query: 310 DVYSFGILLLETFTGKRP 327
D +SFG+LL E G+ P
Sbjct: 178 DWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 45/157 (28%), Positives = 64/157 (40%), Gaps = 19/157 (12%)
Query: 177 NFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSI 236
N RH LV + +C FQ D V E+ G L +H + + + +
Sbjct: 57 NSERHPFLVNLF-AC----FQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP-----RAVFY 106
Query: 237 AVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAK--FLPEATNNFF-- 292
A V L YLH E IV+ DLK N+LLD E + DFGL K + F
Sbjct: 107 AACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCG 163
Query: 293 --NFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRP 327
F E + + + D + G+L+ E G+ P
Sbjct: 164 TPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 29/97 (29%), Positives = 43/97 (44%), Gaps = 9/97 (9%)
Query: 237 AVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFF---- 292
+ S L++LH + I++ DLKP NVLLD + + D GLA L + +
Sbjct: 103 TAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAG 159
Query: 293 --NFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRP 327
F E G E S D ++ G+ L E + P
Sbjct: 160 TPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 38/107 (35%), Positives = 53/107 (49%), Gaps = 13/107 (12%)
Query: 176 NNFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLS 235
N +H LV + S FQ D V ++ VNG E + H RE ++ +
Sbjct: 51 KNV-KHPFLVGLHYS-----FQTADKLYFVLDY-VNGG-ELFFHLQRE--RSFPEPRARF 100
Query: 236 IAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAK 282
A ++ASAL YLH I++ DLKP N+LLD + + DFGL K
Sbjct: 101 YAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 2e-05
Identities = 39/157 (24%), Positives = 70/157 (44%), Gaps = 22/157 (14%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+ H N+++ + F + + +V E+ G+L E++ +L L +I
Sbjct: 56 LSHPNIIEYYEN-----FLEDKALMIVMEYAPGGTLAEYIQKRCNSL-----LDEDTILH 105
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDG-ELTAHVGDFGLAKFLPE--------ATN 289
L LHH I+H DLK N+LLD ++ +GDFG++K L T
Sbjct: 106 FFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTP 165
Query: 290 NFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKR 326
+ + ++ E G + D+++ G +L E + KR
Sbjct: 166 CYISPELCE---GKPYNQKSDIWALGCVLYELASLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 40/116 (34%), Positives = 57/116 (49%), Gaps = 14/116 (12%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
++H LV + S FQ + V ++ VNG E + H RE + + A
Sbjct: 53 LKHPFLVGLHYS-----FQTAEKLYFVLDY-VNGG-ELFFHLQRE--RCFLEPRARFYAA 103
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAK--FLPEATNNFF 292
+VASA+ YLH I++ DLKP N+LLD + + DFGL K PE T + F
Sbjct: 104 EVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTF 156
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 36/137 (26%), Positives = 55/137 (40%), Gaps = 41/137 (29%)
Query: 172 DLSRNNFIRHRNLVK-IITSCAS-------VDFQGNDSEALVYEFMVNGSLEEWLHPNRE 223
D+ + N I H + I+ S FQ + LV E+M G L
Sbjct: 38 DMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDL--------- 88
Query: 224 ALKNLNLLQRLSI---------AVDVASALDYLH--HYCETPIVHCDLKPSNVLLDGELT 272
+NLL R + ++ ALD +H + +H D+KP N+L+D
Sbjct: 89 ----MNLLIRKDVFPEETARFYIAELVLALDSVHKLGF-----IHRDIKPDNILIDA--D 137
Query: 273 AHV--GDFGLAKFLPEA 287
H+ DFGL K + +A
Sbjct: 138 GHIKLADFGLCKKMNKA 154
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 31/97 (31%), Positives = 50/97 (51%), Gaps = 9/97 (9%)
Query: 237 AVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAK--FLPEATNNFF-- 292
+ +++ AL++LH E I++ DLK NVLLD E + D+G+ K P T + F
Sbjct: 102 SAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCG 158
Query: 293 --NFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRP 327
N+ E G + S D ++ G+L+ E G+ P
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 40/186 (21%), Positives = 79/186 (42%), Gaps = 38/186 (20%)
Query: 174 SRNNFIR---------HRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREA 224
+R +F++ N+ +++ C + ++ E+M NG L ++L +
Sbjct: 62 AREDFLKEVKILSRLSDPNIARLLGVCTV-----DPPLCMIMEYMENGDLNQFLQKHVAE 116
Query: 225 LKNLNLLQR-------LSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGD 277
L + L +A +AS + YL VH DL N L+ T + D
Sbjct: 117 TSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIAD 173
Query: 278 FGLAKFLPEATNNFFNFQ---------IA-EYGMGSEVSTSGDVYSFGILLLETFT--GK 325
FG+++ L +++++ Q +A E + + +T DV++FG+ L E T +
Sbjct: 174 FGMSRNL--YSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCRE 231
Query: 326 RPTNEM 331
+P +
Sbjct: 232 QPYEHL 237
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 41/171 (23%), Positives = 69/171 (40%), Gaps = 45/171 (26%)
Query: 177 NFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSI 236
F H ++VK+I + +V E G L +L N+ +L +L+
Sbjct: 63 QF-DHPHIVKLIGVIT------ENPVWIVMELAPLGELRSYLQVNKYSLDLASLIL---Y 112
Query: 237 AVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL------------ 284
+ +++AL YL VH D+ NVL+ +GDFGL+++L
Sbjct: 113 SYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGK 169
Query: 285 -------PEATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRP 327
PE+ NF F +++ DV+ FG+ + E G +P
Sbjct: 170 LPIKWMAPESI-NFRRF-----------TSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 42/153 (27%), Positives = 69/153 (45%), Gaps = 20/153 (13%)
Query: 181 HRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDV 240
H N++ ++ C + +G S +V +M +G L ++ R N + + + V
Sbjct: 55 HPNVLSLLGIC--LPSEG--SPLVVLPYMKHGDLRNFI---RSETHNPTVKDLIGFGLQV 107
Query: 241 ASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPE----ATNNFFNFQI 296
A ++YL VH DL N +LD T V DFGLA+ + + + +N ++
Sbjct: 108 AKGMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKL 164
Query: 297 AEYGMGSE------VSTSGDVYSFGILLLETFT 323
M E +T DV+SFG+LL E T
Sbjct: 165 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 39/132 (29%), Positives = 57/132 (43%), Gaps = 13/132 (9%)
Query: 222 REALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLA 281
E L+L L + VA +D+L +H D+ NVLL A + DFGLA
Sbjct: 203 TEDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLA 259
Query: 282 KFLPEATNNFF--NFQIAEYGMGSE------VSTSGDVYSFGILLLETFT-GKRPTNEMF 332
+ + +N N ++ M E + DV+S+GILL E F+ GK P +
Sbjct: 260 RDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGIL 319
Query: 333 TGNLTLHNFVKE 344
N + VK
Sbjct: 320 V-NSKFYKMVKR 330
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 48/155 (30%), Positives = 69/155 (44%), Gaps = 31/155 (20%)
Query: 196 FQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPI 255
FQ + LV ++M G L + H +E + + IA ++ AL++LH Y I
Sbjct: 65 FQTDSDLYLVTDYMSGGEL--FWHLQKEG-RFSEDRAKFYIA-ELVLALEHLHKY---DI 117
Query: 256 VHCDLKPSNVLLDGELTAHVG--DFGLAK--FLPEATNNFF---------NFQIAEYGMG 302
V+ DLKP N+LLD T H+ DFGL+K T N F + E G
Sbjct: 118 VYRDLKPENILLDA--TGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYT 175
Query: 303 SEVSTSGDVYSFGILLLETFTGKRP-----TNEMF 332
V D +S G+L+ E G P T +M+
Sbjct: 176 KHV----DFWSLGVLVFEMCCGWSPFYAEDTQQMY 206
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 40/139 (28%), Positives = 62/139 (44%), Gaps = 14/139 (10%)
Query: 196 FQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPI 255
++ D+ LV M G L+ ++ EA + + A ++ L+ LH + I
Sbjct: 69 YETKDALCLVLTLMNGGDLKFHIYHMGEA--GFEEGRAVFYAAEICCGLEDLH---QERI 123
Query: 256 VHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIAEYG-MGSEV------STS 308
V+ DLKP N+LLD + D GLA +PE ++ G M EV + S
Sbjct: 124 VYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVGYMAPEVVKNERYTFS 181
Query: 309 GDVYSFGILLLETFTGKRP 327
D ++ G LL E G+ P
Sbjct: 182 PDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 3e-05
Identities = 38/176 (21%), Positives = 78/176 (44%), Gaps = 36/176 (20%)
Query: 174 SRNNF---------IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWL------ 218
+RN+F ++ N+++++ C + +D ++ E+M NG L ++L
Sbjct: 62 ARNDFLKEIKIMSRLKDPNIIRLLAVCIT-----SDPLCMITEYMENGDLNQFLSRHEPQ 116
Query: 219 -HPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGD 277
+ + ++ + +A +AS + YL VH DL N L+ T + D
Sbjct: 117 EAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIAD 173
Query: 278 FGLAKFLPEATNNFFNFQ----------IAEYGMGSEVSTSGDVYSFGILLLETFT 323
FG+++ L + +++ Q E + + +T+ DV++FG+ L E T
Sbjct: 174 FGMSRNL--YSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 38/149 (25%), Positives = 72/149 (48%), Gaps = 31/149 (20%)
Query: 204 LVYEFMVNGSLEEWL---HPNREA----------LKNLNLLQRLSIAVDVASALDYL-HH 249
+++E++ G L E+L P+ + +L+ L IA+ +A+ ++YL H
Sbjct: 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH 143
Query: 250 YCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQI----------AEY 299
+ VH DL N+L+ +L + D GL++ + A +++ Q E
Sbjct: 144 F----FVHKDLAARNILIGEQLHVKISDLGLSREIYSA--DYYRVQPKSLLPIRWMPPEA 197
Query: 300 GMGSEVSTSGDVYSFGILLLETFT-GKRP 327
M + S+ D++SFG++L E F+ G +P
Sbjct: 198 IMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 3e-05
Identities = 43/164 (26%), Positives = 74/164 (45%), Gaps = 26/164 (15%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLH---PNREALKNLNLLQRLS 235
++H N+V+ + + D+ + E + GSL + L E + L Q L
Sbjct: 59 LQHPNIVQYLGTERE-----EDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL 113
Query: 236 IAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQ 295
L+YLH + VH D+K +N+L+D + DFG+AK + + +F+
Sbjct: 114 -------GLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQV-VEFSFAKSFK 162
Query: 296 IAEYGMGSEV-------STSGDVYSFGILLLETFTGKRPTNEMF 332
+ Y M EV + D++S G +LE TGK P +++
Sbjct: 163 GSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE 206
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 16/39 (41%), Positives = 26/39 (66%), Gaps = 3/39 (7%)
Query: 244 LDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAK 282
L Y+H ++H DLKPSN+L++ + +GDFG+A+
Sbjct: 120 LKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR 155
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 29/99 (29%), Positives = 46/99 (46%), Gaps = 9/99 (9%)
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIAE 298
++ LDYLH +H D+K +NVLL + + DFG+A L + F
Sbjct: 109 EILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTP 165
Query: 299 YGMGSEV------STSGDVYSFGILLLETFTGKRPTNEM 331
+ M EV + D++S GI +E G+ P ++M
Sbjct: 166 FWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 49/168 (29%), Positives = 75/168 (44%), Gaps = 31/168 (18%)
Query: 182 RNLVKIITSCASVD----FQGNDSEALVYEFMVNGSLEEWLHPNREA--LKNLNLLQRLS 235
RN+++ + VD FQ L+ E++ G L ++H RE +++
Sbjct: 51 RNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL--FMHLEREGIFMEDTACFYLSE 108
Query: 236 IAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAK---FLPEATNNFF 292
I++ AL++LH I++ DLKP N+LLD + + DFGL K T+ F
Sbjct: 109 ISL----ALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC 161
Query: 293 NFQIAEYGMGSEVST-SG-----DVYSFGILLLETFTGKRPTNEMFTG 334
EY M E+ SG D +S G L+ + TG P FT
Sbjct: 162 G--TIEY-MAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP----FTA 202
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 4e-05
Identities = 35/133 (26%), Positives = 60/133 (45%), Gaps = 15/133 (11%)
Query: 204 LVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPS 263
LV + M G L +++ N++ + + +LL + V +A + YL E +VH DL
Sbjct: 85 LVTQLMPYGCLLDYVRENKDRIGSQDLL---NWCVQIAKGMSYLE---EVRLVHRDLAAR 138
Query: 264 NVLLDGELTAHVGDFGLAKFLPEATNNF--------FNFQIAEYGMGSEVSTSGDVYSFG 315
NVL+ + DFGLA+ L + + E + + DV+S+G
Sbjct: 139 NVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYG 198
Query: 316 ILLLETFT-GKRP 327
+ + E T G +P
Sbjct: 199 VTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 4e-05
Identities = 42/169 (24%), Positives = 73/169 (43%), Gaps = 22/169 (13%)
Query: 168 IENLDLSRNNFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKN 227
I+ +DL + + H N++K S F ++ +V E G L + + K
Sbjct: 50 IKEIDLLKQ--LNHPNVIKYYAS-----FIEDNELNIVLELADAGDLSRMI---KHFKKQ 99
Query: 228 LNLLQRLSI---AVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL 284
L+ ++ V + SAL+++H ++H D+KP+NV + +GD GL +F
Sbjct: 100 KRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156
Query: 285 PEATNNFFNFQIAEYGMGSE-VSTSG-----DVYSFGILLLETFTGKRP 327
T + Y M E + +G D++S G LL E + P
Sbjct: 157 SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 4e-05
Identities = 51/203 (25%), Positives = 87/203 (42%), Gaps = 52/203 (25%)
Query: 181 HRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLH--PN----REALKNLNLLQRL 234
H N+V++ C LV+E V+ L +L P E +K++ + Q L
Sbjct: 63 HPNVVRLFDVCTVSRTDRETKLTLVFEH-VDQDLTTYLDKVPEPGVPTETIKDM-MFQLL 120
Query: 235 SIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNF 294
LD+LH + +VH DLKP N+L+ + DFGLA+ ++F
Sbjct: 121 R-------GLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR--------IYSF 162
Query: 295 QIA-------------EYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNF 341
Q+A E + S +T D++S G + E F ++P +F G+ +
Sbjct: 163 QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKP---LFRGSSDV--- 215
Query: 342 VKEALPERLAEIVDPVLLVEREE 364
++L +I+D + L E+
Sbjct: 216 ------DQLGKILDVIGLPGEED 232
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 5e-05
Identities = 40/142 (28%), Positives = 62/142 (43%), Gaps = 19/142 (13%)
Query: 156 GNIPSSLSSLRGIENLDLSRNNFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLE 215
G IP +LR I+ L +H +VK++ F LV E+M L
Sbjct: 40 GGIP--NQALREIKALQA-----CQHPYVVKLLDV-----FPHGSGFVLVMEYMP-SDLS 86
Query: 216 EWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHV 275
E L R+ + L Q S + + Y+H I+H DLKP+N+L+ + +
Sbjct: 87 EVL---RDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKI 140
Query: 276 GDFGLAKFLPEATNNFFNFQIA 297
DFGLA+ E ++ Q+A
Sbjct: 141 ADFGLARLFSEEEPRLYSHQVA 162
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 5e-05
Identities = 43/152 (28%), Positives = 65/152 (42%), Gaps = 24/152 (15%)
Query: 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVD 239
RH N+V S + D +V E+ GSL++ R L L Q + +
Sbjct: 58 RHPNIVAYFGS-----YLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSEL---QIAYVCRE 109
Query: 240 VASALDYLHHYCETPIVHCDLKPSNVLL--DGELTAHVGDFGLAKFLPEATNNFFNFQIA 297
L YLH ET +H D+K +N+LL DG++ + DFG++ L +F
Sbjct: 110 TLKGLAYLH---ETGKIHRDIKGANILLTEDGDV--KLADFGVSAQLTATIAKRKSFIGT 164
Query: 298 EYGMGSEV----STSG-----DVYSFGILLLE 320
Y M EV G D+++ GI +E
Sbjct: 165 PYWMAPEVAAVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 5e-05
Identities = 29/107 (27%), Positives = 43/107 (40%), Gaps = 24/107 (22%)
Query: 228 LNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA 287
L + Q L I + L YLH I+H D+K N+ ++ +GD G A+F P
Sbjct: 154 LPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQF-PVV 209
Query: 288 TNNFFNFQIAEYGMGSEVSTSG-------------DVYSFGILLLET 321
F G+ V T+ D++S GI+L E
Sbjct: 210 APAF-------LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEM 249
|
Length = 357 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 6e-05
Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 32/168 (19%)
Query: 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQ----RLS 235
+ LVK++ + FQ ++ L E++ G R L NL +L R
Sbjct: 59 KSEWLVKLLYA-----FQDDEYLYLAMEYVPGGDF-------RTLLNNLGVLSEDHARFY 106
Query: 236 IAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHV--GDFGLAKFLPEATNNFF- 292
+A ++ A+D LH E +H DLKP N L+D + H+ DFGL+K + N+
Sbjct: 107 MA-EMFEAVDALH---ELGYIHRDLKPENFLIDA--SGHIKLTDFGLSKGIVTYANSVVG 160
Query: 293 --NFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRP-----TNEMFT 333
++ E G + D +S G +L E G P NE +
Sbjct: 161 SPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWE 208
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 6e-05
Identities = 34/87 (39%), Positives = 46/87 (52%), Gaps = 7/87 (8%)
Query: 196 FQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPI 255
FQ + V +F VNG E + H RE ++ + A ++ASAL YLH I
Sbjct: 65 FQTTEKLYFVLDF-VNGG-ELFFHLQRE--RSFPEPRARFYAAEIASALGYLH---SINI 117
Query: 256 VHCDLKPSNVLLDGELTAHVGDFGLAK 282
V+ DLKP N+LLD + + DFGL K
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 6e-05
Identities = 42/153 (27%), Positives = 67/153 (43%), Gaps = 19/153 (12%)
Query: 238 VDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIA 297
V +A AL YLH E I+H DLK NV L VGD G+A+ L E + + I
Sbjct: 109 VQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVL-ENQCDMASTLIG 164
Query: 298 E-YGMGSEVSTS------GDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEALPE-- 348
Y M E+ ++ DV++ G + E T K N +L ++ ++ LP
Sbjct: 165 TPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL-VYRIIEGKLPPMP 223
Query: 349 -----RLAEIVDPVLLVEREEGETSKANAHKQF 376
L E++ +L E+ + K+ + +
Sbjct: 224 KDYSPELGELIATMLSKRPEKRPSVKSILRQPY 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 6e-05
Identities = 41/138 (29%), Positives = 64/138 (46%), Gaps = 13/138 (9%)
Query: 196 FQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPI 255
FQ D V E+ VNG E + H +RE + + + + ++ SALDYLH I
Sbjct: 64 FQTKDRLCFVMEY-VNGG-ELFFHLSRERVFSED--RTRFYGAEIVSALDYLH---SGKI 116
Query: 256 VHCDLKPSNVLLDGELTAHVGDFGLAK--FLPEATNNFF----NFQIAEYGMGSEVSTSG 309
V+ DLK N++LD + + DFGL K AT F + E ++ +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAV 176
Query: 310 DVYSFGILLLETFTGKRP 327
D + G+++ E G+ P
Sbjct: 177 DWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 6e-05
Identities = 44/166 (26%), Positives = 70/166 (42%), Gaps = 33/166 (19%)
Query: 179 IRHRNLVKIITSCASVDFQG---NDSEA-LVYEFMVNGSLEEWLHPNREALKNLNLLQRL 234
+RH N +++++G + A LV E+ + GS + L +++ L+ + +
Sbjct: 72 LRHPN---------TIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIA--- 118
Query: 235 SIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNF 294
+I L YLH + +H D+K N+LL T + DFG A + A N+F
Sbjct: 119 AICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPA-NSFVG- 173
Query: 295 QIAEYGMGSEV---------STSGDVYSFGILLLETFTGKRPTNEM 331
Y M EV DV+S GI +E K P M
Sbjct: 174 --TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 7e-05
Identities = 48/207 (23%), Positives = 89/207 (42%), Gaps = 31/207 (14%)
Query: 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVD 239
+H N+V++ S + D +V EF+ G+L + + R +N Q ++ +
Sbjct: 75 QHENVVEMYNS-----YLVGDELWVVMEFLEGGALTDIVTHTR-----MNEEQIAAVCLA 124
Query: 240 VASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIAEY 299
V AL LH ++H D+K ++LL + + DFG + + + Y
Sbjct: 125 VLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPY 181
Query: 300 GMGSEVST------SGDVYSFGILLLETFTGKRPT-NEMFTGNLTLHNFVKEALPERLAE 352
M E+ + D++S GI+++E G+ P NE L +++ LP +L
Sbjct: 182 WMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---PPLKAMKMIRDNLPPKLKN 238
Query: 353 I--VDPVL------LVEREEGETSKAN 371
+ V P L L+ R+ + + A
Sbjct: 239 LHKVSPSLKGFLDRLLVRDPAQRATAA 265
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 7e-05
Identities = 47/172 (27%), Positives = 76/172 (44%), Gaps = 24/172 (13%)
Query: 172 DLSRNNFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLL 231
+++ +++++HRN+V+ + S + N + E + GSL L LK+ N
Sbjct: 55 EIALHSYLKHRNIVQYLGSDSE-----NGFFKIFMEQVPGGSLSALLRSKWGPLKD-NEQ 108
Query: 232 QRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDG-ELTAHVGDFGLAKFLP---EA 287
+ + L YLH + IVH D+K NVL++ + DFG +K L
Sbjct: 109 TIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC 165
Query: 288 TNNFFNFQIAEYGMGSEVSTSG--------DVYSFGILLLETFTGKRPTNEM 331
T F +Y M EV G D++S G ++E TGK P E+
Sbjct: 166 TETFTG--TLQY-MAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIEL 214
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 8e-05
Identities = 38/166 (22%), Positives = 73/166 (43%), Gaps = 16/166 (9%)
Query: 168 IENLDLSRNNFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKN 227
++ +DL + + H N++K + S F ++ +V E G L + + ++ +
Sbjct: 50 VKEIDLLKQ--LNHPNVIKYLDS-----FIEDNELNIVLELADAGDLSQMIKYFKKQKRL 102
Query: 228 LNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA 287
+ V + SA++++H ++H D+KP+NV + +GD GL +F
Sbjct: 103 IPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159
Query: 288 TNNFFNFQIAEYGMGSE-VSTSG-----DVYSFGILLLETFTGKRP 327
T + Y M E + +G D++S G LL E + P
Sbjct: 160 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 8e-05
Identities = 34/133 (25%), Positives = 60/133 (45%), Gaps = 15/133 (11%)
Query: 204 LVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPS 263
L+ + M G L +++ +++ + + LL + V +A ++YL E +VH DL
Sbjct: 85 LITQLMPFGCLLDYVREHKDNIGSQYLL---NWCVQIAKGMNYLE---ERRLVHRDLAAR 138
Query: 264 NVLLDGELTAHVGDFGLAKFLPEATNNF--------FNFQIAEYGMGSEVSTSGDVYSFG 315
NVL+ + DFGLAK L + + E + + DV+S+G
Sbjct: 139 NVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYG 198
Query: 316 ILLLETFT-GKRP 327
+ + E T G +P
Sbjct: 199 VTVWELMTFGSKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 8e-05
Identities = 50/163 (30%), Positives = 74/163 (45%), Gaps = 28/163 (17%)
Query: 207 EFMVNGSLE-EWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNV 265
EFM GSL+ P ++L R IAV V L YL I+H D+KPSN+
Sbjct: 79 EFMDGGSLDVYRKIPE-------HVLGR--IAVAVVKGLTYL---WSLKILHRDVKPSNM 126
Query: 266 LLDGELTAHVGDFGLAKFLPEATNNFF---NFQIA-EYGMGSEVSTSGDVYSFGILLLET 321
L++ + DFG++ L + + N +A E G + DV+S GI +E
Sbjct: 127 LVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMEL 186
Query: 322 FTGKRPTNEMFTGNLTLHNFVKEALPERLAE-IVD---PVLLV 360
G+ P ++ +L +P +L + IVD PVL V
Sbjct: 187 ALGRFPYPQIQKNQGSL-------MPLQLLQCIVDEDPPVLPV 222
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.7 bits (104), Expect = 8e-05
Identities = 32/105 (30%), Positives = 50/105 (47%), Gaps = 15/105 (14%)
Query: 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVD 239
H N+VK+ F+ ND V+E+M G+L + L +R+ K + SI
Sbjct: 56 EHPNIVKLKEV-----FRENDELYFVFEYM-EGNLYQ-LMKDRKG-KPFSESVIRSIIYQ 107
Query: 240 VASALDYLHH--YCETPIVHCDLKPSNVLLDGELTAHVGDFGLAK 282
+ L ++H + H DLKP N+L+ G + DFGLA+
Sbjct: 108 ILQGLAHIHKHGF-----FHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 9e-05
Identities = 41/138 (29%), Positives = 65/138 (47%), Gaps = 27/138 (19%)
Query: 204 LVYEFMVNGSLEEWL--HPNREALKN--LNLLQRLSIAVDVASALDYLHHYCETPIVHCD 259
LV+E++ L++++ ++ N L L Q L L Y H ++H D
Sbjct: 80 LVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLR-------GLAYCHQ---RRVLHRD 128
Query: 260 LKPSNVLLD--GELTAHVGDFGLAKFLPEATNNFFN------FQIAEYGMGS-EVSTSGD 310
LKP N+L+ GEL + DFGLA+ + + N ++ + +GS E STS D
Sbjct: 129 LKPQNLLISERGELK--LADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLD 186
Query: 311 VYSFGILLLETFTGKRPT 328
++ G + E TG RP
Sbjct: 187 MWGVGCIFYEMATG-RPL 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 39/157 (24%), Positives = 70/157 (44%), Gaps = 25/157 (15%)
Query: 181 HRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNR------------EALKNL 228
H N++ ++ +C + L E+ +G+L ++L +R L
Sbjct: 55 HPNIINLLGACEHRGYL-----YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 109
Query: 229 NLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAK----FL 284
+ Q L A DVA +DYL + +H DL N+L+ A + DFGL++ ++
Sbjct: 110 SSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 166
Query: 285 PEATNNFFNFQIAEYGMGSEV-STSGDVYSFGILLLE 320
+ +A + V +T+ DV+S+G+LL E
Sbjct: 167 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWE 203
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 1e-04
Identities = 22/92 (23%), Positives = 38/92 (41%), Gaps = 11/92 (11%)
Query: 196 FQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPI 255
+ + L+ E+ + G E L ++ ++ IA +A L LH +
Sbjct: 62 GESDGWSYLLMEW-IEG----------ETLDEVSEEEKEDIAEQLAELLAKLHQLPLLVL 110
Query: 256 VHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA 287
H DL P N+L+D + D+ A + P A
Sbjct: 111 CHGDLHPGNILVDDGKILGIIDWEYAGYGPPA 142
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 40/128 (31%), Positives = 63/128 (49%), Gaps = 29/128 (22%)
Query: 162 LSSLRGIENLDLSRNNFIRHRNLVKIITSCASVDFQGN-DSEALVYEFM---VNGSLEEW 217
++SLR I L L ++H N+V + V N D +V E++ + +E
Sbjct: 49 ITSLREINIL-LK----LQHPNIVTV----KEVVVGSNLDKIYMVMEYVEHDLKSLMETM 99
Query: 218 LHPNREA-LKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLD--GELTAH 274
P ++ +K L +LQ LS + +LH + I+H DLK SN+LL+ G L
Sbjct: 100 KQPFLQSEVKCL-MLQLLS-------GVAHLH---DNWILHRDLKTSNLLLNNRGILK-- 146
Query: 275 VGDFGLAK 282
+ DFGLA+
Sbjct: 147 ICDFGLAR 154
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 41/181 (22%), Positives = 76/181 (41%), Gaps = 44/181 (24%)
Query: 174 SRNNFIRH---------RNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLH----- 219
+RN+F++ N+++++ C D ++ E+M NG L ++L
Sbjct: 62 ARNDFLKEVKILSRLKDPNIIRLLGVCVD-----EDPLCMITEYMENGDLNQFLSSHHLD 116
Query: 220 ----------PNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDG 269
P L ++ L +A+ +AS + YL VH DL N L+
Sbjct: 117 DKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGE 173
Query: 270 ELTAHVGDFGLAKFLPEATNNFFNFQ----------IAEYGMGSEVSTSGDVYSFGILLL 319
LT + DFG+++ L +++ Q E + + +T+ DV++FG+ L
Sbjct: 174 NLTIKIADFGMSRNL--YAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLW 231
Query: 320 E 320
E
Sbjct: 232 E 232
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 41/143 (28%), Positives = 66/143 (46%), Gaps = 20/143 (13%)
Query: 196 FQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV-DVASALDYLHHYCETP 254
FQ + L+ +++ G L L RE K Q + I ++ AL++LH +
Sbjct: 74 FQTDTKLHLILDYINGGELFTHL-SQRERFKE----QEVQIYSGEIVLALEHLH---KLG 125
Query: 255 IVHCDLKPSNVLLDGELTAHVGDFGLAK-FLPEATNNFFNF-QIAEYGMGSEVSTSGDV- 311
I++ D+K N+LLD + DFGL+K F + ++F EY M ++ GD
Sbjct: 126 IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEY-MAPDIVRGGDGG 184
Query: 312 -------YSFGILLLETFTGKRP 327
+S G+L+ E TG P
Sbjct: 185 HDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 8/96 (8%)
Query: 237 AVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLA----KFLPEATNNFF 292
A ++ L+++H+ +V+ DLKP+N+LLD + D GLA K P A+
Sbjct: 103 ATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTH 159
Query: 293 NFQIAE-YGMGSEVSTSGDVYSFGILLLETFTGKRP 327
+ E G+ +S D +S G +L + G P
Sbjct: 160 GYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 39/138 (28%), Positives = 64/138 (46%), Gaps = 12/138 (8%)
Query: 196 FQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPI 255
FQ +D V E+ G L + H +RE + + + + ++ SALDYLH E +
Sbjct: 64 FQTHDRLCFVMEYANGGEL--FFHLSRERVFSED--RARFYGAEIVSALDYLH--SEKNV 117
Query: 256 VHCDLKPSNVLLDGELTAHVGDFGLAK--FLPEATNNFF----NFQIAEYGMGSEVSTSG 309
V+ DLK N++LD + + DFGL K AT F + E ++ +
Sbjct: 118 VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAV 177
Query: 310 DVYSFGILLLETFTGKRP 327
D + G+++ E G+ P
Sbjct: 178 DWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 1e-04
Identities = 32/97 (32%), Positives = 44/97 (45%), Gaps = 14/97 (14%)
Query: 244 LDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPE---ATNNFFNFQIAEYG 300
++YLH IVH D+K +N+L D +GDFG +K L + + Y
Sbjct: 117 VEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYW 173
Query: 301 MGSEVSTSG-------DVYSFGILLLETFTGKRPTNE 330
M EV SG DV+S G ++E T K P E
Sbjct: 174 MSPEV-ISGEGYGRKADVWSVGCTVVEMLTEKPPWAE 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 46/151 (30%), Positives = 74/151 (49%), Gaps = 25/151 (16%)
Query: 204 LVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV-DVASALDYLHHYCETPIVHCDLKP 262
LV+E++ + L+++L + NL + + I + + L Y H I+H DLKP
Sbjct: 80 LVFEYL-DSDLKQYL----DNCGNLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKP 131
Query: 263 SNVLLDGELTAHVGDFGLAKFLPEATNNFFN------FQIAEYGMGS-EVSTSGDVYSFG 315
N+L++ + + DFGLA+ T + N ++ + +GS E ST D++ G
Sbjct: 132 QNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVG 191
Query: 316 ILLLETFTGKRPTNEMFTGNLTLHNFVKEAL 346
+L E TG RP MF G+ VKE L
Sbjct: 192 CILYEMATG-RP---MFPGST-----VKEEL 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 34/110 (30%), Positives = 50/110 (45%), Gaps = 23/110 (20%)
Query: 243 ALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKF-LPEATNNFFNFQIAEYG- 300
L Y+H ++H DLKPSN+LL+ + DFGLA+ PE + F + EY
Sbjct: 118 GLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGF---LTEYVA 171
Query: 301 ---------M--GSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLH 339
M + + D++S G +L E + RP +F G LH
Sbjct: 172 TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RP---LFPGKDYLH 217
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 55/219 (25%), Positives = 93/219 (42%), Gaps = 38/219 (17%)
Query: 140 SCIRLEQLVMNGNF---FRG--NIPSSLSSLRGIENL-----DLSRNNFIR--------- 180
I++E+++ G F RG +PS I L D R F+
Sbjct: 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFD 64
Query: 181 HRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDV 240
H N+V++ V +GN + +V E+M NG+L+ +L R+ L Q + + +
Sbjct: 65 HSNIVRL----EGVITRGN-TMMIVTEYMSNGALDSFL---RKHEGQLVAGQLMGMLPGL 116
Query: 241 ASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGL-------AKFLPEATNNFFN 293
AS + YL E VH L VL++ +L + F A + + +
Sbjct: 117 ASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVL 173
Query: 294 FQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNEM 331
+ E S++ DV+SFGI++ E + G+RP +M
Sbjct: 174 WAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM 212
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 30/97 (30%), Positives = 46/97 (47%), Gaps = 9/97 (9%)
Query: 237 AVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAK--FLPEATNNFF-- 292
A +V AL +LH + +++ DLK N+LLD E + DFG+ K L T F
Sbjct: 102 AAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCG 158
Query: 293 --NFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRP 327
++ E E S D ++ G+L+ E G+ P
Sbjct: 159 TPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 37/138 (26%), Positives = 60/138 (43%), Gaps = 28/138 (20%)
Query: 208 FMVNGSLEEWLHPNR--EALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNV 265
FM +G L +L +R E L L + +D+AS ++YL +H DL N
Sbjct: 88 FMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNC 144
Query: 266 LLDGELTAHVGDFGLAKFLPEATNNFFNFQIAEYGMGSEV---------------STSGD 310
+L+ +T V DFGL+K ++ G S++ +T D
Sbjct: 145 MLNENMTVCVADFGLSK-------KIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSD 197
Query: 311 VYSFGILLLETFT-GKRP 327
V++FG+ + E T G+ P
Sbjct: 198 VWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 27/89 (30%), Positives = 42/89 (47%), Gaps = 8/89 (8%)
Query: 247 LHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFF--NFQIAEYGMGSE 304
+HH ++H D+K +N+LL +GDFG +K ++ F Y + E
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215
Query: 305 V------STSGDVYSFGILLLETFTGKRP 327
+ S D++S G+LL E T KRP
Sbjct: 216 IWRRKPYSKKADMFSLGVLLYELLTLKRP 244
|
Length = 496 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 32/116 (27%), Positives = 53/116 (45%), Gaps = 18/116 (15%)
Query: 225 LKNLNLLQRLSIAVDVASALDYL--------HHYCETPIVHCDLKPSNVLLDGELTAHVG 276
L + NL Q + + +D + YL H I+H DLKPSN+++ + T +
Sbjct: 110 LMDANLCQVIQMELD-HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 168
Query: 277 DFGLAK-----FL--PEATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGK 325
DFGLA+ F+ P ++ GMG + + D++S G ++ E G
Sbjct: 169 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENV--DIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 34/115 (29%), Positives = 52/115 (45%), Gaps = 15/115 (13%)
Query: 237 AVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAK--FLPEATNNFF-- 292
A ++A L +LH I++ DLK NV+LD E + DFG+ K T F
Sbjct: 107 AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCG 163
Query: 293 --NFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRP-----TNEMFTGNLTLHN 340
++ E S D ++FG+LL E G+ P +E+F ++ HN
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ-SIMEHN 217
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 36/137 (26%), Positives = 60/137 (43%), Gaps = 20/137 (14%)
Query: 204 LVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV---DVASALDYLHHYCETPIVHCDL 260
++ E++ GS + L P L+ IA ++ LDYLH + +H D+
Sbjct: 79 IIMEYLGGGSALDLLKPGP--------LEETYIATILREILKGLDYLHSERK---IHRDI 127
Query: 261 KPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIAEYGMGSEV------STSGDVYSF 314
K +NVLL + + DFG+A L + F + M EV D++S
Sbjct: 128 KAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSL 187
Query: 315 GILLLETFTGKRPTNEM 331
GI +E G+ P +++
Sbjct: 188 GITAIELAKGEPPNSDL 204
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 16/50 (32%), Positives = 30/50 (60%), Gaps = 3/50 (6%)
Query: 235 SIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL 284
+I D+ + L+Y+H + I H D+KP N+++DG ++ D+G+A
Sbjct: 130 NIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHF 176
|
Length = 294 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 3e-04
Identities = 29/94 (30%), Positives = 43/94 (45%), Gaps = 20/94 (21%)
Query: 244 LDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIAEYGMG- 302
L Y+H ++H DLKPSN+LL+ + DFGLA+ T + + EY +
Sbjct: 121 LKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLAR-----TTSEKGDFMTEYVVTR 172
Query: 303 -----------SEVSTSGDVYSFGILLLETFTGK 325
SE +T+ DV+S G + E K
Sbjct: 173 WYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 29/99 (29%), Positives = 49/99 (49%), Gaps = 14/99 (14%)
Query: 249 HYC-ETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIA-------EYG 300
H+C + IVH D+KP N+L+ + DFG A+ L E +N + +A E
Sbjct: 114 HWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELL 173
Query: 301 MGSEVSTSGDVYSFGILLLE------TFTGKRPTNEMFT 333
+G+ + D++S G +L E F G+ +++FT
Sbjct: 174 LGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFT 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 35/107 (32%), Positives = 47/107 (43%), Gaps = 14/107 (13%)
Query: 237 AVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAK--FLPEATNNFF-- 292
A ++ASAL YLH IV+ DLKP N+LLD + + DFGL K T + F
Sbjct: 102 AAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCG 158
Query: 293 --NFQIAEYGMGSEVSTSGDVYSFGILLLETFTG-----KRPTNEMF 332
+ E + D + G +L E G R T EM+
Sbjct: 159 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY 205
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 35/121 (28%), Positives = 50/121 (41%), Gaps = 17/121 (14%)
Query: 226 KNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLP 285
K L + +I L+YLH +H D+K N+LL+ E A + DFG++ L
Sbjct: 94 KTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQL- 149
Query: 286 EATNNFFNFQIAE-YGMGSEV-STSG-----DVYSFGILLLETFTGK------RPTNEMF 332
T N I + M EV G D++S GI +E GK P +F
Sbjct: 150 TDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF 209
Query: 333 T 333
Sbjct: 210 M 210
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 27/100 (27%), Positives = 42/100 (42%), Gaps = 14/100 (14%)
Query: 243 ALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIAEYGMG 302
AL++LH ++H DLK N+LL + + DFG++ F Y M
Sbjct: 115 ALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMA 171
Query: 303 SEV-----------STSGDVYSFGILLLETFTGKRPTNEM 331
EV D++S GI L+E + P +E+
Sbjct: 172 PEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL 211
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 30/98 (30%), Positives = 43/98 (43%), Gaps = 12/98 (12%)
Query: 237 AVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQI 296
A ++ L+ LH V+ DLKP N+LLD + D GLA +PE ++
Sbjct: 108 AAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG--ESIRGRV 162
Query: 297 AEYG-MGSEV------STSGDVYSFGILLLETFTGKRP 327
G M EV + S D + G L+ E G+ P
Sbjct: 163 GTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 3e-04
Identities = 31/87 (35%), Positives = 46/87 (52%), Gaps = 7/87 (8%)
Query: 196 FQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPI 255
FQ +D V E+ NG E + H +RE + + + R A ++ SAL YLH +
Sbjct: 64 FQTHDRLCFVMEY-ANGG-ELFFHLSRERVFSEDR-ARFYGA-EIVSALGYLH---SCDV 116
Query: 256 VHCDLKPSNVLLDGELTAHVGDFGLAK 282
V+ DLK N++LD + + DFGL K
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 3e-04
Identities = 36/135 (26%), Positives = 61/135 (45%), Gaps = 16/135 (11%)
Query: 200 DSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCD 259
D +V E++ GSL + + ++ Q ++ + AL++LH ++H D
Sbjct: 89 DELFVVMEYLAGGSLTDVVTET-----CMDEAQIAAVCRECLQALEFLH---ANQVIHRD 140
Query: 260 LKPSNVLLDGELTAHVGDFGL-AKFLPEATNNFFNFQIAEYGMGSEVSTSG------DVY 312
+K NVLL + + + DFG A+ PE + Y M EV T D++
Sbjct: 141 IKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR-STMVGTPYWMAPEVVTRKAYGPKVDIW 199
Query: 313 SFGILLLETFTGKRP 327
S GI+ +E G+ P
Sbjct: 200 SLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 41/133 (30%), Positives = 58/133 (43%), Gaps = 27/133 (20%)
Query: 155 RGNIPSSLSSLRGIENLDLSRNNFIRHRNLVKIITSCASVDFQGN--DSEALVYEFM--- 209
R IP +SSLR I L +RH N+V++ G DS LV E+
Sbjct: 46 RDGIP--ISSLREITLLLN-----LRHPNIVELKEVV-----VGKHLDSIFLVMEYCEQD 93
Query: 210 VNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDG 269
+ L+ P E+ Q + + + L YLH I+H DLK SN+LL
Sbjct: 94 LASLLDNMPTPFSES-------QVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTD 143
Query: 270 ELTAHVGDFGLAK 282
+ + DFGLA+
Sbjct: 144 KGCLKIADFGLAR 156
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 36/138 (26%), Positives = 61/138 (44%), Gaps = 13/138 (9%)
Query: 196 FQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPI 255
FQ +D V E+ G L + H +RE + + ++ SAL+YLH +
Sbjct: 64 FQTHDRLCFVMEYANGGEL--FFHLSRERVFTEE--RARFYGAEIVSALEYLH---SRDV 116
Query: 256 VHCDLKPSNVLLDGELTAHVGDFGLAK--FLPEATNNFF----NFQIAEYGMGSEVSTSG 309
V+ D+K N++LD + + DFGL K AT F + E ++ +
Sbjct: 117 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAV 176
Query: 310 DVYSFGILLLETFTGKRP 327
D + G+++ E G+ P
Sbjct: 177 DWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 4e-04
Identities = 19/50 (38%), Positives = 26/50 (52%), Gaps = 1/50 (2%)
Query: 7 NQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLIT-LNFAEN 55
N F G IP S+G L L+ L L N G +P+++G L NF +N
Sbjct: 476 NSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 54/228 (23%), Positives = 100/228 (43%), Gaps = 33/228 (14%)
Query: 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVD 239
+H+N+V++ S + + ++ EF+ G+L + + R LN Q ++
Sbjct: 76 QHQNVVEMYKS-----YLVGEELWVLMEFLQGGALTDIVSQTR-----LNEEQIATVCES 125
Query: 240 VASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIAEY 299
V AL YLH ++H D+K ++LL + + DFG + + + Y
Sbjct: 126 VLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPY 182
Query: 300 GMGSEV------STSGDVYSFGILLLETFTGKRPTNEMFTGN-LTLHNFVKEALPERL-- 350
M EV T D++S GI+++E G+ P F+ + + ++++ P +L
Sbjct: 183 WMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPP---YFSDSPVQAMKRLRDSPPPKLKN 239
Query: 351 AEIVDPVL------LVEREEGETSKANAHKQ--FTRSFSVKECLVSVL 390
A + PVL ++ RE E + A F + ECLV ++
Sbjct: 240 AHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLPECLVPLI 287
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 4e-04
Identities = 37/148 (25%), Positives = 63/148 (42%), Gaps = 12/148 (8%)
Query: 191 CASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHY 250
C S F D + + + M G L H ++ + + + A ++ L+++H+
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLH--YHLSQHGV--FSEAEMRFYAAEIILGLEHMHNR 116
Query: 251 CETPIVHCDLKPSNVLLDGELTAHVGDFGLA----KFLPEATNNFFNFQIAE-YGMGSEV 305
+V+ DLKP+N+LLD + D GLA K P A+ + E G
Sbjct: 117 F---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAY 173
Query: 306 STSGDVYSFGILLLETFTGKRPTNEMFT 333
+S D +S G +L + G P + T
Sbjct: 174 DSSADWFSLGCMLFKLLRGHSPFRQHKT 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 35/129 (27%), Positives = 59/129 (45%), Gaps = 23/129 (17%)
Query: 161 SLSSLRGIENLDLSRNNFIRHRNLVKIITSCASVDFQGNDSEA---LVYEFMVNGSLEEW 217
+++LR I+ L L ++H N+V +I C + N + LV+EF
Sbjct: 55 PITALREIKILQL-----LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE------- 102
Query: 218 LHPNREALKNLNLLQRLS----IAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTA 273
H L N N+ LS + + + L Y+H I+H D+K +N+L+ +
Sbjct: 103 -HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGIL 158
Query: 274 HVGDFGLAK 282
+ DFGLA+
Sbjct: 159 KLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 5e-04
Identities = 41/173 (23%), Positives = 71/173 (41%), Gaps = 36/173 (20%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREA-------------- 224
+ H +++K+ +C+ + L+ E+ GSL +L +R+
Sbjct: 60 VNHPHVIKLYGACSQ-----DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSS 114
Query: 225 ------LKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDF 278
+ L + +S A ++ + YL E +VH DL NVL+ + DF
Sbjct: 115 YLDNPDERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDF 171
Query: 279 GLAKFLPEATNNFFNFQ--IAEYGMGSE------VSTSGDVYSFGILLLETFT 323
GL++ + E + + I M E +T DV+SFG+LL E T
Sbjct: 172 GLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 5e-04
Identities = 25/60 (41%), Positives = 31/60 (51%), Gaps = 1/60 (1%)
Query: 47 LITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQL 106
L +L+ + N L + NL +LDLS NNLT +P GL SL LDLS N L
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLR-SLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 6e-04
Identities = 44/165 (26%), Positives = 72/165 (43%), Gaps = 20/165 (12%)
Query: 200 DSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCD 259
D +V E++ GSL + + ++ Q ++ + ALD+LH ++H D
Sbjct: 89 DELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALDFLH---SNQVIHRD 140
Query: 260 LKPSNVLLDGELTAHVGDFGL-AKFLPEATNNFFNFQIAEYGMGSEVSTSG------DVY 312
+K N+LL + + + DFG A+ PE + Y M EV T D++
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-STMVGTPYWMAPEVVTRKAYGPKVDIW 199
Query: 313 SFGILLLETFTGKRP---TNEMFTGNLTLHNFVKEAL-PERLAEI 353
S GI+ +E G+ P N + L N E PERL+ +
Sbjct: 200 SLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAV 244
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 6e-04
Identities = 46/164 (28%), Positives = 74/164 (45%), Gaps = 26/164 (15%)
Query: 181 HRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDV 240
H N+VK++ + F ++ ++ EF G+++ + E + L Q +
Sbjct: 61 HPNIVKLLDA-----FYYENNLWILIEFCAGGAVDAVM---LELERPLTEPQIRVVCKQT 112
Query: 241 ASALDYLHHYCETPIVHCDLKPSNVL--LDGELTAHVGDFGLAKFLPEATNNFFNFQIAE 298
AL+YLH E I+H DLK N+L LDG++ + DFG++ +F
Sbjct: 113 LEALNYLH---ENKIIHRDLKAGNILFTLDGDIK--LADFGVSAKNTRTIQRRDSFIGTP 167
Query: 299 YGMGSEV---STS--------GDVYSFGILLLETFTGKRPTNEM 331
Y M EV TS DV+S GI L+E + P +E+
Sbjct: 168 YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHEL 211
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 7e-04
Identities = 40/129 (31%), Positives = 58/129 (44%), Gaps = 37/129 (28%)
Query: 228 LNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLL-DGELTAHVGDFGLAK---- 282
L+ + + + VA+ +++L VH DL NVL+ +G+L + DFGLA+
Sbjct: 236 LSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLV-KICDFGLARDIMR 291
Query: 283 ----------FLP---EATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT------ 323
FLP A + FN + +T DV+SFGILL E FT
Sbjct: 292 DSNYISKGSTFLPLKWMAPESIFN---------NLYTTLSDVWSFGILLWEIFTLGGTPY 342
Query: 324 GKRPTNEMF 332
+ P NE F
Sbjct: 343 PELPMNEQF 351
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 7e-04
Identities = 32/98 (32%), Positives = 44/98 (44%), Gaps = 12/98 (12%)
Query: 237 AVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQI 296
A ++ L+ LH IV+ DLKP N+LLD + D GLA +PE ++
Sbjct: 108 AAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE--GETIRGRV 162
Query: 297 AEYG-MGSEV------STSGDVYSFGILLLETFTGKRP 327
G M EV + S D + G L+ E GK P
Sbjct: 163 GTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 7e-04
Identities = 37/144 (25%), Positives = 65/144 (45%), Gaps = 17/144 (11%)
Query: 195 DFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV---DVASALDYLHHYC 251
DF+ +D L+ E+ G L + + ++ LK Q + + + ALD +H
Sbjct: 133 DFKSDDKLLLIMEYGSGGDLNKQI---KQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK 189
Query: 252 ETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEAT--NNFFNFQIAEYGMGSEV---- 305
++H DLK +N+ L +GDFG +K ++ + +F Y + E+
Sbjct: 190 ---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERK 246
Query: 306 --STSGDVYSFGILLLETFTGKRP 327
S D++S G++L E T RP
Sbjct: 247 RYSKKADMWSLGVILYELLTLHRP 270
|
Length = 478 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 7e-04
Identities = 37/167 (22%), Positives = 62/167 (37%), Gaps = 41/167 (24%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEW-LHPN---REALKNLNLLQRL 234
+RH N+V + + F+ LV+E++ LE P +A++
Sbjct: 57 LRHENIVNLKEA-----FRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVR-------- 103
Query: 235 SIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNF 294
S + A+ Y H I+H D+KP N+L+ + DFG A+ L +
Sbjct: 104 SYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD 160
Query: 295 QIA--------------EYGMGSEVSTSGDVYSFGILLLETFTGKRP 327
+A YG DV++ G ++ E G P
Sbjct: 161 YVATRWYRAPELLVGDTNYGKPV------DVWAIGCIMAELLDG-EP 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 7e-04
Identities = 25/86 (29%), Positives = 41/86 (47%), Gaps = 11/86 (12%)
Query: 247 LHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFF--------NFQIAE 298
+ H I+H DLKPSN+++ + T + DFGLA+ A NF ++ E
Sbjct: 136 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TACTNFMMTPYVVTRYYRAPE 192
Query: 299 YGMGSEVSTSGDVYSFGILLLETFTG 324
+G + D++S G ++ E G
Sbjct: 193 VILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 8e-04
Identities = 17/44 (38%), Positives = 25/44 (56%), Gaps = 7/44 (15%)
Query: 244 LDYLHHYCETPIVHCDLKPSNVLLDGELTAH----VGDFGLAKF 283
+ YLH ++H DLKP+N+L+ GE +GD GLA+
Sbjct: 121 VHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 9e-04
Identities = 35/135 (25%), Positives = 63/135 (46%), Gaps = 19/135 (14%)
Query: 204 LVYEFMVNGSLEEWLHPNREALKN------LNLLQRLSIAVDVASALDYLHHYCETPIVH 257
+V E M +G L+ +L R +N L + + +A ++A + YL+ VH
Sbjct: 86 VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVH 142
Query: 258 CDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQ---IAEYGMGSE------VSTS 308
DL N ++ + T +GDFG+ + + E T+ + + M E +TS
Sbjct: 143 RDLAARNCMVAHDFTVKIGDFGMTRDIYE-TDYYRKGGKGLLPVRWMAPESLKDGVFTTS 201
Query: 309 GDVYSFGILLLETFT 323
D++SFG++L E +
Sbjct: 202 SDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 39/127 (30%), Positives = 56/127 (44%), Gaps = 13/127 (10%)
Query: 226 KNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLP 285
+ L L LS VA +++L VH DL NVLL + DFGLA+ +
Sbjct: 232 EGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIM 288
Query: 286 EATN------NFF--NFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNEMFTGNL 336
+N F + E + +T DV+S+GILL E F+ G P M +
Sbjct: 289 HDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS- 347
Query: 337 TLHNFVK 343
T +N +K
Sbjct: 348 TFYNKIK 354
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.001
Identities = 43/132 (32%), Positives = 55/132 (41%), Gaps = 37/132 (28%)
Query: 225 LKNLNLL----QRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGL 280
LKN+ L R+ A V AL+YLH+Y IVH DLKP N+L+ + DFGL
Sbjct: 92 LKNIGALPVDMARMYFAETVL-ALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGL 147
Query: 281 AKF-LPEATNNFFNFQIA---------------EY---------GMGSEVSTSGDVYSFG 315
+K L T N + I EY G G V D ++ G
Sbjct: 148 SKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPV----DWWAMG 203
Query: 316 ILLLETFTGKRP 327
I+L E G P
Sbjct: 204 IILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 40.5 bits (94), Expect = 0.001
Identities = 42/166 (25%), Positives = 63/166 (37%), Gaps = 17/166 (10%)
Query: 178 FIRHRNLVKIITSCASVDFQGNDSEA-LVYEFMVNGSLEEWLHPNREALKNLNLLQRLSI 236
+ HRN+ + + G D + LV EF GS+ + + + N L+ I
Sbjct: 59 YSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG-----NTLKEEWI 113
Query: 237 AVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQI 296
A L L H + ++H D+K NVLL + DFG++ L F
Sbjct: 114 AYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIG 173
Query: 297 AEYGMGSEV-----------STSGDVYSFGILLLETFTGKRPTNEM 331
Y M EV D++S GI +E G P +M
Sbjct: 174 TPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 219
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.001
Identities = 28/107 (26%), Positives = 49/107 (45%), Gaps = 14/107 (13%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLH-PNREALKNLNLLQRLSIA 237
+RH NLV +I F+ LV+EF+ + L++ PN L+ +
Sbjct: 57 LRHENLVNLIEV-----FRRKKRLYLVFEFVDHTVLDDLEKYPN-----GLDESRVRKYL 106
Query: 238 VDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL 284
+ +++ H + I+H D+KP N+L+ + DFG A+ L
Sbjct: 107 FQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL 150
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 33/132 (25%), Positives = 53/132 (40%), Gaps = 16/132 (12%)
Query: 204 LVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPS 263
LV M G L+ H + L + + + + + + +LH IV+ D+KP
Sbjct: 70 LVMSLMNGGDLK--YHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPE 124
Query: 264 NVLLDGELTAHVGDFGLAKFLPE--------ATNNFFNFQIAEYGMGSEVSTSGDVYSFG 315
NVLLD + + D GLA L + TN + +I S D ++ G
Sbjct: 125 NVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEIL---KEEPYSYPVDWFAMG 181
Query: 316 ILLLETFTGKRP 327
+ E G+ P
Sbjct: 182 CSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 34/135 (25%), Positives = 62/135 (45%), Gaps = 19/135 (14%)
Query: 204 LVYEFMVNGSLEEWLHPNREALKN------LNLLQRLSIAVDVASALDYLHHYCETPIVH 257
++ E M G L+ +L R ++N +L + + +A ++A + YL+ VH
Sbjct: 86 VIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVH 142
Query: 258 CDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNF---------FNFQIAEYGMGSEVSTS 308
DL N ++ + T +GDFG+ + + E T+ + + E +T
Sbjct: 143 RDLAARNCMVAEDFTVKIGDFGMTRDIYE-TDYYRKGGKGLLPVRWMSPESLKDGVFTTY 201
Query: 309 GDVYSFGILLLETFT 323
DV+SFG++L E T
Sbjct: 202 SDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 39/154 (25%), Positives = 61/154 (39%), Gaps = 15/154 (9%)
Query: 177 NFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSI 236
N+I H V + S F+ LV EF++ G +L N+ ++
Sbjct: 86 NYINHPFCVNLYGS-----FKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCF----Y 136
Query: 237 AVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFF---N 293
A + +YL IV+ DLKP N+LLD + + DFG AK + T
Sbjct: 137 AAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLCGTPE 193
Query: 294 FQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRP 327
+ E + + D ++ GI + E G P
Sbjct: 194 YIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 47/161 (29%), Positives = 70/161 (43%), Gaps = 26/161 (16%)
Query: 187 IITSCAS---VDFQGN-DSEALVY---EFMVNGSLEE-WLHPNREALKNLNLLQRLSIAV 238
I+ S VDF G E VY E+M GSL++ + ++L+R I
Sbjct: 52 ILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRR--ITY 109
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIAE 298
V L +L E I+H D+KP+NVL++G + DFG++ L A+ N
Sbjct: 110 AVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNL-VASLAKTNIGCQS 166
Query: 299 YGMGSE------------VSTSGDVYSFGILLLETFTGKRP 327
Y M E + DV+S G+ +LE G+ P
Sbjct: 167 Y-MAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.001
Identities = 36/146 (24%), Positives = 61/146 (41%), Gaps = 15/146 (10%)
Query: 181 HRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDV 240
H +VK S F D+ ++ E+ L+ L + K L+ Q + +
Sbjct: 61 HPAIVKFHAS-----FLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQL 115
Query: 241 ASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIAEYG 300
+ Y+H + I+H DLK N+ L L +GDFG+++ L + + F Y
Sbjct: 116 LLGVHYMH---QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLATTFTGTPYY 171
Query: 301 MGSEV------STSGDVYSFGILLLE 320
M E + D++S G +L E
Sbjct: 172 MSPEALKHQGYDSKSDIWSLGCILYE 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.001
Identities = 50/206 (24%), Positives = 85/206 (41%), Gaps = 42/206 (20%)
Query: 169 ENLDLSRNNFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNL 228
E +DL ++ ++H N+V+ + +C +++ ++ EF+ GS+ L
Sbjct: 51 EEVDLLKS--LKHVNIVQYLGTCLD-----DNTISIFMEFVPGGSISS-------ILNRF 96
Query: 229 NLLQRLSIAVDVASALD---YLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLP 285
L LD YLH+ C +VH D+K +NV+L + DFG A+ L
Sbjct: 97 GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153
Query: 286 EATNNFFNFQIAE------YGMGSEV-STSG-----DVYSFGILLLETFTGKRPTNEM-- 331
+ + + + Y M EV + SG D++S G + E TGK P M
Sbjct: 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR 213
Query: 332 -----FTGNLTLHNFVKEALPERLAE 352
+ G H + LP+ +
Sbjct: 214 LAAMFYIGA---HRGLMPRLPDSFSA 236
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 30/97 (30%), Positives = 44/97 (45%), Gaps = 9/97 (9%)
Query: 237 AVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAK--FLPEATNNFF-- 292
A ++A L +LH I++ DLK NV+LD E + DFG+ K T F
Sbjct: 107 AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCG 163
Query: 293 --NFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRP 327
++ E S D ++FG+LL E G+ P
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.002
Identities = 33/130 (25%), Positives = 60/130 (46%), Gaps = 32/130 (24%)
Query: 205 VYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSN 264
+Y FM + + + W +R LK Q +I + A++Y+H + ++H D+K N
Sbjct: 249 LYSFMYDEAFD-W--KDRPLLK-----QTRAIMKQLLCAVEYIH---DKKLIHRDIKLEN 297
Query: 265 VLLDGELTAHVGDFGLAKFLPEATNNFFNFQIA-EYGMGSEVSTSG-------------D 310
+ L+ + +GDFG A F + A +YG V+T+ D
Sbjct: 298 IFLNCDGKIVLGDFGTA-------MPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITD 350
Query: 311 VYSFGILLLE 320
++S G++LL+
Sbjct: 351 IWSCGLILLD 360
|
Length = 501 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.002
Identities = 35/135 (25%), Positives = 61/135 (45%), Gaps = 16/135 (11%)
Query: 200 DSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCD 259
D +V E++ GSL + + ++ Q ++ + AL++LH ++H D
Sbjct: 90 DELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLH---SNQVIHRD 141
Query: 260 LKPSNVLLDGELTAHVGDFGL-AKFLPEATNNFFNFQIAEYGMGSEVSTSG------DVY 312
+K N+LL + + + DFG A+ PE + Y M EV T D++
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-STMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 313 SFGILLLETFTGKRP 327
S GI+ +E G+ P
Sbjct: 201 SLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.002
Identities = 37/143 (25%), Positives = 58/143 (40%), Gaps = 16/143 (11%)
Query: 197 QGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIV 256
+ + + E+M GS+++ L +A L + + YLH IV
Sbjct: 76 RAEKTLTIFMEYMPGGSVKDQL----KAYGALTESVTRKYTRQILEGMSYLH---SNMIV 128
Query: 257 HCDLKPSNVLLDGELTAHVGDFGLAKFLPE---ATNNFFNFQIAEYGMGSEVST------ 307
H D+K +N+L D +GDFG +K L + + Y M EV +
Sbjct: 129 HRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGR 188
Query: 308 SGDVYSFGILLLETFTGKRPTNE 330
DV+S G ++E T K P E
Sbjct: 189 KADVWSLGCTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 34/117 (29%), Positives = 56/117 (47%), Gaps = 24/117 (20%)
Query: 218 LHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLD--GELTAHV 275
LHP L LL+ L+ Y+H I+H DLKP N+L+ GEL +
Sbjct: 100 LHPYNVRLFMFQLLRGLA----------YIHG---QHILHRDLKPQNLLISYLGELK--L 144
Query: 276 GDFGLA--KFLPEATNN----FFNFQIAEYGMGS-EVSTSGDVYSFGILLLETFTGK 325
DFGLA K +P T + ++ + +G+ + S++ D++ G + +E G+
Sbjct: 145 ADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.002
Identities = 42/136 (30%), Positives = 56/136 (41%), Gaps = 24/136 (17%)
Query: 200 DSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCD 259
DS LV + G L W H ++ ++R A ++ ALD LH IV D
Sbjct: 58 DSVFLVLQHAEGGKL--WSHISKFLNIPEECVKRW--AAEMVVALDALH---REGIVCRD 110
Query: 260 LKPSNVLLDGELTAHVGDFGLAKFLP----------EATNNFFNFQIAEYGMGSEVSTSG 309
L P+N+LLD G L F EA N + E G SE + +
Sbjct: 111 LNPNNILLD-----DRGHIQLTYFSRWSEVEDSCDGEAVENMYC--APEVGGISEETEAC 163
Query: 310 DVYSFGILLLETFTGK 325
D +S G +L E TGK
Sbjct: 164 DWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.002
Identities = 28/96 (29%), Positives = 45/96 (46%), Gaps = 11/96 (11%)
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGL-AKFLPEATNNFFNFQIA 297
+ AL++LH ++H D+K N+LL + + + DFG A+ PE +
Sbjct: 123 ECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR-STMVGT 178
Query: 298 EYGMGSEVSTSG------DVYSFGILLLETFTGKRP 327
Y M EV T D++S GI+ +E G+ P
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.002
Identities = 34/108 (31%), Positives = 48/108 (44%), Gaps = 28/108 (25%)
Query: 243 ALDYLHHYCETPIVHCDLKPSNVL--LDGELTAHVGDFGLAKFLPEATNNFFNFQ--IAE 298
L Y+H ++H DLKP N+L D EL + DFGLA+ E N + E
Sbjct: 117 GLKYIH---SANVLHRDLKPGNLLVNADCELK--ICDFGLARGFSE---NPGENAGFMTE 168
Query: 299 YG----------MGS--EVSTSGDVYSFGILLLETFTGKRPTNEMFTG 334
Y M S + + DV+S G +L E G++P +F G
Sbjct: 169 YVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAE-LLGRKP---VFKG 212
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.002
Identities = 25/96 (26%), Positives = 46/96 (47%), Gaps = 15/96 (15%)
Query: 240 VASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPE---------ATNN 290
+ SA+ Y+H + I+H D+K N+ L +GDFG++K L T
Sbjct: 110 IVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPY 166
Query: 291 FFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKR 326
+ + ++ + G + + D+++ G +L E T KR
Sbjct: 167 YMSPELCQ---GVKYNFKSDIWALGCVLYELLTLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.002
Identities = 28/108 (25%), Positives = 47/108 (43%), Gaps = 16/108 (14%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEW-LHPNREALKNLNLLQRLSIA 237
++H NLV +I F+ LV+E+ + L E +P + I
Sbjct: 57 LKHPNLVNLIEV-----FRRKRKLHLVFEYCDHTVLNELEKNPR-----GVPEHLIKKII 106
Query: 238 VDVASALDYLH-HYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL 284
A+++ H H C +H D+KP N+L+ + + DFG A+ L
Sbjct: 107 WQTLQAVNFCHKHNC----IHRDVKPENILITKQGQIKLCDFGFARIL 150
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 38/106 (35%), Positives = 53/106 (50%), Gaps = 3/106 (2%)
Query: 12 RIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNL 71
+ S+ +L L L L NK ++P SIGNL+ L TL+ + N + S SSLG NL
Sbjct: 223 ELLSSLSNLKNLSGLELSNNKL-EDLPESIGNLSNLETLDLSNNQI--SSISSLGSLTNL 279
Query: 72 ILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGIL 117
LDLS N+L+ P + L L + L+L L N +L
Sbjct: 280 RELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKALELKLNSILL 325
|
Length = 394 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 26/99 (26%), Positives = 47/99 (47%), Gaps = 17/99 (17%)
Query: 244 LDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIAEYGMGS 303
L Y+H I+H DLKP N+ ++ + + DFGLA+ + + + + +
Sbjct: 131 LKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QTDSEMTGYVVTRWYRAP 184
Query: 304 EV-------STSGDVYSFGILLLETFTGKRPTNEMFTGN 335
EV + + D++S G ++ E TGK +F G+
Sbjct: 185 EVILNWMHYTQTVDIWSVGCIMAEMLTGK----PLFKGH 219
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.003
Identities = 43/144 (29%), Positives = 61/144 (42%), Gaps = 25/144 (17%)
Query: 196 FQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPI 255
FQ D V EF+ G L + +R + + A ++ SAL +LH + I
Sbjct: 65 FQTPDRLFFVMEFVNGGDLMFHIQKSRR----FDEARARFYAAEITSALMFLH---DKGI 117
Query: 256 VHCDLKPSNVLLDGELTAHVGDFGLAK---FLPEATNNFFN---------FQIAEYGMGS 303
++ DLK NVLLD E + DFG+ K F + T+ F Q YG
Sbjct: 118 IYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYG--- 174
Query: 304 EVSTSGDVYSFGILLLETFTGKRP 327
S D ++ G+LL E G P
Sbjct: 175 ---PSVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.003
Identities = 45/157 (28%), Positives = 61/157 (38%), Gaps = 37/157 (23%)
Query: 196 FQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYL-------H 248
FQ D+ LV E+ G L L+LL R D A YL H
Sbjct: 70 FQDKDNLYLVMEYQPGGDL-------------LSLLNRYEDQFDEDMAQFYLAELVLAIH 116
Query: 249 HYCETPIVHCDLKPSNVLLDGELTAHV--GDFGLA----------KFLPEATNNFFNFQI 296
+ VH D+KP NVL+D T H+ DFG A LP T ++ ++
Sbjct: 117 SVHQMGYVHRDIKPENVLID--RTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEV 174
Query: 297 AEYGMGSEVSTSG---DVYSFGILLLETFTGKRPTNE 330
G T G D +S G++ E G+ P +E
Sbjct: 175 LTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE 211
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.003
Identities = 30/111 (27%), Positives = 50/111 (45%), Gaps = 18/111 (16%)
Query: 225 LKNLNLLQRLSIAVDVASALDYL--------HHYCETPIVHCDLKPSNVLLDGELTAHVG 276
L + NL Q + + +D + YL H I+H DLKPSN+++ + T +
Sbjct: 103 LMDANLCQVIQMELD-HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 161
Query: 277 DFGLAK-------FLPEATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLE 320
DFGLA+ P ++ GMG + + D++S G ++ E
Sbjct: 162 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENV--DIWSVGCIMGE 210
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.003
Identities = 42/163 (25%), Positives = 61/163 (37%), Gaps = 17/163 (10%)
Query: 181 HRNLVKIITSCASVDFQGNDSEA-LVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVD 239
HRN+ + G+D + LV EF GS+ + + + N L+ IA
Sbjct: 72 HRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG-----NALKEDWIAYI 126
Query: 240 VASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIAEY 299
L L H ++H D+K NVLL + DFG++ L F Y
Sbjct: 127 CREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY 186
Query: 300 GMGSEV-----------STSGDVYSFGILLLETFTGKRPTNEM 331
M EV D++S GI +E G P +M
Sbjct: 187 WMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.003
Identities = 36/138 (26%), Positives = 59/138 (42%), Gaps = 13/138 (9%)
Query: 196 FQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPI 255
FQ D V E++ G L + + + Q + A +++ L +LH I
Sbjct: 70 FQTVDRLYFVMEYVNGGDLMYHI----QQVGKFKEPQAVFYAAEISVGLFFLH---RRGI 122
Query: 256 VHCDLKPSNVLLDGELTAHVGDFGLAK--FLPEATNNFF----NFQIAEYGMGSEVSTSG 309
++ DLK NV+LD E + DFG+ K + T F ++ E S
Sbjct: 123 IYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSV 182
Query: 310 DVYSFGILLLETFTGKRP 327
D +++G+LL E G+ P
Sbjct: 183 DWWAYGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.003
Identities = 29/105 (27%), Positives = 50/105 (47%), Gaps = 16/105 (15%)
Query: 234 LSIAVDVASALDYL--HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGL------AKFLP 285
+ I +A+ +++L HH +VH DL NVL+ +L + D GL A +
Sbjct: 127 VHIVTQIAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYK 181
Query: 286 EATNNFF--NFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRP 327
N+ + E M + S D++S+G++L E F+ G +P
Sbjct: 182 LMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.004
Identities = 56/257 (21%), Positives = 99/257 (38%), Gaps = 56/257 (21%)
Query: 177 NFIRHRNLVKIITSCASVDFQG----NDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQ 232
+ I+ ++ I S++++G + LV E+ + GS + L +++ L+ + +
Sbjct: 71 DIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA- 128
Query: 233 RLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFF 292
+I L YLH + ++H D+K N+LL + DFG A A N+F
Sbjct: 129 --AITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA-NSFV 182
Query: 293 NFQIAEYGMGSEVSTSG---------DVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVK 343
Y M EV + DV+S GI +E K P M + H
Sbjct: 183 G---TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH---- 235
Query: 344 EALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRE 403
+ + E T ++N + R+F V CL ++P++
Sbjct: 236 ----------------IAQNESPTLQSNEWSDYFRNF-VDSCL-----------QKIPQD 267
Query: 404 RMNMEEVAAQLLSFRNK 420
R EE+ + R +
Sbjct: 268 RPTSEELLKHMFVLRER 284
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.004
Identities = 33/114 (28%), Positives = 52/114 (45%), Gaps = 20/114 (17%)
Query: 218 LHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGD 277
LHP L LL+ LS Y+H + I+H DLKP N+L+ + D
Sbjct: 100 LHPENVKLFLFQLLRGLS----------YIH---QRYILHRDLKPQNLLISDTGELKLAD 146
Query: 278 FGLAKFLPEATNNFFN------FQIAEYGMGS-EVSTSGDVYSFGILLLETFTG 324
FGLA+ ++ + N ++ + +GS E ST D++ G + +E G
Sbjct: 147 FGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.4 bits (90), Expect = 0.004
Identities = 16/34 (47%), Positives = 23/34 (67%), Gaps = 1/34 (2%)
Query: 250 YCET-PIVHCDLKPSNVLLDGELTAHVGDFGLAK 282
YC + ++H DLKP N+L+D E + DFGLA+
Sbjct: 114 YCHSHRVLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.004
Identities = 27/79 (34%), Positives = 35/79 (44%), Gaps = 7/79 (8%)
Query: 255 IVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIAEYGMGSEV------STS 308
IV+ DLKP N+LLD + D GLA +PE Y M EV + S
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGY-MAPEVINNEKYTFS 181
Query: 309 GDVYSFGILLLETFTGKRP 327
D + G L+ E G+ P
Sbjct: 182 PDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 427 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.98 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.98 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.98 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.98 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.98 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.98 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.98 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.98 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.98 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.98 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.98 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.98 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.98 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.98 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.98 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.98 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.98 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.98 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.97 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.97 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.97 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.97 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.97 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.97 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.97 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.97 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.97 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.97 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.97 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.97 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.97 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.97 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.97 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.97 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.97 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.97 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.97 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.97 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.97 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.97 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.97 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.97 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.97 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.97 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.97 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.97 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.97 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.97 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.97 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.97 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.97 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.97 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.97 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.97 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.97 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.97 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.97 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.97 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.97 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.97 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.97 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.97 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.97 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.97 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.97 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.96 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.96 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.96 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.96 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.96 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.96 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.96 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.96 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.96 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.96 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.96 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.96 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.96 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.96 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.96 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.96 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.96 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.96 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.96 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.96 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.96 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.96 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.96 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.96 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.96 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.96 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.96 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.95 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.95 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.95 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.95 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.95 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.94 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.94 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.94 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.94 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.94 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.91 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.91 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.9 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.89 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.89 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.88 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.88 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.87 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.85 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.85 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.84 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.83 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.82 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.8 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.76 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.75 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.75 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.74 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.74 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.74 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.74 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.72 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.72 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.68 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.68 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.67 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.64 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.61 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.61 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.6 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.6 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.58 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.57 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.57 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.55 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.55 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.55 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.51 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.51 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.5 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.49 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.49 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.49 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.49 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.48 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.48 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.45 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.45 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.45 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.42 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.42 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.4 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.39 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.31 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.28 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.27 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.26 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.26 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.25 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.17 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.16 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.15 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.15 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.15 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.12 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.1 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.06 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 99.01 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.01 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 98.99 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.96 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.89 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.89 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.87 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.82 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.82 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.76 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.74 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.74 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.7 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.65 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.63 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.61 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.57 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.5 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.45 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.45 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.43 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.4 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.39 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.39 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 98.32 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.31 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.31 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.26 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.25 | |
| KOG1644 | 233 | consensus U2-associated snRNP A' protein [RNA proc | 98.18 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.15 | |
| PRK15386 | 426 | type III secretion protein GogB; Provisional | 98.14 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.12 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.09 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-57 Score=488.25 Aligned_cols=387 Identities=30% Similarity=0.526 Sum_probs=277.1
Q ss_pred eeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccC
Q 042634 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNL 81 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~ 81 (427)
|||++|.++|.+|..+..+++|+.|+|++|++.+.+|..+ ..++|+.|++++|+++|.+|..+..+++|++|++++|++
T Consensus 433 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l 511 (968)
T PLN00113 433 LDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKL 511 (968)
T ss_pred EECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcc
Confidence 3444444444444444445555555555555554444433 335666666677777777777777777777888888888
Q ss_pred cccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCCCC
Q 042634 82 TGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSS 161 (427)
Q Consensus 82 ~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~~ 161 (427)
++.+|..+.++.+| +.|+|++|+++|.+|..+..+++|+.|+|++|+++|.+|..+.++.+|+.+++++|.+.+.+|..
T Consensus 512 ~~~~p~~~~~l~~L-~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~ 590 (968)
T PLN00113 512 SGEIPDELSSCKKL-VSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPST 590 (968)
T ss_pred eeeCChHHcCccCC-CEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCc
Confidence 77777777777777 56888888888888888888888888888888888888888888888888888888877655531
Q ss_pred c--cc-----------------------ccC--------------------------------------Cce--------
Q 042634 162 L--SS-----------------------LRG--------------------------------------IEN-------- 170 (427)
Q Consensus 162 l--~~-----------------------l~~--------------------------------------L~~-------- 170 (427)
- .. +.. .+.
T Consensus 591 ~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 670 (968)
T PLN00113 591 GAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTW 670 (968)
T ss_pred chhcccChhhhcCCccccCCccccCCCCCccccccceeeeehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccccccc
Confidence 0 00 000 000
Q ss_pred -ee------------------------ccCCc------------------------------------ccccccchhhhc
Q 042634 171 -LD------------------------LSRNN------------------------------------FIRHRNLVKIIT 189 (427)
Q Consensus 171 -L~------------------------L~~N~------------------------------------ll~Hpniv~~~~ 189 (427)
+. ++... -++|||||++++
T Consensus 671 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~ 750 (968)
T PLN00113 671 ELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIG 750 (968)
T ss_pred cccccccccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEE
Confidence 00 00000 057999999999
Q ss_pred cccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccccCCceeeCC
Q 042634 190 SCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDG 269 (427)
Q Consensus 190 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrDlkp~NIll~~ 269 (427)
+|.. ....++||||+++|+|.++++ .+++.++..++.|+|+|++|||+.++.+|+||||||+||+++.
T Consensus 751 ~~~~-----~~~~~lv~Ey~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~ 818 (968)
T PLN00113 751 LCRS-----EKGAYLIHEYIEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDG 818 (968)
T ss_pred EEEc-----CCCCEEEEeCCCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECC
Confidence 8754 456799999999999999984 2788999999999999999999766679999999999999999
Q ss_pred CCceEecccccccccC--CcCCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccCCCccHHHHHHHhcc
Q 042634 270 ELTAHVGDFGLAKFLP--EATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEALP 347 (427)
Q Consensus 270 ~~~~kL~DFG~a~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 347 (427)
++.+++. ||.+.... ....++..|+|||++.+..++.++|||||||++|||++|+.||+........+.++.+....
T Consensus 819 ~~~~~~~-~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 897 (968)
T PLN00113 819 KDEPHLR-LSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYS 897 (968)
T ss_pred CCceEEE-eccccccccCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcC
Confidence 8888775 66654432 22367889999999999999999999999999999999999997655555555555544332
Q ss_pred c-chhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHH
Q 042634 348 E-RLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAAQLLSFRNK 420 (427)
Q Consensus 348 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~~~~~ 420 (427)
. .....+|+.+... .....++..++.+++.+||+.||++||||+||+++|+++.+.
T Consensus 898 ~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 898 DCHLDMWIDPSIRGD-----------------VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred ccchhheeCccccCC-----------------CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 1 1222333322110 012344567889999999999999999999999999998763
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=331.34 Aligned_cols=203 Identities=32% Similarity=0.463 Sum_probs=169.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCC-eee
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETP-IVH 257 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~-ivH 257 (427)
++|||||+++|+|.... ...++||||+++|+|.++++... ...+++..++.++.|||+||+||| +.+ |||
T Consensus 96 l~HpNIV~f~G~~~~~~----~~~~iVtEy~~~GsL~~~l~~~~--~~~l~~~~~l~~aldiArGm~YLH---~~~~iIH 166 (362)
T KOG0192|consen 96 LRHPNIVQFYGACTSPP----GSLCIVTEYMPGGSLSVLLHKKR--KRKLPLKVRLRIALDIARGMEYLH---SEGPIIH 166 (362)
T ss_pred CCCCCeeeEEEEEcCCC----CceEEEEEeCCCCcHHHHHhhcc--cCCCCHHHHHHHHHHHHHHHHHHh---cCCCeee
Confidence 78999999999987621 15799999999999999998741 256999999999999999999999 788 999
Q ss_pred ccccCCceeeCCCC-ceEecccccccccCCc------CCCccccccccccC--CCCcCccccchhHHHHHHHHHhCCCCC
Q 042634 258 CDLKPSNVLLDGEL-TAHVGDFGLAKFLPEA------TNNFFNFQIAEYGM--GSEVSTSGDVYSFGILLLETFTGKRPT 328 (427)
Q Consensus 258 rDlkp~NIll~~~~-~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~--~~~~~~~~DiwS~G~vl~ell~g~~pf 328 (427)
|||||+|||++.++ ++||+|||+++..... ..||..|||||++. ...|+.|+||||||+++|||+||+.||
T Consensus 167 rDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf 246 (362)
T KOG0192|consen 167 RDLKSDNILVDLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPF 246 (362)
T ss_pred cccChhhEEEcCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCC
Confidence 99999999999997 9999999999876532 38999999999999 568999999999999999999999999
Q ss_pred CcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 042634 329 NEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME 408 (427)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ 408 (427)
.+... .......+....+ ...+..|+..+..+|.+||+.||++||++.
T Consensus 247 ~~~~~-~~~~~~v~~~~~R-------------------------------p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ 294 (362)
T KOG0192|consen 247 EDLAP-VQVASAVVVGGLR-------------------------------PPIPKECPPHLSSLMERCWLVDPSRRPSFL 294 (362)
T ss_pred CCCCH-HHHHHHHHhcCCC-------------------------------CCCCccCCHHHHHHHHHhCCCCCCcCCCHH
Confidence 87533 1111111111111 112344788899999999999999999999
Q ss_pred HHHHHHHHHHHHHH
Q 042634 409 EVAAQLLSFRNKLV 422 (427)
Q Consensus 409 ev~~~L~~~~~~~~ 422 (427)
|++..|+.+...+.
T Consensus 295 ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 295 EIVSRLESIMSHIS 308 (362)
T ss_pred HHHHHHHHHHHhhc
Confidence 99999999987654
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=315.15 Aligned_cols=196 Identities=24% Similarity=0.309 Sum_probs=162.8
Q ss_pred cccccchhhhccccccCCCCCC-ccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 042634 179 IRHRNLVKIITSCASVDFQGND-SEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVH 257 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivH 257 (427)
.+||+||++++.+.. +. ..+++||||++|||.+++... +++++...-+++.++++||.|||+ +++|||
T Consensus 134 ~~spyIV~~ygaF~~-----~~~~isI~mEYMDgGSLd~~~k~~----g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIH 202 (364)
T KOG0581|consen 134 CQSPYIVGFYGAFYS-----NGEEISICMEYMDGGSLDDILKRV----GRIPEPVLGKIARAVLRGLSYLHE--ERKIIH 202 (364)
T ss_pred CCCCCeeeEeEEEEe-----CCceEEeehhhcCCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhh--ccCeee
Confidence 479999999999644 44 589999999999999998765 459999999999999999999995 489999
Q ss_pred ccccCCceeeCCCCceEecccccccccCCcC----CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccC
Q 042634 258 CDLKPSNVLLDGELTAHVGDFGLAKFLPEAT----NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFT 333 (427)
Q Consensus 258 rDlkp~NIll~~~~~~kL~DFG~a~~~~~~~----~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~ 333 (427)
|||||+|||++..|.+||||||+++.+.... +||..|||||.+.+..|+.++||||||++++|+++|+.||.....
T Consensus 203 RDIKPsNlLvNskGeVKicDFGVS~~lvnS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~ 282 (364)
T KOG0581|consen 203 RDIKPSNLLVNSKGEVKICDFGVSGILVNSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP 282 (364)
T ss_pred ccCCHHHeeeccCCCEEeccccccHHhhhhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC
Confidence 9999999999999999999999999875544 899999999999999999999999999999999999999986523
Q ss_pred CCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchH-HHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 334 GNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVK-ECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
....+.+.+.....+.- +. .+. .++.++.+++..|++.||.+|||+.|+++
T Consensus 283 ~~~~~~~Ll~~Iv~~pp---------------------------P~-lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 283 PYLDIFELLCAIVDEPP---------------------------PR-LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred CCCCHHHHHHHHhcCCC---------------------------CC-CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 33333333322221100 00 122 37788999999999999999999999987
Q ss_pred H
Q 042634 413 Q 413 (427)
Q Consensus 413 ~ 413 (427)
+
T Consensus 335 H 335 (364)
T KOG0581|consen 335 H 335 (364)
T ss_pred C
Confidence 5
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=318.46 Aligned_cols=216 Identities=38% Similarity=0.653 Sum_probs=181.4
Q ss_pred cccccchhhhccccccCCCCCC-ccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 042634 179 IRHRNLVKIITSCASVDFQGND-SEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVH 257 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivH 257 (427)
++|||+|+++|+|.+ .. ..++|+|||++|+|.++++..... .++|..+++|+.++|+||+|||+.+...|+|
T Consensus 128 l~H~Nlv~LlGyC~e-----~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiH 200 (361)
T KOG1187|consen 128 LRHPNLVKLLGYCLE-----GGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIH 200 (361)
T ss_pred CCCcCcccEEEEEec-----CCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEec
Confidence 569999999999976 23 589999999999999999876532 7899999999999999999999866668999
Q ss_pred ccccCCceeeCCCCceEecccccccccCC-cC------CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCc
Q 042634 258 CDLKPSNVLLDGELTAHVGDFGLAKFLPE-AT------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNE 330 (427)
Q Consensus 258 rDlkp~NIll~~~~~~kL~DFG~a~~~~~-~~------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~ 330 (427)
|||||+|||+|+++.+||+|||+|+..+. .. .||.+|+|||+...+..+.|+|||||||++.|+++|+.+.+.
T Consensus 201 rDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~ 280 (361)
T KOG1187|consen 201 RDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQ 280 (361)
T ss_pred CCCCHHHeeECCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCC
Confidence 99999999999999999999999987764 32 689999999999999999999999999999999999988875
Q ss_pred cc-CCCccHHHHHHHhcc-cchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 042634 331 MF-TGNLTLHNFVKEALP-ERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME 408 (427)
Q Consensus 331 ~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ 408 (427)
.. .+...+..|+...+. ..+.+++|+.+.... .....+..++..++.+|++.+|++||+|.
T Consensus 281 ~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~-----------------~~~~~~~~~~~~~a~~C~~~~~~~RP~m~ 343 (361)
T KOG1187|consen 281 SRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGE-----------------YPDEKEVKKLAELALRCLRPDPKERPTMS 343 (361)
T ss_pred CCCcccccHHHHHHHHHHCcchhheeCCCccCCC-----------------CChHHHHHHHHHHHHHHcCcCCCcCcCHH
Confidence 43 334446676655544 368888888765211 01125677799999999999999999999
Q ss_pred HHHHHHHHHH
Q 042634 409 EVAAQLLSFR 418 (427)
Q Consensus 409 ev~~~L~~~~ 418 (427)
||++.|+.+.
T Consensus 344 ~Vv~~L~~~~ 353 (361)
T KOG1187|consen 344 QVVKELEGIL 353 (361)
T ss_pred HHHHHHHhhc
Confidence 9999996654
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=317.84 Aligned_cols=198 Identities=30% Similarity=0.474 Sum_probs=167.2
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|++||+++++|.. +...+||||||+.|+|.++++.... ..+...+.+.++.|||+|++||. ++++|||
T Consensus 258 L~H~~lV~l~gV~~~-----~~piyIVtE~m~~GsLl~yLr~~~~--~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHR 327 (468)
T KOG0197|consen 258 LRHEKLVKLYGVCTK-----QEPIYIVTEYMPKGSLLDYLRTREG--GLLNLPQLLDFAAQIAEGMAYLE---SKNYIHR 327 (468)
T ss_pred CcccCeEEEEEEEec-----CCceEEEEEecccCcHHHHhhhcCC--CccchHHHHHHHHHHHHHHHHHH---hCCccch
Confidence 789999999999866 3468999999999999999987333 56888999999999999999999 9999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC-------CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCCc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT-------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~-------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~~ 330 (427)
||.++||||+++..+||+|||+|+...++. .-+..|.|||.+....++.|||||||||+|||++| |+.||.+
T Consensus 328 DLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ 407 (468)
T KOG0197|consen 328 DLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPG 407 (468)
T ss_pred hhhhhheeeccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCC
Confidence 999999999999999999999999654332 33457999999999999999999999999999999 9999876
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
+.. .+.+.. ++ ...+...|+.||.+++++|..||+.+|++||||+.+
T Consensus 408 msn-----~ev~~~---------le-------------------~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L 454 (468)
T KOG0197|consen 408 MSN-----EEVLEL---------LE-------------------RGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETL 454 (468)
T ss_pred CCH-----HHHHHH---------Hh-------------------ccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHH
Confidence 522 111111 11 112233677799999999999999999999999999
Q ss_pred HHHHHHHHH
Q 042634 411 AAQLLSFRN 419 (427)
Q Consensus 411 ~~~L~~~~~ 419 (427)
...|+++..
T Consensus 455 ~~~l~~~~~ 463 (468)
T KOG0197|consen 455 REVLEDFFT 463 (468)
T ss_pred HHHHHHhhh
Confidence 999988765
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=289.33 Aligned_cols=202 Identities=20% Similarity=0.264 Sum_probs=163.5
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCC--ee
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETP--IV 256 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~--iv 256 (427)
++|||||++++.... .++...+||||||.+|||.++++......+.+++..+++++.|++.||.++|+.. .. |+
T Consensus 75 L~HpNIVqYy~~~f~---~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~Vm 150 (375)
T KOG0591|consen 75 LNHPNIVQYYAHSFI---EDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVM 150 (375)
T ss_pred cCCchHHHHHHHhhh---ccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-ccccee
Confidence 689999999984211 2234489999999999999999877766788999999999999999999999532 34 89
Q ss_pred eccccCCceeeCCCCceEecccccccccCCcC------CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCc
Q 042634 257 HCDLKPSNVLLDGELTAHVGDFGLAKFLPEAT------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNE 330 (427)
Q Consensus 257 HrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~ 330 (427)
||||||.||+++.+|.+||+|||+++.+.... +||+.||+||.+.+.+|+.|+||||+||++|||+.-.+||.+
T Consensus 151 HRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g 230 (375)
T KOG0591|consen 151 HRDIKPANIFLTANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYG 230 (375)
T ss_pred eccCcchheEEcCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccc
Confidence 99999999999999999999999999987765 899999999999999999999999999999999999999986
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
. .+.+...+.-..+. +..+....+.++.+++..|+..||+.||+...+
T Consensus 231 ~-----n~~~L~~KI~qgd~---------------------------~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~ 278 (375)
T KOG0591|consen 231 D-----NLLSLCKKIEQGDY---------------------------PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPY 278 (375)
T ss_pred c-----cHHHHHHHHHcCCC---------------------------CCCcHHHhhhHHHHHHHHHccCCcccCCCcchH
Confidence 3 22222222111110 011335677889999999999999999986555
Q ss_pred HHHHHH
Q 042634 411 AAQLLS 416 (427)
Q Consensus 411 ~~~L~~ 416 (427)
+..+..
T Consensus 279 v~di~~ 284 (375)
T KOG0591|consen 279 VQDIQS 284 (375)
T ss_pred HHHHHH
Confidence 544443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=307.61 Aligned_cols=194 Identities=24% Similarity=0.312 Sum_probs=159.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||++.+.+.. ....|+||||++||+|++++-.+ +.+.+...+.+++|++.|+.||| +.||+||
T Consensus 233 L~HP~IV~~~d~f~~-----~ds~YmVlE~v~GGeLfd~vv~n----k~l~ed~~K~~f~Qll~avkYLH---~~GI~HR 300 (475)
T KOG0615|consen 233 LSHPNIVRIKDFFEV-----PDSSYMVLEYVEGGELFDKVVAN----KYLREDLGKLLFKQLLTAVKYLH---SQGIIHR 300 (475)
T ss_pred cCCCCEEEEeeeeec-----CCceEEEEEEecCccHHHHHHhc----cccccchhHHHHHHHHHHHHHHH---HcCcccc
Confidence 789999999998544 55679999999999999998766 44888889999999999999999 9999999
Q ss_pred cccCCceeeCCC---CceEecccccccccCCcC-----CCccccccccccCCCCc---CccccchhHHHHHHHHHhCCCC
Q 042634 259 DLKPSNVLLDGE---LTAHVGDFGLAKFLPEAT-----NNFFNFQIAEYGMGSEV---STSGDVYSFGILLLETFTGKRP 327 (427)
Q Consensus 259 Dlkp~NIll~~~---~~~kL~DFG~a~~~~~~~-----~~~~~y~aPE~~~~~~~---~~~~DiwS~G~vl~ell~g~~p 327 (427)
||||+|||+..+ ..+||+|||+|+...+.. +||+.|.|||++.+..+ ..++||||+|||+|-+++|.+|
T Consensus 301 DiKPeNILl~~~~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pP 380 (475)
T KOG0615|consen 301 DIKPENILLSNDAEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPP 380 (475)
T ss_pred cCCcceEEeccCCcceEEEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCC
Confidence 999999999665 789999999999987554 99999999999987654 3478999999999999999999
Q ss_pred CCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCH
Q 042634 328 TNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM 407 (427)
Q Consensus 328 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~ 407 (427)
|.+......-..+..+..+. ..+..+.+..++..+++.+||..||++|||+
T Consensus 381 FS~~~~~~sl~eQI~~G~y~-----------------------------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~ 431 (475)
T KOG0615|consen 381 FSEEYTDPSLKEQILKGRYA-----------------------------FGPLQWDRISEEALDLINWMLVVDPENRPSA 431 (475)
T ss_pred cccccCCccHHHHHhcCccc-----------------------------ccChhhhhhhHHHHHHHHHhhEeCcccCcCH
Confidence 98753332122221111111 0112445678889999999999999999999
Q ss_pred HHHHHH
Q 042634 408 EEVAAQ 413 (427)
Q Consensus 408 ~ev~~~ 413 (427)
+|++++
T Consensus 432 ~eaL~h 437 (475)
T KOG0615|consen 432 DEALNH 437 (475)
T ss_pred HHHhcC
Confidence 999864
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=318.02 Aligned_cols=189 Identities=25% Similarity=0.328 Sum_probs=160.5
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||++++. |++.+..|+|.|+|+.++|..+++.+ +.+++.+++.+++||+.||.||| +.+|+||
T Consensus 75 L~HpnIV~f~~~-----FEDs~nVYivLELC~~~sL~el~Krr----k~ltEpEary~l~QIv~GlkYLH---~~~IiHR 142 (592)
T KOG0575|consen 75 LKHPNIVQFYHF-----FEDSNNVYIVLELCHRGSLMELLKRR----KPLTEPEARYFLRQIVEGLKYLH---SLGIIHR 142 (592)
T ss_pred cCCCcEEeeeeE-----eecCCceEEEEEecCCccHHHHHHhc----CCCCcHHHHHHHHHHHHHHHHHH---hcCceec
Confidence 789999999998 55578999999999999999999844 67999999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
|||..|++++++.++||+|||+|..+... .+||+.|.|||++....++..+||||+||+||-|+.|++||+...
T Consensus 143 DLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~ 222 (592)
T KOG0575|consen 143 DLKLGNLFLNENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT 222 (592)
T ss_pred ccchhheeecCcCcEEecccceeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch
Confidence 99999999999999999999999988643 299999999999999999999999999999999999999998531
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
+.+-... .-..++ ..|.....+..+|+.++|+.||.+|||+++|+.
T Consensus 223 -----vkety~~------------Ik~~~Y-----------------~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 223 -----VKETYNK------------IKLNEY-----------------SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred -----HHHHHHH------------HHhcCc-----------------ccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1111111 000000 023345667899999999999999999999986
Q ss_pred H
Q 042634 413 Q 413 (427)
Q Consensus 413 ~ 413 (427)
+
T Consensus 269 h 269 (592)
T KOG0575|consen 269 H 269 (592)
T ss_pred C
Confidence 4
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=313.77 Aligned_cols=216 Identities=21% Similarity=0.345 Sum_probs=179.9
Q ss_pred cccccCCceeeccCCcccccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHH
Q 042634 162 LSSLRGIENLDLSRNNFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVA 241 (427)
Q Consensus 162 l~~l~~L~~L~L~~N~ll~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~ 241 (427)
+...+.|..-++.+-.-++|||||.+.++|.. ..-+|||||||..|-|+.+|+.. ..++......+.++||
T Consensus 152 VKKV~elkETdIKHLRkLkH~NII~FkGVCtq-----sPcyCIiMEfCa~GqL~~VLka~----~~itp~llv~Wsk~IA 222 (904)
T KOG4721|consen 152 VKKVRELKETDIKHLRKLKHPNIITFKGVCTQ-----SPCYCIIMEFCAQGQLYEVLKAG----RPITPSLLVDWSKGIA 222 (904)
T ss_pred hHHHhhhhhhhHHHHHhccCcceeeEeeeecC-----CceeEEeeeccccccHHHHHhcc----CccCHHHHHHHHHHhh
Confidence 33444555555655566899999999999977 45789999999999999999877 4588889999999999
Q ss_pred HHHHHHhhcCCCCeeeccccCCceeeCCCCceEecccccccccCCcC-----CCccccccccccCCCCcCccccchhHHH
Q 042634 242 SALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEAT-----NNFFNFQIAEYGMGSEVSTSGDVYSFGI 316 (427)
Q Consensus 242 ~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~y~aPE~~~~~~~~~~~DiwS~G~ 316 (427)
.|+.||| .+.|||||||.-||||..+..+||+|||.++...+.. +||..|||||++...+.+.|+|||||||
T Consensus 223 ~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGV 299 (904)
T KOG4721|consen 223 GGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGV 299 (904)
T ss_pred hhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHH
Confidence 9999999 8999999999999999999999999999999765432 8999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhc
Q 042634 317 LLLETFTGKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTC 396 (427)
Q Consensus 317 vl~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c 396 (427)
|||||+||..||.+.......+ .. ...-.....+..|++.|.-|++.|
T Consensus 300 VLWEmLT~EiPYkdVdssAIIw-----GV---------------------------GsNsL~LpvPstcP~GfklL~Kqc 347 (904)
T KOG4721|consen 300 VLWEMLTGEIPYKDVDSSAIIW-----GV---------------------------GSNSLHLPVPSTCPDGFKLLLKQC 347 (904)
T ss_pred HHHHHHhcCCCccccchheeEE-----ec---------------------------cCCcccccCcccCchHHHHHHHHH
Confidence 9999999999998643221110 00 000111226778999999999999
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHH
Q 042634 397 SSELPRERMNMEEVAAQLLSFRNKL 421 (427)
Q Consensus 397 l~~dP~~Rpt~~ev~~~L~~~~~~~ 421 (427)
|+..|..||+|.+|+.+|+-...++
T Consensus 348 w~sKpRNRPSFrqil~HldIa~pel 372 (904)
T KOG4721|consen 348 WNSKPRNRPSFRQILLHLDIASPEL 372 (904)
T ss_pred HhcCCCCCccHHHHHHHHhhcCHHH
Confidence 9999999999999999999876654
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=298.95 Aligned_cols=218 Identities=15% Similarity=0.168 Sum_probs=161.4
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeecc
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCD 259 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrD 259 (427)
.|||||++.+++.+ .....++||||| ..+|+++++.++ +.|++..++.|+.||++||+|+| .+|+.|||
T Consensus 67 ~hpniikL~Evi~d----~~~~L~fVfE~M-d~NLYqLmK~R~---r~fse~~irnim~QilqGL~hiH---k~GfFHRD 135 (538)
T KOG0661|consen 67 PHPNIIKLKEVIRD----NDRILYFVFEFM-DCNLYQLMKDRN---RLFSESDIRNIMYQILQGLAHIH---KHGFFHRD 135 (538)
T ss_pred CCCcchhhHHHhhc----cCceEeeeHHhh-hhhHHHHHhhcC---CcCCHHHHHHHHHHHHHHHHHHH---hcCccccc
Confidence 49999999998644 223889999999 779999998874 67999999999999999999999 99999999
Q ss_pred ccCCceeeCCCCceEecccccccccCCcC-----CCccccccccccCC-CCcCccccchhHHHHHHHHHhCCCCCCcccC
Q 042634 260 LKPSNVLLDGELTAHVGDFGLAKFLPEAT-----NNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETFTGKRPTNEMFT 333 (427)
Q Consensus 260 lkp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~ 333 (427)
+||||||+.....+||+|||+||.+.... +.|.+|+|||++.. .-|+.++|+||+|||++|+++-++.|.+..+
T Consensus 136 lKPENiLi~~~~~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE 215 (538)
T KOG0661|consen 136 LKPENILISGNDVIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE 215 (538)
T ss_pred CChhheEecccceeEecccccccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcH
Confidence 99999999999999999999999887655 77889999999865 6689999999999999999999999987533
Q ss_pred CCccHHHHHHHhcccchhcccCccccccccccchhhhccccc-cccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 334 GNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQ-FTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
-+ .+.+...-...+......... ..........+.-++ ......+. ++.++.+++.+|++|||.+||||+|+++
T Consensus 216 ~D-qi~KIc~VLGtP~~~~~~eg~---~La~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~ 290 (538)
T KOG0661|consen 216 ID-QIYKICEVLGTPDKDSWPEGY---NLASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQ 290 (538)
T ss_pred HH-HHHHHHHHhCCCccccchhHH---HHHHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence 22 222222211111100000000 000000000000000 01112223 7788999999999999999999999987
Q ss_pred H
Q 042634 413 Q 413 (427)
Q Consensus 413 ~ 413 (427)
+
T Consensus 291 ~ 291 (538)
T KOG0661|consen 291 H 291 (538)
T ss_pred C
Confidence 4
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=293.88 Aligned_cols=141 Identities=30% Similarity=0.513 Sum_probs=129.8
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||++++++.. .+..|+|||||.||||.+|++.+. .+++..++.++.|+|.||++|| +++||||
T Consensus 66 l~H~nIV~l~d~~~~-----~~~i~lVMEyC~gGDLs~yi~~~~----~l~e~t~r~Fm~QLA~alq~L~---~~~IiHR 133 (429)
T KOG0595|consen 66 LKHPNIVRLLDCIED-----DDFIYLVMEYCNGGDLSDYIRRRG----RLPEATARHFMQQLASALQFLH---ENNIIHR 133 (429)
T ss_pred cCCcceeeEEEEEec-----CCeEEEEEEeCCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCeeec
Confidence 569999999998654 568999999999999999998773 5999999999999999999999 9999999
Q ss_pred cccCCceeeCCC------CceEecccccccccCCcC-----CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCC
Q 042634 259 DLKPSNVLLDGE------LTAHVGDFGLAKFLPEAT-----NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRP 327 (427)
Q Consensus 259 Dlkp~NIll~~~------~~~kL~DFG~a~~~~~~~-----~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~p 327 (427)
||||+|||++.. -.+||+|||+|+.+..+. +|++.|||||+++...|+.|+|+||.|+|+|++++|+.|
T Consensus 134 DLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~P 213 (429)
T KOG0595|consen 134 DLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPP 213 (429)
T ss_pred cCCcceEEeccCCCCCCCceEEecccchhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCC
Confidence 999999999764 579999999999987665 899999999999999999999999999999999999999
Q ss_pred CCcc
Q 042634 328 TNEM 331 (427)
Q Consensus 328 f~~~ 331 (427)
|+..
T Consensus 214 f~a~ 217 (429)
T KOG0595|consen 214 FDAE 217 (429)
T ss_pred cccc
Confidence 9853
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=297.39 Aligned_cols=191 Identities=21% Similarity=0.306 Sum_probs=159.9
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
.+|+|||.+++.+.. .+..|+|||||+||+|.+.+.... +++.++..|++++++||+||| .+||+||
T Consensus 327 ~~H~NiVnfl~Sylv-----~deLWVVMEym~ggsLTDvVt~~~-----~~E~qIA~Icre~l~aL~fLH---~~gIiHr 393 (550)
T KOG0578|consen 327 LHHPNIVNFLDSYLV-----GDELWVVMEYMEGGSLTDVVTKTR-----MTEGQIAAICREILQGLKFLH---ARGIIHR 393 (550)
T ss_pred ccchHHHHHHHHhcc-----cceeEEEEeecCCCchhhhhhccc-----ccHHHHHHHHHHHHHHHHHHH---hcceeee
Confidence 679999999998654 467999999999999999987653 899999999999999999999 9999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
|||.+|||++.++.+||+|||++..+... .+||+.|||||+.....|++|+||||||++++||+-|.+||-..
T Consensus 394 DIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE- 472 (550)
T KOG0578|consen 394 DIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNE- 472 (550)
T ss_pred ccccceeEeccCCcEEEeeeeeeeccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCC-
Confidence 99999999999999999999999876543 38999999999999999999999999999999999999998642
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
........+.....+.+. .++.....+.+++.+||+.||++|||+.|+++
T Consensus 473 -~PlrAlyLIa~ng~P~lk-----------------------------~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 473 -NPLRALYLIATNGTPKLK-----------------------------NPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred -ChHHHHHHHhhcCCCCcC-----------------------------CccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 111111122222221111 23445677999999999999999999999987
Q ss_pred H
Q 042634 413 Q 413 (427)
Q Consensus 413 ~ 413 (427)
+
T Consensus 523 H 523 (550)
T KOG0578|consen 523 H 523 (550)
T ss_pred C
Confidence 5
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=284.89 Aligned_cols=182 Identities=27% Similarity=0.342 Sum_probs=151.3
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
.+||.||+++.. |++....|+|+||+.||.|+.+|++. ..+++..++-++.+|+.||.||| +.|||||
T Consensus 82 v~hPFiv~l~ys-----FQt~~kLylVld~~~GGeLf~hL~~e----g~F~E~~arfYlaEi~lAL~~LH---~~gIiyR 149 (357)
T KOG0598|consen 82 IKHPFIVKLIYS-----FQTEEKLYLVLDYLNGGELFYHLQRE----GRFSEDRARFYLAEIVLALGYLH---SKGIIYR 149 (357)
T ss_pred CCCCcEeeeEEe-----cccCCeEEEEEeccCCccHHHHHHhc----CCcchhHHHHHHHHHHHHHHHHH---hCCeeec
Confidence 689999999877 67788999999999999999999866 45999999999999999999999 9999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+|||+|.+|+++|+|||+|+..-.. .+||+.|||||++.+.+|+.++|+||+||++|||++|.+||....
T Consensus 150 DlKPENILLd~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~ 229 (357)
T KOG0598|consen 150 DLKPENILLDEQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED 229 (357)
T ss_pred cCCHHHeeecCCCcEEEeccccchhcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc
Confidence 99999999999999999999999954222 289999999999999999999999999999999999999997631
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCC
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERM 405 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rp 405 (427)
..++........+ ...+.-.+.+..+++.+.++.||++|-
T Consensus 230 -----~~~~~~~I~~~k~----------------------------~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 230 -----VKKMYDKILKGKL----------------------------PLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred -----HHHHHHHHhcCcC----------------------------CCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 1122222211110 001111345578899999999999995
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=296.43 Aligned_cols=189 Identities=23% Similarity=0.341 Sum_probs=158.3
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
..||.||+++-. |++....|+|+||+++|+|.+++++. ..|++..++.++.||+.||+||| +.|||||
T Consensus 131 ~~hPgivkLy~T-----FQD~~sLYFvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH---~~GIIHR 198 (604)
T KOG0592|consen 131 SGHPGIVKLYFT-----FQDEESLYFVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLH---SNGIIHR 198 (604)
T ss_pred hCCCCeEEEEEE-----eecccceEEEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHH---hcCceec
Confidence 489999999977 66688999999999999999999876 45999999999999999999999 9999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc-------------------CCCccccccccccCCCCcCccccchhHHHHHH
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA-------------------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLL 319 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-------------------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ 319 (427)
||||+|||+|+++++||+|||.|+.+... -+||..|.+||++.....++.+||||||||+|
T Consensus 199 DlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCily 278 (604)
T KOG0592|consen 199 DLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILY 278 (604)
T ss_pred cCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHH
Confidence 99999999999999999999999976321 17889999999999999999999999999999
Q ss_pred HHHhCCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCC
Q 042634 320 ETFTGKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSE 399 (427)
Q Consensus 320 ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~ 399 (427)
.|+.|.+||.+.. +..+.+.+... . + . .++..++.+.+|+.+.|..
T Consensus 279 QmlaG~PPFra~N--eyliFqkI~~l-----------~----y------------~-----fp~~fp~~a~dLv~KLLv~ 324 (604)
T KOG0592|consen 279 QMLAGQPPFRAAN--EYLIFQKIQAL-----------D----Y------------E-----FPEGFPEDARDLIKKLLVR 324 (604)
T ss_pred HHhcCCCCCcccc--HHHHHHHHHHh-----------c----c------------c-----CCCCCCHHHHHHHHHHHcc
Confidence 9999999998641 11111111110 0 0 0 2233456688999999999
Q ss_pred CCCCCCCHHHHHHH
Q 042634 400 LPRERMNMEEVAAQ 413 (427)
Q Consensus 400 dP~~Rpt~~ev~~~ 413 (427)
||.+|+|..||-++
T Consensus 325 dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 325 DPSDRLTSQQIKAH 338 (604)
T ss_pred CccccccHHHHhhC
Confidence 99999999888764
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=313.87 Aligned_cols=201 Identities=26% Similarity=0.488 Sum_probs=168.8
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchh------h----hhccCHHHHHHHHHHHHHHHHHHh
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNRE------A----LKNLNLLQRLSIAVDVASALDYLH 248 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~------~----~~~l~~~~~~~~~~~i~~~L~~LH 248 (427)
++|||||+++|+|.. ++..++|+|||..|||.++|+.+.. . ..+++..+.+.|+.|||.|++||-
T Consensus 546 l~H~nIVrLlGVC~~-----~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs 620 (774)
T KOG1026|consen 546 LQHPNIVRLLGVCRE-----GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS 620 (774)
T ss_pred ccCCCeEEEEEEEcc-----CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 789999999999977 6688999999999999999864321 0 234889999999999999999999
Q ss_pred hcCCCCeeeccccCCceeeCCCCceEecccccccccCCcC--------CCccccccccccCCCCcCccccchhHHHHHHH
Q 042634 249 HYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEAT--------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLE 320 (427)
Q Consensus 249 ~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~--------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~e 320 (427)
++.+|||||..+|+||+++..|||+|||+++...... --..+|||||.++-.+|+.++|||||||||||
T Consensus 621 ---~~~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWE 697 (774)
T KOG1026|consen 621 ---SHHFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWE 697 (774)
T ss_pred ---hCcccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhh
Confidence 8999999999999999999999999999999764433 33468999999999999999999999999999
Q ss_pred HHh-CCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCC
Q 042634 321 TFT-GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSE 399 (427)
Q Consensus 321 ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~ 399 (427)
+++ |+.||.+....+ ..+.++. +++ ...++.||.++++||+.||+.
T Consensus 698 IFsyG~QPy~glSn~E--VIe~i~~---g~l----------------------------L~~Pe~CP~~vY~LM~~CW~~ 744 (774)
T KOG1026|consen 698 IFSYGKQPYYGLSNQE--VIECIRA---GQL----------------------------LSCPENCPTEVYSLMLECWNE 744 (774)
T ss_pred hhccccCcccccchHH--HHHHHHc---CCc----------------------------ccCCCCCCHHHHHHHHHHhhc
Confidence 998 999998763322 1111111 110 115778999999999999999
Q ss_pred CCCCCCCHHHHHHHHHHHHHH
Q 042634 400 LPRERMNMEEVAAQLLSFRNK 420 (427)
Q Consensus 400 dP~~Rpt~~ev~~~L~~~~~~ 420 (427)
+|++|||++||-..|+...+.
T Consensus 745 ~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 745 NPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred CcccCCCHHHHHHHHHHHHhc
Confidence 999999999999999988654
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=290.78 Aligned_cols=198 Identities=26% Similarity=0.369 Sum_probs=154.8
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||+.++...... +...++.|||+++|+|.+++..... .+++..++.+++||++||+||| ++|||||
T Consensus 71 l~~p~IV~~~G~~~~~~---~~~~~i~mEy~~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~ 141 (313)
T KOG0198|consen 71 LNHPNIVQYYGSSSSRE---NDEYNIFMEYAPGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLH---SKGIVHC 141 (313)
T ss_pred CCCCCEEeeCCcccccc---CeeeEeeeeccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHH---hCCEecc
Confidence 44999999999633311 1358899999999999999986642 5999999999999999999999 9999999
Q ss_pred cccCCceeeCC-CCceEecccccccccCC---------cCCCccccccccccCCC-CcCccccchhHHHHHHHHHhCCCC
Q 042634 259 DLKPSNVLLDG-ELTAHVGDFGLAKFLPE---------ATNNFFNFQIAEYGMGS-EVSTSGDVYSFGILLLETFTGKRP 327 (427)
Q Consensus 259 Dlkp~NIll~~-~~~~kL~DFG~a~~~~~---------~~~~~~~y~aPE~~~~~-~~~~~~DiwS~G~vl~ell~g~~p 327 (427)
||||+|||++. ++.+||+|||.++.... ...||+.|||||++... ...+++||||+||++.||+||++|
T Consensus 142 DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~P 221 (313)
T KOG0198|consen 142 DIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPP 221 (313)
T ss_pred CcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCc
Confidence 99999999999 79999999999986652 12899999999999853 334699999999999999999999
Q ss_pred CCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCH
Q 042634 328 TNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM 407 (427)
Q Consensus 328 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~ 407 (427)
|...... .............. ..+...+.+..+++++|++.||++||||
T Consensus 222 W~~~~~~---~~~~~~ig~~~~~P----------------------------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta 270 (313)
T KOG0198|consen 222 WSEFFEE---AEALLLIGREDSLP----------------------------EIPDSLSDEAKDFLRKCFKRDPEKRPTA 270 (313)
T ss_pred chhhcch---HHHHHHHhccCCCC----------------------------CCCcccCHHHHHHHHHHhhcCcccCcCH
Confidence 9763000 00011110000000 1233456678999999999999999999
Q ss_pred HHHHHHHHH
Q 042634 408 EEVAAQLLS 416 (427)
Q Consensus 408 ~ev~~~L~~ 416 (427)
+|++++--.
T Consensus 271 ~eLL~hpf~ 279 (313)
T KOG0198|consen 271 EELLEHPFL 279 (313)
T ss_pred HHHhhChhh
Confidence 999987543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=274.09 Aligned_cols=217 Identities=19% Similarity=0.251 Sum_probs=157.2
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||+|.++++|.. ....++|+|||+..-|.++ +... ..++...+++++.|++.|+.|+| +++++||
T Consensus 58 LkH~NLVnLiEVFrr-----krklhLVFE~~dhTvL~eL-e~~p---~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHR 125 (396)
T KOG0593|consen 58 LKHENLVNLIEVFRR-----KRKLHLVFEYCDHTVLHEL-ERYP---NGVPSELVKKYLYQLLKAIHFCH---KNNCIHR 125 (396)
T ss_pred cccchHHHHHHHHHh-----cceeEEEeeecchHHHHHH-Hhcc---CCCCHHHHHHHHHHHHHHhhhhh---hcCeecc
Confidence 689999999999654 6789999999976555443 3332 45889999999999999999999 9999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc-C-----CCccccccccccCC-CCcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA-T-----NNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-~-----~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
||||+|||++.++.+||||||+|+.+... . +.|.+|+|||.+.+ ..|+.++||||.||++.||++|.+.|.+.
T Consensus 126 DIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~ 205 (396)
T KOG0593|consen 126 DIKPENILITQNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGR 205 (396)
T ss_pred cCChhheEEecCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCc
Confidence 99999999999999999999999998733 2 67889999999988 78999999999999999999999999875
Q ss_pred cCCCccHHHHH--HHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 042634 332 FTGNLTLHNFV--KEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEE 409 (427)
Q Consensus 332 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~e 409 (427)
.+-+. +.... -..+.+....++...-... +.............. .-+....-+.+++..|++.||++|+|.+|
T Consensus 206 SDiDQ-Ly~I~ktLG~L~prhq~iF~~N~~F~---Gv~lP~~~~~epLe~-k~p~~s~~~ld~~k~cL~~dP~~R~sc~q 280 (396)
T KOG0593|consen 206 SDIDQ-LYLIRKTLGNLIPRHQSIFSSNPFFH---GVRLPEPEHPEPLER-KYPKISNVLLDLLKKCLKMDPDDRLSCEQ 280 (396)
T ss_pred chHHH-HHHHHHHHcccCHHHHHHhccCCcee---eeecCCCCCccchhh-hcccchHHHHHHHHHHhcCCccccccHHH
Confidence 33222 21111 1122233333332111000 000000000000000 01223446899999999999999999999
Q ss_pred HHH
Q 042634 410 VAA 412 (427)
Q Consensus 410 v~~ 412 (427)
++.
T Consensus 281 ll~ 283 (396)
T KOG0593|consen 281 LLH 283 (396)
T ss_pred Hhc
Confidence 875
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=300.89 Aligned_cols=191 Identities=21% Similarity=0.314 Sum_probs=163.2
Q ss_pred cccccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCee
Q 042634 177 NFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIV 256 (427)
Q Consensus 177 ~ll~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~iv 256 (427)
+++.|||++++|++ +.++.+.|+|.||+++|.|++++... +++++.++.++++||+.|+.|+| ..+|+
T Consensus 67 kLi~HpnVl~LydV-----we~~~~lylvlEyv~gGELFdylv~k----G~l~e~eaa~ff~QIi~gv~yCH---~~~ic 134 (786)
T KOG0588|consen 67 KLIEHPNVLRLYDV-----WENKQHLYLVLEYVPGGELFDYLVRK----GPLPEREAAHFFRQILDGVSYCH---AFNIC 134 (786)
T ss_pred HHhcCCCeeeeeee-----eccCceEEEEEEecCCchhHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHh---hhcce
Confidence 56899999999999 55588999999999999999999766 56999999999999999999999 89999
Q ss_pred eccccCCceeeCCCCceEecccccccccCCcC-----CCccccccccccCCCCc-CccccchhHHHHHHHHHhCCCCCCc
Q 042634 257 HCDLKPSNVLLDGELTAHVGDFGLAKFLPEAT-----NNFFNFQIAEYGMGSEV-STSGDVYSFGILLLETFTGKRPTNE 330 (427)
Q Consensus 257 HrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~y~aPE~~~~~~~-~~~~DiwS~G~vl~ell~g~~pf~~ 330 (427)
|||+||+|+|+|....+||+|||.|..-..+. +|++.|.|||++++.+| +.++||||.|||||.|++|+.||++
T Consensus 135 HRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD 214 (786)
T KOG0588|consen 135 HRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD 214 (786)
T ss_pred eccCCchhhhhhcccCEeeeccceeecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999998765544 99999999999999998 5789999999999999999999974
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
+.+.....+.-.+. ...|...+.++.+|+++|+..||+.|.|++||
T Consensus 215 -----dNir~LLlKV~~G~-----------------------------f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI 260 (786)
T KOG0588|consen 215 -----DNIRVLLLKVQRGV-----------------------------FEMPSNISSEAQDLLRRMLDVDPSTRITTEEI 260 (786)
T ss_pred -----ccHHHHHHHHHcCc-----------------------------ccCCCcCCHHHHHHHHHHhccCccccccHHHH
Confidence 22333222211110 01445566778999999999999999999999
Q ss_pred HHH
Q 042634 411 AAQ 413 (427)
Q Consensus 411 ~~~ 413 (427)
+++
T Consensus 261 ~kH 263 (786)
T KOG0588|consen 261 LKH 263 (786)
T ss_pred hhC
Confidence 876
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=293.54 Aligned_cols=202 Identities=23% Similarity=0.384 Sum_probs=157.7
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhh-----------------------------------
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREA----------------------------------- 224 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~----------------------------------- 224 (427)
+||||+++++.+.. .+...+++|||+++|+|.+++......
T Consensus 69 ~h~niv~~~~~~~~----~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (338)
T cd05102 69 NHLNVVNLLGACTK----PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASV 144 (338)
T ss_pred cCcceeeEEeEecC----CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCc
Confidence 79999999997643 234578999999999999888643210
Q ss_pred -----------------------hhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccccCCceeeCCCCceEecccccc
Q 042634 225 -----------------------LKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLA 281 (427)
Q Consensus 225 -----------------------~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a 281 (427)
...+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||++
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a 221 (338)
T cd05102 145 LFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLA 221 (338)
T ss_pred cccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccc
Confidence 134778899999999999999999 899999999999999999999999999999
Q ss_pred cccCCc--------CCCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCCcccCCCccHHHHHHHhcccchhc
Q 042634 282 KFLPEA--------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNEMFTGNLTLHNFVKEALPERLAE 352 (427)
Q Consensus 282 ~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 352 (427)
+..... ..++..|+|||++.+..++.++|||||||++|||++ |..||.+..... .+.........
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-~~~~~~~~~~~----- 295 (338)
T cd05102 222 RDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-EFCQRLKDGTR----- 295 (338)
T ss_pred cccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-HHHHHHhcCCC-----
Confidence 865322 134568999999999999999999999999999997 999997532111 11111100000
Q ss_pred ccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHH
Q 042634 353 IVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAAQLLSFRNK 420 (427)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~~~~~ 420 (427)
...+..++.++.+++.+||+.||++|||+.|+++.|+++.++
T Consensus 296 --------------------------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 296 --------------------------MRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred --------------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 001223456689999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=291.26 Aligned_cols=192 Identities=23% Similarity=0.335 Sum_probs=156.2
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeecc
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCD 259 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrD 259 (427)
.||||+++++++.. ....++|||||.+|+|.+++... .++.+..++.+++|++.|++||| ++||+|||
T Consensus 78 ~HpnI~~l~ev~~t-----~~~~~ivmEy~~gGdL~~~i~~~----g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRD 145 (370)
T KOG0583|consen 78 SHPNIIRLLEVFAT-----PTKIYIVMEYCSGGDLFDYIVNK----GRLKEDEARKYFRQLISAVAYCH---SRGIVHRD 145 (370)
T ss_pred cCCCEeEEEEEEec-----CCeEEEEEEecCCccHHHHHHHc----CCCChHHHHHHHHHHHHHHHHHH---hCCEeeCC
Confidence 39999999999544 55699999999999999999874 56899999999999999999999 99999999
Q ss_pred ccCCceeeCCC-CceEecccccccccC-Cc-----CCCccccccccccCCCC-cC-ccccchhHHHHHHHHHhCCCCCCc
Q 042634 260 LKPSNVLLDGE-LTAHVGDFGLAKFLP-EA-----TNNFFNFQIAEYGMGSE-VS-TSGDVYSFGILLLETFTGKRPTNE 330 (427)
Q Consensus 260 lkp~NIll~~~-~~~kL~DFG~a~~~~-~~-----~~~~~~y~aPE~~~~~~-~~-~~~DiwS~G~vl~ell~g~~pf~~ 330 (427)
|||+|||++.+ +.+||+|||++.... .. .+||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||++
T Consensus 146 LK~ENilld~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d 225 (370)
T KOG0583|consen 146 LKPENILLDGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD 225 (370)
T ss_pred CCHHHEEecCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC
Confidence 99999999999 999999999999873 22 28999999999999987 85 789999999999999999999986
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHH-HHHHHHHHhhcCCCCCCCCCCHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKEC-LVSVLGIGVTCSSELPRERMNMEE 409 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~~cl~~dP~~Rpt~~e 409 (427)
. ............ .. ..+... ..++.+++.+|+..||.+|+|+.|
T Consensus 226 ~-----~~~~l~~ki~~~--------~~---------------------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~ 271 (370)
T KOG0583|consen 226 S-----NVPNLYRKIRKG--------EF---------------------KIPSYLLSPEARSLIEKMLVPDPSTRITLLE 271 (370)
T ss_pred c-----cHHHHHHHHhcC--------Cc---------------------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHH
Confidence 2 111111111110 00 011122 556889999999999999999999
Q ss_pred HHHHHHHHH
Q 042634 410 VAAQLLSFR 418 (427)
Q Consensus 410 v~~~L~~~~ 418 (427)
|+ .-.-++
T Consensus 272 i~-~h~w~~ 279 (370)
T KOG0583|consen 272 IL-EHPWFQ 279 (370)
T ss_pred Hh-hChhhc
Confidence 98 444333
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=281.26 Aligned_cols=204 Identities=25% Similarity=0.292 Sum_probs=159.0
Q ss_pred CcccccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 042634 176 NNFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPI 255 (427)
Q Consensus 176 N~ll~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~i 255 (427)
-.+.+||||++++.++.. +...|+||.||.+|++.+.++..-. ..+++..+..|++++++||.||| .+|.
T Consensus 78 msl~~HPNIv~~~~sFvv-----~~~LWvVmpfMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH---~~G~ 147 (516)
T KOG0582|consen 78 MSLIDHPNIVTYHCSFVV-----DSELWVVMPFMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLH---QNGH 147 (516)
T ss_pred hhhcCCCCcceEEEEEEe-----cceeEEeehhhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHH---hcCc
Confidence 345789999999988655 6789999999999999999875433 55999999999999999999999 9999
Q ss_pred eeccccCCceeeCCCCceEecccccccccCCc----------CCCccccccccccCC--CCcCccccchhHHHHHHHHHh
Q 042634 256 VHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA----------TNNFFNFQIAEYGMG--SEVSTSGDVYSFGILLLETFT 323 (427)
Q Consensus 256 vHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~----------~~~~~~y~aPE~~~~--~~~~~~~DiwS~G~vl~ell~ 323 (427)
||||||+.||||+++|.+||+|||++..+... ..||+.|||||+++. ..|+.|+||||||++..|+.+
T Consensus 148 IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~ 227 (516)
T KOG0582|consen 148 IHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAH 227 (516)
T ss_pred eecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhc
Confidence 99999999999999999999999998765322 278999999999654 579999999999999999999
Q ss_pred CCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCC
Q 042634 324 GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRE 403 (427)
Q Consensus 324 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~ 403 (427)
|..||.....-..-+ .-++...|-......+ . .........+.+++..|++.||++
T Consensus 228 G~aPf~k~pPmkvLl-~tLqn~pp~~~t~~~~----~-------------------d~~k~~~ksf~e~i~~CL~kDP~k 283 (516)
T KOG0582|consen 228 GHAPFSKYPPMKVLL-LTLQNDPPTLLTSGLD----K-------------------DEDKKFSKSFREMIALCLVKDPSK 283 (516)
T ss_pred CCCCcccCChHHHHH-HHhcCCCCCcccccCC----h-------------------HHhhhhcHHHHHHHHHHhhcCccc
Confidence 999998652211111 1111111111100011 0 022334557899999999999999
Q ss_pred CCCHHHHHHH
Q 042634 404 RMNMEEVAAQ 413 (427)
Q Consensus 404 Rpt~~ev~~~ 413 (427)
|||++++++.
T Consensus 284 RptAskLlkh 293 (516)
T KOG0582|consen 284 RPTASKLLKH 293 (516)
T ss_pred CCCHHHHhcc
Confidence 9999999864
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=284.27 Aligned_cols=202 Identities=24% Similarity=0.324 Sum_probs=159.9
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+... ..+....++||||+++|+|.+++... ..+++..+..++.|++.|+.|||. ..+++||
T Consensus 75 l~h~nIv~~~g~~~~~-~~~~~~~~lv~Ey~~~g~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hr 147 (283)
T PHA02988 75 IDSNNILKIYGFIIDI-VDDLPRLSLILEYCTRGYLREVLDKE----KDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYK 147 (283)
T ss_pred cCCCCEEEEeeeEEec-ccCCCceEEEEEeCCCCcHHHHHhhC----CCCChhHHHHHHHHHHHHHHHHHh--cCCCCCC
Confidence 5799999999986431 12234678999999999999999765 358899999999999999999993 2589999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc---CCCccccccccccCC--CCcCccccchhHHHHHHHHHhCCCCCCcccC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA---TNNFFNFQIAEYGMG--SEVSTSGDVYSFGILLLETFTGKRPTNEMFT 333 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~~y~aPE~~~~--~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~ 333 (427)
||||+||+++.++.+||+|||+++..... ..++..|+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 148 dlkp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~ 227 (283)
T PHA02988 148 NLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT 227 (283)
T ss_pred cCChhhEEECCCCcEEEcccchHhhhccccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH
Confidence 99999999999999999999999865433 367889999999876 6789999999999999999999999975321
Q ss_pred CCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 042634 334 GNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAAQ 413 (427)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~ 413 (427)
..+...+..... . ...+..++.++.+++.+||+.||++|||++|+++.
T Consensus 228 --~~~~~~i~~~~~-------~-----------------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~ 275 (283)
T PHA02988 228 --KEIYDLIINKNN-------S-----------------------LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYN 275 (283)
T ss_pred --HHHHHHHHhcCC-------C-----------------------CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 111111100000 0 00122356779999999999999999999999999
Q ss_pred HHHHHH
Q 042634 414 LLSFRN 419 (427)
Q Consensus 414 L~~~~~ 419 (427)
|+.+..
T Consensus 276 l~~~~~ 281 (283)
T PHA02988 276 LSLYKF 281 (283)
T ss_pred HHHHHh
Confidence 998864
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=278.96 Aligned_cols=227 Identities=22% Similarity=0.214 Sum_probs=165.2
Q ss_pred ccccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 042634 178 FIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVH 257 (427)
Q Consensus 178 ll~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivH 257 (427)
.++|||||++.-++....-.+.-...+||||| ..+|.++++........++...++-++.||.+||.||| +.||+|
T Consensus 73 ~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym-P~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcH 148 (364)
T KOG0658|consen 73 KLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM-PETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICH 148 (364)
T ss_pred hcCCcCeeeEEEEEEecCCCchhHHHHHHHhc-hHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCccc
Confidence 58899999998776553322223457899999 56899888754334466888999999999999999999 899999
Q ss_pred ccccCCceeeCCC-CceEecccccccccCCcC-----CCccccccccccCC-CCcCccccchhHHHHHHHHHhCCCCCCc
Q 042634 258 CDLKPSNVLLDGE-LTAHVGDFGLAKFLPEAT-----NNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETFTGKRPTNE 330 (427)
Q Consensus 258 rDlkp~NIll~~~-~~~kL~DFG~a~~~~~~~-----~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell~g~~pf~~ 330 (427)
|||||.|+|+|.+ |.+||||||.|+.+..+. ..|..|+|||.+.+ ..|+.+.||||.|||+.||+-|++.|.+
T Consensus 149 RDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG 228 (364)
T KOG0658|consen 149 RDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPG 228 (364)
T ss_pred CCCChheEEEcCCCCeEEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCC
Confidence 9999999999876 999999999999987655 56678999999988 5699999999999999999999999987
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
. .+...+...++-...+...++.........-..+.. ....+.+ ......+.+..+++.++++++|.+|.|+.|+
T Consensus 229 ~-s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~i---k~~~~~~-~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~ 303 (364)
T KOG0658|consen 229 D-SSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQI---KAHPWHK-VFFKRLPPDALDLLSKLLQYSPSKRLSALEA 303 (364)
T ss_pred C-CHHHHHHHHHHHhCCCCHHHHhhcCcccccccCccc---cccccee-ecccCCCHHHHHHHHHHhccChhhcCCHHHH
Confidence 3 333344444443333222222111100000000100 0111111 2334456678999999999999999999999
Q ss_pred HHH
Q 042634 411 AAQ 413 (427)
Q Consensus 411 ~~~ 413 (427)
+++
T Consensus 304 l~h 306 (364)
T KOG0658|consen 304 LAH 306 (364)
T ss_pred hcc
Confidence 864
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=290.79 Aligned_cols=201 Identities=25% Similarity=0.375 Sum_probs=165.3
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
.+|.||+-++|+|.. ....||+.+|+|.+|+.+++..+ ..|...+.+.|++|||+|+.||| .++||||
T Consensus 445 TRH~NIlLFMG~~~~------p~~AIiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLH---AK~IIHr 512 (678)
T KOG0193|consen 445 TRHENILLFMGACMN------PPLAIITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLH---AKNIIHR 512 (678)
T ss_pred cchhhheeeehhhcC------CceeeeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhh---hhhhhhh
Confidence 789999999999765 23489999999999999999876 45899999999999999999999 9999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC--------cCCCccccccccccCCC---CcCccccchhHHHHHHHHHhCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE--------ATNNFFNFQIAEYGMGS---EVSTSGDVYSFGILLLETFTGKRP 327 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~--------~~~~~~~y~aPE~~~~~---~~~~~~DiwS~G~vl~ell~g~~p 327 (427)
|||..||++.++++|||+|||++..... ...|..-|||||+++.. +|++.+||||||||+|||++|..|
T Consensus 513 DLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lP 592 (678)
T KOG0193|consen 513 DLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELP 592 (678)
T ss_pred hccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCC
Confidence 9999999999999999999999975421 12677789999998753 689999999999999999999999
Q ss_pred CCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCH
Q 042634 328 TNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM 407 (427)
Q Consensus 328 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~ 407 (427)
|.. ...+..+...-+.++.++. ......|++++.+|+..||..++++||++
T Consensus 593 ysi-~~~dqIifmVGrG~l~pd~----------------------------s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F 643 (678)
T KOG0193|consen 593 YSI-QNRDQIIFMVGRGYLMPDL----------------------------SKIRSNCPKAMKRLLSDCWKFDREERPLF 643 (678)
T ss_pred cCC-CChhheEEEecccccCccc----------------------------hhhhccCHHHHHHHHHHHHhcCcccCccH
Confidence 983 2222222222222222111 11345688999999999999999999999
Q ss_pred HHHHHHHHHHHHH
Q 042634 408 EEVAAQLLSFRNK 420 (427)
Q Consensus 408 ~ev~~~L~~~~~~ 420 (427)
.+|+..|+++..+
T Consensus 644 ~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 644 PQLLSKLEELLPS 656 (678)
T ss_pred HHHHHHHHHhhhc
Confidence 9999999988764
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=312.88 Aligned_cols=203 Identities=27% Similarity=0.388 Sum_probs=168.8
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchh---hhhccCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNRE---ALKNLNLLQRLSIAVDVASALDYLHHYCETPI 255 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~i 255 (427)
++|||||+++|+|.. ....+|++|||++|||..++++.+. ....++..+.+.++.|||+|++||+ ++++
T Consensus 752 f~HpNiv~liGv~l~-----~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~f 823 (1025)
T KOG1095|consen 752 FDHPNIVSLIGVCLD-----SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHF 823 (1025)
T ss_pred CCCcceeeEEEeecC-----CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCC
Confidence 689999999999865 4578999999999999999987621 1256889999999999999999999 8999
Q ss_pred eeccccCCceeeCCCCceEecccccccccCCcC--------CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCC
Q 042634 256 VHCDLKPSNVLLDGELTAHVGDFGLAKFLPEAT--------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKR 326 (427)
Q Consensus 256 vHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~--------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~ 326 (427)
|||||..+|||+++...+||+|||+|+.+.... .-...|||||.+....++.|+|||||||++||+++ |..
T Consensus 824 vHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~ 903 (1025)
T KOG1095|consen 824 VHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGAT 903 (1025)
T ss_pred cCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCC
Confidence 999999999999999999999999999543222 23458999999999999999999999999999999 999
Q ss_pred CCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCC
Q 042634 327 PTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMN 406 (427)
Q Consensus 327 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt 406 (427)
||.+.... .+...+.... +...|..|++.++++|..||+.+|++||+
T Consensus 904 PY~~~~n~--~v~~~~~~gg-------------------------------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~ 950 (1025)
T KOG1095|consen 904 PYPSRSNF--EVLLDVLEGG-------------------------------RLDPPSYCPEKLYQLMLQCWKHDPEDRPS 950 (1025)
T ss_pred CCCCcchH--HHHHHHHhCC-------------------------------ccCCCCCCChHHHHHHHHHccCChhhCcc
Confidence 99764221 1111111100 12256779999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHH
Q 042634 407 MEEVAAQLLSFRNKLV 422 (427)
Q Consensus 407 ~~ev~~~L~~~~~~~~ 422 (427)
+..+++.+..+.+.+.
T Consensus 951 F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 951 FRTIVEQDPAISNAAL 966 (1025)
T ss_pred HHHHHhhhhhhhhhhc
Confidence 9999999999887654
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=274.72 Aligned_cols=219 Identities=24% Similarity=0.322 Sum_probs=160.4
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|+|||.+++.........-+..|+|+|+| +.||.+.++.+ ..++...+..++.|+++||+|+| +.+|+||
T Consensus 78 ~~HeNIi~l~di~~p~~~~~f~DvYiV~elM-etDL~~iik~~----~~L~d~H~q~f~YQiLrgLKyiH---SAnViHR 149 (359)
T KOG0660|consen 78 LRHENIIGLLDIFRPPSRDKFNDVYLVFELM-ETDLHQIIKSQ----QDLTDDHAQYFLYQILRGLKYIH---SANVIHR 149 (359)
T ss_pred hcCCCcceEEeecccccccccceeEEehhHH-hhHHHHHHHcC----ccccHHHHHHHHHHHHHhcchhh---ccccccc
Confidence 5699999999987664445556789999999 88999999876 34999999999999999999999 9999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC----c----CCCccccccccccCC-CCcCccccchhHHHHHHHHHhCCCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE----A----TNNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETFTGKRPTN 329 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~----~----~~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell~g~~pf~ 329 (427)
|+||.|++++.+..+||||||+|+...+ + -..|..|+|||++.. ..|+.++||||.|||+.||++|++.|.
T Consensus 150 DLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFp 229 (359)
T KOG0660|consen 150 DLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFP 229 (359)
T ss_pred ccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCC
Confidence 9999999999999999999999998852 1 167889999999865 679999999999999999999999997
Q ss_pred cccCCCccHHHHHHHhcc----cchhcccCccccccccccchhh-hccccccccccchHHHHHHHHHHHhhcCCCCCCCC
Q 042634 330 EMFTGNLTLHNFVKEALP----ERLAEIVDPVLLVEREEGETSK-ANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRER 404 (427)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~R 404 (427)
+...-+ .+ +.+...++ ..+..+-...... ...+. .....+|...+ +.......+++.+|+..||.+|
T Consensus 230 G~d~v~-Ql-~lI~~~lGtP~~e~l~~i~s~~ar~----yi~slp~~p~~~f~~~f--p~a~p~AidLlekmL~fdP~kR 301 (359)
T KOG0660|consen 230 GKDYVH-QL-QLILELLGTPSEEDLQKIRSEKARP----YIKSLPQIPKQPFSSIF--PNANPLAIDLLEKMLVFDPKKR 301 (359)
T ss_pred CCchHH-HH-HHHHHhcCCCCHHHHHHhccHHHHH----HHHhCCCCCCCCHHHHc--CCCCHHHHHHHHHHhccCcccc
Confidence 632111 11 11122111 1111111000000 00000 00011111111 2445678999999999999999
Q ss_pred CCHHHHHHH
Q 042634 405 MNMEEVAAQ 413 (427)
Q Consensus 405 pt~~ev~~~ 413 (427)
+|++|++++
T Consensus 302 ita~eAL~h 310 (359)
T KOG0660|consen 302 ITAEEALAH 310 (359)
T ss_pred CCHHHHhcC
Confidence 999999874
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=258.70 Aligned_cols=195 Identities=21% Similarity=0.243 Sum_probs=156.1
Q ss_pred CcccccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 042634 176 NNFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPI 255 (427)
Q Consensus 176 N~ll~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~i 255 (427)
++.++|||||++.+.. +.....|+|+|+|.|++|..-+-.+ ..+++..+-.+++||+.||.|+| .+||
T Consensus 64 C~~LqHP~IvrL~~ti-----~~~~~~ylvFe~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH---~n~I 131 (355)
T KOG0033|consen 64 CRKLQHPNIVRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCH---SNGI 131 (355)
T ss_pred HHhcCCCcEeehhhhh-----cccceeEEEEecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHH---hcCc
Confidence 5668999999999884 4466789999999999998776554 44889999999999999999999 9999
Q ss_pred eeccccCCceeeCC---CCceEecccccccccCCcC-----CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCC
Q 042634 256 VHCDLKPSNVLLDG---ELTAHVGDFGLAKFLPEAT-----NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRP 327 (427)
Q Consensus 256 vHrDlkp~NIll~~---~~~~kL~DFG~a~~~~~~~-----~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~p 327 (427)
||||+||+|+++.+ ..-+||+|||+|..+..+. .||++|||||++...+|+..+||||.|||+|-++.|..|
T Consensus 132 vHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~P 211 (355)
T KOG0033|consen 132 VHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 211 (355)
T ss_pred eeccCChhheeeeeccCCCceeecccceEEEeCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCC
Confidence 99999999999954 4579999999999887543 899999999999999999999999999999999999999
Q ss_pred CCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCH
Q 042634 328 TNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM 407 (427)
Q Consensus 328 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~ 407 (427)
|.+... ...+.+.....+.- +....+...++..+++++|+..||.+|.|+
T Consensus 212 F~~~~~-~rlye~I~~g~yd~-----------------------------~~~~w~~is~~Ak~LvrrML~~dP~kRIta 261 (355)
T KOG0033|consen 212 FWDEDQ-HRLYEQIKAGAYDY-----------------------------PSPEWDTVTPEAKSLIRRMLTVNPKKRITA 261 (355)
T ss_pred CCCccH-HHHHHHHhccccCC-----------------------------CCcccCcCCHHHHHHHHHHhccChhhhccH
Confidence 986311 11111111111100 000223345668899999999999999999
Q ss_pred HHHHH
Q 042634 408 EEVAA 412 (427)
Q Consensus 408 ~ev~~ 412 (427)
.|.+.
T Consensus 262 ~EAL~ 266 (355)
T KOG0033|consen 262 DEALK 266 (355)
T ss_pred HHHhC
Confidence 98764
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=256.66 Aligned_cols=214 Identities=20% Similarity=0.259 Sum_probs=160.0
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|+||+.++++ |.......+|+||| ..||+..+++.. ..++..+++.++.++++|++||| ++.|+||
T Consensus 58 l~h~nIi~LiD~-----F~~~~~l~lVfEfm-~tdLe~vIkd~~---i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHR 125 (318)
T KOG0659|consen 58 LKHPNIIELIDV-----FPHKSNLSLVFEFM-PTDLEVVIKDKN---IILSPADIKSYMLMTLKGLAYCH---SKWILHR 125 (318)
T ss_pred ccCcchhhhhhh-----ccCCCceEEEEEec-cccHHHHhcccc---cccCHHHHHHHHHHHHHHHHHHH---hhhhhcc
Confidence 569999999999 45567889999999 779999998765 56999999999999999999999 9999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC------CCccccccccccCC-CCcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT------NNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~------~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
||||.|+|++++|.+||+|||+|+...... +-|..|+|||.+.+ +.|+..+||||.|||+.||+-|.+-|.+.
T Consensus 126 DlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~ 205 (318)
T KOG0659|consen 126 DLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGD 205 (318)
T ss_pred cCCccceEEcCCCcEEeecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCC
Confidence 999999999999999999999999876543 56789999999887 56899999999999999999999877653
Q ss_pred cCCCccHHHHHHHhcc---cchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 042634 332 FTGNLTLHNFVKEALP---ERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME 408 (427)
Q Consensus 332 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ 408 (427)
. +-+.+....+.... ..+.++.. ..++-+-. ..+..........+.....+++.+||.+||.+|+|+.
T Consensus 206 s-DidQL~~If~~LGTP~~~~WP~~~~---lpdY~~~~-----~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~ 276 (318)
T KOG0659|consen 206 S-DIDQLSKIFRALGTPTPDQWPEMTS---LPDYVKIQ-----QFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITAS 276 (318)
T ss_pred c-hHHHHHHHHHHcCCCCcccCccccc---cccHHHHh-----cCCCCccccccccccHHHHHHHHhhhccCchhcccHH
Confidence 2 22222222222221 22222111 11110000 0000000002233456679999999999999999999
Q ss_pred HHHHH
Q 042634 409 EVAAQ 413 (427)
Q Consensus 409 ev~~~ 413 (427)
|++++
T Consensus 277 qaL~~ 281 (318)
T KOG0659|consen 277 QALKH 281 (318)
T ss_pred HHhcc
Confidence 99864
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=260.27 Aligned_cols=194 Identities=22% Similarity=0.314 Sum_probs=159.6
Q ss_pred ccccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 042634 178 FIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVH 257 (427)
Q Consensus 178 ll~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivH 257 (427)
+..||+|+++.+. ++.+...++|+|.|+.|.|++++... -.++++..++|++|+..|+.||| .++|||
T Consensus 79 v~GHP~II~l~D~-----yes~sF~FlVFdl~prGELFDyLts~----VtlSEK~tR~iMrqlfegVeylH---a~~IVH 146 (411)
T KOG0599|consen 79 VMGHPYIIDLQDV-----YESDAFVFLVFDLMPRGELFDYLTSK----VTLSEKETRRIMRQLFEGVEYLH---ARNIVH 146 (411)
T ss_pred hcCCCcEEEeeee-----ccCcchhhhhhhhcccchHHHHhhhh----eeecHHHHHHHHHHHHHHHHHHH---Hhhhhh
Confidence 3679999999998 44467889999999999999999765 45999999999999999999999 899999
Q ss_pred ccccCCceeeCCCCceEecccccccccCCcC-----CCccccccccccCC------CCcCccccchhHHHHHHHHHhCCC
Q 042634 258 CDLKPSNVLLDGELTAHVGDFGLAKFLPEAT-----NNFFNFQIAEYGMG------SEVSTSGDVYSFGILLLETFTGKR 326 (427)
Q Consensus 258 rDlkp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~y~aPE~~~~------~~~~~~~DiwS~G~vl~ell~g~~ 326 (427)
||+||+|||++++..+||+|||+|..+..+. +||++|.|||.+.. +.|+..+|+||.|||||.++.|.+
T Consensus 147 RDLKpENILlddn~~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcp 226 (411)
T KOG0599|consen 147 RDLKPENILLDDNMNIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCP 226 (411)
T ss_pred cccChhheeeccccceEEeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCC
Confidence 9999999999999999999999999988765 99999999998753 468999999999999999999999
Q ss_pred CCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCC
Q 042634 327 PTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMN 406 (427)
Q Consensus 327 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt 406 (427)
||-... +.+. ++-+..... -.++..+.+....+.+++.+|++.||.+|.|
T Consensus 227 PFwHRk-------QmlM------LR~ImeGky-----------------qF~speWadis~~~KdLIsrlLqVdp~~Rit 276 (411)
T KOG0599|consen 227 PFWHRK-------QMLM------LRMIMEGKY-----------------QFRSPEWADISATVKDLISRLLQVDPTKRIT 276 (411)
T ss_pred chhHHH-------HHHH------HHHHHhccc-----------------ccCCcchhhccccHHHHHHHHHeeCchhccc
Confidence 996420 1100 000000000 0112244556778899999999999999999
Q ss_pred HHHHHHH
Q 042634 407 MEEVAAQ 413 (427)
Q Consensus 407 ~~ev~~~ 413 (427)
++|++++
T Consensus 277 ake~LaH 283 (411)
T KOG0599|consen 277 AKEALAH 283 (411)
T ss_pred HHHHhcC
Confidence 9999875
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=263.99 Aligned_cols=141 Identities=27% Similarity=0.391 Sum_probs=131.6
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
..||.++++++.+. ++...++||||.+||.|+.++++. .+++++.++.++.||+.|++||| +.+|++|
T Consensus 101 v~~PFlv~l~~t~~-----d~~~lymvmeyv~GGElFS~Lrk~----~rF~e~~arFYAAeivlAleylH---~~~iiYR 168 (355)
T KOG0616|consen 101 VSHPFLVKLYGTFK-----DNSNLYMVMEYVPGGELFSYLRKS----GRFSEPHARFYAAEIVLALEYLH---SLDIIYR 168 (355)
T ss_pred ccCceeEEEEEeec-----cCCeEEEEEeccCCccHHHHHHhc----CCCCchhHHHHHHHHHHHHHHHH---hcCeeec
Confidence 56999999998844 477899999999999999999876 45999999999999999999999 9999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC---CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT---NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~---~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
|+||+|||+|++|.+||+|||+|+.+.... +||+.|+|||++...+|+.++|+|||||++|||+.|.+||...
T Consensus 169 DLKPENiLlD~~G~iKitDFGFAK~v~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~ 244 (355)
T KOG0616|consen 169 DLKPENLLLDQNGHIKITDFGFAKRVSGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDD 244 (355)
T ss_pred cCChHHeeeccCCcEEEEeccceEEecCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCC
Confidence 999999999999999999999999887665 9999999999999999999999999999999999999999763
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=253.44 Aligned_cols=210 Identities=17% Similarity=0.238 Sum_probs=165.6
Q ss_pred CCcccccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 042634 175 RNNFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETP 254 (427)
Q Consensus 175 ~N~ll~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ 254 (427)
..+..+|||+++++++...-.-++....|++++|...|+|.+.++........+++.+++.|+.++++||++|| +..
T Consensus 71 ~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH---~~~ 147 (302)
T KOG2345|consen 71 NHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALH---EKE 147 (302)
T ss_pred HHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHh---ccC
Confidence 34557899999999987654444556689999999999999999876655567999999999999999999999 555
Q ss_pred --eeeccccCCceeeCCCCceEecccccccccCCc---------------CCCccccccccccCCC---CcCccccchhH
Q 042634 255 --IVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA---------------TNNFFNFQIAEYGMGS---EVSTSGDVYSF 314 (427)
Q Consensus 255 --ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~---------------~~~~~~y~aPE~~~~~---~~~~~~DiwS~ 314 (427)
++||||||.|||+.+++.++|.|||.+....-. ...|..|+|||.+.-+ ..+.++|||||
T Consensus 148 ~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSL 227 (302)
T KOG2345|consen 148 PPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSL 227 (302)
T ss_pred CcccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhh
Confidence 999999999999999999999999999865321 1678899999998654 45899999999
Q ss_pred HHHHHHHHhCCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHh
Q 042634 315 GILLLETFTGKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGV 394 (427)
Q Consensus 315 G~vl~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 394 (427)
||++|+|+.|..||+.....+..+.- .+..+.+.. . .....++.+.+++.
T Consensus 228 GCtLYa~mf~~sPfe~~~~~GgSlaL-----------Av~n~q~s~----------------P---~~~~yse~l~~lik 277 (302)
T KOG2345|consen 228 GCTLYAMMFGESPFERIYQQGGSLAL-----------AVQNAQISI----------------P---NSSRYSEALHQLIK 277 (302)
T ss_pred hHHHHHHHHcCCcchHHhhcCCeEEE-----------eeecccccc----------------C---CCCCccHHHHHHHH
Confidence 99999999999999865332222110 111111100 0 01115677899999
Q ss_pred hcCCCCCCCCCCHHHHHHHHHHH
Q 042634 395 TCSSELPRERMNMEEVAAQLLSF 417 (427)
Q Consensus 395 ~cl~~dP~~Rpt~~ev~~~L~~~ 417 (427)
+|++.||.+|||+.|++..++.+
T Consensus 278 ~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 278 SMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred HHhcCCcccCCCHHHHHHHHHhh
Confidence 99999999999999999998865
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=294.99 Aligned_cols=203 Identities=25% Similarity=0.276 Sum_probs=163.1
Q ss_pred cccccchhhhccccccCCCCC--CccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCee
Q 042634 179 IRHRNLVKIITSCASVDFQGN--DSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIV 256 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~iv 256 (427)
..|+|||.+++......-.++ -...|.||||.+|.|-+++..+.. ..|++.++++|+.|+|+|+.+||.. ...||
T Consensus 92 ~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~-~pPiI 168 (738)
T KOG1989|consen 92 SGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYL-KPPII 168 (738)
T ss_pred cCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcC-CCccc
Confidence 569999999995433332223 345788999999999999986654 5599999999999999999999954 56799
Q ss_pred eccccCCceeeCCCCceEecccccccccCCc---------------CCCcccccccccc---CCCCcCccccchhHHHHH
Q 042634 257 HCDLKPSNVLLDGELTAHVGDFGLAKFLPEA---------------TNNFFNFQIAEYG---MGSEVSTSGDVYSFGILL 318 (427)
Q Consensus 257 HrDlkp~NIll~~~~~~kL~DFG~a~~~~~~---------------~~~~~~y~aPE~~---~~~~~~~~~DiwS~G~vl 318 (427)
|||||.|||||..++..||||||.|...... ...|+.|+|||++ .+.++++|+||||+||+|
T Consensus 169 HRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclL 248 (738)
T KOG1989|consen 169 HRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLL 248 (738)
T ss_pred hhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHH
Confidence 9999999999999999999999999753211 1688999999986 567889999999999999
Q ss_pred HHHHhCCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCC
Q 042634 319 LETFTGKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSS 398 (427)
Q Consensus 319 ~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~ 398 (427)
|-|+....||++... ..+++..+.. ...+.....+.+||+.||+
T Consensus 249 YkLCy~t~PFe~sg~-----------------laIlng~Y~~-------------------P~~p~ys~~l~~LI~~mL~ 292 (738)
T KOG1989|consen 249 YKLCYFTTPFEESGK-----------------LAILNGNYSF-------------------PPFPNYSDRLKDLIRTMLQ 292 (738)
T ss_pred HHHHHhCCCcCcCcc-----------------eeEEeccccC-------------------CCCccHHHHHHHHHHHHhc
Confidence 999999999986311 1122211111 0124578889999999999
Q ss_pred CCCCCCCCHHHHHHHHHHHHHH
Q 042634 399 ELPRERMNMEEVAAQLLSFRNK 420 (427)
Q Consensus 399 ~dP~~Rpt~~ev~~~L~~~~~~ 420 (427)
.||.+||++-||+..+.++..+
T Consensus 293 ~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 293 PNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred cCcccCCCHHHHHHHHHHHhcC
Confidence 9999999999999999998753
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=282.06 Aligned_cols=198 Identities=25% Similarity=0.399 Sum_probs=168.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||+|+++++|.. ....|||+|||..|+|.+|+++... ..++....+.++.||+.|++||. .+++|||
T Consensus 320 ikHpNLVqLLGVCT~-----EpPFYIiTEfM~yGNLLdYLRecnr--~ev~avvLlyMAtQIsSaMeYLE---kknFIHR 389 (1157)
T KOG4278|consen 320 IKHPNLVQLLGVCTH-----EPPFYIITEFMCYGNLLDYLRECNR--SEVPAVVLLYMATQISSAMEYLE---KKNFIHR 389 (1157)
T ss_pred hcCccHHHHhhhhcc-----CCCeEEEEecccCccHHHHHHHhch--hhcchhHHHHHHHHHHHHHHHHH---Hhhhhhh
Confidence 789999999999977 5678999999999999999987655 55788888999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC----C---CccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCCc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT----N---NFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~----~---~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~~ 330 (427)
||..+|+|+.++..+|++|||+++.+..+. . -...|.|||-+.-..++.|+|||+|||++||+.| |..||.+
T Consensus 390 DLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG 469 (1157)
T KOG4278|consen 390 DLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG 469 (1157)
T ss_pred hhhhhhccccccceEEeeccchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC
Confidence 999999999999999999999999987655 2 2357999999999999999999999999999998 9999987
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
.. +.+.. +++.. ..+...++.|+..+++||+.||+|+|.+||+++|+
T Consensus 470 id-----lSqVY---------~LLEk-------------------gyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaei 516 (1157)
T KOG4278|consen 470 ID-----LSQVY---------GLLEK-------------------GYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEI 516 (1157)
T ss_pred cc-----HHHHH---------HHHhc-------------------cccccCCCCCCHHHHHHHHHHhcCCcccCccHHHH
Confidence 41 11111 11111 11122567799999999999999999999999999
Q ss_pred HHHHHHHHH
Q 042634 411 AAQLLSFRN 419 (427)
Q Consensus 411 ~~~L~~~~~ 419 (427)
-+.++.+-.
T Consensus 517 HqafEtmf~ 525 (1157)
T KOG4278|consen 517 HQAFETMFS 525 (1157)
T ss_pred HHHHHHHhc
Confidence 999998743
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=276.25 Aligned_cols=214 Identities=23% Similarity=0.295 Sum_probs=156.3
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||++.+...... ....|+|+||| .-||..++.... -.|++.+++.+++|++.||+||| .+||+||
T Consensus 173 l~HpNIikL~eivt~~~---~~siYlVFeYM-dhDL~GLl~~p~---vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHR 242 (560)
T KOG0600|consen 173 LDHPNIIKLEEIVTSKL---SGSIYLVFEYM-DHDLSGLLSSPG---VKFTEPQIKCYMKQLLEGLEYCH---SRGVLHR 242 (560)
T ss_pred cCCCcccceeeEEEecC---CceEEEEEecc-cchhhhhhcCCC---cccChHHHHHHHHHHHHHHHHHh---hcCeeec
Confidence 68999999999865531 35789999999 458888887643 45999999999999999999999 9999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC-------CCccccccccccCCC-CcCccccchhHHHHHHHHHhCCCCCCc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT-------NNFFNFQIAEYGMGS-EVSTSGDVYSFGILLLETFTGKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~-------~~~~~y~aPE~~~~~-~~~~~~DiwS~G~vl~ell~g~~pf~~ 330 (427)
|||.+|||||.+|.+||+|||+|+++.... +-|..|+|||.+.+. .|+.++|+||.||||.||+.|++.|.+
T Consensus 243 DIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G 322 (560)
T KOG0600|consen 243 DIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQG 322 (560)
T ss_pred cccccceEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCC
Confidence 999999999999999999999999775433 567899999999884 699999999999999999999999986
Q ss_pred ccCCCccHHHHHHHhcc---cchhcccCccccccccccchhhhccccccccc--cchHHHHHHHHHHHhhcCCCCCCCCC
Q 042634 331 MFTGNLTLHNFVKEALP---ERLAEIVDPVLLVEREEGETSKANAHKQFTRS--FSVKECLVSVLGIGVTCSSELPRERM 405 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~cl~~dP~~Rp 405 (427)
..+- ..+.....--.. ..+. ..+ +.. .......+.+.+. ......+....+|+..+|..||.+|.
T Consensus 323 ~tEv-eQl~kIfklcGSP~e~~W~-~~k--LP~------~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~ 392 (560)
T KOG0600|consen 323 RTEV-EQLHKIFKLCGSPTEDYWP-VSK--LPH------ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRG 392 (560)
T ss_pred ccHH-HHHHHHHHHhCCCChhccc-ccc--CCc------ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccc
Confidence 4221 112221111111 1111 000 000 0000000000000 01222356688999999999999999
Q ss_pred CHHHHHH
Q 042634 406 NMEEVAA 412 (427)
Q Consensus 406 t~~ev~~ 412 (427)
||.+++.
T Consensus 393 tA~~aL~ 399 (560)
T KOG0600|consen 393 TASSALQ 399 (560)
T ss_pred cHHHHhc
Confidence 9999875
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=279.44 Aligned_cols=192 Identities=21% Similarity=0.276 Sum_probs=163.4
Q ss_pred cccccchhhhccccccCCCCCCc-cceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 042634 179 IRHRNLVKIITSCASVDFQGNDS-EALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVH 257 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivH 257 (427)
+.|||||.+.+++.. +.. .+|||+||+||++.+.+..... ..++++.+..++.|++.|++||| +..|+|
T Consensus 60 ~~hP~iv~y~ds~~~-----~~~~l~Ivm~Y~eGg~l~~~i~~~k~--~~f~E~~i~~~~~Q~~~av~ylH---~~~iLH 129 (426)
T KOG0589|consen 60 LLHPNIVEYKDSFEE-----DGQLLCIVMEYCEGGDLAQLIKEQKG--VLFPEERILKWFVQILLAVNYLH---ENRVLH 129 (426)
T ss_pred ccCCCeeeeccchhc-----CCceEEEEEeecCCCCHHHHHHHHhh--ccccHHHHHHHHHHHHHHHHHHH---hhhhhc
Confidence 789999999999644 444 8999999999999999977653 67999999999999999999999 899999
Q ss_pred ccccCCceeeCCCCceEecccccccccCCcC------CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 258 CDLKPSNVLLDGELTAHVGDFGLAKFLPEAT------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 258 rDlkp~NIll~~~~~~kL~DFG~a~~~~~~~------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
||||+.||+++.+..+||+|||+|+.+.... .||+.|+.||++.+.+|+.|+||||+||++|||++-+++|...
T Consensus 130 RDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~ 209 (426)
T KOG0589|consen 130 RDLKCANIFLTKDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS 209 (426)
T ss_pred ccchhhhhhccccCceeecchhhhhhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc
Confidence 9999999999999999999999999987653 8999999999999999999999999999999999999999763
Q ss_pred cCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 042634 332 FTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVA 411 (427)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~ 411 (427)
.+...+....... .++ .+.....++..++..|+..+|+.||++.+++
T Consensus 210 -----~m~~Li~ki~~~~----~~P------------------------lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL 256 (426)
T KOG0589|consen 210 -----NMSELILKINRGL----YSP------------------------LPSMYSSELRSLVKSMLRKNPEHRPSALELL 256 (426)
T ss_pred -----chHHHHHHHhhcc----CCC------------------------CCccccHHHHHHHHHHhhcCCccCCCHHHHh
Confidence 1222222222211 111 2334566789999999999999999999999
Q ss_pred HH
Q 042634 412 AQ 413 (427)
Q Consensus 412 ~~ 413 (427)
.+
T Consensus 257 ~~ 258 (426)
T KOG0589|consen 257 RR 258 (426)
T ss_pred hC
Confidence 87
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=264.61 Aligned_cols=188 Identities=23% Similarity=0.364 Sum_probs=159.4
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||.++.+ |.+...+.|||||..+|.|++|+..+ ..+++.+++.+++||..|+.|+| .++||||
T Consensus 110 LNHPhII~IyEV-----FENkdKIvivMEYaS~GeLYDYiSer----~~LsErEaRhfFRQIvSAVhYCH---knrVvHR 177 (668)
T KOG0611|consen 110 LNHPHIIQIYEV-----FENKDKIVIVMEYASGGELYDYISER----GSLSEREARHFFRQIVSAVHYCH---KNRVVHR 177 (668)
T ss_pred cCCCceeehhhh-----hcCCceEEEEEEecCCccHHHHHHHh----ccccHHHHHHHHHHHHHHHHHHh---hccceec
Confidence 789999999999 55577899999999999999999877 45999999999999999999999 9999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC-----CCccccccccccCCCCc-CccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT-----NNFFNFQIAEYGMGSEV-STSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~y~aPE~~~~~~~-~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
|||.+|||+|.++.+||+|||++-.+.... +|++-|.+||+..+.+| ++.+|.||+||++|.++.|..||++.
T Consensus 178 DLKLENILLD~N~NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~- 256 (668)
T KOG0611|consen 178 DLKLENILLDQNNNIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR- 256 (668)
T ss_pred ccchhheeecCCCCeeeeccchhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc-
Confidence 999999999999999999999998877655 89999999999999988 67899999999999999999999874
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
+...+++..-.+...+ ++.+.....++++|+..+|++|.|+++|..
T Consensus 257 ----Dhk~lvrQIs~GaYrE------------------------------P~~PSdA~gLIRwmLmVNP~RRATieDiAs 302 (668)
T KOG0611|consen 257 ----DHKRLVRQISRGAYRE------------------------------PETPSDASGLIRWMLMVNPERRATIEDIAS 302 (668)
T ss_pred ----hHHHHHHHhhcccccC------------------------------CCCCchHHHHHHHHHhcCcccchhHHHHhh
Confidence 2233333322221110 112334567999999999999999999976
Q ss_pred H
Q 042634 413 Q 413 (427)
Q Consensus 413 ~ 413 (427)
+
T Consensus 303 H 303 (668)
T KOG0611|consen 303 H 303 (668)
T ss_pred h
Confidence 4
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=284.97 Aligned_cols=199 Identities=25% Similarity=0.369 Sum_probs=165.7
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||+++|++.. ....++|||+|.||+|.+++++.. ..++..++..++.++|.||+||| +.+++||
T Consensus 218 l~H~NVVr~yGVa~~-----~~Pl~ivmEl~~gGsL~~~L~k~~---~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHR 286 (474)
T KOG0194|consen 218 LNHPNVVRFYGVAVL-----EEPLMLVMELCNGGSLDDYLKKNK---KSLPTLEKLRFCYDAARGLEYLH---SKNCIHR 286 (474)
T ss_pred CCCCCEEEEEEEEcC-----CCccEEEEEecCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHhHHHHHH---HCCCcch
Confidence 789999999998765 567899999999999999998765 35999999999999999999999 9999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC------CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCCcc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNEM 331 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~~~ 331 (427)
||-++|||++.+..+||+|||+++....-. .-+..|.|||.+....|++++|||||||++||+++ |..||.+.
T Consensus 287 DIAARNcL~~~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~ 366 (474)
T KOG0194|consen 287 DIAARNCLYSKKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGM 366 (474)
T ss_pred hHhHHHheecCCCeEEeCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCC
Confidence 999999999999999999999998764211 24468999999999999999999999999999999 88999875
Q ss_pred cCCCccHHHHH-HHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 332 FTGNLTLHNFV-KEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 332 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
... .....+ ....+ ...+...+..+..++.+||..+|++||||.++
T Consensus 367 ~~~--~v~~kI~~~~~r-------------------------------~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i 413 (474)
T KOG0194|consen 367 KNY--EVKAKIVKNGYR-------------------------------MPIPSKTPKELAKVMKQCWKKDPEDRPTMSTI 413 (474)
T ss_pred CHH--HHHHHHHhcCcc-------------------------------CCCCCCCHHHHHHHHHHhccCChhhccCHHHH
Confidence 221 111111 11111 11233457778899999999999999999999
Q ss_pred HHHHHHHHHHH
Q 042634 411 AAQLLSFRNKL 421 (427)
Q Consensus 411 ~~~L~~~~~~~ 421 (427)
.+.++.+....
T Consensus 414 ~~~l~~~~~~~ 424 (474)
T KOG0194|consen 414 KKKLEALEKKK 424 (474)
T ss_pred HHHHHHHHhcc
Confidence 99999997653
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=283.12 Aligned_cols=199 Identities=24% Similarity=0.384 Sum_probs=155.9
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchh------------------------------------
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNRE------------------------------------ 223 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------ 223 (427)
+|||||++++.+.. ....++|||||++|+|.+++.....
T Consensus 100 ~h~nIv~~~~~~~~-----~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (374)
T cd05106 100 QHKNIVNLLGACTH-----GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFS 174 (374)
T ss_pred cCCceeeEeeEecC-----CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccccccccccc
Confidence 79999999998644 5578999999999999988753211
Q ss_pred ------------------------------hhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccccCCceeeCCCCce
Q 042634 224 ------------------------------ALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTA 273 (427)
Q Consensus 224 ------------------------------~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~ 273 (427)
....+++..+++++.||+.||+||| ++||+||||||+|||++.++.+
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~ 251 (374)
T cd05106 175 SQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVA 251 (374)
T ss_pred ccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeE
Confidence 0124788899999999999999999 8999999999999999999999
Q ss_pred EecccccccccCCcC--------CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCCcccCCCccHHHHHHH
Q 042634 274 HVGDFGLAKFLPEAT--------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNEMFTGNLTLHNFVKE 344 (427)
Q Consensus 274 kL~DFG~a~~~~~~~--------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~~~~~~~~~~~~~~~~ 344 (427)
||+|||+++...... .++..|+|||++....++.++|||||||++|||++ |+.||....... .+......
T Consensus 252 kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~~~~~~ 330 (374)
T cd05106 252 KICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFYKMVKR 330 (374)
T ss_pred EEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHHHHHHc
Confidence 999999998653321 23457999999988899999999999999999997 999997542211 11111111
Q ss_pred hcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHH
Q 042634 345 ALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAAQLLSFR 418 (427)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~~~ 418 (427)
..... .+...+.++.+++.+||+.||++|||+.||++.|+++.
T Consensus 331 ~~~~~-------------------------------~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 331 GYQMS-------------------------------RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred ccCcc-------------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 00000 01112456899999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=275.21 Aligned_cols=190 Identities=22% Similarity=0.271 Sum_probs=151.8
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
.+.|.||+++.+ |++....||||||++|||+.++|... ..|++..++.++.+++.|++-+| ..|++||
T Consensus 198 ~ds~~vVKLyYs-----FQD~~~LYLiMEylPGGD~mTLL~~~----~~L~e~~arfYiaE~vlAI~~iH---~~gyIHR 265 (550)
T KOG0605|consen 198 VDSPWVVKLYYS-----FQDKEYLYLIMEYLPGGDMMTLLMRK----DTLTEDWARFYIAETVLAIESIH---QLGYIHR 265 (550)
T ss_pred cCCCcEEEEEEE-----ecCCCeeEEEEEecCCccHHHHHHhc----CcCchHHHHHHHHHHHHHHHHHH---HcCcccc
Confidence 568999999988 66688999999999999999999766 45999999999999999999999 9999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC--------------------------c-------------------------
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE--------------------------A------------------------- 287 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~--------------------------~------------------------- 287 (427)
||||+|+|||..|++||+|||+|..+.. .
T Consensus 266 DIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a 345 (550)
T KOG0605|consen 266 DIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLA 345 (550)
T ss_pred cCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhh
Confidence 9999999999999999999999963210 0
Q ss_pred --CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccCCCccHHHHHHHhcccchhcccCcccccccccc
Q 042634 288 --TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEG 365 (427)
Q Consensus 288 --~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (427)
.+||+-|+|||++.+..|+..+|+||+|||+|||+.|.+||..... ...+...+... .. +..
T Consensus 346 ~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp-~~T~rkI~nwr------~~----l~f----- 409 (550)
T KOG0605|consen 346 YSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETP-QETYRKIVNWR------ET----LKF----- 409 (550)
T ss_pred hcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHh------hh----ccC-----
Confidence 0799999999999999999999999999999999999999986421 11122211110 00 000
Q ss_pred chhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCC---HHHHH
Q 042634 366 ETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMN---MEEVA 411 (427)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt---~~ev~ 411 (427)
.....+..+..++|.+|+. ||++|-- ++||-
T Consensus 410 --------------P~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK 443 (550)
T KOG0605|consen 410 --------------PEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIK 443 (550)
T ss_pred --------------CCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHh
Confidence 0112234678999999999 9999964 55554
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=255.78 Aligned_cols=203 Identities=22% Similarity=0.235 Sum_probs=162.7
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
..|||||.+++++... +.+..-..+|||.|+||.|+..+++++. ..+++.++-.|++||+.|++||| +.+|.||
T Consensus 112 s~h~~iV~IidVyeNs-~~~rkcLLiVmE~meGGeLfsriq~~g~--~afTErea~eI~~qI~~Av~~lH---~~nIAHR 185 (400)
T KOG0604|consen 112 SGHPHIVSIIDVYENS-YQGRKCLLIVMECMEGGELFSRIQDRGD--QAFTEREASEIMKQIGLAVRYLH---SMNIAHR 185 (400)
T ss_pred cCCCceEEeehhhhhh-ccCceeeEeeeecccchHHHHHHHHccc--ccchHHHHHHHHHHHHHHHHHHH---hcchhhc
Confidence 4699999999987653 4555566789999999999999987765 67999999999999999999999 8999999
Q ss_pred cccCCceeeCC---CCceEecccccccccCCcC-----CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCc
Q 042634 259 DLKPSNVLLDG---ELTAHVGDFGLAKFLPEAT-----NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~---~~~~kL~DFG~a~~~~~~~-----~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~ 330 (427)
||||+|+|... +..+||+|||+|+...... +-|+.|.|||++...+|+..+|+||+||++|-|++|.+||..
T Consensus 186 DlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS 265 (400)
T KOG0604|consen 186 DLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS 265 (400)
T ss_pred cCChhheeeecCCCCcceEecccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccc
Confidence 99999999954 5689999999999766332 678899999999999999999999999999999999999976
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
..+.. +..-++..+ .... --.+...+.+.++...++++.++..+|.+|.|++|+
T Consensus 266 ~hg~a--ispgMk~rI-------~~gq-----------------y~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~ 319 (400)
T KOG0604|consen 266 NHGLA--ISPGMKRRI-------RTGQ-----------------YEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEV 319 (400)
T ss_pred cCCcc--CChhHHhHh-------hccC-----------------ccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHh
Confidence 43211 111111110 0000 011223567788899999999999999999999998
Q ss_pred HHH
Q 042634 411 AAQ 413 (427)
Q Consensus 411 ~~~ 413 (427)
...
T Consensus 320 m~h 322 (400)
T KOG0604|consen 320 MDH 322 (400)
T ss_pred hcC
Confidence 753
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=274.40 Aligned_cols=203 Identities=24% Similarity=0.414 Sum_probs=153.3
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchh---------------hhhccCHHHHHHHHHHHHHH
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNRE---------------ALKNLNLLQRLSIAVDVASA 243 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------------~~~~l~~~~~~~~~~~i~~~ 243 (427)
++||||+++++.+.. ....++||||+++|+|.+++..... ....+++..+..++.|++.|
T Consensus 76 l~h~niv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~a 150 (304)
T cd05096 76 LKDPNIIRLLGVCVD-----EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASG 150 (304)
T ss_pred cCCCCeeEEEEEEec-----CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 579999999998644 4568999999999999988754211 11347788899999999999
Q ss_pred HHHHhhcCCCCeeeccccCCceeeCCCCceEecccccccccCCc--------CCCccccccccccCCCCcCccccchhHH
Q 042634 244 LDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA--------TNNFFNFQIAEYGMGSEVSTSGDVYSFG 315 (427)
Q Consensus 244 L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~DiwS~G 315 (427)
|+||| +.||+||||||+||+++.++.+||+|||+++..... ..++..|+|||++....++.++||||||
T Consensus 151 l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG 227 (304)
T cd05096 151 MKYLS---SLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFG 227 (304)
T ss_pred HHHHH---HCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHH
Confidence 99999 899999999999999999999999999999865332 1346789999999888999999999999
Q ss_pred HHHHHHHh--CCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHH
Q 042634 316 ILLLETFT--GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIG 393 (427)
Q Consensus 316 ~vl~ell~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 393 (427)
|++|||++ +..||..... ......+............ ...+..++..+.+++
T Consensus 228 ~~l~el~~~~~~~p~~~~~~--~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~li 281 (304)
T cd05096 228 VTLWEILMLCKEQPYGELTD--EQVIENAGEFFRDQGRQVY------------------------LFRPPPCPQGLYELM 281 (304)
T ss_pred HHHHHHHHccCCCCCCcCCH--HHHHHHHHHHhhhcccccc------------------------ccCCCCCCHHHHHHH
Confidence 99999987 5567765321 1111111111100000000 001223567789999
Q ss_pred hhcCCCCCCCCCCHHHHHHHHH
Q 042634 394 VTCSSELPRERMNMEEVAAQLL 415 (427)
Q Consensus 394 ~~cl~~dP~~Rpt~~ev~~~L~ 415 (427)
.+||+.||++|||++||.+.|+
T Consensus 282 ~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 282 LQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred HHHccCCchhCcCHHHHHHHHh
Confidence 9999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=281.35 Aligned_cols=198 Identities=23% Similarity=0.372 Sum_probs=154.9
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchh------------------------------------
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNRE------------------------------------ 223 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------ 223 (427)
+||||+++++.+.. +...++|||||++|+|.++++....
T Consensus 97 ~HpnIv~l~~~~~~-----~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 171 (375)
T cd05104 97 NHINIVNLLGACTV-----GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDM 171 (375)
T ss_pred CCcceeeeeeeecc-----CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhc
Confidence 69999999998644 5678999999999999988854221
Q ss_pred -----------------------------------hhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccccCCceeeC
Q 042634 224 -----------------------------------ALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLD 268 (427)
Q Consensus 224 -----------------------------------~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrDlkp~NIll~ 268 (427)
....+++..+..++.||+.||+||| +.||+||||||+||+++
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~ 248 (375)
T cd05104 172 KPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLT 248 (375)
T ss_pred CCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEE
Confidence 0124788899999999999999999 89999999999999999
Q ss_pred CCCceEecccccccccCCcC--------CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCCcccCCCccHH
Q 042634 269 GELTAHVGDFGLAKFLPEAT--------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNEMFTGNLTLH 339 (427)
Q Consensus 269 ~~~~~kL~DFG~a~~~~~~~--------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~~~~~~~~~~~ 339 (427)
.++.+||+|||+++...... .++..|+|||++.+..++.++|||||||++|||++ |..||....... .+.
T Consensus 249 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-~~~ 327 (375)
T cd05104 249 HGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-KFY 327 (375)
T ss_pred CCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-HHH
Confidence 99999999999998654321 23457999999999999999999999999999998 888987542211 111
Q ss_pred HHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHH
Q 042634 340 NFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAAQLLSF 417 (427)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~~ 417 (427)
+.+...... ..+...+.++.+++.+||+.||++|||+.||++.|++.
T Consensus 328 ~~~~~~~~~-------------------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 328 KMIKEGYRM-------------------------------LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HHHHhCccC-------------------------------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 111111000 01112345689999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=278.74 Aligned_cols=197 Identities=22% Similarity=0.380 Sum_probs=170.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||+++|+|.+ ...+||||.++-|.|..|++.+. ..++......++.||+.||.||| +...|||
T Consensus 448 fdHphIikLIGv~~e------~P~WivmEL~~~GELr~yLq~nk---~sL~l~tL~ly~~Qi~talaYLe---SkrfVHR 515 (974)
T KOG4257|consen 448 FDHPHIIKLIGVCVE------QPMWIVMELAPLGELREYLQQNK---DSLPLRTLTLYCYQICTALAYLE---SKRFVHR 515 (974)
T ss_pred CCCcchhheeeeeec------cceeEEEecccchhHHHHHHhcc---ccchHHHHHHHHHHHHHHHHHHH---hhchhhh
Confidence 689999999999876 56899999999999999998765 46888899999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC-------CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCCc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT-------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~-------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~~ 330 (427)
||..+|||+.+...+||+|||+++.+.... .-+..|||||.+....++.++|||-|||.+||++. |..||.+
T Consensus 516 DIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqg 595 (974)
T KOG4257|consen 516 DIAARNILVSSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQG 595 (974)
T ss_pred hhhhhheeecCcceeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccc
Confidence 999999999999999999999999886654 33457999999999999999999999999999987 9999987
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
..+.+.. -. .....+...|+.||..++.+|.+||++||.+||++.|+
T Consensus 596 vkNsDVI-----------------~~----------------iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei 642 (974)
T KOG4257|consen 596 VKNSDVI-----------------GH----------------IENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEI 642 (974)
T ss_pred ccccceE-----------------EE----------------ecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHH
Confidence 6433211 00 01122333678899999999999999999999999999
Q ss_pred HHHHHHHHHH
Q 042634 411 AAQLLSFRNK 420 (427)
Q Consensus 411 ~~~L~~~~~~ 420 (427)
.+.|+++..+
T Consensus 643 ~~~lsdv~qe 652 (974)
T KOG4257|consen 643 KAILSDVLQE 652 (974)
T ss_pred HHHHHHHHHH
Confidence 9999999763
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=272.15 Aligned_cols=218 Identities=21% Similarity=0.260 Sum_probs=156.0
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
..||||+++++.+...........++||||+. ++|.+++..... ..+++..+..++.|++.||+||| +.||+||
T Consensus 61 ~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~ 134 (290)
T cd07862 61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLH---SHRVVHR 134 (290)
T ss_pred cCCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeC
Confidence 46999999999875433444566899999994 789888865432 34889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc-----CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFT 333 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~ 333 (427)
||||+|||++.++.+||+|||+++..... ..++..|+|||++.+..++.++|||||||++|||++|++||.+...
T Consensus 135 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~ 214 (290)
T cd07862 135 DLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 214 (290)
T ss_pred CCCHHHEEEcCCCCEEEccccceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCH
Confidence 99999999999999999999999865432 2578899999999888999999999999999999999999976421
Q ss_pred CCccHHHHHHHhc-c--cchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 334 GNLTLHNFVKEAL-P--ERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 334 ~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
. ..+........ + ..+..... ... .... ........ ......+..+.+++.+||+.||++|||+.|+
T Consensus 215 ~-~~~~~i~~~~~~~~~~~~~~~~~----~~~--~~~~--~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~ 284 (290)
T cd07862 215 V-DQLGKILDVIGLPGEEDWPRDVA----LPR--QAFH--SKSAQPIE-KFVTDIDELGKDLLLKCLTFNPAKRISAYSA 284 (290)
T ss_pred H-HHHHHHHHHhCCCChhhchhhhc----ccc--hhcc--CCCCCCHH-HHccCCCHHHHHHHHHHhccCchhcCCHHHH
Confidence 1 11111111110 0 00000000 000 0000 00000000 0112245678899999999999999999999
Q ss_pred HH
Q 042634 411 AA 412 (427)
Q Consensus 411 ~~ 412 (427)
++
T Consensus 285 l~ 286 (290)
T cd07862 285 LS 286 (290)
T ss_pred hc
Confidence 85
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=258.54 Aligned_cols=223 Identities=19% Similarity=0.196 Sum_probs=158.3
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
.+|||||.+-.+... .+.+..|+||||| .-||..++.... .+|...+++.++.|+++|++||| .+.|+||
T Consensus 132 ~~H~NIV~vkEVVvG---~~~d~iy~VMe~~-EhDLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH---~~wilHR 201 (419)
T KOG0663|consen 132 ARHPNIVEVKEVVVG---SNMDKIYIVMEYV-EHDLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLH---DNWILHR 201 (419)
T ss_pred cCCCCeeeeEEEEec---cccceeeeeHHHH-HhhHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHh---hceeEec
Confidence 469999998877543 2345689999999 558888887654 56999999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC------CCccccccccccCCC-CcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT------NNFFNFQIAEYGMGS-EVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~------~~~~~y~aPE~~~~~-~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
|||++|+|++..|.+||+|||+|+.+.... +-|..|+|||.+.+. .|+.++|+||+|||+.|++++++.|.+.
T Consensus 202 DLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~ 281 (419)
T KOG0663|consen 202 DLKTSNLLLSHKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGK 281 (419)
T ss_pred ccchhheeeccCCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCC
Confidence 999999999999999999999999987653 567899999999884 5899999999999999999999999864
Q ss_pred cCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 042634 332 FTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVA 411 (427)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~ 411 (427)
.. -..+....+....+. ..++.....................+...+......+.-.+++...+.+||.+|.|++|.+
T Consensus 282 sE-~dQl~~If~llGtPt-e~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L 359 (419)
T KOG0663|consen 282 SE-IDQLDKIFKLLGTPS-EAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGL 359 (419)
T ss_pred ch-HHHHHHHHHHhCCCc-cccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhh
Confidence 22 222333222211110 0011000000000000000000001111111111346678999999999999999999987
Q ss_pred HH
Q 042634 412 AQ 413 (427)
Q Consensus 412 ~~ 413 (427)
++
T Consensus 360 ~h 361 (419)
T KOG0663|consen 360 KH 361 (419)
T ss_pred cc
Confidence 63
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=267.05 Aligned_cols=195 Identities=23% Similarity=0.345 Sum_probs=155.9
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. +...++||||+++|+|.+++.... ..+++.+++.++.|++.||+||| +.|++||
T Consensus 63 l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~ 131 (266)
T cd05064 63 FDHSNIVRLEGVITR-----GNTMMIVTEYMSNGALDSFLRKHE---GQLVAGQLMGMLPGLASGMKYLS---EMGYVHK 131 (266)
T ss_pred CCCCCcCeEEEEEec-----CCCcEEEEEeCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCEeec
Confidence 479999999988543 567899999999999999986542 35899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc-------CCCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCCc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA-------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~~ 330 (427)
||||+||+++.++.+|++|||.+...... ..++..|+|||.+.+..++.++|||||||++||+++ |+.||..
T Consensus 132 dikp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~ 211 (266)
T cd05064 132 GLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWD 211 (266)
T ss_pred cccHhhEEEcCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCc
Confidence 99999999999999999999987654222 134568999999999999999999999999999875 9999975
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
.... .+.+.+.... ....+..++..+.+++.+||+.+|++|||++||
T Consensus 212 ~~~~--~~~~~~~~~~-------------------------------~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i 258 (266)
T cd05064 212 MSGQ--DVIKAVEDGF-------------------------------RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQI 258 (266)
T ss_pred CCHH--HHHHHHHCCC-------------------------------CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHH
Confidence 3111 1111110000 000223456778999999999999999999999
Q ss_pred HHHHHHH
Q 042634 411 AAQLLSF 417 (427)
Q Consensus 411 ~~~L~~~ 417 (427)
.+.|+++
T Consensus 259 ~~~l~~~ 265 (266)
T cd05064 259 HSILSKM 265 (266)
T ss_pred HHHHHhh
Confidence 9998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=291.45 Aligned_cols=194 Identities=21% Similarity=0.251 Sum_probs=155.4
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||++++.+.. +...++||||+++|+|.+++.........+++..+..++.|++.||+||| ++||+||
T Consensus 122 l~Hpniv~~~~~~~~-----~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHr 193 (478)
T PTZ00267 122 CDHFGIVKHFDDFKS-----DDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHR 193 (478)
T ss_pred CCCCCEeEEEEEEEE-----CCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEEC
Confidence 689999999998644 56789999999999999888654332245889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc--------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA--------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~ 330 (427)
||||+|||++.++.+||+|||+|+..... ..||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 194 Dlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~ 273 (478)
T PTZ00267 194 DLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG 273 (478)
T ss_pred CcCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999865432 1588999999999999999999999999999999999999964
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
.. ............. .+ .+..++.++.+++.+||+.||++|||++|+
T Consensus 274 ~~-----~~~~~~~~~~~~~----~~------------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~ 320 (478)
T PTZ00267 274 PS-----QREIMQQVLYGKY----DP------------------------FPCPVSSGMKALLDPLLSKNPALRPTTQQL 320 (478)
T ss_pred CC-----HHHHHHHHHhCCC----CC------------------------CCccCCHHHHHHHHHHhccChhhCcCHHHH
Confidence 31 1111111111000 00 111234568999999999999999999999
Q ss_pred HHH
Q 042634 411 AAQ 413 (427)
Q Consensus 411 ~~~ 413 (427)
+..
T Consensus 321 l~~ 323 (478)
T PTZ00267 321 LHT 323 (478)
T ss_pred HhC
Confidence 753
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=274.16 Aligned_cols=188 Identities=27% Similarity=0.384 Sum_probs=160.6
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||.+++. |....+.++|.|||.| +|++++.+. ..++++.++.++.|++.||.||| +.+|+||
T Consensus 58 lkHpniv~m~es-----fEt~~~~~vVte~a~g-~L~~il~~d----~~lpEe~v~~~a~~LVsaL~yLh---s~rilhr 124 (808)
T KOG0597|consen 58 LKHPNIVEMLES-----FETSAHLWVVTEYAVG-DLFTILEQD----GKLPEEQVRAIAYDLVSALYYLH---SNRILHR 124 (808)
T ss_pred cCCcchhhHHHh-----hcccceEEEEehhhhh-hHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHH---hcCcccc
Confidence 689999999998 4557889999999955 999999876 45999999999999999999999 9999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC------CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
|+||.|||++..+++|+||||+|+....+. .||+-|||||.+.+.+|+..+|.||+|||+||+++|++||...
T Consensus 125 d~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~- 203 (808)
T KOG0597|consen 125 DMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR- 203 (808)
T ss_pred cCCcceeeecCCCceeechhhhhhhcccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-
Confidence 999999999999999999999999887654 8999999999999999999999999999999999999999642
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
.+.+.++....+.. ..+.+....+..++...+..||.+|.|-.+++.
T Consensus 204 ----si~~Lv~~I~~d~v-----------------------------~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 204 ----SITQLVKSILKDPV-----------------------------KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred ----HHHHHHHHHhcCCC-----------------------------CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 23333333222110 123355677899999999999999999988875
Q ss_pred H
Q 042634 413 Q 413 (427)
Q Consensus 413 ~ 413 (427)
+
T Consensus 251 H 251 (808)
T KOG0597|consen 251 H 251 (808)
T ss_pred C
Confidence 4
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=277.89 Aligned_cols=189 Identities=21% Similarity=0.244 Sum_probs=151.9
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+. .+...++||||+++|+|.+++... ..+++..+..++.||+.||+||| +.||+||
T Consensus 52 l~hp~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHr 119 (323)
T cd05571 52 TRHPFLTALKYSFQ-----THDRLCFVMEYANGGELFFHLSRE----RVFSEDRARFYGAEIVSALGYLH---SCDVVYR 119 (323)
T ss_pred CCCCCCCCEEEEEE-----cCCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeC
Confidence 57999999988743 356789999999999999888654 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC------cCCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE------ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+||+++.++.+||+|||+++.... ...|++.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus 120 Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 199 (323)
T cd05571 120 DLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (323)
T ss_pred CCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC
Confidence 9999999999999999999999975322 1268899999999999999999999999999999999999996521
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCC-----CH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERM-----NM 407 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rp-----t~ 407 (427)
............. ..+...+.++.+++.+||+.||++|| ++
T Consensus 200 -----~~~~~~~~~~~~~-----------------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~ 245 (323)
T cd05571 200 -----HEKLFELILMEEI-----------------------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDA 245 (323)
T ss_pred -----HHHHHHHHHcCCC-----------------------------CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCH
Confidence 1111111100000 01122345688999999999999999 78
Q ss_pred HHHHHH
Q 042634 408 EEVAAQ 413 (427)
Q Consensus 408 ~ev~~~ 413 (427)
.|++++
T Consensus 246 ~~ll~h 251 (323)
T cd05571 246 KEIMEH 251 (323)
T ss_pred HHHHcC
Confidence 888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=271.99 Aligned_cols=189 Identities=22% Similarity=0.294 Sum_probs=152.6
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+. +....++||||+++|+|.+++... ..+++..+..++.|++.||+||| ++||+||
T Consensus 58 l~hp~iv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~ 125 (291)
T cd05612 58 VSHPFIIRLFWTEH-----DQRFLYMLMEYVPGGELFSYLRNS----GRFSNSTGLFYASEIVCALEYLH---SKEIVYR 125 (291)
T ss_pred CCCCcHhhhHhhhc-----cCCeEEEEEeCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeec
Confidence 57999999998743 356789999999999999998654 35889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC---CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT---NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGN 335 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~---~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~~~ 335 (427)
||||+||+++.++.+||+|||+++...... .|++.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 126 dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~-- 203 (291)
T cd05612 126 DLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP-- 203 (291)
T ss_pred CCCHHHeEECCCCCEEEEecCcchhccCCcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--
Confidence 999999999999999999999998765432 688999999999999999999999999999999999999975311
Q ss_pred ccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCC-----HHHH
Q 042634 336 LTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMN-----MEEV 410 (427)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt-----~~ev 410 (427)
........... . . .+...+..+.+++.+||+.||.+||+ ++|+
T Consensus 204 ---~~~~~~i~~~~--------~----------------~-----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~ 251 (291)
T cd05612 204 ---FGIYEKILAGK--------L----------------E-----FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDV 251 (291)
T ss_pred ---HHHHHHHHhCC--------c----------------C-----CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHH
Confidence 11111110000 0 0 11122456789999999999999995 8888
Q ss_pred HHH
Q 042634 411 AAQ 413 (427)
Q Consensus 411 ~~~ 413 (427)
+++
T Consensus 252 l~h 254 (291)
T cd05612 252 KNH 254 (291)
T ss_pred hcC
Confidence 765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=267.97 Aligned_cols=194 Identities=25% Similarity=0.346 Sum_probs=151.3
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||+++++..+. .....|+|+|||..|.+...=... ..+++.+++++++++..||+||| .+||+||
T Consensus 165 l~H~nVV~LiEvLDDP---~s~~~YlVley~s~G~v~w~p~d~----~els~~~Ar~ylrDvv~GLEYLH---~QgiiHR 234 (576)
T KOG0585|consen 165 LHHPNVVKLIEVLDDP---ESDKLYLVLEYCSKGEVKWCPPDK----PELSEQQARKYLRDVVLGLEYLH---YQGIIHR 234 (576)
T ss_pred cCCcCeeEEEEeecCc---ccCceEEEEEeccCCccccCCCCc----ccccHHHHHHHHHHHHHHHHHHH---hcCeecc
Confidence 7899999999986553 356799999999998875543322 22899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC-----------cCCCccccccccccCCCC----cCccccchhHHHHHHHHHh
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE-----------ATNNFFNFQIAEYGMGSE----VSTSGDVYSFGILLLETFT 323 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~-----------~~~~~~~y~aPE~~~~~~----~~~~~DiwS~G~vl~ell~ 323 (427)
||||+|+|+++++++||+|||++..... ...||+.|+|||...++. .+.+.||||+||++|.++.
T Consensus 235 DIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllf 314 (576)
T KOG0585|consen 235 DIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLF 314 (576)
T ss_pred ccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhh
Confidence 9999999999999999999999986522 138999999999987733 2678999999999999999
Q ss_pred CCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCC
Q 042634 324 GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRE 403 (427)
Q Consensus 324 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~ 403 (427)
|+.||.+.. . .+... .+++.-+... ..++..+.+.+++.++|+.||++
T Consensus 315 G~~PF~~~~--~---~~l~~--------KIvn~pL~fP-------------------~~pe~~e~~kDli~~lL~KdP~~ 362 (576)
T KOG0585|consen 315 GQLPFFDDF--E---LELFD--------KIVNDPLEFP-------------------ENPEINEDLKDLIKRLLEKDPEQ 362 (576)
T ss_pred ccCCcccch--H---HHHHH--------HHhcCcccCC-------------------CcccccHHHHHHHHHHhhcChhh
Confidence 999997531 1 11111 1111111100 11234567899999999999999
Q ss_pred CCCHHHHHHHH
Q 042634 404 RMNMEEVAAQL 414 (427)
Q Consensus 404 Rpt~~ev~~~L 414 (427)
|.+..+|..+.
T Consensus 363 Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 363 RITLPDIKLHP 373 (576)
T ss_pred eeehhhheecc
Confidence 99999987653
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=268.29 Aligned_cols=197 Identities=24% Similarity=0.470 Sum_probs=157.0
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchh------------hhhccCHHHHHHHHHHHHHHHHH
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNRE------------ALKNLNLLQRLSIAVDVASALDY 246 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~~~~~i~~~L~~ 246 (427)
++||||+++++.+.. ....+++|||+++|+|.+++..... ....+++..++.++.|++.||+|
T Consensus 65 l~h~~i~~~~~~~~~-----~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~ 139 (283)
T cd05048 65 LQHPNIVCLLGVCTK-----EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEY 139 (283)
T ss_pred cCCcccceEEEEEcC-----CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHH
Confidence 579999999988543 4568999999999999998864311 11357889999999999999999
Q ss_pred HhhcCCCCeeeccccCCceeeCCCCceEecccccccccCC--------cCCCccccccccccCCCCcCccccchhHHHHH
Q 042634 247 LHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPE--------ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILL 318 (427)
Q Consensus 247 LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~--------~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl 318 (427)
|| +.|++||||||+||+++.++.+||+|||+++.... ...++..|+|||.+.+..++.++|||||||++
T Consensus 140 lH---~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il 216 (283)
T cd05048 140 LS---SHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVL 216 (283)
T ss_pred HH---hCCeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHH
Confidence 99 89999999999999999999999999999976422 12456789999999888999999999999999
Q ss_pred HHHHh-CCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcC
Q 042634 319 LETFT-GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCS 397 (427)
Q Consensus 319 ~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl 397 (427)
|||++ |..||.+.... .+...+..... ...+..++.++.+++.+||
T Consensus 217 ~el~~~g~~p~~~~~~~--~~~~~i~~~~~-------------------------------~~~~~~~~~~~~~l~~~c~ 263 (283)
T cd05048 217 WEIFSYGLQPYYGFSNQ--EVIEMIRSRQL-------------------------------LPCPEDCPARVYALMIECW 263 (283)
T ss_pred HHHHcCCCCCCCCCCHH--HHHHHHHcCCc-------------------------------CCCcccCCHHHHHHHHHHc
Confidence 99998 99998753211 11111111000 0023446778999999999
Q ss_pred CCCCCCCCCHHHHHHHHHH
Q 042634 398 SELPRERMNMEEVAAQLLS 416 (427)
Q Consensus 398 ~~dP~~Rpt~~ev~~~L~~ 416 (427)
+.||++|||+.||++.|+.
T Consensus 264 ~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 264 NEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred cCChhhCcCHHHHHHHHhc
Confidence 9999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=266.68 Aligned_cols=199 Identities=22% Similarity=0.357 Sum_probs=157.6
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+. ....++++||+++|+|.+++.... ..+++..+..++.|++.||+||| +.|++||
T Consensus 66 l~h~~iv~~~~~~~------~~~~~~i~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~ 133 (279)
T cd05111 66 LDHAYIVRLLGICP------GASLQLVTQLSPLGSLLDHVRQHR---DSLDPQRLLNWCVQIAKGMYYLE---EHRMVHR 133 (279)
T ss_pred CCCCCcceEEEEEC------CCccEEEEEeCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH---HCCEecc
Confidence 57999999998753 234678999999999999986543 35899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc--------CCCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA--------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTN 329 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~ 329 (427)
||||+||+++.++.+||+|||.++..... ..++..|+|||++.+..++.++|||||||++||+++ |..||.
T Consensus 134 dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~ 213 (279)
T cd05111 134 NLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYA 213 (279)
T ss_pred ccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 99999999999999999999999865322 145568999999988899999999999999999998 999986
Q ss_pred cccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 042634 330 EMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEE 409 (427)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~e 409 (427)
+... ....+.+...... ..+..++..+.+++.+||..||++|||+.|
T Consensus 214 ~~~~--~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~li~~c~~~~p~~Rps~~e 260 (279)
T cd05111 214 GMRP--HEVPDLLEKGERL-------------------------------AQPQICTIDVYMVMVKCWMIDENVRPTFKE 260 (279)
T ss_pred CCCH--HHHHHHHHCCCcC-------------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHH
Confidence 5311 1111111110000 011123456788999999999999999999
Q ss_pred HHHHHHHHHHHHH
Q 042634 410 VAAQLLSFRNKLV 422 (427)
Q Consensus 410 v~~~L~~~~~~~~ 422 (427)
+++.|..+.+.-+
T Consensus 261 l~~~l~~~~~~~~ 273 (279)
T cd05111 261 LANEFTRMARDPP 273 (279)
T ss_pred HHHHHHHHHhCCc
Confidence 9999999876533
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=263.75 Aligned_cols=196 Identities=25% Similarity=0.391 Sum_probs=156.6
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++.+.. ....+++|||+++++|.+++..... ..+++..++.++.|++.||+||| +.|++||
T Consensus 59 l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~ 128 (263)
T cd05052 59 IKHPNLVQLLGVCTR-----EPPFYIITEFMTYGNLLDYLRECNR--QEVNAVVLLYMATQISSAMEYLE---KKNFIHR 128 (263)
T ss_pred CCCCChhheEEEEcC-----CCCcEEEEEeCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCEeec
Confidence 479999999988544 4567999999999999998865432 45889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC-------CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCCc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT-------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~-------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~~ 330 (427)
||||+||+++.++.+||+|||.++...... ..+..|+|||.+.+..++.++|||||||++|||++ |..||.+
T Consensus 129 dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~ 208 (263)
T cd05052 129 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 208 (263)
T ss_pred ccCcceEEEcCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 999999999999999999999998765432 23457999999998999999999999999999998 9999865
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
.. ..+....... ... ...+..++.++.+++.+||+.||++|||+.|+
T Consensus 209 ~~-----~~~~~~~~~~-----~~~-----------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l 255 (263)
T cd05052 209 ID-----LSQVYELLEK-----GYR-----------------------MERPEGCPPKVYELMRACWQWNPSDRPSFAEI 255 (263)
T ss_pred CC-----HHHHHHHHHC-----CCC-----------------------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence 31 1111111000 000 00122345678999999999999999999999
Q ss_pred HHHHHHH
Q 042634 411 AAQLLSF 417 (427)
Q Consensus 411 ~~~L~~~ 417 (427)
++.|+.+
T Consensus 256 ~~~l~~~ 262 (263)
T cd05052 256 HQAFETM 262 (263)
T ss_pred HHHHHhh
Confidence 9999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=273.92 Aligned_cols=188 Identities=23% Similarity=0.292 Sum_probs=150.7
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+. .....++||||+++|+|.+++... ..+++..+..++.|++.||+||| +.||+||
T Consensus 50 l~h~~iv~~~~~~~-----~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~Hr 117 (312)
T cd05585 50 VNCPFIVPLKFSFQ-----SPEKLYLVLAFINGGELFHHLQRE----GRFDLSRARFYTAELLCALENLH---KFNVIYR 117 (312)
T ss_pred CCCCcEeceeeEEe-----cCCeEEEEEcCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeC
Confidence 47999999988753 356789999999999999988654 35899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+||+++.++.+||+|||+++..... ..||..|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus 118 Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~ 197 (312)
T cd05585 118 DLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN 197 (312)
T ss_pred CCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC
Confidence 99999999999999999999999864221 268899999999999999999999999999999999999997531
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCC---HHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMN---MEE 409 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt---~~e 409 (427)
..+.......... ..+...+.++.+++.+||+.||++||+ +.|
T Consensus 198 -----~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e 243 (312)
T cd05585 198 -----VNEMYRKILQEPL-----------------------------RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQE 243 (312)
T ss_pred -----HHHHHHHHHcCCC-----------------------------CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHH
Confidence 1111111111000 011224556889999999999999985 566
Q ss_pred HHH
Q 042634 410 VAA 412 (427)
Q Consensus 410 v~~ 412 (427)
++.
T Consensus 244 ~l~ 246 (312)
T cd05585 244 IKN 246 (312)
T ss_pred HHc
Confidence 654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=273.19 Aligned_cols=202 Identities=24% Similarity=0.371 Sum_probs=157.6
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchh-----------------------------------
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNRE----------------------------------- 223 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~----------------------------------- 223 (427)
.+||||+++++.|.. .+...+++|||+++++|.+++.....
T Consensus 68 ~~h~niv~~~~~~~~----~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (337)
T cd05054 68 GHHLNVVNLLGACTK----PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSA 143 (337)
T ss_pred ccCcchhheeeeEec----CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCcccccc
Confidence 369999999997643 23567899999999999988753211
Q ss_pred ----------------------hhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccccCCceeeCCCCceEecccccc
Q 042634 224 ----------------------ALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLA 281 (427)
Q Consensus 224 ----------------------~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a 281 (427)
....+++..+..++.||+.||+||| +.||+||||||+||+++.++.+||+|||++
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a 220 (337)
T cd05054 144 SSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLA 220 (337)
T ss_pred ccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccc
Confidence 0135889999999999999999999 899999999999999999999999999999
Q ss_pred cccCCc--------CCCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCCcccCCCccHHHHHHHhcccchhc
Q 042634 282 KFLPEA--------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNEMFTGNLTLHNFVKEALPERLAE 352 (427)
Q Consensus 282 ~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 352 (427)
+.+... ..++..|+|||++.+..++.++|||||||++|||++ |..||.+....+ .+..........
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~---- 295 (337)
T cd05054 221 RDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EFCRRLKEGTRM---- 295 (337)
T ss_pred hhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HHHHHHhccCCC----
Confidence 875322 134567999999999999999999999999999998 999997532111 111111100000
Q ss_pred ccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHH
Q 042634 353 IVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAAQLLSFRN 419 (427)
Q Consensus 353 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~~~~ 419 (427)
..+...+.++.+++.+||+.+|++|||++|+++.|+++.+
T Consensus 296 ---------------------------~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 296 ---------------------------RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred ---------------------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0112234568999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=278.00 Aligned_cols=181 Identities=25% Similarity=0.299 Sum_probs=150.8
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeecc
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCD 259 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrD 259 (427)
+||.++.++.. |+...+.+.||||+.|||+..+.+. ..|++..++-++..|+.||+||| ++|||+||
T Consensus 427 ~HPFL~~L~~~-----fQT~~~l~fvmey~~Ggdm~~~~~~-----~~F~e~rarfyaAev~l~L~fLH---~~~IIYRD 493 (694)
T KOG0694|consen 427 RHPFLVNLFSC-----FQTKEHLFFVMEYVAGGDLMHHIHT-----DVFSEPRARFYAAEVVLGLQFLH---ENGIIYRD 493 (694)
T ss_pred cCCeEeecccc-----cccCCeEEEEEEecCCCcEEEEEec-----ccccHHHHHHHHHHHHHHHHHHH---hcCceeee
Confidence 79999999988 6678899999999999996655543 34999999999999999999999 99999999
Q ss_pred ccCCceeeCCCCceEecccccccccCC------cCCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccC
Q 042634 260 LKPSNVLLDGELTAHVGDFGLAKFLPE------ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFT 333 (427)
Q Consensus 260 lkp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~ 333 (427)
||.+|||+|.+|++||+|||+++.... .-+||+.|+|||++.+..|+.++|+|||||+||||+.|..||.+...
T Consensus 494 lKLdNiLLD~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE 573 (694)
T KOG0694|consen 494 LKLDNLLLDTEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE 573 (694)
T ss_pred cchhheEEcccCcEEecccccccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 999999999999999999999996431 12899999999999999999999999999999999999999986321
Q ss_pred CCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCH
Q 042634 334 GNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM 407 (427)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~ 407 (427)
.. +.|..+..+ ..-|..++.+..++|++++..+|++|--+
T Consensus 574 --ee---------------~FdsI~~d~-----------------~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 574 --EE---------------VFDSIVNDE-----------------VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred --HH---------------HHHHHhcCC-----------------CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 11 111111110 01234467788999999999999999765
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=268.47 Aligned_cols=195 Identities=22% Similarity=0.287 Sum_probs=152.7
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|++++++++.+.. +...++||||+++|+|.+++..... ..+++..+..++.|++.||+||| +.||+||
T Consensus 57 l~~~~iv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~ 126 (285)
T cd05631 57 VNSRFVVSLAYAYET-----KDALCLVLTIMNGGDLKFHIYNMGN--PGFDEQRAIFYAAELCCGLEDLQ---RERIVYR 126 (285)
T ss_pred cCCCcEEEEEEEEcc-----CCeEEEEEEecCCCcHHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeC
Confidence 469999999887543 5678999999999999887754321 35889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc-----CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFT 333 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~ 333 (427)
||||+||++++++.+||+|||+++..... ..|+..|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 127 dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~ 206 (285)
T cd05631 127 DLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKE 206 (285)
T ss_pred CCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCc
Confidence 99999999999999999999999875432 3688999999999999999999999999999999999999975321
Q ss_pred CCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCC-----HH
Q 042634 334 GNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMN-----ME 408 (427)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt-----~~ 408 (427)
.. ....+.......... .+...+.++.+++++||+.||++||| ++
T Consensus 207 ~~--~~~~~~~~~~~~~~~----------------------------~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~ 256 (285)
T cd05631 207 RV--KREEVDRRVKEDQEE----------------------------YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAA 256 (285)
T ss_pred ch--hHHHHHHHhhccccc----------------------------CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHH
Confidence 11 111111110000000 11223456889999999999999997 78
Q ss_pred HHHHH
Q 042634 409 EVAAQ 413 (427)
Q Consensus 409 ev~~~ 413 (427)
|++++
T Consensus 257 ~~~~h 261 (285)
T cd05631 257 GVKQH 261 (285)
T ss_pred HHhcC
Confidence 88874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=268.51 Aligned_cols=203 Identities=29% Similarity=0.467 Sum_probs=160.4
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchh------------hhhccCHHHHHHHHHHHHHHHHH
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNRE------------ALKNLNLLQRLSIAVDVASALDY 246 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~~~~~i~~~L~~ 246 (427)
++||||+++++.+.. ....++||||+++++|.+++..... ....+++..++.++.|++.|++|
T Consensus 64 l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~ 138 (291)
T cd05094 64 LQHEHIVKFYGVCGD-----GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVY 138 (291)
T ss_pred CCCCCcceEEEEEcc-----CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 579999999998543 5568999999999999999864321 11348899999999999999999
Q ss_pred HhhcCCCCeeeccccCCceeeCCCCceEecccccccccCCc--------CCCccccccccccCCCCcCccccchhHHHHH
Q 042634 247 LHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA--------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILL 318 (427)
Q Consensus 247 LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl 318 (427)
|| ++||+||||||+||+++.++.+||+|||.++..... ..++..|+|||++.+..++.++|||||||++
T Consensus 139 lH---~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 215 (291)
T cd05094 139 LA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVIL 215 (291)
T ss_pred HH---hCCeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHH
Confidence 99 899999999999999999999999999999764322 2456789999999999999999999999999
Q ss_pred HHHHh-CCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcC
Q 042634 319 LETFT-GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCS 397 (427)
Q Consensus 319 ~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl 397 (427)
|||++ |+.||...... ............ ..+..++..+.+++.+||
T Consensus 216 ~el~t~g~~p~~~~~~~-----~~~~~~~~~~~~----------------------------~~~~~~~~~~~~li~~~l 262 (291)
T cd05094 216 WEIFTYGKQPWFQLSNT-----EVIECITQGRVL----------------------------ERPRVCPKEVYDIMLGCW 262 (291)
T ss_pred HHHHhCCCCCCCCCCHH-----HHHHHHhCCCCC----------------------------CCCccCCHHHHHHHHHHc
Confidence 99998 99998653111 111110000000 011224567899999999
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHH
Q 042634 398 SELPRERMNMEEVAAQLLSFRNKLV 422 (427)
Q Consensus 398 ~~dP~~Rpt~~ev~~~L~~~~~~~~ 422 (427)
+.+|++|||++||++.|+++.+..+
T Consensus 263 ~~~P~~Rpt~~~v~~~l~~~~~~~~ 287 (291)
T cd05094 263 QREPQQRLNIKEIYKILHALGKATP 287 (291)
T ss_pred ccChhhCcCHHHHHHHHHHHHhhcC
Confidence 9999999999999999999976543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=272.55 Aligned_cols=141 Identities=25% Similarity=0.358 Sum_probs=124.4
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. +...++||||+++|+|.+++... ..+++..+..++.|++.||.|||+ ..+|+||
T Consensus 60 l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~ 128 (331)
T cd06649 60 CNSPYIVGFYGAFYS-----DGEISICMEHMDGGSLDQVLKEA----KRIPEEILGKVSIAVLRGLAYLRE--KHQIMHR 128 (331)
T ss_pred CCCCCCCeEEEEEEE-----CCEEEEEeecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhh--cCCEEcC
Confidence 579999999998543 56789999999999999998654 348899999999999999999993 2469999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc----CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA----TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~ 330 (427)
||||+||+++.++.+||+|||+++..... ..++..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 129 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 129 DVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred CCChhhEEEcCCCcEEEccCcccccccccccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999765432 2688899999999999999999999999999999999999964
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=269.56 Aligned_cols=190 Identities=22% Similarity=0.297 Sum_probs=155.6
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
.+++||.++|+.+.. +...+++||||.||++.+.++... .+.+..+..+++++..|+.|+| .++.+||
T Consensus 68 ~~~~~it~yygsyl~-----g~~LwiiMey~~gGsv~~lL~~~~----~~~E~~i~~ilre~l~~l~ylH---~~~kiHr 135 (467)
T KOG0201|consen 68 CDSPNITEYYGSYLK-----GTKLWIIMEYCGGGSVLDLLKSGN----ILDEFEIAVILREVLKGLDYLH---SEKKIHR 135 (467)
T ss_pred cCcchHHhhhhheee-----cccHHHHHHHhcCcchhhhhccCC----CCccceeeeehHHHHHHhhhhh---hcceecc
Confidence 456999999998543 678999999999999999997653 3578888889999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
|||+.||++..+|.+|++|||++..+... .+||+.|||||++.+..|+.|+||||+|++.+||.+|.+|+....
T Consensus 136 DIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~h 215 (467)
T KOG0201|consen 136 DIKAANILLSESGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLH 215 (467)
T ss_pred cccccceeEeccCcEEEEecceeeeeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccC
Confidence 99999999999999999999999876543 389999999999999999999999999999999999999997642
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
. +.+.-.+.+..|+. ....+...+.+++..|++.||+.||||.++++
T Consensus 216 P--mrvlflIpk~~PP~-------------------------------L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 216 P--MRVLFLIPKSAPPR-------------------------------LDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred c--ceEEEeccCCCCCc-------------------------------cccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 2 00000011111111 11135566899999999999999999999987
Q ss_pred H
Q 042634 413 Q 413 (427)
Q Consensus 413 ~ 413 (427)
+
T Consensus 263 h 263 (467)
T KOG0201|consen 263 H 263 (467)
T ss_pred h
Confidence 4
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=276.61 Aligned_cols=224 Identities=21% Similarity=0.256 Sum_probs=152.8
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++++...........++||||| +++|.+++... ..+++..+..++.|++.||+||| +.||+||
T Consensus 56 l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~ 127 (338)
T cd07859 56 LRHPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKAN----DDLTPEHHQFFLYQLLRALKYIH---TANVFHR 127 (338)
T ss_pred CCCCCEeeecceEeccCCCCCceEEEEEecC-CCCHHHHHHhc----ccCCHHHHHHHHHHHHHHHHHHH---HCCeecC
Confidence 5799999999886543333334579999999 57898888654 34899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC---------cCCCccccccccccCC--CCcCccccchhHHHHHHHHHhCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE---------ATNNFFNFQIAEYGMG--SEVSTSGDVYSFGILLLETFTGKRP 327 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~---------~~~~~~~y~aPE~~~~--~~~~~~~DiwS~G~vl~ell~g~~p 327 (427)
||||+|||++.++.+||+|||+++.... ...++..|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 128 dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~p 207 (338)
T cd07859 128 DLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPL 207 (338)
T ss_pred CCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCC
Confidence 9999999999999999999999985422 1267889999999865 6789999999999999999999999
Q ss_pred CCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCH
Q 042634 328 TNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM 407 (427)
Q Consensus 328 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~ 407 (427)
|.+... ......+................ ..........................+..+.+++.+||+.||++|||+
T Consensus 208 f~~~~~--~~~~~~~~~~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~ 284 (338)
T cd07859 208 FPGKNV--VHQLDLITDLLGTPSPETISRVR-NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTA 284 (338)
T ss_pred CCCCCh--HHHHHHHHHHhCCCCHHHHHHhh-hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCH
Confidence 975321 11111111111000000000000 000000000000000000000001234567899999999999999999
Q ss_pred HHHHHH
Q 042634 408 EEVAAQ 413 (427)
Q Consensus 408 ~ev~~~ 413 (427)
+|++++
T Consensus 285 ~e~l~h 290 (338)
T cd07859 285 EEALAD 290 (338)
T ss_pred HHHhcC
Confidence 999864
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=263.56 Aligned_cols=202 Identities=18% Similarity=0.252 Sum_probs=159.8
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++.+.. ....++++||+++|+|.+++.........+++..+..++.|++.||+||| +.|++||
T Consensus 59 l~h~~i~~~~~~~~~-----~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~ 130 (267)
T cd08228 59 LNHPNVIKYLDSFIE-----DNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHR 130 (267)
T ss_pred CCCcceeeeeeeEEE-----CCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCC
Confidence 469999999987543 45789999999999999888543322245888999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+||+++.++.++|+|||.+...... ..++..|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 131 dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~ 210 (267)
T cd08228 131 DIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred CCCHHHEEEcCCCCEEECccccceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccc
Confidence 99999999999999999999998875432 257788999999988889999999999999999999999986432
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
.....+...+.... . +.......+..+.+++.+||+.+|++|||++||++
T Consensus 211 ~~~~~~~~~~~~~~--------~----------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 211 MNLFSLCQKIEQCD--------Y----------------------PPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred ccHHHHHHHHhcCC--------C----------------------CCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence 11111111111000 0 00122345677899999999999999999999999
Q ss_pred HHHHHH
Q 042634 413 QLLSFR 418 (427)
Q Consensus 413 ~L~~~~ 418 (427)
.+++++
T Consensus 261 ~~~~~~ 266 (267)
T cd08228 261 IAKQMH 266 (267)
T ss_pred HHHHhc
Confidence 998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=258.08 Aligned_cols=231 Identities=19% Similarity=0.263 Sum_probs=161.9
Q ss_pred Cccccccc-chhhhccccccC-CCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCC
Q 042634 176 NNFIRHRN-LVKIITSCASVD-FQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCET 253 (427)
Q Consensus 176 N~ll~Hpn-iv~~~~~~~~~~-~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~ 253 (427)
++-++|+| ||.+.+++.... +......++|+||+ ..+|.+++.........++...++.+++||+.||+||| ++
T Consensus 64 lk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~ 139 (323)
T KOG0594|consen 64 LKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SH 139 (323)
T ss_pred HHHhCCCcceEEEEeeeeecccccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hC
Confidence 44477888 999999876633 12233678999999 77999998765432235777899999999999999999 99
Q ss_pred CeeeccccCCceeeCCCCceEecccccccccCCcC------CCccccccccccCCC-CcCccccchhHHHHHHHHHhCCC
Q 042634 254 PIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEAT------NNFFNFQIAEYGMGS-EVSTSGDVYSFGILLLETFTGKR 326 (427)
Q Consensus 254 ~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~------~~~~~y~aPE~~~~~-~~~~~~DiwS~G~vl~ell~g~~ 326 (427)
+|+||||||+|||++++|.+||+|||+|+...-.. ..|..|+|||++.+. .|+..+||||+|||++||+++++
T Consensus 140 ~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~ 219 (323)
T KOG0594|consen 140 GILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRP 219 (323)
T ss_pred CeecccCCcceEEECCCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCC
Confidence 99999999999999999999999999999765222 678899999999886 68999999999999999999999
Q ss_pred CCCcccCCCccHHHHHHH-hcc--cchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCC
Q 042634 327 PTNEMFTGNLTLHNFVKE-ALP--ERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRE 403 (427)
Q Consensus 327 pf~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~ 403 (427)
.|.+....+ .+....+. ..| ..+..+.. .......+..+......... .+.......+++.+|++++|.+
T Consensus 220 LFpG~se~~-ql~~If~~lGtP~e~~Wp~v~~----~~~~k~~f~~~~~~~~l~~~--~~~~~~~~~dll~~~L~y~p~~ 292 (323)
T KOG0594|consen 220 LFPGDSEID-QLFRIFRLLGTPNEKDWPGVSS----LPDYKAPFPKWPGPKDLSSI--LPKLDPDGIELLSKLLQYDPAK 292 (323)
T ss_pred CCCCCcHHH-HHHHHHHHcCCCCccCCCCccc----cccccccCcCCCCccchHHh--ccccCccHHHHHHHHhccCccc
Confidence 998754311 11111111 111 11111110 00000000000000000000 0111146889999999999999
Q ss_pred CCCHHHHHHH--HHHH
Q 042634 404 RMNMEEVAAQ--LLSF 417 (427)
Q Consensus 404 Rpt~~ev~~~--L~~~ 417 (427)
|.|++.++.+ +..+
T Consensus 293 R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 293 RISAKGALTHPYFSEL 308 (323)
T ss_pred CcCHHHHhcChhhccc
Confidence 9999999886 4444
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=276.26 Aligned_cols=194 Identities=25% Similarity=0.425 Sum_probs=165.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||++|+++.+.. +....+|+|.+..|+|+.|.++. +.+....++.|++||++||.|||++ ..+|+||
T Consensus 98 L~H~NIirfy~SW~d~~---n~~in~iTEL~TSGtLr~Y~kk~----~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHR 169 (632)
T KOG0584|consen 98 LKHPNIIRFYDSWVDTD---NKTINFITELFTSGTLREYRKKH----RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHR 169 (632)
T ss_pred CCCCceeeeeeheecCC---CceeeeeeecccCCcHHHHHHHh----ccCCHHHHHHHHHHHHHHhhhhhcC-CCCcccc
Confidence 78999999999987743 35578899999999999999877 4588899999999999999999986 6899999
Q ss_pred cccCCceeeCCC-CceEecccccccccCCcC----CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccC
Q 042634 259 DLKPSNVLLDGE-LTAHVGDFGLAKFLPEAT----NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFT 333 (427)
Q Consensus 259 Dlkp~NIll~~~-~~~kL~DFG~a~~~~~~~----~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~ 333 (427)
|||.+||+|+++ |.|||+|.|+|+...... .||+.|||||++. ..|+..+||||||++|.||+|+..||.....
T Consensus 170 DLKCDNIFinG~~G~VKIGDLGLAtl~r~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n 248 (632)
T KOG0584|consen 170 DLKCDNIFVNGNLGEVKIGDLGLATLLRKSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN 248 (632)
T ss_pred ccccceEEEcCCcCceeecchhHHHHhhccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC
Confidence 999999999765 899999999999876654 8999999999987 8899999999999999999999999987655
Q ss_pred CCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 042634 334 GNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAAQ 413 (427)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~ 413 (427)
....+.+...+.-|..+..+-| .++.++|.+|+.. ..+|||+.|+++.
T Consensus 249 ~AQIYKKV~SGiKP~sl~kV~d-------------------------------Pevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 249 PAQIYKKVTSGIKPAALSKVKD-------------------------------PEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred HHHHHHHHHcCCCHHHhhccCC-------------------------------HHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 5555555554444555444443 3478899999999 9999999999863
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=275.74 Aligned_cols=189 Identities=23% Similarity=0.278 Sum_probs=152.0
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. +...++||||+++|+|.+++... ..+++..+..++.|++.||+||| +.||+||
T Consensus 75 l~hp~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~ 142 (329)
T PTZ00263 75 LSHPFIVNMMCSFQD-----ENRVYFLLEFVVGGELFTHLRKA----GRFPNDVAKFYHAELVLAFEYLH---SKDIIYR 142 (329)
T ss_pred CCCCCCCcEEEEEEc-----CCEEEEEEcCCCCChHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeec
Confidence 579999999988543 56789999999999999988754 35888999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC---CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT---NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGN 335 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~---~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~~~ 335 (427)
||||+|||++.++.+||+|||+++...... .|++.|+|||++.+..++.++|||||||++|||++|+.||.+...
T Consensus 143 dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-- 220 (329)
T PTZ00263 143 DLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP-- 220 (329)
T ss_pred CCCHHHEEECCCCCEEEeeccCceEcCCCcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH--
Confidence 999999999999999999999998765433 688999999999999999999999999999999999999965311
Q ss_pred ccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCC-----HHHH
Q 042634 336 LTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMN-----MEEV 410 (427)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt-----~~ev 410 (427)
.+......... .. .+...+.++.+++.+||+.||++||+ ++|+
T Consensus 221 ---~~~~~~i~~~~--------~~---------------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l 268 (329)
T PTZ00263 221 ---FRIYEKILAGR--------LK---------------------FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADV 268 (329)
T ss_pred ---HHHHHHHhcCC--------cC---------------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHH
Confidence 11111110000 00 01112345789999999999999997 6777
Q ss_pred HHH
Q 042634 411 AAQ 413 (427)
Q Consensus 411 ~~~ 413 (427)
+.+
T Consensus 269 l~h 271 (329)
T PTZ00263 269 KNH 271 (329)
T ss_pred hcC
Confidence 654
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=289.14 Aligned_cols=197 Identities=22% Similarity=0.423 Sum_probs=167.8
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
.+|||||++-++... .....||.|||++|+|+.+|+.+. ..|++.+...|++.||.|++||- +.++|||
T Consensus 687 FdHPNIIrLEGVVTk-----s~PvMIiTEyMENGsLDsFLR~~D---GqftviQLVgMLrGIAsGMkYLs---dm~YVHR 755 (996)
T KOG0196|consen 687 FDHPNIIRLEGVVTK-----SKPVMIITEYMENGSLDSFLRQND---GQFTVIQLVGMLRGIASGMKYLS---DMNYVHR 755 (996)
T ss_pred CCCCcEEEEEEEEec-----CceeEEEhhhhhCCcHHHHHhhcC---CceEeehHHHHHHHHHHHhHHHh---hcCchhh
Confidence 679999999999554 567889999999999999998876 44999999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC---------CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT---------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPT 328 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~---------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf 328 (427)
||.++|||++.+..+|++|||+++.+.++. .-...|.|||.+.-.+++.++|||||||||||.++ |..||
T Consensus 756 DLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPY 835 (996)
T KOG0196|consen 756 DLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 835 (996)
T ss_pred hhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcc
Confidence 999999999999999999999999886544 12357999999999999999999999999999887 99999
Q ss_pred CcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 042634 329 NEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME 408 (427)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ 408 (427)
-++.+.+ ..+.+.. ..+...|.+||..+++||..||+.|-.+||+|.
T Consensus 836 WdmSNQd--VIkaIe~-------------------------------gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~ 882 (996)
T KOG0196|consen 836 WDMSNQD--VIKAIEQ-------------------------------GYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFA 882 (996)
T ss_pred cccchHH--HHHHHHh-------------------------------ccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHH
Confidence 7753221 1111111 112226778999999999999999999999999
Q ss_pred HHHHHHHHHHH
Q 042634 409 EVAAQLLSFRN 419 (427)
Q Consensus 409 ev~~~L~~~~~ 419 (427)
||+..|.++..
T Consensus 883 qiV~~lDklIr 893 (996)
T KOG0196|consen 883 QIVSTLDKLIR 893 (996)
T ss_pred HHHHHHHHHhc
Confidence 99999999854
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=267.43 Aligned_cols=216 Identities=20% Similarity=0.224 Sum_probs=152.0
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||++++.+..+.... ..+++..++.++.|++.||+||| +.||+||
T Consensus 57 l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~ 124 (287)
T cd07848 57 LKQENIVELKEAFRR-----RGKLYLVFEYVEKNMLELLEEMP----NGVPPEKVRSYIYQLIKAIHWCH---KNDIVHR 124 (287)
T ss_pred CCCccccchhhhEec-----CCEEEEEEecCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecC
Confidence 579999999988543 56789999999887665543322 35889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc-------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA-------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
||||+||+++.++.+||+|||+++..... ..++..|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 125 dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~ 204 (287)
T cd07848 125 DIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGE 204 (287)
T ss_pred CCCHHHEEEcCCCcEEEeeccCcccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999999875432 25788999999999888999999999999999999999999763
Q ss_pred cCCCccHHHHHH--Hhcccchhccc--CccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCH
Q 042634 332 FTGNLTLHNFVK--EALPERLAEIV--DPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM 407 (427)
Q Consensus 332 ~~~~~~~~~~~~--~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~ 407 (427)
.... ....... ...+....... ++.......... ..............+.++.+++.+||+.||++|||+
T Consensus 205 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~ 278 (287)
T cd07848 205 SEID-QLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAV-----NHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLT 278 (287)
T ss_pred CHHH-HHHHHHHhhCCCCHHHHHhhhccchhcccccCcc-----cCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCH
Confidence 2111 1111110 00111000000 000000000000 000000000112245679999999999999999999
Q ss_pred HHHHH
Q 042634 408 EEVAA 412 (427)
Q Consensus 408 ~ev~~ 412 (427)
+|+++
T Consensus 279 ~~~l~ 283 (287)
T cd07848 279 EQCLN 283 (287)
T ss_pred HHHhc
Confidence 99986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=276.19 Aligned_cols=189 Identities=23% Similarity=0.264 Sum_probs=152.6
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. +...++||||+++|+|.+++... ..+++..+..++.|++.||+||| +.||+||
T Consensus 88 l~hp~Iv~~~~~~~~-----~~~~~lv~Ey~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHr 155 (340)
T PTZ00426 88 INHPFCVNLYGSFKD-----ESYLYLVLEFVIGGEFFTFLRRN----KRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYR 155 (340)
T ss_pred CCCCCCcceEEEEEe-----CCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEcc
Confidence 579999999998543 56789999999999999998754 35899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC---CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT---NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGN 335 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~---~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~~~ 335 (427)
||||+|||++.++.+||+|||+++...... .||+.|+|||++.+..++.++|||||||++|||++|..||.....
T Consensus 156 DLkp~NILl~~~~~ikL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-- 233 (340)
T PTZ00426 156 DLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP-- 233 (340)
T ss_pred CCCHHHEEECCCCCEEEecCCCCeecCCCcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH--
Confidence 999999999999999999999998765432 688999999999998899999999999999999999999975311
Q ss_pred ccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCC-----CHHHH
Q 042634 336 LTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERM-----NMEEV 410 (427)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rp-----t~~ev 410 (427)
... ....... ... .+...+..+.+++.+|++.||++|+ |++|+
T Consensus 234 ~~~---~~~i~~~--------~~~---------------------~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~ 281 (340)
T PTZ00426 234 LLI---YQKILEG--------IIY---------------------FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNV 281 (340)
T ss_pred HHH---HHHHhcC--------CCC---------------------CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHH
Confidence 111 1110000 000 0111234578899999999999995 88888
Q ss_pred HHH
Q 042634 411 AAQ 413 (427)
Q Consensus 411 ~~~ 413 (427)
+++
T Consensus 282 ~~h 284 (340)
T PTZ00426 282 KEH 284 (340)
T ss_pred HcC
Confidence 764
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=275.19 Aligned_cols=194 Identities=21% Similarity=0.292 Sum_probs=150.5
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
.+||||+++++.+.. +...++||||+++|+|..++... ..+++..++.++.|++.||+||| +.||+||
T Consensus 53 ~~hp~iv~~~~~~~~-----~~~~~lv~E~~~~~~L~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~ 120 (329)
T cd05618 53 SNHPFLVGLHSCFQT-----ESRLFFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLH---ERGIIYR 120 (329)
T ss_pred CCCCcCCceeeEEEe-----CCEEEEEEeCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeC
Confidence 479999999987533 56789999999999998887544 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC------cCCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE------ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+||+++.++.+||+|||+++.... ...|+..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 121 Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~ 200 (329)
T cd05618 121 DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG 200 (329)
T ss_pred CCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCC
Confidence 9999999999999999999999975321 1267899999999999999999999999999999999999996431
Q ss_pred CCCc---cHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCH--
Q 042634 333 TGNL---TLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM-- 407 (427)
Q Consensus 333 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~-- 407 (427)
.... ........... ... ...+...+.++.+++.+||+.||++|||+
T Consensus 201 ~~~~~~~~~~~~~~~~i~-------~~~---------------------~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~ 252 (329)
T cd05618 201 SSDNPDQNTEDYLFQVIL-------EKQ---------------------IRIPRSLSVKAASVLKSFLNKDPKERLGCHP 252 (329)
T ss_pred CcCCcccccHHHHHHHHh-------cCC---------------------CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCC
Confidence 1111 11111111000 000 00122234567899999999999999984
Q ss_pred ----HHHHH
Q 042634 408 ----EEVAA 412 (427)
Q Consensus 408 ----~ev~~ 412 (427)
+|+++
T Consensus 253 ~~~~~~i~~ 261 (329)
T cd05618 253 QTGFADIQG 261 (329)
T ss_pred CCCHHHHhc
Confidence 56654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=272.88 Aligned_cols=197 Identities=21% Similarity=0.371 Sum_probs=157.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ...++++||+++|+|.+++.... ..+++..+..++.||+.||+||| +.||+||
T Consensus 66 l~h~niv~~~g~~~~------~~~~~v~e~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~ 133 (316)
T cd05108 66 VDNPHVCRLLGICLT------STVQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLE---ERRLVHR 133 (316)
T ss_pred CCCCCCCeEEEEEcC------CCceeeeecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHH---hcCeecc
Confidence 579999999998643 24679999999999999987643 35888899999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC--------CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT--------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTN 329 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~--------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~ 329 (427)
||||+||+++.++.+||+|||+++...... ..+..|+|||++....++.++|||||||++||+++ |+.||.
T Consensus 134 dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~ 213 (316)
T cd05108 134 DLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213 (316)
T ss_pred ccchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence 999999999999999999999998764322 23567999999999999999999999999999997 999986
Q ss_pred cccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 042634 330 EMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEE 409 (427)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~e 409 (427)
+.... .+......... ...+..++.++.+++.+||+.+|++|||+.|
T Consensus 214 ~~~~~--~~~~~~~~~~~-------------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~ 260 (316)
T cd05108 214 GIPAS--EISSILEKGER-------------------------------LPQPPICTIDVYMIMVKCWMIDADSRPKFRE 260 (316)
T ss_pred CCCHH--HHHHHHhCCCC-------------------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHH
Confidence 53111 11111110000 0011224456889999999999999999999
Q ss_pred HHHHHHHHHHH
Q 042634 410 VAAQLLSFRNK 420 (427)
Q Consensus 410 v~~~L~~~~~~ 420 (427)
++..+.++.++
T Consensus 261 l~~~l~~~~~~ 271 (316)
T cd05108 261 LIIEFSKMARD 271 (316)
T ss_pred HHHHHHHHHcC
Confidence 99999988654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=266.98 Aligned_cols=202 Identities=27% Similarity=0.459 Sum_probs=159.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccch---------hhhhccCHHHHHHHHHHHHHHHHHHhh
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNR---------EALKNLNLLQRLSIAVDVASALDYLHH 249 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~l~~~~~~~~~~~i~~~L~~LH~ 249 (427)
++|||++++++.+.. ....++||||+++++|.+++.... .....+++..++.++.|++.||+|||
T Consensus 64 l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH- 137 (288)
T cd05093 64 LQHEHIVKFYGVCVE-----GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA- 137 (288)
T ss_pred CCCCCcceEEEEEec-----CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH-
Confidence 479999999988543 567899999999999999886432 11134899999999999999999999
Q ss_pred cCCCCeeeccccCCceeeCCCCceEecccccccccCCc--------CCCccccccccccCCCCcCccccchhHHHHHHHH
Q 042634 250 YCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA--------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLET 321 (427)
Q Consensus 250 ~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~el 321 (427)
.+|++||||||+||++++++.+||+|||.++..... ..++..|+|||++.+..++.++|||||||++|||
T Consensus 138 --~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l 215 (288)
T cd05093 138 --SQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEI 215 (288)
T ss_pred --hCCeeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHH
Confidence 899999999999999999999999999999865322 1345679999999988999999999999999999
Q ss_pred Hh-CCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCC
Q 042634 322 FT-GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSEL 400 (427)
Q Consensus 322 l~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~d 400 (427)
++ |..||...... ............. .+..++.++.+++.+||+.|
T Consensus 216 ~t~g~~p~~~~~~~-----~~~~~i~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~~ 262 (288)
T cd05093 216 FTYGKQPWYQLSNN-----EVIECITQGRVLQ----------------------------RPRTCPKEVYDLMLGCWQRE 262 (288)
T ss_pred HhCCCCCCCCCCHH-----HHHHHHHcCCcCC----------------------------CCCCCCHHHHHHHHHHccCC
Confidence 98 89998653211 1111100000000 01123456899999999999
Q ss_pred CCCCCCHHHHHHHHHHHHHHH
Q 042634 401 PRERMNMEEVAAQLLSFRNKL 421 (427)
Q Consensus 401 P~~Rpt~~ev~~~L~~~~~~~ 421 (427)
|.+|||+.|+.+.|+.+.+.-
T Consensus 263 p~~Rpt~~~v~~~l~~~~~~~ 283 (288)
T cd05093 263 PHMRLNIKEIHSLLQNLAKAS 283 (288)
T ss_pred hhhCCCHHHHHHHHHHHHHhc
Confidence 999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=271.79 Aligned_cols=187 Identities=21% Similarity=0.290 Sum_probs=149.4
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
.+||||+++++.+. .+...++||||+++|+|..++... ..+++..+..++.|++.||+||| +.||+||
T Consensus 53 ~~hp~i~~~~~~~~-----~~~~~~lv~e~~~gg~L~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~ 120 (316)
T cd05592 53 WEHPFLTHLFCTFQ-----TKEHLFFVMEYLNGGDLMFHIQSS----GRFDEARARFYAAEIICGLQFLH---KKGIIYR 120 (316)
T ss_pred cCCCCccceeeEEE-----cCCEEEEEEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeC
Confidence 47999999988743 356789999999999999888654 35899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC------cCCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE------ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+||+++.++.+||+|||+|+.... ...||..|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 121 dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~ 200 (316)
T cd05592 121 DLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED 200 (316)
T ss_pred CCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999999975422 1268899999999999999999999999999999999999997531
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHH-HHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME-EVA 411 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~-ev~ 411 (427)
. .+........ .+ ..+..++.++.+++.+||+.||++||++. +++
T Consensus 201 ~-----~~~~~~i~~~------~~-----------------------~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 201 E-----DELFDSILND------RP-----------------------HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred H-----HHHHHHHHcC------CC-----------------------CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1 1111110000 00 01122345678999999999999999976 444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=266.68 Aligned_cols=207 Identities=29% Similarity=0.419 Sum_probs=157.8
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++.+.. ..+...+++|||+++++|.+++... .+++.++..++.|++.||+||| +.||+||
T Consensus 63 l~h~~i~~~~~~~~~---~~~~~~~lv~e~~~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~ 131 (283)
T cd05080 63 LYHENIVKYKGCCSE---QGGKGLQLIMEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLH---SQHYIHR 131 (283)
T ss_pred CCCCCEeeEEEEEec---CCCceEEEEecCCCCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHH---HCCeecc
Confidence 579999999987543 1234578999999999999988543 4899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC---------CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT---------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTN 329 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~---------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~ 329 (427)
||||+||+++.++.+||+|||+++...... .++..|+|||...+..++.++|||||||++|||++|..||.
T Consensus 132 dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~ 211 (283)
T cd05080 132 DLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQ 211 (283)
T ss_pred ccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999998654321 34557999999988889999999999999999999999986
Q ss_pred cccCCCccHHHHHHHhcc----cchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCC
Q 042634 330 EMFTGNLTLHNFVKEALP----ERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERM 405 (427)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rp 405 (427)
..... +......... ..+.+..+.. .....+..++.++.+++.+||+.+|++||
T Consensus 212 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp 269 (283)
T cd05080 212 SPPKK---FEEMIGPKQGQMTVVRLIELLERG-------------------MRLPCPKNCPQEVYILMKNCWETEAKFRP 269 (283)
T ss_pred CCcch---hhhhhcccccccchhhhhhhhhcC-------------------CCCCCCCCCCHHHHHHHHHHhccChhhCC
Confidence 43211 1111100000 0000000000 00001234567899999999999999999
Q ss_pred CHHHHHHHHHHHH
Q 042634 406 NMEEVAAQLLSFR 418 (427)
Q Consensus 406 t~~ev~~~L~~~~ 418 (427)
|++++++.|+++.
T Consensus 270 s~~~i~~~l~~~~ 282 (283)
T cd05080 270 TFRSLIPILKEMH 282 (283)
T ss_pred CHHHHHHHHHHhh
Confidence 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=243.70 Aligned_cols=191 Identities=23% Similarity=0.292 Sum_probs=161.0
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++|+.+.+ ....|+++||.++|+++..++..+. ..+++.....+++|+|.|+.|+| .++|+||
T Consensus 79 L~hpnilrlY~~fhd-----~~riyLilEya~~gel~k~L~~~~~--~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhR 148 (281)
T KOG0580|consen 79 LRHPNILRLYGYFHD-----SKRIYLILEYAPRGELYKDLQEGRM--KRFDEQRAATYIKQLANALLYCH---LKRVIHR 148 (281)
T ss_pred cCCccHHhhhhheec-----cceeEEEEEecCCchHHHHHHhccc--ccccccchhHHHHHHHHHHHHhc---cCCcccC
Confidence 789999999999544 6789999999999999999985544 66999999999999999999999 9999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC----CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT----NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTG 334 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~----~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~~ 334 (427)
||||+|+|++.++.+||+|||-+...+.+. +||.-|.+||...+..++.++|+|++|++.||++.|.+||.... .
T Consensus 149 diKpenlLlg~~~~lkiAdfGwsV~~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~ 227 (281)
T KOG0580|consen 149 DIKPENLLLGSAGELKIADFGWSVHAPSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-H 227 (281)
T ss_pred CCCHHHhccCCCCCeeccCCCceeecCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-h
Confidence 999999999999999999999998765443 89999999999999999999999999999999999999998653 2
Q ss_pred CccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 042634 335 NLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAAQ 413 (427)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~ 413 (427)
...+.+..+..+ ..+...+..+.+++.+|+..+|.+|.+..|+++.
T Consensus 228 ~etYkrI~k~~~---------------------------------~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 228 SETYKRIRKVDL---------------------------------KFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred HHHHHHHHHccc---------------------------------cCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 222222111110 0223345668899999999999999999999864
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=261.42 Aligned_cols=194 Identities=24% Similarity=0.403 Sum_probs=154.7
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ...++||||+++++|.+++.... ..+++..++.++.|++.||+||| .+|++||
T Consensus 52 l~h~~ii~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~ 119 (257)
T cd05115 52 LDNPYIVRMIGVCEA------EALMLVMEMASGGPLNKFLSGKK---DEITVSNVVELMHQVSMGMKYLE---GKNFVHR 119 (257)
T ss_pred cCCCCeEEEEEEEcC------CCeEEEEEeCCCCCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHH---hcCeeec
Confidence 479999999987532 35789999999999999886433 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC---------CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT---------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPT 328 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~---------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf 328 (427)
||||+||+++.++.+||+|||+++...... .++..|+|||++....++.++|||||||++||+++ |..||
T Consensus 120 dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~ 199 (257)
T cd05115 120 DLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPY 199 (257)
T ss_pred ccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence 999999999999999999999997553321 22467999999988889999999999999999996 99999
Q ss_pred CcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 042634 329 NEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME 408 (427)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ 408 (427)
...... .....+....+ ...+..++.++.+++.+||+.+|++||++.
T Consensus 200 ~~~~~~--~~~~~~~~~~~-------------------------------~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~ 246 (257)
T cd05115 200 KKMKGP--EVMSFIEQGKR-------------------------------LDCPAECPPEMYALMKDCWIYKWEDRPNFA 246 (257)
T ss_pred CcCCHH--HHHHHHHCCCC-------------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHH
Confidence 754211 11111111000 001223467789999999999999999999
Q ss_pred HHHHHHHHH
Q 042634 409 EVAAQLLSF 417 (427)
Q Consensus 409 ev~~~L~~~ 417 (427)
+|.+.|+.+
T Consensus 247 ~i~~~l~~~ 255 (257)
T cd05115 247 KVEERMRTY 255 (257)
T ss_pred HHHHHHhhh
Confidence 999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=272.79 Aligned_cols=189 Identities=20% Similarity=0.258 Sum_probs=151.4
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. +...++||||+++|+|..++... ..+++..++.++.|++.||+||| +.||+||
T Consensus 52 l~hp~i~~~~~~~~~-----~~~~~lv~E~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~ 119 (323)
T cd05595 52 TRHPFLTALKYAFQT-----HDRLCFVMEYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLH---SRDVVYR 119 (323)
T ss_pred CCCCCCcceeeEEec-----CCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEec
Confidence 579999999887533 56789999999999998887654 35899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC------cCCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE------ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+|||++.++.+||+|||+++.... ...|+..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 120 Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~ 199 (323)
T cd05595 120 DIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (323)
T ss_pred CCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999999875322 1258899999999999999999999999999999999999996531
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCC-----CH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERM-----NM 407 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rp-----t~ 407 (427)
. ............ . .+...+.++.+++.+||+.||++|| ++
T Consensus 200 ~-----~~~~~~~~~~~~----~-------------------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~ 245 (323)
T cd05595 200 H-----ERLFELILMEEI----R-------------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDA 245 (323)
T ss_pred H-----HHHHHHHhcCCC----C-------------------------CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCH
Confidence 1 111111100000 0 1122345688999999999999998 88
Q ss_pred HHHHHH
Q 042634 408 EEVAAQ 413 (427)
Q Consensus 408 ~ev~~~ 413 (427)
.|++++
T Consensus 246 ~~~l~h 251 (323)
T cd05595 246 KEVMEH 251 (323)
T ss_pred HHHHcC
Confidence 888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=273.31 Aligned_cols=189 Identities=22% Similarity=0.255 Sum_probs=151.8
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++.+.+. .+...++||||+++|+|..++... ..+++.++..++.||+.||+||| +.||+||
T Consensus 52 l~hp~iv~~~~~~~-----~~~~~~lv~Ey~~~g~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHr 119 (328)
T cd05593 52 TRHPFLTSLKYSFQ-----TKDRLCFVMEYVNGGELFFHLSRE----RVFSEDRTRFYGAEIVSALDYLH---SGKIVYR 119 (328)
T ss_pred CCCCCCcceEEEEE-----cCCEEEEEEeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEec
Confidence 57999999987743 356789999999999998887654 35899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+|||++.++.+||+|||+++..... ..|+..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 120 Dikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~ 199 (328)
T cd05593 120 DLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (328)
T ss_pred ccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC
Confidence 99999999999999999999998754221 258899999999999999999999999999999999999996531
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCC-----CH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERM-----NM 407 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rp-----t~ 407 (427)
..+.......... . .+...+.++.+++.+||+.||++|| ++
T Consensus 200 -----~~~~~~~~~~~~~------------------------~-----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~ 245 (328)
T cd05593 200 -----HEKLFELILMEDI------------------------K-----FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDA 245 (328)
T ss_pred -----HHHHHHHhccCCc------------------------c-----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCH
Confidence 1111111110000 0 1122345678999999999999997 89
Q ss_pred HHHHHH
Q 042634 408 EEVAAQ 413 (427)
Q Consensus 408 ~ev~~~ 413 (427)
.|++++
T Consensus 246 ~~il~h 251 (328)
T cd05593 246 KEIMRH 251 (328)
T ss_pred HHHhcC
Confidence 998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=271.81 Aligned_cols=187 Identities=21% Similarity=0.257 Sum_probs=149.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
.+||+|+++++.+. .+...++||||+++|+|.+++... ..+++..+..++.|++.||+||| +.||+||
T Consensus 53 ~~~~~i~~~~~~~~-----~~~~~~lv~E~~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHr 120 (316)
T cd05620 53 WENPFLTHLYCTFQ-----TKEHLFFVMEFLNGGDLMFHIQDK----GRFDLYRATFYAAEIVCGLQFLH---SKGIIYR 120 (316)
T ss_pred cCCCCccCeeEEEE-----eCCEEEEEECCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEec
Confidence 47999999998753 356789999999999999888654 35889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC------cCCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE------ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+||+++.++.+||+|||+++.... ...|+..|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus 121 Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~ 200 (316)
T cd05620 121 DLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD 200 (316)
T ss_pred CCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999999875321 2268899999999999999999999999999999999999997531
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHH-HHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME-EVA 411 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~-ev~ 411 (427)
.....+.+....+ . .+...+.++.+++.+||+.||++|||+. ++.
T Consensus 201 --~~~~~~~~~~~~~---------~-----------------------~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 201 --EDELFESIRVDTP---------H-----------------------YPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred --HHHHHHHHHhCCC---------C-----------------------CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 1111111110000 0 0111345678999999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=276.81 Aligned_cols=199 Identities=28% Similarity=0.402 Sum_probs=156.7
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhh-----------------------------------
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREA----------------------------------- 224 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~----------------------------------- 224 (427)
.||||+++++.+.. ....++|||||++|+|.+++......
T Consensus 99 ~HpnIv~l~~~~~~-----~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (400)
T cd05105 99 PHLNIVNLLGACTK-----SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFEN 173 (400)
T ss_pred CCCCeeeEEEEEcc-----CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcc
Confidence 59999999998644 56789999999999999887543210
Q ss_pred ---------------------------------------------------------hhccCHHHHHHHHHHHHHHHHHH
Q 042634 225 ---------------------------------------------------------LKNLNLLQRLSIAVDVASALDYL 247 (427)
Q Consensus 225 ---------------------------------------------------------~~~l~~~~~~~~~~~i~~~L~~L 247 (427)
...+++..+..++.|++.||+||
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L 253 (400)
T cd05105 174 KGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL 253 (400)
T ss_pred cccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHH
Confidence 12478888999999999999999
Q ss_pred hhcCCCCeeeccccCCceeeCCCCceEecccccccccCCc--------CCCccccccccccCCCCcCccccchhHHHHHH
Q 042634 248 HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA--------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLL 319 (427)
Q Consensus 248 H~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ 319 (427)
| ..+|+||||||+||+++.++.+||+|||+++..... ..++..|+|||.+.+..++.++|||||||++|
T Consensus 254 H---~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ 330 (400)
T cd05105 254 A---SKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLW 330 (400)
T ss_pred H---hCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHH
Confidence 9 899999999999999999999999999999865322 13556799999999889999999999999999
Q ss_pred HHHh-CCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCC
Q 042634 320 ETFT-GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSS 398 (427)
Q Consensus 320 ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~ 398 (427)
||++ |..||........ +...+..... ...+..++.++.+++.+||+
T Consensus 331 ellt~g~~P~~~~~~~~~-~~~~~~~~~~-------------------------------~~~~~~~~~~l~~li~~cl~ 378 (400)
T cd05105 331 EIFSLGGTPYPGMIVDST-FYNKIKSGYR-------------------------------MAKPDHATQEVYDIMVKCWN 378 (400)
T ss_pred HHHHCCCCCCcccchhHH-HHHHHhcCCC-------------------------------CCCCccCCHHHHHHHHHHCc
Confidence 9997 9999875421111 1111100000 00122356678999999999
Q ss_pred CCCCCCCCHHHHHHHHHHHH
Q 042634 399 ELPRERMNMEEVAAQLLSFR 418 (427)
Q Consensus 399 ~dP~~Rpt~~ev~~~L~~~~ 418 (427)
.||++|||+.+|.+.|+++.
T Consensus 379 ~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 379 SEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred cCHhHCcCHHHHHHHHHHHc
Confidence 99999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=266.39 Aligned_cols=193 Identities=34% Similarity=0.543 Sum_probs=148.4
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++|+||+++|+|.+++..... ..+++..+..++.||+.||.||| +.+++|+
T Consensus 58 l~h~ni~~~~g~~~~-----~~~~~lv~e~~~~g~L~~~L~~~~~--~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~ 127 (259)
T PF07714_consen 58 LRHPNIVKLYGFCIE-----NEPLFLVMEYCPGGSLDDYLKSKNK--EPLSEQQRLSIAIQIAEALSYLH---SNNIIHG 127 (259)
T ss_dssp HSBTTBE-EEEEEES-----SSSEEEEEE--TTEBHHHHHHHTCT--TTSBHHHHHHHHHHHHHHHHHHH---HTTEEES
T ss_pred ccccccccccccccc-----ccccccccccccccccccccccccc--ccccccccccccccccccccccc---ccccccc
Confidence 489999999999763 4458999999999999999976522 45899999999999999999999 8899999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc--------CCCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA--------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTN 329 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~ 329 (427)
||+++||+++.++.+||+|||+++..... ......|+|||.+....++.++||||||+++||+++ |+.||.
T Consensus 128 ~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~ 207 (259)
T PF07714_consen 128 NLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFS 207 (259)
T ss_dssp T-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999999999999999876321 245568999999988889999999999999999999 788886
Q ss_pred cccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 042634 330 EMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEE 409 (427)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~e 409 (427)
.. ....+...+..... ...+..++..+.+++.+||+.||++||||.|
T Consensus 208 ~~--~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~ 254 (259)
T PF07714_consen 208 DY--DNEEIIEKLKQGQR-------------------------------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQE 254 (259)
T ss_dssp TS--CHHHHHHHHHTTEE-------------------------------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHH
T ss_pred cc--cccccccccccccc-------------------------------ceeccchhHHHHHHHHHHcCCChhhCcCHHH
Confidence 54 11111111111100 0022335667899999999999999999999
Q ss_pred HHHHH
Q 042634 410 VAAQL 414 (427)
Q Consensus 410 v~~~L 414 (427)
+++.|
T Consensus 255 i~~~L 259 (259)
T PF07714_consen 255 ILQEL 259 (259)
T ss_dssp HHHHH
T ss_pred HHhcC
Confidence 99886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=273.32 Aligned_cols=194 Identities=21% Similarity=0.299 Sum_probs=150.4
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
.+||||+++++.+.. ....++||||+++|+|.+++... ..+++..++.++.|++.||+||| +.||+||
T Consensus 53 ~~hp~Iv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~ 120 (329)
T cd05588 53 SNHPFLVGLHSCFQT-----ESRLFFVIEFVSGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNFLH---ERGIIYR 120 (329)
T ss_pred cCCCCCCceEEEEEc-----CCEEEEEEeCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEec
Confidence 369999999987533 56789999999999998887544 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC------cCCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE------ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+||+++.++.+||+|||+++.... ...|+..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 121 dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~ 200 (329)
T cd05588 121 DLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG 200 (329)
T ss_pred CCCHHHeEECCCCCEEECcCccccccccCCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccccc
Confidence 9999999999999999999999875321 1267889999999999999999999999999999999999997432
Q ss_pred CCC---ccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCC---
Q 042634 333 TGN---LTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMN--- 406 (427)
Q Consensus 333 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt--- 406 (427)
... ............ .... ..+...+.++.+++.+||+.||.+|||
T Consensus 201 ~~~~~~~~~~~~~~~~~~-------~~~~---------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~ 252 (329)
T cd05588 201 MSDNPDQNTEDYLFQVIL-------EKQI---------------------RIPRSLSVKASSVLKGFLNKDPKERLGCHP 252 (329)
T ss_pred ccccccccchHHHHHHHH-------cCCC---------------------CCCCCCCHHHHHHHHHHhccCHHHcCCCCC
Confidence 111 001111111000 0000 011223456889999999999999998
Q ss_pred ---HHHHHH
Q 042634 407 ---MEEVAA 412 (427)
Q Consensus 407 ---~~ev~~ 412 (427)
++|+++
T Consensus 253 ~~~~~~i~~ 261 (329)
T cd05588 253 QTGFRDIKS 261 (329)
T ss_pred CCCHHHHhc
Confidence 566654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=272.25 Aligned_cols=183 Identities=23% Similarity=0.257 Sum_probs=147.5
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
.+||||+++++.+. .....++||||+++|+|.+++... ..+++..+..++.|++.||+||| +.||+||
T Consensus 53 ~~h~~iv~~~~~~~-----~~~~~~iv~Ey~~~g~L~~~i~~~----~~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~ 120 (320)
T cd05590 53 RNHPFLTQLYCCFQ-----TPDRLFFVMEFVNGGDLMFHIQKS----RRFDEARARFYAAEITSALMFLH---DKGIIYR 120 (320)
T ss_pred cCCCchhceeeEEE-----cCCEEEEEEcCCCCchHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeC
Confidence 36999999998743 356789999999999999888654 35899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC------cCCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE------ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+||+++.++.+||+|||+++.... ...|++.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 121 dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~ 200 (320)
T cd05590 121 DLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN 200 (320)
T ss_pred CCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC
Confidence 9999999999999999999999875321 1268899999999999999999999999999999999999997531
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM 407 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~ 407 (427)
. ............ . .+...+.++.+++.+||+.||++||++
T Consensus 201 ~-----~~~~~~i~~~~~---~--------------------------~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 201 E-----DDLFEAILNDEV---V--------------------------YPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred H-----HHHHHHHhcCCC---C--------------------------CCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 1 111111110000 0 111234567899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=260.51 Aligned_cols=193 Identities=26% Similarity=0.381 Sum_probs=154.4
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+. ....++||||+++|+|.+++... ..+++..+..++.|++.||+|+| ++||+||
T Consensus 53 l~h~~i~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~ 119 (257)
T cd05116 53 LDNPYIVRMIGICE------AESWMLVMELAELGPLNKFLQKN----KHVTEKNITELVHQVSMGMKYLE---ETNFVHR 119 (257)
T ss_pred CCCCCcceEEEEEc------CCCcEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeec
Confidence 57999999988753 24568999999999999998654 35889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC---------CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT---------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPT 328 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~---------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf 328 (427)
||||.||+++.++.+||+|||.++...... .++..|+|||.+....++.++|||||||++||+++ |..||
T Consensus 120 dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~ 199 (257)
T cd05116 120 DLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPY 199 (257)
T ss_pred ccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999998654321 23468999999988889999999999999999998 99999
Q ss_pred CcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 042634 329 NEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME 408 (427)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ 408 (427)
..... ....+.+...... ..+..++.++.+++.+||+.||++|||++
T Consensus 200 ~~~~~--~~~~~~i~~~~~~-------------------------------~~~~~~~~~l~~li~~~~~~~p~~Rp~~~ 246 (257)
T cd05116 200 KGMKG--NEVTQMIESGERM-------------------------------ECPQRCPPEMYDLMKLCWTYGVDERPGFA 246 (257)
T ss_pred CCCCH--HHHHHHHHCCCCC-------------------------------CCCCCCCHHHHHHHHHHhccCchhCcCHH
Confidence 75321 1111111110000 01123456789999999999999999999
Q ss_pred HHHHHHHHH
Q 042634 409 EVAAQLLSF 417 (427)
Q Consensus 409 ev~~~L~~~ 417 (427)
+|.+.|+.+
T Consensus 247 ~i~~~l~~~ 255 (257)
T cd05116 247 VVELRLRNY 255 (257)
T ss_pred HHHHHHhcc
Confidence 999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=269.58 Aligned_cols=221 Identities=18% Similarity=0.257 Sum_probs=149.9
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+ .++|.+++.... ..+++..+..++.|++.||+||| +.||+||
T Consensus 60 l~h~niv~~~~~~~~-----~~~~~lv~e~~-~~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~ 127 (303)
T cd07869 60 LKHANIVLLHDIIHT-----KETLTLVFEYV-HTDLCQYMDKHP---GGLHPENVKLFLFQLLRGLSYIH---QRYILHR 127 (303)
T ss_pred CCCCCcCeEEEEEec-----CCeEEEEEECC-CcCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecC
Confidence 579999999988543 56789999999 578887775443 45888999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC------cCCCccccccccccCC-CCcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE------ATNNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
||||+||+++.++.+||+|||+++.... ...++..|+|||++.+ ..++.++||||+||++|||++|..||.+.
T Consensus 128 dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 207 (303)
T cd07869 128 DLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM 207 (303)
T ss_pred CCCHHHEEECCCCCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999875432 2367788999999865 45889999999999999999999999764
Q ss_pred cCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 042634 332 FTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVA 411 (427)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~ 411 (427)
......+........... ...................................+..+.+++.+|++.||++|||++|++
T Consensus 208 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l 286 (303)
T cd07869 208 KDIQDQLERIFLVLGTPN-EDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAAL 286 (303)
T ss_pred ccHHHHHHHHHHHhCCCC-hhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHh
Confidence 221111111111110000 0000000000000000000000000000000011235678999999999999999999998
Q ss_pred H
Q 042634 412 A 412 (427)
Q Consensus 412 ~ 412 (427)
+
T Consensus 287 ~ 287 (303)
T cd07869 287 S 287 (303)
T ss_pred c
Confidence 6
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=276.27 Aligned_cols=192 Identities=23% Similarity=0.314 Sum_probs=156.6
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhcc--CHHHHHHHHHHHHHHHHHHhhcCCCCee
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNL--NLLQRLSIAVDVASALDYLHHYCETPIV 256 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l--~~~~~~~~~~~i~~~L~~LH~~~~~~iv 256 (427)
++|.|||+++|++.. +...-|.||-++||+|.++++..- .++ .+.++-.+.+||++||+||| +..||
T Consensus 629 LrHkNIVrYLGs~se-----nGf~kIFMEqVPGGSLSsLLrskW---GPlKDNEstm~fYtkQILeGLkYLH---en~IV 697 (1226)
T KOG4279|consen 629 LRHKNIVRYLGSVSE-----NGFFKIFMEQVPGGSLSSLLRSKW---GPLKDNESTMNFYTKQILEGLKYLH---ENKIV 697 (1226)
T ss_pred HhhHhHHHHhhccCC-----CCeEEEEeecCCCCcHHHHHHhcc---CCCccchhHHHHHHHHHHHHhhhhh---hccee
Confidence 789999999999544 677889999999999999997543 455 67888899999999999999 99999
Q ss_pred eccccCCceeeC-CCCceEecccccccccCC------cCCCccccccccccCCC--CcCccccchhHHHHHHHHHhCCCC
Q 042634 257 HCDLKPSNVLLD-GELTAHVGDFGLAKFLPE------ATNNFFNFQIAEYGMGS--EVSTSGDVYSFGILLLETFTGKRP 327 (427)
Q Consensus 257 HrDlkp~NIll~-~~~~~kL~DFG~a~~~~~------~~~~~~~y~aPE~~~~~--~~~~~~DiwS~G~vl~ell~g~~p 327 (427)
|||||.+|||++ -.|.+||+|||.++.+.. ...||..|||||++..+ .|+.++|||||||++.||.||++|
T Consensus 698 HRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPP 777 (1226)
T KOG4279|consen 698 HRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPP 777 (1226)
T ss_pred eccccCCcEEEeeccceEEecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCC
Confidence 999999999995 579999999999987633 23899999999999764 589999999999999999999999
Q ss_pred CCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCH
Q 042634 328 TNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM 407 (427)
Q Consensus 328 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~ 407 (427)
|.........+.+. ..+. .....|++...+...++.+|+.+||.+||++
T Consensus 778 F~ElgspqAAMFkV--GmyK-----------------------------vHP~iPeelsaeak~FilrcFepd~~~R~sA 826 (1226)
T KOG4279|consen 778 FVELGSPQAAMFKV--GMYK-----------------------------VHPPIPEELSAEAKNFILRCFEPDPCDRPSA 826 (1226)
T ss_pred eeecCChhHhhhhh--ccee-----------------------------cCCCCcHHHHHHHHHHHHHHcCCCcccCccH
Confidence 98652221111110 0000 0112567788889999999999999999999
Q ss_pred HHHHH
Q 042634 408 EEVAA 412 (427)
Q Consensus 408 ~ev~~ 412 (427)
.++++
T Consensus 827 ~~LL~ 831 (1226)
T KOG4279|consen 827 KDLLQ 831 (1226)
T ss_pred HHhcc
Confidence 99875
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=264.43 Aligned_cols=197 Identities=21% Similarity=0.253 Sum_probs=152.9
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++.+.+.. +...++||||+++|+|..++.........+++..++.++.|++.||+||| +.||+||
T Consensus 50 l~~~~i~~~~~~~~~-----~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~ 121 (280)
T cd05608 50 VHSRFIVSLAYAFQT-----KTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYR 121 (280)
T ss_pred CCCCcEeeeeEEEcC-----CCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccC
Confidence 579999999877433 56789999999999998877432222245899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+||+++.++.+||+|||.++..... ..|+..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 122 dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~ 201 (280)
T cd05608 122 DLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARG 201 (280)
T ss_pred CCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999999765432 267889999999999999999999999999999999999997532
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCC-----CH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERM-----NM 407 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rp-----t~ 407 (427)
... ............. ...+...+.++.+++.+||+.||++|| |+
T Consensus 202 ~~~-~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ 251 (280)
T cd05608 202 EKV-ENKELKQRILNDS-----------------------------VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNC 251 (280)
T ss_pred cch-hHHHHHHhhcccC-----------------------------CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCH
Confidence 111 1111111100000 001223456688999999999999999 67
Q ss_pred HHHHHH
Q 042634 408 EEVAAQ 413 (427)
Q Consensus 408 ~ev~~~ 413 (427)
+|++++
T Consensus 252 ~~~l~h 257 (280)
T cd05608 252 DGLRTH 257 (280)
T ss_pred HHHhcC
Confidence 777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=271.53 Aligned_cols=203 Identities=23% Similarity=0.400 Sum_probs=164.0
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||+++++|.. ++..++++|||++|+|.+++..+... .+......+|+.||+.|++||. +.++|||
T Consensus 592 LkhPNIveLvGVC~~-----DePicmI~EYmEnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLe---s~nfVHr 661 (807)
T KOG1094|consen 592 LKHPNIVELLGVCVQ-----DDPLCMITEYMENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLE---SLNFVHR 661 (807)
T ss_pred cCCCCeeEEEeeeec-----CCchHHHHHHHhcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHH---hhchhhc
Confidence 689999999999977 56889999999999999999876431 1455677889999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC--------CCccccccccccCCCCcCccccchhHHHHHHHHHh--CCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT--------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT--GKRPT 328 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~--------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~--g~~pf 328 (427)
|+.+.|||+++++++||+|||.++-+..+. +-+..|||+|.+...+++.++|||+||+++||+++ ...||
T Consensus 662 d~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py 741 (807)
T KOG1094|consen 662 DLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPY 741 (807)
T ss_pred cccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCch
Confidence 999999999999999999999999665443 44578999999999999999999999999999876 78898
Q ss_pred CcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 042634 329 NEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME 408 (427)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ 408 (427)
....++ ...+-....++..-... -...|.-|+.+++++|.+||..|-++|||++
T Consensus 742 ~~lt~e--~vven~~~~~~~~~~~~------------------------~l~~P~~cp~~lyelml~Cw~~es~~RPsFe 795 (807)
T KOG1094|consen 742 SQLTDE--QVVENAGEFFRDQGRQV------------------------VLSRPPACPQGLYELMLRCWRRESEQRPSFE 795 (807)
T ss_pred hhhhHH--HHHHhhhhhcCCCCcce------------------------eccCCCcCcHHHHHHHHHHhchhhhcCCCHH
Confidence 765221 11111122122111111 1114566899999999999999999999999
Q ss_pred HHHHHHHHH
Q 042634 409 EVAAQLLSF 417 (427)
Q Consensus 409 ev~~~L~~~ 417 (427)
++...|++.
T Consensus 796 ~lh~~lq~~ 804 (807)
T KOG1094|consen 796 QLHLFLQED 804 (807)
T ss_pred HHHHHHHHh
Confidence 999988764
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=260.43 Aligned_cols=196 Identities=24% Similarity=0.422 Sum_probs=155.5
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++.+.. ....+++|||+++++|.+++..... ..+++..++.++.|++.||+||| ..+++||
T Consensus 58 l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~ 127 (261)
T cd05072 58 LQHDKLVRLYAVVTK-----EEPIYIITEYMAKGSLLDFLKSDEG--GKVLLPKLIDFSAQIAEGMAYIE---RKNYIHR 127 (261)
T ss_pred CCCCCeeeEEEEEcC-----CCCcEEEEecCCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecc
Confidence 579999999887433 5568999999999999999865422 45888899999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC-------CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCCc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT-------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~-------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~~ 330 (427)
||||+||+++.++.+||+|||.++...... .++..|+|||++....++.++|||||||++|||++ |..||..
T Consensus 128 dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~ 207 (261)
T cd05072 128 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPG 207 (261)
T ss_pred ccchhhEEecCCCcEEECCCccceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCC
Confidence 999999999999999999999998764322 34567999999988889999999999999999998 9999865
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
.... .....+....+. .....++.++.+++.+||+.+|++|||++++
T Consensus 208 ~~~~--~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 254 (261)
T cd05072 208 MSNS--DVMSALQRGYRM-------------------------------PRMENCPDELYDIMKTCWKEKAEERPTFDYL 254 (261)
T ss_pred CCHH--HHHHHHHcCCCC-------------------------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHH
Confidence 3111 111111100000 0111245668999999999999999999999
Q ss_pred HHHHHHH
Q 042634 411 AAQLLSF 417 (427)
Q Consensus 411 ~~~L~~~ 417 (427)
.+.|+++
T Consensus 255 ~~~l~~~ 261 (261)
T cd05072 255 QSVLDDF 261 (261)
T ss_pred HHHHhcC
Confidence 9999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=273.95 Aligned_cols=189 Identities=21% Similarity=0.261 Sum_probs=150.8
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCC-CCeee
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCE-TPIVH 257 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~-~~ivH 257 (427)
++||||+++.+.+. .+...++||||+++|+|.+++... ..+++..+..++.||+.||+||| + .||+|
T Consensus 52 ~~hp~i~~~~~~~~-----~~~~~~lv~E~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH---~~~~ivH 119 (325)
T cd05594 52 SRHPFLTALKYSFQ-----THDRLCFVMEYANGGELFFHLSRE----RVFSEDRARFYGAEIVSALDYLH---SEKNVVY 119 (325)
T ss_pred CCCCCCCceEEEEE-----cCCEEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hcCCEEe
Confidence 57999999988743 356789999999999998887654 35899999999999999999999 6 79999
Q ss_pred ccccCCceeeCCCCceEecccccccccCC------cCCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 258 CDLKPSNVLLDGELTAHVGDFGLAKFLPE------ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 258 rDlkp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
|||||+|||++.++.+||+|||+++.... ...|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 120 rDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~ 199 (325)
T cd05594 120 RDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 199 (325)
T ss_pred cCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCC
Confidence 99999999999999999999999875322 125889999999999999999999999999999999999999653
Q ss_pred cCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCC-----C
Q 042634 332 FTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERM-----N 406 (427)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rp-----t 406 (427)
.. ............ . .+...+.++.+++.+||+.||++|+ +
T Consensus 200 ~~-----~~~~~~i~~~~~------------------------~-----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~ 245 (325)
T cd05594 200 DH-----EKLFELILMEEI------------------------R-----FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDD 245 (325)
T ss_pred CH-----HHHHHHHhcCCC------------------------C-----CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCC
Confidence 11 111111100000 0 1112345688999999999999996 8
Q ss_pred HHHHHHH
Q 042634 407 MEEVAAQ 413 (427)
Q Consensus 407 ~~ev~~~ 413 (427)
+.|++++
T Consensus 246 ~~~il~h 252 (325)
T cd05594 246 AKEIMQH 252 (325)
T ss_pred HHHHhcC
Confidence 9998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=265.86 Aligned_cols=218 Identities=19% Similarity=0.239 Sum_probs=150.6
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||++ |+|.+++.... ..+++..+..++.||+.||+||| +.||+||
T Consensus 60 l~h~niv~~~~~~~~-----~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~ 127 (288)
T cd07871 60 LKHANIVTLHDIIHT-----ERCLTLVFEYLD-SDLKQYLDNCG---NLMSMHNVKIFMFQLLRGLSYCH---KRKILHR 127 (288)
T ss_pred CCCCCEeeEEEEEcC-----CCeEEEEEeCCC-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccC
Confidence 579999999987533 456899999996 58988875432 34788999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC------cCCCccccccccccCC-CCcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE------ATNNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
||||+|||++.++.+||+|||+++.... ...++..|+|||++.+ ..++.++||||+||++|||++|+.||.+.
T Consensus 128 dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~ 207 (288)
T cd07871 128 DLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGS 207 (288)
T ss_pred CCCHHHEEECCCCCEEECcCcceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999976432 2256889999999875 56899999999999999999999999753
Q ss_pred cCCCccHHHHHHHhcccchhcccCcccccccccc-chhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 332 FTGNLTLHNFVKEALPERLAEIVDPVLLVEREEG-ETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
... ..+.... ........+............. ....... .... ......+.+..+++.+|+++||.+|||++|+
T Consensus 208 ~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~ 282 (288)
T cd07871 208 TVK-EELHLIF-RLLGTPTEETWPGITSNEEFRSYLFPQYRA-QPLI--NHAPRLDTDGIDLLSSLLLYETKSRISAEAA 282 (288)
T ss_pred CHH-HHHHHHH-HHhCCCChHHhhccccchhhhccccCccCC-CchH--HhCCCCCHHHHHHHHHhcCcCcccCCCHHHH
Confidence 211 1111111 1111100111100000000000 0000000 0000 0011234567899999999999999999999
Q ss_pred HHH
Q 042634 411 AAQ 413 (427)
Q Consensus 411 ~~~ 413 (427)
+++
T Consensus 283 l~h 285 (288)
T cd07871 283 LRH 285 (288)
T ss_pred hcC
Confidence 853
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=268.99 Aligned_cols=141 Identities=24% Similarity=0.354 Sum_probs=124.4
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. +...++||||+++|+|.+++... ..+++..+..++.|++.||.|||+ ..+|+||
T Consensus 60 l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~ 128 (333)
T cd06650 60 CNSPYIVGFYGAFYS-----DGEISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHR 128 (333)
T ss_pred CCCCcccceeEEEEE-----CCEEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHh--cCCEEec
Confidence 579999999998654 56789999999999999998654 348889999999999999999993 2579999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc----CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA----TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~ 330 (427)
||||+||+++.++.+||+|||++...... ..++..|+|||++.+..++.++|||||||++||+++|+.||..
T Consensus 129 dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 129 DVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred CCChhhEEEcCCCCEEEeeCCcchhhhhhccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999999765332 2678899999999988899999999999999999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=269.44 Aligned_cols=188 Identities=23% Similarity=0.316 Sum_probs=149.8
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
.+||||+++++.+.. +...++||||+++|+|.+++... ..+++.++..++.|++.||+||| +.||+||
T Consensus 53 ~~hp~iv~~~~~~~~-----~~~~~lv~ey~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~LH---~~~ivHr 120 (316)
T cd05619 53 WEHPFLTHLYCTFQT-----KENLFFVMEYLNGGDLMFHIQSC----HKFDLPRATFYAAEIICGLQFLH---SKGIVYR 120 (316)
T ss_pred cCCCcCcceEEEEEe-----CCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeC
Confidence 579999999988543 56789999999999999988654 34889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC------cCCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE------ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+||+++.++.+||+|||+++.... ...|+..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 121 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~ 200 (316)
T cd05619 121 DLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD 200 (316)
T ss_pred CCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999999875321 1267889999999999999999999999999999999999997531
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHH-HHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME-EVA 411 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~-ev~ 411 (427)
. ....+.+... .+. .+...+.++.+++.+||+.||++||++. ++.
T Consensus 201 ~--~~~~~~i~~~---------~~~-----------------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 201 E--EELFQSIRMD---------NPC-----------------------YPRWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred H--HHHHHHHHhC---------CCC-----------------------CCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 1 1111111000 000 1112345678999999999999999997 554
Q ss_pred H
Q 042634 412 A 412 (427)
Q Consensus 412 ~ 412 (427)
+
T Consensus 247 ~ 247 (316)
T cd05619 247 Q 247 (316)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=264.54 Aligned_cols=198 Identities=24% Similarity=0.432 Sum_probs=156.6
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccch------------hhhhccCHHHHHHHHHHHHHHHHHH
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNR------------EALKNLNLLQRLSIAVDVASALDYL 247 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~~~~~i~~~L~~L 247 (427)
+||||+++++.+.. +...+++|||+++|+|.++++... .....+++..++.++.|++.||+||
T Consensus 74 ~h~~i~~~~~~~~~-----~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L 148 (293)
T cd05053 74 KHKNIINLLGVCTQ-----EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFL 148 (293)
T ss_pred CCCCeeeEEEEEcC-----CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH
Confidence 69999999988543 456899999999999999986421 1224688999999999999999999
Q ss_pred hhcCCCCeeeccccCCceeeCCCCceEecccccccccCCcC--------CCccccccccccCCCCcCccccchhHHHHHH
Q 042634 248 HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEAT--------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLL 319 (427)
Q Consensus 248 H~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~--------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ 319 (427)
| +.||+||||||+||+++.++.+||+|||.++...... .++..|+|||++.+..++.++|||||||++|
T Consensus 149 H---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 225 (293)
T cd05053 149 A---SKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLW 225 (293)
T ss_pred H---HCCccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHH
Confidence 9 8999999999999999999999999999998654321 3446799999998889999999999999999
Q ss_pred HHHh-CCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCC
Q 042634 320 ETFT-GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSS 398 (427)
Q Consensus 320 ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~ 398 (427)
|+++ |..||...... ...+....... ...+..++.++.+++.+||+
T Consensus 226 el~~~g~~p~~~~~~~--~~~~~~~~~~~-------------------------------~~~~~~~~~~~~~li~~~l~ 272 (293)
T cd05053 226 EIFTLGGSPYPGIPVE--ELFKLLKEGYR-------------------------------MEKPQNCTQELYHLMRDCWH 272 (293)
T ss_pred HHhcCCCCCCCCCCHH--HHHHHHHcCCc-------------------------------CCCCCCCCHHHHHHHHHHcc
Confidence 9997 99998653110 11111000000 00112345678999999999
Q ss_pred CCCCCCCCHHHHHHHHHHHH
Q 042634 399 ELPRERMNMEEVAAQLLSFR 418 (427)
Q Consensus 399 ~dP~~Rpt~~ev~~~L~~~~ 418 (427)
.||++|||+.|+++.|+++.
T Consensus 273 ~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 273 EVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred cCcccCcCHHHHHHHHHHhh
Confidence 99999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=264.13 Aligned_cols=202 Identities=25% Similarity=0.357 Sum_probs=157.8
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchh------------hhhccCHHHHHHHHHHHHHHHHH
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNRE------------ALKNLNLLQRLSIAVDVASALDY 246 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~~~~~i~~~L~~ 246 (427)
.+||||+++++.+.. ....+++|||+++++|.+++..... ....+++..++.++.|++.||+|
T Consensus 60 ~~hp~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~ 134 (297)
T cd05089 60 GHHPNIINLLGACEN-----RGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQY 134 (297)
T ss_pred cCCCchhheEEEEcc-----CCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHH
Confidence 369999999987543 4568999999999999999864321 11348889999999999999999
Q ss_pred HhhcCCCCeeeccccCCceeeCCCCceEecccccccccCCc-----CCCccccccccccCCCCcCccccchhHHHHHHHH
Q 042634 247 LHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLET 321 (427)
Q Consensus 247 LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~el 321 (427)
|| ++||+||||||+||++++++.+||+|||++...... ...+..|+|||+..+..++.++|||||||++|||
T Consensus 135 lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el 211 (297)
T cd05089 135 LS---EKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEI 211 (297)
T ss_pred HH---HCCcccCcCCcceEEECCCCeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHH
Confidence 99 899999999999999999999999999998753221 1234569999999888899999999999999999
Q ss_pred Hh-CCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCC
Q 042634 322 FT-GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSEL 400 (427)
Q Consensus 322 l~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~d 400 (427)
++ |..||..... .+........ . . ...+..++..+.+++.+||+.+
T Consensus 212 ~t~g~~pf~~~~~-----~~~~~~~~~~-~----~-----------------------~~~~~~~~~~~~~li~~~l~~~ 258 (297)
T cd05089 212 VSLGGTPYCGMTC-----AELYEKLPQG-Y----R-----------------------MEKPRNCDDEVYELMRQCWRDR 258 (297)
T ss_pred HcCCCCCCCCCCH-----HHHHHHHhcC-C----C-----------------------CCCCCCCCHHHHHHHHHHcCCC
Confidence 97 9999965311 1111110000 0 0 0011224567899999999999
Q ss_pred CCCCCCHHHHHHHHHHHHHHH
Q 042634 401 PRERMNMEEVAAQLLSFRNKL 421 (427)
Q Consensus 401 P~~Rpt~~ev~~~L~~~~~~~ 421 (427)
|.+|||++|+++.|+.+.++.
T Consensus 259 p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 259 PYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred hhhCcCHHHHHHHHHHHHHhh
Confidence 999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=258.68 Aligned_cols=192 Identities=26% Similarity=0.436 Sum_probs=152.2
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++.+.. ....++||||+++|+|.+++.... ..+++..++.++.|++.||+||| ..||+||
T Consensus 56 l~h~~i~~~~~~~~~-----~~~~~iv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~ 124 (256)
T cd05114 56 LSHPKLVQLYGVCTQ-----QKPLYIVTEFMENGCLLNYLRQRQ---GKLSKDMLLSMCQDVCEGMEYLE---RNSFIHR 124 (256)
T ss_pred CCCCCceeEEEEEcc-----CCCEEEEEEcCCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHH---HCCcccc
Confidence 479999999988543 456899999999999999886543 34889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC-------CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCCc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT-------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~-------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~~ 330 (427)
||||+||+++.++.+||+|||.++...... .++..|+|||++.+..++.++||||||+++||+++ |+.||..
T Consensus 125 dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~ 204 (256)
T cd05114 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK 204 (256)
T ss_pred ccCcceEEEcCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCC
Confidence 999999999999999999999998653221 34457999999988889999999999999999999 8999865
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
... ......+...... ..+...+.++.+++.+||+.+|++|||++|+
T Consensus 205 ~~~--~~~~~~i~~~~~~-------------------------------~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l 251 (256)
T cd05114 205 KSN--YEVVEMISRGFRL-------------------------------YRPKLASMTVYEVMYSCWHEKPEGRPTFAEL 251 (256)
T ss_pred CCH--HHHHHHHHCCCCC-------------------------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHH
Confidence 311 1111111100000 0011123568999999999999999999999
Q ss_pred HHHH
Q 042634 411 AAQL 414 (427)
Q Consensus 411 ~~~L 414 (427)
++.|
T Consensus 252 ~~~l 255 (256)
T cd05114 252 LRAI 255 (256)
T ss_pred HHhh
Confidence 9886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=263.90 Aligned_cols=197 Identities=22% Similarity=0.376 Sum_probs=153.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhh------hhccCHHHHHHHHHHHHHHHHHHhhcCC
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREA------LKNLNLLQRLSIAVDVASALDYLHHYCE 252 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~------~~~l~~~~~~~~~~~i~~~L~~LH~~~~ 252 (427)
++||||+++++.+.. +...++||||+++|+|.+++...... ...+++..+..++.|++.||+||| +
T Consensus 66 l~~~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~ 137 (277)
T cd05062 66 FNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---A 137 (277)
T ss_pred CCCCCeeeEEEEEcC-----CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---H
Confidence 579999999988533 56789999999999999988643211 123577889999999999999999 8
Q ss_pred CCeeeccccCCceeeCCCCceEecccccccccCCc--------CCCccccccccccCCCCcCccccchhHHHHHHHHHh-
Q 042634 253 TPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA--------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT- 323 (427)
Q Consensus 253 ~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~- 323 (427)
.|++||||||+||++++++.+||+|||+++..... ..++..|+|||++.+..++.++|||||||++|||++
T Consensus 138 ~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~ 217 (277)
T cd05062 138 NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATL 217 (277)
T ss_pred CCcccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcC
Confidence 99999999999999999999999999998754321 134668999999998889999999999999999999
Q ss_pred CCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCC
Q 042634 324 GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRE 403 (427)
Q Consensus 324 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~ 403 (427)
|..||.+... ......+.. ..... .+..++..+.+++.+||+.||++
T Consensus 218 ~~~p~~~~~~--~~~~~~~~~---~~~~~----------------------------~~~~~~~~~~~li~~~l~~~p~~ 264 (277)
T cd05062 218 AEQPYQGMSN--EQVLRFVME---GGLLD----------------------------KPDNCPDMLFELMRMCWQYNPKM 264 (277)
T ss_pred CCCCCCCCCH--HHHHHHHHc---CCcCC----------------------------CCCCCCHHHHHHHHHHcCCChhh
Confidence 7888865311 111111000 00000 11224567899999999999999
Q ss_pred CCCHHHHHHHHHH
Q 042634 404 RMNMEEVAAQLLS 416 (427)
Q Consensus 404 Rpt~~ev~~~L~~ 416 (427)
|||+.|+++.|++
T Consensus 265 Rps~~e~l~~l~~ 277 (277)
T cd05062 265 RPSFLEIISSIKE 277 (277)
T ss_pred CcCHHHHHHHhhC
Confidence 9999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=259.24 Aligned_cols=201 Identities=19% Similarity=0.262 Sum_probs=159.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++.+.. +...+++|||+++++|.+++.........+++..+..++.|++.||.||| +.|++|+
T Consensus 59 ~~h~~i~~~~~~~~~-----~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~ 130 (267)
T cd08229 59 LNHPNVIKYYASFIE-----DNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHR 130 (267)
T ss_pred ccCCchhhhhheeEe-----CCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecC
Confidence 579999999987543 55789999999999999988643222245899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+||+++.++.+||+|||.+...... ..++..|+|||+..+..++.++||||||+++|||++|..||....
T Consensus 131 dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 210 (267)
T cd08229 131 DIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred CCCHHHEEEcCCCCEEECcchhhhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccccc
Confidence 99999999999999999999998765432 257778999999988889999999999999999999999986432
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
.+ ....... ...... +.......+.++.+++.+||+.||++||||.+|++
T Consensus 211 ~~---~~~~~~~-----~~~~~~----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 211 MN---LYSLCKK-----IEQCDY----------------------PPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred ch---HHHHhhh-----hhcCCC----------------------CCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 11 1111110 000000 00012235667999999999999999999999999
Q ss_pred HHHHH
Q 042634 413 QLLSF 417 (427)
Q Consensus 413 ~L~~~ 417 (427)
.++++
T Consensus 261 ~~~~~ 265 (267)
T cd08229 261 VAKRM 265 (267)
T ss_pred HHhhh
Confidence 99876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=269.02 Aligned_cols=187 Identities=24% Similarity=0.284 Sum_probs=149.0
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+. .....++||||+++|+|..++.. ..+++..+..++.|++.||+||| +.||+||
T Consensus 59 l~hp~i~~~~~~~~-----~~~~~~lv~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH---~~~ivHr 125 (324)
T cd05589 59 ERHPFLVNLFACFQ-----TEDHVCFVMEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLH---ENKIVYR 125 (324)
T ss_pred cCCCChhceeeEEE-----cCCEEEEEEcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEec
Confidence 57999999998753 35678999999999999888754 34899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC------cCCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE------ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+||+++.++.+||+|||+++.... ...|+..|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 126 dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~ 205 (324)
T cd05589 126 DLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD 205 (324)
T ss_pred CCCHHHeEECCCCcEEeCcccCCccCCCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999999875322 1257889999999999999999999999999999999999997531
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCC-----CH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERM-----NM 407 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rp-----t~ 407 (427)
. .+......... . ..+...+..+.+++.+||+.||.+|| ++
T Consensus 206 ~-----~~~~~~i~~~~--------~---------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~ 251 (324)
T cd05589 206 E-----EEVFDSIVNDE--------V---------------------RYPRFLSREAISIMRRLLRRNPERRLGSGEKDA 251 (324)
T ss_pred H-----HHHHHHHHhCC--------C---------------------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCH
Confidence 1 11111100000 0 01122355678999999999999999 46
Q ss_pred HHHHH
Q 042634 408 EEVAA 412 (427)
Q Consensus 408 ~ev~~ 412 (427)
.++++
T Consensus 252 ~~l~~ 256 (324)
T cd05589 252 EDVKK 256 (324)
T ss_pred HHHhh
Confidence 66654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=273.82 Aligned_cols=219 Identities=20% Similarity=0.219 Sum_probs=152.7
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||++++.+.. +...++|+|++ .++|.+++... ..+++..++.++.|++.||+||| +.||+||
T Consensus 140 l~HpnIv~~~~~~~~-----~~~~~lv~e~~-~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHr 206 (391)
T PHA03212 140 INHPSIIQLKGTFTY-----NKFTCLILPRY-KTDLYCYLAAK----RNIAICDILAIERSVLRAIQYLH---ENRIIHR 206 (391)
T ss_pred CCCCCCCCEeEEEEE-----CCeeEEEEecC-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccC
Confidence 579999999988543 56789999999 57888887654 34889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC-------cCCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE-------ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~-------~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
||||+|||++.++.+||+|||+|+.... ...||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus 207 DiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~ 286 (391)
T PHA03212 207 DIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEK 286 (391)
T ss_pred CCChHhEEEcCCCCEEEEeCCcccccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCc
Confidence 9999999999999999999999975322 126899999999999999999999999999999999999887542
Q ss_pred cCCC------ccHHHHHHHhcccchhcccCcc--ccccccccchhhhccccccccc--cchHHHHHHHHHHHhhcCCCCC
Q 042634 332 FTGN------LTLHNFVKEALPERLAEIVDPV--LLVEREEGETSKANAHKQFTRS--FSVKECLVSVLGIGVTCSSELP 401 (427)
Q Consensus 332 ~~~~------~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~cl~~dP 401 (427)
.... ..+...+..........-.+.. ..... .. ........+..+. ......+.++.+++.+||+.||
T Consensus 287 ~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP 364 (391)
T PHA03212 287 DGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIY-IG-LAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDA 364 (391)
T ss_pred ccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHH-HH-HHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCCh
Confidence 2111 1111111111100000000000 00000 00 0000000000000 0112346678999999999999
Q ss_pred CCCCCHHHHHH
Q 042634 402 RERMNMEEVAA 412 (427)
Q Consensus 402 ~~Rpt~~ev~~ 412 (427)
++|||++|+++
T Consensus 365 ~~Rpta~elL~ 375 (391)
T PHA03212 365 HHRPSAEALLD 375 (391)
T ss_pred hhCCCHHHHhc
Confidence 99999999986
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=259.43 Aligned_cols=203 Identities=23% Similarity=0.385 Sum_probs=157.4
Q ss_pred cccccchhhhccccccCC-CCCCccceeeeeecCCCcccccccchh--hhhccCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 042634 179 IRHRNLVKIITSCASVDF-QGNDSEALVYEFMVNGSLEEWLHPNRE--ALKNLNLLQRLSIAVDVASALDYLHHYCETPI 255 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~i 255 (427)
++|||++++++.+..... ......+++|||+++|+|.+++..... ....+++..+..++.|++.||+||| +.++
T Consensus 58 l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i 134 (273)
T cd05035 58 FDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNF 134 (273)
T ss_pred CCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCe
Confidence 569999999987654222 223457899999999999988754321 1235889999999999999999999 8999
Q ss_pred eeccccCCceeeCCCCceEecccccccccCCcC--------CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCC
Q 042634 256 VHCDLKPSNVLLDGELTAHVGDFGLAKFLPEAT--------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKR 326 (427)
Q Consensus 256 vHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~--------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~ 326 (427)
+||||||+||++++++.+||+|||.++...... ..+..|+|||++.+..++.++|||||||++|||++ |..
T Consensus 135 ~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~ 214 (273)
T cd05035 135 IHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQT 214 (273)
T ss_pred eccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999998654321 34567999999988889999999999999999999 889
Q ss_pred CCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCC
Q 042634 327 PTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMN 406 (427)
Q Consensus 327 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt 406 (427)
||.+... ....+....... ...+..++.++.+++.+||+.||++|||
T Consensus 215 p~~~~~~--~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~ 261 (273)
T cd05035 215 PYPGVEN--HEIYDYLRHGNR-------------------------------LKQPEDCLDELYDLMYSCWRADPKDRPT 261 (273)
T ss_pred CCCCCCH--HHHHHHHHcCCC-------------------------------CCCCcCCCHHHHHHHHHHcCCChhhCcC
Confidence 9865321 111111110000 0012234567899999999999999999
Q ss_pred HHHHHHHHHHH
Q 042634 407 MEEVAAQLLSF 417 (427)
Q Consensus 407 ~~ev~~~L~~~ 417 (427)
+.|+++.|+++
T Consensus 262 ~~e~~~~l~~~ 272 (273)
T cd05035 262 FTKLREVLENI 272 (273)
T ss_pred HHHHHHHHHhh
Confidence 99999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=258.77 Aligned_cols=197 Identities=28% Similarity=0.390 Sum_probs=155.4
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|+|++++++.+. ..+...+++|||+++++|.+++..... ..+++..+..++.|++.||+||| ++|++||
T Consensus 56 l~~~~i~~~~~~~~----~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~ 126 (256)
T cd05082 56 LRHSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLE---ANNFVHR 126 (256)
T ss_pred CCCCCeeeEEEEEE----cCCCceEEEEECCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCEecc
Confidence 57999999988642 224567999999999999999865432 34788999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC---CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCCcccCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT---NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNEMFTG 334 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~---~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~~~~~~ 334 (427)
||||+||+++.++.+||+|||.++...... ..+..|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 127 dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~--- 203 (256)
T cd05082 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--- 203 (256)
T ss_pred ccchheEEEcCCCcEEecCCccceeccccCCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC---
Confidence 999999999999999999999998654322 44567999999988889999999999999999997 99998642
Q ss_pred CccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 042634 335 NLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAAQL 414 (427)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L 414 (427)
...+........ .. ...+..++..+.+++.+||+.+|++|||++++++.|
T Consensus 204 --~~~~~~~~~~~~-----~~-----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l 253 (256)
T cd05082 204 --PLKDVVPRVEKG-----YK-----------------------MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQL 253 (256)
T ss_pred --CHHHHHHHHhcC-----CC-----------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 111111110000 00 001223466789999999999999999999999998
Q ss_pred HHH
Q 042634 415 LSF 417 (427)
Q Consensus 415 ~~~ 417 (427)
+++
T Consensus 254 ~~~ 256 (256)
T cd05082 254 EHI 256 (256)
T ss_pred hcC
Confidence 764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=270.73 Aligned_cols=189 Identities=20% Similarity=0.260 Sum_probs=151.2
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
.+||||+++++.+.. +...++||||+++|+|..++... ..+++..+..++.|++.||+||| +.||+||
T Consensus 53 ~~hp~i~~~~~~~~~-----~~~~~lv~E~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHr 120 (321)
T cd05591 53 AKHPFLTALHCCFQT-----KDRLFFVMEYVNGGDLMFQIQRS----RKFDEPRSRFYAAEVTLALMFLH---RHGVIYR 120 (321)
T ss_pred cCCCCccceeeEEEc-----CCeEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecc
Confidence 479999999988543 56789999999999999888654 35889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+||+++.++.+||+|||+++..... ..|+..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 121 Dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 200 (321)
T cd05591 121 DLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN 200 (321)
T ss_pred CCCHHHeEECCCCCEEEeecccceecccCCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC
Confidence 99999999999999999999998754221 257889999999999999999999999999999999999997532
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCC-------
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERM------- 405 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rp------- 405 (427)
. ........... .. .+...+.++.+++.+||+.||++||
T Consensus 201 ~-----~~~~~~i~~~~---~~--------------------------~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~ 246 (321)
T cd05591 201 E-----DDLFESILHDD---VL--------------------------YPVWLSKEAVSILKAFMTKNPNKRLGCVASQG 246 (321)
T ss_pred H-----HHHHHHHHcCC---CC--------------------------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCC
Confidence 1 11111111000 00 1111345688999999999999999
Q ss_pred CHHHHHHH
Q 042634 406 NMEEVAAQ 413 (427)
Q Consensus 406 t~~ev~~~ 413 (427)
++++++++
T Consensus 247 ~~~~~~~h 254 (321)
T cd05591 247 GEDAIKQH 254 (321)
T ss_pred CHHHHhcC
Confidence 77777754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=271.83 Aligned_cols=197 Identities=20% Similarity=0.224 Sum_probs=154.5
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+++|+|.+++... ..+++..++.++.|++.||.||| +.||+||
T Consensus 58 ~~h~~iv~~~~~~~~-----~~~~~lv~e~~~g~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~ 125 (333)
T cd05600 58 TKSEWLVKLLYAFQD-----DEYLYLAMEYVPGGDFRTLLNNL----GVLSEDHARFYMAEMFEAVDALH---ELGYIHR 125 (333)
T ss_pred CCCCCCccEEEEEEc-----CCEEEEEEeCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccc
Confidence 459999999987543 56789999999999999998654 35889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC---cCCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE---ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGN 335 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~~~ 335 (427)
||||+||+++.++.+||+|||+++.... ...|+..|+|||++.+..++.++|||||||++|||++|..||......
T Consensus 126 dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~- 204 (333)
T cd05600 126 DLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN- 204 (333)
T ss_pred CCCHHHEEECCCCCEEEEeCcCCcccccccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHH-
Confidence 9999999999999999999999986543 337889999999999999999999999999999999999999753111
Q ss_pred ccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 042634 336 LTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAAQ 413 (427)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~ 413 (427)
.....+.. . ........ .. ......+.++.+++.+||..+|++|||++|++++
T Consensus 205 -~~~~~i~~-~----~~~~~~~~-----------------~~--~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 205 -ETWENLKY-W----KETLQRPV-----------------YD--DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred -HHHHHHHh-c----cccccCCC-----------------CC--ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 01010000 0 00000000 00 0001245678899999999999999999999865
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=259.76 Aligned_cols=203 Identities=23% Similarity=0.400 Sum_probs=155.5
Q ss_pred cccccchhhhccccccCC-CCCCccceeeeeecCCCcccccccch--hhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 042634 179 IRHRNLVKIITSCASVDF-QGNDSEALVYEFMVNGSLEEWLHPNR--EALKNLNLLQRLSIAVDVASALDYLHHYCETPI 255 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~i 255 (427)
++||||+++++.+..... ......+++|||+++|+|.+++.... .....+++..+..++.|++.||+||| ++||
T Consensus 57 l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i 133 (272)
T cd05075 57 FDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSF 133 (272)
T ss_pred CCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCe
Confidence 579999999987643211 12235689999999999988774221 11245889999999999999999999 8999
Q ss_pred eeccccCCceeeCCCCceEecccccccccCCcC--------CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCC
Q 042634 256 VHCDLKPSNVLLDGELTAHVGDFGLAKFLPEAT--------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKR 326 (427)
Q Consensus 256 vHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~--------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~ 326 (427)
+||||||+||+++.++.+||+|||+++...... .++..|+|||+..+..++.++|||||||++||+++ |+.
T Consensus 134 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~ 213 (272)
T cd05075 134 IHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQT 213 (272)
T ss_pred eccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCC
Confidence 999999999999999999999999998754321 34567999999998899999999999999999999 888
Q ss_pred CCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCC
Q 042634 327 PTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMN 406 (427)
Q Consensus 327 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt 406 (427)
||..... ..+...+..... . ..+..++..+.+++.+||+.||++|||
T Consensus 214 p~~~~~~--~~~~~~~~~~~~------~-------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps 260 (272)
T cd05075 214 PYPGVEN--SEIYDYLRQGNR------L-------------------------KQPPDCLDGLYSLMSSCWLLNPKDRPS 260 (272)
T ss_pred CCCCCCH--HHHHHHHHcCCC------C-------------------------CCCCCCCHHHHHHHHHHcCCCcccCcC
Confidence 9865311 111111110000 0 011124556899999999999999999
Q ss_pred HHHHHHHHHHH
Q 042634 407 MEEVAAQLLSF 417 (427)
Q Consensus 407 ~~ev~~~L~~~ 417 (427)
+.|+++.|+++
T Consensus 261 ~~~l~~~l~~~ 271 (272)
T cd05075 261 FETLRCELEKA 271 (272)
T ss_pred HHHHHHHHHhh
Confidence 99999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=259.13 Aligned_cols=198 Identities=24% Similarity=0.410 Sum_probs=153.0
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++.+.. .+...+++|||+.+|+|.+++.... ...++..+..++.|++.||+||| ..+++||
T Consensus 53 l~h~~iv~~~~~~~~----~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~ 122 (262)
T cd05058 53 FSHPNVLSLLGICLP----SEGSPLVVLPYMKHGDLRNFIRSET---HNPTVKDLIGFGLQVAKGMEYLA---SKKFVHR 122 (262)
T ss_pred CCCCCcceEEEEeec----CCCCcEEEEecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccc
Confidence 579999999986533 2345789999999999999986543 33677788999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC----------cCCCccccccccccCCCCcCccccchhHHHHHHHHHhC-CCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE----------ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTG-KRP 327 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~----------~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g-~~p 327 (427)
||||+||+++.++.+||+|||+++.... ...++..|+|||++.+..++.++|||||||++|||++| .+|
T Consensus 123 dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~ 202 (262)
T cd05058 123 DLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 202 (262)
T ss_pred ccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCC
Confidence 9999999999999999999999975432 11345679999999888999999999999999999995 556
Q ss_pred CCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCH
Q 042634 328 TNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM 407 (427)
Q Consensus 328 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~ 407 (427)
|.... ............ +...+..++..+.+++.+||+.+|++|||+
T Consensus 203 ~~~~~-----~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~ 249 (262)
T cd05058 203 YPDVD-----SFDITVYLLQGR----------------------------RLLQPEYCPDPLYEVMLSCWHPKPEMRPTF 249 (262)
T ss_pred CCCCC-----HHHHHHHHhcCC----------------------------CCCCCCcCCHHHHHHHHHHcCCChhhCCCH
Confidence 65321 111111100000 000112234568999999999999999999
Q ss_pred HHHHHHHHHHHH
Q 042634 408 EEVAAQLLSFRN 419 (427)
Q Consensus 408 ~ev~~~L~~~~~ 419 (427)
.|+++.|+++..
T Consensus 250 ~~il~~l~~~~~ 261 (262)
T cd05058 250 SELVSRIEQIFS 261 (262)
T ss_pred HHHHHHHHHHhc
Confidence 999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=269.82 Aligned_cols=189 Identities=22% Similarity=0.271 Sum_probs=150.8
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. +...++||||+++|+|.+++... ..+++..+..++.|++.||+||| +.||+||
T Consensus 57 l~hp~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~ 124 (323)
T cd05584 57 VKHPFIVDLIYAFQT-----GGKLYLILEYLSGGELFMHLERE----GIFMEDTACFYLSEISLALEHLH---QQGIIYR 124 (323)
T ss_pred CCCCchhceeeEEec-----CCeEEEEEeCCCCchHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecC
Confidence 579999999987533 56789999999999999988654 34788899999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC------cCCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE------ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+|||++.++.+||+|||+++.... ...|+..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 125 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~ 204 (323)
T cd05584 125 DLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN 204 (323)
T ss_pred CCCHHHeEECCCCCEEEeeCcCCeecccCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC
Confidence 9999999999999999999999874322 1268889999999998889999999999999999999999997531
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCC-----CH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERM-----NM 407 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rp-----t~ 407 (427)
. ........... .. .+...+.++.+++.+||+.||++|| ++
T Consensus 205 ~-----~~~~~~~~~~~--------~~---------------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 250 (323)
T cd05584 205 R-----KKTIDKILKGK--------LN---------------------LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDA 250 (323)
T ss_pred H-----HHHHHHHHcCC--------CC---------------------CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCH
Confidence 1 11111111100 00 1112345688999999999999999 78
Q ss_pred HHHHHH
Q 042634 408 EEVAAQ 413 (427)
Q Consensus 408 ~ev~~~ 413 (427)
++++++
T Consensus 251 ~~l~~h 256 (323)
T cd05584 251 AEVQSH 256 (323)
T ss_pred HHHhcC
Confidence 887663
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=261.23 Aligned_cols=196 Identities=31% Similarity=0.519 Sum_probs=155.2
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccch----------hhhhccCHHHHHHHHHHHHHHHHHHh
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNR----------EALKNLNLLQRLSIAVDVASALDYLH 248 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~~~~l~~~~~~~~~~~i~~~L~~LH 248 (427)
++|||++++++.+.. ....++||||+++++|.+++.... .....+++..+..++.|++.|++|||
T Consensus 65 l~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH 139 (280)
T cd05049 65 FQHENIVKFYGVCTE-----GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA 139 (280)
T ss_pred cCCCCchheeeEEec-----CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh
Confidence 469999999998544 467899999999999999986432 11245788999999999999999999
Q ss_pred hcCCCCeeeccccCCceeeCCCCceEecccccccccCCc--------CCCccccccccccCCCCcCccccchhHHHHHHH
Q 042634 249 HYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA--------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLE 320 (427)
Q Consensus 249 ~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~e 320 (427)
..|++||||||+||+++.++.+||+|||.++..... ..++..|+|||++.+..++.++|||||||++||
T Consensus 140 ---~~~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e 216 (280)
T cd05049 140 ---SQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWE 216 (280)
T ss_pred ---hCCeeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHH
Confidence 899999999999999999999999999999754221 134568999999999999999999999999999
Q ss_pred HHh-CCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCC
Q 042634 321 TFT-GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSE 399 (427)
Q Consensus 321 ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~ 399 (427)
|++ |..||...... ........ ... ...+..++.++.+++++||+.
T Consensus 217 ~~~~g~~p~~~~~~~--~~~~~~~~---~~~----------------------------~~~~~~~~~~~~~li~~~l~~ 263 (280)
T cd05049 217 IFTYGKQPWYGLSNE--EVIECITQ---GRL----------------------------LQRPRTCPSEVYDIMLGCWKR 263 (280)
T ss_pred HHhcCCCCCCCCCHH--HHHHHHHc---CCc----------------------------CCCCCCCCHHHHHHHHHHcCC
Confidence 998 99998653211 11111110 000 001123456789999999999
Q ss_pred CCCCCCCHHHHHHHHH
Q 042634 400 LPRERMNMEEVAAQLL 415 (427)
Q Consensus 400 dP~~Rpt~~ev~~~L~ 415 (427)
||++|||+.||++.|+
T Consensus 264 ~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 264 DPQQRINIKDIHERLQ 279 (280)
T ss_pred CcccCCCHHHHHHHhh
Confidence 9999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=262.41 Aligned_cols=196 Identities=19% Similarity=0.275 Sum_probs=152.7
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++.+.+. .+...++||||+++++|.+++..... ..+++..+..++.|++.||+||| +.||+||
T Consensus 50 l~hp~i~~~~~~~~-----~~~~~~lv~e~~~g~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~ 119 (277)
T cd05607 50 VNSPFIVNLAYAFE-----SKTHLCLVMSLMNGGDLKYHIYNVGE--RGLEMERVIHYSAQITCGILHLH---SMDIVYR 119 (277)
T ss_pred cCCCcEEEEEEEEe-----cCCeEEEEEecCCCCCHHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHH---HCCEEEc
Confidence 57999999888743 35678999999999999888754332 35888999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc-----CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFT 333 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~ 333 (427)
||||+||+++.++.+||+|||++...... ..++..|+|||++.+..++.++||||+||++|||++|+.||.....
T Consensus 120 dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~ 199 (277)
T cd05607 120 DMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKE 199 (277)
T ss_pred cCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcc
Confidence 99999999999999999999999865432 2678899999999998899999999999999999999999975321
Q ss_pred CCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 042634 334 GNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAAQ 413 (427)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~ 413 (427)
.. .............. . ......+.++.+++.+||+.||++|||++|+++.
T Consensus 200 ~~-~~~~~~~~~~~~~~----~------------------------~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 200 KV-AKEELKRRTLEDEV----K------------------------FEHQNFTEESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred hh-hHHHHHHHhhcccc----c------------------------cccccCCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence 11 11111111110000 0 0011235568999999999999999999776643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=258.66 Aligned_cols=193 Identities=25% Similarity=0.430 Sum_probs=152.9
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. +...+++|||+.+|+|.+++.... ..+++..++.++.|++.||+||| +.|++|+
T Consensus 56 l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~ 124 (256)
T cd05113 56 LSHEKLVQLYGVCTK-----QRPIYIVTEYMSNGCLLNYLREHG---KRFQPSQLLEMCKDVCEGMAYLE---SKQFIHR 124 (256)
T ss_pred CCCCCeeeEEEEEcc-----CCCcEEEEEcCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeecc
Confidence 579999999998644 456799999999999999986543 35899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC-------CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCCc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT-------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~-------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~~ 330 (427)
||||+||+++.++.+||+|||.++...... .++..|+|||...+..++.++|||||||++|||++ |..||..
T Consensus 125 dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~ 204 (256)
T cd05113 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYER 204 (256)
T ss_pred ccCcceEEEcCCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCc
Confidence 999999999999999999999988653322 34567999999988889999999999999999998 9999864
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
.... ............ ..+...+..+.+++.+||+.+|++|||+.++
T Consensus 205 ~~~~--~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l 251 (256)
T cd05113 205 FNNS--ETVEKVSQGLRL-------------------------------YRPHLASEKVYAIMYSCWHEKAEERPTFQQL 251 (256)
T ss_pred CCHH--HHHHHHhcCCCC-------------------------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHH
Confidence 3211 011110000000 0111134678999999999999999999999
Q ss_pred HHHHH
Q 042634 411 AAQLL 415 (427)
Q Consensus 411 ~~~L~ 415 (427)
++.|+
T Consensus 252 l~~~~ 256 (256)
T cd05113 252 LSSIE 256 (256)
T ss_pred HHhhC
Confidence 98764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=260.00 Aligned_cols=198 Identities=25% Similarity=0.366 Sum_probs=154.6
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchh------------hhhccCHHHHHHHHHHHHHHHHHH
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNRE------------ALKNLNLLQRLSIAVDVASALDYL 247 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~~~~~i~~~L~~L 247 (427)
+||||+++++.+.. ....++||||+++|+|.+++..... ....+++.+++.++.|++.|++||
T Consensus 54 ~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~l 128 (270)
T cd05047 54 HHPNIINLLGACEH-----RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 128 (270)
T ss_pred cCCCeeeEEEEEec-----CCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 79999999998644 4567999999999999999865321 113478999999999999999999
Q ss_pred hhcCCCCeeeccccCCceeeCCCCceEecccccccccCCc-----CCCccccccccccCCCCcCccccchhHHHHHHHHH
Q 042634 248 HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETF 322 (427)
Q Consensus 248 H~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell 322 (427)
| +.|++||||||+||++++++.+||+|||+++..... ...+..|+|||++....++.++|||||||++|||+
T Consensus 129 H---~~~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~ 205 (270)
T cd05047 129 S---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 205 (270)
T ss_pred H---HCCEeecccccceEEEcCCCeEEECCCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHH
Confidence 9 899999999999999999999999999998643211 12345699999998888999999999999999999
Q ss_pred h-CCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCC
Q 042634 323 T-GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELP 401 (427)
Q Consensus 323 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP 401 (427)
+ |..||.+... .......... . .. ..+..++.++.+++.+||+.+|
T Consensus 206 ~~g~~pf~~~~~-----~~~~~~~~~~-~--~~-------------------------~~~~~~~~~~~~li~~~l~~~p 252 (270)
T cd05047 206 SLGGTPYCGMTC-----AELYEKLPQG-Y--RL-------------------------EKPLNCDDEVYDLMRQCWREKP 252 (270)
T ss_pred cCCCCCccccCH-----HHHHHHHhCC-C--CC-------------------------CCCCcCCHHHHHHHHHHcccCh
Confidence 7 9999865311 1111111000 0 00 0111244568899999999999
Q ss_pred CCCCCHHHHHHHHHHHH
Q 042634 402 RERMNMEEVAAQLLSFR 418 (427)
Q Consensus 402 ~~Rpt~~ev~~~L~~~~ 418 (427)
.+|||+.|+++.|+++.
T Consensus 253 ~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 253 YERPSFAQILVSLNRML 269 (270)
T ss_pred hhCCCHHHHHHHHHHhh
Confidence 99999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=262.74 Aligned_cols=200 Identities=25% Similarity=0.416 Sum_probs=157.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchh--------------------hhhccCHHHHHHHHH
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNRE--------------------ALKNLNLLQRLSIAV 238 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------------------~~~~l~~~~~~~~~~ 238 (427)
++||||+++++.+.. ....++++||+.+|+|.+++..... ....+++..++.++.
T Consensus 60 l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~ 134 (290)
T cd05045 60 VNHPHVIKLYGACSQ-----DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAW 134 (290)
T ss_pred CCCCCEeeEEEEEec-----CCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHH
Confidence 469999999987543 4568999999999999988753211 113578899999999
Q ss_pred HHHHHHHHHhhcCCCCeeeccccCCceeeCCCCceEecccccccccCCc--------CCCccccccccccCCCCcCcccc
Q 042634 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA--------TNNFFNFQIAEYGMGSEVSTSGD 310 (427)
Q Consensus 239 ~i~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~D 310 (427)
|++.||+||| +.|++||||||+||++++++.+||+|||.++..... ..++..|+|||...+..++.++|
T Consensus 135 ~i~~~l~~LH---~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~D 211 (290)
T cd05045 135 QISRGMQYLA---EMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSD 211 (290)
T ss_pred HHHHHHHHHH---HCCeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhH
Confidence 9999999999 899999999999999999999999999999764321 13456899999998888999999
Q ss_pred chhHHHHHHHHHh-CCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHH
Q 042634 311 VYSFGILLLETFT-GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSV 389 (427)
Q Consensus 311 iwS~G~vl~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (427)
||||||++|||++ |..||.+... ..+.+....... ...+..++.++
T Consensus 212 i~slG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~~~-------------------------------~~~~~~~~~~~ 258 (290)
T cd05045 212 VWSFGVLLWEIVTLGGNPYPGIAP--ERLFNLLKTGYR-------------------------------MERPENCSEEM 258 (290)
T ss_pred HHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHhCCCC-------------------------------CCCCCCCCHHH
Confidence 9999999999998 9999865311 111111110000 00122345678
Q ss_pred HHHHhhcCCCCCCCCCCHHHHHHHHHHHHH
Q 042634 390 LGIGVTCSSELPRERMNMEEVAAQLLSFRN 419 (427)
Q Consensus 390 ~~l~~~cl~~dP~~Rpt~~ev~~~L~~~~~ 419 (427)
.+++.+||+.+|++|||++|+++.|+++..
T Consensus 259 ~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 259 YNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=262.73 Aligned_cols=221 Identities=21% Similarity=0.222 Sum_probs=155.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
.+||||+++++.+...........+++|||+. ++|.+++..... ..+++..++.++.|++.||+||| +.||+||
T Consensus 59 ~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~ 132 (288)
T cd07863 59 FDHPNIVRLMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVPP--PGLPAETIKDLMRQFLRGLDFLH---ANCIVHR 132 (288)
T ss_pred cCCCCeeeeeeeeccccCCCCceEEEEEcccc-cCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecC
Confidence 46999999999865533334456799999996 588888765432 34899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc-----CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFT 333 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~ 333 (427)
||||+||+++.++.+||+|||+++..... ..++..|+|||++.+..++.++||||+||++|||++|++||.....
T Consensus 133 dikp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~ 212 (288)
T cd07863 133 DLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE 212 (288)
T ss_pred CCCHHHEEECCCCCEEECccCccccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCH
Confidence 99999999999999999999999876432 2567889999999988999999999999999999999999865321
Q ss_pred CCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 334 GNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
...+.+............ ......... ... ........ ....+..+.++.+++.+|++.||++|||+.|++.
T Consensus 213 -~~~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~--~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 213 -ADQLGKIFDLIGLPPEDD-WPRDVTLPR--GAF--SPRGPRPV-QSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred -HHHHHHHHHHhCCCChhh-Ccccccccc--ccc--CCCCCCch-HHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 111111111110000000 000000000 000 00000000 0011234567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=258.29 Aligned_cols=196 Identities=27% Similarity=0.478 Sum_probs=157.3
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++.+.. ....++||||+++++|.+++..... ..+++..+..++.|++.|++||| +.||+||
T Consensus 59 l~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~ 128 (261)
T cd05148 59 LRHKHLISLFAVCSV-----GEPVYIITELMEKGSLLAFLRSPEG--QVLPVASLIDMACQVAEGMAYLE---EQNSIHR 128 (261)
T ss_pred CCCcchhheeeeEec-----CCCeEEEEeecccCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecc
Confidence 469999999887543 5578999999999999999976432 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC------CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCCcc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNEM 331 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~~~ 331 (427)
||||+||+++.++.+||+|||.+....... .++..|+|||......++.++||||||+++|++++ |+.||...
T Consensus 129 dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~ 208 (261)
T cd05148 129 DLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGM 208 (261)
T ss_pred ccCcceEEEcCCceEEEccccchhhcCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcC
Confidence 999999999999999999999997654322 34567999999988889999999999999999998 89999653
Q ss_pred cCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 042634 332 FTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVA 411 (427)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~ 411 (427)
.. ............. ..+..++..+.+++.+||+.||++|||++|++
T Consensus 209 ~~--~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~ 255 (261)
T cd05148 209 NN--HEVYDQITAGYRM-------------------------------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALR 255 (261)
T ss_pred CH--HHHHHHHHhCCcC-------------------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence 21 0111111100000 01223456789999999999999999999999
Q ss_pred HHHHHH
Q 042634 412 AQLLSF 417 (427)
Q Consensus 412 ~~L~~~ 417 (427)
+.|+.+
T Consensus 256 ~~L~~~ 261 (261)
T cd05148 256 EELDNI 261 (261)
T ss_pred HHHhcC
Confidence 999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=260.64 Aligned_cols=197 Identities=21% Similarity=0.364 Sum_probs=156.6
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ...++++||+++|+|.+++.... ..+++..++.++.|++.||+||| +.||+||
T Consensus 66 ~~~~~i~~~~~~~~~------~~~~l~~~~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~ 133 (279)
T cd05109 66 VGSPYVCRLLGICLT------STVQLVTQLMPYGCLLDYVRENK---DRIGSQDLLNWCVQIAKGMSYLE---EVRLVHR 133 (279)
T ss_pred cCCCCCceEEEEEcC------CCcEEEEEcCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecc
Confidence 579999999987643 34679999999999999987543 35899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC--------CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT--------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTN 329 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~--------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~ 329 (427)
||||+||+++.++.+||+|||+++...... .++..|+|||...+..++.++|||||||++||+++ |..||.
T Consensus 134 dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~ 213 (279)
T cd05109 134 DLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213 (279)
T ss_pred ccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 999999999999999999999998664221 33567999999988899999999999999999998 899986
Q ss_pred cccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 042634 330 EMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEE 409 (427)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~e 409 (427)
.... ..+...+...... ..+..++.++.+++.+||+.||++|||+.|
T Consensus 214 ~~~~--~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~ 260 (279)
T cd05109 214 GIPA--REIPDLLEKGERL-------------------------------PQPPICTIDVYMIMVKCWMIDSECRPRFRE 260 (279)
T ss_pred CCCH--HHHHHHHHCCCcC-------------------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 5311 1111111110000 011224567889999999999999999999
Q ss_pred HHHHHHHHHHH
Q 042634 410 VAAQLLSFRNK 420 (427)
Q Consensus 410 v~~~L~~~~~~ 420 (427)
+++.|+++..+
T Consensus 261 l~~~l~~~~~~ 271 (279)
T cd05109 261 LVDEFSRMARD 271 (279)
T ss_pred HHHHHHHhhcC
Confidence 99999888654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=260.60 Aligned_cols=202 Identities=25% Similarity=0.441 Sum_probs=160.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhh----hhccCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREA----LKNLNLLQRLSIAVDVASALDYLHHYCETP 254 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~----~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ 254 (427)
++|||++++++.+.. .+...++++||+++|+|.+++...... ...+++..+..++.|++.||+||| +.+
T Consensus 65 l~h~ni~~~~~~~~~----~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ 137 (280)
T cd05043 65 LSHQNILPILHVCIE----DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRG 137 (280)
T ss_pred CCCCCCCeEEEEEec----CCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCC
Confidence 479999999987533 245678999999999999998654221 145889999999999999999999 899
Q ss_pred eeeccccCCceeeCCCCceEecccccccccCCc--------CCCccccccccccCCCCcCccccchhHHHHHHHHHh-CC
Q 042634 255 IVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA--------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GK 325 (427)
Q Consensus 255 ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~ 325 (427)
++||||||+||++++++.+||+|||+++.+... ..++..|+|||++.+..++.++|||||||++||+++ |+
T Consensus 138 i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~ 217 (280)
T cd05043 138 VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQ 217 (280)
T ss_pred EeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCC
Confidence 999999999999999999999999999865322 245667999999988889999999999999999999 99
Q ss_pred CCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCC
Q 042634 326 RPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERM 405 (427)
Q Consensus 326 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rp 405 (427)
.||.... ...+.......... ..+..++.++.+++.+||+.||++||
T Consensus 218 ~p~~~~~--~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp 264 (280)
T cd05043 218 TPYVEID--PFEMAAYLKDGYRL-------------------------------AQPINCPDELFAVMACCWALDPEERP 264 (280)
T ss_pred CCcCcCC--HHHHHHHHHcCCCC-------------------------------CCCCcCCHHHHHHHHHHcCCChhhCC
Confidence 9996531 11111111110000 01122456789999999999999999
Q ss_pred CHHHHHHHHHHHHHH
Q 042634 406 NMEEVAAQLLSFRNK 420 (427)
Q Consensus 406 t~~ev~~~L~~~~~~ 420 (427)
|+.|+++.|+++.++
T Consensus 265 s~~~~~~~l~~~~~~ 279 (280)
T cd05043 265 SFSQLVQCLTDFHAQ 279 (280)
T ss_pred CHHHHHHHHHHHHhc
Confidence 999999999998765
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=257.65 Aligned_cols=190 Identities=21% Similarity=0.327 Sum_probs=147.6
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++++.. +...+++|||+++|+|..++.... ..+++..++.++.||+.||+||| +.||+||
T Consensus 61 l~hp~iv~~~~~~~~-----~~~~~lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~ 129 (262)
T cd05077 61 VSHKHIVLLYGVCVR-----DVENIMVEEFVEFGPLDLFMHRKS---DVLTTPWKFKVAKQLASALSYLE---DKDLVHG 129 (262)
T ss_pred CCCCCEeeEEEEEec-----CCCCEEEEecccCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHhh---hCCeECC
Confidence 579999999998643 456789999999999988876432 35899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCc-------eEecccccccccCCc--CCCccccccccccC-CCCcCccccchhHHHHHHHHH-hCCCC
Q 042634 259 DLKPSNVLLDGELT-------AHVGDFGLAKFLPEA--TNNFFNFQIAEYGM-GSEVSTSGDVYSFGILLLETF-TGKRP 327 (427)
Q Consensus 259 Dlkp~NIll~~~~~-------~kL~DFG~a~~~~~~--~~~~~~y~aPE~~~-~~~~~~~~DiwS~G~vl~ell-~g~~p 327 (427)
||||+|||++.++. +|++|||.+...... ..++..|+|||.+. +..++.++|||||||++|||+ .|..|
T Consensus 130 dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p 209 (262)
T cd05077 130 NVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIP 209 (262)
T ss_pred CCCcccEEEecCCccCCCCceeEeCCCCCCccccCcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCC
Confidence 99999999976653 899999999765432 36778899999886 466899999999999999998 58888
Q ss_pred CCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCH
Q 042634 328 TNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM 407 (427)
Q Consensus 328 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~ 407 (427)
|...... ....... ... . .....+.++.+++.+||+.||++|||+
T Consensus 210 ~~~~~~~--~~~~~~~----~~~-~----------------------------~~~~~~~~~~~li~~cl~~dp~~Rp~~ 254 (262)
T cd05077 210 LKDKTLA--EKERFYE----GQC-M----------------------------LVTPSCKELADLMTHCMNYDPNQRPFF 254 (262)
T ss_pred CCCcchh--HHHHHHh----cCc-c----------------------------CCCCChHHHHHHHHHHcCCChhhCcCH
Confidence 7642110 0000000 000 0 000123568899999999999999999
Q ss_pred HHHHHHH
Q 042634 408 EEVAAQL 414 (427)
Q Consensus 408 ~ev~~~L 414 (427)
.||++.+
T Consensus 255 ~~il~~~ 261 (262)
T cd05077 255 RAIMRDI 261 (262)
T ss_pred HHHHHhc
Confidence 9999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=273.08 Aligned_cols=139 Identities=30% Similarity=0.421 Sum_probs=124.2
Q ss_pred ccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeecccc
Q 042634 182 RNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLK 261 (427)
Q Consensus 182 pniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrDlk 261 (427)
-|+|++++++ ...++.|||+|.+ ..+|+++++.+.. ..++...++.++.||+.||.+|| +.||||+|||
T Consensus 248 ~n~Vrm~d~F-----~fr~HlciVfELL-~~NLYellK~n~f--~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLK 316 (586)
T KOG0667|consen 248 YNIVRMLDYF-----YFRNHLCIVFELL-STNLYELLKNNKF--RGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLK 316 (586)
T ss_pred eeEEEeeecc-----ccccceeeeehhh-hhhHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCC
Confidence 4789999984 4478999999988 8899999987765 56999999999999999999999 9999999999
Q ss_pred CCceeeCCC--CceEecccccccccCCcC---CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 262 PSNVLLDGE--LTAHVGDFGLAKFLPEAT---NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 262 p~NIll~~~--~~~kL~DFG~a~~~~~~~---~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
|||||+... ..+||+|||.|....... ..+..|+|||++.+.+|+.+.||||||||++||++|.+.|.+.
T Consensus 317 PENILL~~~~r~~vKVIDFGSSc~~~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 317 PENILLKDPKRSRIKVIDFGSSCFESQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred hhheeeccCCcCceeEEecccccccCCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 999999543 379999999999877666 4567899999999999999999999999999999999888764
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=269.71 Aligned_cols=184 Identities=24% Similarity=0.245 Sum_probs=148.0
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+++|+|.+++... ..+++..+..++.||+.||+||| +.||+||
T Consensus 53 l~hp~iv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~givH~ 120 (323)
T cd05575 53 VKHPFLVGLHYSFQT-----ADKLYFVLDYVNGGELFFHLQRE----RSFPEPRARFYAAEIASALGYLH---SLNIIYR 120 (323)
T ss_pred CCCCCCCCeeEEEEe-----CCEEEEEEcCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeC
Confidence 579999999887533 56789999999999999888654 45889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC------cCCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE------ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+|||++.++.+||+|||+++.... ...|+..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 121 dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 200 (323)
T cd05575 121 DLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200 (323)
T ss_pred CCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC
Confidence 9999999999999999999999875322 1258889999999999999999999999999999999999997531
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME 408 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ 408 (427)
..+.......... . .+...+.++.+++.+|++.||++||++.
T Consensus 201 -----~~~~~~~i~~~~~----~-------------------------~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 201 -----TAEMYDNILNKPL----R-------------------------LKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred -----HHHHHHHHHcCCC----C-------------------------CCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 1111111110000 0 0111245688999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=263.78 Aligned_cols=201 Identities=26% Similarity=0.383 Sum_probs=156.5
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchh------------hhhccCHHHHHHHHHHHHHHHHH
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNRE------------ALKNLNLLQRLSIAVDVASALDY 246 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~~~~~i~~~L~~ 246 (427)
.+||||+++++.+.. ....++||||+++|+|.+++..... ....+++.+++.++.|++.|++|
T Consensus 65 ~~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~ 139 (303)
T cd05088 65 GHHPNIINLLGACEH-----RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDY 139 (303)
T ss_pred cCCCCcceEEEEECC-----CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHH
Confidence 379999999998543 5678999999999999998864321 11357899999999999999999
Q ss_pred HhhcCCCCeeeccccCCceeeCCCCceEecccccccccCCc-----CCCccccccccccCCCCcCccccchhHHHHHHHH
Q 042634 247 LHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLET 321 (427)
Q Consensus 247 LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~el 321 (427)
|| +.||+||||||+||+++.++.+||+|||+++..... ...+..|+|||++.+..++.++|||||||++||+
T Consensus 140 LH---~~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 216 (303)
T cd05088 140 LS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 216 (303)
T ss_pred HH---hCCccccccchheEEecCCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHH
Confidence 99 899999999999999999999999999998743211 1235579999999888899999999999999999
Q ss_pred Hh-CCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCC
Q 042634 322 FT-GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSEL 400 (427)
Q Consensus 322 l~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~d 400 (427)
++ |..||...... +.... .+... . ...+..++.++.+++.+||+.+
T Consensus 217 lt~g~~p~~~~~~~-----~~~~~-~~~~~----~-----------------------~~~~~~~~~~~~~li~~~l~~~ 263 (303)
T cd05088 217 VSLGGTPYCGMTCA-----ELYEK-LPQGY----R-----------------------LEKPLNCDDEVYDLMRQCWREK 263 (303)
T ss_pred HhcCCCCcccCChH-----HHHHH-HhcCC----c-----------------------CCCCCCCCHHHHHHHHHHcCCC
Confidence 98 99998643111 11111 00000 0 0011123456889999999999
Q ss_pred CCCCCCHHHHHHHHHHHHHH
Q 042634 401 PRERMNMEEVAAQLLSFRNK 420 (427)
Q Consensus 401 P~~Rpt~~ev~~~L~~~~~~ 420 (427)
|++|||++++++.|+++.+.
T Consensus 264 p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 264 PYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred hhhCcCHHHHHHHHHHHHHh
Confidence 99999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=268.22 Aligned_cols=189 Identities=22% Similarity=0.301 Sum_probs=145.5
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|+||+++++.+. .+...++||||+++|+|.+.. ..++..+..++.||+.||+||| +.||+||
T Consensus 129 l~h~~iv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHr 192 (353)
T PLN00034 129 VNHPNVVKCHDMFD-----HNGEIQVLLEFMDGGSLEGTH--------IADEQFLADVARQILSGIAYLH---RRHIVHR 192 (353)
T ss_pred CCCCCcceeeeEec-----cCCeEEEEEecCCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHH---HCCEeec
Confidence 57999999998753 356789999999999986543 2456678889999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCC-----CCcCccccchhHHHHHHHHHhCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMG-----SEVSTSGDVYSFGILLLETFTGKRP 327 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~-----~~~~~~~DiwS~G~vl~ell~g~~p 327 (427)
||||+|||++.++.+||+|||+++..... ..|+..|+|||++.. ...+.++|||||||++|||++|+.|
T Consensus 193 Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~p 272 (353)
T PLN00034 193 DIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272 (353)
T ss_pred CCCHHHEEEcCCCCEEEcccccceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999865432 368899999998743 2345789999999999999999999
Q ss_pred CCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCH
Q 042634 328 TNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM 407 (427)
Q Consensus 328 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~ 407 (427)
|..... ..+........... ....+..++.++.+++.+||+.||++|||+
T Consensus 273 f~~~~~--~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~ 322 (353)
T PLN00034 273 FGVGRQ--GDWASLMCAICMSQ----------------------------PPEAPATASREFRHFISCCLQREPAKRWSA 322 (353)
T ss_pred CCCCCC--ccHHHHHHHHhccC----------------------------CCCCCCccCHHHHHHHHHHccCChhhCcCH
Confidence 973211 11221111110000 000122345678999999999999999999
Q ss_pred HHHHHH
Q 042634 408 EEVAAQ 413 (427)
Q Consensus 408 ~ev~~~ 413 (427)
+|++++
T Consensus 323 ~ell~h 328 (353)
T PLN00034 323 MQLLQH 328 (353)
T ss_pred HHHhcC
Confidence 999875
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=262.76 Aligned_cols=200 Identities=22% Similarity=0.392 Sum_probs=158.0
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchh------------hhhccCHHHHHHHHHHHHHHHHHH
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNRE------------ALKNLNLLQRLSIAVDVASALDYL 247 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~~~~~i~~~L~~L 247 (427)
+||||+++++.+.. ....+++|||+++|+|.+++..... ....+++.++..++.|++.||+||
T Consensus 79 ~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~L 153 (304)
T cd05101 79 KHKNIINLLGACTQ-----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL 153 (304)
T ss_pred cCCCchheeEEEec-----CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHH
Confidence 79999999998543 4577999999999999999865321 113578889999999999999999
Q ss_pred hhcCCCCeeeccccCCceeeCCCCceEecccccccccCCc--------CCCccccccccccCCCCcCccccchhHHHHHH
Q 042634 248 HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA--------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLL 319 (427)
Q Consensus 248 H~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ 319 (427)
| +.||+||||||+||+++.++.+||+|||.++..... ..++..|+|||++.+..++.++|||||||++|
T Consensus 154 H---~~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 230 (304)
T cd05101 154 A---SQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMW 230 (304)
T ss_pred H---HCCeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHH
Confidence 9 899999999999999999999999999999865421 13456799999999888999999999999999
Q ss_pred HHHh-CCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCC
Q 042634 320 ETFT-GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSS 398 (427)
Q Consensus 320 ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~ 398 (427)
|+++ |..||.... ..+......... +...+..++.++.+++.+||+
T Consensus 231 el~~~g~~p~~~~~-----~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~li~~cl~ 277 (304)
T cd05101 231 EIFTLGGSPYPGIP-----VEELFKLLKEGH----------------------------RMDKPANCTNELYMMMRDCWH 277 (304)
T ss_pred HHHcCCCCCcccCC-----HHHHHHHHHcCC----------------------------cCCCCCCCCHHHHHHHHHHcc
Confidence 9998 788886431 111111110000 000122356678999999999
Q ss_pred CCCCCCCCHHHHHHHHHHHHHH
Q 042634 399 ELPRERMNMEEVAAQLLSFRNK 420 (427)
Q Consensus 399 ~dP~~Rpt~~ev~~~L~~~~~~ 420 (427)
.+|++|||+.|+++.|+++...
T Consensus 278 ~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 278 AIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred cChhhCCCHHHHHHHHHHHHHh
Confidence 9999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=267.61 Aligned_cols=188 Identities=20% Similarity=0.257 Sum_probs=150.9
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeecc
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCD 259 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrD 259 (427)
+||||+++++.+.. ....++||||+++|+|..++... ..+++..+..++.|++.||+||| +.||+|||
T Consensus 54 ~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~d 121 (318)
T cd05570 54 KHPFLTQLHSCFQT-----KDRLFFVMEYVNGGDLMFHIQRS----GRFDEPRARFYAAEIVLGLQFLH---ERGIIYRD 121 (318)
T ss_pred CCCCccceeeEEEc-----CCEEEEEEcCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEccC
Confidence 79999999987543 56789999999999998887654 35899999999999999999999 89999999
Q ss_pred ccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccC
Q 042634 260 LKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFT 333 (427)
Q Consensus 260 lkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~ 333 (427)
|||+||+++.++.+||+|||+++..... ..|+..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 122 lkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~- 200 (318)
T cd05570 122 LKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD- 200 (318)
T ss_pred CCHHHeEECCCCcEEecccCCCeecCcCCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC-
Confidence 9999999999999999999998753211 257889999999999999999999999999999999999997531
Q ss_pred CCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCH-----H
Q 042634 334 GNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM-----E 408 (427)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~-----~ 408 (427)
............ . ..+...+.++.+++.+||+.||++|||+ .
T Consensus 201 ----~~~~~~~i~~~~--------~---------------------~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~ 247 (318)
T cd05570 201 ----EDELFQSILEDE--------V---------------------RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQ 247 (318)
T ss_pred ----HHHHHHHHHcCC--------C---------------------CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHH
Confidence 111111110000 0 0112235568999999999999999999 7
Q ss_pred HHHHH
Q 042634 409 EVAAQ 413 (427)
Q Consensus 409 ev~~~ 413 (427)
++++.
T Consensus 248 ~ll~~ 252 (318)
T cd05570 248 DIKGH 252 (318)
T ss_pred HHhcC
Confidence 77653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=256.15 Aligned_cols=193 Identities=22% Similarity=0.368 Sum_probs=152.9
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.||+||
T Consensus 50 l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~ 118 (252)
T cd05084 50 YSHPNIVRLIGVCTQ-----KQPIYIVMELVQGGDFLTFLRTEG---PRLKVKELIQMVENAAAGMEYLE---SKHCIHR 118 (252)
T ss_pred CCCCCcceEEEEEcC-----CCCeEEEEeeccCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccc
Confidence 479999999988643 457899999999999999986432 34889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC--------CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT--------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTN 329 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~--------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~ 329 (427)
||||+||+++.++.+||+|||.++...... ..+..|+|||.+.+..++.++|||||||++||+++ |..||.
T Consensus 119 dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~ 198 (252)
T cd05084 119 DLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYA 198 (252)
T ss_pred ccchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence 999999999999999999999987654322 22346999999988889999999999999999998 888886
Q ss_pred cccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 042634 330 EMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEE 409 (427)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~e 409 (427)
..... ..........+ ...+..++.++.+++.+||+.+|++|||+.|
T Consensus 199 ~~~~~--~~~~~~~~~~~-------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 245 (252)
T cd05084 199 NLSNQ--QTREAIEQGVR-------------------------------LPCPELCPDAVYRLMERCWEYDPGQRPSFST 245 (252)
T ss_pred ccCHH--HHHHHHHcCCC-------------------------------CCCcccCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 43110 00010000000 0012234567899999999999999999999
Q ss_pred HHHHHH
Q 042634 410 VAAQLL 415 (427)
Q Consensus 410 v~~~L~ 415 (427)
+.+.|+
T Consensus 246 ~~~~l~ 251 (252)
T cd05084 246 VHQELQ 251 (252)
T ss_pred HHHHHh
Confidence 999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=256.63 Aligned_cols=194 Identities=25% Similarity=0.401 Sum_probs=155.5
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++.+. ....++||||+++|+|.+++.... .+++..+..++.|++.|++||| ..+++||
T Consensus 53 l~h~~iv~~~~~~~------~~~~~~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~ 119 (257)
T cd05060 53 LDHPCIVRLIGVCK------GEPLMLVMELAPLGPLLKYLKKRR----EIPVSDLKELAHQVAMGMAYLE---SKHFVHR 119 (257)
T ss_pred cCCCCeeeEEEEEc------CCceEEEEEeCCCCcHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHh---hcCeecc
Confidence 57999999988643 235789999999999999997653 4889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC---------CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT---------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPT 328 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~---------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf 328 (427)
||||+||+++.++.+||+|||.++...... .++..|+|||.+.+..++.++|||||||++||+++ |..||
T Consensus 120 di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~ 199 (257)
T cd05060 120 DLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPY 199 (257)
T ss_pred CcccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCc
Confidence 999999999999999999999998653322 22357999999998899999999999999999998 99998
Q ss_pred CcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 042634 329 NEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME 408 (427)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ 408 (427)
..... ..+...+....+ ...+..++..+.+++.+||+.+|++|||+.
T Consensus 200 ~~~~~--~~~~~~~~~~~~-------------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ 246 (257)
T cd05060 200 GEMKG--AEVIAMLESGER-------------------------------LPRPEECPQEIYSIMLSCWKYRPEDRPTFS 246 (257)
T ss_pred ccCCH--HHHHHHHHcCCc-------------------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHH
Confidence 65321 111111111000 001223456789999999999999999999
Q ss_pred HHHHHHHHHH
Q 042634 409 EVAAQLLSFR 418 (427)
Q Consensus 409 ev~~~L~~~~ 418 (427)
++++.|+++.
T Consensus 247 ~l~~~l~~~~ 256 (257)
T cd05060 247 ELESTFRRDP 256 (257)
T ss_pred HHHHHHHhcc
Confidence 9999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=293.01 Aligned_cols=191 Identities=25% Similarity=0.317 Sum_probs=155.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
+.|||+|+++++-.. .+..+|.||||.+|+|.+.++-.+ ..++.-...+..|++.|+.||| ++|||||
T Consensus 1291 lnHpNlV~YyGVEvH-----Rekv~IFMEyC~~GsLa~ll~~gr----i~dE~vt~vyt~qll~gla~LH---~~gIVHR 1358 (1509)
T KOG4645|consen 1291 LNHPNLVRYYGVEVH-----REKVYIFMEYCEGGSLASLLEHGR----IEDEMVTRVYTKQLLEGLAYLH---EHGIVHR 1358 (1509)
T ss_pred ccCccccccCceeec-----HHHHHHHHHHhccCcHHHHHHhcc----hhhhhHHHHHHHHHHHHHHHHH---hcCceec
Confidence 789999999998333 567899999999999999987553 3667778889999999999999 9999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC----------CCccccccccccCCCC---cCccccchhHHHHHHHHHhCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT----------NNFFNFQIAEYGMGSE---VSTSGDVYSFGILLLETFTGK 325 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~----------~~~~~y~aPE~~~~~~---~~~~~DiwS~G~vl~ell~g~ 325 (427)
||||+||+++.+|.+|++|||.|+.+.... .||+.|||||++.+.. ...++||||+|||+.||+||+
T Consensus 1359 DIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGk 1438 (1509)
T KOG4645|consen 1359 DIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGK 1438 (1509)
T ss_pred CCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCC
Confidence 999999999999999999999998765432 8999999999998754 567899999999999999999
Q ss_pred CCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCC
Q 042634 326 RPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERM 405 (427)
Q Consensus 326 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rp 405 (427)
.||......-..+........|. .|+....+-.+++.+|++.||++|.
T Consensus 1439 rPW~~~dne~aIMy~V~~gh~Pq--------------------------------~P~~ls~~g~dFle~Cl~~dP~~Rw 1486 (1509)
T KOG4645|consen 1439 RPWAELDNEWAIMYHVAAGHKPQ--------------------------------IPERLSSEGRDFLEHCLEQDPKMRW 1486 (1509)
T ss_pred CchhhccchhHHHhHHhccCCCC--------------------------------CchhhhHhHHHHHHHHHhcCchhhh
Confidence 99986533322222222222211 2333566678899999999999999
Q ss_pred CHHHHHHH
Q 042634 406 NMEEVAAQ 413 (427)
Q Consensus 406 t~~ev~~~ 413 (427)
++.|+++.
T Consensus 1487 ~~~qlle~ 1494 (1509)
T KOG4645|consen 1487 TASQLLEH 1494 (1509)
T ss_pred HHHHHHHh
Confidence 99888764
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=269.59 Aligned_cols=188 Identities=24% Similarity=0.229 Sum_probs=149.6
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+++|+|.+++... ..+++..++.++.||+.||+||| +.||+||
T Consensus 53 ~~h~~Iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH---~~giiHr 120 (325)
T cd05602 53 VKHPFLVGLHFSFQT-----ADKLYFVLDYINGGELFYHLQRE----RCFLEPRARFYAAEIASALGYLH---SLNIVYR 120 (325)
T ss_pred CCCCCCCceeEEEEc-----CCeEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEec
Confidence 579999999887433 56789999999999999988654 34788899999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC------cCCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE------ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+||+++.++.+||+|||+++.... ...|++.|+|||++.+..++.++||||+||++|||++|..||....
T Consensus 121 Dlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 200 (325)
T cd05602 121 DLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 200 (325)
T ss_pred CCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC
Confidence 9999999999999999999999975422 1268899999999999999999999999999999999999997531
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
. .+.......... . .....+..+.+++.+|++.||.+||++.+.+.
T Consensus 201 ~-----~~~~~~i~~~~~--------~---------------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 201 T-----AEMYDNILNKPL--------Q---------------------LKPNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred H-----HHHHHHHHhCCc--------C---------------------CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 1 111111110000 0 01123456789999999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=256.46 Aligned_cols=195 Identities=24% Similarity=0.421 Sum_probs=156.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. +...+++|||+++++|.+++.... ..+++..+..++.|++.|++||| +.+|+||
T Consensus 62 l~h~~i~~~~~~~~~-----~~~~~iv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~ 130 (266)
T cd05033 62 FDHPNIIRLEGVVTK-----SRPVMIITEYMENGSLDKFLREND---GKFTVGQLVGMLRGIASGMKYLS---EMNYVHR 130 (266)
T ss_pred CCCCCcceEeEEEec-----CCceEEEEEcCCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccC
Confidence 569999999987533 567899999999999999986543 35899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc--------CCCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA--------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTN 329 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~ 329 (427)
||||+||++++++.+||+|||.++..... ..++..|+|||.+.+..++.++||||||+++||+++ |..||.
T Consensus 131 di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~ 210 (266)
T cd05033 131 DLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYW 210 (266)
T ss_pred CCCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCC
Confidence 99999999999999999999999876421 134467999999998899999999999999999998 999986
Q ss_pred cccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 042634 330 EMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEE 409 (427)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~e 409 (427)
..... ............ ..+..++..+.+++.+||+.+|++|||++|
T Consensus 211 ~~~~~--~~~~~~~~~~~~-------------------------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e 257 (266)
T cd05033 211 DMSNQ--DVIKAVEDGYRL-------------------------------PPPMDCPSALYQLMLDCWQKDRNERPTFSQ 257 (266)
T ss_pred CCCHH--HHHHHHHcCCCC-------------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHH
Confidence 43111 111111000000 011234567899999999999999999999
Q ss_pred HHHHHHHH
Q 042634 410 VAAQLLSF 417 (427)
Q Consensus 410 v~~~L~~~ 417 (427)
|++.|+++
T Consensus 258 i~~~l~~~ 265 (266)
T cd05033 258 IVSTLDKM 265 (266)
T ss_pred HHHHHHhh
Confidence 99999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=263.03 Aligned_cols=196 Identities=25% Similarity=0.382 Sum_probs=155.5
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeecc
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCD 259 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrD 259 (427)
+||||+++++.+.. +...+++|||+++|+|.++++.... ..+++.++..++.|++.||+||| +.+|+|+|
T Consensus 97 ~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~i~~~~~--~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~d 166 (302)
T cd05055 97 NHENIVNLLGACTI-----GGPILVITEYCCYGDLLNFLRRKRE--SFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRD 166 (302)
T ss_pred CCCCcceEEEEEec-----CCceEEEEEcCCCCcHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeehhh
Confidence 79999999988543 4568999999999999999865332 33899999999999999999999 89999999
Q ss_pred ccCCceeeCCCCceEecccccccccCCcC--------CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCCc
Q 042634 260 LKPSNVLLDGELTAHVGDFGLAKFLPEAT--------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNE 330 (427)
Q Consensus 260 lkp~NIll~~~~~~kL~DFG~a~~~~~~~--------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~~ 330 (427)
|||+||+++.++.+||+|||.++...... .++..|+|||.+.+..++.++||||+||++||+++ |..||..
T Consensus 167 lkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~ 246 (302)
T cd05055 167 LAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPG 246 (302)
T ss_pred hccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCC
Confidence 99999999999999999999998653321 34567999999998889999999999999999998 9999875
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
..... .+........+. ..+...+.++.+++.+||+.+|++|||+.|+
T Consensus 247 ~~~~~-~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~el 294 (302)
T cd05055 247 MPVDS-KFYKLIKEGYRM-------------------------------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQI 294 (302)
T ss_pred CCchH-HHHHHHHcCCcC-------------------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence 42111 111111100000 0011124568999999999999999999999
Q ss_pred HHHHHHH
Q 042634 411 AAQLLSF 417 (427)
Q Consensus 411 ~~~L~~~ 417 (427)
++.|+++
T Consensus 295 l~~l~~~ 301 (302)
T cd05055 295 VQLIGKQ 301 (302)
T ss_pred HHHHHhh
Confidence 9999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=269.44 Aligned_cols=192 Identities=22% Similarity=0.240 Sum_probs=149.2
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeecc
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCD 259 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrD 259 (427)
+||+|+++++.+. .+...++||||+++|+|.+++... ..+++..+..++.||+.||+||| +.||+|||
T Consensus 63 ~~~~i~~~~~~~~-----~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrD 130 (332)
T cd05614 63 QSPFLVTLHYAFQ-----TEAKLHLILDYVSGGEMFTHLYQR----DNFSEDEVRFYSGEIILALEHLH---KLGIVYRD 130 (332)
T ss_pred CCCCcccEEEEEe-----cCCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcEecC
Confidence 6899999987743 356789999999999999988654 45899999999999999999999 89999999
Q ss_pred ccCCceeeCCCCceEecccccccccCCc-------CCCccccccccccCCC-CcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 260 LKPSNVLLDGELTAHVGDFGLAKFLPEA-------TNNFFNFQIAEYGMGS-EVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 260 lkp~NIll~~~~~~kL~DFG~a~~~~~~-------~~~~~~y~aPE~~~~~-~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
|||+|||++.++.+||+|||+++..... ..||..|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 131 lkp~Nili~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 210 (332)
T cd05614 131 IKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE 210 (332)
T ss_pred CCHHHeEECCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCC
Confidence 9999999999999999999999864221 2588999999998875 4789999999999999999999999743
Q ss_pred cCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCC-----C
Q 042634 332 FTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERM-----N 406 (427)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rp-----t 406 (427)
.... ............ ++. .+...+..+.+++.+||+.||++|| +
T Consensus 211 ~~~~-~~~~~~~~~~~~------~~~-----------------------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~ 260 (332)
T cd05614 211 GERN-TQSEVSRRILKC------DPP-----------------------FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQG 260 (332)
T ss_pred CCCC-CHHHHHHHHhcC------CCC-----------------------CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCC
Confidence 2111 111111111000 000 1112345678999999999999999 6
Q ss_pred HHHHHHH
Q 042634 407 MEEVAAQ 413 (427)
Q Consensus 407 ~~ev~~~ 413 (427)
++|++++
T Consensus 261 ~~~~l~h 267 (332)
T cd05614 261 ASEIKEH 267 (332)
T ss_pred HHHHHcC
Confidence 7777753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=260.61 Aligned_cols=192 Identities=20% Similarity=0.325 Sum_probs=161.3
Q ss_pred CcccccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 042634 176 NNFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPI 255 (427)
Q Consensus 176 N~ll~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~i 255 (427)
-++.+|||||++|++ .+.+...|+|.|.-.+|+|++|+-++. ..+.+..+++++.||..|+.|+| ...|
T Consensus 71 MKLVQHpNiVRLYEV-----iDTQTKlyLiLELGD~GDl~DyImKHe---~Gl~E~La~kYF~QI~~AI~YCH---qLHV 139 (864)
T KOG4717|consen 71 MKLVQHPNIVRLYEV-----IDTQTKLYLILELGDGGDLFDYIMKHE---EGLNEDLAKKYFAQIVHAISYCH---QLHV 139 (864)
T ss_pred HHHhcCcCeeeeeeh-----hcccceEEEEEEecCCchHHHHHHhhh---ccccHHHHHHHHHHHHHHHHHHh---hhhh
Confidence 456789999999998 444778999999999999999997766 45899999999999999999999 7889
Q ss_pred eeccccCCceee-CCCCceEecccccccccCCcC-----CCccccccccccCCCCcC-ccccchhHHHHHHHHHhCCCCC
Q 042634 256 VHCDLKPSNVLL-DGELTAHVGDFGLAKFLPEAT-----NNFFNFQIAEYGMGSEVS-TSGDVYSFGILLLETFTGKRPT 328 (427)
Q Consensus 256 vHrDlkp~NIll-~~~~~~kL~DFG~a~~~~~~~-----~~~~~y~aPE~~~~~~~~-~~~DiwS~G~vl~ell~g~~pf 328 (427)
|||||||+||.+ ..-|-+||.|||++-....+. +|+..|.|||++.+..|+ +++||||+|||+|-+++|++||
T Consensus 140 VHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PF 219 (864)
T KOG4717|consen 140 VHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPF 219 (864)
T ss_pred hcccCCcceeEEeeecCceEeeeccccccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcc
Confidence 999999999876 566899999999998776654 888999999999999995 6899999999999999999999
Q ss_pred CcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 042634 329 NEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME 408 (427)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ 408 (427)
+...+.+. +..+.|-.+ ..|.....+..+++.+|+..||++|.|.+
T Consensus 220 qeANDSET-------------LTmImDCKY---------------------tvPshvS~eCrdLI~sMLvRdPkkRAslE 265 (864)
T KOG4717|consen 220 QEANDSET-------------LTMIMDCKY---------------------TVPSHVSKECRDLIQSMLVRDPKKRASLE 265 (864)
T ss_pred ccccchhh-------------hhhhhcccc---------------------cCchhhhHHHHHHHHHHHhcCchhhccHH
Confidence 87533221 122222111 14556778889999999999999999999
Q ss_pred HHHH
Q 042634 409 EVAA 412 (427)
Q Consensus 409 ev~~ 412 (427)
||+.
T Consensus 266 eI~s 269 (864)
T KOG4717|consen 266 EIVS 269 (864)
T ss_pred HHhc
Confidence 9874
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=255.90 Aligned_cols=196 Identities=30% Similarity=0.456 Sum_probs=155.6
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++.+.. ....+++|||+++++|.+++..... ..+++..+..++.|++.|+.||| +.||+||
T Consensus 58 l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~ 127 (261)
T cd05068 58 LRHPKLIQLYAVCTL-----EEPIYIVTELMKYGSLLEYLQGGAG--RALKLPQLIDMAAQVASGMAYLE---AQNYIHR 127 (261)
T ss_pred CCCCCccceeEEEec-----CCCeeeeeecccCCcHHHHHhccCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeec
Confidence 469999999987543 5568999999999999999865431 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC----C---CccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCCc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT----N---NFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~----~---~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~~ 330 (427)
||||+||+++.++.+||+|||.++...... . .+..|+|||+..+..++.++|||||||++||+++ |+.||.+
T Consensus 128 dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 207 (261)
T cd05068 128 DLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPG 207 (261)
T ss_pred cCCcceEEEcCCCCEEECCcceEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCC
Confidence 999999999999999999999998764322 2 2346999999998899999999999999999999 9999865
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
... ......+..... ...+..++..+.+++.+||+.+|++|||+.++
T Consensus 208 ~~~--~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l 254 (261)
T cd05068 208 MTN--AEVLQQVDQGYR-------------------------------MPCPPGCPKELYDIMLDCWKEDPDDRPTFETL 254 (261)
T ss_pred CCH--HHHHHHHHcCCC-------------------------------CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 311 001111000000 00112245678999999999999999999999
Q ss_pred HHHHHHH
Q 042634 411 AAQLLSF 417 (427)
Q Consensus 411 ~~~L~~~ 417 (427)
++.|+++
T Consensus 255 ~~~l~~~ 261 (261)
T cd05068 255 QWKLEDF 261 (261)
T ss_pred HHHHhcC
Confidence 9999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=260.39 Aligned_cols=197 Identities=20% Similarity=0.379 Sum_probs=154.3
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccch------------hhhhccCHHHHHHHHHHHHHHHHH
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNR------------EALKNLNLLQRLSIAVDVASALDY 246 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~~~~~i~~~L~~ 246 (427)
++||||+++++.+.. ....++++||+.+++|.+++.... .....+++..+..++.|++.||+|
T Consensus 65 l~h~~iv~~~~~~~~-----~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~ 139 (283)
T cd05091 65 LQHPNIVCLLGVVTK-----EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEF 139 (283)
T ss_pred CCCCCcCeEEEEEcC-----CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHH
Confidence 679999999998544 456789999999999998874211 111347888999999999999999
Q ss_pred HhhcCCCCeeeccccCCceeeCCCCceEecccccccccCCc--------CCCccccccccccCCCCcCccccchhHHHHH
Q 042634 247 LHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA--------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILL 318 (427)
Q Consensus 247 LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl 318 (427)
+| ++||+||||||+||++++++.+||+|||+++..... ..+++.|+|||.+.+..++.++|||||||++
T Consensus 140 lH---~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l 216 (283)
T cd05091 140 LS---SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVL 216 (283)
T ss_pred HH---HcCccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHH
Confidence 99 899999999999999999999999999998865322 1345689999999888899999999999999
Q ss_pred HHHHh-CCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcC
Q 042634 319 LETFT-GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCS 397 (427)
Q Consensus 319 ~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl 397 (427)
|||++ |..||.+... .+........... ..+..++..+.+++.+||
T Consensus 217 ~el~~~g~~p~~~~~~-----~~~~~~i~~~~~~----------------------------~~~~~~~~~~~~li~~cl 263 (283)
T cd05091 217 WEVFSYGLQPYCGYSN-----QDVIEMIRNRQVL----------------------------PCPDDCPAWVYTLMLECW 263 (283)
T ss_pred HHHHcCCCCCCCCCCH-----HHHHHHHHcCCcC----------------------------CCCCCCCHHHHHHHHHHh
Confidence 99998 8888865311 1111111111000 012335677899999999
Q ss_pred CCCCCCCCCHHHHHHHHHH
Q 042634 398 SELPRERMNMEEVAAQLLS 416 (427)
Q Consensus 398 ~~dP~~Rpt~~ev~~~L~~ 416 (427)
+.+|++|||++||++.|+.
T Consensus 264 ~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 264 NEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred CCCcccCCCHHHHHHHhhC
Confidence 9999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=258.79 Aligned_cols=191 Identities=22% Similarity=0.321 Sum_probs=148.2
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. +...++||||+++|+|..++.... ..+++..+..++.|+++||+||| ++||+||
T Consensus 73 l~h~niv~~~~~~~~-----~~~~~lv~ey~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~ 141 (274)
T cd05076 73 VSHIHLAFVHGVCVR-----GSENIMVEEFVEHGPLDVCLRKEK---GRVPVAWKITVAQQLASALSYLE---DKNLVHG 141 (274)
T ss_pred CCCCCeeeEEEEEEe-----CCceEEEEecCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---cCCccCC
Confidence 579999999998654 457799999999999998886432 45889999999999999999999 8999999
Q ss_pred cccCCceeeCCCC-------ceEecccccccccCC--cCCCccccccccccCC-CCcCccccchhHHHHHHHHH-hCCCC
Q 042634 259 DLKPSNVLLDGEL-------TAHVGDFGLAKFLPE--ATNNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETF-TGKRP 327 (427)
Q Consensus 259 Dlkp~NIll~~~~-------~~kL~DFG~a~~~~~--~~~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell-~g~~p 327 (427)
||||+||+++..+ .+|++|||.+..... ...++..|+|||.+.+ ..++.++|||||||++||++ +|..|
T Consensus 142 dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p 221 (274)
T cd05076 142 NVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVP 221 (274)
T ss_pred CCCcccEEEeccCcccCccceeeecCCccccccccccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 9999999997543 489999999865432 2356788999998865 56899999999999999995 69999
Q ss_pred CCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCH
Q 042634 328 TNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM 407 (427)
Q Consensus 328 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~ 407 (427)
|...... ........... .+.....++.+++.+||+.+|++|||+
T Consensus 222 ~~~~~~~--~~~~~~~~~~~---------------------------------~~~~~~~~~~~li~~cl~~~p~~Rps~ 266 (274)
T cd05076 222 LKERTPS--EKERFYEKKHR---------------------------------LPEPSCKELATLISQCLTYEPTQRPSF 266 (274)
T ss_pred ccccChH--HHHHHHHhccC---------------------------------CCCCCChHHHHHHHHHcccChhhCcCH
Confidence 8653211 11111100000 000112358899999999999999999
Q ss_pred HHHHHHHH
Q 042634 408 EEVAAQLL 415 (427)
Q Consensus 408 ~ev~~~L~ 415 (427)
.||++.|+
T Consensus 267 ~~il~~L~ 274 (274)
T cd05076 267 RTILRDLT 274 (274)
T ss_pred HHHHHhhC
Confidence 99999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=281.89 Aligned_cols=199 Identities=21% Similarity=0.254 Sum_probs=154.5
Q ss_pred cccccchhhhccccccCCCC---CCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 042634 179 IRHRNLVKIITSCASVDFQG---NDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPI 255 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~i 255 (427)
.+|+|+++....+...+... ....++||||+++|+|.+++.........+++..+..++.|++.||+|+| +.||
T Consensus 88 ~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~I 164 (496)
T PTZ00283 88 CDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHM 164 (496)
T ss_pred CCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCE
Confidence 46899998776543322111 11357999999999999998754433356899999999999999999999 8999
Q ss_pred eeccccCCceeeCCCCceEecccccccccCCc--------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCC
Q 042634 256 VHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA--------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRP 327 (427)
Q Consensus 256 vHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~p 327 (427)
+||||||+|||++.++.+||+|||+++..... ..||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 165 iHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~P 244 (496)
T PTZ00283 165 IHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRP 244 (496)
T ss_pred ecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 99999999999999999999999999865321 2688899999999999999999999999999999999999
Q ss_pred CCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCH
Q 042634 328 TNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM 407 (427)
Q Consensus 328 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~ 407 (427)
|... .....+........ + ..+..++.++.+++.+||+.||++|||+
T Consensus 245 f~~~-----~~~~~~~~~~~~~~----~------------------------~~~~~~~~~l~~li~~~L~~dP~~RPs~ 291 (496)
T PTZ00283 245 FDGE-----NMEEVMHKTLAGRY----D------------------------PLPPSISPEMQEIVTALLSSDPKRRPSS 291 (496)
T ss_pred CCCC-----CHHHHHHHHhcCCC----C------------------------CCCCCCCHHHHHHHHHHcccChhhCcCH
Confidence 9653 11122111111000 0 0122345678999999999999999999
Q ss_pred HHHHHH
Q 042634 408 EEVAAQ 413 (427)
Q Consensus 408 ~ev~~~ 413 (427)
.|++++
T Consensus 292 ~ell~~ 297 (496)
T PTZ00283 292 SKLLNM 297 (496)
T ss_pred HHHHhC
Confidence 999864
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=262.64 Aligned_cols=201 Identities=23% Similarity=0.411 Sum_probs=158.0
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchh------------hhhccCHHHHHHHHHHHHHHHHHH
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNRE------------ALKNLNLLQRLSIAVDVASALDYL 247 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~~~~~i~~~L~~L 247 (427)
+||||+++++.+.. +...+++|||+++|+|.+++..... ....+++.+++.++.|++.||+||
T Consensus 76 ~h~~iv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~l 150 (314)
T cd05099 76 KHKNIINLLGVCTQ-----EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYL 150 (314)
T ss_pred CCCCeeeEEEEEcc-----CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHH
Confidence 69999999998643 4568999999999999999865321 113588899999999999999999
Q ss_pred hhcCCCCeeeccccCCceeeCCCCceEecccccccccCCcC--------CCccccccccccCCCCcCccccchhHHHHHH
Q 042634 248 HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEAT--------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLL 319 (427)
Q Consensus 248 H~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~--------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ 319 (427)
| ++|++||||||+||+++.++.+||+|||.++...... .++..|+|||++.+..++.++|||||||++|
T Consensus 151 H---~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~ 227 (314)
T cd05099 151 E---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMW 227 (314)
T ss_pred H---HCCeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHH
Confidence 9 8999999999999999999999999999998654311 2335799999998888999999999999999
Q ss_pred HHHh-CCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCC
Q 042634 320 ETFT-GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSS 398 (427)
Q Consensus 320 ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~ 398 (427)
|+++ |..||..... ..+......... ...+..++.++.+++.+||+
T Consensus 228 el~~~g~~p~~~~~~--~~~~~~~~~~~~-------------------------------~~~~~~~~~~l~~li~~cl~ 274 (314)
T cd05099 228 EIFTLGGSPYPGIPV--EELFKLLREGHR-------------------------------MDKPSNCTHELYMLMRECWH 274 (314)
T ss_pred HHHhCCCCCCCCCCH--HHHHHHHHcCCC-------------------------------CCCCCCCCHHHHHHHHHHcC
Confidence 9999 8889865311 111111110000 00122345678899999999
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHH
Q 042634 399 ELPRERMNMEEVAAQLLSFRNKL 421 (427)
Q Consensus 399 ~dP~~Rpt~~ev~~~L~~~~~~~ 421 (427)
.+|++|||+.|+++.|+++....
T Consensus 275 ~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 275 AVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred CCcccCcCHHHHHHHHHHHHHHh
Confidence 99999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=259.55 Aligned_cols=196 Identities=23% Similarity=0.379 Sum_probs=154.3
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhh------hhccCHHHHHHHHHHHHHHHHHHhhcCC
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREA------LKNLNLLQRLSIAVDVASALDYLHHYCE 252 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~------~~~l~~~~~~~~~~~i~~~L~~LH~~~~ 252 (427)
++|||++++++.+.. ....++||||+++|+|.+++...... ...+++..+..++.|++.||.||| +
T Consensus 66 ~~~~~i~~~~~~~~~-----~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~ 137 (277)
T cd05032 66 FNCHHVVRLLGVVST-----GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---A 137 (277)
T ss_pred CCCCceeEEEEEEcC-----CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---h
Confidence 579999999998544 46789999999999999998643211 123778899999999999999999 8
Q ss_pred CCeeeccccCCceeeCCCCceEecccccccccCCc--------CCCccccccccccCCCCcCccccchhHHHHHHHHHh-
Q 042634 253 TPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA--------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT- 323 (427)
Q Consensus 253 ~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~- 323 (427)
.+|+||||||+||+++.++.+||+|||.++..... ..++..|+|||.+....++.++|||||||++||+++
T Consensus 138 ~~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~ 217 (277)
T cd05032 138 KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATL 217 (277)
T ss_pred CCccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhcc
Confidence 99999999999999999999999999998764322 145678999999988889999999999999999998
Q ss_pred CCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCC
Q 042634 324 GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRE 403 (427)
Q Consensus 324 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~ 403 (427)
|..||..... ....+....... ...+..++.++.+++.+||+.+|++
T Consensus 218 g~~p~~~~~~--~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~~li~~~l~~~p~~ 264 (277)
T cd05032 218 AEQPYQGLSN--EEVLKFVIDGGH-------------------------------LDLPENCPDKLLELMRMCWQYNPKM 264 (277)
T ss_pred CCCCCccCCH--HHHHHHHhcCCC-------------------------------CCCCCCCCHHHHHHHHHHcCCChhh
Confidence 9999864211 111111110000 0011223567899999999999999
Q ss_pred CCCHHHHHHHHH
Q 042634 404 RMNMEEVAAQLL 415 (427)
Q Consensus 404 Rpt~~ev~~~L~ 415 (427)
|||+.|+++.|+
T Consensus 265 Rpt~~~l~~~l~ 276 (277)
T cd05032 265 RPTFLEIVSSLK 276 (277)
T ss_pred CCCHHHHHHHhc
Confidence 999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=255.28 Aligned_cols=192 Identities=21% Similarity=0.287 Sum_probs=154.8
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++.+.. +...++||||+++++|.+++..... ..+++..+..++.|++.||.||| +.|++||
T Consensus 56 l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~ 125 (256)
T cd08529 56 LDSSYIIRYYESFLD-----KGKLNIVMEYAENGDLHKLLKMQRG--RPLPEDQVWRFFIQILLGLAHLH---SKKILHR 125 (256)
T ss_pred cCCCCeehheeeecc-----CCEEEEEEEeCCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccC
Confidence 579999999988543 4678999999999999999875422 46889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC------CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+||+++.++.+||+|||.++...... .++..|+|||+..+..++.++|||||||++|||++|+.||....
T Consensus 126 dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 205 (256)
T cd08529 126 DIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN 205 (256)
T ss_pred CCCcceEEEeCCCCEEEcccccceeccCccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999988754432 56778999999999889999999999999999999999997532
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
. ........... .. ..+...+.++.+++.+||+.+|++||++.|+++
T Consensus 206 ~-----~~~~~~~~~~~----~~------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 206 Q-----GALILKIIRGV----FP------------------------PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred H-----HHHHHHHHcCC----CC------------------------CCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 1 11111110000 00 011234567899999999999999999999986
Q ss_pred H
Q 042634 413 Q 413 (427)
Q Consensus 413 ~ 413 (427)
.
T Consensus 253 ~ 253 (256)
T cd08529 253 N 253 (256)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=256.39 Aligned_cols=192 Identities=28% Similarity=0.450 Sum_probs=152.7
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+++++|.+++.... ..+++..++.++.|++.|++||| +.|++||
T Consensus 56 l~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~ 124 (256)
T cd05059 56 LSHPNLVQLYGVCTK-----QRPIFIVTEYMANGCLLNYLRERK---GKLGTEWLLDMCSDVCEAMEYLE---SNGFIHR 124 (256)
T ss_pred CCCCCEEEEEEEEcC-----CCceEEEEecCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH---HCCcccc
Confidence 569999999887533 456899999999999999986543 35889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC-------CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCCc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT-------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~-------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~~ 330 (427)
||||+||+++.++.+||+|||.++...... .++..|+|||.+.+..++.++|||||||++||+++ |+.||..
T Consensus 125 dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 204 (256)
T cd05059 125 DLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYER 204 (256)
T ss_pred cccHhhEEECCCCcEEECCcccceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCC
Confidence 999999999999999999999998654322 23347999999998899999999999999999999 8999865
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
.... ........... ...+..++.++.+++.+||+.+|++|||+.|+
T Consensus 205 ~~~~--~~~~~~~~~~~-------------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~ 251 (256)
T cd05059 205 FSNS--EVVESVSAGYR-------------------------------LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKL 251 (256)
T ss_pred CCHH--HHHHHHHcCCc-------------------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHH
Confidence 3111 11111100000 00112246679999999999999999999999
Q ss_pred HHHH
Q 042634 411 AAQL 414 (427)
Q Consensus 411 ~~~L 414 (427)
++.|
T Consensus 252 l~~l 255 (256)
T cd05059 252 LSQL 255 (256)
T ss_pred HHHh
Confidence 9876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=257.55 Aligned_cols=197 Identities=23% Similarity=0.381 Sum_probs=157.5
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++.+.. ...++||||+++|+|.+++.... ..+++..+..++.|++.||+||| +.|++||
T Consensus 64 ~~h~~i~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~ 131 (270)
T cd05056 64 FDHPHIVKLIGVITE------NPVWIVMELAPLGELRSYLQVNK---YSLDLASLILYSYQLSTALAYLE---SKRFVHR 131 (270)
T ss_pred CCCCchhceeEEEcC------CCcEEEEEcCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeecc
Confidence 479999999987543 35689999999999999986543 34899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC-------CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCCc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT-------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~-------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~~ 330 (427)
||||+||+++.++.+||+|||+++...... .++..|+|||.+....++.++|||||||++||+++ |..||..
T Consensus 132 dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~ 211 (270)
T cd05056 132 DIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQG 211 (270)
T ss_pred ccChheEEEecCCCeEEccCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCC
Confidence 999999999999999999999998654322 23457999999988889999999999999999986 9999975
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
..... ......... +...+..++.++.+++.+||..+|++|||+.|+
T Consensus 212 ~~~~~--~~~~~~~~~-------------------------------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~ 258 (270)
T cd05056 212 VKNND--VIGRIENGE-------------------------------RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTEL 258 (270)
T ss_pred CCHHH--HHHHHHcCC-------------------------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 42111 101000000 000122346678999999999999999999999
Q ss_pred HHHHHHHHHH
Q 042634 411 AAQLLSFRNK 420 (427)
Q Consensus 411 ~~~L~~~~~~ 420 (427)
++.|+++.++
T Consensus 259 ~~~l~~~~~~ 268 (270)
T cd05056 259 KAQLSDILQE 268 (270)
T ss_pred HHHHHHHHhc
Confidence 9999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=270.93 Aligned_cols=185 Identities=24% Similarity=0.257 Sum_probs=148.9
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. +...++||||+++|+|.+++... ..+++..+..++.|++.||+||| +.||+||
T Consensus 55 l~h~niv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~ 122 (318)
T cd05582 55 VNHPFIVKLHYAFQT-----EGKLYLILDFLRGGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLH---SLGIIYR 122 (318)
T ss_pred CCCCCcccEEEEEEc-----CCEEEEEEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCEecC
Confidence 479999999887543 56789999999999999988654 35899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+||+++.++.+||+|||+++..... ..|+..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 123 dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~ 202 (318)
T cd05582 123 DLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD 202 (318)
T ss_pred CCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC
Confidence 99999999999999999999999865333 257889999999998889999999999999999999999997531
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEE 409 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~e 409 (427)
. ........... . ..+...+..+.+++++||+.||++|||+.+
T Consensus 203 ~-----~~~~~~i~~~~--------~---------------------~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 203 R-----KETMTMILKAK--------L---------------------GMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred H-----HHHHHHHHcCC--------C---------------------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 1 11111110000 0 011223456789999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=254.99 Aligned_cols=202 Identities=20% Similarity=0.274 Sum_probs=159.7
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|+|+++.++.+.. ....++||||+++|+|.+++.........+++.++..++.|++.|+.||| +.||+||
T Consensus 59 ~~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~ 130 (267)
T cd08224 59 LDHPNVIKYLASFIE-----NNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHR 130 (267)
T ss_pred CCCCCeeeeeeeeec-----CCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecC
Confidence 469999999988543 45789999999999999988643222245889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+||+++.++.+||+|||.++..... ..++..|+|||.+.+..++.++|||||||++|++++|+.||....
T Consensus 131 dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 210 (267)
T cd08224 131 DIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred CcChhhEEECCCCcEEEeccceeeeccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC
Confidence 99999999999999999999998765432 256778999999998889999999999999999999999986432
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
....+......... .........+.++.+++.+||+.+|++|||+.+|++
T Consensus 211 ---~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 211 ---MNLYSLCKKIEKCD---------------------------YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred ---ccHHHHHhhhhcCC---------------------------CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 11111111100000 000112245667899999999999999999999999
Q ss_pred HHHHHH
Q 042634 413 QLLSFR 418 (427)
Q Consensus 413 ~L~~~~ 418 (427)
.|+++.
T Consensus 261 ~~~~~~ 266 (267)
T cd08224 261 VAKEMH 266 (267)
T ss_pred HHHHhc
Confidence 999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=262.14 Aligned_cols=201 Identities=23% Similarity=0.400 Sum_probs=158.4
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchh------------hhhccCHHHHHHHHHHHHHHHHHH
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNRE------------ALKNLNLLQRLSIAVDVASALDYL 247 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~~~~~i~~~L~~L 247 (427)
+||||+++++.+.. +...++||||+++|+|.+++..... ....+++.+++.++.|++.||+||
T Consensus 82 ~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~l 156 (307)
T cd05098 82 KHKNIINLLGACTQ-----DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL 156 (307)
T ss_pred CCCCEeeEEEEEec-----CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHH
Confidence 69999999998644 4578999999999999999865321 113488899999999999999999
Q ss_pred hhcCCCCeeeccccCCceeeCCCCceEecccccccccCCcC--------CCccccccccccCCCCcCccccchhHHHHHH
Q 042634 248 HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEAT--------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLL 319 (427)
Q Consensus 248 H~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~--------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ 319 (427)
| +.|++||||||+||+++.++.+||+|||.++...... .++..|+|||++.+..++.++|||||||++|
T Consensus 157 H---~~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ 233 (307)
T cd05098 157 A---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLW 233 (307)
T ss_pred H---HCCcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHH
Confidence 9 8999999999999999999999999999997653211 2345799999999888999999999999999
Q ss_pred HHHh-CCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCC
Q 042634 320 ETFT-GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSS 398 (427)
Q Consensus 320 ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~ 398 (427)
||++ |..||.... ..+......... ....+..++.++.+++.+||+
T Consensus 234 el~~~g~~p~~~~~-----~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~li~~~l~ 280 (307)
T cd05098 234 EIFTLGGSPYPGVP-----VEELFKLLKEGH----------------------------RMDKPSNCTNELYMMMRDCWH 280 (307)
T ss_pred HHHcCCCCCCCcCC-----HHHHHHHHHcCC----------------------------CCCCCCcCCHHHHHHHHHHcc
Confidence 9998 888885421 111111100000 000122345678899999999
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHH
Q 042634 399 ELPRERMNMEEVAAQLLSFRNKL 421 (427)
Q Consensus 399 ~dP~~Rpt~~ev~~~L~~~~~~~ 421 (427)
.+|++|||+.||++.|+++.+..
T Consensus 281 ~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 281 AVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred cChhhCcCHHHHHHHHHHHHHHh
Confidence 99999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=253.11 Aligned_cols=192 Identities=25% Similarity=0.317 Sum_probs=157.0
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||-+..+|.. |+.....|+|||||+||+|..+.+++.. +.+++..++.++.+++.||+||| -.|||.|
T Consensus 134 lDHPFlPTLYa~-----fet~~~~cl~meyCpGGdL~~LrqkQp~--~~fse~~aRFYaAEvl~ALEYLH---mlGivYR 203 (459)
T KOG0610|consen 134 LDHPFLPTLYAS-----FETDKYSCLVMEYCPGGDLHSLRQKQPG--KRFSESAARFYAAEVLLALEYLH---MLGIVYR 203 (459)
T ss_pred cCCCccchhhhe-----eeccceeEEEEecCCCccHHHHHhhCCC--CccchhhHHHHHHHHHHHHHHHH---hhceeec
Confidence 789999999998 4447789999999999999999887765 77999999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccC------------------------------------Cc---------------
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLP------------------------------------EA--------------- 287 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~------------------------------------~~--------------- 287 (427)
||||+||||-++|++.|+||.++.... ..
T Consensus 204 DLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~ 283 (459)
T KOG0610|consen 204 DLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPEL 283 (459)
T ss_pred cCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhh
Confidence 999999999999999999998774210 00
Q ss_pred -----------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccCCCccHHHHHHHhcccchhcccCc
Q 042634 288 -----------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEALPERLAEIVDP 356 (427)
Q Consensus 288 -----------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 356 (427)
-+||-.|.|||++.+...+.++|+|+|||++|||+.|..||.+.. ...++...+...+.
T Consensus 284 ~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~-~~~Tl~NIv~~~l~--------- 353 (459)
T KOG0610|consen 284 VAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSN-NKETLRNIVGQPLK--------- 353 (459)
T ss_pred hcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCC-chhhHHHHhcCCCc---------
Confidence 067888999999999999999999999999999999999998753 33334333332211
Q ss_pred cccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCC----HHHHHH
Q 042634 357 VLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMN----MEEVAA 412 (427)
Q Consensus 357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt----~~ev~~ 412 (427)
. . ...+.+..+.+||++.|..||.+|-- ++||-+
T Consensus 354 ---F----------------p---~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 354 ---F----------------P---EEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred ---C----------------C---CCCcchhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence 0 0 01134566899999999999999987 777654
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=253.82 Aligned_cols=200 Identities=23% Similarity=0.366 Sum_probs=147.7
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++.+.. ....++||||+++|+|.+++.+.......+++..+..++.|++.||+||| +.+++||
T Consensus 52 l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~ 123 (268)
T cd05086 52 LQHPNILQCLGQCVE-----AIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHS 123 (268)
T ss_pred cCCcchhheEEEecC-----CCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeecc
Confidence 579999999998654 45689999999999999998754322244677788899999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC--------cCCCccccccccccCC-------CCcCccccchhHHHHHHHHHh
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE--------ATNNFFNFQIAEYGMG-------SEVSTSGDVYSFGILLLETFT 323 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~--------~~~~~~~y~aPE~~~~-------~~~~~~~DiwS~G~vl~ell~ 323 (427)
||||+|||++.++.+||+|||++..... ...++..|+|||++.. ..++.++|||||||++|||++
T Consensus 124 dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~ 203 (268)
T cd05086 124 DLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFE 203 (268)
T ss_pred CCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHh
Confidence 9999999999999999999999864321 2256778999998743 245789999999999999997
Q ss_pred -CCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCC
Q 042634 324 -GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPR 402 (427)
Q Consensus 324 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~ 402 (427)
|..||..... ...+...... ......++.+ .......+.+++..|| .+|+
T Consensus 204 ~~~~p~~~~~~-~~~~~~~~~~----~~~~~~~~~~-----------------------~~~~~~~~~~l~~~c~-~~P~ 254 (268)
T cd05086 204 NAAQPYSHLSD-REVLNHVIKD----QQVKLFKPQL-----------------------ELPYSERWYEVLQFCW-LSPE 254 (268)
T ss_pred CCCCCCCCCCH-HHHHHHHHhh----cccccCCCcc-----------------------CCCCcHHHHHHHHHHh-hCcc
Confidence 5678754311 1111111111 0011111110 0112345788999999 6799
Q ss_pred CCCCHHHHHHHHH
Q 042634 403 ERMNMEEVAAQLL 415 (427)
Q Consensus 403 ~Rpt~~ev~~~L~ 415 (427)
+|||++||++.|.
T Consensus 255 ~Rp~~~~i~~~l~ 267 (268)
T cd05086 255 KRATAEEVHRLLT 267 (268)
T ss_pred cCCCHHHHHHHhc
Confidence 9999999998773
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.8e-33 Score=258.28 Aligned_cols=197 Identities=24% Similarity=0.414 Sum_probs=153.8
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccch-------------hhhhccCHHHHHHHHHHHHHHHH
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNR-------------EALKNLNLLQRLSIAVDVASALD 245 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~~l~~~~~~~~~~~i~~~L~ 245 (427)
++|||++++++.+.. ....++||||+++++|.+++.... .....+++.+++.++.|++.||+
T Consensus 64 l~h~niv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~ 138 (283)
T cd05090 64 LHHPNIVCLLGVVTQ-----EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGME 138 (283)
T ss_pred CCCCCeeeEEEEEec-----CCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHH
Confidence 579999999987433 557899999999999999874221 01134788999999999999999
Q ss_pred HHhhcCCCCeeeccccCCceeeCCCCceEecccccccccCCc--------CCCccccccccccCCCCcCccccchhHHHH
Q 042634 246 YLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA--------TNNFFNFQIAEYGMGSEVSTSGDVYSFGIL 317 (427)
Q Consensus 246 ~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~v 317 (427)
||| ++||+||||||+||++++++.+||+|||+++..... ..++..|+|||++.+..++.++|||||||+
T Consensus 139 ~lH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i 215 (283)
T cd05090 139 YLS---SHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVV 215 (283)
T ss_pred HHH---hcCeehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHH
Confidence 999 899999999999999999999999999999865322 134567999999988889999999999999
Q ss_pred HHHHHh-CCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhc
Q 042634 318 LLETFT-GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTC 396 (427)
Q Consensus 318 l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c 396 (427)
+|||++ |..||.+.. ...+.+.+...... ..+..++.++.+++.+|
T Consensus 216 l~el~~~g~~p~~~~~--~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~li~~c 262 (283)
T cd05090 216 LWEIFSFGLQPYYGFS--NQEVIEMVRKRQLL-------------------------------PCSEDCPPRMYSLMTEC 262 (283)
T ss_pred HHHHHcCCCCCCCCCC--HHHHHHHHHcCCcC-------------------------------CCCCCCCHHHHHHHHHH
Confidence 999998 999986531 11111111110000 01123456789999999
Q ss_pred CCCCCCCCCCHHHHHHHHHH
Q 042634 397 SSELPRERMNMEEVAAQLLS 416 (427)
Q Consensus 397 l~~dP~~Rpt~~ev~~~L~~ 416 (427)
|+.||++||++.+|.+.|..
T Consensus 263 l~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 263 WQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred cccCcccCcCHHHHHHHhhc
Confidence 99999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-33 Score=266.31 Aligned_cols=183 Identities=22% Similarity=0.231 Sum_probs=146.0
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
.+||+++++.+.+.. ....++||||+++|+|.+++... ..+++..+..++.|++.||+||| +.||+||
T Consensus 58 ~~~~~i~~~~~~~~~-----~~~~~lv~E~~~~g~L~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHr 125 (323)
T cd05616 58 GKPPFLTQLHSCFQT-----MDRLYFVMEYVNGGDLMYQIQQV----GRFKEPHAVFYAAEIAIGLFFLH---SKGIIYR 125 (323)
T ss_pred cCCCeEeeEEEEEec-----CCEEEEEEcCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEec
Confidence 368888888877433 56789999999999999888654 34889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC------cCCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE------ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+|||++.++.+||+|||+++.... ...||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 126 Dlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~ 205 (323)
T cd05616 126 DLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 205 (323)
T ss_pred CCCHHHeEECCCCcEEEccCCCceecCCCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999999975421 2268899999999999999999999999999999999999997531
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM 407 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~ 407 (427)
. ....+.+.. .. . ..+...+.++.+++.+|++.||++|++.
T Consensus 206 ~--~~~~~~i~~---~~--------~---------------------~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 206 E--DELFQSIME---HN--------V---------------------AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred H--HHHHHHHHh---CC--------C---------------------CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 1 111111100 00 0 0112234567899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-33 Score=274.63 Aligned_cols=224 Identities=20% Similarity=0.199 Sum_probs=150.9
Q ss_pred cccccchhhhccccccCCC---CCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 042634 179 IRHRNLVKIITSCASVDFQ---GNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPI 255 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~i 255 (427)
++|||||++++.+....+. .....++||||++ +++.+++.........+++..++.++.||+.||+||| +.||
T Consensus 116 l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~I 191 (440)
T PTZ00036 116 LNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFI 191 (440)
T ss_pred cCCCCCcceeeeEeecccccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCE
Confidence 5799999988765332221 1234678999995 5777766533222356899999999999999999999 8999
Q ss_pred eeccccCCceeeCCCC-ceEecccccccccCCc-----CCCccccccccccCC-CCcCccccchhHHHHHHHHHhCCCCC
Q 042634 256 VHCDLKPSNVLLDGEL-TAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETFTGKRPT 328 (427)
Q Consensus 256 vHrDlkp~NIll~~~~-~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell~g~~pf 328 (427)
+||||||+|||++.++ .+||+|||+|+..... ..+++.|+|||++.+ ..++.++|||||||++|||++|.+||
T Consensus 192 iHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf 271 (440)
T PTZ00036 192 CHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIF 271 (440)
T ss_pred ecCCcCHHHEEEcCCCCceeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 9999999999998664 7999999999865432 267889999999876 46899999999999999999999999
Q ss_pred CcccCCCccHHHHHHHhcccchhc--ccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCC
Q 042634 329 NEMFTGNLTLHNFVKEALPERLAE--IVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMN 406 (427)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt 406 (427)
.+.... ..+...+.....+.... ...+.... .... ...........+...+.++.+++.+||+.||.+|||
T Consensus 272 ~~~~~~-~~~~~i~~~~~~p~~~~~~~~~~~~~~----~~~~--~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~t 344 (440)
T PTZ00036 272 SGQSSV-DQLVRIIQVLGTPTEDQLKEMNPNYAD----IKFP--DVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLN 344 (440)
T ss_pred CCCChH-HHHHHHHHHhCCCCHHHHHHhchhhhc----ccCC--ccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcC
Confidence 753211 11222211111110000 00000000 0000 000000000112234567899999999999999999
Q ss_pred HHHHHHH
Q 042634 407 MEEVAAQ 413 (427)
Q Consensus 407 ~~ev~~~ 413 (427)
+.|++++
T Consensus 345 a~e~l~h 351 (440)
T PTZ00036 345 PIEALAD 351 (440)
T ss_pred HHHHhCC
Confidence 9999854
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.8e-33 Score=260.04 Aligned_cols=196 Identities=27% Similarity=0.450 Sum_probs=153.5
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhh-----------hhccCHHHHHHHHHHHHHHHHHH
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREA-----------LKNLNLLQRLSIAVDVASALDYL 247 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-----------~~~l~~~~~~~~~~~i~~~L~~L 247 (427)
++||||+++++.+.. ....+++|||+++++|.+++...... ...+++..++.++.|++.|++||
T Consensus 64 l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L 138 (280)
T cd05092 64 LQHQHIVRFYGVCTE-----GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYL 138 (280)
T ss_pred CCCCCCceEEEEEec-----CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHH
Confidence 579999999887543 45679999999999999988653210 12478899999999999999999
Q ss_pred hhcCCCCeeeccccCCceeeCCCCceEecccccccccCCc--------CCCccccccccccCCCCcCccccchhHHHHHH
Q 042634 248 HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA--------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLL 319 (427)
Q Consensus 248 H~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ 319 (427)
| +.|++||||||+||++++++.+||+|||+++..... ..++..|+|||++.+..++.++|||||||++|
T Consensus 139 H---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 215 (280)
T cd05092 139 A---SLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLW 215 (280)
T ss_pred H---HCCeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHH
Confidence 9 899999999999999999999999999999754321 13456799999999889999999999999999
Q ss_pred HHHh-CCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCC
Q 042634 320 ETFT-GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSS 398 (427)
Q Consensus 320 ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~ 398 (427)
||++ |..||...... ..........+ ...+..++..+.+++.+||+
T Consensus 216 el~~~g~~p~~~~~~~--~~~~~~~~~~~-------------------------------~~~~~~~~~~~~~li~~cl~ 262 (280)
T cd05092 216 EIFTYGKQPWYQLSNT--EAIECITQGRE-------------------------------LERPRTCPPEVYAIMQGCWQ 262 (280)
T ss_pred HHHcCCCCCCccCCHH--HHHHHHHcCcc-------------------------------CCCCCCCCHHHHHHHHHHcc
Confidence 9998 89998643111 01000000000 00112345668999999999
Q ss_pred CCCCCCCCHHHHHHHHH
Q 042634 399 ELPRERMNMEEVAAQLL 415 (427)
Q Consensus 399 ~dP~~Rpt~~ev~~~L~ 415 (427)
.||++|||++||++.|+
T Consensus 263 ~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 263 REPQQRMVIKDIHSRLQ 279 (280)
T ss_pred CChhhCCCHHHHHHHHh
Confidence 99999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-33 Score=266.71 Aligned_cols=189 Identities=22% Similarity=0.277 Sum_probs=147.2
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
.+||+|+++++.+.. ....++||||+++|+|..++... ..+++..++.++.|++.||+||| +.||+||
T Consensus 53 ~~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qi~~al~~lH---~~~ivHr 120 (327)
T cd05617 53 SSNPFLVGLHSCFQT-----TSRLFLVIEYVNGGDLMFHMQRQ----RKLPEEHARFYAAEICIALNFLH---ERGIIYR 120 (327)
T ss_pred cCCCCEeeEEEEEEe-----CCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecc
Confidence 469999999887433 56789999999999998887644 35899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC------cCCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE------ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+||+++.++.+||+|||+++.... ...|+..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 121 Dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~ 200 (327)
T cd05617 121 DLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIIT 200 (327)
T ss_pred CCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccC
Confidence 9999999999999999999999975321 1268899999999999999999999999999999999999996432
Q ss_pred CCC-ccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCH
Q 042634 333 TGN-LTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM 407 (427)
Q Consensus 333 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~ 407 (427)
... .............. . ...+...+..+.+++.+||+.||++|+++
T Consensus 201 ~~~~~~~~~~~~~~~~~~-------~---------------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 201 DNPDMNTEDYLFQVILEK-------P---------------------IRIPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCcccccHHHHHHHHHhC-------C---------------------CCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 211 11111111100000 0 00111234557899999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.98 E-value=9e-33 Score=254.93 Aligned_cols=195 Identities=29% Similarity=0.463 Sum_probs=154.3
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+. ....++||||+++|+|.+++..... ..+++..+..++.|++.||+|+| +.+++||
T Consensus 58 l~~~~i~~~~~~~~------~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~ 126 (262)
T cd05071 58 LRHEKLVQLYAVVS------EEPIYIVTEYMSKGSLLDFLKGEMG--KYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 126 (262)
T ss_pred CCCCCcceEEEEEC------CCCcEEEEEcCCCCcHHHHHhhccc--cCCCHHHHHHHHHHHHHHHHHHH---HCCcccc
Confidence 57999999987642 2356899999999999999975322 35789999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC-------CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCCc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT-------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~-------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~~ 330 (427)
||||+||+++.++.+||+|||.++...... .++..|+|||+.....++.++|||||||++||+++ |..||..
T Consensus 127 dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~ 206 (262)
T cd05071 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 206 (262)
T ss_pred ccCcccEEEcCCCcEEeccCCceeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 999999999999999999999998654322 34567999999988889999999999999999999 8888865
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
.... +........ . +...+..++..+.+++.+||+.||++|||++++
T Consensus 207 ~~~~-----~~~~~~~~~-----~-----------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~ 253 (262)
T cd05071 207 MVNR-----EVLDQVERG-----Y-----------------------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYL 253 (262)
T ss_pred CChH-----HHHHHHhcC-----C-----------------------CCCCccccCHHHHHHHHHHccCCcccCCCHHHH
Confidence 3111 111100000 0 000123356678999999999999999999999
Q ss_pred HHHHHHH
Q 042634 411 AAQLLSF 417 (427)
Q Consensus 411 ~~~L~~~ 417 (427)
++.|+..
T Consensus 254 ~~~l~~~ 260 (262)
T cd05071 254 QAFLEDY 260 (262)
T ss_pred HHHHHHh
Confidence 9999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-33 Score=255.48 Aligned_cols=191 Identities=23% Similarity=0.329 Sum_probs=148.3
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++.+.. +...++||||+++|+|.+++.... ..+++..++.++.||+.||+||| +.||+||
T Consensus 56 ~~h~~iv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~ 124 (258)
T cd05078 56 LSHKHLVLNYGVCVC-----GDESIMVQEYVKFGSLDTYLKKNK---NLINISWKLEVAKQLAWALHFLE---DKGLTHG 124 (258)
T ss_pred CCCCChhheeeEEEe-----CCCcEEEEecCCCCcHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecC
Confidence 579999999998543 456899999999999999987653 34889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCc--------eEecccccccccCCc--CCCccccccccccCC-CCcCccccchhHHHHHHHHHhCC-C
Q 042634 259 DLKPSNVLLDGELT--------AHVGDFGLAKFLPEA--TNNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETFTGK-R 326 (427)
Q Consensus 259 Dlkp~NIll~~~~~--------~kL~DFG~a~~~~~~--~~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell~g~-~ 326 (427)
||||+||+++.++. +|++|||.+...... ..++..|+|||++.+ ..++.++|||||||++||+++|. .
T Consensus 125 dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~ 204 (258)
T cd05078 125 NVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDK 204 (258)
T ss_pred CCccceEEEecccccccCCCceEEecccccccccCCchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCC
Confidence 99999999977654 699999998765443 267788999999876 45799999999999999999985 5
Q ss_pred CCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCC
Q 042634 327 PTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMN 406 (427)
Q Consensus 327 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt 406 (427)
||..... .......... . . .+.....++.+++.+||+.||++|||
T Consensus 205 ~~~~~~~--~~~~~~~~~~--~---~----------------------------~~~~~~~~~~~li~~~l~~~p~~Rps 249 (258)
T cd05078 205 PLSALDS--QKKLQFYEDR--H---Q----------------------------LPAPKWTELANLINQCMDYEPDFRPS 249 (258)
T ss_pred ChhhccH--HHHHHHHHcc--c---c----------------------------CCCCCcHHHHHHHHHHhccChhhCCC
Confidence 5543210 0000000000 0 0 01112345889999999999999999
Q ss_pred HHHHHHHHH
Q 042634 407 MEEVAAQLL 415 (427)
Q Consensus 407 ~~ev~~~L~ 415 (427)
++|+++.|+
T Consensus 250 ~~~il~~l~ 258 (258)
T cd05078 250 FRAIIRDLN 258 (258)
T ss_pred HHHHHHhcC
Confidence 999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.1e-33 Score=256.84 Aligned_cols=195 Identities=22% Similarity=0.414 Sum_probs=154.8
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++.+.+.. ....++||||+++++|.+++.... ..+++.++..++.|++.|++||| +.|++||
T Consensus 63 l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~ 131 (268)
T cd05063 63 FSHHNIIRLEGVVTK-----FKPAMIITEYMENGALDKYLRDHD---GEFSSYQLVGMLRGIAAGMKYLS---DMNYVHR 131 (268)
T ss_pred CCCCCeeEEEEEEcc-----CCCcEEEEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecc
Confidence 469999999988543 456899999999999999986532 35889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC---------CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT---------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPT 328 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~---------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf 328 (427)
||||+||+++.++.+||+|||++....... ..+..|+|||++....++.++|||||||++||+++ |+.||
T Consensus 132 dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~ 211 (268)
T cd05063 132 DLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPY 211 (268)
T ss_pred ccchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999998654322 12346999999988889999999999999999997 99998
Q ss_pred CcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 042634 329 NEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME 408 (427)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ 408 (427)
..... ..+...+..... ...+..++.++.+++.+||+.+|++||++.
T Consensus 212 ~~~~~--~~~~~~i~~~~~-------------------------------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~ 258 (268)
T cd05063 212 WDMSN--HEVMKAINDGFR-------------------------------LPAPMDCPSAVYQLMLQCWQQDRARRPRFV 258 (268)
T ss_pred CcCCH--HHHHHHHhcCCC-------------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHH
Confidence 64321 111111110000 001122456789999999999999999999
Q ss_pred HHHHHHHHH
Q 042634 409 EVAAQLLSF 417 (427)
Q Consensus 409 ev~~~L~~~ 417 (427)
+|++.|+++
T Consensus 259 ~i~~~l~~~ 267 (268)
T cd05063 259 DIVNLLDKL 267 (268)
T ss_pred HHHHHHHhh
Confidence 999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-33 Score=266.63 Aligned_cols=184 Identities=24% Similarity=0.248 Sum_probs=146.7
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+++|+|..++... ..+++..+..++.||+.||+||| +.||+||
T Consensus 53 ~~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~ 120 (321)
T cd05603 53 LKHPFLVGLHYSFQT-----AEKLYFVLDYVNGGELFFHLQRE----RCFLEPRARFYAAEVASAIGYLH---SLNIIYR 120 (321)
T ss_pred CCCCCccceeeEEEc-----CCEEEEEEcCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEec
Confidence 579999999887433 56789999999999998877543 45888999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC------cCCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE------ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+||+++.++.+||+|||+++.... ...|+..|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 121 Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 200 (321)
T cd05603 121 DLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200 (321)
T ss_pred cCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC
Confidence 9999999999999999999999875322 1257889999999999899999999999999999999999997531
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME 408 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ 408 (427)
............ . ..+...+.++.+++.+|++.||.+||++.
T Consensus 201 -----~~~~~~~i~~~~--------~---------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 201 -----VSQMYDNILHKP--------L---------------------QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred -----HHHHHHHHhcCC--------C---------------------CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 111111111000 0 01112345688999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-33 Score=268.25 Aligned_cols=187 Identities=24% Similarity=0.246 Sum_probs=148.8
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+++|+|..++... ..+++..+..++.||+.||+||| +.||+||
T Consensus 53 ~~hp~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH---~~givH~ 120 (325)
T cd05604 53 VKHPFLVGLHYSFQT-----TEKLYFVLDFVNGGELFFHLQRE----RSFPEPRARFYAAEIASALGYLH---SINIVYR 120 (325)
T ss_pred CCCCCCccEEEEEec-----CCEEEEEEcCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeec
Confidence 579999999887533 56789999999999998887654 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC------cCCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE------ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+|||++.++.+||+|||+++.... ...|+..|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 121 Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~ 200 (325)
T cd05604 121 DLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD 200 (325)
T ss_pred CCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC
Confidence 9999999999999999999999875322 1258889999999999999999999999999999999999997531
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVA 411 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~ 411 (427)
..+......... .. .....+.++.+++.+|++.+|++||++.+.+
T Consensus 201 -----~~~~~~~~~~~~--------~~---------------------~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 201 -----VAEMYDNILHKP--------LV---------------------LRPGASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred -----HHHHHHHHHcCC--------cc---------------------CCCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 111111111100 00 0011345578899999999999999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=253.01 Aligned_cols=194 Identities=27% Similarity=0.442 Sum_probs=153.6
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++.+. ....+++|||+++++|.+++..... ..+++..+..++.|++.||+||| +.|++||
T Consensus 58 l~h~~i~~~~~~~~------~~~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~ 126 (260)
T cd05069 58 LRHDKLVPLYAVVS------EEPIYIVTEFMGKGSLLDFLKEGDG--KYLKLPQLVDMAAQIADGMAYIE---RMNYIHR 126 (260)
T ss_pred CCCCCeeeEEEEEc------CCCcEEEEEcCCCCCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCEeec
Confidence 57999999887642 2357899999999999999865432 34788999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC-------CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCCc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT-------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~-------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~~ 330 (427)
||||+||++++++.+||+|||.++...... .++..|+|||...+..++.++|||||||++||+++ |..||.+
T Consensus 127 dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 206 (260)
T cd05069 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG 206 (260)
T ss_pred ccCcceEEEcCCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999998653322 34567999999988889999999999999999999 8999875
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
.... ............ ..+...+..+.+++.+||+.||++|||+++|
T Consensus 207 ~~~~--~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 253 (260)
T cd05069 207 MVNR--EVLEQVERGYRM-------------------------------PCPQGCPESLHELMKLCWKKDPDERPTFEYI 253 (260)
T ss_pred CCHH--HHHHHHHcCCCC-------------------------------CCCcccCHHHHHHHHHHccCCcccCcCHHHH
Confidence 3211 111111100000 0112345678999999999999999999999
Q ss_pred HHHHHH
Q 042634 411 AAQLLS 416 (427)
Q Consensus 411 ~~~L~~ 416 (427)
++.|++
T Consensus 254 ~~~l~~ 259 (260)
T cd05069 254 QSFLED 259 (260)
T ss_pred HHHHhc
Confidence 999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.3e-33 Score=257.29 Aligned_cols=196 Identities=27% Similarity=0.389 Sum_probs=152.2
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchh---hhhccCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNRE---ALKNLNLLQRLSIAVDVASALDYLHHYCETPI 255 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~i 255 (427)
++|+||+++++.+.. ....++||||+++++|.+++..... ....+++..++.++.||+.|++||| +.++
T Consensus 66 l~~~~i~~~~~~~~~-----~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i 137 (277)
T cd05036 66 FNHQNIVRLIGVSFE-----RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHF 137 (277)
T ss_pred CCCCCEeeEEEEEcc-----CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCE
Confidence 579999999987543 4567899999999999999865421 1135889999999999999999999 8999
Q ss_pred eeccccCCceeeCCCC---ceEecccccccccCCcC--------CCccccccccccCCCCcCccccchhHHHHHHHHHh-
Q 042634 256 VHCDLKPSNVLLDGEL---TAHVGDFGLAKFLPEAT--------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT- 323 (427)
Q Consensus 256 vHrDlkp~NIll~~~~---~~kL~DFG~a~~~~~~~--------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~- 323 (427)
+||||||+||+++.++ .+||+|||.++...... ..+..|+|||++.+..++.++|||||||++|||++
T Consensus 138 vH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~ 217 (277)
T cd05036 138 IHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSL 217 (277)
T ss_pred eecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcC
Confidence 9999999999997654 69999999998653221 22457999999998899999999999999999997
Q ss_pred CCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCC
Q 042634 324 GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRE 403 (427)
Q Consensus 324 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~ 403 (427)
|..||...... .+...+...... ..+..++.++.+++.+||+.+|++
T Consensus 218 g~~pf~~~~~~--~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~~i~~cl~~~p~~ 264 (277)
T cd05036 218 GYMPYPGRTNQ--EVMEFVTGGGRL-------------------------------DPPKGCPGPVYRIMTDCWQHTPED 264 (277)
T ss_pred CCCCCCCCCHH--HHHHHHHcCCcC-------------------------------CCCCCCCHHHHHHHHHHcCCCccc
Confidence 99998753211 111111100000 011234567899999999999999
Q ss_pred CCCHHHHHHHHH
Q 042634 404 RMNMEEVAAQLL 415 (427)
Q Consensus 404 Rpt~~ev~~~L~ 415 (427)
|||+.||++.|+
T Consensus 265 Rps~~~vl~~l~ 276 (277)
T cd05036 265 RPNFATILERIQ 276 (277)
T ss_pred CcCHHHHHHHhh
Confidence 999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.4e-33 Score=257.82 Aligned_cols=208 Identities=28% Similarity=0.434 Sum_probs=155.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++.+.+... +....++||||+++|+|.+++.... ..+++..+..++.|++.||+||| +.||+||
T Consensus 62 l~h~~iv~~~~~~~~~---~~~~~~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~ 132 (284)
T cd05081 62 LQHDNIVKYKGVCYSA---GRRNLRLVMEYLPYGSLRDYLQKHR---ERLDHRKLLLYASQICKGMEYLG---SKRYVHR 132 (284)
T ss_pred CCCCCeeEEEEEEccC---CCCceEEEEEecCCCCHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHH---HCCceec
Confidence 5799999998875432 2345789999999999999986543 34889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC---------CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT---------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTN 329 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~---------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~ 329 (427)
||||+||+++.++.+||+|||+++...... .++..|+|||++.+..++.++|||||||++|||++|..++.
T Consensus 133 dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~ 212 (284)
T cd05081 133 DLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSC 212 (284)
T ss_pred cCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCC
Confidence 999999999999999999999998764322 23345999999988889999999999999999999887654
Q ss_pred cccCCCccHHHHHHHhcc-----cchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCC
Q 042634 330 EMFTGNLTLHNFVKEALP-----ERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRER 404 (427)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~R 404 (427)
.... .+.+....... ..+.+.+.. ......+..++.++.+++.+||+.+|++|
T Consensus 213 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~li~~cl~~~p~~R 270 (284)
T cd05081 213 SPPA---EFMRMMGNDKQGQMIVYHLIELLKN-------------------NGRLPAPPGCPAEIYAIMKECWNNDPSQR 270 (284)
T ss_pred Ccch---hhhhhcccccccccchHHHHHHHhc-------------------CCcCCCCCCCCHHHHHHHHHHccCChhhC
Confidence 3210 00000000000 000000000 00000123346679999999999999999
Q ss_pred CCHHHHHHHHHHH
Q 042634 405 MNMEEVAAQLLSF 417 (427)
Q Consensus 405 pt~~ev~~~L~~~ 417 (427)
||+.||++.|+.+
T Consensus 271 pt~~ei~~~l~~~ 283 (284)
T cd05081 271 PSFSELALQVEAI 283 (284)
T ss_pred CCHHHHHHHHHhc
Confidence 9999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=256.99 Aligned_cols=211 Identities=27% Similarity=0.405 Sum_probs=154.6
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++.+.+... +....++||||+++++|.+++.... ..+++..+..++.|++.||+||| ++||+||
T Consensus 63 l~h~~i~~~~~~~~~~---~~~~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~ 133 (284)
T cd05079 63 LYHENIVKYKGICTED---GGNGIKLIMEFLPSGSLKEYLPRNK---NKINLKQQLKYAVQICKGMDYLG---SRQYVHR 133 (284)
T ss_pred CCCCCeeeeeeEEecC---CCCceEEEEEccCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeec
Confidence 5799999998876441 1345789999999999999986432 34889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc---------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA---------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTN 329 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~---------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~ 329 (427)
||||+||+++.++.+||+|||+++..... ..++..|+|||++.+..++.++|||||||++||+++++.|+.
T Consensus 134 dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~ 213 (284)
T cd05079 134 DLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSES 213 (284)
T ss_pred ccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCc
Confidence 99999999999999999999999865432 245567999999988889999999999999999999877643
Q ss_pred cccCCCccHHHHHHHhc-ccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 042634 330 EMFTGNLTLHNFVKEAL-PERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME 408 (427)
Q Consensus 330 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ 408 (427)
..... ......... .......+.. .........+..++.++.+++.+||+.+|++|||++
T Consensus 214 ~~~~~---~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~ 274 (284)
T cd05079 214 SPMTL---FLKMIGPTHGQMTVTRLVRV----------------LEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQ 274 (284)
T ss_pred cccch---hhhhcccccccccHHHHHHH----------------HHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHH
Confidence 21100 000000000 0000000000 000000001223567799999999999999999999
Q ss_pred HHHHHHHHH
Q 042634 409 EVAAQLLSF 417 (427)
Q Consensus 409 ev~~~L~~~ 417 (427)
|+++.++++
T Consensus 275 ~il~~l~~~ 283 (284)
T cd05079 275 NLIEGFEAI 283 (284)
T ss_pred HHHHHHHhh
Confidence 999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=254.68 Aligned_cols=200 Identities=24% Similarity=0.336 Sum_probs=147.7
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchh-hhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNRE-ALKNLNLLQRLSIAVDVASALDYLHHYCETPIVH 257 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivH 257 (427)
++||||+++++.+.. ....++||||+++|+|.+++..... .....++..++.++.|++.|++||| +.|++|
T Consensus 52 l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H 123 (269)
T cd05087 52 LQHSNLLQCLGQCTE-----VTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIH 123 (269)
T ss_pred CCCCCEeeEEEEEcC-----CCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEec
Confidence 579999999987544 4567999999999999999865322 1124567788899999999999999 899999
Q ss_pred ccccCCceeeCCCCceEecccccccccCCc--------CCCccccccccccCCC-------CcCccccchhHHHHHHHHH
Q 042634 258 CDLKPSNVLLDGELTAHVGDFGLAKFLPEA--------TNNFFNFQIAEYGMGS-------EVSTSGDVYSFGILLLETF 322 (427)
Q Consensus 258 rDlkp~NIll~~~~~~kL~DFG~a~~~~~~--------~~~~~~y~aPE~~~~~-------~~~~~~DiwS~G~vl~ell 322 (427)
|||||+||+++.++.+||+|||.++..... ..++..|+|||++... .++.++|||||||++|||+
T Consensus 124 ~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~ 203 (269)
T cd05087 124 SDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELF 203 (269)
T ss_pred cccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHH
Confidence 999999999999999999999999754322 2456779999998542 3578999999999999999
Q ss_pred h-CCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCC
Q 042634 323 T-GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELP 401 (427)
Q Consensus 323 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP 401 (427)
+ |+.||....... . .............++. .....+..+.+++.+|| .+|
T Consensus 204 ~~g~~p~~~~~~~~--~---~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~l~~~c~-~~P 254 (269)
T cd05087 204 ELGSQPYRHLSDEQ--V---LTYTVREQQLKLPKPR-----------------------LKLPLSDRWYEVMQFCW-LQP 254 (269)
T ss_pred hCCCCCCCCCChHH--H---HHHHhhcccCCCCCCc-----------------------cCCCCChHHHHHHHHHh-cCc
Confidence 6 999996532111 1 0000000000011100 01113445788999999 589
Q ss_pred CCCCCHHHHHHHHH
Q 042634 402 RERMNMEEVAAQLL 415 (427)
Q Consensus 402 ~~Rpt~~ev~~~L~ 415 (427)
++|||++||++.|+
T Consensus 255 ~~Rpt~~~l~~~l~ 268 (269)
T cd05087 255 EQRPSAEEVHLLLS 268 (269)
T ss_pred ccCCCHHHHHHHhc
Confidence 99999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=263.32 Aligned_cols=202 Identities=23% Similarity=0.344 Sum_probs=154.8
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchh-----------------------------------
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNRE----------------------------------- 223 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~----------------------------------- 223 (427)
.+||||+++++.+.. .+...+++|||+++|+|.+++.....
T Consensus 68 ~~h~niv~~~~~~~~----~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (343)
T cd05103 68 GHHLNVVNLLGACTK----PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITS 143 (343)
T ss_pred cCCccHhhhcceeec----CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhcccccc
Confidence 368999999987643 23457899999999999988754210
Q ss_pred ----------------------------hhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccccCCceeeCCCCceEe
Q 042634 224 ----------------------------ALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHV 275 (427)
Q Consensus 224 ----------------------------~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL 275 (427)
....+++..+..++.|++.||+||| +.||+||||||+||+++.++.+||
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl 220 (343)
T cd05103 144 SQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKI 220 (343)
T ss_pred ccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEE
Confidence 0124788889999999999999999 899999999999999999999999
Q ss_pred cccccccccCCc--------CCCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCCcccCCCccHHHHHHHhc
Q 042634 276 GDFGLAKFLPEA--------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNEMFTGNLTLHNFVKEAL 346 (427)
Q Consensus 276 ~DFG~a~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~~~~~~~~~~~~~~~~~~ 346 (427)
+|||+++..... ..++..|+|||.+.+..++.++|||||||++||+++ |..||....... .+...+....
T Consensus 221 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~~~~~~~~ 299 (343)
T cd05103 221 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFCRRLKEGT 299 (343)
T ss_pred EecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-HHHHHHhccC
Confidence 999999864322 134567999999988899999999999999999997 999986532111 1111110000
Q ss_pred ccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHH
Q 042634 347 PERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAAQLLSFRN 419 (427)
Q Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~~~~ 419 (427)
.. ..+...+.++.+++.+||+.||++|||+.||++.|+.+.+
T Consensus 300 ~~-------------------------------~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 300 RM-------------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CC-------------------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 00 0011123468899999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-33 Score=263.55 Aligned_cols=146 Identities=19% Similarity=0.334 Sum_probs=119.0
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchh-----hhhccCHHHHHHHHHHHHHHHHHHhhcCCC
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNRE-----ALKNLNLLQRLSIAVDVASALDYLHHYCET 253 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-----~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~ 253 (427)
++||||+++++.+.. ..+...+++|||+ +++|.+++..... ....+++..++.++.|++.||+||| +.
T Consensus 55 l~h~niv~~~~~~~~---~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~ 127 (317)
T cd07868 55 LKHPNVISLQKVFLS---HADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---AN 127 (317)
T ss_pred cCCCCCcceeeeEec---CCCcEEEEEEecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hC
Confidence 469999999887543 1234678999998 5688777643211 1135889999999999999999999 89
Q ss_pred CeeeccccCCceee----CCCCceEecccccccccCCc---------CCCccccccccccCC-CCcCccccchhHHHHHH
Q 042634 254 PIVHCDLKPSNVLL----DGELTAHVGDFGLAKFLPEA---------TNNFFNFQIAEYGMG-SEVSTSGDVYSFGILLL 319 (427)
Q Consensus 254 ~ivHrDlkp~NIll----~~~~~~kL~DFG~a~~~~~~---------~~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ 319 (427)
||+||||||+|||+ +.++.+||+|||+|+..... ..+|..|+|||++.+ ..++.++||||+||++|
T Consensus 128 ~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 207 (317)
T cd07868 128 WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFA 207 (317)
T ss_pred CEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHH
Confidence 99999999999999 45678999999999865322 266888999999877 45899999999999999
Q ss_pred HHHhCCCCCCcc
Q 042634 320 ETFTGKRPTNEM 331 (427)
Q Consensus 320 ell~g~~pf~~~ 331 (427)
||++|++||...
T Consensus 208 el~~g~~~f~~~ 219 (317)
T cd07868 208 ELLTSEPIFHCR 219 (317)
T ss_pred HHHhCCCCccCC
Confidence 999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=259.51 Aligned_cols=197 Identities=25% Similarity=0.412 Sum_probs=156.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ...++++||+++|+|.+++.... ..+++..+..++.|++.||+||| ++||+||
T Consensus 66 l~h~niv~~~~~~~~------~~~~~v~e~~~~g~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~ 133 (303)
T cd05110 66 MDHPHLVRLLGVCLS------PTIQLVTQLMPHGCLLDYVHEHK---DNIGSQLLLNWCVQIAKGMMYLE---ERRLVHR 133 (303)
T ss_pred CCCCCcccEEEEEcC------CCceeeehhcCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHh---hcCeecc
Confidence 579999999998643 23578999999999999886543 35888999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC--------CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT--------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTN 329 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~--------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~ 329 (427)
||||+||+++.++.+||+|||+++...... .++..|+|||++.+..++.++|||||||++||+++ |..||.
T Consensus 134 dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~ 213 (303)
T cd05110 134 DLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213 (303)
T ss_pred ccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999998654321 34568999999998899999999999999999997 889986
Q ss_pred cccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 042634 330 EMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEE 409 (427)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~e 409 (427)
+... ....+.+..... . ..+..++..+.+++.+||..+|++|||++|
T Consensus 214 ~~~~--~~~~~~~~~~~~------~-------------------------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~ 260 (303)
T cd05110 214 GIPT--REIPDLLEKGER------L-------------------------PQPPICTIDVYMVMVKCWMIDADSRPKFKE 260 (303)
T ss_pred CCCH--HHHHHHHHCCCC------C-------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 5311 111111111000 0 011123456889999999999999999999
Q ss_pred HHHHHHHHHHH
Q 042634 410 VAAQLLSFRNK 420 (427)
Q Consensus 410 v~~~L~~~~~~ 420 (427)
+++.|+++.+.
T Consensus 261 l~~~l~~~~~~ 271 (303)
T cd05110 261 LAAEFSRMARD 271 (303)
T ss_pred HHHHHHHHHhc
Confidence 99999998654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=252.99 Aligned_cols=194 Identities=26% Similarity=0.460 Sum_probs=153.3
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||+++++++.+. ....+++|||+++++|.+++..... ..+++.++..++.|++.||+||| +.|++||
T Consensus 58 l~~~~i~~~~~~~~------~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~ 126 (260)
T cd05070 58 LRHDKLVQLYAVVS------EEPIYIVTEYMSKGSLLDFLKDGEG--RALKLPNLVDMAAQVAAGMAYIE---RMNYIHR 126 (260)
T ss_pred cCCCceEEEEeEEC------CCCcEEEEEecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccC
Confidence 57999999987642 2357899999999999999865422 45889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC-------CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCCc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT-------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~-------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~~ 330 (427)
||||+||++++++.+||+|||.+....... .++..|+|||+..+..++.++||||||+++||+++ |..||.+
T Consensus 127 di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~ 206 (260)
T cd05070 127 DLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG 206 (260)
T ss_pred CCccceEEEeCCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCC
Confidence 999999999999999999999998654322 34457999999988889999999999999999999 8999865
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
.... ..........+. ..+...+..+.+++.+||+.+|++|||++++
T Consensus 207 ~~~~--~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l 253 (260)
T cd05070 207 MNNR--EVLEQVERGYRM-------------------------------PCPQDCPISLHELMLQCWKKDPEERPTFEYL 253 (260)
T ss_pred CCHH--HHHHHHHcCCCC-------------------------------CCCCcCCHHHHHHHHHHcccCcccCcCHHHH
Confidence 3211 111111100000 0112245668999999999999999999999
Q ss_pred HHHHHH
Q 042634 411 AAQLLS 416 (427)
Q Consensus 411 ~~~L~~ 416 (427)
.+.|++
T Consensus 254 ~~~l~~ 259 (260)
T cd05070 254 QSFLED 259 (260)
T ss_pred HHHHhc
Confidence 998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.6e-33 Score=257.97 Aligned_cols=195 Identities=24% Similarity=0.289 Sum_probs=152.9
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. +...++||||+++|+|.+++..... ..+++..+..++.|++.||+||| +.||+||
T Consensus 57 l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~ 126 (285)
T cd05605 57 VNSRFVVSLAYAYET-----KDALCLVLTLMNGGDLKFHIYNMGN--PGFDEERAVFYAAEITCGLEDLH---RERIVYR 126 (285)
T ss_pred cCCCCEeeeeeeecC-----CCeEEEEEeccCCCcHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcEec
Confidence 469999999887543 5678999999999999988754321 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc-----CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFT 333 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~ 333 (427)
||||+||++++++.+||+|||+++..... ..|+..|+|||++.+..++.++||||+||++||+++|+.||.+...
T Consensus 127 dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~ 206 (285)
T cd05605 127 DLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE 206 (285)
T ss_pred CCCHHHEEECCCCCEEEeeCCCceecCCCCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCch
Confidence 99999999999999999999999875432 2678899999999988999999999999999999999999975311
Q ss_pred CCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCC-----CHH
Q 042634 334 GNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERM-----NME 408 (427)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rp-----t~~ 408 (427)
. ..... +...... .. ...+...+..+.+++.+||+.||++|| +++
T Consensus 207 ~-~~~~~-~~~~~~~----~~------------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~ 256 (285)
T cd05605 207 K-VKREE-VERRVKE----DQ------------------------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAE 256 (285)
T ss_pred h-hHHHH-HHHHhhh----cc------------------------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHH
Confidence 1 11111 1110000 00 001122456688999999999999999 888
Q ss_pred HHHHH
Q 042634 409 EVAAQ 413 (427)
Q Consensus 409 ev~~~ 413 (427)
+++++
T Consensus 257 ~l~~~ 261 (285)
T cd05605 257 EVKAH 261 (285)
T ss_pred HHhcC
Confidence 88664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-33 Score=267.99 Aligned_cols=192 Identities=22% Similarity=0.278 Sum_probs=152.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+. .+...++||||+++++|.+++... ..+++..++.++.|++.||+||| ..||+||
T Consensus 58 ~~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~ 125 (350)
T cd05573 58 ADSPWIVKLYYSFQ-----DEEHLYLVMEYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVH---KLGFIHR 125 (350)
T ss_pred cCCCCccchhhhee-----cCCeEEEEEcCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecc
Confidence 45999999998743 366789999999999999998755 35899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc-----------------------------------CCCccccccccccCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA-----------------------------------TNNFFNFQIAEYGMGS 303 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-----------------------------------~~~~~~y~aPE~~~~~ 303 (427)
||||+||+++.++.+||+|||+++..... ..||..|+|||++.+.
T Consensus 126 Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 205 (350)
T cd05573 126 DIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT 205 (350)
T ss_pred CCCHHHeEECCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC
Confidence 99999999999999999999999865322 2588899999999999
Q ss_pred CcCccccchhHHHHHHHHHhCCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchH
Q 042634 304 EVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVK 383 (427)
Q Consensus 304 ~~~~~~DiwS~G~vl~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (427)
.++.++|||||||++|||++|+.||..... ......... .. ..... . ...
T Consensus 206 ~~~~~~DiwSlG~il~ell~g~~Pf~~~~~-----~~~~~~i~~-----~~-~~~~~----------------p---~~~ 255 (350)
T cd05573 206 PYGLECDWWSLGVILYEMLYGFPPFYSDTL-----QETYNKIIN-----WK-ESLRF----------------P---PDP 255 (350)
T ss_pred CCCCceeeEecchhhhhhccCCCCCCCCCH-----HHHHHHHhc-----cC-CcccC----------------C---CCC
Confidence 999999999999999999999999975321 111111000 00 00000 0 001
Q ss_pred HHHHHHHHHHhhcCCCCCCCCCC-HHHHHHH
Q 042634 384 ECLVSVLGIGVTCSSELPRERMN-MEEVAAQ 413 (427)
Q Consensus 384 ~~~~~~~~l~~~cl~~dP~~Rpt-~~ev~~~ 413 (427)
..+.++.+++.+|+. ||.+||+ ++|++++
T Consensus 256 ~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 256 PVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 135668899999998 9999999 9999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.5e-33 Score=268.54 Aligned_cols=222 Identities=17% Similarity=0.208 Sum_probs=151.9
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+...........++||||+. ++|.+++... ..+++..++.++.|++.||+||| +.||+||
T Consensus 56 l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~ 127 (372)
T cd07853 56 FKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIVSP----QPLSSDHVKVFLYQILRGLKYLH---SAGILHR 127 (372)
T ss_pred CCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCC
Confidence 57999999999865533222236799999994 6887777544 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc-------CCCccccccccccCCC-CcCccccchhHHHHHHHHHhCCCCCCc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA-------TNNFFNFQIAEYGMGS-EVSTSGDVYSFGILLLETFTGKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-------~~~~~~y~aPE~~~~~-~~~~~~DiwS~G~vl~ell~g~~pf~~ 330 (427)
||||+|||++.++.+||+|||+|+..... ..++..|+|||++.+. .++.++||||+||++|||++|+.||.+
T Consensus 128 dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 207 (372)
T cd07853 128 DIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQA 207 (372)
T ss_pred CCChHHEEECCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCC
Confidence 99999999999999999999999865322 2567789999998874 479999999999999999999999975
Q ss_pred ccCCCccHHHHHHHhcc-cchhcccCccccccccccchhhhccccccc--cccchHHHHHHHHHHHhhcCCCCCCCCCCH
Q 042634 331 MFTGNLTLHNFVKEALP-ERLAEIVDPVLLVEREEGETSKANAHKQFT--RSFSVKECLVSVLGIGVTCSSELPRERMNM 407 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~ 407 (427)
.... ..+ ..+..... +...+..... .. ............+.. ........+.++.+++.+||+.||++|||+
T Consensus 208 ~~~~-~~~-~~i~~~~g~~~~~~~~~~~-~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~ 282 (372)
T cd07853 208 QSPI-QQL-DLITDLLGTPSLEAMRSAC-EG--ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISA 282 (372)
T ss_pred CCHH-HHH-HHHHHHcCCCCHHHHHHhh-HH--HHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCH
Confidence 3211 111 11111110 0000000000 00 000000000000000 000112235678999999999999999999
Q ss_pred HHHHHH
Q 042634 408 EEVAAQ 413 (427)
Q Consensus 408 ~ev~~~ 413 (427)
+|++++
T Consensus 283 ~e~l~h 288 (372)
T cd07853 283 ADALAH 288 (372)
T ss_pred HHHhcC
Confidence 999874
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-33 Score=264.30 Aligned_cols=182 Identities=21% Similarity=0.252 Sum_probs=142.9
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeecc
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCD 259 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrD 259 (427)
+|++|+++++.+. .....++||||+++|+|.+++... ..+++..+..++.|++.||+||| +.||+|||
T Consensus 59 ~~~~i~~~~~~~~-----~~~~~~lv~E~~~~g~L~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~d 126 (324)
T cd05587 59 KPPFLTQLHSCFQ-----TMDRLYFVMEYVNGGDLMYHIQQV----GKFKEPHAVFYAAEIAIGLFFLH---SKGIIYRD 126 (324)
T ss_pred CCCceeeeEEEEE-----cCCEEEEEEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecC
Confidence 3456777776643 356789999999999999888654 34889999999999999999999 89999999
Q ss_pred ccCCceeeCCCCceEecccccccccCC------cCCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccC
Q 042634 260 LKPSNVLLDGELTAHVGDFGLAKFLPE------ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFT 333 (427)
Q Consensus 260 lkp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~ 333 (427)
|||+|||++.++.+||+|||+++.... ...|+..|+|||++.+..++.++||||+||++|||++|+.||.+...
T Consensus 127 lkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~ 206 (324)
T cd05587 127 LKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE 206 (324)
T ss_pred CCHHHeEEcCCCCEEEeecCcceecCCCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH
Confidence 999999999999999999999875321 12688999999999999999999999999999999999999975311
Q ss_pred CCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCH
Q 042634 334 GNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM 407 (427)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~ 407 (427)
........... . . .+...+.++.+++.+||+.||.+|++.
T Consensus 207 -----~~~~~~i~~~~--------~----------------~-----~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 207 -----DELFQSIMEHN--------V----------------S-----YPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred -----HHHHHHHHcCC--------C----------------C-----CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 11111110000 0 0 011234567899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-32 Score=253.44 Aligned_cols=195 Identities=24% Similarity=0.430 Sum_probs=155.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. +...++||||+++++|.+++.... ..+++.++..++.|++.|++||| +.|++||
T Consensus 62 l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~ 130 (267)
T cd05066 62 FDHPNIIHLEGVVTK-----SKPVMIVTEYMENGSLDAFLRKHD---GQFTVIQLVGMLRGIASGMKYLS---DMGYVHR 130 (267)
T ss_pred CCCCCcceEEEEEec-----CCccEEEEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCEeeh
Confidence 479999999987533 567899999999999999986543 34889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC---------CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT---------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPT 328 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~---------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf 328 (427)
||||+||+++.++.+||+|||.++...... .++..|+|||++.+..++.++|||||||++||+++ |..||
T Consensus 131 dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~ 210 (267)
T cd05066 131 DLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 210 (267)
T ss_pred hhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCc
Confidence 999999999999999999999998654321 22457999999998889999999999999999886 99998
Q ss_pred CcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 042634 329 NEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME 408 (427)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ 408 (427)
...... .....+...... ..+..++..+.+++.+||+.+|++|||+.
T Consensus 211 ~~~~~~--~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 257 (267)
T cd05066 211 WEMSNQ--DVIKAIEEGYRL-------------------------------PAPMDCPAALHQLMLDCWQKDRNERPKFE 257 (267)
T ss_pred ccCCHH--HHHHHHhCCCcC-------------------------------CCCCCCCHHHHHHHHHHcccCchhCCCHH
Confidence 653211 111111100000 01122456688999999999999999999
Q ss_pred HHHHHHHHH
Q 042634 409 EVAAQLLSF 417 (427)
Q Consensus 409 ev~~~L~~~ 417 (427)
++++.|+++
T Consensus 258 ~i~~~l~~~ 266 (267)
T cd05066 258 QIVSILDKL 266 (267)
T ss_pred HHHHHHHhh
Confidence 999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=253.96 Aligned_cols=200 Identities=24% Similarity=0.324 Sum_probs=148.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhh-hhccCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREA-LKNLNLLQRLSIAVDVASALDYLHHYCETPIVH 257 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivH 257 (427)
++||||+++++.+.. ....++||||+++|+|.+++...... ....++..++.++.|++.||+||| +.||+|
T Consensus 52 l~h~nii~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH 123 (269)
T cd05042 52 LNHPNVLQCLGQCIE-----SIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIH 123 (269)
T ss_pred CCCCCcceEEEEECC-----CCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEec
Confidence 579999999998644 45689999999999999998654321 123567788999999999999999 899999
Q ss_pred ccccCCceeeCCCCceEecccccccccCCc--------CCCccccccccccCC-------CCcCccccchhHHHHHHHHH
Q 042634 258 CDLKPSNVLLDGELTAHVGDFGLAKFLPEA--------TNNFFNFQIAEYGMG-------SEVSTSGDVYSFGILLLETF 322 (427)
Q Consensus 258 rDlkp~NIll~~~~~~kL~DFG~a~~~~~~--------~~~~~~y~aPE~~~~-------~~~~~~~DiwS~G~vl~ell 322 (427)
|||||+||++++++.+||+|||+++..... ..++..|+|||++.. ..++.++|||||||++|||+
T Consensus 124 ~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~ 203 (269)
T cd05042 124 SDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELF 203 (269)
T ss_pred ccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHH
Confidence 999999999999999999999998754221 134567999998743 35688999999999999999
Q ss_pred h-CCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCC
Q 042634 323 T-GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELP 401 (427)
Q Consensus 323 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP 401 (427)
+ |..||...... ..+........ .....+ ..+..++..+.+++..|| .||
T Consensus 204 ~~~~~p~~~~~~~-~~~~~~~~~~~----~~~~~~-----------------------~~~~~~~~~~~~~~~~~~-~dp 254 (269)
T cd05042 204 TAADQPYPDLSDE-QVLKQVVREQD----IKLPKP-----------------------QLDLKYSDRWYEVMQFCW-LDP 254 (269)
T ss_pred hCCCCCCCcCCHH-HHHHHHhhccC----ccCCCC-----------------------cccccCCHHHHHHHHHHh-cCc
Confidence 9 78888653211 11111111100 000000 012234556778999999 599
Q ss_pred CCCCCHHHHHHHHH
Q 042634 402 RERMNMEEVAAQLL 415 (427)
Q Consensus 402 ~~Rpt~~ev~~~L~ 415 (427)
++|||++||++.|.
T Consensus 255 ~~Rpt~~~v~~~l~ 268 (269)
T cd05042 255 ETRPTAEEVHELLT 268 (269)
T ss_pred ccccCHHHHHHHhc
Confidence 99999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.7e-33 Score=254.94 Aligned_cols=191 Identities=22% Similarity=0.282 Sum_probs=152.4
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. +...++|+||+++++|.+++... ..+++..+..++.|++.||.||| +.||+||
T Consensus 61 l~~~~i~~~~~~~~~-----~~~~~~v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~ 128 (263)
T cd06625 61 LQHERIVQYYGCLRD-----DETLSIFMEYMPGGSVKDQLKAY----GALTETVTRKYTRQILEGVEYLH---SNMIVHR 128 (263)
T ss_pred CCCCCeeeeEEEEcc-----CCeEEEEEEECCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecC
Confidence 569999999998543 55889999999999999988654 34888999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc---------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA---------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTN 329 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~---------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~ 329 (427)
||||+||+++.++.+||+|||.++..... ..++..|+|||++.+..++.++||||+||++||+++|+.||.
T Consensus 129 dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 208 (263)
T cd06625 129 DIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWA 208 (263)
T ss_pred CCCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCcc
Confidence 99999999999999999999999765321 245678999999999889999999999999999999999986
Q ss_pred cccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 042634 330 EMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEE 409 (427)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~e 409 (427)
.... ............ ....+..++..+.+++.+||..+|++|||++|
T Consensus 209 ~~~~----~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 256 (263)
T cd06625 209 EFEA----MAAIFKIATQPT----------------------------NPQLPSHVSPDARNFLRRTFVENAKKRPSAEE 256 (263)
T ss_pred ccch----HHHHHHHhccCC----------------------------CCCCCccCCHHHHHHHHHHhhcCcccCCCHHH
Confidence 4311 111100000000 00012234567899999999999999999999
Q ss_pred HHHH
Q 042634 410 VAAQ 413 (427)
Q Consensus 410 v~~~ 413 (427)
+++.
T Consensus 257 ll~~ 260 (263)
T cd06625 257 LLRH 260 (263)
T ss_pred HhhC
Confidence 9864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.1e-33 Score=268.09 Aligned_cols=192 Identities=18% Similarity=0.227 Sum_probs=149.6
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+. .+...++||||+++|+|.+++... .+++..+..++.|++.||+||| +.||+||
T Consensus 100 ~~h~~iv~~~~~~~-----~~~~~~lv~Ey~~gg~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~~LH---~~~ivHr 166 (370)
T cd05596 100 ANSEWIVQLHYAFQ-----DDKYLYMVMEYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIH---SMGFIHR 166 (370)
T ss_pred CCCCCcceEEEEEe-----cCCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHH---HCCeecc
Confidence 57999999988743 356789999999999999988543 3788899999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc-------CCCccccccccccCCC----CcCccccchhHHHHHHHHHhCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA-------TNNFFNFQIAEYGMGS----EVSTSGDVYSFGILLLETFTGKRP 327 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-------~~~~~~y~aPE~~~~~----~~~~~~DiwS~G~vl~ell~g~~p 327 (427)
||||+|||++.++.+||+|||+++..... ..||+.|+|||++.+. .++.++|||||||++|||++|+.|
T Consensus 167 DLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~P 246 (370)
T cd05596 167 DVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246 (370)
T ss_pred CCCHHHEEEcCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCC
Confidence 99999999999999999999999865332 2588999999998653 378999999999999999999999
Q ss_pred CCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCC--CC
Q 042634 328 TNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRE--RM 405 (427)
Q Consensus 328 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~--Rp 405 (427)
|..... ........... .. .. +. .....+.++.+++.+|++.+|++ ||
T Consensus 247 f~~~~~-----~~~~~~i~~~~-----~~-~~----------------~~---~~~~~s~~~~~li~~~L~~~p~r~~R~ 296 (370)
T cd05596 247 FYADSL-----VGTYSKIMDHK-----NS-LT----------------FP---DDIEISKQAKDLICAFLTDREVRLGRN 296 (370)
T ss_pred cCCCCH-----HHHHHHHHcCC-----Cc-CC----------------CC---CcCCCCHHHHHHHHHHccChhhccCCC
Confidence 975311 11111110000 00 00 00 01123566889999999999988 99
Q ss_pred CHHHHHHH
Q 042634 406 NMEEVAAQ 413 (427)
Q Consensus 406 t~~ev~~~ 413 (427)
|++|++++
T Consensus 297 s~~ell~h 304 (370)
T cd05596 297 GVDEIKSH 304 (370)
T ss_pred CHHHHhcC
Confidence 99999765
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=258.10 Aligned_cols=203 Identities=21% Similarity=0.351 Sum_probs=153.7
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchh-------hhhccCHHHHHHHHHHHHHHHHHHhhcC
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNRE-------ALKNLNLLQRLSIAVDVASALDYLHHYC 251 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------~~~~l~~~~~~~~~~~i~~~L~~LH~~~ 251 (427)
++|||++++++.+.. +...+++|||+++++|.+++..... ....+++..++.++.|++.||+|||
T Consensus 76 l~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH--- 147 (296)
T cd05051 76 LSDPNIARLLGVCTV-----DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE--- 147 (296)
T ss_pred cCCCCEeEEEEEEec-----CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---
Confidence 469999999987543 4678999999999999998865431 1125889999999999999999999
Q ss_pred CCCeeeccccCCceeeCCCCceEecccccccccCCc--------CCCccccccccccCCCCcCccccchhHHHHHHHHHh
Q 042634 252 ETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA--------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT 323 (427)
Q Consensus 252 ~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~ 323 (427)
+.||+||||||+||+++.++.+||+|||.++..... ..++..|+|||++.+..++.++|||||||++||+++
T Consensus 148 ~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~ 227 (296)
T cd05051 148 SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227 (296)
T ss_pred HcCccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHh
Confidence 899999999999999999999999999999865322 144568999999988889999999999999999998
Q ss_pred --CCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCC
Q 042634 324 --GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELP 401 (427)
Q Consensus 324 --g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP 401 (427)
|..||..... .............. .. . .....+..++.++.+++.+||+.||
T Consensus 228 ~~~~~p~~~~~~--~~~~~~~~~~~~~~-----~~--------~-----------~~~~~~~~~~~~l~~li~~cl~~~p 281 (296)
T cd05051 228 LCREQPYEHLTD--QQVIENAGHFFRDD-----GR--------Q-----------IYLPRPPNCPKDIYELMLECWRRDE 281 (296)
T ss_pred cCCCCCCCCcCh--HHHHHHHHhccccc-----cc--------c-----------ccCCCccCCCHHHHHHHHHHhccCh
Confidence 6777754311 11111111000000 00 0 0000112345679999999999999
Q ss_pred CCCCCHHHHHHHHH
Q 042634 402 RERMNMEEVAAQLL 415 (427)
Q Consensus 402 ~~Rpt~~ev~~~L~ 415 (427)
++|||+.||++.|+
T Consensus 282 ~~Rpt~~el~~~L~ 295 (296)
T cd05051 282 EDRPTFREIHLFLQ 295 (296)
T ss_pred hcCCCHHHHHHHhc
Confidence 99999999998885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=252.07 Aligned_cols=196 Identities=30% Similarity=0.454 Sum_probs=156.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|+|++++++.+.. ....++||||+++++|.+++..... ..+++..+..++.|++.|+.||| ..|++||
T Consensus 57 l~~~~i~~~~~~~~~-----~~~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~ 126 (256)
T cd05039 57 LRHPNLVQLLGVVLQ-----GNPLYIVTEYMAKGSLVDYLRSRGR--AVITLAQQLGFALDVCEGMEYLE---EKNFVHR 126 (256)
T ss_pred cCCcceeeeEEEEcC-----CCCeEEEEEecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCccch
Confidence 469999999988543 4678999999999999999865432 35899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC---CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCCcccCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT---NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNEMFTG 334 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~---~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~~~~~~ 334 (427)
||||+||+++.++.+||+|||.++...... ..+..|+|||++....++.++||||||+++||+++ |..||.....
T Consensus 127 di~p~Nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~- 205 (256)
T cd05039 127 DLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL- 205 (256)
T ss_pred hcccceEEEeCCCCEEEcccccccccccccccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH-
Confidence 999999999999999999999998764332 33457999999988889999999999999999997 9999864311
Q ss_pred CccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 042634 335 NLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAAQL 414 (427)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L 414 (427)
..+......... ...+..++.++.+++++||+.+|++|||++|++++|
T Consensus 206 -~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l 253 (256)
T cd05039 206 -KDVVPHVEKGYR-------------------------------MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQL 253 (256)
T ss_pred -HHHHHHHhcCCC-------------------------------CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHH
Confidence 111111110000 001122456789999999999999999999999999
Q ss_pred HHH
Q 042634 415 LSF 417 (427)
Q Consensus 415 ~~~ 417 (427)
+.+
T Consensus 254 ~~~ 256 (256)
T cd05039 254 ALI 256 (256)
T ss_pred hcC
Confidence 753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-32 Score=252.74 Aligned_cols=195 Identities=24% Similarity=0.436 Sum_probs=154.5
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++.+.+. .+...++||||+++|+|.+++.... ..+++.+++.++.|++.|++||| +.|++||
T Consensus 62 l~h~ni~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~ 130 (269)
T cd05065 62 FDHPNIIHLEGVVT-----KSRPVMIITEFMENGALDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLS---EMNYVHR 130 (269)
T ss_pred CCCcCcceEEEEEC-----CCCceEEEEecCCCCcHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCEeec
Confidence 57999999988753 3567899999999999999886543 35889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC---------C--CccccccccccCCCCcCccccchhHHHHHHHHHh-CCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT---------N--NFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKR 326 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~---------~--~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~ 326 (427)
||||+||+++.++.+||+|||+++...... . .+..|+|||++.+..++.++|||||||++||+++ |..
T Consensus 131 dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~ 210 (269)
T cd05065 131 DLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER 210 (269)
T ss_pred ccChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCC
Confidence 999999999999999999999987653321 1 1346999999998999999999999999999886 999
Q ss_pred CCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCC
Q 042634 327 PTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMN 406 (427)
Q Consensus 327 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt 406 (427)
||..... ......+....+ ...+.+++..+.+++.+||+.+|++|||
T Consensus 211 p~~~~~~--~~~~~~i~~~~~-------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~ 257 (269)
T cd05065 211 PYWDMSN--QDVINAIEQDYR-------------------------------LPPPMDCPTALHQLMLDCWQKDRNARPK 257 (269)
T ss_pred CCCCCCH--HHHHHHHHcCCc-------------------------------CCCcccCCHHHHHHHHHHcCCChhhCcC
Confidence 9865311 111111110000 0012235567899999999999999999
Q ss_pred HHHHHHHHHHH
Q 042634 407 MEEVAAQLLSF 417 (427)
Q Consensus 407 ~~ev~~~L~~~ 417 (427)
+++|+..|+++
T Consensus 258 ~~~i~~~l~~~ 268 (269)
T cd05065 258 FGQIVSTLDKM 268 (269)
T ss_pred HHHHHHHHHhh
Confidence 99999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-32 Score=260.81 Aligned_cols=220 Identities=17% Similarity=0.203 Sum_probs=152.7
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. +...++||||+++|+|.+++..... ..+++..++.++.|++.||+||| +.||+||
T Consensus 56 l~hpniv~~~~~~~~-----~~~~~lv~e~~~~~~l~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~ 125 (327)
T cd08227 56 FNHPNIVPYRATFIA-----DNELWVVTSFMAYGSAKDLICTHFM--DGMSELAIAYILQGVLKALDYIH---HMGYVHR 125 (327)
T ss_pred cCCCCeeeEEEEEEE-----CCEEEEEEeccCCCcHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEecC
Confidence 589999999988644 5678999999999999999865322 34889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC-------------cCCCccccccccccCC--CCcCccccchhHHHHHHHHHh
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE-------------ATNNFFNFQIAEYGMG--SEVSTSGDVYSFGILLLETFT 323 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~-------------~~~~~~~y~aPE~~~~--~~~~~~~DiwS~G~vl~ell~ 323 (427)
||||+||+++.++.++++|||.+..... ...++..|+|||++.+ ..++.++|||||||++|||++
T Consensus 126 dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~ 205 (327)
T cd08227 126 SVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELAN 205 (327)
T ss_pred CCChhhEEEecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHH
Confidence 9999999999999999999986543311 1145567999999876 468999999999999999999
Q ss_pred CCCCCCcccCCCccHHHHHHHhcccchhcccCcc-------------ccccccccchhh----hccccccccccchHHHH
Q 042634 324 GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPV-------------LLVEREEGETSK----ANAHKQFTRSFSVKECL 386 (427)
Q Consensus 324 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~ 386 (427)
|+.||........ ...... .......+.. ...+........ ................+
T Consensus 206 g~~pf~~~~~~~~-~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (327)
T cd08227 206 GHVPFKDMPATQM-LLEKLN----GTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFS 280 (327)
T ss_pred CCCCCCCcchhHH-HHHHhc----CCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccC
Confidence 9999975422111 111111 1111111000 000000000000 00000000011123345
Q ss_pred HHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 042634 387 VSVLGIGVTCSSELPRERMNMEEVAAQ 413 (427)
Q Consensus 387 ~~~~~l~~~cl~~dP~~Rpt~~ev~~~ 413 (427)
.++.+++.+||+.||++|||++|+++.
T Consensus 281 ~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 281 PHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred HHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 678999999999999999999999873
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.6e-33 Score=266.84 Aligned_cols=141 Identities=24% Similarity=0.328 Sum_probs=125.5
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||+|+++++.+. .....++||||+++|+|.+++... ..+++..++.++.|++.||+||| +.||+||
T Consensus 58 ~~~~~iv~~~~~~~-----~~~~~~lv~E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH---~~givHr 125 (363)
T cd05628 58 ADSLWVVKMFYSFQ-----DKLNLYLIMEFLPGGDMMTLLMKK----DTLTEEETQFYIAETVLAIDSIH---QLGFIHR 125 (363)
T ss_pred CCCCCcceEEEEEe-----cCCeEEEEEcCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEec
Confidence 47999999998743 356789999999999999998654 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC-----------------------------------------cCCCccccccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE-----------------------------------------ATNNFFNFQIA 297 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~-----------------------------------------~~~~~~~y~aP 297 (427)
||||+|||++.++.+||+|||+|+.... ...||..|+||
T Consensus 126 DlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aP 205 (363)
T cd05628 126 DIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAP 205 (363)
T ss_pred CCCHHHeEECCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCH
Confidence 9999999999999999999999875421 12688999999
Q ss_pred cccCCCCcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 298 EYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 298 E~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
|++.+..++.++|||||||++|||++|+.||.+.
T Consensus 206 E~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 206 EVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred HHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=250.58 Aligned_cols=193 Identities=25% Similarity=0.392 Sum_probs=152.9
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++.+.. ....++||||+++++|.+++.... ..+++..+..++.|++.||.|+| .+|++||
T Consensus 49 l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~ 117 (250)
T cd05085 49 YDHPNIVKLIGVCTQ-----RQPIYIVMELVPGGDFLSFLRKKK---DELKTKQLVKFALDAAAGMAYLE---SKNCIHR 117 (250)
T ss_pred CCCCCcCeEEEEEec-----CCccEEEEECCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeec
Confidence 479999999988644 456899999999999999886543 34789999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC-------CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCCc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT-------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~-------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~~ 330 (427)
||||+||+++.++.+||+|||++....... .++..|+|||++.+..++.++|||||||++||+++ |..||..
T Consensus 118 dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~ 197 (250)
T cd05085 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPG 197 (250)
T ss_pred ccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCC
Confidence 999999999999999999999997543322 33457999999988889999999999999999998 9999865
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
.... .....+...... ..+..++.++.+++.+||+.+|++|||+.|+
T Consensus 198 ~~~~--~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l 244 (250)
T cd05085 198 MTNQ--QAREQVEKGYRM-------------------------------SCPQKCPDDVYKVMQRCWDYKPENRPKFSEL 244 (250)
T ss_pred CCHH--HHHHHHHcCCCC-------------------------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHH
Confidence 3111 111100000000 0112245678999999999999999999999
Q ss_pred HHHHH
Q 042634 411 AAQLL 415 (427)
Q Consensus 411 ~~~L~ 415 (427)
++.|.
T Consensus 245 ~~~l~ 249 (250)
T cd05085 245 QKELA 249 (250)
T ss_pred HHHhc
Confidence 99874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=254.14 Aligned_cols=197 Identities=26% Similarity=0.432 Sum_probs=153.9
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhh---hhccCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREA---LKNLNLLQRLSIAVDVASALDYLHHYCETPI 255 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~---~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~i 255 (427)
++||||+++++.+.. ....++||||+++++|.+++...... ...+++.+++.++.|++.||+||| +.++
T Consensus 56 l~h~~i~~~~~~~~~-----~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i 127 (269)
T cd05044 56 FNHPNIVKLLGVCLL-----NEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHF 127 (269)
T ss_pred cCCCCeeeEeeeecC-----CCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCc
Confidence 579999999988543 45689999999999999998643211 134788999999999999999999 8999
Q ss_pred eeccccCCceeeCCCC-----ceEecccccccccCCc--------CCCccccccccccCCCCcCccccchhHHHHHHHHH
Q 042634 256 VHCDLKPSNVLLDGEL-----TAHVGDFGLAKFLPEA--------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETF 322 (427)
Q Consensus 256 vHrDlkp~NIll~~~~-----~~kL~DFG~a~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell 322 (427)
+|+||||+||+++.+. .+||+|||+++..... ..++..|+|||++.+..++.++|||||||++|||+
T Consensus 128 ~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ell 207 (269)
T cd05044 128 IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEIL 207 (269)
T ss_pred ccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHH
Confidence 9999999999998877 8999999999755322 13456899999999989999999999999999999
Q ss_pred h-CCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCC
Q 042634 323 T-GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELP 401 (427)
Q Consensus 323 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP 401 (427)
+ |..||..... ......+.. . . ....+...+..+.+++.+||+.+|
T Consensus 208 t~g~~p~~~~~~--~~~~~~~~~---~---~-------------------------~~~~~~~~~~~~~~li~~~l~~~p 254 (269)
T cd05044 208 TLGQQPYPALNN--QEVLQHVTA---G---G-------------------------RLQKPENCPDKIYQLMTNCWAQDP 254 (269)
T ss_pred HcCCCCCcccCH--HHHHHHHhc---C---C-------------------------ccCCcccchHHHHHHHHHHcCCCc
Confidence 8 9999864311 111111000 0 0 000122346678999999999999
Q ss_pred CCCCCHHHHHHHHHH
Q 042634 402 RERMNMEEVAAQLLS 416 (427)
Q Consensus 402 ~~Rpt~~ev~~~L~~ 416 (427)
++|||++|+++.|++
T Consensus 255 ~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 255 SERPTFDRIQEILQN 269 (269)
T ss_pred ccCCCHHHHHHHHhC
Confidence 999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-32 Score=250.57 Aligned_cols=196 Identities=27% Similarity=0.463 Sum_probs=157.4
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhh-----hhccCHHHHHHHHHHHHHHHHHHhhcCCC
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREA-----LKNLNLLQRLSIAVDVASALDYLHHYCET 253 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-----~~~l~~~~~~~~~~~i~~~L~~LH~~~~~ 253 (427)
++|+|++++++.+.. ....+++|||+++++|.+++...... ...+++..+..++.|++.||+||| ++
T Consensus 53 ~~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~ 124 (262)
T cd00192 53 LGHPNVVRLLGVCTE-----EEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SK 124 (262)
T ss_pred cCCCChheeeeeecC-----CCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cC
Confidence 459999999988544 56789999999999999998765211 145899999999999999999999 89
Q ss_pred CeeeccccCCceeeCCCCceEecccccccccCCc--------CCCccccccccccCCCCcCccccchhHHHHHHHHHh-C
Q 042634 254 PIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA--------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-G 324 (427)
Q Consensus 254 ~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g 324 (427)
|++||||||+||+++.++.+||+|||.+...... ..++..|+|||.+....++.++||||+||++|||++ |
T Consensus 125 ~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g 204 (262)
T cd00192 125 KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLG 204 (262)
T ss_pred CcccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcC
Confidence 9999999999999999999999999999876542 256778999999988889999999999999999999 6
Q ss_pred CCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCC
Q 042634 325 KRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRER 404 (427)
Q Consensus 325 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~R 404 (427)
..||.... ...+.+.... . . ....+..++.++.+++.+||+.+|++|
T Consensus 205 ~~p~~~~~--~~~~~~~~~~---~--------~--------------------~~~~~~~~~~~~~~li~~~l~~~p~~R 251 (262)
T cd00192 205 ATPYPGLS--NEEVLEYLRK---G--------Y--------------------RLPKPEYCPDELYELMLSCWQLDPEDR 251 (262)
T ss_pred CCCCCCCC--HHHHHHHHHc---C--------C--------------------CCCCCccCChHHHHHHHHHccCCcccC
Confidence 99987641 1111111110 0 0 000123346678999999999999999
Q ss_pred CCHHHHHHHHH
Q 042634 405 MNMEEVAAQLL 415 (427)
Q Consensus 405 pt~~ev~~~L~ 415 (427)
||++|+++.|+
T Consensus 252 ps~~~l~~~l~ 262 (262)
T cd00192 252 PTFSELVERLE 262 (262)
T ss_pred cCHHHHHHhhC
Confidence 99999998873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=259.00 Aligned_cols=191 Identities=19% Similarity=0.266 Sum_probs=151.8
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++.+.. +...++||||+++++|.+++.+. .+++.++..++.|++.||+||| ..||+||
T Consensus 74 ~~h~~v~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~ 140 (296)
T cd06654 74 NKNPNIVNYLDSYLV-----GDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLH---SNQVIHR 140 (296)
T ss_pred CCCCCEeeEEEEEEe-----CCEEEEeecccCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHH---HCCcccC
Confidence 479999999987543 56789999999999999988542 3788899999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+||+++.++.+||+|||.+...... ..++..|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 141 dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~ 220 (296)
T cd06654 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (296)
T ss_pred CCCHHHEEEcCCCCEEECccccchhccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999998765322 267788999999998889999999999999999999999996532
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
... .+........+ . ...+...+..+.+++.+||..+|++|||++|+++
T Consensus 221 ~~~-~~~~~~~~~~~----~--------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 221 PLR-ALYLIATNGTP----E--------------------------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred HHH-hHHHHhcCCCC----C--------------------------CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 110 01000000000 0 0012234456889999999999999999999987
Q ss_pred H
Q 042634 413 Q 413 (427)
Q Consensus 413 ~ 413 (427)
.
T Consensus 270 ~ 270 (296)
T cd06654 270 H 270 (296)
T ss_pred C
Confidence 4
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-32 Score=267.22 Aligned_cols=157 Identities=25% Similarity=0.309 Sum_probs=123.3
Q ss_pred ccCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccccCCceeeCCCCceEecccccccccCCc--------CCCcccccccc
Q 042634 227 NLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA--------TNNFFNFQIAE 298 (427)
Q Consensus 227 ~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~--------~~~~~~y~aPE 298 (427)
.+++..++.++.|++.||+||| ..+|+||||||+|||+++++.+||+|||+++..... ..++..|+|||
T Consensus 235 ~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE 311 (401)
T cd05107 235 ALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPE 311 (401)
T ss_pred CCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChH
Confidence 3677788999999999999999 899999999999999999999999999999864321 14567899999
Q ss_pred ccCCCCcCccccchhHHHHHHHHHh-CCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccc
Q 042634 299 YGMGSEVSTSGDVYSFGILLLETFT-GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFT 377 (427)
Q Consensus 299 ~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (427)
.+.+..++.++|||||||++|||++ |..||....... .....+....+.
T Consensus 312 ~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~-~~~~~~~~~~~~----------------------------- 361 (401)
T cd05107 312 SIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE-QFYNAIKRGYRM----------------------------- 361 (401)
T ss_pred HhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH-HHHHHHHcCCCC-----------------------------
Confidence 9998889999999999999999998 888986532111 011111100000
Q ss_pred cccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHH
Q 042634 378 RSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAAQLLSFR 418 (427)
Q Consensus 378 ~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~~~ 418 (427)
..+..++.++.+++.+||+.+|++|||++||++.|+++.
T Consensus 362 --~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 362 --AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred --CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 011224567899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-32 Score=267.23 Aligned_cols=218 Identities=19% Similarity=0.187 Sum_probs=153.7
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+. .....++|||++ .++|.+++... ..+++..++.++.|++.||+||| +.||+||
T Consensus 143 l~h~~iv~~~~~~~-----~~~~~~lv~e~~-~~~l~~~l~~~----~~l~~~~~~~i~~ql~~aL~~LH---~~givHr 209 (392)
T PHA03207 143 ISHRAIINLIHAYR-----WKSTVCMVMPKY-KCDLFTYVDRS----GPLPLEQAITIQRRLLEALAYLH---GRGIIHR 209 (392)
T ss_pred cCCCCccceeeeEe-----eCCEEEEEehhc-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccc
Confidence 57999999998743 356789999999 57888888433 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc--------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA--------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~ 330 (427)
||||+|||++.++.+||+|||+++..... ..||..|+|||++.+..++.++|||||||++|||++|+.||.+
T Consensus 210 Dlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 289 (392)
T PHA03207 210 DVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFG 289 (392)
T ss_pred CCCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999999765432 2688999999999999999999999999999999999999976
Q ss_pred ccCCC--ccHHHHHHHhcccchhcccCc---cccccccccchhhhccccccc--cccchHHHHHHHHHHHhhcCCCCCCC
Q 042634 331 MFTGN--LTLHNFVKEALPERLAEIVDP---VLLVEREEGETSKANAHKQFT--RSFSVKECLVSVLGIGVTCSSELPRE 403 (427)
Q Consensus 331 ~~~~~--~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~~cl~~dP~~ 403 (427)
..... ..+............ +.... .+........ ......+. ........+.++.+++.+||..||++
T Consensus 290 ~~~~~~~~~l~~i~~~~~~~~~-~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~ 365 (392)
T PHA03207 290 KQVKSSSSQLRSIIRCMQVHPL-EFPQNGSTNLCKHFKQYA---IVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEF 365 (392)
T ss_pred CCCCCcHHHHHHHHHHhccCcc-ccCCccchhHHHHHHhhc---ccccCCccccchhhccCcchhHHHHHHHHhccChhh
Confidence 43221 112111111110000 00000 0000000000 00000000 00001123456788999999999999
Q ss_pred CCCHHHHHHH
Q 042634 404 RMNMEEVAAQ 413 (427)
Q Consensus 404 Rpt~~ev~~~ 413 (427)
|||+.|++.+
T Consensus 366 Rpsa~e~l~~ 375 (392)
T PHA03207 366 RPSAQDILSL 375 (392)
T ss_pred CCCHHHHhhC
Confidence 9999999875
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-32 Score=264.06 Aligned_cols=138 Identities=22% Similarity=0.363 Sum_probs=119.9
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+ .++|.+++.... ..+++..++.++.||+.||+||| +.||+||
T Consensus 114 l~h~~iv~~~~~~~~-----~~~~~lv~e~~-~~~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHr 181 (357)
T PHA03209 114 VNHPSVIRMKDTLVS-----GAITCMVLPHY-SSDLYTYLTKRS---RPLPIDQALIIEKQILEGLRYLH---AQRIIHR 181 (357)
T ss_pred CCCCCCcChhheEEe-----CCeeEEEEEcc-CCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecC
Confidence 579999999998644 55789999999 678888876433 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC-----cCCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE-----ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPT 328 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf 328 (427)
||||+|||++.++.+||+|||.++.... ...||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 182 Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 182 DVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred CCCHHHEEECCCCCEEEecCccccccccCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 9999999999999999999999975432 226889999999999999999999999999999999865544
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-33 Score=267.15 Aligned_cols=188 Identities=21% Similarity=0.216 Sum_probs=146.8
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeecc
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCD 259 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrD 259 (427)
+||+|+++++.+.. ....++||||+++|+|.+++... ..+++..++.++.||+.||+||| +.||+|||
T Consensus 54 ~~p~i~~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~qil~al~~LH---~~~ivHrD 121 (330)
T cd05586 54 ESPFIVGLKFSFQT-----DSDLYLVTDYMSGGELFWHLQKE----GRFSEDRAKFYIAELVLALEHLH---KYDIVYRD 121 (330)
T ss_pred CCCcCcceEEEEec-----CCeEEEEEcCCCCChHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecc
Confidence 69999999887433 56789999999999999888654 45899999999999999999999 89999999
Q ss_pred ccCCceeeCCCCceEecccccccccCC------cCCCccccccccccCCC-CcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 260 LKPSNVLLDGELTAHVGDFGLAKFLPE------ATNNFFNFQIAEYGMGS-EVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 260 lkp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~~y~aPE~~~~~-~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
|||+|||++.++.+||+|||+++.... ...||..|+|||++.+. .++.++||||+||++|||++|+.||....
T Consensus 122 lkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~ 201 (330)
T cd05586 122 LKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED 201 (330)
T ss_pred CCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC
Confidence 999999999999999999999875422 12688999999998764 47999999999999999999999996531
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCC----CHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERM----NME 408 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rp----t~~ 408 (427)
..+.......... . + .....+.++.+++.+||+.||++|| +++
T Consensus 202 -----~~~~~~~i~~~~~-~-----------------------~----~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~ 248 (330)
T cd05586 202 -----TQQMYRNIAFGKV-R-----------------------F----PKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAV 248 (330)
T ss_pred -----HHHHHHHHHcCCC-C-----------------------C----CCccCCHHHHHHHHHHcCCCHHHCCCCCCCHH
Confidence 1111111110000 0 0 0111345578899999999999998 455
Q ss_pred HHHH
Q 042634 409 EVAA 412 (427)
Q Consensus 409 ev~~ 412 (427)
|+++
T Consensus 249 ~ll~ 252 (330)
T cd05586 249 ELKE 252 (330)
T ss_pred HHhc
Confidence 6554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-33 Score=256.22 Aligned_cols=197 Identities=20% Similarity=0.250 Sum_probs=151.2
Q ss_pred cccccchhhhccccccCCCC-CCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 042634 179 IRHRNLVKIITSCASVDFQG-NDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVH 257 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivH 257 (427)
.+|||++++++.+......+ ....+++|||+++++|.+++..... ..+++..+..++.|++.|++||| +.+|+|
T Consensus 60 ~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh 134 (272)
T cd06637 60 SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLH---QHKVIH 134 (272)
T ss_pred cCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH---HCCCcc
Confidence 36999999999875532221 2457899999999999998875322 45889999999999999999999 899999
Q ss_pred ccccCCceeeCCCCceEecccccccccCCc------CCCccccccccccC-----CCCcCccccchhHHHHHHHHHhCCC
Q 042634 258 CDLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGM-----GSEVSTSGDVYSFGILLLETFTGKR 326 (427)
Q Consensus 258 rDlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~-----~~~~~~~~DiwS~G~vl~ell~g~~ 326 (427)
|||||+||++++++.+||+|||+++..... ..++..|+|||++. ...++.++|||||||++|||++|..
T Consensus 135 ~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~ 214 (272)
T cd06637 135 RDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 214 (272)
T ss_pred CCCCHHHEEECCCCCEEEccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999865322 25778899999986 3457889999999999999999999
Q ss_pred CCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCC
Q 042634 327 PTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMN 406 (427)
Q Consensus 327 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt 406 (427)
||...... .... ...... . +......++.++.+++.+||..||.+|||
T Consensus 215 p~~~~~~~----~~~~-~~~~~~-----~----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt 262 (272)
T cd06637 215 PLCDMHPM----RALF-LIPRNP-----A----------------------PRLKSKKWSKKFQSFIESCLVKNHSQRPT 262 (272)
T ss_pred CccccCHH----HHHH-HHhcCC-----C----------------------CCCCCCCcCHHHHHHHHHHcCCChhhCCC
Confidence 98643110 0000 000000 0 00011224456899999999999999999
Q ss_pred HHHHHH
Q 042634 407 MEEVAA 412 (427)
Q Consensus 407 ~~ev~~ 412 (427)
++|+++
T Consensus 263 ~~~il~ 268 (272)
T cd06637 263 TEQLMK 268 (272)
T ss_pred HHHHhh
Confidence 999976
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-32 Score=255.89 Aligned_cols=204 Identities=23% Similarity=0.396 Sum_probs=153.2
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhh-------hhccCHHHHHHHHHHHHHHHHHHhhcC
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREA-------LKNLNLLQRLSIAVDVASALDYLHHYC 251 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-------~~~l~~~~~~~~~~~i~~~L~~LH~~~ 251 (427)
++||||+++++.+.. +...+++|||+++|+|.+++...... ...+++.++..++.|++.||+|||
T Consensus 76 l~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH--- 147 (296)
T cd05095 76 LKDPNIIRLLAVCIT-----SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS--- 147 (296)
T ss_pred CCCCCcceEEEEEec-----CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---
Confidence 579999999987533 45689999999999999988653211 124778899999999999999999
Q ss_pred CCCeeeccccCCceeeCCCCceEecccccccccCCcC--------CCccccccccccCCCCcCccccchhHHHHHHHHHh
Q 042634 252 ETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEAT--------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT 323 (427)
Q Consensus 252 ~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~--------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~ 323 (427)
+.|++||||||+||+++.++.+||+|||.++...... .++..|+|||...+..++.++|||||||++|||++
T Consensus 148 ~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~ 227 (296)
T cd05095 148 SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227 (296)
T ss_pred HCCeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHH
Confidence 8999999999999999999999999999998653221 23467999999888889999999999999999998
Q ss_pred --CCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCC
Q 042634 324 --GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELP 401 (427)
Q Consensus 324 --g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP 401 (427)
|..||...... ............ ..... . ...+..++..+.+++.+||+.||
T Consensus 228 ~~~~~p~~~~~~~--~~~~~~~~~~~~----~~~~~------------------~--~~~~~~~~~~~~~li~~cl~~~p 281 (296)
T cd05095 228 LCKEQPYSQLSDE--QVIENTGEFFRD----QGRQV------------------Y--LPKPALCPDSLYKLMLSCWRRNA 281 (296)
T ss_pred hCCCCCccccChH--HHHHHHHHHHhh----ccccc------------------c--CCCCCCCCHHHHHHHHHHcCCCc
Confidence 77887643111 111000000000 00000 0 00122345678999999999999
Q ss_pred CCCCCHHHHHHHHHH
Q 042634 402 RERMNMEEVAAQLLS 416 (427)
Q Consensus 402 ~~Rpt~~ev~~~L~~ 416 (427)
++|||+.||++.|++
T Consensus 282 ~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 282 KERPSFQEIHATLLE 296 (296)
T ss_pred ccCCCHHHHHHHHhC
Confidence 999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=252.04 Aligned_cols=194 Identities=23% Similarity=0.380 Sum_probs=154.6
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++.+.. ...++||||+++++|.+++..... ..+++..+..++.|++.||+||| ..|++||
T Consensus 53 l~h~~iv~~~~~~~~------~~~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~ 121 (257)
T cd05040 53 LDHENLIRLYGVVLT------HPLMMVTELAPLGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLE---SKRFIHR 121 (257)
T ss_pred cCCCCccceeEEEcC------CeEEEEEEecCCCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHH---hCCcccc
Confidence 579999999887533 567999999999999999876532 35889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc---------CCCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA---------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPT 328 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~---------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf 328 (427)
||||+||+++.++.+||+|||.++..... ..++..|+|||++.+..++.++|||||||++|||++ |..||
T Consensus 122 di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~ 201 (257)
T cd05040 122 DLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPW 201 (257)
T ss_pred ccCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999876442 245678999999988899999999999999999998 99998
Q ss_pred CcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 042634 329 NEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME 408 (427)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ 408 (427)
...... ......... . .. ...+...+..+.+++.+||+.+|++|||+.
T Consensus 202 ~~~~~~--~~~~~~~~~--~------~~----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 249 (257)
T cd05040 202 AGLSGS--QILKKIDKE--G------ER----------------------LERPEACPQDIYNVMLQCWAHNPADRPTFA 249 (257)
T ss_pred CCCCHH--HHHHHHHhc--C------Cc----------------------CCCCccCCHHHHHHHHHHCCCCcccCCCHH
Confidence 643111 111111000 0 00 001122456789999999999999999999
Q ss_pred HHHHHHH
Q 042634 409 EVAAQLL 415 (427)
Q Consensus 409 ev~~~L~ 415 (427)
|+++.|.
T Consensus 250 ~~~~~l~ 256 (257)
T cd05040 250 ALREFLP 256 (257)
T ss_pred HHHHHhc
Confidence 9999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-33 Score=266.08 Aligned_cols=193 Identities=19% Similarity=0.227 Sum_probs=150.2
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
.+||||+++++.+.. +...++||||+++|+|.+++.... ..+++..+..++.|++.||+||| +.||+||
T Consensus 58 ~~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~ 126 (330)
T cd05601 58 SNSPWIPQLQYAFQD-----KDNLYLVMEYQPGGDLLSLLNRYE---DQFDEDMAQFYLAELVLAIHSVH---QMGYVHR 126 (330)
T ss_pred CCCCCCcceeeEEec-----CCeEEEEECCCCCCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeEcc
Confidence 579999999887433 567899999999999999986542 35899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc-------CCCccccccccccC------CCCcCccccchhHHHHHHHHHhCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA-------TNNFFNFQIAEYGM------GSEVSTSGDVYSFGILLLETFTGK 325 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-------~~~~~~y~aPE~~~------~~~~~~~~DiwS~G~vl~ell~g~ 325 (427)
||||+||+++.++.+||+|||+++..... ..++..|+|||++. ...++.++|||||||++|||++|+
T Consensus 127 Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~ 206 (330)
T cd05601 127 DIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206 (330)
T ss_pred cCchHheEECCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCC
Confidence 99999999999999999999999865432 25788999999986 456789999999999999999999
Q ss_pred CCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCC
Q 042634 326 RPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERM 405 (427)
Q Consensus 326 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rp 405 (427)
.||..... .......... ..... +. .....+.++.+++.+|++ +|++||
T Consensus 207 ~Pf~~~~~-----~~~~~~i~~~------~~~~~----------------~~---~~~~~~~~~~~li~~ll~-~p~~R~ 255 (330)
T cd05601 207 SPFHEGTS-----AKTYNNIMNF------QRFLK----------------FP---EDPKVSSDFLDLIQSLLC-GQKERL 255 (330)
T ss_pred CCCCCCCH-----HHHHHHHHcC------CCccC----------------CC---CCCCCCHHHHHHHHHHcc-ChhhCC
Confidence 99975311 1111110000 00000 00 011234568889999998 999999
Q ss_pred CHHHHHHH
Q 042634 406 NMEEVAAQ 413 (427)
Q Consensus 406 t~~ev~~~ 413 (427)
|+++++++
T Consensus 256 t~~~l~~h 263 (330)
T cd05601 256 GYEGLCCH 263 (330)
T ss_pred CHHHHhCC
Confidence 99998853
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-32 Score=265.79 Aligned_cols=224 Identities=18% Similarity=0.197 Sum_probs=151.4
Q ss_pred cccccchhhhccccccC-CCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 042634 179 IRHRNLVKIITSCASVD-FQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVH 257 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~-~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivH 257 (427)
++||||+++++.+.... +......++||||++ +++.+.+. ..+++..+..++.|++.||+||| ++||+|
T Consensus 73 l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH---~~givH 142 (355)
T cd07874 73 VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQ------MELDHERMSYLLYQMLCGIKHLH---SAGIIH 142 (355)
T ss_pred hCCCchhceeeeeeccccccccceeEEEhhhhc-ccHHHHHh------hcCCHHHHHHHHHHHHHHHHHHH---hCCccc
Confidence 57999999998764321 122345689999995 56666553 23788899999999999999999 899999
Q ss_pred ccccCCceeeCCCCceEecccccccccCCc-----CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 258 CDLKPSNVLLDGELTAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 258 rDlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
|||||+||+++.++.+||+|||+++..... ..++..|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 143 rDikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 222 (355)
T cd07874 143 RDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_pred CCCChHHEEECCCCCEEEeeCcccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999999875433 267889999999999999999999999999999999999997532
Q ss_pred CCCccHHHHHHHhcc--cchhcccCccccccccccch------hhhcccccc-ccccchHHHHHHHHHHHhhcCCCCCCC
Q 042634 333 TGNLTLHNFVKEALP--ERLAEIVDPVLLVEREEGET------SKANAHKQF-TRSFSVKECLVSVLGIGVTCSSELPRE 403 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~-~~~~~~~~~~~~~~~l~~~cl~~dP~~ 403 (427)
.. ..+...+..... ........+........... ........+ ...........++.+++.+|++.||++
T Consensus 223 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~ 301 (355)
T cd07874 223 YI-DQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 301 (355)
T ss_pred HH-HHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchh
Confidence 11 111111111100 00000000000000000000 000000000 000111223456889999999999999
Q ss_pred CCCHHHHHHH
Q 042634 404 RMNMEEVAAQ 413 (427)
Q Consensus 404 Rpt~~ev~~~ 413 (427)
|||+.|++++
T Consensus 302 Rps~~ell~h 311 (355)
T cd07874 302 RISVDEALQH 311 (355)
T ss_pred cCCHHHHhcC
Confidence 9999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-32 Score=253.92 Aligned_cols=194 Identities=21% Similarity=0.246 Sum_probs=149.4
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++.+.. ....++||||+++++|.+++... ..+++.+++.++.|++.|++||| ..|++||
T Consensus 63 l~h~~ii~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~ 130 (267)
T cd06645 63 CKHSNIVAYFGSYLR-----RDKLWICMEFCGGGSLQDIYHVT----GPLSESQIAYVSRETLQGLYYLH---SKGKMHR 130 (267)
T ss_pred CCCCCeeeEEEEEEe-----CCEEEEEEeccCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecC
Confidence 579999999987543 56789999999999999988654 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccC---CCCcCccccchhHHHHHHHHHhCCCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGM---GSEVSTSGDVYSFGILLLETFTGKRPTN 329 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~---~~~~~~~~DiwS~G~vl~ell~g~~pf~ 329 (427)
||||+||+++.++.+||+|||++...... ..++..|+|||++. ...++.++||||+||++|||++|..||.
T Consensus 131 dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~ 210 (267)
T cd06645 131 DIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMF 210 (267)
T ss_pred CCCHHHEEECCCCCEEECcceeeeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcc
Confidence 99999999999999999999998754322 26788999999874 4557899999999999999999999986
Q ss_pred cccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 042634 330 EMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEE 409 (427)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~e 409 (427)
....... .......... .+.. ......+..+.+++.+||+.+|++|||++|
T Consensus 211 ~~~~~~~-~~~~~~~~~~-------~~~~---------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ 261 (267)
T cd06645 211 DLHPMRA-LFLMTKSNFQ-------PPKL---------------------KDKMKWSNSFHHFVKMALTKNPKKRPTAEK 261 (267)
T ss_pred cccchhh-HHhhhccCCC-------CCcc---------------------cccCCCCHHHHHHHHHHccCCchhCcCHHH
Confidence 4321110 0000000000 0000 000113445789999999999999999999
Q ss_pred HHHH
Q 042634 410 VAAQ 413 (427)
Q Consensus 410 v~~~ 413 (427)
++++
T Consensus 262 ll~~ 265 (267)
T cd06645 262 LLQH 265 (267)
T ss_pred HhcC
Confidence 8763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-32 Score=257.15 Aligned_cols=201 Identities=19% Similarity=0.199 Sum_probs=153.3
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeecc
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCD 259 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrD 259 (427)
+|||++++++.+.......+...++||||+++++|.+++.........+++..+..++.|++.||.||| +.+++|||
T Consensus 73 ~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~d 149 (286)
T cd06638 73 DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRD 149 (286)
T ss_pred cCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccC
Confidence 699999999987554444456789999999999999887533222245888999999999999999999 89999999
Q ss_pred ccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCC-----CCcCccccchhHHHHHHHHHhCCCCC
Q 042634 260 LKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMG-----SEVSTSGDVYSFGILLLETFTGKRPT 328 (427)
Q Consensus 260 lkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~-----~~~~~~~DiwS~G~vl~ell~g~~pf 328 (427)
|||+||+++.++.+||+|||+++..... ..++..|+|||++.. ..++.++||||+||++|||++|+.||
T Consensus 150 lkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~ 229 (286)
T cd06638 150 VKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229 (286)
T ss_pred CCHHhEEECCCCCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCC
Confidence 9999999999999999999999765332 257889999998753 45788999999999999999999998
Q ss_pred CcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 042634 329 NEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME 408 (427)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ 408 (427)
..... .... ...... .... ...+..++.++.+++.+||+.||++|||+.
T Consensus 230 ~~~~~----~~~~-~~~~~~-----~~~~---------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 278 (286)
T cd06638 230 ADLHP----MRAL-FKIPRN-----PPPT---------------------LHQPELWSNEFNDFIRKCLTKDYEKRPTVS 278 (286)
T ss_pred CCCch----hHHH-hhcccc-----CCCc---------------------ccCCCCcCHHHHHHHHHHccCCcccCCCHH
Confidence 65311 0000 000000 0000 001112345688999999999999999999
Q ss_pred HHHHHH
Q 042634 409 EVAAQL 414 (427)
Q Consensus 409 ev~~~L 414 (427)
|+++..
T Consensus 279 ell~~~ 284 (286)
T cd06638 279 DLLQHV 284 (286)
T ss_pred HHhhcc
Confidence 998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-32 Score=260.26 Aligned_cols=199 Identities=24% Similarity=0.400 Sum_probs=156.8
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchh------------hhhccCHHHHHHHHHHHHHHHHHH
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNRE------------ALKNLNLLQRLSIAVDVASALDYL 247 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~~~~~i~~~L~~L 247 (427)
+||||+++++.+.. ....+++|||+++|+|.+++..... ....+++.+++.++.|++.||+||
T Consensus 76 ~h~~iv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L 150 (334)
T cd05100 76 KHKNIINLLGACTQ-----DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL 150 (334)
T ss_pred CCCCeeeeeEEEcc-----CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHH
Confidence 79999999998644 4568999999999999998864321 113478889999999999999999
Q ss_pred hhcCCCCeeeccccCCceeeCCCCceEecccccccccCCcC--------CCccccccccccCCCCcCccccchhHHHHHH
Q 042634 248 HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEAT--------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLL 319 (427)
Q Consensus 248 H~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~--------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ 319 (427)
| ++|++||||||+||+++.++.+||+|||.++...... .++..|+|||++.+..++.++|||||||++|
T Consensus 151 H---~~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 227 (334)
T cd05100 151 A---SQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLW 227 (334)
T ss_pred H---HCCeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHH
Confidence 9 8999999999999999999999999999998653321 3345799999999999999999999999999
Q ss_pred HHHh-CCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCC
Q 042634 320 ETFT-GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSS 398 (427)
Q Consensus 320 ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~ 398 (427)
||++ |..||.... ..+........... ..+..++.++.+++.+||+
T Consensus 228 el~~~g~~p~~~~~-----~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~cl~ 274 (334)
T cd05100 228 EIFTLGGSPYPGIP-----VEELFKLLKEGHRM----------------------------DKPANCTHELYMIMRECWH 274 (334)
T ss_pred HHHhcCCCCCCCCC-----HHHHHHHHHcCCCC----------------------------CCCCCCCHHHHHHHHHHcc
Confidence 9998 888886531 11111111000000 0112245678999999999
Q ss_pred CCCCCCCCHHHHHHHHHHHHH
Q 042634 399 ELPRERMNMEEVAAQLLSFRN 419 (427)
Q Consensus 399 ~dP~~Rpt~~ev~~~L~~~~~ 419 (427)
.+|++|||+.|+++.|+++..
T Consensus 275 ~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 275 AVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred cChhhCcCHHHHHHHHHHHhh
Confidence 999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-32 Score=255.52 Aligned_cols=203 Identities=23% Similarity=0.382 Sum_probs=152.2
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchh--------hhhccCHHHHHHHHHHHHHHHHHHhhc
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNRE--------ALKNLNLLQRLSIAVDVASALDYLHHY 250 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~~l~~~~~~~~~~~i~~~L~~LH~~ 250 (427)
++|||++++++.+.. ....++||||+++++|.+++..... ....+++..+..++.|++.||+|||
T Consensus 74 l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH-- 146 (295)
T cd05097 74 LKNPNIIRLLGVCVS-----DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA-- 146 (295)
T ss_pred CCCCCcCeEEEEEcC-----CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH--
Confidence 569999999998643 5678999999999999998854321 0123678899999999999999999
Q ss_pred CCCCeeeccccCCceeeCCCCceEecccccccccCCcC--------CCccccccccccCCCCcCccccchhHHHHHHHHH
Q 042634 251 CETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEAT--------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETF 322 (427)
Q Consensus 251 ~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~--------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell 322 (427)
+.|++||||||+||+++.++.+||+|||+++...... .++..|+|||++....++.++|||||||++|||+
T Consensus 147 -~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~ 225 (295)
T cd05097 147 -SLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMF 225 (295)
T ss_pred -hcCeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHH
Confidence 8999999999999999999999999999997653221 3356899999998888999999999999999999
Q ss_pred h--CCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCC
Q 042634 323 T--GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSEL 400 (427)
Q Consensus 323 ~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~d 400 (427)
+ |..||..... ............. ...... ...+..++..+.+++++||+.|
T Consensus 226 ~~~~~~p~~~~~~--~~~~~~~~~~~~~----~~~~~~--------------------~~~~~~~~~~l~~li~~~l~~~ 279 (295)
T cd05097 226 TLCKEQPYSLLSD--EQVIENTGEFFRN----QGRQIY--------------------LSQTPLCPSPVFKLMMRCWSRD 279 (295)
T ss_pred HcCCCCCCcccCh--HHHHHHHHHhhhh----cccccc--------------------CCCCCCCCHHHHHHHHHHcCCC
Confidence 8 5667764311 1111111110000 000000 0011123567999999999999
Q ss_pred CCCCCCHHHHHHHHH
Q 042634 401 PRERMNMEEVAAQLL 415 (427)
Q Consensus 401 P~~Rpt~~ev~~~L~ 415 (427)
|++|||+++|++.|+
T Consensus 280 p~~RPs~~~i~~~l~ 294 (295)
T cd05097 280 IKDRPTFNKIHHFLR 294 (295)
T ss_pred chhCcCHHHHHHHHh
Confidence 999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-32 Score=266.99 Aligned_cols=141 Identities=21% Similarity=0.301 Sum_probs=124.3
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+++|+|.+++... ..+++..++.++.|++.||+||| ..||+||
T Consensus 58 l~h~~iv~l~~~~~~-----~~~~~lv~E~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~~LH---~~givHr 125 (381)
T cd05626 58 ADNEWVVKLYYSFQD-----KDNLYFVMDYIPGGDMMSLLIRM----EVFPEVLARFYIAELTLAIESVH---KMGFIHR 125 (381)
T ss_pred cCCCCeeeeEEEEec-----CCEEEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeec
Confidence 579999999988543 56789999999999999998654 34889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccC-----------------------------------------------------
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLP----------------------------------------------------- 285 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~----------------------------------------------------- 285 (427)
||||+|||++.++++||+|||+++...
T Consensus 126 DlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (381)
T cd05626 126 DIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLA 205 (381)
T ss_pred CCcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhcccccccccccc
Confidence 999999999999999999999975321
Q ss_pred CcCCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 286 EATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 286 ~~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
....||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 206 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~ 251 (381)
T cd05626 206 HSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAP 251 (381)
T ss_pred ccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCC
Confidence 0125888999999999989999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-32 Score=264.25 Aligned_cols=223 Identities=18% Similarity=0.206 Sum_probs=150.2
Q ss_pred cccccchhhhccccccC-CCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 042634 179 IRHRNLVKIITSCASVD-FQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVH 257 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~-~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivH 257 (427)
++||||+++++.+.... +......++||||+. +++.+.+. ..+++..+..++.|++.||+||| ++||+|
T Consensus 77 l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH 146 (359)
T cd07876 77 VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIH------MELDHERMSYLLYQMLCGIKHLH---SAGIIH 146 (359)
T ss_pred CCCCCEeeeeeeeccCCCccccceeEEEEeCCC-cCHHHHHh------ccCCHHHHHHHHHHHHHHHHHHH---hCCccc
Confidence 57999999998764321 112235689999995 56665553 23788889999999999999999 899999
Q ss_pred ccccCCceeeCCCCceEecccccccccCCc-----CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 258 CDLKPSNVLLDGELTAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 258 rDlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
|||||+||+++.++.+||+|||+++..... ..++..|+|||++.+..++.++||||+||++|||++|+.||.+..
T Consensus 147 rDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~ 226 (359)
T cd07876 147 RDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD 226 (359)
T ss_pred CCCCHHHEEECCCCCEEEecCCCccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999999865332 267889999999999999999999999999999999999997542
Q ss_pred CCCccHHHHHHHhcccchhcccCcc-------ccccccccchhhhcccccc---ccccchHHHHHHHHHHHhhcCCCCCC
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPV-------LLVEREEGETSKANAHKQF---TRSFSVKECLVSVLGIGVTCSSELPR 402 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~~cl~~dP~ 402 (427)
. ...+.........+ ..+..+.. ..................+ .........+.++.+++.+||+.||+
T Consensus 227 ~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~ 304 (359)
T cd07876 227 H-IDQWNKVIEQLGTP-SAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPD 304 (359)
T ss_pred H-HHHHHHHHHhcCCC-cHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcc
Confidence 1 11111111111000 00000000 0000000000000000000 00001122346688999999999999
Q ss_pred CCCCHHHHHHH
Q 042634 403 ERMNMEEVAAQ 413 (427)
Q Consensus 403 ~Rpt~~ev~~~ 413 (427)
+|||++|++++
T Consensus 305 ~R~t~~e~l~h 315 (359)
T cd07876 305 KRISVDEALRH 315 (359)
T ss_pred cCCCHHHHhcC
Confidence 99999999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-32 Score=269.77 Aligned_cols=139 Identities=25% Similarity=0.375 Sum_probs=121.3
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||++++.+.. +...++|||++ .++|.+++.... ..+++.+++.++.|++.||.||| +.||+||
T Consensus 217 L~HpnIv~l~~~~~~-----~~~~~lv~e~~-~~~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHr 284 (461)
T PHA03211 217 LSHPAVLALLDVRVV-----GGLTCLVLPKY-RSDLYTYLGARL---RPLGLAQVTAVARQLLSAIDYIH---GEGIIHR 284 (461)
T ss_pred CCCCCCCcEEEEEEE-----CCEEEEEEEcc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCEEEC
Confidence 579999999987543 45789999999 578888875432 35899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc--------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA--------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTN 329 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~ 329 (427)
||||+|||++.++.+||+|||+++..... ..||..|+|||++.+..++.++|||||||++|||++|..|+.
T Consensus 285 DLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 285 DIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred cCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 99999999999999999999999865322 258999999999999999999999999999999999887653
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-32 Score=265.33 Aligned_cols=224 Identities=17% Similarity=0.198 Sum_probs=152.0
Q ss_pred cccccchhhhccccccC-CCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 042634 179 IRHRNLVKIITSCASVD-FQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVH 257 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~-~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivH 257 (427)
++||||+++++.+.... +......++||||++ ++|.+++. ..+++..+..++.|++.||+||| ++||+|
T Consensus 80 l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH 149 (364)
T cd07875 80 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQ------MELDHERMSYLLYQMLCGIKHLH---SAGIIH 149 (364)
T ss_pred cCCCCccccceeecccccccccCeEEEEEeCCC-CCHHHHHH------hcCCHHHHHHHHHHHHHHHHHHh---hCCeec
Confidence 67999999998754322 122345799999995 56766663 23788889999999999999999 899999
Q ss_pred ccccCCceeeCCCCceEecccccccccCCc-----CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 258 CDLKPSNVLLDGELTAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 258 rDlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
|||||+||+++.++.+||+|||+++..... ..++..|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 150 ~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 229 (364)
T cd07875 150 RDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229 (364)
T ss_pred CCCCHHHEEECCCCcEEEEeCCCccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999999865432 267889999999999999999999999999999999999997532
Q ss_pred CCCccHHHHHHHhcc--cchhcccCccccccccccchhh-hcccccc------ccccchHHHHHHHHHHHhhcCCCCCCC
Q 042634 333 TGNLTLHNFVKEALP--ERLAEIVDPVLLVEREEGETSK-ANAHKQF------TRSFSVKECLVSVLGIGVTCSSELPRE 403 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~------~~~~~~~~~~~~~~~l~~~cl~~dP~~ 403 (427)
. ...+...+..... +.....+.+............. ......+ ...........++.+++.+|++.||.+
T Consensus 230 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~ 308 (364)
T cd07875 230 H-IDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASK 308 (364)
T ss_pred H-HHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCccc
Confidence 1 1111111111000 0011111100000000000000 0000000 000011123456889999999999999
Q ss_pred CCCHHHHHHH
Q 042634 404 RMNMEEVAAQ 413 (427)
Q Consensus 404 Rpt~~ev~~~ 413 (427)
|||++|++++
T Consensus 309 R~t~~e~L~h 318 (364)
T cd07875 309 RISVDEALQH 318 (364)
T ss_pred CCCHHHHhcC
Confidence 9999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=266.34 Aligned_cols=192 Identities=18% Similarity=0.250 Sum_probs=149.7
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. +...++||||+++|+|.+++... ..+++..++.++.|++.||+||| +.||+||
T Consensus 58 l~h~~iv~~~~~~~~-----~~~~~lv~E~~~~g~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~ 125 (364)
T cd05599 58 ADNPWVVKLYYSFQD-----ENYLYLIMEYLPGGDMMTLLMKK----DTFTEEETRFYIAETILAIDSIH---KLGYIHR 125 (364)
T ss_pred CCCCCCcceEEEEEc-----CCeEEEEECCCCCcHHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEec
Confidence 459999999988543 67889999999999999998654 34899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc--------------------------------------------CCCcccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA--------------------------------------------TNNFFNF 294 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~--------------------------------------------~~~~~~y 294 (427)
||||+|||++.++.+||+|||+++..... ..||+.|
T Consensus 126 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 205 (364)
T cd05599 126 DIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDY 205 (364)
T ss_pred cCCHHHeEECCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccc
Confidence 99999999999999999999998754211 2488999
Q ss_pred ccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhcccc
Q 042634 295 QIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHK 374 (427)
Q Consensus 295 ~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 374 (427)
+|||++....++.++|||||||++|||++|..||..... .+........ .....
T Consensus 206 ~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~-----~~~~~~i~~~------~~~~~--------------- 259 (364)
T cd05599 206 IAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNP-----QETYRKIINW------KETLQ--------------- 259 (364)
T ss_pred cCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCH-----HHHHHHHHcC------CCccC---------------
Confidence 999999999999999999999999999999999975321 1111110000 00000
Q ss_pred ccccccchHHHHHHHHHHHhhcCCCCCCCCCC---HHHHHHH
Q 042634 375 QFTRSFSVKECLVSVLGIGVTCSSELPRERMN---MEEVAAQ 413 (427)
Q Consensus 375 ~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt---~~ev~~~ 413 (427)
+. .....+.++.+++.+|+. +|.+|++ ++|++++
T Consensus 260 -~~---~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 260 -FP---DEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred -CC---CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 00 000124567889999996 9999998 8888763
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-33 Score=268.25 Aligned_cols=140 Identities=21% Similarity=0.274 Sum_probs=124.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+. ++...++||||+++|+|.+++... ..+++..++.++.|++.||+||| +.||+||
T Consensus 58 l~hp~iv~~~~~~~-----~~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH---~~givHr 125 (377)
T cd05629 58 SDSPWVVSLYYSFQ-----DAQYLYLIMEFLPGGDLMTMLIKY----DTFSEDVTRFYMAECVLAIEAVH---KLGFIHR 125 (377)
T ss_pred CCCCCcceEEEEEE-----cCCeeEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecc
Confidence 57999999998854 366789999999999999998654 45889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC----------------------------------------------------
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE---------------------------------------------------- 286 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~---------------------------------------------------- 286 (427)
||||+|||++.++.+||+|||+|+....
T Consensus 126 Dlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (377)
T cd05629 126 DIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMA 205 (377)
T ss_pred CCCHHHEEECCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccc
Confidence 9999999999999999999999863210
Q ss_pred -cCCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCc
Q 042634 287 -ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNE 330 (427)
Q Consensus 287 -~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~ 330 (427)
...||+.|+|||++.+..++.++|||||||++|||++|..||..
T Consensus 206 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~ 250 (377)
T cd05629 206 YSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCS 250 (377)
T ss_pred cccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCC
Confidence 12588899999999999999999999999999999999999965
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-32 Score=266.06 Aligned_cols=192 Identities=20% Similarity=0.239 Sum_probs=147.3
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+. .+...++||||+++|+|.+++... .+++..+..++.||+.||+||| +.||+||
T Consensus 100 ~~hp~iv~~~~~~~-----~~~~~~lv~Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH---~~~IvHr 166 (370)
T cd05621 100 ANSPWVVQLFCAFQ-----DDKYLYMVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIH---SMGLIHR 166 (370)
T ss_pred CCCCCEeeEEEEEE-----cCCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEec
Confidence 67999999998743 366789999999999999988543 3788999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc-------CCCccccccccccCCCC----cCccccchhHHHHHHHHHhCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA-------TNNFFNFQIAEYGMGSE----VSTSGDVYSFGILLLETFTGKRP 327 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-------~~~~~~y~aPE~~~~~~----~~~~~DiwS~G~vl~ell~g~~p 327 (427)
||||+|||++.++.+||+|||+|+..... ..||..|+|||++.+.. ++.++||||+||++|||++|+.|
T Consensus 167 DLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~P 246 (370)
T cd05621 167 DVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246 (370)
T ss_pred CCCHHHEEECCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCC
Confidence 99999999999999999999999865322 25899999999987643 78899999999999999999999
Q ss_pred CCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCC--CC
Q 042634 328 TNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRE--RM 405 (427)
Q Consensus 328 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~--Rp 405 (427)
|..... ...... +.+..... .+. .....+..+.+++.+|+..+|.+ |+
T Consensus 247 f~~~~~-----~~~~~~--------i~~~~~~~--------------~~p---~~~~~s~~~~~li~~~L~~~~~r~~R~ 296 (370)
T cd05621 247 FYADSL-----VGTYSK--------IMDHKNSL--------------NFP---EDVEISKHAKNLICAFLTDREVRLGRN 296 (370)
T ss_pred CCCCCH-----HHHHHH--------HHhCCccc--------------CCC---CcccCCHHHHHHHHHHccCchhccCCC
Confidence 975311 111111 11000000 000 01123455778899999855543 89
Q ss_pred CHHHHHHH
Q 042634 406 NMEEVAAQ 413 (427)
Q Consensus 406 t~~ev~~~ 413 (427)
|++|++++
T Consensus 297 ~~~e~l~h 304 (370)
T cd05621 297 GVEEIKQH 304 (370)
T ss_pred CHHHHhcC
Confidence 99999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-33 Score=254.12 Aligned_cols=192 Identities=20% Similarity=0.244 Sum_probs=153.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++.+.+. .+...+++|||+++|+|.+++..... ..+++..++.++.|++.||.||| +.||+|+
T Consensus 55 l~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~ 124 (255)
T cd08219 55 MKHPNIVAFKESFE-----ADGHLYIVMEYCDGGDLMQKIKLQRG--KLFPEDTILQWFVQMCLGVQHIH---EKRVLHR 124 (255)
T ss_pred CCCCCcceEEEEEE-----ECCEEEEEEeeCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHh---hCCcccC
Confidence 57999999998753 35678999999999999988764322 45789999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+||++++++.++++|||.++..... ..++..|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 125 dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~ 204 (255)
T cd08219 125 DIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS 204 (255)
T ss_pred CCCcceEEECCCCcEEEcccCcceeecccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC
Confidence 99999999999999999999999865432 257788999999988889999999999999999999999996421
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
.............. ..+...+..+.+++.+||+.||++|||+.|++.
T Consensus 205 -----~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 251 (255)
T cd08219 205 -----WKNLILKVCQGSYK----------------------------PLPSHYSYELRSLIKQMFKRNPRSRPSATTILS 251 (255)
T ss_pred -----HHHHHHHHhcCCCC----------------------------CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhh
Confidence 11111111000000 011223456889999999999999999999986
Q ss_pred H
Q 042634 413 Q 413 (427)
Q Consensus 413 ~ 413 (427)
.
T Consensus 252 ~ 252 (255)
T cd08219 252 R 252 (255)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=254.75 Aligned_cols=195 Identities=19% Similarity=0.237 Sum_probs=149.8
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++.+.. +...++||||+++++|.+++... ..+++..+..++.|++.|++||| +.||+||
T Consensus 63 ~~h~~ii~~~~~~~~-----~~~~~iv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~ 130 (267)
T cd06646 63 CKHCNIVAYFGSYLS-----REKLWICMEYCGGGSLQDIYHVT----GPLSELQIAYVCRETLQGLAYLH---SKGKMHR 130 (267)
T ss_pred cCCCCeeeeeEEEEe-----CCEEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccc
Confidence 579999999988543 46789999999999999988644 35889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccC---CCCcCccccchhHHHHHHHHHhCCCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGM---GSEVSTSGDVYSFGILLLETFTGKRPTN 329 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~---~~~~~~~~DiwS~G~vl~ell~g~~pf~ 329 (427)
||||+||+++.++.+||+|||+++..... ..++..|+|||.+. ...++.++|||||||++|||++|+.||.
T Consensus 131 dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~ 210 (267)
T cd06646 131 DIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMF 210 (267)
T ss_pred CCCHHHEEECCCCCEEECcCccceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCcc
Confidence 99999999999999999999999865322 25677899999874 3457889999999999999999999986
Q ss_pred cccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 042634 330 EMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEE 409 (427)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~e 409 (427)
....... . ............ .......+.++.+++.+||+.+|++|||+++
T Consensus 211 ~~~~~~~-~------------~~~~~~~~~~~~----------------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~ 261 (267)
T cd06646 211 DLHPMRA-L------------FLMSKSNFQPPK----------------LKDKTKWSSTFHNFVKISLTKNPKKRPTAER 261 (267)
T ss_pred ccchhhh-h------------eeeecCCCCCCC----------------CccccccCHHHHHHHHHHhhCChhhCcCHHH
Confidence 4311100 0 000000000000 0001123457889999999999999999999
Q ss_pred HHHHH
Q 042634 410 VAAQL 414 (427)
Q Consensus 410 v~~~L 414 (427)
+++.+
T Consensus 262 il~~l 266 (267)
T cd06646 262 LLTHL 266 (267)
T ss_pred HhcCC
Confidence 98754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-32 Score=249.43 Aligned_cols=194 Identities=25% Similarity=0.423 Sum_probs=153.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++.+.. ...+++|||+++++|.+++..... ..+++..+..++.|++.|+.||| +.|++||
T Consensus 56 ~~~~~i~~~~~~~~~------~~~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~ 124 (254)
T cd05083 56 LHHKNLVRLLGVILH------NGLYIVMELMSKGNLVNFLRTRGR--ALVSVIQLLQFSLDVAEGMEYLE---SKKLVHR 124 (254)
T ss_pred CCCCCcCeEEEEEcC------CCcEEEEECCCCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecc
Confidence 579999999887532 246899999999999999865432 35789999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC---CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCCcccCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT---NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNEMFTG 334 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~---~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~~~~~~ 334 (427)
||||+||+++.++.+||+|||.++...... ..+..|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 125 dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~- 203 (254)
T cd05083 125 DLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL- 203 (254)
T ss_pred ccCcceEEEcCCCcEEECCCccceeccccCCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH-
Confidence 999999999999999999999998654322 34467999999988889999999999999999998 9999865311
Q ss_pred CccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 042634 335 NLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAAQL 414 (427)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L 414 (427)
....... ..... ...+..++.++.+++.+||+.+|++|||++++++.|
T Consensus 204 ----~~~~~~~---------~~~~~-------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l 251 (254)
T cd05083 204 ----KEVKECV---------EKGYR-------------------MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKL 251 (254)
T ss_pred ----HHHHHHH---------hCCCC-------------------CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 1111100 00000 001123456788999999999999999999999988
Q ss_pred HH
Q 042634 415 LS 416 (427)
Q Consensus 415 ~~ 416 (427)
++
T Consensus 252 ~~ 253 (254)
T cd05083 252 EK 253 (254)
T ss_pred cc
Confidence 63
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-32 Score=255.31 Aligned_cols=198 Identities=21% Similarity=0.351 Sum_probs=153.2
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchh------hhhccCHHHHHHHHHHHHHHHHHHhhcCC
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNRE------ALKNLNLLQRLSIAVDVASALDYLHHYCE 252 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~------~~~~l~~~~~~~~~~~i~~~L~~LH~~~~ 252 (427)
++||||+++++.+.. +...++||||+++|+|.+++..... .....+...+..++.|++.||.||| +
T Consensus 66 l~~~~i~~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~ 137 (288)
T cd05061 66 FTCHHVVRLLGVVSK-----GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---A 137 (288)
T ss_pred CCCCCeeeEEEEEcC-----CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---h
Confidence 579999999987543 4578999999999999999864221 0123466788999999999999999 8
Q ss_pred CCeeeccccCCceeeCCCCceEecccccccccCCcC--------CCccccccccccCCCCcCccccchhHHHHHHHHHh-
Q 042634 253 TPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEAT--------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT- 323 (427)
Q Consensus 253 ~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~--------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~- 323 (427)
++|+||||||+||++++++.+||+|||+++...... .++..|+|||.+.+..++.++|||||||++||+++
T Consensus 138 ~~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~ 217 (288)
T cd05061 138 KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSL 217 (288)
T ss_pred CCCcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhC
Confidence 999999999999999999999999999998543211 34567999999998889999999999999999998
Q ss_pred CCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCC
Q 042634 324 GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRE 403 (427)
Q Consensus 324 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~ 403 (427)
|..||.+... .+.......... . ..+..++..+.+++.+||+.||++
T Consensus 218 ~~~p~~~~~~-----~~~~~~~~~~~~---~-------------------------~~~~~~~~~~~~li~~~l~~~p~~ 264 (288)
T cd05061 218 AEQPYQGLSN-----EQVLKFVMDGGY---L-------------------------DQPDNCPERVTDLMRMCWQFNPKM 264 (288)
T ss_pred CCCCCCCCCH-----HHHHHHHHcCCC---C-------------------------CCCCCCCHHHHHHHHHHcCCChhH
Confidence 7888865311 111111000000 0 011223567999999999999999
Q ss_pred CCCHHHHHHHHHHH
Q 042634 404 RMNMEEVAAQLLSF 417 (427)
Q Consensus 404 Rpt~~ev~~~L~~~ 417 (427)
|||+.|+++.|++.
T Consensus 265 Rps~~~ll~~l~~~ 278 (288)
T cd05061 265 RPTFLEIVNLLKDD 278 (288)
T ss_pred CcCHHHHHHHHHhh
Confidence 99999999888765
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=260.25 Aligned_cols=182 Identities=20% Similarity=0.252 Sum_probs=144.3
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeecc
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCD 259 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrD 259 (427)
+|++++++.+.+. .....++||||+++|+|.+++... ..+++.+++.++.|++.||+||| +.||+|||
T Consensus 59 ~~~~i~~~~~~~~-----~~~~~~lv~Ey~~~g~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH---~~~ivHrD 126 (323)
T cd05615 59 KPPFLTQLHSCFQ-----TVDRLYFVMEYVNGGDLMYHIQQV----GKFKEPQAVFYAAEISVGLFFLH---RRGIIYRD 126 (323)
T ss_pred CCCchhheeeEEe-----cCCEEEEEEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccC
Confidence 5677777777643 356789999999999999888654 35899999999999999999999 89999999
Q ss_pred ccCCceeeCCCCceEecccccccccCC------cCCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccC
Q 042634 260 LKPSNVLLDGELTAHVGDFGLAKFLPE------ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFT 333 (427)
Q Consensus 260 lkp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~ 333 (427)
|||+||+++.++.+||+|||+++.... ...|+..|+|||++.+..++.++||||+||++|||++|+.||.....
T Consensus 127 ikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~ 206 (323)
T cd05615 127 LKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE 206 (323)
T ss_pred CCHHHeEECCCCCEEEeccccccccCCCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH
Confidence 999999999999999999999875422 12588999999999998999999999999999999999999975311
Q ss_pred CCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCH
Q 042634 334 GNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM 407 (427)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~ 407 (427)
............ ..+...+.++.+++.+||+.+|.+|++.
T Consensus 207 -----~~~~~~i~~~~~-----------------------------~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 207 -----DELFQSIMEHNV-----------------------------SYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred -----HHHHHHHHhCCC-----------------------------CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 111111110000 0111234567899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=256.55 Aligned_cols=197 Identities=26% Similarity=0.441 Sum_probs=153.3
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchh------------------hhhccCHHHHHHHHHHH
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNRE------------------ALKNLNLLQRLSIAVDV 240 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~------------------~~~~l~~~~~~~~~~~i 240 (427)
++|||++++++.+.. +...+++|||+++|+|.+++..... ....+++..++.++.|+
T Consensus 65 l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i 139 (288)
T cd05050 65 FDHPNIVKLLGVCAV-----GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQV 139 (288)
T ss_pred cCCCchheEEEEEcC-----CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHH
Confidence 469999999987543 4568999999999999998863211 11347888999999999
Q ss_pred HHHHHHHhhcCCCCeeeccccCCceeeCCCCceEecccccccccCCc--------CCCccccccccccCCCCcCccccch
Q 042634 241 ASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA--------TNNFFNFQIAEYGMGSEVSTSGDVY 312 (427)
Q Consensus 241 ~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~Diw 312 (427)
+.||.||| ..+++||||||+||++++++.+||+|||.++..... ...+..|+|||...+..++.++|||
T Consensus 140 ~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~ 216 (288)
T cd05050 140 AAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVW 216 (288)
T ss_pred HHHHHHHH---hCCeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHH
Confidence 99999999 899999999999999999999999999998764322 1345579999999888999999999
Q ss_pred hHHHHHHHHHh-CCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHH
Q 042634 313 SFGILLLETFT-GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLG 391 (427)
Q Consensus 313 S~G~vl~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (427)
||||++|||++ |..||.+... .+........... ..+..++.++.+
T Consensus 217 slG~il~el~~~~~~p~~~~~~-----~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~ 263 (288)
T cd05050 217 AYGVVLWEIFSYGMQPYYGMAH-----EEVIYYVRDGNVL----------------------------SCPDNCPLELYN 263 (288)
T ss_pred HHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHhcCCCC----------------------------CCCCCCCHHHHH
Confidence 99999999997 8888864311 1111111000000 011234567899
Q ss_pred HHhhcCCCCCCCCCCHHHHHHHHHH
Q 042634 392 IGVTCSSELPRERMNMEEVAAQLLS 416 (427)
Q Consensus 392 l~~~cl~~dP~~Rpt~~ev~~~L~~ 416 (427)
++.+||+.+|++|||++|+++.|++
T Consensus 264 li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 264 LMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHHcccCcccCCCHHHHHHHhhC
Confidence 9999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-32 Score=256.00 Aligned_cols=201 Identities=20% Similarity=0.163 Sum_probs=152.8
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
.+|||++++++.+...+.......++||||+++++|.++++........+++..++.++.|++.||+||| +.|++||
T Consensus 76 ~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~ 152 (291)
T cd06639 76 PNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHR 152 (291)
T ss_pred cCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecc
Confidence 3699999999987654333345689999999999999988643222246899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC------cCCCccccccccccCCC-----CcCccccchhHHHHHHHHHhCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE------ATNNFFNFQIAEYGMGS-----EVSTSGDVYSFGILLLETFTGKRP 327 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~~y~aPE~~~~~-----~~~~~~DiwS~G~vl~ell~g~~p 327 (427)
||||+||+++.++.+||+|||.++.... ...++..|+|||.+... .++.++|||||||++|||++|+.|
T Consensus 153 dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p 232 (291)
T cd06639 153 DVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPP 232 (291)
T ss_pred CCCHHHEEEcCCCCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCC
Confidence 9999999999999999999999886532 22567889999997543 368899999999999999999999
Q ss_pred CCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCH
Q 042634 328 TNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM 407 (427)
Q Consensus 328 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~ 407 (427)
|...... ... ............ .+......+.+++.+||+.+|++|||+
T Consensus 233 ~~~~~~~----~~~-~~~~~~~~~~~~--------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~ 281 (291)
T cd06639 233 LFDMHPV----KTL-FKIPRNPPPTLL--------------------------HPEKWCRSFNHFISQCLIKDFEARPSV 281 (291)
T ss_pred CCCCcHH----HHH-HHHhcCCCCCCC--------------------------cccccCHHHHHHHHHHhhcChhhCcCH
Confidence 8753211 110 000000000000 112234568999999999999999999
Q ss_pred HHHHHH
Q 042634 408 EEVAAQ 413 (427)
Q Consensus 408 ~ev~~~ 413 (427)
.|++++
T Consensus 282 ~~il~~ 287 (291)
T cd06639 282 THLLEH 287 (291)
T ss_pred HHHhcC
Confidence 999863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-32 Score=251.39 Aligned_cols=191 Identities=23% Similarity=0.313 Sum_probs=154.2
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeecc
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCD 259 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrD 259 (427)
+|||++++++.+.. +...++||||+++++|.+++... ..+++..+..++.|+++||+||| +.|++|||
T Consensus 67 ~h~~iv~~~~~~~~-----~~~~~iv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~d 134 (267)
T PHA03390 67 DNPNFIKLYYSVTT-----LKGHVLIMDYIKDGDLFDLLKKE----GKLSEAEVKKIIRQLVEALNDLH---KHNIIHND 134 (267)
T ss_pred cCCCEEEEEEEEec-----CCeeEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCC
Confidence 69999999988544 45789999999999999998654 25899999999999999999999 89999999
Q ss_pred ccCCceeeCCCC-ceEecccccccccCCcC--CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccCCCc
Q 042634 260 LKPSNVLLDGEL-TAHVGDFGLAKFLPEAT--NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNL 336 (427)
Q Consensus 260 lkp~NIll~~~~-~~kL~DFG~a~~~~~~~--~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~~~~ 336 (427)
|||+||+++.++ .++|+|||.++...... .++..|+|||++.+..++.++||||+||++|||++|+.||........
T Consensus 135 l~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~ 214 (267)
T PHA03390 135 IKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL 214 (267)
T ss_pred CCHHHEEEeCCCCeEEEecCccceecCCCccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh
Confidence 999999999988 99999999998765433 678899999999988999999999999999999999999975433222
Q ss_pred cHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCC-HHHHHH
Q 042634 337 TLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMN-MEEVAA 412 (427)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt-~~ev~~ 412 (427)
....+.... ... ....+..+..+.+++.+||+.+|.+||+ ++|+++
T Consensus 215 ~~~~~~~~~-~~~-----------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 215 DLESLLKRQ-QKK-----------------------------LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred hHHHHHHhh-ccc-----------------------------CCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 222211111 000 0011235567899999999999999996 688875
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-32 Score=253.88 Aligned_cols=198 Identities=22% Similarity=0.374 Sum_probs=158.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++.+.. ...++||||+++|+|.+++.... ..+++..+..++.|++.||+||| +.|++||
T Consensus 66 l~h~~i~~~~~~~~~------~~~~~v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~ 133 (279)
T cd05057 66 VDHPHVVRLLGICLS------SQVQLITQLMPLGCLLDYVRNHK---DNIGSQYLLNWCVQIAKGMSYLE---EKRLVHR 133 (279)
T ss_pred CCCCCcceEEEEEec------CceEEEEecCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH---hCCEEec
Confidence 479999999988643 46789999999999999987643 34899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC--------CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT--------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTN 329 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~--------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~ 329 (427)
||||+||+++.++.+||+|||.++...... .++..|+|||.+....++.++|||||||++||+++ |+.||.
T Consensus 134 di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 213 (279)
T cd05057 134 DLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213 (279)
T ss_pred ccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCC
Confidence 999999999999999999999998654322 23457999999988889999999999999999998 999987
Q ss_pred cccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 042634 330 EMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEE 409 (427)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~e 409 (427)
.... ..+.+.+...... ..+..++..+.+++.+||..+|++|||+.+
T Consensus 214 ~~~~--~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~ 260 (279)
T cd05057 214 GIPA--VEIPDLLEKGERL-------------------------------PQPPICTIDVYMVLVKCWMIDAESRPTFKE 260 (279)
T ss_pred CCCH--HHHHHHHhCCCCC-------------------------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHH
Confidence 5311 1111111110000 011123456889999999999999999999
Q ss_pred HHHHHHHHHHHH
Q 042634 410 VAAQLLSFRNKL 421 (427)
Q Consensus 410 v~~~L~~~~~~~ 421 (427)
+++.|+++.++.
T Consensus 261 l~~~l~~~~~~~ 272 (279)
T cd05057 261 LINEFSKMARDP 272 (279)
T ss_pred HHHHHHHHHhCC
Confidence 999999986643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-33 Score=266.63 Aligned_cols=193 Identities=25% Similarity=0.368 Sum_probs=160.4
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||+|++||+... ....+|||+++.|+|.+.|++.. ...|.......++.|||.|+.||- .++.|||
T Consensus 168 L~H~hliRLyGvVl~------qp~mMV~ELaplGSLldrLrka~--~~~llv~~Lcdya~QiA~aM~YLe---skrlvHR 236 (1039)
T KOG0199|consen 168 LQHPHLIRLYGVVLD------QPAMMVFELAPLGSLLDRLRKAK--KAILLVSRLCDYAMQIAKAMQYLE---SKRLVHR 236 (1039)
T ss_pred ccCcceeEEeeeecc------chhhHHhhhcccchHHHHHhhcc--ccceeHHHHHHHHHHHHHHHHHHh---hhhhhhh
Confidence 689999999998543 56789999999999999998732 256888889999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC---------CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT---------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPT 328 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~---------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf 328 (427)
||..+|+++.....+||+|||+.+.+..+. .-.+.|||||.+....++.++|||+|||++|||++ |..||
T Consensus 237 DLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW 316 (1039)
T KOG0199|consen 237 DLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPW 316 (1039)
T ss_pred hhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCC
Confidence 999999999999999999999999886654 33457999999999999999999999999999998 89999
Q ss_pred CcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 042634 329 NEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME 408 (427)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ 408 (427)
.+.... .+.+.+|. ..+...++.|++.++++|.+||..+|++||||.
T Consensus 317 ~G~~g~--------------qIL~~iD~-------------------~erLpRPk~csedIY~imk~cWah~paDRptFs 363 (1039)
T KOG0199|consen 317 VGCRGI--------------QILKNIDA-------------------GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFS 363 (1039)
T ss_pred CCCCHH--------------HHHHhccc-------------------cccCCCCCCChHHHHHHHHHhccCCccccccHH
Confidence 764211 11111221 011124667999999999999999999999999
Q ss_pred HHHHHHH
Q 042634 409 EVAAQLL 415 (427)
Q Consensus 409 ev~~~L~ 415 (427)
.|.+.+-
T Consensus 364 air~~~~ 370 (1039)
T KOG0199|consen 364 AIREDLV 370 (1039)
T ss_pred HHHHhHH
Confidence 9986554
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-32 Score=257.89 Aligned_cols=218 Identities=18% Similarity=0.228 Sum_probs=150.5
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. +...++||||++ ++|.+++.... ..+++..+..++.|++.||+||| +.||+||
T Consensus 61 l~h~~iv~~~~~~~~-----~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~ 128 (309)
T cd07872 61 LKHANIVTLHDIVHT-----DKSLTLVFEYLD-KDLKQYMDDCG---NIMSMHNVKIFLYQILRGLAYCH---RRKVLHR 128 (309)
T ss_pred CCCCCcceEEEEEee-----CCeEEEEEeCCC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecC
Confidence 579999999998543 567899999995 58887775432 34788899999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCC-CCcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
||||+||+++.++.+||+|||+++..... ..++..|+|||++.+ ..++.++||||+||++|||++|+.||.+.
T Consensus 129 dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~ 208 (309)
T cd07872 129 DLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGS 208 (309)
T ss_pred CCCHHHEEECCCCCEEECccccceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999999764321 256788999998865 56899999999999999999999999754
Q ss_pred cCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 042634 332 FTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVA 411 (427)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~ 411 (427)
... ..+... .........+........................ .......+.++.+++.+|++.||++|||++|++
T Consensus 209 ~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 284 (309)
T cd07872 209 TVE-DELHLI-FRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPL--INHAPRLDTEGIELLTKFLQYESKKRISAEEAM 284 (309)
T ss_pred ChH-HHHHHH-HHHhCCCCHHHHhhhcchhhhhhhhcCccCCCch--hhhccCCCHHHHHHHHHhccCChhhCCCHHHHh
Confidence 211 111111 1111110001000000000000000000000000 001122456788999999999999999999998
Q ss_pred H
Q 042634 412 A 412 (427)
Q Consensus 412 ~ 412 (427)
+
T Consensus 285 ~ 285 (309)
T cd07872 285 K 285 (309)
T ss_pred c
Confidence 7
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-32 Score=253.04 Aligned_cols=211 Identities=27% Similarity=0.440 Sum_probs=158.0
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
+.|||++++++.+.. .++...+++|||+++++|.+++.... ..+++..+..++.|++.||+||| +.|++||
T Consensus 63 l~~~~i~~~~~~~~~---~~~~~~~lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~ 133 (284)
T cd05038 63 LDHENIVKYKGVCEK---PGGRSLRLIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMDYLG---SQRYIHR 133 (284)
T ss_pred CCCCChheEEeeeec---CCCCceEEEEecCCCCCHHHHHHhCc---cccCHHHHHHHHHHHHHHHHHHH---hCCeecC
Confidence 469999999887533 22456899999999999999987643 35899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc---------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA---------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTN 329 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~---------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~ 329 (427)
||||+||+++.++.+||+|||.+...... ..++..|+|||...+..++.++|||||||++|||++|..||.
T Consensus 134 dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~ 213 (284)
T cd05038 134 DLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQ 213 (284)
T ss_pred CCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcc
Confidence 99999999999999999999999876522 133456999999988889999999999999999999999986
Q ss_pred cccCCCccHHHHHHH-hcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 042634 330 EMFTGNLTLHNFVKE-ALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME 408 (427)
Q Consensus 330 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ 408 (427)
........+...... .....+.+.+. ...+...+..++.++.+++.+||+.+|++||||.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ 274 (284)
T cd05038 214 SPPAEFLRMIGIAQGQMIVTRLLELLK-------------------EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFA 274 (284)
T ss_pred cccchhccccccccccccHHHHHHHHH-------------------cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHH
Confidence 532111100000000 00000000000 0000112234567899999999999999999999
Q ss_pred HHHHHHHHH
Q 042634 409 EVAAQLLSF 417 (427)
Q Consensus 409 ev~~~L~~~ 417 (427)
||+++|+.+
T Consensus 275 ei~~~l~~i 283 (284)
T cd05038 275 DLILIVDRL 283 (284)
T ss_pred HHHHHHhhc
Confidence 999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-32 Score=260.92 Aligned_cols=187 Identities=24% Similarity=0.278 Sum_probs=152.8
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
.+||||+++.+.+. ++...++|||.+.++-+.+.+...+ .+. ..+..|+.+|+.|+.||| ++|||||
T Consensus 373 ~~h~niv~~~~v~~-----~~~~~~~v~e~l~g~ell~ri~~~~----~~~-~e~~~w~~~lv~Av~~LH---~~gvvhR 439 (612)
T KOG0603|consen 373 RDHPNIVKSHDVYE-----DGKEIYLVMELLDGGELLRRIRSKP----EFC-SEASQWAAELVSAVDYLH---EQGVVHR 439 (612)
T ss_pred cCCCcceeecceec-----CCceeeeeehhccccHHHHHHHhcc----hhH-HHHHHHHHHHHHHHHHHH---hcCeeec
Confidence 57999999999844 4778999999999988777665442 133 678889999999999999 8999999
Q ss_pred cccCCceee-CCCCceEecccccccccCCc---CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccCC
Q 042634 259 DLKPSNVLL-DGELTAHVGDFGLAKFLPEA---TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTG 334 (427)
Q Consensus 259 Dlkp~NIll-~~~~~~kL~DFG~a~~~~~~---~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~~ 334 (427)
|+||+|||+ ++.++++|+|||.++..... .+-|..|.|||++...+|++++||||||++||+|++|+.||.....+
T Consensus 440 DLkp~NIL~~~~~g~lrltyFG~a~~~~~~~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~ 519 (612)
T KOG0603|consen 440 DLKPGNILLDGSAGHLRLTYFGFWSELERSCDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG 519 (612)
T ss_pred CCChhheeecCCCCcEEEEEechhhhCchhhcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch
Confidence 999999999 68999999999999988765 25677899999999999999999999999999999999999865333
Q ss_pred CccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 042634 335 NLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAAQ 413 (427)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~ 413 (427)
.+.......+.. ....++++.+|+.+||+.||.+||+|.|+...
T Consensus 520 ----~ei~~~i~~~~~-------------------------------s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 520 ----IEIHTRIQMPKF-------------------------------SECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred ----HHHHHhhcCCcc-------------------------------ccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 111111111111 13345678999999999999999999998753
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-32 Score=253.66 Aligned_cols=193 Identities=20% Similarity=0.253 Sum_probs=149.8
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++.+.. ....++|+||+++++|..++.... ..+++..+..++.|++.||+||| +.|++||
T Consensus 59 l~h~~ii~~~~~~~~-----~~~~~~v~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~ 127 (282)
T cd06643 59 CDHPNIVKLLDAFYY-----ENNLWILIEFCAGGAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYLH---ENKIIHR 127 (282)
T ss_pred CCCCCeeeEEEEEee-----CCEEEEEEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeec
Confidence 579999999988543 457899999999999988775432 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC------cCCCccccccccccC-----CCCcCccccchhHHHHHHHHHhCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE------ATNNFFNFQIAEYGM-----GSEVSTSGDVYSFGILLLETFTGKRP 327 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~~y~aPE~~~-----~~~~~~~~DiwS~G~vl~ell~g~~p 327 (427)
||||+||+++.++.+||+|||++..... ...++..|+|||++. +..++.++|||||||++|||++|+.|
T Consensus 128 dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p 207 (282)
T cd06643 128 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPP 207 (282)
T ss_pred CCCcccEEEccCCCEEEccccccccccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCC
Confidence 9999999999999999999999875432 226788999999974 34578899999999999999999999
Q ss_pred CCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCH
Q 042634 328 TNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM 407 (427)
Q Consensus 328 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~ 407 (427)
|...... +.............. .+...+.++.+++.+||+.||++|||+
T Consensus 208 ~~~~~~~-----~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~ 256 (282)
T cd06643 208 HHELNPM-----RVLLKIAKSEPPTLA--------------------------QPSRWSSEFKDFLKKCLEKNVDARWTT 256 (282)
T ss_pred ccccCHH-----HHHHHHhhcCCCCCC--------------------------CccccCHHHHHHHHHHccCChhhCcCH
Confidence 8753211 111110000000000 112235568999999999999999999
Q ss_pred HHHHHH
Q 042634 408 EEVAAQ 413 (427)
Q Consensus 408 ~ev~~~ 413 (427)
+++++.
T Consensus 257 ~~il~~ 262 (282)
T cd06643 257 TQLLQH 262 (282)
T ss_pred HHHhcC
Confidence 998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-32 Score=248.95 Aligned_cols=190 Identities=23% Similarity=0.369 Sum_probs=149.7
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++.+.. ...++||||+++|+|.+++.... ..+++..+..++.|++.||+||| +.||+||
T Consensus 58 l~h~~i~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~ 125 (259)
T cd05037 58 LSHKHLVKLYGVCVR------DENIMVEEYVKFGPLDVFLHREK---NNVSLHWKLDVAKQLASALHYLE---DKKLVHG 125 (259)
T ss_pred CCCcchhheeeEEec------CCcEEEEEcCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHh---hCCeecc
Confidence 579999999987643 34689999999999999987643 25889999999999999999999 8999999
Q ss_pred cccCCceeeCCCC-------ceEecccccccccCCc--CCCccccccccccCCC--CcCccccchhHHHHHHHHHh-CCC
Q 042634 259 DLKPSNVLLDGEL-------TAHVGDFGLAKFLPEA--TNNFFNFQIAEYGMGS--EVSTSGDVYSFGILLLETFT-GKR 326 (427)
Q Consensus 259 Dlkp~NIll~~~~-------~~kL~DFG~a~~~~~~--~~~~~~y~aPE~~~~~--~~~~~~DiwS~G~vl~ell~-g~~ 326 (427)
||||+||+++.++ .+||+|||.+...... ..++..|+|||++.+. .++.++|||||||++||+++ |..
T Consensus 126 dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~ 205 (259)
T cd05037 126 NVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEE 205 (259)
T ss_pred cCccceEEEecCccccCCceeEEeCCCCcccccccccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCC
Confidence 9999999999887 7999999999876542 3566789999998876 78999999999999999999 577
Q ss_pred CCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCC
Q 042634 327 PTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMN 406 (427)
Q Consensus 327 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt 406 (427)
||..... ......... . . .. + .+ ....+.+++.+||+.+|.+|||
T Consensus 206 p~~~~~~--~~~~~~~~~---~------~-~~-------------------~--~~--~~~~~~~li~~~l~~~p~~Rpt 250 (259)
T cd05037 206 PLSTLSS--SEKERFYQD---Q------H-RL-------------------P--MP--DCAELANLINQCWTYDPTKRPS 250 (259)
T ss_pred CcccCCc--hhHHHHHhc---C------C-CC-------------------C--CC--CchHHHHHHHHHhccChhhCCC
Confidence 7754321 111111000 0 0 00 0 00 0156889999999999999999
Q ss_pred HHHHHHHHH
Q 042634 407 MEEVAAQLL 415 (427)
Q Consensus 407 ~~ev~~~L~ 415 (427)
+.||++.|+
T Consensus 251 ~~~il~~l~ 259 (259)
T cd05037 251 FRAILRDLN 259 (259)
T ss_pred HHHHHHhcC
Confidence 999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-32 Score=255.42 Aligned_cols=220 Identities=20% Similarity=0.259 Sum_probs=154.4
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. +...+++|||+++|+|.+++..... ..+++..+..++.|++.||+||| +.+|+||
T Consensus 56 l~h~~i~~~~~~~~~-----~~~~~~~~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~ 125 (314)
T cd08216 56 LQHPNILPYVTSFIV-----DSELYVVSPLMAYGSCEDLLKTHFP--EGLPELAIAFILKDVLNALDYIH---SKGFIHR 125 (314)
T ss_pred cCCcchhhhhheeec-----CCeEEEEEeccCCCCHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH---HCCeecC
Confidence 579999999987543 5678999999999999999875432 34888999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc-------------CCCccccccccccCC--CCcCccccchhHHHHHHHHHh
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA-------------TNNFFNFQIAEYGMG--SEVSTSGDVYSFGILLLETFT 323 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-------------~~~~~~y~aPE~~~~--~~~~~~~DiwS~G~vl~ell~ 323 (427)
||||+||+++.++.+||+|||.+...... ..++..|+|||++.. ..++.++|||||||++|||++
T Consensus 126 dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~ 205 (314)
T cd08216 126 SVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELAN 205 (314)
T ss_pred CCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHh
Confidence 99999999999999999999988654221 145668999999876 358899999999999999999
Q ss_pred CCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccch-----hhhccccccccccchHHHHHHHHHHHhhcCC
Q 042634 324 GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGET-----SKANAHKQFTRSFSVKECLVSVLGIGVTCSS 398 (427)
Q Consensus 324 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~ 398 (427)
|+.||........ ..+......+ ..++............ ....................++.+++.+||+
T Consensus 206 g~~pf~~~~~~~~-~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 280 (314)
T cd08216 206 GHVPFKDMPATQM-LLEKVRGTVP----CLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQ 280 (314)
T ss_pred CCCCCCCCCHHHH-HHHHHhccCc----cccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhh
Confidence 9999975321111 1111111111 1111000000000000 0000000001111223345678999999999
Q ss_pred CCCCCCCCHHHHHHH
Q 042634 399 ELPRERMNMEEVAAQ 413 (427)
Q Consensus 399 ~dP~~Rpt~~ev~~~ 413 (427)
.||++|||++|+++.
T Consensus 281 ~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 281 RDPESRPSASQLLNH 295 (314)
T ss_pred cCCCcCcCHHHHhcC
Confidence 999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-32 Score=257.03 Aligned_cols=222 Identities=20% Similarity=0.255 Sum_probs=155.7
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. +...++||||+++++|.+++... ..+++..+..++.|++.||.|||+ ..+++||
T Consensus 56 l~h~~iv~~~~~~~~-----~~~~~lv~ey~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~ 124 (308)
T cd06615 56 CNSPYIVGFYGAFYS-----DGEISICMEHMDGGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLRE--KHKIMHR 124 (308)
T ss_pred CCCCCCCeEEEEEee-----CCEEEEEeeccCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh--hCCEEEC
Confidence 579999999998643 56789999999999999998654 458899999999999999999993 2589999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc----CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA----TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTG 334 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~~ 334 (427)
||||+||+++.++.+||+|||.+...... ..++..|+|||.+.+..++.++|||||||++||+++|+.||....
T Consensus 125 dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~-- 202 (308)
T cd06615 125 DVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD-- 202 (308)
T ss_pred CCChHHEEEecCCcEEEccCCCcccccccccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc--
Confidence 99999999999999999999998765432 257789999999988889999999999999999999999986432
Q ss_pred CccHHHHHHHhcccc-hhcccCcc-ccccccccchh--h--hccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 042634 335 NLTLHNFVKEALPER-LAEIVDPV-LLVEREEGETS--K--ANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME 408 (427)
Q Consensus 335 ~~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~--~--~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ 408 (427)
............... ........ ........... . ........+.......+.++.+++.+||+.+|++|||++
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~ 282 (308)
T cd06615 203 AKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLK 282 (308)
T ss_pred hhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHH
Confidence 111111111100000 00000000 00000000000 0 000000001111122456789999999999999999999
Q ss_pred HHHHH
Q 042634 409 EVAAQ 413 (427)
Q Consensus 409 ev~~~ 413 (427)
||++.
T Consensus 283 ~ll~~ 287 (308)
T cd06615 283 ELTKH 287 (308)
T ss_pred HHhcC
Confidence 99876
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-32 Score=248.64 Aligned_cols=194 Identities=24% Similarity=0.407 Sum_probs=153.7
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++... ....+++|||+++++|.+++..... ..+++.++..++.|++.||+||| +.|++||
T Consensus 58 l~h~~i~~~~~~~~------~~~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~ 126 (260)
T cd05067 58 LQHPRLVRLYAVVT------QEPIYIITEYMENGSLVDFLKTPEG--IKLTINKLIDMAAQIAEGMAFIE---RKNYIHR 126 (260)
T ss_pred cCCcCeeeEEEEEc------cCCcEEEEEcCCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHh---cCCeecc
Confidence 57999999987632 2457999999999999998865432 45889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC-------CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCCc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT-------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~-------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~~ 330 (427)
||||+||+++.++.++|+|||.+....... .++..|+|||++....++.++||||||+++||+++ |+.||.+
T Consensus 127 dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 206 (260)
T cd05067 127 DLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPG 206 (260)
T ss_pred cccHHhEEEcCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999998654221 34567999999988889999999999999999998 9999975
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
... ............. ..+...+.++.+++.+||+.+|++|||++++
T Consensus 207 ~~~--~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l 253 (260)
T cd05067 207 MTN--PEVIQNLERGYRM-------------------------------PRPDNCPEELYELMRLCWKEKPEERPTFEYL 253 (260)
T ss_pred CCh--HHHHHHHHcCCCC-------------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 321 1111111000000 0112234578999999999999999999999
Q ss_pred HHHHHH
Q 042634 411 AAQLLS 416 (427)
Q Consensus 411 ~~~L~~ 416 (427)
+..|+.
T Consensus 254 ~~~l~~ 259 (260)
T cd05067 254 RSVLED 259 (260)
T ss_pred HHHhhc
Confidence 999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=266.36 Aligned_cols=141 Identities=20% Similarity=0.292 Sum_probs=123.9
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. +...++|||||++|+|.+++... ..+++..++.++.||+.||+||| +.||+||
T Consensus 58 ~~h~~iv~~~~~~~~-----~~~~~lv~E~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~al~~lH---~~~ivHr 125 (382)
T cd05625 58 ADNEWVVRLYYSFQD-----KDNLYFVMDYIPGGDMMSLLIRM----GIFPEDLARFYIAELTCAVESVH---KMGFIHR 125 (382)
T ss_pred CCCCcCCeEEEEEEe-----CCEEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecC
Confidence 579999999988543 56789999999999999988654 34889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccC-----------------------------------------------------
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLP----------------------------------------------------- 285 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~----------------------------------------------------- 285 (427)
||||+|||++.++.+||+|||+|+...
T Consensus 126 DlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (382)
T cd05625 126 DIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLA 205 (382)
T ss_pred CCCHHHEEECCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccc
Confidence 999999999999999999999975321
Q ss_pred CcCCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 286 EATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 286 ~~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
....||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 206 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~ 251 (382)
T cd05625 206 HSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQ 251 (382)
T ss_pred cccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCC
Confidence 0125788999999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-32 Score=252.78 Aligned_cols=192 Identities=19% Similarity=0.237 Sum_probs=150.7
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
.+||+++.+++.+.. ++..++||||+++|+|.+++... ..+++..+..++.|++.||+||| +.+|+||
T Consensus 54 ~~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~ 121 (279)
T cd05633 54 GDCPFIVCMTYAFHT-----PDKLCFILDLMNGGDLHYHLSQH----GVFSEKEMRFYATEIILGLEHMH---NRFVVYR 121 (279)
T ss_pred CCCCcEeEEEEEEec-----CCeEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcCCC
Confidence 468999988877433 45789999999999999888654 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc----CCCccccccccccC-CCCcCccccchhHHHHHHHHHhCCCCCCcccC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA----TNNFFNFQIAEYGM-GSEVSTSGDVYSFGILLLETFTGKRPTNEMFT 333 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~y~aPE~~~-~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~ 333 (427)
||||+||++++++.+||+|||++...... ..++..|+|||.+. +..++.++||||+||++|||++|..||.....
T Consensus 122 dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 201 (279)
T cd05633 122 DLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 201 (279)
T ss_pred CCCHHHEEECCCCCEEEccCCcceeccccCccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCC
Confidence 99999999999999999999998754322 26788999999986 45689999999999999999999999975322
Q ss_pred CCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCC-----CHH
Q 042634 334 GNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERM-----NME 408 (427)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rp-----t~~ 408 (427)
... .. ....... .. ...+...+.++.+++.+||..||++|| |++
T Consensus 202 ~~~--~~-~~~~~~~-----~~-----------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 250 (279)
T cd05633 202 KDK--HE-IDRMTLT-----VN-----------------------VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQ 250 (279)
T ss_pred cCH--HH-HHHHhhc-----CC-----------------------cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHH
Confidence 111 11 1100000 00 002233456789999999999999999 588
Q ss_pred HHHHH
Q 042634 409 EVAAQ 413 (427)
Q Consensus 409 ev~~~ 413 (427)
|++++
T Consensus 251 ~~~~h 255 (279)
T cd05633 251 EVKEH 255 (279)
T ss_pred HHHhC
Confidence 88774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-32 Score=253.79 Aligned_cols=195 Identities=23% Similarity=0.304 Sum_probs=152.3
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|++++.+++.+.. +...++||||+++++|.+++..... ..+++..+..++.|++.||.||| +.||+||
T Consensus 57 l~~~~i~~~~~~~~~-----~~~~~lv~e~~~g~~L~~~l~~~~~--~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~ 126 (285)
T cd05630 57 VNSRFVVSLAYAYET-----KDALCLVLTLMNGGDLKFHIYHMGE--AGFEEGRAVFYAAEICCGLEDLH---QERIVYR 126 (285)
T ss_pred CCCCCeeeeeEEEec-----CCEEEEEEEecCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH---hCCEEeC
Confidence 578999999887543 5678999999999999988854322 45889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc-----CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFT 333 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~ 333 (427)
||||+||+++.++.+||+|||++...... ..|+..|+|||++.+..++.++||||+||++|||++|+.||.....
T Consensus 127 dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~ 206 (285)
T cd05630 127 DLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKK 206 (285)
T ss_pred CCCHHHEEECCCCCEEEeeccceeecCCCccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCc
Confidence 99999999999999999999999765432 2678899999999998999999999999999999999999975321
Q ss_pred CCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCC-----HH
Q 042634 334 GNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMN-----ME 408 (427)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt-----~~ 408 (427)
.. .......... .... ..+..++.++.+++.+||+.||++||| ++
T Consensus 207 ~~--~~~~~~~~~~-~~~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ 256 (285)
T cd05630 207 KI--KREEVERLVK-EVQE---------------------------EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAR 256 (285)
T ss_pred cc--hHHHHHhhhh-hhhh---------------------------hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchH
Confidence 10 0000000000 0000 011223456789999999999999999 88
Q ss_pred HHHHH
Q 042634 409 EVAAQ 413 (427)
Q Consensus 409 ev~~~ 413 (427)
|++++
T Consensus 257 ~~~~h 261 (285)
T cd05630 257 EVKEH 261 (285)
T ss_pred HHHcC
Confidence 88873
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=248.92 Aligned_cols=189 Identities=21% Similarity=0.283 Sum_probs=152.5
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++.+.. +...++||||+++++|.+++.. ..+++..+..++.|++.|+.||| ..|++|+
T Consensus 59 l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~ 125 (277)
T cd06642 59 CDSPYITRYYGSYLK-----GTKLWIIMEYLGGGSALDLLKP-----GPLEETYIATILREILKGLDYLH---SERKIHR 125 (277)
T ss_pred CCCCccHhhhccccc-----CCceEEEEEccCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHh---cCCeecc
Confidence 479999999998543 5678999999999999998864 34788999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC------CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||+|+||+++.++.+||+|||++....... .++..|+|||++.+..++.++|||||||++||+++|+.||....
T Consensus 126 dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~ 205 (277)
T cd06642 126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLH 205 (277)
T ss_pred CCChheEEEeCCCCEEEccccccccccCcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccc
Confidence 999999999999999999999998654332 46778999999999889999999999999999999999986432
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
... .........+. .....++.++.+++.+||+.+|++|||+.|+++
T Consensus 206 ~~~--~~~~~~~~~~~-------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 206 PMR--VLFLIPKNSPP-------------------------------TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred hhh--HHhhhhcCCCC-------------------------------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 111 00000000000 011224566889999999999999999999998
Q ss_pred H
Q 042634 413 Q 413 (427)
Q Consensus 413 ~ 413 (427)
+
T Consensus 253 ~ 253 (277)
T cd06642 253 H 253 (277)
T ss_pred h
Confidence 4
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-32 Score=257.91 Aligned_cols=195 Identities=23% Similarity=0.295 Sum_probs=148.8
Q ss_pred CcccccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 042634 176 NNFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPI 255 (427)
Q Consensus 176 N~ll~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~i 255 (427)
+++.+|.+||+++++-.. +...|+||||- .-||.++|++... .++.-.++.+..|++.|+.++| .+||
T Consensus 414 ~KLkg~~~IIqL~DYEv~-----d~~lYmvmE~G-d~DL~kiL~k~~~---~~~~~~lk~ywkqML~aV~~IH---~~gI 481 (677)
T KOG0596|consen 414 NKLKGHDKIIQLYDYEVT-----DGYLYMVMECG-DIDLNKILKKKKS---IDPDWFLKFYWKQMLLAVKTIH---QHGI 481 (677)
T ss_pred HHhcCCceEEEEeeeecc-----CceEEEEeecc-cccHHHHHHhccC---CCchHHHHHHHHHHHHHHHHHH---Hhce
Confidence 344779999999997332 57899999965 7799999987643 2333488999999999999999 9999
Q ss_pred eeccccCCceeeCCCCceEecccccccccCCcC--------CCccccccccccCCCC-----------cCccccchhHHH
Q 042634 256 VHCDLKPSNVLLDGELTAHVGDFGLAKFLPEAT--------NNFFNFQIAEYGMGSE-----------VSTSGDVYSFGI 316 (427)
Q Consensus 256 vHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~--------~~~~~y~aPE~~~~~~-----------~~~~~DiwS~G~ 316 (427)
||.||||.|+|+-. |.+||+|||.|..+.... +||+.||+||.+.... ++.++||||+||
T Consensus 482 VHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGC 560 (677)
T KOG0596|consen 482 VHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGC 560 (677)
T ss_pred eecCCCcccEEEEe-eeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhh
Confidence 99999999998855 689999999999876543 8999999999986432 468999999999
Q ss_pred HHHHHHhCCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhc
Q 042634 317 LLLETFTGKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTC 396 (427)
Q Consensus 317 vl~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c 396 (427)
|+|+|+.|+.||... ...+. .+..+.++.-..+ |... + ...+++++|+.|
T Consensus 561 ILYqMvYgktPf~~~-------~n~~a-----Kl~aI~~P~~~Ie--------------fp~~--~--~~~~li~~mK~C 610 (677)
T KOG0596|consen 561 ILYQMVYGKTPFGQI-------INQIA-----KLHAITDPNHEIE--------------FPDI--P--ENDELIDVMKCC 610 (677)
T ss_pred HHHHHHhcCCchHHH-------HHHHH-----HHHhhcCCCcccc--------------ccCC--C--CchHHHHHHHHH
Confidence 999999999999753 11111 1233333321111 1111 1 122389999999
Q ss_pred CCCCCCCCCCHHHHHHH
Q 042634 397 SSELPRERMNMEEVAAQ 413 (427)
Q Consensus 397 l~~dP~~Rpt~~ev~~~ 413 (427)
|++||++|||+.|+++.
T Consensus 611 L~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 611 LARDPKKRWSIPELLQH 627 (677)
T ss_pred HhcCcccCCCcHHHhcC
Confidence 99999999999999864
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-32 Score=248.27 Aligned_cols=193 Identities=26% Similarity=0.287 Sum_probs=152.3
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++.+.+.. .+...+++|||+++++|.+++..... ..+++.+++.++.|++.|++||| +.|++||
T Consensus 56 l~~~~i~~~~~~~~~----~~~~~~lv~e~~~~~~l~~~l~~~~~--~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~ 126 (257)
T cd08223 56 LKHPNIVAYRESWEG----EDGLLYIVMGFCEGGDLYHKLKEQKG--KLLPENQVVEWFVQIAMALQYLH---EKHILHR 126 (257)
T ss_pred CCCCCeeeeeeeecC----CCCEEEEEecccCCCcHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecc
Confidence 569999998876422 23457899999999999998865322 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+||+++.++.+||+|||++...... ..++..|+|||+..+..++.++||||+||++||+++|+.||....
T Consensus 127 di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 206 (257)
T cd08223 127 DLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD 206 (257)
T ss_pred CCCchhEEEecCCcEEEecccceEEecccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999999999999999999865432 256788999999999999999999999999999999999986421
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
.............. ..+...+.++.+++.+||+.||++|||+.|+++
T Consensus 207 -----~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 207 -----MNSLVYRIIEGKLP----------------------------PMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred -----HHHHHHHHHhcCCC----------------------------CCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 11111111000000 012234567899999999999999999999986
Q ss_pred H
Q 042634 413 Q 413 (427)
Q Consensus 413 ~ 413 (427)
+
T Consensus 254 ~ 254 (257)
T cd08223 254 Q 254 (257)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-32 Score=269.70 Aligned_cols=141 Identities=23% Similarity=0.307 Sum_probs=118.3
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCC-CCeee
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCE-TPIVH 257 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~-~~ivH 257 (427)
..|++++++++++.. .....++|||++ +++|.+++.+. ..+++..+..++.||+.||+||| . .||+|
T Consensus 188 ~~~~~i~~i~~~~~~----~~~~~~iv~~~~-g~~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~yLH---~~~gIiH 255 (467)
T PTZ00284 188 ADRFPLMKIQRYFQN----ETGHMCIVMPKY-GPCLLDWIMKH----GPFSHRHLAQIIFQTGVALDYFH---TELHLMH 255 (467)
T ss_pred ccCcceeeeEEEEEc----CCceEEEEEecc-CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---hcCCeec
Confidence 456677777766432 234689999998 88898888654 35899999999999999999999 6 59999
Q ss_pred ccccCCceeeCCCC----------------ceEecccccccccCC---cCCCccccccccccCCCCcCccccchhHHHHH
Q 042634 258 CDLKPSNVLLDGEL----------------TAHVGDFGLAKFLPE---ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILL 318 (427)
Q Consensus 258 rDlkp~NIll~~~~----------------~~kL~DFG~a~~~~~---~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl 318 (427)
|||||+|||++.++ .+||+|||.+..... ...||..|+|||++.+..++.++|||||||++
T Consensus 256 rDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil 335 (467)
T PTZ00284 256 TDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCII 335 (467)
T ss_pred CCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHH
Confidence 99999999998655 499999998865432 23788999999999999999999999999999
Q ss_pred HHHHhCCCCCCcc
Q 042634 319 LETFTGKRPTNEM 331 (427)
Q Consensus 319 ~ell~g~~pf~~~ 331 (427)
|||++|+.||.+.
T Consensus 336 ~elltG~~pf~~~ 348 (467)
T PTZ00284 336 YELYTGKLLYDTH 348 (467)
T ss_pred HHHHhCCCCCCCC
Confidence 9999999999753
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-32 Score=252.25 Aligned_cols=191 Identities=23% Similarity=0.341 Sum_probs=150.8
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++.+.. +...++||||+++++|.+++.. ..+++..+..++.||+.||+||| +.||+||
T Consensus 76 l~h~~ii~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~ 142 (292)
T cd06658 76 YHHENVVDMYNSYLV-----GDELWVVMEFLEGGALTDIVTH-----TRMNEEQIATVCLSVLRALSYLH---NQGVIHR 142 (292)
T ss_pred CCCCcHHHHHHheec-----CCeEEEEEeCCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeec
Confidence 579999999988543 5678999999999999988753 23788999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+||+++.++.+||+|||++...... ..++..|+|||.+.+..++.++|||||||++||+++|+.||....
T Consensus 143 dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~ 222 (292)
T cd06658 143 DIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP 222 (292)
T ss_pred CCCHHHEEEcCCCCEEEccCcchhhcccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999998754322 256788999999988889999999999999999999999986421
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
. ......+....+.... .....+..+.+++.+||..||++|||++|+++
T Consensus 223 ~--~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 271 (292)
T cd06658 223 P--LQAMRRIRDNLPPRVK-----------------------------DSHKVSSVLRGFLDLMLVREPSQRATAQELLQ 271 (292)
T ss_pred H--HHHHHHHHhcCCCccc-----------------------------cccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1 0000111111100000 01123456788999999999999999999997
Q ss_pred H
Q 042634 413 Q 413 (427)
Q Consensus 413 ~ 413 (427)
.
T Consensus 272 ~ 272 (292)
T cd06658 272 H 272 (292)
T ss_pred C
Confidence 5
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-32 Score=248.88 Aligned_cols=195 Identities=27% Similarity=0.458 Sum_probs=155.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++.+.. ....+++|||+++++|.+++..... ..+++..+..++.|++.|+.||| +.|++|+
T Consensus 58 l~h~~i~~~~~~~~~-----~~~~~~v~e~~~~~~L~~~i~~~~~--~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~ 127 (261)
T cd05034 58 LRHDKLVQLYAVCSE-----EEPIYIVTEYMSKGSLLDFLKSGEG--KKLRLPQLVDMAAQIAEGMAYLE---SRNYIHR 127 (261)
T ss_pred CCCCCEeeeeeeeec-----CCceEEEEeccCCCCHHHHHhcccc--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccC
Confidence 569999999887433 4568999999999999999876432 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC-------CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCCc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT-------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~-------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~~ 330 (427)
||||+||+++.++.+||+|||.++...... ..+..|+|||.+.+..++.++||||+||++||+++ |+.||.+
T Consensus 128 di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 207 (261)
T cd05034 128 DLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPG 207 (261)
T ss_pred CcchheEEEcCCCCEEECccccceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999998764321 34467999999998889999999999999999998 9999865
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
... ....+....... ...+..++.++.+++.+||+.+|++|||++|+
T Consensus 208 ~~~--~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l 254 (261)
T cd05034 208 MTN--REVLEQVERGYR-------------------------------MPRPPNCPEELYDLMLQCWDKDPEERPTFEYL 254 (261)
T ss_pred CCH--HHHHHHHHcCCC-------------------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHH
Confidence 311 111111000000 00112235678999999999999999999999
Q ss_pred HHHHHH
Q 042634 411 AAQLLS 416 (427)
Q Consensus 411 ~~~L~~ 416 (427)
.+.|+.
T Consensus 255 ~~~l~~ 260 (261)
T cd05034 255 QSFLED 260 (261)
T ss_pred HHHHhc
Confidence 998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=266.98 Aligned_cols=141 Identities=21% Similarity=0.292 Sum_probs=124.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+. .+...++||||+++|+|.+++... ..+++..++.++.||+.||+||| +.||+||
T Consensus 58 l~h~~iv~~~~~~~-----~~~~~~lv~E~~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH---~~~ivHr 125 (376)
T cd05598 58 ADNEWVVKLYYSFQ-----DKDNLYFVMDYIPGGDMMSLLIRL----GIFEEDLARFYIAELTCAIESVH---KMGFIHR 125 (376)
T ss_pred CCCCCcceEEEEEE-----cCCEEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeC
Confidence 57999999998743 367889999999999999998654 34888999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccC-------------------------------------------------CcCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLP-------------------------------------------------EATN 289 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~-------------------------------------------------~~~~ 289 (427)
||||+|||++.++.+||+|||+|.... ....
T Consensus 126 Dlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (376)
T cd05598 126 DIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLV 205 (376)
T ss_pred CCCHHHEEECCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccC
Confidence 999999999999999999999975221 0125
Q ss_pred CccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 290 NFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 290 ~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 206 gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 247 (376)
T cd05598 206 GTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAD 247 (376)
T ss_pred CCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCC
Confidence 888999999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-32 Score=255.17 Aligned_cols=191 Identities=19% Similarity=0.254 Sum_probs=151.9
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++.+.. ....++|+||+++++|.+++.. ..+++.++..++.|++.|++||| +.|++||
T Consensus 73 l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH---~~~i~H~ 139 (296)
T cd06655 73 LKNPNIVNFLDSFLV-----GDELFVVMEYLAGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLH---ANQVIHR 139 (296)
T ss_pred cCCCceeeeeeeEec-----CceEEEEEEecCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHH---HCCcccC
Confidence 579999999988543 5678999999999999998854 34889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+||+++.++.+||+|||++...... ..++..|+|||.+.+..++.++|||||||++|++++|+.||....
T Consensus 140 dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~ 219 (296)
T cd06655 140 DIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (296)
T ss_pred CCCHHHEEECCCCCEEEccCccchhcccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999998765332 256778999999998889999999999999999999999996532
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
... .... ........ ...+..++..+.+++.+||..||++|||+.++++
T Consensus 220 ~~~-~~~~-~~~~~~~~-----------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 220 PLR-ALYL-IATNGTPE-----------------------------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred HHH-HHHH-HHhcCCcc-----------------------------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 110 0000 00000000 0012234556889999999999999999999985
Q ss_pred H
Q 042634 413 Q 413 (427)
Q Consensus 413 ~ 413 (427)
.
T Consensus 269 ~ 269 (296)
T cd06655 269 H 269 (296)
T ss_pred C
Confidence 3
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-32 Score=248.15 Aligned_cols=194 Identities=23% Similarity=0.291 Sum_probs=152.0
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++.+.. +...+++|||+++++|.+++.... ..+++..+..++.|++.|++||| +.|++|+
T Consensus 57 ~~h~~i~~~~~~~~~-----~~~~~l~~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~ 125 (262)
T cd06613 57 CRHPNIVAYFGSYLR-----RDKLWIVMEYCGGGSLQDIYQVTR---GPLSELQIAYVCRETLKGLAYLH---ETGKIHR 125 (262)
T ss_pred CCCCChhceEEEEEe-----CCEEEEEEeCCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHH---hCCceec
Confidence 579999999987533 567899999999999999886542 35889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCCC---CcCccccchhHHHHHHHHHhCCCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMGS---EVSTSGDVYSFGILLLETFTGKRPTN 329 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~~---~~~~~~DiwS~G~vl~ell~g~~pf~ 329 (427)
||||+||+++.++.+||+|||.+...... ..++..|+|||.+.+. .++.++|||||||++|||++|+.||.
T Consensus 126 dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~ 205 (262)
T cd06613 126 DIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMF 205 (262)
T ss_pred CCChhhEEECCCCCEEECccccchhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999998765432 2567789999998776 78999999999999999999999997
Q ss_pred cccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 042634 330 EMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEE 409 (427)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~e 409 (427)
....... .......... ... .......+.++.+++.+||+.+|.+|||+++
T Consensus 206 ~~~~~~~-~~~~~~~~~~-------~~~---------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 256 (262)
T cd06613 206 DLHPMRA-LFLISKSNFP-------PPK---------------------LKDKEKWSPVFHDFIKKCLTKDPKKRPTATK 256 (262)
T ss_pred CCCHHHH-HHHHHhccCC-------Ccc---------------------ccchhhhhHHHHHHHHHHcCCChhhCCCHHH
Confidence 5321100 0000000000 000 0012234567899999999999999999999
Q ss_pred HHH
Q 042634 410 VAA 412 (427)
Q Consensus 410 v~~ 412 (427)
|+.
T Consensus 257 il~ 259 (262)
T cd06613 257 LLQ 259 (262)
T ss_pred Hhc
Confidence 975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-32 Score=258.54 Aligned_cols=223 Identities=17% Similarity=0.180 Sum_probs=150.9
Q ss_pred cccccchhhhccccccCC-CCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 042634 179 IRHRNLVKIITSCASVDF-QGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVH 257 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivH 257 (427)
++||||+++++++..... ......++++|++ +++|.+++.. ..+++..+..++.|++.||+||| +.||+|
T Consensus 71 l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH 141 (343)
T cd07878 71 MKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIH---SAGIIH 141 (343)
T ss_pred cCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeec
Confidence 579999999987643221 1224568999988 8899887753 34899999999999999999999 899999
Q ss_pred ccccCCceeeCCCCceEecccccccccCCcC---CCccccccccccCC-CCcCccccchhHHHHHHHHHhCCCCCCcccC
Q 042634 258 CDLKPSNVLLDGELTAHVGDFGLAKFLPEAT---NNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETFTGKRPTNEMFT 333 (427)
Q Consensus 258 rDlkp~NIll~~~~~~kL~DFG~a~~~~~~~---~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~ 333 (427)
|||||+||+++.++.+||+|||+++...... .++..|+|||++.+ ..++.++||||+||++|||++|+.||.+...
T Consensus 142 rdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 221 (343)
T cd07878 142 RDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY 221 (343)
T ss_pred ccCChhhEEECCCCCEEEcCCccceecCCCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCH
Confidence 9999999999999999999999998765433 67889999999877 5689999999999999999999999975311
Q ss_pred CCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 042634 334 GNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAAQ 413 (427)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~ 413 (427)
...+......... ...+.......... .........................+.+++.+|++.||++|||++|++++
T Consensus 222 -~~~~~~~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 222 -IDQLKRIMEVVGT-PSPEVLKKISSEHA-RKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred -HHHHHHHHHHhCC-CCHHHHHhcchhhH-HHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1111111111000 00000000000000 00000000000000000001123457899999999999999999999865
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-32 Score=281.69 Aligned_cols=198 Identities=20% Similarity=0.301 Sum_probs=150.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcC----CCC
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYC----ETP 254 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~----~~~ 254 (427)
++|||||++++.+.. ......++||||+++|+|.+++.........+++..++.|+.||+.||.|||... ..+
T Consensus 69 L~HPNIVrl~d~f~d---e~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~ 145 (1021)
T PTZ00266 69 LKHKNIVRYIDRFLN---KANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGER 145 (1021)
T ss_pred cCCCCcCeEEEEEEe---cCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCC
Confidence 579999999987543 1245689999999999999998754333346899999999999999999999421 146
Q ss_pred eeeccccCCceeeCC-----------------CCceEecccccccccCCc-----CCCccccccccccCC--CCcCcccc
Q 042634 255 IVHCDLKPSNVLLDG-----------------ELTAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMG--SEVSTSGD 310 (427)
Q Consensus 255 ivHrDlkp~NIll~~-----------------~~~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~--~~~~~~~D 310 (427)
||||||||+|||++. ...+||+|||+++..... ..+|+.|+|||++.+ ..++.++|
T Consensus 146 IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSD 225 (1021)
T PTZ00266 146 VLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSD 225 (1021)
T ss_pred ceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhH
Confidence 999999999999954 235899999999865432 268899999999864 45889999
Q ss_pred chhHHHHHHHHHhCCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHH
Q 042634 311 VYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVL 390 (427)
Q Consensus 311 iwS~G~vl~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (427)
|||||||+|||++|..||.... .+...+...... .. ......+.++.
T Consensus 226 VWSLG~ILYELLTGk~PF~~~~----~~~qli~~lk~~-----p~------------------------lpi~~~S~eL~ 272 (1021)
T PTZ00266 226 MWALGCIIYELCSGKTPFHKAN----NFSQLISELKRG-----PD------------------------LPIKGKSKELN 272 (1021)
T ss_pred HHHHHHHHHHHHHCCCCCCcCC----cHHHHHHHHhcC-----CC------------------------CCcCCCCHHHH
Confidence 9999999999999999996431 122221111000 00 00111345688
Q ss_pred HHHhhcCCCCCCCCCCHHHHHH
Q 042634 391 GIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 391 ~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
+++.+||+.+|.+|||+.|++.
T Consensus 273 dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 273 ILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred HHHHHHhcCChhHCcCHHHHhc
Confidence 9999999999999999999985
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-32 Score=273.71 Aligned_cols=200 Identities=27% Similarity=0.414 Sum_probs=164.4
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccch---hh-------h--hccCHHHHHHHHHHHHHHHHH
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNR---EA-------L--KNLNLLQRLSIAVDVASALDY 246 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~-------~--~~l~~~~~~~~~~~i~~~L~~ 246 (427)
..|||++.+++.|.. ....++|+||+..|+|.++++..+ .. . ..++..+.+.++.|||.|++|
T Consensus 359 g~H~niv~llG~~t~-----~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~ 433 (609)
T KOG0200|consen 359 GKHPNIVNLLGACTQ-----DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEY 433 (609)
T ss_pred cCCcchhhheeeecc-----CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHH
Confidence 679999999999876 467899999999999999998765 00 0 138899999999999999999
Q ss_pred HhhcCCCCeeeccccCCceeeCCCCceEecccccccccCCcC-------C--CccccccccccCCCCcCccccchhHHHH
Q 042634 247 LHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEAT-------N--NFFNFQIAEYGMGSEVSTSGDVYSFGIL 317 (427)
Q Consensus 247 LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~-------~--~~~~y~aPE~~~~~~~~~~~DiwS~G~v 317 (427)
|+ +.++||||+.++|||+.++..+||+|||+|+...... . -...|||||.+....|+.++|||||||+
T Consensus 434 L~---~~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~ 510 (609)
T KOG0200|consen 434 LA---SVPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGIL 510 (609)
T ss_pred Hh---hCCccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHH
Confidence 99 8999999999999999999999999999999543322 2 2346999999999999999999999999
Q ss_pred HHHHHh-CCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhc
Q 042634 318 LLETFT-GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTC 396 (427)
Q Consensus 318 l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c 396 (427)
+||+++ |..||.+..... .+.++++. ..+...|..|..+++++|+.|
T Consensus 511 L~EifsLG~~PYp~~~~~~-~l~~~l~~-------------------------------G~r~~~P~~c~~eiY~iM~~C 558 (609)
T KOG0200|consen 511 LWEIFTLGGTPYPGIPPTE-ELLEFLKE-------------------------------GNRMEQPEHCSDEIYDLMKSC 558 (609)
T ss_pred HHHHhhCCCCCCCCCCcHH-HHHHHHhc-------------------------------CCCCCCCCCCCHHHHHHHHHH
Confidence 999999 999997632111 11112221 112225677889999999999
Q ss_pred CCCCCCCCCCHHHHHHHHHHHH
Q 042634 397 SSELPRERMNMEEVAAQLLSFR 418 (427)
Q Consensus 397 l~~dP~~Rpt~~ev~~~L~~~~ 418 (427)
|+.+|++||++.|+++.++...
T Consensus 559 W~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 559 WNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred hCCCcccCCCHHHHHHHHHHHH
Confidence 9999999999999999999854
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-32 Score=250.81 Aligned_cols=198 Identities=23% Similarity=0.327 Sum_probs=155.6
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
.+|||++++++.+.. +...+++|||+++++|.+++.........+++..++.++.|++.||.|||+ ..|++||
T Consensus 66 ~~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~ 138 (269)
T cd08528 66 LRHPNIVRYYKTFLE-----NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHR 138 (269)
T ss_pred CCCCCeeeEEeeEcc-----CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeec
Confidence 579999999988543 567899999999999998875432223468899999999999999999993 3689999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc-----CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFT 333 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~ 333 (427)
||||+||+++.++.+||+|||.+...... ..++..|+|||++.+..++.++||||||+++||+++|+.||....
T Consensus 139 dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~- 217 (269)
T cd08528 139 DLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN- 217 (269)
T ss_pred CCCHHHEEECCCCcEEEecccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC-
Confidence 99999999999999999999999875543 257788999999998889999999999999999999999986421
Q ss_pred CCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 042634 334 GNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAAQ 413 (427)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~ 413 (427)
................ .....+.++.+++.+||+.||++|||+.|+.++
T Consensus 218 ----~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 218 ----MLSLATKIVEAVYEPL---------------------------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred ----HHHHHHHHhhccCCcC---------------------------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 1111111000000000 011234568899999999999999999999998
Q ss_pred HH
Q 042634 414 LL 415 (427)
Q Consensus 414 L~ 415 (427)
++
T Consensus 267 ~~ 268 (269)
T cd08528 267 IS 268 (269)
T ss_pred hc
Confidence 75
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-32 Score=278.28 Aligned_cols=202 Identities=20% Similarity=0.309 Sum_probs=155.2
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchh-------hhhccCHHHHHHHHHHHHHHHHHHhhcC
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNRE-------ALKNLNLLQRLSIAVDVASALDYLHHYC 251 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------~~~~l~~~~~~~~~~~i~~~L~~LH~~~ 251 (427)
++||||+++++.+.. +...++||||+++|+|.+++..... ....+++..++.++.||+.||+|||
T Consensus 59 L~HPNIVkl~~v~~d-----~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH--- 130 (932)
T PRK13184 59 LIHPGIVPVYSICSD-----GDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH--- 130 (932)
T ss_pred CCCcCcCeEEEEEee-----CCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---
Confidence 579999999988543 5678999999999999998854211 1134567788999999999999999
Q ss_pred CCCeeeccccCCceeeCCCCceEecccccccccCC------------------------cCCCccccccccccCCCCcCc
Q 042634 252 ETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPE------------------------ATNNFFNFQIAEYGMGSEVST 307 (427)
Q Consensus 252 ~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~------------------------~~~~~~~y~aPE~~~~~~~~~ 307 (427)
+.||+||||||+||+++.++.+||+|||+|+.... ...||+.|+|||++.+..++.
T Consensus 131 s~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~ 210 (932)
T PRK13184 131 SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASE 210 (932)
T ss_pred HCCccccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCc
Confidence 89999999999999999999999999999986511 125889999999999999999
Q ss_pred cccchhHHHHHHHHHhCCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHH
Q 042634 308 SGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLV 387 (427)
Q Consensus 308 ~~DiwS~G~vl~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (427)
++|||||||++|||++|+.||.......... .... .++.. .....+.+.
T Consensus 211 kSDIWSLGVILyELLTG~~PF~~~~~~ki~~----~~~i-------~~P~~--------------------~~p~~~iP~ 259 (932)
T PRK13184 211 STDIYALGVILYQMLTLSFPYRRKKGRKISY----RDVI-------LSPIE--------------------VAPYREIPP 259 (932)
T ss_pred HhHHHHHHHHHHHHHHCCCCCCCcchhhhhh----hhhc-------cChhh--------------------ccccccCCH
Confidence 9999999999999999999997532111100 0000 00000 001123456
Q ss_pred HHHHHHhhcCCCCCCCCC-CHHHHHHHHHHHHH
Q 042634 388 SVLGIGVTCSSELPRERM-NMEEVAAQLLSFRN 419 (427)
Q Consensus 388 ~~~~l~~~cl~~dP~~Rp-t~~ev~~~L~~~~~ 419 (427)
.+.+++.+|++.||++|| +++++.+.|+...+
T Consensus 260 ~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 260 FLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 688999999999999995 67788888887754
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-32 Score=249.14 Aligned_cols=189 Identities=21% Similarity=0.297 Sum_probs=151.9
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....+++|||+++++|.+++... ..+++..+..++.|++.||+||| +.|++||
T Consensus 63 l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~ 130 (267)
T cd06628 63 LQHENIVQYLGSSLD-----ADHLNIFLEYVPGGSVAALLNNY----GAFEETLVRNFVRQILKGLNYLH---NRGIIHR 130 (267)
T ss_pred cCCCCeeeEEEEEEe-----CCccEEEEEecCCCCHHHHHHhc----cCccHHHHHHHHHHHHHHHHHHH---hcCcccc
Confidence 479999999987543 56789999999999999998654 34888999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKR 326 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~ 326 (427)
||||+||+++.++.+||+|||.++..... ..++..|+|||.+.+..++.++||||+||++||+++|..
T Consensus 131 di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~ 210 (267)
T cd06628 131 DIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKH 210 (267)
T ss_pred cCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCC
Confidence 99999999999999999999999866421 146678999999998889999999999999999999999
Q ss_pred CCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCC
Q 042634 327 PTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMN 406 (427)
Q Consensus 327 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt 406 (427)
||..... .... ... ..... ...+...+..+.+++.+||+.||++|||
T Consensus 211 p~~~~~~----~~~~-~~~-----~~~~~-----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~ 257 (267)
T cd06628 211 PFPDCTQ----LQAI-FKI-----GENAS-----------------------PEIPSNISSEAIDFLEKTFEIDHNKRPT 257 (267)
T ss_pred CCCCccH----HHHH-HHH-----hccCC-----------------------CcCCcccCHHHHHHHHHHccCCchhCcC
Confidence 9975311 1110 000 00000 0012234567899999999999999999
Q ss_pred HHHHHH
Q 042634 407 MEEVAA 412 (427)
Q Consensus 407 ~~ev~~ 412 (427)
+.||++
T Consensus 258 ~~~il~ 263 (267)
T cd06628 258 AAELLK 263 (267)
T ss_pred HHHHhh
Confidence 999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-32 Score=247.73 Aligned_cols=192 Identities=22% Similarity=0.273 Sum_probs=153.4
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++.+.. ....++++||+++++|.+++.... ..+++..+..++.|++.|+.||| ..+++||
T Consensus 55 l~~~~i~~~~~~~~~-----~~~~~l~~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~ 123 (256)
T cd06612 55 CDSPYIVKYYGSYFK-----NTDLWIVMEYCGAGSVSDIMKITN---KTLTEEEIAAILYQTLKGLEYLH---SNKKIHR 123 (256)
T ss_pred CCCCcEeeeeeeeec-----CCcEEEEEecCCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHH---HCCcccC
Confidence 389999999998544 567899999999999999986433 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC------CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||+|+||+++.++.+||+|||.+....... .++..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 124 dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~ 203 (256)
T cd06612 124 DIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIH 203 (256)
T ss_pred CCCcceEEECCCCcEEEcccccchhcccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 999999999999999999999998754332 46778999999988899999999999999999999999987532
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
.... . .. ... .... ....+...+.++.+++.+||+.||++|||++||++
T Consensus 204 ~~~~----~-~~-~~~----~~~~---------------------~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 204 PMRA----I-FM-IPN----KPPP---------------------TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred hhhh----h-hh-hcc----CCCC---------------------CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 1110 0 00 000 0000 00012334567899999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=254.34 Aligned_cols=146 Identities=19% Similarity=0.332 Sum_probs=118.6
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchh-----hhhccCHHHHHHHHHHHHHHHHHHhhcCCC
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNRE-----ALKNLNLLQRLSIAVDVASALDYLHHYCET 253 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-----~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~ 253 (427)
++||||+++++.+.. ..+...++||||+. ++|.+++..... ....+++..++.++.|++.||+||| +.
T Consensus 55 l~h~niv~~~~~~~~---~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~ 127 (317)
T cd07867 55 LKHPNVIALQKVFLS---HSDRKVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---AN 127 (317)
T ss_pred CCCCCeeeEEEEEec---cCCCeEEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hC
Confidence 579999999887643 22456789999984 577776642211 1134888999999999999999999 89
Q ss_pred CeeeccccCCceee----CCCCceEecccccccccCCc---------CCCccccccccccCC-CCcCccccchhHHHHHH
Q 042634 254 PIVHCDLKPSNVLL----DGELTAHVGDFGLAKFLPEA---------TNNFFNFQIAEYGMG-SEVSTSGDVYSFGILLL 319 (427)
Q Consensus 254 ~ivHrDlkp~NIll----~~~~~~kL~DFG~a~~~~~~---------~~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ 319 (427)
||+||||||+||++ +.++.+||+|||+|+..... ..++..|+|||++.+ ..++.++|||||||++|
T Consensus 128 ~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ 207 (317)
T cd07867 128 WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFA 207 (317)
T ss_pred CEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHH
Confidence 99999999999999 56679999999999865332 256788999999876 45799999999999999
Q ss_pred HHHhCCCCCCcc
Q 042634 320 ETFTGKRPTNEM 331 (427)
Q Consensus 320 ell~g~~pf~~~ 331 (427)
||++|++||...
T Consensus 208 el~tg~~~f~~~ 219 (317)
T cd07867 208 ELLTSEPIFHCR 219 (317)
T ss_pred HHHhCCCCcccc
Confidence 999999999753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=249.68 Aligned_cols=192 Identities=23% Similarity=0.325 Sum_probs=148.9
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++.+.. ....++||||+++++|..+ ..+++..+..++.|++.||+||| +.||+|+
T Consensus 56 l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~l~~~--------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~ 119 (279)
T cd06619 56 CDSPYIIGFYGAFFV-----ENRISICTEFMDGGSLDVY--------RKIPEHVLGRIAVAVVKGLTYLW---SLKILHR 119 (279)
T ss_pred CCCCCeeeEEEEEEE-----CCEEEEEEecCCCCChHHh--------hcCCHHHHHHHHHHHHHHHHHHH---HCCEeeC
Confidence 479999999998654 4567899999999998654 23678888999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc----CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA----TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTG 334 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~~ 334 (427)
||||+||+++.++.+||+|||++...... ..++..|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 120 dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~ 199 (279)
T cd06619 120 DVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKN 199 (279)
T ss_pred CCCHHHEEECCCCCEEEeeCCcceecccccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccc
Confidence 99999999999999999999999865432 36788999999999989999999999999999999999999753222
Q ss_pred CccH--HHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 335 NLTL--HNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 335 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
.... .......... ..+ .......+.++.+++.+||+.+|++||+++|+++
T Consensus 200 ~~~~~~~~~~~~~~~~-----~~~----------------------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~ 252 (279)
T cd06619 200 QGSLMPLQLLQCIVDE-----DPP----------------------VLPVGQFSEKFVHFITQCMRKQPKERPAPENLMD 252 (279)
T ss_pred ccccchHHHHHHHhcc-----CCC----------------------CCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 1110 0000000000 000 0011113456889999999999999999999987
Q ss_pred H
Q 042634 413 Q 413 (427)
Q Consensus 413 ~ 413 (427)
.
T Consensus 253 ~ 253 (279)
T cd06619 253 H 253 (279)
T ss_pred C
Confidence 5
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=248.40 Aligned_cols=193 Identities=23% Similarity=0.317 Sum_probs=148.7
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhcc--CHHHHHHHHHHHHHHHHHHhhcCCCCee
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNL--NLLQRLSIAVDVASALDYLHHYCETPIV 256 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l--~~~~~~~~~~~i~~~L~~LH~~~~~~iv 256 (427)
++|+||+++++.+.. +...++++||+++++|.+++.... ..+ ++..+..++.|++.||+||| ..||+
T Consensus 62 l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~ 130 (268)
T cd06624 62 LKHRNIVQYLGSDSE-----NGFFKIFMEQVPGGSLSALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLH---DNQIV 130 (268)
T ss_pred cCCCCeeeeeeeecc-----CCEEEEEEecCCCCCHHHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHH---HCCEe
Confidence 579999999988544 567899999999999999986532 224 77888999999999999999 89999
Q ss_pred eccccCCceeeCC-CCceEecccccccccCCc------CCCccccccccccCCC--CcCccccchhHHHHHHHHHhCCCC
Q 042634 257 HCDLKPSNVLLDG-ELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMGS--EVSTSGDVYSFGILLLETFTGKRP 327 (427)
Q Consensus 257 HrDlkp~NIll~~-~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~~--~~~~~~DiwS~G~vl~ell~g~~p 327 (427)
||||||+||+++. ++.+||+|||.+...... ..++..|+|||++... .++.++||||||+++|++++|+.|
T Consensus 131 h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p 210 (268)
T cd06624 131 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210 (268)
T ss_pred ecCCCHHHEEEcCCCCeEEEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCC
Confidence 9999999999976 679999999998765321 2577899999998654 378999999999999999999999
Q ss_pred CCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCH
Q 042634 328 TNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM 407 (427)
Q Consensus 328 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~ 407 (427)
|........... ...... . ....+..++.++.+++.+||+.+|++|||+
T Consensus 211 ~~~~~~~~~~~~---~~~~~~----~------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~ 259 (268)
T cd06624 211 FIELGEPQAAMF---KVGMFK----I------------------------HPEIPESLSAEAKNFILRCFEPDPDKRASA 259 (268)
T ss_pred CccccChhhhHh---hhhhhc----c------------------------CCCCCcccCHHHHHHHHHHcCCCchhCCCH
Confidence 864311111000 000000 0 000122345678999999999999999999
Q ss_pred HHHHHH
Q 042634 408 EEVAAQ 413 (427)
Q Consensus 408 ~ev~~~ 413 (427)
.|++++
T Consensus 260 ~~ll~~ 265 (268)
T cd06624 260 HDLLQD 265 (268)
T ss_pred HHHHhC
Confidence 999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=245.25 Aligned_cols=193 Identities=24% Similarity=0.399 Sum_probs=152.9
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+++++|.+++.... ..+++..+..++.|++.|++||| +++++||
T Consensus 49 l~~~~i~~~~~~~~~-----~~~~~~v~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~ 117 (251)
T cd05041 49 YDHPNIVKLIGVCVQ-----KQPIYIVMELVPGGSLLTFLRKKK---NRLTVKKLLQMSLDAAAGMEYLE---SKNCIHR 117 (251)
T ss_pred CCCCCeEEEEEEEec-----CCCeEEEEEcCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---hCCEehh
Confidence 579999999887543 457899999999999999986532 34788899999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC--------CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT--------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTN 329 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~--------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~ 329 (427)
||||+||+++.++.+||+|||.++...... ..+..|+|||.+.+..++.++|||||||++||+++ |..||.
T Consensus 118 di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~ 197 (251)
T cd05041 118 DLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYP 197 (251)
T ss_pred hcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCc
Confidence 999999999999999999999998654211 23456999999988889999999999999999999 888886
Q ss_pred cccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 042634 330 EMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEE 409 (427)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~e 409 (427)
.... ......+..... ...+..++.++.+++.+||+.+|++|||++|
T Consensus 198 ~~~~--~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e 244 (251)
T cd05041 198 GMSN--QQTRERIESGYR-------------------------------MPAPQLCPEEIYRLMLQCWAYDPENRPSFSE 244 (251)
T ss_pred cCCH--HHHHHHHhcCCC-------------------------------CCCCccCCHHHHHHHHHHhccChhhCcCHHH
Confidence 5321 111111100000 0012234567999999999999999999999
Q ss_pred HHHHHH
Q 042634 410 VAAQLL 415 (427)
Q Consensus 410 v~~~L~ 415 (427)
+++.|+
T Consensus 245 ll~~l~ 250 (251)
T cd05041 245 IYNELQ 250 (251)
T ss_pred HHHHhh
Confidence 999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=246.90 Aligned_cols=189 Identities=21% Similarity=0.271 Sum_probs=153.8
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
+.|||++++++.+.. +...++||||+++|+|.+++... .+++.++..++.|++.|++|+| +.+++|+
T Consensus 59 l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~i~~~-----~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~ 125 (277)
T cd06640 59 CDSPYVTKYYGSYLK-----GTKLWIIMEYLGGGSALDLLRAG-----PFDEFQIATMLKEILKGLDYLH---SEKKIHR 125 (277)
T ss_pred CCCCCEeeEEEEEEE-----CCEEEEEEecCCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCccCc
Confidence 579999999998544 56789999999999999988643 4788899999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC------CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||+|+||+++.++.++|+|||.+....... .++..|+|||++.+..++.++|+|||||++|||++|..||....
T Consensus 126 dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~ 205 (277)
T cd06640 126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH 205 (277)
T ss_pred CCChhhEEEcCCCCEEEcccccceeccCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 999999999999999999999997654322 46678999999988889999999999999999999999987532
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
... ......... .......++.++.+++.+||+.+|++|||++|+++
T Consensus 206 ~~~--~~~~~~~~~-------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06640 206 PMR--VLFLIPKNN-------------------------------PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLK 252 (277)
T ss_pred hHh--HhhhhhcCC-------------------------------CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHh
Confidence 110 000000000 00123346778999999999999999999999987
Q ss_pred H
Q 042634 413 Q 413 (427)
Q Consensus 413 ~ 413 (427)
.
T Consensus 253 ~ 253 (277)
T cd06640 253 H 253 (277)
T ss_pred C
Confidence 7
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-32 Score=261.96 Aligned_cols=193 Identities=19% Similarity=0.225 Sum_probs=147.0
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+. .+...++||||+++|+|.+++... .+++..+..++.||+.||+||| +.||+||
T Consensus 100 ~~hp~iv~~~~~~~-----~~~~~~lv~Ey~~gg~L~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH---~~~ivHr 166 (371)
T cd05622 100 ANSPWVVQLFYAFQ-----DDRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIH---SMGFIHR 166 (371)
T ss_pred CCCCCCCeEEEEEE-----cCCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHH---HCCEEeC
Confidence 57999999998753 356789999999999999988543 3788899999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc-------CCCccccccccccCCCC----cCccccchhHHHHHHHHHhCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA-------TNNFFNFQIAEYGMGSE----VSTSGDVYSFGILLLETFTGKRP 327 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-------~~~~~~y~aPE~~~~~~----~~~~~DiwS~G~vl~ell~g~~p 327 (427)
||||+|||++.++.+||+|||+|+..... ..||+.|+|||++.... ++.++|||||||++|||++|+.|
T Consensus 167 DLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~P 246 (371)
T cd05622 167 DVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246 (371)
T ss_pred CCCHHHEEECCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCC
Confidence 99999999999999999999999865432 25889999999987543 78999999999999999999999
Q ss_pred CCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCC--CC
Q 042634 328 TNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRE--RM 405 (427)
Q Consensus 328 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~--Rp 405 (427)
|..... .......... ... .. + ......+..+.+++.+|+..++.+ ||
T Consensus 247 f~~~~~-----~~~~~~i~~~-----~~~-~~----------------~---~~~~~~s~~~~~li~~~L~~~~~r~~r~ 296 (371)
T cd05622 247 FYADSL-----VGTYSKIMNH-----KNS-LT----------------F---PDDNDISKEAKNLICAFLTDREVRLGRN 296 (371)
T ss_pred CCCCCH-----HHHHHHHHcC-----CCc-cc----------------C---CCcCCCCHHHHHHHHHHcCChhhhcCCC
Confidence 975311 1111111000 000 00 0 011123556788999999844433 78
Q ss_pred CHHHHHHHH
Q 042634 406 NMEEVAAQL 414 (427)
Q Consensus 406 t~~ev~~~L 414 (427)
+++|++++.
T Consensus 297 ~~~ei~~h~ 305 (371)
T cd05622 297 GVEEIKRHL 305 (371)
T ss_pred CHHHHhcCc
Confidence 999988753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-32 Score=251.59 Aligned_cols=197 Identities=20% Similarity=0.218 Sum_probs=150.9
Q ss_pred cccccchhhhccccccCC-CCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 042634 179 IRHRNLVKIITSCASVDF-QGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVH 257 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivH 257 (427)
.+|||++++++.+..... ..+...+++|||+++|+|.+++..... ..+++..+..++.|++.|++||| +.||+|
T Consensus 70 ~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH---~~~ivH 144 (282)
T cd06636 70 SHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG--NALKEDWIAYICREILRGLAHLH---AHKVIH 144 (282)
T ss_pred cCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHH---HCCccc
Confidence 369999999988653221 224567999999999999998865332 34788889999999999999999 899999
Q ss_pred ccccCCceeeCCCCceEecccccccccCC------cCCCccccccccccC-----CCCcCccccchhHHHHHHHHHhCCC
Q 042634 258 CDLKPSNVLLDGELTAHVGDFGLAKFLPE------ATNNFFNFQIAEYGM-----GSEVSTSGDVYSFGILLLETFTGKR 326 (427)
Q Consensus 258 rDlkp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~~y~aPE~~~-----~~~~~~~~DiwS~G~vl~ell~g~~ 326 (427)
|||||+||+++.++.+||+|||.+..... ...++..|+|||.+. ...++.++|||||||++|||++|..
T Consensus 145 ~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~ 224 (282)
T cd06636 145 RDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAP 224 (282)
T ss_pred CCCCHHHEEECCCCCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCC
Confidence 99999999999999999999999875432 125778899999876 3467889999999999999999999
Q ss_pred CCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCC
Q 042634 327 PTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMN 406 (427)
Q Consensus 327 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt 406 (427)
||...... ..... . ..... .......++.++.+++.+||+.||.+|||
T Consensus 225 p~~~~~~~----~~~~~-~-----~~~~~----------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~ 272 (282)
T cd06636 225 PLCDMHPM----RALFL-I-----PRNPP----------------------PKLKSKKWSKKFIDFIEGCLVKNYLSRPS 272 (282)
T ss_pred CccccCHH----hhhhh-H-----hhCCC----------------------CCCcccccCHHHHHHHHHHhCCChhhCcC
Confidence 99653110 00000 0 00000 00011234567999999999999999999
Q ss_pred HHHHHH
Q 042634 407 MEEVAA 412 (427)
Q Consensus 407 ~~ev~~ 412 (427)
+.|+++
T Consensus 273 ~~ell~ 278 (282)
T cd06636 273 TEQLLK 278 (282)
T ss_pred HHHHhc
Confidence 999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=245.43 Aligned_cols=195 Identities=24% Similarity=0.429 Sum_probs=153.7
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|+|++++.+.+.. ...+++|||+++++|.+++..... ..+++..++.++.|++.||+||| ..|++||
T Consensus 58 l~~~~i~~~~~~~~~------~~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~ 126 (260)
T cd05073 58 LQHDKLVKLHAVVTK------EPIYIITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIE---QRNYIHR 126 (260)
T ss_pred cCCCCcceEEEEEcC------CCeEEEEEeCCCCcHHHHHHhCCc--cccCHHHHHHHHHHHHHHHHHHH---hCCcccc
Confidence 579999999877433 457899999999999999865432 45788899999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC-------CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCCc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT-------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~-------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~~ 330 (427)
||||+||+++.++.+||+|||.+....... .++..|+|||++....++.++|||||||++|++++ |+.||..
T Consensus 127 dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~ 206 (260)
T cd05073 127 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG 206 (260)
T ss_pred ccCcceEEEcCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCC
Confidence 999999999999999999999997654322 34467999999988889999999999999999998 9999875
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
... ............. ..+...+.++.+++.+||+.+|++|||+.++
T Consensus 207 ~~~--~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l 253 (260)
T cd05073 207 MSN--PEVIRALERGYRM-------------------------------PRPENCPEELYNIMMRCWKNRPEERPTFEYI 253 (260)
T ss_pred CCH--HHHHHHHhCCCCC-------------------------------CCcccCCHHHHHHHHHHcccCcccCcCHHHH
Confidence 311 1111111100000 0112235668999999999999999999999
Q ss_pred HHHHHHH
Q 042634 411 AAQLLSF 417 (427)
Q Consensus 411 ~~~L~~~ 417 (427)
.+.|+.+
T Consensus 254 ~~~L~~~ 260 (260)
T cd05073 254 QSVLDDF 260 (260)
T ss_pred HHHHhcC
Confidence 9998753
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-32 Score=252.37 Aligned_cols=201 Identities=18% Similarity=0.191 Sum_probs=146.0
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
..|++++++++.+.... ......++++|++ ..++.+.+... ...++..+..++.|++.||+||| +.+|+||
T Consensus 80 ~~h~~i~~~~~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHr 150 (294)
T PHA02882 80 IDHLGIPKYYGCGSFKR-CRMYYRFILLEKL-VENTKEIFKRI----KCKNKKLIKNIMKDMLTTLEYIH---EHGISHG 150 (294)
T ss_pred CCCCCCCcEEEeeeEec-CCceEEEEEEehh-ccCHHHHHHhh----ccCCHHHHHHHHHHHHHHHHHHH---hCCeecC
Confidence 57899999887643311 1112346677766 34555544322 23567888999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC-------------cCCCccccccccccCCCCcCccccchhHHHHHHHHHhCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE-------------ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGK 325 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~-------------~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~ 325 (427)
||||+|||++.++.+||+|||+|+.... ...||+.|+|||+..+..++.++|||||||++|||++|+
T Consensus 151 DiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~ 230 (294)
T PHA02882 151 DIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIK 230 (294)
T ss_pred CCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 9999999999999999999999976421 125889999999999999999999999999999999999
Q ss_pred CCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCC
Q 042634 326 RPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERM 405 (427)
Q Consensus 326 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rp 405 (427)
.||.......... ......+... +..... ....++.++.+++..||+.+|++||
T Consensus 231 ~P~~~~~~~~~~~-~~~~~~~~~~---~~~~~~----------------------~~~~~~~~~~~~~~~~~~~~~~~rp 284 (294)
T PHA02882 231 LPWKGFGHNGNLI-HAAKCDFIKR---LHEGKI----------------------KIKNANKFIYDFIECVTKLSYEEKP 284 (294)
T ss_pred CCCCccccchHHH-HHhHHHHHHH---hhhhhh----------------------ccCCCCHHHHHHHHHHHhCCCCCCC
Confidence 9998652222111 1111100000 000000 1123467799999999999999999
Q ss_pred CHHHHHHHH
Q 042634 406 NMEEVAAQL 414 (427)
Q Consensus 406 t~~ev~~~L 414 (427)
+++++.+.+
T Consensus 285 ~~~~l~~~~ 293 (294)
T PHA02882 285 DYDALIKIF 293 (294)
T ss_pred CHHHHHHhh
Confidence 999999875
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-32 Score=256.57 Aligned_cols=190 Identities=24% Similarity=0.295 Sum_probs=156.4
Q ss_pred cccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccc
Q 042634 181 HRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDL 260 (427)
Q Consensus 181 Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrDl 260 (427)
|||||.+.+.+.. ....++|||+|.||.|++.+... .+++..+..++.|++.|++||| +.||+|||+
T Consensus 95 hpniv~l~~~~e~-----~~~~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH---~~gvvHrDl 161 (382)
T KOG0032|consen 95 HPNIVQLKDAFED-----PDSVYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLH---SLGVVHRDL 161 (382)
T ss_pred CCCEEEEEEEEEc-----CCeEEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHH---hCCceeccC
Confidence 9999999999544 56889999999999999998655 2899999999999999999999 899999999
Q ss_pred cCCceeeCC----CCceEecccccccccCCcC-----CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 261 KPSNVLLDG----ELTAHVGDFGLAKFLPEAT-----NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 261 kp~NIll~~----~~~~kL~DFG~a~~~~~~~-----~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
||+|+|+.. ++.+|++|||+|.....+. +||+.|+|||++...+|+..+||||+||++|.|++|.+||.+.
T Consensus 162 KpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~ 241 (382)
T KOG0032|consen 162 KPENLLLASKDEGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGE 241 (382)
T ss_pred CHHHeeeccccCCCCcEEEeeCCCceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCC
Confidence 999999953 3589999999999887632 8999999999999999999999999999999999999999865
Q ss_pred cCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 042634 332 FTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVA 411 (427)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~ 411 (427)
..... ........+ ++- ..........+.+++++|+..||.+|+|+.+++
T Consensus 242 ~~~~~-~~~i~~~~~-----~f~------------------------~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L 291 (382)
T KOG0032|consen 242 TEFEI-FLAILRGDF-----DFT------------------------SEPWDDISESAKDFIRKLLEFDPRKRLTAAQAL 291 (382)
T ss_pred ChhHH-HHHHHcCCC-----CCC------------------------CCCccccCHHHHHHHHHhcccCcccCCCHHHHh
Confidence 32221 111111111 000 012334567789999999999999999999999
Q ss_pred HH
Q 042634 412 AQ 413 (427)
Q Consensus 412 ~~ 413 (427)
++
T Consensus 292 ~H 293 (382)
T KOG0032|consen 292 QH 293 (382)
T ss_pred cC
Confidence 85
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=248.27 Aligned_cols=207 Identities=21% Similarity=0.214 Sum_probs=154.2
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+... .....++||||+++++|.+++.........+++..+..++.|++.||.||| ..|++|+
T Consensus 56 l~h~~iv~~~~~~~~~---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~ 129 (287)
T cd06621 56 CKSPYIVKYYGAFLDE---SSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHR 129 (287)
T ss_pred CCCCCeeeeeeEEEcc---CCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccC
Confidence 5799999999876432 134578999999999998887543222245889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc----CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA----TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTG 334 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~~ 334 (427)
||+|+||+++.++.+||+|||++...... ..++..|+|||.+.+..++.++||||+||++|||++|..||......
T Consensus 130 dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 209 (287)
T cd06621 130 DIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP 209 (287)
T ss_pred CCCHHHEEEecCCeEEEeeccccccccccccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCC
Confidence 99999999999999999999998764432 25677899999999889999999999999999999999999754221
Q ss_pred CccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 042634 335 NLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAAQ 413 (427)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~ 413 (427)
.....+..............+. . ......+..+.+++.+||+.+|.+|||+.|+++.
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~-----~-----------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 210 PLGPIELLSYIVNMPNPELKDE-----P-----------------GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred CCChHHHHHHHhcCCchhhccC-----C-----------------CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 1111111111000000000000 0 0001134568899999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-32 Score=249.87 Aligned_cols=197 Identities=22% Similarity=0.367 Sum_probs=153.8
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhh-----hccCHHHHHHHHHHHHHHHHHHhhcCCC
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREAL-----KNLNLLQRLSIAVDVASALDYLHHYCET 253 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~-----~~l~~~~~~~~~~~i~~~L~~LH~~~~~ 253 (427)
++|||++++++.+.. ....++||||+++|+|.+++....... ..+++..+..++.|++.||+||| +.
T Consensus 65 l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~ 136 (275)
T cd05046 65 LSHKNVVRLLGLCRE-----AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NA 136 (275)
T ss_pred cCCcceeeeEEEECC-----CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hc
Confidence 469999999987543 456799999999999999987543111 15899999999999999999999 89
Q ss_pred CeeeccccCCceeeCCCCceEecccccccccCC-------cCCCccccccccccCCCCcCccccchhHHHHHHHHHh-CC
Q 042634 254 PIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPE-------ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GK 325 (427)
Q Consensus 254 ~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~-------~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~ 325 (427)
+|+||||||+||+++.++.+|++|||+++.... ...++..|+|||.+.+..++.++|||||||++|++++ |.
T Consensus 137 ~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~ 216 (275)
T cd05046 137 RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGE 216 (275)
T ss_pred CcccCcCccceEEEeCCCcEEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999999875432 1245667999999988889999999999999999998 88
Q ss_pred CCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCC
Q 042634 326 RPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERM 405 (427)
Q Consensus 326 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rp 405 (427)
.||..... . ..+.......... ..+..++..+.+++.+||+.+|++||
T Consensus 217 ~p~~~~~~--~---~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~~i~~~l~~~p~~Rp 264 (275)
T cd05046 217 LPFYGLSD--E---EVLNRLQAGKLEL---------------------------PVPEGCPSRLYKLMTRCWAVNPKDRP 264 (275)
T ss_pred CCccccch--H---HHHHHHHcCCcCC---------------------------CCCCCCCHHHHHHHHHHcCCCcccCC
Confidence 88864311 1 1111100000000 01122456789999999999999999
Q ss_pred CHHHHHHHHH
Q 042634 406 NMEEVAAQLL 415 (427)
Q Consensus 406 t~~ev~~~L~ 415 (427)
|+.|+++.|.
T Consensus 265 ~~~~~l~~l~ 274 (275)
T cd05046 265 SFSELVSALG 274 (275)
T ss_pred CHHHHHHHhc
Confidence 9999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-32 Score=241.32 Aligned_cols=193 Identities=22% Similarity=0.300 Sum_probs=159.6
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
.+.|++|++|+++.. +...++|||||..|++.+.++.++ +.+++.++..+++.-+.||+||| ...-+||
T Consensus 85 C~S~yVVKYYGSYFK-----~sDLWIVMEYCGAGSiSDI~R~R~---K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHR 153 (502)
T KOG0574|consen 85 CKSKYVVKYYGSYFK-----HSDLWIVMEYCGAGSISDIMRARR---KPLSEQEISAVLRDTLKGLQYLH---DLKKIHR 153 (502)
T ss_pred cCCchhhhhhhhhcc-----CCceEeehhhcCCCcHHHHHHHhc---CCccHHHHHHHHHHHHhHHHHHH---HHHHHHh
Confidence 457999999998433 567899999999999999997665 67999999999999999999999 6677999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC------CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
|||..|||++.+|.+||+|||+|..+...+ .||+.|||||++..-.|+.++||||+|++..||..|++||.+.-
T Consensus 154 DIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIH 233 (502)
T KOG0574|consen 154 DIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIH 233 (502)
T ss_pred hcccccEEEcccchhhhhhccccchhhhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccc
Confidence 999999999999999999999998775433 89999999999999999999999999999999999999997642
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
.-...+ .+| ..+......++.-+.++.+++++|+-..|++|.|+.++++
T Consensus 234 PMRAIF------MIP-------------------------T~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 234 PMRAIF------MIP-------------------------TKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred ccceeE------ecc-------------------------CCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 110000 000 0011112245666788999999999999999999999987
Q ss_pred H
Q 042634 413 Q 413 (427)
Q Consensus 413 ~ 413 (427)
+
T Consensus 283 H 283 (502)
T KOG0574|consen 283 H 283 (502)
T ss_pred h
Confidence 5
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-32 Score=250.91 Aligned_cols=213 Identities=19% Similarity=0.226 Sum_probs=149.4
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++.+. +....++++||++ ++|.+++.... ..+++..++.++.||++||.||| ..||+||
T Consensus 56 l~h~~i~~~~~~~~-----~~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~ 123 (284)
T cd07839 56 LKHKNIVRLYDVLH-----SDKKLTLVFEYCD-QDLKKYFDSCN---GDIDPEIVKSFMFQLLKGLAFCH---SHNVLHR 123 (284)
T ss_pred cCCCCeeeHHHHhc-----cCCceEEEEecCC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCEecC
Confidence 57999999999854 3567899999995 68877765432 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCCC-CcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMGS-EVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~~-~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
||||+||+++.++.+||+|||.++..... ..++..|+|||++.+. .++.++|||||||++|||++|..||...
T Consensus 124 dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~ 203 (284)
T cd07839 124 DLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 203 (284)
T ss_pred CCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCC
Confidence 99999999999999999999999865332 2557789999998764 4789999999999999999999886532
Q ss_pred cCCCccHHHHHHHhcccc------hhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCC
Q 042634 332 FTGNLTLHNFVKEALPER------LAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERM 405 (427)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rp 405 (427)
......+........... .....+... ... ......+ .......+.++.+++.+||+.||.+||
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~--~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~R~ 273 (284)
T cd07839 204 NDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP------YPM--YPATTSL--VNVVPKLNSTGRDLLQNLLVCNPVQRI 273 (284)
T ss_pred CCHHHHHHHHHHHhCCCChHHhHHhhhcccccc------cCC--CCCcchh--hhhcccCCHHHHHHHHHHhcCChhhcC
Confidence 221111111111100000 000000000 000 0000000 001122456788999999999999999
Q ss_pred CHHHHHHH
Q 042634 406 NMEEVAAQ 413 (427)
Q Consensus 406 t~~ev~~~ 413 (427)
|++|++++
T Consensus 274 t~~~il~h 281 (284)
T cd07839 274 SAEEALQH 281 (284)
T ss_pred CHHHHhcC
Confidence 99999763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=249.97 Aligned_cols=195 Identities=23% Similarity=0.280 Sum_probs=149.4
Q ss_pred ccccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCC-Cee
Q 042634 178 FIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCET-PIV 256 (427)
Q Consensus 178 ll~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~-~iv 256 (427)
..+|||++++++.+.. +...+++|||++ |+|.+++.........+++..+..++.|++.||+||| ++ +++
T Consensus 56 ~~~~~~iv~~~~~~~~-----~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~ 126 (283)
T cd06617 56 SVDCPYTVTFYGALFR-----EGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVI 126 (283)
T ss_pred HcCCCCeeeeeEEEec-----CCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCee
Confidence 3679999999998643 456899999994 7887777543222256899999999999999999999 66 999
Q ss_pred eccccCCceeeCCCCceEecccccccccCCc-----CCCccccccccccCC----CCcCccccchhHHHHHHHHHhCCCC
Q 042634 257 HCDLKPSNVLLDGELTAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMG----SEVSTSGDVYSFGILLLETFTGKRP 327 (427)
Q Consensus 257 HrDlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~----~~~~~~~DiwS~G~vl~ell~g~~p 327 (427)
||||||+||+++.++.+||+|||.++..... ..++..|+|||.+.+ ..++.++|+|||||++|||++|+.|
T Consensus 127 h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p 206 (283)
T cd06617 127 HRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFP 206 (283)
T ss_pred cCCCCHHHEEECCCCCEEEeecccccccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCC
Confidence 9999999999999999999999999865432 256778999998865 4468899999999999999999999
Q ss_pred CCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCH
Q 042634 328 TNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM 407 (427)
Q Consensus 328 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~ 407 (427)
|.........+...... . . ........+.++.+++.+||+.+|++|||+
T Consensus 207 ~~~~~~~~~~~~~~~~~-~--------~----------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~ 255 (283)
T cd06617 207 YDSWKTPFQQLKQVVEE-P--------S----------------------PQLPAEKFSPEFQDFVNKCLKKNYKERPNY 255 (283)
T ss_pred CCccccCHHHHHHHHhc-C--------C----------------------CCCCccccCHHHHHHHHHHccCChhhCcCH
Confidence 86421111111110000 0 0 000112245678999999999999999999
Q ss_pred HHHHH
Q 042634 408 EEVAA 412 (427)
Q Consensus 408 ~ev~~ 412 (427)
+|+++
T Consensus 256 ~~il~ 260 (283)
T cd06617 256 PELLQ 260 (283)
T ss_pred HHHhc
Confidence 99987
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=245.45 Aligned_cols=193 Identities=20% Similarity=0.295 Sum_probs=154.9
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|+||+++++.+.. ....+++|||+++++|.+++..... ..+++..+..++.|++.|+.||| +.|++||
T Consensus 56 ~~h~~i~~~~~~~~~-----~~~~~~~~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~ 125 (256)
T cd08221 56 LQHPNIIAYYNHFMD-----DNTLLIEMEYANGGTLYDKIVRQKG--QLFEEEMVLWYLFQIVSAVSYIH---KAGILHR 125 (256)
T ss_pred CCCCCeeEEEeEEec-----CCeEEEEEEecCCCcHHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHH---hCCcccc
Confidence 469999999998543 5678999999999999999875432 45889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+||++++++.+||+|||.++..... ..++..|+|||+..+..++.++|||||||++|||++|..||....
T Consensus 126 dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~ 205 (256)
T cd08221 126 DIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN 205 (256)
T ss_pred CCChHhEEEeCCCCEEECcCcceEEcccccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC
Confidence 99999999999999999999999865332 257889999999988889999999999999999999999986421
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
..+............ .+..++.++.+++.+||+.+|++|||++|+++
T Consensus 206 -----~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~ 252 (256)
T cd08221 206 -----PLNLVVKIVQGNYTP----------------------------VVSVYSSELISLVHSLLQQDPEKRPTADEVLD 252 (256)
T ss_pred -----HHHHHHHHHcCCCCC----------------------------CccccCHHHHHHHHHHcccCcccCCCHHHHhh
Confidence 111111111110000 11234566889999999999999999999987
Q ss_pred HH
Q 042634 413 QL 414 (427)
Q Consensus 413 ~L 414 (427)
.+
T Consensus 253 ~~ 254 (256)
T cd08221 253 QP 254 (256)
T ss_pred Cc
Confidence 53
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-32 Score=262.36 Aligned_cols=141 Identities=24% Similarity=0.334 Sum_probs=125.2
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||+|+++++.+. .....++||||+++|+|.+++... ..+++..++.++.|++.||+||| +.||+||
T Consensus 58 l~~~~iv~~~~~~~-----~~~~~~lv~E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~~L~~lH---~~givHr 125 (360)
T cd05627 58 ADGAWVVKMFYSFQ-----DKRNLYLIMEFLPGGDMMTLLMKK----DTLSEEATQFYIAETVLAIDAIH---QLGFIHR 125 (360)
T ss_pred CCCCCEeeEEEEEE-----cCCEEEEEEeCCCCccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEcc
Confidence 47999999998743 366789999999999999998654 35899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC-----------------------------------------cCCCccccccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE-----------------------------------------ATNNFFNFQIA 297 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~-----------------------------------------~~~~~~~y~aP 297 (427)
||||+|||++.++.+||+|||+++.... ...||+.|+||
T Consensus 126 DLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 205 (360)
T cd05627 126 DIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAP 205 (360)
T ss_pred CCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCH
Confidence 9999999999999999999999875421 12588899999
Q ss_pred cccCCCCcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 298 EYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 298 E~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
|++.+..++.++|||||||++|||++|+.||...
T Consensus 206 E~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 206 EVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred HHHcCCCCCCcceeccccceeeecccCCCCCCCC
Confidence 9999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=245.95 Aligned_cols=199 Identities=22% Similarity=0.271 Sum_probs=156.5
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcC--CCCee
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYC--ETPIV 256 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~--~~~iv 256 (427)
++|||++++++.+.. ..+...+++|||+++++|.+++.........+++..++.++.|++.||+|||..+ +.+++
T Consensus 56 l~~~~i~~~~~~~~~---~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~ 132 (265)
T cd08217 56 LKHPNIVRYYDRIID---RSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVL 132 (265)
T ss_pred cCCCccceeeeeeec---CCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcce
Confidence 579999999886533 2244578999999999999998754333356899999999999999999999443 57899
Q ss_pred eccccCCceeeCCCCceEecccccccccCCcC------CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCc
Q 042634 257 HCDLKPSNVLLDGELTAHVGDFGLAKFLPEAT------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNE 330 (427)
Q Consensus 257 HrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~ 330 (427)
|+||||+||+++.++.+||+|||.+....... .++..|+|||.+.+..++.++||||||+++|+|++|..||..
T Consensus 133 h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 212 (265)
T cd08217 133 HRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTA 212 (265)
T ss_pred ecCCCHHHEEEecCCCEEEecccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccC
Confidence 99999999999999999999999998764432 577889999999988899999999999999999999999975
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
.. ...+.+.+.... .. ..+...+.++.+++.+||+.+|++|||++||
T Consensus 213 ~~--~~~~~~~~~~~~---~~----------------------------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~i 259 (265)
T cd08217 213 RN--QLQLASKIKEGK---FR----------------------------RIPYRYSSELNEVIKSMLNVDPDKRPSTEEL 259 (265)
T ss_pred cC--HHHHHHHHhcCC---CC----------------------------CCccccCHHHHHHHHHHccCCcccCCCHHHH
Confidence 32 111111111000 00 0122345678999999999999999999999
Q ss_pred HHH
Q 042634 411 AAQ 413 (427)
Q Consensus 411 ~~~ 413 (427)
+++
T Consensus 260 l~~ 262 (265)
T cd08217 260 LQL 262 (265)
T ss_pred hhC
Confidence 864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=248.83 Aligned_cols=200 Identities=23% Similarity=0.239 Sum_probs=153.0
Q ss_pred cccccchhhhccccccCC-CCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 042634 179 IRHRNLVKIITSCASVDF-QGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVH 257 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivH 257 (427)
..|||++++++.+..... ..+...++||||+++++|.+++.........+++..+..++.|++.||+||| +.|++|
T Consensus 60 ~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H 136 (275)
T cd06608 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIH 136 (275)
T ss_pred cCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCccc
Confidence 369999999998755332 2345679999999999999988654322356899999999999999999999 899999
Q ss_pred ccccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCC-----CCcCccccchhHHHHHHHHHhCCC
Q 042634 258 CDLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMG-----SEVSTSGDVYSFGILLLETFTGKR 326 (427)
Q Consensus 258 rDlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~-----~~~~~~~DiwS~G~vl~ell~g~~ 326 (427)
+||+|+||+++.++.+||+|||.+...... ..++..|+|||++.. ..++.++|||||||++||+++|..
T Consensus 137 ~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~ 216 (275)
T cd06608 137 RDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKP 216 (275)
T ss_pred CCCCHHHEEEccCCeEEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCC
Confidence 999999999999999999999998765332 257788999998754 346789999999999999999999
Q ss_pred CCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCC
Q 042634 327 PTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMN 406 (427)
Q Consensus 327 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt 406 (427)
||...... ....+. .... .+ ....+...+.++.+++.+||..||++|||
T Consensus 217 p~~~~~~~-~~~~~~----~~~~-----~~---------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt 265 (275)
T cd06608 217 PLCDMHPM-RALFKI----PRNP-----PP---------------------TLKSPENWSKKFNDFISECLIKNYEQRPF 265 (275)
T ss_pred CccccchH-HHHHHh----hccC-----CC---------------------CCCchhhcCHHHHHHHHHHhhcChhhCcC
Confidence 99643111 001100 0000 00 00012234567899999999999999999
Q ss_pred HHHHHH
Q 042634 407 MEEVAA 412 (427)
Q Consensus 407 ~~ev~~ 412 (427)
++|+++
T Consensus 266 ~~~ll~ 271 (275)
T cd06608 266 MEELLE 271 (275)
T ss_pred HHHHhc
Confidence 999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=255.43 Aligned_cols=192 Identities=21% Similarity=0.270 Sum_probs=153.0
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeecc
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCD 259 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrD 259 (427)
+||+||++++.+.. .+..++..|||.||-+...+..-. ..+++.++..+++|++.||.||| +.+|+|||
T Consensus 87 dHP~ivkLl~ayy~-----enkLwiliEFC~GGAVDaimlEL~---r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRD 155 (1187)
T KOG0579|consen 87 DHPVIVKLLSAYYF-----ENKLWILIEFCGGGAVDAIMLELG---RVLTEDQIQVVCYQVLDALNWLH---SQNIIHRD 155 (1187)
T ss_pred CChHHHHHHHHHhc-----cCceEEEEeecCCchHhHHHHHhc---cccchHHHHHHHHHHHHHHHHHh---hcchhhhh
Confidence 59999999998433 567899999999999988775543 56999999999999999999999 99999999
Q ss_pred ccCCceeeCCCCceEecccccccccC------CcCCCccccccccccC-----CCCcCccccchhHHHHHHHHHhCCCCC
Q 042634 260 LKPSNVLLDGELTAHVGDFGLAKFLP------EATNNFFNFQIAEYGM-----GSEVSTSGDVYSFGILLLETFTGKRPT 328 (427)
Q Consensus 260 lkp~NIll~~~~~~kL~DFG~a~~~~------~~~~~~~~y~aPE~~~-----~~~~~~~~DiwS~G~vl~ell~g~~pf 328 (427)
||+.|||++-+|.++|+|||++.... ....||+.|||||+.+ ..+|++++||||||+++.||..+.+|.
T Consensus 156 LKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPH 235 (1187)
T KOG0579|consen 156 LKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPH 235 (1187)
T ss_pred ccccceEEEecCcEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCc
Confidence 99999999999999999999987543 2338999999999875 467999999999999999999999997
Q ss_pred CcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 042634 329 NEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME 408 (427)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ 408 (427)
..... +...-.+...-|+ ....|..-...|.+++.+|+..||..||+++
T Consensus 236 helnp--MRVllKiaKSePP-----------------------------TLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aa 284 (1187)
T KOG0579|consen 236 HELNP--MRVLLKIAKSEPP-----------------------------TLLQPSHWSRSFSDFLKRCLVKNPRNRPPAA 284 (1187)
T ss_pred cccch--HHHHHHHhhcCCC-----------------------------cccCcchhhhHHHHHHHHHHhcCCccCCCHH
Confidence 65311 0000000111111 1112333456789999999999999999999
Q ss_pred HHHHH
Q 042634 409 EVAAQ 413 (427)
Q Consensus 409 ev~~~ 413 (427)
+++++
T Consensus 285 qll~H 289 (1187)
T KOG0579|consen 285 QLLKH 289 (1187)
T ss_pred HHhhC
Confidence 99864
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=250.13 Aligned_cols=191 Identities=21% Similarity=0.310 Sum_probs=151.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++.+.. +...++++||+++++|.+++.. ..+++..+..++.|++.||+||| +.|++||
T Consensus 75 l~hp~i~~~~~~~~~-----~~~~~iv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~ 141 (297)
T cd06659 75 YQHQNVVEMYKSYLV-----GEELWVLMEFLQGGALTDIVSQ-----TRLNEEQIATVCESVLQALCYLH---SQGVIHR 141 (297)
T ss_pred CCCCchhhhhhheee-----CCeEEEEEecCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHH---hCCeecC
Confidence 579999999998543 5678999999999999887743 34889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+||+++.++.+||+|||++...... ..++..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 142 dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 221 (297)
T cd06659 142 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS 221 (297)
T ss_pred CCCHHHeEEccCCcEEEeechhHhhcccccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999998754332 257788999999998889999999999999999999999986421
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
................ ......+..+.+++.+||+.+|++|||++|+++
T Consensus 222 --~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 222 --PVQAMKRLRDSPPPKL-----------------------------KNAHKISPVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred --HHHHHHHHhccCCCCc-----------------------------cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 1111111110000000 011123455789999999999999999999998
Q ss_pred H
Q 042634 413 Q 413 (427)
Q Consensus 413 ~ 413 (427)
.
T Consensus 271 ~ 271 (297)
T cd06659 271 H 271 (297)
T ss_pred C
Confidence 5
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=245.33 Aligned_cols=192 Identities=27% Similarity=0.457 Sum_probs=151.4
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
+.|||++++++.+.. ....+++|||+++++|.+++.... ..+++..+..++.|++.|++||| +.+++||
T Consensus 56 l~~~~i~~~~~~~~~-----~~~~~~v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~ 124 (256)
T cd05112 56 LSHPKLVQLYGVCTE-----RSPICLVFEFMEHGCLSDYLRAQR---GKFSQETLLGMCLDVCEGMAYLE---SSNVIHR 124 (256)
T ss_pred CCCCCeeeEEEEEcc-----CCceEEEEEcCCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHH---HCCcccc
Confidence 469999999887533 456799999999999999886543 34788999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC-------CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCCc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT-------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~-------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~~ 330 (427)
||||+||+++.++.+||+|||.++...... .++..|+|||.+.+..++.++|||||||++||+++ |..||..
T Consensus 125 dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~ 204 (256)
T cd05112 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN 204 (256)
T ss_pred ccccceEEEcCCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCc
Confidence 999999999999999999999987653321 34467999999988889999999999999999998 9999864
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
... ....... . +.... ..+...+..+.+++.+||+.+|++|||+.|+
T Consensus 205 ~~~-----~~~~~~~-~----~~~~~-----------------------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~ 251 (256)
T cd05112 205 RSN-----SEVVETI-N----AGFRL-----------------------YKPRLASQSVYELMQHCWKERPEDRPSFSLL 251 (256)
T ss_pred CCH-----HHHHHHH-h----CCCCC-----------------------CCCCCCCHHHHHHHHHHcccChhhCCCHHHH
Confidence 311 1111110 0 00000 0011124568999999999999999999999
Q ss_pred HHHH
Q 042634 411 AAQL 414 (427)
Q Consensus 411 ~~~L 414 (427)
++.|
T Consensus 252 l~~l 255 (256)
T cd05112 252 LHQL 255 (256)
T ss_pred HHhh
Confidence 9886
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=250.50 Aligned_cols=192 Identities=20% Similarity=0.242 Sum_probs=148.5
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++.+.. +...++||||+++++|..++.+.. ..+++..+..++.|++.|++||| +.||+||
T Consensus 66 l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~ 134 (292)
T cd06644 66 CNHPYIVKLLGAFYW-----DGKLWIMIEFCPGGAVDAIMLELD---RGLTEPQIQVICRQMLEALQYLH---SMKIIHR 134 (292)
T ss_pred CCCCcEeeeEEEEEe-----CCeEEEEEecCCCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHh---cCCeeec
Confidence 579999999987543 457899999999999988775432 35889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccC-----CCCcCccccchhHHHHHHHHHhCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGM-----GSEVSTSGDVYSFGILLLETFTGKRP 327 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~-----~~~~~~~~DiwS~G~vl~ell~g~~p 327 (427)
||||+||+++.++.+||+|||.+...... ..++..|+|||++. ...++.++|||||||++|||++|+.|
T Consensus 135 dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p 214 (292)
T cd06644 135 DLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 214 (292)
T ss_pred CCCcceEEEcCCCCEEEccCccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCC
Confidence 99999999999999999999998754322 25677899999985 34468899999999999999999999
Q ss_pred CCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCH
Q 042634 328 TNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM 407 (427)
Q Consensus 328 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~ 407 (427)
|..... ............... ..+...+.++.+++.+||+.+|++|||+
T Consensus 215 ~~~~~~-----~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~ 263 (292)
T cd06644 215 HHELNP-----MRVLLKIAKSEPPTL--------------------------SQPSKWSMEFRDFLKTALDKHPETRPSA 263 (292)
T ss_pred CccccH-----HHHHHHHhcCCCccC--------------------------CCCcccCHHHHHHHHHHhcCCcccCcCH
Confidence 865311 011111000000000 0112234568899999999999999999
Q ss_pred HHHHH
Q 042634 408 EEVAA 412 (427)
Q Consensus 408 ~ev~~ 412 (427)
+|+++
T Consensus 264 ~~il~ 268 (292)
T cd06644 264 AQLLE 268 (292)
T ss_pred HHHhc
Confidence 99976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-32 Score=253.46 Aligned_cols=190 Identities=18% Similarity=0.238 Sum_probs=151.3
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++.+.. +...++||||+++++|.+++.+ ..+++.++..++.|++.||.||| +.|++||
T Consensus 73 ~~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~ 139 (297)
T cd06656 73 NKNPNIVNYLDSYLV-----GDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLH---SNQVIHR 139 (297)
T ss_pred CCCCCEeeEEEEEec-----CCEEEEeecccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccC
Confidence 679999999988543 5678999999999999998854 23788899999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+||+++.++.+||+|||.+...... ..++..|+|||.+.+..++.++|||||||++|++++|+.||....
T Consensus 140 dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~ 219 (297)
T cd06656 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (297)
T ss_pred CCCHHHEEECCCCCEEECcCccceEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999998765332 256778999999998889999999999999999999999996531
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
...... ...... . .....+...+..+.+++.+||+.+|++|||++|+++
T Consensus 220 ~~~~~~-~~~~~~---------~---------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 220 PLRALY-LIATNG---------T---------------------PELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred cchhee-eeccCC---------C---------------------CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 110000 000000 0 000012234556789999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=246.08 Aligned_cols=195 Identities=29% Similarity=0.405 Sum_probs=152.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+++++|.+++... ..+++..+..++.|+++||+||| +.||+||
T Consensus 55 l~~~~i~~~~~~~~~-----~~~~~~v~~~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~ 122 (260)
T PF00069_consen 55 LRHPNIVQILDVFQD-----DNYLYIVMEYCPGGSLQDYLQKN----KPLSEEEILKIAYQILEALAYLH---SKGIVHR 122 (260)
T ss_dssp HTBTTBCHEEEEEEE-----SSEEEEEEEEETTEBHHHHHHHH----SSBBHHHHHHHHHHHHHHHHHHH---HTTEEES
T ss_pred ccccccccccccccc-----ccccccccccccccccccccccc----ccccccccccccccccccccccc---ccccccc
Confidence 469999999988554 56788999999998999998722 55899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccC------CcCCCccccccccccC-CCCcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLP------EATNNFFNFQIAEYGM-GSEVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~------~~~~~~~~y~aPE~~~-~~~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
||||+||+++.++.+||+|||.+.... ....++..|+|||+.. +..++.++||||+|+++|+|++|..||...
T Consensus 123 dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 123 DIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp SBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999999999999999997531 1236788999999998 788999999999999999999999999764
Q ss_pred cCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 042634 332 FTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVA 411 (427)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~ 411 (427)
. ..................... .......++.+++.+||+.||++|||++|++
T Consensus 203 ~--~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~ 255 (260)
T PF00069_consen 203 N--SDDQLEIIEKILKRPLPSSSQ-------------------------QSREKSEELRDLIKKMLSKDPEQRPSAEELL 255 (260)
T ss_dssp S--HHHHHHHHHHHHHTHHHHHTT-------------------------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHH
T ss_pred c--chhhhhhhhhccccccccccc-------------------------ccchhHHHHHHHHHHHccCChhHCcCHHHHh
Confidence 1 001111111111000000000 0011126789999999999999999999998
Q ss_pred H
Q 042634 412 A 412 (427)
Q Consensus 412 ~ 412 (427)
+
T Consensus 256 ~ 256 (260)
T PF00069_consen 256 K 256 (260)
T ss_dssp T
T ss_pred c
Confidence 5
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=247.64 Aligned_cols=191 Identities=21% Similarity=0.283 Sum_probs=147.2
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ..+...++++||+++++|.+++... ..+++..++.++.|++.||+||| +.+|+||
T Consensus 61 l~h~~i~~~~~~~~~---~~~~~~~l~~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~ 130 (266)
T cd06651 61 LQHERIVQYYGCLRD---RAEKTLTIFMEYMPGGSVKDQLKAY----GALTESVTRKYTRQILEGMSYLH---SNMIVHR 130 (266)
T ss_pred cCCCCeeeEEEEEEc---CCCCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeC
Confidence 579999999886432 1134678999999999999988654 34888999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc---------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA---------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTN 329 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~---------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~ 329 (427)
||||+||+++.++.+||+|||+++..... ..++..|+|||++.+..++.++|||||||++||+++|+.||.
T Consensus 131 ~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~ 210 (266)
T cd06651 131 DIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWA 210 (266)
T ss_pred CCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcc
Confidence 99999999999999999999998754321 246778999999998889999999999999999999999997
Q ss_pred cccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 042634 330 EMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEE 409 (427)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~e 409 (427)
.... ... ........ .. ...+...++.+.+++ +||..+|++|||++|
T Consensus 211 ~~~~----~~~-~~~~~~~~----~~-----------------------~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~e 257 (266)
T cd06651 211 EYEA----MAA-IFKIATQP----TN-----------------------PQLPSHISEHARDFL-GCIFVEARHRPSAEE 257 (266)
T ss_pred ccch----HHH-HHHHhcCC----CC-----------------------CCCchhcCHHHHHHH-HHhcCChhhCcCHHH
Confidence 5311 110 11000000 00 001223345566677 688899999999999
Q ss_pred HHH
Q 042634 410 VAA 412 (427)
Q Consensus 410 v~~ 412 (427)
|++
T Consensus 258 il~ 260 (266)
T cd06651 258 LLR 260 (266)
T ss_pred Hhc
Confidence 975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-32 Score=234.95 Aligned_cols=193 Identities=22% Similarity=0.254 Sum_probs=149.8
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeecc
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCD 259 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrD 259 (427)
+.|.||+.++++.. +....+.||.| ..-+..+++.- +.++++..+-++...++.||.||.+ .+||+|||
T Consensus 149 dcpyIV~c~GyFi~-----n~dV~IcMelM-s~C~ekLlkri---k~piPE~ilGk~tva~v~AL~YLKe--KH~viHRD 217 (391)
T KOG0983|consen 149 DCPYIVQCFGYFIT-----NTDVFICMELM-STCAEKLLKRI---KGPIPERILGKMTVAIVKALYYLKE--KHGVIHRD 217 (391)
T ss_pred CCCeeeeeeeEEee-----CchHHHHHHHH-HHHHHHHHHHh---cCCchHHhhhhhHHHHHHHHHHHHH--hcceeecc
Confidence 36999999998544 66788999988 44455555432 2568888888999999999999997 78999999
Q ss_pred ccCCceeeCCCCceEecccccccccCCcC-----CCccccccccccCC---CCcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 260 LKPSNVLLDGELTAHVGDFGLAKFLPEAT-----NNFFNFQIAEYGMG---SEVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 260 lkp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~y~aPE~~~~---~~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
+||+|||+|+.|.+|+||||++..+.+.. +|.+.|||||.+.- ..|+.++||||||++++|+.||..||.+.
T Consensus 218 vKPSNILlDe~GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c 297 (391)
T KOG0983|consen 218 VKPSNILLDERGNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGC 297 (391)
T ss_pred cCccceEEccCCCEEeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCC
Confidence 99999999999999999999998775543 78889999999864 46899999999999999999999999864
Q ss_pred cCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 042634 332 FTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVA 411 (427)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~ 411 (427)
..+-..+..... ..|+.+.. ....+..|.+++..|+..|+.+||.-.+++
T Consensus 298 ~tdFe~ltkvln-~ePP~L~~-----------------------------~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll 347 (391)
T KOG0983|consen 298 KTDFEVLTKVLN-EEPPLLPG-----------------------------HMGFSPDFQSFVKDCLTKDHRKRPKYNKLL 347 (391)
T ss_pred CccHHHHHHHHh-cCCCCCCc-----------------------------ccCcCHHHHHHHHHHhhcCcccCcchHHHh
Confidence 322222222221 22221110 011355689999999999999999999988
Q ss_pred HH
Q 042634 412 AQ 413 (427)
Q Consensus 412 ~~ 413 (427)
++
T Consensus 348 ~h 349 (391)
T KOG0983|consen 348 EH 349 (391)
T ss_pred cC
Confidence 64
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=250.23 Aligned_cols=219 Identities=19% Similarity=0.203 Sum_probs=149.6
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++.+.. +...++||||++ ++|.+++..... ...+++..+..++.|++.||+||| +.||+||
T Consensus 56 l~h~~i~~~~~~~~~-----~~~~~~v~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~ 125 (285)
T cd07861 56 LQHPNIVCLQDVLMQ-----ESRLYLIFEFLS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCH---SRRVLHR 125 (285)
T ss_pred cCCCCEeeeEEEEee-----CCeEEEEEecCC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHH---hCCeeec
Confidence 459999999998543 567899999996 688888754322 145899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCC-CCcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
||||+||+++.++.+||+|||++...... ..++..|+|||++.+ ..++.++|||||||++|||++|+.||.+.
T Consensus 126 dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~ 205 (285)
T cd07861 126 DLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGD 205 (285)
T ss_pred CCCHHHEEEcCCCcEEECcccceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 99999999999999999999998754322 245778999998865 45789999999999999999999999753
Q ss_pred cCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 042634 332 FTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVA 411 (427)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~ 411 (427)
.... ............ ................. ................+.++.+++.+||+.||++|||+.||+
T Consensus 206 ~~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll 280 (285)
T cd07861 206 SEID-QLFRIFRILGTP-TEDVWPGVTSLPDYKNT---FPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKAL 280 (285)
T ss_pred CHHH-HHHHHHHHhCCC-ChhhhhcchhhHHHHhh---ccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHh
Confidence 2111 111111100000 00000000000000000 000000000001112456788999999999999999999997
Q ss_pred H
Q 042634 412 A 412 (427)
Q Consensus 412 ~ 412 (427)
.
T Consensus 281 ~ 281 (285)
T cd07861 281 N 281 (285)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=252.11 Aligned_cols=215 Identities=20% Similarity=0.255 Sum_probs=150.8
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||++ ++|.+++.... ..+++..+..++.|++.||+||| +.||+||
T Consensus 61 l~h~nI~~~~~~~~~-----~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~ 128 (301)
T cd07873 61 LKHANIVTLHDIIHT-----EKSLTLVFEYLD-KDLKQYLDDCG---NSINMHNVKLFLFQLLRGLNYCH---RRKVLHR 128 (301)
T ss_pred cCCCCcceEEEEEec-----CCeEEEEEeccc-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCC
Confidence 479999999998543 567899999995 68888876543 35888999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCC-CCcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
||||+||+++.++.+||+|||+++..... ..++..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 129 dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~ 208 (301)
T cd07873 129 DLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGS 208 (301)
T ss_pred CCCHHHEEECCCCcEEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999999764321 256778999998865 45788999999999999999999999753
Q ss_pred cCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccc---cchHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 042634 332 FTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRS---FSVKECLVSVLGIGVTCSSELPRERMNME 408 (427)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ 408 (427)
... .....+........................ ..+..... ......+..+.+++.+|++.||.+|||++
T Consensus 209 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~ 281 (301)
T cd07873 209 TVE--EQLHFIFRILGTPTEETWPGILSNEEFKSY-----NYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAE 281 (301)
T ss_pred CHH--HHHHHHHHHcCCCChhhchhhhcccccccc-----ccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHH
Confidence 211 111111111111111111111000000000 00000000 01122355688999999999999999999
Q ss_pred HHHH
Q 042634 409 EVAA 412 (427)
Q Consensus 409 ev~~ 412 (427)
|+++
T Consensus 282 eil~ 285 (301)
T cd07873 282 EAMK 285 (301)
T ss_pred HHhc
Confidence 9987
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=249.05 Aligned_cols=195 Identities=22% Similarity=0.256 Sum_probs=150.5
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|++++.+.+.+.. +...+++|||+++++|.+++..... ..+++..+..++.|++.||.||| +.||+||
T Consensus 57 l~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~ 126 (285)
T cd05632 57 VNSQFVVNLAYAYET-----KDALCLVLTIMNGGDLKFHIYNMGN--PGFEEERALFYAAEILCGLEDLH---RENTVYR 126 (285)
T ss_pred cCCcCceeEEEEEec-----CCEEEEEEEeccCccHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeec
Confidence 569999998777433 5678999999999999888754321 35899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc-----CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFT 333 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~ 333 (427)
||||+||++++++.+||+|||++...... ..|+..|+|||++.+..++.++|||||||++||+++|..||.....
T Consensus 127 dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~ 206 (285)
T cd05632 127 DLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE 206 (285)
T ss_pred CCCHHHEEECCCCCEEEecCCcceecCCCCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999999999999999999999765322 2678899999999988999999999999999999999999975311
Q ss_pred CCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCC-----HH
Q 042634 334 GNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMN-----ME 408 (427)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt-----~~ 408 (427)
.. ....+.......... .+...+.++.+++.+||+.||++||| ++
T Consensus 207 ~~--~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~ 256 (285)
T cd05632 207 KV--KREEVDRRVLETEEV----------------------------YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAG 256 (285)
T ss_pred HH--HHHHHHHhhhccccc----------------------------cCccCCHHHHHHHHHHccCCHhHcCCCcccChH
Confidence 10 001111111000000 11123456789999999999999999 66
Q ss_pred HHHHH
Q 042634 409 EVAAQ 413 (427)
Q Consensus 409 ev~~~ 413 (427)
|++..
T Consensus 257 ~l~~~ 261 (285)
T cd05632 257 EVKRH 261 (285)
T ss_pred HHHcC
Confidence 66653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=244.06 Aligned_cols=197 Identities=24% Similarity=0.309 Sum_probs=155.3
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCC-CCeee
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCE-TPIVH 257 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~-~~ivH 257 (427)
++||||+++++.+.. ....++++||+++++|.+++.... ..+++..+..++.|++.|++|+| + .|++|
T Consensus 56 ~~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H 124 (265)
T cd06605 56 CNSPYIVGFYGAFYN-----NGDISICMEYMDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLH---EKHKIIH 124 (265)
T ss_pred CCCCchhhhheeeec-----CCEEEEEEEecCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHc---CCCCeec
Confidence 459999999988544 467899999999999999987543 45889999999999999999999 7 99999
Q ss_pred ccccCCceeeCCCCceEecccccccccCCc----CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccC
Q 042634 258 CDLKPSNVLLDGELTAHVGDFGLAKFLPEA----TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFT 333 (427)
Q Consensus 258 rDlkp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~ 333 (427)
|||||+||+++.++.+||+|||.+...... ..++..|+|||++.+..++.++|||||||++|++++|+.||.....
T Consensus 125 ~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 204 (265)
T cd06605 125 RDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPEND 204 (265)
T ss_pred CCCCHHHEEECCCCCEEEeecccchhhHHHHhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccc
Confidence 999999999999999999999998765322 3677889999999999999999999999999999999999975422
Q ss_pred CCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 042634 334 GNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAAQ 413 (427)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~ 413 (427)
......+.......... ........+.++.+++.+||..||++|||+.|++..
T Consensus 205 ~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 205 PPDGIFELLQYIVNEPP---------------------------PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred ccccHHHHHHHHhcCCC---------------------------CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 21222222111111000 000111256678999999999999999999999853
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=249.49 Aligned_cols=204 Identities=22% Similarity=0.264 Sum_probs=154.9
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+++++|.+++... ..+++..+..++.|++.||.|||+ ..+++||
T Consensus 60 l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~ 128 (284)
T cd06620 60 CRSPYIVSFYGAFLN-----ENNICMCMEFMDCGSLDRIYKKG----GPIPVEILGKIAVAVVEGLTYLYN--VHRIMHR 128 (284)
T ss_pred cCCCCcceEeeeEec-----CCEEEEEEecCCCCCHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHH--hcCeecc
Confidence 579999999988544 46789999999999999887653 358899999999999999999994 3689999
Q ss_pred cccCCceeeCCCCceEecccccccccCC----cCCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE----ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTG 334 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~~ 334 (427)
||||+||+++.++.++|+|||++..... ...++..|+|||++.+..++.++|||||||++||+++|+.||......
T Consensus 129 dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~ 208 (284)
T cd06620 129 DIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNID 208 (284)
T ss_pred CCCHHHEEECCCCcEEEccCCcccchhhhccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchh
Confidence 9999999999999999999999875432 226788999999998888999999999999999999999999754221
Q ss_pred CccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 042634 335 NLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAAQL 414 (427)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L 414 (427)
...- ..+..+.+.+...... .........++.++.+++.+||+.||++|||++|++++.
T Consensus 209 ~~~~------~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 209 DDGQ------DDPMGILDLLQQIVQE---------------PPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred hhhh------hhhhHHHHHHHHHhhc---------------cCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 1000 0000000000000000 000011123566789999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=253.83 Aligned_cols=232 Identities=18% Similarity=0.240 Sum_probs=155.2
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++++.. +...++||||+.++++.+++..... ..+++..+..++.|++.||+||| +.||+||
T Consensus 56 l~h~niv~~~~~~~~-----~~~~~~v~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHr 125 (328)
T cd08226 56 FRHPNIMTSWTVFTT-----GSWLWVISPFMAYGSANSLLKTYFP--EGMSEALIGNILFGALRGLNYLH---QNGYIHR 125 (328)
T ss_pred CCCCCcceEeeeEec-----CCceEEEEecccCCCHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeecC
Confidence 679999999998544 5678999999999999998875432 34889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc-------------CCCccccccccccCCC--CcCccccchhHHHHHHHHHh
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA-------------TNNFFNFQIAEYGMGS--EVSTSGDVYSFGILLLETFT 323 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-------------~~~~~~y~aPE~~~~~--~~~~~~DiwS~G~vl~ell~ 323 (427)
||||+||+++.++.+|++||+.+...... ..++..|+|||++.+. .++.++|||||||++|||++
T Consensus 126 Dlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~ 205 (328)
T cd08226 126 NIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELAT 205 (328)
T ss_pred CCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHh
Confidence 99999999999999999999865432111 1234569999998763 47899999999999999999
Q ss_pred CCCCCCcccCCCccHHHHHHHhcccc--------hhcccCccccccccccchhhh-----ccccccccccchHHHHHHHH
Q 042634 324 GKRPTNEMFTGNLTLHNFVKEALPER--------LAEIVDPVLLVEREEGETSKA-----NAHKQFTRSFSVKECLVSVL 390 (427)
Q Consensus 324 g~~pf~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 390 (427)
|+.||...................+. .....+.....+......... ..............++..+.
T Consensus 206 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (328)
T cd08226 206 GRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQ 285 (328)
T ss_pred CCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHH
Confidence 99999764221111100000000000 000000000000000000000 00000011122345678899
Q ss_pred HHHhhcCCCCCCCCCCHHHHHHH--HHHHHHH
Q 042634 391 GIGVTCSSELPRERMNMEEVAAQ--LLSFRNK 420 (427)
Q Consensus 391 ~l~~~cl~~dP~~Rpt~~ev~~~--L~~~~~~ 420 (427)
+++++||+.||++|||++|+++. ++.+++.
T Consensus 286 ~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~ 317 (328)
T cd08226 286 NLVELCLQQDPEKRPSASSLLSHAFFKQVKEQ 317 (328)
T ss_pred HHHHHHccCCcccCCCHHHHhhCHHHHHHHHh
Confidence 99999999999999999999753 4444443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=244.48 Aligned_cols=192 Identities=22% Similarity=0.326 Sum_probs=151.4
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||+++.++.+. .....++||||+++++|.+++..... ..+++..+..++.|++.|++||| ++|++||
T Consensus 56 ~~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~ 125 (256)
T cd08220 56 LSHPNIIEYYENFL-----EDKALMIVMEYAPGGTLAEYIQKRCN--SLLDEDTILHFFVQILLALHHVH---TKLILHR 125 (256)
T ss_pred CCCCchhheeeeEe-----cCCEEEEEEecCCCCCHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeecC
Confidence 46999999988743 35678999999999999999865432 45889999999999999999999 8999999
Q ss_pred cccCCceeeCCC-CceEecccccccccCCc-----CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGE-LTAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~-~~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+||+++.+ ..+||+|||.++..... ..++..|+|||.+.+..++.++||||||+++|+|++|+.||....
T Consensus 126 dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 205 (256)
T cd08220 126 DLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN 205 (256)
T ss_pred CCCHHHEEEcCCCCEEEEccCCCceecCCCccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc
Confidence 999999999754 56899999999876543 256778999999998889999999999999999999999986531
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
. .............. .+..++.++.+++.+||+.+|++|||++|+++
T Consensus 206 ~-----~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 206 L-----PALVLKIMSGTFAP----------------------------ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred h-----HHHHHHHHhcCCCC----------------------------CCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1 11111110000000 11124556889999999999999999999986
Q ss_pred H
Q 042634 413 Q 413 (427)
Q Consensus 413 ~ 413 (427)
+
T Consensus 253 ~ 253 (256)
T cd08220 253 Q 253 (256)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=246.67 Aligned_cols=192 Identities=19% Similarity=0.220 Sum_probs=150.7
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
..||+++++.+.+.. ....++||||+++|+|.+++... ..+++..++.++.|++.|++||| +.+|+||
T Consensus 54 ~~~~~i~~~~~~~~~-----~~~~~~v~e~~~g~~L~~~l~~~----~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~ 121 (278)
T cd05606 54 GDCPFIVCMSYAFHT-----PDKLSFILDLMNGGDLHYHLSQH----GVFSEAEMRFYAAEIILGLEHMH---NRFVVYR 121 (278)
T ss_pred CCCCcEeeeeeeeec-----CCEEEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEcC
Confidence 468999998877443 56789999999999999888643 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc----CCCccccccccccCCC-CcCccccchhHHHHHHHHHhCCCCCCcccC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA----TNNFFNFQIAEYGMGS-EVSTSGDVYSFGILLLETFTGKRPTNEMFT 333 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~y~aPE~~~~~-~~~~~~DiwS~G~vl~ell~g~~pf~~~~~ 333 (427)
||||+||+++.++.+||+|||.++..... ..|+..|+|||++.+. .++.++||||+||++|||++|+.||.....
T Consensus 122 di~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~ 201 (278)
T cd05606 122 DLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 201 (278)
T ss_pred CCCHHHEEECCCCCEEEccCcCccccCccCCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCc
Confidence 99999999999999999999998755332 2678899999998754 689999999999999999999999975321
Q ss_pred CCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCC-----CHH
Q 042634 334 GNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERM-----NME 408 (427)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rp-----t~~ 408 (427)
... ......... ... ..+...+.++.+++.+|+..+|.+|| |+.
T Consensus 202 ~~~--~~~~~~~~~------~~~-----------------------~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~ 250 (278)
T cd05606 202 KDK--HEIDRMTLT------MAV-----------------------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQ 250 (278)
T ss_pred cch--HHHHHHhhc------cCC-----------------------CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHH
Confidence 111 000000000 000 01122356789999999999999999 999
Q ss_pred HHHHH
Q 042634 409 EVAAQ 413 (427)
Q Consensus 409 ev~~~ 413 (427)
|+++.
T Consensus 251 ~ll~~ 255 (278)
T cd05606 251 EVKEH 255 (278)
T ss_pred HHHhC
Confidence 99863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=252.23 Aligned_cols=194 Identities=20% Similarity=0.207 Sum_probs=150.0
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. +...++||||+++++|.+++... ..+++..+..++.|++.|++||| +.|++||
T Consensus 58 ~~~~~i~~~~~~~~~-----~~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~ 125 (305)
T cd05609 58 AENPFVVSMFCSFET-----KRHLCMVMEYVEGGDCATLLKNI----GALPVDMARMYFAETVLALEYLH---NYGIVHR 125 (305)
T ss_pred CCCCCeeeeEEEEec-----CCEEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccc
Confidence 679999999987533 56789999999999999998654 34889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC---------------------cCCCccccccccccCCCCcCccccchhHHHH
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE---------------------ATNNFFNFQIAEYGMGSEVSTSGDVYSFGIL 317 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~---------------------~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~v 317 (427)
||||+||+++.++.+||+|||.++.... ...++..|+|||.+....++.++|||||||+
T Consensus 126 dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~v 205 (305)
T cd05609 126 DLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGII 205 (305)
T ss_pred CCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHH
Confidence 9999999999999999999999874210 1145678999999988889999999999999
Q ss_pred HHHHHhCCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcC
Q 042634 318 LLETFTGKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCS 397 (427)
Q Consensus 318 l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl 397 (427)
+||+++|..||.+.. ..+.......... ..+ .....++.++.+++.+||
T Consensus 206 l~el~~g~~pf~~~~-----~~~~~~~~~~~~~---~~~-----------------------~~~~~~~~~~~~li~~~l 254 (305)
T cd05609 206 LYEFLVGCVPFFGDT-----PEELFGQVISDDI---EWP-----------------------EGDEALPADAQDLISRLL 254 (305)
T ss_pred HHHHHhCCCCCCCCC-----HHHHHHHHHhccc---CCC-----------------------CccccCCHHHHHHHHHHh
Confidence 999999999996431 1111111100000 000 001124566899999999
Q ss_pred CCCCCCCCCHHHHHHHHH
Q 042634 398 SELPRERMNMEEVAAQLL 415 (427)
Q Consensus 398 ~~dP~~Rpt~~ev~~~L~ 415 (427)
+.||++|||+.++.+.|+
T Consensus 255 ~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 255 RQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred ccChhhccCccCHHHHHh
Confidence 999999999765555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=247.88 Aligned_cols=193 Identities=21% Similarity=0.267 Sum_probs=150.9
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++.+.. +...++||||+++++|.+++.... ..+++..++.++.|++.||.||| +.||+||
T Consensus 59 l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~ 127 (280)
T cd06611 59 CKHPNIVGLYEAYFY-----ENKLWILIEFCDGGALDSIMLELE---RGLTEPQIRYVCRQMLEALNFLH---SHKVIHR 127 (280)
T ss_pred CCCCceeEEEEEEec-----CCeEEEEeeccCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccC
Confidence 569999999998543 567899999999999999886543 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccC-----CCCcCccccchhHHHHHHHHHhCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGM-----GSEVSTSGDVYSFGILLLETFTGKRP 327 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~-----~~~~~~~~DiwS~G~vl~ell~g~~p 327 (427)
||||+||+++.++.+||+|||.+...... ..++..|+|||.+. ...++.++|||||||++|||++|+.|
T Consensus 128 dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p 207 (280)
T cd06611 128 DLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPP 207 (280)
T ss_pred CCChhhEEECCCCCEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999998755332 25778899999875 34568899999999999999999999
Q ss_pred CCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCH
Q 042634 328 TNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM 407 (427)
Q Consensus 328 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~ 407 (427)
|...... +........ ..+.. ..+..++.++.+++.+||+.+|.+|||+
T Consensus 208 ~~~~~~~-----~~~~~~~~~-----~~~~~---------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~ 256 (280)
T cd06611 208 HHELNPM-----RVLLKILKS-----EPPTL---------------------DQPSKWSSSFNDFLKSCLVKDPDDRPTA 256 (280)
T ss_pred cccCCHH-----HHHHHHhcC-----CCCCc---------------------CCcccCCHHHHHHHHHHhccChhhCcCH
Confidence 9753111 111000000 00000 0112245568899999999999999999
Q ss_pred HHHHHH
Q 042634 408 EEVAAQ 413 (427)
Q Consensus 408 ~ev~~~ 413 (427)
+++++.
T Consensus 257 ~~il~~ 262 (280)
T cd06611 257 AELLKH 262 (280)
T ss_pred HHHhcC
Confidence 999876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-31 Score=244.75 Aligned_cols=197 Identities=18% Similarity=0.251 Sum_probs=151.4
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. +...++||||+++++|.+++..... ...+++..+..++.|++.||.|||+ ..||+||
T Consensus 56 ~~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~ 127 (286)
T cd06622 56 AVSPYIVDFYGAFFI-----EGAVYMCMEYMDAGSLDKLYAGGVA-TEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHR 127 (286)
T ss_pred cCCCcHHhhhhheec-----CCeEEEEEeecCCCCHHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeC
Confidence 579999999997543 5678999999999999888865311 1358999999999999999999993 3599999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc----CCCccccccccccCCC------CcCccccchhHHHHHHHHHhCCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA----TNNFFNFQIAEYGMGS------EVSTSGDVYSFGILLLETFTGKRPT 328 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~y~aPE~~~~~------~~~~~~DiwS~G~vl~ell~g~~pf 328 (427)
||||+||+++.++.+||+|||.+...... ..++..|+|||.+.+. .++.++|||||||++||+++|+.||
T Consensus 128 dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf 207 (286)
T cd06622 128 DVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPY 207 (286)
T ss_pred CCCHHHEEECCCCCEEEeecCCcccccCCccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCC
Confidence 99999999999999999999999765332 2567789999998554 3588999999999999999999999
Q ss_pred CcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 042634 329 NEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME 408 (427)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ 408 (427)
..... .............. ....+..++.++.+++.+||+.+|++|||++
T Consensus 208 ~~~~~--~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ 257 (286)
T cd06622 208 PPETY--ANIFAQLSAIVDGD----------------------------PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYA 257 (286)
T ss_pred CCcch--hhHHHHHHHHhhcC----------------------------CCCCCcccCHHHHHHHHHHcccCcccCCCHH
Confidence 65311 11111111100000 0002233567789999999999999999999
Q ss_pred HHHHH
Q 042634 409 EVAAQ 413 (427)
Q Consensus 409 ev~~~ 413 (427)
|++..
T Consensus 258 ~l~~~ 262 (286)
T cd06622 258 QLLEH 262 (286)
T ss_pred HHhcC
Confidence 99874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=245.53 Aligned_cols=190 Identities=22% Similarity=0.304 Sum_probs=152.3
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++.+.+.. +...++|+||+++++|.+++... .+++..+..++.|++.|+.||| ..+++||
T Consensus 56 l~h~~i~~~~~~~~~-----~~~~~~v~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~ 122 (274)
T cd06609 56 CRSPYITKYYGSFLK-----GSKLWIIMEYCGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLH---EEGKIHR 122 (274)
T ss_pred cCCCCeeeeeEEEEE-----CCeEEEEEEeeCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHH---hCCcccC
Confidence 469999999887543 46789999999999999998653 4889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||+|+||++++++.++|+|||.++..... ..++..|+|||++.+..++.++|||||||++||+++|+.||....
T Consensus 123 dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~ 202 (274)
T cd06609 123 DIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH 202 (274)
T ss_pred CCCHHHEEECCCCCEEEcccccceeecccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc
Confidence 99999999999999999999999876543 256778999999999889999999999999999999999996532
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
. ......+....+.. .....++.++.+++.+||..+|++|||++++++
T Consensus 203 ~--~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 203 P--MRVLFLIPKNNPPS------------------------------LEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred h--HHHHHHhhhcCCCC------------------------------CcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1 11100001000000 000114556889999999999999999999976
Q ss_pred H
Q 042634 413 Q 413 (427)
Q Consensus 413 ~ 413 (427)
.
T Consensus 251 ~ 251 (274)
T cd06609 251 H 251 (274)
T ss_pred C
Confidence 3
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-32 Score=242.87 Aligned_cols=209 Identities=19% Similarity=0.255 Sum_probs=151.2
Q ss_pred CCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccccCCceeeCC---------
Q 042634 199 NDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDG--------- 269 (427)
Q Consensus 199 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrDlkp~NIll~~--------- 269 (427)
.++.|+|+|.+ |-|+++++..+.. .+++..+++.|+.|++++++||| +.+++|-||||+|||+.+
T Consensus 163 rghiCivfell-G~S~~dFlk~N~y--~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~ 236 (415)
T KOG0671|consen 163 RGHICIVFELL-GLSTFDFLKENNY--IPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNP 236 (415)
T ss_pred cCceEEEEecc-ChhHHHHhccCCc--cccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEecc
Confidence 67899999988 7799999987654 67999999999999999999999 899999999999999821
Q ss_pred -----------CCceEecccccccccCCcC---CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccC-C
Q 042634 270 -----------ELTAHVGDFGLAKFLPEAT---NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFT-G 334 (427)
Q Consensus 270 -----------~~~~kL~DFG~a~~~~~~~---~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~-~ 334 (427)
+..+|++|||.|+...+.. +.|..|+|||++.+-.|+.++||||+|||++|+++|...|+.-.+ +
T Consensus 237 k~~~~~~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 237 KKKVCFIRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred CCccceeccCCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 2358999999999877665 889999999999999999999999999999999999999986431 1
Q ss_pred CccHHHHHHHhcccchhcccCccccccccccchhhhccc-----------cccccccchHHHHHHHHHHHhhcCCCCCCC
Q 042634 335 NLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAH-----------KQFTRSFSVKECLVSVLGIGVTCSSELPRE 403 (427)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~ 403 (427)
...+.+.+-..+|..+....++.--...+.-.+...... +.............++.+|+++|+..||.+
T Consensus 317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence 112222222233322111110000000000000000000 011112234556778999999999999999
Q ss_pred CCCHHHHHHH
Q 042634 404 RMNMEEVAAQ 413 (427)
Q Consensus 404 Rpt~~ev~~~ 413 (427)
|+|+.|++.+
T Consensus 397 RiTl~EAL~H 406 (415)
T KOG0671|consen 397 RITLREALSH 406 (415)
T ss_pred cccHHHHhcC
Confidence 9999999864
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=246.08 Aligned_cols=191 Identities=21% Similarity=0.284 Sum_probs=151.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|+|++++.+.+.. ....++++||+++++|.+++... ..+++..+..++.|++.||+||| +.+|+|+
T Consensus 59 l~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~ 126 (265)
T cd06631 59 LKHVNIVQYLGTCLD-----DNTISIFMEFVPGGSISSILNRF----GPLPEPVFCKYTKQILDGVAYLH---NNCVVHR 126 (265)
T ss_pred cCCCCEeeEeeEeec-----CCeEEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccC
Confidence 569999999998644 46789999999999999998654 34789999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC------------cCCCccccccccccCCCCcCccccchhHHHHHHHHHhCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE------------ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKR 326 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~------------~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~ 326 (427)
||||+||+++.++.+||+|||.+..... ...++..|+|||++.+..++.++|||||||++||+++|..
T Consensus 127 dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~ 206 (265)
T cd06631 127 DIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKP 206 (265)
T ss_pred CcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999875421 1256778999999998889999999999999999999999
Q ss_pred CCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCC
Q 042634 327 PTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMN 406 (427)
Q Consensus 327 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt 406 (427)
||....... ..... ... .. .. + ..+...+.++.+++++||+.+|++|||
T Consensus 207 p~~~~~~~~-~~~~~-~~~-~~----~~-~-----------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~ 255 (265)
T cd06631 207 PLASMDRLA-AMFYI-GAH-RG----LM-P-----------------------RLPDSFSAAAIDFVTSCLTRDQHERPS 255 (265)
T ss_pred ccccCChHH-HHHHh-hhc-cC----CC-C-----------------------CCCCCCCHHHHHHHHHHhcCCcccCCC
Confidence 996531110 00000 000 00 00 0 011224566899999999999999999
Q ss_pred HHHHHH
Q 042634 407 MEEVAA 412 (427)
Q Consensus 407 ~~ev~~ 412 (427)
++|+++
T Consensus 256 ~~~~l~ 261 (265)
T cd06631 256 ALQLLR 261 (265)
T ss_pred HHHHhc
Confidence 999975
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=242.00 Aligned_cols=193 Identities=28% Similarity=0.480 Sum_probs=153.2
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++.+.. ....+++|||+++++|.+++..... ..+++..+..++.|++.|++||| +.|++||
T Consensus 58 l~~~~i~~~~~~~~~-----~~~~~~i~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~ 127 (258)
T smart00219 58 LDHPNIVKLLGVCTE-----EEPLMIVMEYMEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLE---SKNFIHR 127 (258)
T ss_pred cCCCchheEEEEEcC-----CCeeEEEEeccCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHHh---cCCeeec
Confidence 479999999988544 4578999999999999999875432 22899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc-------CCCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCCc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA-------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~~ 330 (427)
||||+||+++.++.+||+|||.++..... ..++..|+|||...+..++.++||||+||++|||++ |..||..
T Consensus 128 dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~ 207 (258)
T smart00219 128 DLAARNCLVGENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG 207 (258)
T ss_pred ccccceEEEccCCeEEEcccCCceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999999866543 235678999999988889999999999999999998 7888864
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
. . ............. ...+..++.++.+++.+||..||++|||+.|+
T Consensus 208 ~--~---~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l 254 (258)
T smart00219 208 M--S---NEEVLEYLKKGYR----------------------------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSEL 254 (258)
T ss_pred C--C---HHHHHHHHhcCCC----------------------------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHH
Confidence 2 1 1111111100000 00112246678999999999999999999999
Q ss_pred HHHH
Q 042634 411 AAQL 414 (427)
Q Consensus 411 ~~~L 414 (427)
++.|
T Consensus 255 l~~l 258 (258)
T smart00219 255 VEIL 258 (258)
T ss_pred HhhC
Confidence 8764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=243.99 Aligned_cols=192 Identities=20% Similarity=0.224 Sum_probs=151.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
.+|||++++++.+.. +...++|+||+++++|.+++... ..+++..+..++.|++.||.||| +.+++||
T Consensus 54 ~~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~ 121 (260)
T cd05611 54 GESPYVAKLYYSFQS-----KDYLYLVMEYLNGGDCASLIKTL----GGLPEDWAKQYIAEVVLGVEDLH---QRGIIHR 121 (260)
T ss_pred CCCCCeeeeeeeEEc-----CCeEEEEEeccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecC
Confidence 479999999988543 56789999999999999998654 34889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC--cCCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccCCCc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE--ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNL 336 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~~~~ 336 (427)
||+|+||+++.++.+||+|||+++.... ...++..|+|||.+.+..++.++||||||+++||+++|..||.....
T Consensus 122 dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--- 198 (260)
T cd05611 122 DIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP--- 198 (260)
T ss_pred CCCHHHeEECCCCcEEEeecccceeccccccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH---
Confidence 9999999999999999999999986543 23678889999999888889999999999999999999999965311
Q ss_pred cHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 337 TLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
........... .+ .+......++.++.+++.+||+.+|++|||+.++.+
T Consensus 199 --~~~~~~~~~~~----~~---------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~ 247 (260)
T cd05611 199 --DAVFDNILSRR----IN---------------------WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQE 247 (260)
T ss_pred --HHHHHHHHhcc----cC---------------------CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence 11111100000 00 000011235667899999999999999997765544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=266.57 Aligned_cols=224 Identities=17% Similarity=0.145 Sum_probs=147.0
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhh-hhccCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREA-LKNLNLLQRLSIAVDVASALDYLHHYCETPIVH 257 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivH 257 (427)
++|||||++++++.. ....++|+|++ .+++.+++...... ........++.++.|++.||+||| ++||+|
T Consensus 220 l~HpnIv~l~~~~~~-----~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiH 290 (501)
T PHA03210 220 LNHENILKIEEILRS-----EANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIH 290 (501)
T ss_pred CCCCCcCcEeEEEEE-----CCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeec
Confidence 579999999998544 55679999998 56777766432210 122345678889999999999999 899999
Q ss_pred ccccCCceeeCCCCceEecccccccccCCc-------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCC-CC
Q 042634 258 CDLKPSNVLLDGELTAHVGDFGLAKFLPEA-------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRP-TN 329 (427)
Q Consensus 258 rDlkp~NIll~~~~~~kL~DFG~a~~~~~~-------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~p-f~ 329 (427)
|||||+|||++.++.+||+|||+++..... ..|+..|+|||++.+..++.++|||||||++|||++|..+ |.
T Consensus 291 rDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~ 370 (501)
T PHA03210 291 RDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIG 370 (501)
T ss_pred CCCCHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCcc
Confidence 999999999999999999999999865432 2688999999999999999999999999999999998754 43
Q ss_pred cccCCC-ccHHHHHHHhcccchhcccCccccc-cccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCH
Q 042634 330 EMFTGN-LTLHNFVKEALPERLAEIVDPVLLV-EREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM 407 (427)
Q Consensus 330 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~ 407 (427)
...... ..+.+.+.. +.....+..+..... +.-..... ................+..+.+++.+|+++||++|||+
T Consensus 371 ~~~~~~~~~~~~~~~~-~~~~~~~~p~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa 448 (501)
T PHA03210 371 DGGGKPGKQLLKIIDS-LSVCDEEFPDPPCKLFDYIDSAEI-DHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGA 448 (501)
T ss_pred CCCCCHHHHHHHHHHh-cccChhhcCCcHHHHHHHhhhhhc-ccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCH
Confidence 221111 111111111 000000000000000 00000000 00000000000111134567888999999999999999
Q ss_pred HHHHHH
Q 042634 408 EEVAAQ 413 (427)
Q Consensus 408 ~ev~~~ 413 (427)
.|++++
T Consensus 449 ~elL~h 454 (501)
T PHA03210 449 AELLAL 454 (501)
T ss_pred HHHhhC
Confidence 999864
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=244.47 Aligned_cols=192 Identities=21% Similarity=0.283 Sum_probs=153.2
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++.+.+. .....++||||+++++|.+++..... ..+++.++..++.|++.|+.||| +.|++|+
T Consensus 56 l~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~ 125 (256)
T cd08218 56 MKHPNIVQYQESFE-----ENGNLYIVMDYCEGGDLYKKINAQRG--VLFPEDQILDWFVQICLALKHVH---DRKILHR 125 (256)
T ss_pred CCCCCeeeeEeeec-----CCCeEEEEEecCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH---hCCEecC
Confidence 46999999988743 35678999999999999998865322 34788999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC------CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||+|+||+++.++.+||+|||.+....... .++..|+|||+..+..++.++|+|||||++|++++|+.||....
T Consensus 126 ~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~ 205 (256)
T cd08218 126 DIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN 205 (256)
T ss_pred CCCHHHEEEcCCCCEEEeeccceeecCcchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC
Confidence 999999999999999999999998664432 56778999999988889999999999999999999999986421
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
....+......... ..+...+.++.+++.+||+.+|++||++.||++
T Consensus 206 -----~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 206 -----MKNLVLKIIRGSYP----------------------------PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred -----HHHHHHHHhcCCCC----------------------------CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 11111111110000 012234567899999999999999999999987
Q ss_pred H
Q 042634 413 Q 413 (427)
Q Consensus 413 ~ 413 (427)
+
T Consensus 253 ~ 253 (256)
T cd08218 253 K 253 (256)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=253.21 Aligned_cols=195 Identities=17% Similarity=0.192 Sum_probs=147.5
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
.+|++|+++++.+. .....++||||+++|+|.+++.... ..+++..++.++.|++.||+||| +.||+||
T Consensus 58 ~~~~~i~~~~~~~~-----~~~~~~lv~ey~~~g~L~~~l~~~~---~~l~~~~~~~~~~qi~~al~~lH---~~~iiHr 126 (332)
T cd05623 58 GDNQWITTLHYAFQ-----DENNLYLVMDYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVIAIDSVH---QLHYVHR 126 (332)
T ss_pred CCCCCEeeEEEEEe-----cCCEEEEEEeccCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeEec
Confidence 57999999988743 3567899999999999999996532 35889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc-------CCCccccccccccC-----CCCcCccccchhHHHHHHHHHhCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA-------TNNFFNFQIAEYGM-----GSEVSTSGDVYSFGILLLETFTGKR 326 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-------~~~~~~y~aPE~~~-----~~~~~~~~DiwS~G~vl~ell~g~~ 326 (427)
||||+||+++.++.+||+|||+++..... ..||..|+|||++. ...++.++|||||||++|||++|+.
T Consensus 127 Dlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~ 206 (332)
T cd05623 127 DIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGET 206 (332)
T ss_pred CCCHHHEEECCCCCEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCC
Confidence 99999999999999999999998754321 26889999999986 3457899999999999999999999
Q ss_pred CCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCC--C
Q 042634 327 PTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRE--R 404 (427)
Q Consensus 327 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~--R 404 (427)
||.... ..+.......... . .........++.++.+++++|+..++.+ |
T Consensus 207 Pf~~~~-----~~~~~~~i~~~~~-~-----------------------~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r 257 (332)
T cd05623 207 PFYAES-----LVETYGKIMNHKE-R-----------------------FQFPAQVTDVSEDAKDLIRRLICSREHRLGQ 257 (332)
T ss_pred CCCCCC-----HHHHHHHHhCCCc-c-----------------------ccCCCccccCCHHHHHHHHHHccChhhhcCC
Confidence 997531 1111111110000 0 0000011224566888999988655444 6
Q ss_pred CCHHHHHHH
Q 042634 405 MNMEEVAAQ 413 (427)
Q Consensus 405 pt~~ev~~~ 413 (427)
+|++|++++
T Consensus 258 ~~~~~~~~h 266 (332)
T cd05623 258 NGIEDFKQH 266 (332)
T ss_pred CCHHHHhCC
Confidence 899999876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=246.13 Aligned_cols=217 Identities=21% Similarity=0.268 Sum_probs=151.8
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++.+.. ....++||||++++.|..+.... ..+++..++.++.|++.||+||| +.|++||
T Consensus 57 ~~h~~i~~~~~~~~~-----~~~~~~v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~ 124 (286)
T cd07847 57 LKHPNLVNLIEVFRR-----KRKLHLVFEYCDHTVLNELEKNP----RGVPEHLIKKIIWQTLQAVNFCH---KHNCIHR 124 (286)
T ss_pred CCCCCEeeeeeEEee-----CCEEEEEEeccCccHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---HCCceec
Confidence 569999999988543 56789999999998888776543 34899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC------CCccccccccccCC-CCcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT------NNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~------~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
||||+||+++.++.+||+|||.+....... .++..|+|||++.+ ..++.++|||||||++|||++|+.||.+.
T Consensus 125 dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~ 204 (286)
T cd07847 125 DVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGK 204 (286)
T ss_pred CCChhhEEEcCCCcEEECccccceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999998764432 46678999999876 55789999999999999999999999754
Q ss_pred cCCCccHHHHHHHh--cccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 042634 332 FTGNLTLHNFVKEA--LPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEE 409 (427)
Q Consensus 332 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~e 409 (427)
...+ ......... ......+..+..... .............. .......+..+.+++.+||+.+|++|||+.|
T Consensus 205 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e 279 (286)
T cd07847 205 SDVD-QLYLIRKTLGDLIPRHQQIFSTNQFF---KGLSIPEPETREPL-ESKFPNISSPALSFLKGCLQMDPTERLSCEE 279 (286)
T ss_pred ChHH-HHHHHHHHhCCCChHHhhhccccccc---ccccCCCcccccCH-HHHhccCCHHHHHHHHHHhcCCccccCCHHH
Confidence 3211 111111100 000001111000000 00000000000000 0001123567899999999999999999999
Q ss_pred HHH
Q 042634 410 VAA 412 (427)
Q Consensus 410 v~~ 412 (427)
++.
T Consensus 280 il~ 282 (286)
T cd07847 280 LLE 282 (286)
T ss_pred Hhc
Confidence 975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=253.72 Aligned_cols=192 Identities=23% Similarity=0.321 Sum_probs=153.9
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
+.|||+|.+-+++.. ....|+||||| -|+-.+++.-.. +++.+.++..|..+.+.||.||| +.+.|||
T Consensus 83 l~HPntieYkgCyLr-----e~TaWLVMEYC-lGSAsDlleVhk---KplqEvEIAAi~~gaL~gLaYLH---S~~~IHR 150 (948)
T KOG0577|consen 83 LRHPNTIEYKGCYLR-----EHTAWLVMEYC-LGSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLH---SHNRIHR 150 (948)
T ss_pred ccCCCcccccceeec-----cchHHHHHHHH-hccHHHHHHHHh---ccchHHHHHHHHHHHHHHHHHHH---HhhHHhh
Confidence 679999999887433 55689999999 677777775543 66889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC--CCccccccccccCC---CCcCccccchhHHHHHHHHHhCCCCCCcccC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT--NNFFNFQIAEYGMG---SEVSTSGDVYSFGILLLETFTGKRPTNEMFT 333 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~--~~~~~y~aPE~~~~---~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~ 333 (427)
|||..|||+++.|.|||+|||.|....... +||+.|||||++.. +.|+.|+||||+|+++.|+..+++|+..+..
T Consensus 151 DiKAGNILLse~g~VKLaDFGSAsi~~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA 230 (948)
T KOG0577|consen 151 DIKAGNILLSEPGLVKLADFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 230 (948)
T ss_pred hccccceEecCCCeeeeccccchhhcCchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH
Confidence 999999999999999999999998876543 99999999999853 6799999999999999999999999765411
Q ss_pred CCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 042634 334 GNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAAQ 413 (427)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~ 413 (427)
+..--.+...-+ + .....+-...|..++..|++.-|.+|||.++++++
T Consensus 231 --MSALYHIAQNes--------P----------------------tLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 231 --MSALYHIAQNES--------P----------------------TLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred --HHHHHHHHhcCC--------C----------------------CCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 100001111111 1 11223346678999999999999999999998875
Q ss_pred H
Q 042634 414 L 414 (427)
Q Consensus 414 L 414 (427)
-
T Consensus 279 ~ 279 (948)
T KOG0577|consen 279 R 279 (948)
T ss_pred c
Confidence 3
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=245.00 Aligned_cols=203 Identities=26% Similarity=0.412 Sum_probs=153.1
Q ss_pred cccccchhhhccccccCCCC-CCccceeeeeecCCCcccccccch--hhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 042634 179 IRHRNLVKIITSCASVDFQG-NDSEALVYEFMVNGSLEEWLHPNR--EALKNLNLLQRLSIAVDVASALDYLHHYCETPI 255 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~i 255 (427)
++|||++++++.+......+ ....++++||+.+|+|.+++.... .....+++..++.++.|++.|++||| +.||
T Consensus 58 l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i 134 (273)
T cd05074 58 FDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNF 134 (273)
T ss_pred CCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCE
Confidence 57999999998764422111 123468899999999988764321 11134788999999999999999999 8999
Q ss_pred eeccccCCceeeCCCCceEecccccccccCCcC--------CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCC
Q 042634 256 VHCDLKPSNVLLDGELTAHVGDFGLAKFLPEAT--------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKR 326 (427)
Q Consensus 256 vHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~--------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~ 326 (427)
+||||||+||+++.++.+||+|||.++...... .++..|++||.+....++.++|||||||++||+++ |+.
T Consensus 135 ~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~ 214 (273)
T cd05074 135 IHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQT 214 (273)
T ss_pred eecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCC
Confidence 999999999999999999999999998653221 34467999999988889999999999999999999 888
Q ss_pred CCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCC
Q 042634 327 PTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMN 406 (427)
Q Consensus 327 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt 406 (427)
||..... .......... ... ..+..++..+.+++.+||+.+|++|||
T Consensus 215 p~~~~~~--~~~~~~~~~~--~~~-----------------------------~~~~~~~~~~~~l~~~~l~~~p~~Rps 261 (273)
T cd05074 215 PYAGVEN--SEIYNYLIKG--NRL-----------------------------KQPPDCLEDVYELMCQCWSPEPKCRPS 261 (273)
T ss_pred CCCCCCH--HHHHHHHHcC--CcC-----------------------------CCCCCCCHHHHHHHHHHcCCChhhCcC
Confidence 8864311 1111111100 000 011123567899999999999999999
Q ss_pred HHHHHHHHHHH
Q 042634 407 MEEVAAQLLSF 417 (427)
Q Consensus 407 ~~ev~~~L~~~ 417 (427)
+.|+++.|+++
T Consensus 262 ~~~~~~~l~~~ 272 (273)
T cd05074 262 FQHLRDQLELI 272 (273)
T ss_pred HHHHHHHHHhh
Confidence 99999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=251.46 Aligned_cols=141 Identities=23% Similarity=0.274 Sum_probs=122.8
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
.+||||+++++.+.. +...++||||+++|+|.+++.... ..+++..+..++.||+.||+||| ++||+||
T Consensus 58 ~~~~~i~~~~~~~~~-----~~~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~ 126 (331)
T cd05597 58 GDRRWITNLHYAFQD-----ENNLYLVMDYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVLAIDSVH---QLGYVHR 126 (331)
T ss_pred CCCCCCCceEEEEec-----CCeEEEEEecCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeEEC
Confidence 579999999887543 567899999999999999986432 35889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc-------CCCccccccccccCC-----CCcCccccchhHHHHHHHHHhCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA-------TNNFFNFQIAEYGMG-----SEVSTSGDVYSFGILLLETFTGKR 326 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-------~~~~~~y~aPE~~~~-----~~~~~~~DiwS~G~vl~ell~g~~ 326 (427)
||||+|||++.++.+||+|||++...... ..|+..|+|||++.. ..++.++||||+||++|||++|+.
T Consensus 127 dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~ 206 (331)
T cd05597 127 DIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGET 206 (331)
T ss_pred CCCHHHEEECCCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCC
Confidence 99999999999999999999998765332 258899999999863 457889999999999999999999
Q ss_pred CCCc
Q 042634 327 PTNE 330 (427)
Q Consensus 327 pf~~ 330 (427)
||..
T Consensus 207 Pf~~ 210 (331)
T cd05597 207 PFYA 210 (331)
T ss_pred CCCC
Confidence 9965
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=243.28 Aligned_cols=192 Identities=20% Similarity=0.225 Sum_probs=148.6
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||++.++.+... .....+++|||+++++|.+++... ..+++..++.++.|++.||+||| +.+|+|+
T Consensus 61 l~h~~i~~~~~~~~~~---~~~~~~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~ 130 (265)
T cd06652 61 LLHERIVQYYGCLRDP---MERTLSIFMEHMPGGSIKDQLKSY----GALTENVTRKYTRQILEGVSYLH---SNMIVHR 130 (265)
T ss_pred cCCCCeeeEEeEeccC---CCceEEEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---hCCEecC
Confidence 4799999998864331 124578999999999999988644 34788899999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC---------cCCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE---------ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTN 329 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~---------~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~ 329 (427)
||||+||+++.++.+||+|||.++.... ...++..|+|||.+.+..++.++|||||||++||+++|+.||.
T Consensus 131 dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~ 210 (265)
T cd06652 131 DIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWA 210 (265)
T ss_pred CCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCC
Confidence 9999999999999999999999975432 1257778999999988889999999999999999999999986
Q ss_pred cccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 042634 330 EMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEE 409 (427)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~e 409 (427)
... ..... ....... .....+......+.+++.+||. +|++|||++|
T Consensus 211 ~~~----~~~~~-~~~~~~~---------------------------~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~ 257 (265)
T cd06652 211 EFE----AMAAI-FKIATQP---------------------------TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADE 257 (265)
T ss_pred ccc----hHHHH-HHHhcCC---------------------------CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHH
Confidence 421 01111 0000000 0001223345678889999994 9999999999
Q ss_pred HHHH
Q 042634 410 VAAQ 413 (427)
Q Consensus 410 v~~~ 413 (427)
|++.
T Consensus 258 il~~ 261 (265)
T cd06652 258 LLRH 261 (265)
T ss_pred HhcC
Confidence 9863
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=242.14 Aligned_cols=192 Identities=23% Similarity=0.249 Sum_probs=152.8
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. +...++++||+++++|.+++.+. ..+++..+..++.|++.||+|+| +.|++|+
T Consensus 50 l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~ 117 (262)
T cd05572 50 CNHPFIVKLYRTFKD-----KKYIYMLMEYCLGGELWTILRDR----GLFDEYTARFYIACVVLAFEYLH---NRGIIYR 117 (262)
T ss_pred CCCCCEeeeeeeEEc-----CCccEEEEecCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHh---hCCcccC
Confidence 579999999987533 56789999999999999999764 34889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc-----CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFT 333 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~ 333 (427)
||||+||+++.++.+||+|||.++..... ..++..|+|||.+.+..++.++|+||+|+++||+++|..||.....
T Consensus 118 dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 197 (262)
T cd05572 118 DLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE 197 (262)
T ss_pred CCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC
Confidence 99999999999999999999999876543 2567889999999888899999999999999999999999976432
Q ss_pred CCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCC-----HH
Q 042634 334 GNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMN-----ME 408 (427)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt-----~~ 408 (427)
+. .+...... +... ....+...+.++.+++.+||+.+|++||| ++
T Consensus 198 ~~---~~~~~~~~--------~~~~-------------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~ 247 (262)
T cd05572 198 DP---MEIYNDIL--------KGNG-------------------KLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIK 247 (262)
T ss_pred CH---HHHHHHHh--------ccCC-------------------CCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHH
Confidence 11 11111110 0000 00012223567899999999999999999 66
Q ss_pred HHHH
Q 042634 409 EVAA 412 (427)
Q Consensus 409 ev~~ 412 (427)
|+++
T Consensus 248 ~l~~ 251 (262)
T cd05572 248 DIKK 251 (262)
T ss_pred HHhc
Confidence 6655
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=244.27 Aligned_cols=190 Identities=22% Similarity=0.325 Sum_probs=150.6
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++.+.. ....++++||+++++|.+++.. ..+++..+..++.|++.|++||| +.|++||
T Consensus 73 ~~h~~vv~~~~~~~~-----~~~~~~v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~ 139 (285)
T cd06648 73 YQHPNIVEMYSSYLV-----GDELWVVMEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLH---AQGVIHR 139 (285)
T ss_pred cCCCChheEEEEEEc-----CCeEEEEEeccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecC
Confidence 469999999987543 5678999999999999998865 23888999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+||+++.++.+||+|||.+...... ..++..|+|||...+..++.++|||||||++|||++|+.||....
T Consensus 140 dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~ 219 (285)
T cd06648 140 DIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP 219 (285)
T ss_pred CCChhhEEEcCCCcEEEcccccchhhccCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC
Confidence 99999999999999999999988754332 257788999999988889999999999999999999999986421
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
. ...........+.. . ......+..+.+++.+||+.+|++|||+.|+++
T Consensus 220 ~--~~~~~~~~~~~~~~--------~---------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 220 P--LQAMKRIRDNLPPK--------L---------------------KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred H--HHHHHHHHhcCCCC--------C---------------------cccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 1 00001011000000 0 011123457899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=249.92 Aligned_cols=192 Identities=24% Similarity=0.242 Sum_probs=150.6
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. +...++||||+.+++|.+++..... ..+++..+..++.|++.||+||| ..|++||
T Consensus 58 l~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~ 127 (316)
T cd05574 58 LDHPFLPTLYASFQT-----ETYLCLVMDYCPGGELFRLLQRQPG--KCLSEEVARFYAAEVLLALEYLH---LLGIVYR 127 (316)
T ss_pred CCCCCchhheeeeec-----CCEEEEEEEecCCCCHHHHHHhCCC--CccCHHHHHHHHHHHHHHHHHHH---HCCeecc
Confidence 469999999988533 5678999999999999999865432 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc-----------------------------------CCCccccccccccCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA-----------------------------------TNNFFNFQIAEYGMGS 303 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-----------------------------------~~~~~~y~aPE~~~~~ 303 (427)
||||+||+++.++.+||+|||.+...... ..|+..|+|||++.+.
T Consensus 128 dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 207 (316)
T cd05574 128 DLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD 207 (316)
T ss_pred CCChHHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC
Confidence 99999999999999999999998754221 1467789999999988
Q ss_pred CcCccccchhHHHHHHHHHhCCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchH
Q 042634 304 EVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVK 383 (427)
Q Consensus 304 ~~~~~~DiwS~G~vl~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 383 (427)
.++.++|||||||++|++++|+.||...... ..+... .+..... ....
T Consensus 208 ~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~~~~~~------------~~~~~~~-------------------~~~~ 255 (316)
T cd05574 208 GHGSAVDWWTLGILLYEMLYGTTPFKGSNRD-ETFSNI------------LKKEVTF-------------------PGSP 255 (316)
T ss_pred CCCchHHHHHHHHHHHHHhhCCCCCCCCchH-HHHHHH------------hcCCccC-------------------CCcc
Confidence 8999999999999999999999999753211 111110 0000000 0011
Q ss_pred HHHHHHHHHHhhcCCCCCCCCCC----HHHHHH
Q 042634 384 ECLVSVLGIGVTCSSELPRERMN----MEEVAA 412 (427)
Q Consensus 384 ~~~~~~~~l~~~cl~~dP~~Rpt----~~ev~~ 412 (427)
..+.++.+++.+||+.||++||| ++|++.
T Consensus 256 ~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 256 PVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred ccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 14567899999999999999999 666665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=245.91 Aligned_cols=141 Identities=23% Similarity=0.387 Sum_probs=120.5
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++++.. +...++||||+. ++|.+++.... ..+++..++.++.|++.||.||| +.||+||
T Consensus 60 l~h~~i~~~~~~~~~-----~~~~~lv~e~~~-~~L~~~~~~~~---~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~ 127 (291)
T cd07844 60 LKHANIVTLHDIIHT-----KKTLTLVFEYLD-TDLKQYMDDCG---GGLSMHNVRLFLFQLLRGLAYCH---QRRVLHR 127 (291)
T ss_pred CCCcceeeEEEEEec-----CCeEEEEEecCC-CCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeecc
Confidence 579999999988543 567899999996 58988876543 35889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCC-CCcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
||||+||+++.++.+||+|||.++..... ..++..|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 128 dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~ 207 (291)
T cd07844 128 DLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGS 207 (291)
T ss_pred cCCHHHEEEcCCCCEEECccccccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999998754321 245678999999875 45789999999999999999999999754
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=241.30 Aligned_cols=190 Identities=22% Similarity=0.273 Sum_probs=150.8
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++.+.. ....++++||+++++|.+++... ..+++..+..++.|++.|++||| +.||+|+
T Consensus 59 ~~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~ 126 (258)
T cd06632 59 LQHPNIVQYLGTERE-----EDNLYIFLELVPGGSLAKLLKKY----GSFPEPVIRLYTRQILLGLEYLH---DRNTVHR 126 (258)
T ss_pred cCCCCchheeeeEec-----CCeEEEEEEecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccC
Confidence 579999999987533 46789999999999999998654 34889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc-----CCCccccccccccCCCC-cCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMGSE-VSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~~~-~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||+|+||+++.++.+||+|||.+...... ..++..|+|||.+.... ++.++|+|||||++|++++|+.||....
T Consensus 127 dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~ 206 (258)
T cd06632 127 DIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE 206 (258)
T ss_pred CCCHHHEEECCCCCEEEccCccceeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc
Confidence 99999999999999999999998865332 25778899999987766 8999999999999999999999997532
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
. ............. ...+...+..+.+++++||+.+|++|||++|++.
T Consensus 207 ~----~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 207 G----VAAVFKIGRSKEL----------------------------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred H----HHHHHHHHhcccC----------------------------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 1 1111000000000 0011224566789999999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=251.98 Aligned_cols=233 Identities=21% Similarity=0.211 Sum_probs=166.5
Q ss_pred cccccchhhhccccccC-CCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 042634 179 IRHRNLVKIITSCASVD-FQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVH 257 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~-~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivH 257 (427)
++|||||+++++-.... +.-.....+|||||.+|||+..+++.... ..+++.+.+.++.+++.||.||| ++||+|
T Consensus 68 Lnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~-~GLpE~e~l~lL~d~~~al~~Lr---En~IvH 143 (732)
T KOG4250|consen 68 LNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENA-YGLPESEFLDLLSDLVSALRHLR---ENGIVH 143 (732)
T ss_pred cCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccc-cCCCHHHHHHHHHHHHHHHHHHH---HcCcee
Confidence 45999999998743321 11245678999999999999999875543 56999999999999999999999 999999
Q ss_pred ccccCCceee--CC--CCceEecccccccccCCcC-----CCccccccccccCC-CCcCccccchhHHHHHHHHHhCCCC
Q 042634 258 CDLKPSNVLL--DG--ELTAHVGDFGLAKFLPEAT-----NNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETFTGKRP 327 (427)
Q Consensus 258 rDlkp~NIll--~~--~~~~kL~DFG~a~~~~~~~-----~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell~g~~p 327 (427)
|||||.||++ ++ ....||+|||.|+.+.++. +||..|.+||.+.. +.|+..+|.|||||++||++||..|
T Consensus 144 RDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lP 223 (732)
T KOG4250|consen 144 RDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELP 223 (732)
T ss_pred ccCCCCcEEEeecCCCceEEeeecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCC
Confidence 9999999998 33 3468999999999988766 89999999999984 8899999999999999999999999
Q ss_pred CCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCC--
Q 042634 328 TNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERM-- 405 (427)
Q Consensus 328 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rp-- 405 (427)
|....+.... .+.+..........++-..... ......+...-++..+ ........+-.++..++.++|++|-
T Consensus 224 F~p~~~pk~~-~~~~~~~~tkkp~~v~i~~~~~---eNgpv~~s~~lP~p~~-Ls~~l~~~~~kwLa~~L~~~~~~~~~~ 298 (732)
T KOG4250|consen 224 FIPFGGPKNN-KEIMWHIITKKPSGVAIGAQEE---ENGPVEWSSTLPQPNH-LSRGLATRLTKWLASMLEWNPRKRGHE 298 (732)
T ss_pred CCcCCCcccc-chhhhhhhccCCCceeEeeecc---cCCceeeeccCCCccc-ccHHHHhhhhHHHHHHHhhhHHHhCCC
Confidence 9865332211 1111111111111111100001 1111111122222111 2233455677788899999999999
Q ss_pred CHHHHHHHHHHHHHH
Q 042634 406 NMEEVAAQLLSFRNK 420 (427)
Q Consensus 406 t~~ev~~~L~~~~~~ 420 (427)
.+.+..+.+..|.+.
T Consensus 299 ~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 299 GFDRFFAEVDDILNL 313 (732)
T ss_pred CcchHHHHHHHHHhh
Confidence 888888888877654
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=252.56 Aligned_cols=215 Identities=21% Similarity=0.259 Sum_probs=152.4
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++.+....+......++++||+. +++.+++.. ..+++..+..++.|++.||+||| +.||+||
T Consensus 60 l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~ 130 (336)
T cd07849 60 FKHENIIGILDIIRPPSFESFNDVYIVQELME-TDLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIH---SANVLHR 130 (336)
T ss_pred CCCCCcCchhheeecccccccceEEEEehhcc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecc
Confidence 45999999998876555545556899999994 688777654 34899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc---------CCCccccccccccCC-CCcCccccchhHHHHHHHHHhCCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA---------TNNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETFTGKRPT 328 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~---------~~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell~g~~pf 328 (427)
||||+||+++.++.+||+|||+++..... ..++..|+|||.+.+ ..++.++||||+||++|||++|+.||
T Consensus 131 dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f 210 (336)
T cd07849 131 DLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLF 210 (336)
T ss_pred CCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999765321 256778999998754 56899999999999999999999999
Q ss_pred CcccCCCccHHHHHHHhc----ccchhcccCccccccccccchhhhcccccccccc----chHHHHHHHHHHHhhcCCCC
Q 042634 329 NEMFTGNLTLHNFVKEAL----PERLAEIVDPVLLVEREEGETSKANAHKQFTRSF----SVKECLVSVLGIGVTCSSEL 400 (427)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~~cl~~d 400 (427)
.+.... ..+ ..+...+ ++.+..+.+..... .. ...+..+.. ..+..+.++.+++.+||+.|
T Consensus 211 ~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~~------~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d 279 (336)
T cd07849 211 PGKDYL-HQL-NLILGVLGTPSQEDLNCIISLRARN------YI---KSLPFKPKVPWNKLFPNADPKALDLLDKMLTFN 279 (336)
T ss_pred CCCCHH-HHH-HHHHHHcCCCCHHHHHHhhchhhhh------HH---hhcCcCCcccHHHHhcccCcHHHHHHHHHcCCC
Confidence 653110 011 1111111 11111111110000 00 000000000 01123567899999999999
Q ss_pred CCCCCCHHHHHHH
Q 042634 401 PRERMNMEEVAAQ 413 (427)
Q Consensus 401 P~~Rpt~~ev~~~ 413 (427)
|++|||+.|++++
T Consensus 280 P~~Rpt~~e~l~h 292 (336)
T cd07849 280 PHKRITVEEALAH 292 (336)
T ss_pred hhhCcCHHHHhcC
Confidence 9999999999876
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-31 Score=245.48 Aligned_cols=191 Identities=19% Similarity=0.249 Sum_probs=151.2
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++.+.. ....++|+||+++++|.+++.+. .+++..+..++.|++.|+.||| +.|++||
T Consensus 73 l~hp~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH---~~gi~H~ 139 (293)
T cd06647 73 NKHPNIVNYLDSYLV-----GDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLH---SNQVIHR 139 (293)
T ss_pred cCCCCeeehhheeee-----CCcEEEEEecCCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHH---hCCEeec
Confidence 579999999988543 56789999999999999988643 3788899999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC------CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+||+++.++.+||+|||++....... .++..|+|||.+....++.++|||||||++||+++|+.||....
T Consensus 140 dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~ 219 (293)
T cd06647 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (293)
T ss_pred cCCHHHEEEcCCCCEEEccCcceecccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999887553322 56778999999988889999999999999999999999997532
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
.... .... .. .. . .....+...+..+.+++++||+.+|++|||++|++.
T Consensus 220 ~~~~-~~~~-~~----------~~--------~-----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 268 (293)
T cd06647 220 PLRA-LYLI-AT----------NG--------T-----------PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 268 (293)
T ss_pred hhhh-eeeh-hc----------CC--------C-----------CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1110 0000 00 00 0 000012224556889999999999999999999987
Q ss_pred H
Q 042634 413 Q 413 (427)
Q Consensus 413 ~ 413 (427)
+
T Consensus 269 h 269 (293)
T cd06647 269 H 269 (293)
T ss_pred C
Confidence 5
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=250.01 Aligned_cols=224 Identities=17% Similarity=0.212 Sum_probs=152.6
Q ss_pred cccccchhhhccccccC-CCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 042634 179 IRHRNLVKIITSCASVD-FQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVH 257 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~-~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivH 257 (427)
++|||++++++.+.... +.+....++||||+ .++|.+.+.. .+++..+..++.|++.||+||| ..||+|
T Consensus 72 l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH---~~gi~H 141 (353)
T cd07850 72 VNHKNIIGLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQM------DLDHERMSYLLYQMLCGIKHLH---SAGIIH 141 (353)
T ss_pred cCCCCCcceeeeeccCCCccccCcEEEEEecc-CCCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHH---hCCeee
Confidence 57999999998754321 22234579999999 5688777642 2788899999999999999999 899999
Q ss_pred ccccCCceeeCCCCceEecccccccccCCcC-----CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 258 CDLKPSNVLLDGELTAHVGDFGLAKFLPEAT-----NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 258 rDlkp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
|||||+||+++.++.+||+|||.++...... .++..|+|||.+.+..++.++|||||||++|+|++|+.||....
T Consensus 142 ~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~ 221 (353)
T cd07850 142 RDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD 221 (353)
T ss_pred CCCCHHHEEECCCCCEEEccCccceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCC
Confidence 9999999999999999999999998764432 46778999999999999999999999999999999999997531
Q ss_pred CCCccHHHHHHHhc--ccchhcccCccccccccccc------hhhhccccccc--cccchHHHHHHHHHHHhhcCCCCCC
Q 042634 333 TGNLTLHNFVKEAL--PERLAEIVDPVLLVEREEGE------TSKANAHKQFT--RSFSVKECLVSVLGIGVTCSSELPR 402 (427)
Q Consensus 333 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~--~~~~~~~~~~~~~~l~~~cl~~dP~ 402 (427)
. ...+........ +..+.+.++.........+. .........+. ........+.++.+++.+||+.||+
T Consensus 222 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 300 (353)
T cd07850 222 H-IDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPE 300 (353)
T ss_pred H-HHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChh
Confidence 1 111111111100 01111111110000000000 00000000000 0001223466788999999999999
Q ss_pred CCCCHHHHHHH
Q 042634 403 ERMNMEEVAAQ 413 (427)
Q Consensus 403 ~Rpt~~ev~~~ 413 (427)
+|||+.|+++.
T Consensus 301 ~R~t~~eiL~~ 311 (353)
T cd07850 301 KRISVDDALQH 311 (353)
T ss_pred hCcCHHHHhcC
Confidence 99999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=250.50 Aligned_cols=141 Identities=21% Similarity=0.248 Sum_probs=123.5
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
.+|++|+++++.+. .....++||||+++|+|.+++.... ..+++..+..++.|++.||+||| ++||+||
T Consensus 58 ~~~~~i~~l~~~~~-----~~~~~~lv~Ey~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHr 126 (331)
T cd05624 58 GDCQWITTLHYAFQ-----DENYLYLVMDYYVGGDLLTLLSKFE---DRLPEDMARFYIAEMVLAIHSIH---QLHYVHR 126 (331)
T ss_pred CCCCCEeeEEEEEE-----cCCEEEEEEeCCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeec
Confidence 57999999988743 3567899999999999999986532 35889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc-------CCCccccccccccCC-----CCcCccccchhHHHHHHHHHhCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA-------TNNFFNFQIAEYGMG-----SEVSTSGDVYSFGILLLETFTGKR 326 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-------~~~~~~y~aPE~~~~-----~~~~~~~DiwS~G~vl~ell~g~~ 326 (427)
||||+||+++.++.+||+|||+++..... ..|+..|+|||++.+ ..++.++|||||||++|||++|+.
T Consensus 127 Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~ 206 (331)
T cd05624 127 DIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGET 206 (331)
T ss_pred cCchHHEEEcCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCC
Confidence 99999999999999999999999765432 258899999999875 467899999999999999999999
Q ss_pred CCCc
Q 042634 327 PTNE 330 (427)
Q Consensus 327 pf~~ 330 (427)
||..
T Consensus 207 Pf~~ 210 (331)
T cd05624 207 PFYA 210 (331)
T ss_pred CccC
Confidence 9964
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-31 Score=247.57 Aligned_cols=191 Identities=24% Similarity=0.321 Sum_probs=148.8
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++.+.+.. ....++||||+. |++.+++.... ..+++..+..++.|++.||.||| +.||+||
T Consensus 72 l~h~niv~~~~~~~~-----~~~~~lv~e~~~-g~l~~~~~~~~---~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~ 139 (307)
T cd06607 72 LRHPNTIEYKGCYLR-----EHTAWLVMEYCL-GSASDILEVHK---KPLQEVEIAAICHGALQGLAYLH---SHERIHR 139 (307)
T ss_pred CCCCCEEEEEEEEEe-----CCeEEEEHHhhC-CCHHHHHHHcc---cCCCHHHHHHHHHHHHHHHHHHH---HCCceec
Confidence 579999999998654 456799999995 67766664322 35899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC--CCccccccccccC---CCCcCccccchhHHHHHHHHHhCCCCCCcccC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT--NNFFNFQIAEYGM---GSEVSTSGDVYSFGILLLETFTGKRPTNEMFT 333 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~--~~~~~y~aPE~~~---~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~ 333 (427)
||+|+||+++.++.+||+|||++....... .++..|+|||++. ...++.++||||||+++|||++|..||.....
T Consensus 140 dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~ 219 (307)
T cd06607 140 DIKAGNILLTEPGTVKLADFGSASLVSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219 (307)
T ss_pred CCCcccEEECCCCCEEEeecCcceecCCCCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH
Confidence 999999999999999999999998664332 6778899999874 35688999999999999999999999865311
Q ss_pred CCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 042634 334 GNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAAQ 413 (427)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~ 413 (427)
. ......... + ........++.++.+++.+||+.+|++|||+.+|+.+
T Consensus 220 ~-----~~~~~~~~~------~---------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 220 M-----SALYHIAQN------D---------------------SPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred H-----HHHHHHhcC------C---------------------CCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0 000000000 0 0001123356679999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-31 Score=242.55 Aligned_cols=195 Identities=22% Similarity=0.296 Sum_probs=151.3
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++.+.. ....++||||+++++|.+++... ..+++..+..++.|++.||.||| +.+++||
T Consensus 65 l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~ 132 (272)
T cd06629 65 LDHLNIVQYLGFETT-----EEYLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLH---SKGILHR 132 (272)
T ss_pred cCCCCcceEEEEecc-----CCceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHh---hCCeeec
Confidence 469999999987543 56789999999999999998765 35889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc--------CCCccccccccccCCCC--cCccccchhHHHHHHHHHhCCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA--------TNNFFNFQIAEYGMGSE--VSTSGDVYSFGILLLETFTGKRPT 328 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~--------~~~~~~y~aPE~~~~~~--~~~~~DiwS~G~vl~ell~g~~pf 328 (427)
||||+||+++.++.+||+|||.++..... ..++..|+|||.+.... ++.++|+||||+++||+++|..||
T Consensus 133 dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~ 212 (272)
T cd06629 133 DLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPW 212 (272)
T ss_pred CCChhhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999865321 25677899999987654 789999999999999999999998
Q ss_pred CcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 042634 329 NEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME 408 (427)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ 408 (427)
..... ..... ..........+. ......++.++.+++.+||+.+|++|||++
T Consensus 213 ~~~~~----~~~~~-~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 264 (272)
T cd06629 213 SDEEA----IAAMF-KLGNKRSAPPIP-----------------------PDVSMNLSPVALDFLNACFTINPDNRPTAR 264 (272)
T ss_pred cCcch----HHHHH-HhhccccCCcCC-----------------------ccccccCCHHHHHHHHHHhcCChhhCCCHH
Confidence 64211 11110 000000000000 001123466789999999999999999999
Q ss_pred HHHHH
Q 042634 409 EVAAQ 413 (427)
Q Consensus 409 ev~~~ 413 (427)
||+++
T Consensus 265 ~il~~ 269 (272)
T cd06629 265 ELLQH 269 (272)
T ss_pred HHhhC
Confidence 99864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=253.21 Aligned_cols=191 Identities=22% Similarity=0.323 Sum_probs=155.6
Q ss_pred cccccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCee
Q 042634 177 NFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIV 256 (427)
Q Consensus 177 ~ll~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~iv 256 (427)
..+.|||||+++.+... ....|+||||+.+|.+++++.... ++.+..+..++.|+.+|++||| .++||
T Consensus 110 k~l~HPnIvkl~~v~~t-----~~~lylV~eya~~ge~~~yl~~~g----r~~e~~ar~~F~q~vsaveYcH---~k~iv 177 (596)
T KOG0586|consen 110 KSLNHPNIVKLFSVIET-----EATLYLVMEYASGGELFDYLVKHG----RMKEKEARAKFRQIVSAVEYCH---SKNIV 177 (596)
T ss_pred HhcCCcceeeeeeeeee-----cceeEEEEEeccCchhHHHHHhcc----cchhhhhhhhhHHHHHHHHHHh---hccee
Confidence 34789999999998544 567899999999999999998774 4677899999999999999999 99999
Q ss_pred eccccCCceeeCCCCceEecccccccccCCcC-----CCccccccccccCCCCc-CccccchhHHHHHHHHHhCCCCCCc
Q 042634 257 HCDLKPSNVLLDGELTAHVGDFGLAKFLPEAT-----NNFFNFQIAEYGMGSEV-STSGDVYSFGILLLETFTGKRPTNE 330 (427)
Q Consensus 257 HrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~y~aPE~~~~~~~-~~~~DiwS~G~vl~ell~g~~pf~~ 330 (427)
|||||++|||++.+..+||+|||++..+..+. .|++.|.|||++.+.+| ++.+|+||+|+++|-|+.|..||++
T Consensus 178 HrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG 257 (596)
T KOG0586|consen 178 HRDLKAENILLDENMNIKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDG 257 (596)
T ss_pred ccccchhhcccccccceeeeccccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCC
Confidence 99999999999999999999999999876543 89999999999999887 6789999999999999999999986
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
.. +.+.-++.+.+... .+.+ ...+..+++++++-.+|.+|++++++
T Consensus 258 ~~-----------------lk~Lr~rvl~gk~r-------------Ip~~----ms~dce~lLrk~lvl~Pskr~~~dqi 303 (596)
T KOG0586|consen 258 QN-----------------LKELRPRVLRGKYR-------------IPFY----MSCDCEDLLRKFLVLNPSKRGPCDQI 303 (596)
T ss_pred cc-----------------cccccchheeeeec-------------ccce----eechhHHHHHHhhccCccccCCHHHh
Confidence 31 11111111111110 0111 22345779999999999999999998
Q ss_pred HHH
Q 042634 411 AAQ 413 (427)
Q Consensus 411 ~~~ 413 (427)
.+.
T Consensus 304 m~~ 306 (596)
T KOG0586|consen 304 MKD 306 (596)
T ss_pred hhh
Confidence 753
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=243.91 Aligned_cols=216 Identities=21% Similarity=0.258 Sum_probs=151.6
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|+||+++++.+.. +...+++|||++++.+..+.... ..+++..+..++.|++.|++||| ..|++||
T Consensus 57 l~~~~i~~~~~~~~~-----~~~~~iv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~ 124 (288)
T cd07833 57 LRHENIVNLKEAFRR-----KGRLYLVFEYVERTLLELLEASP----GGLPPDAVRSYIWQLLQAIAYCH---SHNIIHR 124 (288)
T ss_pred cCCCCeeehhheEEE-----CCEEEEEEecCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecC
Confidence 459999999998644 55789999999887766555433 34889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC-------CCccccccccccCCC-CcCccccchhHHHHHHHHHhCCCCCCc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT-------NNFFNFQIAEYGMGS-EVSTSGDVYSFGILLLETFTGKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~-------~~~~~y~aPE~~~~~-~~~~~~DiwS~G~vl~ell~g~~pf~~ 330 (427)
||+|+||++++++.+||+|||.+....... .++..|+|||++.+. .++.++||||||+++|++++|+.||..
T Consensus 125 dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~ 204 (288)
T cd07833 125 DIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPG 204 (288)
T ss_pred CCCHHHeEECCCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999998754432 456779999999887 789999999999999999999999975
Q ss_pred ccCCCccHHHHHH--Hhcccchhccc--CccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCC
Q 042634 331 MFTGNLTLHNFVK--EALPERLAEIV--DPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMN 406 (427)
Q Consensus 331 ~~~~~~~~~~~~~--~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt 406 (427)
....+ .+..... ...+....... ++.... ................+..++.++.+++++||+.+|++|||
T Consensus 205 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 278 (288)
T cd07833 205 DSDID-QLYLIQKCLGPLPPSHQELFSSNPRFAG-----VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLT 278 (288)
T ss_pred CCHHH-HHHHHHHHhCCCCHHHhhhcccCccccc-----cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhccc
Confidence 32111 1111000 00111000000 000000 00000000000000112234678999999999999999999
Q ss_pred HHHHHH
Q 042634 407 MEEVAA 412 (427)
Q Consensus 407 ~~ev~~ 412 (427)
++++++
T Consensus 279 ~~~il~ 284 (288)
T cd07833 279 CDELLQ 284 (288)
T ss_pred HHHHhc
Confidence 999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=238.78 Aligned_cols=193 Identities=22% Similarity=0.312 Sum_probs=151.9
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++.+.. +...++||||+++++|.+++... ..+++..+..++.|++.||+||| +.|++||
T Consensus 60 l~h~~iv~~~~~~~~-----~~~~~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~ql~~al~~LH---~~~i~H~ 127 (268)
T cd06630 60 LNHPHIIRMLGATCE-----DSHFNLFVEWMAGGSVSHLLSKY----GAFKEAVIINYTEQLLRGLSYLH---ENQIIHR 127 (268)
T ss_pred cCCCceehhhceecc-----CCeEEEEEeccCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecC
Confidence 579999999998543 56789999999999999988643 45889999999999999999999 8999999
Q ss_pred cccCCceeeCCCC-ceEecccccccccCCc----------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCC
Q 042634 259 DLKPSNVLLDGEL-TAHVGDFGLAKFLPEA----------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRP 327 (427)
Q Consensus 259 Dlkp~NIll~~~~-~~kL~DFG~a~~~~~~----------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~p 327 (427)
||||+||+++.++ .+||+|||.+...... ..++..|+|||.+.+..++.++||||+||++|++++|..|
T Consensus 128 ~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p 207 (268)
T cd06630 128 DVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207 (268)
T ss_pred CCCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCC
Confidence 9999999998775 6999999998765432 1467789999999888899999999999999999999999
Q ss_pred CCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCH
Q 042634 328 TNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM 407 (427)
Q Consensus 328 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~ 407 (427)
|...... ............ ......+...+.++.+++.+||+.+|++|||+
T Consensus 208 ~~~~~~~--~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~ 258 (268)
T cd06630 208 WNAEKHS--NHLALIFKIASA---------------------------TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPS 258 (268)
T ss_pred CCCCCCc--chHHHHHHHhcc---------------------------CCCCCCchhhCHHHHHHHHHHcCCCcccCcCH
Confidence 8643111 111111000000 00001233456778999999999999999999
Q ss_pred HHHHH
Q 042634 408 EEVAA 412 (427)
Q Consensus 408 ~ev~~ 412 (427)
.|+++
T Consensus 259 ~~ll~ 263 (268)
T cd06630 259 RELLK 263 (268)
T ss_pred HHHhc
Confidence 99985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=244.03 Aligned_cols=217 Identities=19% Similarity=0.217 Sum_probs=152.4
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|+|++++++.+.. +...++||||+ +|+|.+++.... ..+++..++.++.|+++||.||| +.||+||
T Consensus 59 ~~h~~i~~~~~~~~~-----~~~~~lv~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~ 126 (298)
T cd07841 59 LKHPNIIGLLDVFGH-----KSNINLVFEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLH---SNWILHR 126 (298)
T ss_pred cCCCCChhhhheeec-----CCEEEEEEccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeec
Confidence 569999999998544 56789999999 999999987543 25899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC------CCccccccccccCC-CCcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT------NNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~------~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
||||+||+++.++.+||+|||.++...... .++..|+|||.+.+ ..++.++|||||||++||+++|.+||...
T Consensus 127 dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~ 206 (298)
T cd07841 127 DLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGD 206 (298)
T ss_pred CCChhhEEEcCCCCEEEccceeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCC
Confidence 999999999999999999999998764432 45667999998865 45789999999999999999998877643
Q ss_pred cCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 042634 332 FTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVA 411 (427)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~ 411 (427)
.. ...+..... ................ .....................+.++.+++.+||+.||++|||++|++
T Consensus 207 ~~-~~~~~~~~~-~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l 280 (298)
T cd07841 207 SD-IDQLGKIFE-ALGTPTEENWPGVTSL----PDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQAL 280 (298)
T ss_pred cc-HHHHHHHHH-HcCCCchhhhhhcccc----cccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHh
Confidence 21 111111111 1100000000000000 00000000000000001123457789999999999999999999998
Q ss_pred HH
Q 042634 412 AQ 413 (427)
Q Consensus 412 ~~ 413 (427)
+.
T Consensus 281 ~~ 282 (298)
T cd07841 281 EH 282 (298)
T ss_pred hC
Confidence 73
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=248.75 Aligned_cols=223 Identities=18% Similarity=0.250 Sum_probs=153.0
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++.+.+.... ......++||||+ +++|.+++... ..+++..+..++.|++.||+||| ..||+||
T Consensus 61 l~h~~iv~~~~~~~~~~-~~~~~~~lv~e~~-~~~l~~~~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~ 131 (334)
T cd07855 61 FKHDNIIAIRDILRPPG-ADFKDVYVVMDLM-ESDLHHIIHSD----QPLTEEHIRYFLYQLLRGLKYIH---SANVIHR 131 (334)
T ss_pred cCCCCccCHHHhccccC-CCCceEEEEEehh-hhhHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecC
Confidence 46999999998764422 2345679999999 57898888654 34899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc----------CCCccccccccccCC-CCcCccccchhHHHHHHHHHhCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA----------TNNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETFTGKRP 327 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~----------~~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell~g~~p 327 (427)
||||+||++++++.+||+|||.++..... ..++..|+|||.+.+ ..++.++|||||||++|||++|+.|
T Consensus 132 dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~p 211 (334)
T cd07855 132 DLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQL 211 (334)
T ss_pred CCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCc
Confidence 99999999999999999999999765321 256778999998765 5689999999999999999999999
Q ss_pred CCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCH
Q 042634 328 TNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM 407 (427)
Q Consensus 328 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~ 407 (427)
|.+..... .+ ..+.........+..+.......... ...................+.++.+++.+||+.+|++|||+
T Consensus 212 f~~~~~~~-~~-~~~~~~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~ 288 (334)
T cd07855 212 FPGKNYVH-QL-KLILSVLGSPSEEVLNRIGSDRVRKY-IQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITV 288 (334)
T ss_pred cCCCChHH-HH-HHHHHHhCCChhHhhhhhchhhHHHH-HhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCH
Confidence 97532111 11 11111111111111110000000000 00000000000000112346779999999999999999999
Q ss_pred HHHHHH
Q 042634 408 EEVAAQ 413 (427)
Q Consensus 408 ~ev~~~ 413 (427)
+|++..
T Consensus 289 ~~~l~~ 294 (334)
T cd07855 289 EQALQH 294 (334)
T ss_pred HHHHhC
Confidence 998874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-31 Score=237.88 Aligned_cols=179 Identities=24% Similarity=0.183 Sum_probs=144.2
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeecc
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCD 259 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrD 259 (427)
.|||++++++.+.. ....+++|||+++|+|.+++... ..+++..+..++.|++.||+||| +.||+|||
T Consensus 43 ~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~d 110 (237)
T cd05576 43 CVPNMVCLHKYIVS-----EDSVFLVLQHAEGGKLWSHISKF----LNIPEECVKRWAAEMVVALDALH---REGIVCRD 110 (237)
T ss_pred CCCceeehhhheec-----CCeEEEEEecCCCCCHHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccC
Confidence 48999999988543 56789999999999999988654 34899999999999999999999 89999999
Q ss_pred ccCCceeeCCCCceEecccccccccCCcC---CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccCCCc
Q 042634 260 LKPSNVLLDGELTAHVGDFGLAKFLPEAT---NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNL 336 (427)
Q Consensus 260 lkp~NIll~~~~~~kL~DFG~a~~~~~~~---~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~~~~ 336 (427)
|||+||+++.++.+|++|||.+....... .++..|+|||......++.++||||+||++||+++|+.||......
T Consensus 111 lkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-- 188 (237)
T cd05576 111 LNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-- 188 (237)
T ss_pred CCHHHEEEcCCCCEEEecccchhccccccccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh--
Confidence 99999999999999999999887654432 4556799999998888999999999999999999999887532100
Q ss_pred cHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 042634 337 TLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME 408 (427)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ 408 (427)
...... . ..+...+.++.+++.+|++.||++|||+.
T Consensus 189 -------------~~~~~~--~---------------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 189 -------------INTHTT--L---------------------NIPEWVSEEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred -------------cccccc--c---------------------CCcccCCHHHHHHHHHHccCCHHHhcCCC
Confidence 000000 0 01122345688999999999999999974
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=245.04 Aligned_cols=222 Identities=20% Similarity=0.217 Sum_probs=150.4
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+... .....++||||+. ++|.+++.... ..+++..++.++.|++.||+||| +.|++||
T Consensus 61 l~h~ni~~~~~~~~~~---~~~~~~lv~e~~~-~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~ 130 (293)
T cd07843 61 LQHPNIVTVKEVVVGS---NLDKIYMVMEYVE-HDLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLH---DNWILHR 130 (293)
T ss_pred cCCCCEEEEEEEEEec---CCCcEEEEehhcC-cCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeec
Confidence 4699999998875431 1267899999995 58888876543 35899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCCC-CcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMGS-EVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~~-~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
||||+||+++.++.+||+|||.++..... ..++..|+|||.+.+. .++.++||||+||++|||++|..||...
T Consensus 131 dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~ 210 (293)
T cd07843 131 DLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGK 210 (293)
T ss_pred cCCHHHEEECCCCcEEEeecCceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999999876443 2566789999998764 4689999999999999999999999753
Q ss_pred cCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 042634 332 FTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVA 411 (427)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~ 411 (427)
.. ...+.... ....................................+.....++.+.+++++||+.||++|||++|++
T Consensus 211 ~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell 288 (293)
T cd07843 211 SE-IDQLNKIF-KLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDAL 288 (293)
T ss_pred Ch-HHHHHHHH-HHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHh
Confidence 21 11111111 11100000000000000000000000000000000111111356688999999999999999999998
Q ss_pred H
Q 042634 412 A 412 (427)
Q Consensus 412 ~ 412 (427)
.
T Consensus 289 ~ 289 (293)
T cd07843 289 K 289 (293)
T ss_pred c
Confidence 6
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=243.17 Aligned_cols=199 Identities=24% Similarity=0.242 Sum_probs=146.4
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccc-hhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPN-REALKNLNLLQRLSIAVDVASALDYLHHYCETPIVH 257 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivH 257 (427)
..||||+++++.+.. ....+++|||+. +++.++.... ......+++..+..++.|++.||+|||+ ..+++|
T Consensus 60 ~~~~~iv~~~~~~~~-----~~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H 131 (288)
T cd06616 60 SDCPYIVKFYGALFR-----EGDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIH 131 (288)
T ss_pred cCCCCEeeeeeEEec-----CCcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeec
Confidence 359999999987533 456789999984 5554433211 0111458999999999999999999993 359999
Q ss_pred ccccCCceeeCCCCceEecccccccccCCc-----CCCccccccccccCCC---CcCccccchhHHHHHHHHHhCCCCCC
Q 042634 258 CDLKPSNVLLDGELTAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMGS---EVSTSGDVYSFGILLLETFTGKRPTN 329 (427)
Q Consensus 258 rDlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~~---~~~~~~DiwS~G~vl~ell~g~~pf~ 329 (427)
|||||+||+++.++.+||+|||+++..... ..++..|+|||++... .++.++|||||||++||+++|+.||.
T Consensus 132 ~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 211 (288)
T cd06616 132 RDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYP 211 (288)
T ss_pred cCCCHHHEEEccCCcEEEeecchhHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCch
Confidence 999999999999999999999999765332 2577889999998776 68999999999999999999999997
Q ss_pred cccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 042634 330 EMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEE 409 (427)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~e 409 (427)
... ...+............ + .......++.++.+++.+||+.+|++|||++|
T Consensus 212 ~~~----~~~~~~~~~~~~~~~~-----~-------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ 263 (288)
T cd06616 212 KWN----SVFDQLTQVVKGDPPI-----L-------------------SNSEEREFSPSFVNFINLCLIKDESKRPKYKE 263 (288)
T ss_pred hcc----hHHHHHhhhcCCCCCc-----C-------------------CCcCCCccCHHHHHHHHHHccCChhhCcCHHH
Confidence 532 1111111111000000 0 00011235667899999999999999999999
Q ss_pred HHHH
Q 042634 410 VAAQ 413 (427)
Q Consensus 410 v~~~ 413 (427)
|++.
T Consensus 264 i~~~ 267 (288)
T cd06616 264 LLEH 267 (288)
T ss_pred HhcC
Confidence 9875
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=243.77 Aligned_cols=218 Identities=21% Similarity=0.271 Sum_probs=151.2
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++.+. .+...++||||+++++|..+.... ..+++..++.++.|++.||+||| +.|++||
T Consensus 57 l~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~ 124 (286)
T cd07846 57 LRHENLVNLIEVFR-----RKKRLYLVFEFVDHTVLDDLEKYP----NGLDESRVRKYLFQILRGIEFCH---SHNIIHR 124 (286)
T ss_pred cCCcchhhHHHhcc-----cCCeEEEEEecCCccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccc
Confidence 57999999999854 356789999999998888776543 34889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCC-CCcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
||+|+||++++++.+||+|||++...... ..++..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 125 ~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~ 204 (286)
T cd07846 125 DIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGD 204 (286)
T ss_pred CCCHHHEEECCCCcEEEEeeeeeeeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCC
Confidence 99999999999999999999999865432 246778999999875 45788999999999999999999998643
Q ss_pred cCCCccHHHHHHH--hcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 042634 332 FTGNLTLHNFVKE--ALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEE 409 (427)
Q Consensus 332 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~e 409 (427)
.. ...+...... ..........+..........+... ...... ...+..+..+.+++.+||+.+|++|||+.|
T Consensus 205 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~ 279 (286)
T cd07846 205 SD-IDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVK--EIEPLE--KRFPKLSGLVLDLAKQCLRIDPDDRPSSSQ 279 (286)
T ss_pred ch-HHHHHHHHHHhCCCchhhHHHhccchHhhcccccccc--CcchHH--HhCCCcCHHHHHHHHHHhcCCcccchhHHH
Confidence 11 1111111100 0000000000000000000000000 000000 011234677999999999999999999999
Q ss_pred HHHH
Q 042634 410 VAAQ 413 (427)
Q Consensus 410 v~~~ 413 (427)
+++.
T Consensus 280 il~~ 283 (286)
T cd07846 280 LLHH 283 (286)
T ss_pred HhcC
Confidence 9863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=243.00 Aligned_cols=218 Identities=20% Similarity=0.241 Sum_probs=149.3
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+. ++...++||||+. ++|.+++..... ..+++..+..++.|++.||+||| ..|++||
T Consensus 56 l~h~~i~~~~~~~~-----~~~~~~~v~e~~~-~~l~~~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~ 124 (284)
T cd07860 56 LNHPNIVKLLDVIH-----TENKLYLVFEFLH-QDLKKFMDASPL--SGIPLPLIKSYLFQLLQGLAFCH---SHRVLHR 124 (284)
T ss_pred cCCCCCcchhhhcc-----cCCcEEEEeeccc-cCHHHHHHhCCC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecC
Confidence 47999999999854 3567899999994 688888764332 45889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCCCC-cCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMGSE-VSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~~~-~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
||+|+||+++.++.+||+|||+++..... ..++..|+|||++.+.. ++.++|||||||++|||++|+.||...
T Consensus 125 ~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~ 204 (284)
T cd07860 125 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 204 (284)
T ss_pred CCCHHHEEECCCCCEEEeeccchhhcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 99999999999999999999998765432 14567899999887644 588999999999999999999999753
Q ss_pred cCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 042634 332 FTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVA 411 (427)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~ 411 (427)
.. .....+.......+ ....................+. ...+.. .....+.++.+++.+||+.||++|||++|++
T Consensus 205 ~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l 279 (284)
T cd07860 205 SE-IDQLFRIFRTLGTP-DEVVWPGVTSLPDYKPSFPKWA-RQDFSK--VVPPLDEDGRDLLSQMLHYDPNKRISAKAAL 279 (284)
T ss_pred CH-HHHHHHHHHHhCCC-ChhhhhhhhHHHHHHhhccccc-ccCHHH--HcccCCHHHHHHHHHhcCCCcccCCCHHHHh
Confidence 21 11111111111100 0000000000000000000000 000000 0112345678999999999999999999998
Q ss_pred H
Q 042634 412 A 412 (427)
Q Consensus 412 ~ 412 (427)
+
T Consensus 280 ~ 280 (284)
T cd07860 280 A 280 (284)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=243.23 Aligned_cols=188 Identities=24% Similarity=0.264 Sum_probs=150.6
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+++++|.+++... ..+++..+..++.|++.||+||| +.||+||
T Consensus 58 l~h~~i~~~~~~~~~-----~~~~~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~ 125 (290)
T cd05580 58 IRHPFLVNLYGSFQD-----DSNLYLVMEYVPGGELFSHLRKS----GRFPEPVARFYAAQVVLALEYLH---SLDIVYR 125 (290)
T ss_pred CCCCCccceeeEEEc-----CCeEEEEEecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCEecC
Confidence 469999999987533 56789999999999999998655 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC---CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT---NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGN 335 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~---~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~~~ 335 (427)
||+|+||+++.++.+||+|||+++...... .++..|+|||.+.+...+.++||||||+++|+|++|+.||....
T Consensus 126 dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--- 202 (290)
T cd05580 126 DLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN--- 202 (290)
T ss_pred CCCHHHEEECCCCCEEEeeCCCccccCCCCCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC---
Confidence 999999999999999999999998764432 57788999999988888999999999999999999999986532
Q ss_pred ccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCC-----CHHHH
Q 042634 336 LTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERM-----NMEEV 410 (427)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rp-----t~~ev 410 (427)
............. ..+...+..+.+++.+||+.||.+|+ +++|+
T Consensus 203 --~~~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l 251 (290)
T cd05580 203 --PIQIYEKILEGKV-----------------------------RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDI 251 (290)
T ss_pred --HHHHHHHHhcCCc-----------------------------cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHH
Confidence 1111111000000 01112245688999999999999999 77777
Q ss_pred HH
Q 042634 411 AA 412 (427)
Q Consensus 411 ~~ 412 (427)
++
T Consensus 252 ~~ 253 (290)
T cd05580 252 KN 253 (290)
T ss_pred Hc
Confidence 64
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=244.93 Aligned_cols=223 Identities=18% Similarity=0.245 Sum_probs=148.5
Q ss_pred cccccchhhhccccccCCC---CCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 042634 179 IRHRNLVKIITSCASVDFQ---GNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPI 255 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~i 255 (427)
++||||+++++.+...... .....++||||+. ++|.+++.... ..+++.+++.++.|++.||+||| +.|+
T Consensus 68 l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH---~~~i 140 (310)
T cd07865 68 LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKN---VKFTLSEIKKVMKMLLNGLYYIH---RNKI 140 (310)
T ss_pred CCCCCccceEEEEecccccccCCCceEEEEEcCCC-cCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH---HCCe
Confidence 5799999999886553221 2234689999994 68877775432 35899999999999999999999 8999
Q ss_pred eeccccCCceeeCCCCceEecccccccccCCc----------CCCccccccccccCCC-CcCccccchhHHHHHHHHHhC
Q 042634 256 VHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA----------TNNFFNFQIAEYGMGS-EVSTSGDVYSFGILLLETFTG 324 (427)
Q Consensus 256 vHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~----------~~~~~~y~aPE~~~~~-~~~~~~DiwS~G~vl~ell~g 324 (427)
+|+||||+||+++.++.+||+|||.+...... ..++..|+|||.+.+. .++.++||||||+++|||++|
T Consensus 141 ~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~ 220 (310)
T cd07865 141 LHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTR 220 (310)
T ss_pred eccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhC
Confidence 99999999999999999999999999765322 1456779999988664 468899999999999999999
Q ss_pred CCCCCcccCCCccHHHHHHH---hcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCC
Q 042634 325 KRPTNEMFTGNLTLHNFVKE---ALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELP 401 (427)
Q Consensus 325 ~~pf~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP 401 (427)
+.||..... ......+.. ..++......+.....+...... ..................+.+++.+||..||
T Consensus 221 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P 295 (310)
T cd07865 221 SPIMQGNTE--QHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQ---GQKRKVKERLKPYVKDPHALDLIDKLLVLDP 295 (310)
T ss_pred CCCCCCCCH--HHHHHHHHHHhCCCChhhcccccchhhhhhccCCC---ccchhhHHhcccccCCHHHHHHHHHHhcCCh
Confidence 999875321 111111111 11111100000000000000000 0000000000011123456889999999999
Q ss_pred CCCCCHHHHHHH
Q 042634 402 RERMNMEEVAAQ 413 (427)
Q Consensus 402 ~~Rpt~~ev~~~ 413 (427)
++|||++|++++
T Consensus 296 ~~R~t~~e~l~h 307 (310)
T cd07865 296 AKRIDADTALNH 307 (310)
T ss_pred hhccCHHHHhcC
Confidence 999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=240.76 Aligned_cols=190 Identities=22% Similarity=0.307 Sum_probs=149.2
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
..|||++++++.+.. +...++||||+++++|.+++... .+++..+..++.|++.||.||| ..||+||
T Consensus 59 ~~~~~vi~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~ 125 (277)
T cd06917 59 SQPPNITKYYGSYLK-----GPRLWIIMEYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIH---KVGVIHR 125 (277)
T ss_pred CCCCCeeeEeeeeee-----CCEEEEEEecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHH---hCCcccC
Confidence 359999999987533 56789999999999999987543 4889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC------CCccccccccccCC-CCcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT------NNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~------~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
||+|+||+++.++.+||+|||.+....... .++..|+|||.+.+ ..++.++|||||||++|+|++|..||...
T Consensus 126 dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~ 205 (277)
T cd06917 126 DIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDV 205 (277)
T ss_pred CcCHHHEEEcCCCCEEEccCCceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999998764332 57778999998865 45689999999999999999999999753
Q ss_pred cCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 042634 332 FTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVA 411 (427)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~ 411 (427)
... ..... .. ....+ .......+.++.+++.+||+.||++|||+.|++
T Consensus 206 ~~~-----~~~~~-~~----~~~~~----------------------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il 253 (277)
T cd06917 206 DAF-----RAMML-IP----KSKPP----------------------RLEDNGYSKLLREFVAACLDEEPKERLSAEELL 253 (277)
T ss_pred Chh-----hhhhc-cc----cCCCC----------------------CCCcccCCHHHHHHHHHHcCCCcccCcCHHHHh
Confidence 110 00000 00 00000 001111345689999999999999999999997
Q ss_pred HH
Q 042634 412 AQ 413 (427)
Q Consensus 412 ~~ 413 (427)
+.
T Consensus 254 ~~ 255 (277)
T cd06917 254 KS 255 (277)
T ss_pred hC
Confidence 64
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-30 Score=248.21 Aligned_cols=225 Identities=21% Similarity=0.211 Sum_probs=155.9
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+...........++|+||+ +++|.+++... ..+++..+..++.|++.||+||| +.+++||
T Consensus 61 l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~ 132 (337)
T cd07858 61 LDHENVIAIKDIMPPPHREAFNDVYIVYELM-DTDLHQIIRSS----QTLSDDHCQYFLYQLLRGLKYIH---SANVLHR 132 (337)
T ss_pred cCCCCccchHHheecccccccCcEEEEEeCC-CCCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCEecC
Confidence 5799999999976543323334579999999 57888887654 35899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCC-CCcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
||||+||+++.++.+||+|||+++..... ..++..|+|||.+.. ..++.++|||||||++|+|++|+.||.+.
T Consensus 133 dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 212 (337)
T cd07858 133 DLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGK 212 (337)
T ss_pred CCCHHHEEEcCCCCEEECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCC
Confidence 99999999999999999999999876433 156778999998765 46899999999999999999999999653
Q ss_pred cCCCccHHHHHHHh---cccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 042634 332 FTGNLTLHNFVKEA---LPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME 408 (427)
Q Consensus 332 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ 408 (427)
.. ...+....... .+..+..+.+..... .................+.++.++.+++++||+.+|++|||++
T Consensus 213 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ 286 (337)
T cd07858 213 DY-VHQLKLITELLGSPSEEDLGFIRNEKARR-----YIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVE 286 (337)
T ss_pred Ch-HHHHHHHHHHhCCCChHHhhhcCchhhhH-----HHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHH
Confidence 11 00111010000 001111111100000 0000000000000001123567789999999999999999999
Q ss_pred HHHHH--HHHH
Q 042634 409 EVAAQ--LLSF 417 (427)
Q Consensus 409 ev~~~--L~~~ 417 (427)
|++++ ++.+
T Consensus 287 ell~h~~~~~~ 297 (337)
T cd07858 287 EALAHPYLASL 297 (337)
T ss_pred HHHcCcchhhh
Confidence 99987 5544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-30 Score=237.76 Aligned_cols=220 Identities=22% Similarity=0.293 Sum_probs=169.8
Q ss_pred eccCCcccccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhh--
Q 042634 172 DLSRNNFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHH-- 249 (427)
Q Consensus 172 ~L~~N~ll~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~-- 249 (427)
++.+.-+++|+||..++++=.. +-..-...++|.+|-+.|||++||... .++....++++..+|.||+|||.
T Consensus 255 EIYqTvmLRHENILgFIaaD~~-~~gs~TQLwLvTdYHe~GSL~DyL~r~-----tv~~~~ml~LalS~AsGLaHLH~eI 328 (513)
T KOG2052|consen 255 EIYQTVMLRHENILGFIAADNK-DNGSWTQLWLVTDYHEHGSLYDYLNRN-----TVTTEGMLKLALSIASGLAHLHMEI 328 (513)
T ss_pred HHHHHHHhccchhhhhhhcccc-CCCceEEEEEeeecccCCcHHHHHhhc-----cCCHHHHHHHHHHHhhhHHHHHHHH
Confidence 4556677999999999986221 112234679999999999999999764 38899999999999999999994
Q ss_pred ---cCCCCeeeccccCCceeeCCCCceEecccccccccCCc----------CCCccccccccccCCCCc-----C-cccc
Q 042634 250 ---YCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA----------TNNFFNFQIAEYGMGSEV-----S-TSGD 310 (427)
Q Consensus 250 ---~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~----------~~~~~~y~aPE~~~~~~~-----~-~~~D 310 (427)
+....|.|||||+.|||+..++.+-|+|+|+|...... .+||..|||||++...-- + ..+|
T Consensus 329 ~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~AD 408 (513)
T KOG2052|consen 329 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRAD 408 (513)
T ss_pred hcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHH
Confidence 33667999999999999999999999999999865443 389999999999865321 2 3589
Q ss_pred chhHHHHHHHHHhC----------CCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhcccccccccc
Q 042634 311 VYSFGILLLETFTG----------KRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSF 380 (427)
Q Consensus 311 iwS~G~vl~ell~g----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (427)
|||||.|+||++.+ ..||.+....+..+.++..-..-.+++..+...+
T Consensus 409 IYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW---------------------- 466 (513)
T KOG2052|consen 409 IYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRW---------------------- 466 (513)
T ss_pred HHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCccc----------------------
Confidence 99999999999853 4678777666666655433322222322222222
Q ss_pred chHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHH
Q 042634 381 SVKECLVSVLGIGVTCSSELPRERMNMEEVAAQLLSFRN 419 (427)
Q Consensus 381 ~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~~~~ 419 (427)
...++...+.++|+.||..+|..|-|+--|.+.|.++.+
T Consensus 467 ~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 467 KSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 234467789999999999999999999999999998864
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-30 Score=238.07 Aligned_cols=190 Identities=22% Similarity=0.284 Sum_probs=152.5
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+. ++...++|+||+.+++|.+++... ..+++..+..++.|+++||.||| ..|++|+
T Consensus 57 l~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~ 124 (258)
T cd05578 57 LNHPFLVNLWYSFQ-----DEENMYLVVDLLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLH---SKGIIHR 124 (258)
T ss_pred CCCCChHHHHHhhc-----CCCeEEEEEeCCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHH---hCCeecc
Confidence 57999999998853 366789999999999999988654 35889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc-----CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFT 333 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~ 333 (427)
||||+||++++++.+||+|||.+...... ..++..|+|||++....++.++|+||+|+++|++++|..||.....
T Consensus 125 dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 204 (258)
T cd05578 125 DIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSR 204 (258)
T ss_pred CCCHHHeEEcCCCCEEEeecccccccCCCccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCc
Confidence 99999999999999999999999876543 3677789999999888899999999999999999999999975422
Q ss_pred CCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCH--HHHH
Q 042634 334 GNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM--EEVA 411 (427)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~--~ev~ 411 (427)
. .......... . . ....+...+..+.+++.+||+.||.+||++ +|++
T Consensus 205 ~--~~~~~~~~~~-~-----~-----------------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 205 T--IRDQIRAKQE-T-----A-----------------------DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred c--HHHHHHHHhc-c-----c-----------------------cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 1 1111111100 0 0 000222345778999999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-30 Score=239.51 Aligned_cols=193 Identities=24% Similarity=0.323 Sum_probs=155.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCC-CCeee
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCE-TPIVH 257 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~-~~ivH 257 (427)
++|||++++++.+.. ....++||||+++++|.+++... ..+++..+..++.|+++|++||| + .|++|
T Consensus 56 l~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H 123 (264)
T cd06623 56 CESPYVVKCYGAFYK-----EGEISIVLEYMDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLH---TKRHIIH 123 (264)
T ss_pred cCCCCeeeEEEEEcc-----CCeEEEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHh---ccCCCcc
Confidence 459999999988543 46789999999999999998754 45899999999999999999999 8 99999
Q ss_pred ccccCCceeeCCCCceEecccccccccCCcC------CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 258 CDLKPSNVLLDGELTAHVGDFGLAKFLPEAT------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 258 rDlkp~NIll~~~~~~kL~DFG~a~~~~~~~------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
|||+|+||+++.++.+||+|||.+....... .++..|+|||.+....++.++||||||+++||+++|..||...
T Consensus 124 ~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~ 203 (264)
T cd06623 124 RDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPP 203 (264)
T ss_pred CCCCHHHEEECCCCCEEEccCccceecccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 9999999999999999999999998764433 4567899999999888999999999999999999999999764
Q ss_pred cCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHH-HHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 332 FTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKE-CLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
.. ....+........... . .+.. .+..+.+++.+||+.+|++|||+.|+
T Consensus 204 ~~--~~~~~~~~~~~~~~~~---------------------------~-~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l 253 (264)
T cd06623 204 GQ--PSFFELMQAICDGPPP---------------------------S-LPAEEFSPEFRDFISACLQKDPKKRPSAAEL 253 (264)
T ss_pred cc--cCHHHHHHHHhcCCCC---------------------------C-CCcccCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 32 1122221111100000 0 1111 45678999999999999999999999
Q ss_pred HHH
Q 042634 411 AAQ 413 (427)
Q Consensus 411 ~~~ 413 (427)
++.
T Consensus 254 l~~ 256 (264)
T cd06623 254 LQH 256 (264)
T ss_pred HhC
Confidence 874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-30 Score=238.15 Aligned_cols=192 Identities=26% Similarity=0.333 Sum_probs=149.8
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|+||+++++.+.. ....++|+||+++++|.+++... ..+++..+..++.|++.|++||| +.||+|+
T Consensus 56 l~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~ 123 (264)
T cd06626 56 LKHPNLVKYYGVEVH-----REKVYIFMEYCSGGTLEELLEHG----RILDEHVIRVYTLQLLEGLAYLH---SHGIVHR 123 (264)
T ss_pred CCCCChhheeeeEec-----CCEEEEEEecCCCCcHHHHHhhc----CCCChHHHHHHHHHHHHHHHHHH---HCCcccC
Confidence 579999999987433 56789999999999999998754 34788999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc----------CCCccccccccccCCCC---cCccccchhHHHHHHHHHhCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA----------TNNFFNFQIAEYGMGSE---VSTSGDVYSFGILLLETFTGK 325 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~----------~~~~~~y~aPE~~~~~~---~~~~~DiwS~G~vl~ell~g~ 325 (427)
||+|+||+++.++.+||+|||.+...... ..++..|+|||++.+.. ++.++||||||+++||+++|+
T Consensus 124 dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~ 203 (264)
T cd06626 124 DIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGK 203 (264)
T ss_pred CCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCC
Confidence 99999999999999999999999875432 24567899999988766 789999999999999999999
Q ss_pred CCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCC
Q 042634 326 RPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERM 405 (427)
Q Consensus 326 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rp 405 (427)
.||....... .............+ .....++..+.+++.+||+.+|++||
T Consensus 204 ~pf~~~~~~~-~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~~l~~~p~~R~ 253 (264)
T cd06626 204 RPWSELDNEF-QIMFHVGAGHKPPI-----------------------------PDSLQLSPEGKDFLDRCLESDPKKRP 253 (264)
T ss_pred CCccCCcchH-HHHHHHhcCCCCCC-----------------------------CcccccCHHHHHHHHHHccCCcccCC
Confidence 9997532110 00000000000000 00112355678999999999999999
Q ss_pred CHHHHHH
Q 042634 406 NMEEVAA 412 (427)
Q Consensus 406 t~~ev~~ 412 (427)
|++|++.
T Consensus 254 ~~~~i~~ 260 (264)
T cd06626 254 TASELLQ 260 (264)
T ss_pred CHHHHhc
Confidence 9999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-30 Score=241.59 Aligned_cols=216 Identities=19% Similarity=0.218 Sum_probs=152.0
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++.+.. +...++||||+ +++|.+++.... ..+++.+++.++.|++.||+||| +.|++|+
T Consensus 56 ~~~~~i~~~~~~~~~-----~~~~~~v~e~~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~ 123 (286)
T cd07832 56 CQHPYVVKLLDVFPH-----GSGFVLVMEYM-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMH---ANGIMHR 123 (286)
T ss_pred CCCCCCcceeeEEec-----CCeeEEEeccc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecC
Confidence 459999999988543 56789999999 999999886543 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc-------CCCccccccccccCCC-CcCccccchhHHHHHHHHHhCCCCCCc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA-------TNNFFNFQIAEYGMGS-EVSTSGDVYSFGILLLETFTGKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-------~~~~~~y~aPE~~~~~-~~~~~~DiwS~G~vl~ell~g~~pf~~ 330 (427)
||||+||+++.++.+||+|||.+...... ..++..|+|||++.+. .++.++||||+||++|||++|.+||..
T Consensus 124 dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~ 203 (286)
T cd07832 124 DLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPG 203 (286)
T ss_pred CcCHHHEEEcCCCcEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCC
Confidence 99999999999999999999999876432 2567789999998654 468999999999999999999887764
Q ss_pred ccCCCccHHHHHHHhccc---chhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCH
Q 042634 331 MFTGNLTLHNFVKEALPE---RLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM 407 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~ 407 (427)
... ...+.......... .+.+..+.. ................ ....+.+.++.+++.+|++.+|++|||+
T Consensus 204 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~ 276 (286)
T cd07832 204 END-IEQLAIVFRTLGTPNEETWPGLTSLP----DYNKITFPESKPIPLE--EIFPDASPEALDLLKGLLVYDPSKRLSA 276 (286)
T ss_pred CCH-HHHHHHHHHHcCCCChHHHhhccCcc----hhhcccCCCCCcchHH--HhCCCccHHHHHHHHHHhccChhhCCCH
Confidence 321 11111111111000 000000000 0000000000000000 0112235788999999999999999999
Q ss_pred HHHHHH
Q 042634 408 EEVAAQ 413 (427)
Q Consensus 408 ~ev~~~ 413 (427)
++++++
T Consensus 277 ~~~l~h 282 (286)
T cd07832 277 AEALRH 282 (286)
T ss_pred HHHhhC
Confidence 999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-30 Score=243.88 Aligned_cols=220 Identities=17% Similarity=0.251 Sum_probs=146.6
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|+||+++.+.+.. +...++||||+ .+++.+++.... ..+++..+..++.|++.||+||| ..||+||
T Consensus 60 l~h~ni~~~~~~~~~-----~~~~~lv~e~~-~~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~ 127 (291)
T cd07870 60 LKHANIVLLHDIIHT-----KETLTFVFEYM-HTDLAQYMIQHP---GGLHPYNVRLFMFQLLRGLAYIH---GQHILHR 127 (291)
T ss_pred cCCCCEeEEEEEEec-----CCeEEEEEecc-cCCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccC
Confidence 579999999887533 55789999999 477776664332 34778889999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCC-CCcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
||||+||+++.++.+||+|||.++..... ..++..|+|||++.+ ..++.++|||||||++||+++|+.||...
T Consensus 128 dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~ 207 (291)
T cd07870 128 DLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGV 207 (291)
T ss_pred CCChHHEEEcCCCcEEEeccccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 99999999999999999999998754321 246788999999875 45788999999999999999999999754
Q ss_pred cCCCccHHHHHHHh-cccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 332 FTGNLTLHNFVKEA-LPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 332 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
......+.+.+... .+.. ..................................+.++.+++.+|++.||++|||++|+
T Consensus 208 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~ 285 (291)
T cd07870 208 SDVFEQLEKIWTVLGVPTE--DTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDA 285 (291)
T ss_pred hhHHHHHHHHHHHcCCCCh--hhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHH
Confidence 22111111111100 0000 00000000000000000000000000000000114567899999999999999999998
Q ss_pred HH
Q 042634 411 AA 412 (427)
Q Consensus 411 ~~ 412 (427)
+.
T Consensus 286 l~ 287 (291)
T cd07870 286 LL 287 (291)
T ss_pred hc
Confidence 75
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-30 Score=244.13 Aligned_cols=223 Identities=17% Similarity=0.174 Sum_probs=150.3
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhh-hhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREA-LKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
+|||++++++.+...+..+....++||||++ ++|.+++...... ...+++..++.++.||+.||+||| +.||+||
T Consensus 59 ~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~ 134 (295)
T cd07837 59 ESIYIVRLLDVEHVEEKNGKPSLYLVFEYLD-SDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHR 134 (295)
T ss_pred CCCCccceeeeEeecCCCCCceEEEEeeccC-cCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeec
Confidence 5799999998765533323334789999996 5888887543221 245899999999999999999999 8999999
Q ss_pred cccCCceeeCC-CCceEecccccccccCCc------CCCccccccccccCC-CCcCccccchhHHHHHHHHHhCCCCCCc
Q 042634 259 DLKPSNVLLDG-ELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETFTGKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~-~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell~g~~pf~~ 330 (427)
||||+||+++. ++.+||+|||.++..... ..+++.|+|||++.+ ..++.++|||||||++|||++|..||.+
T Consensus 135 dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~ 214 (295)
T cd07837 135 DLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPG 214 (295)
T ss_pred CCChHHEEEecCCCeEEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Confidence 99999999998 889999999999865322 245678999998865 4578999999999999999999999975
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
.... ............+. .......... ..........+.......+..+.++.+++.+||+.||++|||++|+
T Consensus 215 ~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~ei 288 (295)
T cd07837 215 DSEL-QQLLHIFKLLGTPT-EQVWPGVSKL----RDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAA 288 (295)
T ss_pred CCHH-HHHHHHHHHhCCCC-hhhCcchhhc----cchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHH
Confidence 3111 11111111100000 0000000000 0000000000000000112356778999999999999999999999
Q ss_pred HH
Q 042634 411 AA 412 (427)
Q Consensus 411 ~~ 412 (427)
+.
T Consensus 289 l~ 290 (295)
T cd07837 289 LT 290 (295)
T ss_pred hc
Confidence 75
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.9e-30 Score=239.06 Aligned_cols=220 Identities=20% Similarity=0.203 Sum_probs=155.3
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
+.|||++++++.+...+..+....+++|||+. ++|.+++..... ..+++..++.++.|++.||+||| +.+++|+
T Consensus 58 ~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~-~~l~~~l~~~~~--~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~ 131 (287)
T cd07838 58 FEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSKCPK--PGLPPETIKDLMRQLLRGVDFLH---SHRIVHR 131 (287)
T ss_pred cCCCCcceEEEEEeeccCCCCceeEEEehhcc-cCHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeec
Confidence 35999999999876644333345899999995 588888765332 35899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC-----CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT-----NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFT 333 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~ 333 (427)
||+|+||+++.++.+||+|||.+....... .++..|+|||++.+..++.++|||||||++|||++|..||.....
T Consensus 132 ~l~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~ 211 (287)
T cd07838 132 DLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE 211 (287)
T ss_pred cCChhhEEEccCCCEEEeccCcceeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh
Confidence 999999999999999999999998764332 467789999999998999999999999999999999999875321
Q ss_pred CCccHHHHHHHhcc-cchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 334 GNLTLHNFVKEALP-ERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 334 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
...+......... ............. . .................+..+.+++.+||+.||++|||++|++.
T Consensus 212 -~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~--~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 212 -ADQLDKIFDVIGLPSEEEWPRNVSLPR-----S--SFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred -HHHHHHHHHHcCCCChHhcCCCcccch-----h--hcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 1112222111110 0000000000000 0 00000000001112334577889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-30 Score=242.55 Aligned_cols=194 Identities=23% Similarity=0.261 Sum_probs=150.0
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++.+.. ....++||||+++++|.+++..... ..+++..+..++.|++.||.||| ..|++||
T Consensus 50 l~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~ 119 (277)
T cd05577 50 VSSRFIVSLAYAFET-----KDDLCLVMTLMNGGDLKYHIYNVGE--PGFPEARAIFYAAQIICGLEHLH---QRRIVYR 119 (277)
T ss_pred CCCCCEeeeeeEEec-----CCeEEEEEecCCCCcHHHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccC
Confidence 469999999887533 5678999999999999998865432 35899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc-----CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFT 333 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~ 333 (427)
||+|+||+++.++.+||+|||.+...... ..++..|+|||++.+..++.++||||+||++|+|++|+.||.....
T Consensus 120 di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 199 (277)
T cd05577 120 DLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKE 199 (277)
T ss_pred CCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcc
Confidence 99999999999999999999998765422 2567789999999888899999999999999999999999975322
Q ss_pred CCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCC-----CHH
Q 042634 334 GNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERM-----NME 408 (427)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rp-----t~~ 408 (427)
.. ..... ....... ....+...+..+.+++.+||+.||++|| ++.
T Consensus 200 ~~-~~~~~-~~~~~~~----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 249 (277)
T cd05577 200 KV-EKEEL-KRRTLEM----------------------------AVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSAD 249 (277)
T ss_pred cc-cHHHH-Hhccccc----------------------------cccCCccCCHHHHHHHHHHccCChhHccCCCcccHH
Confidence 11 11111 0000000 0001122355688999999999999999 555
Q ss_pred HHHH
Q 042634 409 EVAA 412 (427)
Q Consensus 409 ev~~ 412 (427)
+++.
T Consensus 250 ~ll~ 253 (277)
T cd05577 250 EVRE 253 (277)
T ss_pred HHHh
Confidence 5554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-30 Score=240.98 Aligned_cols=191 Identities=22% Similarity=0.334 Sum_probs=150.9
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||+++.++.+.. +...+++|||+++++|.+++... .+++..+..++.|++.|++||| +.|++||
T Consensus 74 l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH---~~givH~ 140 (292)
T cd06657 74 YQHENVVEMYNSYLV-----GDELWVVMEFLEGGALTDIVTHT-----RMNEEQIAAVCLAVLKALSVLH---AQGVIHR 140 (292)
T ss_pred cCCcchhheeeEEEe-----CCEEEEEEecCCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeecC
Confidence 569999999987543 56789999999999999877532 3788999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+||+++.++.+||+|||.+...... ..++..|+|||.+.+..++.++||||+||++||+++|..||....
T Consensus 141 dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~ 220 (292)
T cd06657 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 220 (292)
T ss_pred CCCHHHEEECCCCCEEEcccccceecccccccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999998765332 256778999999988889999999999999999999999986421
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
............+..+. .....+..+.+++.+||+.+|.+|||++|+++
T Consensus 221 --~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 221 --PLKAMKMIRDNLPPKLK-----------------------------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred --HHHHHHHHHhhCCcccC-----------------------------CcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 11111111111111100 01123455788999999999999999999987
Q ss_pred H
Q 042634 413 Q 413 (427)
Q Consensus 413 ~ 413 (427)
+
T Consensus 270 ~ 270 (292)
T cd06657 270 H 270 (292)
T ss_pred C
Confidence 3
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-30 Score=240.66 Aligned_cols=219 Identities=17% Similarity=0.160 Sum_probs=149.8
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
.+|||++++++.+... .....++||||++ |++.+++.... ..+++.++..++.|++.||+||| ..|++||
T Consensus 55 ~~h~~i~~~~~~~~~~---~~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~ 124 (282)
T cd07831 55 SPHPNILRLIEVLFDR---KTGRLALVFELMD-MNLYELIKGRK---RPLPEKRVKSYMYQLLKSLDHMH---RNGIFHR 124 (282)
T ss_pred CCCCCccceEEEEecC---CCCcEEEEEecCC-ccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH---HCCceec
Confidence 3599999999886441 1256799999995 68887775432 35899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC-----CCccccccccccCC-CCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT-----NNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+||+++. +.+||+|||.++...... .++..|+|||++.. ..++.++||||+||++|||++|..||.+..
T Consensus 125 dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~ 203 (282)
T cd07831 125 DIKPENILIKD-DILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN 203 (282)
T ss_pred ccCHHHEEEcC-CCeEEEecccccccccCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCC
Confidence 99999999999 999999999998664322 46778999997654 557899999999999999999999997532
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
. .................. ......... ............. .......+.++.+++.+||+.+|++|||++|+++
T Consensus 204 ~--~~~~~~~~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 204 E--LDQIAKIHDVLGTPDAEV-LKKFRKSRH-MNYNFPSKKGTGL-RKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred H--HHHHHHHHHHcCCCCHHH-HHhhccccc-ccccCcccccccH-HHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 1 111111111111000000 000000000 0000000000000 0011235788999999999999999999999986
Q ss_pred H
Q 042634 413 Q 413 (427)
Q Consensus 413 ~ 413 (427)
.
T Consensus 279 ~ 279 (282)
T cd07831 279 H 279 (282)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-30 Score=237.37 Aligned_cols=194 Identities=22% Similarity=0.261 Sum_probs=155.6
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++.+.+.. ....++||||+++++|.+++.........+++..+..++.|++.||+||| +.|++|+
T Consensus 56 l~~~~i~~~~~~~~~-----~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~ 127 (256)
T cd08530 56 VNHPNIISYKEAFLD-----GNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHR 127 (256)
T ss_pred CCCCCchhhhhhhcc-----CCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccC
Confidence 459999999887543 46789999999999999998664333356889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc----CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA----TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTG 334 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~~ 334 (427)
||+|+||+++.++.+||+|||.++..... ..++..|+|||.+.+..++.++|+||+|+++||+++|+.||.....
T Consensus 128 ~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~- 206 (256)
T cd08530 128 DLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM- 206 (256)
T ss_pred CCCcceEEEecCCcEEEeeccchhhhccCCcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-
Confidence 99999999999999999999999876443 2567789999999999999999999999999999999999975321
Q ss_pred CccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 042634 335 NLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAAQ 413 (427)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~ 413 (427)
..+...... .... ..+...+.++.+++.+||+.+|++|||+.|+++.
T Consensus 207 -~~~~~~~~~---~~~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 207 -QDLRYKVQR---GKYP----------------------------PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred -HHHHHHHhc---CCCC----------------------------CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 111111000 0000 0122456678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-30 Score=235.94 Aligned_cols=192 Identities=23% Similarity=0.311 Sum_probs=151.5
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|+|++++++.+.. +...++++||+++++|.+++..... ..+++..+..++.|++.||.||| +.+++|+
T Consensus 56 ~~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~ 125 (257)
T cd08225 56 MKHPNIVTFFASFQE-----NGRLFIVMEYCDGGDLMKRINRQRG--VLFSEDQILSWFVQISLGLKHIH---DRKILHR 125 (257)
T ss_pred CCCCChhhhhheecc-----CCeEEEEEecCCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccc
Confidence 469999999987543 5678999999999999998865432 34789999999999999999999 8999999
Q ss_pred cccCCceeeCCCC-ceEecccccccccCCcC------CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 259 DLKPSNVLLDGEL-TAHVGDFGLAKFLPEAT------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 259 Dlkp~NIll~~~~-~~kL~DFG~a~~~~~~~------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
||||+||++++++ .+||+|||.+....... .++..|+|||+..+..++.++|+|||||++||+++|..||...
T Consensus 126 dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 205 (257)
T cd08225 126 DIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN 205 (257)
T ss_pred cCCHHHEEEcCCCCeEEecccccchhccCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 9999999998875 57999999998764432 5777899999998888999999999999999999999998642
Q ss_pred cCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 042634 332 FTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVA 411 (427)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~ 411 (427)
. ..+............ .....+.++.+++.+||+.+|++|||+.|++
T Consensus 206 ~-----~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll 252 (257)
T cd08225 206 N-----LHQLVLKICQGYFAP----------------------------ISPNFSRDLRSLISQLFKVSPRDRPSITSIL 252 (257)
T ss_pred c-----HHHHHHHHhcccCCC----------------------------CCCCCCHHHHHHHHHHhccChhhCcCHHHHh
Confidence 1 111111111110000 0112345688999999999999999999998
Q ss_pred HH
Q 042634 412 AQ 413 (427)
Q Consensus 412 ~~ 413 (427)
+.
T Consensus 253 ~~ 254 (257)
T cd08225 253 KR 254 (257)
T ss_pred hC
Confidence 63
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-30 Score=246.59 Aligned_cols=146 Identities=21% Similarity=0.362 Sum_probs=120.2
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhh-hccCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREAL-KNLNLLQRLSIAVDVASALDYLHHYCETPIVH 257 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~-~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivH 257 (427)
++|||++++++.+... .+...++||||++ +++.+++....... ..+++..++.++.|++.||+||| +.+|+|
T Consensus 59 l~h~~i~~~~~~~~~~---~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h 131 (316)
T cd07842 59 LKHENVVSLVEVFLEH---ADKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLH 131 (316)
T ss_pred cCCCCccceEEEEeCC---CCceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEee
Confidence 5799999999986541 1357899999995 56766664332211 35889999999999999999999 899999
Q ss_pred ccccCCceeeCC----CCceEecccccccccCCc---------CCCccccccccccCC-CCcCccccchhHHHHHHHHHh
Q 042634 258 CDLKPSNVLLDG----ELTAHVGDFGLAKFLPEA---------TNNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETFT 323 (427)
Q Consensus 258 rDlkp~NIll~~----~~~~kL~DFG~a~~~~~~---------~~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell~ 323 (427)
|||||+||+++. ++.+||+|||+++..... ..++..|+|||++.+ ..++.++|||||||++|||++
T Consensus 132 ~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~ 211 (316)
T cd07842 132 RDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211 (316)
T ss_pred CCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHh
Confidence 999999999999 899999999999865322 245778999998876 457899999999999999999
Q ss_pred CCCCCCcc
Q 042634 324 GKRPTNEM 331 (427)
Q Consensus 324 g~~pf~~~ 331 (427)
|+.||...
T Consensus 212 ~~~~~~~~ 219 (316)
T cd07842 212 LEPIFKGR 219 (316)
T ss_pred cCCCCcCC
Confidence 99999764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-31 Score=256.99 Aligned_cols=199 Identities=24% Similarity=0.384 Sum_probs=167.7
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||+++++++|... ...||++||+.|+|.++++.++ .++..+..+.|..|||+||.||| ++++|||
T Consensus 755 ldHpnl~RLLgvc~~s------~~qlvtq~mP~G~LlDyvr~hr---~~igsq~lLnw~~QIAkgM~YLe---~qrlVHr 822 (1177)
T KOG1025|consen 755 LDHPNLLRLLGVCMLS------TLQLVTQLMPLGCLLDYVREHR---DNIGSQDLLNWCYQIAKGMKYLE---EQRLVHR 822 (1177)
T ss_pred CCCchHHHHhhhcccc------hHHHHHHhcccchHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHH---hcchhhh
Confidence 7899999999998662 3789999999999999998766 56888999999999999999999 9999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC--------CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT--------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTN 329 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~--------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~ 329 (427)
||..+|||+.+-..+||.|||+|+.+.... .-.+.|||-|.+....|+.++|||||||++||++| |..||+
T Consensus 823 dLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~ 902 (1177)
T KOG1025|consen 823 DLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYD 902 (1177)
T ss_pred hhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccC
Confidence 999999999999999999999999875543 23457999999999999999999999999999998 999998
Q ss_pred cccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 042634 330 EMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEE 409 (427)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~e 409 (427)
+....+ +.+.... ..+...|+.|+..++.+|.+||..|++.||+|+|
T Consensus 903 gi~~~e--I~dlle~-------------------------------geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fke 949 (1177)
T KOG1025|consen 903 GIPAEE--IPDLLEK-------------------------------GERLSQPPICTIDVYMVMVKCWMIDADSRPTFKE 949 (1177)
T ss_pred CCCHHH--hhHHHhc-------------------------------cccCCCCCCccHHHHHHHHHHhccCcccCccHHH
Confidence 752211 1111111 1112256779999999999999999999999999
Q ss_pred HHHHHHHHHHHHH
Q 042634 410 VAAQLLSFRNKLV 422 (427)
Q Consensus 410 v~~~L~~~~~~~~ 422 (427)
+.....++.....
T Consensus 950 l~~~fs~~ardpq 962 (1177)
T KOG1025|consen 950 LAEEFSRMARDPQ 962 (1177)
T ss_pred HHHHHHHHhcCcc
Confidence 9999999876543
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-30 Score=241.40 Aligned_cols=193 Identities=22% Similarity=0.284 Sum_probs=153.5
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|+|++++++.+.. ....++++||+++++|.+++.... ..+++..+..++.|++.||.||| ..|++|+
T Consensus 72 l~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~ 140 (286)
T cd06614 72 CKHPNIVDYYDSYLV-----GDELWVVMEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLH---SQNVIHR 140 (286)
T ss_pred CCCCCeeEEEEEEEE-----CCEEEEEEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeC
Confidence 579999999988644 467899999999999999987643 35899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||+|+||+++.++.+||+|||.+...... ..++..|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 141 dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~ 220 (286)
T cd06614 141 DIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREP 220 (286)
T ss_pred CCChhhEEEcCCCCEEECccchhhhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999998765432 146678999999988889999999999999999999999986431
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
.. ... ......... .......++..+.+++.+||+.+|.+|||+.|+++
T Consensus 221 ~~----~~~-~~~~~~~~~--------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 221 PL----RAL-FLITTKGIP--------------------------PLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred HH----HHH-HHHHhcCCC--------------------------CCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 11 000 000000000 00012224567899999999999999999999986
Q ss_pred H
Q 042634 413 Q 413 (427)
Q Consensus 413 ~ 413 (427)
.
T Consensus 270 ~ 270 (286)
T cd06614 270 H 270 (286)
T ss_pred C
Confidence 3
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-30 Score=244.40 Aligned_cols=193 Identities=23% Similarity=0.328 Sum_probs=149.6
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++.+.. ....++||||+. |++.+.+.... ..+++.++..++.|++.|+.||| ..||+||
T Consensus 82 l~h~~iv~~~~~~~~-----~~~~~lv~e~~~-g~l~~~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~ 149 (317)
T cd06635 82 IKHPNSIEYKGCYLR-----EHTAWLVMEYCL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLH---SHNMIHR 149 (317)
T ss_pred CCCCCEEEEEEEEee-----CCeEEEEEeCCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccC
Confidence 579999999998644 456799999995 57777664332 45889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc--CCCccccccccccC---CCCcCccccchhHHHHHHHHHhCCCCCCcccC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA--TNNFFNFQIAEYGM---GSEVSTSGDVYSFGILLLETFTGKRPTNEMFT 333 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~--~~~~~~y~aPE~~~---~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~ 333 (427)
||+|+||+++.++.+||+|||.+...... ..++..|+|||++. ...++.++|||||||++|||++|..||.....
T Consensus 150 dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~ 229 (317)
T cd06635 150 DIKAGNILLTEPGQVKLADFGSASIASPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 229 (317)
T ss_pred CCCcccEEECCCCCEEEecCCCccccCCcccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH
Confidence 99999999999999999999998765443 26778899999974 35688999999999999999999999865311
Q ss_pred CCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 042634 334 GNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAAQ 413 (427)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~ 413 (427)
. ...........+ .......+..+.+++.+||+.+|.+|||+.|+++.
T Consensus 230 ~-~~~~~~~~~~~~-------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 277 (317)
T cd06635 230 M-SALYHIAQNESP-------------------------------TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKH 277 (317)
T ss_pred H-HHHHHHHhccCC-------------------------------CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhC
Confidence 0 001111000000 00122345568999999999999999999999986
Q ss_pred HH
Q 042634 414 LL 415 (427)
Q Consensus 414 L~ 415 (427)
.-
T Consensus 278 ~~ 279 (317)
T cd06635 278 MF 279 (317)
T ss_pred hh
Confidence 43
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-30 Score=239.12 Aligned_cols=188 Identities=24% Similarity=0.288 Sum_probs=149.7
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeecc
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCD 259 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrD 259 (427)
..+.||.+--. |...+..|+|+..|.||||.-++.+... ..|++..++.++.+|+.||++|| ..+||.||
T Consensus 243 ~s~FiVslaYA-----feTkd~LClVLtlMNGGDLkfHiyn~g~--~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRD 312 (591)
T KOG0986|consen 243 SSPFIVSLAYA-----FETKDALCLVLTLMNGGDLKFHIYNHGN--PGFDEQRARFYAAEIICGLEHLH---RRRIVYRD 312 (591)
T ss_pred ccCcEEEEeee-----ecCCCceEEEEEeecCCceeEEeeccCC--CCCchHHHHHHHHHHHhhHHHHH---hcceeecc
Confidence 35666665444 5557789999999999999999877654 56999999999999999999999 99999999
Q ss_pred ccCCceeeCCCCceEecccccccccCCcC-----CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccCC
Q 042634 260 LKPSNVLLDGELTAHVGDFGLAKFLPEAT-----NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTG 334 (427)
Q Consensus 260 lkp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~~ 334 (427)
+||+|||+|+.|+++|+|.|+|..+.++. +||.+|||||++....|+..+|+||+||++|||+.|+.||......
T Consensus 313 LKPeNILLDd~GhvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK 392 (591)
T KOG0986|consen 313 LKPENILLDDHGHVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK 392 (591)
T ss_pred CChhheeeccCCCeEeeccceEEecCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh
Confidence 99999999999999999999999876543 8999999999999999999999999999999999999999643111
Q ss_pred CccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCH
Q 042634 335 NLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM 407 (427)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~ 407 (427)
. . .+-+|++...+.. ..++..+++..++.+..++.||++|--.
T Consensus 393 v-k-------------~eEvdrr~~~~~~----------------ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 393 V-K-------------REEVDRRTLEDPE----------------EYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred h-h-------------HHHHHHHHhcchh----------------hcccccCHHHHHHHHHHHccCHHHhccC
Confidence 0 0 0011111111110 0224456678889999999999998643
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-30 Score=236.71 Aligned_cols=193 Identities=19% Similarity=0.220 Sum_probs=151.9
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++.+.. ....++|+||+++++|.+++.........+++..++.++.|++.|++||| +.|++|+
T Consensus 59 l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~ 130 (260)
T cd08222 59 LDHPAIVKFHASFLE-----RDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHR 130 (260)
T ss_pred CCCCcHHHHHHHHhc-----CCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCcccc
Confidence 569999999988543 45689999999999999888653333356899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+||+++. +.+||+|||.++..... ..++..|+|||.+.+..++.++|+||||+++|++++|..||....
T Consensus 131 ~l~~~nili~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~ 209 (260)
T cd08222 131 DLKAKNIFLKN-NLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN 209 (260)
T ss_pred CCChhheEeec-CCEeecccCceeecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 99999999975 56999999998765332 256778999999988888999999999999999999999986421
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
............ . ...+..++.++.+++.+||+.+|++||++.|+++
T Consensus 210 -----~~~~~~~~~~~~-----~-----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 210 -----FLSVVLRIVEGP-----T-----------------------PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred -----HHHHHHHHHcCC-----C-----------------------CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 111111110000 0 0012345667899999999999999999999986
Q ss_pred H
Q 042634 413 Q 413 (427)
Q Consensus 413 ~ 413 (427)
.
T Consensus 257 ~ 257 (260)
T cd08222 257 N 257 (260)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-30 Score=239.10 Aligned_cols=189 Identities=22% Similarity=0.307 Sum_probs=152.0
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++.+.. +...++||||+++++|.+++... .+++..+..++.|++.|+.||| +.|++|+
T Consensus 59 l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~l~~~i~~~-----~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~ 125 (277)
T cd06641 59 CDSPYVTKYYGSYLK-----DTKLWIIMEYLGGGSALDLLEPG-----PLDETQIATILREILKGLDYLH---SEKKIHR 125 (277)
T ss_pred cCCCCEeEEEEEEEe-----CCeEEEEEEeCCCCcHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHc---cCCeecC
Confidence 479999999988543 56789999999999999988643 4889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC------CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+||+++.++.++|+|||++....... .++..|+|||.+.+..++.++|||||||++|++++|..||....
T Consensus 126 dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 205 (277)
T cd06641 126 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELH 205 (277)
T ss_pred CCCHHhEEECCCCCEEEeecccceecccchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccc
Confidence 999999999999999999999987654322 46778999999988888999999999999999999999986431
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
. ......+....+. .....++.++.+++.+||+.+|.+||+++|+++
T Consensus 206 ~--~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 206 P--MKVLFLIPKNNPP-------------------------------TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK 252 (277)
T ss_pred h--HHHHHHHhcCCCC-------------------------------CCCcccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 1 0010000000000 011224566889999999999999999999999
Q ss_pred H
Q 042634 413 Q 413 (427)
Q Consensus 413 ~ 413 (427)
+
T Consensus 253 ~ 253 (277)
T cd06641 253 H 253 (277)
T ss_pred C
Confidence 5
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-30 Score=242.59 Aligned_cols=194 Identities=22% Similarity=0.271 Sum_probs=146.4
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
..||||+++++.+.. ....+++|||+ ++++.++..... ..+++..+..++.|++.|++|||+ ..||+||
T Consensus 71 ~~~~~i~~~~~~~~~-----~~~~~~v~e~~-~~~l~~l~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~ 139 (296)
T cd06618 71 HDCPYIVKCYGYFIT-----DSDVFICMELM-STCLDKLLKRIQ---GPIPEDILGKMTVAIVKALHYLKE--KHGVIHR 139 (296)
T ss_pred cCCCchHhhheeeec-----CCeEEEEeecc-CcCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh--hCCEecC
Confidence 469999999998644 45789999998 556766654322 358899999999999999999993 2599999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC-----CCccccccccccCCCC----cCccccchhHHHHHHHHHhCCCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT-----NNFFNFQIAEYGMGSE----VSTSGDVYSFGILLLETFTGKRPTN 329 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~y~aPE~~~~~~----~~~~~DiwS~G~vl~ell~g~~pf~ 329 (427)
||+|+||+++.++.+||+|||.+....... .++..|+|||.+.+.. ++.++||||||+++|||++|+.||.
T Consensus 140 dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 219 (296)
T cd06618 140 DVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYK 219 (296)
T ss_pred CCcHHHEEEcCCCCEEECccccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999997654322 4667899999987654 7889999999999999999999996
Q ss_pred cccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 042634 330 EMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEE 409 (427)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~e 409 (427)
...... +.............- ....++.++.+++.+||+.||++|||+++
T Consensus 220 ~~~~~~----~~~~~~~~~~~~~~~--------------------------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~ 269 (296)
T cd06618 220 NCKTEF----EVLTKILQEEPPSLP--------------------------PNEGFSPDFCSFVDLCLTKDHRKRPKYRE 269 (296)
T ss_pred cchhHH----HHHHHHhcCCCCCCC--------------------------CCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 531111 111110000000000 00123566899999999999999999999
Q ss_pred HHHH
Q 042634 410 VAAQ 413 (427)
Q Consensus 410 v~~~ 413 (427)
+++.
T Consensus 270 il~~ 273 (296)
T cd06618 270 LLQH 273 (296)
T ss_pred HhcC
Confidence 9865
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-30 Score=233.04 Aligned_cols=207 Identities=24% Similarity=0.389 Sum_probs=169.2
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccch----hhhhccCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNR----EALKNLNLLQRLSIAVDVASALDYLHHYCETP 254 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ 254 (427)
..|||+..+.+++.. ........+.++.-|+|..++...+ .....++..+...++.|++.|++||| .+|
T Consensus 344 ~sH~nll~V~~V~ie----~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ 416 (563)
T KOG1024|consen 344 ASHPNLLSVLGVSIE----DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHG 416 (563)
T ss_pred CcCCCccceeEEEee----ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcC
Confidence 569999999998765 2355678889998899999987221 12245778899999999999999999 999
Q ss_pred eeeccccCCceeeCCCCceEecccccccccCC--------cCCCccccccccccCCCCcCccccchhHHHHHHHHHh-CC
Q 042634 255 IVHCDLKPSNVLLDGELTAHVGDFGLAKFLPE--------ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GK 325 (427)
Q Consensus 255 ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~--------~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~ 325 (427)
|||.||..+|++||+..++||+|-.+++.+-. +...+..||+||.+....|+.++|||||||++|||+| |+
T Consensus 417 ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~ 496 (563)
T KOG1024|consen 417 VIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGK 496 (563)
T ss_pred cccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCC
Confidence 99999999999999999999999999997643 3356678999999999999999999999999999999 99
Q ss_pred CCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCC
Q 042634 326 RPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERM 405 (427)
Q Consensus 326 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rp 405 (427)
.||.+... ..+..+..+.. +...|-+||++++.+|.-||..+|++||
T Consensus 497 ~PyaeIDP--fEm~~ylkdGy-------------------------------RlaQP~NCPDeLf~vMacCWallpeeRP 543 (563)
T KOG1024|consen 497 LPYAEIDP--FEMEHYLKDGY-------------------------------RLAQPFNCPDELFTVMACCWALLPEERP 543 (563)
T ss_pred CCccccCH--HHHHHHHhccc-------------------------------eecCCCCCcHHHHHHHHHHHhcCcccCC
Confidence 99875421 11222222111 1124667999999999999999999999
Q ss_pred CHHHHHHHHHHHHHHHHhhc
Q 042634 406 NMEEVAAQLLSFRNKLVKNI 425 (427)
Q Consensus 406 t~~ev~~~L~~~~~~~~~~~ 425 (427)
+++|++.-|.++...+..+|
T Consensus 544 sf~Qlv~cLseF~~qlt~YV 563 (563)
T KOG1024|consen 544 SFSQLVICLSEFHTQLTRYV 563 (563)
T ss_pred CHHHHHHHHHHHHHHHhhcC
Confidence 99999999999988877654
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-30 Score=237.09 Aligned_cols=198 Identities=24% Similarity=0.300 Sum_probs=152.7
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|+|++++++.+.. ....+++||++++++|.+++..... ...+++..+..++.|++.|++||| +.|++||
T Consensus 56 l~~~~i~~~~~~~~~-----~~~~~iv~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~ 126 (267)
T cd06610 56 CNHPNVVKYYTSFVV-----GDELWLVMPYLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLH---SNGQIHR 126 (267)
T ss_pred cCCCCEEEEEEEEee-----CCEEEEEEeccCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecC
Confidence 579999999887533 5678999999999999999865321 135889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC----------CCccccccccccCCC-CcCccccchhHHHHHHHHHhCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT----------NNFFNFQIAEYGMGS-EVSTSGDVYSFGILLLETFTGKRP 327 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~----------~~~~~y~aPE~~~~~-~~~~~~DiwS~G~vl~ell~g~~p 327 (427)
||||+||++++++.+||+|||.+....... .++..|+|||++... .++.++|+|||||++|||++|+.|
T Consensus 127 ~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p 206 (267)
T cd06610 127 DIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAP 206 (267)
T ss_pred CCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCC
Confidence 999999999999999999999987654321 467789999998776 789999999999999999999999
Q ss_pred CCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCH
Q 042634 328 TNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM 407 (427)
Q Consensus 328 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~ 407 (427)
|...... ..+.+.... .+.. . .........+.++.+++.+||+.||++|||+
T Consensus 207 ~~~~~~~-~~~~~~~~~-~~~~--------~------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~ 258 (267)
T cd06610 207 YSKYPPM-KVLMLTLQN-DPPS--------L------------------ETGADYKKYSKSFRKMISLCLQKDPSKRPTA 258 (267)
T ss_pred ccccChh-hhHHHHhcC-CCCC--------c------------------CCccccccccHHHHHHHHHHcCCChhhCcCH
Confidence 9754221 111111110 0000 0 0000112345678999999999999999999
Q ss_pred HHHHHH
Q 042634 408 EEVAAQ 413 (427)
Q Consensus 408 ~ev~~~ 413 (427)
+|+++.
T Consensus 259 ~~ll~~ 264 (267)
T cd06610 259 EELLKH 264 (267)
T ss_pred HHHhhC
Confidence 999863
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-30 Score=237.27 Aligned_cols=218 Identities=19% Similarity=0.227 Sum_probs=151.2
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeecc
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCD 259 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrD 259 (427)
+|||++++++.+.. +...++||||+ +|+|.+++..... ..+++..+..++.|++.||.||| +.|++|+|
T Consensus 56 ~h~~i~~~~~~~~~-----~~~~~lv~e~~-~~~l~~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~d 124 (283)
T cd07830 56 EHPNIVKLKEVFRE-----NDELYFVFEYM-EGNLYQLMKDRKG--KPFSESVIRSIIYQILQGLAHIH---KHGFFHRD 124 (283)
T ss_pred CCCCchhHHHHhhc-----CCcEEEEEecC-CCCHHHHHHhccc--ccCCHHHHHHHHHHHHHHHHHHH---HCCcccCC
Confidence 39999999998644 56789999999 8899888865431 35899999999999999999999 89999999
Q ss_pred ccCCceeeCCCCceEecccccccccCCc-----CCCccccccccccCC-CCcCccccchhHHHHHHHHHhCCCCCCcccC
Q 042634 260 LKPSNVLLDGELTAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETFTGKRPTNEMFT 333 (427)
Q Consensus 260 lkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~ 333 (427)
|+|+||+++.++.+||+|||.++..... ..++..|+|||++.. ..++.++||||||+++||+++|+.||.....
T Consensus 125 l~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~ 204 (283)
T cd07830 125 LKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSE 204 (283)
T ss_pred CChhhEEEcCCCCEEEeecccceeccCCCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCCh
Confidence 9999999999999999999999866542 256778999998754 5578999999999999999999999965421
Q ss_pred CCccHHHHHHHhcccchhccc-CccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 334 GNLTLHNFVKEALPERLAEIV-DPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
. ..+..... .......... +....... ... .................+..+.+++++||+.||++|||++|++.
T Consensus 205 ~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 205 I-DQLYKICS-VLGTPTKQDWPEGYKLASK-LGF--RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred H-HHHHHHHH-hcCCCChhhhhhHhhhhcc-ccc--cccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 1 11111111 1100000000 00000000 000 00000000000000112466899999999999999999999975
Q ss_pred H
Q 042634 413 Q 413 (427)
Q Consensus 413 ~ 413 (427)
.
T Consensus 280 ~ 280 (283)
T cd07830 280 H 280 (283)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.7e-30 Score=235.88 Aligned_cols=213 Identities=23% Similarity=0.274 Sum_probs=157.4
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcC------C
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYC------E 252 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~------~ 252 (427)
+.|+||+++++.-..-+-. ....++|+||.+.|+|.+||..+. ++|....+++..+++||+|||+.. .
T Consensus 261 m~h~nIl~Fi~~ekr~t~~-~~eywLVt~fh~kGsL~dyL~~nt-----isw~~~cria~SmarGLa~LHee~p~~d~~K 334 (534)
T KOG3653|consen 261 MKHENILQFIGAEKRGTAD-RMEYWLVTEFHPKGSLCDYLKANT-----ISWNSLCRIAESMARGLAHLHEELPRGDHHK 334 (534)
T ss_pred ccchhHHHhhchhccCCcc-ccceeEEeeeccCCcHHHHHHhcc-----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCC
Confidence 7899999999874432222 346799999999999999998753 899999999999999999999643 4
Q ss_pred CCeeeccccCCceeeCCCCceEecccccccccCCcC--------CCccccccccccCCCC-c-----CccccchhHHHHH
Q 042634 253 TPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEAT--------NNFFNFQIAEYGMGSE-V-----STSGDVYSFGILL 318 (427)
Q Consensus 253 ~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~--------~~~~~y~aPE~~~~~~-~-----~~~~DiwS~G~vl 318 (427)
.+|+|||||++||||..|+++-|+|||+|..+..+. +||.+|||||++.+.. + -.+.||||+|.|+
T Consensus 335 p~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVL 414 (534)
T KOG3653|consen 335 PPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVL 414 (534)
T ss_pred CccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHH
Confidence 579999999999999999999999999999875432 8999999999987643 2 2468999999999
Q ss_pred HHHHhCCCCCC------------cccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHH
Q 042634 319 LETFTGKRPTN------------EMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECL 386 (427)
Q Consensus 319 ~ell~g~~pf~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (427)
||++++...+. ...+....+.++..-.+.++.+..+...+ ......
T Consensus 415 WEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W----------------------~~h~~~ 472 (534)
T KOG3653|consen 415 WEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAW----------------------RKHAGM 472 (534)
T ss_pred HHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhh----------------------hcCccH
Confidence 99998765442 11122222222211111111111111000 011235
Q ss_pred HHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHH
Q 042634 387 VSVLGIGVTCSSELPRERMNMEEVAAQLLSFRN 419 (427)
Q Consensus 387 ~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~~~~ 419 (427)
.-+.+.+..||..||+.|-|+.=|.+++.++..
T Consensus 473 ~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 473 AVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred HHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 568889999999999999999999888887753
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-30 Score=241.36 Aligned_cols=220 Identities=21% Similarity=0.225 Sum_probs=149.8
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|+|++++++.+... .....++||||+. ++|.+++.... ..+++.++..++.|++.||+||| +.|++||
T Consensus 63 l~h~~i~~~~~~~~~~---~~~~~~lv~e~~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~ 132 (309)
T cd07845 63 LRHPNIVELKEVVVGK---HLDSIFLVMEYCE-QDLASLLDNMP---TPFSESQVKCLMLQLLRGLQYLH---ENFIIHR 132 (309)
T ss_pred CCCCCCcceEEEEecC---CCCeEEEEEecCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH---hCCeecC
Confidence 5799999998875431 1245799999995 58888776432 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC------CCccccccccccCC-CCcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT------NNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~------~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
||||+||+++.++.+||+|||.++...... .++..|+|||.+.+ ..++.++||||+||++|||++|+.||...
T Consensus 133 dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~ 212 (309)
T cd07845 133 DLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGK 212 (309)
T ss_pred CCCHHHEEECCCCCEEECccceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999998764321 34567999999865 55789999999999999999999999753
Q ss_pred cCCCccHHHHHHHhcccchhcccCccccccccccchhhhcccccccc-ccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 332 FTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTR-SFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
. .......+.................... ...... ....... .......+.++.+++.+|++.||++|||++|+
T Consensus 213 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~i 287 (309)
T cd07845 213 S--EIEQLDLIIQLLGTPNESIWPGFSDLPL-VGKFTL--PKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEA 287 (309)
T ss_pred C--HHHHHHHHHHhcCCCChhhchhhhcccc-cccccc--cCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHH
Confidence 2 1111111111111110010000000000 000000 0000000 00001135667899999999999999999999
Q ss_pred HHH
Q 042634 411 AAQ 413 (427)
Q Consensus 411 ~~~ 413 (427)
+++
T Consensus 288 l~h 290 (309)
T cd07845 288 LES 290 (309)
T ss_pred hcC
Confidence 864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-30 Score=239.15 Aligned_cols=196 Identities=20% Similarity=0.206 Sum_probs=150.9
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
.+|||++++++.+ ..+...++||||+++|+|.+++... ..+++..+..++.|+++||+||| ..|++||
T Consensus 62 ~~~~~i~~~~~~~-----~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~ 129 (288)
T cd05583 62 RRCPFLVTLHYAF-----QTDTKLHLILDYVNGGELFTHLYQR----EHFTESEVRVYIAEIVLALDHLH---QLGIIYR 129 (288)
T ss_pred cCCcchhhhheee-----ecCCEEEEEEecCCCCcHHHHHhhc----CCcCHHHHHHHHHHHHHHHHHHH---HCCeecc
Confidence 3699999998874 3356789999999999999988654 34889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc-------CCCccccccccccCCCC--cCccccchhHHHHHHHHHhCCCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA-------TNNFFNFQIAEYGMGSE--VSTSGDVYSFGILLLETFTGKRPTN 329 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-------~~~~~~y~aPE~~~~~~--~~~~~DiwS~G~vl~ell~g~~pf~ 329 (427)
||||+||+++.++.+||+|||+++..... ..++..|+|||...+.. .+.++||||||+++|||++|..||.
T Consensus 130 dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~ 209 (288)
T cd05583 130 DIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFT 209 (288)
T ss_pred CCCHHHeEECCCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcc
Confidence 99999999999999999999998764332 24678899999987655 7889999999999999999999986
Q ss_pred cccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 042634 330 EMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEE 409 (427)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~e 409 (427)
.... .............. . ...+...+..+.+++.+||+.||++|||+.+
T Consensus 210 ~~~~-~~~~~~~~~~~~~~----~-------------------------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~ 259 (288)
T cd05583 210 VDGE-QNSQSEISRRILKS----K-------------------------PPFPKTMSAEARDFIQKLLEKDPKKRLGANG 259 (288)
T ss_pred cCcc-cchHHHHHHHHHcc----C-------------------------CCCCcccCHHHHHHHHHHhcCCHhhccCcch
Confidence 3211 11111111110000 0 0011223456889999999999999999888
Q ss_pred HHHHHHH
Q 042634 410 VAAQLLS 416 (427)
Q Consensus 410 v~~~L~~ 416 (427)
+.+.|+.
T Consensus 260 ~~~~l~~ 266 (288)
T cd05583 260 ADEIKNH 266 (288)
T ss_pred HHHHhcC
Confidence 8766553
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-30 Score=236.23 Aligned_cols=190 Identities=23% Similarity=0.311 Sum_probs=149.6
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++.+. .+...++++||+++++|.+++... ..+++..+..++.|++.||+||| ..|++||
T Consensus 50 ~~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~ 117 (265)
T cd05579 50 AQSPYVVKLYYSFQ-----GKKNLYLVMEYLPGGDLASLLENV----GSLDEDVARIYIAEIVLALEYLH---SNGIIHR 117 (265)
T ss_pred CCCcchhHHHHhee-----cCcEEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HcCeecC
Confidence 45999999988743 356789999999999999988654 34899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc--------------CCCccccccccccCCCCcCccccchhHHHHHHHHHhC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA--------------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTG 324 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~--------------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g 324 (427)
||+|+||+++.++.+||+|||++...... ..++..|+|||.......+.++||||||+++||+++|
T Consensus 118 di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g 197 (265)
T cd05579 118 DLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197 (265)
T ss_pred CCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhC
Confidence 99999999999999999999998764332 1466789999999888899999999999999999999
Q ss_pred CCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHH--HHHHHHHHHhhcCCCCCC
Q 042634 325 KRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKE--CLVSVLGIGVTCSSELPR 402 (427)
Q Consensus 325 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~cl~~dP~ 402 (427)
..||..... ........... .. .+.. .+..+.+++.+||+.+|+
T Consensus 198 ~~p~~~~~~-----~~~~~~~~~~~----~~-------------------------~~~~~~~~~~~~~~i~~~l~~~p~ 243 (265)
T cd05579 198 IPPFHGETP-----EEIFQNILNGK----IE-------------------------WPEDVEVSDEAIDLISKLLVPDPE 243 (265)
T ss_pred CCCCCCCCH-----HHHHHHHhcCC----cC-------------------------CCccccCCHHHHHHHHHHhcCCHh
Confidence 999965321 11111100000 00 0111 256789999999999999
Q ss_pred CCCCHHHHHHHH
Q 042634 403 ERMNMEEVAAQL 414 (427)
Q Consensus 403 ~Rpt~~ev~~~L 414 (427)
+|||+.++.+.|
T Consensus 244 ~Rpt~~~~~~~l 255 (265)
T cd05579 244 KRLGAKSIEEIK 255 (265)
T ss_pred hcCCCccHHHHh
Confidence 999995555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-30 Score=241.39 Aligned_cols=193 Identities=22% Similarity=0.313 Sum_probs=148.6
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|+|++++.+.+.. ....++||||+. |++.+++.... ..+++.++..++.|++.|+.||| +.+++||
T Consensus 72 l~h~~i~~~~~~~~~-----~~~~~lv~e~~~-~~l~~~~~~~~---~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~ 139 (308)
T cd06634 72 LRHPNTIQYRGCYLR-----EHTAWLVMEYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLH---SHNMIHR 139 (308)
T ss_pred CCCCCcccEEEEEEc-----CCeeEEEEEccC-CCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccC
Confidence 569999999987544 457799999995 68777664332 45889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC--CCccccccccccC---CCCcCccccchhHHHHHHHHHhCCCCCCcccC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT--NNFFNFQIAEYGM---GSEVSTSGDVYSFGILLLETFTGKRPTNEMFT 333 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~--~~~~~y~aPE~~~---~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~ 333 (427)
||||+||+++.++.+||+|||.+....... .++..|+|||.+. ...++.++|||||||++|||++|..||.....
T Consensus 140 dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 219 (308)
T cd06634 140 DVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219 (308)
T ss_pred CCCHHhEEECCCCcEEECCcccceeecCcccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH
Confidence 999999999999999999999988654432 6778899999974 34578899999999999999999999865311
Q ss_pred CCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 042634 334 GNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAAQ 413 (427)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~ 413 (427)
.. .......... ........+..+.+++.+||+.+|++|||+++++..
T Consensus 220 ~~-~~~~~~~~~~-------------------------------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 220 MS-ALYHIAQNES-------------------------------PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred HH-HHHHHhhcCC-------------------------------CCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 10 0000000000 000112345668899999999999999999999876
Q ss_pred HH
Q 042634 414 LL 415 (427)
Q Consensus 414 L~ 415 (427)
--
T Consensus 268 ~~ 269 (308)
T cd06634 268 RF 269 (308)
T ss_pred cc
Confidence 43
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=236.37 Aligned_cols=218 Identities=20% Similarity=0.228 Sum_probs=153.3
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++.+.. +...++++||++ +++.+++.... ..+++..+..++.|++.||.||| ..+|+|+
T Consensus 55 l~~~~i~~~~~~~~~-----~~~~~~v~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~ 122 (283)
T cd05118 55 LNHPNIIKLLDVFRH-----KGDLYLVFEFMD-TDLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCH---SHGILHR 122 (283)
T ss_pred hcCCCcchHHHhhcc-----CCCEEEEEeccC-CCHHHHHHhhc---ccCCHHHHHHHHHHHHHHHHHHH---HCCeeec
Confidence 469999999998543 567899999995 58888776532 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC------CCccccccccccCCC-CcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT------NNFFNFQIAEYGMGS-EVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~------~~~~~y~aPE~~~~~-~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
||||+||+++.++.+||+|||.+....... .++..|+|||.+.+. .++.++||||+|+++|++++|+.||...
T Consensus 123 dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~ 202 (283)
T cd05118 123 DLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGK 202 (283)
T ss_pred CcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999998765432 466789999998876 7899999999999999999999999653
Q ss_pred cCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 042634 332 FTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVA 411 (427)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~ 411 (427)
.. ...+.... ....................... ..............+..+.++.+++.+||+.||.+||+++|++
T Consensus 203 ~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll 278 (283)
T cd05118 203 SE-IDQLFKIF-RTLGTPDPEVWPKFTSLARNYKF--SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQAL 278 (283)
T ss_pred CH-HHHHHHHH-HHcCCCchHhcccchhhhhhhhh--hhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHh
Confidence 21 11111111 11110000000000000000000 0000000000112234678899999999999999999999998
Q ss_pred H
Q 042634 412 A 412 (427)
Q Consensus 412 ~ 412 (427)
.
T Consensus 279 ~ 279 (283)
T cd05118 279 A 279 (283)
T ss_pred h
Confidence 6
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-30 Score=225.18 Aligned_cols=202 Identities=22% Similarity=0.276 Sum_probs=155.4
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
..|+||+++++. |.++...|+|||-|.||.|...++++ +.|++.++..+.++|+.||.||| .+||.||
T Consensus 133 qgh~nilqLief-----FEdd~~FYLVfEKm~GGplLshI~~~----~~F~E~EAs~vvkdia~aLdFlH---~kgIAHR 200 (463)
T KOG0607|consen 133 QGHKNILQLIEF-----FEDDTRFYLVFEKMRGGPLLSHIQKR----KHFNEREASRVVKDIASALDFLH---TKGIAHR 200 (463)
T ss_pred cCCccHHHHHHH-----hcccceEEEEEecccCchHHHHHHHh----hhccHHHHHHHHHHHHHHHHHHh---hcCcccc
Confidence 579999999998 55578899999999999999999876 45999999999999999999999 9999999
Q ss_pred cccCCceeeCCC---CceEecccccccccCCc-------------CCCccccccccccC-----CCCcCccccchhHHHH
Q 042634 259 DLKPSNVLLDGE---LTAHVGDFGLAKFLPEA-------------TNNFFNFQIAEYGM-----GSEVSTSGDVYSFGIL 317 (427)
Q Consensus 259 Dlkp~NIll~~~---~~~kL~DFG~a~~~~~~-------------~~~~~~y~aPE~~~-----~~~~~~~~DiwS~G~v 317 (427)
|+||+|||-... .-+|||||.++.-.... .+|+..|||||+.. ...|+.++|.||+|||
T Consensus 201 DlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvI 280 (463)
T KOG0607|consen 201 DLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVI 280 (463)
T ss_pred cCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHH
Confidence 999999998544 36899999887643211 16777899999863 2458999999999999
Q ss_pred HHHHHhCCCCCCcccCCCccHH-----HHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHH
Q 042634 318 LLETFTGKRPTNEMFTGNLTLH-----NFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGI 392 (427)
Q Consensus 318 l~ell~g~~pf~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 392 (427)
+|-|++|.+||.+..+.+-.+. ...+..+-+.+.+ .... .+...+...+.+..++
T Consensus 281 lYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQE---GkYe-----------------FPdkdWahIS~eakdl 340 (463)
T KOG0607|consen 281 LYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQE---GKYE-----------------FPDKDWAHISSEAKDL 340 (463)
T ss_pred HHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhc---cCCc-----------------CChhhhHHhhHHHHHH
Confidence 9999999999998655433222 1222222111111 1000 1111345567788999
Q ss_pred HhhcCCCCCCCCCCHHHHHH
Q 042634 393 GVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 393 ~~~cl~~dP~~Rpt~~ev~~ 412 (427)
+...+..||.+|-++.+++.
T Consensus 341 isnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 341 ISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHHHHhccHHhhhhhhhccC
Confidence 99999999999999998876
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=242.32 Aligned_cols=229 Identities=19% Similarity=0.191 Sum_probs=157.0
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++.+.+......+....+++|||++ ++|.+++... ..+++..+..++.|++.||+||| +.||+||
T Consensus 56 l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~----~~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~ 127 (330)
T cd07834 56 LRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKSP----QPLTDDHIQYFLYQILRGLKYLH---SANVIHR 127 (330)
T ss_pred cCCcchhhhhhhhcccCcccccceEEEecchh-hhHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecC
Confidence 45999999999865533223346799999996 6888888654 35899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC---------CCccccccccccCCC-CcCccccchhHHHHHHHHHhCCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT---------NNFFNFQIAEYGMGS-EVSTSGDVYSFGILLLETFTGKRPT 328 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~---------~~~~~y~aPE~~~~~-~~~~~~DiwS~G~vl~ell~g~~pf 328 (427)
||||+||+++.++.+||+|||.+....... .++..|+|||++.+. .++.++||||+||++|+|++|+.||
T Consensus 128 dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf 207 (330)
T cd07834 128 DLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLF 207 (330)
T ss_pred CCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCc
Confidence 999999999999999999999998764432 456789999999887 7899999999999999999999999
Q ss_pred CcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 042634 329 NEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME 408 (427)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ 408 (427)
...... ..+.. +.........+................ ................+..+.+++.+||+.+|++|||++
T Consensus 208 ~~~~~~-~~~~~-i~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~ 284 (330)
T cd07834 208 PGRDYI-DQLNL-IVEVLGTPSEEDLKFITSEKARNYLKS-LPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITAD 284 (330)
T ss_pred CCCCHH-HHHHH-HHHhcCCCChhHhhhccccchhhHHhh-cccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHH
Confidence 754211 11111 111111000000000000000000000 000000000001122466789999999999999999999
Q ss_pred HHHHH--HHHHH
Q 042634 409 EVAAQ--LLSFR 418 (427)
Q Consensus 409 ev~~~--L~~~~ 418 (427)
++++. ++.++
T Consensus 285 ~ll~~~~~~~~~ 296 (330)
T cd07834 285 EALAHPYLAQLH 296 (330)
T ss_pred HHHhCccHHhhc
Confidence 99975 44443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-30 Score=234.21 Aligned_cols=194 Identities=23% Similarity=0.333 Sum_probs=154.3
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||+++..+.+.. ....++++||+++++|.+++.........+++..+..++.|++.||.||| +.|++|+
T Consensus 56 l~~~~~~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~ 127 (258)
T cd08215 56 LNHPNIIKYYESFEE-----KGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHR 127 (258)
T ss_pred cCCCChhheEEEEec-----CCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecc
Confidence 459999999887433 46789999999999999998764322256899999999999999999999 8899999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||+|+||+++.++.+||+|||.+...... ..++..|+|||...+..++.++|+||+|+++|++++|+.||....
T Consensus 128 dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 207 (258)
T cd08215 128 DIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN 207 (258)
T ss_pred cCChHHeEEcCCCcEEECCccceeecccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc
Confidence 99999999999999999999999875443 256778999999988889999999999999999999999986531
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
..+......... ..+ .+..++.++.+++.+||..+|++|||+.|+++
T Consensus 208 -----~~~~~~~~~~~~----~~~------------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 208 -----LLELALKILKGQ----YPP------------------------IPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred -----HHHHHHHHhcCC----CCC------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 111111111000 000 11124566899999999999999999999986
Q ss_pred H
Q 042634 413 Q 413 (427)
Q Consensus 413 ~ 413 (427)
.
T Consensus 255 ~ 255 (258)
T cd08215 255 S 255 (258)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-30 Score=237.90 Aligned_cols=218 Identities=20% Similarity=0.231 Sum_probs=149.8
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++.+.. +...+++|||+ +++|.+++..... ..+++..+..++.|++.||+||| +.+++||
T Consensus 55 l~~~~iv~~~~~~~~-----~~~~~iv~e~~-~~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~ 123 (283)
T cd07835 55 LNHPNIVRLLDVVHS-----ENKLYLVFEFL-DLDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCH---SHRVLHR 123 (283)
T ss_pred cCCCCccCHhheecc-----CCeEEEEEecc-CcCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCC
Confidence 469999999998543 56789999999 5789888865432 35899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCCC-CcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMGS-EVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~~-~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
||+|+||+++.++.+||+|||.++..... ..++..|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 124 dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 203 (283)
T cd07835 124 DLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGD 203 (283)
T ss_pred CCCHHHEEEcCCCcEEEeecccccccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999999765321 2456789999987654 5789999999999999999999999653
Q ss_pred cCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 042634 332 FTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVA 411 (427)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~ 411 (427)
.. .....+........ ..................... ............+.++.+++.+||+.||++|||++|++
T Consensus 204 ~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il 278 (283)
T cd07835 204 SE-IDQLFRIFRTLGTP-DEDVWPGVTSLPDYKPTFPKW---ARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAAL 278 (283)
T ss_pred CH-HHHHHHHHHHhCCC-ChHHhhhhhhchhhhhhcccc---cccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHh
Confidence 11 11111111111000 000000000000000000000 00000001112345688999999999999999999998
Q ss_pred H
Q 042634 412 A 412 (427)
Q Consensus 412 ~ 412 (427)
+
T Consensus 279 ~ 279 (283)
T cd07835 279 Q 279 (283)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=216.10 Aligned_cols=169 Identities=21% Similarity=0.226 Sum_probs=128.8
Q ss_pred CCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccccCCceeeCCCCceEecccccccccCCc-CCC
Q 042634 212 GSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA-TNN 290 (427)
Q Consensus 212 g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~-~~~ 290 (427)
|+|.+++.... ..+++.+++.++.|++.||+||| +.+ ||+||+++.++.+|+ ||.++..... ..|
T Consensus 1 GsL~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~~~g 66 (176)
T smart00750 1 VSLADILEVRG---RPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQSRV 66 (176)
T ss_pred CcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeeccccCCC
Confidence 67888886532 45999999999999999999999 666 999999999999999 9999876443 378
Q ss_pred ccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhh
Q 042634 291 FFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKA 370 (427)
Q Consensus 291 ~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 370 (427)
+..|+|||++.+..++.++|||||||++|||++|+.||.........+........+... . .
T Consensus 67 ~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----~--------~------ 128 (176)
T smart00750 67 DPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDP----R--------D------ 128 (176)
T ss_pred cccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCc----c--------c------
Confidence 899999999999999999999999999999999999996532211112221111110000 0 0
Q ss_pred ccccccccccchHHHHH--HHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHH
Q 042634 371 NAHKQFTRSFSVKECLV--SVLGIGVTCSSELPRERMNMEEVAAQLLSFRNK 420 (427)
Q Consensus 371 ~~~~~~~~~~~~~~~~~--~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~~~~~ 420 (427)
...+..... ++.+++.+||+.+|++|||+.|+++++..+..+
T Consensus 129 --------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 129 --------RSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred --------cccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 001122222 689999999999999999999999999887654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=242.60 Aligned_cols=218 Identities=24% Similarity=0.307 Sum_probs=148.7
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeecc
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCD 259 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrD 259 (427)
+||||+++++.+.. .+....++||||+. ++|..++... .+++..+..++.|++.||+||| +.||+|||
T Consensus 65 ~h~ni~~~~~~~~~---~~~~~~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~d 132 (337)
T cd07852 65 DHPNIVKLLNVIKA---ENDKDIYLVFEYME-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIH---SGNVIHRD 132 (337)
T ss_pred CCCCccceeeeecc---CCCceEEEEecccc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---HCCeecCC
Confidence 79999999987543 12345799999995 6888887543 4788899999999999999999 89999999
Q ss_pred ccCCceeeCCCCceEecccccccccCCcC-----------CCccccccccccCC-CCcCccccchhHHHHHHHHHhCCCC
Q 042634 260 LKPSNVLLDGELTAHVGDFGLAKFLPEAT-----------NNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETFTGKRP 327 (427)
Q Consensus 260 lkp~NIll~~~~~~kL~DFG~a~~~~~~~-----------~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell~g~~p 327 (427)
|||+||+++.++.+||+|||.++...... .++..|+|||.+.+ ..++.++|||||||++|||++|+.|
T Consensus 133 l~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~p 212 (337)
T cd07852 133 LKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPL 212 (337)
T ss_pred CCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999998653221 46778999998765 4578999999999999999999999
Q ss_pred CCcccCCCccHHHHHHHhcccchhcccCccccccccccch-hhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCC
Q 042634 328 TNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGET-SKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMN 406 (427)
Q Consensus 328 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt 406 (427)
|...... ............. ..+.++............ ......... ......++.++.+++.+||+.||++|||
T Consensus 213 f~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~P~~Rps 288 (337)
T cd07852 213 FPGTSTL-NQLEKIIEVIGPP-SAEDIESIKSPFAATMLDSLPSRPRKPL--DELLPKASDDALDLLKKLLVFNPNKRLT 288 (337)
T ss_pred CCCCChH-HHHHHHHHHhCCC-CHHHHHHHHhhhHHHhhhhcccccccch--hhhccCCCHHHHHHHHHhccCCcccccC
Confidence 9653211 1111111110000 000000000000000000 000000000 0011124677899999999999999999
Q ss_pred HHHHHHH
Q 042634 407 MEEVAAQ 413 (427)
Q Consensus 407 ~~ev~~~ 413 (427)
+.|+++.
T Consensus 289 ~~~il~~ 295 (337)
T cd07852 289 AEEALEH 295 (337)
T ss_pred HHHHhhC
Confidence 9999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=224.72 Aligned_cols=181 Identities=23% Similarity=0.268 Sum_probs=147.5
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
.+||.+..+--+ |+.+...|.||||+.||.|+-++... +.+++...+.+-.+|+.||.||| +++||.|
T Consensus 225 ~~HPFLt~LKYs-----FQt~drlCFVMeyanGGeLf~HLsre----r~FsE~RtRFYGaEIvsAL~YLH---s~~ivYR 292 (516)
T KOG0690|consen 225 CRHPFLTSLKYS-----FQTQDRLCFVMEYANGGELFFHLSRE----RVFSEDRTRFYGAEIVSALGYLH---SRNIVYR 292 (516)
T ss_pred ccCcHHHHhhhh-----hccCceEEEEEEEccCceEeeehhhh----hcccchhhhhhhHHHHHHhhhhh---hCCeeee
Confidence 468887766544 66688999999999999999999765 45999999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC------cCCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE------ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
|+|.+|.|+|.+|++||+|||+++.--. .-+||+.|.|||++....|+.++|+|.+|||||||++|+.||...
T Consensus 293 DlKLENLlLDkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~- 371 (516)
T KOG0690|consen 293 DLKLENLLLDKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK- 371 (516)
T ss_pred echhhhheeccCCceEeeecccchhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc-
Confidence 9999999999999999999999985322 128999999999999999999999999999999999999999753
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCC
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERM 405 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rp 405 (427)
+...+.+.+.. .. .. .|.....+...++...+..||.+|-
T Consensus 372 -dh~kLFeLIl~---ed------------------------~k-----FPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 372 -DHEKLFELILM---ED------------------------LK-----FPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred -chhHHHHHHHh---hh------------------------cc-----CCccCCHHHHHHHHHHhhcChHhhc
Confidence 22222222111 00 00 2223345578899999999999994
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=241.64 Aligned_cols=222 Identities=19% Similarity=0.198 Sum_probs=149.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
.+||||+++++.+... .......++++||+ +++|.+++... ..+++..++.++.|++.||+||| ..||+||
T Consensus 59 ~~h~~iv~~~~~~~~~-~~~~~~~~~~~e~~-~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH---~~givH~ 129 (332)
T cd07857 59 RGHKNITCLYDMDIVF-PGNFNELYLYEELM-EADLHQIIRSG----QPLTDAHFQSFIYQILCGLKYIH---SANVLHR 129 (332)
T ss_pred cCCCChheeeeeeeec-cccCCcEEEEEecc-cCCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccC
Confidence 3699999998864331 12234568889988 57898888654 35899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc----------CCCccccccccccCC-CCcCccccchhHHHHHHHHHhCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA----------TNNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETFTGKRP 327 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~----------~~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell~g~~p 327 (427)
||||+||+++.++.+||+|||.++..... ..++..|+|||+..+ ..++.++||||+||++|++++|+.|
T Consensus 130 dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~p 209 (332)
T cd07857 130 DLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPV 209 (332)
T ss_pred CCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcC
Confidence 99999999999999999999999864321 157788999998765 5689999999999999999999999
Q ss_pred CCcccCCCccHHHHHHHhcccchhcccCccccccccccchhh-hccccccccccchHHHHHHHHHHHhhcCCCCCCCCCC
Q 042634 328 TNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSK-ANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMN 406 (427)
Q Consensus 328 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt 406 (427)
|...... ..+...+.. ......+................. ......+.. ....++..+.+++.+|++.||++|||
T Consensus 210 f~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~R~t 285 (332)
T cd07857 210 FKGKDYV-DQLNQILQV-LGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFES--IFPNANPLALDLLEKLLAFDPTKRIS 285 (332)
T ss_pred CCCCCHH-HHHHHHHHH-hCCCCHHHHHhhhhhhHHHHHHhccccCCcchHh--hCCCCCHHHHHHHHHHccCCcccCCC
Confidence 8753211 111111111 000000000000000000000000 000000000 01113467899999999999999999
Q ss_pred HHHHHHH
Q 042634 407 MEEVAAQ 413 (427)
Q Consensus 407 ~~ev~~~ 413 (427)
++|+++.
T Consensus 286 ~~~ll~~ 292 (332)
T cd07857 286 VEEALEH 292 (332)
T ss_pred HHHHhcC
Confidence 9998754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=239.04 Aligned_cols=191 Identities=24% Similarity=0.315 Sum_probs=147.0
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++.+.+.. ....++||||+ .|++.+++.... ..+++.++..++.|++.|+.||| +.|++||
T Consensus 78 l~h~~iv~~~~~~~~-----~~~~~lv~e~~-~~~l~~~l~~~~---~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~ 145 (313)
T cd06633 78 LKHPNTIEYKGCYLK-----EHTAWLVMEYC-LGSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLH---SHNMIHR 145 (313)
T ss_pred CCCCCCccEEEEEEe-----CCEEEEEEecC-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecC
Confidence 579999999988544 45789999999 467777765432 45889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc--CCCccccccccccC---CCCcCccccchhHHHHHHHHHhCCCCCCcccC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA--TNNFFNFQIAEYGM---GSEVSTSGDVYSFGILLLETFTGKRPTNEMFT 333 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~--~~~~~~y~aPE~~~---~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~ 333 (427)
||||+||+++.++.+||+|||.+...... ..++..|+|||++. ...++.++|||||||++|||++|..||.....
T Consensus 146 dl~p~nili~~~~~~kL~dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~ 225 (313)
T cd06633 146 DIKAGNILLTEPGQVKLADFGSASKSSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 225 (313)
T ss_pred CCChhhEEECCCCCEEEeecCCCcccCCCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 99999999999999999999998754332 26778899999974 35688899999999999999999999865311
Q ss_pred CCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 042634 334 GNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAAQ 413 (427)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~ 413 (427)
.. ..........+ . ......+..+.+++.+||+.+|++|||+.|++..
T Consensus 226 ~~-~~~~~~~~~~~----~---------------------------~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 226 MS-ALYHIAQNDSP----T---------------------------LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred HH-HHHHHHhcCCC----C---------------------------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 10 00000000000 0 0111233457889999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=233.87 Aligned_cols=192 Identities=19% Similarity=0.235 Sum_probs=149.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++.+... .....++++||+++++|.+++... ..+++..++.++.|++.||.||| +.|++||
T Consensus 61 l~h~~i~~~~~~~~~~---~~~~~~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~al~~LH---~~~i~H~ 130 (264)
T cd06653 61 LRHDRIVQYYGCLRDP---EEKKLSIFVEYMPGGSIKDQLKAY----GALTENVTRRYTRQILQGVSYLH---SNMIVHR 130 (264)
T ss_pred cCCCCcceEEEEEEcC---CCCEEEEEEEeCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---hCCEecC
Confidence 4799999999875331 134578999999999999888643 34788899999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC---------cCCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE---------ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTN 329 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~---------~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~ 329 (427)
||||+||+++.++.+||+|||+++.... ...++..|+|||++.+..++.++|||||||++||+++|+.||.
T Consensus 131 dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 210 (264)
T cd06653 131 DIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWA 210 (264)
T ss_pred CCCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999986432 1246778999999998889999999999999999999999996
Q ss_pred cccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 042634 330 EMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEE 409 (427)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~e 409 (427)
... ...... ....... +...+....+++.+++.+||+ +|..|||+.+
T Consensus 211 ~~~----~~~~~~-~~~~~~~---------------------------~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~ 257 (264)
T cd06653 211 EYE----AMAAIF-KIATQPT---------------------------KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEF 257 (264)
T ss_pred ccC----HHHHHH-HHHcCCC---------------------------CCCCCcccCHHHHHHHHHHhc-CcccCccHHH
Confidence 431 111111 1100000 000223345678999999999 5799999998
Q ss_pred HHHH
Q 042634 410 VAAQ 413 (427)
Q Consensus 410 v~~~ 413 (427)
++.+
T Consensus 258 ~~~~ 261 (264)
T cd06653 258 LLRH 261 (264)
T ss_pred HhcC
Confidence 8753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=234.98 Aligned_cols=219 Identities=21% Similarity=0.273 Sum_probs=151.3
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++.+.... ....++|+||++ ++|.+++.... ..+++..++.++.|++.||+||| ..|++|+
T Consensus 55 l~~~~i~~~~~~~~~~~---~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~ 124 (287)
T cd07840 55 LRHPNIVRLKEIVTSKG---KGSIYMVFEYMD-HDLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLH---SNGILHR 124 (287)
T ss_pred ccCCCeeeheeeEecCC---CCcEEEEecccc-ccHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH---HCCceec
Confidence 46999999998865421 257899999996 58888876542 35899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC-------CCccccccccccCC-CCcCccccchhHHHHHHHHHhCCCCCCc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT-------NNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETFTGKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~-------~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell~g~~pf~~ 330 (427)
||||+||++++++.+||+|||.+....... .++..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 125 dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~ 204 (287)
T cd07840 125 DIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQG 204 (287)
T ss_pred cCcHHHeEEcCCCCEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999998764432 45677999998765 4578999999999999999999999975
Q ss_pred ccCCCccHHHHHHHhcc---cchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCH
Q 042634 331 MFTGNLTLHNFVKEALP---ERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM 407 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~ 407 (427)
... ...+......... ..+....+..... ............ .......++.++.+++++||+.+|++|||+
T Consensus 205 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~ 278 (287)
T cd07840 205 STE-LEQLEKIFELCGSPTDENWPGVSKLPWFE----NLKPKKPYKRRL-REFFKHLIDPSALDLLDKLLTLDPKKRISA 278 (287)
T ss_pred CCh-HHHHHHHHHHhCCCchhhccccccchhhh----hccccccchhHH-HHHhcccCCHHHHHHHHHHcCCChhhCcCH
Confidence 321 1111111111000 0000000000000 000000000000 000011136778999999999999999999
Q ss_pred HHHHHH
Q 042634 408 EEVAAQ 413 (427)
Q Consensus 408 ~ev~~~ 413 (427)
+|+++.
T Consensus 279 ~~~l~~ 284 (287)
T cd07840 279 DQALQH 284 (287)
T ss_pred HHHhhC
Confidence 999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=230.99 Aligned_cols=193 Identities=24% Similarity=0.320 Sum_probs=152.2
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||+++++.+.+.. ....++++||+++++|.+++.... ..+++..+..++.|++.|++||| ..|++||
T Consensus 54 l~~~~i~~~~~~~~~-----~~~~~l~~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~ 122 (253)
T cd05122 54 CKHPNIVKYYGSYLK-----KDELWIVMEFCSGGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLH---SNGIIHR 122 (253)
T ss_pred CCCCCEeEEEEEEec-----CCeEEEEEecCCCCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhh---cCCEecC
Confidence 458999999887543 467899999999999999886542 35899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc-----CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFT 333 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~ 333 (427)
||+|+||+++.++.+||+|||.+...... ..++..|+|||.+.+..++.++||||||+++|++++|+.||.....
T Consensus 123 dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 202 (253)
T cd05122 123 DIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP 202 (253)
T ss_pred CCCHHHEEEccCCeEEEeeccccccccccccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch
Confidence 99999999999999999999999876543 2567789999999888889999999999999999999999875311
Q ss_pred CCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 042634 334 GNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAAQ 413 (427)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~ 413 (427)
. ........ ....... .....+.++.+++.+||+.||++|||++|+++.
T Consensus 203 ~--~~~~~~~~---~~~~~~~--------------------------~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 203 M--KALFKIAT---NGPPGLR--------------------------NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred H--HHHHHHHh---cCCCCcC--------------------------cccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 00000000 0000000 111124568999999999999999999999863
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=235.01 Aligned_cols=216 Identities=18% Similarity=0.214 Sum_probs=150.9
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++.+.. ....++||||++ ++|.+++..... ...+++..+..++.|++.||+||| +.|++||
T Consensus 55 l~h~~i~~~~~~~~~-----~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~ 124 (284)
T cd07836 55 LKHENIVRLHDVIHT-----ENKLMLVFEYMD-KDLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCH---ENRVLHR 124 (284)
T ss_pred hcCCCEeeeeeeEee-----CCcEEEEEecCC-ccHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeC
Confidence 579999999988544 457899999996 588887754331 135899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCC-CCcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
||||+||++++++.+||+|||.++..... ..++..|++||++.+ ..++.++|||||||++||+++|+.||.+.
T Consensus 125 dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~ 204 (284)
T cd07836 125 DLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGT 204 (284)
T ss_pred CCCHHHEEECCCCcEEEeecchhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999999754322 246778999998866 45689999999999999999999999754
Q ss_pred cCCCccHHHHHHHhcc---cchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 042634 332 FTGNLTLHNFVKEALP---ERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME 408 (427)
Q Consensus 332 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ 408 (427)
... ............ ..+..+.+. ....... ............+..+..+.+++.+|++.||.+|||++
T Consensus 205 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~ 276 (284)
T cd07836 205 NNE-DQLLKIFRIMGTPTESTWPGISQL----PEYKPTF---PRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAH 276 (284)
T ss_pred CcH-HHHHHHHHHhCCCChhhHHHHhcC----chhcccc---cCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHH
Confidence 221 111111111100 000000000 0000000 00000000001123467789999999999999999999
Q ss_pred HHHH
Q 042634 409 EVAA 412 (427)
Q Consensus 409 ev~~ 412 (427)
|+++
T Consensus 277 ~~l~ 280 (284)
T cd07836 277 DALQ 280 (284)
T ss_pred HHhc
Confidence 9975
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=265.37 Aligned_cols=204 Identities=17% Similarity=0.239 Sum_probs=145.8
Q ss_pred CceeeccCCccccc-ccchhhhccccccC--CCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHH
Q 042634 168 IENLDLSRNNFIRH-RNLVKIITSCASVD--FQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASAL 244 (427)
Q Consensus 168 L~~L~L~~N~ll~H-pniv~~~~~~~~~~--~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L 244 (427)
+...+....+-..| +||.++++.+..-. .......+.++||+ +++|.+++.... ..+++.+++.++.||++||
T Consensus 18 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al 93 (793)
T PLN00181 18 VSEFCTDGSKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD---RSVDAFECFHVFRQIVEIV 93 (793)
T ss_pred ccccCCCccchhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc---ccccHHHHHHHHHHHHHHH
Confidence 34445555556677 68888888752211 11123467778987 779999997542 4589999999999999999
Q ss_pred HHHhhcCCCCeeeccccCCceeeCC-------------------CCceEecccccccccCC-------------------
Q 042634 245 DYLHHYCETPIVHCDLKPSNVLLDG-------------------ELTAHVGDFGLAKFLPE------------------- 286 (427)
Q Consensus 245 ~~LH~~~~~~ivHrDlkp~NIll~~-------------------~~~~kL~DFG~a~~~~~------------------- 286 (427)
+||| ++||+||||||+|||++. ++.+|++|||+++....
T Consensus 94 ~~lH---~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~ 170 (793)
T PLN00181 94 NAAH---SQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPM 170 (793)
T ss_pred HHHH---hCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcc
Confidence 9999 899999999999999943 45678888888764211
Q ss_pred ---cCCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccCCCccHHHHHHHhcccchhcccCcccccccc
Q 042634 287 ---ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVERE 363 (427)
Q Consensus 287 ---~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (427)
...+|+.|+|||++.+..++.++|||||||++|||++|..|+.... ..+........++.
T Consensus 171 ~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~---~~~~~~~~~~~~~~-------------- 233 (793)
T PLN00181 171 KQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS---RTMSSLRHRVLPPQ-------------- 233 (793)
T ss_pred cccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH---HHHHHHHHhhcChh--------------
Confidence 0146778999999999999999999999999999999988865310 00111100000000
Q ss_pred ccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 042634 364 EGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAAQ 413 (427)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~ 413 (427)
......+..+++.+||+.+|.+||||.|++++
T Consensus 234 ------------------~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 234 ------------------ILLNWPKEASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred ------------------hhhcCHHHHHHHHHhCCCChhhCcChHHHhhc
Confidence 00012234678889999999999999999763
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=231.22 Aligned_cols=194 Identities=23% Similarity=0.285 Sum_probs=153.7
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++.+.... ....++++||+++++|.+++.... .+++..+..++.|++.|++||| +.|++|+
T Consensus 56 l~~~~i~~~~~~~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~ 125 (260)
T cd06606 56 LQHPNIVRYYGSERDEE---KNTLNIFLEYVSGGSLSSLLKKFG----KLPEPVIRKYTRQILEGLAYLH---SNGIVHR 125 (260)
T ss_pred cCCCCEeeEEEEEecCC---CCeEEEEEEecCCCcHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHH---HCCcccc
Confidence 45999999988754411 256899999999999999987542 5899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC--------CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT--------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~--------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~ 330 (427)
||+|+||+++.++.+||+|||.+....... .++..|+|||...+...+.++||||||+++|++++|..||..
T Consensus 126 dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 205 (260)
T cd06606 126 DIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSE 205 (260)
T ss_pred CCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999998764432 567789999999888899999999999999999999999976
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
.. ......... ..... ....+...+..+.+++.+|++.+|++|||+.|+
T Consensus 206 ~~----~~~~~~~~~--------~~~~~-------------------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~l 254 (260)
T cd06606 206 LG----NPMAALYKI--------GSSGE-------------------PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADEL 254 (260)
T ss_pred CC----chHHHHHhc--------cccCC-------------------CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHH
Confidence 43 111111100 00000 000122336778999999999999999999999
Q ss_pred HHH
Q 042634 411 AAQ 413 (427)
Q Consensus 411 ~~~ 413 (427)
+..
T Consensus 255 l~~ 257 (260)
T cd06606 255 LQH 257 (260)
T ss_pred hhC
Confidence 863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-29 Score=234.16 Aligned_cols=220 Identities=20% Similarity=0.234 Sum_probs=149.3
Q ss_pred cccccchhhhccccccC-----CCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCC
Q 042634 179 IRHRNLVKIITSCASVD-----FQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCET 253 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~-----~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~ 253 (427)
++|||++++++.+.... ..++...++|+||+++ ++.+.+.... ..+++..++.++.|++.||+||| +.
T Consensus 63 l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH---~~ 135 (302)
T cd07864 63 LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGL---VHFSEDHIKSFMKQLLEGLNYCH---KK 135 (302)
T ss_pred CCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hC
Confidence 57999999998765422 1223478999999965 6766665432 35899999999999999999999 89
Q ss_pred CeeeccccCCceeeCCCCceEecccccccccCCcC-------CCccccccccccCC-CCcCccccchhHHHHHHHHHhCC
Q 042634 254 PIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEAT-------NNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETFTGK 325 (427)
Q Consensus 254 ~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~-------~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell~g~ 325 (427)
||+||||||+||++++++.+||+|||.+....... .++..|+|||.+.+ ..++.++|||||||++|||++|+
T Consensus 136 ~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~ 215 (302)
T cd07864 136 NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215 (302)
T ss_pred CeecCCCCHHHEEECCCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999998654322 34667999998765 45789999999999999999999
Q ss_pred CCCCcccCCCccHHHHHHHh---cccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCC
Q 042634 326 RPTNEMFTGNLTLHNFVKEA---LPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPR 402 (427)
Q Consensus 326 ~pf~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~ 402 (427)
.||.... ....+....... .+....++.............. ...... ......+.++.+++.+||+.||.
T Consensus 216 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~-~~~~~~~~~~~~li~~~l~~~P~ 288 (302)
T cd07864 216 PIFQANQ-ELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQ-----YRRRLR-EEFSFIPTPALDLLDHMLTLDPS 288 (302)
T ss_pred CCCCCCC-hHHHHHHHHHHhCCCChhhcccccccccccccccccc-----cccchh-hhcCCCCHHHHHHHHHHccCChh
Confidence 9997431 111111111110 0111111110000000000000 000000 00112356789999999999999
Q ss_pred CCCCHHHHHH
Q 042634 403 ERMNMEEVAA 412 (427)
Q Consensus 403 ~Rpt~~ev~~ 412 (427)
+|||++|++.
T Consensus 289 ~Rp~~~~il~ 298 (302)
T cd07864 289 KRCTAEEALN 298 (302)
T ss_pred hCCCHHHHhc
Confidence 9999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=235.30 Aligned_cols=216 Identities=19% Similarity=0.209 Sum_probs=147.0
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++.+.. +...++||||++ ++|.+++..... ..+++..+..++.||+.||+||| ++|++||
T Consensus 58 l~h~~i~~~~~~~~~-----~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~ 126 (294)
T PLN00009 58 MQHGNIVRLQDVVHS-----EKRLYLVFEYLD-LDLKKHMDSSPD--FAKNPRLIKTYLYQILRGIAYCH---SHRVLHR 126 (294)
T ss_pred ccCCCEeeEEEEEec-----CCeEEEEEeccc-ccHHHHHHhCCC--CCcCHHHHHHHHHHHHHHHHHHH---hCCeeCC
Confidence 579999999998543 567899999994 688777654322 33678888999999999999999 8999999
Q ss_pred cccCCceeeCC-CCceEecccccccccCCc------CCCccccccccccCC-CCcCccccchhHHHHHHHHHhCCCCCCc
Q 042634 259 DLKPSNVLLDG-ELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETFTGKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~-~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell~g~~pf~~ 330 (427)
||||+||+++. ++.+||+|||.+...... ..++..|+|||++.+ ..++.++||||+||++|+|++|..||..
T Consensus 127 dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~ 206 (294)
T PLN00009 127 DLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPG 206 (294)
T ss_pred CCCcceEEEECCCCEEEEcccccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999985 567999999999764322 245678999998866 4578999999999999999999999975
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccc---cchHHHHHHHHHHHhhcCCCCCCCCCCH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRS---FSVKECLVSVLGIGVTCSSELPRERMNM 407 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~~cl~~dP~~Rpt~ 407 (427)
.... ..+.+.... .........+.......... . ...+... ......+.++.+++.+|++.+|++|||+
T Consensus 207 ~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~-----~-~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~ 278 (294)
T PLN00009 207 DSEI-DELFKIFRI-LGTPNEETWPGVTSLPDYKS-----A-FPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITA 278 (294)
T ss_pred CCHH-HHHHHHHHH-hCCCChhhccccccchhhhh-----h-cccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCH
Confidence 3211 111111110 00000011000000000000 0 0000000 0012234568899999999999999999
Q ss_pred HHHHHH
Q 042634 408 EEVAAQ 413 (427)
Q Consensus 408 ~ev~~~ 413 (427)
+|+++.
T Consensus 279 ~~~l~~ 284 (294)
T PLN00009 279 RAALEH 284 (294)
T ss_pred HHHhcC
Confidence 999863
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=222.03 Aligned_cols=145 Identities=22% Similarity=0.364 Sum_probs=123.2
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchh-hhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNRE-ALKNLNLLQRLSIAVDVASALDYLHHYCETPIVH 257 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivH 257 (427)
++|||+|.+..++.. .+...++++||+ .-||...++-.+. ..+.++...++.++.||+.|+.||| ++=|+|
T Consensus 84 l~h~nvi~Lv~Vfl~----~d~~v~l~fdYA-EhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlH 155 (438)
T KOG0666|consen 84 LKHPNVISLVKVFLS----HDKKVWLLFDYA-EHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLH 155 (438)
T ss_pred hcCCcchhHHHHHhc----cCceEEEEehhh-hhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheee
Confidence 679999999888644 246789999999 4588888764332 1256889999999999999999999 888999
Q ss_pred ccccCCceeeCCC----CceEecccccccccCCcC---------CCccccccccccCCCC-cCccccchhHHHHHHHHHh
Q 042634 258 CDLKPSNVLLDGE----LTAHVGDFGLAKFLPEAT---------NNFFNFQIAEYGMGSE-VSTSGDVYSFGILLLETFT 323 (427)
Q Consensus 258 rDlkp~NIll~~~----~~~kL~DFG~a~~~~~~~---------~~~~~y~aPE~~~~~~-~~~~~DiwS~G~vl~ell~ 323 (427)
||+||.|||+..+ |.|||+|||+|+...... +-|..|+|||.+.+.. |+++.||||.|||+.||++
T Consensus 156 RDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLt 235 (438)
T KOG0666|consen 156 RDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLT 235 (438)
T ss_pred ccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHc
Confidence 9999999999877 899999999999764432 5678999999998854 8999999999999999999
Q ss_pred CCCCCCcc
Q 042634 324 GKRPTNEM 331 (427)
Q Consensus 324 g~~pf~~~ 331 (427)
-++.|.+.
T Consensus 236 l~PlF~g~ 243 (438)
T KOG0666|consen 236 LEPLFKGR 243 (438)
T ss_pred cCccccch
Confidence 99998764
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=230.15 Aligned_cols=189 Identities=23% Similarity=0.315 Sum_probs=151.3
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++.+.+.. ....+++|||+++++|.+++... ..+++..+..++.|++.|+.||| +.||+||
T Consensus 56 l~~~~i~~~~~~~~~-----~~~~~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~ 123 (254)
T cd06627 56 LKHPNIVKYIGSIET-----SDSLYIILEYAENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLH---EQGVIHR 123 (254)
T ss_pred CCCCCccEEEEEEEe-----CCEEEEEEecCCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHh---hCCcccC
Confidence 468999998887543 46789999999999999988654 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC------CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+||+++.++.+||+|||.+....... .++..|+|||...+..++.++||||+|+++|++++|..||....
T Consensus 124 dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~ 203 (254)
T cd06627 124 DIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN 203 (254)
T ss_pred CCCHHHEEECCCCCEEEeccccceecCCCcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc
Confidence 999999999999999999999998764432 56778999999888788999999999999999999999986532
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
. ........ .... ...+...+..+.+++.+||..+|++|||+.|++.
T Consensus 204 ~----~~~~~~~~-~~~~----------------------------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 204 P----MAALFRIV-QDDH----------------------------PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred H----HHHHHHHh-ccCC----------------------------CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1 11110100 0000 0011223567889999999999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=214.36 Aligned_cols=222 Identities=19% Similarity=0.288 Sum_probs=154.9
Q ss_pred ccccccchhhhccccccCCCC---CCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 042634 178 FIRHRNLVKIITSCASVDFQG---NDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETP 254 (427)
Q Consensus 178 ll~Hpniv~~~~~~~~~~~~~---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ 254 (427)
++.|+|++.+++.|....-.. ....++||.+| .-||..++.+.. .+++..++.+++.++..||.|+| +..
T Consensus 72 ~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~c-ehDLaGlLsn~~---vr~sls~Ikk~Mk~Lm~GL~~iH---r~k 144 (376)
T KOG0669|consen 72 LLKHENVVNLIEICRTKATPTNRDRATFYLVFDFC-EHDLAGLLSNRK---VRFSLSEIKKVMKGLMNGLYYIH---RNK 144 (376)
T ss_pred HhcchhHHHHHHHHhhccCCcccccceeeeeHHHh-hhhHHHHhcCcc---ccccHHHHHHHHHHHHHHHHHHH---Hhh
Confidence 367999999999886643222 23478999999 558888887654 45899999999999999999999 899
Q ss_pred eeeccccCCceeeCCCCceEecccccccccCCcC----------CCccccccccccCC-CCcCccccchhHHHHHHHHHh
Q 042634 255 IVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEAT----------NNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETFT 323 (427)
Q Consensus 255 ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~----------~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell~ 323 (427)
|+|||+||+|+||+.++.+||+|||+|+...... +-|..|++||.+.+ ..|+++.|||+.|||+.||.+
T Consensus 145 ilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwt 224 (376)
T KOG0669|consen 145 ILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWT 224 (376)
T ss_pred HHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHc
Confidence 9999999999999999999999999998654322 34778999999887 568999999999999999999
Q ss_pred CCCCCCcccCCCc--cHHHHHHHhcccchhcccCccccccc-----cccchhh-hccccccccccchHHHHHHHHHHHhh
Q 042634 324 GKRPTNEMFTGNL--TLHNFVKEALPERLAEIVDPVLLVER-----EEGETSK-ANAHKQFTRSFSVKECLVSVLGIGVT 395 (427)
Q Consensus 324 g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~~ 395 (427)
|.+.+++...... .+........++-+..+..--+.... .++.... ....+++. -.++..+++..
T Consensus 225 rspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~-------kd~~a~dLle~ 297 (376)
T KOG0669|consen 225 RSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYV-------KDDEALDLLEK 297 (376)
T ss_pred cCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhccccc-------CChhHHHHHHH
Confidence 9999876322110 01111111111111111110000000 0000000 00000111 13467899999
Q ss_pred cCCCCCCCCCCHHHHHHH
Q 042634 396 CSSELPRERMNMEEVAAQ 413 (427)
Q Consensus 396 cl~~dP~~Rpt~~ev~~~ 413 (427)
++..||.+|+++++++.+
T Consensus 298 ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 298 LLKLDPTKRIDADQALNH 315 (376)
T ss_pred HhccCcccCcchHhhhch
Confidence 999999999999998854
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=240.50 Aligned_cols=221 Identities=18% Similarity=0.226 Sum_probs=150.8
Q ss_pred cccccchhhhccccccCC-CCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 042634 179 IRHRNLVKIITSCASVDF-QGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVH 257 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivH 257 (427)
++|||++++.+.+..... ......++|+||+ +++|.+++.. ..+++..+..++.|++.||+||| +.||+|
T Consensus 71 l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H 141 (343)
T cd07851 71 MDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIH---SAGIIH 141 (343)
T ss_pred ccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeec
Confidence 579999999887544222 2233479999998 7799888764 34899999999999999999999 899999
Q ss_pred ccccCCceeeCCCCceEecccccccccCCcC---CCccccccccccCC-CCcCccccchhHHHHHHHHHhCCCCCCcccC
Q 042634 258 CDLKPSNVLLDGELTAHVGDFGLAKFLPEAT---NNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETFTGKRPTNEMFT 333 (427)
Q Consensus 258 rDlkp~NIll~~~~~~kL~DFG~a~~~~~~~---~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~ 333 (427)
|||||+||+++.++.+||+|||.+....... .++..|+|||.+.+ ..++.++||||+||++||+++|+.||.....
T Consensus 142 ~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~ 221 (343)
T cd07851 142 RDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH 221 (343)
T ss_pred CCCCHHHeEECCCCCEEEccccccccccccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 9999999999999999999999998764432 56778999999865 3678999999999999999999999975321
Q ss_pred CCccHHHHHHHhcccchhcccCccccccccccchhhhcc--ccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 042634 334 GNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANA--HKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVA 411 (427)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~ 411 (427)
...+... .................. ........... ...+.. .....+.++.+++.+||+.||++|||+.||+
T Consensus 222 -~~~~~~i-~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~--~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell 296 (343)
T cd07851 222 -IDQLKRI-MNLVGTPDEELLQKISSE-SARNYIQSLPQMPKKDFKE--VFSGANPLAIDLLEKMLVLDPDKRITAAEAL 296 (343)
T ss_pred -HHHHHHH-HHhcCCCCHHHHhhccch-hHHHHHHhccccCCCCHHH--HhccCCHHHHHHHHHhCCCChhhCCCHHHHh
Confidence 1111111 111110000111000000 00000000000 000000 0112356789999999999999999999997
Q ss_pred HH
Q 042634 412 AQ 413 (427)
Q Consensus 412 ~~ 413 (427)
+.
T Consensus 297 ~h 298 (343)
T cd07851 297 AH 298 (343)
T ss_pred cC
Confidence 63
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=233.99 Aligned_cols=192 Identities=20% Similarity=0.252 Sum_probs=147.1
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeecc
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCD 259 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrD 259 (427)
+|+||+++++.+. .+...++||||+++++|.+++... ..+++..+..++.|++.||+||| +.|++|||
T Consensus 63 ~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH---~~~i~H~d 130 (290)
T cd05613 63 QSPFLVTLHYAFQ-----TDTKLHLILDYINGGELFTHLSQR----ERFKEQEVQIYSGEIVLALEHLH---KLGIIYRD 130 (290)
T ss_pred cCCChhceeeEee-----cCCeEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccC
Confidence 6899999887743 356788999999999999988654 34888999999999999999999 89999999
Q ss_pred ccCCceeeCCCCceEecccccccccCCc-------CCCccccccccccCCC--CcCccccchhHHHHHHHHHhCCCCCCc
Q 042634 260 LKPSNVLLDGELTAHVGDFGLAKFLPEA-------TNNFFNFQIAEYGMGS--EVSTSGDVYSFGILLLETFTGKRPTNE 330 (427)
Q Consensus 260 lkp~NIll~~~~~~kL~DFG~a~~~~~~-------~~~~~~y~aPE~~~~~--~~~~~~DiwS~G~vl~ell~g~~pf~~ 330 (427)
|||+||+++.++.+||+|||+++..... ..++..|+|||.+... .++.++||||||+++|++++|..||..
T Consensus 131 l~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~ 210 (290)
T cd05613 131 IKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV 210 (290)
T ss_pred CCHHHeEECCCCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCc
Confidence 9999999999999999999999865432 1467889999998753 467899999999999999999999863
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCC-----
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERM----- 405 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rp----- 405 (427)
... .............. . ...+..++..+.+++.+||+.||++||
T Consensus 211 ~~~-~~~~~~~~~~~~~~------~-----------------------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~ 260 (290)
T cd05613 211 DGE-KNSQAEISRRILKS------E-----------------------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPS 260 (290)
T ss_pred CCc-cccHHHHHHHhhcc------C-----------------------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCC
Confidence 211 11111111110000 0 001122455688999999999999997
Q ss_pred CHHHHHHH
Q 042634 406 NMEEVAAQ 413 (427)
Q Consensus 406 t~~ev~~~ 413 (427)
++++++..
T Consensus 261 ~~~~l~~~ 268 (290)
T cd05613 261 DADEIKKH 268 (290)
T ss_pred CHHHHHcC
Confidence 67777653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=232.96 Aligned_cols=187 Identities=23% Similarity=0.335 Sum_probs=150.3
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeecc
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCD 259 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrD 259 (427)
+||||+++++.+. ++...++||||+++++|.+++... ..+++..+..++.|++.||.||| +.|++|+|
T Consensus 60 ~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~d 127 (280)
T cd05581 60 GHPGIIKLYYTFQ-----DEENLYFVLEYAPNGELLQYIRKY----GSLDEKCTRFYAAEILLALEYLH---SKGIIHRD 127 (280)
T ss_pred cCCCchhHHHHhc-----CCceEEEEEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecC
Confidence 4999999998853 356789999999999999998755 35899999999999999999999 89999999
Q ss_pred ccCCceeeCCCCceEecccccccccCCcC--------------------------CCccccccccccCCCCcCccccchh
Q 042634 260 LKPSNVLLDGELTAHVGDFGLAKFLPEAT--------------------------NNFFNFQIAEYGMGSEVSTSGDVYS 313 (427)
Q Consensus 260 lkp~NIll~~~~~~kL~DFG~a~~~~~~~--------------------------~~~~~y~aPE~~~~~~~~~~~DiwS 313 (427)
|||+||+++.++.++|+|||.+....... .++..|+|||......++.++||||
T Consensus 128 l~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~s 207 (280)
T cd05581 128 LKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWA 207 (280)
T ss_pred CCHHHeEECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHH
Confidence 99999999999999999999998654322 3567899999998888999999999
Q ss_pred HHHHHHHHHhCCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHH
Q 042634 314 FGILLLETFTGKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIG 393 (427)
Q Consensus 314 ~G~vl~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 393 (427)
+|+++|++++|+.||.... . . ....... +... ..+...++.+.+++
T Consensus 208 lG~~l~~l~~g~~p~~~~~--~--~-~~~~~~~--------~~~~---------------------~~~~~~~~~~~~li 253 (280)
T cd05581 208 LGCIIYQMLTGKPPFRGSN--E--Y-LTFQKIL--------KLEY---------------------SFPPNFPPDAKDLI 253 (280)
T ss_pred HHHHHHHHHhCCCCCCCcc--H--H-HHHHHHH--------hcCC---------------------CCCCccCHHHHHHH
Confidence 9999999999999997532 0 0 0001100 0000 01122356689999
Q ss_pred hhcCCCCCCCCCCH----HHHHH
Q 042634 394 VTCSSELPRERMNM----EEVAA 412 (427)
Q Consensus 394 ~~cl~~dP~~Rpt~----~ev~~ 412 (427)
.+||+.+|++|||+ +|+++
T Consensus 254 ~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 254 EKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHhcCCHhhCCCcccCHHHHhc
Confidence 99999999999999 77764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=235.49 Aligned_cols=184 Identities=22% Similarity=0.311 Sum_probs=153.3
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
.+.|.||++|.. |.++...|+.||-|-||.+.+.++++ ..|....++.++..+.+|++||| ++|||.|
T Consensus 477 ~~s~fIvrLYrT-----frd~kyvYmLmEaClGGElWTiLrdR----g~Fdd~tarF~~acv~EAfeYLH---~k~iIYR 544 (732)
T KOG0614|consen 477 CRSDFIVRLYRT-----FRDSKYVYMLMEACLGGELWTILRDR----GSFDDYTARFYVACVLEAFEYLH---RKGIIYR 544 (732)
T ss_pred cCchHHHHHHHH-----hccchhhhhhHHhhcCchhhhhhhhc----CCcccchhhhhHHHHHHHHHHHH---hcCceec
Confidence 346888999887 55578899999999999999999887 45999999999999999999999 9999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC-----CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT-----NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFT 333 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~ 333 (427)
||||+|.+++.+|.+||.|||+|+.+..+. +||+.|.|||++..+..+.++|.||+|+++||+++|++||.+.
T Consensus 545 DLKPENllLd~~Gy~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~-- 622 (732)
T KOG0614|consen 545 DLKPENLLLDNRGYLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGV-- 622 (732)
T ss_pred cCChhheeeccCCceEEeehhhHHHhccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCC--
Confidence 999999999999999999999999987665 8999999999999999999999999999999999999999864
Q ss_pred CCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCC
Q 042634 334 GNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMN 406 (427)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt 406 (427)
+.+.....+-..+ |.+- .|........++|++....+|.+|--
T Consensus 623 dpmktYn~ILkGi--------d~i~----------------------~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 623 DPMKTYNLILKGI--------DKIE----------------------FPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred chHHHHHHHHhhh--------hhhh----------------------cccccchhHHHHHHHHHhcCcHhhhc
Confidence 2222222221111 1110 23445566788999999999999864
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-29 Score=238.00 Aligned_cols=219 Identities=19% Similarity=0.237 Sum_probs=149.4
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++.+.+.. .....++++||+ +++|.+++... .+++..+..++.|+++||+||| ..||+||
T Consensus 66 l~hpniv~~~~~~~~----~~~~~~lv~e~~-~~~L~~~~~~~-----~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~ 132 (328)
T cd07856 66 LRHENIISLSDIFIS----PLEDIYFVTELL-GTDLHRLLTSR-----PLEKQFIQYFLYQILRGLKYVH---SAGVVHR 132 (328)
T ss_pred cCCCCeeeEeeeEec----CCCcEEEEeehh-ccCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHH---hCCcccC
Confidence 579999999887532 234678999998 67888877543 3788888999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC---CCccccccccccCC-CCcCccccchhHHHHHHHHHhCCCCCCcccCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT---NNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETFTGKRPTNEMFTG 334 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~---~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~~ 334 (427)
||||+||+++.++.+||+|||.+....... .++..|+|||.+.+ ..++.++|||||||++||+++|+.||.....
T Consensus 133 dl~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~- 211 (328)
T cd07856 133 DLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH- 211 (328)
T ss_pred CCCHHHEeECCCCCEEeCccccccccCCCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCH-
Confidence 999999999999999999999998654332 56778999998766 5689999999999999999999999965321
Q ss_pred CccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 042634 335 NLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAAQ 413 (427)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~ 413 (427)
......+.........+..++.......+.. ...............+.++.++.+++.+||+.+|++|||++|++..
T Consensus 212 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 212 -VNQFSIITDLLGTPPDDVINTICSENTLRFV-QSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred -HHHHHHHHHHhCCCCHHHHHhccchhhHHHH-hhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0011111111110001111100000000000 0000000000000011245678999999999999999999999865
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=239.07 Aligned_cols=222 Identities=19% Similarity=0.240 Sum_probs=149.9
Q ss_pred cccccchhhhccccccCC-CCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 042634 179 IRHRNLVKIITSCASVDF-QGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVH 257 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivH 257 (427)
++||||+++++.+..... ......++|+||+. .++..+.. ..+++..+..++.|++.||+||| ..||+|
T Consensus 71 l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H 140 (342)
T cd07879 71 MQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ-TDLQKIMG------HPLSEDKVQYLVYQMLCGLKYIH---SAGIIH 140 (342)
T ss_pred cCCCCccchhheecccccCCCCceEEEEecccc-cCHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCccc
Confidence 579999999988654221 12234689999984 46665542 24888999999999999999999 899999
Q ss_pred ccccCCceeeCCCCceEecccccccccCCcC---CCccccccccccCC-CCcCccccchhHHHHHHHHHhCCCCCCcccC
Q 042634 258 CDLKPSNVLLDGELTAHVGDFGLAKFLPEAT---NNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETFTGKRPTNEMFT 333 (427)
Q Consensus 258 rDlkp~NIll~~~~~~kL~DFG~a~~~~~~~---~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~ 333 (427)
|||||+||+++.++.+||+|||+++...... .++..|+|||.+.+ ..++.++|||||||++|||++|+.||.+...
T Consensus 141 ~dlkp~NIll~~~~~~kL~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~ 220 (342)
T cd07879 141 RDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY 220 (342)
T ss_pred CCCCHHHEEECCCCCEEEeeCCCCcCCCCCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999999999999999999998754432 55778999999876 4688999999999999999999999975311
Q ss_pred CCccHHHHHHHh-cc-cchhcccCccccccccccchhhhcccccccc---ccchHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 042634 334 GNLTLHNFVKEA-LP-ERLAEIVDPVLLVEREEGETSKANAHKQFTR---SFSVKECLVSVLGIGVTCSSELPRERMNME 408 (427)
Q Consensus 334 ~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ 408 (427)
...+....... .+ +...+........ .... ......+ .......+.++.+++.+||+.||++|||++
T Consensus 221 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~ 292 (342)
T cd07879 221 -LDQLTQILKVTGVPGPEFVQKLEDKAAK-----SYIK--SLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTAT 292 (342)
T ss_pred -HHHHHHHHHhcCCCCHHHHHHhcccchH-----HHHh--hcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHH
Confidence 11111111100 00 0010100000000 0000 0000000 000012345688999999999999999999
Q ss_pred HHHHH--HHHHH
Q 042634 409 EVAAQ--LLSFR 418 (427)
Q Consensus 409 ev~~~--L~~~~ 418 (427)
|++.+ ++.++
T Consensus 293 e~l~h~~f~~~~ 304 (342)
T cd07879 293 EALEHPYFDSFR 304 (342)
T ss_pred HHhcCcchhhcc
Confidence 99965 55554
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-29 Score=237.90 Aligned_cols=212 Identities=20% Similarity=0.224 Sum_probs=149.2
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++.+.. +...++||||+. |+|.+++... ..+++..+..++.|++.||+||| +.||+||
T Consensus 77 l~h~~iv~~~~~~~~-----~~~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~ 143 (335)
T PTZ00024 77 IKHENIMGLVDVYVE-----GDFINLVMDIMA-SDLKKVVDRK----IRLTESQVKCILLQILNGLNVLH---KWYFMHR 143 (335)
T ss_pred CCCcceeeeeEEEec-----CCcEEEEEeccc-cCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecc
Confidence 469999999988543 567899999995 7898888643 35899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC--------------------cCCCccccccccccCCC-CcCccccchhHHHH
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE--------------------ATNNFFNFQIAEYGMGS-EVSTSGDVYSFGIL 317 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~--------------------~~~~~~~y~aPE~~~~~-~~~~~~DiwS~G~v 317 (427)
||||+||+++.++.+||+|||.++.... ...++..|+|||.+.+. .++.++||||+||+
T Consensus 144 dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~ 223 (335)
T PTZ00024 144 DLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCI 223 (335)
T ss_pred cccHHHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHH
Confidence 9999999999999999999999976541 11346679999998764 46899999999999
Q ss_pred HHHHHhCCCCCCcccCCCccHHHHHHHhccc---chhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHh
Q 042634 318 LLETFTGKRPTNEMFTGNLTLHNFVKEALPE---RLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGV 394 (427)
Q Consensus 318 l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 394 (427)
+|||++|..||...... ..+.........+ .+....+....... . .............++.++.+++.
T Consensus 224 l~el~tg~~p~~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~--~------~~~~~~~~~~~~~~~~~~~~li~ 294 (335)
T PTZ00024 224 FAELLTGKPLFPGENEI-DQLGRIFELLGTPNEDNWPQAKKLPLYTEF--T------PRKPKDLKTIFPNASDDAIDLLQ 294 (335)
T ss_pred HHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCchhhCcchhhccccccc--C------cCCcccHHHhCcCCChHHHHHHH
Confidence 99999999999754211 1111111110000 00000000000000 0 00000000011223567889999
Q ss_pred hcCCCCCCCCCCHHHHHH
Q 042634 395 TCSSELPRERMNMEEVAA 412 (427)
Q Consensus 395 ~cl~~dP~~Rpt~~ev~~ 412 (427)
+||+.+|++|||++|++.
T Consensus 295 ~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 295 SLLKLNPLERISAKEALK 312 (335)
T ss_pred HHcCCCchhccCHHHHhc
Confidence 999999999999999986
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-30 Score=224.84 Aligned_cols=198 Identities=24% Similarity=0.251 Sum_probs=148.8
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCccccccc-chhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHP-NREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
..||||++||.+.. ....|+.||.| .-|+..+... .......+++.-.-.|....+.||.||-+ ...|+||
T Consensus 121 ~cp~IVkfyGa~F~-----EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHR 192 (361)
T KOG1006|consen 121 NCPNIVKFYGALFS-----EGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHR 192 (361)
T ss_pred CCcHHHHHhhhhhc-----CCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--Hhhhhhc
Confidence 46999999999643 45679999999 6677655432 12223568888888899999999999986 7899999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc-----CCCccccccccccCC--CCcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMG--SEVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~--~~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
|+||+|||++..|.+||||||.+..+... .+|...|||||.+.. ..|+.++||||+|+++||+.||+.||...
T Consensus 193 DvKPSNILldr~G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w 272 (361)
T KOG1006|consen 193 DVKPSNILLDRHGDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKW 272 (361)
T ss_pred cCChhheEEecCCCEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchH
Confidence 99999999999999999999999876543 378889999999864 35899999999999999999999999764
Q ss_pred cCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 042634 332 FTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVA 411 (427)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~ 411 (427)
..--..+.+.+....| .+.. .....+...++..++..|+-.|-.+||...++.
T Consensus 273 ~svfeql~~Vv~gdpp----~l~~-----------------------~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk 325 (361)
T KOG1006|consen 273 DSVFEQLCQVVIGDPP----ILLF-----------------------DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLK 325 (361)
T ss_pred HHHHHHHHHHHcCCCC----eecC-----------------------cccccccCHHHHHHHHHHhhcccccCcchhhhh
Confidence 2211111111111111 1110 001122456689999999999999999999876
Q ss_pred H
Q 042634 412 A 412 (427)
Q Consensus 412 ~ 412 (427)
+
T Consensus 326 ~ 326 (361)
T KOG1006|consen 326 K 326 (361)
T ss_pred c
Confidence 5
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.9e-29 Score=227.04 Aligned_cols=185 Identities=26% Similarity=0.305 Sum_probs=148.8
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||++++++.+ ..+...+++|||+++++|.+++... ..+++..+..++.|++.|+.|+| ..+++|+
T Consensus 50 l~h~~i~~~~~~~-----~~~~~~~~v~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~ 117 (250)
T cd05123 50 INHPFIVKLHYAF-----QTEEKLYLVLEYAPGGELFSHLSKE----GRFSEERARFYAAEIVLALEYLH---SLGIIYR 117 (250)
T ss_pred cCCCcHHHHHHHe-----ecCCeeEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCceec
Confidence 4599999999874 3367789999999999999998654 34889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||+|+||+++.++.++|+|||.+...... ..++..|+|||...+...+.++|+||||+++||+++|..||....
T Consensus 118 ~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~ 197 (250)
T cd05123 118 DLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED 197 (250)
T ss_pred CCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 99999999999999999999999875442 256778999999988888999999999999999999999996531
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEE 409 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~e 409 (427)
. .+........ .. ..+...+.++.+++.+||..||++|||+.+
T Consensus 198 ~-----~~~~~~~~~~--------~~---------------------~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 198 R-----KEIYEKILKD--------PL---------------------RFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred H-----HHHHHHHhcC--------CC---------------------CCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 1 1111111100 00 011122566889999999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-29 Score=238.69 Aligned_cols=221 Identities=20% Similarity=0.253 Sum_probs=145.3
Q ss_pred cccccchhhhccccccC---------CCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhh
Q 042634 179 IRHRNLVKIITSCASVD---------FQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHH 249 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~---------~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~ 249 (427)
++|||++++++.+.... +......++||||++ ++|.+++.. ..+++..++.++.||+.||+|||
T Consensus 59 l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH- 131 (342)
T cd07854 59 LDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIH- 131 (342)
T ss_pred cCCCcchhhHhhhcccccccccccccccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH-
Confidence 57999999987754321 111235689999995 688877753 24889999999999999999999
Q ss_pred cCCCCeeeccccCCceeeCC-CCceEecccccccccCCc---------CCCccccccccccCC-CCcCccccchhHHHHH
Q 042634 250 YCETPIVHCDLKPSNVLLDG-ELTAHVGDFGLAKFLPEA---------TNNFFNFQIAEYGMG-SEVSTSGDVYSFGILL 318 (427)
Q Consensus 250 ~~~~~ivHrDlkp~NIll~~-~~~~kL~DFG~a~~~~~~---------~~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl 318 (427)
..||+||||||+||+++. +..+||+|||.++..... ..++..|+|||.+.. ..++.++|||||||++
T Consensus 132 --~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil 209 (342)
T cd07854 132 --SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIF 209 (342)
T ss_pred --hCCcccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHH
Confidence 899999999999999974 567899999999764321 246778999998654 5678999999999999
Q ss_pred HHHHhCCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCC
Q 042634 319 LETFTGKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSS 398 (427)
Q Consensus 319 ~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~ 398 (427)
|||++|+.||...... ....... ...+....+......................... ......+.++.+++.+||+
T Consensus 210 ~el~~g~~pf~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~ 285 (342)
T cd07854 210 AEMLTGKPLFAGAHEL-EQMQLIL-ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLR--DLLPGVNPEALDFLEQILT 285 (342)
T ss_pred HHHHhCCCCCCCCCHH-HHHHHHH-HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHH--HHccCCCHHHHHHHHHHhC
Confidence 9999999999753211 1111111 1111000000000000000000000000000000 0011245678899999999
Q ss_pred CCCCCCCCHHHHHH
Q 042634 399 ELPRERMNMEEVAA 412 (427)
Q Consensus 399 ~dP~~Rpt~~ev~~ 412 (427)
.||++|||++|++.
T Consensus 286 ~dP~~R~t~~ell~ 299 (342)
T cd07854 286 FNPMDRLTAEEALM 299 (342)
T ss_pred CCchhccCHHHHhC
Confidence 99999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=228.65 Aligned_cols=214 Identities=22% Similarity=0.244 Sum_probs=150.7
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|+|++++.+.+.. ....++|+||++ ++|.+++.... ..+++..+..++.|++.||+||| ..||+||
T Consensus 55 ~~~~~i~~~~~~~~~-----~~~~~~v~e~~~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~ 122 (282)
T cd07829 55 LKHPNIVKLLDVIHT-----ERKLYLVFEYCD-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCH---SHRILHR 122 (282)
T ss_pred cCCCCHHHHHhhhhc-----CCceEEEecCcC-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHH---HCCcccC
Confidence 359999999998544 467899999996 68999987542 35899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC------CCccccccccccCCC-CcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT------NNFFNFQIAEYGMGS-EVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~------~~~~~y~aPE~~~~~-~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
||+|+||+++.++.+||+|||.++...... .++..|+|||.+.+. .++.++|||||||++||+++|+.||...
T Consensus 123 ~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 202 (282)
T cd07829 123 DLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGD 202 (282)
T ss_pred CCChheEEEcCCCCEEEecCCcccccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 999999999999999999999998654322 345679999998776 7899999999999999999999998653
Q ss_pred cCCCccHHHHHHHhc---ccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 042634 332 FTGNLTLHNFVKEAL---PERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME 408 (427)
Q Consensus 332 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ 408 (427)
.. ...+........ +..+....+-. .. ........ .... ....+..+..+.+++++||+.||++|||++
T Consensus 203 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~-~~---~~~~~~~~-~~~~--~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~ 274 (282)
T cd07829 203 SE-IDQLFKIFQILGTPTEESWPGVTKLP-DY---KPTFPKFP-PKDL--EKVLPRLDPEGIDLLSKMLQYNPAKRISAK 274 (282)
T ss_pred cH-HHHHHHHHHHhCCCcHHHHHhhcccc-cc---cccccccC-ccch--HHhcccccHHHHHHHHHhhccCcccCCCHH
Confidence 21 111111111000 00000000000 00 00000000 0000 000111256799999999999999999999
Q ss_pred HHHH
Q 042634 409 EVAA 412 (427)
Q Consensus 409 ev~~ 412 (427)
|++.
T Consensus 275 ~~l~ 278 (282)
T cd07829 275 EALK 278 (282)
T ss_pred HHhh
Confidence 9975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=231.92 Aligned_cols=221 Identities=20% Similarity=0.198 Sum_probs=146.5
Q ss_pred cccccchhhhccccccCC---CCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 042634 179 IRHRNLVKIITSCASVDF---QGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPI 255 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~---~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~i 255 (427)
++||||+++++.+..... ......++|+||+. +++...+.... ..+++..+..++.|+++||+||| +.||
T Consensus 64 l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~-~~l~~~~~~~~---~~~~~~~~~~i~~~l~~al~~lH---~~~i 136 (311)
T cd07866 64 LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD-HDLSGLLENPS---VKLTESQIKCYMLQLLEGINYLH---ENHI 136 (311)
T ss_pred cCCCCccchhhheecccccccccCceEEEEEecCC-cCHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHH---hCCe
Confidence 579999999887544221 12335689999994 56766665432 45899999999999999999999 8999
Q ss_pred eeccccCCceeeCCCCceEecccccccccCCcC-----------------CCccccccccccCC-CCcCccccchhHHHH
Q 042634 256 VHCDLKPSNVLLDGELTAHVGDFGLAKFLPEAT-----------------NNFFNFQIAEYGMG-SEVSTSGDVYSFGIL 317 (427)
Q Consensus 256 vHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~-----------------~~~~~y~aPE~~~~-~~~~~~~DiwS~G~v 317 (427)
+||||||+||++++++.+||+|||+++...... .++..|+|||.+.+ ..++.++|||||||+
T Consensus 137 ~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~i 216 (311)
T cd07866 137 LHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCV 216 (311)
T ss_pred ecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHH
Confidence 999999999999999999999999998653321 23567999998765 457899999999999
Q ss_pred HHHHHhCCCCCCcccCCCccHHHHHHHhcc--cchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhh
Q 042634 318 LLETFTGKRPTNEMFTGNLTLHNFVKEALP--ERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVT 395 (427)
Q Consensus 318 l~ell~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 395 (427)
+|||++|++||.+.... ............ +......+....... ... .......... ........+.+++.+
T Consensus 217 l~el~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~--~~~~~~~~~~~~i~~ 290 (311)
T cd07866 217 FAEMFTRRPILQGKSDI-DQLHLIFKLCGTPTEETWPGWRSLPGCEG-VHS--FTNYPRTLEE--RFGKLGPEGLDLLSK 290 (311)
T ss_pred HHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCChhhchhhhhcccccc-ccc--CCCCCccHHH--HcccCChhHHHHHHH
Confidence 99999999999753211 111111111000 000000000000000 000 0000000000 001123568899999
Q ss_pred cCCCCCCCCCCHHHHHH
Q 042634 396 CSSELPRERMNMEEVAA 412 (427)
Q Consensus 396 cl~~dP~~Rpt~~ev~~ 412 (427)
|++.||++|||+.|++.
T Consensus 291 ~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 291 LLSLDPYKRLTASDALE 307 (311)
T ss_pred HcccCcccCcCHHHHhc
Confidence 99999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=224.38 Aligned_cols=179 Identities=24% Similarity=0.248 Sum_probs=143.3
Q ss_pred cccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccc
Q 042634 181 HRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDL 260 (427)
Q Consensus 181 Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrDl 260 (427)
-|.++++... |+..+..|.||||+.||+|...+++. ..+.++.+..++.+||-||-||| ++||+.|||
T Consensus 409 ppFL~qlHSc-----FQTmDRLyFVMEyvnGGDLMyhiQQ~----GkFKEp~AvFYAaEiaigLFFLh---~kgIiYRDL 476 (683)
T KOG0696|consen 409 PPFLVQLHSC-----FQTMDRLYFVMEYVNGGDLMYHIQQV----GKFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDL 476 (683)
T ss_pred CchHHHHHHH-----hhhhhheeeEEEEecCchhhhHHHHh----cccCCchhhhhhHHHHHHhhhhh---cCCeeeeec
Confidence 4556666555 45567899999999999999998876 44888999999999999999999 999999999
Q ss_pred cCCceeeCCCCceEecccccccccCC------cCCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccCC
Q 042634 261 KPSNVLLDGELTAHVGDFGLAKFLPE------ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTG 334 (427)
Q Consensus 261 kp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~~ 334 (427)
|.+|||+|.+|++||+|||+++.-.- .-.||+.|+|||++.-++|+.++|+|||||++|||+.|.+||++..
T Consensus 477 KLDNvmLd~eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeD-- 554 (683)
T KOG0696|consen 477 KLDNVMLDSEGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED-- 554 (683)
T ss_pred cccceEeccCCceEeeecccccccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCC--
Confidence 99999999999999999999985322 1289999999999999999999999999999999999999998752
Q ss_pred CccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCC
Q 042634 335 NLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERM 405 (427)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rp 405 (427)
+..+.+.+.+..- .-+...+.+.+++....+...|.+|-
T Consensus 555 E~elF~aI~ehnv--------------------------------syPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 555 EDELFQAIMEHNV--------------------------------SYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred HHHHHHHHHHccC--------------------------------cCcccccHHHHHHHHHHhhcCCcccc
Confidence 2222222222100 02333455677788888888888874
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-28 Score=243.87 Aligned_cols=199 Identities=21% Similarity=0.215 Sum_probs=163.2
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
..|||++.+++++...+...++..|+|||||.+||..++++... ..++.|..+..|++.++.|+.||| ...++||
T Consensus 73 ~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH---~nkviHR 147 (953)
T KOG0587|consen 73 SHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLH---NNKVIHR 147 (953)
T ss_pred cCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHh---hcceeee
Confidence 57999999999988877777889999999999999999987655 367999999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC------CCccccccccccCCC-----CcCccccchhHHHHHHHHHhCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT------NNFFNFQIAEYGMGS-----EVSTSGDVYSFGILLLETFTGKRP 327 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~------~~~~~y~aPE~~~~~-----~~~~~~DiwS~G~vl~ell~g~~p 327 (427)
|||-.|||++.++.+||+|||++..+.... .||+.|||||++... .|+.++|+||+|++..||.-|.+|
T Consensus 148 DikG~NiLLT~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PP 227 (953)
T KOG0587|consen 148 DIKGQNVLLTENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPP 227 (953)
T ss_pred cccCceEEEeccCcEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCC
Confidence 999999999999999999999998775433 899999999998653 368899999999999999999999
Q ss_pred CCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCH
Q 042634 328 TNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM 407 (427)
Q Consensus 328 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~ 407 (427)
+.++-... +-..++..- ......+..-.++|.+++..|+..|-++||++
T Consensus 228 l~DmHPmr------aLF~IpRNP-------------------------PPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~ 276 (953)
T KOG0587|consen 228 LCDMHPMR------ALFLIPRNP-------------------------PPKLKRPKKWSKKFNDFISTCLVKDYEQRPST 276 (953)
T ss_pred ccCcchhh------hhccCCCCC-------------------------CccccchhhHHHHHHHHHHHHHhhccccCcch
Confidence 87641100 000011000 00111244456789999999999999999999
Q ss_pred HHHHHH
Q 042634 408 EEVAAQ 413 (427)
Q Consensus 408 ~ev~~~ 413 (427)
.+++++
T Consensus 277 ~~ll~h 282 (953)
T KOG0587|consen 277 EELLKH 282 (953)
T ss_pred hhhccC
Confidence 998763
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-29 Score=222.04 Aligned_cols=221 Identities=18% Similarity=0.194 Sum_probs=153.5
Q ss_pred cccccchhhhccccccCC-CCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 042634 179 IRHRNLVKIITSCASVDF-QGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVH 257 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivH 257 (427)
+.|+|+++++..+.-... ......|+|||+| ..+|...+.- .++...+.+++.|++.|++||| +.||+|
T Consensus 72 v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m-~~nl~~vi~~------elDH~tis~i~yq~~~~ik~lh---s~~Iih 141 (369)
T KOG0665|consen 72 VNHKNIISLLNVFTPQKTLEEFQEVYLVMELM-DANLCQVILM------ELDHETISYILYQMLCGIKHLH---SAGIIH 141 (369)
T ss_pred hcccceeeeeeccCccccHHHHHhHHHHHHhh-hhHHHHHHHH------hcchHHHHHHHHHHHHHHHHHH---hcceee
Confidence 679999999988644221 1224568999999 7788888762 2778899999999999999999 999999
Q ss_pred ccccCCceeeCCCCceEecccccccccCCcC-----CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 258 CDLKPSNVLLDGELTAHVGDFGLAKFLPEAT-----NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 258 rDlkp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
|||||+||++..+..+||.|||+|+.-.... ..+..|+|||++.+..+...+||||.||++.||++|...|.+.
T Consensus 142 RdLkPsnivv~~~~~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~- 220 (369)
T KOG0665|consen 142 RDLKPSNIVVNSDCTLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK- 220 (369)
T ss_pred cccCcccceecchhheeeccchhhcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc-
Confidence 9999999999999999999999999765552 6677899999999988999999999999999999999988742
Q ss_pred CCCccHHHHHH---Hhc--c----cchhcccCcccc--ccccccchhhhcccccccc-ccchHHHHHHHHHHHhhcCCCC
Q 042634 333 TGNLTLHNFVK---EAL--P----ERLAEIVDPVLL--VEREEGETSKANAHKQFTR-SFSVKECLVSVLGIGVTCSSEL 400 (427)
Q Consensus 333 ~~~~~~~~~~~---~~~--~----~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~cl~~d 400 (427)
..+.+|.+ ... . .++.....-... ..+........-....|.. ...++-....+.+++.+|+-.|
T Consensus 221 ---d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~ 297 (369)
T KOG0665|consen 221 ---DHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVID 297 (369)
T ss_pred ---hHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccC
Confidence 22222211 100 0 011111100000 0000000000000111111 1111123345788999999999
Q ss_pred CCCCCCHHHHHHH
Q 042634 401 PRERMNMEEVAAQ 413 (427)
Q Consensus 401 P~~Rpt~~ev~~~ 413 (427)
|++|.|+++++++
T Consensus 298 pe~Risv~daL~H 310 (369)
T KOG0665|consen 298 PEKRISVDDALRH 310 (369)
T ss_pred hhhcccHHHHhcC
Confidence 9999999999863
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-28 Score=236.31 Aligned_cols=220 Identities=17% Similarity=0.177 Sum_probs=149.9
Q ss_pred cccccchhhhccccccC-CCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 042634 179 IRHRNLVKIITSCASVD-FQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVH 257 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~-~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivH 257 (427)
++||||+++++.+.... .......++||||+ +++|.+++.. ..+++..++.++.|++.||+||| +.||+|
T Consensus 71 l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH---~~gi~H 141 (343)
T cd07880 71 MKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIH---AAGIIH 141 (343)
T ss_pred cCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeec
Confidence 56999999988764321 11112458999999 7899888754 34889999999999999999999 899999
Q ss_pred ccccCCceeeCCCCceEecccccccccCCcC---CCccccccccccCC-CCcCccccchhHHHHHHHHHhCCCCCCcccC
Q 042634 258 CDLKPSNVLLDGELTAHVGDFGLAKFLPEAT---NNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETFTGKRPTNEMFT 333 (427)
Q Consensus 258 rDlkp~NIll~~~~~~kL~DFG~a~~~~~~~---~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~ 333 (427)
|||||+||+++.++.+||+|||.++...... .++..|+|||.+.+ ..++.++||||+||++|++++|+.||.....
T Consensus 142 ~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 221 (343)
T cd07880 142 RDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH 221 (343)
T ss_pred CCCCHHHEEEcCCCCEEEeecccccccccCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999999999999999999998765433 56788999999876 4578999999999999999999999975321
Q ss_pred CCccHHHHHHHhc--ccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 042634 334 GNLTLHNFVKEAL--PERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVA 411 (427)
Q Consensus 334 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~ 411 (427)
. ..+........ +..+...+...... ....................++.++.+++.+|++.||++|||+.|++
T Consensus 222 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l 296 (343)
T cd07880 222 L-DQLMEIMKVTGTPSKEFVQKLQSEDAK----NYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEAL 296 (343)
T ss_pred H-HHHHHHHHhcCCCCHHHHHhhcchhHH----HHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHh
Confidence 1 11111111100 11111111000000 00000000000000001123455688999999999999999999998
Q ss_pred H
Q 042634 412 A 412 (427)
Q Consensus 412 ~ 412 (427)
.
T Consensus 297 ~ 297 (343)
T cd07880 297 A 297 (343)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-28 Score=234.89 Aligned_cols=219 Identities=16% Similarity=0.207 Sum_probs=149.9
Q ss_pred cccccchhhhccccccC-CCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 042634 179 IRHRNLVKIITSCASVD-FQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVH 257 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~-~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivH 257 (427)
++||||+++.+.+.... +......+++++++ +++|.+++.. ..+++..+..++.|+++||+||| +.||+|
T Consensus 73 l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH 143 (345)
T cd07877 73 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIH---SADIIH 143 (345)
T ss_pred cCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeee
Confidence 57999999998764321 12234467888887 8899887754 24889999999999999999999 899999
Q ss_pred ccccCCceeeCCCCceEecccccccccCCcC---CCccccccccccCC-CCcCccccchhHHHHHHHHHhCCCCCCcccC
Q 042634 258 CDLKPSNVLLDGELTAHVGDFGLAKFLPEAT---NNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETFTGKRPTNEMFT 333 (427)
Q Consensus 258 rDlkp~NIll~~~~~~kL~DFG~a~~~~~~~---~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~ 333 (427)
|||||+||+++.++.+||+|||+++...... .++..|+|||.+.+ ..++.++|||||||++|||++|+.||.....
T Consensus 144 ~dlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~ 223 (345)
T cd07877 144 RDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 223 (345)
T ss_pred cCCChHHEEEcCCCCEEEecccccccccccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999999999999999999998764433 56778999999866 5678999999999999999999999964321
Q ss_pred CCccHHHHHHHhc--ccchhcccCccccccccccchhhhcc--ccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 042634 334 GNLTLHNFVKEAL--PERLAEIVDPVLLVEREEGETSKANA--HKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEE 409 (427)
Q Consensus 334 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~e 409 (427)
...+........ +......+..... ......... ...+.. .....+.++.+++.+|++.||++|||+.|
T Consensus 224 -~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dp~~R~t~~e 296 (345)
T cd07877 224 -IDQLKLILRLVGTPGAELLKKISSESA----RNYIQSLTQMPKMNFAN--VFIGANPLAVDLLEKMLVLDSDKRITAAQ 296 (345)
T ss_pred -HHHHHHHHHHhCCCCHHHHhhcccHhH----HHHHHHhcccCCcchhh--hcCCCCHHHHHHHHHHcCCChhhcCCHHH
Confidence 111111111110 0111000000000 000000000 000000 00113456889999999999999999999
Q ss_pred HHHH
Q 042634 410 VAAQ 413 (427)
Q Consensus 410 v~~~ 413 (427)
++.+
T Consensus 297 ~l~h 300 (345)
T cd07877 297 ALAH 300 (345)
T ss_pred HhcC
Confidence 9865
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-29 Score=207.68 Aligned_cols=167 Identities=23% Similarity=0.278 Sum_probs=133.8
Q ss_pred CCceeeccCCcccccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHH
Q 042634 167 GIENLDLSRNNFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDY 246 (427)
Q Consensus 167 ~L~~L~L~~N~ll~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~ 246 (427)
-|..||++ +.-...|.+|.+|+.... ....++.||.| ..||..+.++--.....+++...-+|+..+.+||.|
T Consensus 91 ~L~dldi~-~r~~~CPf~V~FyGa~~r-----egdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~ 163 (282)
T KOG0984|consen 91 LLMDLDII-MRTVDCPFTVHFYGALFR-----EGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEF 163 (282)
T ss_pred HHHhhhhh-ccCCCCCeEEEeehhhhc-----cccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHH
Confidence 34555554 344678999999997432 45789999999 678877765443334668999999999999999999
Q ss_pred HhhcCCCCeeeccccCCceeeCCCCceEecccccccccCCcC-----CCccccccccccCC----CCcCccccchhHHHH
Q 042634 247 LHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEAT-----NNFFNFQIAEYGMG----SEVSTSGDVYSFGIL 317 (427)
Q Consensus 247 LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~y~aPE~~~~----~~~~~~~DiwS~G~v 317 (427)
||+ ...|+|||+||+|||++.+|++|+||||.+..+.... .|...|||||.+.. ..|+.|+||||+|++
T Consensus 164 L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGIt 241 (282)
T KOG0984|consen 164 LHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGIT 241 (282)
T ss_pred HHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhh
Confidence 997 5789999999999999999999999999999886654 67778999998754 368999999999999
Q ss_pred HHHHHhCCCCCCcccCCCccHHHHH
Q 042634 318 LLETFTGKRPTNEMFTGNLTLHNFV 342 (427)
Q Consensus 318 l~ell~g~~pf~~~~~~~~~~~~~~ 342 (427)
+.||.+++.||+.....-..+.+.+
T Consensus 242 miElA~lr~PY~~w~tpF~qLkqvV 266 (282)
T KOG0984|consen 242 MIEMAILRFPYESWGTPFQQLKQVV 266 (282)
T ss_pred hhhhhhccccccccCCHHHHHHHHh
Confidence 9999999999986543333343433
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-29 Score=218.86 Aligned_cols=229 Identities=17% Similarity=0.194 Sum_probs=155.8
Q ss_pred cccccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCee
Q 042634 177 NFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIV 256 (427)
Q Consensus 177 ~ll~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~iv 256 (427)
++.+|.|+...++...-...+--+..|+++|.| ..||.+.+-.. ..++...++-++.||++||+||| +.+|.
T Consensus 107 cfFkHdNVLSaLDILQPph~dfFqEiYV~TELm-QSDLHKIIVSP----Q~Ls~DHvKVFlYQILRGLKYLH---sA~IL 178 (449)
T KOG0664|consen 107 SSFRHDNVLSLLDILQPANPSFFQELYVLTELM-QSDLHKIIVSP----QALTPDHVKVFVYQILRGLKYLH---TANIL 178 (449)
T ss_pred HhhccccHHHHHHhcCCCCchHHHHHHHHHHHH-HhhhhheeccC----CCCCcchhhhhHHHHHhhhHHHh---hcchh
Confidence 457899999998875443332234578899988 78898888655 45999999999999999999999 99999
Q ss_pred eccccCCceeeCCCCceEecccccccccCCcC-------CCccccccccccCCC-CcCccccchhHHHHHHHHHhCCCCC
Q 042634 257 HCDLKPSNVLLDGELTAHVGDFGLAKFLPEAT-------NNFFNFQIAEYGMGS-EVSTSGDVYSFGILLLETFTGKRPT 328 (427)
Q Consensus 257 HrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~-------~~~~~y~aPE~~~~~-~~~~~~DiwS~G~vl~ell~g~~pf 328 (427)
||||||.|.|++++..+||||||+|+...... .-|..|+|||++++. .|+.++||||.|||+.|++.++..|
T Consensus 179 HRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILF 258 (449)
T KOG0664|consen 179 HRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILF 258 (449)
T ss_pred hccCCCccEEeccCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhh
Confidence 99999999999999999999999999865443 456689999999985 5899999999999999999999988
Q ss_pred CcccCCCccHHHHHHHhcc-cchhcccCccccccc-cccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCC
Q 042634 329 NEMFTGNLTLHNFVKEALP-ERLAEIVDPVLLVER-EEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMN 406 (427)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt 406 (427)
..... ..--+.+.+.+. +....+.-.+..... --+.....+...-......+..-..+...+...++..||++|.+
T Consensus 259 QAq~P--iqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris 336 (449)
T KOG0664|consen 259 QAAGP--IEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRIS 336 (449)
T ss_pred hccCh--HHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCccccc
Confidence 75321 111112222111 111111100000000 00000000000000011122223345677888999999999999
Q ss_pred HHHHHHHHH
Q 042634 407 MEEVAAQLL 415 (427)
Q Consensus 407 ~~ev~~~L~ 415 (427)
.++.+..+-
T Consensus 337 ~~~A~~~~~ 345 (449)
T KOG0664|consen 337 VEEALQHRY 345 (449)
T ss_pred Hhhhccccc
Confidence 999877643
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-29 Score=245.80 Aligned_cols=192 Identities=23% Similarity=0.325 Sum_probs=146.0
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
-.|||||++++. -++....||+.|.| ..+|.+++...............+..+.|++.||+||| +.+||||
T Consensus 560 D~H~NviRyyc~-----E~d~qF~YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHR 630 (903)
T KOG1027|consen 560 DEHPNVIRYYCS-----EQDRQFLYIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHR 630 (903)
T ss_pred cCCCceEEEEee-----ccCCceEEEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccc
Confidence 469999999976 34467899999999 77999999874111111122456788999999999999 8999999
Q ss_pred cccCCceeeCC-----CCceEecccccccccCCcC---------CCccccccccccCCCCcCccccchhHHHHHHHHHh-
Q 042634 259 DLKPSNVLLDG-----ELTAHVGDFGLAKFLPEAT---------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT- 323 (427)
Q Consensus 259 Dlkp~NIll~~-----~~~~kL~DFG~a~~~~~~~---------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~- 323 (427)
||||.||||+. ..+++|+|||+++.+..+. .||.+|+|||++....-+.++||||+|||+|+.++
T Consensus 631 DLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltg 710 (903)
T KOG1027|consen 631 DLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTG 710 (903)
T ss_pred cCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecC
Confidence 99999999965 3589999999999876543 78999999999999888899999999999999998
Q ss_pred CCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCC
Q 042634 324 GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRE 403 (427)
Q Consensus 324 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~ 403 (427)
|.+||.+....+..+ +.+. ..... .....+| +..+|+.+|++.||..
T Consensus 711 G~HpFGd~~~R~~NI-------l~~~-~~L~~-----------------------L~~~~d~--eA~dLI~~ml~~dP~~ 757 (903)
T KOG1027|consen 711 GSHPFGDSLERQANI-------LTGN-YTLVH-----------------------LEPLPDC--EAKDLISRMLNPDPQL 757 (903)
T ss_pred CccCCCchHHhhhhh-------hcCc-cceee-----------------------eccCchH--HHHHHHHHhcCCCccc
Confidence 599997642221111 0000 00000 0011222 6889999999999999
Q ss_pred CCCHHHHHH
Q 042634 404 RMNMEEVAA 412 (427)
Q Consensus 404 Rpt~~ev~~ 412 (427)
||||.+|+.
T Consensus 758 RPsa~~VL~ 766 (903)
T KOG1027|consen 758 RPSATDVLN 766 (903)
T ss_pred CCCHHHHhC
Confidence 999999974
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-28 Score=223.23 Aligned_cols=197 Identities=23% Similarity=0.392 Sum_probs=151.5
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||.||++|+++.. ++...|-|+|||+|.+|.-|++.. +.+++.+++.|+.||+.||.||... ...|+|-
T Consensus 524 LDHpRIVKlYDyfsl----DtdsFCTVLEYceGNDLDFYLKQh----klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHY 594 (775)
T KOG1151|consen 524 LDHPRIVKLYDYFSL----DTDSFCTVLEYCEGNDLDFYLKQH----KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHY 594 (775)
T ss_pred cCcceeeeeeeeeee----ccccceeeeeecCCCchhHHHHhh----hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeee
Confidence 789999999998643 246689999999999999999877 4599999999999999999999855 6889999
Q ss_pred cccCCceeeC---CCCceEecccccccccCCcC-------------CCccccccccccCCC----CcCccccchhHHHHH
Q 042634 259 DLKPSNVLLD---GELTAHVGDFGLAKFLPEAT-------------NNFFNFQIAEYGMGS----EVSTSGDVYSFGILL 318 (427)
Q Consensus 259 Dlkp~NIll~---~~~~~kL~DFG~a~~~~~~~-------------~~~~~y~aPE~~~~~----~~~~~~DiwS~G~vl 318 (427)
||||.|||+- .-|.+||.|||+++++.... .||.+|.+||.+.-+ +++.|+||||.|||+
T Consensus 595 DLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIF 674 (775)
T KOG1151|consen 595 DLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIF 674 (775)
T ss_pred ccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhh
Confidence 9999999983 44789999999999875432 789999999998643 478999999999999
Q ss_pred HHHHhCCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCC
Q 042634 319 LETFTGKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSS 398 (427)
Q Consensus 319 ~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~ 398 (427)
|.++.|+.||........ ..... .++... ...|. .-+....+..+++++|++
T Consensus 675 yQClYGrKPFGhnqsQQd----ILqeN------TIlkAt---------------EVqFP---~KPvVsseAkaFIRRCLa 726 (775)
T KOG1151|consen 675 YQCLYGRKPFGHNQSQQD----ILQEN------TILKAT---------------EVQFP---PKPVVSSEAKAFIRRCLA 726 (775)
T ss_pred hhhhccCCCCCCchhHHH----HHhhh------chhcce---------------eccCC---CCCccCHHHHHHHHHHHH
Confidence 999999999975311111 11110 111110 01111 112234457889999999
Q ss_pred CCCCCCCCHHHHHH
Q 042634 399 ELPRERMNMEEVAA 412 (427)
Q Consensus 399 ~dP~~Rpt~~ev~~ 412 (427)
+.-++|...-|+..
T Consensus 727 YRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 727 YRKEDRIDVQQLAC 740 (775)
T ss_pred hhhhhhhhHHHHcc
Confidence 99999988877754
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-28 Score=248.76 Aligned_cols=174 Identities=24% Similarity=0.307 Sum_probs=129.8
Q ss_pred ccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccccCCceeeCCCCceEeccccc
Q 042634 201 SEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGL 280 (427)
Q Consensus 201 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~ 280 (427)
..||-||||+...++++++++... -.....+++++||++||.|+| +.|||||||||.||+++++..|||+|||+
T Consensus 670 ~LYIQMEyCE~~ll~~iI~~N~~~---~~~d~~wrLFreIlEGLaYIH---~~giIHRDLKP~NIFLd~~~~VKIGDFGL 743 (1351)
T KOG1035|consen 670 ILYIQMEYCEKTLLRDIIRRNHFN---SQRDEAWRLFREILEGLAYIH---DQGIIHRDLKPRNIFLDSRNSVKIGDFGL 743 (1351)
T ss_pred EEEEEHhhhhhhHHHHHHHhcccc---hhhHHHHHHHHHHHHHHHHHH---hCceeeccCCcceeEEcCCCCeeeccccc
Confidence 468899999988888888765310 036788999999999999999 89999999999999999999999999999
Q ss_pred ccccC------------------------CcCCCccccccccccCCCC---cCccccchhHHHHHHHHHhCCCCCCcccC
Q 042634 281 AKFLP------------------------EATNNFFNFQIAEYGMGSE---VSTSGDVYSFGILLLETFTGKRPTNEMFT 333 (427)
Q Consensus 281 a~~~~------------------------~~~~~~~~y~aPE~~~~~~---~~~~~DiwS~G~vl~ell~g~~pf~~~~~ 333 (427)
|+... ...+||..|+|||++.+.. |+.|+|+||+|||++||+. ||...-.
T Consensus 744 At~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME 820 (1351)
T KOG1035|consen 744 ATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSME 820 (1351)
T ss_pred chhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHH
Confidence 98621 0127899999999997754 9999999999999999985 4654322
Q ss_pred CCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 334 GNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
....+...-...+|.. ..+ ..+.++. -..++++|++.||.+||||.|++.
T Consensus 821 Ra~iL~~LR~g~iP~~-~~f---------------------------~~~~~~~-e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 821 RASILTNLRKGSIPEP-ADF---------------------------FDPEHPE-EASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHHHhcccCCCCCC-ccc---------------------------ccccchH-HHHHHHHHhcCCCccCCCHHHHhh
Confidence 2111111111111111 111 1122222 367999999999999999999985
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-28 Score=205.92 Aligned_cols=220 Identities=20% Similarity=0.230 Sum_probs=155.5
Q ss_pred ccccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 042634 178 FIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVH 257 (427)
Q Consensus 178 ll~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivH 257 (427)
+..|||||++++...+.. .....+++||..+.+...+. ..++...++.++.|++.||.|+| +.||+|
T Consensus 89 L~gg~NIi~L~DiV~Dp~---SktpaLiFE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCH---S~GImH 155 (338)
T KOG0668|consen 89 LRGGPNIIKLLDIVKDPE---SKTPSLIFEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCH---SMGIMH 155 (338)
T ss_pred ccCCCCeeehhhhhcCcc---ccCchhHhhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHH---hcCccc
Confidence 357999999999865532 45578999999988876665 33777889999999999999999 999999
Q ss_pred ccccCCceeeCCC-CceEecccccccccCCcC-----CCccccccccccCC-CCcCccccchhHHHHHHHHHhCCCCCCc
Q 042634 258 CDLKPSNVLLDGE-LTAHVGDFGLAKFLPEAT-----NNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETFTGKRPTNE 330 (427)
Q Consensus 258 rDlkp~NIll~~~-~~~kL~DFG~a~~~~~~~-----~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell~g~~pf~~ 330 (427)
||+||.|+++|.. ..++|+|+|+|.+...+. ..+..|..||.+.. +.|+..-|+|||||.+..|+..+.||..
T Consensus 156 RDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFh 235 (338)
T KOG0668|consen 156 RDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 235 (338)
T ss_pred ccCCcceeeechhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccC
Confidence 9999999999864 589999999999886655 56677899999877 5689999999999999999999999865
Q ss_pred ccCCCccHHHHHHHhcccchhcc-------cCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCC
Q 042634 331 MFTGNLTLHNFVKEALPERLAEI-------VDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRE 403 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~ 403 (427)
.....+.+...++-.....+... +|+....--+......| ..|..+....-...++.+++.+.+.+|-++
T Consensus 236 G~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w---~~Fi~~~n~hl~~peaiDlldklLrYDHqe 312 (338)
T KOG0668|consen 236 GHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPW---SRFINSENQHLVSPEAIDLLDKLLRYDHQE 312 (338)
T ss_pred CCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccH---HHhCCccccccCChHHHHHHHHHHhhcccc
Confidence 43433333333322222211111 12111110000000000 011111111112356899999999999999
Q ss_pred CCCHHHHHHH
Q 042634 404 RMNMEEVAAQ 413 (427)
Q Consensus 404 Rpt~~ev~~~ 413 (427)
|+|+.|+.++
T Consensus 313 RlTakEam~H 322 (338)
T KOG0668|consen 313 RLTAKEAMAH 322 (338)
T ss_pred ccchHHHhcC
Confidence 9999998764
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=216.88 Aligned_cols=192 Identities=28% Similarity=0.353 Sum_probs=152.5
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|+|++++.+.+.. ....++++||+++++|.+++.... .+++..+..++.+++.++.||| ..+++|+
T Consensus 44 l~~~~i~~~~~~~~~-----~~~~~l~~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~ 111 (244)
T smart00220 44 LKHPNIVRLYDVFED-----EDKLYLVMEYCDGGDLFDLLKKRG----RLSEDEARFYARQILSALEYLH---SNGIIHR 111 (244)
T ss_pred CCCCcHHHHHhheee-----CCEEEEEEeCCCCCCHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHH---HcCeecC
Confidence 379999999998644 457899999999999999886543 2788999999999999999999 8899999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc-----CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFT 333 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~ 333 (427)
||+|+||+++.++.++|+|||.+...... ..++..|++||......++.++||||+|+++|++++|..||.....
T Consensus 112 ~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~ 191 (244)
T smart00220 112 DLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ 191 (244)
T ss_pred CcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 99999999999999999999999877553 3677889999999888899999999999999999999999865311
Q ss_pred CCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 334 GNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
. ....+........ .. ......+.++.+++.+||..+|++|||+.++++
T Consensus 192 ~-~~~~~~~~~~~~~----~~-------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 192 L-LELFKKIGKPKPP----FP-------------------------PPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred H-HHHHHHHhccCCC----Cc-------------------------cccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 1 1111111100000 00 000004567899999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-27 Score=210.41 Aligned_cols=140 Identities=28% Similarity=0.361 Sum_probs=126.7
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
.+||.+|.+... |+.....+.|.||++||+|.-++++++ .++++.++.+..+|+.||.||| ++||+.|
T Consensus 308 sn~pflvglhsc-----fqtesrlffvieyv~ggdlmfhmqrqr----klpeeharfys~ei~lal~flh---~rgiiyr 375 (593)
T KOG0695|consen 308 SNNPFLVGLHSC-----FQTESRLFFVIEYVNGGDLMFHMQRQR----KLPEEHARFYSAEICLALNFLH---ERGIIYR 375 (593)
T ss_pred cCCCeEEehhhh-----hcccceEEEEEEEecCcceeeehhhhh----cCcHHHhhhhhHHHHHHHHHHh---hcCeeee
Confidence 468888888776 555778899999999999998887764 4999999999999999999999 9999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC------cCCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE------ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~ 330 (427)
|+|..|+|+|..|++||.|+|.++..-. .-+||+.|.|||++++..|...+|+|++||+++||+.|+.||+-
T Consensus 376 dlkldnvlldaeghikltdygmcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 376 DLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred eccccceEEccCCceeecccchhhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 9999999999999999999999986422 22899999999999999999999999999999999999999974
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.3e-28 Score=243.69 Aligned_cols=137 Identities=26% Similarity=0.323 Sum_probs=122.1
Q ss_pred ccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeecccc
Q 042634 182 RNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLK 261 (427)
Q Consensus 182 pniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrDlk 261 (427)
+-|+++.-. |+++.+.|+|||||+||||..++.+.. ++++..++.++..|+-||.-+| +-|+||||||
T Consensus 135 ~Wiv~LhyA-----FQD~~~LYlVMdY~pGGDlltLlSk~~----~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiK 202 (1317)
T KOG0612|consen 135 EWIVQLHYA-----FQDERYLYLVMDYMPGGDLLTLLSKFD----RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIK 202 (1317)
T ss_pred HHHHHHHHH-----hcCccceEEEEecccCchHHHHHhhcC----CChHHHHHHHHHHHHHHHHHHH---hccceeccCC
Confidence 456665544 777899999999999999999997763 5999999999999999999999 8999999999
Q ss_pred CCceeeCCCCceEecccccccccCCc-------CCCccccccccccCC-----CCcCccccchhHHHHHHHHHhCCCCCC
Q 042634 262 PSNVLLDGELTAHVGDFGLAKFLPEA-------TNNFFNFQIAEYGMG-----SEVSTSGDVYSFGILLLETFTGKRPTN 329 (427)
Q Consensus 262 p~NIll~~~~~~kL~DFG~a~~~~~~-------~~~~~~y~aPE~~~~-----~~~~~~~DiwS~G~vl~ell~g~~pf~ 329 (427)
|+|||+|..|++||+|||.+-.+..+ .+|||-|.+||++.. +.|++.+|+||+||++|||+.|..||.
T Consensus 203 PDNvLld~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY 282 (1317)
T KOG0612|consen 203 PDNVLLDKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY 282 (1317)
T ss_pred cceeEecccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch
Confidence 99999999999999999999876533 289999999999853 568999999999999999999999997
Q ss_pred c
Q 042634 330 E 330 (427)
Q Consensus 330 ~ 330 (427)
.
T Consensus 283 a 283 (1317)
T KOG0612|consen 283 A 283 (1317)
T ss_pred H
Confidence 4
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.9e-28 Score=242.08 Aligned_cols=197 Identities=18% Similarity=0.143 Sum_probs=128.2
Q ss_pred CCCccceeeeeecCCCcccccccchhh----------------hhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeecccc
Q 042634 198 GNDSEALVYEFMVNGSLEEWLHPNREA----------------LKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLK 261 (427)
Q Consensus 198 ~~~~~~lv~e~~~~g~L~~~l~~~~~~----------------~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrDlk 261 (427)
.....++|+||+.+++|.+++...... ........+..++.|++.||+||| +++|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCC
Confidence 355789999999999999888643210 001123456789999999999999 8999999999
Q ss_pred CCceeeCC-CCceEecccccccccCC-------cCCCccccccccccCCC----------------------CcCccccc
Q 042634 262 PSNVLLDG-ELTAHVGDFGLAKFLPE-------ATNNFFNFQIAEYGMGS----------------------EVSTSGDV 311 (427)
Q Consensus 262 p~NIll~~-~~~~kL~DFG~a~~~~~-------~~~~~~~y~aPE~~~~~----------------------~~~~~~Di 311 (427)
|+|||++. ++.+||+|||+|+.... ...+++.|+|||.+... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999986 57999999999986532 22678899999965322 23456799
Q ss_pred hhHHHHHHHHHhCCCCCCcccCCCccHHHHHHHhcc--cchhcccCccccccccccchhhhccccccccccchHHHHHHH
Q 042634 312 YSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEALP--ERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSV 389 (427)
Q Consensus 312 wS~G~vl~ell~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (427)
|||||++|||+++..+++.. ...+...+..... ..+.....+....+. ...+ ..........
T Consensus 363 wSlGviL~el~~~~~~~~~~---~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~----------~~~~---~~~d~~~~~~ 426 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSN---LIQFNRQLKRNDYDLVAWRKLVEPRASPDL----------RRGF---EVLDLDGGAG 426 (566)
T ss_pred HHHHHHHHHHHhCcCCCchH---HHHHHHHHHhcCCcHHHHHHhhccccchhh----------hhhh---hhccccchHH
Confidence 99999999999977664421 0011111110000 001111110000000 0000 0001122345
Q ss_pred HHHHhhcCCCCCCCCCCHHHHHHH
Q 042634 390 LGIGVTCSSELPRERMNMEEVAAQ 413 (427)
Q Consensus 390 ~~l~~~cl~~dP~~Rpt~~ev~~~ 413 (427)
.+++.+|++.||++|||++|++++
T Consensus 427 ~dLi~~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 427 WELLKSMMRFKGRQRISAKAALAH 450 (566)
T ss_pred HHHHHHHccCCcccCCCHHHHhCC
Confidence 689999999999999999999874
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.5e-28 Score=249.73 Aligned_cols=93 Identities=33% Similarity=0.512 Sum_probs=82.5
Q ss_pred ccccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 042634 178 FIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVH 257 (427)
Q Consensus 178 ll~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivH 257 (427)
.++||||++++..+.. ....++||||+.+++|.+++... ..+++..++.++.||+.||+||| ..||+|
T Consensus 60 ~l~hp~Iv~~~~~~~~-----~~~~~lVmEy~~g~~L~~li~~~----~~l~~~~~~~i~~qil~aL~yLH---~~gIiH 127 (669)
T cd05610 60 LSKSPFIVHLYYSLQS-----ANNVYLVMEYLIGGDVKSLLHIY----GYFDEEMAVKYISEVALALDYLH---RHGIIH 127 (669)
T ss_pred hcCCCCcCeEEEEEEE-----CCEEEEEEeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCEEe
Confidence 3679999999877433 56789999999999999998654 34788999999999999999999 889999
Q ss_pred ccccCCceeeCCCCceEeccccccc
Q 042634 258 CDLKPSNVLLDGELTAHVGDFGLAK 282 (427)
Q Consensus 258 rDlkp~NIll~~~~~~kL~DFG~a~ 282 (427)
|||||+|||++.++.+||+|||+++
T Consensus 128 rDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 128 RDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.6e-28 Score=196.70 Aligned_cols=211 Identities=19% Similarity=0.260 Sum_probs=152.2
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|.|||++++..+. +....+|+||| ..+|.++...-. ..++.+.++.++.|+++|+.|+| ++++.||
T Consensus 58 lkhknivrl~dvlhs-----dkkltlvfe~c-dqdlkkyfdsln---g~~d~~~~rsfmlqllrgl~fch---shnvlhr 125 (292)
T KOG0662|consen 58 LKHKNIVRLHDVLHS-----DKKLTLVFEFC-DQDLKKYFDSLN---GDLDPEIVRSFMLQLLRGLGFCH---SHNVLHR 125 (292)
T ss_pred hhhcceeehhhhhcc-----CceeEEeHHHh-hHHHHHHHHhcC---CcCCHHHHHHHHHHHHhhhhhhh---hhhhhhc
Confidence 579999999998544 67889999999 778888876543 45889999999999999999999 9999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC------CCccccccccccCCCC-cCccccchhHHHHHHHHHh-CCCCCCc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT------NNFFNFQIAEYGMGSE-VSTSGDVYSFGILLLETFT-GKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~------~~~~~y~aPE~~~~~~-~~~~~DiwS~G~vl~ell~-g~~pf~~ 330 (427)
|+||.|.+|+.+|..|++|||+|+..+-.. .-|..|++|.++.+.+ |+...|+||.||++.|+.. |++.|.+
T Consensus 126 dlkpqnllin~ngelkladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg 205 (292)
T KOG0662|consen 126 DLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 205 (292)
T ss_pred cCCcceEEeccCCcEEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCC
Confidence 999999999999999999999999765433 6678999999998865 7999999999999999987 7777776
Q ss_pred ccCCCccHHHHHHHhcc---cchhcccCccccccccccchhhhccccccccccch----HHHHHHHHHHHhhcCCCCCCC
Q 042634 331 MFTGNLTLHNFVKEALP---ERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSV----KECLVSVLGIGVTCSSELPRE 403 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~~cl~~dP~~ 403 (427)
.. .++.+....+.... +++..+.. ..++.. -+.+...... +.....=.+++.+.+.-+|.+
T Consensus 206 ~d-vddqlkrif~~lg~p~ed~wps~t~---lpdyk~--------yp~ypattswsqivp~lns~grdllqkll~cnp~q 273 (292)
T KOG0662|consen 206 ND-VDDQLKRIFRLLGTPTEDQWPSMTK---LPDYKP--------YPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQ 273 (292)
T ss_pred Cc-HHHHHHHHHHHhCCCccccCCcccc---CCCCcc--------cCCccccchHHHHhhhhcchhHHHHHHHhccCccc
Confidence 42 22223332222111 11111110 000000 0001111111 122233467888899999999
Q ss_pred CCCHHHHHHH
Q 042634 404 RMNMEEVAAQ 413 (427)
Q Consensus 404 Rpt~~ev~~~ 413 (427)
|.++++.++.
T Consensus 274 risaeaalqh 283 (292)
T KOG0662|consen 274 RISAEAALQH 283 (292)
T ss_pred ccCHHHHhcC
Confidence 9999998763
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-27 Score=226.02 Aligned_cols=143 Identities=22% Similarity=0.324 Sum_probs=125.6
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeecc
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCD 259 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrD 259 (427)
+.+-||++|-+ |++.+..|+||+|++|||+..+|-+. ..|++..++.++.++..|+++.| .-|+||||
T Consensus 687 Dn~WVVrLyyS-----FQDkdnLYFVMdYIPGGDmMSLLIrm----gIFeE~LARFYIAEltcAiesVH---kmGFIHRD 754 (1034)
T KOG0608|consen 687 DNEWVVRLYYS-----FQDKDNLYFVMDYIPGGDMMSLLIRM----GIFEEDLARFYIAELTCAIESVH---KMGFIHRD 754 (1034)
T ss_pred CCcceEEEEEE-----eccCCceEEEEeccCCccHHHHHHHh----ccCHHHHHHHHHHHHHHHHHHHH---hccceecc
Confidence 45678888876 66678899999999999999998765 45889999999999999999999 89999999
Q ss_pred ccCCceeeCCCCceEecccccccccC---------Cc---------------------------------------CCCc
Q 042634 260 LKPSNVLLDGELTAHVGDFGLAKFLP---------EA---------------------------------------TNNF 291 (427)
Q Consensus 260 lkp~NIll~~~~~~kL~DFG~a~~~~---------~~---------------------------------------~~~~ 291 (427)
|||+|||||.+|++||.|||++.-.. ++ .+||
T Consensus 755 iKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt 834 (1034)
T KOG0608|consen 755 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGT 834 (1034)
T ss_pred cCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCC
Confidence 99999999999999999999996321 00 0789
Q ss_pred cccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccCC
Q 042634 292 FNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTG 334 (427)
Q Consensus 292 ~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~~ 334 (427)
..|+|||++....|+..+|+||.|||||||+.|+.||.....+
T Consensus 835 ~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~ 877 (1034)
T KOG0608|consen 835 PNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPG 877 (1034)
T ss_pred CcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCC
Confidence 9999999999999999999999999999999999999765433
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.8e-27 Score=218.33 Aligned_cols=226 Identities=19% Similarity=0.204 Sum_probs=159.1
Q ss_pred cccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccc
Q 042634 181 HRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDL 260 (427)
Q Consensus 181 Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrDl 260 (427)
-..||++++.+... ..++.+.|+|+|++ |-+|..++..... +.++...++.|++||+.||.|||. +.||+|.||
T Consensus 141 ~~~VV~LlD~Fkhs-GpNG~HVCMVfEvL-GdnLLklI~~s~Y--rGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDl 214 (590)
T KOG1290|consen 141 KKCVVQLLDHFKHS-GPNGQHVCMVFEVL-GDNLLKLIKYSNY--RGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDL 214 (590)
T ss_pred Cceeeeeeccceec-CCCCcEEEEEehhh-hhHHHHHHHHhCC--CCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCC
Confidence 35789999987653 56678999999999 8899999976554 669999999999999999999997 679999999
Q ss_pred cCCceeeC------------------------------------------------------------------------
Q 042634 261 KPSNVLLD------------------------------------------------------------------------ 268 (427)
Q Consensus 261 kp~NIll~------------------------------------------------------------------------ 268 (427)
||+|||+.
T Consensus 215 KPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~ 294 (590)
T KOG1290|consen 215 KPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGI 294 (590)
T ss_pred CcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccc
Confidence 99999982
Q ss_pred ------------------------------------------C-------------------------------------
Q 042634 269 ------------------------------------------G------------------------------------- 269 (427)
Q Consensus 269 ------------------------------------------~------------------------------------- 269 (427)
.
T Consensus 295 ~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~ 374 (590)
T KOG1290|consen 295 EEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTI 374 (590)
T ss_pred cccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCcccc
Confidence 0
Q ss_pred ---------------CCceEecccccccccCCc---CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 270 ---------------ELTAHVGDFGLAKFLPEA---TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 270 ---------------~~~~kL~DFG~a~~~~~~---~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
+.++||+|||-|...... ...|..|+|||++.+..|++.+||||++|++|||+||...|+.-
T Consensus 375 ~~n~~v~p~~~~~~~di~vKIaDlGNACW~~khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePh 454 (590)
T KOG1290|consen 375 ASNPLVNPDIPLPECDIRVKIADLGNACWVHKHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPH 454 (590)
T ss_pred ccccccCCCCCCCccceeEEEeeccchhhhhhhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCC
Confidence 013678888888765432 36788999999999999999999999999999999999999754
Q ss_pred cCCC-----ccHHHHHHH--hcccc-------hhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcC
Q 042634 332 FTGN-----LTLHNFVKE--ALPER-------LAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCS 397 (427)
Q Consensus 332 ~~~~-----~~~~~~~~~--~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl 397 (427)
.+.. +.+...+.- .+|.. .++++++.-.-..-.+...+.....--.....+.+...++.+++.-||
T Consensus 455 sG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmL 534 (590)
T KOG1290|consen 455 SGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPML 534 (590)
T ss_pred CCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHH
Confidence 3322 222222111 11211 112221110000000000000000001122345677899999999999
Q ss_pred CCCCCCCCCHHHHHH
Q 042634 398 SELPRERMNMEEVAA 412 (427)
Q Consensus 398 ~~dP~~Rpt~~ev~~ 412 (427)
+.+|++||||.+.++
T Consensus 535 ef~PeKR~tA~~cl~ 549 (590)
T KOG1290|consen 535 EFDPEKRPTAAQCLK 549 (590)
T ss_pred hcCccccccHHHHhc
Confidence 999999999999885
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-28 Score=227.38 Aligned_cols=191 Identities=22% Similarity=0.306 Sum_probs=153.6
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||.||.+.-.| ...+..++|||-+ +||..+++..... .++++...+.++.||+.||+||| -++|||+
T Consensus 620 l~HPGiV~le~M~-----ET~ervFVVMEKl-~GDMLEMILSsEk--gRL~er~TkFlvtQIL~ALr~LH---~knIvHC 688 (888)
T KOG4236|consen 620 LHHPGIVNLECMF-----ETPERVFVVMEKL-HGDMLEMILSSEK--GRLPERITKFLVTQILVALRYLH---FKNIVHC 688 (888)
T ss_pred cCCCCeeEEEEee-----cCCceEEEEehhh-cchHHHHHHHhhc--ccchHHHHHHHHHHHHHHHHHhh---hcceeec
Confidence 6799999887664 4467889999999 7777776654433 67999999999999999999999 8999999
Q ss_pred cccCCceeeCCC---CceEecccccccccCCcC-----CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCc
Q 042634 259 DLKPSNVLLDGE---LTAHVGDFGLAKFLPEAT-----NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~~---~~~kL~DFG~a~~~~~~~-----~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~ 330 (427)
|+||+|||+.+. -.+||||||+|+++++.. +||+.|.|||+++.+.|+..-|+||.|||+|--++|..||..
T Consensus 689 DLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE 768 (888)
T KOG4236|consen 689 DLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE 768 (888)
T ss_pred cCCchheeeccCCCCCceeeccccceeecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC
Confidence 999999999654 379999999999987765 899999999999999999999999999999999999999965
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
. .++.+.++..- -..+..++.+.....++++...++..-.+|-|.+..
T Consensus 769 d----EdIndQIQNAa----------------------------FMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~ 816 (888)
T KOG4236|consen 769 D----EDINDQIQNAA----------------------------FMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKS 816 (888)
T ss_pred c----cchhHHhhccc----------------------------cccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhh
Confidence 2 22222222110 001122456667778999999999999999998765
Q ss_pred HH
Q 042634 411 AA 412 (427)
Q Consensus 411 ~~ 412 (427)
+.
T Consensus 817 ls 818 (888)
T KOG4236|consen 817 LS 818 (888)
T ss_pred cc
Confidence 43
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.2e-27 Score=218.05 Aligned_cols=222 Identities=19% Similarity=0.211 Sum_probs=156.6
Q ss_pred ccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeecccc
Q 042634 182 RNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLK 261 (427)
Q Consensus 182 pniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrDlk 261 (427)
-|+++++.. |...++.|+|+|-+ ..+|.+++++.... ..|....+..++.|+.-||.+|- ..||+|.|||
T Consensus 494 ~Hclrl~r~-----F~hknHLClVFE~L-slNLRevLKKyG~n-vGL~ikaVRsYaqQLflALklLK---~c~vlHaDIK 563 (752)
T KOG0670|consen 494 FHCLRLFRH-----FKHKNHLCLVFEPL-SLNLREVLKKYGRN-VGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIK 563 (752)
T ss_pred hHHHHHHHH-----hhhcceeEEEehhh-hchHHHHHHHhCcc-cceeehHHHHHHHHHHHHHHHHH---hcCeeecccC
Confidence 356777766 44478999999987 77999999865432 45888999999999999999999 8999999999
Q ss_pred CCceeeCCC-CceEecccccccccCCcCCCc----cccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccCCCc
Q 042634 262 PSNVLLDGE-LTAHVGDFGLAKFLPEATNNF----FNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNL 336 (427)
Q Consensus 262 p~NIll~~~-~~~kL~DFG~a~~~~~~~~~~----~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~~~~ 336 (427)
|.|||+++. ..+||||||.|....+....+ ..|+|||++.+-+|++..|+||.||++||++||+..|.+.....+
T Consensus 564 PDNiLVNE~k~iLKLCDfGSA~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~M 643 (752)
T KOG0670|consen 564 PDNILVNESKNILKLCDFGSASFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQM 643 (752)
T ss_pred ccceEeccCcceeeeccCccccccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHH
Confidence 999999865 579999999999887776443 479999999999999999999999999999999999987644332
Q ss_pred c-HHHHHHHhcccch-------hcccCccccccccccchh----------------hhccccccc--cccchHHHHHHHH
Q 042634 337 T-LHNFVKEALPERL-------AEIVDPVLLVEREEGETS----------------KANAHKQFT--RSFSVKECLVSVL 390 (427)
Q Consensus 337 ~-~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~--~~~~~~~~~~~~~ 390 (427)
. +..-+...+|..+ ...+|..+..-+-+.... ......... -.........++.
T Consensus 644 Lrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~r 723 (752)
T KOG0670|consen 644 LRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLR 723 (752)
T ss_pred HHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHH
Confidence 1 1111222222111 111222111100000000 000000000 0112233567899
Q ss_pred HHHhhcCCCCCCCCCCHHHHHHH
Q 042634 391 GIGVTCSSELPRERMNMEEVAAQ 413 (427)
Q Consensus 391 ~l~~~cl~~dP~~Rpt~~ev~~~ 413 (427)
+|+..|+..||++|.|..|++++
T Consensus 724 dLLdkml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 724 DLLDKMLILDPEKRITVNQALKH 746 (752)
T ss_pred HHHHHHhccChhhcCCHHHHhcC
Confidence 99999999999999999998864
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.5e-26 Score=196.00 Aligned_cols=199 Identities=20% Similarity=0.280 Sum_probs=148.7
Q ss_pred cccccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCee
Q 042634 177 NFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIV 256 (427)
Q Consensus 177 ~ll~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~iv 256 (427)
.+..|.||+..|++. |+..+..+.++||++.|||.+-+... .+-+...+.++.|+++|+.||| ++++|
T Consensus 76 ~Ls~H~hIi~tY~va----Fqt~d~YvF~qE~aP~gdL~snv~~~-----GigE~~~K~v~~ql~SAi~fMH---sknlV 143 (378)
T KOG1345|consen 76 FLSPHQHIIDTYEVA----FQTSDAYVFVQEFAPRGDLRSNVEAA-----GIGEANTKKVFAQLLSAIEFMH---SKNLV 143 (378)
T ss_pred eeccchhhhHHHHHH----hhcCceEEEeeccCccchhhhhcCcc-----cccHHHHHHHHHHHHHHHHHhh---ccchh
Confidence 445799999998874 55566788999999999999988764 3778889999999999999999 99999
Q ss_pred eccccCCceee-C-CCCceEecccccccccCCcC---CCccccccccccCCC-----CcCccccchhHHHHHHHHHhCCC
Q 042634 257 HCDLKPSNVLL-D-GELTAHVGDFGLAKFLPEAT---NNFFNFQIAEYGMGS-----EVSTSGDVYSFGILLLETFTGKR 326 (427)
Q Consensus 257 HrDlkp~NIll-~-~~~~~kL~DFG~a~~~~~~~---~~~~~y~aPE~~~~~-----~~~~~~DiwS~G~vl~ell~g~~ 326 (427)
|||||.+|||| + +..++||||||..+..+... ..+..|.+||..... ...+.+|||.||+++|.+++|..
T Consensus 144 HRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~ 223 (378)
T KOG1345|consen 144 HRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKF 223 (378)
T ss_pred hcccccceEEEecCCccEEEeeecccccccCceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCC
Confidence 99999999999 3 33589999999998754432 445578999986543 24778999999999999999999
Q ss_pred CCCcccCCCccHHHHHHHhcc--cchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCC
Q 042634 327 PTNEMFTGNLTLHNFVKEALP--ERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRER 404 (427)
Q Consensus 327 pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~R 404 (427)
||+.....+..+.++..-.-. ..+.+... ...+.+.++.++-+..+|++|
T Consensus 224 PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~----------------------------~fs~~a~r~Fkk~lt~~~~dr 275 (378)
T KOG1345|consen 224 PWQKASIMDKPYWEWEQWLKRKNPALPKKFN----------------------------PFSEKALRLFKKSLTPRFKDR 275 (378)
T ss_pred cchhhhccCchHHHHHHHhcccCccCchhhc----------------------------ccCHHHHHHHHHhcCCccccc
Confidence 999665555555554432211 11111111 123446778888999999999
Q ss_pred CCHHHHHHHHH
Q 042634 405 MNMEEVAAQLL 415 (427)
Q Consensus 405 pt~~ev~~~L~ 415 (427)
--..++.+...
T Consensus 276 cki~~~kk~rk 286 (378)
T KOG1345|consen 276 CKIWTAKKMRK 286 (378)
T ss_pred chhHHHHHHHH
Confidence 65555555443
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-24 Score=214.63 Aligned_cols=209 Identities=17% Similarity=0.155 Sum_probs=137.7
Q ss_pred cccchhhhccccccCC---CCCCccceeeeeecCCCcccccccchh--------------------hhhccCHHHHHHHH
Q 042634 181 HRNLVKIITSCASVDF---QGNDSEALVYEFMVNGSLEEWLHPNRE--------------------ALKNLNLLQRLSIA 237 (427)
Q Consensus 181 Hpniv~~~~~~~~~~~---~~~~~~~lv~e~~~~g~L~~~l~~~~~--------------------~~~~l~~~~~~~~~ 237 (427)
++++++++++|..... ......++||||+++++|.++++.... ....+++..++.++
T Consensus 236 ~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~ 315 (507)
T PLN03224 236 AASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVM 315 (507)
T ss_pred hhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHH
Confidence 3445666666543211 112457999999999999998864210 01234677889999
Q ss_pred HHHHHHHHHHhhcCCCCeeeccccCCceeeCCCCceEecccccccccCCcC-------CCccccccccccCCCCc-----
Q 042634 238 VDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEAT-------NNFFNFQIAEYGMGSEV----- 305 (427)
Q Consensus 238 ~~i~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~-------~~~~~y~aPE~~~~~~~----- 305 (427)
.|++.||.|+| ..+|+||||||+||+++.++.+||+|||+++...... .+++.|+|||.+.....
T Consensus 316 ~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~ 392 (507)
T PLN03224 316 RQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAP 392 (507)
T ss_pred HHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccc
Confidence 99999999999 8999999999999999999999999999997653321 34678999998754321
Q ss_pred -----------------CccccchhHHHHHHHHHhCCC-CCCcccCCCccHHHHHHHhcccchhcccCccccccccccch
Q 042634 306 -----------------STSGDVYSFGILLLETFTGKR-PTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGET 367 (427)
Q Consensus 306 -----------------~~~~DiwS~G~vl~ell~g~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (427)
..+.||||+||++|+|++|.. ||.........+...- .....+.......
T Consensus 393 ~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~--~~~~~~r~~~~~~---------- 460 (507)
T PLN03224 393 APAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYD--NDLNRWRMYKGQK---------- 460 (507)
T ss_pred hhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhcc--chHHHHHhhcccC----------
Confidence 134799999999999999875 6653211100000000 0000000000000
Q ss_pred hhhccccccccccchHHHHHHHHHHHhhcCCCCC---CCCCCHHHHHHH
Q 042634 368 SKANAHKQFTRSFSVKECLVSVLGIGVTCSSELP---RERMNMEEVAAQ 413 (427)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP---~~Rpt~~ev~~~ 413 (427)
..+ ...........+++.+|+..+| .+|+|++|++++
T Consensus 461 ------~~~---~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 461 ------YDF---SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred ------CCc---ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 000 0122345678899999999766 689999999864
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-25 Score=211.70 Aligned_cols=139 Identities=23% Similarity=0.341 Sum_probs=125.4
Q ss_pred ccccchhhhccccccCCCCCCccceeeeee-cCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFM-VNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~-~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
.|+||+++++. |.+++..|++||-- ++-+|++++.-. ..+++.+++.|++|++.|+++|| +.|||||
T Consensus 627 sH~NIlKlLdf-----FEddd~yyl~te~hg~gIDLFd~IE~k----p~m~E~eAk~IFkQV~agi~hlh---~~~ivhr 694 (772)
T KOG1152|consen 627 SHENILKLLDF-----FEDDDYYYLETEVHGEGIDLFDFIEFK----PRMDEPEAKLIFKQVVAGIKHLH---DQGIVHR 694 (772)
T ss_pred Cccchhhhhhe-----eecCCeeEEEecCCCCCcchhhhhhcc----CccchHHHHHHHHHHHhcccccc---ccCceec
Confidence 49999999998 55688899999965 345999999766 45999999999999999999999 9999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC----CCccccccccccCCCCc-CccccchhHHHHHHHHHhCCCCCCc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT----NNFFNFQIAEYGMGSEV-STSGDVYSFGILLLETFTGKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~----~~~~~y~aPE~~~~~~~-~~~~DiwS~G~vl~ell~g~~pf~~ 330 (427)
|||-+|+.++.+|.+||+|||.|.....+. .||..|.|||++.+.+| +..-||||+|+++|.++....||..
T Consensus 695 dikdenvivd~~g~~klidfgsaa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 695 DIKDENVIVDSNGFVKLIDFGSAAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred ccccccEEEecCCeEEEeeccchhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 999999999999999999999998877665 89999999999999888 5678999999999999999999864
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.3e-24 Score=196.03 Aligned_cols=220 Identities=20% Similarity=0.257 Sum_probs=152.5
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
..+.||+++.+. +..++..++|+||+++.+..++.. .++..+++.+++.+..||+|+| ..|||||
T Consensus 92 gG~~ni~~~~~~-----~rnnd~v~ivlp~~~H~~f~~l~~-------~l~~~~i~~Yl~~ll~Al~~~h---~~GIvHR 156 (418)
T KOG1167|consen 92 GGSDNIIKLNGC-----FRNNDQVAIVLPYFEHDRFRDLYR-------SLSLAEIRWYLRNLLKALAHLH---KNGIVHR 156 (418)
T ss_pred ccchhhhcchhh-----hccCCeeEEEecccCccCHHHHHh-------cCCHHHHHHHHHHHHHHhhhhh---ccCcccc
Confidence 457788888887 455788999999999988877763 3678899999999999999999 9999999
Q ss_pred cccCCceeeCC-CCceEeccccccccc-----------------CC---------------------------------c
Q 042634 259 DLKPSNVLLDG-ELTAHVGDFGLAKFL-----------------PE---------------------------------A 287 (427)
Q Consensus 259 Dlkp~NIll~~-~~~~kL~DFG~a~~~-----------------~~---------------------------------~ 287 (427)
||||.|+|.+. .++..|+|||+|... .. .
T Consensus 157 DiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~an 236 (418)
T KOG1167|consen 157 DIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERAN 236 (418)
T ss_pred CCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecc
Confidence 99999999975 468899999999711 00 0
Q ss_pred CCCccccccccccCC-CCcCccccchhHHHHHHHHHhCCCCCCcccCCCccHHHHHHHhcccchhc---ccCc--ccccc
Q 042634 288 TNNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEALPERLAE---IVDP--VLLVE 361 (427)
Q Consensus 288 ~~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~~--~~~~~ 361 (427)
..||++|+|||++.. +.-+.++||||.|||+..+++++.||.....+...+.+.+.-..+..++. ..+. .+...
T Consensus 237 rAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ks 316 (418)
T KOG1167|consen 237 RAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKS 316 (418)
T ss_pred cCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccc
Confidence 178999999999876 45689999999999999999999999876555554444332221111111 1111 00000
Q ss_pred c-cc-----cchhhh--ccc---cc--cccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 042634 362 R-EE-----GETSKA--NAH---KQ--FTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAAQ 413 (427)
Q Consensus 362 ~-~~-----~~~~~~--~~~---~~--~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~ 413 (427)
. .. ..+... ..- .. .......+..+..+++++.+|++.||.+|.|++|.+++
T Consensus 317 n~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 317 NIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred cccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 0 00 000000 000 00 01111112234478999999999999999999999864
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-23 Score=227.14 Aligned_cols=176 Identities=44% Similarity=0.626 Sum_probs=110.1
Q ss_pred eeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccC
Q 042634 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNL 81 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~ 81 (427)
|+|++|.+++.+|..++.+++|++|+|++|.+.+.+|..++++++|++|+|++|.+++.+|..++.+++|++|++++|.+
T Consensus 145 L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l 224 (968)
T PLN00113 145 LDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNL 224 (968)
T ss_pred EECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCcc
Confidence 56666666666666666666666666666666666666666666666666666666666666666666666666666666
Q ss_pred cccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCCCC
Q 042634 82 TGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSS 161 (427)
Q Consensus 82 ~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~~ 161 (427)
++.+|..+.++.+| +.|++++|.+++.+|..++++++|+.|++++|++++.+|..++++++|+.|++++|.+.+.+|..
T Consensus 225 ~~~~p~~l~~l~~L-~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~ 303 (968)
T PLN00113 225 SGEIPYEIGGLTSL-NHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPEL 303 (968)
T ss_pred CCcCChhHhcCCCC-CEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChh
Confidence 66666666666666 45666666666666666666666666666666666555655555555555555555555555555
Q ss_pred cccccCCceeeccCCcc
Q 042634 162 LSSLRGIENLDLSRNNF 178 (427)
Q Consensus 162 l~~l~~L~~L~L~~N~l 178 (427)
+..+++|+.|++++|.+
T Consensus 304 ~~~l~~L~~L~l~~n~~ 320 (968)
T PLN00113 304 VIQLQNLEILHLFSNNF 320 (968)
T ss_pred HcCCCCCcEEECCCCcc
Confidence 55555555555544433
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.4e-24 Score=213.85 Aligned_cols=196 Identities=18% Similarity=0.196 Sum_probs=150.8
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
+.|||++..+..+... ....-+||||++ ||+.++... ..++..++-.+++|++.|++|+| ..||.||
T Consensus 378 l~h~~~~e~l~~~~~~-----~~~~~~mE~~~~-Dlf~~~~~~----~~~~~~e~~c~fKqL~~Gv~y~h---~~Giahr 444 (601)
T KOG0590|consen 378 LSHPNIIETLDIVQEI-----DGILQSMEYCPY-DLFSLVMSN----GKLTPLEADCFFKQLLRGVKYLH---SMGLAHR 444 (601)
T ss_pred ccCCchhhhHHHHhhc-----ccchhhhhcccH-HHHHHHhcc----cccchhhhhHHHHHHHHHHHHHH---hcCceec
Confidence 6899998877765442 222333999999 999998764 24888999999999999999999 9999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC----------cCCCccccccccccCCCCcCc-cccchhHHHHHHHHHhCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE----------ATNNFFNFQIAEYGMGSEVST-SGDVYSFGILLLETFTGKRP 327 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~----------~~~~~~~y~aPE~~~~~~~~~-~~DiwS~G~vl~ell~g~~p 327 (427)
|+|++|++++.++.+||+|||.+..... +..|+..|.|||++.+.+|++ .+||||.|+++..|++|+.|
T Consensus 445 dlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~ 524 (601)
T KOG0590|consen 445 DLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFP 524 (601)
T ss_pred cCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCc
Confidence 9999999999999999999999986432 227888999999999999976 48999999999999999999
Q ss_pred CCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCH
Q 042634 328 TNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM 407 (427)
Q Consensus 328 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~ 407 (427)
|......+..+.... .... ..+ ...+.......+.+...+|.+|+++||.+|.|+
T Consensus 525 Wk~a~~~~~~~~~~~---~~~~-~~~---------------------~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti 579 (601)
T KOG0590|consen 525 WKVAKKSDNSFKTNN---YSDQ-RNI---------------------FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITI 579 (601)
T ss_pred cccccccccchhhhc---cccc-ccc---------------------ccChHHHHHhchhhHHHHHHHHccCChhheecH
Confidence 986544433320000 0000 000 001111334556778889999999999999999
Q ss_pred HHHHH
Q 042634 408 EEVAA 412 (427)
Q Consensus 408 ~ev~~ 412 (427)
++|++
T Consensus 580 ~~i~~ 584 (601)
T KOG0590|consen 580 EQILN 584 (601)
T ss_pred HHHhh
Confidence 99986
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.1e-23 Score=181.68 Aligned_cols=159 Identities=29% Similarity=0.456 Sum_probs=137.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
+.|++++++++.+.. ....++++||+++++|.+++.... ..+++..+..++.++++++++|| ..|++|+
T Consensus 48 l~~~~i~~~~~~~~~-----~~~~~~~~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~ 116 (215)
T cd00180 48 LNHPNIVKLYGVFED-----ENHLYLVMEYCEGGSLKDLLKENE---GKLSEDEILRILLQILEGLEYLH---SNGIIHR 116 (215)
T ss_pred cCCCCeeeEeeeeec-----CCeEEEEEecCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeecc
Confidence 456899998887543 357899999999899999886542 24888999999999999999999 8899999
Q ss_pred cccCCceeeCC-CCceEecccccccccCCc------CCCccccccccccCCC-CcCccccchhHHHHHHHHHhCCCCCCc
Q 042634 259 DLKPSNVLLDG-ELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMGS-EVSTSGDVYSFGILLLETFTGKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~-~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~~-~~~~~~DiwS~G~vl~ell~g~~pf~~ 330 (427)
||+|.||+++. ++.++|+|||.+...... ..+...|++||..... ..+.++|+|++|++++++
T Consensus 117 dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------- 187 (215)
T cd00180 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------- 187 (215)
T ss_pred CCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------
Confidence 99999999999 899999999999876543 3567789999998877 788999999999999998
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
.++.+++.+|++.+|++|||++++
T Consensus 188 --------------------------------------------------------~~~~~~l~~~l~~~p~~R~~~~~l 211 (215)
T cd00180 188 --------------------------------------------------------PELKDLIRKMLQKDPEKRPSAKEI 211 (215)
T ss_pred --------------------------------------------------------HHHHHHHHHHhhCCcccCcCHHHH
Confidence 125779999999999999999999
Q ss_pred HHH
Q 042634 411 AAQ 413 (427)
Q Consensus 411 ~~~ 413 (427)
++.
T Consensus 212 ~~~ 214 (215)
T cd00180 212 LEH 214 (215)
T ss_pred hhC
Confidence 875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.9e-23 Score=201.08 Aligned_cols=193 Identities=20% Similarity=0.260 Sum_probs=147.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
-+|||||.+++.+.. ....+++||||.+|+|++..+.. .++++.++..+.++.++|++||| +.|-+||
T Consensus 69 c~h~nivay~gsylr-----~dklwicMEycgggslQdiy~~T----gplselqiayvcRetl~gl~ylh---s~gk~hR 136 (829)
T KOG0576|consen 69 CRHPNIVAYFGSYLR-----RDKLWICMEYCGGGSLQDIYHVT----GPLSELQIAYVCRETLQGLKYLH---SQGKIHR 136 (829)
T ss_pred CCCcChHHHHhhhhh-----hcCcEEEEEecCCCcccceeeec----ccchhHHHHHHHhhhhccchhhh---cCCcccc
Confidence 469999999998544 56889999999999999987765 45999999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC------cCCCccccccccccC---CCCcCccccchhHHHHHHHHHhCCCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE------ATNNFFNFQIAEYGM---GSEVSTSGDVYSFGILLLETFTGKRPTN 329 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~~y~aPE~~~---~~~~~~~~DiwS~G~vl~ell~g~~pf~ 329 (427)
|||-.||++++.+.+|++|||.+..+.. ...||+.|||||+.. ...|...+|||+.|++..|+-.-.+|-.
T Consensus 137 diKGanilltd~gDvklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplf 216 (829)
T KOG0576|consen 137 DIKGANILLTDEGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLF 216 (829)
T ss_pred cccccceeecccCceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccc
Confidence 9999999999999999999999976532 348999999999864 3568999999999999999987776632
Q ss_pred cccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 042634 330 EMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEE 409 (427)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~e 409 (427)
+.-. ......+.+. ..++-...+ ...-.+-|.++++.|+..+|++|||++-
T Consensus 217 dlhp--mr~l~LmTkS-------~~qpp~lkD--------------------k~kws~~fh~fvK~altknpKkRptaek 267 (829)
T KOG0576|consen 217 DLHP--MRALFLMTKS-------GFQPPTLKD--------------------KTKWSEFFHNFVKGALTKNPKKRPTAEK 267 (829)
T ss_pred ccch--HHHHHHhhcc-------CCCCCcccC--------------------CccchHHHHHHHHHHhcCCCccCCChhh
Confidence 2100 0000000110 011100000 0011345788999999999999999997
Q ss_pred HHH
Q 042634 410 VAA 412 (427)
Q Consensus 410 v~~ 412 (427)
++.
T Consensus 268 lL~ 270 (829)
T KOG0576|consen 268 LLQ 270 (829)
T ss_pred hee
Confidence 765
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-22 Score=175.53 Aligned_cols=200 Identities=22% Similarity=0.279 Sum_probs=151.4
Q ss_pred ccccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 042634 178 FIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVH 257 (427)
Q Consensus 178 ll~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivH 257 (427)
+..||||+.+++.|.. .....++..||+.|+|+..+++... ...+..++.+++.++|+|+.|||+. +.-|.-
T Consensus 243 ifshpnilpvlgacns-----ppnlv~isq~mp~gslynvlhe~t~--vvvd~sqav~faldiargmaflhsl-ep~ipr 314 (448)
T KOG0195|consen 243 IFSHPNILPVLGACNS-----PPNLVIISQYMPFGSLYNVLHEQTS--VVVDHSQAVRFALDIARGMAFLHSL-EPMIPR 314 (448)
T ss_pred eecCCchhhhhhhccC-----CCCceEeeeeccchHHHHHHhcCcc--EEEecchHHHHHHHHHhhHHHHhhc-chhhhh
Confidence 3579999999999876 3567899999999999999987654 5577889999999999999999974 344445
Q ss_pred ccccCCceeeCCCCceEec--ccccccccCCcCCCccccccccccCCCCc---CccccchhHHHHHHHHHhCCCCCCccc
Q 042634 258 CDLKPSNVLLDGELTAHVG--DFGLAKFLPEATNNFFNFQIAEYGMGSEV---STSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 258 rDlkp~NIll~~~~~~kL~--DFG~a~~~~~~~~~~~~y~aPE~~~~~~~---~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
--+.+..+++|++.+++|+ |--++ +...+..-.+.||+||.+...+- -.++|+|||++++||+.|+..||.+..
T Consensus 315 ~~lns~hvmidedltarismad~kfs-fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadls 393 (448)
T KOG0195|consen 315 FYLNSKHVMIDEDLTARISMADTKFS-FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLS 393 (448)
T ss_pred hhcccceEEecchhhhheecccceee-eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCC
Confidence 5789999999999888773 32222 12334466788999999987654 357999999999999999999998653
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
.-+..+.-. -+.+. ...++.....+.++|.-|+..||.+||.++.|+-
T Consensus 394 pmecgmkia-leglr-------------------------------v~ippgis~hm~klm~icmnedpgkrpkfdmivp 441 (448)
T KOG0195|consen 394 PMECGMKIA-LEGLR-------------------------------VHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVP 441 (448)
T ss_pred chhhhhhhh-hcccc-------------------------------ccCCCCccHHHHHHHHHHhcCCCCcCCCcceehh
Confidence 322221111 01111 1123334556788999999999999999999999
Q ss_pred HHHHHH
Q 042634 413 QLLSFR 418 (427)
Q Consensus 413 ~L~~~~ 418 (427)
.|+++.
T Consensus 442 ilekm~ 447 (448)
T KOG0195|consen 442 ILEKMI 447 (448)
T ss_pred hHHHhc
Confidence 998864
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.4e-21 Score=186.75 Aligned_cols=205 Identities=26% Similarity=0.393 Sum_probs=156.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
+.|.|+.++++.+.. +...++|.+||..|+|.+.+.... ..+++.....++++|+.||+|+|+ +..-.|+
T Consensus 4 l~h~n~~~f~g~~~~-----~~~~~~i~~~c~rGsl~D~i~~~~---~~~d~~F~~s~~rdi~~Gl~ylh~--s~i~~hg 73 (484)
T KOG1023|consen 4 LDHDNLNKFIGASVD-----GPEMIVIWEYCSRGSLLDILSNED---IKLDYFFILSFIRDISKGLAYLHN--SPIGYHG 73 (484)
T ss_pred cchhhhhhheeeEec-----CCceEEEEeeecCccHHhHHhccc---cCccHHHHHHHHHHHHHHHHHHhc--Ccceeee
Confidence 579999999999755 367889999999999999997743 458889999999999999999994 3333999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc---C-----CCccccccccccCCCC-------cCccccchhHHHHHHHHHh
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA---T-----NNFFNFQIAEYGMGSE-------VSTSGDVYSFGILLLETFT 323 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~---~-----~~~~~y~aPE~~~~~~-------~~~~~DiwS~G~vl~ell~ 323 (427)
.+++.|++++....+||+|||+....... . ....-|.|||.+.+.. .+.+.||||||++++|+++
T Consensus 74 ~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~ 153 (484)
T KOG1023|consen 74 ALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILF 153 (484)
T ss_pred eeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHh
Confidence 99999999999999999999999877431 1 2223589999987742 3677999999999999999
Q ss_pred CCCCCCcccCCCcc--HHHHHHHhcccchhcccCccccccccccchhhhccccccccccc-hHHHHHHHHHHHhhcCCCC
Q 042634 324 GKRPTNEMFTGNLT--LHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFS-VKECLVSVLGIGVTCSSEL 400 (427)
Q Consensus 324 g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~~cl~~d 400 (427)
.+.||......... +...+..... ... .+... ..+.+.++..++.+||..+
T Consensus 154 r~~~~~~~~~~~~~~eii~~~~~~~~----~~~----------------------rP~i~~~~e~~~~l~~l~~~cw~e~ 207 (484)
T KOG1023|consen 154 RSGPFDLRNLVEDPDEIILRVKKGGS----NPF----------------------RPSIELLNELPPELLLLVARCWEEI 207 (484)
T ss_pred ccCccccccccCChHHHHHHHHhcCC----CCc----------------------CcchhhhhhcchHHHHHHHHhcccC
Confidence 99999864333221 1111111000 000 11111 1134457899999999999
Q ss_pred CCCCCCHHHHHHHHHHHHH
Q 042634 401 PRERMNMEEVAAQLLSFRN 419 (427)
Q Consensus 401 P~~Rpt~~ev~~~L~~~~~ 419 (427)
|++||++++|...++.+..
T Consensus 208 P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 208 PEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred hhhCccHHHHHhhhhhhcc
Confidence 9999999999999988765
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.7e-21 Score=173.54 Aligned_cols=140 Identities=29% Similarity=0.440 Sum_probs=121.6
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeecc
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCD 259 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrD 259 (427)
+|+|++++++.+.. ....++++||+++++|.+++..... .+++..+..++.+++.++.+|| ..+++|+|
T Consensus 55 ~~~~i~~~~~~~~~-----~~~~~~v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~d 123 (225)
T smart00221 55 KHPNIVKLYGVFED-----PEPLYLVMEYCEGGDLFDYLRKKGG---KLSEEEARFYLRQILEALEYLH---SLGIVHRD 123 (225)
T ss_pred CCCChhhheeeeec-----CCceEEEEeccCCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHH---hCCeecCC
Confidence 68999999887543 4578899999999999998865431 1788999999999999999999 88999999
Q ss_pred ccCCceeeCCCCceEecccccccccCCc-------CCCcccccccccc-CCCCcCccccchhHHHHHHHHHhCCCCCCc
Q 042634 260 LKPSNVLLDGELTAHVGDFGLAKFLPEA-------TNNFFNFQIAEYG-MGSEVSTSGDVYSFGILLLETFTGKRPTNE 330 (427)
Q Consensus 260 lkp~NIll~~~~~~kL~DFG~a~~~~~~-------~~~~~~y~aPE~~-~~~~~~~~~DiwS~G~vl~ell~g~~pf~~ 330 (427)
++|+||+++.++.++|+|||.+...... ..++..|++||.. ....++.++||||||++++|+++|+.||..
T Consensus 124 i~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 124 LKPENILLGMDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred CCHHHEEEcCCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 9999999999999999999999876543 2566779999998 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.3e-23 Score=165.51 Aligned_cols=168 Identities=26% Similarity=0.442 Sum_probs=144.3
Q ss_pred cccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccCcccCCCCccccccc
Q 042634 16 SIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSL 95 (427)
Q Consensus 16 ~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~~~l~~l 95 (427)
.+.++++++.|.||+|+++ .+|+.+..+.+|+.|+++||+++ ++|..+++++.|+.|+++-|++. .+|.+|+.++.|
T Consensus 28 gLf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~l 104 (264)
T KOG0617|consen 28 GLFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPAL 104 (264)
T ss_pred cccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchh
Confidence 4677888899999999998 78888999999999999999999 99999999999999999999997 889999999998
Q ss_pred cceeeccCCcCc-CCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCCCCcccccCCceeecc
Q 042634 96 SIYLDLSQNQLN-GPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLS 174 (427)
Q Consensus 96 ~~~L~l~~n~~~-~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~ 174 (427)
+.|||++|.+. ..+|+.|..++.|+.|+|+.|.+. .+|..++++++|+.|.+..|.+- .+|..++.++.|+.|.+.
T Consensus 105 -evldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiq 181 (264)
T KOG0617|consen 105 -EVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQ 181 (264)
T ss_pred -hhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcc
Confidence 57999998886 478888888999999999999988 78999999999999999988887 478888999999999999
Q ss_pred CCcccccccchhhhc
Q 042634 175 RNNFIRHRNLVKIIT 189 (427)
Q Consensus 175 ~N~ll~Hpniv~~~~ 189 (427)
+|.+.--|--+.-++
T Consensus 182 gnrl~vlppel~~l~ 196 (264)
T KOG0617|consen 182 GNRLTVLPPELANLD 196 (264)
T ss_pred cceeeecChhhhhhh
Confidence 988876665444333
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.9e-20 Score=170.78 Aligned_cols=198 Identities=20% Similarity=0.196 Sum_probs=140.3
Q ss_pred cccccccchhhhccccccC----------------------CCCCCccceeeeeecCCCcccccccchhhhhccCHHHHH
Q 042634 177 NFIRHRNLVKIITSCASVD----------------------FQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRL 234 (427)
Q Consensus 177 ~ll~Hpniv~~~~~~~~~~----------------------~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~ 234 (427)
++-+|||||++++.+.+.- ...+...|+||.-. ..+|.+++..+. .+.....
T Consensus 271 hLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~-----~s~r~~~ 344 (598)
T KOG4158|consen 271 HLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH-----RSYRTGR 344 (598)
T ss_pred ccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC-----CchHHHH
Confidence 4578999999988764320 11234567888877 557888776543 5566778
Q ss_pred HHHHHHHHHHHHHhhcCCCCeeeccccCCceee--CCCC--ceEecccccccccCC------------cCCCcccccccc
Q 042634 235 SIAVDVASALDYLHHYCETPIVHCDLKPSNVLL--DGEL--TAHVGDFGLAKFLPE------------ATNNFFNFQIAE 298 (427)
Q Consensus 235 ~~~~~i~~~L~~LH~~~~~~ivHrDlkp~NIll--~~~~--~~kL~DFG~a~~~~~------------~~~~~~~y~aPE 298 (427)
-++.|+++|+.||| .+||.|||+|++|||+ |+|+ .+.++|||++-.-.. +..|....||||
T Consensus 345 ~~laQlLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPE 421 (598)
T KOG4158|consen 345 VILAQLLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPE 421 (598)
T ss_pred HHHHHHHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchh
Confidence 89999999999999 9999999999999998 4444 578899999854322 114555689999
Q ss_pred ccCCCCc------CccccchhHHHHHHHHHhCCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhcc
Q 042634 299 YGMGSEV------STSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANA 372 (427)
Q Consensus 299 ~~~~~~~------~~~~DiwS~G~vl~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (427)
+....+- -.|+|.|+.|.+.||+++...||.....-..+...+-...+|
T Consensus 422 i~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLP------------------------- 476 (598)
T KOG4158|consen 422 IATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLP------------------------- 476 (598)
T ss_pred hhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCC-------------------------
Confidence 9865331 358999999999999999999997621111111111111111
Q ss_pred ccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 042634 373 HKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAAQLL 415 (427)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~ 415 (427)
..++.|+..+.+++...++.||.+|++..=....|.
T Consensus 477 -------alp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 477 -------ALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred -------CCcccCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 134556777889999999999999999876655544
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.8e-22 Score=163.84 Aligned_cols=158 Identities=34% Similarity=0.549 Sum_probs=145.4
Q ss_pred eeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccC
Q 042634 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNL 81 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~ 81 (427)
|.||.|.++ .+|+.+..|.+|+.|++++|+++ .+|..+++++.|+.|+++-|++. .+|..|+.++.|+.||+++|++
T Consensus 38 LtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl 114 (264)
T KOG0617|consen 38 LTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNL 114 (264)
T ss_pred hhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhcccccc
Confidence 578999999 78999999999999999999998 89999999999999999999999 9999999999999999999999
Q ss_pred c-ccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCCC
Q 042634 82 T-GTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPS 160 (427)
Q Consensus 82 ~-~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~ 160 (427)
. ..+|..|..+..| ..|.|+.|.|. .+|..++++++|+.|.+..|.+. ++|.+++.+..|++|++++|.++- +|.
T Consensus 115 ~e~~lpgnff~m~tl-ralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~v-lpp 190 (264)
T KOG0617|consen 115 NENSLPGNFFYMTTL-RALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLTV-LPP 190 (264)
T ss_pred ccccCCcchhHHHHH-HHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceeee-cCh
Confidence 5 5678889999999 57999999997 89999999999999999999988 799999999999999999999994 666
Q ss_pred Cccccc
Q 042634 161 SLSSLR 166 (427)
Q Consensus 161 ~l~~l~ 166 (427)
.++.+.
T Consensus 191 el~~l~ 196 (264)
T KOG0617|consen 191 ELANLD 196 (264)
T ss_pred hhhhhh
Confidence 665543
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.80 E-value=9.1e-22 Score=188.30 Aligned_cols=163 Identities=31% Similarity=0.420 Sum_probs=101.1
Q ss_pred CcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccCcccCCCCccccccccceeeccCCcCcCCCCCCCcCC
Q 042634 38 PSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGIL 117 (427)
Q Consensus 38 p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l 117 (427)
|.++-.|.+|..+|||.|++. .+|..+..+.+|+.|+||+|+++ .+......+.++ ..|+|+.|+++ .+|+.+++|
T Consensus 215 Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~l-EtLNlSrNQLt-~LP~avcKL 290 (1255)
T KOG0444|consen 215 PTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENL-ETLNLSRNQLT-VLPDAVCKL 290 (1255)
T ss_pred CCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhh-hhhccccchhc-cchHHHhhh
Confidence 334444444444444444444 44555555555555555555554 444444444444 34555556655 566677777
Q ss_pred CCCCeEECcCCccc-ccCCccccccccccceeeeeeeccccCCCCcccccCCceeeccCCcccccccchhhhccccccCC
Q 042634 118 KNLGAIDISENKLS-GQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNFIRHRNLVKIITSCASVDF 196 (427)
Q Consensus 118 ~~L~~l~l~~n~~~-~~~p~~~~~~~~l~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~ll~Hpniv~~~~~~~~~~~ 196 (427)
++|+.|++.+|+++ .-||+.||.+..|+.+..++|.+. ..|..+..+..|+.|.|+.|+++.-|.-|.++.....++.
T Consensus 291 ~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLiTLPeaIHlL~~l~vLDl 369 (1255)
T KOG0444|consen 291 TKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLITLPEAIHLLPDLKVLDL 369 (1255)
T ss_pred HHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhcccccceeechhhhhhcCCcceeec
Confidence 77777777776544 126777777777777777777776 5677888888888889999999888888888777666666
Q ss_pred CCCCccceeee
Q 042634 197 QGNDSEALVYE 207 (427)
Q Consensus 197 ~~~~~~~lv~e 207 (427)
..+. -+||+
T Consensus 370 reNp--nLVMP 378 (1255)
T KOG0444|consen 370 RENP--NLVMP 378 (1255)
T ss_pred cCCc--CccCC
Confidence 5543 34554
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.8e-20 Score=176.61 Aligned_cols=176 Identities=32% Similarity=0.472 Sum_probs=97.2
Q ss_pred eecCCcc-cccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcC-ccCCCCCCeEEccCcc
Q 042634 3 TLVGNQF-TGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSS-LGKCQNLILLDLSNNN 80 (427)
Q Consensus 3 ~l~~n~l-~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~-~~~l~~L~~l~l~~N~ 80 (427)
+++.|+| +..+|+++..|..|+.||||+|+++ .+|..+-.-.++-+|+||+|++. ++|.. +.+++-|-.||||+|+
T Consensus 84 ~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~Nr 161 (1255)
T KOG0444|consen 84 IVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNR 161 (1255)
T ss_pred hhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccch
Confidence 3444444 2234555555555555555555555 55555555555555555555555 55543 3445555555555555
Q ss_pred CcccCCCCccccccccceeeccCCcCc-------------------------CCCCCCCcCCCCCCeEECcCCcccccCC
Q 042634 81 LTGTTPTEVIGLSSLSIYLDLSQNQLN-------------------------GPLPSNFGILKNLGAIDISENKLSGQIP 135 (427)
Q Consensus 81 ~~~~~p~~~~~l~~l~~~L~l~~n~~~-------------------------~~~p~~~~~l~~L~~l~l~~n~~~~~~p 135 (427)
+. .+|.....+.+| ++|+|++|++. .-+|.++..+.+|..+|+|.|.+. .+|
T Consensus 162 Le-~LPPQ~RRL~~L-qtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vP 238 (1255)
T KOG0444|consen 162 LE-MLPPQIRRLSML-QTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVP 238 (1255)
T ss_pred hh-hcCHHHHHHhhh-hhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cch
Confidence 55 344444455555 34555555541 234555555556666666666665 566
Q ss_pred ccccccccccceeeeeeeccccCCCCcccccCCceeeccCCcccccccc
Q 042634 136 SSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNFIRHRNL 184 (427)
Q Consensus 136 ~~~~~~~~l~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~ll~Hpni 184 (427)
+.+-.+.+|+.|+||+|+++ .+....+.+.+++.|++|.|++..-|..
T Consensus 239 ecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt~LP~a 286 (1255)
T KOG0444|consen 239 ECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLTVLPDA 286 (1255)
T ss_pred HHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhccchHH
Confidence 66666666666666666666 3444555556666666666666555543
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.1e-19 Score=171.04 Aligned_cols=201 Identities=22% Similarity=0.254 Sum_probs=137.5
Q ss_pred eeecCCcccccCCccccCCCCCCEeeeecccceeecCc-chhccccCCEeeeccccCcccC-CcCccCCCCCCeEEccCc
Q 042634 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPS-SIGNLTLLITLNFAENMLEGSI-PSSLGKCQNLILLDLSNN 79 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~-~~~~l~~L~~L~l~~n~l~~~~-p~~~~~l~~L~~l~l~~N 79 (427)
|+|++|++|..=-..|..|.+|..|.|++|+++ .+|. .|.+|++|+.|+|..|++. .+ --.|.++++|+.|.|..|
T Consensus 178 L~La~N~It~l~~~~F~~lnsL~tlkLsrNrit-tLp~r~Fk~L~~L~~LdLnrN~ir-ive~ltFqgL~Sl~nlklqrN 255 (873)
T KOG4194|consen 178 LNLASNRITTLETGHFDSLNSLLTLKLSRNRIT-TLPQRSFKRLPKLESLDLNRNRIR-IVEGLTFQGLPSLQNLKLQRN 255 (873)
T ss_pred EeeccccccccccccccccchheeeecccCccc-ccCHHHhhhcchhhhhhcccccee-eehhhhhcCchhhhhhhhhhc
Confidence 566666666443455666666666666666665 4543 4555666666666666665 33 234555666666666666
Q ss_pred cCcccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCC
Q 042634 80 NLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIP 159 (427)
Q Consensus 80 ~~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p 159 (427)
.+...-...|.++.++ ++|+|+.|+++.--.+++.+|++|+.|+||+|.|...-++.+.-+++|++|+|++|.++...+
T Consensus 256 ~I~kL~DG~Fy~l~km-e~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~ 334 (873)
T KOG4194|consen 256 DISKLDDGAFYGLEKM-EHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDE 334 (873)
T ss_pred CcccccCcceeeeccc-ceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCCh
Confidence 6654444456667777 568888888875556788889999999999999887778888889999999999999998888
Q ss_pred CCcccccCCceeeccCCcccc-cccchhhhccccccCCCCCCcccee
Q 042634 160 SSLSSLRGIENLDLSRNNFIR-HRNLVKIITSCASVDFQGNDSEALV 205 (427)
Q Consensus 160 ~~l~~l~~L~~L~L~~N~ll~-Hpniv~~~~~~~~~~~~~~~~~~lv 205 (427)
.+|..|..|+.|.|++|.+.. |.+....+......+...+...+.|
T Consensus 335 ~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~I 381 (873)
T KOG4194|consen 335 GSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCI 381 (873)
T ss_pred hHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEE
Confidence 888888899999998888743 3444444555555555555544443
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.6e-20 Score=169.99 Aligned_cols=233 Identities=29% Similarity=0.493 Sum_probs=149.6
Q ss_pred eeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccC
Q 042634 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNL 81 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~ 81 (427)
|++..|+++ .+|++++.+.+++.|+.|+|+++ .+|+.++++.+|..|++++|.+. ++|++++.+-.|..++..+|++
T Consensus 73 l~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i 149 (565)
T KOG0472|consen 73 LNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQI 149 (565)
T ss_pred EEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhcccccc
Confidence 456666666 56666666666666666666666 56666666666666666666666 6666666666666666666666
Q ss_pred cccCCCCccccccccceeeccCCcCc----------------------CCCCCCCcCCCCCCeEECcCCcccccCCcccc
Q 042634 82 TGTTPTEVIGLSSLSIYLDLSQNQLN----------------------GPLPSNFGILKNLGAIDISENKLSGQIPSSIG 139 (427)
Q Consensus 82 ~~~~p~~~~~l~~l~~~L~l~~n~~~----------------------~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~ 139 (427)
+ ..|..++.+.++ ..|++.+|++. +.+|..++.+.+|..||+..|++. .+| +|.
T Consensus 150 ~-slp~~~~~~~~l-~~l~~~~n~l~~l~~~~i~m~~L~~ld~~~N~L~tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~ 225 (565)
T KOG0472|consen 150 S-SLPEDMVNLSKL-SKLDLEGNKLKALPENHIAMKRLKHLDCNSNLLETLPPELGGLESLELLYLRRNKIR-FLP-EFP 225 (565)
T ss_pred c-cCchHHHHHHHH-HHhhccccchhhCCHHHHHHHHHHhcccchhhhhcCChhhcchhhhHHHHhhhcccc-cCC-CCC
Confidence 5 455555555555 33555555543 356666666767777777777766 566 667
Q ss_pred ccccccceeeeeeeccccCCCCc-ccccCCceeeccCCcccccccchhhhccccccCCCCCCccceeeeeecCCCc--cc
Q 042634 140 SCIRLEQLVMNGNFFRGNIPSSL-SSLRGIENLDLSRNNFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSL--EE 216 (427)
Q Consensus 140 ~~~~l~~l~l~~n~l~~~~p~~l-~~l~~L~~L~L~~N~ll~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L--~~ 216 (427)
+|..|++++.+.|++.- +|+.+ ..+..+..||+..|++..-|--+.++......|.+++....+.++ -|++ ..
T Consensus 226 gcs~L~Elh~g~N~i~~-lpae~~~~L~~l~vLDLRdNklke~Pde~clLrsL~rLDlSNN~is~Lp~s---LgnlhL~~ 301 (565)
T KOG0472|consen 226 GCSLLKELHVGENQIEM-LPAEHLKHLNSLLVLDLRDNKLKEVPDEICLLRSLERLDLSNNDISSLPYS---LGNLHLKF 301 (565)
T ss_pred ccHHHHHHHhcccHHHh-hHHHHhcccccceeeeccccccccCchHHHHhhhhhhhcccCCccccCCcc---cccceeee
Confidence 77777777777777763 45444 478889999999999999888887777777777777776666554 3454 11
Q ss_pred ccccchhhhhccCHHHHHHHHHHHHHHHHHHhh
Q 042634 217 WLHPNREALKNLNLLQRLSIAVDVASALDYLHH 249 (427)
Q Consensus 217 ~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~ 249 (427)
..-.. .++....+--+-..-++-++|||+
T Consensus 302 L~leG----NPlrTiRr~ii~~gT~~vLKyLrs 330 (565)
T KOG0472|consen 302 LALEG----NPLRTIRREIISKGTQEVLKYLRS 330 (565)
T ss_pred hhhcC----CchHHHHHHHHcccHHHHHHHHHH
Confidence 11111 223222222334455667999993
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.74 E-value=3e-20 Score=169.57 Aligned_cols=167 Identities=32% Similarity=0.466 Sum_probs=132.8
Q ss_pred eeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccC
Q 042634 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNL 81 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~ 81 (427)
+|..+|+++ ++|++++.+.+|..|++.+|+++ ++|+..-+++.|+.||+.+|-++ ++|++++.+.+|..|++..|++
T Consensus 142 l~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~-~l~~~~i~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki 218 (565)
T KOG0472|consen 142 LDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLK-ALPENHIAMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKI 218 (565)
T ss_pred hhccccccc-cCchHHHHHHHHHHhhccccchh-hCCHHHHHHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhccc
Confidence 355667776 56777777777777777777776 56666656777888888888877 8888888888888888888888
Q ss_pred cccCCCCccccccccceeeccCCcCcCCCCCCCc-CCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCCC
Q 042634 82 TGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFG-ILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPS 160 (427)
Q Consensus 82 ~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~-~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~ 160 (427)
. .+| +|.++..| .+|+++.|++. .+|.+.+ .+.++..||+..|++. +.|++++-+.+|..||+|+|.+++ +|.
T Consensus 219 ~-~lP-ef~gcs~L-~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~-Lp~ 292 (565)
T KOG0472|consen 219 R-FLP-EFPGCSLL-KELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISS-LPY 292 (565)
T ss_pred c-cCC-CCCccHHH-HHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCcccc-CCc
Confidence 7 666 67888877 67888888886 6776665 7888888999999888 788888888888899999999886 678
Q ss_pred CcccccCCceeeccCCcc
Q 042634 161 SLSSLRGIENLDLSRNNF 178 (427)
Q Consensus 161 ~l~~l~~L~~L~L~~N~l 178 (427)
.++++ .|..|.+.+|.+
T Consensus 293 sLgnl-hL~~L~leGNPl 309 (565)
T KOG0472|consen 293 SLGNL-HLKFLALEGNPL 309 (565)
T ss_pred ccccc-eeeehhhcCCch
Confidence 88888 788888888876
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.5e-18 Score=175.93 Aligned_cols=192 Identities=20% Similarity=0.243 Sum_probs=141.9
Q ss_pred CcccccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 042634 176 NNFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPI 255 (427)
Q Consensus 176 N~ll~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~i 255 (427)
+.+.+|||.+.+...... +.-.|+|-+|. .-+|++.+..++- +...+.+.|+.|++.|+.-+| ..||
T Consensus 75 ~~l~~~pn~lPfqk~~~t-----~kAAylvRqyv-khnLyDRlSTRPF----L~~iEKkWiaFQLL~al~qcH---~~gV 141 (1431)
T KOG1240|consen 75 FALMKAPNCLPFQKVLVT-----DKAAYLVRQYV-KHNLYDRLSTRPF----LVLIEKKWIAFQLLKALSQCH---KLGV 141 (1431)
T ss_pred HHhhcCCcccchHHHHHh-----hHHHHHHHHHH-hhhhhhhhccchH----HHHHHHHHHHHHHHHHHHHHH---HcCc
Confidence 556789999888766322 55678999998 6689999987743 778899999999999999999 9999
Q ss_pred eeccccCCceeeCCCCceEeccccccccc--CCcC-----------CCccccccccccCCCC-----------cCccccc
Q 042634 256 VHCDLKPSNVLLDGELTAHVGDFGLAKFL--PEAT-----------NNFFNFQIAEYGMGSE-----------VSTSGDV 311 (427)
Q Consensus 256 vHrDlkp~NIll~~~~~~kL~DFG~a~~~--~~~~-----------~~~~~y~aPE~~~~~~-----------~~~~~Di 311 (427)
.|+|||.+||||++-.-+.|+||..-+.. +++. ..-..|.|||.+.... .+++.||
T Consensus 142 cHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDI 221 (1431)
T KOG1240|consen 142 CHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDI 221 (1431)
T ss_pred cccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhh
Confidence 99999999999999999999999876643 2222 1123699999875421 4789999
Q ss_pred hhHHHHHHHHHh-CCCCCCcccCCCccHHHHHHH--hcccchhcccCccccccccccchhhhccccccccccchHHHHHH
Q 042634 312 YSFGILLLETFT-GKRPTNEMFTGNLTLHNFVKE--ALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVS 388 (427)
Q Consensus 312 wS~G~vl~ell~-g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (427)
||+|||+.|+++ |++||.-. .+..+... ..++.+.+.+ ....
T Consensus 222 FS~GCViaELf~Eg~PlF~LS-----QL~aYr~~~~~~~e~~Le~I------------------------------ed~~ 266 (1431)
T KOG1240|consen 222 FSAGCVIAELFLEGRPLFTLS-----QLLAYRSGNADDPEQLLEKI------------------------------EDVS 266 (1431)
T ss_pred hhhhHHHHHHHhcCCCcccHH-----HHHhHhccCccCHHHHHHhC------------------------------cCcc
Confidence 999999999988 89998632 00000000 0001111101 1124
Q ss_pred HHHHHhhcCCCCCCCCCCHHHHHHHHH
Q 042634 389 VLGIGVTCSSELPRERMNMEEVAAQLL 415 (427)
Q Consensus 389 ~~~l~~~cl~~dP~~Rpt~~ev~~~L~ 415 (427)
+..++..|++.||.+|-++++.++.-+
T Consensus 267 ~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 267 LRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred HHHHHHHHHccCchhccCHHHHHHhhh
Confidence 677999999999999999999998743
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.1e-18 Score=168.68 Aligned_cols=137 Identities=29% Similarity=0.337 Sum_probs=120.6
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeecc
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCD 259 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrD 259 (427)
.||.+|++-.. ++.....+++++|..+|++...+.... .+++.....+...++-|++++| ..+|+|||
T Consensus 55 ~~~f~v~lhya-----fqt~~kl~l~ld~~rgg~lft~l~~~~----~f~~~~~~~~~aelaLald~lh---~l~iiyrd 122 (612)
T KOG0603|consen 55 NTPFLVKLHYA-----FQTDGKLYLILDFLRGGDLFTRLSKEV----MFDELDVAFYLAELALALDHLH---KLGIAYRD 122 (612)
T ss_pred CCCceeeeeee-----eccccchhHhhhhcccchhhhccccCC----chHHHHHHHHHHHHHHHHhhcc---hhHHHHhc
Confidence 47888877655 444678899999999999999987764 4777888888999999999999 89999999
Q ss_pred ccCCceeeCCCCceEecccccccccCCcC--CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCc
Q 042634 260 LKPSNVLLDGELTAHVGDFGLAKFLPEAT--NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNE 330 (427)
Q Consensus 260 lkp~NIll~~~~~~kL~DFG~a~~~~~~~--~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~ 330 (427)
+|++||+++.+|++|+.|||.++...+.. +||..|||||+.. .+..++|+||||++++||++|..||..
T Consensus 123 ~k~enilld~~Ghi~~tdfglske~v~~~~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 123 YKLENVLLLLEGHIKLTDFGLSKEAVKEKIACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ccccceeecccCccccCCchhhhHhHhhhhcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 99999999999999999999999765544 6799999999987 678899999999999999999999975
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.74 E-value=5.7e-19 Score=167.37 Aligned_cols=121 Identities=26% Similarity=0.418 Sum_probs=104.4
Q ss_pred ccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccccCCceeeCCCCceEeccccc
Q 042634 201 SEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGL 280 (427)
Q Consensus 201 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~ 280 (427)
..++.|++|...+|.+|+..++.. ..-++...+.++.|++.|++| ++.+|||+||.||+...+..+||.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~-e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTG-EERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcc-cccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhh
Confidence 578999999999999999754332 446778899999999999998 5899999999999999999999999999
Q ss_pred ccccCCcC------------CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCC
Q 042634 281 AKFLPEAT------------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPT 328 (427)
Q Consensus 281 a~~~~~~~------------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf 328 (427)
........ .||..||+||.+.+..|+.|+||||+|++++|++. -..+|
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~ 463 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQF 463 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHH
Confidence 87654322 78899999999999999999999999999999987 44443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.1e-17 Score=156.48 Aligned_cols=202 Identities=29% Similarity=0.391 Sum_probs=145.7
Q ss_pred ccc-cchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 180 RHR-NLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 180 ~Hp-niv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
.|+ +++++.+.+. .....+++++++.++++.+++...... ..++......++.|++.+++|+| ..+++||
T Consensus 55 ~~~~~i~~~~~~~~-----~~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hr 125 (384)
T COG0515 55 NHPPNIVKLYDFFQ-----DEGSLYLVMEYVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLH---SKGIIHR 125 (384)
T ss_pred cCCcceeeEEEEEe-----cCCEEEEEEecCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeecc
Confidence 344 7888887752 233479999999999999666543211 25888999999999999999999 8999999
Q ss_pred cccCCceeeCCCC-ceEecccccccccCC------------cCCCccccccccccCC---CCcCccccchhHHHHHHHHH
Q 042634 259 DLKPSNVLLDGEL-TAHVGDFGLAKFLPE------------ATNNFFNFQIAEYGMG---SEVSTSGDVYSFGILLLETF 322 (427)
Q Consensus 259 Dlkp~NIll~~~~-~~kL~DFG~a~~~~~------------~~~~~~~y~aPE~~~~---~~~~~~~DiwS~G~vl~ell 322 (427)
|+||+||+++... .+|++|||.++.... ...++..|+|||...+ ..++...|+||+|+++++++
T Consensus 126 d~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~ 205 (384)
T COG0515 126 DIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELL 205 (384)
T ss_pred CCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHH
Confidence 9999999999988 799999999975432 2378889999999987 57889999999999999999
Q ss_pred hCCCCCCcccCC--CccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCC
Q 042634 323 TGKRPTNEMFTG--NLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSEL 400 (427)
Q Consensus 323 ~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~d 400 (427)
+|..||...... .......+.............. . ........+.+++.+|+..+
T Consensus 206 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------~-~~~~~~~~~~~~~~~~~~~~ 262 (384)
T COG0515 206 TGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSP----------------------S-NPELISKAASDLLKKLLAKD 262 (384)
T ss_pred hCCCCCCCCCccccHHHHHHHHHhcCCcccccccCc----------------------c-ccchhhHHHHHHHHHHHhcC
Confidence 999997654221 1111111111111100000000 0 00223356788999999999
Q ss_pred CCCCCCHHHHHHH
Q 042634 401 PRERMNMEEVAAQ 413 (427)
Q Consensus 401 P~~Rpt~~ev~~~ 413 (427)
|..|.++.+....
T Consensus 263 ~~~r~~~~~~~~~ 275 (384)
T COG0515 263 PKNRLSSSSDLSH 275 (384)
T ss_pred chhcCCHHHHhhc
Confidence 9999999887765
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.6e-19 Score=168.18 Aligned_cols=176 Identities=28% Similarity=0.300 Sum_probs=138.9
Q ss_pred eeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccC
Q 042634 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNL 81 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~ 81 (427)
|.|.+|.++-.-...|..|.++++|+|+.|+++..--.++.+|++|+.||||+|.+...-+..-..+++|++|+||+|++
T Consensus 250 lklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i 329 (873)
T KOG4194|consen 250 LKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRI 329 (873)
T ss_pred hhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEecccccc
Confidence 45667777755456688888888888888888843445788888888888888888866666666677888888888888
Q ss_pred cccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCc---cccccccccceeeeeeeccccC
Q 042634 82 TGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPS---SIGSCIRLEQLVMNGNFFRGNI 158 (427)
Q Consensus 82 ~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~---~~~~~~~l~~l~l~~n~l~~~~ 158 (427)
+...+..|..+..| ++|.|+.|+++-.--..|..+++|+.|||++|.+++.|.+ .|.++++|+.|++.+|++....
T Consensus 330 ~~l~~~sf~~L~~L-e~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~ 408 (873)
T KOG4194|consen 330 TRLDEGSFRVLSQL-EELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIP 408 (873)
T ss_pred ccCChhHHHHHHHh-hhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecc
Confidence 86666677778888 5788888888754456778888899999999988877765 4667888999999999988766
Q ss_pred CCCcccccCCceeeccCCcc
Q 042634 159 PSSLSSLRGIENLDLSRNNF 178 (427)
Q Consensus 159 p~~l~~l~~L~~L~L~~N~l 178 (427)
-.+|.++.+|+.|+|.+|-+
T Consensus 409 krAfsgl~~LE~LdL~~Nai 428 (873)
T KOG4194|consen 409 KRAFSGLEALEHLDLGDNAI 428 (873)
T ss_pred hhhhccCcccceecCCCCcc
Confidence 67888899999999888876
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.1e-17 Score=150.26 Aligned_cols=160 Identities=22% Similarity=0.263 Sum_probs=106.2
Q ss_pred ceeeeeecCCCccccccc---chhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccccCCceeeCCCCceEecccc
Q 042634 203 ALVYEFMVNGSLEEWLHP---NREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFG 279 (427)
Q Consensus 203 ~lv~e~~~~g~L~~~l~~---~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG 279 (427)
+++|+-+ .+||.+++.. .......+....+..+..|+++.+++|| ..|+||+||||+|++++.+|.++|+||+
T Consensus 115 ~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVHgdi~~~nfll~~~G~v~Lg~F~ 190 (288)
T PF14531_consen 115 FLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVHGDIKPENFLLDQDGGVFLGDFS 190 (288)
T ss_dssp EEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEE-TTS-EEE--GG
T ss_pred hhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEecccceeeEEEcCCCCEEEcChH
Confidence 5667766 6788776542 1111123555667788899999999999 8999999999999999999999999998
Q ss_pred cccccCCcC---CCccccccccccCC--------CCcCccccchhHHHHHHHHHhCCCCCCcccCCCccHHHHHHHhccc
Q 042634 280 LAKFLPEAT---NNFFNFQIAEYGMG--------SEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEALPE 348 (427)
Q Consensus 280 ~a~~~~~~~---~~~~~y~aPE~~~~--------~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 348 (427)
.....+... ..+..|.+||.... ..++.+.|.|++|+++|.+.+|+.||.........-.
T Consensus 191 ~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~--------- 261 (288)
T PF14531_consen 191 SLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW--------- 261 (288)
T ss_dssp GEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG---------
T ss_pred HHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc---------
Confidence 877654432 33456889997643 2468899999999999999999999975422111100
Q ss_pred chhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCC
Q 042634 349 RLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRER 404 (427)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~R 404 (427)
.|.. .. +.++.+.++++.+++.+|++|
T Consensus 262 --------------------------~f~~--C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 262 --------------------------DFSR--CR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp --------------------------GGTT--SS----HHHHHHHHHHT-SSGGGS
T ss_pred --------------------------cchh--cC-CcCHHHHHHHHHHccCCcccC
Confidence 0000 22 578889999999999999988
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.68 E-value=7.7e-19 Score=166.89 Aligned_cols=178 Identities=29% Similarity=0.429 Sum_probs=162.8
Q ss_pred eeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccC
Q 042634 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNL 81 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~ 81 (427)
.||+.|++. .+|.+++.+..|+.+.|+.|.+. .+|..+.++..|++|||+.|+++ .+|..++.|+ |+.|-+++|++
T Consensus 80 aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl 155 (722)
T KOG0532|consen 80 ADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKL 155 (722)
T ss_pred hhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCcc
Confidence 589999999 89999999999999999999998 89999999999999999999999 9999999998 99999999999
Q ss_pred cccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCCCC
Q 042634 82 TGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSS 161 (427)
Q Consensus 82 ~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~~ 161 (427)
+ .+|..++.+..| ..|+.+.|.+. .+|..++++.+|+.|.+..|++. .+|.+++ +-.|..||++.|+++ .+|..
T Consensus 156 ~-~lp~~ig~~~tl-~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~-~LpLi~lDfScNkis-~iPv~ 229 (722)
T KOG0532|consen 156 T-SLPEEIGLLPTL-AHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELC-SLPLIRLDFSCNKIS-YLPVD 229 (722)
T ss_pred c-cCCcccccchhH-HHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHh-CCceeeeecccCcee-ecchh
Confidence 8 888888888888 57999999997 89999999999999999999998 7999998 667899999999999 58999
Q ss_pred cccccCCceeeccCCcccccccchhhhc
Q 042634 162 LSSLRGIENLDLSRNNFIRHRNLVKIIT 189 (427)
Q Consensus 162 l~~l~~L~~L~L~~N~ll~Hpniv~~~~ 189 (427)
|.+|+.|+.|.|.+|.+..-|--|...|
T Consensus 230 fr~m~~Lq~l~LenNPLqSPPAqIC~kG 257 (722)
T KOG0532|consen 230 FRKMRHLQVLQLENNPLQSPPAQICEKG 257 (722)
T ss_pred hhhhhhheeeeeccCCCCCChHHHHhcc
Confidence 9999999999999999876654444433
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=6.6e-16 Score=146.52 Aligned_cols=187 Identities=23% Similarity=0.246 Sum_probs=140.3
Q ss_pred CCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccccCCceeeCCC-----Cce
Q 042634 199 NDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGE-----LTA 273 (427)
Q Consensus 199 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrDlkp~NIll~~~-----~~~ 273 (427)
+...++||+.+ |.+|.++..... ...++..++..++.|++.+|+++| +.|++||||||.|++++.. ..+
T Consensus 93 ~~~~~iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~ 166 (322)
T KOG1164|consen 93 EDFNFIVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTL 166 (322)
T ss_pred CceeEEEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceE
Confidence 45679999988 999999775444 256999999999999999999999 9999999999999999754 479
Q ss_pred Eeccccccc--cc---------CC-c----CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccCCCcc
Q 042634 274 HVGDFGLAK--FL---------PE-A----TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLT 337 (427)
Q Consensus 274 kL~DFG~a~--~~---------~~-~----~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~~~~~ 337 (427)
.|.|||+|+ .. .. . ..||..|+++....+.+.+.+.|+||++-++.|+..|..||........
T Consensus 167 ~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~- 245 (322)
T KOG1164|consen 167 YLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL- 245 (322)
T ss_pred EEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-
Confidence 999999998 31 01 1 1489999999999999999999999999999999999999965422211
Q ss_pred HHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHH
Q 042634 338 LHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAAQLLSF 417 (427)
Q Consensus 338 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~~ 417 (427)
..+....... ..... .....+.++.+++..+-+.+..++|.-..+...++..
T Consensus 246 ~~~~~~~~~~----~~~~~------------------------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~ 297 (322)
T KOG1164|consen 246 KSKFEKDPRK----LLTDR------------------------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDV 297 (322)
T ss_pred HHHHHHHhhh----hcccc------------------------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence 1111111000 00000 0111344566677767779999999999999998777
Q ss_pred HHH
Q 042634 418 RNK 420 (427)
Q Consensus 418 ~~~ 420 (427)
..+
T Consensus 298 ~~~ 300 (322)
T KOG1164|consen 298 FDS 300 (322)
T ss_pred HHh
Confidence 554
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.3e-16 Score=149.70 Aligned_cols=112 Identities=23% Similarity=0.223 Sum_probs=84.2
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|+|++..+.. ....++||||+++++|... ... . ...++.|+++||.||| +.||+||
T Consensus 78 L~h~~iv~~l~~--------~~~~~LVmE~~~G~~L~~~-~~~-------~---~~~~~~~i~~aL~~lH---~~gIiHr 135 (365)
T PRK09188 78 VRGIGVVPQLLA--------TGKDGLVRGWTEGVPLHLA-RPH-------G---DPAWFRSAHRALRDLH---RAGITHN 135 (365)
T ss_pred ccCCCCCcEEEE--------cCCcEEEEEccCCCCHHHh-Ccc-------c---hHHHHHHHHHHHHHHH---HCCCeeC
Confidence 468888853322 1246999999999999632 111 1 1467899999999999 8999999
Q ss_pred cc-cCCceeeCCCCceEecccccccccCCcC--------------CCccccccccccCCCC------cCccccch
Q 042634 259 DL-KPSNVLLDGELTAHVGDFGLAKFLPEAT--------------NNFFNFQIAEYGMGSE------VSTSGDVY 312 (427)
Q Consensus 259 Dl-kp~NIll~~~~~~kL~DFG~a~~~~~~~--------------~~~~~y~aPE~~~~~~------~~~~~Diw 312 (427)
|| ||+|||++.++.+||+|||+|+...... .+++.|+|||++...+ .+..+|-|
T Consensus 136 DL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 136 DLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred CCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 99 9999999999999999999999654322 4566799999986543 34456666
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.6e-16 Score=161.34 Aligned_cols=131 Identities=22% Similarity=0.253 Sum_probs=101.1
Q ss_pred HHHHHHHhhcCCCCeeeccccCCceeeCCCCceEecccccccccC---------------------CcCCCccccccccc
Q 042634 241 ASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLP---------------------EATNNFFNFQIAEY 299 (427)
Q Consensus 241 ~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~---------------------~~~~~~~~y~aPE~ 299 (427)
+.+++|+| ..||+|||+||+|.+|+.-|++|+.|||+++..- +..+||+.|.|||+
T Consensus 153 vla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeV 229 (1205)
T KOG0606|consen 153 VLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEV 229 (1205)
T ss_pred hHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhh
Confidence 78899999 8999999999999999999999999999998531 12289999999999
Q ss_pred cCCCCcCccccchhHHHHHHHHHhCCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccc
Q 042634 300 GMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRS 379 (427)
Q Consensus 300 ~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (427)
+..+.|+..+|+|++|+|+||.+.|..||.+...++ -+.+++...+. +.+
T Consensus 230 ilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee-lfg~visd~i~--wpE--------------------------- 279 (1205)
T KOG0606|consen 230 ILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE-LFGQVISDDIE--WPE--------------------------- 279 (1205)
T ss_pred hhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH-HHhhhhhhhcc--ccc---------------------------
Confidence 999999999999999999999999999997642111 11111111100 000
Q ss_pred cchHHHHHHHHHHHhhcCCCCCCCCC
Q 042634 380 FSVKECLVSVLGIGVTCSSELPRERM 405 (427)
Q Consensus 380 ~~~~~~~~~~~~l~~~cl~~dP~~Rp 405 (427)
..+..+.++.+++.+.++.+|.+|-
T Consensus 280 -~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 280 -EDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred -cCcCCCHHHHHHHHHHHHhChHhhc
Confidence 1122345678899999999999994
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.8e-15 Score=134.30 Aligned_cols=202 Identities=15% Similarity=0.174 Sum_probs=146.3
Q ss_pred cccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccc
Q 042634 181 HRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDL 260 (427)
Q Consensus 181 Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrDl 260 (427)
.+.|-..+-. .+.+.+-.+|+|.+ |.||.+++.-.. +.|+.+++..+|.|++.-++|+| ++.+|.|||
T Consensus 83 ~~GIP~vYYF-----GqeG~~NiLVidLL-GPSLEDLFD~Cg---R~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDI 150 (449)
T KOG1165|consen 83 TEGIPQVYYF-----GQEGKYNILVIDLL-GPSLEDLFDLCG---RRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDI 150 (449)
T ss_pred CCCCCceeee-----ccccchhhhhhhhh-CcCHHHHHHHhc---CcccHHhHHHHHHHHHHHHHHHH---hcceeeccc
Confidence 3455444433 34456678999988 889988876554 56999999999999999999999 999999999
Q ss_pred cCCceeeCCC-----CceEecccccccccCCcC-------------CCccccccccccCCCCcCccccchhHHHHHHHHH
Q 042634 261 KPSNVLLDGE-----LTAHVGDFGLAKFLPEAT-------------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETF 322 (427)
Q Consensus 261 kp~NIll~~~-----~~~kL~DFG~a~~~~~~~-------------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell 322 (427)
||+|.||+.. ..+.++|||+|+.+.... .||..||+--.-.+.+-+.+-|.=|+|-++++.+
T Consensus 151 KPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFL 230 (449)
T KOG1165|consen 151 KPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFL 230 (449)
T ss_pred CccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhc
Confidence 9999999654 468999999999764432 7899999999999999999999999999999999
Q ss_pred hCCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCC
Q 042634 323 TGKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPR 402 (427)
Q Consensus 323 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~ 402 (427)
.|..||++..... ..+...+.....-..-+ ....+..|.++..-++-.-..+-.
T Consensus 231 RGsLPWQGLKA~t--nK~kYeKIGe~Kr~T~i------------------------~~Lc~g~P~efa~Yl~yvR~L~F~ 284 (449)
T KOG1165|consen 231 RGSLPWQGLKADT--NKEKYEKIGETKRSTPI------------------------EVLCEGFPEEFATYLRYVRRLDFF 284 (449)
T ss_pred cCCCccccccCcc--hHHHHHHhccccccCCH------------------------HHHHhcCHHHHHHHHHHHHhcCcc
Confidence 9999999863222 11111111100000000 001233466677777766666777
Q ss_pred CCCCHHHHHHHHHHHHHH
Q 042634 403 ERMNMEEVAAQLLSFRNK 420 (427)
Q Consensus 403 ~Rpt~~ev~~~L~~~~~~ 420 (427)
+-|.-+-+...+..+.+.
T Consensus 285 E~PDYdylr~Lf~dvldr 302 (449)
T KOG1165|consen 285 ETPDYDYLRKLFDDVLDR 302 (449)
T ss_pred cCCCHHHHHHHHHHHHHh
Confidence 778877777666666554
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.5e-15 Score=130.25 Aligned_cols=188 Identities=19% Similarity=0.217 Sum_probs=139.1
Q ss_pred CCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccccCCceeeCCC---CceE
Q 042634 198 GNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGE---LTAH 274 (427)
Q Consensus 198 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrDlkp~NIll~~~---~~~k 274 (427)
+.....+||+.. |.+|.+++.-.. +.++..+++-++-|++.-++|+| .++.+||||||+|.|.+-+ .++-
T Consensus 82 e~~ynvlVMdLL-GPsLEdLfnfC~---R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~ 154 (341)
T KOG1163|consen 82 EKDYNVLVMDLL-GPSLEDLFNFCS---RRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLY 154 (341)
T ss_pred ccccceeeeecc-CccHHHHHHHHh---hhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEE
Confidence 355678999998 999998876443 56999999999999999999999 8999999999999998643 3688
Q ss_pred ecccccccccCCcC-------------CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccCCC--ccHH
Q 042634 275 VGDFGLAKFLPEAT-------------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGN--LTLH 339 (427)
Q Consensus 275 L~DFG~a~~~~~~~-------------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~~~--~~~~ 339 (427)
++|||+|+...+.. .||..|.+--...+.+-+.+-|+=|+|-++...-.|..||++..... ..+.
T Consensus 155 LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyE 234 (341)
T KOG1163|consen 155 LIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYE 234 (341)
T ss_pred EEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHH
Confidence 99999999764321 78888988777777778899999999999999999999999863221 1111
Q ss_pred HHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHH
Q 042634 340 NFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAAQLLSFRN 419 (427)
Q Consensus 340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~~~~ 419 (427)
........-.+.. .....|.++.-.+.-|-..--++-|.-.-+.+....+..
T Consensus 235 kI~EkK~s~~ie~----------------------------LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr 286 (341)
T KOG1163|consen 235 KISEKKMSTPIEV----------------------------LCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFR 286 (341)
T ss_pred HHHHhhcCCCHHH----------------------------HhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHh
Confidence 1111111111100 112246677888888888888888888777776666544
Q ss_pred H
Q 042634 420 K 420 (427)
Q Consensus 420 ~ 420 (427)
.
T Consensus 287 ~ 287 (341)
T KOG1163|consen 287 T 287 (341)
T ss_pred h
Confidence 3
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.6e-15 Score=131.21 Aligned_cols=128 Identities=16% Similarity=0.067 Sum_probs=92.1
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeecc
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCD 259 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrD 259 (427)
+|+++.++++. ...+++|||+.|.+|.+.... ....++.|++.+|+++| ..||+|||
T Consensus 60 ~~~~vP~ll~~---------~~~~lvmeyI~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH---~~GIvHrD 116 (218)
T PRK12274 60 GLPRTPRLLHW---------DGRHLDRSYLAGAAMYQRPPR-----------GDLAYFRAARRLLQQLH---RCGVAHND 116 (218)
T ss_pred CCCCCCEEEEE---------cCEEEEEeeecCccHHhhhhh-----------hhHHHHHHHHHHHHHHH---HCcCccCC
Confidence 34666666654 235899999999888654311 11347889999999999 89999999
Q ss_pred c-cCCceeeCCCCceEecccccccccCCcC-------------------CCccccccccccCC-CCcC-ccccchhHHHH
Q 042634 260 L-KPSNVLLDGELTAHVGDFGLAKFLPEAT-------------------NNFFNFQIAEYGMG-SEVS-TSGDVYSFGIL 317 (427)
Q Consensus 260 l-kp~NIll~~~~~~kL~DFG~a~~~~~~~-------------------~~~~~y~aPE~~~~-~~~~-~~~DiwS~G~v 317 (427)
| ||+|||++.++.++|+|||+|....... ..++.|.+|+.-.. ...+ .+.++++-|+-
T Consensus 117 L~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~ 196 (218)
T PRK12274 117 LAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKP 196 (218)
T ss_pred CCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcch
Confidence 9 7999999999999999999998544322 12233344432211 1223 45678899999
Q ss_pred HHHHHhCCCCCCc
Q 042634 318 LLETFTGKRPTNE 330 (427)
Q Consensus 318 l~ell~g~~pf~~ 330 (427)
+|.++||+.++-+
T Consensus 197 ~~~~~~~~~~~~~ 209 (218)
T PRK12274 197 VYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHhccCCccc
Confidence 9999999988654
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.58 E-value=4.1e-15 Score=153.29 Aligned_cols=162 Identities=24% Similarity=0.430 Sum_probs=97.7
Q ss_pred CeeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCcc
Q 042634 1 AFTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNN 80 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~ 80 (427)
.|+|++|+|+ .+|..+. ++|+.|+|++|+++ .+|..+. .+|+.|+|++|.++ .+|..+. ++|++|++++|+
T Consensus 203 ~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~ 273 (754)
T PRK15370 203 TLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNK 273 (754)
T ss_pred EEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCc
Confidence 3688888888 5676554 47888888888887 5776553 35666666666666 5665543 356666666666
Q ss_pred CcccCCCCccccccccceeeccCCcCcCCCCCCCc-------------------CCCCCCeEECcCCcccccCCcccccc
Q 042634 81 LTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFG-------------------ILKNLGAIDISENKLSGQIPSSIGSC 141 (427)
Q Consensus 81 ~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~-------------------~l~~L~~l~l~~n~~~~~~p~~~~~~ 141 (427)
++ .+|..+. .+| ..|+|++|+++ .+|..+. -.++|+.|++++|.++ .+|..+.
T Consensus 274 L~-~LP~~l~--~sL-~~L~Ls~N~Lt-~LP~~lp~sL~~L~Ls~N~Lt~LP~~l~~sL~~L~Ls~N~Lt-~LP~~l~-- 345 (754)
T PRK15370 274 IS-CLPENLP--EEL-RYLSVYDNSIR-TLPAHLPSGITHLNVQSNSLTALPETLPPGLKTLEAGENALT-SLPASLP-- 345 (754)
T ss_pred cC-ccccccC--CCC-cEEECCCCccc-cCcccchhhHHHHHhcCCccccCCccccccceeccccCCccc-cCChhhc--
Confidence 65 3444332 244 34555555554 3333221 1245666666666666 3565543
Q ss_pred ccccceeeeeeeccccCCCCcccccCCceeeccCCcccccc
Q 042634 142 IRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNFIRHR 182 (427)
Q Consensus 142 ~~l~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~ll~Hp 182 (427)
++|+.|++++|.++. +|..+. ++|+.|++++|++...|
T Consensus 346 ~sL~~L~Ls~N~L~~-LP~~lp--~~L~~LdLs~N~Lt~LP 383 (754)
T PRK15370 346 PELQVLDVSKNQITV-LPETLP--PTITTLDVSRNALTNLP 383 (754)
T ss_pred CcccEEECCCCCCCc-CChhhc--CCcCEEECCCCcCCCCC
Confidence 567777777777763 454442 46777777777776555
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.57 E-value=3.9e-15 Score=153.37 Aligned_cols=158 Identities=26% Similarity=0.432 Sum_probs=122.1
Q ss_pred CeeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCcc
Q 042634 1 AFTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNN 80 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~ 80 (427)
.|+|+++.++ .+|..+. ++|+.|+|++|+++ .+|..+. ++|+.|++++|+|+ .+|..+. ++|+.|++++|.
T Consensus 182 ~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~ 252 (754)
T PRK15370 182 ELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINR 252 (754)
T ss_pred EEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCc
Confidence 3789999999 6787664 58999999999999 7998775 59999999999999 8887664 479999999999
Q ss_pred CcccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCCC
Q 042634 81 LTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPS 160 (427)
Q Consensus 81 ~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~ 160 (427)
++ .+|..+. .+| ..|++++|+++ .+|..+. ++|+.|++++|+++ .+|..+. .+|+.|++++|.++. +|.
T Consensus 253 L~-~LP~~l~--s~L-~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt~-LP~ 321 (754)
T PRK15370 253 IT-ELPERLP--SAL-QSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLTA-LPE 321 (754)
T ss_pred cC-cCChhHh--CCC-CEEECcCCccC-ccccccC--CCCcEEECCCCccc-cCcccch--hhHHHHHhcCCcccc-CCc
Confidence 98 7776653 467 68999999998 6888764 58999999999999 5776554 356777777777764 343
Q ss_pred CcccccCCceeeccCCcccc
Q 042634 161 SLSSLRGIENLDLSRNNFIR 180 (427)
Q Consensus 161 ~l~~l~~L~~L~L~~N~ll~ 180 (427)
.+. ++|+.|++++|.+..
T Consensus 322 ~l~--~sL~~L~Ls~N~Lt~ 339 (754)
T PRK15370 322 TLP--PGLKTLEAGENALTS 339 (754)
T ss_pred ccc--ccceeccccCCcccc
Confidence 322 355555555555543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.57 E-value=5.7e-16 Score=136.79 Aligned_cols=121 Identities=11% Similarity=0.196 Sum_probs=87.7
Q ss_pred cccccchhhhccccccC---CCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 042634 179 IRHRNLVKIITSCASVD---FQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPI 255 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~---~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~i 255 (427)
+.||+|....+...... +......+++|||++|.+|.++.. +++ ....+++.++..+| ..|+
T Consensus 92 L~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH---~~gi 156 (232)
T PRK10359 92 VRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLH---QHGM 156 (232)
T ss_pred HHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHH---HcCC
Confidence 46788777665533211 111345789999999999977631 222 24569999999999 9999
Q ss_pred eeccccCCceeeCCCCceEecccccccccCCcCCCccccccccccCCCCcCccccchhHHHHHHHH
Q 042634 256 VHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLET 321 (427)
Q Consensus 256 vHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~el 321 (427)
+|||+||+||+++.++ ++|+|||.++......... .+.....++.++||||||+++.-.
T Consensus 157 ~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~d------~~vler~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 157 VSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAKD------RIDLERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred ccCCCChHHEEEeCCC-EEEEECCCcccccchhhHH------HHHHHhHhcccccccceeEeehHH
Confidence 9999999999999888 9999999887664332111 133445577899999999987654
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.55 E-value=9.9e-15 Score=149.72 Aligned_cols=74 Identities=27% Similarity=0.315 Sum_probs=52.2
Q ss_pred ceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCCCCcccccCCceeeccCC
Q 042634 97 IYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRN 176 (427)
Q Consensus 97 ~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N 176 (427)
..|++++|+++ .+|.. .++|+.|++++|+++ .+|... .+|+.|++++|+++ .+|..+..++++..+++++|
T Consensus 385 ~~LdLs~N~Lt-~LP~l---~s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N 455 (788)
T PRK15387 385 KELIVSGNRLT-SLPVL---PSELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGN 455 (788)
T ss_pred ceEEecCCccc-CCCCc---ccCCCEEEccCCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCC
Confidence 34666666665 35543 245677777777777 466543 35677888888887 47888888899999999999
Q ss_pred ccc
Q 042634 177 NFI 179 (427)
Q Consensus 177 ~ll 179 (427)
.+.
T Consensus 456 ~Ls 458 (788)
T PRK15387 456 PLS 458 (788)
T ss_pred CCC
Confidence 885
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.5e-16 Score=159.23 Aligned_cols=199 Identities=26% Similarity=0.391 Sum_probs=140.2
Q ss_pred CeeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCcc
Q 042634 1 AFTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNN 80 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~ 80 (427)
++|++.|+++ .+|.+++.+.+|+.|+..+|+++ ++|..+...++|++|.+.+|.++ .+|+....+++|++|+|..|+
T Consensus 245 ~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~ 321 (1081)
T KOG0618|consen 245 YLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNN 321 (1081)
T ss_pred eeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhcc
Confidence 4799999999 66899999999999999999997 89999999999999999999999 999999999999999999999
Q ss_pred CcccCCCC-ccccc-------------------------cccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccC
Q 042634 81 LTGTTPTE-VIGLS-------------------------SLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQI 134 (427)
Q Consensus 81 ~~~~~p~~-~~~l~-------------------------~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~ 134 (427)
+. .+|.. +..+. .| +.|.+.+|+++...-.-+-+.+.|+.|+|++|++. ++
T Consensus 322 L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~L-q~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-~f 398 (1081)
T KOG0618|consen 322 LP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAAL-QELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN-SF 398 (1081)
T ss_pred cc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHH-HHHHHhcCcccccchhhhccccceeeeeecccccc-cC
Confidence 98 44443 22111 11 24666666666554445566667777777777776 56
Q ss_pred Cc-cccccccccceeeeeeeccccCCCCcccccCCceeeccCCcccccccchhhhccccccCCCCCCccceeee
Q 042634 135 PS-SIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNFIRHRNLVKIITSCASVDFQGNDSEALVYE 207 (427)
Q Consensus 135 p~-~~~~~~~l~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~ll~Hpniv~~~~~~~~~~~~~~~~~~lv~e 207 (427)
|+ .+.++..|+.|+||+|+++. +|..+..+..|+.|...+|++..-|++.++- ....+|.+.++...+..+
T Consensus 399 pas~~~kle~LeeL~LSGNkL~~-Lp~tva~~~~L~tL~ahsN~l~~fPe~~~l~-qL~~lDlS~N~L~~~~l~ 470 (1081)
T KOG0618|consen 399 PASKLRKLEELEELNLSGNKLTT-LPDTVANLGRLHTLRAHSNQLLSFPELAQLP-QLKVLDLSCNNLSEVTLP 470 (1081)
T ss_pred CHHHHhchHHhHHHhcccchhhh-hhHHHHhhhhhHHHhhcCCceeechhhhhcC-cceEEecccchhhhhhhh
Confidence 65 45667777777777777763 4566666666666655556665556443322 223334444444433333
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.4e-14 Score=146.93 Aligned_cols=164 Identities=24% Similarity=0.325 Sum_probs=83.3
Q ss_pred eeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCC-------------
Q 042634 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKC------------- 68 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l------------- 68 (427)
|||++|.|+ .+|+.+.. +|+.|++++|+++ .+|.. +++|++|+|++|+|+ .+|....++
T Consensus 206 LdLs~~~Lt-sLP~~l~~--~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lt-sLP~lp~sL~~L~Ls~N~L~~L 277 (788)
T PRK15387 206 LNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHL 277 (788)
T ss_pred EEcCCCCCC-cCCcchhc--CCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccC-cccCcccccceeeccCCchhhh
Confidence 677777777 56765542 5666666666665 45532 345555555555555 444321110
Q ss_pred ----CCCCeEEccCccCcccCCCCccccccccceeeccCCcCcCCCCCC---CcC--------------CCCCCeEECcC
Q 042634 69 ----QNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSN---FGI--------------LKNLGAIDISE 127 (427)
Q Consensus 69 ----~~L~~l~l~~N~~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~---~~~--------------l~~L~~l~l~~ 127 (427)
++|+.|++++|+++ .+|.. +++| +.|+|++|++++ +|.. +.. ..+|+.|+|++
T Consensus 278 p~lp~~L~~L~Ls~N~Lt-~LP~~---p~~L-~~LdLS~N~L~~-Lp~lp~~L~~L~Ls~N~L~~LP~lp~~Lq~LdLS~ 351 (788)
T PRK15387 278 PALPSGLCKLWIFGNQLT-SLPVL---PPGL-QELSVSDNQLAS-LPALPSELCKLWAYNNQLTSLPTLPSGLQELSVSD 351 (788)
T ss_pred hhchhhcCEEECcCCccc-ccccc---cccc-ceeECCCCcccc-CCCCcccccccccccCccccccccccccceEecCC
Confidence 11223333333333 12211 1233 344455554442 2221 100 12567777777
Q ss_pred CcccccCCccccc-----------------cccccceeeeeeeccccCCCCcccccCCceeeccCCcccccccc
Q 042634 128 NKLSGQIPSSIGS-----------------CIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNFIRHRNL 184 (427)
Q Consensus 128 n~~~~~~p~~~~~-----------------~~~l~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~ll~Hpni 184 (427)
|+|+ .+|....+ ..+|+.|++++|.+++ +|.. .++|..|++++|.+..-|..
T Consensus 352 N~Ls-~LP~lp~~L~~L~Ls~N~L~~LP~l~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~LssIP~l 420 (788)
T PRK15387 352 NQLA-SLPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTSLPML 420 (788)
T ss_pred CccC-CCCCCCcccceehhhccccccCcccccccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCCCCcc
Confidence 7776 34432211 1356677777777774 4432 25678888888888766654
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.51 E-value=7.7e-14 Score=152.88 Aligned_cols=170 Identities=27% Similarity=0.332 Sum_probs=102.7
Q ss_pred eeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccC
Q 042634 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNL 81 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~ 81 (427)
|+|++|++. .+|..+..+++|+.|+|++|...+.+|. ++.+++|+.|+|++|.....+|..++.+++|++|++++|..
T Consensus 616 L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~ 693 (1153)
T PLN03210 616 LQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCEN 693 (1153)
T ss_pred EECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCC
Confidence 667777776 5677777777777777776654446654 77777777777777665557777777777777777777654
Q ss_pred cccCCCCccccccccceeeccCCcCcC--------------------CCCCCC---------------------------
Q 042634 82 TGTTPTEVIGLSSLSIYLDLSQNQLNG--------------------PLPSNF--------------------------- 114 (427)
Q Consensus 82 ~~~~p~~~~~l~~l~~~L~l~~n~~~~--------------------~~p~~~--------------------------- 114 (427)
-..+|..+ ++.+| ..|++++|...+ .+|..+
T Consensus 694 L~~Lp~~i-~l~sL-~~L~Lsgc~~L~~~p~~~~nL~~L~L~~n~i~~lP~~~~l~~L~~L~l~~~~~~~l~~~~~~l~~ 771 (1153)
T PLN03210 694 LEILPTGI-NLKSL-YRLNLSGCSRLKSFPDISTNISWLDLDETAIEEFPSNLRLENLDELILCEMKSEKLWERVQPLTP 771 (1153)
T ss_pred cCccCCcC-CCCCC-CEEeCCCCCCccccccccCCcCeeecCCCccccccccccccccccccccccchhhccccccccch
Confidence 44566543 34444 344444443322 333221
Q ss_pred ---cCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCCCCcccccCCceeeccCC
Q 042634 115 ---GILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRN 176 (427)
Q Consensus 115 ---~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N 176 (427)
...++|+.|++++|...+.+|.+++++++|+.|++++|..-+.+|..+ .+++|+.|++++|
T Consensus 772 ~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c 835 (1153)
T PLN03210 772 LMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGC 835 (1153)
T ss_pred hhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCC
Confidence 012355666666665555677777777777777777654333455443 4555555555554
|
syringae 6; Provisional |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.51 E-value=3.3e-15 Score=151.01 Aligned_cols=194 Identities=25% Similarity=0.291 Sum_probs=148.7
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCccccc-ccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWL-HPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l-~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
+|+|++.+++.. ......+++++|..++++.+.+ .... ...+...+..++.|+..|+.|+|. ..++.||
T Consensus 79 ~h~n~~~~~~~~-----~~~~~~~~~~~~s~g~~~f~~i~~~~~---~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~ 148 (601)
T KOG0590|consen 79 KHSNTVHMIEPS-----SSPRSYLLSLSYSDGGSLFSKISHPDS---TGTSSSSASRYLPQLNSGLSYLHP--ENGVTHR 148 (601)
T ss_pred ccccccccCCcc-----CCCcccccccCcccccccccccccCCc---cCCCCcchhhhhhhhccCccccCc--ccccccC
Confidence 399999999884 3356788999999999999988 4432 246777889999999999999995 6899999
Q ss_pred cccCCceeeCCCC-ceEecccccccccCC-cC--------CC-ccccccccccCCCCc-CccccchhHHHHHHHHHhCCC
Q 042634 259 DLKPSNVLLDGEL-TAHVGDFGLAKFLPE-AT--------NN-FFNFQIAEYGMGSEV-STSGDVYSFGILLLETFTGKR 326 (427)
Q Consensus 259 Dlkp~NIll~~~~-~~kL~DFG~a~~~~~-~~--------~~-~~~y~aPE~~~~~~~-~~~~DiwS~G~vl~ell~g~~ 326 (427)
|+||+|.+++..+ ..|++|||+|..... .. .| ++.|+|||...+..+ .+..|+||.|+++.-+++|..
T Consensus 149 ~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~ 228 (601)
T KOG0590|consen 149 DIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGEL 228 (601)
T ss_pred CCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCC
Confidence 9999999999999 999999999987755 21 77 899999999988544 678999999999999999999
Q ss_pred CCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCC
Q 042634 327 PTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMN 406 (427)
Q Consensus 327 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt 406 (427)
|+.........+..+.... ................++..+++..+|..|.+
T Consensus 229 p~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s 279 (601)
T KOG0590|consen 229 PWDFPSRKDGRYSSWKSNK-----------------------------GRFTQLPWNSISDQAHDLLHKILKENPSNRLS 279 (601)
T ss_pred Cccccccccccceeecccc-----------------------------cccccCccccCChhhhhcccccccCCchhccc
Confidence 9875433332222221111 00001122233445678888999999999999
Q ss_pred HHHHHH
Q 042634 407 MEEVAA 412 (427)
Q Consensus 407 ~~ev~~ 412 (427)
.+++..
T Consensus 280 ~~~~~~ 285 (601)
T KOG0590|consen 280 IEELKL 285 (601)
T ss_pred cccccc
Confidence 887643
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.50 E-value=2.9e-14 Score=127.73 Aligned_cols=147 Identities=23% Similarity=0.390 Sum_probs=121.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
+.|.|+|++..++.+..+.+.....++.|||.-|++.++|++.....+.+....-.+|+.||..||.|||+. ...|+|+
T Consensus 124 lvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Ppiihg 202 (458)
T KOG1266|consen 124 LVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPPIIHG 202 (458)
T ss_pred HHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCccccC
Confidence 569999999999888776666778899999999999999988777667788888999999999999999965 7889999
Q ss_pred cccCCceeeCCCCceEecccccccccCC----------cCCCccccccccccCCCCcCccccchhHHHHHHHHHhCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE----------ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKR 326 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~----------~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~ 326 (427)
++..+-|++..++-+|+.--.-...... ...+-++|.+||+-.....+.++|||+||+...||..+..
T Consensus 203 nlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEi 280 (458)
T KOG1266|consen 203 NLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEI 280 (458)
T ss_pred CcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhee
Confidence 9999999999999888754322211110 1145678999999877788899999999999999988764
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.49 E-value=3e-14 Score=124.17 Aligned_cols=76 Identities=18% Similarity=0.188 Sum_probs=63.9
Q ss_pred cceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHH-hhcCCCCeeeccccCCceeeCCCCceEeccccc
Q 042634 202 EALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYL-HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGL 280 (427)
Q Consensus 202 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~L-H~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~ 280 (427)
.++||||++++++....... ..++...+..++.|++.+|.|+ | ..||+||||||+||+++ ++.++|+|||+
T Consensus 92 ~~iVmE~i~g~~l~~~~~~~----~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~-~~~v~LiDFG~ 163 (190)
T cd05147 92 HVLVMEFIGDDGWAAPRLKD----APLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH-DGKLYIIDVSQ 163 (190)
T ss_pred CEEEEEEeCCCCCcchhhhc----CCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-CCcEEEEEccc
Confidence 38999999887765543222 3488899999999999999999 6 78999999999999998 47899999999
Q ss_pred ccccC
Q 042634 281 AKFLP 285 (427)
Q Consensus 281 a~~~~ 285 (427)
|....
T Consensus 164 a~~~~ 168 (190)
T cd05147 164 SVEHD 168 (190)
T ss_pred cccCC
Confidence 97653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.49 E-value=3.4e-14 Score=145.55 Aligned_cols=113 Identities=33% Similarity=0.511 Sum_probs=100.1
Q ss_pred CCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccCcccCCCCccccccccceeec
Q 042634 22 KLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDL 101 (427)
Q Consensus 22 ~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~~~l~~l~~~L~l 101 (427)
.++.|+|++|.++|.+|..++.+++|+.|+|++|.++|.+|..++.+++|+.|+|++|+++|.+|..++++.+| +.|+|
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L-~~L~L 497 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSL-RILNL 497 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCC-CEEEC
Confidence 47889999999999999999999999999999999999999999999999999999999999999999999999 67999
Q ss_pred cCCcCcCCCCCCCcCC-CCCCeEECcCCcccccCC
Q 042634 102 SQNQLNGPLPSNFGIL-KNLGAIDISENKLSGQIP 135 (427)
Q Consensus 102 ~~n~~~~~~p~~~~~l-~~L~~l~l~~n~~~~~~p 135 (427)
++|+++|.+|..++.+ .++..+++++|......|
T Consensus 498 s~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p 532 (623)
T PLN03150 498 NGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532 (623)
T ss_pred cCCcccccCChHHhhccccCceEEecCCccccCCC
Confidence 9999999999988764 467889999986543333
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.4e-15 Score=144.95 Aligned_cols=152 Identities=30% Similarity=0.443 Sum_probs=136.8
Q ss_pred eeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccC
Q 042634 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNL 81 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~ 81 (427)
+.|..|++. .+|..++.|..|++|||+.|+++ .+|..+..|+ |+.|-++||+++ .+|..++.+..|..||.|.|.+
T Consensus 103 liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei 178 (722)
T KOG0532|consen 103 LILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEI 178 (722)
T ss_pred HHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhh
Confidence 457789999 89999999999999999999998 8999887775 799999999999 9999999888999999999999
Q ss_pred cccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCCCC
Q 042634 82 TGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSS 161 (427)
Q Consensus 82 ~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~~ 161 (427)
. .+|..++++.+| ..|++..|++. .+|.+.+.| .|..||++.|+++ .||-.|.+|+.|+.|-|.+|.++.+ |.+
T Consensus 179 ~-slpsql~~l~sl-r~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqSP-PAq 252 (722)
T KOG0532|consen 179 Q-SLPSQLGYLTSL-RDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQSP-PAQ 252 (722)
T ss_pred h-hchHHhhhHHHH-HHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCCCC-hHH
Confidence 8 888889999999 56999999997 799998855 5999999999999 8999999999999999999999964 555
Q ss_pred cc
Q 042634 162 LS 163 (427)
Q Consensus 162 l~ 163 (427)
+.
T Consensus 253 IC 254 (722)
T KOG0532|consen 253 IC 254 (722)
T ss_pred HH
Confidence 53
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.49 E-value=7.7e-16 Score=140.71 Aligned_cols=125 Identities=26% Similarity=0.382 Sum_probs=89.9
Q ss_pred eeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeecc-ccCcccCCcC-ccCCCCCCeEEccCc
Q 042634 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAE-NMLEGSIPSS-LGKCQNLILLDLSNN 79 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~-n~l~~~~p~~-~~~l~~L~~l~l~~N 79 (427)
+.|..|+|+...|..|+.+.+|+.||||+|+|+-.-|..|.++.+|..|-+-+ |+|+ .+|.. |+++.+|+.|.+.-|
T Consensus 72 irLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~-~l~k~~F~gL~slqrLllNan 150 (498)
T KOG4237|consen 72 IRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT-DLPKGAFGGLSSLQRLLLNAN 150 (498)
T ss_pred EEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh-hhhhhHhhhHHHHHHHhcChh
Confidence 67888888866667888899999999999988865677888888877766654 8888 77754 777888888777777
Q ss_pred cCcccCCCCccccccccceeeccCCcCcCCCCC-CCcCCCCCCeEECcCCc
Q 042634 80 NLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPS-NFGILKNLGAIDISENK 129 (427)
Q Consensus 80 ~~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~-~~~~l~~L~~l~l~~n~ 129 (427)
++.-.....|..++++ ..|.+..|.+. .++. +|..+..++.+.+..|.
T Consensus 151 ~i~Cir~~al~dL~~l-~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np 199 (498)
T KOG4237|consen 151 HINCIRQDALRDLPSL-SLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNP 199 (498)
T ss_pred hhcchhHHHHHHhhhc-chhcccchhhh-hhccccccchhccchHhhhcCc
Confidence 7776666666667666 45777777765 4443 55555555555554444
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.7e-15 Score=151.83 Aligned_cols=170 Identities=28% Similarity=0.343 Sum_probs=138.8
Q ss_pred eeecCCcccccCCccccCCCCCCEeeeecccceeecCcchh--------------------------ccccCCEeeeccc
Q 042634 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIG--------------------------NLTLLITLNFAEN 55 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~--------------------------~l~~L~~L~l~~n 55 (427)
|+...|.+. -+|+....++.|+.|+|..|++. .+|+.+- .++.|+.|++.+|
T Consensus 292 l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN 369 (1081)
T KOG0618|consen 292 LSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANN 369 (1081)
T ss_pred HHhhhhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcC
Confidence 345566776 67787788888888888888886 5655221 1344888999999
Q ss_pred cCcccCCcCccCCCCCCeEEccCccCcccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCC
Q 042634 56 MLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIP 135 (427)
Q Consensus 56 ~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p 135 (427)
.|+...-+.+...+.|+.|+|++|++.......+.++..| ++|+|++|.++ .+|.++.++.+|++|...+|++. .+|
T Consensus 370 ~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~L-eeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP 446 (1081)
T KOG0618|consen 370 HLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEEL-EELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP 446 (1081)
T ss_pred cccccchhhhccccceeeeeecccccccCCHHHHhchHHh-HHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech
Confidence 9998777788889999999999999985665778889899 68999999998 89999999999999999999998 788
Q ss_pred ccccccccccceeeeeeeccccC-CCCcccccCCceeeccCCcc
Q 042634 136 SSIGSCIRLEQLVMNGNFFRGNI-PSSLSSLRGIENLDLSRNNF 178 (427)
Q Consensus 136 ~~~~~~~~l~~l~l~~n~l~~~~-p~~l~~l~~L~~L~L~~N~l 178 (427)
++..++.|+++|++.|.++... |.... .++|++||+++|.-
T Consensus 447 -e~~~l~qL~~lDlS~N~L~~~~l~~~~p-~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 447 -ELAQLPQLKVLDLSCNNLSEVTLPEALP-SPNLKYLDLSGNTR 488 (1081)
T ss_pred -hhhhcCcceEEecccchhhhhhhhhhCC-CcccceeeccCCcc
Confidence 8899999999999999998543 33332 38999999999873
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.1e-14 Score=140.37 Aligned_cols=174 Identities=39% Similarity=0.504 Sum_probs=127.5
Q ss_pred eeecCCcccccCCccccCCC-CCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCcc
Q 042634 2 FTLVGNQFTGRIPGSIGDLH-KLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNN 80 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~-~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~ 80 (427)
|++.+|.++ .+|+....+. +|+.|++++|++. .+|..++.+++|+.|++++|+++ .+|...+.+++|+.|++++|+
T Consensus 121 L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ls~N~ 197 (394)
T COG4886 121 LDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNK 197 (394)
T ss_pred EecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhheeccCCc
Confidence 567777777 6677777774 7888888888887 67777788888888888888888 777777677778888888888
Q ss_pred CcccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCCC
Q 042634 81 LTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPS 160 (427)
Q Consensus 81 ~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~ 160 (427)
++ .+|.....+..| .+|.+++|+.. ..+..+.+++++..+.+++|++. .++..++.+++++.|++++|.++.. +.
T Consensus 198 i~-~l~~~~~~~~~L-~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~~i-~~ 272 (394)
T COG4886 198 IS-DLPPEIELLSAL-EELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISSI-SS 272 (394)
T ss_pred cc-cCchhhhhhhhh-hhhhhcCCcce-ecchhhhhcccccccccCCceee-eccchhccccccceecccccccccc-cc
Confidence 87 666544444456 56777888543 56777777777777777888776 4577777777788888888888753 33
Q ss_pred CcccccCCceeeccCCcccccccc
Q 042634 161 SLSSLRGIENLDLSRNNFIRHRNL 184 (427)
Q Consensus 161 ~l~~l~~L~~L~L~~N~ll~Hpni 184 (427)
++.+..++.+++++|.+...++.
T Consensus 273 -~~~~~~l~~L~~s~n~~~~~~~~ 295 (394)
T COG4886 273 -LGSLTNLRELDLSGNSLSNALPL 295 (394)
T ss_pred -ccccCccCEEeccCccccccchh
Confidence 77777888888887777655443
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.45 E-value=3.8e-15 Score=141.34 Aligned_cols=177 Identities=22% Similarity=0.225 Sum_probs=131.0
Q ss_pred eeecCCccc------ccCCccccCCCCCCEeeeecccceeecCcchhcccc---CCEeeeccccCcc----cCCcCccCC
Q 042634 2 FTLVGNQFT------GRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTL---LITLNFAENMLEG----SIPSSLGKC 68 (427)
Q Consensus 2 l~l~~n~l~------~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~---L~~L~l~~n~l~~----~~p~~~~~l 68 (427)
|++++|.+. ..++..+..+++|+.|+|++|.+.+..+..+..+.+ |++|++++|.+++ .+...+..+
T Consensus 56 l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~ 135 (319)
T cd00116 56 LCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDL 135 (319)
T ss_pred EeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhC
Confidence 577777776 234566788899999999999998667777777776 9999999999883 334456666
Q ss_pred -CCCCeEEccCccCccc----CCCCccccccccceeeccCCcCcCC----CCCCCcCCCCCCeEECcCCccccc----CC
Q 042634 69 -QNLILLDLSNNNLTGT----TPTEVIGLSSLSIYLDLSQNQLNGP----LPSNFGILKNLGAIDISENKLSGQ----IP 135 (427)
Q Consensus 69 -~~L~~l~l~~N~~~~~----~p~~~~~l~~l~~~L~l~~n~~~~~----~p~~~~~l~~L~~l~l~~n~~~~~----~p 135 (427)
++|++|++++|.+++. ++..+..+..+ +.|++++|.+++. ++..+..+++|+.|++++|.+++. ++
T Consensus 136 ~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L-~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~ 214 (319)
T cd00116 136 PPALEKLVLGRNRLEGASCEALAKALRANRDL-KELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALA 214 (319)
T ss_pred CCCceEEEcCCCcCCchHHHHHHHHHHhCCCc-CEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHH
Confidence 8899999999999843 23345556678 6799999999742 334455667999999999988743 33
Q ss_pred ccccccccccceeeeeeeccccCCCCcc-----cccCCceeeccCCccc
Q 042634 136 SSIGSCIRLEQLVMNGNFFRGNIPSSLS-----SLRGIENLDLSRNNFI 179 (427)
Q Consensus 136 ~~~~~~~~l~~l~l~~n~l~~~~p~~l~-----~l~~L~~L~L~~N~ll 179 (427)
..+..+++|+.|++++|.+++.....+. ..+.|+.|++++|.+.
T Consensus 215 ~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~ 263 (319)
T cd00116 215 ETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDIT 263 (319)
T ss_pred HHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCC
Confidence 4566778899999999988763333322 2378999999998875
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.45 E-value=9.2e-14 Score=121.45 Aligned_cols=77 Identities=21% Similarity=0.172 Sum_probs=64.0
Q ss_pred cceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCC-CCeeeccccCCceeeCCCCceEeccccc
Q 042634 202 EALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCE-TPIVHCDLKPSNVLLDGELTAHVGDFGL 280 (427)
Q Consensus 202 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~-~~ivHrDlkp~NIll~~~~~~kL~DFG~ 280 (427)
.++||||++++++....... ..++......++.|++.++.++| . .||+||||||+||+++ ++.++|+|||+
T Consensus 92 ~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll~-~~~~~liDFG~ 163 (190)
T cd05145 92 NVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILYH-DGKPYIIDVSQ 163 (190)
T ss_pred CEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEEE-CCCEEEEEccc
Confidence 48999999887554332111 34778889999999999999999 6 9999999999999999 78999999999
Q ss_pred ccccCC
Q 042634 281 AKFLPE 286 (427)
Q Consensus 281 a~~~~~ 286 (427)
|+....
T Consensus 164 a~~~~~ 169 (190)
T cd05145 164 AVELDH 169 (190)
T ss_pred ceecCC
Confidence 987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.45 E-value=7e-13 Score=145.42 Aligned_cols=148 Identities=26% Similarity=0.269 Sum_probs=101.9
Q ss_pred eeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccC
Q 042634 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNL 81 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~ 81 (427)
|+|++|...+.+|. ++.+++|+.|+|++|.....+|..++++++|+.|++++|..-+.+|..+ ++++|++|++++|..
T Consensus 639 L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~ 716 (1153)
T PLN03210 639 IDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSR 716 (1153)
T ss_pred EECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCC
Confidence 67777665446664 7788888888888876656788888888888888888764444777655 566666666655533
Q ss_pred cc--------------------cCCCCc------------------------------cccccccceeeccCCcCcCCCC
Q 042634 82 TG--------------------TTPTEV------------------------------IGLSSLSIYLDLSQNQLNGPLP 111 (427)
Q Consensus 82 ~~--------------------~~p~~~------------------------------~~l~~l~~~L~l~~n~~~~~~p 111 (427)
.+ .+|..+ ...++| +.|+|++|...+.+|
T Consensus 717 L~~~p~~~~nL~~L~L~~n~i~~lP~~~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL-~~L~Ls~n~~l~~lP 795 (1153)
T PLN03210 717 LKSFPDISTNISWLDLDETAIEEFPSNLRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSL-TRLFLSDIPSLVELP 795 (1153)
T ss_pred ccccccccCCcCeeecCCCccccccccccccccccccccccchhhccccccccchhhhhccccc-hheeCCCCCCccccC
Confidence 22 233211 011345 468888888888899
Q ss_pred CCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeee
Q 042634 112 SNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNF 153 (427)
Q Consensus 112 ~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~ 153 (427)
.+++++++|+.|++++|...+.+|..+ .+++|+.|++++|.
T Consensus 796 ~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~ 836 (1153)
T PLN03210 796 SSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCS 836 (1153)
T ss_pred hhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCC
Confidence 999999999999999975445788765 56666666666543
|
syringae 6; Provisional |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.42 E-value=5.1e-13 Score=138.35 Aligned_cols=122 Identities=21% Similarity=0.272 Sum_probs=106.0
Q ss_pred CCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccccCCceeeC-------CCC
Q 042634 199 NDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLD-------GEL 271 (427)
Q Consensus 199 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrDlkp~NIll~-------~~~ 271 (427)
.+..++|+||.+.|+|.+++... +.+++..+..++.|++.-+++|| ..+|||+||||+|.||. ...
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N~~----~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~ 838 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLINTN----KVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSK 838 (974)
T ss_pred CCcceeeeeccccccHHHhhccC----CCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCccc
Confidence 34568999999999999999844 56999999999999999999999 99999999999999993 235
Q ss_pred ceEecccccccccC---Cc-----CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCC
Q 042634 272 TAHVGDFGLAKFLP---EA-----TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRP 327 (427)
Q Consensus 272 ~~kL~DFG~a~~~~---~~-----~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~p 327 (427)
-++|+|||.|..+. .+ ..+|-.+-.+|+..+.+|++.+|.|.++.+++-|+.|+..
T Consensus 839 ~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 839 GLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred ceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 69999999997542 22 2566778899999999999999999999999999999864
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.42 E-value=2.1e-13 Score=139.78 Aligned_cols=110 Identities=29% Similarity=0.510 Sum_probs=101.6
Q ss_pred cCCEeeeccccCcccCCcCccCCCCCCeEEccCccCcccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEEC
Q 042634 46 LLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDI 125 (427)
Q Consensus 46 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l 125 (427)
.++.|+|++|.++|.+|..++.+++|++|+|++|.++|.+|..+..+.+| +.|+|++|+++|.+|..+++|++|+.|+|
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L-~~LdLs~N~lsg~iP~~l~~L~~L~~L~L 497 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSL-EVLDLSYNSFNGSIPESLGQLTSLRILNL 497 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCC-CEEECCCCCCCCCCchHHhcCCCCCEEEC
Confidence 48899999999999999999999999999999999999999999999999 68999999999999999999999999999
Q ss_pred cCCcccccCCcccccc-ccccceeeeeeeccc
Q 042634 126 SENKLSGQIPSSIGSC-IRLEQLVMNGNFFRG 156 (427)
Q Consensus 126 ~~n~~~~~~p~~~~~~-~~l~~l~l~~n~l~~ 156 (427)
++|.++|.+|..++.. .++..+++++|....
T Consensus 498 s~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc 529 (623)
T PLN03150 498 NGNSLSGRVPAALGGRLLHRASFNFTDNAGLC 529 (623)
T ss_pred cCCcccccCChHHhhccccCceEEecCCcccc
Confidence 9999999999998764 466788888886543
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.40 E-value=1e-14 Score=138.32 Aligned_cols=179 Identities=23% Similarity=0.305 Sum_probs=138.9
Q ss_pred CeeecCCccccc----CCccccCCCCCCEeeeeccccee------ecCcchhccccCCEeeeccccCcccCCcCccCCCC
Q 042634 1 AFTLVGNQFTGR----IPGSIGDLHKLQRLTLEMNKFWG------EIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQN 70 (427)
Q Consensus 1 ~l~l~~n~l~~~----~p~~~~~l~~L~~L~l~~n~~~~------~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~ 70 (427)
+|+++++.+++. ++..+...++|+.|+++.|.+.+ .++..+..+++|+.|++++|.+.+..+..+..+.+
T Consensus 27 ~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~ 106 (319)
T cd00116 27 VLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLR 106 (319)
T ss_pred EEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhc
Confidence 378999998543 56677888899999999998862 34557788999999999999998777777777666
Q ss_pred ---CCeEEccCccCcc----cCCCCcccc-ccccceeeccCCcCcC----CCCCCCcCCCCCCeEECcCCccccc----C
Q 042634 71 ---LILLDLSNNNLTG----TTPTEVIGL-SSLSIYLDLSQNQLNG----PLPSNFGILKNLGAIDISENKLSGQ----I 134 (427)
Q Consensus 71 ---L~~l~l~~N~~~~----~~p~~~~~l-~~l~~~L~l~~n~~~~----~~p~~~~~l~~L~~l~l~~n~~~~~----~ 134 (427)
|++|++++|++++ .+...+..+ .+| +.|++++|.+++ .++..+..++.|+.|++++|.+++. +
T Consensus 107 ~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L-~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l 185 (319)
T cd00116 107 SSSLQELKLNNNGLGDRGLRLLAKGLKDLPPAL-EKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRAL 185 (319)
T ss_pred cCcccEEEeeCCccchHHHHHHHHHHHhCCCCc-eEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHH
Confidence 9999999999973 222334455 677 679999999984 2344567788999999999999853 3
Q ss_pred CccccccccccceeeeeeeccccC----CCCcccccCCceeeccCCcccc
Q 042634 135 PSSIGSCIRLEQLVMNGNFFRGNI----PSSLSSLRGIENLDLSRNNFIR 180 (427)
Q Consensus 135 p~~~~~~~~l~~l~l~~n~l~~~~----p~~l~~l~~L~~L~L~~N~ll~ 180 (427)
+..+..+++|+.|++++|.+++.. +..+..+++|+.|++++|.+.+
T Consensus 186 ~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~ 235 (319)
T cd00116 186 AEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTD 235 (319)
T ss_pred HHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCch
Confidence 344556679999999999987443 3445678899999999998753
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.39 E-value=2.4e-13 Score=119.71 Aligned_cols=92 Identities=18% Similarity=0.175 Sum_probs=68.4
Q ss_pred cccccchhhhccccccCCCCCCccceeeee--ecCCCcccccccchhhhhccCHHHHHHHHHHHHHHH-HHHhhcCCCCe
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEF--MVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASAL-DYLHHYCETPI 255 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~--~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L-~~LH~~~~~~i 255 (427)
..||||+++++.+..-. ..+....+|+|| +.+|+|.+++.+. .+++. ..++.|++.++ +||| +++|
T Consensus 58 ~~h~nIvr~yg~~et~~-g~g~v~~~I~e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh---~~~I 126 (210)
T PRK10345 58 IDWSGIPRYYGTVETDC-GTGYVYDVIADFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLL---DNRI 126 (210)
T ss_pred CCCcccceeeEEEEeCC-CCeEEEEEEecCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHH---HCCE
Confidence 46999999999864411 111223478999 5579999999653 25554 35678888777 9999 8999
Q ss_pred eeccccCCceeeCC----CCceEecccccc
Q 042634 256 VHCDLKPSNVLLDG----ELTAHVGDFGLA 281 (427)
Q Consensus 256 vHrDlkp~NIll~~----~~~~kL~DFG~a 281 (427)
+||||||+|||++. +..++|+||+.+
T Consensus 127 vhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 127 VTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred eecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 99999999999974 348999995444
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.2e-12 Score=128.00 Aligned_cols=174 Identities=33% Similarity=0.483 Sum_probs=148.7
Q ss_pred eeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccc-cCCEeeeccccCcccCCcCccCCCCCCeEEccCcc
Q 042634 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLT-LLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNN 80 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~-~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~ 80 (427)
+++++|.+... +..+..++.++.|++.+|.++ .+|+..+.++ +|+.|++++|.+. .+|..+..+++|+.|++++|+
T Consensus 98 l~~~~~~~~~~-~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~ 174 (394)
T COG4886 98 LDLNLNRLRSN-ISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFND 174 (394)
T ss_pred eeccccccccC-chhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCch
Confidence 56777777533 556777899999999999998 8999888885 9999999999999 998899999999999999999
Q ss_pred CcccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCCC
Q 042634 81 LTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPS 160 (427)
Q Consensus 81 ~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~ 160 (427)
++ .+|...+.+.+| ..|++++|+++ .+|..+..+..|+.|.+++|++. .++..+..+.++..+.+++|++.. ++.
T Consensus 175 l~-~l~~~~~~~~~L-~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~-~~~ 249 (394)
T COG4886 175 LS-DLPKLLSNLSNL-NNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED-LPE 249 (394)
T ss_pred hh-hhhhhhhhhhhh-hheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeee-ccc
Confidence 98 777655577788 57999999998 88888877888999999999755 688889999999999999999884 367
Q ss_pred CcccccCCceeeccCCccccccc
Q 042634 161 SLSSLRGIENLDLSRNNFIRHRN 183 (427)
Q Consensus 161 ~l~~l~~L~~L~L~~N~ll~Hpn 183 (427)
.++.+.+++.|++++|.+..-+.
T Consensus 250 ~~~~l~~l~~L~~s~n~i~~i~~ 272 (394)
T COG4886 250 SIGNLSNLETLDLSNNQISSISS 272 (394)
T ss_pred hhccccccceecccccccccccc
Confidence 78889999999999998866554
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.28 E-value=5.2e-12 Score=113.91 Aligned_cols=76 Identities=20% Similarity=0.198 Sum_probs=63.9
Q ss_pred cceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCC-eeeccccCCceeeCCCCceEeccccc
Q 042634 202 EALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETP-IVHCDLKPSNVLLDGELTAHVGDFGL 280 (427)
Q Consensus 202 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~-ivHrDlkp~NIll~~~~~~kL~DFG~ 280 (427)
.++||||++++++....... ..+....+..++.|++.++++|| ..| |+||||||+||+++ ++.++|+|||.
T Consensus 123 ~~lV~E~~~g~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~NIli~-~~~i~LiDFg~ 194 (237)
T smart00090 123 NVLVMEFIGGDGLPAPRLKD----VEPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEYNILVH-DGKVVIIDVSQ 194 (237)
T ss_pred ceEEEEEecCCccccccccc----CCcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChhhEEEE-CCCEEEEEChh
Confidence 48999999888887665322 23556667899999999999999 889 99999999999999 88999999999
Q ss_pred ccccC
Q 042634 281 AKFLP 285 (427)
Q Consensus 281 a~~~~ 285 (427)
|....
T Consensus 195 a~~~~ 199 (237)
T smart00090 195 SVELD 199 (237)
T ss_pred hhccC
Confidence 87543
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.27 E-value=2.7e-13 Score=120.15 Aligned_cols=140 Identities=28% Similarity=0.343 Sum_probs=114.3
Q ss_pred cccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccCcccCCCCc
Q 042634 10 TGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEV 89 (427)
Q Consensus 10 ~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~ 89 (427)
+|..-..+-....|+.||||+|.|+ .+..+..-++.++.|++|+|.+. ++-. +..+++|+.||||+|.++ .+..+-
T Consensus 273 ~G~~~~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls-~~~Gwh 348 (490)
T KOG1259|consen 273 NGSALVSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLA-ECVGWH 348 (490)
T ss_pred CCceEEecchHhhhhhccccccchh-hhhhhhhhccceeEEecccccee-eehh-hhhcccceEeecccchhH-hhhhhH
Confidence 4444455666678999999999998 88888989999999999999999 6654 888999999999999998 676777
Q ss_pred cccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCC--ccccccccccceeeeeeecccc
Q 042634 90 IGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIP--SSIGSCIRLEQLVMNGNFFRGN 157 (427)
Q Consensus 90 ~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p--~~~~~~~~l~~l~l~~n~l~~~ 157 (427)
..+.+. ..|.|++|.+. . -+.+.+|-+|..||+++|++. .+- ..||+++-|..+.|.+|.+++.
T Consensus 349 ~KLGNI-KtL~La~N~iE-~-LSGL~KLYSLvnLDl~~N~Ie-~ldeV~~IG~LPCLE~l~L~~NPl~~~ 414 (490)
T KOG1259|consen 349 LKLGNI-KTLKLAQNKIE-T-LSGLRKLYSLVNLDLSSNQIE-ELDEVNHIGNLPCLETLRLTGNPLAGS 414 (490)
T ss_pred hhhcCE-eeeehhhhhHh-h-hhhhHhhhhheeccccccchh-hHHHhcccccccHHHHHhhcCCCcccc
Confidence 778888 67999999985 2 245677888999999999987 333 3688888888888888888753
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.26 E-value=3.7e-12 Score=107.99 Aligned_cols=124 Identities=26% Similarity=0.330 Sum_probs=41.3
Q ss_pred ccCCCCCCEeeeecccceeecCcchh-ccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccCcccCCCCc-ccccc
Q 042634 17 IGDLHKLQRLTLEMNKFWGEIPSSIG-NLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEV-IGLSS 94 (427)
Q Consensus 17 ~~~l~~L~~L~l~~n~~~~~~p~~~~-~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~-~~l~~ 94 (427)
+.+...++.|+|++|.|+ .+ ..++ .+++|+.||||+|.++ .++ .+..++.|++|++++|+++ .++..+ ..+++
T Consensus 15 ~~n~~~~~~L~L~~n~I~-~I-e~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~ 89 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQIS-TI-ENLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPN 89 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT
T ss_pred cccccccccccccccccc-cc-cchhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCc
Confidence 345556788888888887 45 3466 5778888888888888 664 5667778888888888887 444333 24667
Q ss_pred ccceeeccCCcCcCCCC--CCCcCCCCCCeEECcCCcccccCCc----ccccccccccee
Q 042634 95 LSIYLDLSQNQLNGPLP--SNFGILKNLGAIDISENKLSGQIPS----SIGSCIRLEQLV 148 (427)
Q Consensus 95 l~~~L~l~~n~~~~~~p--~~~~~l~~L~~l~l~~n~~~~~~p~----~~~~~~~l~~l~ 148 (427)
| ++|++++|++.. +. ..++.+++|+.|++.+|.++ .-+. .+..+++|+.||
T Consensus 90 L-~~L~L~~N~I~~-l~~l~~L~~l~~L~~L~L~~NPv~-~~~~YR~~vi~~lP~Lk~LD 146 (175)
T PF14580_consen 90 L-QELYLSNNKISD-LNELEPLSSLPKLRVLSLEGNPVC-EKKNYRLFVIYKLPSLKVLD 146 (175)
T ss_dssp ---EEE-TTS---S-CCCCGGGGG-TT--EEE-TT-GGG-GSTTHHHHHHHH-TT-SEET
T ss_pred C-CEEECcCCcCCC-hHHhHHHHcCCCcceeeccCCccc-chhhHHHHHHHHcChhheeC
Confidence 7 567777777752 21 34556677777777777776 3333 245566666655
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.26 E-value=2.4e-12 Score=109.13 Aligned_cols=118 Identities=30% Similarity=0.368 Sum_probs=53.1
Q ss_pred CeeecCCcccccCCcccc-CCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCcc-CCCCCCeEEccC
Q 042634 1 AFTLVGNQFTGRIPGSIG-DLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLG-KCQNLILLDLSN 78 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~~-~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~-~l~~L~~l~l~~ 78 (427)
+|+|+||.++ .+. .++ .+.+|+.|+||+|.++ .++ .+..++.|+.|++++|+++ .+++.+. .+++|++|++++
T Consensus 23 ~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~~ 97 (175)
T PF14580_consen 23 ELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLSN 97 (175)
T ss_dssp ---------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE-TT
T ss_pred cccccccccc-ccc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEECcC
Confidence 4899999999 555 466 5899999999999998 675 5999999999999999999 7766554 589999999999
Q ss_pred ccCcccCC-CCccccccccceeeccCCcCcCCCCC----CCcCCCCCCeEEC
Q 042634 79 NNLTGTTP-TEVIGLSSLSIYLDLSQNQLNGPLPS----NFGILKNLGAIDI 125 (427)
Q Consensus 79 N~~~~~~p-~~~~~l~~l~~~L~l~~n~~~~~~p~----~~~~l~~L~~l~l 125 (427)
|++...-. ..+..+++| ..|+|.+|+++. .+. -+..+++|+.||-
T Consensus 98 N~I~~l~~l~~L~~l~~L-~~L~L~~NPv~~-~~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 98 NKISDLNELEPLSSLPKL-RVLSLEGNPVCE-KKNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp S---SCCCCGGGGG-TT---EEE-TT-GGGG-STTHHHHHHHH-TT-SEETT
T ss_pred CcCCChHHhHHHHcCCCc-ceeeccCCcccc-hhhHHHHHHHHcChhheeCC
Confidence 99974322 346678888 689999999983 343 2677899999874
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.25 E-value=2e-13 Score=125.09 Aligned_cols=175 Identities=25% Similarity=0.327 Sum_probs=147.3
Q ss_pred eeecCCcccccCCccccCCCCCCEeeeec-ccceeecCc-chhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCc
Q 042634 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEM-NKFWGEIPS-SIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNN 79 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~~L~~L~l~~-n~~~~~~p~-~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 79 (427)
||||.|+|+-.-|+.|.+|.+|..|-+.+ |+|+ .+|+ .|++|.+|+.|.+.-|.+.-.....+.++++|..|.+..|
T Consensus 96 LdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~-~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn 174 (498)
T KOG4237|consen 96 LDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT-DLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDN 174 (498)
T ss_pred ecccccchhhcChHhhhhhHhhhHHHhhcCCchh-hhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccch
Confidence 79999999988899999999988887777 9998 7885 6899999999999999999555567999999999999999
Q ss_pred cCcccCCC-CccccccccceeeccCCcCc---------------------------------------------------
Q 042634 80 NLTGTTPT-EVIGLSSLSIYLDLSQNQLN--------------------------------------------------- 107 (427)
Q Consensus 80 ~~~~~~p~-~~~~l~~l~~~L~l~~n~~~--------------------------------------------------- 107 (427)
.+. .++. .+..+.++ +.+++..|++-
T Consensus 175 ~~q-~i~~~tf~~l~~i-~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~ 252 (498)
T KOG4237|consen 175 KIQ-SICKGTFQGLAAI-KTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLP 252 (498)
T ss_pred hhh-hhccccccchhcc-chHhhhcCccccccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHH
Confidence 998 5665 67777777 56777777730
Q ss_pred ----------CCCC-CCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCCCCcccccCCceeeccCC
Q 042634 108 ----------GPLP-SNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRN 176 (427)
Q Consensus 108 ----------~~~p-~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N 176 (427)
+.-| ..|..|++|+.|+|++|++++.-+.+|.+.++++.|.|..|++...-...|.++.+|..|+|++|
T Consensus 253 s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N 332 (498)
T KOG4237|consen 253 SRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDN 332 (498)
T ss_pred HhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCC
Confidence 0001 12677889999999999999777789999999999999999998665667889999999999999
Q ss_pred ccc
Q 042634 177 NFI 179 (427)
Q Consensus 177 ~ll 179 (427)
++.
T Consensus 333 ~it 335 (498)
T KOG4237|consen 333 QIT 335 (498)
T ss_pred eeE
Confidence 874
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.17 E-value=3.7e-12 Score=113.00 Aligned_cols=127 Identities=31% Similarity=0.404 Sum_probs=111.3
Q ss_pred CeeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCcc
Q 042634 1 AFTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNN 80 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~ 80 (427)
.+|||+|.++ .+..++.-++.++.|++|+|.+. .+-. +..|++|+.||||+|.++ .+-.+=..+-+.+.|.|++|.
T Consensus 288 elDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~ 363 (490)
T KOG1259|consen 288 ELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQNK 363 (490)
T ss_pred hccccccchh-hhhhhhhhccceeEEecccccee-eehh-hhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhhh
Confidence 3799999999 89999999999999999999998 6755 999999999999999999 877777778899999999999
Q ss_pred CcccCCCCccccccccceeeccCCcCcCCCC--CCCcCCCCCCeEECcCCcccccCCc
Q 042634 81 LTGTTPTEVIGLSSLSIYLDLSQNQLNGPLP--SNFGILKNLGAIDISENKLSGQIPS 136 (427)
Q Consensus 81 ~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p--~~~~~l~~L~~l~l~~n~~~~~~p~ 136 (427)
+. .+ .++..+.+| ..||+.+|++. .+- ..+++|+-|+++.|.+|.+.+ +|+
T Consensus 364 iE-~L-SGL~KLYSL-vnLDl~~N~Ie-~ldeV~~IG~LPCLE~l~L~~NPl~~-~vd 416 (490)
T KOG1259|consen 364 IE-TL-SGLRKLYSL-VNLDLSSNQIE-ELDEVNHIGNLPCLETLRLTGNPLAG-SVD 416 (490)
T ss_pred Hh-hh-hhhHhhhhh-eeccccccchh-hHHHhcccccccHHHHHhhcCCCccc-cch
Confidence 97 33 367788888 78999999996 332 578999999999999999994 554
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.16 E-value=2.4e-11 Score=107.01 Aligned_cols=69 Identities=26% Similarity=0.481 Sum_probs=60.2
Q ss_pred CccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccccCCceeeCCCCceEecccc
Q 042634 200 DSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFG 279 (427)
Q Consensus 200 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG 279 (427)
...+++|||++|++|.+++.... . .++.|++.+|.++| ..|++|||++|+||+++ ++.++++|||
T Consensus 70 ~~~~lv~e~~~g~~l~~~~~~~~-----~------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg 134 (199)
T TIGR03724 70 DNKTIVMEYIEGKPLKDVIEEGN-----D------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFG 134 (199)
T ss_pred CCCEEEEEEECCccHHHHHhhcH-----H------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECC
Confidence 35689999999999988764321 0 78999999999999 89999999999999999 7899999999
Q ss_pred cccc
Q 042634 280 LAKF 283 (427)
Q Consensus 280 ~a~~ 283 (427)
.++.
T Consensus 135 ~a~~ 138 (199)
T TIGR03724 135 LGKY 138 (199)
T ss_pred CCcC
Confidence 9875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.15 E-value=4.7e-11 Score=105.14 Aligned_cols=73 Identities=16% Similarity=0.120 Sum_probs=61.9
Q ss_pred ccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccccCCceeeCCCCceEeccccc
Q 042634 201 SEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGL 280 (427)
Q Consensus 201 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~ 280 (427)
..++||||+++++|...... .....++.+++.++.++| ..||+||||||+||++++++.++|+|||.
T Consensus 105 ~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~Nill~~~~~~~liDfg~ 171 (198)
T cd05144 105 RHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAY---KHGIIHGDLSEFNILVDDDEKIYIIDWPQ 171 (198)
T ss_pred CceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCcccEEEcCCCcEEEEECCc
Confidence 45899999999998765431 234578899999999999 89999999999999999999999999999
Q ss_pred ccccCC
Q 042634 281 AKFLPE 286 (427)
Q Consensus 281 a~~~~~ 286 (427)
+.....
T Consensus 172 ~~~~~~ 177 (198)
T cd05144 172 MVSTDH 177 (198)
T ss_pred cccCCC
Confidence 965543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.15 E-value=2.6e-11 Score=123.01 Aligned_cols=85 Identities=24% Similarity=0.352 Sum_probs=67.4
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|++++.....+. .....++||||+++++|.+++. ....++.|++++|.||| ..|++||
T Consensus 393 l~~~~i~~p~~~~~-----~~~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH---~~giiHr 452 (535)
T PRK09605 393 ARRAGVPTPVIYDV-----DPEEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLH---KAGIVHG 452 (535)
T ss_pred hcccCCCeeEEEEE-----eCCCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHH---hCCCccC
Confidence 45666654433221 1345689999999999987763 34678999999999999 8999999
Q ss_pred cccCCceeeCCCCceEeccccccccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFL 284 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~ 284 (427)
|+||+||++ .++.++|+|||+|+..
T Consensus 453 Dlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 453 DLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred CCChHHEEE-ECCcEEEEeCcccccC
Confidence 999999999 6778999999999753
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.15 E-value=3.5e-11 Score=107.06 Aligned_cols=72 Identities=28% Similarity=0.519 Sum_probs=63.2
Q ss_pred CccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccccCCceeeCCCCceEecccc
Q 042634 200 DSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFG 279 (427)
Q Consensus 200 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG 279 (427)
...+++|||++|++|.+++... .. .+..++.+++.+|.++| ..|++|||++|.||+++ ++.++|+|||
T Consensus 72 ~~~~lv~e~~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~ 139 (211)
T PRK14879 72 ENFIIVMEYIEGEPLKDLINSN-------GM-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFG 139 (211)
T ss_pred CCCEEEEEEeCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECC
Confidence 4568999999999998887532 12 78889999999999999 89999999999999999 7889999999
Q ss_pred cccc
Q 042634 280 LAKF 283 (427)
Q Consensus 280 ~a~~ 283 (427)
.++.
T Consensus 140 ~a~~ 143 (211)
T PRK14879 140 LAEF 143 (211)
T ss_pred cccC
Confidence 8864
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.12 E-value=5.9e-11 Score=107.24 Aligned_cols=71 Identities=20% Similarity=0.256 Sum_probs=59.5
Q ss_pred cceeeeeecC-CCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccccCCceeeCCCCceEeccccc
Q 042634 202 EALVYEFMVN-GSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGL 280 (427)
Q Consensus 202 ~~lv~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~ 280 (427)
.++|||++++ .+|.+++... .++.. .+.|++.++.+|| ..||+||||||+|||++.++.++|+|||.
T Consensus 121 ~~lV~e~l~G~~~L~~~l~~~-----~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LIDfg~ 188 (239)
T PRK01723 121 ADILIERIEGARDLVALLQEA-----PLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLIDFDR 188 (239)
T ss_pred eeEEEEecCCCCCHHHHHhcC-----CCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEEECCC
Confidence 3599999987 6888887542 24433 3678999999999 99999999999999999888999999999
Q ss_pred cccc
Q 042634 281 AKFL 284 (427)
Q Consensus 281 a~~~ 284 (427)
++..
T Consensus 189 ~~~~ 192 (239)
T PRK01723 189 GELR 192 (239)
T ss_pred cccC
Confidence 8764
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.10 E-value=5.9e-11 Score=121.43 Aligned_cols=139 Identities=25% Similarity=0.315 Sum_probs=112.0
Q ss_pred cccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccc
Q 042634 181 HRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDL 260 (427)
Q Consensus 181 Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrDl 260 (427)
+|-+++.... +......+++++|..+++|...++... ..+..-.+.....+.++.+||| ...+.|||+
T Consensus 863 ~P~v~~~~~s-----~~~rsP~~L~~~~~~~~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~ 930 (1205)
T KOG0606|consen 863 SPAVVRSFPS-----FPCRSPLPLVGHYLNGGDLPSKLHNSG----CLSAEPARSPILERVQSLESLH---SSLRKHRDL 930 (1205)
T ss_pred CCceecccCC-----CCCCCCcchhhHHhccCCchhhhhcCC----CcccccccchhHHHHhhhhccc---cchhhcccc
Confidence 4555554433 334567899999999999999988654 2555566777888889999999 777999999
Q ss_pred cCCceeeCCCCceEecccccccccCC-------------------------------------cCCCccccccccccCCC
Q 042634 261 KPSNVLLDGELTAHVGDFGLAKFLPE-------------------------------------ATNNFFNFQIAEYGMGS 303 (427)
Q Consensus 261 kp~NIll~~~~~~kL~DFG~a~~~~~-------------------------------------~~~~~~~y~aPE~~~~~ 303 (427)
+|.|+++..++..++.|||......- ...+|+.|.+||...+.
T Consensus 931 ~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~ 1010 (1205)
T KOG0606|consen 931 KPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGR 1010 (1205)
T ss_pred cccchhhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccc
Confidence 99999999999999999984432100 01578889999999999
Q ss_pred CcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 304 EVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 304 ~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
....++|+|++|++++|.++|.+||...
T Consensus 1011 ~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 1011 RHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred cCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence 9999999999999999999999999764
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.06 E-value=2e-10 Score=111.67 Aligned_cols=152 Identities=24% Similarity=0.328 Sum_probs=120.2
Q ss_pred ccCCceeeccCCcccccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHH--
Q 042634 165 LRGIENLDLSRNNFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVAS-- 242 (427)
Q Consensus 165 l~~L~~L~L~~N~ll~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~-- 242 (427)
+..++.+ .+.-++-.|++.++.... +.+....++-+|+| +.+|.++.+... ..++....+....+..+
T Consensus 162 ~~k~~~~-~s~~~i~~~~~~v~~~~~-----~e~~~~lfiqtE~~-~~sl~~~~~~~~---~~~p~~~l~~~~~~~~~~~ 231 (524)
T KOG0601|consen 162 KRKLREF-LSHHKIDSHENPVRDSPA-----WEGSGILFIQTELC-GESLQSYCHTPC---NFLPDNLLWNSLRDWLSRD 231 (524)
T ss_pred ccccchh-hcccccCccccccccCcc-----cccCCcceeeeccc-cchhHHhhhccc---ccCCchhhhhHHhhhhhcc
Confidence 3344443 344555678888886555 45577888999988 688888876543 33777888888888888
Q ss_pred --HHHHHhhcCCCCeeeccccCCceeeCCC-CceEecccccccccCCcC-----------CCccccccccccCCCCcCcc
Q 042634 243 --ALDYLHHYCETPIVHCDLKPSNVLLDGE-LTAHVGDFGLAKFLPEAT-----------NNFFNFQIAEYGMGSEVSTS 308 (427)
Q Consensus 243 --~L~~LH~~~~~~ivHrDlkp~NIll~~~-~~~kL~DFG~a~~~~~~~-----------~~~~~y~aPE~~~~~~~~~~ 308 (427)
|+.++| ..+++|-|+||.||+...+ ...+++|||+...+.... .+...|++||... .-++.+
T Consensus 232 ~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~ 307 (524)
T KOG0601|consen 232 VTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFA 307 (524)
T ss_pred cccccccC---CCcccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchH
Confidence 999999 9999999999999999999 889999999998775543 4556799999854 456889
Q ss_pred ccchhHHHHHHHHHhCCCCCCc
Q 042634 309 GDVYSFGILLLETFTGKRPTNE 330 (427)
Q Consensus 309 ~DiwS~G~vl~ell~g~~pf~~ 330 (427)
.||||+|.|..+...+..++..
T Consensus 308 ~di~sl~ev~l~~~l~~~~~~~ 329 (524)
T KOG0601|consen 308 SDIFSLGEVILEAILGSHLPSV 329 (524)
T ss_pred hhhcchhhhhHhhHhhcccccC
Confidence 9999999999999998876543
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=99.01 E-value=3.4e-10 Score=79.05 Aligned_cols=60 Identities=45% Similarity=0.572 Sum_probs=48.7
Q ss_pred CCCCEeeeecccceeecC-cchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccC
Q 042634 21 HKLQRLTLEMNKFWGEIP-SSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNL 81 (427)
Q Consensus 21 ~~L~~L~l~~n~~~~~~p-~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~ 81 (427)
++|++|++++|+++ .+| ..|.++++|++|++++|.++...|..|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~-~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLT-EIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTES-EECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCC-ccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 47888899988888 455 5778889999999999988855556788888888888888875
|
... |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.01 E-value=4.2e-10 Score=98.04 Aligned_cols=75 Identities=24% Similarity=0.246 Sum_probs=59.7
Q ss_pred ccceeeeeecCCCcccc-cccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCC-CCeeeccccCCceeeCCCCceEeccc
Q 042634 201 SEALVYEFMVNGSLEEW-LHPNREALKNLNLLQRLSIAVDVASALDYLHHYCE-TPIVHCDLKPSNVLLDGELTAHVGDF 278 (427)
Q Consensus 201 ~~~lv~e~~~~g~L~~~-l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~-~~ivHrDlkp~NIll~~~~~~kL~DF 278 (427)
..++||||++++++... +.... . ...+..++.+++.++.++| . .||+||||||+||+++ ++.++|+||
T Consensus 89 ~~~lv~e~~~g~~~~~~~l~~~~-----~-~~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~-~~~~~liDf 158 (187)
T cd05119 89 RHVLVMEFIGGDGIPAPRLKDVR-----L-LEDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD-DGKVYIIDV 158 (187)
T ss_pred CCEEEEEEeCCCCccChhhhhhh-----h-cccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE-CCcEEEEEC
Confidence 35899999988654322 21110 1 1567889999999999999 7 9999999999999999 899999999
Q ss_pred ccccccC
Q 042634 279 GLAKFLP 285 (427)
Q Consensus 279 G~a~~~~ 285 (427)
|.|....
T Consensus 159 g~a~~~~ 165 (187)
T cd05119 159 PQAVEID 165 (187)
T ss_pred ccccccc
Confidence 9997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=98.99 E-value=6.1e-10 Score=92.97 Aligned_cols=73 Identities=26% Similarity=0.343 Sum_probs=61.0
Q ss_pred CccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccccCCceeeCCCCceEecccc
Q 042634 200 DSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFG 279 (427)
Q Consensus 200 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG 279 (427)
...+++|||+.++.+..+ +......++.+++++++++|.....+++|+|++|+||+++..+.++++|||
T Consensus 66 ~~~~~v~e~~~g~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~ 134 (155)
T cd05120 66 GWSYLLMEWIEGETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWE 134 (155)
T ss_pred CccEEEEEecCCeecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecc
Confidence 567999999988777654 334567789999999999995333589999999999999998999999999
Q ss_pred cccc
Q 042634 280 LAKF 283 (427)
Q Consensus 280 ~a~~ 283 (427)
.++.
T Consensus 135 ~~~~ 138 (155)
T cd05120 135 YAGY 138 (155)
T ss_pred cccC
Confidence 8864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.96 E-value=8.7e-09 Score=96.23 Aligned_cols=181 Identities=19% Similarity=0.187 Sum_probs=123.0
Q ss_pred hccCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccccCCceeeCCCCceEecccccccccCC-----cCCCcccccccccc
Q 042634 226 KNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPE-----ATNNFFNFQIAEYG 300 (427)
Q Consensus 226 ~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~y~aPE~~ 300 (427)
....|...++.++.++.+..-|| ..|.+-+|+.++|+|+.+++.+.|.|-..-..... ..+|...|.+||.-
T Consensus 112 P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ng~~~~cpVg~~eftPPElQ 188 (637)
T COG4248 112 PHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQINANGTLHLCPVGVSEFTPPELQ 188 (637)
T ss_pred CccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcccceeeccCCceEecccCccccCCHHHh
Confidence 45779999999999999999999 89999999999999999999999987433222222 22778899999975
Q ss_pred C-----CCCcCccccchhHHHHHHHHHhC-CCCCCcccCCCccHHHHHHHhcccchh-cccCccccccccccchhhhccc
Q 042634 301 M-----GSEVSTSGDVYSFGILLLETFTG-KRPTNEMFTGNLTLHNFVKEALPERLA-EIVDPVLLVEREEGETSKANAH 373 (427)
Q Consensus 301 ~-----~~~~~~~~DiwS~G~vl~ell~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 373 (427)
. +..-+...|-|.+|+++++++.| ++||.+....... ++... ++.........+.+.. -
T Consensus 189 ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~a---------p~p~E~~Ia~g~f~ya~~~~~g-----~ 254 (637)
T COG4248 189 TLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDA---------PNPLETDIAHGRFAYASDQRRG-----L 254 (637)
T ss_pred ccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCC---------CCcchhhhhcceeeechhccCC-----C
Confidence 4 23346779999999999999885 9999876322110 01111 1111111111101100 0
Q ss_pred cccccccchHHHHHHHHHHHhhcCCCC--CCCCCCHHHHHHHHHHHHHHHHh
Q 042634 374 KQFTRSFSVKECLVSVLGIGVTCSSEL--PRERMNMEEVAAQLLSFRNKLVK 423 (427)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~l~~~cl~~d--P~~Rpt~~ev~~~L~~~~~~~~~ 423 (427)
++..........+..+..+..+|+... +.-|||++.-+..|.++++++.+
T Consensus 255 ~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~ 306 (637)
T COG4248 255 KPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKK 306 (637)
T ss_pred CCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhh
Confidence 111112233444566778888888654 57899999999999999988764
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.89 E-value=4.6e-10 Score=110.80 Aligned_cols=144 Identities=19% Similarity=0.283 Sum_probs=100.6
Q ss_pred HHHHHHHHHHHHhhcCCCCeeeccccCCceeeCCCCceEecccccccccCCcC---------------CCcccccccccc
Q 042634 236 IAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEAT---------------NNFFNFQIAEYG 300 (427)
Q Consensus 236 ~~~~i~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~---------------~~~~~y~aPE~~ 300 (427)
=+.+++.|+.|+|. +.++||++|.|++|.++..+..||+.|+.+....... .....|.|||++
T Consensus 104 nl~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~ 181 (700)
T KOG2137|consen 104 NLGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYL 181 (700)
T ss_pred hhhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhh
Confidence 34566689999996 7899999999999999999999999999987654422 233469999999
Q ss_pred CCCCcCccccchhHHHHHHHHHh-CCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccc
Q 042634 301 MGSEVSTSGDVYSFGILLLETFT-GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRS 379 (427)
Q Consensus 301 ~~~~~~~~~DiwS~G~vl~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 379 (427)
.+...+.++|+||+||++|-+.. |+..+.. .+..... ...+... .... .
T Consensus 182 ~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a-~~~~~~~-~~~~~~~--~~~~--------------------------~ 231 (700)
T KOG2137|consen 182 LGTTNTPASDVFSLGVLIYTIYNGGKSIIAA-NGGLLSY-SFSRNLL--NAGA--------------------------F 231 (700)
T ss_pred ccccccccccceeeeeEEEEEecCCcchhhc-cCCcchh-hhhhccc--cccc--------------------------c
Confidence 99888999999999999999995 5544432 1111111 1111000 0000 0
Q ss_pred cchHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 042634 380 FSVKECLVSVLGIGVTCSSELPRERMNMEEVA 411 (427)
Q Consensus 380 ~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~ 411 (427)
-...+.+.++.+=+.+++..++.-||++.++.
T Consensus 232 ~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 232 GYSNNLPSELRESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred cccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence 01234566677788888888999999776654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.2e-09 Score=106.39 Aligned_cols=191 Identities=19% Similarity=0.170 Sum_probs=133.8
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
..|.++++....+.. ....++--|||.++++..... ....+.+..++++..|++.++.++| +..++|+
T Consensus 323 ~~~~~~~g~~~~W~~-----~r~~~ip~e~~~~~s~~l~~~----~~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~ 390 (524)
T KOG0601|consen 323 GSHLPSVGKNSSWSQ-----LRQGYIPLEFCEGGSSSLRSV----TSQMLDEDPRLRLTAQILTALNVIH---SKLFVHL 390 (524)
T ss_pred hcccccCCCCCCccc-----cccccCchhhhcCcchhhhhH----HHHhcCcchhhhhHHHHHhcccccc---chhhhcc
Confidence 347777777766443 456779999999998766552 1245788889999999999999999 9999999
Q ss_pred cccCCceeeCCC-CceEecccccccccCCc----CCCcccc-ccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGE-LTAHVGDFGLAKFLPEA----TNNFFNF-QIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~-~~~kL~DFG~a~~~~~~----~~~~~~y-~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
|+||+||++..+ +..++.|||++..+.-. ...+..| .+++......+..++|++|||..+.|..++...-...
T Consensus 391 d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~- 469 (524)
T KOG0601|consen 391 DVKPSNILISNDGFFSKLGDFGCWTRLAFSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG- 469 (524)
T ss_pred cccccceeeccchhhhhccccccccccceecccccccccccccchhhccccccccccccccccccccccccCcccCccc-
Confidence 999999999876 88999999999742211 1233334 2555556677889999999999999999887532211
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
..+ ..+....+ . .......++..+...+...++..||.+.+...
T Consensus 470 ---~~~------------~~i~~~~~--------------------p-~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~ 513 (524)
T KOG0601|consen 470 ---VQS------------LTIRSGDT--------------------P-NLPGLKLQLQVLLKVMINPDRKRRPSAVELSL 513 (524)
T ss_pred ---ccc------------eeeecccc--------------------c-CCCchHHhhhhhhhhhcCCccccchhhhhhcc
Confidence 000 00000000 0 01112255677888899999999999998877
Q ss_pred HHHHHH
Q 042634 413 QLLSFR 418 (427)
Q Consensus 413 ~L~~~~ 418 (427)
+.+..+
T Consensus 514 ~~~~~~ 519 (524)
T KOG0601|consen 514 HSEFYR 519 (524)
T ss_pred cchhhh
Confidence 665543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.87 E-value=1e-08 Score=101.00 Aligned_cols=132 Identities=22% Similarity=0.239 Sum_probs=97.9
Q ss_pred cccccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCee
Q 042634 177 NFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIV 256 (427)
Q Consensus 177 ~ll~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~iv 256 (427)
+.++||+|+++++.... ....|+|+|-+. -|..++. .++...+..-+.||+.||.|||+ ..+++
T Consensus 64 KtlRHP~Il~yL~t~e~-----~~~~ylvTErV~--Pl~~~lk-------~l~~~~v~~Gl~qIl~AL~FL~~--d~~lv 127 (690)
T KOG1243|consen 64 KTLRHPNILSYLDTTEE-----EGTLYLVTERVR--PLETVLK-------ELGKEEVCLGLFQILAALSFLND--DCNLV 127 (690)
T ss_pred hhccCchhhhhhhhhcc-----cCceEEEeeccc--cHHHHHH-------HhHHHHHHHHHHHHHHHHHHHhc--cCCee
Confidence 34789999999998443 567899999773 3444443 24456677789999999999986 78999
Q ss_pred eccccCCceeeCCCCceEecccccccccCCcC------CCccccccccccCCCCcCccccchhHHHHHHHHHhCCC
Q 042634 257 HCDLKPSNVLLDGELTAHVGDFGLAKFLPEAT------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKR 326 (427)
Q Consensus 257 HrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~ 326 (427)
|++|.-..|+++..|..||++|-.+....... ..-..|..|+...... -..|.|-|||++||++.|..
T Consensus 128 HgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 128 HGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred eccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCccc
Confidence 99999999999999999999998875433222 1111345555432222 34699999999999999943
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.82 E-value=3.3e-09 Score=73.99 Aligned_cols=60 Identities=47% Similarity=0.634 Sum_probs=40.8
Q ss_pred ccCCEeeeccccCcccCC-cCccCCCCCCeEEccCccCcccCCCCccccccccceeeccCCcC
Q 042634 45 TLLITLNFAENMLEGSIP-SSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQL 106 (427)
Q Consensus 45 ~~L~~L~l~~n~l~~~~p-~~~~~l~~L~~l~l~~N~~~~~~p~~~~~l~~l~~~L~l~~n~~ 106 (427)
++|++|++++|+++ .+| ..+..+++|++|++++|+++...|..|.++++| ++|++++|++
T Consensus 1 p~L~~L~l~~n~l~-~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L-~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLT-EIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNL-RYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTES-EECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTE-SEEEETSSSB
T ss_pred CcCcEEECCCCCCC-ccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCC-CEEeCcCCcC
Confidence 46777777777777 445 456677777777777777775555666666666 4566666654
|
... |
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.82 E-value=7.4e-10 Score=108.78 Aligned_cols=144 Identities=24% Similarity=0.297 Sum_probs=96.6
Q ss_pred eeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccC
Q 042634 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNL 81 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~ 81 (427)
++++.|.+. .+-..++.+++|+.|++..|+|. .+...+..+++|++|++++|.|+ .+. .+..++.|+.|++++|.+
T Consensus 77 l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~-~i~-~l~~l~~L~~L~l~~N~i 152 (414)
T KOG0531|consen 77 LNLRQNLIA-KILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKIT-KLE-GLSTLTLLKELNLSGNLI 152 (414)
T ss_pred hccchhhhh-hhhcccccccceeeeeccccchh-hcccchhhhhcchheeccccccc-ccc-chhhccchhhheeccCcc
Confidence 345666666 34455788888888888888888 45555788888888888888888 443 455666688888888888
Q ss_pred cccCCCCccccccccceeeccCCcCcCCCCCC-CcCCCCCCeEECcCCcccccCCccccccccccceeeeeeecc
Q 042634 82 TGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSN-FGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFR 155 (427)
Q Consensus 82 ~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~-~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~ 155 (427)
+ .++ .+..+..| ..+++++|++.. +... ...+.+++.+++.+|.+.. ...+..+..+..+++..|.++
T Consensus 153 ~-~~~-~~~~l~~L-~~l~l~~n~i~~-ie~~~~~~~~~l~~l~l~~n~i~~--i~~~~~~~~l~~~~l~~n~i~ 221 (414)
T KOG0531|consen 153 S-DIS-GLESLKSL-KLLDLSYNRIVD-IENDELSELISLEELDLGGNSIRE--IEGLDLLKKLVLLSLLDNKIS 221 (414)
T ss_pred h-hcc-CCccchhh-hcccCCcchhhh-hhhhhhhhccchHHHhccCCchhc--ccchHHHHHHHHhhcccccce
Confidence 7 443 34446677 568888888873 3332 4677788888888887762 222333333333444555444
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.76 E-value=2e-10 Score=90.61 Aligned_cols=101 Identities=26% Similarity=0.323 Sum_probs=52.6
Q ss_pred eeecCCcccccCCccccC---CCCCCEeeeecccceeecCcchh-ccccCCEeeeccccCcccCCcCccCCCCCCeEEcc
Q 042634 2 FTLVGNQFTGRIPGSIGD---LHKLQRLTLEMNKFWGEIPSSIG-NLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLS 77 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~---l~~L~~L~l~~n~~~~~~p~~~~-~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~ 77 (427)
+||++++|. .+++.... ...|+..+|++|.+. ..|+.|. ..+.++.|+|++|.++ .+|.++..++.|+.|+++
T Consensus 32 ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~ 108 (177)
T KOG4579|consen 32 LDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLR 108 (177)
T ss_pred cccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccc
Confidence 355555554 34443333 333444466666665 4554443 3345666666666666 666666666666666666
Q ss_pred CccCcccCCCCccccccccceeeccCCcCc
Q 042634 78 NNNLTGTTPTEVIGLSSLSIYLDLSQNQLN 107 (427)
Q Consensus 78 ~N~~~~~~p~~~~~l~~l~~~L~l~~n~~~ 107 (427)
.|++. ..|.-+..+.++ ..|+..+|...
T Consensus 109 ~N~l~-~~p~vi~~L~~l-~~Lds~~na~~ 136 (177)
T KOG4579|consen 109 FNPLN-AEPRVIAPLIKL-DMLDSPENARA 136 (177)
T ss_pred cCccc-cchHHHHHHHhH-HHhcCCCCccc
Confidence 66665 344444444444 34555555543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.74 E-value=1.6e-08 Score=87.56 Aligned_cols=76 Identities=22% Similarity=0.192 Sum_probs=58.2
Q ss_pred ccceeeeeecCCCccc-ccccchhhhhccCHHHHHHHHHHHHHHHHHH-hhcCCCCeeeccccCCceeeCCCCceEeccc
Q 042634 201 SEALVYEFMVNGSLEE-WLHPNREALKNLNLLQRLSIAVDVASALDYL-HHYCETPIVHCDLKPSNVLLDGELTAHVGDF 278 (427)
Q Consensus 201 ~~~lv~e~~~~g~L~~-~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~L-H~~~~~~ivHrDlkp~NIll~~~~~~kL~DF 278 (427)
..++||||+.++.+.. .+++ ..++..+...+..+++.+|..+ | ..||||+|+++.||++.+ +.+.|+||
T Consensus 98 ~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs~~NIL~~~-~~v~iIDF 168 (197)
T cd05146 98 KHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLSEYNMLWHD-GKVWFIDV 168 (197)
T ss_pred CCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEC-CcEEEEEC
Confidence 4589999996554422 2221 1244556677889999999998 7 889999999999999974 67999999
Q ss_pred ccccccC
Q 042634 279 GLAKFLP 285 (427)
Q Consensus 279 G~a~~~~ 285 (427)
|.|....
T Consensus 169 ~qav~~~ 175 (197)
T cd05146 169 SQSVEPT 175 (197)
T ss_pred CCceeCC
Confidence 9987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.74 E-value=2.2e-09 Score=100.15 Aligned_cols=161 Identities=25% Similarity=0.251 Sum_probs=122.0
Q ss_pred cccCCCCCCEeeeecccceeecC--cchhccccCCEeeeccccCcccCCcCc-cCCCCCCeEEccCccCcccCCC-Cccc
Q 042634 16 SIGDLHKLQRLTLEMNKFWGEIP--SSIGNLTLLITLNFAENMLEGSIPSSL-GKCQNLILLDLSNNNLTGTTPT-EVIG 91 (427)
Q Consensus 16 ~~~~l~~L~~L~l~~n~~~~~~p--~~~~~l~~L~~L~l~~n~l~~~~p~~~-~~l~~L~~l~l~~N~~~~~~p~-~~~~ 91 (427)
....+++++.||||.|-++..-| .-...|++|+.|+||.|++.-..-... ..+++|+.|.++.|-+++.--. .+..
T Consensus 141 ~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~ 220 (505)
T KOG3207|consen 141 YSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLT 220 (505)
T ss_pred hhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHh
Confidence 56789999999999999885433 334678999999999999983222222 2457899999999999744332 2456
Q ss_pred cccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCC--ccccccccccceeeeeeecccc-CCCC-----cc
Q 042634 92 LSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIP--SSIGSCIRLEQLVMNGNFFRGN-IPSS-----LS 163 (427)
Q Consensus 92 l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p--~~~~~~~~l~~l~l~~n~l~~~-~p~~-----l~ 163 (427)
++++ ..|+|+.|...+........++.|+.|||++|++- ..+ ..++.++.|+.|+++.+.+... .|+. ..
T Consensus 221 fPsl-~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~ 298 (505)
T KOG3207|consen 221 FPSL-EVLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTH 298 (505)
T ss_pred CCcH-HHhhhhcccccceecchhhhhhHHhhccccCCccc-ccccccccccccchhhhhccccCcchhcCCCccchhhhc
Confidence 7788 57999999644455666777889999999999887 566 5678999999999999988753 2332 35
Q ss_pred cccCCceeeccCCcc
Q 042634 164 SLRGIENLDLSRNNF 178 (427)
Q Consensus 164 ~l~~L~~L~L~~N~l 178 (427)
.+.+|+.|++..|++
T Consensus 299 ~f~kL~~L~i~~N~I 313 (505)
T KOG3207|consen 299 TFPKLEYLNISENNI 313 (505)
T ss_pred ccccceeeecccCcc
Confidence 678899999999988
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.70 E-value=2.2e-09 Score=105.39 Aligned_cols=151 Identities=31% Similarity=0.395 Sum_probs=106.2
Q ss_pred cCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccCcccCCCCccccccccc
Q 042634 18 GDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSI 97 (427)
Q Consensus 18 ~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~~~l~~l~~ 97 (427)
..+..++.+++..|.+. .+-..+..+++|+.|++.+|++. .+...+..+++|++|++++|.|+..-+ +..+..| .
T Consensus 69 ~~l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L-~ 143 (414)
T KOG0531|consen 69 ESLTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKLEG--LSTLTLL-K 143 (414)
T ss_pred HHhHhHHhhccchhhhh-hhhcccccccceeeeeccccchh-hcccchhhhhcchheeccccccccccc--hhhccch-h
Confidence 45677788888888887 44455888888999999999988 665557778889999999999884443 4455556 5
Q ss_pred eeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCcc-ccccccccceeeeeeeccccCCCCcccccCCceeeccCC
Q 042634 98 YLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSS-IGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRN 176 (427)
Q Consensus 98 ~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~-~~~~~~l~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N 176 (427)
.|++++|.++ .+ ..+..+++|+.+++++|+++ .+... ...+.+++.+.+++|.+... ..+..+..+..+++..|
T Consensus 144 ~L~l~~N~i~-~~-~~~~~l~~L~~l~l~~n~i~-~ie~~~~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~~l~~n 218 (414)
T KOG0531|consen 144 ELNLSGNLIS-DI-SGLESLKSLKLLDLSYNRIV-DIENDELSELISLEELDLGGNSIREI--EGLDLLKKLVLLSLLDN 218 (414)
T ss_pred hheeccCcch-hc-cCCccchhhhcccCCcchhh-hhhhhhhhhccchHHHhccCCchhcc--cchHHHHHHHHhhcccc
Confidence 7888999886 33 34455888888899998888 45543 57788888888888887642 23333333333344444
Q ss_pred cc
Q 042634 177 NF 178 (427)
Q Consensus 177 ~l 178 (427)
.+
T Consensus 219 ~i 220 (414)
T KOG0531|consen 219 KI 220 (414)
T ss_pred cc
Confidence 44
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.65 E-value=2.7e-08 Score=97.92 Aligned_cols=77 Identities=23% Similarity=0.333 Sum_probs=60.5
Q ss_pred ccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHH-HHHHHhhcCCCCeeeccccCCceeeCCCCceEecccc
Q 042634 201 SEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVAS-ALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFG 279 (427)
Q Consensus 201 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~-~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG 279 (427)
..++||||++|++|.++..... ... ....++.+++. .+..+| ..|++|+|+||.||+++.++.++++|||
T Consensus 232 ~~vLvmE~i~G~~L~~~~~~~~---~~~---~~~~ia~~~~~~~l~ql~---~~g~~H~D~hPgNilv~~~g~i~liDfG 302 (437)
T TIGR01982 232 ERVLTMEWIDGIPLSDIAALDE---AGL---DRKALAENLARSFLNQVL---RDGFFHADLHPGNIFVLKDGKIIALDFG 302 (437)
T ss_pred CceEEEEeECCcccccHHHHHh---cCC---CHHHHHHHHHHHHHHHHH---hCCceeCCCCcccEEECCCCcEEEEeCC
Confidence 4689999999999988754221 111 23456666665 467888 8999999999999999999999999999
Q ss_pred cccccCC
Q 042634 280 LAKFLPE 286 (427)
Q Consensus 280 ~a~~~~~ 286 (427)
++..+..
T Consensus 303 ~~~~l~~ 309 (437)
T TIGR01982 303 IVGRLSE 309 (437)
T ss_pred CeeECCH
Confidence 9987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.63 E-value=6.5e-10 Score=109.59 Aligned_cols=125 Identities=30% Similarity=0.375 Sum_probs=94.5
Q ss_pred CCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccCcccCCC-Cccccccccceee
Q 042634 22 KLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPT-EVIGLSSLSIYLD 100 (427)
Q Consensus 22 ~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~-~~~~l~~l~~~L~ 100 (427)
.|...+.++|.+. .+..++.-++.|+.||||+|+++ .+. .+-.|+.|++|||++|.+. .+|. ...++. | ..|.
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~-~v~-~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L-~~L~ 238 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFT-KVD-NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-L-QLLN 238 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhh-hhH-HHHhcccccccccccchhc-cccccchhhhh-h-eeee
Confidence 5777888888887 78888888888899999999888 554 7778888889999999888 5554 233333 5 5688
Q ss_pred ccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCC-ccccccccccceeeeeeec
Q 042634 101 LSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIP-SSIGSCIRLEQLVMNGNFF 154 (427)
Q Consensus 101 l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p-~~~~~~~~l~~l~l~~n~l 154 (427)
+.||.++ ++ ..+-+|++|+.||++.|.+.+.-- ..++.+.+|+.|+|.+|.+
T Consensus 239 lrnN~l~-tL-~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl 291 (1096)
T KOG1859|consen 239 LRNNALT-TL-RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPL 291 (1096)
T ss_pred ecccHHH-hh-hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcc
Confidence 8888886 33 456788889999999988875211 2456778888888888876
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.61 E-value=3e-09 Score=84.03 Aligned_cols=107 Identities=20% Similarity=0.277 Sum_probs=87.7
Q ss_pred eeecCCcccccCCccccC-CCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCcc
Q 042634 2 FTLVGNQFTGRIPGSIGD-LHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNN 80 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~-l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~ 80 (427)
.+|++|.|. .+|+.|.. .+.++.|+|++|.++ .+|.++..++.|+.|++++|.+. ..|..+..+.+|.+||.-+|.
T Consensus 58 i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na 134 (177)
T KOG4579|consen 58 ISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSPENA 134 (177)
T ss_pred Eecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcCCCCc
Confidence 589999999 56766555 569999999999998 89999999999999999999999 999999999999999999999
Q ss_pred CcccCCCCccccccccceeeccCCcCcCCCCCC
Q 042634 81 LTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSN 113 (427)
Q Consensus 81 ~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~ 113 (427)
.. .+|..+....+. ...++.++.+.+.-+..
T Consensus 135 ~~-eid~dl~~s~~~-al~~lgnepl~~~~~~k 165 (177)
T KOG4579|consen 135 RA-EIDVDLFYSSLP-ALIKLGNEPLGDETKKK 165 (177)
T ss_pred cc-cCcHHHhccccH-HHHHhcCCcccccCccc
Confidence 98 777554433333 34667777777654444
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.57 E-value=7.5e-09 Score=96.72 Aligned_cols=153 Identities=25% Similarity=0.252 Sum_probs=114.5
Q ss_pred eeecCCcccccCC--ccccCCCCCCEeeeecccceeecCcc-hhccccCCEeeeccccCcc-cCCcCccCCCCCCeEEcc
Q 042634 2 FTLVGNQFTGRIP--GSIGDLHKLQRLTLEMNKFWGEIPSS-IGNLTLLITLNFAENMLEG-SIPSSLGKCQNLILLDLS 77 (427)
Q Consensus 2 l~l~~n~l~~~~p--~~~~~l~~L~~L~l~~n~~~~~~p~~-~~~l~~L~~L~l~~n~l~~-~~p~~~~~l~~L~~l~l~ 77 (427)
||||+|=|+-..| .-+..|++|+.|+||.|++.-..... -..+++|+.|.|+.|.|+- .+-.-+..+++|..|+|.
T Consensus 151 LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~ 230 (505)
T KOG3207|consen 151 LDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLE 230 (505)
T ss_pred ecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhh
Confidence 7899998876555 44677999999999999997433332 2457899999999999984 233345567899999999
Q ss_pred CccCcccCCCCccccccccceeeccCCcCcCCCC--CCCcCCCCCCeEECcCCccccc-CCcc-----ccccccccceee
Q 042634 78 NNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLP--SNFGILKNLGAIDISENKLSGQ-IPSS-----IGSCIRLEQLVM 149 (427)
Q Consensus 78 ~N~~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p--~~~~~l~~L~~l~l~~n~~~~~-~p~~-----~~~~~~l~~l~l 149 (427)
+|.....-......+..| ++|+|++|++- .++ .-.+.++.|..|.++.+.++.. +|+. ....++|+.|++
T Consensus 231 ~N~~~~~~~~~~~i~~~L-~~LdLs~N~li-~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i 308 (505)
T KOG3207|consen 231 ANEIILIKATSTKILQTL-QELDLSNNNLI-DFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNI 308 (505)
T ss_pred cccccceecchhhhhhHH-hhccccCCccc-ccccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeec
Confidence 996433333334456677 67999999986 555 5678899999999999988731 2332 235689999999
Q ss_pred eeeeccc
Q 042634 150 NGNFFRG 156 (427)
Q Consensus 150 ~~n~l~~ 156 (427)
+.|++..
T Consensus 309 ~~N~I~~ 315 (505)
T KOG3207|consen 309 SENNIRD 315 (505)
T ss_pred ccCcccc
Confidence 9999963
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.50 E-value=1.9e-07 Score=79.79 Aligned_cols=66 Identities=29% Similarity=0.338 Sum_probs=52.5
Q ss_pred cceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCC-----eeeccccCCceeeCCCCceEec
Q 042634 202 EALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETP-----IVHCDLKPSNVLLDGELTAHVG 276 (427)
Q Consensus 202 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~-----ivHrDlkp~NIll~~~~~~kL~ 276 (427)
.++||||+++.++.+.- . .....+.+++++++.|| ..+ ++|+|++|.||+++ ++.++++
T Consensus 66 ~~lv~e~i~G~~l~~~~---------~---~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~li 129 (170)
T cd05151 66 GVLITEFIEGSELLTED---------F---SDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLI 129 (170)
T ss_pred CeEEEEecCCCcccccc---------c---cCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEE
Confidence 47999999998876531 0 11235678999999999 565 59999999999999 6689999
Q ss_pred ccccccc
Q 042634 277 DFGLAKF 283 (427)
Q Consensus 277 DFG~a~~ 283 (427)
|||.+..
T Consensus 130 Df~~a~~ 136 (170)
T cd05151 130 DWEYAGM 136 (170)
T ss_pred ecccccC
Confidence 9998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.9e-07 Score=85.46 Aligned_cols=78 Identities=21% Similarity=0.175 Sum_probs=63.5
Q ss_pred ccceeeeeecCC-CcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccccCCceeeCC-------CCc
Q 042634 201 SEALVYEFMVNG-SLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDG-------ELT 272 (427)
Q Consensus 201 ~~~lv~e~~~~g-~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrDlkp~NIll~~-------~~~ 272 (427)
..++|+|++++. +|.+++..... ...+...+..++.+++..+.-|| ..||+|+|++++|||++. +..
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~~--~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWAT--NPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCce
Confidence 468999999775 78888753211 23456677899999999999999 999999999999999975 468
Q ss_pred eEecccccccc
Q 042634 273 AHVGDFGLAKF 283 (427)
Q Consensus 273 ~kL~DFG~a~~ 283 (427)
+.++||+.++.
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 99999998854
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.45 E-value=2.6e-07 Score=77.60 Aligned_cols=69 Identities=33% Similarity=0.512 Sum_probs=57.0
Q ss_pred CccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccccCCceeeCCCCceEecccc
Q 042634 200 DSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFG 279 (427)
Q Consensus 200 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG 279 (427)
....|+|||.+|..|.+.+... ...++..+-.-+.-|| ..||+|+|+.++||++.++. +-++|||
T Consensus 72 ~~~~I~me~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfG 136 (204)
T COG3642 72 DNGLIVMEYIEGELLKDALEEA-----------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFG 136 (204)
T ss_pred CCCEEEEEEeCChhHHHHHHhc-----------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECC
Confidence 4457999999888887777543 2446777778888899 99999999999999998765 8999999
Q ss_pred cccc
Q 042634 280 LAKF 283 (427)
Q Consensus 280 ~a~~ 283 (427)
++..
T Consensus 137 Lg~~ 140 (204)
T COG3642 137 LGEF 140 (204)
T ss_pred cccc
Confidence 9974
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.43 E-value=1.4e-07 Score=60.51 Aligned_cols=36 Identities=33% Similarity=0.533 Sum_probs=18.9
Q ss_pred CCCEeeeecccceeecCcchhccccCCEeeeccccCc
Q 042634 22 KLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLE 58 (427)
Q Consensus 22 ~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~ 58 (427)
+|++|+|++|+|+ .+|+.+++|++|+.|++++|.++
T Consensus 2 ~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 4555555555555 45555555555555555555555
|
... |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.40 E-value=8.3e-08 Score=101.29 Aligned_cols=102 Identities=30% Similarity=0.445 Sum_probs=50.3
Q ss_pred CCCEeeeeccc--ceeecCc-chhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccCcccCCCCccccccccce
Q 042634 22 KLQRLTLEMNK--FWGEIPS-SIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIY 98 (427)
Q Consensus 22 ~L~~L~l~~n~--~~~~~p~-~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~~~l~~l~~~ 98 (427)
.|+.|-+..|. +. .++. .|..++.|.+||||+|.=-+.+|..++++-+|++|++++..++ .+|..+.++..| .+
T Consensus 546 ~L~tLll~~n~~~l~-~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L-~~ 622 (889)
T KOG4658|consen 546 KLRTLLLQRNSDWLL-EISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKL-IY 622 (889)
T ss_pred ccceEEEeecchhhh-hcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhh-he
Confidence 45555555553 22 2222 2444555555555554444455555555555555555555554 555555555555 34
Q ss_pred eeccCCcCcCCCCCCCcCCCCCCeEECc
Q 042634 99 LDLSQNQLNGPLPSNFGILKNLGAIDIS 126 (427)
Q Consensus 99 L~l~~n~~~~~~p~~~~~l~~L~~l~l~ 126 (427)
|++..+.....+|.....|++|++|.+.
T Consensus 623 Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~ 650 (889)
T KOG4658|consen 623 LNLEVTGRLESIPGILLELQSLRVLRLP 650 (889)
T ss_pred eccccccccccccchhhhcccccEEEee
Confidence 5555544433444444445555555443
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.39 E-value=2.1e-07 Score=92.98 Aligned_cols=78 Identities=19% Similarity=0.226 Sum_probs=54.5
Q ss_pred CccceeeeeecCCCcccc--cccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccccCCceeeCCCC----ce
Q 042634 200 DSEALVYEFMVNGSLEEW--LHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGEL----TA 273 (427)
Q Consensus 200 ~~~~lv~e~~~~g~L~~~--l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~----~~ 273 (427)
...++||||+.|+.+.++ +.......+.+....+..++.|+ + ..|++|+|+||.||+++.++ ++
T Consensus 234 t~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f---~~GffHaDpHPGNIlv~~~g~~~~~i 303 (537)
T PRK04750 234 SETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------F---RDGFFHADMHPGNIFVSYDPPENPRY 303 (537)
T ss_pred CCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------H---hCCeeeCCCChHHeEEecCCCCCCeE
Confidence 356899999999999764 22211101123333333444443 3 57999999999999999887 99
Q ss_pred EecccccccccCCc
Q 042634 274 HVGDFGLAKFLPEA 287 (427)
Q Consensus 274 kL~DFG~a~~~~~~ 287 (427)
+++|||++..+...
T Consensus 304 ~llDFGivg~l~~~ 317 (537)
T PRK04750 304 IALDFGIVGSLNKE 317 (537)
T ss_pred EEEecceEEECCHH
Confidence 99999999877553
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.39 E-value=5e-09 Score=103.47 Aligned_cols=121 Identities=31% Similarity=0.361 Sum_probs=85.0
Q ss_pred eecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcC-ccCCCCCCeEEccCccC
Q 042634 3 TLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSS-LGKCQNLILLDLSNNNL 81 (427)
Q Consensus 3 ~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~-~~~l~~L~~l~l~~N~~ 81 (427)
+.+.|.|+ .+...+.-++.|+.|+|++|+++ .+ ..+-.|+.|+.|||+.|++. .+|.- ...+. |+.|.++||.+
T Consensus 170 ~fsyN~L~-~mD~SLqll~ale~LnLshNk~~-~v-~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~lrnN~l 244 (1096)
T KOG1859|consen 170 SFSYNRLV-LMDESLQLLPALESLNLSHNKFT-KV-DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLNLRNNAL 244 (1096)
T ss_pred hcchhhHH-hHHHHHHHHHHhhhhccchhhhh-hh-HHHHhcccccccccccchhc-cccccchhhhh-heeeeecccHH
Confidence 55677777 66777788888888888888887 34 36778888888888888888 77743 33344 88888888888
Q ss_pred cccCCCCccccccccceeeccCCcCcC-CCCCCCcCCCCCCeEECcCCccc
Q 042634 82 TGTTPTEVIGLSSLSIYLDLSQNQLNG-PLPSNFGILKNLGAIDISENKLS 131 (427)
Q Consensus 82 ~~~~p~~~~~l~~l~~~L~l~~n~~~~-~~p~~~~~l~~L~~l~l~~n~~~ 131 (427)
+... ++.++.+| ..|||++|-+.+ +--..++.|..|+.|+|.+|.+-
T Consensus 245 ~tL~--gie~LksL-~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 245 TTLR--GIENLKSL-YGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred Hhhh--hHHhhhhh-hccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 7333 45667777 568888888764 11133455667778888888765
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=98.32 E-value=2.9e-07 Score=58.96 Aligned_cols=37 Identities=32% Similarity=0.507 Sum_probs=32.4
Q ss_pred ccCCEeeeccccCcccCCcCccCCCCCCeEEccCccCc
Q 042634 45 TLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLT 82 (427)
Q Consensus 45 ~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~~ 82 (427)
++|++|++++|+++ .+|+.++.|++|++|++++|+++
T Consensus 1 ~~L~~L~l~~N~i~-~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 1 KNLEELDLSNNQIT-DLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp TT-SEEEETSSS-S-SHGGHGTTCTTSSEEEETSSCCS
T ss_pred CcceEEEccCCCCc-ccCchHhCCCCCCEEEecCCCCC
Confidence 57899999999999 88988999999999999999998
|
... |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.31 E-value=8.6e-07 Score=76.55 Aligned_cols=75 Identities=25% Similarity=0.313 Sum_probs=50.5
Q ss_pred ccceeeeeec--CCCcccccccchhhhhccCHHHHHHHHHHHHHHHHH-HhhcCCCCeeeccccCCceeeCCCCceEecc
Q 042634 201 SEALVYEFMV--NGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDY-LHHYCETPIVHCDLKPSNVLLDGELTAHVGD 277 (427)
Q Consensus 201 ~~~lv~e~~~--~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~-LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 277 (427)
..++||||++ |..+.. +.... ++......++.+++..+.. +| ..||+|+|+.+.||+++++ .+.|+|
T Consensus 80 ~~~ivME~I~~~G~~~~~-l~~~~-----~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~iID 149 (188)
T PF01163_consen 80 RNVIVMEYIGEDGVPLPR-LKDVD-----LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYIID 149 (188)
T ss_dssp TTEEEEE--EETTEEGGC-HHHCG-----GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE--
T ss_pred CCEEEEEecCCCccchhh-HHhcc-----ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEEEe
Confidence 3479999997 444433 32211 2234566788888886665 57 8999999999999999887 899999
Q ss_pred cccccccC
Q 042634 278 FGLAKFLP 285 (427)
Q Consensus 278 FG~a~~~~ 285 (427)
||.|....
T Consensus 150 f~qav~~~ 157 (188)
T PF01163_consen 150 FGQAVDSS 157 (188)
T ss_dssp GTTEEETT
T ss_pred cCcceecC
Confidence 99887654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.31 E-value=6.7e-07 Score=79.05 Aligned_cols=77 Identities=27% Similarity=0.349 Sum_probs=64.8
Q ss_pred ccceeeeeecC-CCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccccCCceeeCCCC---ceEec
Q 042634 201 SEALVYEFMVN-GSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGEL---TAHVG 276 (427)
Q Consensus 201 ~~~lv~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~---~~kL~ 276 (427)
..++|+|++++ .+|.+++.... ..+......++.+++..+.-|| ..||+|+|+++.|||++.+. .+.++
T Consensus 91 ~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~i~~lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lI 163 (206)
T PF06293_consen 91 RSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARLIAKLH---DAGIYHGDLNPSNILVDPDDGQYRFYLI 163 (206)
T ss_pred eEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHHHHHHH---HCcCCCCCCCcccEEEeCCCCceeEEEE
Confidence 45899999987 47888886532 1556678899999999999999 99999999999999998876 89999
Q ss_pred cccccccc
Q 042634 277 DFGLAKFL 284 (427)
Q Consensus 277 DFG~a~~~ 284 (427)
||+-++..
T Consensus 164 Dld~~~~~ 171 (206)
T PF06293_consen 164 DLDRMRFR 171 (206)
T ss_pred cchhceeC
Confidence 99988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.26 E-value=1e-06 Score=73.87 Aligned_cols=80 Identities=24% Similarity=0.373 Sum_probs=59.9
Q ss_pred CCccceeeeeecC-CCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccccCCceeeCCCC---ceE
Q 042634 199 NDSEALVYEFMVN-GSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGEL---TAH 274 (427)
Q Consensus 199 ~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~---~~k 274 (427)
...-.++|||.++ .++.+++...-. ..........+++.|-+.+.-|| ..+|+|+||..+||++..++ .+-
T Consensus 82 ~~~~~i~ME~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~ 156 (229)
T KOG3087|consen 82 TYGGQIYMEFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPI 156 (229)
T ss_pred cCCCeEEEEeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceE
Confidence 3455899999966 367777654321 12223333788999999999999 99999999999999996544 568
Q ss_pred ecccccccc
Q 042634 275 VGDFGLAKF 283 (427)
Q Consensus 275 L~DFG~a~~ 283 (427)
++|||++..
T Consensus 157 lIdfgls~~ 165 (229)
T KOG3087|consen 157 LIDFGLSSV 165 (229)
T ss_pred EEeecchhc
Confidence 999999865
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.25 E-value=3.3e-08 Score=90.03 Aligned_cols=161 Identities=20% Similarity=0.207 Sum_probs=80.0
Q ss_pred ccCCCCCCEeeeecccceeecCc----chhccccCCEeeeccccCccc-------------CCcCccCCCCCCeEEccCc
Q 042634 17 IGDLHKLQRLTLEMNKFWGEIPS----SIGNLTLLITLNFAENMLEGS-------------IPSSLGKCQNLILLDLSNN 79 (427)
Q Consensus 17 ~~~l~~L~~L~l~~n~~~~~~p~----~~~~l~~L~~L~l~~n~l~~~-------------~p~~~~~l~~L~~l~l~~N 79 (427)
+...+.|++||||.|.|.-.-++ -+.+++.|+.|+|.||-+... .-.-+++-++|+++..++|
T Consensus 88 L~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rN 167 (382)
T KOG1909|consen 88 LLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRN 167 (382)
T ss_pred HhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeecc
Confidence 34445666666666666532222 234456666666666666511 1112333445666666666
Q ss_pred cCcccCCC----CccccccccceeeccCCcCcC----CCCCCCcCCCCCCeEECcCCccccc----CCccccccccccce
Q 042634 80 NLTGTTPT----EVIGLSSLSIYLDLSQNQLNG----PLPSNFGILKNLGAIDISENKLSGQ----IPSSIGSCIRLEQL 147 (427)
Q Consensus 80 ~~~~~~p~----~~~~l~~l~~~L~l~~n~~~~----~~p~~~~~l~~L~~l~l~~n~~~~~----~p~~~~~~~~l~~l 147 (427)
++...... .+...++| ..+.++.|.+.- .+-..+..++.|+.|||..|-|+.. +...+..+++|+.|
T Consensus 168 rlen~ga~~~A~~~~~~~~l-eevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El 246 (382)
T KOG1909|consen 168 RLENGGATALAEAFQSHPTL-EEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLREL 246 (382)
T ss_pred ccccccHHHHHHHHHhcccc-ceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheee
Confidence 66522221 23344455 456666666531 0112345566666666666655522 22234455566666
Q ss_pred eeeeeeccccCCCCc-----ccccCCceeeccCCcc
Q 042634 148 VMNGNFFRGNIPSSL-----SSLRGIENLDLSRNNF 178 (427)
Q Consensus 148 ~l~~n~l~~~~p~~l-----~~l~~L~~L~L~~N~l 178 (427)
+++.+.+......++ ...++|+.+.+.+|.+
T Consensus 247 ~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeI 282 (382)
T KOG1909|consen 247 NLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEI 282 (382)
T ss_pred cccccccccccHHHHHHHHhccCCCCceeccCcchh
Confidence 666665544332222 1234455555555544
|
|
| >KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.18 E-value=2.3e-06 Score=72.48 Aligned_cols=121 Identities=21% Similarity=0.259 Sum_probs=65.8
Q ss_pred eeecCCcccccCCccccC-CCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccC-CCCCCeEEccCc
Q 042634 2 FTLVGNQFTGRIPGSIGD-LHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGK-CQNLILLDLSNN 79 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~-l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~-l~~L~~l~l~~N 79 (427)
+||++.++. .+-. ++. +.+...+||+.|.+. .++ .|..++.|..|.|++|+++ .+-+.+.. +++|+.|.+++|
T Consensus 24 ~~LR~lkip-~ien-lg~~~d~~d~iDLtdNdl~-~l~-~lp~l~rL~tLll~nNrIt-~I~p~L~~~~p~l~~L~LtnN 98 (233)
T KOG1644|consen 24 LDLRGLKIP-VIEN-LGATLDQFDAIDLTDNDLR-KLD-NLPHLPRLHTLLLNNNRIT-RIDPDLDTFLPNLKTLILTNN 98 (233)
T ss_pred ccccccccc-chhh-ccccccccceecccccchh-hcc-cCCCccccceEEecCCcce-eeccchhhhccccceEEecCc
Confidence 455555554 2222 333 235666777777765 443 3666777777777777777 55555544 355677777777
Q ss_pred cCcccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCc----cccccccccceeeeee
Q 042634 80 NLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPS----SIGSCIRLEQLVMNGN 152 (427)
Q Consensus 80 ~~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~----~~~~~~~l~~l~l~~n 152 (427)
.+. .+- .+ .-+..|++|+.|.+-+|..+ .-+. .+..+++|+.||+++=
T Consensus 99 si~-~l~----dl-------------------~pLa~~p~L~~Ltll~Npv~-~k~~YR~yvl~klp~l~~LDF~kV 150 (233)
T KOG1644|consen 99 SIQ-ELG----DL-------------------DPLASCPKLEYLTLLGNPVE-HKKNYRLYVLYKLPSLRTLDFQKV 150 (233)
T ss_pred chh-hhh----hc-------------------chhccCCccceeeecCCchh-cccCceeEEEEecCcceEeehhhh
Confidence 665 221 11 11233555566655555554 2222 3456666777666654
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.15 E-value=1.2e-06 Score=92.69 Aligned_cols=132 Identities=28% Similarity=0.316 Sum_probs=110.9
Q ss_pred ccCCCCCCEeeeecccceeecCcchhccccCCEeeecccc--CcccCCcC-ccCCCCCCeEEccCccCcccCCCCccccc
Q 042634 17 IGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENM--LEGSIPSS-LGKCQNLILLDLSNNNLTGTTPTEVIGLS 93 (427)
Q Consensus 17 ~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~--l~~~~p~~-~~~l~~L~~l~l~~N~~~~~~p~~~~~l~ 93 (427)
..+....+.+.+.+|.+. .++... ..+.|++|-+..|. +. .++.. |..++.|++||||+|.--+.+|..++++.
T Consensus 519 ~~~~~~~rr~s~~~~~~~-~~~~~~-~~~~L~tLll~~n~~~l~-~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li 595 (889)
T KOG4658|consen 519 VKSWNSVRRMSLMNNKIE-HIAGSS-ENPKLRTLLLQRNSDWLL-EISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELV 595 (889)
T ss_pred ccchhheeEEEEeccchh-hccCCC-CCCccceEEEeecchhhh-hcCHHHHhhCcceEEEECCCCCccCcCChHHhhhh
Confidence 345578899999999987 566544 34479999999997 55 66655 66699999999999988889999999999
Q ss_pred cccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeee
Q 042634 94 SLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNF 153 (427)
Q Consensus 94 ~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~ 153 (427)
+| ++|++++..++ .+|..+.+|+.|.+|++..+.-...+|..+..+.+|+.|.+-...
T Consensus 596 ~L-ryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~ 653 (889)
T KOG4658|consen 596 HL-RYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSA 653 (889)
T ss_pred hh-hcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccc
Confidence 99 69999999998 899999999999999999987665677777889999999887765
|
|
| >PRK15386 type III secretion protein GogB; Provisional | Back alignment and domain information |
|---|
Probab=98.14 E-value=4.5e-06 Score=79.70 Aligned_cols=117 Identities=15% Similarity=0.273 Sum_probs=59.1
Q ss_pred cCCCCCCEeeeecccceeecCcchhccccCCEeeecc-ccCcccCCcCccCCCCCCeEEccCc-cCcccCCCCccccccc
Q 042634 18 GDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAE-NMLEGSIPSSLGKCQNLILLDLSNN-NLTGTTPTEVIGLSSL 95 (427)
Q Consensus 18 ~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~-n~l~~~~p~~~~~l~~L~~l~l~~N-~~~~~~p~~~~~l~~l 95 (427)
..+.+++.|++++|.++ .+|. + -.+|+.|.+++ +.++ .+|..+. ++|++|++++| .+. .+|.. |
T Consensus 49 ~~~~~l~~L~Is~c~L~-sLP~-L--P~sLtsL~Lsnc~nLt-sLP~~LP--~nLe~L~Ls~Cs~L~-sLP~s------L 114 (426)
T PRK15386 49 EEARASGRLYIKDCDIE-SLPV-L--PNELTEITIENCNNLT-TLPGSIP--EGLEKLTVCHCPEIS-GLPES------V 114 (426)
T ss_pred HHhcCCCEEEeCCCCCc-ccCC-C--CCCCcEEEccCCCCcc-cCCchhh--hhhhheEccCccccc-ccccc------c
Confidence 34566677777766666 5652 1 23466666665 4444 5554432 45667777666 333 44433 2
Q ss_pred cceeeccCCcCc--CCCCCCCcCC------------------CCCCeEECcCCcccccCCccccccccccceeeeee
Q 042634 96 SIYLDLSQNQLN--GPLPSNFGIL------------------KNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGN 152 (427)
Q Consensus 96 ~~~L~l~~n~~~--~~~p~~~~~l------------------~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n 152 (427)
..|++..|... +.+|..+..| ++|+.|++++|... .+|..+- .+|+.|.++.|
T Consensus 115 -e~L~L~~n~~~~L~~LPssLk~L~I~~~n~~~~~~lp~~LPsSLk~L~Is~c~~i-~LP~~LP--~SLk~L~ls~n 187 (426)
T PRK15386 115 -RSLEIKGSATDSIKNVPNGLTSLSINSYNPENQARIDNLISPSLKTLSLTGCSNI-ILPEKLP--ESLQSITLHIE 187 (426)
T ss_pred -ceEEeCCCCCcccccCcchHhheeccccccccccccccccCCcccEEEecCCCcc-cCccccc--ccCcEEEeccc
Confidence 23444443321 2344332222 35666666666544 3343333 35666666555
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.12 E-value=3.9e-07 Score=83.19 Aligned_cols=186 Identities=22% Similarity=0.326 Sum_probs=131.4
Q ss_pred CeeecCCcccc----cCCccccCCCCCCEeeeecccceee----cCc-------chhccccCCEeeeccccCcccCCcC-
Q 042634 1 AFTLVGNQFTG----RIPGSIGDLHKLQRLTLEMNKFWGE----IPS-------SIGNLTLLITLNFAENMLEGSIPSS- 64 (427)
Q Consensus 1 ~l~l~~n~l~~----~~p~~~~~l~~L~~L~l~~n~~~~~----~p~-------~~~~l~~L~~L~l~~n~l~~~~p~~- 64 (427)
.++||||.|.. .+...+...++|+..++|. -++|. +|+ .+-++++|++||||.|-|....++.
T Consensus 34 ~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd-~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g~~~l 112 (382)
T KOG1909|consen 34 KLDLSGNTFGTEAARAIAKVLASKKELREVNLSD-MFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKGIRGL 112 (382)
T ss_pred EEeccCCchhHHHHHHHHHHHhhcccceeeehHh-hhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccchHHH
Confidence 37999999953 3445677888999999984 56654 344 3345679999999999999766654
Q ss_pred ---ccCCCCCCeEEccCccCcccCCC--------------CccccccccceeeccCCcCcC----CCCCCCcCCCCCCeE
Q 042634 65 ---LGKCQNLILLDLSNNNLTGTTPT--------------EVIGLSSLSIYLDLSQNQLNG----PLPSNFGILKNLGAI 123 (427)
Q Consensus 65 ---~~~l~~L~~l~l~~N~~~~~~p~--------------~~~~l~~l~~~L~l~~n~~~~----~~p~~~~~l~~L~~l 123 (427)
+.++++|++|.|.||-+. .... ....-+.| +.+..+.|++.. .+...+...+.|+.+
T Consensus 113 ~~ll~s~~~L~eL~L~N~Glg-~~ag~~l~~al~~l~~~kk~~~~~~L-rv~i~~rNrlen~ga~~~A~~~~~~~~leev 190 (382)
T KOG1909|consen 113 EELLSSCTDLEELYLNNCGLG-PEAGGRLGRALFELAVNKKAASKPKL-RVFICGRNRLENGGATALAEAFQSHPTLEEV 190 (382)
T ss_pred HHHHHhccCHHHHhhhcCCCC-hhHHHHHHHHHHHHHHHhccCCCcce-EEEEeeccccccccHHHHHHHHHhccccceE
Confidence 455788999999999885 2211 12233456 568889999852 112346777899999
Q ss_pred ECcCCccccc----CCccccccccccceeeeeeecccc----CCCCcccccCCceeeccCCcccccccchhhhcc
Q 042634 124 DISENKLSGQ----IPSSIGSCIRLEQLVMNGNFFRGN----IPSSLSSLRGIENLDLSRNNFIRHRNLVKIITS 190 (427)
Q Consensus 124 ~l~~n~~~~~----~p~~~~~~~~l~~l~l~~n~l~~~----~p~~l~~l~~L~~L~L~~N~ll~Hpniv~~~~~ 190 (427)
.++.|.+... +...+..|++|+.|+++.|.|+.. +...+..++.|+.++++.+.+. ....+.+...
T Consensus 191 r~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~-~~Ga~a~~~a 264 (382)
T KOG1909|consen 191 RLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLE-NEGAIAFVDA 264 (382)
T ss_pred EEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccc-cccHHHHHHH
Confidence 9999987621 123567899999999999999754 3455678889999998887653 3344444444
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.09 E-value=3.3e-05 Score=74.59 Aligned_cols=133 Identities=21% Similarity=0.273 Sum_probs=101.8
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecC-CCcccccccc-----------hhhhhccCHHHHHHHHHHHHHHHHH
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVN-GSLEEWLHPN-----------REALKNLNLLQRLSIAVDVASALDY 246 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~-----------~~~~~~l~~~~~~~~~~~i~~~L~~ 246 (427)
+.|+|+|++-+++....|.+ ...++|++|.++ ++|.++.-.. .......++...+.++.|+..||.+
T Consensus 330 l~h~NvV~frevf~t~tF~D-~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~s 408 (655)
T KOG3741|consen 330 LCHTNVVPFREVFLTYTFGD-LSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYS 408 (655)
T ss_pred hccCceeehhhhhhhhccCc-ceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHH
Confidence 56999999999887555543 467899999876 5776643211 1112347788999999999999999
Q ss_pred HhhcCCCCeeeccccCCceeeCCCCceEecccccccccCCcCCCccccccccccCCCCcCccccchhHHHHHHHHHhCCC
Q 042634 247 LHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKR 326 (427)
Q Consensus 247 LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~ 326 (427)
+| +.|..-+-+.+.+|+++++.+++|+.-|....+..+.. |.+. --.+-|.=.||.++.-|.+|..
T Consensus 409 IH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~~--------~~le---~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 409 IH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDPT--------EPLE---SQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred HH---hcCceeecccHhHeEeeCcceEEEecccceeeecCCCC--------cchh---HHhhhhHHHHHHHHHHHhhccc
Confidence 99 89999999999999999999999998888776654431 1111 1245688899999999999964
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 427 | ||||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-20 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-20 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 9e-20 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 1e-19 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-14 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-13 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-13 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 6e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-12 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-12 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-12 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-12 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-12 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-12 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-12 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-12 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-12 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-12 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-12 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-12 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-12 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-12 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-11 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-11 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-11 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 6e-11 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-11 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-10 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-10 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-10 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-10 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-10 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-10 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 3e-10 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-10 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-10 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-10 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-10 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-10 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-10 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-10 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-10 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-10 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-10 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-10 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 6e-10 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 9e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 9e-10 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-09 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-09 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-09 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-09 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-09 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-09 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-09 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-09 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-09 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-09 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-09 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-09 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-09 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-09 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-09 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-09 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-09 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-09 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-09 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-09 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-09 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-09 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-09 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-09 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-09 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-09 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-09 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-09 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-09 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-09 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-09 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 6e-09 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-09 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-09 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-09 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-09 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-09 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-09 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-09 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-09 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 7e-09 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-09 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-09 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 8e-09 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 8e-09 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 8e-09 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 8e-09 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 8e-09 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 8e-09 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 9e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-08 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-08 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-08 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-08 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-08 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-08 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-08 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-08 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-08 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-08 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-08 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-08 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-08 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-08 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-08 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-08 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-08 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-08 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-08 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-08 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-08 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-08 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-08 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-08 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-08 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-08 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-08 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-08 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 8e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 9e-08 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 9e-08 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 9e-08 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 9e-08 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 9e-08 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-07 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-07 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-07 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-07 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-07 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-07 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-07 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-07 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-07 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-07 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-07 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-07 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-07 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-07 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-07 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-07 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-07 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-07 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-07 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-07 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-07 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-07 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-07 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-07 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-07 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-07 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-07 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-07 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-07 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-07 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-07 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-07 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-07 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-07 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-07 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 7e-07 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 8e-07 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 8e-07 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 9e-07 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 9e-07 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 9e-07 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 9e-07 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-07 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-07 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-06 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-06 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-06 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-06 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-06 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-06 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-06 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-06 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-06 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-06 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-06 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-06 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-06 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-06 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-06 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-06 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-06 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-06 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-06 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-06 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-06 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-06 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-06 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-06 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-06 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-06 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-06 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-06 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-06 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-06 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-06 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-06 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-06 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-06 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-06 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-06 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-06 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-06 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-06 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-06 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-06 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-06 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-06 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-06 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-06 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-06 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-06 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-06 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-06 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-06 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-06 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-06 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-06 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-06 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-06 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-06 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-06 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-06 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-06 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-06 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 6e-06 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 6e-06 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-06 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 7e-06 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 7e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-06 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-06 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 9e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 9e-06 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-05 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-05 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-05 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-05 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-05 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-05 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-05 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-05 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-05 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-05 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-05 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-05 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-05 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-05 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-05 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-05 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-05 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-05 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-05 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-05 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-05 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-05 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-05 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-05 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-05 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-05 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-05 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-05 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-05 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-05 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-05 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-05 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-05 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-05 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-05 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-05 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-05 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-05 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-05 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-05 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-05 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-05 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-05 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-05 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-05 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-05 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-05 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-05 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-05 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-05 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-05 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-05 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-05 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-05 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 5e-05 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-05 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-05 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-05 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-05 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-05 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-05 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-05 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-05 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-05 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 6e-05 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 6e-05 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-05 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-05 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-05 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-05 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 7e-05 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-05 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 8e-05 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 8e-05 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 9e-05 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 9e-05 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-04 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-04 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-04 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-04 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-04 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-04 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-04 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-04 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-04 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-04 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-04 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-04 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-04 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-04 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-04 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-04 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-04 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-04 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-04 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-04 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-04 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-04 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-04 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-04 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-04 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-04 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-04 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-04 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-04 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-04 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-04 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-04 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-04 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-04 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-04 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-04 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-04 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-04 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-04 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-04 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-04 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-04 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-04 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-04 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-04 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-04 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-04 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-04 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-04 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-04 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-04 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-04 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-04 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-04 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-04 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-04 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-04 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-04 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-04 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-04 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-04 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-04 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-04 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-04 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-04 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-04 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-04 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-04 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 4e-04 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-04 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-04 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-04 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-04 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-04 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-04 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-04 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-04 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-04 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-04 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-04 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-04 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-04 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-04 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-04 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-04 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-04 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-04 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-04 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-04 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-04 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-04 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-04 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-04 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-04 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-04 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-04 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-04 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-04 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-04 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-04 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-04 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-04 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 5e-04 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-04 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-04 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-04 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-04 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-04 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-04 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-04 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-04 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 6e-04 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-04 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-04 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-04 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-04 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-04 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 6e-04 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-04 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-04 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-04 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 6e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 6e-04 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-04 | ||
| 2kty_A | 368 | Solution Structure Of Human Vaccinia Related Kinase | 7e-04 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 7e-04 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 7e-04 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-04 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-04 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-04 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 7e-04 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 7e-04 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 7e-04 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 7e-04 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-04 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-04 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 7e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-04 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 7e-04 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-04 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-04 | ||
| 2lav_A | 361 | Nmr Solution Structure Of Human Vaccinia-Related Ki | 7e-04 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-04 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 7e-04 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-04 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 7e-04 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 8e-04 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 8e-04 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-04 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-04 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 8e-04 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 8e-04 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 8e-04 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 8e-04 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-04 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 8e-04 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-04 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 8e-04 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 8e-04 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 9e-04 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-04 |
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2KTY|A Chain A, Solution Structure Of Human Vaccinia Related Kinase-1 Length = 368 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2LAV|A Chain A, Nmr Solution Structure Of Human Vaccinia-Related Kinase 1 Length = 361 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 208 bits (533), Expect = 1e-64
Identities = 48/172 (27%), Positives = 79/172 (45%), Gaps = 2/172 (1%)
Query: 7 NQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLG 66
N G IP +I L +L L + G IP + + L+TL+F+ N L G++P S+
Sbjct: 87 NNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSIS 146
Query: 67 KCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDIS 126
NL+ + N ++G P S L + +S+N+L G +P F L NL +D+S
Sbjct: 147 SLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLS 205
Query: 127 ENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178
N L G GS +++ + N ++ + + + LDL N
Sbjct: 206 RNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRI 256
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 1e-53
Identities = 52/178 (29%), Positives = 83/178 (46%), Gaps = 4/178 (2%)
Query: 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSI 61
+ +G IP + + L L N G +P SI +L L+ + F N + G+I
Sbjct: 106 LYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAI 165
Query: 62 PSSLGKCQNLI-LLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNL 120
P S G L + +S N LTG P +L+ ++DLS+N L G FG KN
Sbjct: 166 PDSYGSFSKLFTSMTISRNRLTGKIPPT-FANLNLA-FVDLSRNMLEGDASVLFGSDKNT 223
Query: 121 GAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178
I +++N L+ + +G L L + N G +P L+ L+ + +L++S NN
Sbjct: 224 QKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNL 280
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 5e-52
Identities = 50/180 (27%), Positives = 87/180 (48%), Gaps = 6/180 (3%)
Query: 3 TLVGNQFTGR--IPGSIGDLHKLQRLTL-EMNKFWGEIPSSIGNLTLLITLNFAENMLEG 59
L G IP S+ +L L L + +N G IP +I LT L L + G
Sbjct: 56 DLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSG 115
Query: 60 SIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKN 119
+IP L + + L+ LD S N L+GT P + L +L + N+++G +P ++G
Sbjct: 116 AIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLV-GITFDGNRISGAIPDSYGSFSK 174
Query: 120 LG-AIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178
L ++ IS N+L+G+IP + + L + ++ N G+ S + + + L++N+
Sbjct: 175 LFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSL 233
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 166 bits (424), Expect = 2e-48
Identities = 48/175 (27%), Positives = 77/175 (44%), Gaps = 5/175 (2%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLT-LLITLNFAENMLEGSIP 62
N +G +P SI L L +T + N+ G IP S G+ + L ++ + N L G IP
Sbjct: 132 FSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIP 191
Query: 63 SSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGA 122
+ NL +DLS N L G + + L++N L L G+ KNL
Sbjct: 192 PTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQ-KIHLAKNSLAFDLGK-VGLSKNLNG 248
Query: 123 IDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNN 177
+D+ N++ G +P + L L ++ N G IP +L+ + + N
Sbjct: 249 LDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNK 302
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 6e-48
Identities = 54/176 (30%), Positives = 84/176 (47%), Gaps = 6/176 (3%)
Query: 7 NQFTGRIPGSIGDLHKLQRLTLEMNKFWGE--IPSSIGNLTLLITLNFA-ENMLEGSIPS 63
+ G + + +++ L L IPSS+ NL L L N L G IP
Sbjct: 36 RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPP 95
Query: 64 SLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAI 123
++ K L L +++ N++G P + + +L LD S N L+G LP + L NL I
Sbjct: 96 AIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLV-TLDFSYNALSGTLPPSISSLPNLVGI 154
Query: 124 DISENKLSGQIPSSIGSCIRLEQ-LVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178
N++SG IP S GS +L + ++ N G IP + ++L + +DLSRN
Sbjct: 155 TFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNML 209
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 8e-34
Identities = 39/150 (26%), Positives = 61/150 (40%), Gaps = 8/150 (5%)
Query: 36 EIPSSIGNLTLL----ITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTT--PTEV 89
+I +GN T L T + G + + + + LDLS NL P+ +
Sbjct: 13 QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL 72
Query: 90 IGLSSLSIYLDLS-QNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLV 148
L L+ +L + N L GP+P L L + I+ +SG IP + L L
Sbjct: 73 ANLPYLN-FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLD 131
Query: 149 MNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178
+ N G +P S+SSL + + N
Sbjct: 132 FSYNALSGTLPPSISSLPNLVGITFDGNRI 161
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-24
Identities = 27/111 (24%), Positives = 43/111 (38%), Gaps = 5/111 (4%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS 63
L N G G Q++ L N ++ +G L L+ N + G++P
Sbjct: 204 LSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQ 262
Query: 64 SLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQL--NGPLPS 112
L + + L L++S NNL G P L + N+ PLP+
Sbjct: 263 GLTQLKFLHSLNVSFNNLCGEIPQGGN-LQRFD-VSAYANNKCLCGSPLPA 311
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 44.8 bits (107), Expect = 3e-05
Identities = 13/61 (21%), Positives = 23/61 (37%), Gaps = 2/61 (3%)
Query: 121 GAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRG--NIPSSLSSLRGIENLDLSRNNF 178
D G + + R+ L ++G IPSSL++L + L + N
Sbjct: 29 PTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINN 88
Query: 179 I 179
+
Sbjct: 89 L 89
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 183 bits (468), Expect = 7e-55
Identities = 70/254 (27%), Positives = 110/254 (43%), Gaps = 40/254 (15%)
Query: 173 LSRNNFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQ 232
+S HRNL+++ C + LVY +M NGS+ L E+ L+ +
Sbjct: 81 ISM---AVHRNLLRLRGFCMT-----PTERLLVYPYMANGSVASCLRERPESQPPLDWPK 132
Query: 233 RLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFF 292
R IA+ A L YLH +C+ I+H D+K +N+LLD E A VGDFGLAK + +
Sbjct: 133 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 192
Query: 293 NFQIA--------EYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKE 344
+ EY + S DV+ +G++LLE TG+R + N +
Sbjct: 193 T-AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251
Query: 345 ALP----ERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSEL 400
++L +VD L +G + +E + ++ + + C+
Sbjct: 252 VKGLLKEKKLEALVDVDL-----QGN-------------YKDEE-VEQLIQVALLCTQSS 292
Query: 401 PRERMNMEEVAAQL 414
P ER M EV L
Sbjct: 293 PMERPKMSEVVRML 306
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 2e-49
Identities = 63/254 (24%), Positives = 103/254 (40%), Gaps = 44/254 (17%)
Query: 173 LSRNNFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQ 232
LS RH +LV +I C + L+Y++M NG+L+ L+ + +++ Q
Sbjct: 89 LSF---CRHPHLVSLIGFCDE-----RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQ 140
Query: 233 RLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFF 292
RL I + A L YLH I+H D+K N+LLD + DFG++K E
Sbjct: 141 RLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL 197
Query: 293 NFQIA--------EYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKE 344
+ + EY + ++ DVYSFG++L E + + + N +
Sbjct: 198 STVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE--MVNLAEW 255
Query: 345 ALP----ERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSEL 400
A+ +L +IVDP L + E L V C +
Sbjct: 256 AVESHNNGQLEQIVDPNL-----ADKIR--------------PESLRKFGDTAVKCLALS 296
Query: 401 PRERMNMEEVAAQL 414
+R +M +V +L
Sbjct: 297 SEDRPSMGDVLWKL 310
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 4e-49
Identities = 64/177 (36%), Positives = 93/177 (52%), Gaps = 5/177 (2%)
Query: 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSI 61
L N FTG+IP ++ + +L L L N G IPSS+G+L+ L L NMLEG I
Sbjct: 399 LYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEI 458
Query: 62 PSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLG 121
P L + L L L N+LTG P+ + ++L ++ LS N+L G +P G L+NL
Sbjct: 459 PQELMYVKTLETLILDFNDLTGEIPSGLSNCTNL-NWISLSNNRLTGEIPKWIGRLENLA 517
Query: 122 AIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178
+ +S N SG IP+ +G C L L +N N F G IP+++ ++ N
Sbjct: 518 ILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS----GKIAANFI 570
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 1e-48
Identities = 58/178 (32%), Positives = 85/178 (47%), Gaps = 3/178 (1%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIP-SSIGNLTLLITLNFAENMLEGSIP 62
L GN F G +P G L+ L L N F GE+P ++ + L L+ + N G +P
Sbjct: 301 LSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELP 360
Query: 63 SSLGKC-QNLILLDLSNNNLTGTTPTEVIGLSSLSI-YLDLSQNQLNGPLPSNFGILKNL 120
SL +L+ LDLS+NN +G + ++ L L N G +P L
Sbjct: 361 ESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSEL 420
Query: 121 GAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178
++ +S N LSG IPSS+GS +L L + N G IP L ++ +E L L N+
Sbjct: 421 VSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDL 478
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 1e-47
Identities = 49/199 (24%), Positives = 75/199 (37%), Gaps = 21/199 (10%)
Query: 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSI 61
L N TG IP + + L ++L N+ GEIP IG L L L + N G+I
Sbjct: 471 LILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNI 530
Query: 62 PSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSL---------------------SIYLD 100
P+ LG C++LI LDL+ N GT P + S +
Sbjct: 531 PAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGA 590
Query: 101 LSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPS 160
+ + G L +I+ G + + + L M+ N G IP
Sbjct: 591 GNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPK 650
Query: 161 SLSSLRGIENLDLSRNNFI 179
+ S+ + L+L N+
Sbjct: 651 EIGSMPYLFILNLGHNDIS 669
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 2e-47
Identities = 58/175 (33%), Positives = 85/175 (48%), Gaps = 5/175 (2%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS 63
L N +G IP S+G L KL+ L L +N GEIP + + L TL N L G IPS
Sbjct: 425 LSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPS 484
Query: 64 SLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAI 123
L C NL + LSNN LTG P + L +L+I L LS N +G +P+ G ++L +
Sbjct: 485 GLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAI-LKLSNNSFSGNIPAELGDCRSLIWL 543
Query: 124 DISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178
D++ N +G IP+++ + NF G + + + + N
Sbjct: 544 DLNTNLFNGTIPAAMFKQSGK----IAANFIAGKRYVYIKNDGMKKECHGAGNLL 594
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 7e-46
Identities = 51/177 (28%), Positives = 74/177 (41%), Gaps = 7/177 (3%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS 63
L N F+G IP +GD L L L N F G IP+++ + I A N + G
Sbjct: 521 LSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKI----AANFIAGKRYV 576
Query: 64 SLGKCQNLILLDLSNN--NLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLG 121
+ + N G ++ LS+ +++ G F ++
Sbjct: 577 YIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTR-NPCNITSRVYGGHTSPTFDNNGSMM 635
Query: 122 AIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178
+D+S N LSG IP IGS L L + N G+IP + LRG+ LDLS N
Sbjct: 636 FLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKL 692
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 3e-45
Identities = 58/177 (32%), Positives = 89/177 (50%), Gaps = 8/177 (4%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS 63
+ GN+ +G + + L+ L + N F IP +G+ + L L+ + N L G
Sbjct: 185 ISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSR 241
Query: 64 SLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSN-FGILKNLGA 122
++ C L LL++S+N G P L SL YL L++N+ G +P G L
Sbjct: 242 AISTCTELKLLNISSNQFVGPIPPL--PLKSLQ-YLSLAENKFTGEIPDFLSGACDTLTG 298
Query: 123 IDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIP-SSLSSLRGIENLDLSRNNF 178
+D+S N G +P GSC LE L ++ N F G +P +L +RG++ LDLS N F
Sbjct: 299 LDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEF 355
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 4e-45
Identities = 61/178 (34%), Positives = 89/178 (50%), Gaps = 7/178 (3%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS 63
+ N F+ IP +GD LQ L + NK G+ +I T L LN + N G IP
Sbjct: 207 VSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP 265
Query: 64 SLGKCQNLILLDLSNNNLTGTTPTEVIG-LSSLSIYLDLSQNQLNGPLPSNFGILKNLGA 122
++L L L+ N TG P + G +L+ LDLS N G +P FG L +
Sbjct: 266 L--PLKSLQYLSLAENKFTGEIPDFLSGACDTLT-GLDLSGNHFYGAVPPFFGSCSLLES 322
Query: 123 IDISENKLSGQIP-SSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRG-IENLDLSRNNF 178
+ +S N SG++P ++ L+ L ++ N F G +P SL++L + LDLS NNF
Sbjct: 323 LALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNF 380
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 3e-42
Identities = 56/177 (31%), Positives = 85/177 (48%), Gaps = 10/177 (5%)
Query: 6 GNQFTGRIPGSI---GDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIP 62
N +G +L+ L + NK G++ + L L+ + N IP
Sbjct: 160 ANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP 217
Query: 63 SSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGA 122
LG C L LD+S N L+G + + L L++S NQ GP+P LK+L
Sbjct: 218 -FLGDCSALQHLDISGNKLSGDFSRAISTCTELK-LLNISSNQFVGPIPP--LPLKSLQY 273
Query: 123 IDISENKLSGQIPSSI-GSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178
+ ++ENK +G+IP + G+C L L ++GN F G +P S +E+L LS NNF
Sbjct: 274 LSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNF 330
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-40
Identities = 48/180 (26%), Positives = 83/180 (46%), Gaps = 9/180 (5%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPS--SIGNLTLLITLNFAENMLEGSI 61
L + G + L L L N G + + S+G+ + L LN + N L+
Sbjct: 84 LSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPG 142
Query: 62 PSSLG-KCQNLILLDLSNNNLTGTTPTEVIGLSSLS--IYLDLSQNQLNGPLPSNFGILK 118
S G K +L +LDLS N+++G + +L +S N+++G +
Sbjct: 143 KVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCV 200
Query: 119 NLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178
NL +D+S N S IP +G C L+ L ++GN G+ ++S+ ++ L++S N F
Sbjct: 201 NLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQF 259
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-38
Identities = 51/182 (28%), Positives = 79/182 (43%), Gaps = 14/182 (7%)
Query: 4 LVGNQFTGRIP--GSIGDLHKLQRLTLEMNKFWGEIPSSIG-NLTLLITLNFAENMLEGS 60
L N +G + S+G L+ L + N S G L L L+ + N + G+
Sbjct: 107 LSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGA 166
Query: 61 IPSSL---GKCQNLILLDLSNNNLTGTTPTEVIG-LSSLSIYLDLSQNQLNGPLPSNFGI 116
C L L +S N ++G + +L +LD+S N + +P G
Sbjct: 167 NVVGWVLSDGCGELKHLAISGNKISGDVD---VSRCVNLE-FLDVSSNNFSTGIPF-LGD 221
Query: 117 LKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRN 176
L +DIS NKLSG +I +C L+ L ++ N F G IP L+ ++ L L+ N
Sbjct: 222 CSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAEN 279
Query: 177 NF 178
F
Sbjct: 280 KF 281
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 6e-37
Identities = 39/160 (24%), Positives = 70/160 (43%), Gaps = 3/160 (1%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMN--KFWGEIPSSIGNLTLLITLNFAENMLEGSI 61
+ N G+ I + + N +F G + L+ N + G
Sbjct: 565 IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHT 624
Query: 62 PSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLG 121
+ +++ LD+S N L+G P E+ + L L+L N ++G +P G L+ L
Sbjct: 625 SPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYL-FILNLGHNDISGSIPDEVGDLRGLN 683
Query: 122 AIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSS 161
+D+S NKL G+IP ++ + L ++ ++ N G IP
Sbjct: 684 ILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM 723
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 8e-36
Identities = 50/178 (28%), Positives = 80/178 (44%), Gaps = 11/178 (6%)
Query: 7 NQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS--S 64
N + S+ L L+ L L + G + L +L+ + N L G + + S
Sbjct: 63 NVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPVTTLTS 121
Query: 65 LGKCQNLILLDLSNNNLTGTTPTE-VIGLSSLSIYLDLSQNQLNGPLPSNFGI---LKNL 120
LG C L L++S+N L + L+SL LDLS N ++G + + L
Sbjct: 122 LGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLE-VLDLSANSISGANVVGWVLSDGCGEL 180
Query: 121 GAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178
+ IS NK+SG + + C+ LE L ++ N F IP L +++LD+S N
Sbjct: 181 KHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKL 235
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 9e-30
Identities = 48/167 (28%), Positives = 83/167 (49%), Gaps = 10/167 (5%)
Query: 18 GDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLS 77
+ + + +N + + SS+ +LT L +L + + + GS+ +L LDLS
Sbjct: 50 DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLS 108
Query: 78 NNNLTGTTPTEV-IG-LSSLSIYLDLSQNQLNGPLPSNFGI-LKNLGAIDISENKLSGQI 134
N+L+G T +G S L +L++S N L+ P + G+ L +L +D+S N +SG
Sbjct: 109 RNSLSGPVTTLTSLGSCSGLK-FLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGAN 167
Query: 135 PSSI---GSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178
C L+ L ++GN G++ +S +E LD+S NNF
Sbjct: 168 VVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNF 212
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-29
Identities = 38/126 (30%), Positives = 58/126 (46%), Gaps = 2/126 (1%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS 63
+ + G + + + L + N G IP IG++ L LN N + GSIP
Sbjct: 615 ITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPD 674
Query: 64 SLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAI 123
+G + L +LDLS+N L G P + L+ L+ +DLS N L+GP+P G +
Sbjct: 675 EVGDLRGLNILDLSSNKLDGRIPQAMSALTMLT-EIDLSNNNLSGPIPEM-GQFETFPPA 732
Query: 124 DISENK 129
N
Sbjct: 733 KFLNNP 738
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 156 bits (398), Expect = 8e-45
Identities = 56/255 (21%), Positives = 103/255 (40%), Gaps = 50/255 (19%)
Query: 173 LSRNNFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQ 232
+++ +H NLV+++ + D LVY +M NGSL + L + L+
Sbjct: 84 MAK---CQHENLVELLGFSSD-----GDDLCLVYVYMPNGSLLDRLS-CLDGTPPLSWHM 134
Query: 233 RLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFF 292
R IA A+ +++LH E +H D+K +N+LLD TA + DFGLA+ +
Sbjct: 135 RCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVM 191
Query: 293 NFQIA--------EYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKE 344
+I E + E++ D+YSFG++LLE TG +E + +
Sbjct: 192 TSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDE----HREPQLLLDI 246
Query: 345 ALP-----ERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSE 399
+ + + +D + + ++ + C E
Sbjct: 247 KEEIEDEEKTIEDYIDKKM-------------------NDADSTS-VEAMYSVASQCLHE 286
Query: 400 LPRERMNMEEVAAQL 414
+R ++++V L
Sbjct: 287 KKNKRPDIKKVQQLL 301
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-36
Identities = 52/187 (27%), Positives = 80/187 (42%), Gaps = 20/187 (10%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+ H N+VK+ +C + LV E+ GSL LH E L +S +
Sbjct: 58 VNHPNIVKLYGAC-------LNPVCLVMEYAEGGSLYNVLH-GAEPLPYYTAAHAMSWCL 109
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELT-AHVGDFGLAKFLPEA-TNNFFNFQ- 295
+ + YLH ++H DLKP N+LL T + DFG A + TNN +
Sbjct: 110 QCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAW 169
Query: 296 IA-EYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEAL-------- 346
+A E GS S DV+S+GI+L E T ++P +E+ + V
Sbjct: 170 MAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNL 229
Query: 347 PERLAEI 353
P+ + +
Sbjct: 230 PKPIESL 236
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-35
Identities = 41/176 (23%), Positives = 68/176 (38%), Gaps = 32/176 (18%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEA---LVYEFMVNGSLEEWLHPNREALKNLNLLQRLS 235
++H N+++ I + +G + L+ F GSL ++L N ++ +
Sbjct: 75 MKHENILQFIGAEK----RGTSVDVDLWLITAFHEKGSLSDFLKANV-----VSWNELCH 125
Query: 236 IAVDVASALDYLHH-------YCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEAT 288
IA +A L YLH + I H D+K NVLL LTA + DFGLA
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185
Query: 289 NNFFNFQIA--------EYGMGS-----EVSTSGDVYSFGILLLETFTGKRPTNEM 331
+ E G+ + D+Y+ G++L E + +
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 6e-35
Identities = 52/165 (31%), Positives = 83/165 (50%), Gaps = 25/165 (15%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+RH N+V + + + ++V E++ GSL LH A + L+ +RLS+A
Sbjct: 91 LRHPNIVLFMGAVTQ-----PPNLSIVTEYLSRGSLYRLLH-KSGAREQLDERRRLSMAY 144
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIAE 298
DVA ++YLH+ PIVH +LK N+L+D + T V DFGL++ F ++
Sbjct: 145 DVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS------TFLSSK 197
Query: 299 YGMGS------EV------STSGDVYSFGILLLETFTGKRPTNEM 331
G+ EV + DVYSFG++L E T ++P +
Sbjct: 198 SAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL 242
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 1e-34
Identities = 36/166 (21%), Positives = 64/166 (38%), Gaps = 28/166 (16%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
H N++ ++ +C S L+ +M GSL LH ++ Q + A+
Sbjct: 64 FSHPNVLPVLGACQS---PPAPHPTLITHWMPYGSLYNVLHEGTN--FVVDQSQAVKFAL 118
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL-------------P 285
D+A + +LH E I L +V++D ++TA + + P
Sbjct: 119 DMARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAPAWVAP 177
Query: 286 EATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEM 331
EA Q + D++SF +LL E T + P ++
Sbjct: 178 EA------LQKKPEDTNRRSA---DMWSFAVLLWELVTREVPFADL 214
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-32
Identities = 46/165 (27%), Positives = 70/165 (42%), Gaps = 22/165 (13%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
++H N++ + C + LV EF G L L K + ++ AV
Sbjct: 63 LKHPNIIALRGVCLK-----EPNLCLVMEFARGGPLNRVLSG-----KRIPPDILVNWAV 112
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAH--------VGDFGLAKFLPEATNN 290
+A ++YLH PI+H DLK SN+L+ ++ + DFGLA+ T
Sbjct: 113 QIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM 172
Query: 291 FFNFQIA----EYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEM 331
A E S S DV+S+G+LL E TG+ P +
Sbjct: 173 SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI 217
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 7e-32
Identities = 35/205 (17%), Positives = 70/205 (34%), Gaps = 31/205 (15%)
Query: 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGE-------------------IPSSIG 42
+ N T + ++ L KL++ + + F E
Sbjct: 188 IGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWD 246
Query: 43 NLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLT--------GTTPTEVIGLSS 94
NL L + +P+ L + L++++ N +
Sbjct: 247 NLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEK 306
Query: 95 LSIYLDLSQNQL-NGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNF 153
+ I + + N L P+ ++ +K LG ++ N+L G++P + GS I+L L + N
Sbjct: 307 IQI-IYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQ 364
Query: 154 FRGNIPSSLSSLRGIENLDLSRNNF 178
+ +ENL + N
Sbjct: 365 ITEIPANFCGFTEQVENLSFAHNKL 389
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 9e-32
Identities = 37/189 (19%), Positives = 72/189 (38%), Gaps = 18/189 (9%)
Query: 6 GNQF-TGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSS 64
N T + S+ + KL L N+ G++P+ G+ L +LN A N + +
Sbjct: 314 YNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQITEIPANF 372
Query: 65 LGKCQNLILLDLSNNNLTGTTPTEVIG-LSSLSIYLDLSQNQLNG-------PLPSNFGI 116
G + + L ++N L +S +S +D S N++ PL
Sbjct: 373 CGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMS-AIDFSYNEIGSVDGKNFDPLDPTPFK 431
Query: 117 LKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRG-------NIPSSLSSLRGIE 169
N+ +I++S N++S + L + + GN + + + +
Sbjct: 432 GINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLT 491
Query: 170 NLDLSRNNF 178
++DL N
Sbjct: 492 SIDLRFNKL 500
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-31
Identities = 32/201 (15%), Positives = 62/201 (30%), Gaps = 28/201 (13%)
Query: 2 FTLVGNQFTGRIP--GSIGDLHKLQRLTLEMNKF-------WGEIPSSIGNLTLLITLNF 52
+ N+ IP + + + N+ + + + + ++N
Sbjct: 382 LSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINL 440
Query: 53 AENMLEGSIPSSLGKCQNLILLDLSNNNLTG-------TTPTEVIGLSSLSIYLDLSQNQ 105
+ N + L ++L N LT L+ +DL N+
Sbjct: 441 SNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLT-SIDLRFNK 499
Query: 106 LNGPLPSNFGI--LKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMN------GNFFRGN 157
L L +F L L ID+S N S P+ + L+ + GN
Sbjct: 500 LTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLRE 557
Query: 158 IPSSLSSLRGIENLDLSRNNF 178
P ++ + L + N+
Sbjct: 558 WPEGITLCPSLTQLQIGSNDI 578
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-30
Identities = 36/203 (17%), Positives = 75/203 (36%), Gaps = 22/203 (10%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPS--SIGNLTLLITLNFAENMLEG-- 59
L NQ T G +++ L+ NK IP+ +++++ ++F+ N +
Sbjct: 360 LAYNQITEIPANFCGFTEQVENLSFAHNKL-KYIPNIFDAKSVSVMSAIDFSYNEIGSVD 418
Query: 60 -----SIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNG------ 108
+ + K N+ ++LSNN ++ S LS ++L N L
Sbjct: 419 GKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLS-SINLMGNMLTEIPKNSL 477
Query: 109 -PLPSNFGILKNLGAIDISENKLSGQIPSSI--GSCIRLEQLVMNGNFFRGNIPSSLSSL 165
NF L +ID+ NKL+ + + L + ++ N F P+ +
Sbjct: 478 KDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNS 535
Query: 166 RGIENLDLSRNNFIRHRNLVKII 188
++ + + ++
Sbjct: 536 STLKGFGIRNQRDAQGNRTLREW 558
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 7e-30
Identities = 36/195 (18%), Positives = 57/195 (29%), Gaps = 26/195 (13%)
Query: 6 GNQFTG-------RIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLE 58
N+ + + + + L N+ + L ++N NML
Sbjct: 411 YNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT 470
Query: 59 G-------SIPSSLGKCQNLILLDLSNNNLTGTTPTEVIG-LSSLSIYLDLSQNQLNGPL 110
+ L +DL N LT + L L +DLS N +
Sbjct: 471 EIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLV-GIDLSYNSFSK-F 528
Query: 111 PSNFGILKNL------GAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSS 164
P+ L D N+ + P I C L QL + N R +
Sbjct: 529 PTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKITPN 588
Query: 165 LRGIENLDLSRNNFI 179
+ LD+ N I
Sbjct: 589 I---SVLDIKDNPNI 600
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-29
Identities = 35/187 (18%), Positives = 71/187 (37%), Gaps = 14/187 (7%)
Query: 3 TLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENML----- 57
Q +L L + + ++P+ + L + +N A N
Sbjct: 231 NSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQ 290
Query: 58 ---EGSIPSSLGKCQNLILLDLSNNNL-TGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSN 113
+ + + + ++ + NNL T T + + L L+ NQL G LP+
Sbjct: 291 LKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLG-MLECLYNQLEGKLPA- 348
Query: 114 FGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLS--SLRGIENL 171
FG L +++++ N+++ + G ++E L N + IP+ S+ + +
Sbjct: 349 FGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAI 407
Query: 172 DLSRNNF 178
D S N
Sbjct: 408 DFSYNEI 414
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-26
Identities = 26/221 (11%), Positives = 62/221 (28%), Gaps = 27/221 (12%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWG----EIPSSIGNLTLLITLNFAENMLEG 59
L G +GR+P +IG L +L+ L L + P I +
Sbjct: 88 LEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQK 147
Query: 60 SIPSSLGKCQ--NLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGIL 117
+ + +LI ++++ + ++ + N + + L
Sbjct: 148 TFVDYDPREDFSDLIKDCINSDPQQKSIKKS-SRITLKDTQIGQLSNNITF-VSKAVMRL 205
Query: 118 KNLGAIDISENKLSGQ-------------------IPSSIGSCIRLEQLVMNGNFFRGNI 158
L + + + + L + + +
Sbjct: 206 TKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKL 265
Query: 159 PSSLSSLRGIENLDLSRNNFIRHRNLVKIITSCASVDFQGN 199
P+ L +L ++ ++++ N I L + A
Sbjct: 266 PTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEK 306
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 27/185 (14%), Positives = 55/185 (29%), Gaps = 7/185 (3%)
Query: 11 GRIPG-SIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEG----SIPSSL 65
G PG S+ ++ L+LE G +P +IG LT L L + + P +
Sbjct: 70 GAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGI 129
Query: 66 GKCQNLILLDLSNNNLTGTTPTEVIGLSSLSI-YLDLSQNQLNGPLPSNFGILKNLGAID 124
+ + T + ++ + + + I I
Sbjct: 130 SANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIG 189
Query: 125 ISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNFIRHRNL 184
N ++ + ++ +L Q M + F E + ++ NL
Sbjct: 190 QLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNL 248
Query: 185 VKIIT 189
+
Sbjct: 249 KDLTD 253
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 5e-22
Identities = 32/187 (17%), Positives = 60/187 (32%), Gaps = 29/187 (15%)
Query: 4 LVGNQFTG-------RIPGSIGDLHKLQRLTLEMNKFWGEIPSSI--GNLTLLITLNFAE 54
L+GN T + + + L + L NK ++ L L+ ++ +
Sbjct: 464 LMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKL-TKLSDDFRATTLPYLVGIDLSY 522
Query: 55 NMLEGSIPSSLGKCQNLILLDLSN------NNLTGTTPTEVIGLSSLSIYLDLSQNQLNG 108
N P+ L + N N P + SL+ L + N +
Sbjct: 523 NSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLT-QLQIGSNDIRK 580
Query: 109 PLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGI 168
+ I N+ +DI +N S + I ++ + +RG
Sbjct: 581 -VNEK--ITPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYD--------KTQDIRGC 629
Query: 169 ENLDLSR 175
+ LD+ R
Sbjct: 630 DALDIKR 636
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 20/152 (13%), Positives = 46/152 (30%), Gaps = 7/152 (4%)
Query: 34 WGEIPS-SIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEV--- 89
WG P S+ + + L+ G +P ++G+ L +L L ++
Sbjct: 69 WGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKG 128
Query: 90 IGLSSLSIYLDLSQNQLNGPLPSNFG--ILKNLGAIDISENKLSGQIPSSIGSCIRLEQL 147
I + + +L I+ + I S ++ Q+
Sbjct: 129 ISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQI 188
Query: 148 VMNGNFFRGNIPSSLSSLRGIENLDLSRNNFI 179
N + ++ L + + + F+
Sbjct: 189 GQLSNNITF-VSKAVMRLTKLRQFYMGNSPFV 219
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 21/153 (13%), Positives = 34/153 (22%), Gaps = 11/153 (7%)
Query: 32 KFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEVIG 91
G N N +M SL + L L +G P +
Sbjct: 48 SQQGFGTQPGANWNF----NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQ 103
Query: 92 LSSLSIYLDLSQNQLNGP----LPSNFGILKNLGAIDISENKLSGQIPSSIG--SCIRLE 145
L+ L L L + P + L
Sbjct: 104 LTELE-VLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLI 162
Query: 146 QLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178
+ +N + + +I S + NN
Sbjct: 163 KDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI 195
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 20/85 (23%), Positives = 32/85 (37%), Gaps = 3/85 (3%)
Query: 97 IYLDLSQNQLNGPLPSNFGILKNLGA---IDISENKLSGQIPSSIGSCIRLEQLVMNGNF 153
+ L + LNG S G GA + + Q S+ S R+ L + G
Sbjct: 33 LALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEGFG 92
Query: 154 FRGNIPSSLSSLRGIENLDLSRNNF 178
G +P ++ L +E L L +
Sbjct: 93 ASGRVPDAIGQLTELEVLALGSHGE 117
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 7e-32
Identities = 40/177 (22%), Positives = 65/177 (36%), Gaps = 3/177 (1%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS 63
L NQ + +L L + N P L +L LN N L
Sbjct: 32 LTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDK 91
Query: 64 SLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAI 123
+ C NL L L +N++ + +L I LDLS N L+ L+NL +
Sbjct: 92 TFAFCTNLTELHLMSNSIQKIKNNPFVKQKNL-ITLDLSHNGLSSTKLGTQVQLENLQEL 150
Query: 124 DISENKLSGQIPS--SIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178
+S NK+ I + L++L ++ N + P ++ + L L+
Sbjct: 151 LLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQL 207
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-31
Identities = 44/180 (24%), Positives = 72/180 (40%), Gaps = 6/180 (3%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS 63
+ N + P L L+ L L+ N+ + T L L+ N ++ +
Sbjct: 56 VGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNN 115
Query: 64 SLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKN--LG 121
K +NLI LDLS+N L+ T + L +L L LS N++ I N L
Sbjct: 116 PFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQ-ELLLSNNKIQALKSEELDIFANSSLK 174
Query: 122 AIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLS---SLRGIENLDLSRNNF 178
+++S N++ P + RL L +N ++ L + I NL LS +
Sbjct: 175 KLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQL 234
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-30
Identities = 43/209 (20%), Positives = 74/209 (35%), Gaps = 14/209 (6%)
Query: 4 LVGNQFTGRIPGS-IGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEG--S 60
L N+ + G L + + L NK+ +S + L L L+ S
Sbjct: 412 LGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDS 471
Query: 61 IPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLN--------GPLPS 112
PS +NL +LDLSNNN+ + GL L LDL N L G
Sbjct: 472 SPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKL-EILDLQHNNLARLWKHANPGGPIY 530
Query: 113 NFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLD 172
L +L +++ N L+ + + N S ++ +++L+
Sbjct: 531 FLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLN 590
Query: 173 LSRNNF--IRHRNLVKIITSCASVDFQGN 199
L +N + + + +D + N
Sbjct: 591 LQKNLITSVEKKVFGPAFRNLTELDMRFN 619
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-27
Identities = 37/189 (19%), Positives = 71/189 (37%), Gaps = 15/189 (7%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEI---------PSSIGNLTLLITLNFAE 54
L N S+ L ++ L L+ + I S L L LN +
Sbjct: 279 LEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMED 338
Query: 55 NMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEVI----GLSSLSIYLDLSQNQLNGPL 110
N + G + NL L LSN+ + T T S L L+L++N+++
Sbjct: 339 NDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLH-ILNLTKNKISKIE 397
Query: 111 PSNFGILKNLGAIDISENKLSGQIP-SSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIE 169
F L +L +D+ N++ ++ + ++ ++ N + +S + + ++
Sbjct: 398 SDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQ 457
Query: 170 NLDLSRNNF 178
L L R
Sbjct: 458 RLMLRRVAL 466
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-27
Identities = 36/175 (20%), Positives = 70/175 (40%), Gaps = 6/175 (3%)
Query: 6 GNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSL 65
+ T ++P + + L L N+ ++ + L +L+ N + P
Sbjct: 13 HLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELC 69
Query: 66 GKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDI 125
K L +L+L +N L+ + ++L+ L L N + + F KNL +D+
Sbjct: 70 QKLPMLKVLNLQHNELSQLSDKTFAFCTNLT-ELHLMSNSIQKIKNNPFVKQKNLITLDL 128
Query: 126 SENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSL--RGIENLDLSRNNF 178
S N LS + L++L+++ N + L ++ L+LS N
Sbjct: 129 SHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQI 183
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-27
Identities = 36/184 (19%), Positives = 64/184 (34%), Gaps = 8/184 (4%)
Query: 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIG----NLTLLITLNFAENML 57
+ N G L L+ L+L + ++ + L LN +N +
Sbjct: 334 LNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKI 393
Query: 58 EGSIPSSLGKCQNLILLDLSNNNLTGTTPTEVI-GLSSLSIYLDLSQNQLNGPLPSNFGI 116
+ +L +LDL N + + GL ++ + LS N+ ++F +
Sbjct: 394 SKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIF-EIYLSYNKYLQLTRNSFAL 452
Query: 117 LKNLGAIDISENKLSG--QIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLS 174
+ +L + + L PS L L ++ N L L +E LDL
Sbjct: 453 VPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQ 512
Query: 175 RNNF 178
NN
Sbjct: 513 HNNL 516
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-26
Identities = 40/188 (21%), Positives = 69/188 (36%), Gaps = 15/188 (7%)
Query: 6 GNQFTGRIPGSIGDLH--KLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS 63
N+ + L++L L N+ P + L L L S+
Sbjct: 154 NNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTE 213
Query: 64 SLGKCQN---LILLDLSNNNLTGTTPTEVIGLSSLSI-YLDLSQNQLNGPLPSNFGILKN 119
L + L LSN+ L+ T+ T +GL ++ LDLS N LN +F L
Sbjct: 214 KLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQ 273
Query: 120 LGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNI---------PSSLSSLRGIEN 170
L + N + S+ + L + +F + +I S L+ +E+
Sbjct: 274 LEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEH 333
Query: 171 LDLSRNNF 178
L++ N+
Sbjct: 334 LNMEDNDI 341
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 9e-15
Identities = 25/113 (22%), Positives = 47/113 (41%), Gaps = 5/113 (4%)
Query: 67 KCQ-NLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDI 125
KC + + D S+ LT P ++ ++++ L+L+ NQL +NF L ++D+
Sbjct: 1 KCTVSHEVADCSHLKLT-QVPDDL--PTNIT-VLNLTHNQLRRLPAANFTRYSQLTSLDV 56
Query: 126 SENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178
N +S P L+ L + N + + + L L N+
Sbjct: 57 GFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSI 109
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 24/111 (21%), Positives = 36/111 (32%), Gaps = 2/111 (1%)
Query: 3 TLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIP 62
L + G + L L L LE N F +L L ++ N L
Sbjct: 518 RLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPA 577
Query: 63 SSLGKCQNLILLDLSNNNLTGTTPTEV-IGLSSLSIYLDLSQNQLNGPLPS 112
S +L L+L N +T +L+ LD+ N + S
Sbjct: 578 SVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLT-ELDMRFNPFDCTCES 627
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 9e-32
Identities = 38/169 (22%), Positives = 67/169 (39%), Gaps = 33/169 (19%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+ H N+VK+ ++ +V EF+ G L L + +L + +
Sbjct: 80 LNHPNIVKLYGLM-------HNPPRMVMEFVPCGDLYHRLLDKA---HPIKWSVKLRLML 129
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLD-----GELTAHVGDFGLAKFLPEATNNF-- 291
D+A ++Y+ + PIVH DL+ N+ L + A V DFGL++ + +
Sbjct: 130 DIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLG 188
Query: 292 ---------FNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEM 331
+ Y + D YSF ++L TG+ P +E
Sbjct: 189 NFQWMAPETIGAEEESY------TEKADTYSFAMILYTILTGEGPFDEY 231
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-31
Identities = 36/178 (20%), Positives = 63/178 (35%), Gaps = 7/178 (3%)
Query: 6 GNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSL 65
N S +LQ L L + + +L+ L TL N ++ +
Sbjct: 37 FNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAF 96
Query: 66 GKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNG-PLPSNFGILKNLGAID 124
+L L NL + L +L L+++ N + LP F L NL +D
Sbjct: 97 SGLSSLQKLVAVETNLASLENFPIGHLKTLK-ELNVAHNLIQSFKLPEYFSNLTNLEHLD 155
Query: 125 ISENKLSGQIPSSIGSCIRLE----QLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178
+S NK+ + + ++ L ++ N P + +R + L L N
Sbjct: 156 LSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFD 212
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-30
Identities = 36/178 (20%), Positives = 70/178 (39%), Gaps = 5/178 (2%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSI-GNLTLLITLNFAENMLEGSIP 62
L N + + L +L+ L + + S+ +L LI L+ + +
Sbjct: 380 LSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFN 438
Query: 63 SSLGKCQNLILLDLSNNNLTGTTPTEVIG-LSSLSIYLDLSQNQLNGPLPSNFGILKNLG 121
+L +L ++ N+ ++ L +L+ +LDLSQ QL P+ F L +L
Sbjct: 439 GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLT-FLDLSQCQLEQLSPTAFNSLSSLQ 497
Query: 122 AIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSL-RGIENLDLSRNNF 178
+++S N L+ L + N + L + L+L++N+F
Sbjct: 498 VLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 555
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-30
Identities = 45/193 (23%), Positives = 74/193 (38%), Gaps = 8/193 (4%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS 63
L + G+ L L L L N + L+ L L E L
Sbjct: 59 LSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENF 118
Query: 64 SLGKCQNLILLDLSNNNLTGTTPTEVIG-LSSLSIYLDLSQNQLNGPLPSNFGILKNLGA 122
+G + L L++++N + E L++L +LDLS N++ ++ +L +
Sbjct: 119 PIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLE-HLDLSSNKIQSIYCTDLRVLHQMPL 177
Query: 123 ----IDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPS-SLSSLRGIENLDLSRNN 177
+D+S N ++ I IRL +L + NF N+ + L G+E L
Sbjct: 178 LNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGE 236
Query: 178 FIRHRNLVKIITS 190
F NL K S
Sbjct: 237 FRNEGNLEKFDKS 249
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-30
Identities = 45/179 (25%), Positives = 70/179 (39%), Gaps = 6/179 (3%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNK--FWGEIPSSIGNLTLLITLNFAENMLEGSI 61
L G S DL L+ L L N F G S T L L+ + N + +
Sbjct: 330 LTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-M 388
Query: 62 PSSLGKCQNLILLDLSNNNLTGTTPTEVI-GLSSLSIYLDLSQNQLNGPLPSNFGILKNL 120
S+ + L LD ++NL + V L +L IYLD+S F L +L
Sbjct: 389 SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNL-IYLDISHTHTRVAFNGIFNGLSSL 447
Query: 121 GAIDISENKLSGQI-PSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178
+ ++ N P L L ++ P++ +SL ++ L++S NNF
Sbjct: 448 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNF 506
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-28
Identities = 37/171 (21%), Positives = 63/171 (36%), Gaps = 8/171 (4%)
Query: 13 IPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLI 72
IP ++ + L L N S + L L+ + ++ + +L
Sbjct: 22 IPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLS 79
Query: 73 LLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKL-S 131
L L+ N + GLSSL L + L G LK L ++++ N + S
Sbjct: 80 TLILTGNPIQSLALGAFSGLSSLQ-KLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138
Query: 132 GQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIEN----LDLSRNNF 178
++P + LE L ++ N + + L L + LDLS N
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM 189
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 5e-22
Identities = 46/181 (25%), Positives = 67/181 (37%), Gaps = 12/181 (6%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS 63
LV S Q L L KF + +L L + +G
Sbjct: 289 LVSVTIERVKDFSY--NFGWQHLELVNCKFGQFPTLKLKSLKRLTFTS-----NKGGNAF 341
Query: 64 SLGKCQNLILLDLSNNNLT--GTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLG 121
S +L LDLS N L+ G G +SL YLDLS N + + SNF L+ L
Sbjct: 342 SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLK-YLDLSFNGVIT-MSSNFLGLEQLE 399
Query: 122 AIDISENKLSGQIPSSI-GSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNFIR 180
+D + L S+ S L L ++ R + L +E L ++ N+F
Sbjct: 400 HLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQE 459
Query: 181 H 181
+
Sbjct: 460 N 460
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 28/135 (20%), Positives = 50/135 (37%), Gaps = 3/135 (2%)
Query: 6 GNQFTGRI-PGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSS 64
GN F P +L L L L + P++ +L+ L LN + N
Sbjct: 454 GNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFP 513
Query: 65 LGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSN--FGILKNLGA 122
+L +LD S N++ + E+ S +L+L+QN +K+
Sbjct: 514 YKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQ 573
Query: 123 IDISENKLSGQIPSS 137
+ + ++ PS
Sbjct: 574 LLVEVERMECATPSD 588
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 37/206 (17%), Positives = 63/206 (30%), Gaps = 35/206 (16%)
Query: 4 LVGNQFTGRIP-GSIGDLHKLQRLTLEMNKFWGE------IPSSIGNLTLLITLNFAENM 56
L N + + I L L+ L + +F E S++ L L F
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266
Query: 57 LEGS---IPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLN------ 107
L+ I N+ L + + +L+L +
Sbjct: 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQ-HLELVNCKFGQFPTLK 323
Query: 108 -------------GPLPSNFGILKNLGAIDISENKLS--GQIPSSIGSCIRLEQLVMNGN 152
G + L +L +D+S N LS G S L+ L ++ N
Sbjct: 324 LKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFN 383
Query: 153 FFRGNIPSSLSSLRGIENLDLSRNNF 178
+ S+ L +E+LD +N
Sbjct: 384 GVIT-MSSNFLGLEQLEHLDFQHSNL 408
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 4e-14
Identities = 22/112 (19%), Positives = 36/112 (32%), Gaps = 5/112 (4%)
Query: 67 KCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDIS 126
N+ N L + LDLS N L +F L +D+S
Sbjct: 6 VVPNITY-QCMELNFYKIPD----NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLS 60
Query: 127 ENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178
++ + S L L++ GN + + S L ++ L N
Sbjct: 61 RCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNL 112
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 4e-30
Identities = 46/166 (27%), Positives = 72/166 (43%), Gaps = 27/166 (16%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
RH N++ + + A+V ++ SL LH + + + + IA
Sbjct: 77 TRHVNILLFMGYSTAPQL------AIVTQWCEGSSLYHHLHASE---TKFEMKKLIDIAR 127
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIAE 298
A +DYLH I+H DLK +N+ L + T +GDFGLA ++ + +
Sbjct: 128 QTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATE--KSRWSGSHQFEQL 182
Query: 299 YG----MGSEV---------STSGDVYSFGILLLETFTGKRPTNEM 331
G M EV S DVY+FGI+L E TG+ P + +
Sbjct: 183 SGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI 228
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-30
Identities = 41/187 (21%), Positives = 71/187 (37%), Gaps = 15/187 (8%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS 63
L + P L LQ +T++ E+P ++ L TL A N L ++P+
Sbjct: 88 LRSVPLP-QFPDQAFRLSHLQHMTIDAAGL-MELPDTMQQFAGLETLTLARNPLR-ALPA 144
Query: 64 SLGKCQNLILLDLSNNNL---------TGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNF 114
S+ L L + + E GL +L L L + LP++
Sbjct: 145 SIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQ-SLRLEWTGIRS-LPASI 202
Query: 115 GILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLS 174
L+NL ++ I + LS + +I +LE+L + G N P ++ L L
Sbjct: 203 ANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILK 261
Query: 175 RNNFIRH 181
+ +
Sbjct: 262 DCSNLLT 268
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 37/188 (19%), Positives = 65/188 (34%), Gaps = 16/188 (8%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS 63
+ +P ++ L+ LTL N +P+SI +L L L+ +P
Sbjct: 111 IDAAGLM-ELPDTMQQFAGLETLTLARNPL-RALPASIASLNRLRELSIRACPELTELPE 168
Query: 64 SLGKC---------QNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNF 114
L NL L L + + P + L +L L + + L+ L
Sbjct: 169 PLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKS-LKIRNSPLSA-LGPAI 225
Query: 115 GILKNLGAIDISENKLSGQIPSSIGSCIRLEQL-VMNGNFFRGNIPSSLSSLRGIENLDL 173
L L +D+ P G L++L + + + +P + L +E LDL
Sbjct: 226 HHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDL 284
Query: 174 SRNNFIRH 181
+
Sbjct: 285 RGCVNLSR 292
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 5e-24
Identities = 39/182 (21%), Positives = 70/182 (38%), Gaps = 13/182 (7%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTL---------LITLNFAE 54
L N +P SI L++L+ L++ E+P + + L +L
Sbjct: 134 LARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEW 192
Query: 55 NMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNF 114
+ S+P+S+ QNL L + N+ L+ + L L LDL P F
Sbjct: 193 TGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKL-EELDLRGCTALRNYPPIF 249
Query: 115 GILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLS 174
G L + + + +P I +LE+L + G +PS ++ L + +
Sbjct: 250 GGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVP 309
Query: 175 RN 176
+
Sbjct: 310 PH 311
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 3e-21
Identities = 33/155 (21%), Positives = 53/155 (34%), Gaps = 5/155 (3%)
Query: 12 RIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNL 71
G L LQ L LE +P+SI NL L +L + L ++ ++ L
Sbjct: 174 DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKL 231
Query: 72 ILLDLSNNNLTGTTPTEVIGLSSLSIYLDLS-QNQLNGPLPSNFGILKNLGAIDISENKL 130
LDL P G + L L L + L LP + L L +D+
Sbjct: 232 EELDLRGCTALRNYPPIFGGRAPLK-RLILKDCSNLLT-LPLDIHRLTQLEKLDLRGCVN 289
Query: 131 SGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSL 165
++PS I +++ + +
Sbjct: 290 LSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVAR 324
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 8e-18
Identities = 23/156 (14%), Positives = 47/156 (30%), Gaps = 9/156 (5%)
Query: 23 LQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLT 82
+ L + + + + N + + L
Sbjct: 14 RENLYFQGSTALRPYHDVLSQWQRHYNADRNRW----HSAWRQANSNNPQIETRTGRALK 69
Query: 83 GTTPTEVIGLSSLS-IYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSC 141
T + + + L+L L P L +L + I L ++P ++
Sbjct: 70 -ATADLLEDATQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQF 126
Query: 142 IRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNN 177
LE L + N R +P+S++SL + L +
Sbjct: 127 AGLETLTLARNPLR-ALPASIASLNRLRELSIRACP 161
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 2e-09
Identities = 16/79 (20%), Positives = 28/79 (35%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS 63
L G P G L+RL L+ +P I LT L L+ + +PS
Sbjct: 236 LRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPS 295
Query: 64 SLGKCQNLILLDLSNNNLT 82
+ + ++ + +
Sbjct: 296 LIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 5e-08
Identities = 15/140 (10%), Positives = 32/140 (22%), Gaps = 22/140 (15%)
Query: 59 GSIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIY------------------LD 100
GS L + + ++
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIE 61
Query: 101 LSQNQLNGPLPSNFGILK--NLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNI 158
+ A+++ L Q P L+ + ++ +
Sbjct: 62 TRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-EL 119
Query: 159 PSSLSSLRGIENLDLSRNNF 178
P ++ G+E L L+RN
Sbjct: 120 PDTMQQFAGLETLTLARNPL 139
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-29
Identities = 42/202 (20%), Positives = 65/202 (32%), Gaps = 39/202 (19%)
Query: 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVD 239
H N++K I + + E++ G+L + QR+S A D
Sbjct: 65 EHPNVLKFIGVLYK-----DKRLNFITEYIKGGTLRGIIKSMD---SQYPWSQRVSFAKD 116
Query: 240 VASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIA-- 297
+AS + YLH I+H DL N L+ V DFGLA+ + + +
Sbjct: 117 IASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKK 173
Query: 298 --EYGMGSEVSTSG----------------DVYSFGILLLETFTGKRPTNEMFTGNLTLH 339
+ V DV+SFGI+L E + +
Sbjct: 174 PDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG 233
Query: 340 NFVKEAL--------PERLAEI 353
V+ L P I
Sbjct: 234 LNVRGFLDRYCPPNCPPSFFPI 255
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 5e-29
Identities = 42/170 (24%), Positives = 61/170 (35%), Gaps = 27/170 (15%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+RH N++ I + L+ ++ NGSL ++L L+ L +A
Sbjct: 88 MRHENILGFIAAD-IKGTGSWTQLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAY 141
Query: 239 DVASALDYLH-----HYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFN 293
S L +LH + I H DLK N+L+ T + D GLA TN
Sbjct: 142 SSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDI 201
Query: 294 FQIAEYG----MGSEVSTSG------------DVYSFGILLLETFTGKRP 327
G M EV D+YSFG++L E
Sbjct: 202 PPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVS 251
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 9e-29
Identities = 40/173 (23%), Positives = 64/173 (36%), Gaps = 27/173 (15%)
Query: 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVD 239
RH N++ I S + L+ + GSL ++L L+ + L I +
Sbjct: 60 RHENILGFIASD-MTSRHSSTQLWLITHYHEMGSLYDYLQLTT-----LDTVSCLRIVLS 113
Query: 240 VASALDYLH-----HYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNF 294
+AS L +LH + I H DLK N+L+ + D GLA ++TN
Sbjct: 114 IASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVG 173
Query: 295 QIAEYG----MGSEV------------STSGDVYSFGILLLETFTGKRPTNEM 331
G M EV D+++FG++L E +
Sbjct: 174 NNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV 226
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-28
Identities = 39/175 (22%), Positives = 66/175 (37%), Gaps = 29/175 (16%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSE-ALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIA 237
+RH N++ I + G ++ LV ++ +GSL ++L+ + + + +A
Sbjct: 93 LRHENILGFIAAD--NKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLA 145
Query: 238 VDVASALDYLH-----HYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFF 292
+ AS L +LH + I H DLK N+L+ T + D GLA AT+
Sbjct: 146 LSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTID 205
Query: 293 NFQIAEYG----MGSEV------------STSGDVYSFGILLLETFTGKRPTNEM 331
G M EV D+Y+ G++ E
Sbjct: 206 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 8e-28
Identities = 32/173 (18%), Positives = 52/173 (30%), Gaps = 32/173 (18%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
RH N+V + +C S A++ +L + + L++ + IA
Sbjct: 86 TRHENVVLFMGACMS-----PPHLAIITSLCKGRTLYSVVRDAK---IVLDVNKTRQIAQ 137
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNN-------- 290
++ + YLH I+H DLK NV D + DFGL
Sbjct: 138 EIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRI 193
Query: 291 ------------FFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEM 331
S DV++ G + E + P
Sbjct: 194 QNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ 246
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 8e-28
Identities = 41/186 (22%), Positives = 66/186 (35%), Gaps = 34/186 (18%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+ H N+ + I V G LV E+ NGSL ++L + + + +A
Sbjct: 64 MEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-----SDWVSSCRLAH 118
Query: 239 DVASALDYLH------HYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFF 292
V L YLH + + I H DL NVL+ + T + DFGL+ L
Sbjct: 119 SVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRP 178
Query: 293 NFQIA--------------EYGMGS-------EVSTSGDVYSFGILLLETFTGKRPTNEM 331
+ E G+ D+Y+ G++ E F R T+
Sbjct: 179 GEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM--RCTDLF 236
Query: 332 FTGNLT 337
++
Sbjct: 237 PGESVP 242
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-26
Identities = 35/206 (16%), Positives = 62/206 (30%), Gaps = 33/206 (16%)
Query: 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKF-------------------WGEIPSSIG 42
+ N+ T I +I L KLQ + + F + S
Sbjct: 430 IGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWS 488
Query: 43 NLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTT---------PTEVIGLS 93
NL L + +P L L L+++ N +
Sbjct: 489 NLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGP 548
Query: 94 SLSIYLDLSQNQLNG-PLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGN 152
+ I + N L P ++ + LG +D NK+ + G+ ++L L ++ N
Sbjct: 549 KIQI-FYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR--HLEAFGTNVKLTDLKLDYN 605
Query: 153 FFRGNIPSSLSSLRGIENLDLSRNNF 178
+ +E L S N
Sbjct: 606 QIEEIPEDFCAFTDQVEGLGFSHNKL 631
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-26
Identities = 32/196 (16%), Positives = 63/196 (32%), Gaps = 24/196 (12%)
Query: 4 LVGNQFTGRIP--GSIGDLHKLQRLTLEMNKF---WGEIPSSIGNLTL--LITLNFAENM 56
N+ IP + ++ + + NK I S+ + T+ + N
Sbjct: 626 FSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNE 684
Query: 57 LEGSIPSSLGKCQNLILLDLSNNNLT-------GTTPTEVIGLSSLSIYLDLSQNQLNG- 108
++ + + LSNN +T L+ +DL N+L
Sbjct: 685 IQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLT-TIDLRFNKLTSL 743
Query: 109 PLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQL------VMNGNFFRGNIPSSL 162
L L +D+S N S P+ + +L+ GN P+ +
Sbjct: 744 SDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGI 802
Query: 163 SSLRGIENLDLSRNNF 178
++ + L + N+
Sbjct: 803 TTCPSLIQLQIGSNDI 818
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 40/196 (20%), Positives = 64/196 (32%), Gaps = 24/196 (12%)
Query: 4 LVGNQFTG---RIPGSIGDLH--KLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLE 58
N+ I S+ D +TL N+ + + T+ + N++
Sbjct: 651 FSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT 710
Query: 59 -------GSIPSSLGKCQNLILLDLSNNNLTGTTPTEVIG-LSSLSIYLDLSQNQLNGPL 110
+ L +DL N LT + L LS +D+S N +
Sbjct: 711 SIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLS-NMDVSYNCFSS-F 768
Query: 111 PSNFGILKNLGAIDISE------NKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSS 164
P+ L A I N++ Q P+ I +C L QL + N R
Sbjct: 769 PTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRKVDEKLTPQ 828
Query: 165 LRGIENLDLSRNNFIR 180
L LD++ N I
Sbjct: 829 LY---ILDIADNPNIS 841
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 7e-24
Identities = 35/202 (17%), Positives = 70/202 (34%), Gaps = 22/202 (10%)
Query: 4 LVGNQFTGRIPGSIG-DLHKLQRLTLEMNKFWGEIPS--SIGNLTLLITLNFAENMLEG- 59
L NQ IP +++ L NK IP+ + ++ ++ +++F+ N +
Sbjct: 602 LDYNQIEE-IPEDFCAFTDQVEGLGFSHNKL-KYIPNIFNAKSVYVMGSVDFSYNKIGSE 659
Query: 60 ----SIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQL-------NG 108
S K N + LS N + S +S + LS N +
Sbjct: 660 GRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPIS-TIILSNNLMTSIPENSLK 718
Query: 109 PLPSNFGILKNLGAIDISENKLSGQIPSSI--GSCIRLEQLVMNGNFFRGNIPSSLSSLR 166
P N+ L ID+ NKL+ + + L + ++ N F P+ +
Sbjct: 719 PKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSS 776
Query: 167 GIENLDLSRNNFIRHRNLVKII 188
++ + +++
Sbjct: 777 QLKAFGIRHQRDAEGNRILRQW 798
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 5e-23
Identities = 28/190 (14%), Positives = 55/190 (28%), Gaps = 19/190 (10%)
Query: 4 LVGNQFTG-RIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIP 62
+ N S+ + KL L NK + G L L N +E IP
Sbjct: 555 MGYNNLEEFPASASLQKMVKLGLLDCVHNKV--RHLEAFGTNVKLTDLKLDYNQIE-EIP 611
Query: 63 SSLGK-CQNLILLDLSNNNLTGTTPTEVIG-LSSLSIYLDLSQNQLNGPLPSNFG----- 115
+ L S+N L + + +D S N++ +
Sbjct: 612 EDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMG-SVDFSYNKIGSEGRNISCSMDDY 670
Query: 116 ILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFR-------GNIPSSLSSLRGI 168
N + +S N++ + + ++++ N + + +
Sbjct: 671 KGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLL 730
Query: 169 ENLDLSRNNF 178
+DL N
Sbjct: 731 TTIDLRFNKL 740
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 2e-20
Identities = 29/198 (14%), Positives = 66/198 (33%), Gaps = 25/198 (12%)
Query: 7 NQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLG 66
+ + + + + ++ L+L G +P +IG LT L L+F + S
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGD 368
Query: 67 KCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLN-----GPLPSNFGILKNLG 121
+ + + + + + DL Q+ +N P+ + I
Sbjct: 369 EELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDT 428
Query: 122 AIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRG-------------------NIPSSL 162
I N+++ I +I +L+ + + F N S
Sbjct: 429 QIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSW 487
Query: 163 SSLRGIENLDLSRNNFIR 180
S+L+ + +++L +
Sbjct: 488 SNLKDLTDVELYNCPNMT 505
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 1e-18
Identities = 28/188 (14%), Positives = 54/188 (28%), Gaps = 35/188 (18%)
Query: 4 LVGNQFT-------GRIPGSIGDLHKLQRLTLEMNKFWGEIPSSI--GNLTLLITLNFAE 54
L N T G+ + + L + L NK + L L ++ +
Sbjct: 704 LSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKL-TSLSDDFRATTLPYLSNMDVSY 762
Query: 55 NMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNF 114
N S P+ L + + D N++ P+
Sbjct: 763 NCFS-SFPTQPLNSSQLKAFGIRHQ-------------------RDAEGNRILRQWPTGI 802
Query: 115 GILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGN-FFRGNIPSSLSSLR-GIENLD 172
+L + I N + + + +L L + N ++ S + G+ L
Sbjct: 803 TTCPSLIQLQIGSNDIRK-VDEKLTP--QLYILDIADNPNISIDVTSVCPYIEAGMYVLL 859
Query: 173 LSRNNFIR 180
+ IR
Sbjct: 860 YDKTQDIR 867
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 4e-07
Identities = 16/160 (10%), Positives = 43/160 (26%), Gaps = 3/160 (1%)
Query: 29 EMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTE 88
++ + I + L+ ++ N + + +
Sbjct: 260 QLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNW-NFNKELDMWGDQPGVD 318
Query: 89 VIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLV 148
+ + L L+ G +P G L L + + + + +
Sbjct: 319 LDNNGRV-TGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSE 377
Query: 149 MNGNFFRGNIPS-SLSSLRGIENLDLSRNNFIRHRNLVKI 187
+ R + L + + DL ++ R+ + I
Sbjct: 378 ERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPI 417
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 14/90 (15%), Positives = 30/90 (33%), Gaps = 3/90 (3%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS 63
GN+ + P I L +L + N ++ + L L+ A+N +
Sbjct: 789 AEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKL--TPQLYILDIADNPNISIDVT 845
Query: 64 SLGKCQNLILLDLSNNNLTGTTPTEVIGLS 93
S+ + L + + +G+
Sbjct: 846 SVCPYIEAGMYVLLYDKTQDIRGCDALGIE 875
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 34/177 (19%), Positives = 65/177 (36%), Gaps = 4/177 (2%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIP-SSIGNLTLLITLNFAENMLEGSIP 62
L N + + L +LQ L + + S+ +L L+ L+ + +
Sbjct: 383 LSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFD 441
Query: 63 SSLGKCQNLILLDLSNNNLTGTTPTEVI-GLSSLSIYLDLSQNQLNGPLPSNFGILKNLG 121
+L L ++ N+ T + V ++L+ +LDLS+ QL F L L
Sbjct: 442 GIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLT-FLDLSKCQLEQISWGVFDTLHRLQ 500
Query: 122 AIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178
+++S N L S L L + N + + + +L+ N+
Sbjct: 501 LLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-25
Identities = 47/193 (24%), Positives = 72/193 (37%), Gaps = 8/193 (4%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS 63
L + + LH L L L N P S LT L L E L
Sbjct: 63 LSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESF 122
Query: 64 SLGKCQNLILLDLSNNNLTGTTPTEVI-GLSSLSIYLDLSQNQLNGPLPSNFGILKNLGA 122
+G+ L L++++N + L++L ++DLS N + ++ L+
Sbjct: 123 PIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLV-HVDLSYNYIQTITVNDLQFLRENPQ 181
Query: 123 ----IDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPS-SLSSLRGIENLDLSRNN 177
+D+S N + I I+L +L + GNF NI L +L G+ L
Sbjct: 182 VNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGE 240
Query: 178 FIRHRNLVKIITS 190
F RNL S
Sbjct: 241 FKDERNLEIFEPS 253
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-23
Identities = 34/178 (19%), Positives = 69/178 (38%), Gaps = 9/178 (5%)
Query: 6 GNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSL 65
+ + ++P I + + L N S N + L L+ + +E +
Sbjct: 20 DQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAW 76
Query: 66 GKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDI 125
+L L L+ N + +P GL+SL L + +L G L L +++
Sbjct: 77 HGLHHLSNLILTGNPIQSFSPGSFSGLTSLE-NLVAVETKLASLESFPIGQLITLKKLNV 135
Query: 126 SENKLSG-QIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRG----IENLDLSRNNF 178
+ N + ++P+ + L + ++ N+ + + L LR +LD+S N
Sbjct: 136 AHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPI 193
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-19
Identities = 40/180 (22%), Positives = 70/180 (38%), Gaps = 10/180 (5%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS 63
L G + K Q L++ + + P+ +L L +L N SI
Sbjct: 292 LAGVSIKY--LEDVPKHFKWQSLSIIRCQL-KQFPTL--DLPFLKSLTLTMNKG--SISF 344
Query: 64 SLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSI-YLDLSQNQLNGPLPSNFGILKNLGA 122
+L LDLS N L+ + L + S+ +LDLS N + +NF L+ L
Sbjct: 345 KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQH 403
Query: 123 IDISENKLSGQIP-SSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNFIRH 181
+D + L S+ S +L L ++ + + L + L ++ N+F +
Sbjct: 404 LDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDN 463
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 5e-19
Identities = 33/154 (21%), Positives = 50/154 (32%), Gaps = 3/154 (1%)
Query: 4 LVGNQFTGRIP-GSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIP 62
+ + L KL L + + LT L TL A N + +
Sbjct: 406 FQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTL 465
Query: 63 SS-LGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLG 121
S+ NL LDLS L + L L L++S N L S++ L +L
Sbjct: 466 SNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQ-LLNMSHNNLLFLDSSHYNQLYSLS 524
Query: 122 AIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFR 155
+D S N++ L + N
Sbjct: 525 TLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 6e-19
Identities = 51/179 (28%), Positives = 68/179 (37%), Gaps = 11/179 (6%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS 63
++ Q P DL L+ LTL MNK G I L L L+ + N L S
Sbjct: 314 IIRCQLKQ-FPTL--DLPFLKSLTLTMNK--GSISFKKVALPSLSYLDLSRNALSFSGCC 368
Query: 64 SL--GKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNG-PLPSNFGILKNL 120
S +L LDLS N +GL L +LD + L S F L+ L
Sbjct: 369 SYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQ-HLDFQHSTLKRVTEFSAFLSLEKL 426
Query: 121 GAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSS-LSSLRGIENLDLSRNNF 178
+DIS L L M GN F+ N S+ ++ + LDLS+
Sbjct: 427 LYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQL 485
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 6e-14
Identities = 38/207 (18%), Positives = 67/207 (32%), Gaps = 19/207 (9%)
Query: 4 LVGNQFTGRIP-GSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLL--------ITLNFAE 54
L GN + I + +L L L + +F E I +++
Sbjct: 211 LRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTY 270
Query: 55 NMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNF 114
N+ + L+ ++ +V L + + QL +
Sbjct: 271 TNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQS-LSIIRCQLKQFPTLDL 327
Query: 115 GILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRG--IENLD 172
LK+L ++ NK S I + L L ++ N + S S L + +LD
Sbjct: 328 PFLKSL---TLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLD 382
Query: 173 LSRNNFIRHRNLVKIITSCASVDFQGN 199
LS N I + +DFQ +
Sbjct: 383 LSFNGAIIMSANFMGLEELQHLDFQHS 409
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 6e-14
Identities = 26/120 (21%), Positives = 44/120 (36%), Gaps = 5/120 (4%)
Query: 59 GSIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILK 118
GS+ + N+ + L+ P + S + +DLS N L +F
Sbjct: 2 GSLNPCIEVVPNITY-QCMDQKLS-KVPD---DIPSSTKNIDLSFNPLKILKSYSFSNFS 56
Query: 119 NLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178
L +D+S ++ + L L++ GN + P S S L +ENL
Sbjct: 57 ELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKL 116
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 33/177 (18%), Positives = 57/177 (32%), Gaps = 5/177 (2%)
Query: 6 GNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSL 65
IPG++ + + L N ++ L L L+ + +
Sbjct: 21 NLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTF 77
Query: 66 GKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDI 125
L L L+ N L T + G +L +L Q ++ K L ++ +
Sbjct: 78 QSQHRLDTLVLTANPLIFMAETALSGPKALK-HLFFIQTGISSIDFIPLHNQKTLESLYL 136
Query: 126 SENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLS-RNNFIRH 181
N +S +L+ L N +SSL+ NL L+ N I
Sbjct: 137 GSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG 193
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 27/179 (15%), Positives = 51/179 (28%), Gaps = 4/179 (2%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS 63
N + L L L L + + + + L TL N L +
Sbjct: 40 FSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAET 99
Query: 64 SLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAI 123
+L + L L ++ + +L L L N ++ + L +
Sbjct: 100 ALSGPKALKHLFFIQTGISSIDFIPLHNQKTL-ESLYLGSNHISSIKLPKGFPTEKLKVL 158
Query: 124 DISENKLSGQIPSSIGSCIRLEQLV--MNGNFFRGNIPSSLSSLRGIENLDLSRNNFIR 180
D N + + S + L +NGN I ++L+ +
Sbjct: 159 DFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI-AGIEPGAFDSAVFQSLNFGGTQNLL 216
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 38/179 (21%), Positives = 65/179 (36%), Gaps = 6/179 (3%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS 63
L + F + LQ L L E+PS + L+ L L + N E
Sbjct: 261 LQKHYFFNISSNTFHCFSGLQELDLTATHL-SELPSGLVGLSTLKKLVLSANKFENLCQI 319
Query: 64 SLGKCQNLILLDLSNNNLTGTTPTEVI-GLSSLSIYLDLSQNQLN--GPLPSNFGILKNL 120
S +L L + N T + L +L LDLS + + L +L
Sbjct: 320 SASNFPSLTHLSIKGNTKRLELGTGCLENLENLR-ELDLSHDDIETSDCCNLQLRNLSHL 378
Query: 121 GAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIP-SSLSSLRGIENLDLSRNNF 178
++++S N+ + C +LE L + + S +L ++ L+LS +
Sbjct: 379 QSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLL 437
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-23
Identities = 42/197 (21%), Positives = 82/197 (41%), Gaps = 7/197 (3%)
Query: 8 QFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIP-SSLG 66
+ + + +L LQ L L N+ + L L+ A L+ S
Sbjct: 363 ETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQ 422
Query: 67 KCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQL---NGPLPSNFGILKNLGAI 123
L +L+LS++ L ++ GL +L +L+L N N ++ L L +
Sbjct: 423 NLHLLKVLNLSHSLLDISSEQLFDGLPAL-QHLNLQGNHFPKGNIQKTNSLQTLGRLEIL 481
Query: 124 DISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF-IRHR 182
+S LS + S + + ++ N + +LS L+GI L+L+ N+ I
Sbjct: 482 VLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILP 540
Query: 183 NLVKIITSCASVDFQGN 199
+L+ I++ +++ + N
Sbjct: 541 SLLPILSQQRTINLRQN 557
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-22
Identities = 42/182 (23%), Positives = 69/182 (37%), Gaps = 8/182 (4%)
Query: 4 LVGNQFTGRI-PGSIGDLHKLQRLTLEMNKFW--GEIPSSIGNLTLLITLNFAENMLEGS 60
+ GN + G + +L L+ L L + + NL+ L +LN + N
Sbjct: 332 IKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSL 391
Query: 61 IPSSLGKCQNLILLDLSNNNLTGTTPTEVI-GLSSLSIYLDLSQNQLNGPLPSNFGILKN 119
+ +C L LLDL+ L L L L+LS + L+ F L
Sbjct: 392 KTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLL-KVLNLSHSLLDISSEQLFDGLPA 450
Query: 120 LGAIDISENKLSGQIPSSIGS---CIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRN 176
L +++ N S RLE LV++ + +SL+ + ++DLS N
Sbjct: 451 LQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHN 510
Query: 177 NF 178
Sbjct: 511 RL 512
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 6e-19
Identities = 34/184 (18%), Positives = 70/184 (38%), Gaps = 9/184 (4%)
Query: 4 LVGNQFTGRIPGSIG--DLHKLQRLTLEMNKFWGEIPSSIGNLTL--LITLNFAENMLEG 59
G Q I + + L T E P+ L + ++N ++
Sbjct: 209 FGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFN 268
Query: 60 SIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKN 119
++ L LDL+ +L+ P+ ++GLS+L L LS N+ + +
Sbjct: 269 ISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLK-KLVLSANKFENLCQISASNFPS 326
Query: 120 LGAIDISENKLSGQIPS-SIGSCIRLEQLVMNGNFFR--GNIPSSLSSLRGIENLDLSRN 176
L + I N ++ + + + L +L ++ + L +L +++L+LS N
Sbjct: 327 LTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYN 386
Query: 177 NFIR 180
+
Sbjct: 387 EPLS 390
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-17
Identities = 32/132 (24%), Positives = 54/132 (40%), Gaps = 5/132 (3%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKF---WGEIPSSIGNLTLLITLNFAENMLEGS 60
L + L LQ L L+ N F + +S+ L L L + L
Sbjct: 432 LSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSI 491
Query: 61 IPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNL 120
+ + + +DLS+N LT ++ + L + YL+L+ N ++ LPS IL
Sbjct: 492 DQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI--YLNLASNHISIILPSLLPILSQQ 549
Query: 121 GAIDISENKLSG 132
I++ +N L
Sbjct: 550 RTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 22/105 (20%), Positives = 42/105 (40%), Gaps = 4/105 (3%)
Query: 74 LDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQ 133
+ N L P L + + L+ S N L + F L NL +D++ ++
Sbjct: 17 YNCENLGLN-EIPG---TLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWI 72
Query: 134 IPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178
+ S RL+ LV+ N ++LS + +++L +
Sbjct: 73 HEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGI 117
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 94.5 bits (236), Expect = 1e-21
Identities = 39/174 (22%), Positives = 72/174 (41%), Gaps = 13/174 (7%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS 63
+ ++ P I +L L L+L N+ P + +LT L N + P
Sbjct: 162 VTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP- 216
Query: 64 SLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAI 123
+ L L + NN +T +P LS L+ +L++ NQ++ + L L +
Sbjct: 217 -VANMTRLNSLKIGNNKITDLSPLA--NLSQLT-WLEIGTNQISDI--NAVKDLTKLKML 270
Query: 124 DISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNN 177
++ N++S S + + +L L +N N + L + L LS+N+
Sbjct: 271 NVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNH 322
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 2e-19
Identities = 39/174 (22%), Positives = 69/174 (39%), Gaps = 13/174 (7%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS 63
L NQ P + L L T +N+ + + N+T L +L N + P
Sbjct: 184 LNYNQIEDISP--LASLTSLHYFTAYVNQI--TDITPVANMTRLNSLKIGNNKITDLSP- 238
Query: 64 SLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAI 123
L L L++ N ++ V L+ L L++ NQ++ S L L ++
Sbjct: 239 -LANLSQLTWLEIGTNQIS--DINAVKDLTKLK-MLNVGSNQISDI--SVLNNLSQLNSL 292
Query: 124 DISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNN 177
++ N+L + IG L L ++ N P L+SL +++ D +
Sbjct: 293 FLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQV 344
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 81.4 bits (202), Expect = 3e-17
Identities = 40/174 (22%), Positives = 69/174 (39%), Gaps = 14/174 (8%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS 63
+ N+ T ++ +L L+ L L + S + NLT + +LN N S S
Sbjct: 95 IGTNKIT--DISALQNLTNLRELYLNEDNI--SDISPLANLTKMYSLNLGANHNL-SDLS 149
Query: 64 SLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAI 123
L L L ++ + + TP L+ L L L+ NQ+ S L +L
Sbjct: 150 PLSNMTGLNYLTVTESKVKDVTPIA--NLTDL-YSLSLNYNQIED--ISPLASLTSLHYF 204
Query: 124 DISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNN 177
N+++ P + + RL L + N S L++L + L++ N
Sbjct: 205 TAYVNQITDITP--VANMTRLNSLKIGNNKITD--LSPLANLSQLTWLEIGTNQ 254
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 5e-16
Identities = 34/162 (20%), Positives = 66/162 (40%), Gaps = 12/162 (7%)
Query: 16 SIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLD 75
DL + R L+ + L + L A + SI + NL L+
Sbjct: 17 PDADLAEGIRAVLQKASV--TDVVTQEELESITKLVVAGEKVA-SIQG-IEYLTNLEYLN 72
Query: 76 LSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIP 135
L+ N +T +P L L+ L + N++ S L NL + ++E+ +S
Sbjct: 73 LNGNQITDISPLS--NLVKLT-NLYIGTNKITD--ISALQNLTNLRELYLNEDNISD--I 125
Query: 136 SSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNN 177
S + + ++ L + N ++ S LS++ G+ L ++ +
Sbjct: 126 SPLANLTKMYSLNLGANHNLSDL-SPLSNMTGLNYLTVTESK 166
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 71.8 bits (177), Expect = 5e-14
Identities = 31/128 (24%), Positives = 53/128 (41%), Gaps = 9/128 (7%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS 63
+ N+ T P + +L +L L + N+ +++ +LT L LN N + S
Sbjct: 228 IGNNKITDLSP--LANLSQLTWLEIGTNQI--SDINAVKDLTKLKMLNVGSNQISD--IS 281
Query: 64 SLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAI 123
L L L L+NN L + GL++L+ L LSQN + L + +
Sbjct: 282 VLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLT-TLFLSQNHITDI--RPLASLSKMDSA 338
Query: 124 DISENKLS 131
D + +
Sbjct: 339 DFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 48.3 bits (116), Expect = 2e-06
Identities = 21/104 (20%), Positives = 38/104 (36%), Gaps = 9/104 (8%)
Query: 74 LDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQ 133
L + P L+ I L + + + L+++ + ++ K++
Sbjct: 5 LATLPAPINQIFPDA--DLAEG-IRAVLQKASVTDVVT--QEELESITKLVVAGEKVAS- 58
Query: 134 IPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNN 177
I LE L +NGN P LS+L + NL + N
Sbjct: 59 -IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNK 99
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 50/168 (29%), Positives = 72/168 (42%), Gaps = 43/168 (25%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+RH NLV+++ + +V E+M GSL ++L L L ++
Sbjct: 243 LRHSNLVQLLGVI----VEEKGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSL 296
Query: 239 DVASALDYL--HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL------------ 284
DV A++YL +++ VH DL NVL+ + A V DFGL K
Sbjct: 297 DVCEAMEYLEGNNF-----VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK 351
Query: 285 ---PEA-TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRP 327
PEA F ST DV+SFGILL E ++ G+ P
Sbjct: 352 WTAPEALREKKF-------------STKSDVWSFGILLWEIYSFGRVP 386
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 4e-21
Identities = 42/169 (24%), Positives = 64/169 (37%), Gaps = 39/169 (23%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+ +VK G S LV E++ +G L ++L +R L LL +
Sbjct: 81 LHSDFIVKYRGVSYG---PGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLL---LYSS 134
Query: 239 DVASALDYL--HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQI 296
+ ++YL VH DL N+L++ E + DFGLAK LP +
Sbjct: 135 QICKGMEYLGSRRC-----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKD------- 182
Query: 297 AEYGMGSEV-----------------STSGDVYSFGILLLETFT-GKRP 327
Y + S DV+SFG++L E FT +
Sbjct: 183 -YYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS 230
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 5e-21
Identities = 39/173 (22%), Positives = 66/173 (38%), Gaps = 49/173 (28%)
Query: 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVD 239
H++LV C D LV EF+ GSL+ +L N+ + L L+ +A
Sbjct: 70 SHKHLVLNYGVCVC-----GDENILVQEFVKFGSLDTYLKKNKNCINILWKLE---VAKQ 121
Query: 240 VASALDYL--HHYCETPIVHCDLKPSNVLLDGELTAH--------VGDFGLAKFL----- 284
+A+A+ +L + +H ++ N+LL E + D G++ +
Sbjct: 122 LAAAMHFLEENTL-----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI 176
Query: 285 ---------PEATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRP 327
PE N N + + D +SFG L E + G +P
Sbjct: 177 LQERIPWVPPECIENPKNL-----------NLATDKWSFGTTLWEICSGGDKP 218
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 5e-21
Identities = 48/178 (26%), Positives = 70/178 (39%), Gaps = 49/178 (27%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+ H N+VK C G + L+ EF+ +GSL+E+L N+ + L AV
Sbjct: 80 LYHENIVKYKGICTE---DGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQL---KYAV 133
Query: 239 DVASALDYL--HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL------------ 284
+ +DYL Y VH DL NVL++ E +GDFGL K +
Sbjct: 134 QICKGMDYLGSRQY-----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDD 188
Query: 285 ---------PEATN-NFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNEM 331
PE + F + DV+SFG+ L E T ++ M
Sbjct: 189 RDSPVFWYAPECLMQSKF-------------YIASDVWSFGVTLHELLTYCDSDSSPM 233
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 8e-21
Identities = 41/169 (24%), Positives = 64/169 (37%), Gaps = 44/169 (26%)
Query: 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVD 239
H N+V++I C +V E + G +L L + L + D
Sbjct: 170 SHPNIVRLIGVCT-----QKQPIYIVMELVQGGDFLTFLRTEG---ARLRVKTLLQMVGD 221
Query: 240 VASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL--------------- 284
A+ ++YL +H DL N L+ + + DFG+++
Sbjct: 222 AAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVP 278
Query: 285 -----PEATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRP 327
PEA N + + S+ DV+SFGILL ETF+ G P
Sbjct: 279 VKWTAPEALN-YGRY-----------SSESDVWSFGILLWETFSLGASP 315
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 9e-21
Identities = 50/168 (29%), Positives = 72/168 (42%), Gaps = 43/168 (25%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+RH NLV+++ + +V E+M GSL ++L L L ++
Sbjct: 71 LRHSNLVQLLGVI----VEEKGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSL 124
Query: 239 DVASALDYL--HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL------------ 284
DV A++YL +++ VH DL NVL+ + A V DFGL K
Sbjct: 125 DVCEAMEYLEGNNF-----VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK 179
Query: 285 ---PEATN-NFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRP 327
PEA F ST DV+SFGILL E ++ G+ P
Sbjct: 180 WTAPEALREKKF-------------STKSDVWSFGILLWEIYSFGRVP 214
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-20
Identities = 40/175 (22%), Positives = 72/175 (41%), Gaps = 44/175 (25%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNR--EALKNLNLLQRLSI 236
H N+++++ C + QG ++ FM G L +L +R K++ L L
Sbjct: 93 FSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKF 152
Query: 237 AVDVASALDYL--HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL---------- 284
VD+A ++YL ++ +H DL N +L ++T V DFGL+K +
Sbjct: 153 MVDIALGMEYLSNRNF-----LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGR 207
Query: 285 ----------PEA-TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRP 327
E+ + + ++ DV++FG+ + E T G P
Sbjct: 208 IAKMPVKWIAIESLADRVY-------------TSKSDVWAFGVTMWEIATRGMTP 249
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 1e-20
Identities = 45/185 (24%), Positives = 72/185 (38%), Gaps = 14/185 (7%)
Query: 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVD 239
+H N+V+ S S +G LV E M +G+L+ +L K + + S
Sbjct: 83 QHPNIVRFYDSWESTV-KGKKCIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQ 137
Query: 240 VASALDYLHHYCETPIVHCDLKPSNVLLDGEL-TAHVGDFGLAKFLPEATNNFFNFQIAE 298
+ L +LH PI+H DLK N+ + G + +GD GLA +
Sbjct: 138 ILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK--AVIGTP 194
Query: 299 YGMGSEVSTSG-----DVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEALPERLAEI 353
M E+ DVY+FG+ +LE T + P +E P ++
Sbjct: 195 EFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV 254
Query: 354 VDPVL 358
P +
Sbjct: 255 AIPEV 259
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-20
Identities = 44/171 (25%), Positives = 65/171 (38%), Gaps = 47/171 (27%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+ H LV++ C LV EFM +G L ++L R LL + +
Sbjct: 60 LSHPKLVQLYGVCLE-----QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLG---MCL 111
Query: 239 DVASALDYL--HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL------------ 284
DV + YL +H DL N L+ V DFG+ +F+
Sbjct: 112 DVCEGMAYLEEACV-----IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK 166
Query: 285 -------PEATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRP 327
PE +F + S+ DV+SFG+L+ E F+ GK P
Sbjct: 167 FPVKWASPEVF-SFSRY-----------SSKSDVWSFGVLMWEVFSEGKIP 205
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-20
Identities = 44/169 (26%), Positives = 73/169 (43%), Gaps = 48/169 (28%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
++H N+VK C S G + L+ E++ GSL ++L ++E ++ ++ L
Sbjct: 68 LQHDNIVKYKGVCYS---AGRRNLKLIMEYLPYGSLRDYLQKHKE---RIDHIKLLQYTS 121
Query: 239 DVASALDYL--HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL------------ 284
+ ++YL Y +H DL N+L++ E +GDFGL K L
Sbjct: 122 QICKGMEYLGTKRY-----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEP 176
Query: 285 ---------PEATN-NFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT 323
PE+ + F S + DV+SFG++L E FT
Sbjct: 177 GESPIFWYAPESLTESKF-------------SVASDVWSFGVVLYELFT 212
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-20
Identities = 34/172 (19%), Positives = 66/172 (38%), Gaps = 49/172 (28%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+ + ++ +++ C + + L+ + M G L +++ +++ N+ L+ V
Sbjct: 74 VDNPHVCRLLGICLT------STVQLITQLMPFGCLLDYVREHKD---NIGSQYLLNWCV 124
Query: 239 DVASALDYL--HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL------------ 284
+A ++YL VH DL NVL+ + DFGLAK L
Sbjct: 125 QIAKGMNYLEDRRL-----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 285 --------PEATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRP 327
E+ + + DV+S+G+ + E T G +P
Sbjct: 180 KVPIKWMALESI-LHRIY-----------THQSDVWSYGVTVWELMTFGSKP 219
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 2e-20
Identities = 40/171 (23%), Positives = 68/171 (39%), Gaps = 47/171 (27%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+ H LV++ C ++ E+M NG L +L R Q L +
Sbjct: 76 LSHEKLVQLYGVCTK-----QRPIFIITEYMANGCLLNYLREMR---HRFQTQQLLEMCK 127
Query: 239 DVASALDYL--HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL------------ 284
DV A++YL + +H DL N L++ + V DFGL++++
Sbjct: 128 DVCEAMEYLESKQF-----LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK 182
Query: 285 -------PEATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRP 327
PE + F S+ D+++FG+L+ E ++ GK P
Sbjct: 183 FPVRWSPPEVL-MYSKF-----------SSKSDIWAFGVLMWEIYSLGKMP 221
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 2e-20
Identities = 43/172 (25%), Positives = 70/172 (40%), Gaps = 50/172 (29%)
Query: 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVD 239
+ +V++I C + ++ LV E G L ++L RE + N+ + +
Sbjct: 68 DNPYIVRLIGVCQA------EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAE---LLHQ 118
Query: 240 VASALDYL--HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL------------- 284
V+ + YL ++ VH DL NVLL A + DFGL+K L
Sbjct: 119 VSMGMKYLEEKNF-----VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 173
Query: 285 --------PEATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRP 327
PE NF F S+ DV+S+G+ + E + G++P
Sbjct: 174 KWPLKWYAPECI-NFRKF-----------SSRSDVWSYGVTMWEALSYGQKP 213
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 2e-20
Identities = 42/172 (24%), Positives = 63/172 (36%), Gaps = 50/172 (29%)
Query: 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVD 239
HRNL+++ + + +V E GSL + L ++ + L AV
Sbjct: 79 DHRNLIRLYGVVLTPPMK------MVTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQ 129
Query: 240 VASALDYL--HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL------------- 284
VA + YL + +H DL N+LL +GDFGL + L
Sbjct: 130 VAEGMGYLESKRF-----IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR 184
Query: 285 --------PEATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRP 327
PE+ F S + D + FG+ L E FT G+ P
Sbjct: 185 KVPFAWCAPESL-KTRTF-----------SHASDTWMFGVTLWEMFTYGQEP 224
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 2e-20
Identities = 43/171 (25%), Positives = 75/171 (43%), Gaps = 47/171 (27%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
++H+ LV++ + ++ E+M NGSL ++L L + + L +A
Sbjct: 65 LQHQRLVRLYAVVT------QEPIYIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAA 116
Query: 239 DVASALDYL--HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL------------ 284
+A + ++ +Y +H DL+ +N+L+ L+ + DFGLA+ +
Sbjct: 117 QIAEGMAFIEERNY-----IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK 171
Query: 285 -------PEATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRP 327
PEA N+ F + DV+SFGILL E T G+ P
Sbjct: 172 FPIKWTAPEAI-NYGTF-----------TIKSDVWSFGILLTEIVTHGRIP 210
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 2e-20
Identities = 45/172 (26%), Positives = 72/172 (41%), Gaps = 51/172 (29%)
Query: 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVD 239
+ +V++I C + +S LV E G L ++L NR + + +
Sbjct: 76 DNPYIVRMIGICEA------ESWMLVMEMAELGPLNKYLQQNRH----VKDKNIIELVHQ 125
Query: 240 VASALDYL--HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL------------- 284
V+ + YL ++ VH DL NVLL + A + DFGL+K L
Sbjct: 126 VSMGMKYLEESNF-----VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 180
Query: 285 --------PEATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRP 327
PE N++ F S+ DV+SFG+L+ E F+ G++P
Sbjct: 181 KWPVKWYAPECI-NYYKF-----------SSKSDVWSFGVLMWEAFSYGQKP 220
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-20
Identities = 45/171 (26%), Positives = 71/171 (41%), Gaps = 47/171 (27%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+ H LVK C+ +V E++ NG L +L + K L Q L +
Sbjct: 60 LSHPKLVKFYGVCSK-----EYPIYIVTEYISNGCLLNYLRSHG---KGLEPSQLLEMCY 111
Query: 239 DVASALDYL--HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL------------ 284
DV + +L H + +H DL N L+D +L V DFG+ +++
Sbjct: 112 DVCEGMAFLESHQF-----IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTK 166
Query: 285 -------PEATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRP 327
PE ++F + S+ DV++FGIL+ E F+ GK P
Sbjct: 167 FPVKWSAPEVF-HYFKY-----------SSKSDVWAFGILMWEVFSLGKMP 205
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 3e-20
Identities = 45/169 (26%), Positives = 73/169 (43%), Gaps = 48/169 (28%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
++H N+VK C S G + L+ E++ GSL ++L ++E + ++ LL
Sbjct: 99 LQHDNIVKYKGVCYS---AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL---QYTS 152
Query: 239 DVASALDYL--HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL------------ 284
+ ++YL Y +H DL N+L++ E +GDFGL K L
Sbjct: 153 QICKGMEYLGTKRY-----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEP 207
Query: 285 ---------PEATN-NFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT 323
PE+ + F S + DV+SFG++L E FT
Sbjct: 208 GESPIFWYAPESLTESKF-------------SVASDVWSFGVVLYELFT 243
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 4e-20
Identities = 45/174 (25%), Positives = 68/174 (39%), Gaps = 53/174 (30%)
Query: 180 RHRNLVKIITSCASVDFQGNDSEAL--VYEFMVNGSLEEWLHPNREALKNLNLLQRLSIA 237
H N++++ V E+M NGSL+ +L + + L+ +
Sbjct: 108 DHPNIIRLEGVVT-------RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVG---ML 157
Query: 238 VDVASALDYL--HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL----------- 284
V + + YL Y VH DL NVL+D L V DFGL++ L
Sbjct: 158 RGVGAGMRYLSDLGY-----VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT 212
Query: 285 ----------PEATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRP 327
PEA F F S++ DV+SFG+++ E G+RP
Sbjct: 213 GGKIPIRWTAPEAI-AFRTF-----------SSASDVWSFGVVMWEVLAYGERP 254
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 4e-20
Identities = 43/171 (25%), Positives = 73/171 (42%), Gaps = 47/171 (27%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
++H LVK+ + ++ EFM GSL ++L + L + + +
Sbjct: 240 LQHDKLVKLHAVVT------KEPIYIITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSA 291
Query: 239 DVASALDYL--HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL------------ 284
+A + ++ +Y +H DL+ +N+L+ L + DFGLA+ +
Sbjct: 292 QIAEGMAFIEQRNY-----IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAK 346
Query: 285 -------PEATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRP 327
PEA NF +F + DV+SFGILL+E T G+ P
Sbjct: 347 FPIKWTAPEAI-NFGSF-----------TIKSDVWSFGILLMEIVTYGRIP 385
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 4e-20
Identities = 43/172 (25%), Positives = 72/172 (41%), Gaps = 48/172 (27%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
I+H NLV+++ C ++ EFM G+L ++L + ++ + L +A
Sbjct: 66 IKHPNLVQLLGVCTR-----EPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMAT 118
Query: 239 DVASALDYL--HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL------------ 284
++SA++YL ++ +H DL N L+ V DFGL++ +
Sbjct: 119 QISSAMEYLEKKNF-----IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 173
Query: 285 -------PEATN-NFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRP 327
PE+ N F S DV++FG+LL E T G P
Sbjct: 174 FPIKWTAPESLAYNKF-------------SIKSDVWAFGVLLWEIATYGMSP 212
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 91.5 bits (227), Expect = 5e-20
Identities = 38/188 (20%), Positives = 67/188 (35%), Gaps = 28/188 (14%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNG-SLEEWLH---PNREALKNLNLLQRL 234
+ H ++V+I D G+ +V E+ V G SL+ P EA+
Sbjct: 136 VVHPSIVQIFNFVEHTDRHGDPVGYIVMEY-VGGQSLKRSKGQKLPVAEAI--------- 185
Query: 235 SIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFF-- 292
+ +++ AL YLH +V+ DLKP N++L E + D G + + +
Sbjct: 186 AYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI-NSFGYLYGT 240
Query: 293 -NFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEALPERLA 351
FQ E + D+Y+ G L G ++ +
Sbjct: 241 PGFQAPEIVRTGPTVAT-DIYTVGRTLAALTLDLPT----RNGRYVDG-LPEDDPVLKTY 294
Query: 352 EIVDPVLL 359
+ +L
Sbjct: 295 DSYGRLLR 302
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 6e-20
Identities = 39/170 (22%), Positives = 70/170 (41%), Gaps = 48/170 (28%)
Query: 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVD 239
H ++VK+I + ++ E G L +L N+ +LK L L+ ++
Sbjct: 71 DHPHIVKLIGIIEE------EPTWIIMELYPYGELGHYLERNKNSLKVLTLVL---YSLQ 121
Query: 240 VASALDYL--HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL------------- 284
+ A+ YL + VH D+ N+L+ +GDFGL++++
Sbjct: 122 ICKAMAYLESINC-----VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL 176
Query: 285 ------PEATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRP 327
PE+ NF F +T+ DV+ F + + E + GK+P
Sbjct: 177 PIKWMSPESI-NFRRF-----------TTASDVWMFAVCMWEILSFGKQP 214
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 8e-20
Identities = 44/190 (23%), Positives = 73/190 (38%), Gaps = 8/190 (4%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS 63
L + G+ L L L L N + L+ L L E L
Sbjct: 59 LSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENF 118
Query: 64 SLGKCQNLILLDLSNNNLT-GTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGA 122
+G + L L++++N + P L++L +LDLS N++ ++ +L +
Sbjct: 119 PIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLE-HLDLSSNKIQSIYCTDLRVLHQMPL 177
Query: 123 ----IDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPS-SLSSLRGIENLDLSRNN 177
+D+S N ++ I IRL +L + NF N+ + L G+E L
Sbjct: 178 LNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGE 236
Query: 178 FIRHRNLVKI 187
F NL K
Sbjct: 237 FRNEGNLEKF 246
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 1e-18
Identities = 43/173 (24%), Positives = 69/173 (39%), Gaps = 4/173 (2%)
Query: 8 QFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSS-LG 66
F G S L+ L L N + S+ L L L+F + L+ S
Sbjct: 360 SFKGCCSQSDFGTTSLKYLDLSFNGV-ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 418
Query: 67 KCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSN-FGILKNLGAIDI 125
+NLI LD+S+ + GLSSL L ++ N + F L+NL +D+
Sbjct: 419 SLRNLIYLDISHTHTRVAFNGIFNGLSSLE-VLKMAGNSFQENFLPDIFTELRNLTFLDL 477
Query: 126 SENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178
S+ +L P++ S L+ L M N + L ++ + L N +
Sbjct: 478 SQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 8e-18
Identities = 41/180 (22%), Positives = 70/180 (38%), Gaps = 8/180 (4%)
Query: 3 TLVGNQFTGRIPGSIGDLHKLQRLTLEMNK--FWGEIPSSIGNLTLLITLNFAENMLEGS 60
T N+ DL L+ L L N F G S T L L+ + N + +
Sbjct: 331 TFTSNKGGNAFSEV--DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-T 387
Query: 61 IPSSLGKCQNLILLDLSNNNLTGTTPTEV-IGLSSLSIYLDLSQNQLNGPLPSNFGILKN 119
+ S+ + L LD ++NL + V + L +L IYLD+S F L +
Sbjct: 388 MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNL-IYLDISHTHTRVAFNGIFNGLSS 446
Query: 120 LGAIDISENKLSGQIPSSI-GSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178
L + ++ N I L L ++ P++ +SL ++ L+++ N
Sbjct: 447 LEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQL 506
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 35/161 (21%), Positives = 59/161 (36%), Gaps = 6/161 (3%)
Query: 23 LQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLT 82
+ L L N S + L L+ + ++ + +L L L+ N +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 83 GTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKL-SGQIPSSIGSC 141
GLSSL L + L G LK L ++++ N + S ++P +
Sbjct: 90 SLALGAFSGLSSLQ-KLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNL 148
Query: 142 IRLEQLVMNGNFFRGNIPSSLSSLRGIEN----LDLSRNNF 178
LE L ++ N + + L L + LDLS N
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM 189
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 31/130 (23%), Positives = 45/130 (34%), Gaps = 3/130 (2%)
Query: 4 LVGNQFTGRIPGSI-GDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIP 62
+ S+ L L L + L+ L L A N + +
Sbjct: 403 FQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL 462
Query: 63 S-SLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLG 121
+ +NL LDLS L +PT LSSL L+++ NQL F L +L
Sbjct: 463 PDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSL-QVLNMASNQLKSVPDGIFDRLTSLQ 521
Query: 122 AIDISENKLS 131
I + N
Sbjct: 522 KIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 39/208 (18%), Positives = 63/208 (30%), Gaps = 20/208 (9%)
Query: 4 LVGNQFTGRIP-GSIGDLHKLQRLTLEMNKFWGEI------PSSIGNLTLLITLNFAENM 56
L N + + I L L+ L + +F E S++ L L F
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266
Query: 57 LEGS---IPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSN 113
L+ I N+ L + + +L+L +
Sbjct: 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQ-HLELVNCKFGQFPTLK 323
Query: 114 FGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFR--GNIPSSLSSLRGIENL 171
LK L + NK S + LE L ++ N G S ++ L
Sbjct: 324 LKSLKRL---TFTSNKGGN-AFSEVD-LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYL 378
Query: 172 DLSRNNFIRHRNLVKIITSCASVDFQGN 199
DLS N I + + +DFQ +
Sbjct: 379 DLSFNGVITMSSNFLGLEQLEHLDFQHS 406
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 22/104 (21%), Positives = 35/104 (33%), Gaps = 4/104 (3%)
Query: 75 DLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQI 134
N P L + LDLS N L +F L +D+S ++
Sbjct: 13 QCMELNFY-KIPD---NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIE 68
Query: 135 PSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178
+ S L L++ GN + + S L ++ L N
Sbjct: 69 DGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNL 112
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 19/82 (23%), Positives = 31/82 (37%), Gaps = 1/82 (1%)
Query: 4 LVGNQFTGRI-PGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIP 62
+ GN F P +L L L L + P++ +L+ L LN A N L+
Sbjct: 452 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPD 511
Query: 63 SSLGKCQNLILLDLSNNNLTGT 84
+ +L + L N +
Sbjct: 512 GIFDRLTSLQKIWLHTNPWDCS 533
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 8e-20
Identities = 49/171 (28%), Positives = 74/171 (43%), Gaps = 47/171 (27%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+RH LV++ + + +V E+M GSL ++L K L L Q + +A
Sbjct: 236 LRHEKLVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAA 287
Query: 239 DVASALDYL--HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL------------ 284
+AS + Y+ +Y VH DL+ +N+L+ L V DFGLA+ +
Sbjct: 288 QIASGMAYVERMNY-----VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK 342
Query: 285 -------PEATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRP 327
PEA + F + DV+SFGILL E T G+ P
Sbjct: 343 FPIKWTAPEAA-LYGRF-----------TIKSDVWSFGILLTELTTKGRVP 381
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-19
Identities = 38/170 (22%), Positives = 68/170 (40%), Gaps = 48/170 (28%)
Query: 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVD 239
H ++VK+I + ++ E G L +L + +L +L+ A
Sbjct: 74 DHPHIVKLIGVITE------NPVWIIMELCTLGELRSFLQVRKYSLDLASLIL---YAYQ 124
Query: 240 VASALDYL--HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL------------- 284
+++AL YL + VH D+ NVL+ +GDFGL++++
Sbjct: 125 LSTALAYLESKRF-----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL 179
Query: 285 ------PEATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRP 327
PE+ NF F +++ DV+ FG+ + E G +P
Sbjct: 180 PIKWMAPESI-NFRRF-----------TSASDVWMFGVCMWEILMHGVKP 217
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-19
Identities = 32/175 (18%), Positives = 56/175 (32%), Gaps = 12/175 (6%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS 63
L N + ++ L N + S + A N +
Sbjct: 87 LNNNYVQ-----ELLVGPSIETLHAANNNI-SRVSCSR--GQGKKNIYLANNKITMLRDL 138
Query: 64 SLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAI 123
G + LDL N + E+ S +L+L N + + L +
Sbjct: 139 DEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQVV-FAKLKTL 196
Query: 124 DISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178
D+S NKL+ + S + + + N I +L + +E+ DL N F
Sbjct: 197 DLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGF 249
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 1e-17
Identities = 29/165 (17%), Positives = 61/165 (36%), Gaps = 11/165 (6%)
Query: 13 IPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLI 72
I + ++ + + + + S + + L+ + N L + L L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 73 LLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSG 132
LL+LS+N L ++ LS+L LDL+ N + + ++ + + N +S
Sbjct: 62 LLNLSSNVL--YETLDLESLSTL-RTLDLNNNYV-----QELLVGPSIETLHAANNNIS- 112
Query: 133 QIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNN 177
++ S G + + + N ++ LDL N
Sbjct: 113 RVSCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNE 155
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-17
Identities = 31/192 (16%), Positives = 66/192 (34%), Gaps = 24/192 (12%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIP- 62
+ + + ++ L L N + + T L LN + N+L ++
Sbjct: 17 VTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLDL 76
Query: 63 ----------------SSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQL 106
L ++ L +NNN++ + + G + + L+ N++
Sbjct: 77 ESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQGKKN----IYLANNKI 132
Query: 107 NGPLPSNFGILKNLGAIDISENKLSG-QIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSL 165
+ G + +D+ N++ S LE L + NF ++ +
Sbjct: 133 TMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VF 190
Query: 166 RGIENLDLSRNN 177
++ LDLS N
Sbjct: 191 AKLKTLDLSSNK 202
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 3e-10
Identities = 23/119 (19%), Positives = 43/119 (36%), Gaps = 8/119 (6%)
Query: 60 SIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKN 119
+I + +++++L + ++ LDLS N L+ ++
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVK-ELDLSGNPLSQISAADLAPFTK 59
Query: 120 LGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178
L +++S N L + S L L +N N+ L IE L + NN
Sbjct: 60 LELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNI 111
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 6e-08
Identities = 22/140 (15%), Positives = 40/140 (28%), Gaps = 7/140 (5%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS 63
L N + G + KL+ L L NK + + + ++ N L I
Sbjct: 176 LQYNFIY-DVKGQVV-FAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLV-LIEK 231
Query: 64 SLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAI 123
+L QNL DL N T + + + + L + +
Sbjct: 232 ALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKK---LTGQNEEECTVPTL 288
Query: 124 DISENKLSGQIPSSIGSCIR 143
+P+ +
Sbjct: 289 GHYGAYCCEDLPAPFADRLI 308
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-19
Identities = 40/164 (24%), Positives = 70/164 (42%), Gaps = 29/164 (17%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+ H N++ +I ++ +M +G L +++ + +N + +S +
Sbjct: 79 LNHPNVLALIGIM----LPPEGLPHVLLPYMCHGDLLQFIRSPQ---RNPTVKDLISFGL 131
Query: 239 DVASALDYL--HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQI 296
VA ++YL + VH DL N +LD T V DFGLA+ + + +++ Q
Sbjct: 132 QVARGMEYLAEQKF-----VHRDLAARNCMLDESFTVKVADFGLARDILD--REYYSVQQ 184
Query: 297 AEYG------MGSEV------STSGDVYSFGILLLETFT-GKRP 327
+ E +T DV+SFG+LL E T G P
Sbjct: 185 HRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 1e-19
Identities = 42/174 (24%), Positives = 77/174 (44%), Gaps = 53/174 (30%)
Query: 180 RHRNLVKIITSCASVDFQGNDSEAL--VYEFMVNGSLEEWLHPNREALKNLNLLQRLSIA 237
H N++++ + + + + E+M NG+L+++L ++LQ + +
Sbjct: 104 SHHNIIRLEGVIS-------KYKPMMIITEYMENGALDKFLREKD---GEFSVLQLVGML 153
Query: 238 VDVASALDYL--HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL----------- 284
+A+ + YL +Y VH DL N+L++ L V DFGL++ L
Sbjct: 154 RGIAAGMKYLANMNY-----VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS 208
Query: 285 ----------PEATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRP 327
PEA ++ F +++ DV+SFGI++ E T G+RP
Sbjct: 209 GGKIPIRWTAPEAI-SYRKF-----------TSASDVWSFGIVMWEVMTYGERP 250
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 1e-19
Identities = 49/171 (28%), Positives = 74/171 (43%), Gaps = 47/171 (27%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+RH LV++ + + +V E+M GSL ++L K L L Q + +A
Sbjct: 319 LRHEKLVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAA 370
Query: 239 DVASALDYL--HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL------------ 284
+AS + Y+ +Y VH DL+ +N+L+ L V DFGLA+ +
Sbjct: 371 QIASGMAYVERMNY-----VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK 425
Query: 285 -------PEATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRP 327
PEA + F + DV+SFGILL E T G+ P
Sbjct: 426 FPIKWTAPEAA-LYGRF-----------TIKSDVWSFGILLTELTTKGRVP 464
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 90.0 bits (223), Expect = 1e-19
Identities = 42/172 (24%), Positives = 70/172 (40%), Gaps = 50/172 (29%)
Query: 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVD 239
+ +V++I C + ++ LV E G L ++L RE + N+ + +
Sbjct: 394 DNPYIVRLIGVCQA------EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAE---LLHQ 444
Query: 240 VASALDYL--HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL------------- 284
V+ + YL ++ VH +L NVLL A + DFGL+K L
Sbjct: 445 VSMGMKYLEEKNF-----VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 499
Query: 285 --------PEATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRP 327
PE NF F S+ DV+S+G+ + E + G++P
Sbjct: 500 KWPLKWYAPECI-NFRKF-----------SSRSDVWSYGVTMWEALSYGQKP 539
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 2e-19
Identities = 41/169 (24%), Positives = 71/169 (42%), Gaps = 42/169 (24%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
I+H NLV+++ C ++ EFM G+L ++L + ++ + L +A
Sbjct: 273 IKHPNLVQLLGVCTR-----EPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMAT 325
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL-------------- 284
++SA++YL + +H +L N L+ V DFGL++ +
Sbjct: 326 QISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 382
Query: 285 -----PEATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRP 327
PE+ + F S DV++FG+LL E T G P
Sbjct: 383 IKWTAPESL-AYNKF-----------SIKSDVWAFGVLLWEIATYGMSP 419
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 2e-19
Identities = 41/164 (25%), Positives = 66/164 (40%), Gaps = 29/164 (17%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
H N++ ++ C + S +V +M +G L ++ N + + +
Sbjct: 147 FSHPNVLSLLGIC----LRSEGSPLVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGL 199
Query: 239 DVASALDYL--HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQI 296
VA + +L + VH DL N +LD + T V DFGLA+ + + F +
Sbjct: 200 QVAKGMKFLASKKF-----VHRDLAARNCMLDEKFTVKVADFGLARDMYD--KEFDSVHN 252
Query: 297 AEYG------MGSE------VSTSGDVYSFGILLLETFT-GKRP 327
M E +T DV+SFG+LL E T G P
Sbjct: 253 KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-19
Identities = 41/164 (25%), Positives = 67/164 (40%), Gaps = 29/164 (17%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
H N++ ++ C + S +V +M +G L ++ N + + +
Sbjct: 83 FSHPNVLSLLGIC----LRSEGSPLVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGL 135
Query: 239 DVASALDYL--HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQI 296
VA + YL + VH DL N +LD + T V DFGLA+ + + +++
Sbjct: 136 QVAKGMKYLASKKF-----VHRDLAARNCMLDEKFTVKVADFGLARDMYD--KEYYSVHN 188
Query: 297 AEYG------MGSE------VSTSGDVYSFGILLLETFT-GKRP 327
M E +T DV+SFG+LL E T G P
Sbjct: 189 KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 3e-19
Identities = 40/172 (23%), Positives = 65/172 (37%), Gaps = 49/172 (28%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+ H ++V+++ C S LV +++ GSL + + +R L L+ V
Sbjct: 72 LDHAHIVRLLGLCPG------SSLQLVTQYLPLGSLLDHVRQHRG---ALGPQLLLNWGV 122
Query: 239 DVASALDYL--HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL------------ 284
+A + YL H VH +L NVLL V DFG+A L
Sbjct: 123 QIAKGMYYLEEHGM-----VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEA 177
Query: 285 --------PEATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRP 327
E+ +F + + DV+S+G+ + E T G P
Sbjct: 178 KTPIKWMALESI-HFGKY-----------THQSDVWSYGVTVWELMTFGAEP 217
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 5e-19
Identities = 39/176 (22%), Positives = 71/176 (40%), Gaps = 45/176 (25%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEAL-VYEFMVNGSLEEWLHPNR--EALKNLNLLQRLS 235
H ++ K++ +G + + FM +G L +L +R E NL L +
Sbjct: 82 FDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVR 141
Query: 236 IAVDVASALDYL--HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL--------- 284
VD+A ++YL ++ +H DL N +L ++T V DFGL++ +
Sbjct: 142 FMVDIACGMEYLSSRNF-----IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQG 196
Query: 285 -----------PEA-TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRP 327
E+ +N + + DV++FG+ + E T G+ P
Sbjct: 197 CASKLPVKWLALESLADNLY-------------TVHSDVWAFGVTMWEIMTRGQTP 239
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 8e-19
Identities = 44/164 (26%), Positives = 74/164 (45%), Gaps = 29/164 (17%)
Query: 181 HRNLVKIITSCASVDFQGNDSEA--LVYEFMVNG-SLEEWLHPNREALKNLNLLQRLSIA 237
H+N+V +I D + + LV E+ + G +L E++ + L++ ++
Sbjct: 70 HQNIVSMI------D-VDEEDDCYYLVMEY-IEGPTLSEYIESHGP----LSVDTAINFT 117
Query: 238 VDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQI- 296
+ + + H + IVH D+KP N+L+D T + DFG+AK L E + N +
Sbjct: 118 NQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLG 174
Query: 297 -AEY-----GMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTG 334
+Y G D+YS GI+L E G+ P F G
Sbjct: 175 TVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP----FNG 214
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-18
Identities = 34/172 (19%), Positives = 66/172 (38%), Gaps = 49/172 (28%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+ + ++ +++ C + + L+ + M G L +++ +++ N+ L+ V
Sbjct: 74 VDNPHVCRLLGICLT------STVQLITQLMPFGCLLDYVREHKD---NIGSQYLLNWCV 124
Query: 239 DVASALDYL--HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL------------ 284
+A ++YL VH DL NVL+ + DFGLAK L
Sbjct: 125 QIAKGMNYLEDRRL-----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGG 179
Query: 285 --------PEATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRP 327
E+ + + DV+S+G+ + E T G +P
Sbjct: 180 KVPIKWMALESI-LHRIY-----------THQSDVWSYGVTVWELMTFGSKP 219
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 44/174 (25%), Positives = 73/174 (41%), Gaps = 53/174 (30%)
Query: 180 RHRNLVKIITSCASVDFQGNDSEAL--VYEFMVNGSLEEWLHPNREALKNLNLLQRLSIA 237
H N++++ S+ + V E+M NGSL+ +L + ++Q + +
Sbjct: 104 DHPNIIRLEGVVT-------KSKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGML 153
Query: 238 VDVASALDYL--HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL----------- 284
+AS + YL Y VH DL N+L++ L V DFGL + L
Sbjct: 154 RGIASGMKYLSDMGY-----VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR 208
Query: 285 ----------PEATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRP 327
PEA + F +++ DV+S+GI+L E + G+RP
Sbjct: 209 GGKIPIRWTSPEAI-AYRKF-----------TSASDVWSYGIVLWEVMSYGERP 250
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-18
Identities = 47/179 (26%), Positives = 66/179 (36%), Gaps = 51/179 (28%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+ H +++K C G S LV E++ GSL ++L + L L L A
Sbjct: 90 LYHEHIIKYKGCCED---AGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQ 141
Query: 239 DVASALDYLH--HYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL------------ 284
+ + YLH HY +H DL NVLLD + +GDFGLAK +
Sbjct: 142 QICEGMAYLHAQHY-----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRED 196
Query: 285 ---------PEATN-NFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNEMF 332
PE F + DV+SFG+ L E T +
Sbjct: 197 GDSPVFWYAPECLKEYKF-------------YYASDVWSFGVTLYELLTHCDSSQSPPT 242
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 86.3 bits (213), Expect = 1e-18
Identities = 34/205 (16%), Positives = 70/205 (34%), Gaps = 26/205 (12%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMV--NGSLEEWLHPNREALKNLNLLQRLSI 236
++ K+I S +Y M + E L + K+L RL +
Sbjct: 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQL 216
Query: 237 AVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQI 296
+ V L LHHY +VH L+P +++LD + F + +
Sbjct: 217 TLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGF 273
Query: 297 A--EY----------GMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVK- 343
A E + ++ + D ++ G+ + + P T + L
Sbjct: 274 APPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP----NTDDAALGGSEWI 329
Query: 344 ----EALPERLAEIVDPVLLVEREE 364
+ +P+ + +++ L +E+
Sbjct: 330 FRSCKNIPQPVRALLEGFLRYPKED 354
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 5e-18
Identities = 38/171 (22%), Positives = 68/171 (39%), Gaps = 48/171 (28%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
H ++VK+I + ++ E G L +L + +L +L+ A
Sbjct: 448 FDHPHIVKLIGVITE------NPVWIIMELCTLGELRSFLQVRKFSLDLASLIL---YAY 498
Query: 239 DVASALDYL--HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL------------ 284
+++AL YL + VH D+ NVL+ +GDFGL++++
Sbjct: 499 QLSTALAYLESKRF-----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 553
Query: 285 -------PEATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRP 327
PE+ NF F +++ DV+ FG+ + E G +P
Sbjct: 554 LPIKWMAPESI-NFRRF-----------TSASDVWMFGVCMWEILMHGVKP 592
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 5e-18
Identities = 28/115 (24%), Positives = 47/115 (40%), Gaps = 14/115 (12%)
Query: 228 LNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA 287
L + ++I + SALD H H D+KP N+L+ + A++ DFG+A +
Sbjct: 131 LAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDE 187
Query: 288 TNNFFNFQIA-------EYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGN 335
+ E S + D+Y+ +L E TG P + G+
Sbjct: 188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP----YQGD 238
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 2e-17
Identities = 38/192 (19%), Positives = 71/192 (36%), Gaps = 63/192 (32%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNR------------EALK 226
++H N+V ++ + ++++ + +G L E+L
Sbjct: 69 LQHPNVVCLLGVVTK-----DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 123
Query: 227 NLNLLQRLSIAVDVASALDYL--HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL 284
L + + +A+ ++YL HH VH DL NVL+ +L + D GL + +
Sbjct: 124 ALEPPDFVHLVAQIAAGMEYLSSHHV-----VHKDLATRNVLVYDKLNVKISDLGLFREV 178
Query: 285 --------------------PEATN-NFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT 323
PEA F S D++S+G++L E F+
Sbjct: 179 YAADYYKLLGNSLLPIRWMAPEAIMYGKF-------------SIDSDIWSYGVVLWEVFS 225
Query: 324 -GKRP----TNE 330
G +P +N+
Sbjct: 226 YGLQPYCGYSNQ 237
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 2e-17
Identities = 50/185 (27%), Positives = 77/185 (41%), Gaps = 59/185 (31%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNR------------EALK 226
++H ++VK C D +V+E+M +G L ++L + +A
Sbjct: 74 LQHEHIVKFYGVCGD-----GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKG 128
Query: 227 NLNLLQRLSIAVDVASALDYL--HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL 284
L L Q L IA +AS + YL H+ VH DL N L+ L +GDFG+++ +
Sbjct: 129 ELGLSQMLHIASQIASGMVYLASQHF-----VHRDLATRNCLVGANLLVKIGDFGMSRDV 183
Query: 285 --------------------PEATN-NFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT 323
PE+ F +T DV+SFG++L E FT
Sbjct: 184 YSTDYYRVGGHTMLPIRWMPPESIMYRKF-------------TTESDVWSFGVILWEIFT 230
Query: 324 -GKRP 327
GK+P
Sbjct: 231 YGKQP 235
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 16/182 (8%), Positives = 41/182 (22%), Gaps = 23/182 (12%)
Query: 157 NIPSSLSSLRGIENLDLSRNNFIRHRNLVKIITSCASVDFQGNDSEALVYEFMV--NGSL 214
+ + R + D + ++ D + L+ L
Sbjct: 123 SPEEARDRRRLLLPSDA-----VAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELL 177
Query: 215 EEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAH 274
L + +L + + L +VH P N+ + +
Sbjct: 178 FSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLM 234
Query: 275 VGDFGLAKFLPEATNNFFN---------FQIAEYGMGSEVSTSGDVYSFGILLLETFTGK 325
+GD + + + + + G+ + +
Sbjct: 235 LGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHAL----NAWQLGLSIYRVWCLF 290
Query: 326 RP 327
P
Sbjct: 291 LP 292
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-17
Identities = 36/179 (20%), Positives = 69/179 (38%), Gaps = 53/179 (29%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNR------EALKNLNLLQ 232
++V+++ + ++ E M G L+ +L R L +L +
Sbjct: 85 FNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 139
Query: 233 RLSIAVDVASALDYL--HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL------ 284
+ +A ++A + YL + + VH DL N ++ + T +GDFG+ + +
Sbjct: 140 MIQMAGEIADGMAYLNANKF-----VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 194
Query: 285 --------------PEATN-NFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRP 327
PE+ F +T DV+SFG++L E T ++P
Sbjct: 195 RKGGKGLLPVRWMSPESLKDGVF-------------TTYSDVWSFGVVLWEIATLAEQP 240
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 3e-17
Identities = 42/180 (23%), Positives = 71/180 (39%), Gaps = 55/180 (30%)
Query: 181 HRNLVKIITSCASVDFQGNDSEA------LVYEFMVNG-SLEEWLH-----PNREALKNL 228
H +V + D G +V E+ V+G +L + +H + A+
Sbjct: 71 HPAIVAVY------D-TGEAETPAGPLPYIVMEY-VDGVTLRDIVHTEGPMTPKRAI--- 119
Query: 229 NLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEAT 288
+ D AL++ H + I+H D+KP+N+++ V DFG+A+ + ++
Sbjct: 120 ------EVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 170
Query: 289 NNFFNFQIAEYGM--------------GSEVSTSGDVYSFGILLLETFTGKRPTNEMFTG 334
N + + G V DVYS G +L E TG+ P FTG
Sbjct: 171 N-----SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTG 221
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 46/175 (26%), Positives = 73/175 (41%), Gaps = 15/175 (8%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS 63
+ N+ + + L L+ L N+ P +G LT L L+ N L+
Sbjct: 184 ISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IG 237
Query: 64 SLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAI 123
+L NL LDL+NN ++ P + GL+ L L L NQ++ S L L +
Sbjct: 238 TLASLTNLTDLDLANNQISNLAP--LSGLTKL-TELKLGANQISN--ISPLAGLTALTNL 292
Query: 124 DISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178
+++EN+L S I + L L + N P +SSL ++ L N
Sbjct: 293 ELNENQLED--ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKV 343
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 31/161 (19%), Positives = 62/161 (38%), Gaps = 13/161 (8%)
Query: 16 SIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLD 75
+ L + + L + +L + TL + + NL ++
Sbjct: 19 TDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQIN 74
Query: 76 LSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIP 135
SNN LT TP + L+ L + + ++ NQ+ + L NL + + N+++ P
Sbjct: 75 FSNNQLTDITP--LKNLTKL-VDILMNNNQIAD--ITPLANLTNLTGLTLFNNQITDIDP 129
Query: 136 SSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRN 176
+ + L +L ++ N S+LS L ++ L
Sbjct: 130 --LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFGNQ 166
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 5e-11
Identities = 33/159 (20%), Positives = 54/159 (33%), Gaps = 10/159 (6%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS 63
L N + P + L KLQRL NK SS+ NLT + L+ N + P
Sbjct: 316 LYFNNISDISP--VSSLTKLQRLFFYNNKV--SDVSSLANLTNINWLSAGHNQISDLTP- 370
Query: 64 SLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAI 123
L + L L++ T +S + +++ + S+ G
Sbjct: 371 -LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAPATISDGGSYTEP--- 426
Query: 124 DISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSL 162
DI+ N S + + + F G + L
Sbjct: 427 DITWNLPS-YTNEVSYTFSQPVTIGKGTTTFSGTVTQPL 464
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 23/115 (20%), Positives = 42/115 (36%), Gaps = 9/115 (7%)
Query: 63 SSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGA 122
+ + L N+T T L ++ L + + L NL
Sbjct: 18 FTDTALAEKMKTVLGKTNVTDTVSQT--DLDQVT-TLQADRLGIKS--IDGVEYLNNLTQ 72
Query: 123 IDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNN 177
I+ S N+L+ P + + +L ++MN N + L++L + L L N
Sbjct: 73 INFSNNQLTDITP--LKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQ 123
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 3e-17
Identities = 45/179 (25%), Positives = 69/179 (38%), Gaps = 53/179 (29%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLH---PNREALKNLNLLQRLS 235
H+N+V+ I Q ++ E M G L+ +L P +L +L L
Sbjct: 90 FNHQNIVRCIGVS----LQS-LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 144
Query: 236 IAVDVASALDYL--HHYCETPIVHCDLKPSNVLLDGE---LTAHVGDFGLAKFL------ 284
+A D+A YL +H+ +H D+ N LL A +GDFG+A+ +
Sbjct: 145 VARDIACGCQYLEENHF-----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY 199
Query: 285 --------------PEA-TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRP 327
PEA F ++ D +SFG+LL E F+ G P
Sbjct: 200 RKGGCAMLPVKWMPPEAFMEGIF-------------TSKTDTWSFGVLLWEIFSLGYMP 245
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 4e-17
Identities = 41/184 (22%), Positives = 70/184 (38%), Gaps = 56/184 (30%)
Query: 177 NFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNR------------EA 224
H N++ ++ +C L E+ +G+L ++L +R
Sbjct: 81 KLGHHPNIINLLGACEH-----RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST 135
Query: 225 LKNLNLLQRLSIAVDVASALDYL--HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAK 282
L+ Q L A DVA +DYL + +H DL N+L+ A + DFGL++
Sbjct: 136 ASTLSSQQLLHFAADVARGMDYLSQKQF-----IHRDLAARNILVGENYVAKIADFGLSR 190
Query: 283 FL-----------------PEATN-NFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT- 323
E+ N + + +T+ DV+S+G+LL E +
Sbjct: 191 GQEVYVKKTMGRLPVRWMAIESLNYSVY-------------TTNSDVWSYGVLLWEIVSL 237
Query: 324 GKRP 327
G P
Sbjct: 238 GGTP 241
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 81.2 bits (200), Expect = 4e-17
Identities = 30/165 (18%), Positives = 54/165 (32%), Gaps = 20/165 (12%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMV--NGSLEEWLHPNREALKNLNLLQRLSI 236
++ K+I S +Y M + E L + K+L RL +
Sbjct: 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQL 211
Query: 237 AVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL------------ 284
+ V L LHHY +VH L+P +++LD + F
Sbjct: 212 TLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVSRGF 268
Query: 285 --PEATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRP 327
PE + ++ S D ++ G+++ + P
Sbjct: 269 EPPELEARRATISYHRDR-RTLMTFSFDAWALGLVIYWIWCADLP 312
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 5e-17
Identities = 31/192 (16%), Positives = 66/192 (34%), Gaps = 24/192 (12%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIP- 62
+ + + ++ L L N + + T L LN + N+L ++
Sbjct: 17 VTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLDL 76
Query: 63 ----------------SSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQL 106
L ++ L +NNN++ + + G + + L+ N++
Sbjct: 77 ESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQGKKN----IYLANNKI 132
Query: 107 NGPLPSNFGILKNLGAIDISENKLSG-QIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSL 165
+ G + +D+ N++ S LE L + NF ++ +
Sbjct: 133 TMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VF 190
Query: 166 RGIENLDLSRNN 177
++ LDLS N
Sbjct: 191 AKLKTLDLSSNK 202
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 3e-11
Identities = 28/178 (15%), Positives = 48/178 (26%), Gaps = 10/178 (5%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS 63
L N + G + KL+ L L NK + + + ++ N L I
Sbjct: 176 LQYNFIY-DVKGQVV-FAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLV-LIEK 231
Query: 64 SLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAI 123
+L QNL DL N T + S +++ + N
Sbjct: 232 ALRFSQNLEHFDLRGNGFHCGTLRD--FFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLG 289
Query: 124 DISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRG----IENLDLSRNN 177
I L++ +G+ L R +D +
Sbjct: 290 HYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQ 347
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 23/119 (19%), Positives = 43/119 (36%), Gaps = 8/119 (6%)
Query: 60 SIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKN 119
+I + +++++L + ++ LDLS N L+ ++
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVK-ELDLSGNPLSQISAADLAPFTK 59
Query: 120 LGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178
L +++S N L + S L L +N N+ L IE L + NN
Sbjct: 60 LELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNI 111
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 9e-17
Identities = 48/191 (25%), Positives = 78/191 (40%), Gaps = 62/191 (32%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNR-----------EALKN 227
++H+++V+ C +V+E+M +G L +L + A
Sbjct: 100 LQHQHIVRFFGVCTE-----GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGP 154
Query: 228 LNLLQRLSIAVDVASALDYL--HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL- 284
L L Q L++A VA+ + YL H+ VH DL N L+ L +GDFG+++ +
Sbjct: 155 LGLGQLLAVASQVAAGMVYLAGLHF-----VHRDLATRNCLVGQGLVVKIGDFGMSRDIY 209
Query: 285 -------------------PEA-TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT- 323
PE+ F +T DV+SFG++L E FT
Sbjct: 210 STDYYRVGGRTMLPIRWMPPESILYRKF-------------TTESDVWSFGVVLWEIFTY 256
Query: 324 GKRP----TNE 330
GK+P +N
Sbjct: 257 GKQPWYQLSNT 267
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 1e-16
Identities = 40/189 (21%), Positives = 66/189 (34%), Gaps = 61/189 (32%)
Query: 177 NFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREAL----------- 225
H N+V ++ +C ++ E+ G L +L R++
Sbjct: 82 YLGNHMNIVNLLGACTI-----GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 136
Query: 226 ---KNLNLLQRLSIAVDVASALDYL--HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGL 280
L+L LS + VA + +L + +H DL N+LL + DFGL
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFLASKNC-----IHRDLAARNILLTHGRITKICDFGL 191
Query: 281 AKFL--------------------PEA-TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLL 319
A+ + PE+ N + + DV+S+GI L
Sbjct: 192 ARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY-------------TFESDVWSYGIFLW 238
Query: 320 ETFT-GKRP 327
E F+ G P
Sbjct: 239 ELFSLGSSP 247
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 1e-16
Identities = 39/187 (20%), Positives = 66/187 (35%), Gaps = 58/187 (31%)
Query: 177 NFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREAL----------- 225
+ H N+V ++ +C + ++ EF G+L +L R
Sbjct: 86 HIGHHLNVVNLLGAC----TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 141
Query: 226 -KNLNLLQRLSIAVDVASALDYL--HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAK 282
L L + + VA +++L +H DL N+LL + + DFGLA+
Sbjct: 142 KDFLTLEHLICYSFQVAKGMEFLASRKC-----IHRDLAARNILLSEKNVVKICDFGLAR 196
Query: 283 FL--------------------PEA-TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLET 321
+ PE + + + DV+SFG+LL E
Sbjct: 197 DIYKDPDYVRKGDARLPLKWMAPETIFDRVY-------------TIQSDVWSFGVLLWEI 243
Query: 322 FT-GKRP 327
F+ G P
Sbjct: 244 FSLGASP 250
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 1e-16
Identities = 39/167 (23%), Positives = 62/167 (37%), Gaps = 7/167 (4%)
Query: 19 DLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSI-PSSLGKCQNLILLDLS 77
L+ +RL L N SS L L L +I + NL +LDL
Sbjct: 22 VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLG 81
Query: 78 NNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPL--PSNFGILKNLGAIDISENKLSG-QI 134
++ + P GL L L L L+ + F LK L +D+S+N++ +
Sbjct: 82 SSKIYFLHPDAFQGLFHLF-ELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYL 140
Query: 135 PSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRG--IENLDLSRNNFI 179
S G L+ + + N L L+G + L+ N+
Sbjct: 141 HPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLY 187
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 3e-15
Identities = 42/187 (22%), Positives = 65/187 (34%), Gaps = 13/187 (6%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEI-PSSIGNLTLLITLNFAENMLEGSIP 62
L N S L +LQ L L I + NL L L+ + + P
Sbjct: 31 LSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHP 90
Query: 63 SSLGKCQNLILLDLSNNNLTGTT--PTEVIGLSSLSIYLDLSQNQLNG-PLPSNFGILKN 119
+ +L L L L+ L +L+ LDLS+NQ+ L +FG L +
Sbjct: 91 DAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALT-RLDLSKNQIRSLYLHPSFGKLNS 149
Query: 120 LGAIDISENKLSGQIPSSIGS--CIRLEQLVMNGNFFRGNIPSSLSSLRG------IENL 171
L +ID S N++ + L + N + +E L
Sbjct: 150 LKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEIL 209
Query: 172 DLSRNNF 178
D+S N +
Sbjct: 210 DVSGNGW 216
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 6e-14
Identities = 31/147 (21%), Positives = 56/147 (38%), Gaps = 8/147 (5%)
Query: 36 EIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEVI-GLSS 94
++P + L + N + SS + L LL+L + T E L +
Sbjct: 18 QVPQVLNTTE---RLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPN 74
Query: 95 LSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQI--PSSIGSCIRLEQLVMNGN 152
L LDL +++ P F L +L + + LS + + L +L ++ N
Sbjct: 75 L-RILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKN 133
Query: 153 FFRG-NIPSSLSSLRGIENLDLSRNNF 178
R + S L ++++D S N
Sbjct: 134 QIRSLYLHPSFGKLNSLKSIDFSSNQI 160
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 41/224 (18%), Positives = 73/224 (32%), Gaps = 14/224 (6%)
Query: 19 DLHKLQRLTLEMNKFWGEIPS----SIGNLTLLITLNFAENMLEGSIPSSLGKCQNLIL- 73
D+ F I S+ ++ F + ++ ++ +
Sbjct: 210 DVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVR 269
Query: 74 -LDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSG 132
LDLS+ + L L L+L+ N++N F L NL +++S N L
Sbjct: 270 HLDLSHGFVFSLNSRVFETLKDLK-VLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGE 328
Query: 133 QIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNFIRHRNLVKIITSCA 192
S+ ++ + + N + L ++ LDL N + S
Sbjct: 329 LYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFI----PSIP 384
Query: 193 SVDFQGNDSEALVYEFMVNGSLEEWLHPNR-EALKNLNLLQRLS 235
+ GN L + + L NR E L L L R+
Sbjct: 385 DIFLSGNKLVTLPKINLTANLI--HLSENRLENLDILYFLLRVP 426
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 36/178 (20%), Positives = 61/178 (34%), Gaps = 11/178 (6%)
Query: 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSI 61
L L L+ L L NK + L L LN + N+L
Sbjct: 271 LDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELY 330
Query: 62 PSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLG 121
S+ + +DL N++ L L LDL N L + + ++
Sbjct: 331 SSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQ-TLDLRDNAL-----TTIHFIPSIP 384
Query: 122 AIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRG-NIPSSLSSLRGIENLDLSRNNF 178
I +S NKL + + + ++ N +I L + ++ L L++N F
Sbjct: 385 DIFLSGNKLV----TLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRF 438
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 6e-08
Identities = 20/108 (18%), Positives = 36/108 (33%), Gaps = 8/108 (7%)
Query: 73 LLDLSNNNLTGTTPTEV-IGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLS 131
+ NLT +V L++ L LS N + S+F L+ L +++
Sbjct: 8 IAFYRFCNLT-----QVPQVLNTT-ERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTP 61
Query: 132 GQI-PSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178
I + + L L + + P + L + L L
Sbjct: 62 LTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGL 109
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 43/198 (21%), Positives = 72/198 (36%), Gaps = 14/198 (7%)
Query: 4 LVGNQFTG-RIPGSIGDLHKLQRLTLEMNKFWGEIPSSI-----GNLTLLITLNFAENML 57
L N+F+ + + L++L L N + + L+ L L N L
Sbjct: 433 LNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYL 492
Query: 58 EGSIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGIL 117
P L L L++N LT + ++ ++L LD+S+NQL P P F
Sbjct: 493 NSLPPGVFSHLTALRGLSLNSNRLTVLSHNDL--PANLE-ILDISRNQLLAPNPDVF--- 546
Query: 118 KNLGAIDISENKLSGQIP-SSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRN 176
+L +DI+ NK + S+ + + + + G S G+ LS
Sbjct: 547 VSLSVLDITHNKFICECELSTFINWLNHTNVTIAGP-PADIYCVYPDSFSGVSLFSLSTE 605
Query: 177 NFIRHRNLVKIITSCASV 194
L + S V
Sbjct: 606 GCDEEEVLKSLKFSLFIV 623
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-16
Identities = 39/187 (20%), Positives = 69/187 (36%), Gaps = 59/187 (31%)
Query: 177 NFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWL------------HPNREA 224
+H+N++ ++ +C + ++ E+ G+L E+L NR
Sbjct: 96 MIGKHKNIINLLGACTQ-----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150
Query: 225 LKNLNLLQRLSIAVDVASALDYL--HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAK 282
+ + +S +A ++YL +H DL NVL+ + DFGLA+
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQKC-----IHRDLAARNVLVTENNVMKIADFGLAR 205
Query: 283 FL--------------------PEA-TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLET 321
+ PEA + + + DV+SFG+L+ E
Sbjct: 206 DINNIDYYKKTTNGRLPVKWMAPEALFDRVY-------------THQSDVWSFGVLMWEI 252
Query: 322 FT-GKRP 327
FT G P
Sbjct: 253 FTLGGSP 259
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 1e-16
Identities = 39/185 (21%), Positives = 66/185 (35%), Gaps = 57/185 (30%)
Query: 177 NFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREAL----------K 226
+ +H N+V ++ +C ++ E+ G L +L L
Sbjct: 105 HLGQHENIVNLLGACTH-----GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANS 159
Query: 227 NLNLLQRLSIAVDVASALDYL--HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL 284
+ L + VA + +L + +H D+ NVLL A +GDFGLA+ +
Sbjct: 160 TASTRDLLHFSSQVAQGMAFLASKNC-----IHRDVAARNVLLTNGHVAKIGDFGLARDI 214
Query: 285 --------------------PEA-TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT 323
PE+ + + + DV+S+GILL E F+
Sbjct: 215 MNDSNYIVKGNARLPVKWMAPESIFDCVY-------------TVQSDVWSYGILLWEIFS 261
Query: 324 -GKRP 327
G P
Sbjct: 262 LGLNP 266
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 45/179 (25%), Positives = 69/179 (38%), Gaps = 53/179 (29%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLH---PNREALKNLNLLQRLS 235
H+N+V+ I Q ++ E M G L+ +L P +L +L L
Sbjct: 131 FNHQNIVRCIGVS----LQS-LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 185
Query: 236 IAVDVASALDYL--HHYCETPIVHCDLKPSNVLLDGE---LTAHVGDFGLAKFL------ 284
+A D+A YL +H+ +H D+ N LL A +GDFG+A+ +
Sbjct: 186 VARDIACGCQYLEENHF-----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY 240
Query: 285 --------------PEA-TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRP 327
PEA F ++ D +SFG+LL E F+ G P
Sbjct: 241 RKGGCAMLPVKWMPPEAFMEGIF-------------TSKTDTWSFGVLLWEIFSLGYMP 286
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 2e-16
Identities = 52/249 (20%), Positives = 75/249 (30%), Gaps = 40/249 (16%)
Query: 3 TLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIP 62
+ GNQ T +P LQ L++ N+ +P+ L L N N L S+P
Sbjct: 127 WIFGNQLT-SLPVLPP---GLQELSVSDNQL-ASLPALPSELCKLWAYN---NQLT-SLP 177
Query: 63 SSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIY----------------LDLSQNQL 106
L L +S+N L + PT L L Y L +S N+L
Sbjct: 178 MLPS---GLQELSVSDNQLA-SLPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRL 233
Query: 107 NGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLR 166
LP LK L +S N+L+ +P L L + N +P SL L
Sbjct: 234 TS-LPVLPSELKEL---MVSGNRLT-SLPMLPSG---LLSLSVYRNQLT-RLPESLIHLS 284
Query: 167 GIENLDLSRNNFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALK 226
++L N + S LH
Sbjct: 285 SETTVNLEGNPLSERTLQ--ALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWL 342
Query: 227 NLNLLQRLS 235
+
Sbjct: 343 VPAREGEPA 351
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 2e-16
Identities = 39/189 (20%), Positives = 62/189 (32%), Gaps = 40/189 (21%)
Query: 6 GNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSL 65
+ T +P + + L + N +P+ L TL + N L S+P
Sbjct: 49 ESGLT-TLPDCLPA--HITTLVIPDNNL-TSLPALPPELR---TLEVSGNQLT-SLPVLP 100
Query: 66 GKCQNLILLDLSNNNLTGTTPTEVIGLSSLSI----------------YLDLSQNQLNGP 109
L + +L P GL L I L +S NQL
Sbjct: 101 PGLLELSIFSNPLTHL----PALPSGLCKLWIFGNQLTSLPVLPPGLQELSVSDNQLAS- 155
Query: 110 LPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIE 169
LP+ L L N+L+ +P L++L ++ N ++P+ S L
Sbjct: 156 LPALPSELCKL---WAYNNQLT-SLPMLPSG---LQELSVSDNQLA-SLPTLPSELY--- 204
Query: 170 NLDLSRNNF 178
L N
Sbjct: 205 KLWAYNNRL 213
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 6e-11
Identities = 30/172 (17%), Positives = 61/172 (35%), Gaps = 31/172 (18%)
Query: 68 CQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISE 127
+L++ + LT T P + + ++ L + N L LP+ L+ L ++S
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCL--PAHIT-TLVIPDNNLTS-LPALPPELRTL---EVSG 90
Query: 128 NKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNFIRHRNLVKI 187
N+L+ +P + L ++P+ S L L + N +L +
Sbjct: 91 NQLT-SLPVLPPGLLELSIFSNPLT----HLPALPSGLC---KLWIFGNQL---TSLPVL 139
Query: 188 ITSCASVDFQGNDSEALVYEFMVNGSLEE-WLHPNR--------EALKNLNL 230
+ N +L L + W + N+ L+ L++
Sbjct: 140 PPGLQELSVSDNQLASLPALP---SELCKLWAYNNQLTSLPMLPSGLQELSV 188
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 4e-09
Identities = 27/155 (17%), Positives = 50/155 (32%), Gaps = 13/155 (8%)
Query: 3 TLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIP 62
+ GN+ T +P +L+ L + N+ +P L +L+ N L +P
Sbjct: 227 IVSGNRLT-SLPVLPS---ELKELMVSGNRL-TSLPMLPSGLL---SLSVYRNQLT-RLP 277
Query: 63 SSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYL--DLSQNQLNGPLPSNFGILKNL 120
SL + ++L N L+ T + ++S Y + + P L
Sbjct: 278 ESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLA 337
Query: 121 GAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFR 155
A + + P+ Q F
Sbjct: 338 AADWLVPAREGEPAPADRWH--MFGQEDNADAFSL 370
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 42/187 (22%), Positives = 73/187 (39%), Gaps = 59/187 (31%)
Query: 177 NFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWL------------HPNREA 224
+H+N++ ++ +C + ++ E+ G+L E+L +P+
Sbjct: 130 MIGKHKNIINLLGACTQ-----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 184
Query: 225 LKNLNLLQRLSIAVDVASALDYL--HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAK 282
+ L+ +S A VA ++YL +H DL NVL+ + + DFGLA+
Sbjct: 185 EEQLSSKDLVSCAYQVARGMEYLASKKC-----IHRDLAARNVLVTEDNVMKIADFGLAR 239
Query: 283 FL--------------------PEA-TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLET 321
+ PEA + + + DV+SFG+LL E
Sbjct: 240 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-------------THQSDVWSFGVLLWEI 286
Query: 322 FT-GKRP 327
FT G P
Sbjct: 287 FTLGGSP 293
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 42/175 (24%), Positives = 65/175 (37%), Gaps = 6/175 (3%)
Query: 6 GNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSL 65
FT IP + ++ L L NK + L L + + +
Sbjct: 14 SRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAF 70
Query: 66 GKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNG-PLPSNFGILKNLGAID 124
+L LDLS+N+L+ + + LSSL YL+L N + S F L NL +
Sbjct: 71 YSLGSLEHLDLSDNHLSSLSSSWFGPLSSLK-YLNLMGNPYQTLGVTSLFPNLTNLQTLR 129
Query: 125 ISENKLSGQIP-SSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178
I + +I L +L + R SL S+R I +L L +
Sbjct: 130 IGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSES 184
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 5e-16
Identities = 41/252 (16%), Positives = 84/252 (33%), Gaps = 8/252 (3%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS 63
L N+ T G + LQ L L+ ++ + +L L L+ ++N L S
Sbjct: 33 LSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSS 92
Query: 64 SLGKCQNLILLDLSNNNLTGTTPTEVI-GLSSLSIYLDLS-QNQLNGPLPSNFGILKNLG 121
G +L L+L N T + L++L L + + +F L +L
Sbjct: 93 WFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQ-TLRIGNVETFSEIRRIDFAGLTSLN 151
Query: 122 AIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNN---- 177
++I L S+ S + L ++ + + L + L+L N
Sbjct: 152 ELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARF 211
Query: 178 FIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIA 237
+ ++ + + F+G+ + ++ L L + + L
Sbjct: 212 QFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLK-LLRYILELSEVEFDDCTLNGLGDFN 270
Query: 238 VDVASALDYLHH 249
+ + L
Sbjct: 271 PSESDVVSELGK 282
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 35/179 (19%), Positives = 60/179 (33%), Gaps = 16/179 (8%)
Query: 6 GNQFTGRI---PGSIGDLHKLQRLTLEMNKFW--GEIPSSIGNLTLLITLNFAENMLEGS 60
N G LQ L L N + + L L +L+ + N
Sbjct: 343 ENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-P 401
Query: 61 IPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNL 120
+P S + + L+LS+ + +L LD+S N L+ L L
Sbjct: 402 MPDSCQWPEKMRFLNLSSTGIRVVKTC---IPQTLE-VLDVSNNNLDS-FSLF---LPRL 453
Query: 121 GAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNFI 179
+ IS NKL +P + L + ++ N + L ++ + L N +
Sbjct: 454 QELYISRNKLK-TLPDA-SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 36/161 (22%), Positives = 63/161 (39%), Gaps = 10/161 (6%)
Query: 23 LQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLT 82
++RL + + ++ + L + + + + S ++L LDLS N +
Sbjct: 288 IRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMV 347
Query: 83 ---GTTPTEVIGLSSLSIYLDLSQNQLN--GPLPSNFGILKNLGAIDISENKLSGQIPSS 137
SL L LSQN L LKNL ++DIS N +P S
Sbjct: 348 EEYLKNSACKGAWPSLQ-TLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDS 405
Query: 138 IGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178
++ L ++ R + + + + +E LD+S NN
Sbjct: 406 CQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNL 443
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 30/193 (15%), Positives = 60/193 (31%), Gaps = 17/193 (8%)
Query: 3 TLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIP 62
+ S+ + + LTL +++ + L+ + L + L
Sbjct: 154 EIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQF 213
Query: 63 SSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIY---------LDLSQNQLNGPLPSN 113
S L + + + T L L Y D + N L PS
Sbjct: 214 SPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSE 273
Query: 114 FGILKNLGAI--------DISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSL 165
++ LG + I + L + + +++++ + + S L
Sbjct: 274 SDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHL 333
Query: 166 RGIENLDLSRNNF 178
+ +E LDLS N
Sbjct: 334 KSLEFLDLSENLM 346
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 6e-09
Identities = 32/147 (21%), Positives = 51/147 (34%), Gaps = 25/147 (17%)
Query: 4 LVGNQFT--GRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSI 61
L N + + L L L + N F +P S + LN + + +
Sbjct: 368 LSQNHLRSMQKTGEILLTLKNLTSLDISRNTF-HPMPDSCQWPEKMRFLNLSSTGIR-VV 425
Query: 62 PSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSI------------------YLDLSQ 103
+ + Q L +LD+SNNNL + + L L I + +S+
Sbjct: 426 KTCI--PQTLEVLDVSNNNLD-SFSLFLPRLQELYISRNKLKTLPDASLFPVLLVMKISR 482
Query: 104 NQLNGPLPSNFGILKNLGAIDISENKL 130
NQL F L +L I + N
Sbjct: 483 NQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 23/111 (20%), Positives = 46/111 (41%), Gaps = 4/111 (3%)
Query: 68 CQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISE 127
C + D + + T + P+ GL++ LDLS N++ + NL + +
Sbjct: 4 CDASGVCDGRSRSFT-SIPS---GLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKS 59
Query: 128 NKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178
++++ + S LE L ++ N S L ++ L+L N +
Sbjct: 60 SRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPY 110
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 3e-16
Identities = 35/156 (22%), Positives = 64/156 (41%), Gaps = 16/156 (10%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+ H N++K S F ++ +V E G L + ++ + + V
Sbjct: 89 LNHPNVIKYYAS-----FIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFV 143
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQI-A 297
+ SAL+++H ++H D+KP+NV + +GD GL +F + + +
Sbjct: 144 QLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLVGT 199
Query: 298 EYGMGSEV------STSGDVYSFGILLLETFTGKRP 327
Y M E + D++S G LL E + P
Sbjct: 200 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 4e-16
Identities = 43/194 (22%), Positives = 65/194 (33%), Gaps = 66/194 (34%)
Query: 177 NFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNR-------------- 222
H N+V ++ +C + L++E+ G L +L R
Sbjct: 104 QLGSHENIVNLLGACTL-----SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 158
Query: 223 -----EALKNLNLLQRLSIAVDVASALDYL--HHYCETPIVHCDLKPSNVLLDGELTAHV 275
E L L L A VA +++L VH DL NVL+ +
Sbjct: 159 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSC-----VHRDLAARNVLVTHGKVVKI 213
Query: 276 GDFGLAKFL--------------------PEA-TNNFFNFQIAEYGMGSEVSTSGDVYSF 314
DFGLA+ + PE+ + + DV+S+
Sbjct: 214 CDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY-------------TIKSDVWSY 260
Query: 315 GILLLETFT-GKRP 327
GILL E F+ G P
Sbjct: 261 GILLWEIFSLGVNP 274
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 4e-16
Identities = 39/187 (20%), Positives = 69/187 (36%), Gaps = 59/187 (31%)
Query: 177 NFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWL------------HPNREA 224
+H+N++ ++ +C + ++ E+ G+L E+L NR
Sbjct: 142 MIGKHKNIINLLGACTQ-----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 196
Query: 225 LKNLNLLQRLSIAVDVASALDYL--HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAK 282
+ + +S +A ++YL +H DL NVL+ + DFGLA+
Sbjct: 197 EEQMTFKDLVSCTYQLARGMEYLASQKC-----IHRDLAARNVLVTENNVMKIADFGLAR 251
Query: 283 FL--------------------PEA-TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLET 321
+ PEA + + + DV+SFG+L+ E
Sbjct: 252 DINNIDYYKKTTNGRLPVKWMAPEALFDRVY-------------THQSDVWSFGVLMWEI 298
Query: 322 FT-GKRP 327
FT G P
Sbjct: 299 FTLGGSP 305
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 9e-16
Identities = 31/160 (19%), Positives = 57/160 (35%), Gaps = 25/160 (15%)
Query: 207 EFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVL 266
+ +L++W++ R +L++ L I + +A A+++LH ++H DLKPSN+
Sbjct: 141 QLCRKENLKDWMN-RRCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIF 196
Query: 267 LDGELTAHVGDFGLAKFLPEATNNFFNFQIAEYGMGS------------EVSTSG----- 309
+ VGDFGL + + E
Sbjct: 197 FTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHK 256
Query: 310 -DVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEALPE 348
D++S G++L E E + + P
Sbjct: 257 VDIFSLGLILFELLYSFSTQMER---VRIITDVRNLKFPL 293
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 35/175 (20%), Positives = 69/175 (39%), Gaps = 16/175 (9%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS 63
L N+ T + + + L + N S++ + L+ + N + +
Sbjct: 172 LSSNRLT-HVD--LSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSIN-VVRG 222
Query: 64 SLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAI 123
+ L +L L +NNLT ++ L + +DLS N+L + F ++ L +
Sbjct: 223 PV--NVELTILKLQHNNLT--DTAWLLNYPGL-VEVDLSYNELEKIMYHPFVKMQRLERL 277
Query: 124 DISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178
IS N+L + L+ L ++ N ++ + +ENL L N+
Sbjct: 278 YISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSI 330
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 37/175 (21%), Positives = 66/175 (37%), Gaps = 16/175 (9%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS 63
+ N + ++ ++ L N + + L L N L + +
Sbjct: 193 VSYNLLS-----TLAIPIAVEELDASHNSI-NVVRGPV--NVELTILKLQHNNL--TDTA 242
Query: 64 SLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAI 123
L L+ +DLS N L + + L L +S N+L L + L +
Sbjct: 243 WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLE-RLYISNNRLVA-LNLYGQPIPTLKVL 300
Query: 124 DISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178
D+S N L + + RLE L ++ N + LS+ ++NL LS N++
Sbjct: 301 DLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDW 351
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 5e-13
Identities = 31/175 (17%), Positives = 57/175 (32%), Gaps = 11/175 (6%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSI-GNLTLLITLNFAENMLEGSIP 62
+ + +++ L L + EI + + L N + P
Sbjct: 52 FKNSTMRKLPAALLDSFRQVELLNLNDLQI-EEIDTYAFAYAHTIQKLYMGFNAIRYLPP 110
Query: 63 SSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGA 122
L +L L N+L+ L L +S N L F +L
Sbjct: 111 HVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKL-TTLSMSNNNLERIEDDTFQATTSLQN 169
Query: 123 IDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNN 177
+ +S N+L+ + + L ++ N S+L+ +E LD S N+
Sbjct: 170 LQLSSNRLT-HVD--LSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNS 216
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 27/167 (16%), Positives = 57/167 (34%), Gaps = 3/167 (1%)
Query: 13 IPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLI 72
I ++ + ++M L + F + + + L + +
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72
Query: 73 LLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSG 132
LL+L++ + ++ L + N + P F + L + + N LS
Sbjct: 73 LLNLNDLQIEEIDTYAFAYAHTIQ-KLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS- 130
Query: 133 QIPSSI-GSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178
+P I + +L L M+ N + + ++NL LS N
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRL 177
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 35/174 (20%), Positives = 65/174 (37%), Gaps = 13/174 (7%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS 63
N + G + +L L L+ N + + N L+ ++ + N LE +
Sbjct: 212 ASHNSIN-VVRGPV--NVELTILKLQHNNL--TDTAWLLNYPGLVEVDLSYNELEKIMYH 266
Query: 64 SLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAI 123
K Q L L +SNN L + +L + LDLS N L + N L +
Sbjct: 267 PFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKV-LDLSHNHLLH-VERNQPQFDRLENL 323
Query: 124 DISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNN 177
+ N + + + + L+ L ++ N + N S + R + + +
Sbjct: 324 YLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCN--SLRALFRNVARPAVDDAD 372
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 40/170 (23%), Positives = 62/170 (36%), Gaps = 28/170 (16%)
Query: 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVD 239
+H V++ + ++ L E SL++ +L Q D
Sbjct: 115 QHPCCVRLEQA-----WEEGGILYLQTEL-CGPSLQQHC---EAWGASLPEAQVWGYLRD 165
Query: 240 VASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQI--A 297
AL +LH +VH D+KP+N+ L +GDFGL L T Q
Sbjct: 166 TLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL--GTAGAGEVQEGDP 220
Query: 298 EYGMGSEV-----STSGDVYSFGILLLETFTGKRP------TNEMFTGNL 336
Y M E+ T+ DV+S G+ +LE ++ G L
Sbjct: 221 RY-MAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYL 269
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 39/179 (21%), Positives = 63/179 (35%), Gaps = 23/179 (12%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS 63
N+ + +P L+ L ++ N+ +P L +N N L +P
Sbjct: 107 ACDNRLS-TLPELPA---SLKHLDVDNNQL-TMLPELPALLE---YINADNNQLT-MLPE 157
Query: 64 SLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNL--- 120
+L +L + NN LT SL LD+S N L LP+ +
Sbjct: 158 LPT---SLEVLSVRNNQLTFLPEL----PESLEA-LDVSTNLLES-LPAVPVRNHHSEET 208
Query: 121 -GAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178
EN+++ IP +I S +++ N I SLS + R F
Sbjct: 209 EIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYF 266
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 49/234 (20%), Positives = 86/234 (36%), Gaps = 35/234 (14%)
Query: 13 IPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLI 72
+ K N+ + + + L L S+P +L +
Sbjct: 29 YFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSELQLNRLNLS-SLPDNLP--PQIT 83
Query: 73 LLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSG 132
+L+++ N L + P +SL YLD N+L+ LP LK+L D+ N+L+
Sbjct: 84 VLEITQNALI-SLPEL---PASLE-YLDACDNRLST-LPELPASLKHL---DVDNNQLT- 133
Query: 133 QIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNFIRHRNLVKIITSCA 192
+P LE + + N +P +SL E L + N L ++ S
Sbjct: 134 MLPELPAL---LEYINADNNQLT-MLPELPTSL---EVLSVRNNQL---TFLPELPESLE 183
Query: 193 SVDFQGNDSEALVYEFMVNGSLEE-----WLHPNR-----EALKNLNLLQRLSI 236
++D N E+L + N EE NR E + +L+ + +
Sbjct: 184 ALDVSTNLLESLPAVPVRNHHSEETEIFFRCRENRITHIPENILSLDPTCTIIL 237
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 6e-07
Identities = 18/114 (15%), Positives = 33/114 (28%), Gaps = 10/114 (8%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLT----LLITLNFAENMLEG 59
+ NQ T +P L+ L + N +P+ I EN +
Sbjct: 167 VRNNQLT-FLPELPE---SLEALDVSTNLL-ESLPAVPVRNHHSEETEIFFRCRENRIT- 220
Query: 60 SIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSN 113
IP ++ + L +N L+ + ++ Y N
Sbjct: 221 HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQN 274
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 44.6 bits (105), Expect = 5e-05
Identities = 16/108 (14%), Positives = 36/108 (33%), Gaps = 9/108 (8%)
Query: 72 ILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPS-NFGILKNLGAIDISENKL 130
+ + N ++ T + L N + ++ + ++ L
Sbjct: 13 LSQNSFYNTIS-GTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSELQLNRLNL 71
Query: 131 SGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178
S +P ++ ++ L + N ++P +SL E LD N
Sbjct: 72 S-SLPDNLPP--QITVLEITQNALI-SLPELPASL---EYLDACDNRL 112
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 2e-15
Identities = 43/178 (24%), Positives = 73/178 (41%), Gaps = 6/178 (3%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNK--FWGEIPSSIGNLTLLITLNFAENMLEGSI 61
L N+ G L +L +L+L N F G S T L L+ + N + ++
Sbjct: 35 LESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TM 93
Query: 62 PSSLGKCQNLILLDLSNNNLTGTTPTEV-IGLSSLSIYLDLSQNQLNGPLPSNFGILKNL 120
S+ + L LD ++NL + V + L +L IYLD+S F L +L
Sbjct: 94 SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNL-IYLDISHTHTRVAFNGIFNGLSSL 152
Query: 121 GAIDISENKLSGQIPSSI-GSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNN 177
+ ++ N I L L ++ P++ +SL ++ L++S NN
Sbjct: 153 EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNN 210
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 1e-12
Identities = 53/178 (29%), Positives = 69/178 (38%), Gaps = 11/178 (6%)
Query: 6 GNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLE--GSIPS 63
T +P I RL LE NK LT L L+ + N L G
Sbjct: 16 SKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQ 72
Query: 64 SLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNG-PLPSNFGILKNLGA 122
S +L LDLS N + T + +GL L +LD + L S F L+NL
Sbjct: 73 SDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQL-EHLDFQHSNLKQMSEFSVFLSLRNLIY 130
Query: 123 IDISENKLSGQIPSSI-GSCIRLEQLVMNGNFFRGNIPS-SLSSLRGIENLDLSRNNF 178
+DIS + I LE L M GN F+ N + LR + LDLS+
Sbjct: 131 LDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 187
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 5e-12
Identities = 39/149 (26%), Positives = 60/149 (40%), Gaps = 7/149 (4%)
Query: 36 EIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLT--GTTPTEVIGLS 93
+P+ I + L N L+ K L L LS+N L+ G G +
Sbjct: 21 SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78
Query: 94 SLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSI-GSCIRLEQLVMNGN 152
SL YLDLS N + + SNF L+ L +D + L S+ S L L ++
Sbjct: 79 SLK-YLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 136
Query: 153 FFRGNIPSSLSSLRGIENLDLSRNNFIRH 181
R + L +E L ++ N+F +
Sbjct: 137 HTRVAFNGIFNGLSSLEVLKMAGNSFQEN 165
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 6e-12
Identities = 35/179 (19%), Positives = 70/179 (39%), Gaps = 7/179 (3%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSS--IGNLTLLITLNFAENMLEGSI 61
L N + + L +L+ L + + ++ +L LI L+ + +
Sbjct: 85 LSFNGVI-TMSSNFLGLEQLEHLDFQHSNL-KQMSEFSVFLSLRNLIYLDISHTHTRVAF 142
Query: 62 PSSLGKCQNLILLDLSNNNLTGTTPTEV-IGLSSLSIYLDLSQNQLNGPLPSNFGILKNL 120
+L +L ++ N+ ++ L +L+ +LDLSQ QL P+ F L +L
Sbjct: 143 NGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLT-FLDLSQCQLEQLSPTAFNSLSSL 201
Query: 121 GAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSL-RGIENLDLSRNNF 178
+++S N L+ L + N + L + L+L++N+F
Sbjct: 202 QVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 6e-07
Identities = 24/106 (22%), Positives = 42/106 (39%), Gaps = 3/106 (2%)
Query: 4 LVGNQFTGRI-PGSIGDLHKLQRLTLEMNKFWGEIPSSI-GNLTLLITLNFAENMLEGSI 61
+ GN F P +L L L L + ++ + +L+ L LN + N
Sbjct: 157 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLD 215
Query: 62 PSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLN 107
+L +LD S N++ + E+ S +L+L+QN
Sbjct: 216 TFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 27/106 (25%), Positives = 46/106 (43%), Gaps = 7/106 (6%)
Query: 74 LDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQ 133
+ ++ LT + PT G+ S + L+L N+L F L L + +S N LS +
Sbjct: 12 IRCNSKGLT-SVPT---GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFK 67
Query: 134 --IPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNN 177
S L+ L ++ N + S+ L +E+LD +N
Sbjct: 68 GCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSN 112
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 3e-15
Identities = 38/193 (19%), Positives = 69/193 (35%), Gaps = 67/193 (34%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNR---------------- 222
+ H +++K+ +C+ + L+ E+ GSL +L +R
Sbjct: 83 VNHPHVIKLYGACSQ-----DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSS 137
Query: 223 ----EALKNLNLLQRLSIAVDVASALDYL--HHYCETPIVHCDLKPSNVLLDGELTAHVG 276
+ L + +S A ++ + YL VH DL N+L+ +
Sbjct: 138 SLDHPDERALTMGDLISFAWQISQGMQYLAEMKL-----VHRDLAARNILVAEGRKMKIS 192
Query: 277 DFGLAKFL--------------------PEA-TNNFFNFQIAEYGMGSEVSTSGDVYSFG 315
DFGL++ + E+ ++ + +T DV+SFG
Sbjct: 193 DFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIY-------------TTQSDVWSFG 239
Query: 316 ILLLETFT-GKRP 327
+LL E T G P
Sbjct: 240 VLLWEIVTLGGNP 252
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 5e-15
Identities = 42/193 (21%), Positives = 72/193 (37%), Gaps = 67/193 (34%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNR---------------- 222
+ N+VK++ CA L++E+M G L E+L
Sbjct: 107 FDNPNIVKLLGVCAV-----GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 161
Query: 223 ----EALKNLNLLQRLSIAVDVASALDYL--HHYCETPIVHCDLKPSNVLLDGELTAHVG 276
L+ ++L IA VA+ + YL + VH DL N L+ + +
Sbjct: 162 RVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF-----VHRDLATRNCLVGENMVVKIA 216
Query: 277 DFGLAKFL--------------------PEA-TNNFFNFQIAEYGMGSEVSTSGDVYSFG 315
DFGL++ + PE+ N + +T DV+++G
Sbjct: 217 DFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY-------------TTESDVWAYG 263
Query: 316 ILLLETFT-GKRP 327
++L E F+ G +P
Sbjct: 264 VVLWEIFSYGLQP 276
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 6e-15
Identities = 42/173 (24%), Positives = 67/173 (38%), Gaps = 31/173 (17%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEAL--VYEFMVNGSLEEWLHPNREALKNLNLLQRLSI 236
++H N+V+ + L V E+ G L + + + L+ L +
Sbjct: 62 LKHPNIVRYYDR-----IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRV 116
Query: 237 AVDVASALDYLH--HYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNF 294
+ AL H ++H DLKP+NV LDG+ +GDFGLA+ L +
Sbjct: 117 MTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH------DT 170
Query: 295 QIAEYGMGS------EV------STSGDVYSFGILLLETFTGKRPTNEMFTGN 335
A+ +G+ E + D++S G LL E P FT
Sbjct: 171 SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP----FTAF 219
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 8e-15
Identities = 36/180 (20%), Positives = 59/180 (32%), Gaps = 5/180 (2%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSI-GNLTLLITLNFAENMLEGSIP 62
L N+ L+ L L N + NL L TL N L+ IP
Sbjct: 39 LGKNRIKTLNQDEFASFPHLEELELNENIV-SAVEPGAFNNLFNLRTLGLRSNRLK-LIP 96
Query: 63 S-SLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLG 121
NL LD+S N + L +L L++ N L F L +L
Sbjct: 97 LGVFTGLSNLTKLDISENKIVILLDYMFQDLYNL-KSLEVGDNDLVYISHRAFSGLNSLE 155
Query: 122 AIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNFIRH 181
+ + + L+ ++ L L + S L ++ L++S ++
Sbjct: 156 QLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDT 215
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 41/178 (23%), Positives = 62/178 (34%), Gaps = 3/178 (1%)
Query: 3 TLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSI-GNLTLLITLNFAENMLEGSI 61
TL T ++ LH L L L I L L L + ++
Sbjct: 158 TLEKCNLTSIPTEALSHLHGLIVLRLRHLNI-NAIRDYSFKRLYRLKVLEISHWPYLDTM 216
Query: 62 PSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLG 121
+ NL L +++ NLT V L L +L+LS N ++ S L L
Sbjct: 217 TPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLR-FLNLSYNPISTIEGSMLHELLRLQ 275
Query: 122 AIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNFI 179
I + +L+ P + L L ++GN S S+ +E L L N
Sbjct: 276 EIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 48/249 (19%), Positives = 90/249 (36%), Gaps = 22/249 (8%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSI-GNLTLLITLNFAENMLEGSIP 62
L N + PG+ +L L+ L L N+ IP + L+ L L+ +EN + +
Sbjct: 63 LNENIVSAVEPGAFNNLFNLRTLGLRSNRL-KLIPLGVFTGLSNLTKLDISENKIVILLD 121
Query: 63 SSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGA 122
NL L++ +N+L + GL+SL L L + L L L
Sbjct: 122 YMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQ-LTLEKCNLTSIPTEALSHLHGLIV 180
Query: 123 IDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNN----- 177
+ + ++ S RL+ L ++ + + + + +L ++ N
Sbjct: 181 LRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVP 240
Query: 178 ---FIRHRNLVKI------ITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNL 228
L + I++ L +V G L + P A + L
Sbjct: 241 YLAVRHLVYLRFLNLSYNPISTIEGSMLHELLR--LQEIQLVGGQLAV-VEPY--AFRGL 295
Query: 229 NLLQRLSIA 237
N L+ L+++
Sbjct: 296 NYLRVLNVS 304
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 40/156 (25%), Positives = 62/156 (39%), Gaps = 1/156 (0%)
Query: 23 LQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLT 82
+ L L N+ + L L EN++ P + NL L L +N L
Sbjct: 34 TRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK 93
Query: 83 GTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCI 142
GLS+L+ LD+S+N++ L F L NL ++++ +N L +
Sbjct: 94 LIPLGVFTGLSNLT-KLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLN 152
Query: 143 RLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178
LEQL + +LS L G+ L L N
Sbjct: 153 SLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNI 188
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 8e-15
Identities = 32/168 (19%), Positives = 63/168 (37%), Gaps = 31/168 (18%)
Query: 179 IRHRNLVKIITSC----ASVDFQGNDSEALVY---EFMVNGSLEEWLHPNREALKNLNLL 231
+ H +V+ + + Q + + +Y + +L++W++ R ++
Sbjct: 60 LEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMN-GRCTIEERERS 118
Query: 232 QRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNF 291
L I + +A A+++LH ++H DLKPSN+ + VGDFGL + +
Sbjct: 119 VCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM-DQDEEE 174
Query: 292 FNFQIAEYGMGSEVSTSG-------------------DVYSFGILLLE 320
G D++S G++L E
Sbjct: 175 QTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 9e-15
Identities = 45/201 (22%), Positives = 67/201 (33%), Gaps = 26/201 (12%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS 63
N T +P L L + P L L + N LE +P
Sbjct: 98 ASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPL-------LEYLGVSNNQLE-KLPE 148
Query: 64 SLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAI 123
L L ++D+ NN+L P SL ++ NQL LP L L AI
Sbjct: 149 -LQNSSFLKIIDVDNNSLK-KLPDL---PPSL-EFIAAGNNQLEE-LP-ELQNLPFLTAI 200
Query: 124 DISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNFIRHRN 183
N L ++P S LE +V N L +L + + N +
Sbjct: 201 YADNNSLK-KLPDLPLS---LESIVAGNNILE--ELPELQNLPFLTTIYADNNLL---KT 251
Query: 184 LVKIITSCASVDFQGNDSEAL 204
L + S +++ + N L
Sbjct: 252 LPDLPPSLEALNVRDNYLTDL 272
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 8e-14
Identities = 40/176 (22%), Positives = 63/176 (35%), Gaps = 25/176 (14%)
Query: 3 TLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIP 62
NQ +P + +L L + + N ++P +L ++ N+L
Sbjct: 179 AAGNNQLE-ELP-ELQNLPFLTAIYADNNSL-KKLPDLPLSLE---SIVAGNNIL--EEL 230
Query: 63 SSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGA 122
L L + NN L T P L + L++ N L LP L L
Sbjct: 231 PELQNLPFLTTIYADNNLLK-TLPDLPPSLEA----LNVRDNYLTD-LPELPQSLTFL-- 282
Query: 123 IDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178
D+SEN S + + L L + N R ++ SL E L++S N
Sbjct: 283 -DVSENIFS-GLSELPPN---LYYLNASSNEIR-SLCDLPPSL---EELNVSNNKL 329
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 30/190 (15%), Positives = 57/190 (30%), Gaps = 37/190 (19%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS 63
+ T +P ++ +++ P G + + +
Sbjct: 18 RHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCL------- 69
Query: 64 SLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAI 123
+ L+L+N L+ + P L S L S N L LP LK+L
Sbjct: 70 ----DRQAHELELNNLGLS-SLPELPPHLES----LVASCNSLT-ELPELPQSLKSLLVD 119
Query: 124 DISENKLSGQIPS---------------SIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGI 168
+ + LS P + + L+ + ++ N + +P SL
Sbjct: 120 NNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLK-KLPDLPPSL--- 175
Query: 169 ENLDLSRNNF 178
E + N
Sbjct: 176 EFIAAGNNQL 185
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 9e-11
Identities = 39/177 (22%), Positives = 58/177 (32%), Gaps = 30/177 (16%)
Query: 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSI 61
+ N T +P L L + + NL LN + N + S+
Sbjct: 262 LNVRDNYLT-DLPELPQSLTFLDVSENIFSG----LSELPPNLY---YLNASSNEIR-SL 312
Query: 62 PSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLG 121
+L L++SNN L P L L S N L +P LK L
Sbjct: 313 CDLPP---SLEELNVSNNKLI-ELPALPPRLE----RLIASFNHLAE-VPELPQNLKQL- 362
Query: 122 AIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178
+ N L + P S +E L MN + +P +L+ L + N
Sbjct: 363 --HVEYNPLR-EFPDIPES---VEDLRMNSHL--AEVPELPQNLK---QLHVETNPL 408
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 3e-09
Identities = 27/165 (16%), Positives = 50/165 (30%), Gaps = 32/165 (19%)
Query: 3 TLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIP 62
N+ + L+ L + NK E+P+ L L + N L +P
Sbjct: 303 NASSNEIR-SLCDL---PPSLEELNVSNNKL-IELPALPPRLE---RLIASFNHLA-EVP 353
Query: 63 SSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSI---------------YLDLSQNQLN 107
NL L + N L P + L + L + N L
Sbjct: 354 ELPQ---NLKQLHVEYNPLR-EFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR 409
Query: 108 GPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGN 152
P +++L ++ ++ + + +LE V +
Sbjct: 410 E-FPDIPESVEDL---RMNSERVVDPYEFAHETTDKLEDDVFEHH 450
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 22/142 (15%), Positives = 38/142 (26%), Gaps = 30/142 (21%)
Query: 6 GNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSL 65
N+ +P +L+RL N E+P NL L+ N L P
Sbjct: 326 NNKLI-ELPALPP---RLERLIASFNHLA-EVPELPQNLK---QLHVEYNPLR-EFPDIP 376
Query: 66 GKCQNLIL----------------LDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGP 109
++L + L + N L P + L ++ ++ P
Sbjct: 377 ESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIPESVE----DLRMNSERVVDP 431
Query: 110 LPSNFGILKNLGAIDISENKLS 131
L +
Sbjct: 432 YEFAHETTDKLEDDVFEHHHHH 453
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-14
Identities = 41/174 (23%), Positives = 66/174 (37%), Gaps = 31/174 (17%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEA-----------LVYEFMVNGSLEEWLHPNREALKN 227
+ H N+V D+ S + EF G+LE+W+ R +
Sbjct: 61 LDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG--EK 118
Query: 228 LNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA 287
L+ + L + + +DY+H +++ DLKPSN+ L +GDFGL L +
Sbjct: 119 LDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL-KN 174
Query: 288 TNNFFNF----------QIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEM 331
QI+ G EV D+Y+ G++L E E
Sbjct: 175 DGKRTRSKGTLRYMSPEQISSQDYGKEV----DLYALGLILAELLHVCDTAFET 224
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 74.9 bits (183), Expect = 1e-14
Identities = 78/438 (17%), Positives = 140/438 (31%), Gaps = 101/438 (23%)
Query: 5 VGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAEN-----MLEG 59
+ N + P ++ L LQ+L +++ W N+ L I + + +
Sbjct: 189 LKNCNS---PETV--LEMLQKLLYQIDPNWTSRSDHSSNIKLRI--HSIQAELRRLLKSK 241
Query: 60 SIPSSLGKCQNLILLDLSNNN------------LTGTTPTEVIGLSSLSIYLDLSQNQLN 107
+ L L+LL++ N LT T +V S + +S + +
Sbjct: 242 PYENCL-----LVLLNVQNAKAWNAFNLSCKILLT-TRFKQVTDFLSAATTTHISLDHHS 295
Query: 108 GPL--PSNFGILKNLGAIDISENKLSGQI----P---SSIGSCIRLEQLVMNGNFFRGN- 157
L +L +D L ++ P S I IR + L N+ N
Sbjct: 296 MTLTPDEVKSLLLK--YLDCRPQDLPREVLTTNPRRLSIIAESIR-DGLATWDNWKHVNC 352
Query: 158 ------IPSSLSSLRGIENLDLSRNNFIRHRNL------VKIITSCASV---DFQGNDSE 202
I SSL+ L E R F L I T S+ D +D
Sbjct: 353 DKLTTIIESSLNVLEPAEY----RKMF---DRLSVFPPSAHIPTILLSLIWFDVIKSDVM 405
Query: 203 ALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLH-----HYCETPIVH 257
+V + +E+ + ++ ++ L ++ + + A LH HY P
Sbjct: 406 VVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYA-----LHRSIVDHY-NIPKTF 459
Query: 258 CDLKPSNVLLDGELTAHVG----DFGLAKFLPEATNNFFNFQ----------IAEYGMGS 303
LD +H+G + + + F +F+ A GS
Sbjct: 460 DSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGS 519
Query: 304 EVSTSGDV--YSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEALPERL-AEIVDPVLLV 360
++T + Y P E + +F+ + + ++ D + +
Sbjct: 520 ILNTLQQLKFYK------PYICDNDPKYERLVN--AILDFLPKIEENLICSKYTDLLRIA 571
Query: 361 EREEGETSKANAHKQFTR 378
E E AHKQ R
Sbjct: 572 LMAEDEAIFEEAHKQVQR 589
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-14
Identities = 26/158 (16%), Positives = 60/158 (37%), Gaps = 9/158 (5%)
Query: 20 LHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNN 79
L + + + L + A + + + + N+ L ++N
Sbjct: 22 FKAYLNGLLGQSST---ANITEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNI 76
Query: 80 NLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIG 139
+ T P + GLS+L L + + N L +L +DIS + I + I
Sbjct: 77 HATNYNP--ISGLSNLE-RLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 140 SCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNN 177
+ ++ + ++ N +I L +L +++L++ +
Sbjct: 134 TLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDG 170
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 1e-13
Identities = 25/162 (15%), Positives = 55/162 (33%), Gaps = 8/162 (4%)
Query: 16 SIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLD 75
+ ++ L +TL + I + L + + NL L
Sbjct: 39 TEAQMNSLTYITLANINV--TDLTGIEYAHNIKDLTINNIHATNY--NPISGLSNLERLR 94
Query: 76 LSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIP 135
+ ++T + GL+SL+ LD+S + + + + L + +ID+S N I
Sbjct: 95 IMGKDVTSDKIPNLSGLTSLT-LLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI- 152
Query: 136 SSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNN 177
+ + L+ L + + + + + L
Sbjct: 153 MPLKTLPELKSLNIQFDGVH-DY-RGIEDFPKLNQLYAFSQT 192
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 6e-12
Identities = 23/129 (17%), Positives = 45/129 (34%), Gaps = 6/129 (4%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS 63
+ T P I L L+RL + + ++ LT L L+ + + + SI +
Sbjct: 73 INNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILT 130
Query: 64 SLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAI 123
+ + +DLS N T + L L L++ + ++ L +
Sbjct: 131 KINTLPKVNSIDLSYNGAI-TDIMPLKTLPELK-SLNIQFDGVHD--YRGIEDFPKLNQL 186
Query: 124 DISENKLSG 132
+ G
Sbjct: 187 YAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 5e-11
Identities = 21/137 (15%), Positives = 51/137 (37%), Gaps = 8/137 (5%)
Query: 43 NLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLS 102
+ ++ + + +L + L+N N+T T E ++ L ++
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQM---NSLTYITLANINVTDLTGIE--YAHNIK-DLTIN 74
Query: 103 QNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSL 162
+ L NL + I ++ ++ L L ++ + +I + +
Sbjct: 75 NIHATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI 132
Query: 163 SSLRGIENLDLSRNNFI 179
++L + ++DLS N I
Sbjct: 133 NTLPKVNSIDLSYNGAI 149
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 2e-14
Identities = 33/168 (19%), Positives = 58/168 (34%), Gaps = 24/168 (14%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEA-LVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIA 237
H N+++++ + +G EA L+ F G+L + ++ L Q L +
Sbjct: 83 FNHPNILRLVAY--CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLL 140
Query: 238 VDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNN-----FF 292
+ + L+ +H H DLKP+N+LL E + D G
Sbjct: 141 LGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTL 197
Query: 293 NFQIAEYG-------------MGSEVSTSGDVYSFGILLLETFTGKRP 327
A+ + DV+S G +L G+ P
Sbjct: 198 QDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 3e-14
Identities = 34/171 (19%), Positives = 63/171 (36%), Gaps = 25/171 (14%)
Query: 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMV--NGSLEEWLHPNREALKNLNLLQRLSIA 237
H N+V+ ++ + + + +A G L E+L E+ L+ L I
Sbjct: 84 GHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLK-KMESRGPLSCDTVLKIF 142
Query: 238 VDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQ-- 295
A+ ++H + PI+H DLK N+LL + T + DFG A + + ++ Q
Sbjct: 143 YQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRR 201
Query: 296 ------IAEYG-------------MGSEVSTSGDVYSFGILLLETFTGKRP 327
I + D+++ G +L + P
Sbjct: 202 ALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 4e-14
Identities = 45/177 (25%), Positives = 69/177 (38%), Gaps = 6/177 (3%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSI-GNLTLLITLNFAENMLEGSIP 62
L GN+ + S L L L N I ++ L LL L+ ++N S+
Sbjct: 39 LHGNRISHVPAASFRACRNLTILWLHSNVL-ARIDAAAFTGLALLEQLDLSDNAQLRSVD 97
Query: 63 SS-LGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSN-FGILKNL 120
+ L L L L P GL++L YL L N L LP + F L NL
Sbjct: 98 PATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQ-YLYLQDNALQA-LPDDTFRDLGNL 155
Query: 121 GAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNN 177
+ + N++S + L++L+++ N P + L + L L NN
Sbjct: 156 THLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANN 212
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 4e-13
Identities = 37/177 (20%), Positives = 67/177 (37%), Gaps = 4/177 (2%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSI-GNLTLLITLNFAENMLEGSIP 62
L N + L L++L L N + + L L TL+ L+ +
Sbjct: 63 LHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELG 121
Query: 63 S-SLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLG 121
L L L +N L L +L+ +L L N+++ F L +L
Sbjct: 122 PGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLT-HLFLHGNRISSVPERAFRGLHSLD 180
Query: 122 AIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178
+ + +N+++ P + RL L + N +L+ LR ++ L L+ N +
Sbjct: 181 RLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 31/146 (21%), Positives = 52/146 (35%), Gaps = 8/146 (5%)
Query: 36 EIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSL 95
+P I + N + +S C+NL +L L +N L GL+ L
Sbjct: 25 AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 96 SIYLDLSQNQLNGPLPSN-FGILKNLGAIDISENKLSGQIPSSI-GSCIRLEQLVMNGNF 153
LDLS N + F L L + + L ++ + L+ L + N
Sbjct: 83 E-QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNA 140
Query: 154 FRGNIPS-SLSSLRGIENLDLSRNNF 178
+ +P + L + +L L N
Sbjct: 141 LQ-ALPDDTFRDLGNLTHLFLHGNRI 165
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 4e-06
Identities = 26/105 (24%), Positives = 38/105 (36%), Gaps = 3/105 (2%)
Query: 4 LVGNQFTGRIP-GSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIP 62
L N +P + DL L L L N+ + L L L +N + P
Sbjct: 136 LQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHP 194
Query: 63 SSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLN 107
+ L+ L L NNL+ + L +L YL L+ N
Sbjct: 195 HAFRDLGRLMTLYLFANNLSALPTEALAPLRALQ-YLRLNDNPWV 238
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 4e-14
Identities = 35/171 (20%), Positives = 65/171 (38%), Gaps = 35/171 (20%)
Query: 179 IRHRNLVKIITS-----CASVDFQGNDSEALVY---EFMVNGSLEEWLHPNREALKNLNL 230
+ H+ +V+ + ++ ++ E+ NG+L + +H N
Sbjct: 59 LNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN---LNQQR 115
Query: 231 LQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNN 290
+ + + AL Y+H I+H DLKP N+ +D +GDFGLAK + + +
Sbjct: 116 DEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDI 172
Query: 291 FFNFQIAEYGMGSEVSTS-G--------------------DVYSFGILLLE 320
G ++++ G D+YS GI+ E
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 8e-14
Identities = 51/200 (25%), Positives = 83/200 (41%), Gaps = 9/200 (4%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSI-GNLTLLITLNFAENMLEGSIP 62
L N G+ L L L L N+ IP+ L+ L L N +E SIP
Sbjct: 95 LSRNHIRTIEIGAFNGLANLNTLELFDNRL-TTIPNGAFVYLSKLKELWLRNNPIE-SIP 152
Query: 63 SSL-GKCQNLILLDLSNNN-LTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNL 120
S + +L LDL L+ + GLS+L YL+L+ L +P+ L L
Sbjct: 153 SYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLR-YLNLAMCNLRE-IPN-LTPLIKL 209
Query: 121 GAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNFIR 180
+D+S N LS P S + L++L M + + ++ +L+ + ++L+ NN
Sbjct: 210 DELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTL 269
Query: 181 -HRNLVKIITSCASVDFQGN 199
+L + + N
Sbjct: 270 LPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 6e-13
Identities = 52/236 (22%), Positives = 88/236 (37%), Gaps = 27/236 (11%)
Query: 23 LQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLT 82
+ L L N+ +S +L L L + N + + NL L+L +N LT
Sbjct: 66 TRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT 125
Query: 83 GTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISE-NKLSGQIPSSIGSC 141
+ LS L L L N + F + +L +D+ E +LS +
Sbjct: 126 TIPNGAFVYLSKLK-ELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGL 184
Query: 142 IRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNFIRHRNLVKIITSCASVDFQGNDS 201
L L + R IP +L+ L ++ LDLS N+ +++ FQG
Sbjct: 185 SNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNH----------LSAIRPGSFQGLMH 232
Query: 202 EALVYEFMVNGSLEEWLHPNREALKNLNLLQRL--------SIAVDVASALDYLHH 249
L +M+ ++ + N A NL L + + D+ + L +L
Sbjct: 233 --LQKLWMIQSQIQV-IERN--AFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLER 283
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 26/104 (25%), Positives = 41/104 (39%), Gaps = 3/104 (2%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS 63
L IP ++ L KL L L N P S L L L ++ ++ +
Sbjct: 192 LAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERN 249
Query: 64 SLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLN 107
+ Q+L+ ++L++NNLT L L + L N N
Sbjct: 250 AFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLE-RIHLHHNPWN 292
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-13
Identities = 41/157 (26%), Positives = 62/157 (39%), Gaps = 18/157 (11%)
Query: 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVD 239
+H+N+V+ + S F N + E + GSL L LK+
Sbjct: 77 KHKNIVQYLGS-----FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIG-FYTKQ 130
Query: 240 VASALDYLHHYCETPIVHCDLKPSNVLLDGEL-TAHVGDFGLAKFLPEATNNFFNFQIAE 298
+ L YLH + IVH D+K NVL++ + DFG +K L F
Sbjct: 131 ILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTL 187
Query: 299 YGMGSEV--------STSGDVYSFGILLLETFTGKRP 327
M E+ + D++S G ++E TGK P
Sbjct: 188 QYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 69.2 bits (169), Expect = 3e-13
Identities = 35/169 (20%), Positives = 57/169 (33%), Gaps = 16/169 (9%)
Query: 20 LHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKC-------QNLI 72
L+ L++ + L TL+ ++N G C Q L
Sbjct: 148 KPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLA 207
Query: 73 LLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNG-PLPSNFGILKNLGAIDISENKLS 131
L + +G L LDLS N L + L ++++S L
Sbjct: 208 LRNAGMETPSGVCSALAAARVQLQ-GLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK 266
Query: 132 GQIPSSIGSCIRLEQLVMNGNFFRGN-IPSSLSSLRGIENLDLSRNNFI 179
Q+P + + +L L ++ N N P L + NL L N F+
Sbjct: 267 -QVPKGLPA--KLSVLDLSYNRLDRNPSPDELPQVG---NLSLKGNPFL 309
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 69.2 bits (169), Expect = 3e-13
Identities = 36/161 (22%), Positives = 52/161 (32%), Gaps = 12/161 (7%)
Query: 3 TLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEI-------PSSIGNLTLLITLNFAEN 55
++ + L L L N GE P L +L N
Sbjct: 155 SIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGME 214
Query: 56 MLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFG 115
G + L LDLS+N+L S L+LS L +P G
Sbjct: 215 TPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPK--G 271
Query: 116 ILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRG 156
+ L +D+S N+L P S ++ L + GN F
Sbjct: 272 LPAKLSVLDLSYNRLDR-NP-SPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 8e-12
Identities = 31/172 (18%), Positives = 60/172 (34%), Gaps = 15/172 (8%)
Query: 22 KLQRLTLEMNKFWGEIPSS---IGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSN 78
L+RLT+ + I + ++ L L + G+ P L + L L+
Sbjct: 69 SLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNL 128
Query: 79 NNLTGTT----PTEVIGLSSLSI-YLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQ 133
N++ T E+ + L ++Q + L +D+S+N G+
Sbjct: 129 RNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGE 188
Query: 134 IPSSIGSCIR----LEQLVMNGNFFR---GNIPSSLSSLRGIENLDLSRNNF 178
C L+ L + G + ++ ++ LDLS N+
Sbjct: 189 RGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSL 240
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 5e-11
Identities = 41/194 (21%), Positives = 71/194 (36%), Gaps = 20/194 (10%)
Query: 3 TLVGNQFTGRIPGS---IGDLHKLQRLTLEMNKFWGEIPSSIGNLTL--LITLNFAENML 57
T+ + RI + + LQ LTLE + G P + T L LN N+
Sbjct: 74 TVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNL-RNVS 132
Query: 58 EGSIPSSLGKCQNLIL-----LDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPL-- 110
+ + L + Q + L ++ + + +V +LS LDLS N G
Sbjct: 133 WATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALS-TLDLSDNPELGERGL 191
Query: 111 -----PSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSS- 164
P F L+ L + SG + + ++L+ L ++ N R +
Sbjct: 192 ISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDW 251
Query: 165 LRGIENLDLSRNNF 178
+ +L+LS
Sbjct: 252 PSQLNSLNLSFTGL 265
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 2e-07
Identities = 21/151 (13%), Positives = 47/151 (31%), Gaps = 8/151 (5%)
Query: 42 GNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLS--IYL 99
G +L L + + + + K +L L + + + + +S L
Sbjct: 41 GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100
Query: 100 DLSQNQLNGPLPSNFGIL--KNLGAIDISENKLSG--QIPSSIGSCI--RLEQLVMNGNF 153
L ++ G P +L +++ + + + + L+ L +
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAH 160
Query: 154 FRGNIPSSLSSLRGIENLDLSRNNFIRHRNL 184
+ + LDLS N + R L
Sbjct: 161 SLNFSCEQVRVFPALSTLDLSDNPELGERGL 191
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 2e-06
Identities = 23/104 (22%), Positives = 33/104 (31%), Gaps = 7/104 (6%)
Query: 7 NQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSI-GNLTLLITLNFAENMLEGSIPSSL 65
+G +LQ L L N + + L +LN + L+ +P L
Sbjct: 214 ETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL 272
Query: 66 GKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGP 109
L +LDLS N L L + L L N
Sbjct: 273 P--AKLSVLDLSYNRLDRNPSP--DELPQVG-NLSLKGNPFLDS 311
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 3e-13
Identities = 40/159 (25%), Positives = 71/159 (44%), Gaps = 24/159 (15%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
++H N+V+ S F+ N S +V ++ G L + ++ + L Q L V
Sbjct: 80 MKHPNIVQYRES-----FEENGSLYIVMDYCEGGDLFKRINAQKGVL--FQEDQILDWFV 132
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIAE 298
+ AL ++H + I+H D+K N+ L + T +GDFG+A+ L +T I
Sbjct: 133 QICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL-NSTVELARACI-- 186
Query: 299 YG----MGSEV------STSGDVYSFGILLLETFTGKRP 327
G + E+ + D+++ G +L E T K
Sbjct: 187 -GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 4e-13
Identities = 47/178 (26%), Positives = 77/178 (43%), Gaps = 13/178 (7%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSI-GNLTLLITLNFAENMLEGSIP 62
L N+ T G +L L L L NK +I L L L ++N L+ +P
Sbjct: 59 LQNNKITEIKDGDFKNLKNLHTLILINNKI-SKISPGAFAPLVKLERLYLSKNQLK-ELP 116
Query: 63 SSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQL-NGPLPSN-FGILKNL 120
+ K L L + N +T + GL+ + I ++L N L + + + F +K L
Sbjct: 117 EKMPK--TLQELRVHENEITKVRKSVFNGLNQM-IVVELGTNPLKSSGIENGAFQGMKKL 173
Query: 121 GAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPS-SLSSLRGIENLDLSRNN 177
I I++ ++ IP G L +L ++GN + + SL L + L LS N+
Sbjct: 174 SYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNS 227
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 3e-12
Identities = 31/172 (18%), Positives = 55/172 (31%), Gaps = 15/172 (8%)
Query: 14 PGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS-SLGKCQNLI 72
G+ + KL + + IP G L L+ N + + + SL NL
Sbjct: 164 NGAFQGMKKLSYIRIADTNI-TTIPQ--GLPPSLTELHLDGNKIT-KVDAASLKGLNNLA 219
Query: 73 LLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSG 132
L LS N+++ + L L L+ N+L +P K + + + N +S
Sbjct: 220 KLGLSFNSISAVDNGSLANTPHLR-ELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISA 277
Query: 133 ------QIPSSIGSCIRLEQLVMNGNFFR-GNIPSSL-SSLRGIENLDLSRN 176
P + + N + I S + + L
Sbjct: 278 IGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 9e-12
Identities = 41/178 (23%), Positives = 76/178 (42%), Gaps = 12/178 (6%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSI-GNLTLLITLNFAENMLEGSI- 61
L NQ +P + LQ L + N+ ++ S+ L +I + N L+ S
Sbjct: 107 LSKNQLK-ELPEKM--PKTLQELRVHENEI-TKVRKSVFNGLNQMIVVELGTNPLKSSGI 162
Query: 62 -PSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNL 120
+ + L + +++ N+T T P + SL+ L L N++ ++ L NL
Sbjct: 163 ENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLT-ELHLDGNKITKVDAASLKGLNNL 218
Query: 121 GAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178
+ +S N +S S+ + L +L +N N +P L+ + I+ + L NN
Sbjct: 219 AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNI 275
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 4e-11
Identities = 35/157 (22%), Positives = 54/157 (34%), Gaps = 9/157 (5%)
Query: 23 LQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLT 82
L L+ NK NL L TL N + P + L L LS N L
Sbjct: 54 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 113
Query: 83 GTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKL-SGQIPSSI-GS 140
P ++ +L L + +N++ S F L + +++ N L S I +
Sbjct: 114 -ELPEKM--PKTLQ-ELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQG 169
Query: 141 CIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNN 177
+L + + IP L + L L N
Sbjct: 170 MKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNK 203
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 4e-13
Identities = 21/179 (11%), Positives = 50/179 (27%), Gaps = 42/179 (23%)
Query: 179 IRHRNLVKIITSCASVDF-QGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIA 237
I + +++ D +V E++ GSL+E + + + +
Sbjct: 88 IDKPGVARVL------DVVHTRAGGLVVAEWIRGGSLQEVAD------TSPSPVGAIRAM 135
Query: 238 VDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIA 297
+A+A D H + PS V + + +
Sbjct: 136 QSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYP------------------- 173
Query: 298 EYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEALPERLAEIVDP 356
+ + D+ G L + P + + + A + + ++P
Sbjct: 174 --ATMPDANPQDDIRGIGASLYALLVNRWP----LPEA-GVRSGLAPAERDTAGQPIEP 225
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 4e-13
Identities = 41/177 (23%), Positives = 66/177 (37%), Gaps = 6/177 (3%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSI-GNLTLLITLNFAE-NMLEGSI 61
L N T G+ L KL+ L L N IPS + L+ L+ E LE
Sbjct: 130 LFDNWLTVIPSGAFEYLSKLRELWLRNNPI-ESIPSYAFNRVPSLMRLDLGELKKLEYIS 188
Query: 62 PSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLG 121
+ NL L+L N+ + L L L++S N P +F L +L
Sbjct: 189 EGAFEGLFNLKYLNLGMCNIK--DMPNLTPLVGLE-ELEMSGNHFPEIRPGSFHGLSSLK 245
Query: 122 AIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178
+ + +++S ++ L +L + N + LR + L L N +
Sbjct: 246 KLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 7e-13
Identities = 47/230 (20%), Positives = 79/230 (34%), Gaps = 22/230 (9%)
Query: 6 GNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSL 65
+ +P I + L L N + +L L L N + +
Sbjct: 63 RRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAF 119
Query: 66 GKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDI 125
+L L+L +N LT LS L L L N + F + +L +D+
Sbjct: 120 NGLASLNTLELFDNWLTVIPSGAFEYLSKLR-ELWLRNNPIESIPSYAFNRVPSLMRLDL 178
Query: 126 SE-NKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNFIRHRNL 184
E KL + L+ L + + ++P +L+ L G+E L++S N+
Sbjct: 179 GELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNH------- 229
Query: 185 VKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRL 234
F G S L +++N + + N A L L L
Sbjct: 230 ---FPEIRPGSFHGLSS--LKKLWVMNSQVSL-IERN--AFDGLASLVEL 271
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 9e-12
Identities = 49/223 (21%), Positives = 79/223 (35%), Gaps = 31/223 (13%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNK--------FWG---------------EIPSS 40
L+ N + LH L+ L L N F G IPS
Sbjct: 82 LMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSG 141
Query: 41 I-GNLTLLITLNFAENMLEGSIPS-SLGKCQNLILLDLSNNN-LTGTTPTEVIGLSSLSI 97
L+ L L N +E SIPS + + +L+ LDL L + GL +L
Sbjct: 142 AFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLK- 199
Query: 98 YLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGN 157
YL+L + +P+ L L +++S N P S L++L + +
Sbjct: 200 YLNLGMCNIKD-MPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLI 257
Query: 158 IPSSLSSLRGIENLDLSRNNFIR-HRNLVKIITSCASVDFQGN 199
++ L + L+L+ NN +L + + N
Sbjct: 258 ERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 24/105 (22%), Positives = 40/105 (38%), Gaps = 3/105 (2%)
Query: 3 TLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIP 62
L +P ++ L L+ L + N F P S L+ L L + +
Sbjct: 202 NLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIER 259
Query: 63 SSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLN 107
++ +L+ L+L++NNL+ L L L L N N
Sbjct: 260 NAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLV-ELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 5e-05
Identities = 24/113 (21%), Positives = 41/113 (36%), Gaps = 7/113 (6%)
Query: 68 CQNLIL-LDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDIS 126
C N + + L+ P G+ S + YL+L +N + F L +L + +
Sbjct: 52 CSNQFSKVVCTRRGLS-EVPQ---GIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLG 107
Query: 127 ENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPS-SLSSLRGIENLDLSRNNF 178
N + + L L + N+ IPS + L + L L N
Sbjct: 108 RNSIRQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPI 159
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 8e-13
Identities = 46/269 (17%), Positives = 104/269 (38%), Gaps = 40/269 (14%)
Query: 165 LRGIENLDLSRNNFIRHRNLVKIITSCASVDFQGNDSE--ALVYEFMVNGSLEEWLHPNR 222
L+ + + D ++ + + +++K++ + +G + +V+E + +L +
Sbjct: 69 LQRVNDADNTKEDSMGANHILKLLDH---FNHKGPNGVHVVMVFEVL-GENLLALIKKYE 124
Query: 223 EALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAH------VG 276
L +++ I+ + LDY+H C I+H D+KP NVL++ + +
Sbjct: 125 HRGIPLIYVKQ--ISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIA 180
Query: 277 DFGLAKFLPEATNNFF--NFQIA-EYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFT 333
D G A + E N + E +G+ D++S L+ E TG +F
Sbjct: 181 DLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF----LFE 236
Query: 334 GNLTLHNFVKEALPERLAEIVD-----PVLLVEREEGETSKANAHKQFTRSFSVKECLVS 388
+ H++ K+ + +A+I++ P L+ + F ++
Sbjct: 237 PD-EGHSYTKDD--DHIAQIIELLGELPSYLLRNGK------YTRTFFNSRGLLRNISKL 287
Query: 389 VLGIGVTCSSELPRERMNMEEVAAQLLSF 417
L + ++ A ++ F
Sbjct: 288 ---KFWPLEDVLTEKYKFSKDEAKEISDF 313
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 32/180 (17%), Positives = 62/180 (34%), Gaps = 9/180 (5%)
Query: 3 TLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIP 62
+ + L N + + G+LT L TL N L+ +
Sbjct: 306 NFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELS 364
Query: 63 SSLG---KCQNLILLDLSNNNLTGTTPTEVI-GLSSLSIYLDLSQNQLNGPLPSNFGILK 118
+ ++L LD+S N+++ SL L++S N L +
Sbjct: 365 KIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLL-SLNMSSNILTDTIFRCL--PP 421
Query: 119 NLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178
+ +D+ NK+ IP + L++L + N + L ++ + L N +
Sbjct: 422 RIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 3e-11
Identities = 41/206 (19%), Positives = 68/206 (33%), Gaps = 6/206 (2%)
Query: 23 LQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLT 82
L + N S I +L+ L L + N ++ S Q L LDLS+N L
Sbjct: 23 TTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV 82
Query: 83 GTTPTEVIGLSSLSIYLDLSQNQLNG-PLPSNFGILKNLGAIDISENKLSGQIPSSIGSC 141
+ +L +LDLS N + P+ FG + L + +S L I
Sbjct: 83 KISCH---PTVNLK-HLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHL 138
Query: 142 IRLE-QLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNFIRHRNLVKIITSCASVDFQGND 200
+ LV+ + P L + N H L + + A+++
Sbjct: 139 NISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIK 198
Query: 201 SEALVYEFMVNGSLEEWLHPNREALK 226
+ S+ L N +
Sbjct: 199 CVLEDNKCSYFLSILAKLQTNPKLSN 224
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 4e-09
Identities = 37/234 (15%), Positives = 68/234 (29%), Gaps = 13/234 (5%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS 63
+ N + I L KL+ L + N+ S L L+ + N L I
Sbjct: 28 ISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISC 86
Query: 64 SLGKCQNLILLDLSNNNLTGTTPTEVIG-LSSLSIYLDLSQNQLNGPLPSNFGILKNLGA 122
NL LDLS N + G +S L +L LS L L
Sbjct: 87 --HPTVNLKHLDLSFNAFDALPICKEFGNMSQLK-FLGLSTTHLEKSSVLPIAHLNISKV 143
Query: 123 IDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNFIRHR 182
+ + + E L + + I ++ + +
Sbjct: 144 LLVLGETYGEKEDPEGLQDFNTESLHIV--------FPTNKEFHFILDVSVKTVANLELS 195
Query: 183 NLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSI 236
N+ ++ F ++ + N +L ++ L L+ ++
Sbjct: 196 NIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTV 249
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 25/160 (15%), Positives = 55/160 (34%), Gaps = 6/160 (3%)
Query: 23 LQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLT 82
+ + L+ + + S +L L ++ N+ + + + +
Sbjct: 254 ISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTR 313
Query: 83 GTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIG--- 139
+S +LD S N L + N G L L + + N+L ++
Sbjct: 314 MVHMLCPSKISPFL-HLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTT 371
Query: 140 SCIRLEQLVMNGNFFRGNIPSSL-SSLRGIENLDLSRNNF 178
L+QL ++ N + S + + +L++S N
Sbjct: 372 QMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNIL 411
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 3e-06
Identities = 30/109 (27%), Positives = 46/109 (42%), Gaps = 7/109 (6%)
Query: 70 NLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENK 129
+ L+D S N L P LS + L++SQN ++ S+ L L + IS N+
Sbjct: 1 SEFLVDRSKNGLI-HVPK---DLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNR 56
Query: 130 LSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178
+ S LE L ++ N +L+ +LDLS N F
Sbjct: 57 IQYLDISVFKFNQELEYLDLSHNKLVKISCHPTVNLK---HLDLSFNAF 102
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 3e-04
Identities = 16/113 (14%), Positives = 30/113 (26%), Gaps = 4/113 (3%)
Query: 70 NLILLDLSNNNLTGTTPTEVIGLSSLSI----YLDLSQNQLNGPLPSNFGILKNLGAIDI 125
+ +SN L G S S+ + + P + I N+ +
Sbjct: 248 TVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNF 307
Query: 126 SENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178
+ + L + N + + L +E L L N
Sbjct: 308 TVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQL 360
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 35/167 (20%), Positives = 64/167 (38%), Gaps = 33/167 (19%)
Query: 180 RHRNLVKIITSCASVDFQGNDSEALVYEFM--VNGSLEEWLHPNREALKNLNLLQRLSIA 237
H N+++ + F Y + +L+E++ A L + +++
Sbjct: 76 EHPNVIRYFCTEKDRQF--------QYIAIELCAATLQEYVEQKDFAHLGL---EPITLL 124
Query: 238 VDVASALDYLHHYCETPIVHCDLKPSNVLL-----DGELTAHVGDFGLAKFLPEATNNFF 292
S L +LH IVH DLKP N+L+ G++ A + DFGL K L ++F
Sbjct: 125 QQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFS 181
Query: 293 NFQIA---EYGMGSEV---------STSGDVYSFGILLLETFTGKRP 327
E + E+ + + D++S G + +
Sbjct: 182 RRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 68.2 bits (166), Expect = 2e-12
Identities = 45/166 (27%), Positives = 63/166 (37%), Gaps = 29/166 (17%)
Query: 179 IRHRNLVKII-TSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIA 237
+ H N+V ND L E+ G L ++L+ E L ++
Sbjct: 69 LNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLN-QFENCCGLKEGPIRTLL 127
Query: 238 VDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAH---VGDFGLAKFLPEATNNFFN- 293
D++SAL YLH E I+H DLKP N++L + D G AK L +
Sbjct: 128 SDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ--GELCTE 182
Query: 294 ------------FQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRP 327
+ +Y V D +SFG L E TG RP
Sbjct: 183 FVGTLQYLAPELLEQKKY--TVTV----DYWSFGTLAFECITGFRP 222
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 2e-12
Identities = 53/278 (19%), Positives = 98/278 (35%), Gaps = 53/278 (19%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+ H+N+VK+ A + + L+ EF GSL L L + L +
Sbjct: 64 LNHKNIVKLF---AIEEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLR 119
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLL----DGELTAHVGDFGLAKFL---------- 284
DV +++L E IVH ++KP N++ DG+ + DFG A+ L
Sbjct: 120 DVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY 176
Query: 285 -------PEATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLT 337
P+ + + G+ V D++S G+ TG P
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATV----DLWSIGVTFYHAATGSLP---------- 222
Query: 338 LHNFVKEALPERLAEIVDPVLL---VEREEGETSKANAHKQFTRSFSVKECLVSVLGIGV 394
F P R E++ ++ G N ++ V L L + +
Sbjct: 223 ---FRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLL 279
Query: 395 T--CSSEL---PRERMNMEEVAAQLLSFRNKLVKNILC 427
T ++ L + ++ A+ +++V ++
Sbjct: 280 TPVLANILEADQEKCWGFDQFFAETSDILHRMVIHVFS 317
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-12
Identities = 40/170 (23%), Positives = 66/170 (38%), Gaps = 32/170 (18%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+ H+N+VK+ A + + L+ EF GSL L L + L +
Sbjct: 64 LNHKNIVKLF---AIEEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLR 119
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLL----DGELTAHVGDFGLAKFL---------- 284
DV +++L E IVH ++KP N++ DG+ + DFG A+ L
Sbjct: 120 DVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY 176
Query: 285 -------PEATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRP 327
P+ + + G+ V D++S G+ TG P
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATV----DLWSIGVTFYHAATGSLP 222
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 3e-12
Identities = 37/169 (21%), Positives = 67/169 (39%), Gaps = 37/169 (21%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
I++ + D ++YE+M N S+ ++ KN + +
Sbjct: 100 IKNEYCLTCEGI-----ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK 154
Query: 239 ----DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL---------- 284
V ++ Y+H+ E I H D+KPSN+L+D + DFG ++++
Sbjct: 155 CIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRG 212
Query: 285 ------PEATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRP 327
PE +N ++ G++V D++S GI L F P
Sbjct: 213 TYEFMPPEFFSNESSYN------GAKV----DIWSLGICLYVMFYNVVP 251
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 31/175 (17%), Positives = 57/175 (32%), Gaps = 11/175 (6%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSI-GNLTLLITLNFAENMLEGSIP 62
+ + +++ L L + EI + + L N + P
Sbjct: 58 FKNSTMRKLPAALLDSFRQVELLNLNDLQI-EEIDTYAFAYAHTIQKLYMGFNAIRYLPP 116
Query: 63 SSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGA 122
L +L L N+L+ L L +S N L F +L
Sbjct: 117 HVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKL-TTLSMSNNNLERIEDDTFQATTSLQN 175
Query: 123 IDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNN 177
+ +S N+L+ + + L ++ N S+L+ +E LD S N+
Sbjct: 176 LQLSSNRLT-HVD--LSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNS 222
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 1e-11
Identities = 38/226 (16%), Positives = 81/226 (35%), Gaps = 19/226 (8%)
Query: 19 DLHKLQRLTLEMNKFWGEIPSSI-GNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLS 77
L+ + +T + + ++P+++ + + LN + +E + + L +
Sbjct: 49 TLNNQKIVTFKNSTM-RKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMG 107
Query: 78 NNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSS 137
N + P + L L L +N L+ F L + +S N L +I
Sbjct: 108 FNAIRYLPPHVFQNVPLL-TVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDD 165
Query: 138 I-GSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNFIRHRNLVKIITSCASVDF 196
+ L+ L ++ N ++ LS + + + ++S N + + I + +D
Sbjct: 166 TFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLL----STLAIPIAVEELDA 218
Query: 197 QGNDSEALVYEFMVNGSLEE-WLHPNR----EALKNLNLLQRLSIA 237
N + VN L L N L N L + ++
Sbjct: 219 SHNSINVV--RGPVNVELTILKLQHNNLTDTAWLLNYPGLVEVDLS 262
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 4e-10
Identities = 47/252 (18%), Positives = 89/252 (35%), Gaps = 41/252 (16%)
Query: 3 TLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIP 62
N + G + +L L L+ N + + N L+ ++ + N LE +
Sbjct: 217 DASHNSIN-VVRGPV--NVELTILKLQHNNL--TDTAWLLNYPGLVEVDLSYNELEKIMY 271
Query: 63 SSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGA 122
K Q L L +SNN L L + L
Sbjct: 272 HPFVKMQRLERLYISNNRLVA--------------------------LNLYGQPIPTLKV 305
Query: 123 IDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNFIRHR 182
+D+S N L + + RLE L ++ N + LS+ ++NL LS N+
Sbjct: 306 LDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHND-WDCN 360
Query: 183 NLVKIITSCASVDFQGNDSEALVYEFMVNG-----SLEEWLHPNREALKNLNLLQRLSIA 237
+L + + A D + + +G S + +L + + ++++++ A
Sbjct: 361 SLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRA 420
Query: 238 VDVASALDYLHH 249
SA D ++
Sbjct: 421 QGRCSATDTINS 432
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 18/142 (12%), Positives = 42/142 (29%), Gaps = 1/142 (0%)
Query: 36 EIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSL 95
I S++ + ++ + N ++ N+ + + +
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 77
Query: 96 SIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFR 155
L+L+ Q+ F + + + N + P + L LV+ N
Sbjct: 78 E-LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 136
Query: 156 GNIPSSLSSLRGIENLDLSRNN 177
+ + L +S NN
Sbjct: 137 SLPRGIFHNTPKLTTLSMSNNN 158
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 4e-12
Identities = 43/204 (21%), Positives = 77/204 (37%), Gaps = 41/204 (20%)
Query: 179 IRHRNL--VKIITSCASVDFQGNDSEALVYEFM--VNGSLEEWLHPNREALKNLNLLQRL 234
++ + +++ D++ D +Y M N L WL K+++ +R
Sbjct: 111 LQQHSDKIIRLY------DYEITDQY--IYMVMECGNIDLNSWLKKK----KSIDPWERK 158
Query: 235 SIAVDVASALDYLHHYCETPIVHCDLKPSNVLLD-GELTAHVGDFGLAKFLPEATNNFF- 292
S ++ A+ +H + IVH DLKP+N L+ G L + DFG+A + T +
Sbjct: 159 SYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGML--KLIDFGIANQMQPDTTSVVK 213
Query: 293 ------------------NFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTG 334
+ S++S DV+S G +L GK P ++
Sbjct: 214 DSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ 273
Query: 335 NLTLHNFVKEALPERLAEIVDPVL 358
LH + +I + L
Sbjct: 274 ISKLHAIIDPNHEIEFPDIPEKDL 297
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 4e-12
Identities = 36/163 (22%), Positives = 54/163 (33%), Gaps = 30/163 (18%)
Query: 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNR---EALKNLNLLQRLSI 236
+V + + + + E + GSL + + E L Q L
Sbjct: 108 SSPRIVPLYGA-----VREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALE- 161
Query: 237 AVDVASALDYLHHYCETPIVHCDLKPSNVLLDGE-LTAHVGDFGLAKFLPE-----ATNN 290
L+YLH I+H D+K NVLL + A + DFG A L +
Sbjct: 162 ------GLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLT 212
Query: 291 FFNFQIAEYGMGSEV------STSGDVYSFGILLLETFTGKRP 327
E M EV D++S ++L G P
Sbjct: 213 GDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 4e-12
Identities = 37/144 (25%), Positives = 58/144 (40%), Gaps = 30/144 (20%)
Query: 204 LVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPS 263
+V E N L WL K+++ +R S ++ A+ +H + IVH DLKP+
Sbjct: 105 MVMEC-GNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPA 156
Query: 264 NVLLD-GELTAHVGDFGLAKFLPEATNNFF-------------------NFQIAEYGMGS 303
N L+ G L + DFG+A + T + + S
Sbjct: 157 NFLIVDGML--KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKS 214
Query: 304 EVSTSGDVYSFGILLLETFTGKRP 327
++S DV+S G +L GK P
Sbjct: 215 KISPKSDVWSLGCILYYMTYGKTP 238
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 6e-12
Identities = 39/169 (23%), Positives = 66/169 (39%), Gaps = 39/169 (23%)
Query: 181 HRNLVKIITSCASVDFQGNDSEALVYEFM--VNGSLEEWLHPNREALKNLNLLQRLSIAV 238
++++ D++ D +Y M N L WL K+++ +R S
Sbjct: 68 SDKIIRLY------DYEITDQY--IYMVMECGNIDLNSWLKKK----KSIDPWERKSYWK 115
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLD-GELTAHVGDFGLAKFLPEATNNFF----- 292
++ A+ +H + IVH DLKP+N L+ G L + DFG+A + T +
Sbjct: 116 NMLEAVHTIH---QHGIVHSDLKPANFLIVDGML--KLIDFGIANQMQPDTTSVVKDSQV 170
Query: 293 --------------NFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRP 327
+ S++S DV+S G +L GK P
Sbjct: 171 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 65.4 bits (159), Expect = 7e-12
Identities = 29/235 (12%), Positives = 64/235 (27%), Gaps = 31/235 (13%)
Query: 168 IENLDLSRNNFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREAL-K 226
I + R +K ++ + LV E G+L ++ + K
Sbjct: 113 IGTQLMERLKPSMQHMFMKFYSA-----HLFQNGSVLVGELYSYGTLLNAINLYKNTPEK 167
Query: 227 NLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVG---------- 276
+ +S A+ + ++ +H + I+H D+KP N +L
Sbjct: 168 VMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLAL 224
Query: 277 -DFGLAKFLPEATNNFFNFQIA---EYGMGSEV------STSGDVYSFGILLLETFTGKR 326
D G + + + E+ + D + + G
Sbjct: 225 IDLGQSIDMKLFPKGTIFTAKCETSGF-QCVEMLSNKPWNYQIDYFGVAATVYCMLFGTY 283
Query: 327 PTNEMFTGNLTLHNFVKEAL-PERLAEIVDPVLLVEREEGETSKANAHKQFTRSF 380
+ G + + E +L + S ++ + F
Sbjct: 284 MKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF 338
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 8e-12
Identities = 42/191 (21%), Positives = 64/191 (33%), Gaps = 19/191 (9%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSI-GNLTLLITLNFAENMLEGSIP 62
L N S L LQ L +E I ++ L+ LI L N +
Sbjct: 37 LSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLE 95
Query: 63 SS-LGKCQNLILLDLSNNNLTGTT-PTEV-IGLSSLSIYLDLSQNQLNGPLPSN-FGILK 118
+ NL +L L+ NL G L+SL L L N + P++ F ++
Sbjct: 96 TGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLE-MLVLRDNNIKKIQPASFFLNMR 154
Query: 119 NLGAIDISENKLSGQIPSSIGSCIRLEQLV-----------MNGNFFRGNIPSSLSSLRG 167
+D++ NK+ I + + MN + +
Sbjct: 155 RFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTS 213
Query: 168 IENLDLSRNNF 178
I LDLS N F
Sbjct: 214 ITTLDLSGNGF 224
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 37/195 (18%), Positives = 75/195 (38%), Gaps = 24/195 (12%)
Query: 3 TLVGNQFTGRIPGSIGDLHKLQRL-TLEMNKFWGEIPSSIGN--------------LTLL 47
L GN F + D ++ +L ++ + S + +
Sbjct: 218 DLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGV 277
Query: 48 ITLNFAENMLEGSIPSSL-GKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQL 106
T + +++ + ++ S+ +L L L+ N + GL+ L L+LSQN L
Sbjct: 278 KTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLL-KLNLSQNFL 335
Query: 107 NGPLPSN-FGILKNLGAIDISENKLSGQIPSSI-GSCIRLEQLVMNGNFFRGNIPSS-LS 163
G + S F L L +D+S N + + L++L ++ N + ++P
Sbjct: 336 -GSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPDGIFD 392
Query: 164 SLRGIENLDLSRNNF 178
L ++ + L N +
Sbjct: 393 RLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 36/188 (19%), Positives = 64/188 (34%), Gaps = 20/188 (10%)
Query: 7 NQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLG 66
G+ + L L N F + + + ++ SS G
Sbjct: 198 YWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFG 257
Query: 67 KCQ---------------NLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLP 111
+ DLS + + + + L L L+QN++N +
Sbjct: 258 HTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLE-QLTLAQNEIN-KID 315
Query: 112 SN-FGILKNLGAIDISENKLSGQIPSSI-GSCIRLEQLVMNGNFFRGNIPSSLSSLRGIE 169
N F L +L +++S+N L I S + + +LE L ++ N R S L ++
Sbjct: 316 DNAFWGLTHLLKLNLSQNFLGS-IDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLK 374
Query: 170 NLDLSRNN 177
L L N
Sbjct: 375 ELALDTNQ 382
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 5e-07
Identities = 32/135 (23%), Positives = 53/135 (39%), Gaps = 7/135 (5%)
Query: 49 TLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEVI-GLSSLSIYLDLSQNQLN 107
++ + N + +S + Q+L L + GLSSL L L NQ
Sbjct: 34 YVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLI-ILKLDYNQFL 92
Query: 108 GPLPSN-FGILKNLGAIDISENKL-SGQIPSSI-GSCIRLEQLVMNGNFFRGNIPSSL-S 163
L + F L NL + +++ L + + LE LV+ N + P+S
Sbjct: 93 Q-LETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFL 151
Query: 164 SLRGIENLDLSRNNF 178
++R LDL+ N
Sbjct: 152 NMRRFHVLDLTFNKV 166
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 40/226 (17%), Positives = 70/226 (30%), Gaps = 53/226 (23%)
Query: 4 LVGNQFTGRIPGSIGD-LHKLQRLTLEMNKFWGEIPSSI------GNLTLL-----ITLN 51
L N P S + + L L NK I + TLL +
Sbjct: 136 LRDNNIKKIQPASFFLNMRRFHVLDLTFNK-VKSICEEDLLNFQGKHFTLLRLSSITLQD 194
Query: 52 FAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLS--------------- 96
E L + K ++ LDLS N + + +
Sbjct: 195 MNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGS 254
Query: 97 -----------------------IYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQ 133
DLS++++ L S F +L + +++N+++ +
Sbjct: 255 SFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN-K 313
Query: 134 IPSSI-GSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178
I + L +L ++ NF +L +E LDLS N+
Sbjct: 314 IDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHI 359
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 32/159 (20%), Positives = 63/159 (39%), Gaps = 13/159 (8%)
Query: 19 DLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSN 78
+ + L+ + L + + + ++ S+ + N+ L L+
Sbjct: 19 AFAETIKDNLKKKSV--TDAVTQNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNG 74
Query: 79 NNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSI 138
N LT P L +L +L L +N++ S+ LK L ++ + N +S I + +
Sbjct: 75 NKLTDIKPLT--NLKNLG-WLFLDENKIKD--LSSLKDLKKLKSLSLEHNGIS-DI-NGL 127
Query: 139 GSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNN 177
+LE L + N + + LS L ++ L L N
Sbjct: 128 VHLPQLESLYLGNN--KITDITVLSRLTKLDTLSLEDNQ 164
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 60.1 bits (145), Expect = 6e-10
Identities = 35/174 (20%), Positives = 70/174 (40%), Gaps = 13/174 (7%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS 63
L N+ + + DL KL+ L+LE N +I + + +L L +L N + + +
Sbjct: 94 LDENKIK-DLSS-LKDLKKLKSLSLEHNGI-SDI-NGLVHLPQLESLYLGNNKI--TDIT 147
Query: 64 SLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAI 123
L + L L L +N ++ P + GL+ L L LS+N ++ LKNL +
Sbjct: 148 VLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQ-NLYLSKNHISD--LRALAGLKNLDVL 202
Query: 124 DISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNN 177
++ + + + + + + P +S E ++ +
Sbjct: 203 ELFSQECLNKPINHQSNLVVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKWHL 254
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 40/198 (20%), Positives = 70/198 (35%), Gaps = 32/198 (16%)
Query: 63 SSLGKCQNLILLDLSNNNLTGTTP-TEVIGLSSLSIY------------------LDLSQ 103
I +L ++T E+ + + L L+
Sbjct: 15 FPDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQYLPNVTKLFLNG 74
Query: 104 NQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLS 163
N+L LKNLG + + ENK+ + SS+ +L+ L + N +I + L
Sbjct: 75 NKLTD--IKPLTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLEHNGIS-DI-NGLV 128
Query: 164 SLRGIENLDLSRNNFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEE-WLHPNR 222
L +E+L L N I ++ +T ++ + N +V L+ +L N
Sbjct: 129 HLPQLESLYLGNNK-ITDITVLSRLTKLDTLSLEDNQISDIV-PLAGLTKLQNLYLSKNH 186
Query: 223 ----EALKNLNLLQRLSI 236
AL L L L +
Sbjct: 187 ISDLRALAGLKNLDVLEL 204
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 40.9 bits (95), Expect = 7e-04
Identities = 26/163 (15%), Positives = 50/163 (30%), Gaps = 9/163 (5%)
Query: 16 SIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLD 75
+ L KL L+LE N+ + LT L L ++N + S +L +NL +L+
Sbjct: 148 VLSRLTKLDTLSLEDNQI--SDIVPLAGLTKLQNLYLSKNHI--SDLRALAGLKNLDVLE 203
Query: 76 LSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLP-SNFGILKNLGAIDISENKLSGQI 134
L + L + + + L P S+ G + ++ +
Sbjct: 204 LFSQECLNKPINHQSNLVVPN-TVKNTDGSLVTPEIISDDGDYEKP---NVKWHLPEFTN 259
Query: 135 PSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNN 177
S + F ++D +
Sbjct: 260 EVSFIFYQPVTIGKAKARFHGRVTQPLKEVYTVSYDVDGTVIK 302
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 41/177 (23%), Positives = 65/177 (36%), Gaps = 12/177 (6%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPS-SIGNLTLLITLNFAENMLEGSIP 62
L N + L L L L NK +I + L L L ++N L IP
Sbjct: 61 LQNNDISELRKDDFKGLQHLYALVLVNNKI-SKIHEKAFSPLRKLQKLYISKNHLV-EIP 118
Query: 63 SSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQL-NGPLPSNFGILKNLG 121
+L +L+ L + +N + GL ++ +++ N L N L
Sbjct: 119 PNLPS--SLVELRIHDNRIRKVPKGVFSGLRNM-NCIEMGGNPLENSGFEPGAFDGLKLN 175
Query: 122 AIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPS-SLSSLRGIENLDLSRNN 177
+ ISE KL+ IP + L +L ++ N + I L + L L N
Sbjct: 176 YLRISEAKLT-GIPKDLPE--TLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQ 228
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 4e-11
Identities = 32/177 (18%), Positives = 64/177 (36%), Gaps = 11/177 (6%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSI-GNLTLLITLNFAENML-EGSI 61
+ N IP ++ L L + N+ ++P + L + + N L
Sbjct: 109 ISKNHLV-EIPPNL--PSSLVELRIHDNRI-RKVPKGVFSGLRNMNCIEMGGNPLENSGF 164
Query: 62 PSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLG 121
L L +S LT P ++ +L+ L L N++ + L
Sbjct: 165 EPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLN-ELHLDHNKIQAIELEDLLRYSKLY 220
Query: 122 AIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178
+ + N++ S+ L +L ++ N +P+ L L+ ++ + L NN
Sbjct: 221 RLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNI 276
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 32/156 (20%), Positives = 52/156 (33%), Gaps = 8/156 (5%)
Query: 23 LQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLT 82
L L+ N L L L N + + + L L +S N+L
Sbjct: 56 TTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV 115
Query: 83 GTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKL-SGQIPSSIGSC 141
P + SSL L + N++ F L+N+ I++ N L +
Sbjct: 116 -EIPPNL--PSSLV-ELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDG 171
Query: 142 IRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNN 177
++L L ++ IP L + L L N
Sbjct: 172 LKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNK 204
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 6e-07
Identities = 29/135 (21%), Positives = 48/135 (35%), Gaps = 12/135 (8%)
Query: 4 LVGNQFTGRIP-GSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIP 62
L N+ I + KL RL L N+ S+ L L L+ N L +P
Sbjct: 200 LDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVP 257
Query: 63 SSLGKCQNLILLDLSNNNLTG------TTPTEVIGLSSLSIYLDLSQNQLNGPL--PSNF 114
+ L + L ++ L NN+T + + + + L N + P+ F
Sbjct: 258 AGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYN-GISLFNNPVPYWEVQPATF 316
Query: 115 GILKNLGAIDISENK 129
+ + AI K
Sbjct: 317 RCVTDRLAIQFGNYK 331
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-11
Identities = 30/199 (15%), Positives = 65/199 (32%), Gaps = 50/199 (25%)
Query: 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVD 239
+H ++V+ ++ + +D + E+ GSL + + N + + + +
Sbjct: 69 QHSHVVRYFSA-----WAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQ 123
Query: 240 VASALDYLHHYCETPIVHCDLKPSNVLLD-------------------GELTAHVGDFGL 280
V L Y+H +VH D+KPSN+ + ++ +GD G
Sbjct: 124 VGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 180
Query: 281 AKFLPEATNNFFNFQIAEYG----MGSEV-------STSGDVYSFGILLLETFTGKRPTN 329
+ E G + +EV D+++ + ++ +
Sbjct: 181 VTRISSPQ--------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL-- 230
Query: 330 EMFTGNLTLHNFVKEALPE 348
H + LP
Sbjct: 231 --PRNGDQWHEIRQGRLPR 247
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 4e-11
Identities = 40/181 (22%), Positives = 69/181 (38%), Gaps = 53/181 (29%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSI-- 236
+ H VK+ + FQ ++ + NG L L ++++
Sbjct: 87 LDHPFFVKLYFT-----FQDDEKLYFGLSYAKNGEL-------------LKYIRKIGSFD 128
Query: 237 -------AVDVASALDYLHHYCETPIVHCDLKPSNVLLDGE----LTAHVGDFGLAKFLP 285
++ SAL+YLH I+H DLKP N+LL+ + +T DFG AK L
Sbjct: 129 ETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQIT----DFGTAKVLS 181
Query: 286 EATNNFFNFQI---AEYGMGSEV------STSGDVYSFGILLLETFTGKRP-----TNEM 331
+ A+Y + E+ S D+++ G ++ + G P +
Sbjct: 182 PESKQARANSFVGTAQY-VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI 240
Query: 332 F 332
F
Sbjct: 241 F 241
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 5e-11
Identities = 32/102 (31%), Positives = 44/102 (43%), Gaps = 23/102 (22%)
Query: 240 VASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPE--ATNNFFNFQIA 297
+ ALDYL + I+H D+KP N+LLD H+ DF +A LP A
Sbjct: 124 LVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTM-----A 175
Query: 298 ---EYGMGSEV---------STSGDVYSFGILLLETFTGKRP 327
Y M E+ S + D +S G+ E G+RP
Sbjct: 176 GTKPY-MAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 6e-11
Identities = 40/153 (26%), Positives = 70/153 (45%), Gaps = 17/153 (11%)
Query: 186 KIITSCAS---VDFQGN-DSEALVY---EFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+++ C S V F G S+ + E M GSL++ L + +++
Sbjct: 83 QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSI 138
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFF---NFQ 295
V L YL + I+H D+KPSN+L++ + DFG++ L ++ N F
Sbjct: 139 AVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSY 196
Query: 296 IA-EYGMGSEVSTSGDVYSFGILLLETFTGKRP 327
++ E G+ S D++S G+ L+E G+ P
Sbjct: 197 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 9e-11
Identities = 37/170 (21%), Positives = 63/170 (37%), Gaps = 31/170 (18%)
Query: 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV- 238
H N+V + F ++ +V FM GS ++ + + + + L+IA
Sbjct: 84 NHPNIVPYRAT-----FIADNELWVVTSFMAYGSAKDLICTHFM-----DGMNELAIAYI 133
Query: 239 --DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEAT---NNFFN 293
V ALDY+HH VH +K S++L+ + ++ + +
Sbjct: 134 LQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHD 190
Query: 294 FQIAE----YGMGSEV---STSG-----DVYSFGILLLETFTGKRPTNEM 331
F + EV + G D+YS GI E G P +M
Sbjct: 191 FPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 240
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 1e-10
Identities = 40/174 (22%), Positives = 69/174 (39%), Gaps = 7/174 (4%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS 63
L N ++ +L +L L+ + ++ G L +L TL+ + N L+ S+P
Sbjct: 38 LSENLLYTFSLATLMPYTRLTQLNLDRAEL-TKLQVD-GTLPVLGTLDLSHNQLQ-SLPL 94
Query: 64 SLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAI 123
L +LD+S N LT + GL L L L N+L P L +
Sbjct: 95 LGQTLPALTVLDVSFNRLTSLPLGALRGLGELQ-ELYLKGNELKTLPPGLLTPTPKLEKL 153
Query: 124 DISENKLSGQIPSSI-GSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRN 176
++ N L+ ++P+ + L+ L++ N IP + L N
Sbjct: 154 SLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 4e-08
Identities = 40/157 (25%), Positives = 63/157 (40%), Gaps = 8/157 (5%)
Query: 23 LQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLT 82
L L N + +++ T L LN L + G L LDLS+N L
Sbjct: 33 TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVD-GTLPVLGTLDLSHNQLQ 90
Query: 83 GTTPTEVIGLSSLSIYLDLSQNQLNGPLPSN-FGILKNLGAIDISENKLSGQIPSSI-GS 140
+ P L +L+ LD+S N+L LP L L + + N+L +P +
Sbjct: 91 -SLPLLGQTLPALT-VLDVSFNRLTS-LPLGALRGLGELQELYLKGNELK-TLPPGLLTP 146
Query: 141 CIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNN 177
+LE+L + N L+ L ++ L L N+
Sbjct: 147 TPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENS 183
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 40/143 (27%), Positives = 61/143 (42%), Gaps = 10/143 (6%)
Query: 37 IPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLS 96
+P + L+ +EN+L ++L L L+L L T L L
Sbjct: 25 LPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL--TKLQVDGTLPVLG 80
Query: 97 IYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSI-GSCIRLEQLVMNGNFFR 155
LDLS NQL LP L L +D+S N+L+ +P L++L + GN +
Sbjct: 81 -TLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK 137
Query: 156 GNIPSSL-SSLRGIENLDLSRNN 177
+P L + +E L L+ NN
Sbjct: 138 -TLPPGLLTPTPKLEKLSLANNN 159
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 32/158 (20%), Positives = 67/158 (42%), Gaps = 13/158 (8%)
Query: 20 LHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNN 79
L ++ + + +L + TL+ + +I + NLI L+L +N
Sbjct: 18 LANAIKIAAGKSNV--TDTVTQADLDGITTLSAFGTGVT-TI-EGVQYLNNLIGLELKDN 73
Query: 80 NLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIG 139
+T P + L+ ++ L+LS N L S L+++ +D++ +++ P +
Sbjct: 74 QITDLAPLK--NLTKIT-ELELSGNPLKN--VSAIAGLQSIKTLDLTSTQITDVTP--LA 126
Query: 140 SCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNN 177
L+ L ++ N NI S L+ L ++ L +
Sbjct: 127 GLSNLQVLYLDLNQIT-NI-SPLAGLTNLQYLSIGNAQ 162
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 5e-10
Identities = 32/162 (19%), Positives = 62/162 (38%), Gaps = 13/162 (8%)
Query: 16 SIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLD 75
+ DL + L+ + L LI L +N + + + L + L+
Sbjct: 36 TQADLDGITTLSAFGTGV--TTIEGVQYLNNLIGLELKDNQIT-DL-APLKNLTKITELE 91
Query: 76 LSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIP 135
LS N L + + GL S+ LDL+ Q+ + L NL + + N+++
Sbjct: 92 LSGNPL--KNVSAIAGLQSI-KTLDLTSTQITD--VTPLAGLSNLQVLYLDLNQITN--I 144
Query: 136 SSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNN 177
S + L+ L + ++ + L++L + L N
Sbjct: 145 SPLAGLTNLQYLSIGNAQVS-DL-TPLANLSKLTTLKADDNK 184
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 7e-08
Identities = 34/172 (19%), Positives = 66/172 (38%), Gaps = 19/172 (11%)
Query: 16 SIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLD 75
+I L ++ L L + + + L+ L L N + +I S L NL L
Sbjct: 102 AIAGLQSIKTLDLTSTQI--TDVTPLAGLSNLQVLYLDLNQIT-NI-SPLAGLTNLQYLS 157
Query: 76 LSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIP 135
+ N ++ TP LS L+ L N+++ S L NL + + N++S
Sbjct: 158 IGNAQVSDLTPLA--NLSKLTT-LKADDNKISD--ISPLASLPNLIEVHLKNNQISDV-- 210
Query: 136 SSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNFIRHRNLVKI 187
S + + L + + ++++ N +L N ++ + I
Sbjct: 211 SPLANTSNLFIVTLTNQ--------TITNQPVFYNNNLVVPNVVKGPSGAPI 254
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 4e-05
Identities = 20/115 (17%), Positives = 47/115 (40%), Gaps = 9/115 (7%)
Query: 63 SSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGA 122
N I + +N+T T L ++ L + L NL
Sbjct: 13 FPDPALANAIKIAAGKSNVTDTVTQA--DLDGIT-TLSAFGTGVTT--IEGVQYLNNLIG 67
Query: 123 IDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNN 177
+++ +N+++ + + + ++ +L ++GN S+++ L+ I+ LDL+
Sbjct: 68 LELKDNQITD--LAPLKNLTKITELELSGN--PLKNVSAIAGLQSIKTLDLTSTQ 118
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 4e-04
Identities = 22/105 (20%), Positives = 39/105 (37%), Gaps = 4/105 (3%)
Query: 16 SIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLD 75
+ +L KL L + NK S + +L LI ++ N + S L NL ++
Sbjct: 168 PLANLSKLTTLKADDNKI--SDISPLASLPNLIEVHLKNNQISDV--SPLANTSNLFIVT 223
Query: 76 LSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNL 120
L+N +T L ++ S + S+ G +
Sbjct: 224 LTNQTITNQPVFYNNNLVVPNVVKGPSGAPIAPATISDNGTYASP 268
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 62.5 bits (151), Expect = 1e-10
Identities = 25/126 (19%), Positives = 45/126 (35%), Gaps = 7/126 (5%)
Query: 7 NQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLG 66
++F + ++ L L + + L L+ L+ + N L ++P +L
Sbjct: 427 SKFLLENSVLKMEYADVRVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLR-ALPPALA 483
Query: 67 KCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNG-PLPSNFGILKNLGAIDI 125
+ L +L S+N L V L L L L N+L L +++
Sbjct: 484 ALRCLEVLQASDNAL--ENVDGVANLPRLQE-LLLCNNRLQQSAAIQPLVSCPRLVLLNL 540
Query: 126 SENKLS 131
N L
Sbjct: 541 QGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 59.0 bits (142), Expect = 1e-09
Identities = 31/172 (18%), Positives = 66/172 (38%), Gaps = 18/172 (10%)
Query: 28 LEMNKFWGEIPSSIGNLTLLITLN-----FAENMLEGSIPSSLGKCQNLILLDLSNNNLT 82
L+ + E L + + + + ++ +L L++ +LT
Sbjct: 395 LDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT 454
Query: 83 GTTPTEVIGLSSLSI--YLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGS 140
+ L L + +LDLS N+L LP L+ L + S+N L + + +
Sbjct: 455 -----VLCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALE-NVDG-VAN 506
Query: 141 CIRLEQLVMNGNFFRGNIPS--SLSSLRGIENLDLSRNNFIRHRNLVKIITS 190
RL++L++ N + + L S + L+L N+ + + + +
Sbjct: 507 LPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAE 557
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 42.4 bits (99), Expect = 2e-04
Identities = 31/223 (13%), Positives = 74/223 (33%), Gaps = 24/223 (10%)
Query: 14 PGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLIL 73
+L R L + K + S + + L L +I + L+
Sbjct: 342 CRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLY 400
Query: 74 LDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQ 133
+ + T V + + + S+ L + + + ++ L+
Sbjct: 401 EKETLQYFS--TLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRV--LHLAHKDLT-- 454
Query: 134 IPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNFIRHRNLVKIITSCAS 193
+ + + + L ++ N R +P +L++LR +E L S +N + + + V +
Sbjct: 455 VLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQAS-DNALENVDGVANLPRLQE 512
Query: 194 VDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSI 236
+ N L++ + L + L L++
Sbjct: 513 LLLCNN-------------RLQQS--AAIQPLVSCPRLVLLNL 540
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 44/165 (26%), Positives = 68/165 (41%), Gaps = 24/165 (14%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWL-HPNREALKNLNLLQRLSIA 237
H N+V TS F D LV + + GS+ + + H + +L +IA
Sbjct: 70 CHHPNIVSYYTS-----FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIA 124
Query: 238 V---DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNF 294
+V L+YLH + +H D+K N+LL + + + DFG++ FL + N
Sbjct: 125 TILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNK 181
Query: 295 QIAE-----YGMGSEVSTSG-------DVYSFGILLLETFTGKRP 327
M EV D++SFGI +E TG P
Sbjct: 182 VRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 40/183 (21%), Positives = 64/183 (34%), Gaps = 45/183 (24%)
Query: 173 LSRNNFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQ 232
LS + +V + + F D + + + M G L H ++
Sbjct: 243 LSLVSTGDCPFIVCMSYA-----FHTPDKLSFILDLMNGGDL--HYHLSQH--------G 287
Query: 233 RLSI------AVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHV--GDFGLAKFL 284
S A ++ L+++H +V+ DLKP+N+LLD HV D GLA
Sbjct: 288 VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEH--GHVRISDLGLACDF 342
Query: 285 PEATNNFFNFQIAEYGMGSEVSTSGDVY-------SFGILLLETFTGKRP--------TN 329
+ + Y M EV G Y S G +L + G P +
Sbjct: 343 SKKKPHASVGTH-GY-MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH 400
Query: 330 EMF 332
E+
Sbjct: 401 EID 403
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 3e-10
Identities = 38/185 (20%), Positives = 64/185 (34%), Gaps = 12/185 (6%)
Query: 4 LVGNQFTGRIPGSI-GDLHKLQRLTLEMNKFWGEIPSSI-GNLTLLITLNFAENMLEGSI 61
L+GN + S+ L KLQ L + + +I LT L L + L+
Sbjct: 131 LLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYE 190
Query: 62 PSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGP----LPS----N 113
P SL QN+ L L V SS+ L+L L+ L + +
Sbjct: 191 PKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVE-CLELRDTDLDTFHFSELSTGETNS 249
Query: 114 FGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDL 173
+ I++ L Q+ + L +L + N + L ++ + L
Sbjct: 250 LIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWL 308
Query: 174 SRNNF 178
N +
Sbjct: 309 HTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 4e-10
Identities = 48/253 (18%), Positives = 83/253 (32%), Gaps = 23/253 (9%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSI-GNLTLLITLNFAENMLEGSIP 62
L N+ T + LQ L L N I +L L L+ + N L ++
Sbjct: 59 LSNNRITYISNSDLQRCVNLQALVLTSNGI-NTIEEDSFSSLGSLEHLDLSYNYLS-NLS 116
Query: 63 SSL-GKCQNLILLDLSNNNLTGTTPTEV-IGLSSLSIYLDLSQNQLNGPLPSNFGILKNL 120
SS +L L+L N T + L+ L I + + +F L L
Sbjct: 117 SSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFL 176
Query: 121 GAIDISENKLSGQIPSSIGSCIRLEQLVMNGN---FFRGNIPSSLSSLRGIE--NLDLSR 175
++I + L P S+ S + L+++ SS+ +E + DL
Sbjct: 177 EELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDT 236
Query: 176 NNF-----IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEE-WLHPN------RE 223
+F +L+K + +V ++ L E N
Sbjct: 237 FHFSELSTGETNSLIK-KFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDG 295
Query: 224 ALKNLNLLQRLSI 236
L LQ++ +
Sbjct: 296 IFDRLTSLQKIWL 308
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 7e-08
Identities = 24/137 (17%), Positives = 50/137 (36%), Gaps = 12/137 (8%)
Query: 3 TLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEG--- 59
+ + P S+ + + L L M + + + + + L + L+
Sbjct: 180 EIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHF 239
Query: 60 -SIPS----SLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSN- 113
+ + SL K + +++ +L + +S L L+ S+NQL +P
Sbjct: 240 SELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLL-ELEFSRNQLKS-VPDGI 296
Query: 114 FGILKNLGAIDISENKL 130
F L +L I + N
Sbjct: 297 FDRLTSLQKIWLHTNPW 313
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 3e-10
Identities = 33/138 (23%), Positives = 59/138 (42%), Gaps = 28/138 (20%)
Query: 207 EFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVL 266
E M + SL+++ + + + IAV + AL++LH + ++H D+KPSNVL
Sbjct: 86 ELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS--KLSVIHRDVKPSNVL 142
Query: 267 LDGELTAHVGDFGLAKFL-----------------PEATNNFFNFQIAEYGMGSEVSTSG 309
++ + DFG++ +L PE +I S
Sbjct: 143 INALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPE--------RINPELNQKGYSVKS 194
Query: 310 DVYSFGILLLETFTGKRP 327
D++S GI ++E + P
Sbjct: 195 DIWSLGITMIELAILRFP 212
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 3e-10
Identities = 32/148 (21%), Positives = 52/148 (35%), Gaps = 39/148 (26%)
Query: 219 HPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDF 278
P L L + + VA +++L +H DL N+LL + + DF
Sbjct: 181 APEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDF 237
Query: 279 GLAKFL--------------------PEA-TNNFFNFQIAEYGMGSEVSTSGDVYSFGIL 317
GLA+ + PE + + + DV+SFG+L
Sbjct: 238 GLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-------------TIQSDVWSFGVL 284
Query: 318 LLETFT-GKRPTNEMFTGNLTLHNFVKE 344
L E F+ G P + + +KE
Sbjct: 285 LWEIFSLGASPYPGV-KIDEEFCRRLKE 311
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 3e-10
Identities = 35/159 (22%), Positives = 61/159 (38%), Gaps = 28/159 (17%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLS--- 235
+RH N++++ F L+ E+ G++ + L L +
Sbjct: 66 LRHPNILRLYGY-----FHDATRVYLILEYAPLGTV----------YRELQKLSKFDEQR 110
Query: 236 ---IAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFF 292
++A+AL Y H ++H D+KP N+LL + DFG + P +
Sbjct: 111 TATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDL 167
Query: 293 ----NFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRP 327
++ E G D++S G+L E GK P
Sbjct: 168 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 7e-10
Identities = 37/162 (22%), Positives = 60/162 (37%), Gaps = 11/162 (6%)
Query: 23 LQRLTLEMNKFWGEIPSSI--GNLTLLITLNFAENMLEGSIPS-SLGKCQNLILLDLSNN 79
L L N + + LT L +L + N L I S + NL LDLS+N
Sbjct: 41 TALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSN 98
Query: 80 NLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIP---- 135
+L L +L L L N + + F + L + +S+N++S + P
Sbjct: 99 HLHTLDEFLFSDLQALE-VLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELI 156
Query: 136 SSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNN 177
+L L ++ N + + L L L +N
Sbjct: 157 KDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 6e-06
Identities = 23/127 (18%), Positives = 41/127 (32%), Gaps = 6/127 (4%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSI-GNLTLLITLNFAENMLEGSIP 62
L N + + L+ L L N + + +L L L N + +
Sbjct: 71 LSHNHLNFISSEAFVPVPNLRYLDLSSNHL-HTLDEFLFSDLQALEVLLLYNNHIV-VVD 128
Query: 63 S-SLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLS--IYLDLSQNQLNGPLPSNFGILKN 119
+ L L LS N ++ + + L + LDLS N+L ++ L
Sbjct: 129 RNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPA 188
Query: 120 LGAIDIS 126
+
Sbjct: 189 WVKNGLY 195
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 9e-05
Identities = 27/110 (24%), Positives = 40/110 (36%), Gaps = 8/110 (7%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSI-GNLTLLITLNFAENMLEGSIP 62
L N DL L+ L L N + + ++ L L ++N + P
Sbjct: 95 LSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFP 152
Query: 63 ----SSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLS-IYLDLSQNQLN 107
K L+LLDLS+N L T++ L + L L N L
Sbjct: 153 VELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 8e-10
Identities = 39/175 (22%), Positives = 69/175 (39%), Gaps = 46/175 (26%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLS--- 235
+ LVK+ S F+ N + +V E++ G + + H R R S
Sbjct: 98 VNFPFLVKLEFS-----FKDNSNLYMVMEYVAGGEM--FSHLRRI--------GRFSEPH 142
Query: 236 ---IAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGE----LTAHVGDFGLAKFLPEAT 288
A + +YLH +++ DLKP N+L+D + +T DFG AK + T
Sbjct: 143 ARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVT----DFGFAKRVKGRT 195
Query: 289 NNFFNFQIAEYGMGSEV------STSGDVYSFGILLLETFTGKRP-----TNEMF 332
E + E+ + + D ++ G+L+ E G P +++
Sbjct: 196 WTLCGTP--EA-LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY 247
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 8e-10
Identities = 37/123 (30%), Positives = 57/123 (46%), Gaps = 18/123 (14%)
Query: 216 EWLHPN-REALK-------NLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLL 267
E L N E +K +L L+++ A + LD LH + I+HCDLKP N+LL
Sbjct: 179 ELLSMNLYELIKKNKFQGFSLPLVRK--FAHSILQCLDALH---KNRIIHCDLKPENILL 233
Query: 268 DGELTAH--VGDFGLAKFLPEATNNFFN--FQIA-EYGMGSEVSTSGDVYSFGILLLETF 322
+ + V DFG + + + + F A E +G+ D++S G +L E
Sbjct: 234 KQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELL 293
Query: 323 TGK 325
TG
Sbjct: 294 TGY 296
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 34/183 (18%), Positives = 64/183 (34%), Gaps = 46/183 (25%)
Query: 180 RHRNLVKIITSCASVDFQGNDSEALVYEFM--VNGSLEEWL---HPNREALKNLNLLQRL 234
H N+++ S + F +Y + N +L++ + + + E LK +
Sbjct: 67 DHPNVIRYYCSETTDRF--------LYIALELCNLNLQDLVESKNVSDENLKLQKEYNPI 118
Query: 235 SIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVG-------------DFGLA 281
S+ +AS + +LH I+H DLKP N+L+ DFGL
Sbjct: 119 SLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC 175
Query: 282 KFLPEATNNFFNF-----------------QIAEYGMGSEVSTSGDVYSFGILLLETFTG 324
K L ++F + ++ S D++S G + +
Sbjct: 176 KKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
Query: 325 KRP 327
+
Sbjct: 236 GKH 238
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 58.3 bits (142), Expect = 1e-09
Identities = 37/108 (34%), Positives = 52/108 (48%), Gaps = 25/108 (23%)
Query: 240 VASALDYLHHYCETPIVHCDLKPSNVLLDGE----LTAHVGDFGLAKFLPEATNNFFNFQ 295
V AL+YLH I++ DLKP N+LLD +T DFG AK++P+ T
Sbjct: 115 VCLALEYLHSK---DIIYRDLKPENILLDKNGHIKIT----DFGFAKYVPDVTYTLCGT- 166
Query: 296 IAEYGMGSEV------STSGDVYSFGILLLETFTGKRP-----TNEMF 332
+Y + EV + S D +SFGIL+ E G P T + +
Sbjct: 167 -PDY-IAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY 212
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 40/178 (22%), Positives = 75/178 (42%), Gaps = 23/178 (12%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS 63
+ + G I L + +L L NK +I + NL L L EN ++ + S
Sbjct: 53 ANNSDIK-SVQG-IQYLPNVTKLFLNGNKL-TDI-KPLANLKNLGWLFLDENKVK-DL-S 106
Query: 64 SLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLS--IYLDLSQNQLNGPLPSNFGILKNLG 121
SL + L L L +N + +++ GL L L L N++ + L L
Sbjct: 107 SLKDLKKLKSLSLEHNGI-----SDINGLVHLPQLESLYLGNNKITD--ITVLSRLTKLD 159
Query: 122 AIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIP--SSLSSLRGIENLDLSRNN 177
+ + +N++S I + +L+ L ++ N +I +L+ L+ ++ L+L
Sbjct: 160 TLSLEDNQIS-DI-VPLAGLTKLQNLYLSKN----HISDLRALAGLKNLDVLELFSQE 211
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 8e-08
Identities = 31/164 (18%), Positives = 66/164 (40%), Gaps = 15/164 (9%)
Query: 16 SIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLD 75
S+ DL KL+ L+LE N + + +L L +L N + + + L + L L
Sbjct: 107 SLKDLKKLKSLSLEHNGI--SDINGLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLS 162
Query: 76 LSNNNLTGTTPTEVIGLSSLS--IYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQ 133
L +N ++ +++ L+ L+ L LS+N ++ LKNL +++ + +
Sbjct: 163 LEDNQIS-----DIVPLAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNK 215
Query: 134 IPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNN 177
+ + + + P +S E ++ +
Sbjct: 216 PINHQSNLVVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKWHL 257
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 3e-07
Identities = 31/141 (21%), Positives = 57/141 (40%), Gaps = 15/141 (10%)
Query: 39 SSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLS-- 96
S I N + + + + ++ + +N+++ V G+ L
Sbjct: 18 FSDDAFAETIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDI-----KSVQGIQYLPNV 70
Query: 97 IYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRG 156
L L+ N+L LKNLG + + ENK+ + SS+ +L+ L + N
Sbjct: 71 TKLFLNGNKLTD--IKPLANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGIS- 125
Query: 157 NIPSSLSSLRGIENLDLSRNN 177
+I + L L +E+L L N
Sbjct: 126 DI-NGLVHLPQLESLYLGNNK 145
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 2e-09
Identities = 38/163 (23%), Positives = 66/163 (40%), Gaps = 16/163 (9%)
Query: 16 SIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLD 75
S +L +Q + + + + + T L L+ + N + + S L L L
Sbjct: 36 SQKELSGVQNFNGDNSNI--QSLAGMQFFTNLKELHLSHNQIS-DL-SPLKDLTKLEELS 91
Query: 76 LSNNNLTGTTPTEVIGLSSLSI-YLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQI 134
++ N L + G+ S + L L N+L + LKNL + I NKL
Sbjct: 92 VNRNRL-----KNLNGIPSACLSRLFLDNNELRD--TDSLIHLKNLEILSIRNNKLK--S 142
Query: 135 PSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNN 177
+G +LE L ++GN N L+ L+ + +DL+
Sbjct: 143 IVMLGFLSKLEVLDLHGNEIT-NT-GGLTRLKKVNWIDLTGQK 183
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 1e-06
Identities = 25/143 (17%), Positives = 52/143 (36%), Gaps = 20/143 (13%)
Query: 39 SSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLS-- 96
L + N + + + S + + + N+N+ + G+ +
Sbjct: 13 FPDPGLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNI-----QSLAGMQFFTNL 65
Query: 97 IYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRG 156
L LS NQ++ S L L + ++ N+L + + L +L ++ N
Sbjct: 66 KELHLSHNQISD--LSPLKDLTKLEELSVNRNRLK-NL--NGIPSACLSRLFLDNN---- 116
Query: 157 NIP--SSLSSLRGIENLDLSRNN 177
+ SL L+ +E L + N
Sbjct: 117 ELRDTDSLIHLKNLEILSIRNNK 139
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 2e-09
Identities = 39/162 (24%), Positives = 62/162 (38%), Gaps = 25/162 (15%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+ K S + + ++ E++ GS + L P L IA
Sbjct: 77 CDSPYVTKYYGS-----YLKDTKLWIIMEYLGGGSALDLLEPGP--------LDETQIAT 123
Query: 239 ---DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQ 295
++ LDYLH +H D+K +NVLL + DFG+A L + F
Sbjct: 124 ILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV 180
Query: 296 IAEYGMGSEVSTSG------DVYSFGILLLETFTGKRPTNEM 331
+ M EV D++S GI +E G+ P +E+
Sbjct: 181 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 222
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 33/180 (18%), Positives = 61/180 (33%), Gaps = 9/180 (5%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS 63
L + L N F + L L TL N L+ +
Sbjct: 336 LSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFK 394
Query: 64 ---SLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNL 120
+L LD+S N+L + + L+LS N L G + + +
Sbjct: 395 VALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFR--CLPPKV 452
Query: 121 GAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIP-SSLSSLRGIENLDLSRNNFI 179
+D+ N++ IP + L++L + N + ++P L ++ + L N +
Sbjct: 453 KVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPWD 510
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 40/193 (20%), Positives = 75/193 (38%), Gaps = 12/193 (6%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSI-GNLTLLITLNFAENMLEGSIP 62
L N + I L +L+ L L N+ + + L L+ + N L+ +I
Sbjct: 59 LSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQ-NIS 116
Query: 63 SSLGKCQNLILLDLSNNNLTGTTPTEVIG-LSSLSIYLDLSQNQL-NGPLPSNFGILKNL 120
+L LDLS N+ + G L+ L+ +L LS + L + +
Sbjct: 117 C--CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLT-FLGLSAAKFRQLDLLPVAHLHLSC 173
Query: 121 GAIDISENKLSGQIPSSIGS-CIRLEQLVMNGN-FFRGNIPSSLSSLRGIE--NLDLSRN 176
+D+ + G S+ + LV + N F + S+++L ++ N+ L+
Sbjct: 174 ILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDE 233
Query: 177 NFIRHRNLVKIIT 189
N R + +T
Sbjct: 234 NCQRLMTFLSELT 246
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 31/210 (14%), Positives = 69/210 (32%), Gaps = 21/210 (10%)
Query: 47 LITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQL 106
+ L E + S ++L++ + N + + ++I LS +
Sbjct: 283 IYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNI-KMLSISDT 341
Query: 107 NGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFR--GNIPSSLSS 164
+ ++ ++N + + + RL+ L++ N + + +
Sbjct: 342 PFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKN 401
Query: 165 LRGIENLDLSRNNFIRHRN--LVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNR 222
+ +E LD+S N+ H S ++ N V+ L P
Sbjct: 402 MSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVF---------RCLPPK- 451
Query: 223 EALKNLNL----LQRLSIAVDVASALDYLH 248
+K L+L + + V AL L+
Sbjct: 452 --VKVLDLHNNRIMSIPKDVTHLQALQELN 479
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 3e-09
Identities = 28/180 (15%), Positives = 65/180 (36%), Gaps = 7/180 (3%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSI-GNLTLLITLNFAENMLEGSIP 62
L+ + +L + R+ + ++ ++ S NL+ + + I
Sbjct: 38 LIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYID 97
Query: 63 SS-LGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSN-FGILKN- 119
L + L L + N L + + + L+++ N +P N F L N
Sbjct: 98 PDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNE 157
Query: 120 LGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPS-SLSSLR-GIENLDLSRNN 177
+ + N + + + +L+ + +N N + I + + G LD+S+ +
Sbjct: 158 TLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTS 216
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 5e-09
Identities = 27/165 (16%), Positives = 59/165 (35%), Gaps = 9/165 (5%)
Query: 23 LQRLTLEMNKFWGEIPS-SIGNLTLLITLNFAENMLEGSIPS-SLGKCQNLILLDLSNNN 80
Q L L IPS + NL + + + ++ + S S + +++ N
Sbjct: 33 TQTLKLIETHL-RTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91
Query: 81 LTGTTPTEVI-GLSSLSIYLDLSQNQLNG-PLPSNFGILKNLGAIDISENKLSGQIPSSI 138
+ + L L +L + L P + ++I++N IP +
Sbjct: 92 NLTYIDPDALKELPLLK-FLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNA 150
Query: 139 --GSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNFIRH 181
G C L + N F ++ + ++ + L++N ++
Sbjct: 151 FQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTV 194
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 1e-05
Identities = 22/126 (17%), Positives = 43/126 (34%), Gaps = 9/126 (7%)
Query: 60 SIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSN-FGILK 118
IPS + L L +L L ++S + +S + L S+ F L
Sbjct: 25 RIPSLP---PSTQTLKLIETHLRTIPSHAFSNLPNIS-RIYVSIDVTLQQLESHSFYNLS 80
Query: 119 NLGAIDISENKLSGQIPSSI-GSCIRLEQLVMNGNFFRGNIP--SSLSSLRGIENLDLSR 175
+ I+I + I L+ L + + P + + S L+++
Sbjct: 81 KVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITD 139
Query: 176 NNFIRH 181
N ++
Sbjct: 140 NPYMTS 145
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 6e-04
Identities = 25/123 (20%), Positives = 38/123 (30%), Gaps = 9/123 (7%)
Query: 4 LVGNQFTGRIPG--SIGDLHKLQRLTLEMNKFWGEIPS-SIGNLT-LLITLNFAENMLEG 59
+ P + L + N + IP + L +TL N
Sbjct: 112 IFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT- 169
Query: 60 SIPSSLGKCQNLILLDLSNNNLTGTTPTEV-IGLSSLSIYLDLSQNQLNGPLPSN-FGIL 117
S+ L + L+ N + G+ S LD+SQ + LPS L
Sbjct: 170 SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA-LPSKGLEHL 228
Query: 118 KNL 120
K L
Sbjct: 229 KEL 231
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 35/163 (21%), Positives = 61/163 (37%), Gaps = 17/163 (10%)
Query: 16 SIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLD 75
S L L L + + I LT L L N + ++ L + NL L
Sbjct: 37 SEEQLATLTSLDCHNSSI--TDMTGIEKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLA 91
Query: 76 LSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIP 135
+N LT +V L+ L+ YL+ N+L + L ++ + N L+ +I
Sbjct: 92 CDSNKLTNL---DVTPLTKLT-YLNCDTNKLT---KLDVSQNPLLTYLNCARNTLT-EID 143
Query: 136 SSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178
+ +L +L + N + ++ + LD S N
Sbjct: 144 --VSHNTQLTELDCHLN--KKITKLDVTPQTQLTTLDCSFNKI 182
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 6e-09
Identities = 36/179 (20%), Positives = 56/179 (31%), Gaps = 33/179 (18%)
Query: 17 IGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDL 76
I L L +L N + + T L L N L ++ + L L+
Sbjct: 60 IEKLTGLTKLICTSNNI-TTLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNC 113
Query: 77 SNNNLTGTTPTEVIGLSSLSI-----------------YLDLSQNQLNGPLPSNFGILKN 119
N LT ++ L+ L+ LD N+ L
Sbjct: 114 DTNKLTKLDVSQNPLLTYLNCARNTLTEIDVSHNTQLTELDCHLNKKITKLD--VTPQTQ 171
Query: 120 LGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPS-SLSSLRGIENLDLSRNN 177
L +D S NK++ + L +L + N NI L+ + LD S N
Sbjct: 172 LTTLDCSFNKITE---LDVSQNKLLNRLNCDTN----NITKLDLNQNIQLTFLDCSSNK 223
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 7e-08
Identities = 27/178 (15%), Positives = 54/178 (30%), Gaps = 27/178 (15%)
Query: 16 SIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLD 75
+ L RL + N ++ + L L+ + N L I + L D
Sbjct: 186 DVSQNKLLNRLNCDTNNI-TKLD--LNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFD 239
Query: 76 LSNNNLTGTTPTEVIGLSSLSIY------LDLSQN---------QLNGPLPSNFGILKNL 120
S N LT + + L++L +DL+ N + L
Sbjct: 240 CSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKIKELDVTHNTQL 299
Query: 121 GAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178
+D ++ + +L L +N + +S +++L +
Sbjct: 300 YLLDCQAAGIT---ELDLSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHI 351
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 26/135 (19%), Positives = 46/135 (34%), Gaps = 15/135 (11%)
Query: 43 NLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLS 102
N + F + S + L LD N+++ T T + L+ L+ L +
Sbjct: 19 NFASEVAAAFEMQATD---TISEEQLATLTSLDCHNSSI--TDMTGIEKLTGLT-KLICT 72
Query: 103 QNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSL 162
N + + NL + NKL+ + + +L L + N S
Sbjct: 73 SNNITTL---DLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLTKLDVSQN 126
Query: 163 SSLRGIENLDLSRNN 177
L L+ +RN
Sbjct: 127 PLL---TYLNCARNT 138
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 8e-05
Identities = 25/159 (15%), Positives = 49/159 (30%), Gaps = 17/159 (10%)
Query: 16 SIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLD 75
+ +L E + E+ + + T L L+ + + L + L+ L
Sbjct: 270 DLTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLY 324
Query: 76 LSNNNLTGTTPTEVIGLSSLS--IYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQ 133
L+N LT + +S + L + S G + L +E +
Sbjct: 325 LNNTELT------ELDVSHNTKLKSLSCVNAHIQD-FSS-VGKIPALNNNFEAEGQTI-T 375
Query: 134 IPSSIGSCIRLEQLVMNGNF-FRGNIPSSLSSLRGIENL 171
+P + L V GN + G+ +
Sbjct: 376 MPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQ 414
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 3e-09
Identities = 41/203 (20%), Positives = 67/203 (33%), Gaps = 33/203 (16%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSI-GNLTLLITLNFAENMLEGSIP 62
L N S +LQ L L + I +L+ L TL N ++ S+
Sbjct: 35 LSFNPLRHLGSYSFFSFPELQVLDLSRCEI-QTIEDGAYQSLSHLSTLILTGNPIQ-SLA 92
Query: 63 SSL-GKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQL-NGPLPSNFGILKNL 120
+L L NL + L +L L+++ N + + LP F L NL
Sbjct: 93 LGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLK-ELNVAHNLIQSFKLPEYFSNLTNL 151
Query: 121 GAIDISENKLS---------------------------GQIPSSIGSCIRLEQLVMNGNF 153
+D+S NK+ I IRL++L ++ N
Sbjct: 152 EHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQ 211
Query: 154 FRGNIPSSLSSLRGIENLDLSRN 176
+ L ++ + L N
Sbjct: 212 LKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 7e-06
Identities = 39/146 (26%), Positives = 58/146 (39%), Gaps = 16/146 (10%)
Query: 37 IPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEV-IGLSSL 95
+P S NL L + N L S L +LDLS + T LS L
Sbjct: 26 LPFSTKNLDL------SFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHL 78
Query: 96 SIYLDLSQNQLNGPLPSN-FGILKNLGAIDISENKLSGQIPSSI-GSCIRLEQLVMNGNF 153
S L L+ N + L F L +L + E L+ + + G L++L + N
Sbjct: 79 S-TLILTGNPIQS-LALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNL 135
Query: 154 FRGNIPSS--LSSLRGIENLDLSRNN 177
+ + S+L +E+LDLS N
Sbjct: 136 IQ-SFKLPEYFSNLTNLEHLDLSSNK 160
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 3e-09
Identities = 32/163 (19%), Positives = 61/163 (37%), Gaps = 33/163 (20%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNL---NLLQRLS 235
++H +++++ F+ ++ LV E NG + +L + + + ++
Sbjct: 68 LKHPSILELYNY-----FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQI- 121
Query: 236 IAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQ 295
+ + YLH + I+H DL SN+LL + + DFGLA + +
Sbjct: 122 -----ITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLAT-QLKMPHEKHYTL 172
Query: 296 -----------IAEYGMGSEVSTSGDVYSFGILLLETFTGKRP 327
G E DV+S G + G+ P
Sbjct: 173 CGTPNYISPEIATRSAHGLES----DVWSLGCMFYTLLIGRPP 211
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 3e-09
Identities = 48/177 (27%), Positives = 76/177 (42%), Gaps = 9/177 (5%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSI-GNLTLLITLNFAENMLEGSIP 62
L N+ + + L KL+ L L NK +P+ I L L TL +N L+ ++P
Sbjct: 44 LQSNKLSSLPSKAFHRLTKLRLLYLNDNKL-QTLPAGIFKELKNLETLWVTDNKLQ-ALP 101
Query: 63 SSL-GKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSN-FGILKNL 120
+ + NL L L N L P L+ L+ YL L N+L LP F L +L
Sbjct: 102 IGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLT-YLSLGYNELQS-LPKGVFDKLTSL 159
Query: 121 GAIDISENKLSGQIPSSI-GSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRN 176
+ + N+L ++P L+ L ++ N + + SL ++ L L N
Sbjct: 160 KELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 9e-05
Identities = 31/106 (29%), Positives = 52/106 (49%), Gaps = 7/106 (6%)
Query: 74 LDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSN-FGILKNLGAIDISENKLSG 132
LDL +N L+ L+ L L L+ N+L LP+ F LKNL + +++NKL
Sbjct: 42 LDLQSNKLSSLPSKAFHRLTKLR-LLYLNDNKLQT-LPAGIFKELKNLETLWVTDNKLQ- 98
Query: 133 QIPSSIGSC-IRLEQLVMNGNFFRGNIPSSL-SSLRGIENLDLSRN 176
+P + + L +L ++ N + ++P + SL + L L N
Sbjct: 99 ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYN 143
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 34/110 (30%), Positives = 50/110 (45%), Gaps = 20/110 (18%)
Query: 237 AVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHV--GDFGLAK--FLPEATNNFF 292
A ++A L +L I++ DLK NV+LD E H+ DFG+ K T F
Sbjct: 448 AAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSE--GHIKIADFGMCKENIWDGVTTKTF 502
Query: 293 ----NFQIA-EYGMGSEVSTSGDVYSFGILLLETFTGKRP-----TNEMF 332
++ IA E S D ++FG+LL E G+ P +E+F
Sbjct: 503 CGTPDY-IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF 551
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 4e-09
Identities = 46/206 (22%), Positives = 76/206 (36%), Gaps = 60/206 (29%)
Query: 207 EFMVNGSLEEWLHPNREALKNL---NLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPS 263
E M + S +++ L ++ +L + I + AL++L I+H D+KPS
Sbjct: 101 ELM-STSFDKFYKYVYSVLDDVIPEEILGK--ITLATVKALNHLKE--NLKIIHRDIKPS 155
Query: 264 NVLLDGELTAHVGDFGLAKFL-----------------PEATNNFFNFQIAEYGMGSEVS 306
N+LLD + DFG++ L PE +I
Sbjct: 156 NILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPE--------RIDPSASRQGYD 207
Query: 307 TSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEALPERLAEIVD---PVLLVERE 363
DV+S GI L E TG+ P ++ ++L ++V P L
Sbjct: 208 VRSDVWSLGITLYELATGRFP-------YPKWNSVF-----DQLTQVVKGDPPQL----- 250
Query: 364 EGETSKANAHKQFTRSFS--VKECLV 387
+ ++F+ SF V CL
Sbjct: 251 -----SNSEEREFSPSFINFVNLCLT 271
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 4e-09
Identities = 36/167 (21%), Positives = 54/167 (32%), Gaps = 52/167 (31%)
Query: 196 FQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVA--------SALDYL 247
FQ + +V E+M G L +NL+ + A ALD +
Sbjct: 138 FQDDRYLYMVMEYMPGGDL-------------VNLMSNYDVPEKWARFYTAEVVLALDAI 184
Query: 248 HHYCETPIVHCDLKPSNVLLDGELTAHV--GDFGLAKFLPEA----TNNF---------- 291
H +H D+KP N+LLD H+ DFG + + +
Sbjct: 185 HSMG---FIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPE 239
Query: 292 -FNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRP-----TNEMF 332
Q + G E D +S G+ L E G P +
Sbjct: 240 VLKSQGGDGYYGREC----DWWSVGVFLYEMLVGDTPFYADSLVGTY 282
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 4e-09
Identities = 42/159 (26%), Positives = 62/159 (38%), Gaps = 25/159 (15%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+ R +V + + ++ D+ LV M G L H + + A
Sbjct: 241 VNSRFVVSLAYA-----YETKDALCLVLTLMNGGDL--KFHIYHMGQAGFPEARAVFYAA 293
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHV--GDFGLAKFLPEA--TNNFFNF 294
++ L+ LH IV+ DLKP N+LLD H+ D GLA +PE
Sbjct: 294 EICCGLEDLH---RERIVYRDLKPENILLDDH--GHIRISDLGLAVHVPEGQTIKGRVG- 347
Query: 295 QIAEYGMGSEV------STSGDVYSFGILLLETFTGKRP 327
Y M EV + S D ++ G LL E G+ P
Sbjct: 348 -TVGY-MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 5e-09
Identities = 36/109 (33%), Positives = 54/109 (49%), Gaps = 18/109 (16%)
Query: 237 AVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHV--GDFGLAK--FLPEATNNFF 292
A ++ L +LH IV+ DLK N+LLD + H+ DFG+ K L +A N F
Sbjct: 124 AAEIILGLQFLH---SKGIVYRDLKLDNILLDKD--GHIKIADFGMCKENMLGDAKTNTF 178
Query: 293 ----NFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRP-----TNEMF 332
++ E +G + + S D +SFG+LL E G+ P E+F
Sbjct: 179 CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF 227
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 5e-09
Identities = 17/47 (36%), Positives = 25/47 (53%), Gaps = 3/47 (6%)
Query: 240 VASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPE 286
+ + LH + IVH DLKP N+LLD ++ + DFG + L
Sbjct: 133 LLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP 176
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 5e-09
Identities = 33/168 (19%), Positives = 57/168 (33%), Gaps = 46/168 (27%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLH-----PNREALKNLNLLQR 233
+RH N++++ F L+ EF G L + L + +
Sbjct: 71 LRHPNILRMYNY-----FHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSAT------- 118
Query: 234 LSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFN 293
++A AL Y H ++H D+KP N+L+ + + DFG + P
Sbjct: 119 --FMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS------L 167
Query: 294 FQ--------------IAEYGMGSEVSTSGDVYSFGILLLETFTGKRP 327
+ I +V D++ G+L E G P
Sbjct: 168 RRRTMCGTLDYLPPEMIEGKTHDEKV----DLWCAGVLCYEFLVGMPP 211
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 5e-09
Identities = 31/109 (28%), Positives = 50/109 (45%), Gaps = 17/109 (15%)
Query: 237 AVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHV--GDFGLAK--FLPEATNNFF 292
++ SALDYLH E +V+ DLK N++LD + H+ DFGL K AT F
Sbjct: 254 GAEIVSALDYLHS--EKNVVYRDLKLENLMLDKD--GHIKITDFGLCKEGIKDGATMKTF 309
Query: 293 ----NFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRP-----TNEMF 332
+ E ++ + D + G+++ E G+ P ++F
Sbjct: 310 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF 358
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 6e-09
Identities = 35/154 (22%), Positives = 66/154 (42%), Gaps = 19/154 (12%)
Query: 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVD 239
++ N+V + S + D +V E++ GSL + + ++ Q ++ +
Sbjct: 75 KNPNIVNYLDS-----YLVGDELWVVMEYLAGGSLTDVVTETC-----MDEGQIAAVCRE 124
Query: 240 VASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIAEY 299
AL++LH ++H D+K N+LL + + + DFG + + Y
Sbjct: 125 CLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPY 181
Query: 300 GMGSEVSTSG------DVYSFGILLLETFTGKRP 327
M EV T D++S GI+ +E G+ P
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 7e-09
Identities = 29/102 (28%), Positives = 45/102 (44%), Gaps = 12/102 (11%)
Query: 236 IAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPE--ATNNFFN 293
+ V + AL YL + ++H D+KPSN+LLD + DFG++ L + A +
Sbjct: 129 MTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAG 186
Query: 294 FQ--------IAEYGMGSEVSTSGDVYSFGILLLETFTGKRP 327
+ DV+S GI L+E TG+ P
Sbjct: 187 CAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 7e-09
Identities = 39/166 (23%), Positives = 61/166 (36%), Gaps = 40/166 (24%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLS--- 235
+ H+++V F+ ND +V E SL E + L+
Sbjct: 98 LAHQHVVGFHGF-----FEDNDFVFVVLELCRRRSLLELHKRRK----------ALTEPE 142
Query: 236 ---IAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFF 292
+ YLH ++H DLK N+ L+ +L +GDFGLA E
Sbjct: 143 ARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLAT-KVEYDGERK 198
Query: 293 -------NFQ----IAEYGMGSEVSTSGDVYSFGILLLETFTGKRP 327
N+ +++ G EV DV+S G ++ GK P
Sbjct: 199 KVLCGTPNYIAPEVLSKKGHSFEV----DVWSIGCIMYTLLVGKPP 240
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 8e-09
Identities = 28/106 (26%), Positives = 42/106 (39%), Gaps = 33/106 (31%)
Query: 240 VASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL--------------- 284
+ YLH ++H DLK N+ L+ +L +GDFGLA +
Sbjct: 124 IVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN 180
Query: 285 ---PEATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRP 327
PE +++ G EV DV+S G ++ GK P
Sbjct: 181 YIAPEV--------LSKKGHSFEV----DVWSIGCIMYTLLVGKPP 214
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 8e-09
Identities = 36/123 (29%), Positives = 59/123 (47%), Gaps = 16/123 (13%)
Query: 216 EWLHPN-REALK-------NLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLL 267
E L N + L+ +LNL ++ A + +AL +L E I+HCDLKP N+LL
Sbjct: 136 EMLSYNLYDLLRNTNFRGVSLNLTRK--FAQQMCTALLFLATP-ELSIIHCDLKPENILL 192
Query: 268 DGELTAH--VGDFGLAKFLPEATNNFFN--FQIA-EYGMGSEVSTSGDVYSFGILLLETF 322
+ + DFG + L + + F + E +G + D++S G +L+E
Sbjct: 193 CNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMH 252
Query: 323 TGK 325
TG+
Sbjct: 253 TGE 255
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 9e-09
Identities = 29/110 (26%), Positives = 50/110 (45%), Gaps = 20/110 (18%)
Query: 237 AVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHV--GDFGLAK--FLPEATNNFF 292
++ SAL+YLH +V+ D+K N++LD + H+ DFGL K AT F
Sbjct: 111 GAEIVSALEYLH---SRDVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTF 165
Query: 293 ----NFQIA-EYGMGSEVSTSGDVYSFGILLLETFTGKRP-----TNEMF 332
+ +A E ++ + D + G+++ E G+ P +F
Sbjct: 166 CGTPEY-LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF 214
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 36/170 (21%), Positives = 59/170 (34%), Gaps = 55/170 (32%)
Query: 196 FQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVD----------VASALD 245
FQ +++ LV ++ V G L L LL + + + A+D
Sbjct: 143 FQDDNNLYLVMDYYVGGDL-------------LTLLSKFEDRLPEEMARFYLAEMVIAID 189
Query: 246 YLHHYCETPIVHCDLKPSNVLLDGELTAHV--GDFGLAKFLPE----ATNNF-------- 291
+H VH D+KP N+L+D H+ DFG L E ++
Sbjct: 190 SVHQLH---YVHRDIKPDNILMDMN--GHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 244
Query: 292 ----FNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRP-----TNEMF 332
+ + G E D +S G+ + E G+ P E +
Sbjct: 245 PEILQAMEGGKGRYGPEC----DWWSLGVCMYEMLYGETPFYAESLVETY 290
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 1e-08
Identities = 36/107 (33%), Positives = 49/107 (45%), Gaps = 20/107 (18%)
Query: 240 VASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHV--GDFGLAK--FLPEATNNFF--- 292
+ASAL YLH IV+ DLKP N+LLD + H+ DFGL K +T + F
Sbjct: 148 IASALGYLH---SLNIVYRDLKPENILLDSQ--GHIVLTDFGLCKENIEHNSTTSTFCGT 202
Query: 293 -NFQIA-EYGMGSEVSTSGDVYSFGILLLETFTGKRP-----TNEMF 332
+ +A E + D + G +L E G P T EM+
Sbjct: 203 PEY-LAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY 248
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 55.6 bits (134), Expect = 1e-08
Identities = 35/155 (22%), Positives = 57/155 (36%), Gaps = 24/155 (15%)
Query: 196 FQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPI 255
F+ LV M G + ++ E + + + S L++LH + I
Sbjct: 254 FETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNI 310
Query: 256 VHCDLKPSNVLLDGELTAHV--GDFGLAKFLPEATNNFFNF-QIAEYGMGSEV------S 306
++ DLKP NVLLD + +V D GLA L + + M E+
Sbjct: 311 IYRDLKPENVLLDDD--GNVRISDLGLAVELKAGQTKTKGYAGTPGF-MAPELLLGEEYD 367
Query: 307 TSGDVYSFGILLLETFTGKRP---------TNEMF 332
S D ++ G+ L E + P E+
Sbjct: 368 FSVDYFALGVTLYEMIAARGPFRARGEKVENKELK 402
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 2e-08
Identities = 34/110 (30%), Positives = 50/110 (45%), Gaps = 20/110 (18%)
Query: 237 AVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHV--GDFGLAK--FLPEATNNFF 292
A ++A L +L I++ DLK NV+LD E H+ DFG+ K T F
Sbjct: 127 AAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSE--GHIKIADFGMCKENIWDGVTTKTF 181
Query: 293 ----NFQIA-EYGMGSEVSTSGDVYSFGILLLETFTGKRP-----TNEMF 332
++ IA E S D ++FG+LL E G+ P +E+F
Sbjct: 182 CGTPDY-IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF 230
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 2e-08
Identities = 40/108 (37%), Positives = 52/108 (48%), Gaps = 22/108 (20%)
Query: 240 VASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHV--GDFGLAK--FLPEATNNFFNFQ 295
+A ALD+LH I++ DLKP N+LLD E H+ DFGL+K E F
Sbjct: 135 LALALDHLH---SLGIIYRDLKPENILLDEE--GHIKLTDFGLSKESIDHEKKAYSFCGT 189
Query: 296 IAEYGMGSEV------STSGDVYSFGILLLETFTGKRP-----TNEMF 332
+ EY M EV + S D +SFG+L+ E TG P E
Sbjct: 190 V-EY-MAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETM 235
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 29/101 (28%), Positives = 41/101 (40%), Gaps = 23/101 (22%)
Query: 242 SALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFF--------N 293
L+YLH IVH D+KP N+LL T + G+A+ L +
Sbjct: 120 DGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPA 176
Query: 294 FQIAE-------YGMGSEVSTSGDVYSFGILLLETFTGKRP 327
FQ E + G +V D++S G+ L TG P
Sbjct: 177 FQPPEIANGLDTFS-GFKV----DIWSAGVTLYNITTGLYP 212
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 33/103 (32%), Positives = 44/103 (42%), Gaps = 31/103 (30%)
Query: 242 SALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLA------KFL----------- 284
SA+ Y H IVH DLK N+LLD ++ + DFG + L
Sbjct: 125 SAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAA 181
Query: 285 PEATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRP 327
PE FQ +Y G EV DV+S G++L +G P
Sbjct: 182 PEL------FQGKKY-DGPEV----DVWSLGVILYTLVSGSLP 213
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 37/154 (24%), Positives = 68/154 (44%), Gaps = 19/154 (12%)
Query: 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVD 239
+H N+V++ S + + ++ EF+ G+L + + R LN Q ++
Sbjct: 100 QHFNVVEMYKS-----YLVGEELWVLMEFLQGGALTDIVSQVR-----LNEEQIATVCEA 149
Query: 240 VASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIAEY 299
V AL YLH ++H D+K ++LL + + DFG + + + Y
Sbjct: 150 VLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPY 206
Query: 300 GMGSEVSTSG------DVYSFGILLLETFTGKRP 327
M EV + D++S GI+++E G+ P
Sbjct: 207 WMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 20/52 (38%), Positives = 27/52 (51%), Gaps = 3/52 (5%)
Query: 235 SIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPE 286
SI + A+ +LH IVH DLKP N+LLD + + DFG + L
Sbjct: 204 SIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP 252
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 22/92 (23%), Positives = 37/92 (40%), Gaps = 23/92 (25%)
Query: 240 VASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFN------ 293
+ SA+ YL I+H D+K N+++ + T + DFG A +L F
Sbjct: 139 LVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLER--GKLFYTFCGTI 193
Query: 294 -------FQIAEYGMGSEVSTSGDVYSFGILL 318
Y G E+ +++S G+ L
Sbjct: 194 EYCAPEVLMGNPYR-GPEL----EMWSLGVTL 220
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 26/104 (25%), Positives = 45/104 (43%), Gaps = 16/104 (15%)
Query: 243 ALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIA----- 297
+ +LH I+H DLKPSN+++ + T + DFGLA+ T+ +
Sbjct: 139 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 193
Query: 298 --EYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLH 339
E +G + D++S G ++ E G +F G +
Sbjct: 194 APEVILGMGYKENVDIWSVGCIMGEMIKGG----VLFPGTDHID 233
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 39/174 (22%), Positives = 55/174 (31%), Gaps = 61/174 (35%)
Query: 196 FQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVD----------VASALD 245
FQ + LV E+ V G L L LL + + + A+D
Sbjct: 130 FQDENYLYLVMEYYVGGDL-------------LTLLSKFGERIPAEMARFYLAEIVMAID 176
Query: 246 YLHHYCETPIVHCDLKPSNVLLDGELTAHV--GDFGLAKFL----PEATNNF-------- 291
+H VH D+KP N+LLD H+ DFG L +
Sbjct: 177 SVHRLG---YVHRDIKPDNILLDRC--GHIRLADFGSCLKLRADGTVRSLVAVGTPDYLS 231
Query: 292 --------FNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRP-----TNEMF 332
YG E D ++ G+ E F G+ P T E +
Sbjct: 232 PEILQAVGGGPGTGSYGP--EC----DWWALGVFAYEMFYGQTPFYADSTAETY 279
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 3e-08
Identities = 46/186 (24%), Positives = 78/186 (41%), Gaps = 41/186 (22%)
Query: 158 IPSSLSSLRGIENLDLSRNNFIRHRNLVKIITSCASVDFQGNDSEALVYEFM---VNGSL 214
+P S ++R + + L H N+V++ C LV+E + + L
Sbjct: 54 MPLS--TIREV-AV-LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYL 109
Query: 215 EEWLHP--NREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELT 272
++ P E +K++ + Q L LD+LH + +VH DLKP N+L+
Sbjct: 110 DKVPEPGVPTETIKDM-MFQLLR-------GLDFLHSHR---VVHRDLKPQNILVTSSGQ 158
Query: 273 AHVGDFGLAKFLPEATNNFFNFQIA-------------EYGMGSEVSTSGDVYSFGILLL 319
+ DFGLA+ ++FQ+A E + S +T D++S G +
Sbjct: 159 IKLADFGLAR--------IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFA 210
Query: 320 ETFTGK 325
E F K
Sbjct: 211 EMFRRK 216
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 3e-08
Identities = 34/181 (18%), Positives = 65/181 (35%), Gaps = 9/181 (4%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSI-GNLTLLITLNFAE-NMLEGSI 61
V + G+ L+++ + N I + + NL L + + N L I
Sbjct: 37 FVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLL-YI 95
Query: 62 PSS-LGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSN--FGILK 118
NL L +SN + I LD+ N + N G+
Sbjct: 96 NPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKV-LLDIQDNINIHTIERNSFVGLSF 154
Query: 119 NLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPS-SLSSLRGIENLDLSRNN 177
+ +++N + +I +S + +L++L ++ N +P+ G LD+SR
Sbjct: 155 ESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTR 213
Query: 178 F 178
Sbjct: 214 I 214
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 9e-06
Identities = 32/173 (18%), Positives = 55/173 (31%), Gaps = 30/173 (17%)
Query: 36 EIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEV-IGLSS 94
EIPS + I L F L + +L +++S N++ +V L
Sbjct: 23 EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80
Query: 95 LSI------------------------YLDLSQNQLNGPLPSNFGILKNLGAIDISENKL 130
L YL +S + + +DI +N
Sbjct: 81 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNIN 140
Query: 131 SGQIPSSI--GSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNFIRH 181
I + G L +N N + I +S + ++ L+LS NN +
Sbjct: 141 IHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEE 192
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 5e-05
Identities = 29/131 (22%), Positives = 45/131 (34%), Gaps = 7/131 (5%)
Query: 3 TLVGNQFTGRIP-GSIGDLHKLQRLTLEMNKFWGEIPS-SIGNLT-LLITLNFAENMLEG 59
+ +P + L ++ N I S L+ + L +N ++
Sbjct: 110 LISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE 168
Query: 60 SIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSN-FGILK 118
S+ Q L NNNL G S I LD+S+ +++ LPS LK
Sbjct: 169 IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVI-LDISRTRIH-SLPSYGLENLK 226
Query: 119 NLGAIDISENK 129
L A K
Sbjct: 227 KLRARSTYNLK 237
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 53.3 bits (129), Expect = 5e-08
Identities = 48/184 (26%), Positives = 78/184 (42%), Gaps = 31/184 (16%)
Query: 155 RGNIPSSLSSLRGIENLDLSRNNFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSL 214
G +P S ++R + L L R H N+V+++ CA+ LV+E + + L
Sbjct: 51 GGGLPIS--TVREV-AL-LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDL 105
Query: 215 EEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAH 274
+L ++ + LD+LH C IVH DLKP N+L+ T
Sbjct: 106 RTYLDKAPPPGLPAETIK--DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVK 160
Query: 275 VGDFGLAKFLPEATNNFFNFQIA-------------EYGMGSEVSTSGDVYSFGILLLET 321
+ DFGLA+ +++Q+A E + S +T D++S G + E
Sbjct: 161 LADFGLAR--------IYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 212
Query: 322 FTGK 325
F K
Sbjct: 213 FRRK 216
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 5e-08
Identities = 34/110 (30%), Positives = 50/110 (45%), Gaps = 20/110 (18%)
Query: 237 AVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHV--GDFGLAK--FLPEATNNFF 292
A ++ SAL +LH + I++ DLK NVLLD E H DFG+ K T F
Sbjct: 130 AAEIISALMFLH---DKGIIYRDLKLDNVLLDHE--GHCKLADFGMCKEGICNGVTTATF 184
Query: 293 ----NFQIA-EYGMGSEVSTSGDVYSFGILLLETFTGKRP-----TNEMF 332
++ IA E + D ++ G+LL E G P +++F
Sbjct: 185 CGTPDY-IAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLF 233
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 53.3 bits (129), Expect = 5e-08
Identities = 31/108 (28%), Positives = 49/108 (45%), Gaps = 22/108 (20%)
Query: 240 VASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHV--GDFGLAK--FLPEATNNFFNFQ 295
++ AL +LH + I++ DLKP N++L+ + HV DFGL K + F
Sbjct: 130 ISMALGHLH---QKGIIYRDLKPENIMLNHQ--GHVKLTDFGLCKESIHDGTVTHTFCGT 184
Query: 296 IAEYGMGSEV------STSGDVYSFGILLLETFTGKRP-----TNEMF 332
I EY M E+ + + D +S G L+ + TG P +
Sbjct: 185 I-EY-MAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTI 230
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 52.9 bits (128), Expect = 5e-08
Identities = 40/171 (23%), Positives = 73/171 (42%), Gaps = 36/171 (21%)
Query: 179 IRHRNLVKIITSCASVD-FQGNDSEALVYEFMVNGSLEEWLHPNREAL-----KNLNLLQ 232
++H+N+V++ D + LV+EF + L+++ L K+ L Q
Sbjct: 58 LKHKNIVRLH------DVLHSDKKLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSF-LFQ 109
Query: 233 RLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFF 292
L L + H ++H DLKP N+L++ + +FGLA+ +
Sbjct: 110 LLK-------GLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS 159
Query: 293 NFQIA-------EYGMGSEV-STSGDVYSFGILLLETFTGKRPTNEMFTGN 335
++ + G+++ STS D++S G + E RP +F GN
Sbjct: 160 A-EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP---LFPGN 206
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 7e-08
Identities = 31/112 (27%), Positives = 48/112 (42%), Gaps = 20/112 (17%)
Query: 180 RHRNLVK---IITSCASVDFQGNDSEALVYEFM---VNGSLEEWLHPNREALKNLNLLQR 233
+H N+V I + AS + S LV++F + G L L + +
Sbjct: 74 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML 133
Query: 234 LSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLD--GELTAHVGDFGLAKF 283
L+ L Y+H I+H D+K +NVL+ G L + DFGLA+
Sbjct: 134 LN-------GLYYIHRNK---ILHRDMKAANVLITRDGVLK--LADFGLARA 173
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 7e-08
Identities = 27/107 (25%), Positives = 49/107 (45%), Gaps = 19/107 (17%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNR----EALKNLNLLQRL 234
+ H N+VK++ +D D +V+E + G + E +A Q
Sbjct: 93 LDHPNVVKLVEV---LDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARF---YFQ-- 144
Query: 235 SIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLA 281
D+ ++YLH+ I+H D+KPSN+L+ + + DFG++
Sbjct: 145 ----DLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVS 184
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 7e-08
Identities = 37/152 (24%), Positives = 65/152 (42%), Gaps = 24/152 (15%)
Query: 177 NFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSI 236
+ +RH LV + + F+ ++ ++YEFM G L E + A ++ + + ++
Sbjct: 209 SVLRHPTLVNLHDA-----FEDDNEMVMIYEFMSGGELFE-----KVADEHNKMSEDEAV 258
Query: 237 AV--DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHV--GDFGLAKFLPEATNNFF 292
V L ++H E VH DLKP N++ + + + DFGL L +
Sbjct: 259 EYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV 315
Query: 293 NFQIAEYGMGSEV------STSGDVYSFGILL 318
AE+ EV D++S G+L
Sbjct: 316 TTGTAEF-AAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 9e-08
Identities = 31/105 (29%), Positives = 49/105 (46%), Gaps = 28/105 (26%)
Query: 240 VASALDYLHHYCETPIVHCDLKPSNVLLDGE----LTAHVGDFGLAK-FLPEATNNFFNF 294
+ AL++LH + I++ D+K N+LLD LT DFGL+K F+ + T ++F
Sbjct: 168 IVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLT----DFGLSKEFVADETERAYDF 220
Query: 295 ------------QIAEYGMGSEVSTSGDVYSFGILLLETFTGKRP 327
+ + G V D +S G+L+ E TG P
Sbjct: 221 CGTIEYMAPDIVRGGDSGHDKAV----DWWSLGVLMYELLTGASP 261
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 9e-08
Identities = 21/93 (22%), Positives = 34/93 (36%), Gaps = 25/93 (26%)
Query: 240 VASALDYLHHYCETPIVHCDLKPSNVLLDGE-LTAHVGDFGLAKFLPEATNNFFN----- 293
V A+ + H+ ++H D+K N+L+D + DFG L + +
Sbjct: 158 VLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGT 211
Query: 294 --------FQIAEYGMGSEVSTSGDVYSFGILL 318
+ Y G V+S GILL
Sbjct: 212 RVYSPPEWIRYHRY-HGRSA----AVWSLGILL 239
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 22/93 (23%), Positives = 34/93 (36%), Gaps = 25/93 (26%)
Query: 240 VASALDYLHHYCETPIVHCDLKPSNVLLDGE-LTAHVGDFGLAKFLPEATNNFFN----- 293
V +A+ + H +VH D+K N+L+D A + DFG L + +
Sbjct: 148 VVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLH---DEPYTDFDGT 201
Query: 294 --------FQIAEYGMGSEVSTSGDVYSFGILL 318
+Y V+S GILL
Sbjct: 202 RVYSPPEWISRHQY-HALPA----TVWSLGILL 229
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 44/185 (23%), Positives = 73/185 (39%), Gaps = 45/185 (24%)
Query: 177 NFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSI 236
N N++ + V + + ALV+E + N + L Q L+
Sbjct: 86 NLRGGPNIITLA---DIVKDPVSRTPALVFEHVNNTDFK-------------QLYQTLTD 129
Query: 237 AVDVAS-------ALDYLHHYCETPIVHCDLKPSNVLLD---GELTAHVGDFGLAKFLPE 286
D+ ALDY H I+H D+KP NV++D +L + D+GLA+F
Sbjct: 130 Y-DIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLR--LIDWGLAEF--Y 181
Query: 287 ATNNFFNFQIA-------EYGMGSEV-STSGDVYSFGILLLETFTGKRPTNEMFTGNLTL 338
+N ++A E + ++ S D++S G +L K P F G+
Sbjct: 182 HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP---FFHGHDNY 238
Query: 339 HNFVK 343
V+
Sbjct: 239 DQLVR 243
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 32/168 (19%), Positives = 65/168 (38%), Gaps = 43/168 (25%)
Query: 179 IRHRNLVKIITSCASVD-FQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIA 237
++HRN++++ N L++E+ L++++ + ++++ S
Sbjct: 90 LQHRNIIELK------SVIHHNHRLHLIFEYA-ENDLKKYM----DKNPDVSMRVIKSFL 138
Query: 238 VDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVG-----DFGLAKFLPEATNNFF 292
+ + +++ H +H DLKP N+LL + DFGLA+ F
Sbjct: 139 YQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR--------AF 187
Query: 293 NFQIAEYG--------------MGSEV-STSGDVYSFGILLLETFTGK 325
I ++ +GS STS D++S + E
Sbjct: 188 GIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 17/57 (29%), Positives = 27/57 (47%), Gaps = 6/57 (10%)
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLL---DGELTAHVGDFGLAKFLPEATNNFF 292
+ SA+ ++H + +VH DLKP N+L + L + DFG A+ P
Sbjct: 114 KLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLK 167
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 2e-07
Identities = 42/167 (25%), Positives = 65/167 (38%), Gaps = 23/167 (13%)
Query: 180 RHRNLVKIITSCASVDFQGNDSEA-LVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
HRN+ + + G D + LV EF GS+ + + + N L+ IA
Sbjct: 79 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG-----NTLKEEWIAY 133
Query: 239 ---DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQ 295
++ L +LH + ++H D+K NVLL + DFG++ L F
Sbjct: 134 ICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI 190
Query: 296 IAEYGMGSEVSTSG-----------DVYSFGILLLETFTGKRPTNEM 331
Y M EV D++S GI +E G P +M
Sbjct: 191 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 237
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 2e-07
Identities = 16/51 (31%), Positives = 26/51 (50%), Gaps = 6/51 (11%)
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLL---DGELTAHVGDFGLAKFLPE 286
D+ +A+ +LH I H D+KP N+L + + + DFG AK +
Sbjct: 136 DIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ 183
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 35/100 (35%), Positives = 53/100 (53%), Gaps = 15/100 (15%)
Query: 237 AVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHV--GDFGLAK--FLPEATNNFF 292
+ +++ AL+YLH E I++ DLK NVLLD E H+ D+G+ K P T + F
Sbjct: 159 SAEISLALNYLH---ERGIIYRDLKLDNVLLDSE--GHIKLTDYGMCKEGLRPGDTTSTF 213
Query: 293 ----NFQIA-EYGMGSEVSTSGDVYSFGILLLETFTGKRP 327
N+ IA E G + S D ++ G+L+ E G+ P
Sbjct: 214 CGTPNY-IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 51.0 bits (123), Expect = 3e-07
Identities = 45/161 (27%), Positives = 72/161 (44%), Gaps = 33/161 (20%)
Query: 179 IRHRNLVKIITSCASVD-FQGNDSEALVYEFMVNGSLEEWLHPNREAL-----KNLNLLQ 232
+ H N+V +I D LV+EFM L++ L N+ L K L Q
Sbjct: 76 LHHPNIVSLI------DVIHSERCLTLVFEFM-EKDLKKVLDENKTGLQDSQIKIY-LYQ 127
Query: 233 RLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFF 292
L + + H + I+H DLKP N+L++ + + DFGLA+ ++
Sbjct: 128 LLR-------GVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYT 177
Query: 293 NFQIA-------EYGMGSEV-STSGDVYSFGILLLETFTGK 325
+ ++ + MGS+ STS D++S G + E TGK
Sbjct: 178 H-EVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 3e-07
Identities = 35/100 (35%), Positives = 53/100 (53%), Gaps = 15/100 (15%)
Query: 237 AVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHV--GDFGLAK--FLPEATNNFF 292
+ +++ AL+YLH E I++ DLK NVLLD E H+ D+G+ K P T + F
Sbjct: 116 SAEISLALNYLH---ERGIIYRDLKLDNVLLDSE--GHIKLTDYGMCKEGLRPGDTTSTF 170
Query: 293 ----NFQIA-EYGMGSEVSTSGDVYSFGILLLETFTGKRP 327
N+ IA E G + S D ++ G+L+ E G+ P
Sbjct: 171 CGTPNY-IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 4e-07
Identities = 43/162 (26%), Positives = 71/162 (43%), Gaps = 35/162 (21%)
Query: 179 IRHRNLVKIITSCASVD-FQGNDSEALVYEFMVNGSLEEWLHPNREALKNLN----LLQR 233
++H N+V + D S LV+E++ + L+++L + N L Q
Sbjct: 57 LKHANIVTLH------DIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQL 109
Query: 234 LSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLD--GELTAHVGDFGLAKFLPEATNNF 291
L L Y H ++H DLKP N+L++ GEL + DFGLA+ T +
Sbjct: 110 LR-------GLAYCHRQK---VLHRDLKPQNLLINERGELK--LADFGLARAKSIPTKTY 157
Query: 292 FNFQIA-------EYGMGSEV-STSGDVYSFGILLLETFTGK 325
N ++ + +GS ST D++ G + E TG+
Sbjct: 158 DN-EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 4e-07
Identities = 19/40 (47%), Positives = 25/40 (62%), Gaps = 3/40 (7%)
Query: 242 SALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLA 281
A++Y H + IVH DLKP N+LLD L + DFGL+
Sbjct: 119 CAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLS 155
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 51.0 bits (122), Expect = 4e-07
Identities = 34/170 (20%), Positives = 66/170 (38%), Gaps = 24/170 (14%)
Query: 178 FIRHRNLVKIITSCASVDFQGNDSEA-LVYEFMVNGSLEEWLHPNREALKNLNLLQRLSI 236
+ H+N++ ++ + LV E M + L + L+ + +
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLC--QVIQMELDHERMSYL 169
Query: 237 AVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQI 296
+ + +LH I+H DLKPSN+++ + T + DFGLA+ T+ +
Sbjct: 170 LYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYV 224
Query: 297 A-------EYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLH 339
E +G + D++S G ++ E K +F G +
Sbjct: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK----ILFPGRDYID 270
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 4e-07
Identities = 20/40 (50%), Positives = 26/40 (65%), Gaps = 3/40 (7%)
Query: 242 SALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLA 281
S +DY H + +VH DLKP NVLLD + A + DFGL+
Sbjct: 127 SGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLS 163
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 4e-07
Identities = 33/114 (28%), Positives = 51/114 (44%), Gaps = 24/114 (21%)
Query: 243 ALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIAEYGMG 302
A+ LH + ++H DLKPSN+L++ V DFGLA+ + E+ + + GM
Sbjct: 124 AVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMV 180
Query: 303 SEVST-----------------SGDVYSFGILLLETFTGKRPTNEMFTGNLTLH 339
V+T + DV+S G +L E F + P +F G H
Sbjct: 181 EFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR-P---IFPGRDYRH 230
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 4e-07
Identities = 21/40 (52%), Positives = 27/40 (67%), Gaps = 3/40 (7%)
Query: 242 SALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLA 281
SA+DY H + +VH DLKP NVLLD + A + DFGL+
Sbjct: 122 SAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLS 158
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 5e-07
Identities = 33/161 (20%), Positives = 69/161 (42%), Gaps = 33/161 (20%)
Query: 179 IRHRNLVKIITSCASVD-FQGNDSEALVYEFMVNGSLEEWLHPNREAL-----KNLNLLQ 232
++H NLV ++ + F+ LV+E+ + ++ L + + K++ Q
Sbjct: 59 LKHPNLVNLL------EVFRRKRRLHLVFEYC-DHTVLHELDRYQRGVPEHLVKSI-TWQ 110
Query: 233 RLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFF 292
L A+++ H + +H D+KP N+L+ + DFG A+ L ++ +
Sbjct: 111 TLQ-------AVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYD 160
Query: 293 NFQIA-------EYGMGSEV-STSGDVYSFGILLLETFTGK 325
+ ++A E +G DV++ G + E +G
Sbjct: 161 D-EVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 5e-07
Identities = 36/179 (20%), Positives = 58/179 (32%), Gaps = 37/179 (20%)
Query: 177 NFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLN----LLQ 232
N H N++ + + LV E M L + +H R + + +
Sbjct: 84 NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYFMYH 142
Query: 233 RLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFF 292
L L LH E +VH DL P N+LL + DF LA+
Sbjct: 143 ILL-------GLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTA------ 186
Query: 293 NFQIAEY------------GMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLH 339
+ Y + D++S G ++ E F K +F G+ +
Sbjct: 187 DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK----ALFRGSTFYN 241
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 5e-07
Identities = 40/169 (23%), Positives = 67/169 (39%), Gaps = 40/169 (23%)
Query: 177 NFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSL------EEWLHPNREALKNLNL 230
N RHRN++ + S F+ + +++EF+ + + RE +
Sbjct: 56 NIARHRNILHLHES-----FESMEELVMIFEFISGLDIFERINTSAFELNEREIVS---- 106
Query: 231 LQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHV--GDFGLAKFLPEAT 288
V AL +LH I H D++P N++ ++ + +FG A+ L
Sbjct: 107 -----YVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158
Query: 289 NNFFNFQIAEYGMGSEV------STSGDVYSFG----ILLLETFTGKRP 327
N F EY EV ST+ D++S G +LL +G P
Sbjct: 159 NFRLLFTAPEY-YAPEVHQHDVVSTATDMWSLGTLVYVLL----SGINP 202
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 6e-07
Identities = 29/132 (21%), Positives = 51/132 (38%), Gaps = 7/132 (5%)
Query: 24 QRLTLEMNKFWGEIPSSI-GNLTLLITLNFAENMLEGSIPS-SLGKCQNLILLDLSNNNL 81
+ LE N IP L ++ + N + + + ++L L L N +
Sbjct: 35 TEIRLEQNTI-KVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKI 92
Query: 82 TGTTPTEVI-GLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGS 140
T P + GL SL L L+ N++N F L NL + + +NKL +
Sbjct: 93 T-ELPKSLFEGLFSLQ-LLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSP 150
Query: 141 CIRLEQLVMNGN 152
++ + + N
Sbjct: 151 LRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 5e-06
Identities = 31/128 (24%), Positives = 52/128 (40%), Gaps = 7/128 (5%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSI-GNLTLLITLNFAENMLEGSIP 62
L N PG+ KL+R+ L N+ E+ L L +L N + +P
Sbjct: 39 LEQNTIKVIPPGAFSPYKKLRRIDLSNNQI-SELAPDAFQGLRSLNSLVLYGNKIT-ELP 96
Query: 63 SSL-GKCQNLILLDLSNNNLTGTTPTEVI-GLSSLSIYLDLSQNQLNGPLPSNFGILKNL 120
SL +L LL L+ N + + L +L+ L L N+L F L+ +
Sbjct: 97 KSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLN-LLSLYDNKLQTIAKGTFSPLRAI 154
Query: 121 GAIDISEN 128
+ +++N
Sbjct: 155 QTMHLAQN 162
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 6e-07
Identities = 21/54 (38%), Positives = 27/54 (50%), Gaps = 6/54 (11%)
Query: 236 IAVDVASALDYLHHYCETPIVHCDLKPSNVLL---DGELTAHVGDFGLAKFLPE 286
+ V SA+ YLH E IVH DLKP N+L + + DFGL+K
Sbjct: 111 VIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 6e-07
Identities = 22/116 (18%), Positives = 51/116 (43%), Gaps = 20/116 (17%)
Query: 179 IRHRNLVK---IITSCASVDFQGNDSEALVYEFMVN--GSLEEWLHPNREALKNLNLLQR 233
++H N++ + S + L++++ + + ++ ++ K + L +
Sbjct: 75 LKHPNVISLQKVFLS------HADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRG 128
Query: 234 L--SIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAH----VGDFGLAKF 283
+ S+ + + YLH ++H DLKP+N+L+ GE + D G A+
Sbjct: 129 MVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL 181
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 7e-07
Identities = 17/42 (40%), Positives = 22/42 (52%), Gaps = 3/42 (7%)
Query: 242 SALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKF 283
+ + YLH I H D+KP N+LLD + DFGLA
Sbjct: 116 AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATV 154
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 7e-07
Identities = 18/58 (31%), Positives = 26/58 (44%), Gaps = 6/58 (10%)
Query: 240 VASALDYLHHYCETPIVHCDLKPSNVLL---DGELTAHVGDFGLAKFLPEATNNFFNF 294
+ AL Y H + I+H D+KP VLL + +G FG+A L E+
Sbjct: 139 ILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR 193
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 8e-07
Identities = 36/161 (22%), Positives = 69/161 (42%), Gaps = 33/161 (20%)
Query: 179 IRHRNLVKIITSCASVD-FQGNDSEALVYEFMVNGSLEEWLHPNREAL-----KNLNLLQ 232
+RH NLV ++ + + LV+EF+ + ++ + L L + L Q
Sbjct: 81 LRHENLVNLL------EVCKKKKRWYLVFEFV-DHTILDDLELFPNGLDYQVVQKY-LFQ 132
Query: 233 RLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFF 292
++ + + H + I+H D+KP N+L+ + DFG A+ L +
Sbjct: 133 IIN-------GIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYD 182
Query: 293 NFQIA-------EYGMGSEV-STSGDVYSFGILLLETFTGK 325
+ ++A E +G + DV++ G L+ E F G+
Sbjct: 183 D-EVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 8e-07
Identities = 37/113 (32%), Positives = 54/113 (47%), Gaps = 28/113 (24%)
Query: 179 IRHRNLVKIITSCASVD-FQGNDSEALVYEFMVNGSLEEWLHPNREAL-----KNLNLLQ 232
+ H N++ ++ D F + +LV++FM LE + N L K +L
Sbjct: 69 LSHPNIIGLL------DAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAY-MLM 120
Query: 233 RLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLD--GELTAHVGDFGLAKF 283
L L+YLH + I+H DLKP+N+LLD G L + DFGLAK
Sbjct: 121 TLQ-------GLEYLHQHW---ILHRDLKPNNLLLDENGVLK--LADFGLAKS 161
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 8e-07
Identities = 17/42 (40%), Positives = 22/42 (52%), Gaps = 3/42 (7%)
Query: 242 SALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKF 283
+ + YLH I H D+KP N+LLD + DFGLA
Sbjct: 116 AGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATV 154
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 8e-07
Identities = 30/123 (24%), Positives = 46/123 (37%), Gaps = 27/123 (21%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPN-----REALKNLNLLQR 233
+H N++ + + +V E M G L + + REA
Sbjct: 73 GQHPNIITLKDV-----YDDGKYVYVVTELMKGGELLDKILRQKFFSEREASA------- 120
Query: 234 LSIAVDVASALDYLHHYCETPIVHCDLKPSNVLL----DGELTAHVGDFGLAKFLPEATN 289
+ + ++YLH +VH DLKPSN+L + + DFG AK L A N
Sbjct: 121 --VLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL-RAEN 174
Query: 290 NFF 292
Sbjct: 175 GLL 177
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 9e-07
Identities = 43/165 (26%), Positives = 69/165 (41%), Gaps = 36/165 (21%)
Query: 179 IRHRNLVKIITSCASVD-FQGNDSEALVYEFMVNGSLEEWL--HPNREALKNLNLLQRLS 235
++H N+V++ D + LV+EFM + L++++ + L L
Sbjct: 60 LKHENIVRLY------DVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKY 112
Query: 236 IAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQ 295
+ L + H I+H DLKP N+L++ +GDFGLA+ F
Sbjct: 113 FQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLAR--------AFGIP 161
Query: 296 IAEYG--------------MGSEV-STSGDVYSFGILLLETFTGK 325
+ + MGS STS D++S G +L E TGK
Sbjct: 162 VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 9e-07
Identities = 39/161 (24%), Positives = 61/161 (37%), Gaps = 23/161 (14%)
Query: 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV- 238
++VK S + N +V E+ GS+ + + L IA
Sbjct: 82 DSPHVVKYYGS-----YFKNTDLWIVMEYCGAGSVSDIIRLRN------KTLTEDEIATI 130
Query: 239 --DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQI 296
L+YLH +H D+K N+LL+ E A + DFG+A L +
Sbjct: 131 LQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIG 187
Query: 297 AEYGMGSEVSTSG------DVYSFGILLLETFTGKRPTNEM 331
+ M EV D++S GI +E GK P ++
Sbjct: 188 TPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADI 228
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 35/120 (29%), Positives = 48/120 (40%), Gaps = 37/120 (30%)
Query: 181 HRNLVKIITSCASVDFQGNDSEALVYEFMVNGSL-----------EEWLHPNREALKNLN 229
HRN++++I F+ D LV+E M GS+ E EA
Sbjct: 70 HRNVLELIEF-----FEEEDRFYLVFEKMRGGSILSHIHKRRHFNE------LEASV--- 115
Query: 230 LLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLL---DGELTAHVGDFGLAKFLPE 286
+ DVASALD+LH I H DLKP N+L + + DF L +
Sbjct: 116 ------VVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 33/112 (29%), Positives = 44/112 (39%), Gaps = 27/112 (24%)
Query: 240 VASALDYLHHYCETPIVHCDLKPSNVLL---DGELTAHVGDFGLAKFLPEATNNFFNF-- 294
+ A+ YLH E IVH DLKP N+L + + DFGL+K +
Sbjct: 157 ILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH-QVLMKTVCG 212
Query: 295 --------QIAEYGMGSEVSTSGDVYSFG----ILL--LETFTGKRPTNEMF 332
+ G EV D++S G ILL E F +R MF
Sbjct: 213 TPGYCAPEILRGCAYGPEV----DMWSVGIITYILLCGFEPFYDERGDQFMF 260
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 34/156 (21%), Positives = 58/156 (37%), Gaps = 32/156 (20%)
Query: 177 NFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSL------EEWLHPNREALKNLNL 230
N + H L+ + + F+ L+ EF+ G L E++ E +
Sbjct: 103 NQLHHPKLINLHDA-----FEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVIN---- 153
Query: 231 LQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHV--GDFGLAKFLPEAT 288
L ++H E IVH D+KP N++ + + + V DFGLA L
Sbjct: 154 -----YMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205
Query: 289 NNFFNFQIAEYGMGSEV------STSGDVYSFGILL 318
AE+ E+ D+++ G+L
Sbjct: 206 IVKVTTATAEF-AAPEIVDREPVGFYTDMWAIGVLG 240
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 49.4 bits (117), Expect = 1e-06
Identities = 21/97 (21%), Positives = 36/97 (37%), Gaps = 3/97 (3%)
Query: 60 SIPSSLGKCQNLILLDLSNNNLTGTTPTEVI-GLSSLSIYLDLSQNQLNGPLPSNFGILK 118
L +NL L + N + GL L L + ++ L P F
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELR-NLTIVKSGLRFVAPDAFHFTP 80
Query: 119 NLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFR 155
L +++S N L + + L++LV++GN
Sbjct: 81 RLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 46.3 bits (109), Expect = 1e-05
Identities = 21/97 (21%), Positives = 34/97 (35%), Gaps = 3/97 (3%)
Query: 12 RIPGSIGDLHKLQRLTLEMNKFWGEIPS-SIGNLTLLITLNFAENMLEGSIPSSLGKCQN 70
+ L L +E + + + L L L ++ L P +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 71 LILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLN 107
L L+LS N L + + + SL L LS N L+
Sbjct: 82 LSRLNLSFNALE-SLSWKTVQGLSLQE-LVLSGNPLH 116
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 21/50 (42%), Positives = 28/50 (56%), Gaps = 6/50 (12%)
Query: 240 VASALDYLHHYCETPIVHCDLKPSNVLL---DGELTAHVGDFGLAKFLPE 286
+ A+ YLH E I+H DLKP NVLL + + + DFG +K L E
Sbjct: 123 MLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 169
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 1e-06
Identities = 16/51 (31%), Positives = 21/51 (41%), Gaps = 6/51 (11%)
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLL---DGELTAHVGDFGLAKFLPE 286
+ A+ YLH I H D+KP N+L + DFG AK
Sbjct: 169 SIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 1e-06
Identities = 44/169 (26%), Positives = 72/169 (42%), Gaps = 49/169 (28%)
Query: 179 IRHRNLVKIITSCASVD-FQGNDSEALVYEFMVNGSLEEWLHPNREALKNLN----LLQR 233
++H N+VK+ D LV+E + + L++ L L+++ LLQ
Sbjct: 57 LKHSNIVKLY------DVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQL 109
Query: 234 LSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLD--GELTAHVGDFGLAKFLPEATNNF 291
L+ + Y H ++H DLKP N+L++ GEL + DFGLA+
Sbjct: 110 LN-------GIAYCHDRR---VLHRDLKPQNLLINREGELK--IADFGLAR--------A 149
Query: 292 FNFQIAEYG--------------MGSEV-STSGDVYSFGILLLETFTGK 325
F + +Y MGS+ ST+ D++S G + E G
Sbjct: 150 FGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 35/173 (20%), Positives = 63/173 (36%), Gaps = 43/173 (24%)
Query: 178 FIRHRNLVKIITSCASVDFQGNDS--EALVYEFMVNGSLEEWLHPNREALKNLNLLQRLS 235
+ H N+V++ + ++ + +V E++ + LH R
Sbjct: 75 VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-----PDTLH--RCCRNYYRRQVAPP 127
Query: 236 IAV------DVASALDYLHHYCETPIVHCDLKPSNVLLD---GELTAHVGDFGLAKFLPE 286
+ + ++ LH + H D+KP NVL++ G L + DFG AK L
Sbjct: 128 PILIKVFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLK--LCDFGSAKKLSP 184
Query: 287 ATNN--------------FFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGK 325
+ N F Q Y +T+ D++S G + E G+
Sbjct: 185 SEPNVAYICSRYYRAPELIFGNQ--HY------TTAVDIWSVGCIFAEMMLGE 229
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 17/44 (38%), Positives = 20/44 (45%), Gaps = 5/44 (11%)
Query: 242 SALDYLHHYCETPIVHCDLKPSNVLLDGELTAH--VGDFGLAKF 283
S + Y H I H DLK N LLDG + DFG +K
Sbjct: 127 SGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 48.7 bits (116), Expect = 2e-06
Identities = 22/65 (33%), Positives = 34/65 (52%), Gaps = 7/65 (10%)
Query: 204 LVYEFMVNG-SLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKP 262
+V+E + G L +W+ + L +++ I V LDYLH C I+H D+KP
Sbjct: 122 MVFEVL--GHHLLKWIIKSNYQGLPLPCVKK--IIQQVLQGLDYLHTKCR--IIHTDIKP 175
Query: 263 SNVLL 267
N+LL
Sbjct: 176 ENILL 180
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 30/116 (25%), Positives = 45/116 (38%), Gaps = 26/116 (22%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWL-----HPNREALKNLNLLQR 233
+ H ++KI +F + +V E M G L + +
Sbjct: 197 LNHPCIIKIK------NFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKL------- 243
Query: 234 LSIAVDVASALDYLHHYCETPIVHCDLKPSNVLL---DGELTAHVGDFGLAKFLPE 286
+ A+ YLH E I+H DLKP NVLL + + + DFG +K L E
Sbjct: 244 --YFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 294
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 3e-06
Identities = 16/50 (32%), Positives = 24/50 (48%), Gaps = 6/50 (12%)
Query: 240 VASALDYLHHYCETPIVHCDLKPSNVLL---DGELTAHVGDFGLAKFLPE 286
+ ++ Y H IVH +LKP N+LL + DFGLA + +
Sbjct: 137 ILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 3e-06
Identities = 39/156 (25%), Positives = 67/156 (42%), Gaps = 28/156 (17%)
Query: 177 NFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSI 236
N + H NL+++ + F+ + LV E++ G L + R ++ NL + +I
Sbjct: 141 NQLDHANLIQLYDA-----FESKNDIVLVMEYVDGGELFD-----RIIDESYNLTELDTI 190
Query: 237 AV--DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHV--GDFGLAKFLPEATNNFF 292
+ + ++H + I+H DLKP N+L + DFGLA+
Sbjct: 191 LFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV 247
Query: 293 NFQIAEYGMGSEV------STSGDVYSFG----ILL 318
NF E+ + EV S D++S G +LL
Sbjct: 248 NFGTPEF-LAPEVVNYDFVSFPTDMWSVGVIAYMLL 282
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 3e-06
Identities = 20/58 (34%), Positives = 27/58 (46%), Gaps = 5/58 (8%)
Query: 235 SIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHV--GDFGLAKFLPEATNN 290
+I + SAL YLH I H D+KP N L + + DFGL+K + N
Sbjct: 172 NIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNG 226
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 4e-06
Identities = 18/50 (36%), Positives = 26/50 (52%), Gaps = 6/50 (12%)
Query: 240 VASALDYLHHYCETPIVHCDLKPSNVLLDGEL-TAHV--GDFGLAKFLPE 286
+ ++ Y H IVH +LKP N+LL + A V DFGLA + +
Sbjct: 114 ILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 4e-06
Identities = 30/142 (21%), Positives = 46/142 (32%), Gaps = 39/142 (27%)
Query: 216 EWLHPN-REALK-------NLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLL 267
E L N E LK L ++ +A + AL +LH E + H DLKP N+L
Sbjct: 102 ELLGKNTFEFLKENNFQPYPLPHVRH--MAYQLCHALRFLH---ENQLTHTDLKPENILF 156
Query: 268 DGELTAHVGDFGLAKFLPEATNN-----------FFNFQIAEY-------------GMGS 303
+ + + N F + +G
Sbjct: 157 VNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELG- 215
Query: 304 EVSTSGDVYSFGILLLETFTGK 325
+ DV+S G +L E + G
Sbjct: 216 -WAQPCDVWSIGCILFEYYRGF 236
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 4e-06
Identities = 36/184 (19%), Positives = 68/184 (36%), Gaps = 53/184 (28%)
Query: 178 FIRHRNLVKIITSCASVDFQGNDSEA-LVYEFMVNGSLEEWLHPNREALKNLNLLQRLS- 235
++H N++ ++ N + LV FM + L + + + S
Sbjct: 79 HMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQ---KIMG-----LKFSE 125
Query: 236 -----IAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFL------ 284
+ + L Y+H +VH DLKP N+ ++ + + DFGLA+
Sbjct: 126 EKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG 182
Query: 285 ---------PEATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGN 335
PE ++ ++ + + D++S G ++ E TGK +F G
Sbjct: 183 YVVTRWYRAPEVILSWMHY-----------NQTVDIWSVGCIMAEMLTGK----TLFKGK 227
Query: 336 LTLH 339
L
Sbjct: 228 DYLD 231
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 5e-06
Identities = 17/58 (29%), Positives = 27/58 (46%), Gaps = 6/58 (10%)
Query: 240 VASALDYLHHYCETPIVHCDLKPSNVLL---DGELTAHVGDFGLAKFLPEATNNFFNF 294
+ A+ + H + +VH +LKP N+LL + DFGLA + +F F
Sbjct: 119 ILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGF 173
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 5e-06
Identities = 42/170 (24%), Positives = 69/170 (40%), Gaps = 42/170 (24%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSE-ALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIA 237
+ H N+V++ S + ++ LV +++ E ++ R A Q L +
Sbjct: 104 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-----PETVY--RVARHYSRAKQTLPVI 156
Query: 238 V------DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHV--GDFGLAKFLPEATN 289
+ +L Y+H + I H D+KP N+LLD + TA + DFG AK L
Sbjct: 157 YVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPD-TAVLKLCDFGSAKQLVRGEP 212
Query: 290 N--------------FFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGK 325
N F +Y ++S DV+S G +L E G+
Sbjct: 213 NVSYICSRYYRAPELIFGAT--DY------TSSIDVWSAGCVLAELLLGQ 254
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 5e-06
Identities = 38/163 (23%), Positives = 68/163 (41%), Gaps = 22/163 (13%)
Query: 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVD 239
H +VK++ + + + ++ EF G+++ + E + L Q +
Sbjct: 74 DHPYIVKLLGA-----YYHDGKLWIMIEFCPGGAVDAIM---LELDRGLTEPQIQVVCRQ 125
Query: 240 VASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIAEY 299
+ AL++LH I+H DLK NVL+ E + DFG++ + +F Y
Sbjct: 126 MLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPY 182
Query: 300 GMGSEVSTSG-----------DVYSFGILLLETFTGKRPTNEM 331
M EV D++S GI L+E + P +E+
Sbjct: 183 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 225
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 6e-06
Identities = 16/47 (34%), Positives = 21/47 (44%), Gaps = 6/47 (12%)
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLL---DGELTAHVGDFGLAK 282
+ A+ YLH I H D+KP N+L + DFG AK
Sbjct: 125 SIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 8e-06
Identities = 28/109 (25%), Positives = 45/109 (41%), Gaps = 21/109 (19%)
Query: 243 ALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIAEY--- 299
L Y+H ++H DLKPSN+LL+ + DFGLA+ ++ + EY
Sbjct: 140 GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH--TGFLTEYVAT 194
Query: 300 ---------GMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLH 339
+ S D++S G +L E + + +F G L
Sbjct: 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR----PIFPGKHYLD 239
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 8e-06
Identities = 31/162 (19%), Positives = 63/162 (38%), Gaps = 45/162 (27%)
Query: 204 LVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV------DVASALDYLHHYCETPIVH 257
++ E++ + LH + + + + + + + A+ ++H I H
Sbjct: 115 VIMEYV-----PDTLH--KVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICH 164
Query: 258 CDLKPSNVLLDGELTAHV--GDFGLAKFLPEATNN--------------FFNFQIAEYGM 301
D+KP N+L++ + + DFG AK L + + EY
Sbjct: 165 RDIKPQNLLVNSK-DNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGAT--EY-- 219
Query: 302 GSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVK 343
+ S D++S G + E GK P +F+G ++ V+
Sbjct: 220 ----TPSIDLWSIGCVFGELILGK-P---LFSGETSIDQLVR 253
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 46.4 bits (109), Expect = 8e-06
Identities = 27/130 (20%), Positives = 41/130 (31%), Gaps = 8/130 (6%)
Query: 195 DFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETP 254
DF +D +V EF G E + K +L SI + ++L
Sbjct: 130 DFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTASLAVAEASLR-- 182
Query: 255 IVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIAEYGMGSEVSTSGDVYSF 314
H DL NVLL + K + I +Y + V+
Sbjct: 183 FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCG-LQVSIIDYTLSRLERDGIVVFCD 241
Query: 315 GILLLETFTG 324
+ + FTG
Sbjct: 242 VSMDEDLFTG 251
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 27/110 (24%), Positives = 49/110 (44%), Gaps = 22/110 (20%)
Query: 243 ALDYLHHYCETPIVHCDLKPSNVLLDGE-LTAHVGDFGLAKFLPEATNNFFNFQIAEY-- 299
L Y+H ++H DLKP+N+ ++ E L +GDFGLA+ + ++ ++E
Sbjct: 132 GLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSH--KGHLSEGLV 186
Query: 300 ----------GMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLH 339
+ + + D+++ G + E TGK +F G L
Sbjct: 187 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK----TLFAGAHELE 232
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 38/170 (22%), Positives = 67/170 (39%), Gaps = 42/170 (24%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEA-LVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIA 237
++H N+V + S + ++ LV E++ E ++ R + L Q + +
Sbjct: 89 VKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-----PETVY--RASRHYAKLKQTMPML 141
Query: 238 V------DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHV--GDFGLAKFLPEATN 289
+ + +L Y+H I H D+KP N+LLD + + DFG AK L
Sbjct: 142 LIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPP-SGVLKLIDFGSAKILIAGEP 197
Query: 290 N--------------FFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGK 325
N F Y +T+ D++S G ++ E G+
Sbjct: 198 NVSYICSRYYRAPELIFGAT--NY------TTNIDIWSTGCVMAELMQGQ 239
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 1e-05
Identities = 26/111 (23%), Positives = 46/111 (41%), Gaps = 20/111 (18%)
Query: 177 NFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLS- 235
N ++ ++++ D D +V E + L K L+
Sbjct: 80 NRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-----DSDLK------KLFKTPIFLTE 128
Query: 236 -----IAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLA 281
I ++ +++H E+ I+H DLKP+N LL+ + + V DFGLA
Sbjct: 129 EHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLA 176
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 1e-05
Identities = 38/184 (20%), Positives = 72/184 (39%), Gaps = 52/184 (28%)
Query: 178 FIRHRNLVK---IITSCASVDFQGNDSEA-LVYEFMVNGSLEEWLHPNREALKNLNLLQR 233
++H N++ + T S++ ++ LV M L+ +K Q+
Sbjct: 84 HMKHENVIGLLDVFTPARSLE---EFNDVYLVTHLM-----GADLN---NIVKC----QK 128
Query: 234 LS------IAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAK----F 283
L+ + + L Y+H I+H DLKPSN+ ++ + + DFGLA+
Sbjct: 129 LTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE 185
Query: 284 LPE--------ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGN 335
+ A N+ Y + + D++S G ++ E TG+ +F G
Sbjct: 186 MTGYVATRWYRAPEIMLNWM--HY------NQTVDIWSVGCIMAELLTGR----TLFPGT 233
Query: 336 LTLH 339
+
Sbjct: 234 DHID 237
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 1e-05
Identities = 29/111 (26%), Positives = 45/111 (40%), Gaps = 11/111 (9%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+ H N++KI F+ + +V E G L E + + K L+ +
Sbjct: 77 LDHPNIIKIFEV-----FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMK 131
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLL---DGELTAHVGDFGLAKFLPE 286
+ +AL Y H +VH DLKP N+L + DFGLA+
Sbjct: 132 QMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 1e-05
Identities = 26/105 (24%), Positives = 46/105 (43%), Gaps = 8/105 (7%)
Query: 177 NFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSI 236
N + H ++VK++ D + D +V E + L L ++
Sbjct: 107 NRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-----DSDFKKLFRTPVYLTELHIKTL 161
Query: 237 AVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLA 281
++ + Y+H I+H DLKP+N L++ + + V DFGLA
Sbjct: 162 LYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLA 203
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-05
Identities = 31/135 (22%), Positives = 57/135 (42%), Gaps = 16/135 (11%)
Query: 47 LITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLS--IYLDLSQN 104
+ L+ +E + ++L + L LS NN+ ++ LS + L L +N
Sbjct: 27 KVELHGMIPPIEK-MDATLSTLKACKHLALSTNNI-----EKISSLSGMENLRILSLGRN 80
Query: 105 QLN--GPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRG-NIPSS 161
+ L + L+ L IS N+++ + S I + L L M+ N
Sbjct: 81 LIKKIENLDAVADTLEEL---WISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWGEIDK 135
Query: 162 LSSLRGIENLDLSRN 176
L++L +E+L L+ N
Sbjct: 136 LAALDKLEDLLLAGN 150
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-05
Identities = 33/154 (21%), Positives = 57/154 (37%), Gaps = 36/154 (23%)
Query: 24 QRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTG 83
+R+ LE+ PS + L L + + EG + + + L L N LT
Sbjct: 5 RRIHLELR---NRTPSDVKELVLDNSRS-----NEGKLEGLTDEFEELEFLSTINVGLT- 55
Query: 84 TTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIR 143
SI +N L L +++S+N++SG + C
Sbjct: 56 ------------SI--------------ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPN 89
Query: 144 LEQLVMNGNFFRG-NIPSSLSSLRGIENLDLSRN 176
L L ++GN + + L L +++LDL
Sbjct: 90 LTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 38.9 bits (91), Expect = 7e-04
Identities = 25/99 (25%), Positives = 40/99 (40%), Gaps = 12/99 (12%)
Query: 11 GRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNL---TLLITLNFAENMLEGSIPSSLGK 67
G++ G + +L+ L+ +SI NL L L ++N + G + K
Sbjct: 32 GKLEGLTDEFEELEFLSTINVGL-----TSIANLPKLNKLKKLELSDNRVSGGLEVLAEK 86
Query: 68 CQNLILLDLSNNNLTGTTPTEVIGLSSLS--IYLDLSQN 104
C NL L+LS N + + + L L LDL
Sbjct: 87 CPNLTHLNLSGNKI--KDLSTIEPLKKLENLKSLDLFNC 123
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 1e-05
Identities = 40/130 (30%), Positives = 54/130 (41%), Gaps = 12/130 (9%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSI-GNLTLLITLNFAENMLEGSIP 62
L NQ T PG L L+ L L N+ G +P + +LT L L+ N L +P
Sbjct: 47 LHDNQITKLEPGVFDSLINLKELYLGSNQL-GALPVGVFDSLTQLTVLDLGTNQLT-VLP 104
Query: 63 S----SLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILK 118
S L L L + N LT P + L+ L+ +L L QNQL F L
Sbjct: 105 SAVFDRLVH---LKELFMCCNKLT-ELPRGIERLTHLT-HLALDQNQLKSIPHGAFDRLS 159
Query: 119 NLGAIDISEN 128
+L + N
Sbjct: 160 SLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 7e-05
Identities = 31/109 (28%), Positives = 45/109 (41%), Gaps = 6/109 (5%)
Query: 24 QRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSL-GKCQNLILLDLSNNNLT 82
Q L L N+ P +L L L N L ++P + L +LDL N LT
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT 101
Query: 83 GTTPTEVIG-LSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKL 130
P+ V L L L + N+L LP L +L + + +N+L
Sbjct: 102 -VLPSAVFDRLVHLK-ELFMCCNKLTE-LPRGIERLTHLTHLALDQNQL 147
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 29/109 (26%), Positives = 46/109 (42%), Gaps = 27/109 (24%)
Query: 243 ALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAK-FLPEATNN----------- 290
L Y+H I+H DLKP N+ ++ + + DFGLA+ E T
Sbjct: 140 GLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEV 196
Query: 291 FFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLH 339
N+ Y + + D++S G ++ E TGK +F G+ L
Sbjct: 197 ILNWM--RY------TQTVDIWSVGCIMAEMITGK----TLFKGSDHLD 233
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 40/155 (25%), Positives = 59/155 (38%), Gaps = 21/155 (13%)
Query: 181 HRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDV 240
H N++K+ F+ + LV E G L + + N + I V
Sbjct: 95 HPNIMKLYDF-----FEDKRNYYLVMECYKGGELFDEI----IHRMKFNEVDAAVIIKQV 145
Query: 241 ASALDYLHHYCETPIVHCDLKPSNVLL---DGELTAHVGDFGLAKFLPEATNNFFNFQIA 297
S + YLH + IVH DLKP N+LL + + + DFGL+
Sbjct: 146 LSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN-QKKMKERLGT 201
Query: 298 EYGMGSEV-----STSGDVYSFGILLLETFTGKRP 327
Y + EV DV+S G++L G P
Sbjct: 202 AYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPP 236
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 2e-05
Identities = 18/50 (36%), Positives = 27/50 (54%), Gaps = 6/50 (12%)
Query: 240 VASALDYLHHYCETPIVHCDLKPSNVLL---DGELTAHVGDFGLAKFLPE 286
V S + Y+H + IVH DLKP N+LL + + + DFGL+ +
Sbjct: 130 VFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 17/39 (43%), Positives = 24/39 (61%), Gaps = 3/39 (7%)
Query: 243 ALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLA 281
+ YLH ++H D+KPSN+LL+ E V DFGL+
Sbjct: 121 VIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLS 156
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 2e-05
Identities = 31/155 (20%), Positives = 56/155 (36%), Gaps = 33/155 (21%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPN-----REALKNLNLLQR 233
+ H N++ + ++ L+ E + G L ++L EA
Sbjct: 72 VLHHNVITLHDV-----YENRTDVVLILELVSGGELFDFLAQKESLSEEEATS------- 119
Query: 234 LSIAVDVASALDYLHHYCETPIVHCDLKPSNVLL----DGELTAHVGDFGLAKFLPEATN 289
+ ++YLH I H DLKP N++L + DFGLA + +
Sbjct: 120 --FIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174
Query: 290 NFFNFQIAEYGMGSEV------STSGDVYSFGILL 318
F E+ + E+ D++S G++
Sbjct: 175 FKNIFGTPEF-VAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 3e-05
Identities = 17/50 (34%), Positives = 22/50 (44%), Gaps = 6/50 (12%)
Query: 240 VASALDYLHHYCETPIVHCDLKPSNVLL---DGELTAHVGDFGLAKFLPE 286
V SA+ Y H + + H DLKP N L + + DFGLA
Sbjct: 115 VLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 16/60 (26%), Positives = 29/60 (48%), Gaps = 13/60 (21%)
Query: 216 EWLHPN-REALK-------NLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLL 267
E L P+ E + ++ ++ +++ AL+YL + + H DLKP N+LL
Sbjct: 116 EPLGPSLYEIITRNNYNGFHIEDIK--LYCIEILKALNYLR---KMSLTHTDLKPENILL 170
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 3e-05
Identities = 32/129 (24%), Positives = 55/129 (42%), Gaps = 8/129 (6%)
Query: 4 LVGNQFTGRIP-GSIGDLHKLQRLTLEMNKFWGEIPSSI-GNLTLLITLNFAENMLEGSI 61
L N+FT G L +L+++ NK +I + + + N LE ++
Sbjct: 39 LNNNEFTVLEATGIFKKLPQLRKINFSNNKI-TDIEEGAFEGASGVNEILLTSNRLE-NV 96
Query: 62 PSSL-GKCQNLILLDLSNNNLTGTTPTEV-IGLSSLSIYLDLSQNQLNGPLPSNFGILKN 119
+ ++L L L +N +T + IGLSS+ L L NQ+ P F L +
Sbjct: 97 QHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVR-LLSLYDNQITTVAPGAFDTLHS 154
Query: 120 LGAIDISEN 128
L +++ N
Sbjct: 155 LSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 4e-05
Identities = 22/107 (20%), Positives = 38/107 (35%), Gaps = 4/107 (3%)
Query: 74 LDLSNNNLTGTTPTEV-IGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSG 132
L L+NN T T + L L ++ S N++ F + I ++ N+L
Sbjct: 37 LRLNNNEFTVLEATGIFKKLPQLR-KINFSNNKITDIEEGAFEGASGVNEILLTSNRLEN 95
Query: 133 QIPSSI-GSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178
+ + L+ L++ N S L + L L N
Sbjct: 96 -VQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQI 141
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 3e-05
Identities = 24/88 (27%), Positives = 41/88 (46%), Gaps = 13/88 (14%)
Query: 240 VASALDYLHHYCETPIVHCDLKPSNVLLDGELTAH---VGDFGLAKFLPEATNNFFNFQI 296
+ + YLH + IVH DLKP N+LL + DFG+++ + A
Sbjct: 140 ILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGT 196
Query: 297 AEYGMGSEV------STSGDVYSFGILL 318
EY + E+ +T+ D+++ GI+
Sbjct: 197 PEY-LAPEILNYDPITTATDMWNIGIIA 223
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 5e-05
Identities = 24/142 (16%), Positives = 50/142 (35%), Gaps = 39/142 (27%)
Query: 216 EWLHPN-REALK-------NLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLL 267
E L + + +K L+ +++ +A + ++++LH + H DLKP N+L
Sbjct: 97 ELLGLSTYDFIKENGFLPFRLDHIRK--MAYQICKSVNFLH---SNKLTHTDLKPENILF 151
Query: 268 DGELTAHVGDFGLAKFLPEATNN-----------FFNFQIAEY-------------GMGS 303
+ + + N + + + +G
Sbjct: 152 VQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALG- 210
Query: 304 EVSTSGDVYSFGILLLETFTGK 325
S DV+S G +L+E + G
Sbjct: 211 -WSQPCDVWSIGCILIEYYLGF 231
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 5e-05
Identities = 31/155 (20%), Positives = 58/155 (37%), Gaps = 33/155 (21%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPN-----REALKNLNLLQR 233
+ H N++ + ++ L+ E + G L ++L EA
Sbjct: 72 VLHPNIITLHDV-----YENRTDVVLILELVSGGELFDFLAQKESLSEEEATS------- 119
Query: 234 LSIAVDVASALDYLHHYCETPIVHCDLKPSNVLL---DGELTA-HVGDFGLAKFLPEATN 289
+ ++YLH I H DLKP N++L + + + DFGLA + +
Sbjct: 120 --FIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE 174
Query: 290 NFFNFQIAEYGMGSEV------STSGDVYSFGILL 318
F E+ + E+ D++S G++
Sbjct: 175 FKNIFGTPEF-VAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 6e-05
Identities = 39/158 (24%), Positives = 64/158 (40%), Gaps = 7/158 (4%)
Query: 24 QRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSL-GKCQNLILLDLSNNNLT 82
++L L+ ++ LT L LN N L+ ++ + + L L L+NN L
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA 96
Query: 83 GTTPTEVIGLSSLSIYLDLSQNQLNGPLPSN-FGILKNLGAIDISENKLSGQIPSSI-GS 140
L+ L L L NQL LPS F L L + ++ N+L IP+
Sbjct: 97 SLPLGVFDHLTQLD-KLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDK 153
Query: 141 CIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178
L+ L ++ N + + L ++ + L N F
Sbjct: 154 LTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQF 191
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 3e-04
Identities = 39/128 (30%), Positives = 53/128 (41%), Gaps = 7/128 (5%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSI-GNLTLLITLNFAENMLEGSIP 62
L NQ G DL +L L L N+ +P + +LT L L N L+ S+P
Sbjct: 66 LDYNQLQTLSAGVFDDLTELGTLGLANNQL-ASLPLGVFDHLTQLDKLYLGGNQLK-SLP 123
Query: 63 SSL-GKCQNLILLDLSNNNLTGTTPTEVI-GLSSLSIYLDLSQNQLNGPLPSNFGILKNL 120
S + + L L L+ N L + P L++L L LS NQL F L L
Sbjct: 124 SGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQ-TLSLSTNQLQSVPHGAFDRLGKL 181
Query: 121 GAIDISEN 128
I + N
Sbjct: 182 QTITLFGN 189
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 7e-05
Identities = 19/85 (22%), Positives = 36/85 (42%), Gaps = 15/85 (17%)
Query: 206 YEFMVNGSLEEWLHPNREALKNLNLLQRLS------IAVDVASALDYLHHYCETPIVHCD 259
Y F+V L + ++ +++ LS +A + AL++LH VH +
Sbjct: 132 YRFLV----LPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGN 184
Query: 260 LKPSNVLLDGELTAHV--GDFGLAK 282
+ N+ +D E + V +G A
Sbjct: 185 VTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 7e-05
Identities = 22/138 (15%), Positives = 50/138 (36%), Gaps = 13/138 (9%)
Query: 50 LNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSI---YLDLSQNQL 106
+ ++E + + LDL + + L + +D S N++
Sbjct: 2 VKLTAELIEQA--AQYTNAVRDRELDLRGYKIP-----VIENLGATLDQFDAIDFSDNEI 54
Query: 107 NGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRG-NIPSSLSSL 165
L F +L+ L + ++ N++ + L +L++ N L+SL
Sbjct: 55 R-KL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASL 112
Query: 166 RGIENLDLSRNNFIRHRN 183
+ + L + RN ++
Sbjct: 113 KSLTYLCILRNPVTNKKH 130
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 8e-05
Identities = 41/155 (26%), Positives = 63/155 (40%), Gaps = 21/155 (13%)
Query: 181 HRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDV 240
H N++K+ F+ LV E G L + + + K + + I V
Sbjct: 85 HPNIMKLYEF-----FEDKGYFYLVGEVYTGGELFDEI----ISRKRFSEVDAARIIRQV 135
Query: 241 ASALDYLHHYCETPIVHCDLKPSNVLL---DGELTAHVGDFGLAKFLPEATNNFFNFQIA 297
S + Y+H IVH DLKP N+LL + + DFGL+ EA+ +
Sbjct: 136 LSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHF-EASKKMKDKIGT 191
Query: 298 EYGMGSEV-----STSGDVYSFGILLLETFTGKRP 327
Y + EV DV+S G++L +G P
Sbjct: 192 AYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 1e-04
Identities = 32/154 (20%), Positives = 55/154 (35%), Gaps = 36/154 (23%)
Query: 24 QRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTG 83
+R+ LE+ P+++ L L + +G I + NL L L N L
Sbjct: 12 RRIHLELR---NRTPAAVRELVLDNCKS-----NDGKIEGLTAEFVNLEFLSLINVGLI- 62
Query: 84 TTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIR 143
S+ SN L L +++SEN++ G +
Sbjct: 63 ------------SV--------------SNLPKLPKLKKLELSENRIFGGLDMLAEKLPN 96
Query: 144 LEQLVMNGNFFRG-NIPSSLSSLRGIENLDLSRN 176
L L ++GN + + L L +++LDL
Sbjct: 97 LTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 39.3 bits (92), Expect = 6e-04
Identities = 26/98 (26%), Positives = 40/98 (40%), Gaps = 6/98 (6%)
Query: 11 GRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQN 70
G+I G + L+ L+L S++ L L L +EN + G + K N
Sbjct: 39 GKIEGLTAEFVNLEFLSLINVGL--ISVSNLPKLPKLKKLELSENRIFGGLDMLAEKLPN 96
Query: 71 LILLDLSNNNLTGTTPTEVIGLSSLS--IYLDLSQNQL 106
L L+LS N L + + L L LDL ++
Sbjct: 97 LTHLNLSGNKL--KDISTLEPLKKLECLKSLDLFNCEV 132
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 21/95 (22%), Positives = 39/95 (41%), Gaps = 12/95 (12%)
Query: 191 CASVDFQGNDSEALVYEFMVNG-SLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHH 249
+F+G +V E + G L++ N L + + + L+Y+H
Sbjct: 116 SGLTEFKGRSYRFMVMERL--GIDLQKISGQNG----TFKKSTVLQLGIRMLDVLEYIHE 169
Query: 250 YCETPIVHCDLKPSNVLLD--GELTAHVGDFGLAK 282
VH D+K +N+LL ++ D+GL+
Sbjct: 170 NE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 28/102 (27%), Positives = 46/102 (45%), Gaps = 24/102 (23%)
Query: 240 VASALDYLHHYCETPIVHCDLKPSNVLL---DGELTAHVGDFGLAKFLPEATNNFFNFQI 296
+ S + YLH + IVH D+KP N+LL + L + DFGL+ F + + ++
Sbjct: 155 ILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK--DYKLRDRL 209
Query: 297 AEYGMGS------EV-----STSGDVYSFGILLLETFTGKRP 327
G+ EV + DV+S G+++ G P
Sbjct: 210 -----GTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 41/172 (23%), Positives = 61/172 (35%), Gaps = 47/172 (27%)
Query: 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV- 238
RH N ++ + + LV E+ GS + L +++ L+ + IA
Sbjct: 112 RHPNTIQYRGC-----YLREHTAWLVMEYC-LGSASDLLEVHKKPLQ------EVEIAAV 159
Query: 239 --DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQI 296
L YLH ++H D+K N+LL +GDFG A +
Sbjct: 160 THGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSAS------------IM 204
Query: 297 AE--------YGMGSEVSTSG---------DVYSFGILLLETFTGKRPTNEM 331
A Y M EV + DV+S GI +E K P M
Sbjct: 205 APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 256
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 2e-04
Identities = 27/117 (23%), Positives = 44/117 (37%), Gaps = 26/117 (22%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSL-----EEWLHPNREALKNLNLLQR 233
IRH N++ + F+ L+ E + G L E+ EA +
Sbjct: 65 IRHPNIITLHDI-----FENKTDVVLILELVSGGELFDFLAEKESLTEDEATQ------- 112
Query: 234 LSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAH----VGDFGLAKFLPE 286
+ + YLH I H DLKP N++L + + + DFG+A +
Sbjct: 113 --FLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 164
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 18/50 (36%), Positives = 27/50 (54%), Gaps = 6/50 (12%)
Query: 240 VASALDYLHHYCETPIVHCDLKPSNVLL---DGELTAHVGDFGLAKFLPE 286
V S + Y+H + IVH DLKP N+LL + + + DFGL+ +
Sbjct: 130 VFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 4e-04
Identities = 32/155 (20%), Positives = 56/155 (36%), Gaps = 33/155 (21%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSL-----EEWLHPNREALKNLNLLQR 233
I+H N++ + ++ L+ E + G L E+ EA +
Sbjct: 71 IQHPNVITLHEV-----YENKTDVILILELVAGGELFDFLAEKESLTEEEATE------- 118
Query: 234 LSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAH----VGDFGLAKFLPEATN 289
+ + + YLH I H DLKP N++L + DFGLA +
Sbjct: 119 --FLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173
Query: 290 NFFNFQIAEYGMGSEV------STSGDVYSFGILL 318
F E+ + E+ D++S G++
Sbjct: 174 FKNIFGTPEF-VAPEIVNYEPLGLEADMWSIGVIT 207
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 4e-04
Identities = 16/51 (31%), Positives = 29/51 (56%), Gaps = 5/51 (9%)
Query: 234 LSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLD--GELTAHVGDFGLAK 282
L +++ + L+Y+H + VH D+K SN+LL+ ++ D+GLA
Sbjct: 155 LQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 6e-04
Identities = 29/159 (18%), Positives = 49/159 (30%), Gaps = 33/159 (20%)
Query: 47 LITLNFAENML--EG--SIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLS------ 96
+ L+ L G + S+L L L LS+N L GL L
Sbjct: 87 IQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDA------GLQLLCEGLLDP 140
Query: 97 ----IYLDLSQNQLN----GPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIR----- 143
L L L+ PL S + + +S N ++ + ++
Sbjct: 141 QCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQ 200
Query: 144 LEQLVMNGNFFR----GNIPSSLSSLRGIENLDLSRNNF 178
LE L + ++ ++S + L L N
Sbjct: 201 LEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKL 239
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 427 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.98 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.98 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.98 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.98 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.98 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.97 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.97 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.97 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.97 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.97 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.97 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.97 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.97 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.97 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.97 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.96 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.96 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.95 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.95 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.94 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 99.94 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.93 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.93 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.92 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.92 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.92 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.92 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.92 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.91 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.9 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.9 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.9 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.9 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.9 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.9 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.9 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.9 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.89 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.89 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.89 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.89 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.89 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.89 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.89 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.88 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.88 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.88 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.88 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.88 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.88 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.88 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.88 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.88 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.88 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.87 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.87 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.87 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.87 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.87 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.87 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.87 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.87 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.86 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.86 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.86 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.86 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.86 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.86 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.86 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.86 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.86 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.86 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.85 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.85 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.85 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.85 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.85 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.85 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.85 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.85 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.85 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.85 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.85 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.84 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.84 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.84 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.84 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.84 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.84 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.84 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.84 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.83 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.83 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.83 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.83 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.83 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.82 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.82 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.82 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.82 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.82 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.82 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.81 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.81 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.81 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.81 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.8 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.8 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.8 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.79 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.78 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.78 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.78 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.78 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.77 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.77 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.77 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.77 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.77 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.77 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.76 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.76 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.76 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.76 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.76 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.76 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.75 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.75 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.75 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.74 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.74 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.74 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.73 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.73 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.73 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.73 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.73 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.72 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.72 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.72 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.7 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.7 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.69 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.69 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.65 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.65 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.63 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.61 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.6 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.6 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.6 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.59 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.59 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.59 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.49 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.45 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.41 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.34 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.32 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.3 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.29 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.28 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.24 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.09 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.08 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.04 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.0 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 98.97 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.84 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.8 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.73 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.72 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.54 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.45 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.25 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.22 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.17 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.09 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 97.83 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 97.83 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 97.71 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 97.67 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.67 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 97.62 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 97.62 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.57 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 97.39 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.07 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.03 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 96.96 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.92 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.56 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 96.35 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.35 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 96.33 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 95.9 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 95.39 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 94.35 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 93.54 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 92.04 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 91.12 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 91.07 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 87.46 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 86.53 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 86.52 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 86.47 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 85.39 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 84.2 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 84.15 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=368.30 Aligned_cols=203 Identities=26% Similarity=0.402 Sum_probs=162.4
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||++++++.. +..++|||||++|+|.++++... ..+++.+++.++.|||.||+||| +++||||
T Consensus 89 l~HpNIV~l~g~~~~------~~~~iVmEy~~gGsL~~~l~~~~---~~l~~~~~~~i~~qia~gL~yLH---~~~IiHR 156 (307)
T 3omv_A 89 TRHVNILLFMGYMTK------DNLAIVTQWCEGSSLYKHLHVQE---TKFQMFQLIDIARQTAQGMDYLH---AKNIIHR 156 (307)
T ss_dssp CCCTTBCCEEEEECS------SSCEEEEECCSSCBHHHHHHTSC---CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCS
T ss_pred CCCCCEeeEEEEEEC------CeEEEEEEcCCCCCHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCccCC
Confidence 579999999998643 35799999999999999996543 45999999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC--------cCCCccccccccccCC---CCcCccccchhHHHHHHHHHhCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE--------ATNNFFNFQIAEYGMG---SEVSTSGDVYSFGILLLETFTGKRP 327 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~--------~~~~~~~y~aPE~~~~---~~~~~~~DiwS~G~vl~ell~g~~p 327 (427)
||||+|||+++++.+||+|||+|+.... ...||+.|||||++.+ .+|+.++|||||||++|||+||+.|
T Consensus 157 DlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~P 236 (307)
T 3omv_A 157 DMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELP 236 (307)
T ss_dssp CCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred ccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCC
Confidence 9999999999999999999999987542 1279999999999864 4589999999999999999999999
Q ss_pred CCcccCCCccHHHHHHHhc-ccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCC
Q 042634 328 TNEMFTGNLTLHNFVKEAL-PERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMN 406 (427)
Q Consensus 328 f~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt 406 (427)
|.+.... ..+...+.... ++... ..+..++.++.+++.+||+.||++|||
T Consensus 237 f~~~~~~-~~~~~~~~~~~~~p~~~----------------------------~~~~~~~~~l~~li~~cl~~dP~~RPs 287 (307)
T 3omv_A 237 YSHINNR-DQIIFMVGRGYASPDLS----------------------------KLYKNCPKAMKRLVADCVKKVKEERPL 287 (307)
T ss_dssp TTTCCCH-HHHHHHHHTTCCCCCST----------------------------TSCTTSCHHHHHHHHHHTCSSSTTSCC
T ss_pred CCCCChH-HHHHHHHhcCCCCCCcc----------------------------cccccchHHHHHHHHHHcCCCHhHCcC
Confidence 9764211 11111111111 00000 022346778999999999999999999
Q ss_pred HHHHHHHHHHHHHHHH
Q 042634 407 MEEVAAQLLSFRNKLV 422 (427)
Q Consensus 407 ~~ev~~~L~~~~~~~~ 422 (427)
|+||++.|+.++..++
T Consensus 288 ~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 288 FPQILSSIELLQHSLP 303 (307)
T ss_dssp HHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHhccCC
Confidence 9999999999876653
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=362.27 Aligned_cols=202 Identities=26% Similarity=0.421 Sum_probs=166.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchh---------hhhccCHHHHHHHHHHHHHHHHHHhh
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNRE---------ALKNLNLLQRLSIAVDVASALDYLHH 249 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------~~~~l~~~~~~~~~~~i~~~L~~LH~ 249 (427)
++|||||+++++|.. +...++|||||++|+|.++++.... ....+++.+++.++.|||+||+|||
T Consensus 72 l~HpnIV~l~g~~~~-----~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH- 145 (299)
T 4asz_A 72 LQHEHIVKFYGVCVE-----GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA- 145 (299)
T ss_dssp CCCTTBCCEEEEECS-----SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH-
T ss_pred CCCCCCccEEEEEee-----CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH-
Confidence 579999999999754 5678999999999999999975421 1246999999999999999999999
Q ss_pred cCCCCeeeccccCCceeeCCCCceEecccccccccCCc--------CCCccccccccccCCCCcCccccchhHHHHHHHH
Q 042634 250 YCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA--------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLET 321 (427)
Q Consensus 250 ~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~el 321 (427)
+++||||||||+|||+++++.+||+|||+|+..... ..||+.|||||++.+..|+.++|||||||++|||
T Consensus 146 --~~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~El 223 (299)
T 4asz_A 146 --SQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEI 223 (299)
T ss_dssp --HTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred --hCCcccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHH
Confidence 899999999999999999999999999999865332 2578899999999999999999999999999999
Q ss_pred Hh-CCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCC
Q 042634 322 FT-GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSEL 400 (427)
Q Consensus 322 l~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~d 400 (427)
+| |+.||.+... ..+...+..... ...+..++.++.++|.+||+.|
T Consensus 224 lt~G~~Pf~~~~~--~~~~~~i~~~~~-------------------------------~~~p~~~~~~~~~li~~cl~~d 270 (299)
T 4asz_A 224 FTYGKQPWYQLSN--NEVIECITQGRV-------------------------------LQRPRTCPQEVYELMLGCWQRE 270 (299)
T ss_dssp HTTTCCTTTTSCH--HHHHHHHHHTCC-------------------------------CCCCTTCCHHHHHHHHHHTCSS
T ss_pred HcCCCCCCCCCCH--HHHHHHHHcCCC-------------------------------CCCCccchHHHHHHHHHHcCCC
Confidence 98 8999976421 111111111000 0023346778999999999999
Q ss_pred CCCCCCHHHHHHHHHHHHHHH
Q 042634 401 PRERMNMEEVAAQLLSFRNKL 421 (427)
Q Consensus 401 P~~Rpt~~ev~~~L~~~~~~~ 421 (427)
|++||||+||.+.|+++.+.-
T Consensus 271 P~~RPs~~~i~~~L~~~~~~~ 291 (299)
T 4asz_A 271 PHMRKNIKGIHTLLQNLAKAS 291 (299)
T ss_dssp GGGSCCHHHHHHHHHHHHHHS
T ss_pred hhHCcCHHHHHHHHHHHHhcC
Confidence 999999999999999987653
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=360.62 Aligned_cols=201 Identities=27% Similarity=0.443 Sum_probs=160.6
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchh-----------hhhccCHHHHHHHHHHHHHHHHHH
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNRE-----------ALKNLNLLQRLSIAVDVASALDYL 247 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~l~~~~~~~~~~~i~~~L~~L 247 (427)
++|||||+++++|.. ....++|||||++|+|.++++.... ...++++.+++.++.|||.||+||
T Consensus 100 l~HpnIV~l~g~~~~-----~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yL 174 (329)
T 4aoj_A 100 LQHQHIVRFFGVCTE-----GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL 174 (329)
T ss_dssp CCCTTBCCEEEEECS-----SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCcEEEEEEE-----CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHH
Confidence 579999999999755 5678999999999999999865421 124589999999999999999999
Q ss_pred hhcCCCCeeeccccCCceeeCCCCceEecccccccccCCc--------CCCccccccccccCCCCcCccccchhHHHHHH
Q 042634 248 HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA--------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLL 319 (427)
Q Consensus 248 H~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ 319 (427)
| +++||||||||+|||+++++.+||+|||+|+..... ..||+.|||||++.+..|+.++|||||||++|
T Consensus 175 H---~~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~ 251 (329)
T 4aoj_A 175 A---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLW 251 (329)
T ss_dssp H---HTTCCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred h---cCCeecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHH
Confidence 9 899999999999999999999999999999865322 26889999999999999999999999999999
Q ss_pred HHHh-CCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCC
Q 042634 320 ETFT-GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSS 398 (427)
Q Consensus 320 ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~ 398 (427)
||+| |+.||.+... ..+...+....+ ...+..++.++.++|.+||+
T Consensus 252 Ellt~G~~Pf~~~~~--~~~~~~i~~g~~-------------------------------~~~p~~~~~~~~~li~~cl~ 298 (329)
T 4aoj_A 252 EIFTYGKQPWYQLSN--TEAIDCITQGRE-------------------------------LERPRACPPEVYAIMRGCWQ 298 (329)
T ss_dssp HHHTTSCCTTCSSCH--HHHHHHHHHTCC-------------------------------CCCCTTCCHHHHHHHHHHCC
T ss_pred HHHcCCCCCCCCCCH--HHHHHHHHcCCC-------------------------------CCCcccccHHHHHHHHHHcC
Confidence 9999 8999976421 111111111100 01233466789999999999
Q ss_pred CCCCCCCCHHHHHHHHHHHHHH
Q 042634 399 ELPRERMNMEEVAAQLLSFRNK 420 (427)
Q Consensus 399 ~dP~~Rpt~~ev~~~L~~~~~~ 420 (427)
.||++||||+||++.|+.+.+.
T Consensus 299 ~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 299 REPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp SSTTTSCCHHHHHHHHHHHHHS
T ss_pred cChhHCcCHHHHHHHHHHHhhC
Confidence 9999999999999999998764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-48 Score=359.85 Aligned_cols=198 Identities=20% Similarity=0.393 Sum_probs=162.7
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccch------------hhhhccCHHHHHHHHHHHHHHHHH
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNR------------EALKNLNLLQRLSIAVDVASALDY 246 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~~~~~i~~~L~~ 246 (427)
++|||||+++++|.. ....++|||||++|+|.+++.... .....+++.+++.++.|||+||+|
T Consensus 86 l~HpNIV~l~g~~~~-----~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~y 160 (308)
T 4gt4_A 86 LQHPNVVCLLGVVTK-----DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEY 160 (308)
T ss_dssp CCCTTBCCEEEEECS-----SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCcceEEEE-----CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHH
Confidence 579999999999755 457899999999999999985432 112458999999999999999999
Q ss_pred HhhcCCCCeeeccccCCceeeCCCCceEecccccccccCC--------cCCCccccccccccCCCCcCccccchhHHHHH
Q 042634 247 LHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPE--------ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILL 318 (427)
Q Consensus 247 LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~--------~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl 318 (427)
|| +++||||||||+|||+++++.+||+|||+|+.... ...||+.|||||++.+..|+.++|||||||++
T Consensus 161 LH---~~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl 237 (308)
T 4gt4_A 161 LS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVL 237 (308)
T ss_dssp HH---HTTCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred HH---hCCCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHH
Confidence 99 89999999999999999999999999999986532 22788999999999999999999999999999
Q ss_pred HHHHh-CCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcC
Q 042634 319 LETFT-GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCS 397 (427)
Q Consensus 319 ~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl 397 (427)
|||+| |+.||.+... ..+...+..... ...+..|+.++.++|.+||
T Consensus 238 ~El~t~g~~Pf~~~~~--~~~~~~i~~~~~-------------------------------~~~p~~~~~~~~~li~~C~ 284 (308)
T 4gt4_A 238 WEVFSYGLQPYCGYSN--QDVVEMIRNRQV-------------------------------LPCPDDCPAWVYALMIECW 284 (308)
T ss_dssp HHHHTTTCCTTTTCCH--HHHHHHHHTTCC-------------------------------CCCCTTCCHHHHHHHHHHT
T ss_pred HHHHhCCCCCCCCCCH--HHHHHHHHcCCC-------------------------------CCCcccchHHHHHHHHHHc
Confidence 99998 8999976421 111111111000 0023456778999999999
Q ss_pred CCCCCCCCCHHHHHHHHHHH
Q 042634 398 SELPRERMNMEEVAAQLLSF 417 (427)
Q Consensus 398 ~~dP~~Rpt~~ev~~~L~~~ 417 (427)
+.||++||||+||++.|+.+
T Consensus 285 ~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 285 NEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp CSSGGGSCCHHHHHHHHHTS
T ss_pred CCChhHCcCHHHHHHHHHhc
Confidence 99999999999999999865
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=357.01 Aligned_cols=200 Identities=21% Similarity=0.251 Sum_probs=164.0
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||++++++.. +...|+|||||+||+|.++++.. ..+++.+++.++.||+.||+||| ++|||||
T Consensus 107 l~HpnIV~l~~~~~~-----~~~~~ivmEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHR 174 (336)
T 4g3f_A 107 LSSPRIVPLYGAVRE-----GPWVNIFMELLEGGSLGQLIKQM----GCLPEDRALYYLGQALEGLEYLH---TRRILHG 174 (336)
T ss_dssp CCCTTBCCEEEEEEE-----TTEEEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH---TTTEECS
T ss_pred CCCCCCCcEEEEEEE-----CCEEEEEEeccCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCceec
Confidence 679999999998544 56789999999999999999654 45999999999999999999999 9999999
Q ss_pred cccCCceeeCCCC-ceEecccccccccCCc-----------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCC
Q 042634 259 DLKPSNVLLDGEL-TAHVGDFGLAKFLPEA-----------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKR 326 (427)
Q Consensus 259 Dlkp~NIll~~~~-~~kL~DFG~a~~~~~~-----------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~ 326 (427)
||||+|||++.++ .+||+|||+|+..... ..||+.|||||++.+..|+.++||||+||++|||++|+.
T Consensus 175 DlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~ 254 (336)
T 4g3f_A 175 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCH 254 (336)
T ss_dssp CCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcC
Confidence 9999999999987 6999999999876432 269999999999999999999999999999999999999
Q ss_pred CCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCC
Q 042634 327 PTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMN 406 (427)
Q Consensus 327 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt 406 (427)
||.+..... .+........+ ..+ .++.++.++.+++.+||+.||++|||
T Consensus 255 Pf~~~~~~~-~~~~i~~~~~~--~~~----------------------------~~~~~s~~~~~li~~~L~~dP~~R~s 303 (336)
T 4g3f_A 255 PWTQYFRGP-LCLKIASEPPP--IRE----------------------------IPPSCAPLTAQAIQEGLRKEPVHRAS 303 (336)
T ss_dssp SSTTTCCSC-CHHHHHHSCCG--GGG----------------------------SCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred CCCCCCHHH-HHHHHHcCCCC--chh----------------------------cCccCCHHHHHHHHHHccCCHhHCcC
Confidence 997643222 12221111100 000 12335667899999999999999999
Q ss_pred HHHHHHHHHHHHHHH
Q 042634 407 MEEVAAQLLSFRNKL 421 (427)
Q Consensus 407 ~~ev~~~L~~~~~~~ 421 (427)
++|++++|.....+.
T Consensus 304 a~el~~~l~~~l~~~ 318 (336)
T 4g3f_A 304 AMELRRKVGKALQEV 318 (336)
T ss_dssp HHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhhh
Confidence 999999998877653
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=361.49 Aligned_cols=203 Identities=22% Similarity=0.334 Sum_probs=164.8
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhh------------hhccCHHHHHHHHHHHHHHHHH
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREA------------LKNLNLLQRLSIAVDVASALDY 246 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~------------~~~l~~~~~~~~~~~i~~~L~~ 246 (427)
.+|||||+++++|.. .+...++|||||++|+|.++++..... ...+++.+++.++.|||+||+|
T Consensus 125 ~hhpnIV~l~g~~~~----~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~y 200 (353)
T 4ase_A 125 GHHLNVVNLLGACTK----PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEF 200 (353)
T ss_dssp CCCTTBCCEEEEECC----TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHH
T ss_pred CCCCcEEEEEEEEEe----cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHh
Confidence 356999999998744 235679999999999999999754321 2458999999999999999999
Q ss_pred HhhcCCCCeeeccccCCceeeCCCCceEecccccccccCCcC--------CCccccccccccCCCCcCccccchhHHHHH
Q 042634 247 LHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEAT--------NNFFNFQIAEYGMGSEVSTSGDVYSFGILL 318 (427)
Q Consensus 247 LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~--------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl 318 (427)
|| +++||||||||+|||+++++.+||+|||+|+...... .||+.|||||++.+..|+.++|||||||++
T Consensus 201 LH---~~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l 277 (353)
T 4ase_A 201 LA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 277 (353)
T ss_dssp HH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred Hh---hCCeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHH
Confidence 99 8999999999999999999999999999998764322 578899999999999999999999999999
Q ss_pred HHHHh-CCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcC
Q 042634 319 LETFT-GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCS 397 (427)
Q Consensus 319 ~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl 397 (427)
|||+| |+.||.+.... ..+...+...... ..+..++.++.++|.+||
T Consensus 278 ~El~t~G~~Pf~~~~~~-~~~~~~i~~g~~~-------------------------------~~p~~~~~~~~~li~~c~ 325 (353)
T 4ase_A 278 WEIFSLGASPYPGVKID-EEFCRRLKEGTRM-------------------------------RAPDYTTPEMYQTMLDCW 325 (353)
T ss_dssp HHHTTTSCCSSTTCCCS-HHHHHHHHHTCCC-------------------------------CCCTTCCHHHHHHHHHHT
T ss_pred HHHHhCCCCCCCCCCHH-HHHHHHHHcCCCC-------------------------------CCCccCCHHHHHHHHHHc
Confidence 99998 99999764222 1222222221110 022335667899999999
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHH
Q 042634 398 SELPRERMNMEEVAAQLLSFRNK 420 (427)
Q Consensus 398 ~~dP~~Rpt~~ev~~~L~~~~~~ 420 (427)
+.||++||||+||+++|+++.+.
T Consensus 326 ~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 326 HGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp CSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CcChhHCcCHHHHHHHHHHHHHH
Confidence 99999999999999999998654
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=347.82 Aligned_cols=214 Identities=21% Similarity=0.248 Sum_probs=161.2
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhc-----CCC
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHY-----CET 253 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~-----~~~ 253 (427)
++|||||++++++...+ ......++|||||++|+|.++++.. .+++..+.+++.|++.||+|||+. ...
T Consensus 54 l~HpNIv~l~g~~~~~~-~~~~~~~lV~Ey~~~gsL~~~l~~~-----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~ 127 (303)
T 3hmm_A 54 LRHENILGFIAADNKDN-GTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP 127 (303)
T ss_dssp CCCTTBCCEEEEEEEEC-SSSEEEEEEEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC
T ss_pred CCCCCCCcEEEEEEecC-CCceEEEEEecCCCCCcHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCC
Confidence 68999999999976522 1123568999999999999999643 489999999999999999999932 012
Q ss_pred CeeeccccCCceeeCCCCceEecccccccccCCc----------CCCccccccccccCCC------CcCccccchhHHHH
Q 042634 254 PIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA----------TNNFFNFQIAEYGMGS------EVSTSGDVYSFGIL 317 (427)
Q Consensus 254 ~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~----------~~~~~~y~aPE~~~~~------~~~~~~DiwS~G~v 317 (427)
+||||||||+|||++.++.+||+|||+|+..... ..||+.|||||++.+. .++.++|||||||+
T Consensus 128 ~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvv 207 (303)
T 3hmm_A 128 AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLV 207 (303)
T ss_dssp CEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHH
T ss_pred CEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHH
Confidence 9999999999999999999999999999865332 2699999999998764 46889999999999
Q ss_pred HHHHHhCCCCCCcccCCCcc----------HHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHH
Q 042634 318 LLETFTGKRPTNEMFTGNLT----------LHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLV 387 (427)
Q Consensus 318 l~ell~g~~pf~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (427)
+|||+||..||......... ............ .++ .........+++.
T Consensus 208 l~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~----~rp------------------~~p~~~~~~~~~~ 265 (303)
T 3hmm_A 208 FWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQK----LRP------------------NIPNRWQSCEALR 265 (303)
T ss_dssp HHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSC----CCC------------------CCCGGGGSSHHHH
T ss_pred HHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhccc----CCC------------------CCCccccchHHHH
Confidence 99999998887543222111 111111111000 000 0011112345678
Q ss_pred HHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHH
Q 042634 388 SVLGIGVTCSSELPRERMNMEEVAAQLLSFRNK 420 (427)
Q Consensus 388 ~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~~~~~ 420 (427)
.+.++|.+||+.||++||||+||++.|+++.++
T Consensus 266 ~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 266 VMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 899999999999999999999999999999764
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=354.88 Aligned_cols=192 Identities=21% Similarity=0.297 Sum_probs=157.9
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||++++++.. +...|+|||||+||+|.+++..... ..+++.+++.++.||+.||+||| ++|||||
T Consensus 80 l~HpnIV~~~~~~~~-----~~~~yiVmEy~~gg~L~~~i~~~~~--~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHR 149 (350)
T 4b9d_A 80 MKHPNIVQYRESFEE-----NGSLYIVMDYCEGGDLFKRINAQKG--VLFQEDQILDWFVQICLALKHVH---DRKILHR 149 (350)
T ss_dssp CCCTTBCCEEEEEEE-----TTEEEEEEECCTTCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHH---HTTCEET
T ss_pred CCCCCCCcEEEEEEE-----CCEEEEEEeCCCCCcHHHHHHHcCC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeec
Confidence 579999999998544 6678999999999999999965432 45789999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC------CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+|||++.++.+||+|||+|+...... .||+.|||||++.+..|+.++||||+||++|||++|+.||.+..
T Consensus 150 DlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~ 229 (350)
T 4b9d_A 150 DIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS 229 (350)
T ss_dssp TCCGGGEEECTTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cCCHHHEEECCCCCEEEcccccceeecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 999999999999999999999999875432 79999999999999999999999999999999999999997531
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
..+............ .+..++.++.+++.+||+.||++|||++|+++
T Consensus 230 -----~~~~~~~i~~~~~~~----------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 230 -----MKNLVLKIISGSFPP----------------------------VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp -----HHHHHHHHHHTCCCC----------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----HHHHHHHHHcCCCCC----------------------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 112111111110000 11223556899999999999999999999986
Q ss_pred H
Q 042634 413 Q 413 (427)
Q Consensus 413 ~ 413 (427)
+
T Consensus 277 h 277 (350)
T 4b9d_A 277 K 277 (350)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-46 Score=343.23 Aligned_cols=195 Identities=26% Similarity=0.373 Sum_probs=152.5
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCC--ee
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETP--IV 256 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~--iv 256 (427)
++|||||++++++... ..+....++|||||++|+|.+++... ..+++..++.++.||+.||+||| ++| |+
T Consensus 82 l~HpnIV~~~~~~~~~-~~~~~~~~lvmEy~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~ylH---~~~~~Ii 153 (290)
T 3fpq_A 82 LQHPNIVRFYDSWEST-VKGKKCIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLH---TRTPPII 153 (290)
T ss_dssp CCCTTBCCEEEEEEEE-ETTEEEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCC
T ss_pred CCCCCCCcEEEEEeec-cCCCcEEEEEEeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCCCEE
Confidence 5799999999986442 12234579999999999999999654 46999999999999999999999 777 99
Q ss_pred eccccCCceeeCC-CCceEecccccccccCCcC----CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 257 HCDLKPSNVLLDG-ELTAHVGDFGLAKFLPEAT----NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 257 HrDlkp~NIll~~-~~~~kL~DFG~a~~~~~~~----~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
||||||+|||++. ++.+||+|||+|+...... .||+.|||||++.+ +|+.++|||||||++|||++|+.||.+.
T Consensus 154 HRDlKp~NILl~~~~g~vKl~DFGla~~~~~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~ 232 (290)
T 3fpq_A 154 HRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC 232 (290)
T ss_dssp CCCCCGGGEEESSTTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ecccChhheeEECCCCCEEEEeCcCCEeCCCCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 9999999999974 7999999999998654332 79999999999865 6999999999999999999999999753
Q ss_pred cCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 042634 332 FTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVA 411 (427)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~ 411 (427)
.. ............ .+ ...+..++.++.+++.+||+.||++|||++|++
T Consensus 233 ~~----~~~~~~~i~~~~-----~~----------------------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l 281 (290)
T 3fpq_A 233 QN----AAQIYRRVTSGV-----KP----------------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 281 (290)
T ss_dssp SS----HHHHHHHHTTTC-----CC----------------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred Cc----HHHHHHHHHcCC-----CC----------------------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 21 111111111000 00 001111234588999999999999999999998
Q ss_pred HH
Q 042634 412 AQ 413 (427)
Q Consensus 412 ~~ 413 (427)
++
T Consensus 282 ~H 283 (290)
T 3fpq_A 282 NH 283 (290)
T ss_dssp TS
T ss_pred cC
Confidence 63
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=350.74 Aligned_cols=191 Identities=23% Similarity=0.331 Sum_probs=157.2
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||++++++.. +...|+|||||++|+|.+++.. ..+++.+++.++.||+.||+||| ++||+||
T Consensus 128 l~HpnIV~l~~~~~~-----~~~~~ivmEy~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHR 194 (346)
T 4fih_A 128 YQHENVVEMYNSYLV-----GDELWVVMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLH---AQGVIHR 194 (346)
T ss_dssp CCCTTBCCEEEEEEE-----TTEEEEEECCCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred CCCCCCCcEEEEEEE-----CCEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccc
Confidence 579999999998654 5688999999999999998854 34999999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+|||++.++.+||+|||+|+..... ..||+.|||||++.+..|+.++||||+||++|||++|+.||.+..
T Consensus 195 DlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~ 274 (346)
T 4fih_A 195 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 274 (346)
T ss_dssp CCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred cCCHHHEEECCCCCEEEecCcCceecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 99999999999999999999999876432 279999999999999999999999999999999999999997531
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
.......+....+... ..+..++.++.+++.+||+.||++|||++|+++
T Consensus 275 --~~~~~~~i~~~~~~~~-----------------------------~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 275 --PLKAMKMIRDNLPPRL-----------------------------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp --HHHHHHHHHHSSCCCC-----------------------------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --HHHHHHHHHcCCCCCC-----------------------------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111112221111100 011224566899999999999999999999976
Q ss_pred H
Q 042634 413 Q 413 (427)
Q Consensus 413 ~ 413 (427)
+
T Consensus 324 H 324 (346)
T 4fih_A 324 H 324 (346)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=343.04 Aligned_cols=188 Identities=20% Similarity=0.285 Sum_probs=154.9
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||++++++. ++...|+|||||+||+|.+++.+. ..+++..++.++.||+.||+||| ++||+||
T Consensus 89 l~HpnIv~l~~~~~-----~~~~~yivmEy~~gG~L~~~i~~~----~~l~e~~~~~~~~qi~~al~ylH---~~~IiHR 156 (311)
T 4aw0_A 89 LDHPFFVKLYFTFQ-----DDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLH---GKGIIHR 156 (311)
T ss_dssp CCCTTBCCEEEEEE-----CSSEEEEEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECS
T ss_pred CCCCCCCeEEEEEE-----eCCEEEEEEecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCCccC
Confidence 57999999999853 467899999999999999999754 45999999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc--------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA--------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~ 330 (427)
||||+|||++.++.+||+|||+|+.+... .+||+.|||||++.+..|+.++||||+||++|||++|+.||.+
T Consensus 157 DlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~ 236 (311)
T 4aw0_A 157 DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 236 (311)
T ss_dssp CCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999876321 2799999999999999999999999999999999999999975
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
.. ..+.......... + .+...+.++.+++.+||+.||++|||++|+
T Consensus 237 ~~-----~~~~~~~i~~~~~----~-------------------------~p~~~s~~~~dli~~lL~~dp~~R~t~~e~ 282 (311)
T 4aw0_A 237 GN-----EGLIFAKIIKLEY----D-------------------------FPEKFFPKARDLVEKLLVLDATKRLGCEEM 282 (311)
T ss_dssp SS-----HHHHHHHHHHTCC----C-------------------------CCTTCCHHHHHHHHHHSCSSGGGSTTSGGG
T ss_pred CC-----HHHHHHHHHcCCC----C-------------------------CCcccCHHHHHHHHHHccCCHhHCcChHHH
Confidence 31 1111111111000 0 111234567899999999999999999987
Q ss_pred HH
Q 042634 411 AA 412 (427)
Q Consensus 411 ~~ 412 (427)
..
T Consensus 283 ~~ 284 (311)
T 4aw0_A 283 EG 284 (311)
T ss_dssp TC
T ss_pred cC
Confidence 53
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=340.79 Aligned_cols=188 Identities=24% Similarity=0.279 Sum_probs=153.0
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||++++++.. +...|+|||||+||+|.+++.+. ..+++.+++.++.||+.||+||| ++||+||
T Consensus 83 l~HpnIv~l~~~~~~-----~~~~~ivmEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHR 150 (304)
T 3ubd_A 83 VNHPFIVKLHYAFQT-----EGKLYLILDFLRGGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLH---SLGIIYR 150 (304)
T ss_dssp CCCTTEECEEEEEEE-----TTEEEEEECCCTTCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred CCCCCCCeEEEEEEE-----CCEEEEEEEcCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCCcCC
Confidence 579999999998544 66889999999999999999754 45999999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC------cCCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE------ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+|||++.++.+||+|||+|+.... ...||+.|||||++.+..|+.++||||+||++|||++|+.||.+..
T Consensus 151 DlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~ 230 (304)
T 3ubd_A 151 DLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD 230 (304)
T ss_dssp SCCGGGEEECTTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCHHHeEEcCCCCEEecccccceeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC
Confidence 9999999999999999999999986432 2379999999999999999999999999999999999999997531
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCH-----
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM----- 407 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~----- 407 (427)
..+.......... . .+..++.++.+++.+||+.||++|||+
T Consensus 231 -----~~~~~~~i~~~~~----~-------------------------~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~ 276 (304)
T 3ubd_A 231 -----RKETMTMILKAKL----G-------------------------MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGV 276 (304)
T ss_dssp -----HHHHHHHHHHCCC----C-------------------------CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTH
T ss_pred -----HHHHHHHHHcCCC----C-------------------------CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCH
Confidence 1111111110000 0 112234568899999999999999985
Q ss_pred HHHHH
Q 042634 408 EEVAA 412 (427)
Q Consensus 408 ~ev~~ 412 (427)
+|+++
T Consensus 277 ~eil~ 281 (304)
T 3ubd_A 277 EEIKR 281 (304)
T ss_dssp HHHHT
T ss_pred HHHHc
Confidence 56654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=351.84 Aligned_cols=191 Identities=23% Similarity=0.336 Sum_probs=156.9
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||++++++.. +...|+|||||+||+|.+++.. ..+++.++..++.||+.||+||| ++|||||
T Consensus 205 l~HpnIV~l~~~~~~-----~~~~~iVmEy~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH---~~~IiHR 271 (423)
T 4fie_A 205 YQHENVVEMYNSYLV-----GDELWVVMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLH---AQGVIHR 271 (423)
T ss_dssp CCCTTBCCEEEEEEE-----TTEEEEEEECCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred CCCCCCCceEEEEEE-----CCEEEEEEeCCCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHH---HCCeecc
Confidence 679999999998654 5678999999999999998853 34999999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+|||++.++.+||+|||+|+.+... .+||+.|||||++.+..|+.++||||+||++|||++|+.||.+..
T Consensus 272 DiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~ 351 (423)
T 4fie_A 272 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 351 (423)
T ss_dssp CCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred cCCHHHEEEcCCCCEEEecCccceECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 99999999999999999999999876432 279999999999999999999999999999999999999997531
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
.......+....+..+. .+..++.++.+++.+||+.||++|||++|+++
T Consensus 352 --~~~~~~~i~~~~~~~~~-----------------------------~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 352 --PLKAMKMIRDNLPPRLK-----------------------------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp --HHHHHHHHHHSCCCCCS-----------------------------CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --HHHHHHHHHcCCCCCCc-----------------------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11111222221111100 11223456889999999999999999999976
Q ss_pred H
Q 042634 413 Q 413 (427)
Q Consensus 413 ~ 413 (427)
+
T Consensus 401 H 401 (423)
T 4fie_A 401 H 401 (423)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=333.52 Aligned_cols=188 Identities=22% Similarity=0.347 Sum_probs=147.3
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||++++++. +....++||||| +|+|.+++.+. ..+++.+++.++.||+.||+||| ++||+||
T Consensus 70 l~HpnIv~~~~~~~-----~~~~~~ivmEy~-~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~ylH---~~~IiHR 136 (275)
T 3hyh_A 70 LRHPHIIKLYDVIK-----SKDEIIMVIEYA-GNELFDYIVQR----DKMSEQEARRFFQQIISAVEYCH---RHKIVHR 136 (275)
T ss_dssp CCCTTBCCEEEEEE-----CSSEEEEEEECC-CEEHHHHHHHS----CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCC
T ss_pred CCCCCCCeEEEEEE-----ECCEEEEEEeCC-CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccc
Confidence 57999999999854 367889999999 78999988654 45999999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc-----CCCccccccccccCCCCc-CccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMGSEV-STSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~~~~-~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+|||++.++.+||+|||+|+..... ..||+.|||||++.+..+ +.++||||+||++|||++|+.||.+..
T Consensus 137 DiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~ 216 (275)
T 3hyh_A 137 DLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES 216 (275)
T ss_dssp CCCTTTEEECTTCCEEECCSSCC---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCChHHeEECCCCCEEEeecCCCeecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC
Confidence 99999999999999999999999876433 379999999999998886 579999999999999999999997531
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
............. . .+...+.++.+++.+||+.||++|||++|+++
T Consensus 217 -----~~~~~~~i~~~~~------------------------~-----~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 217 -----IPVLFKNISNGVY------------------------T-----LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp -----HHHHHHHHHHTCC------------------------C-----CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -----HHHHHHHHHcCCC------------------------C-----CCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1111111100000 0 11123456889999999999999999999987
Q ss_pred H
Q 042634 413 Q 413 (427)
Q Consensus 413 ~ 413 (427)
+
T Consensus 263 h 263 (275)
T 3hyh_A 263 D 263 (275)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=327.92 Aligned_cols=195 Identities=18% Similarity=0.280 Sum_probs=144.7
Q ss_pred cccccchhhhccccccCC-------CCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcC
Q 042634 179 IRHRNLVKIITSCASVDF-------QGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYC 251 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~ 251 (427)
++|||||++++++...+- ......|+|||||++|+|.+++..... ....++..++.++.||+.||+|||
T Consensus 60 l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH--- 135 (299)
T 4g31_A 60 LEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLH--- 135 (299)
T ss_dssp CCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHH---
T ss_pred CCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHH---
Confidence 579999999998654221 122346899999999999999976432 133566778999999999999999
Q ss_pred CCCeeeccccCCceeeCCCCceEecccccccccCCc------------------CCCccccccccccCCCCcCccccchh
Q 042634 252 ETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA------------------TNNFFNFQIAEYGMGSEVSTSGDVYS 313 (427)
Q Consensus 252 ~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~------------------~~~~~~y~aPE~~~~~~~~~~~DiwS 313 (427)
++||+||||||+|||++.++.+||+|||+|+..... ..||+.|||||++.+..|+.++||||
T Consensus 136 ~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwS 215 (299)
T 4g31_A 136 SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFS 215 (299)
T ss_dssp HTTCCCCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHH
T ss_pred HCcCccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHH
Confidence 899999999999999999999999999999876432 25999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHH
Q 042634 314 FGILLLETFTGKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIG 393 (427)
Q Consensus 314 ~G~vl~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 393 (427)
|||++|||++ ||..... ....+.. +.+... ............+++
T Consensus 216 lGvilyell~---Pf~~~~~----~~~~~~~--------~~~~~~--------------------p~~~~~~~~~~~~li 260 (299)
T 4g31_A 216 LGLILFELLY---PFSTQME----RVRTLTD--------VRNLKF--------------------PPLFTQKYPCEYVMV 260 (299)
T ss_dssp HHHHHHHHHS---CCSSHHH----HHHHHHH--------HHTTCC--------------------CHHHHHHCHHHHHHH
T ss_pred HHHHHHHHcc---CCCCccH----HHHHHHH--------HhcCCC--------------------CCCCcccCHHHHHHH
Confidence 9999999996 7753210 0000000 000000 001223344567899
Q ss_pred hhcCCCCCCCCCCHHHHHH
Q 042634 394 VTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 394 ~~cl~~dP~~Rpt~~ev~~ 412 (427)
.+||+.||++|||+.|+++
T Consensus 261 ~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 261 QDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHTCSSGGGSCCHHHHHT
T ss_pred HHHcCCChhHCcCHHHHhc
Confidence 9999999999999999986
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=327.11 Aligned_cols=138 Identities=23% Similarity=0.333 Sum_probs=122.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
.+|||||++++++.. +...++|||||++|+|.+++. .+++.+++.++.|++.||+||| ++||+||
T Consensus 77 ~~h~nIv~l~~~~~~-----~~~~~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH---~~gIiHR 141 (361)
T 4f9c_A 77 GGQDNVMGVKYCFRK-----NDHVVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIH---QFGIVHR 141 (361)
T ss_dssp CSBTTBCCCSEEEEE-----TTEEEEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHH---HTTEECS
T ss_pred cCCCCCceEEEEEEE-----CCEEEEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeC
Confidence 469999999998543 678899999999999999883 3889999999999999999999 8999999
Q ss_pred cccCCceeeCCC-CceEecccccccccCCc----------------------------------CCCccccccccccCCC
Q 042634 259 DLKPSNVLLDGE-LTAHVGDFGLAKFLPEA----------------------------------TNNFFNFQIAEYGMGS 303 (427)
Q Consensus 259 Dlkp~NIll~~~-~~~kL~DFG~a~~~~~~----------------------------------~~~~~~y~aPE~~~~~ 303 (427)
||||+|||++.+ +.+||+|||+|+..... .+||+.|+|||++.+.
T Consensus 142 DiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~ 221 (361)
T 4f9c_A 142 DVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC 221 (361)
T ss_dssp CCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTC
T ss_pred cCCHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCC
Confidence 999999999876 79999999999754321 2699999999999875
Q ss_pred -CcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 304 -EVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 304 -~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
.|+.++||||+||++|||++|+.||...
T Consensus 222 ~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 222 PNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred CCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 5899999999999999999999999654
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=326.82 Aligned_cols=221 Identities=17% Similarity=0.196 Sum_probs=156.5
Q ss_pred cccccchhhhcccccc-CCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 042634 179 IRHRNLVKIITSCASV-DFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVH 257 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~-~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivH 257 (427)
++|||||++++++... .+......|+||||| +|+|.+++... ..+++.+++.++.||+.||+||| ++||||
T Consensus 110 l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~-~g~L~~~i~~~----~~l~~~~~~~~~~qil~al~ylH---~~~iiH 181 (398)
T 4b99_A 110 FKHDNIIAIKDILRPTVPYGEFKSVYVVLDLM-ESDLHQIIHSS----QPLTLEHVRYFLYQLLRGLKYMH---SAQVIH 181 (398)
T ss_dssp CCCTTBCCEEEECCCSSCTTTCCCEEEEEECC-SEEHHHHHTSS----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBC
T ss_pred cCCCCcceEeeeeecccccccCCEEEEEEeCC-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCcCcC
Confidence 5799999999987543 244456789999999 57899998765 45999999999999999999999 899999
Q ss_pred ccccCCceeeCCCCceEecccccccccCC----------cCCCccccccccccCCC-CcCccccchhHHHHHHHHHhCCC
Q 042634 258 CDLKPSNVLLDGELTAHVGDFGLAKFLPE----------ATNNFFNFQIAEYGMGS-EVSTSGDVYSFGILLLETFTGKR 326 (427)
Q Consensus 258 rDlkp~NIll~~~~~~kL~DFG~a~~~~~----------~~~~~~~y~aPE~~~~~-~~~~~~DiwS~G~vl~ell~g~~ 326 (427)
|||||+|||++.++.+||+|||+|+.... ...||+.|||||++.+. .++.++||||+||++|||++|++
T Consensus 182 RDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~ 261 (398)
T 4b99_A 182 RDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261 (398)
T ss_dssp CCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSC
T ss_pred CCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCC
Confidence 99999999999999999999999986532 22899999999998875 56999999999999999999999
Q ss_pred CCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccc---cchHHHHHHHHHHHhhcCCCCCCC
Q 042634 327 PTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRS---FSVKECLVSVLGIGVTCSSELPRE 403 (427)
Q Consensus 327 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~~cl~~dP~~ 403 (427)
||.+... ...+.........+.. ........... ...........+. ...+..+.++.+++.+||+.||++
T Consensus 262 pF~g~~~-~~~l~~I~~~~g~p~~-~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~ 335 (398)
T 4b99_A 262 LFPGKNY-VHQLQLIMMVLGTPSP-AVIQAVGAERV----RAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSA 335 (398)
T ss_dssp SSCCSSH-HHHHHHHHHHHCCCCG-GGTC-----CH----HHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTT
T ss_pred CCCCCCH-HHHHHHHHHhcCCCCh-HHhhhhhhhhh----hhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhH
Confidence 9976321 1111122221111110 00000000000 0000000000000 001123456899999999999999
Q ss_pred CCCHHHHHHH
Q 042634 404 RMNMEEVAAQ 413 (427)
Q Consensus 404 Rpt~~ev~~~ 413 (427)
|||++|++++
T Consensus 336 R~ta~e~L~H 345 (398)
T 4b99_A 336 RISAAAALRH 345 (398)
T ss_dssp SCCHHHHTTS
T ss_pred CcCHHHHhcC
Confidence 9999999863
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=337.25 Aligned_cols=191 Identities=19% Similarity=0.214 Sum_probs=155.2
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||++++++ .+....|+|||||+||+|.+++... ..+++..++.++.||+.||+||| ++|||||
T Consensus 249 ~~HP~IV~l~~~f-----~~~~~lylVmEy~~GGdL~~~l~~~----~~l~E~~a~~y~~qIl~aL~yLH---~~gIiHR 316 (689)
T 3v5w_A 249 GDCPFIVCMSYAF-----HTPDKLSFILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMH---NRFVVYR 316 (689)
T ss_dssp SCCTTBCCEEEEE-----ECSSEEEEEECCCCSCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHH---TTTEECC
T ss_pred CCCCCEeEEEEEE-----EECCEEEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccc
Confidence 5799999999984 4467899999999999999999754 45999999999999999999999 9999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc----CCCccccccccccCC-CCcCccccchhHHHHHHHHHhCCCCCCcccC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA----TNNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETFTGKRPTNEMFT 333 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~ 333 (427)
||||+|||++.++.+||+|||+|+..... .+||+.|||||++.. ..|+.++||||+||++|||++|+.||.+...
T Consensus 317 DLKPeNILld~~G~vKL~DFGlA~~~~~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~ 396 (689)
T 3v5w_A 317 DLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 396 (689)
T ss_dssp CCSGGGEEECTTSCEEECCCTTCEECSSCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGC
T ss_pred CCchHHeEEeCCCCEEecccceeeecCCCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 99999999999999999999999876543 389999999999964 6799999999999999999999999976422
Q ss_pred CCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCC-----HH
Q 042634 334 GNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMN-----ME 408 (427)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt-----~~ 408 (427)
.. ............. ..+...+.++.+++.+||+.||++|++ ++
T Consensus 397 ~~--~~~i~~~i~~~~~-----------------------------~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ 445 (689)
T 3v5w_A 397 KD--KHEIDRMTLTMAV-----------------------------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQ 445 (689)
T ss_dssp CC--HHHHHHHHHHCCC-----------------------------CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHH
T ss_pred HH--HHHHHHhhcCCCC-----------------------------CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHH
Confidence 21 1111111111000 011223456889999999999999998 67
Q ss_pred HHHH
Q 042634 409 EVAA 412 (427)
Q Consensus 409 ev~~ 412 (427)
||.+
T Consensus 446 ei~~ 449 (689)
T 3v5w_A 446 EVKE 449 (689)
T ss_dssp HHTT
T ss_pred HHhc
Confidence 7764
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=328.21 Aligned_cols=194 Identities=21% Similarity=0.282 Sum_probs=156.7
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||++++++. .....++|||||+||+|.+++.... ..+++.+++.++.||+.||+||| ++||+||
T Consensus 211 l~hpnIv~l~~~~~-----~~~~~~iv~E~~~gg~L~~~i~~~~---~~l~e~~~~~~~~qi~~al~ylH---~~~iiHR 279 (573)
T 3uto_A 211 LRHPTLVNLHDAFE-----DDNEMVMIYEFMSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMH---ENNYVHL 279 (573)
T ss_dssp TCCTTBCCEEEEEE-----CSSEEEEEEECCCCCBHHHHHTCTT---SCEEHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred CCCCCCCeEEEEEE-----ECCEEEEEEeecCCCcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeec
Confidence 67999999999854 4678999999999999999986543 45999999999999999999999 8999999
Q ss_pred cccCCceeeCCC--CceEecccccccccCCcC-----CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 259 DLKPSNVLLDGE--LTAHVGDFGLAKFLPEAT-----NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 259 Dlkp~NIll~~~--~~~kL~DFG~a~~~~~~~-----~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
||||+|||++.+ +.+||+|||+|+.+.... .||+.|||||++.+..|+.++||||+||++|||++|+.||.+.
T Consensus 280 DlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~ 359 (573)
T 3uto_A 280 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE 359 (573)
T ss_dssp CCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred cCChhhccccCCCCCCEEEeeccceeEccCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 999999999854 799999999999876543 7999999999999999999999999999999999999999753
Q ss_pred cCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 042634 332 FTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVA 411 (427)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~ 411 (427)
.. .+......... ... ........+.++.+++.+||+.||++|||++|++
T Consensus 360 ~~-----~~~~~~i~~~~--------~~~-----------------~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l 409 (573)
T 3uto_A 360 ND-----DETLRNVKSCD--------WNM-----------------DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQAL 409 (573)
T ss_dssp SH-----HHHHHHHHTTC--------CCC-----------------CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred CH-----HHHHHHHHhCC--------CCC-----------------CcccccCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 11 11111110000 000 0001122345688999999999999999999998
Q ss_pred HH
Q 042634 412 AQ 413 (427)
Q Consensus 412 ~~ 413 (427)
++
T Consensus 410 ~H 411 (573)
T 3uto_A 410 EH 411 (573)
T ss_dssp HS
T ss_pred cC
Confidence 63
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=299.09 Aligned_cols=222 Identities=21% Similarity=0.270 Sum_probs=163.2
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCC-----
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCET----- 253 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~----- 253 (427)
++||||+++++.+..... .....++||||+++|+|.+++... .+++..++.++.|++.||+||| +.
T Consensus 75 l~hpniv~~~~~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~al~~LH---~~~~~l~ 145 (322)
T 3soc_A 75 MKHENILQFIGAEKRGTS-VDVDLWLITAFHEKGSLSDFLKAN-----VVSWNELCHIAETMARGLAYLH---EDIPGLK 145 (322)
T ss_dssp CCCTTBCCEEEEEEEECS-SSEEEEEEEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHT---CCEEEET
T ss_pred CCCCCchhhcceeccCCC-CCceEEEEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHH---hhccccc
Confidence 469999999998755221 123468999999999999999643 4899999999999999999999 78
Q ss_pred -----CeeeccccCCceeeCCCCceEecccccccccCCc--------CCCccccccccccCC-----CCcCccccchhHH
Q 042634 254 -----PIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA--------TNNFFNFQIAEYGMG-----SEVSTSGDVYSFG 315 (427)
Q Consensus 254 -----~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~--------~~~~~~y~aPE~~~~-----~~~~~~~DiwS~G 315 (427)
||+||||||+|||++.++.+||+|||+|+..... ..||..|+|||++.+ ..++.++||||||
T Consensus 146 ~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG 225 (322)
T 3soc_A 146 DGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMG 225 (322)
T ss_dssp TEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHH
T ss_pred cccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHH
Confidence 9999999999999999999999999999765332 268899999999886 3567889999999
Q ss_pred HHHHHHHhCCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhh
Q 042634 316 ILLLETFTGKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVT 395 (427)
Q Consensus 316 ~vl~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 395 (427)
|++|||++|+.||.+................+ ....+.+..... ..............++.++.+++.+
T Consensus 226 ~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~l~~li~~ 294 (322)
T 3soc_A 226 LVLWELASRCTAADGPVDEYMLPFEEEIGQHP-SLEDMQEVVVHK----------KKRPVLRDYWQKHAGMAMLCETIEE 294 (322)
T ss_dssp HHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSC-CHHHHHHHHTTS----------CCCCCCCGGGGSSHHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCCCCcchhccchhhhhccCC-chhhhhhhhhcc----------cCCCCccccccccchHHHHHHHHHH
Confidence 99999999999998643322111110000000 000000000000 0000011111234567789999999
Q ss_pred cCCCCCCCCCCHHHHHHHHHHHHHH
Q 042634 396 CSSELPRERMNMEEVAAQLLSFRNK 420 (427)
Q Consensus 396 cl~~dP~~Rpt~~ev~~~L~~~~~~ 420 (427)
||+.||++|||++||++.|+++.+.
T Consensus 295 cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 295 CWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HccCChhhCcCHHHHHHHHHHHHHH
Confidence 9999999999999999999999875
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=295.53 Aligned_cols=214 Identities=29% Similarity=0.447 Sum_probs=169.6
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+++|+|.+++.........+++..++.++.|++.||+||| ++||+||
T Consensus 92 l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~ 163 (321)
T 2qkw_B 92 CRHPHLVSLIGFCDE-----RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHR 163 (321)
T ss_dssp CCCTTBCCEEEECCC-----TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECS
T ss_pred CCCCCEeeEEEEEcC-----CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecC
Confidence 469999999998543 56789999999999999999765433345899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc--------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA--------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~ 330 (427)
||||+||+++.++.+||+|||+++..... ..||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 164 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~ 243 (321)
T 2qkw_B 164 DVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQ 243 (321)
T ss_dssp CCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSC
T ss_pred CCCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccc
Confidence 99999999999999999999999864321 1478899999999888999999999999999999999999976
Q ss_pred ccCCC-ccHHHHHHH-hcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 042634 331 MFTGN-LTLHNFVKE-ALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME 408 (427)
Q Consensus 331 ~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ 408 (427)
..... .....+... .....+...+++.. ......+++.++.+++.+||+.||++|||++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 304 (321)
T 2qkw_B 244 SLPREMVNLAEWAVESHNNGQLEQIVDPNL-------------------ADKIRPESLRKFGDTAVKCLALSSEDRPSMG 304 (321)
T ss_dssp SSSSSCCCHHHHTHHHHTTTCCCSSSSSSC-------------------TTCSCHHHHHHHHHHHHHHTCSSGGGSCCHH
T ss_pred cCcHHHHHHHHHhhhccccccHHHhcChhh-------------------ccccCHHHHHHHHHHHHHHcCCCcccCcCHH
Confidence 43322 122222111 11112222222111 1113456788999999999999999999999
Q ss_pred HHHHHHHHHHH
Q 042634 409 EVAAQLLSFRN 419 (427)
Q Consensus 409 ev~~~L~~~~~ 419 (427)
|+++.|+.+.+
T Consensus 305 ell~~L~~~l~ 315 (321)
T 2qkw_B 305 DVLWKLEYALR 315 (321)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHhh
Confidence 99999998865
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=294.68 Aligned_cols=211 Identities=21% Similarity=0.304 Sum_probs=162.9
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcC-----CC
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYC-----ET 253 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~-----~~ 253 (427)
++||||+++++.+... .......++||||+++|+|.++++.. .+++..++.++.|++.||+|||... +.
T Consensus 59 l~h~niv~~~~~~~~~-~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~ 132 (301)
T 3q4u_A 59 LRHENILGFIASDMTS-RHSSTQLWLITHYHEMGSLYDYLQLT-----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP 132 (301)
T ss_dssp CCCTTBCCEEEEEEEE-ETTEEEEEEEECCCTTCBHHHHHTTC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC
T ss_pred ccCcCeeeEEEeeccc-cCCCceeEEehhhccCCCHHHHHhhc-----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC
Confidence 6799999999875442 22234578999999999999999643 4899999999999999999999321 47
Q ss_pred CeeeccccCCceeeCCCCceEecccccccccCCc----------CCCccccccccccCCC------CcCccccchhHHHH
Q 042634 254 PIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA----------TNNFFNFQIAEYGMGS------EVSTSGDVYSFGIL 317 (427)
Q Consensus 254 ~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~----------~~~~~~y~aPE~~~~~------~~~~~~DiwS~G~v 317 (427)
||+||||||+|||++.++.+||+|||+|+..... ..||+.|+|||++.+. .++.++|||||||+
T Consensus 133 ~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~i 212 (301)
T 3q4u_A 133 AIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLV 212 (301)
T ss_dssp EEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHH
T ss_pred CeecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHH
Confidence 9999999999999999999999999999754322 2689999999999876 56689999999999
Q ss_pred HHHHHhC----------CCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHH
Q 042634 318 LLETFTG----------KRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLV 387 (427)
Q Consensus 318 l~ell~g----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (427)
+|||++| ..||......................... .........++.
T Consensus 213 l~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~ 270 (301)
T 3q4u_A 213 LWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPN----------------------IPNRWFSDPTLT 270 (301)
T ss_dssp HHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCC----------------------CCGGGGGSHHHH
T ss_pred HHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCC----------------------CChhhccCccHH
Confidence 9999999 78886654444333332222111100000 001112345778
Q ss_pred HHHHHHhhcCCCCCCCCCCHHHHHHHHHHH
Q 042634 388 SVLGIGVTCSSELPRERMNMEEVAAQLLSF 417 (427)
Q Consensus 388 ~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~~ 417 (427)
++.+++.+||+.||++|||++||++.|+++
T Consensus 271 ~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 271 SLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 899999999999999999999999999986
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=297.97 Aligned_cols=203 Identities=25% Similarity=0.382 Sum_probs=164.0
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. +...++||||+++|+|.+++.... ..+++.++..++.|++.||+||| +.||+||
T Consensus 64 l~hp~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~ 132 (310)
T 3s95_A 64 LEHPNVLKFIGVLYK-----DKRLNFITEYIKGGTLRGIIKSMD---SQYPWSQRVSFAKDIASGMAYLH---SMNIIHR 132 (310)
T ss_dssp CCCTTBCCEEEEEEE-----TTEEEEEEECCTTCBHHHHHHHCC---TTSCHHHHHHHHHHHHHHHHHHH---HTTEECS
T ss_pred CCCcCcccEEEEEec-----CCeeEEEEEecCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH---hCCccCC
Confidence 469999999998654 567899999999999999997533 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC--------------------cCCCccccccccccCCCCcCccccchhHHHHH
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE--------------------ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILL 318 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~--------------------~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl 318 (427)
||||+||+++.++.+||+|||+++.... ...||+.|+|||++.+..++.++|||||||++
T Consensus 133 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l 212 (310)
T 3s95_A 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVL 212 (310)
T ss_dssp CCSTTSEEECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHH
T ss_pred CCCcCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHH
Confidence 9999999999999999999999986532 22588899999999999999999999999999
Q ss_pred HHHHhCCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCC
Q 042634 319 LETFTGKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSS 398 (427)
Q Consensus 319 ~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~ 398 (427)
|||++|..||................... ...+..++.++.+++.+||+
T Consensus 213 ~el~~g~~~~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~l~~li~~~l~ 261 (310)
T 3s95_A 213 CEIIGRVNADPDYLPRTMDFGLNVRGFLD-------------------------------RYCPPNCPPSFFPITVRCCD 261 (310)
T ss_dssp HHHHHTCCSSTTTSCBCTTSSBCHHHHHH-------------------------------HTCCTTCCTTHHHHHHHHTC
T ss_pred HHHhcCCCCCcchhhhHHHHhhhhhcccc-------------------------------ccCCCCCCHHHHHHHHHHcc
Confidence 99999999987542221111000000000 00112244568899999999
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHh
Q 042634 399 ELPRERMNMEEVAAQLLSFRNKLVK 423 (427)
Q Consensus 399 ~dP~~Rpt~~ev~~~L~~~~~~~~~ 423 (427)
.||++|||++|+++.|+.++..+..
T Consensus 262 ~dP~~Rps~~~l~~~L~~l~~~~~~ 286 (310)
T 3s95_A 262 LDPEKRPSFVKLEHWLETLRMHLAG 286 (310)
T ss_dssp SSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred CChhhCcCHHHHHHHHHHHHHhccC
Confidence 9999999999999999999887643
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=306.88 Aligned_cols=213 Identities=19% Similarity=0.209 Sum_probs=168.1
Q ss_pred ccccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 042634 178 FIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVH 257 (427)
Q Consensus 178 ll~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivH 257 (427)
.++||||+++++.+... ..+....++||||+ +++|.+++.... ..+++..++.++.||+.||+||| +.||+|
T Consensus 104 ~l~h~~iv~~~~~~~~~-~~~~~~~~lv~e~~-g~~L~~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH---~~~iiH 175 (364)
T 3op5_A 104 KLKYLGVPKYWGSGLHD-KNGKSYRFMIMDRF-GSDLQKIYEANA---KRFSRKTVLQLSLRILDILEYIH---EHEYVH 175 (364)
T ss_dssp TCSCCCSCCEEEEEEEE-ETTEEEEEEEEECE-EEEHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHH---HTTEEC
T ss_pred hccCCCCCeEEeeeeec-cCCcceEEEEEeCC-CCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeEE
Confidence 35799999999986552 12234579999999 999999986542 45999999999999999999999 889999
Q ss_pred ccccCCceeeC--CCCceEecccccccccCCc-------------CCCccccccccccCCCCcCccccchhHHHHHHHHH
Q 042634 258 CDLKPSNVLLD--GELTAHVGDFGLAKFLPEA-------------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETF 322 (427)
Q Consensus 258 rDlkp~NIll~--~~~~~kL~DFG~a~~~~~~-------------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell 322 (427)
|||||+|||++ .++.+||+|||+|+..... ..||..|+|||++.+..++.++|||||||++|||+
T Consensus 176 rDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~ 255 (364)
T 3op5_A 176 GDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWL 255 (364)
T ss_dssp CCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHH
Confidence 99999999998 8899999999999765322 14899999999999999999999999999999999
Q ss_pred hCCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCC
Q 042634 323 TGKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPR 402 (427)
Q Consensus 323 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~ 402 (427)
+|+.||.+.... ..............+..+.++.+. ...++.++.+++.+||+.||+
T Consensus 256 ~g~~Pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~li~~cl~~~p~ 312 (364)
T 3op5_A 256 TGHLPWEDNLKD-PKYVRDSKIRYRENIASLMDKCFP----------------------AANAPGEIAKYMETVKLLDYT 312 (364)
T ss_dssp HSCCTTGGGTTC-HHHHHHHHHHHHHCHHHHHHHHSC----------------------TTCCCHHHHHHHHHHHTCCTT
T ss_pred hCCCCccccccC-HHHHHHHHHHhhhhHHHHHHHhcc----------------------cccCHHHHHHHHHHHhcCCCC
Confidence 999999864322 222222222222233333322211 122456789999999999999
Q ss_pred CCCCHHHHHHHHHHHHHHH
Q 042634 403 ERMNMEEVAAQLLSFRNKL 421 (427)
Q Consensus 403 ~Rpt~~ev~~~L~~~~~~~ 421 (427)
+|||+++|++.|+++.++.
T Consensus 313 ~RP~~~~l~~~l~~~~~~~ 331 (364)
T 3op5_A 313 EKPLYENLRDILLQGLKAI 331 (364)
T ss_dssp CCCCHHHHHHHHHHHHHHT
T ss_pred CCCCHHHHHHHHHHHHHHc
Confidence 9999999999999998764
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=294.42 Aligned_cols=212 Identities=24% Similarity=0.332 Sum_probs=163.2
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCC-----
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCET----- 253 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~----- 253 (427)
++||||+++++.+.... ......++||||+++|+|.++++. ..+++..++.++.|++.||+||| +.
T Consensus 88 ~~h~~i~~~~~~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~ 158 (337)
T 3mdy_A 88 MRHENILGFIAADIKGT-GSWTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLH---TEIFSTQ 158 (337)
T ss_dssp CCCTTBCCEEEEEEESC-GGGCEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHH---SCBCSTT
T ss_pred hcCCCeeeEEEEEccCC-CCCCceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHH---Hhhhhhc
Confidence 57999999998865421 112467999999999999999954 34899999999999999999999 77
Q ss_pred ---CeeeccccCCceeeCCCCceEecccccccccCC----------cCCCccccccccccCCCCcCcc------ccchhH
Q 042634 254 ---PIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPE----------ATNNFFNFQIAEYGMGSEVSTS------GDVYSF 314 (427)
Q Consensus 254 ---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~----------~~~~~~~y~aPE~~~~~~~~~~------~DiwS~ 314 (427)
||+||||||+||+++.++.+||+|||+|+.... ...||..|+|||++.+..++.+ +|||||
T Consensus 159 ~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Diwsl 238 (337)
T 3mdy_A 159 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSF 238 (337)
T ss_dssp CBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHH
T ss_pred cCCCEEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHH
Confidence 999999999999999999999999999976532 2268899999999987766554 999999
Q ss_pred HHHHHHHHhC----------CCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHH
Q 042634 315 GILLLETFTG----------KRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKE 384 (427)
Q Consensus 315 G~vl~ell~g----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (427)
||++|||++| ..||....................... ..+........
T Consensus 239 G~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~ 296 (337)
T 3mdy_A 239 GLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLR----------------------PSFPNRWSSDE 296 (337)
T ss_dssp HHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCC----------------------CCCCGGGGGSH
T ss_pred HHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccC----------------------ccccccchhhH
Confidence 9999999999 555554333332222221111111000 00111123456
Q ss_pred HHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHH
Q 042634 385 CLVSVLGIGVTCSSELPRERMNMEEVAAQLLSFRNKL 421 (427)
Q Consensus 385 ~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~~~~~~ 421 (427)
++.++.+++.+||+.||++|||++||++.|+++.+..
T Consensus 297 ~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 297 CLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp HHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 8889999999999999999999999999999998764
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=295.43 Aligned_cols=214 Identities=34% Similarity=0.533 Sum_probs=168.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++++.. ....++||||+++|+|.+++.........+++..+..++.|++.||+|||+.+..||+||
T Consensus 84 l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~ 158 (326)
T 3uim_A 84 AVHRNLLRLRGFCMT-----PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHR 158 (326)
T ss_dssp CCCTTBCCCCEEECC-----SSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECC
T ss_pred ccCCCccceEEEEec-----CCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeC
Confidence 569999999998644 567799999999999999998765444569999999999999999999993222299999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC-------CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT-------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~-------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
||||+||+++.++.+||+|||+++...... .||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 159 Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 238 (326)
T 3uim_A 159 DVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLA 238 (326)
T ss_dssp CCSGGGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHH
T ss_pred CCchhhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccccc
Confidence 999999999999999999999998764322 5899999999998888999999999999999999999999632
Q ss_pred ---cCCCccHHHHHHHhccc-chhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCH
Q 042634 332 ---FTGNLTLHNFVKEALPE-RLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM 407 (427)
Q Consensus 332 ---~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~ 407 (427)
.........++...... ......+... .......++.++.+++.+||+.||++|||+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 299 (326)
T 3uim_A 239 RLANDDDVMLLDWVKGLLKEKKLEALVDVDL-------------------QGNYKDEEVEQLIQVALLCTQSSPMERPKM 299 (326)
T ss_dssp HHTTTSCSBHHHHHTTTTSSCCSTTSSCTTC-------------------TTSCCHHHHHHHHHHHHHHTCSCGGGSCCH
T ss_pred ccccccchhHHHHHHHHhhchhhhhhcChhh-------------------ccccCHHHHHHHHHHHHHHhCcCCccCCCH
Confidence 12222333333322221 1122222111 111345678899999999999999999999
Q ss_pred HHHHHHHHH
Q 042634 408 EEVAAQLLS 416 (427)
Q Consensus 408 ~ev~~~L~~ 416 (427)
+||+++|+.
T Consensus 300 ~ell~~L~~ 308 (326)
T 3uim_A 300 SEVVRMLEG 308 (326)
T ss_dssp HHHHHHHHT
T ss_pred HHHHHHhcC
Confidence 999999975
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=301.42 Aligned_cols=201 Identities=22% Similarity=0.395 Sum_probs=162.4
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchh------------hhhccCHHHHHHHHHHHHHHHHHH
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNRE------------ALKNLNLLQRLSIAVDVASALDYL 247 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~~~~~i~~~L~~L 247 (427)
+||||+++++.+.. ....++||||+++|+|.+++..... ....+++.+++.++.||+.||+||
T Consensus 145 ~hpnIv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L 219 (370)
T 2psq_A 145 KHKNIINLLGACTQ-----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL 219 (370)
T ss_dssp CCTTBCCEEEEECS-----SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred CCCCEeeEEEEEcc-----CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHH
Confidence 79999999998644 5678999999999999999865421 113478999999999999999999
Q ss_pred hhcCCCCeeeccccCCceeeCCCCceEecccccccccCCc--------CCCccccccccccCCCCcCccccchhHHHHHH
Q 042634 248 HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA--------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLL 319 (427)
Q Consensus 248 H~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ 319 (427)
| ++||+||||||+|||++.++.+||+|||+|+..... ..+++.|+|||++.+..++.++|||||||++|
T Consensus 220 H---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ 296 (370)
T 2psq_A 220 A---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMW 296 (370)
T ss_dssp H---HTTEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHH
T ss_pred H---hCCeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHH
Confidence 9 899999999999999999999999999999865432 25667899999999999999999999999999
Q ss_pred HHHh-CCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCC
Q 042634 320 ETFT-GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSS 398 (427)
Q Consensus 320 ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~ 398 (427)
||++ |..||.+... ..+...+..... ...+..++.++.+++.+||+
T Consensus 297 ellt~g~~p~~~~~~--~~~~~~~~~~~~-------------------------------~~~~~~~~~~l~~li~~~l~ 343 (370)
T 2psq_A 297 EIFTLGGSPYPGIPV--EELFKLLKEGHR-------------------------------MDKPANCTNELYMMMRDCWH 343 (370)
T ss_dssp HHHTTSCCSSTTCCG--GGHHHHHHTTCC-------------------------------CCCCTTSCHHHHHHHHHHTC
T ss_pred HHHcCCCCCCCCCCH--HHHHHHHhcCCC-------------------------------CCCCCCCCHHHHHHHHHHcC
Confidence 9999 9999975321 111111111100 00122355678999999999
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHH
Q 042634 399 ELPRERMNMEEVAAQLLSFRNKL 421 (427)
Q Consensus 399 ~dP~~Rpt~~ev~~~L~~~~~~~ 421 (427)
.||++|||++|+++.|+++....
T Consensus 344 ~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 344 AVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp SSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CChhhCcCHHHHHHHHHHHHHHh
Confidence 99999999999999999997654
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=296.07 Aligned_cols=201 Identities=27% Similarity=0.377 Sum_probs=155.4
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCC--ee
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETP--IV 256 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~--iv 256 (427)
++||||+++++.+.. ....++||||+++|+|.+++..... ...+++..++.++.|++.||+||| +.| |+
T Consensus 91 l~hp~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~iv 161 (309)
T 3p86_A 91 LRHPNIVLFMGAVTQ-----PPNLSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLH---NRNPPIV 161 (309)
T ss_dssp CCCTTBCCEEEEECS-----TTCCEEEEECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCC
T ss_pred CCCCCEeeEEEEEEE-----CCceEEEEecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEE
Confidence 469999999998543 5578999999999999999976532 145899999999999999999999 888 99
Q ss_pred eccccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCc
Q 042634 257 HCDLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNE 330 (427)
Q Consensus 257 HrDlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~ 330 (427)
||||||+||+++.++.+||+|||+++..... ..||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 162 H~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~ 241 (309)
T 3p86_A 162 HRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGN 241 (309)
T ss_dssp CTTCCGGGEEECTTCCEEECCCC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTT
T ss_pred CCCCChhhEEEeCCCcEEECCCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999999865432 3788999999999999999999999999999999999999975
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
.... .....+..... ....+..++.++.+++.+||+.||++|||++|+
T Consensus 242 ~~~~--~~~~~~~~~~~------------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l 289 (309)
T 3p86_A 242 LNPA--QVVAAVGFKCK------------------------------RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATI 289 (309)
T ss_dssp SCHH--HHHHHHHHSCC------------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCHH--HHHHHHHhcCC------------------------------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 3111 11111000000 000122345668999999999999999999999
Q ss_pred HHHHHHHHHH
Q 042634 411 AAQLLSFRNK 420 (427)
Q Consensus 411 ~~~L~~~~~~ 420 (427)
++.|+.+.+.
T Consensus 290 l~~L~~~~~~ 299 (309)
T 3p86_A 290 MDLLRPLIKS 299 (309)
T ss_dssp HHHHHHHHC-
T ss_pred HHHHHHHHHh
Confidence 9999998654
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=300.79 Aligned_cols=226 Identities=21% Similarity=0.259 Sum_probs=164.4
Q ss_pred ccccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCC----
Q 042634 178 FIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCET---- 253 (427)
Q Consensus 178 ll~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~---- 253 (427)
.++||||+++++.+......+....++||||+++|+|.+++... ..++..+..++.|++.||+||| +.
T Consensus 63 ~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~~L~~LH---~~~~~~ 134 (336)
T 3g2f_A 63 LMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-----TSDWVSSCRLAHSVTRGLAYLH---TELPRG 134 (336)
T ss_dssp TCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHH---CCBCCG
T ss_pred hccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhc-----ccchhHHHHHHHHHHHHHHHHH---hhhccc
Confidence 36899999999866554455556678999999999999998543 3688899999999999999999 77
Q ss_pred -----CeeeccccCCceeeCCCCceEecccccccccCCc--------------CCCccccccccccCC-------CCcCc
Q 042634 254 -----PIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA--------------TNNFFNFQIAEYGMG-------SEVST 307 (427)
Q Consensus 254 -----~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~--------------~~~~~~y~aPE~~~~-------~~~~~ 307 (427)
||+||||||+|||++.++.+||+|||+|+..... ..||..|+|||++.+ ..++.
T Consensus 135 ~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~ 214 (336)
T 3g2f_A 135 DHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALK 214 (336)
T ss_dssp GGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHH
T ss_pred cccccceeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCccccccccccc
Confidence 9999999999999999999999999999865421 258899999999987 45678
Q ss_pred cccchhHHHHHHHHHhCCCCCCcccCCCccHHHHHHHh-cccc---hhcccCccccccccccchhhhcccccc-ccccch
Q 042634 308 SGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEA-LPER---LAEIVDPVLLVEREEGETSKANAHKQF-TRSFSV 382 (427)
Q Consensus 308 ~~DiwS~G~vl~ell~g~~pf~~~~~~~~~~~~~~~~~-~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 382 (427)
++|||||||++|||++|..||............+.... ..+. ....+.... ....+ ......
T Consensus 215 ~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~ 281 (336)
T 3g2f_A 215 QVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREK-------------QRPKFPEAWKEN 281 (336)
T ss_dssp HHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSC-------------CCCCCCTTCCCC
T ss_pred ccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccc-------------cCCCCCcccccc
Confidence 99999999999999999777643221111000000000 0000 000000000 00000 000122
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHhh
Q 042634 383 KECLVSVLGIGVTCSSELPRERMNMEEVAAQLLSFRNKLVKN 424 (427)
Q Consensus 383 ~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~~~~~~~~~ 424 (427)
..++.++.+++.+||+.||++|||++|+++.|+++.+.+.+|
T Consensus 282 ~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~ 323 (336)
T 3g2f_A 282 SLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERN 323 (336)
T ss_dssp SHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC-
T ss_pred cchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhc
Confidence 346778999999999999999999999999999998765443
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=304.78 Aligned_cols=198 Identities=24% Similarity=0.391 Sum_probs=161.4
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++++.. ....++||||+++|+|.+++.... ..+++..+..++.|++.||+||| +.||+||
T Consensus 169 l~hpniv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHr 237 (377)
T 3cbl_A 169 YSHPNIVRLIGVCTQ-----KQPIYIVMELVQGGDFLTFLRTEG---ARLRVKTLLQMVGDAAAGMEYLE---SKCCIHR 237 (377)
T ss_dssp CCCTTBCCEEEEECS-----SSSCEEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHH---HTTEECS
T ss_pred CCCCCEEEEEEEEec-----CCCcEEEEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCcCCc
Confidence 579999999998644 457899999999999999986543 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC--------CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT--------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTN 329 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~--------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~ 329 (427)
||||+|||++.++.+||+|||+|+...... .++..|+|||++....++.++|||||||++|||++ |..||.
T Consensus 238 Dlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~ 317 (377)
T 3cbl_A 238 DLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYP 317 (377)
T ss_dssp CCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999998654321 24567999999988899999999999999999998 999997
Q ss_pred cccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 042634 330 EMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEE 409 (427)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~e 409 (427)
.... ......+..... ...+..++.++.+++.+||+.||++|||++|
T Consensus 318 ~~~~--~~~~~~~~~~~~-------------------------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~ 364 (377)
T 3cbl_A 318 NLSN--QQTREFVEKGGR-------------------------------LPCPELCPDAVFRLMEQCWAYEPGQRPSFST 364 (377)
T ss_dssp TSCH--HHHHHHHHTTCC-------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCH--HHHHHHHHcCCC-------------------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHH
Confidence 6421 111111111000 0012335667899999999999999999999
Q ss_pred HHHHHHHHHHH
Q 042634 410 VAAQLLSFRNK 420 (427)
Q Consensus 410 v~~~L~~~~~~ 420 (427)
+++.|++++++
T Consensus 365 i~~~L~~i~~~ 375 (377)
T 3cbl_A 365 IYQELQSIRKR 375 (377)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHhh
Confidence 99999999865
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=292.38 Aligned_cols=190 Identities=19% Similarity=0.259 Sum_probs=154.0
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+++|+|.+++... .+++..+..++.|++.||+||| +.||+||
T Consensus 74 l~hp~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~ 140 (297)
T 3fxz_A 74 NKNPNIVNYLDSYLV-----GDELWVVMEYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLH---SNQVIHR 140 (297)
T ss_dssp CCCTTBCCEEEEEEE-----TTEEEEEEECCTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred CCCCCCCeEeEEEEE-----CCEEEEEEECCCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHH---hCCceeC
Confidence 579999999998654 55789999999999999998643 4899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+||+++.++.+||+|||+|+..... ..||+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus 141 Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 220 (297)
T 3fxz_A 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (297)
T ss_dssp CCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CCCHHHEEECCCCCEEEeeCCCceecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999999865432 278999999999999999999999999999999999999997531
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
... ..........+ . ...+..++..+.+++.+||+.||++|||++|+++
T Consensus 221 ~~~-~~~~~~~~~~~-~-----------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 221 PLR-ALYLIATNGTP-E-----------------------------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp HHH-HHHHHHHHCSC-C-----------------------------CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHH-HHHHHHhCCCC-C-----------------------------CCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 110 00000000000 0 0012234566899999999999999999999986
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=294.85 Aligned_cols=198 Identities=24% Similarity=0.395 Sum_probs=160.0
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++++.. +...++||||+++|+|.+++.... ..+++..++.++.|++.||+||| +.||+||
T Consensus 107 l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~ 175 (325)
T 3kul_A 107 FDHPNIIRLEGVVTR-----GRLAMIVTEYMENGSLDTFLRTHD---GQFTIMQLVGMLRGVGAGMRYLS---DLGYVHR 175 (325)
T ss_dssp CCCTTBCCEEEEECG-----GGCCEEEEECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHH---HTTEECS
T ss_pred CCCCCCCcEEEEEEe-----CCccEEEeeCCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH---HCCeeCC
Confidence 479999999998644 567899999999999999986543 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC---------CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT---------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPT 328 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~---------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf 328 (427)
||||+||+++.++.+||+|||+++...... .+|..|+|||++.+..++.++|||||||++|||++ |..||
T Consensus 176 Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~ 255 (325)
T 3kul_A 176 DLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPY 255 (325)
T ss_dssp CCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCc
Confidence 999999999999999999999998764322 45668999999998899999999999999999999 99999
Q ss_pred CcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 042634 329 NEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME 408 (427)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ 408 (427)
..... ......+..... ...+..++.++.+++.+||+.||++|||++
T Consensus 256 ~~~~~--~~~~~~~~~~~~-------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 302 (325)
T 3kul_A 256 WNMTN--RDVISSVEEGYR-------------------------------LPAPMGCPHALHQLMLDCWHKDRAQRPRFS 302 (325)
T ss_dssp TTSCH--HHHHHHHHTTCC-------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred ccCCH--HHHHHHHHcCCC-------------------------------CCCCCCcCHHHHHHHHHHccCChhhCcCHH
Confidence 65311 111111111000 001223456789999999999999999999
Q ss_pred HHHHHHHHHHHH
Q 042634 409 EVAAQLLSFRNK 420 (427)
Q Consensus 409 ev~~~L~~~~~~ 420 (427)
||++.|+.+.+.
T Consensus 303 eil~~L~~l~~~ 314 (325)
T 3kul_A 303 QIVSVLDALIRS 314 (325)
T ss_dssp HHHHHHHHHHHS
T ss_pred HHHHHHHHHHhC
Confidence 999999998754
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=292.05 Aligned_cols=218 Identities=23% Similarity=0.392 Sum_probs=160.4
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+...+ ....++||||+++|+|.+++.... ..+++..+..++.|++.||+||| +.||+||
T Consensus 68 l~h~~iv~~~~~~~~~~---~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~ 138 (295)
T 3ugc_A 68 LQHDNIVKYKGVCYSAG---RRNLKLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLG---TKRYIHR 138 (295)
T ss_dssp CCCTTBCCEEEEECHHH---HTSCEEEEECCTTCBHHHHHHHCG---GGCCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred CCCCCEeeEEEEEecCC---CCceEEEEEeCCCCCHHHHHHhcc---cccCHHHHHHHHHHHHHHHHHHh---cCCcccC
Confidence 46999999999864421 345789999999999999997653 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc---------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA---------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTN 329 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~---------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~ 329 (427)
||||+||+++.++.+||+|||+++..... ..++..|+|||.+.+..++.++|||||||++|||++|..||.
T Consensus 139 Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~ 218 (295)
T 3ugc_A 139 DLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK 218 (295)
T ss_dssp CCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTC
T ss_pred CCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccC
Confidence 99999999999999999999999876432 246667999999999999999999999999999999999986
Q ss_pred cccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 042634 330 EMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEE 409 (427)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~e 409 (427)
... ................. ...........+...+..++.++.+++.+||+.||++|||++|
T Consensus 219 ~~~------~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e 281 (295)
T 3ugc_A 219 SPP------AEFMRMIGNDKQGQMIV-----------FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRD 281 (295)
T ss_dssp SHH------HHHHHHHCTTCCTHHHH-----------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CCh------HHHHhhhcCccccchhH-----------HHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHH
Confidence 421 01100000000000000 0000000000011123345678999999999999999999999
Q ss_pred HHHHHHHHHHHHH
Q 042634 410 VAAQLLSFRNKLV 422 (427)
Q Consensus 410 v~~~L~~~~~~~~ 422 (427)
+++.|+++++.+.
T Consensus 282 l~~~L~~l~~~l~ 294 (295)
T 3ugc_A 282 LALRVDQIRDNMA 294 (295)
T ss_dssp HHHHHHHHHHC--
T ss_pred HHHHHHHHHHhcc
Confidence 9999999987653
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=303.83 Aligned_cols=200 Identities=28% Similarity=0.375 Sum_probs=162.2
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. .....++||||+++|+|.+++..... ..+++..++.++.|++.||+||| ++||+||
T Consensus 243 l~h~niv~~~~~~~~----~~~~~~iv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHr 313 (450)
T 1k9a_A 243 LRHSNLVQLLGVIVE----EKGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHR 313 (450)
T ss_dssp CCCTTBCCEEEEEEC----TTSCEEEEEECCTTCBHHHHHHHHCT--TTCCHHHHHHHHHHHHHHHHHHH---HTTEECS
T ss_pred ccCCCEEEEEEEEEc----CCCceEEEEEecCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCC
Confidence 579999999998643 23468999999999999999975432 34789999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc---CCCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCCcccCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA---TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNEMFTG 334 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~~~~~~ 334 (427)
||||+|||++.++.+||+|||+++..... ..++..|+|||++.+..++.++|||||||++|||++ |+.||......
T Consensus 314 Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~ 393 (450)
T 1k9a_A 314 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK 393 (450)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCEECC------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT
T ss_pred CCCHhhEEECCCCCEEEeeCCCcccccccccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999999999865432 256778999999999999999999999999999998 99999764221
Q ss_pred CccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 042634 335 NLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAAQL 414 (427)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L 414 (427)
.....+..... ...+..++.++.++|.+||+.||++|||++|+++.|
T Consensus 394 --~~~~~i~~~~~-------------------------------~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L 440 (450)
T 1k9a_A 394 --DVVPRVEKGYK-------------------------------MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQL 440 (450)
T ss_dssp --THHHHHHTTCC-------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred --HHHHHHHcCCC-------------------------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 11111111100 002234567799999999999999999999999999
Q ss_pred HHHHHH
Q 042634 415 LSFRNK 420 (427)
Q Consensus 415 ~~~~~~ 420 (427)
+.+...
T Consensus 441 ~~i~~~ 446 (450)
T 1k9a_A 441 EHIRTH 446 (450)
T ss_dssp HHHHHT
T ss_pred HHHHHh
Confidence 998753
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=297.61 Aligned_cols=203 Identities=23% Similarity=0.356 Sum_probs=161.7
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhh-----------------------------------
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREA----------------------------------- 224 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~----------------------------------- 224 (427)
+||||+++++.+.. .+...++||||+++|+|.+++......
T Consensus 84 ~hpniv~~~~~~~~----~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (359)
T 3vhe_A 84 HHLNVVNLLGACTK----PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSS 159 (359)
T ss_dssp CCTTBCCEEEEECS----TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------
T ss_pred CCcceeeeeeeeec----CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcc
Confidence 79999999998644 234579999999999999998754320
Q ss_pred ---------------------------hhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccccCCceeeCCCCceEecc
Q 042634 225 ---------------------------LKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGD 277 (427)
Q Consensus 225 ---------------------------~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 277 (427)
...+++..++.++.|++.||+||| +.||+||||||+||+++.++.+||+|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~D 236 (359)
T 3vhe_A 160 QSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICD 236 (359)
T ss_dssp ------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECC
T ss_pred ccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEe
Confidence 122899999999999999999999 89999999999999999999999999
Q ss_pred cccccccCCc--------CCCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCCcccCCCccHHHHHHHhccc
Q 042634 278 FGLAKFLPEA--------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNEMFTGNLTLHNFVKEALPE 348 (427)
Q Consensus 278 FG~a~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~ 348 (427)
||+++..... ..+|..|+|||++.+..++.++|||||||++|||++ |..||.+..... .+...+......
T Consensus 237 fg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-~~~~~~~~~~~~ 315 (359)
T 3vhe_A 237 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFCRRLKEGTRM 315 (359)
T ss_dssp CGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-HHHHHHHHTCCC
T ss_pred ccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH-HHHHHHHcCCCC
Confidence 9999865332 256778999999999999999999999999999998 999997642221 111111111100
Q ss_pred chhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHH
Q 042634 349 RLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAAQLLSFRNKL 421 (427)
Q Consensus 349 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~~~~~~ 421 (427)
. .+..++.++.+++.+||+.||++|||++|++++|+++.+..
T Consensus 316 ~-------------------------------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 316 R-------------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp C-------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred C-------------------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 0 11223456899999999999999999999999999997653
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=292.87 Aligned_cols=189 Identities=21% Similarity=0.317 Sum_probs=153.6
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++++.. ....++||||+++|+|.+++... ..+++..+..++.|++.||+||| +.||+||
T Consensus 71 l~hpnIv~l~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH---~~~ivHr 138 (328)
T 3fe3_A 71 LNHPNIVKLFEVIET-----EKTLYLIMEYASGGEVFDYLVAH----GRMKEKEARSKFRQIVSAVQYCH---QKRIVHR 138 (328)
T ss_dssp CCCTTBCCEEEEEEC-----SSEEEEEECCCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred CCCCCEeeEEEEEEE-----CCEEEEEEECCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCEecc
Confidence 579999999998543 56789999999999999998654 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc-----CCCccccccccccCCCCcC-ccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMGSEVS-TSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~~~~~-~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+||+++.++.+||+|||+|+..... ..||+.|+|||++.+..++ .++||||+||++|||++|+.||.+..
T Consensus 139 Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 218 (328)
T 3fe3_A 139 DLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218 (328)
T ss_dssp CCCGGGEEECTTSCEEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCHHHEEEcCCCCEEEeeccCceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999999865433 2789999999999888775 89999999999999999999997531
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
............. . .+...+.++.+++.+||+.||++|||++|+++
T Consensus 219 -----~~~~~~~i~~~~~----~-------------------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 219 -----LKELRERVLRGKY----R-------------------------IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp -----HHHHHHHHHHCCC----C-------------------------CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred -----HHHHHHHHHhCCC----C-------------------------CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1111111110000 0 11113455789999999999999999999976
Q ss_pred H
Q 042634 413 Q 413 (427)
Q Consensus 413 ~ 413 (427)
+
T Consensus 265 h 265 (328)
T 3fe3_A 265 D 265 (328)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=283.32 Aligned_cols=210 Identities=28% Similarity=0.423 Sum_probs=164.7
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+++|+|.+++..... ...+++..+..++.|++.||+||| +.||+||
T Consensus 87 l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~ 157 (307)
T 2nru_A 87 CQHENLVELLGFSSD-----GDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSWHMRCKIAQGAANGINFLH---ENHHIHR 157 (307)
T ss_dssp CCCTTBCCEEEEECS-----SSSCEEEEECCTTCBHHHHHHTGGG-CCCCCHHHHHHHHHHHHHHHHHHH---HTTEECS
T ss_pred cCCCCeEEEEEEEec-----CCceEEEEEecCCCcHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHh---cCCeecC
Confidence 469999999998543 5678999999999999999865332 145899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc--------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA--------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~ 330 (427)
||||+||+++.++.+||+|||+++..... ..|+..|+|||.+.+ .++.++|||||||++|||++|..||..
T Consensus 158 dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~ 236 (307)
T 2nru_A 158 DIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDE 236 (307)
T ss_dssp CCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCT
T ss_pred CCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCccc
Confidence 99999999999999999999999865432 268899999998765 589999999999999999999999986
Q ss_pred ccCCCccHHHHHHHh--cccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 042634 331 MFTGNLTLHNFVKEA--LPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME 408 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ 408 (427)
..... .+..+.... ....+.+.+++.. ...+..++..+.+++.+||+.||++|||++
T Consensus 237 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ 295 (307)
T 2nru_A 237 HREPQ-LLLDIKEEIEDEEKTIEDYIDKKM--------------------NDADSTSVEAMYSVASQCLHEKKNKRPDIK 295 (307)
T ss_dssp TBSSS-BTTHHHHHHHTTSCCHHHHSCSSC--------------------SCCCHHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred CcchH-HHHHHHHHhhhhhhhhhhhccccc--------------------cccchHHHHHHHHHHHHHcCCCcccCcCHH
Confidence 43322 121211111 1111222222211 113456788899999999999999999999
Q ss_pred HHHHHHHHHHH
Q 042634 409 EVAAQLLSFRN 419 (427)
Q Consensus 409 ev~~~L~~~~~ 419 (427)
||++.|+++..
T Consensus 296 ~l~~~L~~l~~ 306 (307)
T 2nru_A 296 KVQQLLQEMTA 306 (307)
T ss_dssp HHHHHHHHHC-
T ss_pred HHHHHHHHHhc
Confidence 99999998854
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=297.60 Aligned_cols=198 Identities=24% Similarity=0.425 Sum_probs=152.2
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++++.. ....++||||+++|+|.+++.... ..+++.+++.++.|++.||+||| +.||+||
T Consensus 103 l~h~niv~~~~~~~~-----~~~~~lv~e~~~~~sL~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~ 171 (373)
T 2qol_A 103 FDHPNIIRLEGVVTK-----SKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKYLS---DMGYVHR 171 (373)
T ss_dssp CCCTTBCCEEEEECS-----SSSCEEEEECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred CCCCCCCeEEEEEee-----CCceEEEEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCC
Confidence 479999999998644 567899999999999999997543 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC---------CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT---------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPT 328 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~---------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf 328 (427)
||||+||+++.++.+||+|||+++...... .++..|+|||++.+..++.++|||||||++||+++ |+.||
T Consensus 172 Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~ 251 (373)
T 2qol_A 172 DLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY 251 (373)
T ss_dssp CCCGGGEEECTTCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTT
T ss_pred CCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999998764322 34567999999999999999999999999999998 99999
Q ss_pred CcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 042634 329 NEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME 408 (427)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ 408 (427)
..... ......+..... ...+..++.++.+++.+||+.||++|||++
T Consensus 252 ~~~~~--~~~~~~i~~~~~-------------------------------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ 298 (373)
T 2qol_A 252 WEMSN--QDVIKAVDEGYR-------------------------------LPPPMDCPAALYQLMLDCWQKDRNNRPKFE 298 (373)
T ss_dssp TTCCH--HHHHHHHHTTEE-------------------------------CCCCTTCBHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCCH--HHHHHHHHcCCC-------------------------------CCCCccccHHHHHHHHHHhCcChhhCcCHH
Confidence 75321 111111111000 001223456789999999999999999999
Q ss_pred HHHHHHHHHHHH
Q 042634 409 EVAAQLLSFRNK 420 (427)
Q Consensus 409 ev~~~L~~~~~~ 420 (427)
||++.|+++.+.
T Consensus 299 ~i~~~L~~~~~~ 310 (373)
T 2qol_A 299 QIVSILDKLIRN 310 (373)
T ss_dssp HHHHHHHHHHHC
T ss_pred HHHHHHHHHHhC
Confidence 999999998754
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=293.13 Aligned_cols=197 Identities=21% Similarity=0.365 Sum_probs=160.7
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++++.. ...++|+||+.+|+|.+++.... ..+++..++.++.|++.||+||| +.||+||
T Consensus 74 l~h~~iv~~~~~~~~------~~~~~v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~ 141 (327)
T 3poz_A 74 VDNPHVCRLLGICLT------STVQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHR 141 (327)
T ss_dssp CCBTTBCCEEEEEES------SSEEEEEECCTTCBHHHHHHHST---TSCCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred CCCCCEeEEEEEEec------CCeEEEEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHh---hCCeeCC
Confidence 579999999998654 34689999999999999987543 45899999999999999999999 8899999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC--------CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT--------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTN 329 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~--------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~ 329 (427)
||||+|||++.++.+||+|||+|+...... .+|..|+|||++.+..++.++|||||||++|||++ |+.||.
T Consensus 142 Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 221 (327)
T 3poz_A 142 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221 (327)
T ss_dssp CCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCcc
Confidence 999999999999999999999998654322 55778999999999999999999999999999999 999997
Q ss_pred cccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 042634 330 EMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEE 409 (427)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~e 409 (427)
.... ..+...+...... ..+..++.++.+++.+||+.||++|||++|
T Consensus 222 ~~~~--~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e 268 (327)
T 3poz_A 222 GIPA--SEISSILEKGERL-------------------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRE 268 (327)
T ss_dssp TCCG--GGHHHHHHTTCCC-------------------------------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHH
T ss_pred CCCH--HHHHHHHHcCCCC-------------------------------CCCccCCHHHHHHHHHHcCCChhhCCCHHH
Confidence 5421 1122221111100 011224556899999999999999999999
Q ss_pred HHHHHHHHHHH
Q 042634 410 VAAQLLSFRNK 420 (427)
Q Consensus 410 v~~~L~~~~~~ 420 (427)
+++.|+.+...
T Consensus 269 ll~~l~~~~~~ 279 (327)
T 3poz_A 269 LIIEFSKMARD 279 (327)
T ss_dssp HHHHHHHHHTS
T ss_pred HHHHHHHHHhh
Confidence 99999998654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=283.83 Aligned_cols=198 Identities=26% Similarity=0.431 Sum_probs=160.4
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+++++|.+++.... ..+++..+..++.|++.||+||| +.||+||
T Consensus 62 l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~ 130 (269)
T 4hcu_A 62 LSHPKLVQLYGVCLE-----QAPICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLE---EACVIHR 130 (269)
T ss_dssp CCCTTBCCEEEEECS-----SSSEEEEEECCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred CCCCCEeeEEEEEec-----CCceEEEEEeCCCCcHHHHHHhcC---cccCHHHHHHHHHHHHHHHHHHH---hCCeecC
Confidence 469999999998543 567899999999999999986543 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc-------CCCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCCc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA-------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~~ 330 (427)
||||+||+++.++.+||+|||+++..... ..++..|+|||++.+..++.++||||+||++|||++ |+.||..
T Consensus 131 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~ 210 (269)
T 4hcu_A 131 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 210 (269)
T ss_dssp CCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred CcchheEEEcCCCCEEeccccccccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCC
Confidence 99999999999999999999999865432 256678999999998999999999999999999999 9999975
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
... ......+...... ..+...+.++.+++.+||+.||++|||++|+
T Consensus 211 ~~~--~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l 257 (269)
T 4hcu_A 211 RSN--SEVVEDISTGFRL-------------------------------YKPRLASTHVYQIMNHCWRERPEDRPAFSRL 257 (269)
T ss_dssp CCH--HHHHHHHHTTCCC-------------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCH--HHHHHHHhcCccC-------------------------------CCCCcCCHHHHHHHHHHccCCcccCcCHHHH
Confidence 311 1111111110000 0112234568999999999999999999999
Q ss_pred HHHHHHHHHH
Q 042634 411 AAQLLSFRNK 420 (427)
Q Consensus 411 ~~~L~~~~~~ 420 (427)
++.|+++.++
T Consensus 258 l~~l~~l~~~ 267 (269)
T 4hcu_A 258 LRQLAEIAES 267 (269)
T ss_dssp HHHHHHHHHC
T ss_pred HHHHHHHHHc
Confidence 9999998763
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-37 Score=296.88 Aligned_cols=201 Identities=22% Similarity=0.394 Sum_probs=155.2
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. .+...++||||+++|+|.+++.... ..+++..++.++.|++.||+||| +.||+||
T Consensus 147 l~hpnIv~~~~~~~~----~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHr 216 (373)
T 3c1x_A 147 FSHPNVLSLLGICLR----SEGSPLVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLA---SKKFVHR 216 (373)
T ss_dssp CCCTTBCCCCEEECC----CSSCCEEEEECCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred CCCCCcceEEEEEEc----CCCCeEEEEECCCCCCHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHH---HCCEecC
Confidence 579999999997633 2356789999999999999997543 45889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc----------CCCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA----------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRP 327 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~----------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~p 327 (427)
||||+||+++.++.+||+|||+++..... ..++..|+|||++.+..++.++|||||||++|||++ |.+|
T Consensus 217 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p 296 (373)
T 3c1x_A 217 DLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296 (373)
T ss_dssp CCCGGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCC
Confidence 99999999999999999999999865322 255678999999999999999999999999999999 7778
Q ss_pred CCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCH
Q 042634 328 TNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM 407 (427)
Q Consensus 328 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~ 407 (427)
|...... .....+..... ...+..++.++.+++.+||+.||++|||+
T Consensus 297 ~~~~~~~--~~~~~~~~~~~-------------------------------~~~p~~~~~~l~~li~~cl~~dp~~RPs~ 343 (373)
T 3c1x_A 297 YPDVNTF--DITVYLLQGRR-------------------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSF 343 (373)
T ss_dssp CTTSCSS--CHHHHHHTTCC-------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCCCCHH--HHHHHHHcCCC-------------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCH
Confidence 7653221 12111111100 00122345678999999999999999999
Q ss_pred HHHHHHHHHHHHHHH
Q 042634 408 EEVAAQLLSFRNKLV 422 (427)
Q Consensus 408 ~ev~~~L~~~~~~~~ 422 (427)
+|+++.|+++...+.
T Consensus 344 ~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 344 SELVSRISAIFSTFI 358 (373)
T ss_dssp HHHHHHHHHHHHTCC
T ss_pred HHHHHHHHHHHHhcc
Confidence 999999999987653
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=288.48 Aligned_cols=204 Identities=26% Similarity=0.375 Sum_probs=154.9
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+. +..++||||+++|+|.+++..... ...+++..++.++.|+++||+|||+...+||+||
T Consensus 58 l~hp~iv~~~~~~~-------~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~ 129 (307)
T 2eva_A 58 VNHPNIVKLYGACL-------NPVCLVMEYAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHR 129 (307)
T ss_dssp CCCTTBCCEEEBCT-------TTTEEEEECCTTCBHHHHHHCSSS-EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCC
T ss_pred CCCCCcCeEEEEEc-------CCcEEEEEcCCCCCHHHHHhccCC-CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecC
Confidence 46999999998754 247899999999999999875432 1347889999999999999999993222899999
Q ss_pred cccCCceeeCCCCc-eEecccccccccCCc---CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccCC
Q 042634 259 DLKPSNVLLDGELT-AHVGDFGLAKFLPEA---TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTG 334 (427)
Q Consensus 259 Dlkp~NIll~~~~~-~kL~DFG~a~~~~~~---~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~~ 334 (427)
||||+||+++.++. +||+|||+++..... ..|+..|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 130 dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~ 209 (307)
T 2eva_A 130 DLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP 209 (307)
T ss_dssp CCSGGGEEEETTTTEEEECCCCC------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS
T ss_pred CCChhHEEEeCCCCEEEEcccccccccccccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc
Confidence 99999999988876 799999999865432 37889999999999999999999999999999999999999754222
Q ss_pred CccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 042634 335 NLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAAQL 414 (427)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L 414 (427)
.............. .....++..+.+++.+||+.||++|||++|+++.|
T Consensus 210 ~~~~~~~~~~~~~~-------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 258 (307)
T 2eva_A 210 AFRIMWAVHNGTRP-------------------------------PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIM 258 (307)
T ss_dssp HHHHHHHHHTTCCC-------------------------------CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHhcCCCC-------------------------------CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 11111111100000 01122455688999999999999999999999999
Q ss_pred HHHHHHH
Q 042634 415 LSFRNKL 421 (427)
Q Consensus 415 ~~~~~~~ 421 (427)
+.+.+.+
T Consensus 259 ~~~~~~~ 265 (307)
T 2eva_A 259 THLMRYF 265 (307)
T ss_dssp HHHGGGC
T ss_pred HHHHHhc
Confidence 9987654
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=285.20 Aligned_cols=198 Identities=22% Similarity=0.363 Sum_probs=152.5
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+. ....++||||+++|+|.+++.... ..+++..+..++.|++.||+||| +.||+||
T Consensus 73 l~h~~iv~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~ 140 (281)
T 1mp8_A 73 FDHPHIVKLIGVIT------ENPVWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLE---SKRFVHR 140 (281)
T ss_dssp CCCTTBCCEEEEEC------SSSCEEEEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred CCCCccceEEEEEc------cCccEEEEecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeecc
Confidence 46999999998752 246789999999999999986543 35899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC-------CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCCc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT-------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~-------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~~ 330 (427)
||||+||+++.++.+||+|||+++...... .+++.|+|||++.+..++.++|||||||++|||++ |..||.+
T Consensus 141 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~ 220 (281)
T 1mp8_A 141 DIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 220 (281)
T ss_dssp CCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cccHHHEEECCCCCEEECccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCc
Confidence 999999999999999999999998764322 45678999999988899999999999999999996 9999976
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
.... .....+...... ..+..++.++.+++.+||+.||++|||++|+
T Consensus 221 ~~~~--~~~~~i~~~~~~-------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 267 (281)
T 1mp8_A 221 VKNN--DVIGRIENGERL-------------------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 267 (281)
T ss_dssp CCGG--GHHHHHHTTCCC-------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCHH--HHHHHHHcCCCC-------------------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 4221 111111110000 0122345678999999999999999999999
Q ss_pred HHHHHHHHHHH
Q 042634 411 AAQLLSFRNKL 421 (427)
Q Consensus 411 ~~~L~~~~~~~ 421 (427)
++.|+++.++-
T Consensus 268 ~~~l~~~~~~~ 278 (281)
T 1mp8_A 268 KAQLSTILEEE 278 (281)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHh
Confidence 99999997764
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=287.95 Aligned_cols=197 Identities=24% Similarity=0.379 Sum_probs=159.2
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++++. +...++||||+++|+|.+++.... ..+++..++.++.|++.||+||| +.||+||
T Consensus 72 l~h~~iv~~~~~~~------~~~~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~ 139 (325)
T 3kex_A 72 LDHAHIVRLLGLCP------GSSLQLVTQYLPLGSLLDHVRQHR---GALGPQLLLNWGVQIAKGMYYLE---EHGMVHR 139 (325)
T ss_dssp CCCTTBCCEEEEEC------BSSEEEEEECCTTCBSHHHHHSSG---GGSCTTHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred CCCCCcCeEEEEEc------CCccEEEEEeCCCCCHHHHHHHcc---ccCCHHHHHHHHHHHHHHHHHHH---hCCCCCC
Confidence 47999999999753 245789999999999999987653 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC--------CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT--------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTN 329 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~--------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~ 329 (427)
||||+|||++.++.+||+|||+|+...... .++..|+|||++.+..++.++|||||||++|||++ |+.||.
T Consensus 140 Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 219 (325)
T 3kex_A 140 NLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYA 219 (325)
T ss_dssp CCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCcc
Confidence 999999999999999999999998764322 56678999999998999999999999999999999 999997
Q ss_pred cccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 042634 330 EMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEE 409 (427)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~e 409 (427)
+... ......+....... .+..++.++.+++.+||+.||++|||++|
T Consensus 220 ~~~~--~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~e 266 (325)
T 3kex_A 220 GLRL--AEVPDLLEKGERLA-------------------------------QPQICTIDVYMVMVKCWMIDENIRPTFKE 266 (325)
T ss_dssp TSCT--THHHHHHHTTCBCC-------------------------------CCTTBCTTTTHHHHHHTCSCTTTSCCHHH
T ss_pred ccCH--HHHHHHHHcCCCCC-------------------------------CCCcCcHHHHHHHHHHcCCChhhCcCHHH
Confidence 6421 11222211111000 11113345788999999999999999999
Q ss_pred HHHHHHHHHHH
Q 042634 410 VAAQLLSFRNK 420 (427)
Q Consensus 410 v~~~L~~~~~~ 420 (427)
+++.|+++...
T Consensus 267 l~~~l~~~~~~ 277 (325)
T 3kex_A 267 LANEFTRMARD 277 (325)
T ss_dssp HHHHHHHHTTS
T ss_pred HHHHHHHHHhc
Confidence 99999998654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=284.08 Aligned_cols=198 Identities=26% Similarity=0.441 Sum_probs=159.3
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+++++|.+++.... ..+++..+..++.|++.||+||| +.||+||
T Consensus 60 l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~ 128 (268)
T 3sxs_A 60 LSHPKLVKFYGVCSK-----EYPIYIVTEYISNGCLLNYLRSHG---KGLEPSQLLEMCYDVCEGMAFLE---SHQFIHR 128 (268)
T ss_dssp CCCTTBCCEEEEECS-----SSSEEEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHH---HTTEEES
T ss_pred CCCCCEeeEEEEEcc-----CCceEEEEEccCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecC
Confidence 469999999998543 567899999999999999986543 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC-------CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCCc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT-------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~-------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~~ 330 (427)
||||+||+++.++.+||+|||.++...... .++..|+|||.+.+..++.++||||+||++|||++ |+.||..
T Consensus 129 dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 208 (268)
T 3sxs_A 129 DLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDL 208 (268)
T ss_dssp SCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CcCcceEEECCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccc
Confidence 999999999999999999999998654432 45667999999998899999999999999999999 9999975
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
.... .......... . ...+..++.++.+++.+||+.||++|||++|+
T Consensus 209 ~~~~-----~~~~~~~~~~-----~-----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 255 (268)
T 3sxs_A 209 YTNS-----EVVLKVSQGH-----R-----------------------LYRPHLASDTIYQIMYSCWHELPEKRPTFQQL 255 (268)
T ss_dssp SCHH-----HHHHHHHTTC-----C-----------------------CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHH
T ss_pred cChH-----HHHHHHHcCC-----C-----------------------CCCCCcChHHHHHHHHHHcCCChhhCcCHHHH
Confidence 3211 1111100000 0 00111234568899999999999999999999
Q ss_pred HHHHHHHHHH
Q 042634 411 AAQLLSFRNK 420 (427)
Q Consensus 411 ~~~L~~~~~~ 420 (427)
++.|+.++++
T Consensus 256 l~~L~~l~~~ 265 (268)
T 3sxs_A 256 LSSIEPLREK 265 (268)
T ss_dssp HHHHGGGCC-
T ss_pred HHHHHHhhhc
Confidence 9999998655
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-37 Score=288.29 Aligned_cols=201 Identities=24% Similarity=0.398 Sum_probs=161.7
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchh--------------------hhhccCHHHHHHHHH
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNRE--------------------ALKNLNLLQRLSIAV 238 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------------------~~~~l~~~~~~~~~~ 238 (427)
++||||+++++.+.. ....++||||+++|+|.+++..... ....+++.+++.++.
T Consensus 83 l~hp~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 157 (314)
T 2ivs_A 83 VNHPHVIKLYGACSQ-----DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAW 157 (314)
T ss_dssp CCCTTBCCEEEEECS-----SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHH
T ss_pred CCCCceeeEEEEEec-----CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHH
Confidence 479999999998543 5678999999999999999875432 113489999999999
Q ss_pred HHHHHHHHHhhcCCCCeeeccccCCceeeCCCCceEecccccccccCCc--------CCCccccccccccCCCCcCcccc
Q 042634 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA--------TNNFFNFQIAEYGMGSEVSTSGD 310 (427)
Q Consensus 239 ~i~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~D 310 (427)
|++.||+||| +.||+||||||+||+++.++.+||+|||+++..... ..++..|+|||.+.+..++.++|
T Consensus 158 qi~~~l~~lH---~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 234 (314)
T 2ivs_A 158 QISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSD 234 (314)
T ss_dssp HHHHHHHHHH---HTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHH
T ss_pred HHHHHHHHHH---HCCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhh
Confidence 9999999999 899999999999999999999999999999865332 25667899999999888999999
Q ss_pred chhHHHHHHHHHh-CCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHH
Q 042634 311 VYSFGILLLETFT-GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSV 389 (427)
Q Consensus 311 iwS~G~vl~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (427)
||||||++|||++ |..||.+... ..+...+...... ..+..++.++
T Consensus 235 i~slG~il~el~t~g~~p~~~~~~--~~~~~~~~~~~~~-------------------------------~~~~~~~~~~ 281 (314)
T 2ivs_A 235 VWSFGVLLWEIVTLGGNPYPGIPP--ERLFNLLKTGHRM-------------------------------ERPDNCSEEM 281 (314)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCG--GGHHHHHHTTCCC-------------------------------CCCTTCCHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHhhcCCcC-------------------------------CCCccCCHHH
Confidence 9999999999999 9999975421 1121111111000 0112345678
Q ss_pred HHHHhhcCCCCCCCCCCHHHHHHHHHHHHHH
Q 042634 390 LGIGVTCSSELPRERMNMEEVAAQLLSFRNK 420 (427)
Q Consensus 390 ~~l~~~cl~~dP~~Rpt~~ev~~~L~~~~~~ 420 (427)
.+++.+||+.||++|||++|+++.|+++..+
T Consensus 282 ~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 282 YRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 9999999999999999999999999998654
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=304.45 Aligned_cols=197 Identities=24% Similarity=0.426 Sum_probs=160.7
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++++. ....++||||+++|+|.+++..... ..+++..++.++.||+.||+||| ++||+||
T Consensus 240 l~h~~iv~l~~~~~------~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHr 308 (454)
T 1qcf_A 240 LQHDKLVKLHAVVT------KEPIYIITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIE---QRNYIHR 308 (454)
T ss_dssp CCCTTBCCEEEEEC------SSSCEEEECCCTTCBHHHHHHSHHH--HTCCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred CCCCCEeeEEEEEe------CCccEEEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH---hCCccCC
Confidence 57999999998853 3467999999999999999976533 45889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc-------CCCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCCc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA-------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~~ 330 (427)
||||+|||++.++.+||+|||+|+..... ..++..|+|||++....++.++|||||||++|||++ |+.||.+
T Consensus 309 Dlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~ 388 (454)
T 1qcf_A 309 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG 388 (454)
T ss_dssp SCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999999876432 255678999999988899999999999999999999 9999975
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
... ......+..... ...+..++.++.++|.+||+.||++|||+++|
T Consensus 389 ~~~--~~~~~~i~~~~~-------------------------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i 435 (454)
T 1qcf_A 389 MSN--PEVIRALERGYR-------------------------------MPRPENCPEELYNIMMRCWKNRPEERPTFEYI 435 (454)
T ss_dssp CCH--HHHHHHHHHTCC-------------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCH--HHHHHHHHcCCC-------------------------------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 421 111111111100 00123456779999999999999999999999
Q ss_pred HHHHHHHHH
Q 042634 411 AAQLLSFRN 419 (427)
Q Consensus 411 ~~~L~~~~~ 419 (427)
++.|+.+..
T Consensus 436 ~~~L~~~~~ 444 (454)
T 1qcf_A 436 QSVLDDFYT 444 (454)
T ss_dssp HHHHHTSSS
T ss_pred HHHHHHHHh
Confidence 999998753
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-37 Score=288.98 Aligned_cols=192 Identities=21% Similarity=0.315 Sum_probs=154.8
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. +...++||||+++|+|.+++... ..+++..++.++.|++.||+||| +.||+||
T Consensus 62 l~hpnIv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~givH~ 129 (323)
T 3tki_A 62 LNHENVVKFYGHRRE-----GNIQYLFLEYCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLH---GIGITHR 129 (323)
T ss_dssp CCCTTBCCEEEEEEC-----SSEEEEEEECCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHH---HTTEECS
T ss_pred CCCCCCCeEEEEEec-----CCeEEEEEEcCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccc
Confidence 579999999998543 56789999999999999999765 45999999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC--------cCCCccccccccccCCCCc-CccccchhHHHHHHHHHhCCCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE--------ATNNFFNFQIAEYGMGSEV-STSGDVYSFGILLLETFTGKRPTN 329 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~--------~~~~~~~y~aPE~~~~~~~-~~~~DiwS~G~vl~ell~g~~pf~ 329 (427)
||||+||+++.++.+||+|||+++.... ...||..|+|||++.+..+ +.++||||+||++|||++|+.||.
T Consensus 130 Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 209 (323)
T 3tki_A 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209 (323)
T ss_dssp CCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCS
T ss_pred ccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999986532 2378999999999988775 789999999999999999999997
Q ss_pred cccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 042634 330 EMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEE 409 (427)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~e 409 (427)
........+..+...... .. .....+.++.+++.+||+.||++|||++|
T Consensus 210 ~~~~~~~~~~~~~~~~~~------~~-------------------------~~~~~~~~~~~li~~~L~~dP~~R~t~~e 258 (323)
T 3tki_A 210 QPSDSCQEYSDWKEKKTY------LN-------------------------PWKKIDSAPLALLHKILVENPSARITIPD 258 (323)
T ss_dssp SSCTTSHHHHHHHTTCTT------ST-------------------------TGGGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CCchHHHHHHHHhccccc------CC-------------------------ccccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 643322222111111000 00 11223456789999999999999999999
Q ss_pred HHHH
Q 042634 410 VAAQ 413 (427)
Q Consensus 410 v~~~ 413 (427)
+++.
T Consensus 259 il~h 262 (323)
T 3tki_A 259 IKKD 262 (323)
T ss_dssp HTTC
T ss_pred HhhC
Confidence 9763
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-37 Score=295.53 Aligned_cols=200 Identities=24% Similarity=0.398 Sum_probs=161.6
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchh------------hhhccCHHHHHHHHHHHHHHHHHH
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNRE------------ALKNLNLLQRLSIAVDVASALDYL 247 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~~~~~i~~~L~~L 247 (427)
+||||+++++.+.. ....++||||+++|+|.+++..... ....+++..++.++.|++.||+||
T Consensus 133 ~hpnIv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 207 (382)
T 3tt0_A 133 KHKNIINLLGACTQ-----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL 207 (382)
T ss_dssp CCTTBCCEEEEECS-----SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred CCchhhhheeeecc-----CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHH
Confidence 79999999998644 5678999999999999999865421 113489999999999999999999
Q ss_pred hhcCCCCeeeccccCCceeeCCCCceEecccccccccCCc--------CCCccccccccccCCCCcCccccchhHHHHHH
Q 042634 248 HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA--------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLL 319 (427)
Q Consensus 248 H~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ 319 (427)
| +.||+||||||+|||++.++.+||+|||+|+..... ..++..|+|||++.+..++.++|||||||++|
T Consensus 208 H---~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ 284 (382)
T 3tt0_A 208 A---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLW 284 (382)
T ss_dssp H---HTTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHH
T ss_pred H---hCCEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHH
Confidence 9 899999999999999999999999999999865432 25677899999999999999999999999999
Q ss_pred HHHh-CCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCC
Q 042634 320 ETFT-GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSS 398 (427)
Q Consensus 320 ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~ 398 (427)
||++ |..||.... ...+.+.+...... ..+..++.++.+++.+||+
T Consensus 285 ellt~g~~p~~~~~--~~~~~~~~~~~~~~-------------------------------~~~~~~~~~l~~li~~~l~ 331 (382)
T 3tt0_A 285 EIFTLGGSPYPGVP--VEELFKLLKEGHRM-------------------------------DKPSNCTNELYMMMRDCWH 331 (382)
T ss_dssp HHHTTSCCSSTTCC--HHHHHHHHHTTCCC-------------------------------CCCSSCCHHHHHHHHHHTC
T ss_pred HHHhCCCCCCCCCC--HHHHHHHHHcCCCC-------------------------------CCCccCCHHHHHHHHHHcC
Confidence 9999 999997531 11111111111000 0112245678999999999
Q ss_pred CCCCCCCCHHHHHHHHHHHHHH
Q 042634 399 ELPRERMNMEEVAAQLLSFRNK 420 (427)
Q Consensus 399 ~dP~~Rpt~~ev~~~L~~~~~~ 420 (427)
.||++|||++||++.|+++...
T Consensus 332 ~dP~~Rps~~ell~~L~~~~~~ 353 (382)
T 3tt0_A 332 AVPSQRPTFKQLVEDLDRIVAL 353 (382)
T ss_dssp SSGGGSCCHHHHHHHHHHHHHH
T ss_pred CChhhCcCHHHHHHHHHHHHHH
Confidence 9999999999999999999764
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=293.47 Aligned_cols=204 Identities=23% Similarity=0.340 Sum_probs=159.8
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhh-------------------hhccCHHHHHHHHHHH
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREA-------------------LKNLNLLQRLSIAVDV 240 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-------------------~~~l~~~~~~~~~~~i 240 (427)
+||||+++++.+.. ....++||||+++|+|.+++...... ...+++..++.++.|+
T Consensus 107 ~hp~iv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 181 (344)
T 1rjb_A 107 SHENIVNLLGACTL-----SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQV 181 (344)
T ss_dssp CCTTBCCEEEEECS-----SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHH
T ss_pred CCCCeeeEEEEEee-----CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHH
Confidence 79999999998644 56789999999999999998754321 1347899999999999
Q ss_pred HHHHHHHhhcCCCCeeeccccCCceeeCCCCceEecccccccccCCcC--------CCccccccccccCCCCcCccccch
Q 042634 241 ASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEAT--------NNFFNFQIAEYGMGSEVSTSGDVY 312 (427)
Q Consensus 241 ~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~--------~~~~~y~aPE~~~~~~~~~~~Diw 312 (427)
+.||+||| +.||+||||||+||+++.++.+||+|||+++...... .+|..|+|||++.+..++.++|||
T Consensus 182 ~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~ 258 (344)
T 1rjb_A 182 AKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVW 258 (344)
T ss_dssp HHHHHHHH---HTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHH
T ss_pred HHHHHHHH---hCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHH
Confidence 99999999 8999999999999999999999999999998654322 456789999999888999999999
Q ss_pred hHHHHHHHHHh-CCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHH
Q 042634 313 SFGILLLETFT-GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLG 391 (427)
Q Consensus 313 S~G~vl~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (427)
||||++|||++ |..||.+.... ..+...+....... .+..++.++.+
T Consensus 259 slG~il~el~t~g~~p~~~~~~~-~~~~~~~~~~~~~~-------------------------------~~~~~~~~l~~ 306 (344)
T 1rjb_A 259 SYGILLWEIFSLGVNPYPGIPVD-ANFYKLIQNGFKMD-------------------------------QPFYATEEIYI 306 (344)
T ss_dssp HHHHHHHHHTTTSCCSSTTCCCS-HHHHHHHHTTCCCC-------------------------------CCTTCCHHHHH
T ss_pred HHHHHHHHHHcCCCCCcccCCcH-HHHHHHHhcCCCCC-------------------------------CCCCCCHHHHH
Confidence 99999999998 99999764221 11212211111000 11223567899
Q ss_pred HHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHh
Q 042634 392 IGVTCSSELPRERMNMEEVAAQLLSFRNKLVK 423 (427)
Q Consensus 392 l~~~cl~~dP~~Rpt~~ev~~~L~~~~~~~~~ 423 (427)
++.+||+.||++|||++|+++.|+.+......
T Consensus 307 li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 338 (344)
T 1rjb_A 307 IMQSCWAFDSRKRPSFPNLTSFLGCQLADAEE 338 (344)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHC-----
T ss_pred HHHHHcCCCchhCcCHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999998765543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-36 Score=282.94 Aligned_cols=223 Identities=18% Similarity=0.229 Sum_probs=164.8
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+... .....++||||+++++|.+++...... ..+++..++.++.|++.||+||| +.||+||
T Consensus 64 l~h~~iv~~~~~~~~~---~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~ 136 (319)
T 4euu_A 64 LNHKNIVKLFAIEEET---TTRHKVLIMEFCPCGSLYTVLEEPSNA-YGLPESEFLIVLRDVVGGMNHLR---ENGIVHR 136 (319)
T ss_dssp CCCTTBCCEEEEEECT---TTCCEEEEEECCTTCBHHHHHHSGGGT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECS
T ss_pred cCCCCcceEEEEeecC---CCceEEEEEeCCCCCCHHHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHH---HCCEecC
Confidence 4699999999875431 234679999999999999999765321 33899999999999999999999 8999999
Q ss_pred cccCCceee----CCCCceEecccccccccCCcC-----CCccccccccccC--------CCCcCccccchhHHHHHHHH
Q 042634 259 DLKPSNVLL----DGELTAHVGDFGLAKFLPEAT-----NNFFNFQIAEYGM--------GSEVSTSGDVYSFGILLLET 321 (427)
Q Consensus 259 Dlkp~NIll----~~~~~~kL~DFG~a~~~~~~~-----~~~~~y~aPE~~~--------~~~~~~~~DiwS~G~vl~el 321 (427)
||||+||++ +.++.+||+|||+|+...... .||..|+|||++. +..++.++|||||||++|||
T Consensus 137 Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el 216 (319)
T 4euu_A 137 NIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHA 216 (319)
T ss_dssp CCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHH
T ss_pred CCCHHHEEEeccCCCCceEEEccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHH
Confidence 999999999 788899999999998764432 6889999999986 57789999999999999999
Q ss_pred HhCCCCCCcccCCCccHHHHHHHh---ccc-chhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcC
Q 042634 322 FTGKRPTNEMFTGNLTLHNFVKEA---LPE-RLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCS 397 (427)
Q Consensus 322 l~g~~pf~~~~~~~~~~~~~~~~~---~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl 397 (427)
++|+.||......... ...+... .+. .+........ ... .+... ...........+..+.+++.+||
T Consensus 217 ~~g~~pf~~~~~~~~~-~~~~~~~~~~~p~~~~~~~~~~~~------~~~-~~~~~-~~~~~~~~~~~~~~l~~ll~~~L 287 (319)
T 4euu_A 217 ATGSLPFRPFEGPRRN-KEVMYKIITGKPSGAISGVQKAEN------GPI-DWSGD-MPVSCSLSRGLQVLLTPVLANIL 287 (319)
T ss_dssp HHSSCSEECTTCGGGC-HHHHHHHHHHCCTTCCEEEECSTT------CCE-EEESS-CCTTCSSCHHHHHHHHHHHHHHS
T ss_pred HhCCCCCCCCCccchh-HHHHHHHhcCCCcccchhhhcccC------Ccc-ccCcc-CCcccccchhHHHHhHHHHHHhc
Confidence 9999999754322221 1222211 111 1111111000 000 00000 00112234677889999999999
Q ss_pred CCCCCCCCCHHHHHHHHHHH
Q 042634 398 SELPRERMNMEEVAAQLLSF 417 (427)
Q Consensus 398 ~~dP~~Rpt~~ev~~~L~~~ 417 (427)
+.||++|||++|+++...+-
T Consensus 288 ~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 288 EADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp CCCTTTSCCHHHHHHHHHHH
T ss_pred cCChhhhccHHHhhhccHHH
Confidence 99999999999999998764
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=293.11 Aligned_cols=208 Identities=20% Similarity=0.233 Sum_probs=161.6
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+... +.+....++||||+ +++|.+++.... .+++..++.++.||+.||+||| +.||+||
T Consensus 105 l~h~ni~~~~~~~~~~-~~~~~~~~lv~e~~-~~~L~~~l~~~~----~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~ 175 (345)
T 2v62_A 105 LDYLGIPLFYGSGLTE-FKGRSYRFMVMERL-GIDLQKISGQNG----TFKKSTVLQLGIRMLDVLEYIH---ENEYVHG 175 (345)
T ss_dssp CSCCCCCCEEEEEEEE-SSSCEEEEEEEECE-EEEHHHHCBGGG----BCCHHHHHHHHHHHHHHHHHHH---HTTEECS
T ss_pred ccccCcceeecccccc-cCCCcEEEEEEecc-CCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH---hCCeeCC
Confidence 5799999999986542 23456789999999 999999997653 5999999999999999999999 8899999
Q ss_pred cccCCceeeCCCC--ceEecccccccccCC-------------cCCCccccccccccCCCCcCccccchhHHHHHHHHHh
Q 042634 259 DLKPSNVLLDGEL--TAHVGDFGLAKFLPE-------------ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT 323 (427)
Q Consensus 259 Dlkp~NIll~~~~--~~kL~DFG~a~~~~~-------------~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~ 323 (427)
||||+||+++.++ .+||+|||+|+.... ...||..|+|||++.+..++.++|||||||++|||++
T Consensus 176 Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~ 255 (345)
T 2v62_A 176 DIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLC 255 (345)
T ss_dssp CCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHH
T ss_pred CcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHh
Confidence 9999999998877 999999999976532 2268899999999999999999999999999999999
Q ss_pred CCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCC
Q 042634 324 GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRE 403 (427)
Q Consensus 324 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~ 403 (427)
|+.||................ ........+.... ....++.++.+++.+||+.||++
T Consensus 256 g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~----------------------~~~~~~~~l~~li~~~l~~dp~~ 312 (345)
T 2v62_A 256 GKLPWEQNLKDPVAVQTAKTN-LLDELPQSVLKWA----------------------PSGSSCCEIAQFLVCAHSLAYDE 312 (345)
T ss_dssp SSCTTGGGTTCHHHHHHHHHH-HHHTTTHHHHHHS----------------------CTTSCCHHHHHHHHHHHTCCTTC
T ss_pred CCCCccccccccHHHHHHHHh-hcccccHHHHhhc----------------------cccccHHHHHHHHHHHhhcCccc
Confidence 999996532222212111111 1111100000000 01134567999999999999999
Q ss_pred CCCHHHHHHHHHHHH
Q 042634 404 RMNMEEVAAQLLSFR 418 (427)
Q Consensus 404 Rpt~~ev~~~L~~~~ 418 (427)
|||++||++.|+++.
T Consensus 313 Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 313 KPNYQALKKILNPHG 327 (345)
T ss_dssp CCCHHHHHHHHCTTC
T ss_pred CCCHHHHHHHHhccC
Confidence 999999999998753
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=283.03 Aligned_cols=198 Identities=24% Similarity=0.436 Sum_probs=160.9
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+++++|.+++.... ..+++..++.++.|++.||+||| ++||+||
T Consensus 76 l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~ 144 (283)
T 3gen_A 76 LSHEKLVQLYGVCTK-----QRPIFIITEYMANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLE---SKQFLHR 144 (283)
T ss_dssp CCCTTBCCEEEEECS-----SSSEEEEECCCTTCBHHHHHHCGG---GCCCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred CCCCCEeeEEEEEec-----CCCeEEEEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHH---HCCccCC
Confidence 469999999998543 567899999999999999997643 45999999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc-------CCCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCCc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA-------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~~ 330 (427)
||||+||+++.++.+||+|||.++..... ..++..|+|||++.+..++.++||||+||++|||++ |+.||..
T Consensus 145 dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~ 224 (283)
T 3gen_A 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER 224 (283)
T ss_dssp SCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CCccceEEEcCCCCEEEccccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 99999999999999999999999865432 256778999999998899999999999999999998 9999975
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
... ......+...... ..+..++..+.+++.+||+.||++|||++|+
T Consensus 225 ~~~--~~~~~~~~~~~~~-------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 271 (283)
T 3gen_A 225 FTN--SETAEHIAQGLRL-------------------------------YRPHLASEKVYTIMYSCWHEKADERPTFKIL 271 (283)
T ss_dssp SCH--HHHHHHHHTTCCC-------------------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHH
T ss_pred cCh--hHHHHHHhcccCC-------------------------------CCCCcCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 321 1111111110000 0111234568899999999999999999999
Q ss_pred HHHHHHHHHH
Q 042634 411 AAQLLSFRNK 420 (427)
Q Consensus 411 ~~~L~~~~~~ 420 (427)
++.|+++.++
T Consensus 272 l~~L~~~~~~ 281 (283)
T 3gen_A 272 LSNILDVMDE 281 (283)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHhhc
Confidence 9999998764
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=284.59 Aligned_cols=200 Identities=23% Similarity=0.396 Sum_probs=159.6
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. .+...++||||+++|+|.+++.... ..+++..+..++.|++.||+||| ++||+||
T Consensus 83 l~h~~iv~~~~~~~~----~~~~~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~ 152 (298)
T 3f66_A 83 FSHPNVLSLLGICLR----SEGSPLVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKYLA---SKKFVHR 152 (298)
T ss_dssp CCCTTBCCCCEEECC----SSSCCEEEEECCTTCBHHHHHHCTT---CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred CCCCCEeeeeeEEEc----CCCceEEEEeCCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH---hCCccCC
Confidence 469999999997533 2456789999999999999996543 45889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc----------CCCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA----------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRP 327 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~----------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~p 327 (427)
||||+||+++.++.+||+|||.|+..... ..+|..|+|||.+.+..++.++||||+||++|||++ |.+|
T Consensus 153 dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~ 232 (298)
T 3f66_A 153 DLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232 (298)
T ss_dssp CCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred CCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999999865332 256678999999999999999999999999999999 5566
Q ss_pred CCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCH
Q 042634 328 TNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM 407 (427)
Q Consensus 328 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~ 407 (427)
|...... ........... ...+..++.++.+++.+||+.||++|||+
T Consensus 233 ~~~~~~~--~~~~~~~~~~~-------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 279 (298)
T 3f66_A 233 YPDVNTF--DITVYLLQGRR-------------------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSF 279 (298)
T ss_dssp STTSCTT--THHHHHHTTCC-------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CccCCHH--HHHHHHhcCCC-------------------------------CCCCccCCHHHHHHHHHHcCCChhhCcCH
Confidence 6543211 11111111000 00112234568999999999999999999
Q ss_pred HHHHHHHHHHHHHH
Q 042634 408 EEVAAQLLSFRNKL 421 (427)
Q Consensus 408 ~ev~~~L~~~~~~~ 421 (427)
+|+++.|+++...+
T Consensus 280 ~ell~~L~~~~~~~ 293 (298)
T 3f66_A 280 SELVSRISAIFSTF 293 (298)
T ss_dssp HHHHHHHHHHHHTS
T ss_pred HHHHHHHHHHHHhh
Confidence 99999999998764
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=285.77 Aligned_cols=208 Identities=24% Similarity=0.383 Sum_probs=157.9
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccch--hhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCee
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNR--EALKNLNLLQRLSIAVDVASALDYLHHYCETPIV 256 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~iv 256 (427)
++||||+++++.+......+....++||||+++|+|.+++.... .....+++..++.++.|++.||.||| +.||+
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~iv 169 (313)
T 3brb_A 93 FSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFL 169 (313)
T ss_dssp CCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCC
T ss_pred CCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcc
Confidence 46999999999876543333345699999999999999884321 11245899999999999999999999 89999
Q ss_pred eccccCCceeeCCCCceEecccccccccCCc--------CCCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCC
Q 042634 257 HCDLKPSNVLLDGELTAHVGDFGLAKFLPEA--------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRP 327 (427)
Q Consensus 257 HrDlkp~NIll~~~~~~kL~DFG~a~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~p 327 (427)
||||||+||+++.++.+||+|||+++..... ..++..|+|||.+.+..++.++|||||||++|||++ |..|
T Consensus 170 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p 249 (313)
T 3brb_A 170 HRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249 (313)
T ss_dssp CCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred cCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCC
Confidence 9999999999999999999999999865432 256778999999999999999999999999999999 8899
Q ss_pred CCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCH
Q 042634 328 TNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM 407 (427)
Q Consensus 328 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~ 407 (427)
|..... ............. ..+..++.++.+++.+||+.||++|||+
T Consensus 250 ~~~~~~--~~~~~~~~~~~~~-------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~ 296 (313)
T 3brb_A 250 YPGVQN--HEMYDYLLHGHRL-------------------------------KQPEDCLDELYEIMYSCWRTDPLDRPTF 296 (313)
T ss_dssp STTCCG--GGHHHHHHTTCCC-------------------------------CCBTTCCHHHHHHHHHTTCSSGGGSCCH
T ss_pred CccCCH--HHHHHHHHcCCCC-------------------------------CCCccccHHHHHHHHHHcCCChhhCcCH
Confidence 875321 1111111111000 0112345678999999999999999999
Q ss_pred HHHHHHHHHHHHHHH
Q 042634 408 EEVAAQLLSFRNKLV 422 (427)
Q Consensus 408 ~ev~~~L~~~~~~~~ 422 (427)
+|+++.|+++.++++
T Consensus 297 ~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 297 SVLRLQLEKLLESLP 311 (313)
T ss_dssp HHHHHHHHHHHHHC-
T ss_pred HHHHHHHHHHHHhcC
Confidence 999999999988764
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=285.76 Aligned_cols=200 Identities=26% Similarity=0.408 Sum_probs=151.8
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+. ....++||||+++++|.+++.... ..+++..++.++.|++.||+||| +.||+||
T Consensus 77 l~h~~iv~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~ 144 (289)
T 3og7_A 77 TRHVNILLFMGYST------APQLAIVTQWCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLH---AKSIIHR 144 (289)
T ss_dssp CCCTTBCCEEEEEC------SSSCEEEEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred CCCCcEEEEEeecc------CCccEEEEEecCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccc
Confidence 46999999988532 346799999999999999986554 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC--------cCCCccccccccccC---CCCcCccccchhHHHHHHHHHhCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE--------ATNNFFNFQIAEYGM---GSEVSTSGDVYSFGILLLETFTGKRP 327 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~--------~~~~~~~y~aPE~~~---~~~~~~~~DiwS~G~vl~ell~g~~p 327 (427)
||||+||+++.++.+||+|||+++.... ...|+..|+|||++. +..++.++|||||||++|||++|+.|
T Consensus 145 Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p 224 (289)
T 3og7_A 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224 (289)
T ss_dssp CCCGGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCT
T ss_pred cCccceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCC
Confidence 9999999999999999999999976532 126889999999986 56788999999999999999999999
Q ss_pred CCcccCCCccHHHHHHHh-cccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCC
Q 042634 328 TNEMFTGNLTLHNFVKEA-LPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMN 406 (427)
Q Consensus 328 f~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt 406 (427)
|....... .+...+... ....... ....++.++.+++.+||+.||++|||
T Consensus 225 ~~~~~~~~-~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps 275 (289)
T 3og7_A 225 YSNINNRD-QIIEMVGRGSLSPDLSK----------------------------VRSNCPKRMKRLMAECLKKKRDERPS 275 (289)
T ss_dssp TSSCCCHH-HHHHHHHHTSCCCCTTS----------------------------SCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred ccccchHH-HHHHHhcccccCcchhh----------------------------ccccCCHHHHHHHHHHccCChhhCCC
Confidence 97642211 111111111 1111000 11234567899999999999999999
Q ss_pred HHHHHHHHHHHHH
Q 042634 407 MEEVAAQLLSFRN 419 (427)
Q Consensus 407 ~~ev~~~L~~~~~ 419 (427)
++|+++.|+++.+
T Consensus 276 ~~ell~~L~~l~~ 288 (289)
T 3og7_A 276 FPRILAEIEELAR 288 (289)
T ss_dssp HHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHhh
Confidence 9999999998753
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=288.64 Aligned_cols=205 Identities=23% Similarity=0.376 Sum_probs=163.9
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhh--------------hhccCHHHHHHHHHHHHHHHH
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREA--------------LKNLNLLQRLSIAVDVASALD 245 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~--------------~~~l~~~~~~~~~~~i~~~L~ 245 (427)
+||||+++++.+.. ....++||||+++|+|.+++...... ...+++..++.++.|++.||+
T Consensus 85 ~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~ 159 (313)
T 1t46_A 85 NHMNIVNLLGACTI-----GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMA 159 (313)
T ss_dssp CCTTBCCEEEEECS-----SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHH
T ss_pred cCCCeeeEEEEEec-----CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHH
Confidence 79999999998644 56789999999999999998654311 124899999999999999999
Q ss_pred HHhhcCCCCeeeccccCCceeeCCCCceEecccccccccCCcC--------CCccccccccccCCCCcCccccchhHHHH
Q 042634 246 YLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEAT--------NNFFNFQIAEYGMGSEVSTSGDVYSFGIL 317 (427)
Q Consensus 246 ~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~--------~~~~~y~aPE~~~~~~~~~~~DiwS~G~v 317 (427)
||| +.||+||||||+||+++.++.+||+|||+++...... .++..|+|||++.+..++.++|||||||+
T Consensus 160 ~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 236 (313)
T 1t46_A 160 FLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIF 236 (313)
T ss_dssp HHH---HTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred HHH---HCCeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHH
Confidence 999 8999999999999999999999999999998764432 45668999999998999999999999999
Q ss_pred HHHHHh-CCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhc
Q 042634 318 LLETFT-GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTC 396 (427)
Q Consensus 318 l~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c 396 (427)
+|||++ |+.||....... ............ ..+..++.++.+++.+|
T Consensus 237 l~ellt~g~~p~~~~~~~~-~~~~~~~~~~~~-------------------------------~~~~~~~~~l~~li~~~ 284 (313)
T 1t46_A 237 LWELFSLGSSPYPGMPVDS-KFYKMIKEGFRM-------------------------------LSPEHAPAEMYDIMKTC 284 (313)
T ss_dssp HHHHHTTTCCSSTTCCSSH-HHHHHHHHTCCC-------------------------------CCCTTSCHHHHHHHHHH
T ss_pred HHHHHhCCCCCCCcccchh-HHHHHhccCCCC-------------------------------CCcccCCHHHHHHHHHH
Confidence 999998 999997642211 111111111110 01122356689999999
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHhh
Q 042634 397 SSELPRERMNMEEVAAQLLSFRNKLVKN 424 (427)
Q Consensus 397 l~~dP~~Rpt~~ev~~~L~~~~~~~~~~ 424 (427)
|+.||++|||++|+++.|+++..+...+
T Consensus 285 l~~dp~~Rps~~ell~~L~~~~~~~~~~ 312 (313)
T 1t46_A 285 WDADPLKRPTFKQIVQLIEKQISESTNH 312 (313)
T ss_dssp TCSSGGGSCCHHHHHHHHHHHHHHTCC-
T ss_pred cCCCchhCcCHHHHHHHHHHHHHHhhcC
Confidence 9999999999999999999998775543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=281.59 Aligned_cols=196 Identities=24% Similarity=0.388 Sum_probs=155.3
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCC--ee
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETP--IV 256 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~--iv 256 (427)
++||||+++++.+.. ..++||||+++|+|.+++.... ..+++..++.++.|++.||+||| +.| |+
T Consensus 80 l~h~~i~~~~~~~~~-------~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH---~~~~~iv 146 (287)
T 4f0f_A 80 LNHPNIVKLYGLMHN-------PPRMVMEFVPCGDLYHRLLDKA---HPIKWSVKLRLMLDIALGIEYMQ---NQNPPIV 146 (287)
T ss_dssp CCCTTBCCEEEEETT-------TTEEEEECCTTCBHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHH---TSSSCCB
T ss_pred CCCCCchhhheeecC-------CCeEEEEecCCCCHHHHHhccc---CCccHHHHHHHHHHHHHHHHHHH---hCCCCee
Confidence 469999999998533 2379999999999988886543 45899999999999999999999 888 99
Q ss_pred eccccCCceeeCCCCc-----eEecccccccccCCc---CCCccccccccccC--CCCcCccccchhHHHHHHHHHhCCC
Q 042634 257 HCDLKPSNVLLDGELT-----AHVGDFGLAKFLPEA---TNNFFNFQIAEYGM--GSEVSTSGDVYSFGILLLETFTGKR 326 (427)
Q Consensus 257 HrDlkp~NIll~~~~~-----~kL~DFG~a~~~~~~---~~~~~~y~aPE~~~--~~~~~~~~DiwS~G~vl~ell~g~~ 326 (427)
||||||+||+++.++. +||+|||+++..... ..++..|+|||++. ...++.++||||+||++|||++|+.
T Consensus 147 H~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 226 (287)
T 4f0f_A 147 HRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG 226 (287)
T ss_dssp CSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSC
T ss_pred cCCCCcceEEEeccCCCCceeEEeCCCCccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCC
Confidence 9999999999987776 999999999865443 37889999999984 4567899999999999999999999
Q ss_pred CCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCC
Q 042634 327 PTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMN 406 (427)
Q Consensus 327 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt 406 (427)
||................... . ...+..++.++.+++.+||+.||++|||
T Consensus 227 pf~~~~~~~~~~~~~~~~~~~-------~-----------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps 276 (287)
T 4f0f_A 227 PFDEYSYGKIKFINMIREEGL-------R-----------------------PTIPEDCPPRLRNVIELCWSGDPKKRPH 276 (287)
T ss_dssp TTTTCCCCHHHHHHHHHHSCC-------C-----------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred CCccccccHHHHHHHHhccCC-------C-----------------------CCCCcccCHHHHHHHHHHhcCChhhCcC
Confidence 997643322211111111000 0 0012234567899999999999999999
Q ss_pred HHHHHHHHHHH
Q 042634 407 MEEVAAQLLSF 417 (427)
Q Consensus 407 ~~ev~~~L~~~ 417 (427)
++|+++.|+++
T Consensus 277 ~~~ll~~L~~l 287 (287)
T 4f0f_A 277 FSYIVKELSEL 287 (287)
T ss_dssp HHHHHHHHHTC
T ss_pred HHHHHHHHHhC
Confidence 99999999864
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=296.89 Aligned_cols=189 Identities=22% Similarity=0.288 Sum_probs=149.4
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
.+||||+++++++.. ....++||||+++|+|..++... ..+++..++.++.||+.||+||| +.||+||
T Consensus 110 ~~hp~Iv~l~~~~~~-----~~~~~lV~E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH---~~givHr 177 (396)
T 4dc2_A 110 SNHPFLVGLHSCFQT-----ESRLFFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLH---ERGIIYR 177 (396)
T ss_dssp TTCTTBCCEEEEEEC-----SSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCC
T ss_pred CCCCCcCeeEEEEEE-----CCEEEEEEEcCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEec
Confidence 479999999998543 56789999999999999988654 45999999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC------cCCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE------ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+|||++.++.+||+|||+|+.... ...||+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus 178 DLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~ 257 (396)
T 4dc2_A 178 DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG 257 (396)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTT
T ss_pred cCCHHHEEECCCCCEEEeecceeeecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc
Confidence 9999999999999999999999986322 2278999999999999999999999999999999999999997532
Q ss_pred CCCcc---HHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCH
Q 042634 333 TGNLT---LHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM 407 (427)
Q Consensus 333 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~ 407 (427)
..... ....+..... ... ...+...+.++.+++.+||+.||++||++
T Consensus 258 ~~~~~~~~~~~~~~~~i~-------~~~---------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 258 SSDNPDQNTEDYLFQVIL-------EKQ---------------------IRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp C------CCHHHHHHHHH-------HCC---------------------CCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred cccccchhhHHHHHHHHh-------ccc---------------------cCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 11110 0010100000 000 00112235568899999999999999996
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=295.72 Aligned_cols=201 Identities=26% Similarity=0.389 Sum_probs=159.0
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchh---hhhccCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNRE---ALKNLNLLQRLSIAVDVASALDYLHHYCETPI 255 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~i 255 (427)
++||||+++++.+.. ....++||||+++|+|.+++..... ....+++.+++.++.|++.||+||| ++||
T Consensus 131 l~hpnIv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~i 202 (367)
T 3l9p_A 131 FNHQNIVRCIGVSLQ-----SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHF 202 (367)
T ss_dssp CCCTTBCCEEEEECS-----SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTC
T ss_pred CCCCCCCeEEEEEec-----CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence 479999999998543 5567999999999999999865321 1134889999999999999999999 8999
Q ss_pred eeccccCCceeeCCCC---ceEecccccccccCC--------cCCCccccccccccCCCCcCccccchhHHHHHHHHHh-
Q 042634 256 VHCDLKPSNVLLDGEL---TAHVGDFGLAKFLPE--------ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT- 323 (427)
Q Consensus 256 vHrDlkp~NIll~~~~---~~kL~DFG~a~~~~~--------~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~- 323 (427)
+||||||+|||++.++ .+||+|||+|+.... ...+|+.|+|||++.+..++.++|||||||++|||++
T Consensus 203 vHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~ 282 (367)
T 3l9p_A 203 IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL 282 (367)
T ss_dssp CCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred eCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhC
Confidence 9999999999998554 599999999975421 1256789999999999999999999999999999998
Q ss_pred CCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCC
Q 042634 324 GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRE 403 (427)
Q Consensus 324 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~ 403 (427)
|..||.... ...+...+..... ...+..++.++.+++.+||+.||++
T Consensus 283 g~~pf~~~~--~~~~~~~i~~~~~-------------------------------~~~~~~~~~~l~~li~~~l~~dP~~ 329 (367)
T 3l9p_A 283 GYMPYPSKS--NQEVLEFVTSGGR-------------------------------MDPPKNCPGPVYRIMTQCWQHQPED 329 (367)
T ss_dssp SCCSSTTCC--HHHHHHHHHTTCC-------------------------------CCCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred CCCCCCCCC--HHHHHHHHHcCCC-------------------------------CCCCccCCHHHHHHHHHHcCCCHhH
Confidence 999997531 1111111111000 0012234566899999999999999
Q ss_pred CCCHHHHHHHHHHHHHH
Q 042634 404 RMNMEEVAAQLLSFRNK 420 (427)
Q Consensus 404 Rpt~~ev~~~L~~~~~~ 420 (427)
|||++||++.|+.+.+.
T Consensus 330 Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 330 RPNFAIILERIEYCTQD 346 (367)
T ss_dssp SCCHHHHHHHHHHHHHC
T ss_pred CcCHHHHHHHHHHHhhC
Confidence 99999999999998754
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=287.81 Aligned_cols=194 Identities=22% Similarity=0.290 Sum_probs=155.9
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+++|+|.+++.... ..+++..+..++.|++.||+||| +.||+||
T Consensus 58 l~hpnIv~~~~~~~~-----~~~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH---~~givH~ 126 (321)
T 1tki_A 58 ARHRNILHLHESFES-----MEELVMIFEFISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLH---SHNIGHF 126 (321)
T ss_dssp SCCTTBCCEEEEEEE-----TTEEEEEECCCCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred CCCCCCCeEeEEEec-----CCEEEEEEEeCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcC
Confidence 579999999998644 567899999999999999987543 35899999999999999999999 8999999
Q ss_pred cccCCceeeCC--CCceEecccccccccCCcC-----CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 259 DLKPSNVLLDG--ELTAHVGDFGLAKFLPEAT-----NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 259 Dlkp~NIll~~--~~~~kL~DFG~a~~~~~~~-----~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
||||+||+++. ++.+||+|||+++...... .+|+.|+|||++.+..++.++||||+||++|||++|..||.+.
T Consensus 127 Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 206 (321)
T 1tki_A 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE 206 (321)
T ss_dssp CCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred CCCHHHEEEccCCCCCEEEEECCCCeECCCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCC
Confidence 99999999987 7899999999998775443 6889999999999988999999999999999999999999753
Q ss_pred cCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 042634 332 FTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVA 411 (427)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~ 411 (427)
.. ......+...... . ........+.++.+++.+||+.||++|||++|++
T Consensus 207 ~~--~~~~~~i~~~~~~-----------~-----------------~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l 256 (321)
T 1tki_A 207 TN--QQIIENIMNAEYT-----------F-----------------DEEAFKEISIEAMDFVDRLLVKERKSRMTASEAL 256 (321)
T ss_dssp SH--HHHHHHHHHTCCC-----------C-----------------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred CH--HHHHHHHHcCCCC-----------C-----------------ChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 11 1111111110000 0 0001122456789999999999999999999998
Q ss_pred HH
Q 042634 412 AQ 413 (427)
Q Consensus 412 ~~ 413 (427)
++
T Consensus 257 ~h 258 (321)
T 1tki_A 257 QH 258 (321)
T ss_dssp HS
T ss_pred cC
Confidence 74
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=282.41 Aligned_cols=201 Identities=21% Similarity=0.264 Sum_probs=158.6
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCC--ee
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETP--IV 256 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~--iv 256 (427)
++||||+++++.+... .....++||||+++|+|.+++..... ..+++..++.++.|++.||+||| +.| |+
T Consensus 64 l~h~~iv~~~~~~~~~---~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~ 135 (271)
T 3kmu_A 64 FSHPNVLPVLGACQSP---PAPHPTLITHWMPYGSLYNVLHEGTN--FVVDQSQAVKFALDMARGMAFLH---TLEPLIP 135 (271)
T ss_dssp CSCTTEECEEEEECTT---TSSSCEEEEECCTTCBHHHHHHSCSS--CCCCHHHHHHHHHHHHHHHHHHT---TSSSCCT
T ss_pred cCCCchhheEEEEccC---CCCCeEeeecccCCCcHHHHHhhccc--CCCCHHHHHHHHHHHHHHHHHHh---cCCCcee
Confidence 4699999999986442 13567999999999999999976532 35899999999999999999999 888 99
Q ss_pred eccccCCceeeCCCCceEecccccccccCC-cCCCccccccccccCCCCcCc---cccchhHHHHHHHHHhCCCCCCccc
Q 042634 257 HCDLKPSNVLLDGELTAHVGDFGLAKFLPE-ATNNFFNFQIAEYGMGSEVST---SGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 257 HrDlkp~NIll~~~~~~kL~DFG~a~~~~~-~~~~~~~y~aPE~~~~~~~~~---~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||||+||+++.++.+||+|||++..... ...+|+.|+|||++.+..++. ++|||||||++|||++|+.||....
T Consensus 136 H~dikp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 215 (271)
T 3kmu_A 136 RHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS 215 (271)
T ss_dssp TCCCSGGGEEECTTSCEEEEGGGSCCTTSCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC
T ss_pred cCCCccceEEEcCCcceeEEeccceeeecccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC
Confidence 999999999999999999999888765443 347899999999998765544 7999999999999999999997532
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
... ............ ..+..++.++.+++.+||+.||++|||++|+++
T Consensus 216 ~~~-~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 216 NME-IGMKVALEGLRP-------------------------------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp HHH-HHHHHHHSCCCC-------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hHH-HHHHHHhcCCCC-------------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 110 000000000000 012234566899999999999999999999999
Q ss_pred HHHHHHH
Q 042634 413 QLLSFRN 419 (427)
Q Consensus 413 ~L~~~~~ 419 (427)
.|+++.+
T Consensus 264 ~L~~l~~ 270 (271)
T 3kmu_A 264 ILEKMQD 270 (271)
T ss_dssp HHHHHCC
T ss_pred HHHHhhc
Confidence 9998864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=293.96 Aligned_cols=205 Identities=24% Similarity=0.408 Sum_probs=160.7
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchh--------------------hhhccCHHHHHHHHH
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNRE--------------------ALKNLNLLQRLSIAV 238 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------------------~~~~l~~~~~~~~~~ 238 (427)
++||||+++++.+.. +...++||||+++|+|.+++..... ....+++.+++.++.
T Consensus 107 l~hp~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~ 181 (343)
T 1luf_A 107 FDNPNIVKLLGVCAV-----GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIAR 181 (343)
T ss_dssp CCCTTBCCEEEEECS-----SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHH
T ss_pred CCCCCEEEEEEEEcc-----CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHH
Confidence 479999999998644 5678999999999999999865321 014589999999999
Q ss_pred HHHHHHHHHhhcCCCCeeeccccCCceeeCCCCceEecccccccccCC--------cCCCccccccccccCCCCcCcccc
Q 042634 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPE--------ATNNFFNFQIAEYGMGSEVSTSGD 310 (427)
Q Consensus 239 ~i~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~--------~~~~~~~y~aPE~~~~~~~~~~~D 310 (427)
||+.||+||| ++||+||||||+||+++.++.+||+|||+++.... ...++..|+|||++.+..++.++|
T Consensus 182 qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 258 (343)
T 1luf_A 182 QVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESD 258 (343)
T ss_dssp HHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHH
T ss_pred HHHHHHHHHH---hCCeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccc
Confidence 9999999999 89999999999999999999999999999976432 226778899999999889999999
Q ss_pred chhHHHHHHHHHh-CCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHH
Q 042634 311 VYSFGILLLETFT-GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSV 389 (427)
Q Consensus 311 iwS~G~vl~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (427)
||||||++|||++ |..||.+... .+........... ..+..++.++
T Consensus 259 i~slG~il~el~t~g~~p~~~~~~-----~~~~~~~~~~~~~----------------------------~~~~~~~~~l 305 (343)
T 1luf_A 259 VWAYGVVLWEIFSYGLQPYYGMAH-----EEVIYYVRDGNIL----------------------------ACPENCPLEL 305 (343)
T ss_dssp HHHHHHHHHHHHTTTCCTTTTSCH-----HHHHHHHHTTCCC----------------------------CCCTTCCHHH
T ss_pred cHHHHHHHHHHHhcCCCcCCCCCh-----HHHHHHHhCCCcC----------------------------CCCCCCCHHH
Confidence 9999999999999 9999975311 1111111000000 0122345678
Q ss_pred HHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHHHhh
Q 042634 390 LGIGVTCSSELPRERMNMEEVAAQLLSFRNKLVKN 424 (427)
Q Consensus 390 ~~l~~~cl~~dP~~Rpt~~ev~~~L~~~~~~~~~~ 424 (427)
.+++.+||+.||++|||++|+++.|+++.++...+
T Consensus 306 ~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~~~ 340 (343)
T 1luf_A 306 YNLMRLCWSKLPADRPSFCSIHRILQRMCERAEGT 340 (343)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-----
T ss_pred HHHHHHHcccCcccCCCHHHHHHHHHHHHhhhhhh
Confidence 99999999999999999999999999997766443
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=305.82 Aligned_cols=197 Identities=23% Similarity=0.393 Sum_probs=161.3
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++++.. ....++||||+++|+|.+++..... ..+++..++.++.||+.||+||| ++||+||
T Consensus 273 l~hpniv~l~~~~~~-----~~~~~lv~E~~~~g~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHr 342 (495)
T 1opk_A 273 IKHPNLVQLLGVCTR-----EPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLE---KKNFIHR 342 (495)
T ss_dssp CCCTTBCCEEEEECS-----SSSCEEEEECCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHH---HTTEECS
T ss_pred cCCCCEeeEEEEEec-----CCcEEEEEEccCCCCHHHHHHhcCc--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccC
Confidence 579999999998654 4578999999999999999975332 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC-------CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCCc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT-------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~-------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~~ 330 (427)
||||+|||++.++.+||+|||+++...... .++..|+|||++....++.++|||||||++|||++ |..||.+
T Consensus 343 Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~ 422 (495)
T 1opk_A 343 NLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 422 (495)
T ss_dssp CCSGGGEEECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCChhhEEECCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999998764322 45678999999998899999999999999999999 9999976
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
... ..+.+.+..... ...+..++.++.++|.+||+.||++|||++||
T Consensus 423 ~~~--~~~~~~~~~~~~-------------------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el 469 (495)
T 1opk_A 423 IDL--SQVYELLEKDYR-------------------------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEI 469 (495)
T ss_dssp CCG--GGHHHHHHTTCC-------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCH--HHHHHHHHcCCC-------------------------------CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHH
Confidence 421 111111111100 00223456778999999999999999999999
Q ss_pred HHHHHHHH
Q 042634 411 AAQLLSFR 418 (427)
Q Consensus 411 ~~~L~~~~ 418 (427)
++.|+.+.
T Consensus 470 ~~~L~~~~ 477 (495)
T 1opk_A 470 HQAFETMF 477 (495)
T ss_dssp HHHHHTSC
T ss_pred HHHHHHHH
Confidence 99998873
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=282.46 Aligned_cols=204 Identities=15% Similarity=0.175 Sum_probs=161.4
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
.+|++++++++.+.. ....++||||+ +++|.+++.... ..+++..+..++.|++.||+||| ++||+||
T Consensus 63 ~~~~~i~~~~~~~~~-----~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~ 130 (298)
T 1csn_A 63 AGCTGIPNVYYFGQE-----GLHNVLVIDLL-GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIH---EKSLVYR 130 (298)
T ss_dssp TTCTTCCCEEEEEEE-----TTEEEEEEECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHH---TTTEECC
T ss_pred hcCCCCCeEEeecCC-----CceeEEEEEec-CCCHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHH---hCCEecC
Confidence 368999998887533 56789999999 999999997543 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCc-----eEecccccccccCCc-------------CCCccccccccccCCCCcCccccchhHHHHHHH
Q 042634 259 DLKPSNVLLDGELT-----AHVGDFGLAKFLPEA-------------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLE 320 (427)
Q Consensus 259 Dlkp~NIll~~~~~-----~kL~DFG~a~~~~~~-------------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~e 320 (427)
||||+||+++.++. +||+|||+|+..... ..||..|+|||++.+..++.++|||||||++||
T Consensus 131 Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~e 210 (298)
T 1csn_A 131 DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMY 210 (298)
T ss_dssp CCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred CCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHH
Confidence 99999999987765 999999999865432 258899999999999999999999999999999
Q ss_pred HHhCCCCCCcccCCCcc--HHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCC
Q 042634 321 TFTGKRPTNEMFTGNLT--LHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSS 398 (427)
Q Consensus 321 ll~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~ 398 (427)
|++|+.||......... +........+..... ....++.++.+++.+||+
T Consensus 211 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~ 262 (298)
T 1csn_A 211 FLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE----------------------------LCAGFPEEFYKYMHYARN 262 (298)
T ss_dssp HHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH----------------------------HTTTSCHHHHHHHHHHHH
T ss_pred HHcCCCCcchhhccccHHHHHHHHhhccCccHHH----------------------------HHhhCcHHHHHHHHHHhc
Confidence 99999999864322110 111111100000000 011245678999999999
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHH
Q 042634 399 ELPRERMNMEEVAAQLLSFRNKLV 422 (427)
Q Consensus 399 ~dP~~Rpt~~ev~~~L~~~~~~~~ 422 (427)
.||++|||++||++.|+++.+++.
T Consensus 263 ~dp~~RP~~~~l~~~l~~~~~~~~ 286 (298)
T 1csn_A 263 LAFDATPDYDYLQGLFSKVLERLN 286 (298)
T ss_dssp CCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred CCcccCCCHHHHHHHHHHHHHhcC
Confidence 999999999999999999987653
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=294.61 Aligned_cols=201 Identities=19% Similarity=0.255 Sum_probs=153.6
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
.+||||+++++++... +.+....++|||||++|+|.+++..... ..+++..++.++.||+.||+||| +.||+||
T Consensus 112 ~~hp~iv~l~~~~~~~-~~~~~~~~lv~E~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHr 185 (400)
T 1nxk_A 112 SQCPHIVRIVDVYENL-YAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLH---SINIAHR 185 (400)
T ss_dssp TTSTTBCCEEEEEEEE-ETTEEEEEEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred cCCCCcceEeEEEeec-ccCCcEEEEEEEeCCCCcHHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccc
Confidence 5799999999986432 2234568999999999999999976532 45999999999999999999999 8999999
Q ss_pred cccCCceeeCC---CCceEecccccccccCCc-----CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCc
Q 042634 259 DLKPSNVLLDG---ELTAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~---~~~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~ 330 (427)
||||+|||++. ++.+||+|||+++..... ..||..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 186 Dlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 265 (400)
T 1nxk_A 186 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS 265 (400)
T ss_dssp CCCGGGEEESSSSTTCCEEECCCTTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CcCcceEEEecCCCCccEEEEecccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Confidence 99999999987 789999999999876432 2678999999999999999999999999999999999999976
Q ss_pred ccCCCc--cHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 042634 331 MFTGNL--TLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME 408 (427)
Q Consensus 331 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ 408 (427)
...... .....+...... . .......++.++.+++++||+.||++|||++
T Consensus 266 ~~~~~~~~~~~~~i~~~~~~----~------------------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ 317 (400)
T 1nxk_A 266 NHGLAISPGMKTRIRMGQYE----F------------------------PNPEWSEVSEEVKMLIRNLLKTEPTQRMTIT 317 (400)
T ss_dssp CTTCSSCCSHHHHHHHTCCC----C------------------------CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHH
T ss_pred CccccccHHHHHHHHcCccc----C------------------------CCcccccCCHHHHHHHHHHCCCChhHCcCHH
Confidence 432211 111111110000 0 0001122456689999999999999999999
Q ss_pred HHHHH
Q 042634 409 EVAAQ 413 (427)
Q Consensus 409 ev~~~ 413 (427)
|++++
T Consensus 318 eil~h 322 (400)
T 1nxk_A 318 EFMNH 322 (400)
T ss_dssp HHHHS
T ss_pred HHhcC
Confidence 99875
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=288.21 Aligned_cols=189 Identities=20% Similarity=0.259 Sum_probs=153.5
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+++|+|.+++... ..+++..++.++.||+.||+||| ++||+||
T Consensus 62 l~hp~iv~l~~~~~~-----~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHr 129 (337)
T 1o6l_A 62 TRHPFLTALKYAFQT-----HDRLCFVMEYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLH---SRDVVYR 129 (337)
T ss_dssp CCCTTBCCEEEEEEC-----SSEEEEEEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCC
T ss_pred CCCCcCcceEEEEEe-----CCEEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecC
Confidence 479999999988543 56789999999999999988643 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC------cCCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE------ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+|||++.++.+||+|||+|+.... ...||+.|+|||++.+..++.++||||+||++|||++|+.||.+..
T Consensus 130 Dlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 209 (337)
T 1o6l_A 130 DIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209 (337)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCCHHHEEECCCCCEEEeeccchhhcccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC
Confidence 9999999999999999999999986422 2268899999999999999999999999999999999999997531
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCC-----CH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERM-----NM 407 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rp-----t~ 407 (427)
............. . .+...+.++.+++.+||+.||++|| |+
T Consensus 210 -----~~~~~~~i~~~~~------------------------~-----~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~ 255 (337)
T 1o6l_A 210 -----HERLFELILMEEI------------------------R-----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDA 255 (337)
T ss_dssp -----HHHHHHHHHHCCC------------------------C-----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTH
T ss_pred -----HHHHHHHHHcCCC------------------------C-----CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCH
Confidence 1111111110000 0 1112345688999999999999999 89
Q ss_pred HHHHHH
Q 042634 408 EEVAAQ 413 (427)
Q Consensus 408 ~ev~~~ 413 (427)
+|++++
T Consensus 256 ~ei~~h 261 (337)
T 1o6l_A 256 KEVMEH 261 (337)
T ss_dssp HHHHTS
T ss_pred HHHHcC
Confidence 998764
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=286.42 Aligned_cols=215 Identities=21% Similarity=0.269 Sum_probs=164.0
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcC-----CC
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYC-----ET 253 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~-----~~ 253 (427)
++||||+++++.+.... ......++||||+++|+|.+++.. ..+++..++.++.|++.||+|||... +.
T Consensus 93 l~h~ni~~~~~~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~ 166 (342)
T 1b6c_B 93 LRHENILGFIAADNKDN-GTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP 166 (342)
T ss_dssp CCCTTBCCEEEEEECCC-SSCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC
T ss_pred cCCCcEEEEEeeecccC-CccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC
Confidence 67999999999864421 111367999999999999999854 34899999999999999999999311 36
Q ss_pred CeeeccccCCceeeCCCCceEecccccccccCCc----------CCCccccccccccCCC------CcCccccchhHHHH
Q 042634 254 PIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA----------TNNFFNFQIAEYGMGS------EVSTSGDVYSFGIL 317 (427)
Q Consensus 254 ~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~----------~~~~~~y~aPE~~~~~------~~~~~~DiwS~G~v 317 (427)
||+||||||+||+++.++.+||+|||+++..... ..||..|+|||++.+. .++.++|||||||+
T Consensus 167 ~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~i 246 (342)
T 1b6c_B 167 AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLV 246 (342)
T ss_dssp EEECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHH
T ss_pred CeeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHH
Confidence 8999999999999999999999999999765332 2688999999998775 34578999999999
Q ss_pred HHHHHhC----------CCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHH
Q 042634 318 LLETFTG----------KRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLV 387 (427)
Q Consensus 318 l~ell~g----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (427)
+|||++| ..||............+............+ .......+++.
T Consensus 247 l~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~ 304 (342)
T 1b6c_B 247 FWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNI----------------------PNRWQSCEALR 304 (342)
T ss_dssp HHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCC----------------------CGGGGTSHHHH
T ss_pred HHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCC----------------------cccccchhHHH
Confidence 9999999 677765433333333332221111100000 00112345778
Q ss_pred HHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHHH
Q 042634 388 SVLGIGVTCSSELPRERMNMEEVAAQLLSFRNKL 421 (427)
Q Consensus 388 ~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~~~~~~ 421 (427)
.+.+++.+||+.||++|||++||++.|+++.++.
T Consensus 305 ~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 305 VMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 8999999999999999999999999999998764
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=288.47 Aligned_cols=197 Identities=20% Similarity=0.356 Sum_probs=156.2
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ...++++||+.+|+|.+++.... ..+++..++.++.|++.||+||| +.||+||
T Consensus 74 l~hp~iv~~~~~~~~------~~~~~v~~~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~ 141 (327)
T 3lzb_A 74 VDNPHVCRLLGICLT------STVQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHR 141 (327)
T ss_dssp CCBTTBCCCCEEEES------SSEEEEECCCSSCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred CCCCCeeEEEEEEec------CCceEEEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHh---hCCCcCC
Confidence 469999999998643 34789999999999999986543 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC--------CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT--------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTN 329 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~--------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~ 329 (427)
||||+||+++.++.+||+|||+|+...... .++..|+|||++.+..++.++|||||||++|||++ |+.||.
T Consensus 142 Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~ 221 (327)
T 3lzb_A 142 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221 (327)
T ss_dssp CCCGGGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCC
Confidence 999999999999999999999998754322 55678999999999999999999999999999999 999997
Q ss_pred cccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 042634 330 EMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEE 409 (427)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~e 409 (427)
+... ..+...+...... ..+..++.++.+++.+||+.||++|||++|
T Consensus 222 ~~~~--~~~~~~~~~~~~~-------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~e 268 (327)
T 3lzb_A 222 GIPA--SEISSILEKGERL-------------------------------PQPPICTIDVYMIMRKCWMIDADSRPKFRE 268 (327)
T ss_dssp TCCG--GGHHHHHHTTCCC-------------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCH--HHHHHHHHcCCCC-------------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 6422 1122221111100 011224556899999999999999999999
Q ss_pred HHHHHHHHHHH
Q 042634 410 VAAQLLSFRNK 420 (427)
Q Consensus 410 v~~~L~~~~~~ 420 (427)
+++.|+++.+.
T Consensus 269 ll~~L~~~~~~ 279 (327)
T 3lzb_A 269 LIIEFSKMARD 279 (327)
T ss_dssp HHHHHHHHHTS
T ss_pred HHHHHHHHHhC
Confidence 99999999754
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-37 Score=283.69 Aligned_cols=194 Identities=26% Similarity=0.378 Sum_probs=149.3
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCC---e
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETP---I 255 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~---i 255 (427)
++||||+++++.+.. ....++||||+++++|.+++.. ..+++..+..++.|++.||+||| +.| |
T Consensus 63 l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i 129 (271)
T 3dtc_A 63 LKHPNIIALRGVCLK-----EPNLCLVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLH---DEAIVPI 129 (271)
T ss_dssp CCCTTBCCEEEEECC-----C--CEEEEECCTTEEHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHH---HSSSSCC
T ss_pred cCCCCEeeEEEEEec-----CCceEEEEEcCCCCCHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCCCce
Confidence 569999999998644 5678999999999999998864 34899999999999999999999 677 9
Q ss_pred eeccccCCceeeCC--------CCceEecccccccccCCc----CCCccccccccccCCCCcCccccchhHHHHHHHHHh
Q 042634 256 VHCDLKPSNVLLDG--------ELTAHVGDFGLAKFLPEA----TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT 323 (427)
Q Consensus 256 vHrDlkp~NIll~~--------~~~~kL~DFG~a~~~~~~----~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~ 323 (427)
+||||||+||+++. ++.+||+|||.++..... ..++..|+|||.+.+..++.++|||||||++|||++
T Consensus 130 ~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 209 (271)
T 3dtc_A 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLT 209 (271)
T ss_dssp CCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHH
T ss_pred eecCCchHHEEEecccccccccCcceEEccCCcccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHh
Confidence 99999999999985 678999999999865433 378899999999998899999999999999999999
Q ss_pred CCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCC
Q 042634 324 GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRE 403 (427)
Q Consensus 324 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~ 403 (427)
|+.||...... ........... ....+..++.++.+++.+||+.||++
T Consensus 210 g~~p~~~~~~~-----~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~li~~~l~~~p~~ 257 (271)
T 3dtc_A 210 GEVPFRGIDGL-----AVAYGVAMNKL---------------------------ALPIPSTCPEPFAKLMEDCWNPDPHS 257 (271)
T ss_dssp CCCTTTTSCHH-----HHHHHHHTSCC---------------------------CCCCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred CCCCCCCCCHH-----HHHHhhhcCCC---------------------------CCCCCcccCHHHHHHHHHHhcCCccc
Confidence 99999753211 00000000000 00012234567899999999999999
Q ss_pred CCCHHHHHHHHHHH
Q 042634 404 RMNMEEVAAQLLSF 417 (427)
Q Consensus 404 Rpt~~ev~~~L~~~ 417 (427)
|||++|++++|+++
T Consensus 258 Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 258 RPSFTNILDQLTTI 271 (271)
T ss_dssp SCCHHHHHHHHHC-
T ss_pred CcCHHHHHHHHhcC
Confidence 99999999999864
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=290.09 Aligned_cols=203 Identities=22% Similarity=0.358 Sum_probs=162.1
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhh----------hhccCHHHHHHHHHHHHHHHHHHhh
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREA----------LKNLNLLQRLSIAVDVASALDYLHH 249 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~----------~~~l~~~~~~~~~~~i~~~L~~LH~ 249 (427)
+||||+++++.+.. ....++||||+++|+|.+++...... ...+++..++.++.|++.||+|||
T Consensus 108 ~h~~iv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH- 181 (333)
T 2i1m_A 108 QHENIVNLLGACTH-----GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA- 181 (333)
T ss_dssp CCTTBCCEEEEECS-----SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH-
T ss_pred CCCCeeeEEEEEec-----CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh-
Confidence 79999999998644 56789999999999999998754321 134789999999999999999999
Q ss_pred cCCCCeeeccccCCceeeCCCCceEecccccccccCCc--------CCCccccccccccCCCCcCccccchhHHHHHHHH
Q 042634 250 YCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA--------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLET 321 (427)
Q Consensus 250 ~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~el 321 (427)
+.||+||||||+||+++.++.+||+|||+++..... ..++..|+|||++.+..++.++|||||||++|||
T Consensus 182 --~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 259 (333)
T 2i1m_A 182 --SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 259 (333)
T ss_dssp --HTTEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred --cCCcccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHH
Confidence 889999999999999999999999999999865332 2456789999999988999999999999999999
Q ss_pred Hh-CCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCC
Q 042634 322 FT-GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSEL 400 (427)
Q Consensus 322 l~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~d 400 (427)
++ |..||.+..... .+........... .+..++.++.+++.+||+.|
T Consensus 260 ~t~g~~p~~~~~~~~-~~~~~~~~~~~~~-------------------------------~~~~~~~~l~~li~~~l~~~ 307 (333)
T 2i1m_A 260 FSLGLNPYPGILVNS-KFYKLVKDGYQMA-------------------------------QPAFAPKNIYSIMQACWALE 307 (333)
T ss_dssp TTTSCCSSTTCCSSH-HHHHHHHHTCCCC-------------------------------CCTTCCHHHHHHHHHHTCSS
T ss_pred HcCCCCCCcccchhH-HHHHHHhcCCCCC-------------------------------CCCCCCHHHHHHHHHHhccC
Confidence 98 999997642211 1112211111100 11123456889999999999
Q ss_pred CCCCCCHHHHHHHHHHHHHHHH
Q 042634 401 PRERMNMEEVAAQLLSFRNKLV 422 (427)
Q Consensus 401 P~~Rpt~~ev~~~L~~~~~~~~ 422 (427)
|++|||++|+++.|+++..+..
T Consensus 308 p~~Rps~~~l~~~L~~~~~~~~ 329 (333)
T 2i1m_A 308 PTHRPTFQQICSFLQEQAQEDR 329 (333)
T ss_dssp GGGSCCHHHHHHHHHHHHHHHH
T ss_pred hhhCcCHHHHHHHHHHHHHhhh
Confidence 9999999999999999977643
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=289.51 Aligned_cols=195 Identities=21% Similarity=0.238 Sum_probs=154.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++|||||++|+|.+++.........+++..+..++.||+.||+||| ++||+||
T Consensus 83 l~hpnIv~~~~~~~~-----~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHr 154 (351)
T 3c0i_A 83 LKHPHIVELLETYSS-----DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHR 154 (351)
T ss_dssp CCCTTBCCEEEEEEE-----TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECS
T ss_pred CCCCCCCcEEEEEEe-----CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceec
Confidence 579999999998644 56789999999999999888654433345899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCc---eEecccccccccCCc------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCC
Q 042634 259 DLKPSNVLLDGELT---AHVGDFGLAKFLPEA------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTN 329 (427)
Q Consensus 259 Dlkp~NIll~~~~~---~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~ 329 (427)
||||+|||++.++. +||+|||+++..... ..||+.|+|||++.+..++.++||||+||++|||++|+.||.
T Consensus 155 Dlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 234 (351)
T 3c0i_A 155 DVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFY 234 (351)
T ss_dssp CCSGGGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCChHHeEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCC
Confidence 99999999976554 999999999876432 268999999999999999999999999999999999999997
Q ss_pred cccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 042634 330 EMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEE 409 (427)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~e 409 (427)
+.. . .......... .... .......+.++.+++.+||+.||++|||+.|
T Consensus 235 ~~~---~---~~~~~i~~~~--------~~~~-----------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e 283 (351)
T 3c0i_A 235 GTK---E---RLFEGIIKGK--------YKMN-----------------PRQWSHISESAKDLVRRMLMLDPAERITVYE 283 (351)
T ss_dssp SSH---H---HHHHHHHHTC--------CCCC-----------------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred CcH---H---HHHHHHHcCC--------CCCC-----------------ccccccCCHHHHHHHHHHCCCChhHCcCHHH
Confidence 531 1 1111100000 0000 0001123567899999999999999999999
Q ss_pred HHH
Q 042634 410 VAA 412 (427)
Q Consensus 410 v~~ 412 (427)
+++
T Consensus 284 ~l~ 286 (351)
T 3c0i_A 284 ALN 286 (351)
T ss_dssp HHT
T ss_pred Hhc
Confidence 986
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-37 Score=285.51 Aligned_cols=199 Identities=24% Similarity=0.388 Sum_probs=156.8
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. +...++||||+++++|.+++... ..+++..++.++.|++.||+||| +.||+||
T Consensus 68 l~hp~iv~~~~~~~~-----~~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~ 135 (294)
T 4eqm_A 68 LSHQNIVSMIDVDEE-----DDCYYLVMEYIEGPTLSEYIESH----GPLSVDTAINFTNQILDGIKHAH---DMRIVHR 135 (294)
T ss_dssp CCBTTBCCEEEEEEC-----SSEEEEEEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCC
T ss_pred CCCCCCceEEEeeee-----CCeEEEEEeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccC
Confidence 579999999998533 56789999999999999998654 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc-------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA-------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
||||+||+++.++.+||+|||+++..... ..||+.|+|||.+.+..++.++||||+||++|||++|+.||.+.
T Consensus 136 Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~ 215 (294)
T 4eqm_A 136 DIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGE 215 (294)
T ss_dssp CCCGGGEEECTTSCEEECCCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred CCCHHHEEECCCCCEEEEeCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999999876432 25889999999999999999999999999999999999999753
Q ss_pred cCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCC-CHHHH
Q 042634 332 FTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERM-NMEEV 410 (427)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rp-t~~ev 410 (427)
.. ............... .......++..+.+++.+||+.||++|| +++++
T Consensus 216 ~~-----~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l 266 (294)
T 4eqm_A 216 TA-----VSIAIKHIQDSVPNV------------------------TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEM 266 (294)
T ss_dssp CH-----HHHHHHHHSSCCCCH------------------------HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHH
T ss_pred Ch-----HHHHHHHhhccCCCc------------------------chhcccCCCHHHHHHHHHHhcCCHhHccccHHHH
Confidence 21 111111110000000 0001122456789999999999999998 99999
Q ss_pred HHHHHHHH
Q 042634 411 AAQLLSFR 418 (427)
Q Consensus 411 ~~~L~~~~ 418 (427)
.+.|+.+.
T Consensus 267 ~~~l~~~~ 274 (294)
T 4eqm_A 267 KDDLSSVL 274 (294)
T ss_dssp HHHHHTSS
T ss_pred HHHHHHHH
Confidence 99998764
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-36 Score=281.01 Aligned_cols=202 Identities=23% Similarity=0.372 Sum_probs=160.0
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. .+...++||||+.+|+|.+++.... ..+++..+..++.|++.||+||| +.||+||
T Consensus 79 l~h~~iv~~~~~~~~----~~~~~~~v~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~ 148 (298)
T 3pls_A 79 LNHPNVLALIGIMLP----PEGLPHVLLPYMCHGDLLQFIRSPQ---RNPTVKDLISFGLQVARGMEYLA---EQKFVHR 148 (298)
T ss_dssp CCCTTBCCCCEEECC----SSSCCEEEECCCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred CCCCCeeeEEEEEec----CCCCcEEEEecccCCCHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHH---hCCcccC
Confidence 469999999998643 2334589999999999999997643 45889999999999999999999 8899999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc----------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA----------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPT 328 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~----------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf 328 (427)
||||+||+++.++.+||+|||+++..... ..++..|+|||.+.+..++.++|||||||++|||++|..|+
T Consensus 149 dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~ 228 (298)
T 3pls_A 149 DLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228 (298)
T ss_dssp CCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCT
T ss_pred CCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCC
Confidence 99999999999999999999999754321 25678899999999999999999999999999999965554
Q ss_pred CcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 042634 329 NEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME 408 (427)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ 408 (427)
.... ............... ..+..++.++.+++.+||+.||++|||++
T Consensus 229 ~~~~-~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 276 (298)
T 3pls_A 229 YRHI-DPFDLTHFLAQGRRL-------------------------------PQPEYCPDSLYQVMQQCWEADPAVRPTFR 276 (298)
T ss_dssp TTTS-CGGGHHHHHHTTCCC-------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CccC-CHHHHHHHhhcCCCC-------------------------------CCCccchHHHHHHHHHHccCChhhCcCHH
Confidence 3321 111222221111100 01122345689999999999999999999
Q ss_pred HHHHHHHHHHHHHH
Q 042634 409 EVAAQLLSFRNKLV 422 (427)
Q Consensus 409 ev~~~L~~~~~~~~ 422 (427)
|+++.|+++.+.+.
T Consensus 277 ~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 277 VLVGEVEQIVSALL 290 (298)
T ss_dssp HHHHHHHHHHHHCC
T ss_pred HHHHHHHHHHHHHh
Confidence 99999999988763
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=288.92 Aligned_cols=192 Identities=18% Similarity=0.250 Sum_probs=154.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+++|+|.+++... ..+++..+..++.||+.||+||| +.||+||
T Consensus 72 l~hpnIv~l~~~~~~-----~~~~~lv~e~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~givHr 139 (361)
T 2yab_A 72 VLHPNIITLHDVYEN-----RTDVVLILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLH---TKKIAHF 139 (361)
T ss_dssp CCCTTBCCEEEEEEC-----SSEEEEEEECCCSCBHHHHHTTC----SCCBHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred CCCcCCCcEEEEEEe-----CCEEEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccC
Confidence 469999999998543 56789999999999999999765 45999999999999999999999 8999999
Q ss_pred cccCCceeeCCCC----ceEecccccccccCCc-----CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCC
Q 042634 259 DLKPSNVLLDGEL----TAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTN 329 (427)
Q Consensus 259 Dlkp~NIll~~~~----~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~ 329 (427)
||||+||+++.++ .+||+|||+++..... ..||+.|+|||++.+..++.++||||+||++|||++|..||.
T Consensus 140 Dlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~ 219 (361)
T 2yab_A 140 DLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 219 (361)
T ss_dssp CCSGGGEEESCTTSSSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSC
T ss_pred CCCHHHEEEeCCCCCccCEEEEecCCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 9999999998776 7999999999876443 378999999999999999999999999999999999999997
Q ss_pred cccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 042634 330 EMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEE 409 (427)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~e 409 (427)
+... .......... ..... .......+.++.+++.+||..||++|||++|
T Consensus 220 ~~~~-----~~~~~~i~~~--------~~~~~-----------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e 269 (361)
T 2yab_A 220 GDTK-----QETLANITAV--------SYDFD-----------------EEFFSQTSELAKDFIRKLLVKETRKRLTIQE 269 (361)
T ss_dssp CSSH-----HHHHHHHHTT--------CCCCC-----------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CCCH-----HHHHHHHHhc--------CCCCC-----------------chhccCCCHHHHHHHHHHCCCChhHCcCHHH
Confidence 5311 1111111000 00000 0011223556889999999999999999999
Q ss_pred HHH
Q 042634 410 VAA 412 (427)
Q Consensus 410 v~~ 412 (427)
+++
T Consensus 270 ~l~ 272 (361)
T 2yab_A 270 ALR 272 (361)
T ss_dssp HHT
T ss_pred Hhc
Confidence 985
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-36 Score=283.19 Aligned_cols=191 Identities=21% Similarity=0.295 Sum_probs=154.3
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+++++|.+++... .+++..+..++.|++.||+||| +.||+||
T Consensus 99 l~h~niv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~-----~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~ 165 (321)
T 2c30_A 99 YQHFNVVEMYKSYLV-----GEELWVLMEFLQGGALTDIVSQV-----RLNEEQIATVCEAVLQALAYLH---AQGVIHR 165 (321)
T ss_dssp CCCTTBCCEEEEEEE-----TTEEEEEECCCCSCBHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred CCCCCcceEEEEEEE-----CCEEEEEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHH---HCCeecC
Confidence 579999999998654 45789999999999999988643 4899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+||+++.++.+||+|||+++..... ..||..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 166 Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~ 245 (321)
T 2c30_A 166 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS 245 (321)
T ss_dssp CCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CCCHHHEEECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999999865432 278999999999999999999999999999999999999997531
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
.......+....+.. .. .....+.++.+++.+||+.||++|||++|+++
T Consensus 246 --~~~~~~~~~~~~~~~--------~~---------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 246 --PVQAMKRLRDSPPPK--------LK---------------------NSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp --HHHHHHHHHHSSCCC--------CT---------------------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --HHHHHHHHhcCCCCC--------cC---------------------ccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111111111111000 00 11123456889999999999999999999987
Q ss_pred H
Q 042634 413 Q 413 (427)
Q Consensus 413 ~ 413 (427)
.
T Consensus 295 h 295 (321)
T 2c30_A 295 H 295 (321)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=292.54 Aligned_cols=187 Identities=22% Similarity=0.262 Sum_probs=150.7
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeecc
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCD 259 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrD 259 (427)
+||||+++++.+.. ....++||||+++|+|.+++... ..+++..++.++.||+.||+||| +.||+|||
T Consensus 82 ~hp~Iv~l~~~~~~-----~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH---~~givHrD 149 (353)
T 3txo_A 82 NHPFLTQLFCCFQT-----PDRLFFVMEFVNGGDLMFHIQKS----RRFDEARARFYAAEIISALMFLH---DKGIIYRD 149 (353)
T ss_dssp TCTTBCCEEEEEEC-----SSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCC
T ss_pred CCCceeeEEEEEEe-----CCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCCcccC
Confidence 69999999998543 56789999999999999998654 45999999999999999999999 89999999
Q ss_pred ccCCceeeCCCCceEecccccccccCC------cCCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccC
Q 042634 260 LKPSNVLLDGELTAHVGDFGLAKFLPE------ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFT 333 (427)
Q Consensus 260 lkp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~ 333 (427)
|||+|||++.++.+||+|||+|+.... ...||+.|+|||++.+..++.++||||+||++|||++|+.||.+...
T Consensus 150 lkp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~ 229 (353)
T 3txo_A 150 LKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE 229 (353)
T ss_dssp CCGGGEEECTTSCEEECCCTTCBCSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CCHHHEEECCCCCEEEccccceeecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH
Confidence 999999999999999999999986432 22789999999999988999999999999999999999999975311
Q ss_pred CCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCH------
Q 042634 334 GNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM------ 407 (427)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~------ 407 (427)
.+......... . . .+...+.++.+++.+||+.||++||++
T Consensus 230 -----~~~~~~i~~~~--------~----------------~-----~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~ 275 (353)
T 3txo_A 230 -----DDLFEAILNDE--------V----------------V-----YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGE 275 (353)
T ss_dssp -----HHHHHHHHHCC--------C----------------C-----CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCT
T ss_pred -----HHHHHHHHcCC--------C----------------C-----CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCH
Confidence 11111111000 0 0 111134558899999999999999998
Q ss_pred HHHHH
Q 042634 408 EEVAA 412 (427)
Q Consensus 408 ~ev~~ 412 (427)
+|+++
T Consensus 276 ~~il~ 280 (353)
T 3txo_A 276 HAILR 280 (353)
T ss_dssp HHHHT
T ss_pred HHHhh
Confidence 67664
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=308.02 Aligned_cols=198 Identities=23% Similarity=0.356 Sum_probs=161.3
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||++++++.. ...++|||||++|+|.+++.... ..+++..+..++.||+.||+||| ++||+||
T Consensus 393 l~hpniv~l~~~~~~------~~~~lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHr 460 (613)
T 2ozo_A 393 LDNPYIVRLIGVCQA------EALMLVMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLE---EKNFVHR 460 (613)
T ss_dssp CCCTTBCCEEEEEES------SSEEEEEECCTTCBHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred CCCCCEeeEEEEecc------CCeEEEEEeCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHH---HCCEEcC
Confidence 579999999998643 35899999999999999987543 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC---------CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT---------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPT 328 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~---------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf 328 (427)
||||+|||++.++.+||+|||+|+...... .++..|+|||++.+..++.++|||||||++|||++ |+.||
T Consensus 461 Dlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf 540 (613)
T 2ozo_A 461 NLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY 540 (613)
T ss_dssp CCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred cCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 999999999999999999999998764321 34578999999998999999999999999999998 99999
Q ss_pred CcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 042634 329 NEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME 408 (427)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ 408 (427)
.+... ..+...+..... ...+..++.++.++|.+||+.||++|||++
T Consensus 541 ~~~~~--~~~~~~i~~~~~-------------------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ 587 (613)
T 2ozo_A 541 KKMKG--PEVMAFIEQGKR-------------------------------MECPPECPPELYALMSDCWIYKWEDRPDFL 587 (613)
T ss_dssp TTCCS--HHHHHHHHTTCC-------------------------------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHH
T ss_pred CCCCH--HHHHHHHHcCCC-------------------------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHH
Confidence 76422 111111111100 002234567899999999999999999999
Q ss_pred HHHHHHHHHHHHH
Q 042634 409 EVAAQLLSFRNKL 421 (427)
Q Consensus 409 ev~~~L~~~~~~~ 421 (427)
||++.|+.+...+
T Consensus 588 ~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 588 TVEQRMRACYYSL 600 (613)
T ss_dssp HHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHh
Confidence 9999999987665
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=284.94 Aligned_cols=206 Identities=22% Similarity=0.360 Sum_probs=154.6
Q ss_pred cccccchhhhccccccCCCC-CCccceeeeeecCCCcccccccchhh--hhccCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 042634 179 IRHRNLVKIITSCASVDFQG-NDSEALVYEFMVNGSLEEWLHPNREA--LKNLNLLQRLSIAVDVASALDYLHHYCETPI 255 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~--~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~i 255 (427)
++||||+++++++......+ ....++||||+++|+|.+++...... ...+++..++.++.|++.||+||| +.||
T Consensus 82 l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i 158 (323)
T 3qup_A 82 FDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNF 158 (323)
T ss_dssp CCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTC
T ss_pred CCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCc
Confidence 47999999999865422111 11238999999999999998643311 125899999999999999999999 8999
Q ss_pred eeccccCCceeeCCCCceEecccccccccCCc--------CCCccccccccccCCCCcCccccchhHHHHHHHHHh-CCC
Q 042634 256 VHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA--------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKR 326 (427)
Q Consensus 256 vHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~ 326 (427)
+||||||+||+++.++.+||+|||+|+..... ..++..|+|||.+.+..++.++|||||||++|||++ |..
T Consensus 159 vH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~ 238 (323)
T 3qup_A 159 IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQT 238 (323)
T ss_dssp CCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred ccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCC
Confidence 99999999999999999999999999865332 255678999999999999999999999999999999 999
Q ss_pred CCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCC
Q 042634 327 PTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMN 406 (427)
Q Consensus 327 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt 406 (427)
||.+... ......+..... ...+..++.++.+++.+||+.||++|||
T Consensus 239 p~~~~~~--~~~~~~~~~~~~-------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps 285 (323)
T 3qup_A 239 PYAGIEN--AEIYNYLIGGNR-------------------------------LKQPPECMEEVYDLMYQCWSADPKQRPS 285 (323)
T ss_dssp TTTTCCG--GGHHHHHHTTCC-------------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCC
T ss_pred CccccCh--HHHHHHHhcCCC-------------------------------CCCCCccCHHHHHHHHHHccCChhhCcC
Confidence 9976421 111111111000 0011234567899999999999999999
Q ss_pred HHHHHHHHHHHHHH
Q 042634 407 MEEVAAQLLSFRNK 420 (427)
Q Consensus 407 ~~ev~~~L~~~~~~ 420 (427)
+.|+++.|+++.+.
T Consensus 286 ~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 286 FTCLRMELENILGH 299 (323)
T ss_dssp HHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHHHHH
Confidence 99999999998753
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-36 Score=284.66 Aligned_cols=203 Identities=17% Similarity=0.219 Sum_probs=161.1
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeecc
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCD 259 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrD 259 (427)
+||||+++++.+.. ....++||||+ +++|.+++.... ..+++..++.++.|++.||+||| +.||+|||
T Consensus 63 ~h~~i~~~~~~~~~-----~~~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrD 130 (330)
T 2izr_A 63 SGDGIPQVYYFGPC-----GKYNAMVLELL-GPSLEDLFDLCD---RTFSLKTVLMIAIQLISRMEYVH---SKNLIYRD 130 (330)
T ss_dssp SCTTSCCEEEEEEE-----TTEEEEEEECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCC
T ss_pred CCCCCCEEEEEEec-----CCccEEEEEeC-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccC
Confidence 79999999988544 56789999999 999999987542 46999999999999999999999 89999999
Q ss_pred ccCCceeeCCCCc-----eEecccccccccCC-------------cCCCccccccccccCCCCcCccccchhHHHHHHHH
Q 042634 260 LKPSNVLLDGELT-----AHVGDFGLAKFLPE-------------ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLET 321 (427)
Q Consensus 260 lkp~NIll~~~~~-----~kL~DFG~a~~~~~-------------~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~el 321 (427)
|||+|||++.++. +||+|||+|+.... ...||..|+|||++.+..++.++|||||||++|||
T Consensus 131 lkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el 210 (330)
T 2izr_A 131 VKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYF 210 (330)
T ss_dssp CCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred CCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHH
Confidence 9999999998887 99999999986532 23688999999999999999999999999999999
Q ss_pred HhCCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCC
Q 042634 322 FTGKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELP 401 (427)
Q Consensus 322 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP 401 (427)
++|+.||.+.... ...+..............+ .....++ ++.+++.+||+.||
T Consensus 211 l~g~~Pf~~~~~~--~~~~~~~~i~~~~~~~~~~------------------------~~~~~~p-~~~~li~~~l~~~p 263 (330)
T 2izr_A 211 LRGSLPWQGLKAD--TLKERYQKIGDTKRATPIE------------------------VLCENFP-EMATYLRYVRRLDF 263 (330)
T ss_dssp HHSSCTTTTCCCS--SHHHHHHHHHHHHHHSCHH------------------------HHTTTCH-HHHHHHHHHHHCCT
T ss_pred hcCCCCccccccc--cHHHHHHHHHhhhccCCHH------------------------HHhccCh-HHHHHHHHHHhCCC
Confidence 9999999864222 2222111110000000000 0011134 78999999999999
Q ss_pred CCCCCHHHHHHHHHHHHHHH
Q 042634 402 RERMNMEEVAAQLLSFRNKL 421 (427)
Q Consensus 402 ~~Rpt~~ev~~~L~~~~~~~ 421 (427)
.+|||+++|.+.|+++.++.
T Consensus 264 ~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 264 FEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp TCCCCHHHHHHHHHHHHHHT
T ss_pred CCCCCHHHHHHHHHHHHHHc
Confidence 99999999999999987764
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=281.09 Aligned_cols=197 Identities=20% Similarity=0.337 Sum_probs=158.2
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ...++||||+++++|.+++.... ..+++..+..++.|++.||+||| +.||+||
T Consensus 70 l~h~~i~~~~~~~~~------~~~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~ 137 (281)
T 3cc6_A 70 LDHPHIVKLIGIIEE------EPTWIIMELYPYGELGHYLERNK---NSLKVLTLVLYSLQICKAMAYLE---SINCVHR 137 (281)
T ss_dssp HCCTTBCCEEEEECS------SSCEEEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCC
T ss_pred CCCCCcceEEEEEcC------CCCEEEEecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHH---HCCcccC
Confidence 469999999987532 35689999999999999986532 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc-------CCCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCCc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA-------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~~ 330 (427)
||||+||+++.++.+||+|||.++..... ..++..|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus 138 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~ 217 (281)
T 3cc6_A 138 DIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFW 217 (281)
T ss_dssp CCSGGGEEEEETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CCccceEEECCCCcEEeCccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCccc
Confidence 99999999999999999999999876432 256778999999988899999999999999999998 9999975
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
... ......+...... ..+..++..+.+++.+||+.||++|||++|+
T Consensus 218 ~~~--~~~~~~~~~~~~~-------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~el 264 (281)
T 3cc6_A 218 LEN--KDVIGVLEKGDRL-------------------------------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTEL 264 (281)
T ss_dssp SCG--GGHHHHHHHTCCC-------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCh--HHHHHHHhcCCCC-------------------------------CCCCCCCHHHHHHHHHHccCCchhCcCHHHH
Confidence 321 1121111111000 0112234568999999999999999999999
Q ss_pred HHHHHHHHHH
Q 042634 411 AAQLLSFRNK 420 (427)
Q Consensus 411 ~~~L~~~~~~ 420 (427)
++.|+++.+.
T Consensus 265 l~~L~~~~~~ 274 (281)
T 3cc6_A 265 VCSLSDVYQM 274 (281)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHh
Confidence 9999998754
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=283.67 Aligned_cols=188 Identities=23% Similarity=0.314 Sum_probs=154.2
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+++|+|.+++... ..+++..++.++.||+.||+||| ++||+||
T Consensus 63 l~hp~Iv~~~~~~~~-----~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHr 130 (318)
T 1fot_A 63 VTHPFIIRMWGTFQD-----AQQIFMIMDYIEGGELFSLLRKS----QRFPNPVAKFYAAEVCLALEYLH---SKDIIYR 130 (318)
T ss_dssp CCBTTBCCEEEEEEC-----SSEEEEEECCCCSCBHHHHHHHT----SSCCHHHHHHHHHHHHHHHHHHH---TTTEECC
T ss_pred CCCCCCceEeEEEEe-----CCEEEEEEeCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccc
Confidence 579999999998543 56789999999999999998654 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc---CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA---TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGN 335 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~~~ 335 (427)
||||+||+++.++.+||+|||+|+..... ..||+.|+|||++.+..++.++||||+||++|||++|+.||.+...
T Consensus 131 Dlkp~NIll~~~g~~kL~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-- 208 (318)
T 1fot_A 131 DLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-- 208 (318)
T ss_dssp CCCGGGEEECTTSCEEECCCSSCEECSSCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--
T ss_pred CCChheEEEcCCCCEEEeecCcceecCCccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--
Confidence 99999999999999999999999876543 3789999999999999999999999999999999999999975311
Q ss_pred ccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCC-----CHHHH
Q 042634 336 LTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERM-----NMEEV 410 (427)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rp-----t~~ev 410 (427)
........... .. .+...+.++.+++.+||+.||++|| +++|+
T Consensus 209 ---~~~~~~i~~~~--------~~---------------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i 256 (318)
T 1fot_A 209 ---MKTYEKILNAE--------LR---------------------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDV 256 (318)
T ss_dssp ---HHHHHHHHHCC--------CC---------------------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHH
T ss_pred ---HHHHHHHHhCC--------CC---------------------CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHH
Confidence 11111111000 00 0112345688999999999999999 88888
Q ss_pred HH
Q 042634 411 AA 412 (427)
Q Consensus 411 ~~ 412 (427)
++
T Consensus 257 ~~ 258 (318)
T 1fot_A 257 KN 258 (318)
T ss_dssp HT
T ss_pred hc
Confidence 75
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=300.27 Aligned_cols=197 Identities=29% Similarity=0.456 Sum_probs=157.0
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ...++||||+++|+|.+++..... ..+++..+..++.|++.||+||| ++||+||
T Consensus 236 l~hp~iv~~~~~~~~------~~~~iv~e~~~~gsL~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHr 304 (452)
T 1fmk_A 236 LRHEKLVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 304 (452)
T ss_dssp CCCTTBCCEEEEECS------SSCEEEECCCTTCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred CCCCCEeeEEEEEcC------CceEEEehhhcCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCC
Confidence 579999999988532 457999999999999999975432 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc-------CCCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCCc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA-------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~~ 330 (427)
||||+|||++.++.+||+|||+++..... ..++..|+|||++....++.++|||||||++|||++ |+.||.+
T Consensus 305 Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~ 384 (452)
T 1fmk_A 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 384 (452)
T ss_dssp CCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred CCChhhEEECCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999999876432 245678999999998899999999999999999999 9999975
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
.... .....+..... ...+..++..+.++|.+||+.||++|||++++
T Consensus 385 ~~~~--~~~~~i~~~~~-------------------------------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l 431 (452)
T 1fmk_A 385 MVNR--EVLDQVERGYR-------------------------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYL 431 (452)
T ss_dssp CCHH--HHHHHHHTTCC-------------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCHH--HHHHHHHcCCC-------------------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 4211 11111111000 00123456778999999999999999999999
Q ss_pred HHHHHHHHH
Q 042634 411 AAQLLSFRN 419 (427)
Q Consensus 411 ~~~L~~~~~ 419 (427)
++.|+.+..
T Consensus 432 ~~~L~~~~~ 440 (452)
T 1fmk_A 432 QAFLEDYFT 440 (452)
T ss_dssp HHHHHTTTS
T ss_pred HHHHHHHhc
Confidence 999998753
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=285.36 Aligned_cols=203 Identities=23% Similarity=0.356 Sum_probs=161.4
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhh------------hhccCHHHHHHHHHHHHHHHHHH
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREA------------LKNLNLLQRLSIAVDVASALDYL 247 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~------------~~~l~~~~~~~~~~~i~~~L~~L 247 (427)
+||||+++++.+.. .+...++||||+++|+|.+++...... ...+++..++.++.|++.||+||
T Consensus 89 ~hp~iv~~~~~~~~----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~l 164 (316)
T 2xir_A 89 HHLNVVNLLGACTK----PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL 164 (316)
T ss_dssp CCTTBCCEEEEECC----TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHH
T ss_pred cCCCeeeEEEEEec----CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHH
Confidence 69999999998643 234589999999999999998765321 12388999999999999999999
Q ss_pred hhcCCCCeeeccccCCceeeCCCCceEecccccccccCCcC--------CCccccccccccCCCCcCccccchhHHHHHH
Q 042634 248 HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEAT--------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLL 319 (427)
Q Consensus 248 H~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~--------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ 319 (427)
| +.||+||||||+||+++.++.+||+|||.++...... .++..|+|||++.+..++.++|||||||++|
T Consensus 165 H---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ 241 (316)
T 2xir_A 165 A---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLW 241 (316)
T ss_dssp H---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred H---hCCcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHH
Confidence 9 8999999999999999999999999999998654322 4567899999999999999999999999999
Q ss_pred HHHh-CCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCC
Q 042634 320 ETFT-GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSS 398 (427)
Q Consensus 320 ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~ 398 (427)
||++ |..||....... .+...+....... .+..++.++.+++.+||+
T Consensus 242 ~l~t~g~~p~~~~~~~~-~~~~~~~~~~~~~-------------------------------~~~~~~~~l~~li~~~l~ 289 (316)
T 2xir_A 242 EIFSLGASPYPGVKIDE-EFCRRLKEGTRMR-------------------------------APDYTTPEMYQTMLDCWH 289 (316)
T ss_dssp HHHTTSCCSSTTCCCSH-HHHHHHHHTCCCC-------------------------------CCTTCCHHHHHHHHHHTC
T ss_pred HHHhCCCCCCcccchhH-HHHHHhccCccCC-------------------------------CCCCCCHHHHHHHHHHcC
Confidence 9998 999997642221 1111111111000 111234568999999999
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHH
Q 042634 399 ELPRERMNMEEVAAQLLSFRNKL 421 (427)
Q Consensus 399 ~dP~~Rpt~~ev~~~L~~~~~~~ 421 (427)
.||++|||++|+++.|+.+.+..
T Consensus 290 ~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 290 GEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp SSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CChhhCcCHHHHHHHHHHHHhhh
Confidence 99999999999999999997654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=288.68 Aligned_cols=189 Identities=22% Similarity=0.304 Sum_probs=149.0
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
.+||||+++++.+.. ....++||||+++|+|.+++... ..+++..++.++.||+.||+||| +.||+||
T Consensus 67 ~~hp~iv~l~~~~~~-----~~~~~lv~e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHr 134 (345)
T 3a8x_A 67 SNHPFLVGLHSCFQT-----ESRLFFVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLH---ERGIIYR 134 (345)
T ss_dssp TTCTTBCCEEEEEEC-----SSEEEEEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCC
T ss_pred CCCCccCeEEEEEEe-----CCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCceec
Confidence 479999999998543 56789999999999999988643 45999999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC------cCCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE------ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+|||++.++.+||+|||+|+.... ...||+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus 135 Dlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 214 (345)
T 3a8x_A 135 DLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG 214 (345)
T ss_dssp CCCGGGEEECTTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTT
T ss_pred CCCHHHEEECCCCCEEEEeccccccccCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcc
Confidence 9999999999999999999999986322 2278999999999999999999999999999999999999997532
Q ss_pred CCCcc---HHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCH
Q 042634 333 TGNLT---LHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM 407 (427)
Q Consensus 333 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~ 407 (427)
..... ......... ..... ..+...+.++.+++.+||+.||++|||+
T Consensus 215 ~~~~~~~~~~~~~~~~i-------~~~~~---------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 215 SSDNPDQNTEDYLFQVI-------LEKQI---------------------RIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp C-------CHHHHHHHH-------HHCCC---------------------CCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred cccccccccHHHHHHHH-------HcCCC---------------------CCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 11110 000000000 00000 0112234568899999999999999996
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-36 Score=286.67 Aligned_cols=142 Identities=28% Similarity=0.401 Sum_probs=126.0
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
..||||+++++.+.. ....++||||+ +++|.+++..... ..+++..++.++.||+.||+||| +.||+||
T Consensus 93 ~~h~~iv~~~~~~~~-----~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHr 161 (360)
T 3llt_A 93 INNNNIVKYHGKFMY-----YDHMCLIFEPL-GPSLYEIITRNNY--NGFHIEDIKLYCIEILKALNYLR---KMSLTHT 161 (360)
T ss_dssp TTGGGBCCEEEEEEE-----TTEEEEEECCC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECS
T ss_pred CCCCCeecccceeeE-----CCeeEEEEcCC-CCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeC
Confidence 469999999998654 45789999999 9999999875432 45899999999999999999999 8999999
Q ss_pred cccCCceeeCC-------------------------CCceEecccccccccCCc---CCCccccccccccCCCCcCcccc
Q 042634 259 DLKPSNVLLDG-------------------------ELTAHVGDFGLAKFLPEA---TNNFFNFQIAEYGMGSEVSTSGD 310 (427)
Q Consensus 259 Dlkp~NIll~~-------------------------~~~~kL~DFG~a~~~~~~---~~~~~~y~aPE~~~~~~~~~~~D 310 (427)
||||+|||++. ++.+||+|||+|+..... ..||..|+|||++.+..++.++|
T Consensus 162 Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 241 (360)
T 3llt_A 162 DLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSD 241 (360)
T ss_dssp CCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHH
T ss_pred CCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccc
Confidence 99999999975 789999999999875443 37899999999999999999999
Q ss_pred chhHHHHHHHHHhCCCCCCcc
Q 042634 311 VYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 311 iwS~G~vl~ell~g~~pf~~~ 331 (427)
||||||++|||++|+.||...
T Consensus 242 iwslG~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 242 MWSFGCVLAELYTGSLLFRTH 262 (360)
T ss_dssp HHHHHHHHHHHHHSSCSCCCS
T ss_pred hHHHHHHHHHHHHCCCCCCCC
Confidence 999999999999999999753
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-36 Score=281.36 Aligned_cols=221 Identities=21% Similarity=0.205 Sum_probs=157.4
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeecc
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCD 259 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrD 259 (427)
.||||+++++.+...........++||||+. |+|.+++..... ..+++..++.++.|++.||+||| +.||+|||
T Consensus 72 ~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~D 145 (308)
T 3g33_A 72 EHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPP--PGLPAETIKDLMRQFLRGLDFLH---ANCIVHRD 145 (308)
T ss_dssp CCTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCT--TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred CCCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCC
Confidence 5999999999876533222335789999995 799999876543 34899999999999999999999 89999999
Q ss_pred ccCCceeeCCCCceEecccccccccCCcC-----CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccCC
Q 042634 260 LKPSNVLLDGELTAHVGDFGLAKFLPEAT-----NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTG 334 (427)
Q Consensus 260 lkp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~~ 334 (427)
|||+||+++.++.+||+|||+|+...... .+|..|+|||++.+..++.++||||+||++|||++|+.||.+....
T Consensus 146 lkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 225 (308)
T 3g33_A 146 LKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA 225 (308)
T ss_dssp CCTTTEEECTTSCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH
T ss_pred CCHHHEEEcCCCCEEEeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999999999999999999998764332 6788999999999999999999999999999999999999753211
Q ss_pred CccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 042634 335 NLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAAQ 413 (427)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~ 413 (427)
..+.............. ............ .............+.+.++.+++.+||+.||++|||++|++++
T Consensus 226 -~~~~~i~~~~~~~~~~~-~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 226 -DQLGKIFDLIGLPPEDD-WPRDVSLPRGAF-----PPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp -HHHHHHHHHHCCCCTTT-SCSSCSSCGGGS-----CCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -HHHHHHHHHhCCCChhh-ccchhhcccccc-----CCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 11112111111110000 000000000000 0000000000112245678999999999999999999999863
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-36 Score=293.67 Aligned_cols=192 Identities=18% Similarity=0.211 Sum_probs=154.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++|||||++|+|.+++... ..+++..+..++.||+.||+||| +.||+||
T Consensus 67 l~hpnIv~l~~~~~~-----~~~~~lv~E~~~gg~L~~~i~~~----~~~~e~~~~~i~~qil~aL~~lH---~~givHr 134 (444)
T 3soa_A 67 LKHPNIVRLHDSISE-----EGHHYLIFDLVTGGELFEDIVAR----EYYSEADASHCIQQILEAVLHCH---QMGVVHR 134 (444)
T ss_dssp CCBTTBCCEEEEEEC-----SSEEEEEECCCBCCBHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCC
T ss_pred CCCcCCCeEEEEEEE-----CCEEEEEEEeCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccc
Confidence 579999999998543 56789999999999999988754 45899999999999999999999 8999999
Q ss_pred cccCCceeeC---CCCceEecccccccccCCc------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCC
Q 042634 259 DLKPSNVLLD---GELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTN 329 (427)
Q Consensus 259 Dlkp~NIll~---~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~ 329 (427)
||||+|||++ .++.+||+|||+|+..... ..||+.|+|||++.+..++.++||||+||++|+|++|..||.
T Consensus 135 DlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~ 214 (444)
T 3soa_A 135 NLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFW 214 (444)
T ss_dssp CCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCCHHHEEEeccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCC
Confidence 9999999998 4678999999999876432 378999999999999999999999999999999999999996
Q ss_pred cccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 042634 330 EMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEE 409 (427)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~e 409 (427)
+.. ...+...+...... ... .....++.++.+++.+||+.||++|||++|
T Consensus 215 ~~~--~~~~~~~i~~~~~~----~~~------------------------~~~~~~s~~~~~li~~~L~~dP~~Rpta~e 264 (444)
T 3soa_A 215 DED--QHRLYQQIKAGAYD----FPS------------------------PEWDTVTPEAKDLINKMLTINPSKRITAAE 264 (444)
T ss_dssp CSS--HHHHHHHHHHTCCC----CCT------------------------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred Ccc--HHHHHHHHHhCCCC----CCc------------------------cccccCCHHHHHHHHHHcCCChhHCCCHHH
Confidence 531 11111111111000 000 011223556889999999999999999999
Q ss_pred HHH
Q 042634 410 VAA 412 (427)
Q Consensus 410 v~~ 412 (427)
+++
T Consensus 265 ~L~ 267 (444)
T 3soa_A 265 ALK 267 (444)
T ss_dssp HHH
T ss_pred Hhc
Confidence 986
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=287.19 Aligned_cols=188 Identities=24% Similarity=0.390 Sum_probs=152.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++++.. ....++||||+ +|+|.+++... ..+++..++.++.|++.||+||| +.||+||
T Consensus 66 l~hpnIv~l~~~~~~-----~~~~~lv~E~~-~g~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~givH~ 132 (336)
T 3h4j_B 66 LRHPHIIKLYDVITT-----PTDIVMVIEYA-GGELFDYIVEK----KRMTEDEGRRFFQQIICAIEYCH---RHKIVHR 132 (336)
T ss_dssp CCCTTBCCEEEEEEC-----SSEEEEEECCC-CEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHH---HHTCCCC
T ss_pred CCCCCCCeEEEEEEe-----CCEEEEEEECC-CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEec
Confidence 569999999998544 56789999999 78998888654 45999999999999999999999 8899999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc-----CCCccccccccccCCCCc-CccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMGSEV-STSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~~~~-~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+||+++.++.+||+|||+++..... ..||+.|+|||++.+..+ ++++||||+||++|||++|+.||.+..
T Consensus 133 Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~ 212 (336)
T 3h4j_B 133 DLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF 212 (336)
T ss_dssp CCSTTTEEECTTCCEEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSS
T ss_pred CCchhhEEEcCCCCEEEEEeccceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCcc
Confidence 99999999999999999999999876443 278999999999988876 789999999999999999999997532
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
... +...+.... ...+...+.++.+++++||+.||.+|||++|+++
T Consensus 213 ~~~--------------~~~~i~~~~--------------------~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 213 IPN--------------LFKKVNSCV--------------------YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp STT--------------CBCCCCSSC--------------------CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred HHH--------------HHHHHHcCC--------------------CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 111 000000000 0011223456889999999999999999999976
Q ss_pred H
Q 042634 413 Q 413 (427)
Q Consensus 413 ~ 413 (427)
.
T Consensus 259 h 259 (336)
T 3h4j_B 259 D 259 (336)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=278.73 Aligned_cols=200 Identities=27% Similarity=0.366 Sum_probs=155.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. .....++||||+++++|.+++..... ..+++..+..++.|++.||+||| +.||+||
T Consensus 71 l~h~~iv~~~~~~~~----~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~ 141 (278)
T 1byg_A 71 LRHSNLVQLLGVIVE----EKGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHR 141 (278)
T ss_dssp CCCTTBCCEEEEECC----C--CCEEEECCCTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred CCCCCEeeEEEEEEc----CCCceEEEEecCCCCCHHHHHHhccc--ccCCHHHHHHHHHHHHHHHHHHH---hCCcccc
Confidence 469999999997533 23467999999999999999865432 34889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc---CCCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCCcccCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA---TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNEMFTG 334 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~~~~~~ 334 (427)
||||+||+++.++.+||+|||.++..... ..++..|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 142 dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~- 220 (278)
T 1byg_A 142 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL- 220 (278)
T ss_dssp CCSGGGEEECTTSCEEECCCCC------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG-
T ss_pred CCCcceEEEeCCCcEEEeeccccccccccccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH-
Confidence 99999999999999999999999865433 266788999999988899999999999999999998 9999975321
Q ss_pred CccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 042634 335 NLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAAQL 414 (427)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L 414 (427)
......+..... ...+..++.++.+++.+||+.||++|||++|+++.|
T Consensus 221 -~~~~~~~~~~~~-------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L 268 (278)
T 1byg_A 221 -KDVVPRVEKGYK-------------------------------MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQL 268 (278)
T ss_dssp -GGHHHHHTTTCC-------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred -HHHHHHHhcCCC-------------------------------CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHH
Confidence 111111100000 001223456789999999999999999999999999
Q ss_pred HHHHHH
Q 042634 415 LSFRNK 420 (427)
Q Consensus 415 ~~~~~~ 420 (427)
++++..
T Consensus 269 ~~i~~~ 274 (278)
T 1byg_A 269 EHIKTH 274 (278)
T ss_dssp HHHHHH
T ss_pred HHHHhh
Confidence 999764
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=290.11 Aligned_cols=187 Identities=22% Similarity=0.298 Sum_probs=151.7
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
.+||||+++++.+.. ....++||||+++|+|.+++... ..+++..++.++.||+.||+||| +.||+||
T Consensus 75 ~~hp~iv~l~~~~~~-----~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHr 142 (345)
T 1xjd_A 75 WEHPFLTHMFCTFQT-----KENLFFVMEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLH---SKGIVYR 142 (345)
T ss_dssp TTCTTBCCEEEEEEC-----SSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCC
T ss_pred CCCCCCCcEEEEEEe-----CCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeC
Confidence 479999999988543 56789999999999999998653 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC------cCCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE------ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+|||++.++.+||+|||+|+.... ...||+.|+|||++.+..++.++||||+||++|||++|+.||.+..
T Consensus 143 Dlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 222 (345)
T 1xjd_A 143 DLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 222 (345)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCChhhEEECCCCCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC
Confidence 9999999999999999999999986422 2278999999999999999999999999999999999999997531
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHH-HHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME-EVA 411 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~-ev~ 411 (427)
. ..+...+....+ . .+...+.++.+++.+||+.||++|||+. ||+
T Consensus 223 ~--~~~~~~i~~~~~---------------------------~-----~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 223 E--EELFHSIRMDNP---------------------------F-----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp H--HHHHHHHHHCCC---------------------------C-----CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred H--HHHHHHHHhCCC---------------------------C-----CCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 1 111111110000 0 1112345688999999999999999997 664
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-36 Score=283.20 Aligned_cols=193 Identities=19% Similarity=0.245 Sum_probs=154.3
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+++|+|.+++... ..+++..+..++.|++.||+||| +.||+||
T Consensus 71 l~hp~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~ 138 (326)
T 2y0a_A 71 IQHPNVITLHEVYEN-----KTDVILILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLH---SLQIAHF 138 (326)
T ss_dssp CCCTTBCCEEEEEEC-----SSEEEEEEECCCSCBHHHHHTTS----SCCBHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred CCCCCCCcEEEEEEe-----CCEEEEEEEcCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHH---HCCeEcC
Confidence 469999999998543 56789999999999999998754 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCC----ceEecccccccccCCc-----CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCC
Q 042634 259 DLKPSNVLLDGEL----TAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTN 329 (427)
Q Consensus 259 Dlkp~NIll~~~~----~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~ 329 (427)
||||+||+++.++ .+||+|||+++..... ..||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 139 Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 218 (326)
T 2y0a_A 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218 (326)
T ss_dssp CCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSC
T ss_pred CCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCC
Confidence 9999999998877 8999999999876432 378999999999999999999999999999999999999996
Q ss_pred cccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 042634 330 EMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEE 409 (427)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~e 409 (427)
+... ......+...... . . ......++..+.+++.+||+.||++|||++|
T Consensus 219 ~~~~--~~~~~~~~~~~~~----~-~-----------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 268 (326)
T 2y0a_A 219 GDTK--QETLANVSAVNYE----F-E-----------------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQD 268 (326)
T ss_dssp CSSH--HHHHHHHHHTCCC----C-C-----------------------HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CCCH--HHHHHHHHhcCCC----c-C-----------------------ccccccCCHHHHHHHHHHccCChhhCCCHHH
Confidence 5311 0011101000000 0 0 0011223556889999999999999999999
Q ss_pred HHHH
Q 042634 410 VAAQ 413 (427)
Q Consensus 410 v~~~ 413 (427)
++++
T Consensus 269 ~l~h 272 (326)
T 2y0a_A 269 SLQH 272 (326)
T ss_dssp HHHS
T ss_pred HhcC
Confidence 9873
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=276.66 Aligned_cols=198 Identities=26% Similarity=0.420 Sum_probs=159.9
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+++++|.+++.... ..+++..+..++.|++.||+||| +.||+||
T Consensus 60 l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~ 128 (267)
T 3t9t_A 60 LSHPKLVQLYGVCLE-----QAPICLVTEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLE---EACVIHR 128 (267)
T ss_dssp CCCTTBCCEEEEECS-----SSSCEEEECCCTTCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred CCCCCEeeEEEEEcc-----CCCeEEEEeCCCCCcHHHHHhhCc---ccCCHHHHHHHHHHHHHHHHHHH---hCCcccC
Confidence 469999999998543 457899999999999999986543 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC-------cCCCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCCc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE-------ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~-------~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~~ 330 (427)
||||+||+++.++.+||+|||.++.... ...++..|+|||++.+..++.++||||+|+++|||++ |+.||..
T Consensus 129 dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 208 (267)
T 3t9t_A 129 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 208 (267)
T ss_dssp SCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred CCchheEEECCCCCEEEcccccccccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCC
Confidence 9999999999999999999999986533 2256678999999988889999999999999999999 8999875
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
... ......+...... ..+..++.++.+++.+||+.||++|||++|+
T Consensus 209 ~~~--~~~~~~i~~~~~~-------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 255 (267)
T 3t9t_A 209 RSN--SEVVEDISTGFRL-------------------------------YKPRLASTHVYQIMNHCWRERPEDRPAFSRL 255 (267)
T ss_dssp CCH--HHHHHHHHTTCCC-------------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCH--HHHHHHHhcCCcC-------------------------------CCCccCcHHHHHHHHHHccCChhhCcCHHHH
Confidence 311 1111111110000 0111234568899999999999999999999
Q ss_pred HHHHHHHHHH
Q 042634 411 AAQLLSFRNK 420 (427)
Q Consensus 411 ~~~L~~~~~~ 420 (427)
++.|+++.++
T Consensus 256 l~~L~~l~~~ 265 (267)
T 3t9t_A 256 LRQLAEIAES 265 (267)
T ss_dssp HHHHHHHHHC
T ss_pred HHHHHHHHhc
Confidence 9999999763
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-36 Score=278.61 Aligned_cols=200 Identities=23% Similarity=0.353 Sum_probs=162.3
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+. ....++||||+++++|.+++.... ..+++..+..++.|++.||+||| +.||+||
T Consensus 67 l~h~~i~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~ 134 (287)
T 1u59_A 67 LDNPYIVRLIGVCQ------AEALMLVMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLE---EKNFVHR 134 (287)
T ss_dssp CCCTTBCCEEEEEE------SSSEEEEEECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred CCCCCEeEEEEEec------CCCcEEEEEeCCCCCHHHHHHhCC---ccCCHHHHHHHHHHHHHHHHHHH---HCCEeeC
Confidence 46999999999862 245899999999999999986543 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC---------CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT---------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPT 328 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~---------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf 328 (427)
||||+||+++.++.+||+|||+++...... .++..|+|||++.+..++.++|||||||++|||++ |+.||
T Consensus 135 dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~ 214 (287)
T 1u59_A 135 DLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY 214 (287)
T ss_dssp CCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCc
Confidence 999999999999999999999998764321 45788999999988889999999999999999998 99999
Q ss_pred CcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 042634 329 NEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME 408 (427)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ 408 (427)
..... ......+...... ..+..++.++.+++.+||+.||++|||+.
T Consensus 215 ~~~~~--~~~~~~i~~~~~~-------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 261 (287)
T 1u59_A 215 KKMKG--PEVMAFIEQGKRM-------------------------------ECPPECPPELYALMSDCWIYKWEDRPDFL 261 (287)
T ss_dssp TTCCT--HHHHHHHHTTCCC-------------------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHH
T ss_pred ccCCH--HHHHHHHhcCCcC-------------------------------CCCCCcCHHHHHHHHHHcCCChhhCcCHH
Confidence 75321 1111111110000 01223456789999999999999999999
Q ss_pred HHHHHHHHHHHHHHh
Q 042634 409 EVAAQLLSFRNKLVK 423 (427)
Q Consensus 409 ev~~~L~~~~~~~~~ 423 (427)
|+++.|+++..+...
T Consensus 262 ~l~~~l~~~~~~~~~ 276 (287)
T 1u59_A 262 TVEQRMRACYYSLAS 276 (287)
T ss_dssp HHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHhcCC
Confidence 999999999876543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-36 Score=287.92 Aligned_cols=191 Identities=23% Similarity=0.322 Sum_probs=152.3
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||++++.+.. ....++||||+.+|+|.+++... ..+++..++.++.||+.||+||| +.||+||
T Consensus 72 l~hp~Iv~l~~~~~~-----~~~~~lv~e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH---~~givHr 139 (384)
T 4fr4_A 72 LEHPFLVNLWYSFQD-----EEDMFMVVDLLLGGDLRYHLQQN----VHFKEETVKLFICELVMALDYLQ---NQRIIHR 139 (384)
T ss_dssp CCCTTBCCEEEEEEC-----SSEEEEEECCCTTEEHHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred CCCCCCCcEEEEEEe-----CCEEEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCceec
Confidence 479999999988543 56789999999999999998764 45999999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc-----CCCccccccccccCC---CCcCccccchhHHHHHHHHHhCCCCCCc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMG---SEVSTSGDVYSFGILLLETFTGKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~---~~~~~~~DiwS~G~vl~ell~g~~pf~~ 330 (427)
||||+|||++.++.+||+|||+|+..... ..||+.|+|||++.. ..++.++|||||||++|||++|+.||..
T Consensus 140 Dlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~ 219 (384)
T 4fr4_A 140 DMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHI 219 (384)
T ss_dssp CCSGGGEEECTTSCEEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCcHHHeEECCCCCEEEeccceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999876433 278999999999874 4589999999999999999999999975
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCC-HHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMN-MEE 409 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt-~~e 409 (427)
.... ............. . ..+..++.++.+++.+||+.||++||+ +++
T Consensus 220 ~~~~--~~~~~~~~~~~~~----~-------------------------~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~ 268 (384)
T 4fr4_A 220 RSST--SSKEIVHTFETTV----V-------------------------TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSD 268 (384)
T ss_dssp CTTS--CHHHHHHHHHHCC----C-------------------------CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHH
T ss_pred CCCc--cHHHHHHHHhhcc----c-------------------------CCCCcCCHHHHHHHHHHhcCCHhHhcccHHH
Confidence 3221 1111111110000 0 011223456899999999999999998 666
Q ss_pred HHH
Q 042634 410 VAA 412 (427)
Q Consensus 410 v~~ 412 (427)
+.+
T Consensus 269 l~~ 271 (384)
T 4fr4_A 269 VQN 271 (384)
T ss_dssp HHT
T ss_pred HHc
Confidence 553
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-36 Score=284.62 Aligned_cols=198 Identities=22% Similarity=0.416 Sum_probs=156.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+++|+|.+++.... ..+++..++.++.|++.||+||| +.||+||
T Consensus 103 l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~ 171 (333)
T 1mqb_A 103 FSHHNIIRLEGVISK-----YKPMMIITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLA---NMNYVHR 171 (333)
T ss_dssp CCCTTBCCEEEEECS-----SSSEEEEEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred CCCCCCCcEEEEEec-----CCCcEEEEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCC
Confidence 479999999998543 567899999999999999986542 45899999999999999999999 8899999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC---------CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT---------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPT 328 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~---------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf 328 (427)
||||+||+++.++.+||+|||.++...... .++..|+|||++.+..++.++|||||||++|||++ |+.||
T Consensus 172 Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf 251 (333)
T 1mqb_A 172 DLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY 251 (333)
T ss_dssp CCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCc
Confidence 999999999999999999999998764321 45678999999999999999999999999999999 99999
Q ss_pred CcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 042634 329 NEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME 408 (427)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ 408 (427)
..... ......+...... ..+..++.++.+++.+||+.||++|||++
T Consensus 252 ~~~~~--~~~~~~~~~~~~~-------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 298 (333)
T 1mqb_A 252 WELSN--HEVMKAINDGFRL-------------------------------PTPMDCPSAIYQLMMQCWQQERARRPKFA 298 (333)
T ss_dssp TTCCH--HHHHHHHHTTCCC-------------------------------CCCTTCBHHHHHHHHHHTCSSTTTSCCHH
T ss_pred ccCCH--HHHHHHHHCCCcC-------------------------------CCcccCCHHHHHHHHHHcCCChhhCcCHH
Confidence 65311 1111111110000 01122456689999999999999999999
Q ss_pred HHHHHHHHHHHH
Q 042634 409 EVAAQLLSFRNK 420 (427)
Q Consensus 409 ev~~~L~~~~~~ 420 (427)
|+++.|+++.+.
T Consensus 299 ~l~~~L~~~~~~ 310 (333)
T 1mqb_A 299 DIVSILDKLIRA 310 (333)
T ss_dssp HHHHHHHHHHHS
T ss_pred HHHHHHHHHHhc
Confidence 999999998764
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-36 Score=286.84 Aligned_cols=193 Identities=19% Similarity=0.247 Sum_probs=153.8
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+++|+|.+++... ..+++..+..++.||+.||+||| +.||+||
T Consensus 85 l~hpnIv~~~~~~~~-----~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~ 152 (362)
T 2bdw_A 85 LQHPNIVRLHDSIQE-----ESFHYLVFDLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCH---SNGIVHR 152 (362)
T ss_dssp CCCTTBCCEEEEEEC-----SSEEEEEECCCCSCBHHHHHTTC----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCC
T ss_pred CCCCCCCeEEEEEEe-----CCEEEEEEecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEec
Confidence 579999999998543 56789999999999999988765 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCC---CceEecccccccccCCc-----CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCc
Q 042634 259 DLKPSNVLLDGE---LTAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~~---~~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~ 330 (427)
||||+|||++.+ +.+||+|||+++..... ..||+.|+|||++.+..++.++|||||||++|||++|..||.+
T Consensus 153 Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~ 232 (362)
T 2bdw_A 153 NLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 232 (362)
T ss_dssp CCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCchHHEEEecCCCCCCEEEeecCcceEecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 999999999765 45999999999876543 3789999999999999999999999999999999999999975
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
.. ...+...+...... .. ......++.++.+++.+||+.||++|||++|+
T Consensus 233 ~~--~~~~~~~i~~~~~~----~~------------------------~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~ 282 (362)
T 2bdw_A 233 ED--QHRLYAQIKAGAYD----YP------------------------SPEWDTVTPEAKSLIDSMLTVNPKKRITADQA 282 (362)
T ss_dssp SS--HHHHHHHHHHTCCC----CC------------------------TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred CC--HHHHHHHHHhCCCC----CC------------------------cccccCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 31 11111111110000 00 00112235668999999999999999999998
Q ss_pred HHH
Q 042634 411 AAQ 413 (427)
Q Consensus 411 ~~~ 413 (427)
+++
T Consensus 283 l~h 285 (362)
T 2bdw_A 283 LKV 285 (362)
T ss_dssp TTS
T ss_pred hcC
Confidence 864
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-36 Score=286.92 Aligned_cols=215 Identities=17% Similarity=0.153 Sum_probs=163.8
Q ss_pred cccccchhhhcccccc-----------CCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHH
Q 042634 179 IRHRNLVKIITSCASV-----------DFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYL 247 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~-----------~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~L 247 (427)
++||||+++++..... ....+...++||||+ +++|.+++..... ..+++..++.++.|++.||+||
T Consensus 99 l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~L 175 (352)
T 2jii_A 99 AAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK--HVLSERSVLQVACRLLDALEFL 175 (352)
T ss_dssp HCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHH
T ss_pred hcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCc--CCCCHHHHHHHHHHHHHHHHHH
Confidence 5699999866543221 111245679999999 9999999976532 5699999999999999999999
Q ss_pred hhcCCCCeeeccccCCceeeCCCC--ceEecccccccccCCc-------------CCCccccccccccCCCCcCccccch
Q 042634 248 HHYCETPIVHCDLKPSNVLLDGEL--TAHVGDFGLAKFLPEA-------------TNNFFNFQIAEYGMGSEVSTSGDVY 312 (427)
Q Consensus 248 H~~~~~~ivHrDlkp~NIll~~~~--~~kL~DFG~a~~~~~~-------------~~~~~~y~aPE~~~~~~~~~~~Diw 312 (427)
| ++||+||||||+||+++.++ .+||+|||+++..... ..||..|+|||++.+..++.++|||
T Consensus 176 H---~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~ 252 (352)
T 2jii_A 176 H---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQ 252 (352)
T ss_dssp H---HTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHH
T ss_pred H---hCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHH
Confidence 9 88999999999999999998 9999999999765321 2688899999999999999999999
Q ss_pred hHHHHHHHHHhCCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHH
Q 042634 313 SFGILLLETFTGKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGI 392 (427)
Q Consensus 313 S~G~vl~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 392 (427)
||||++|||++|+.||.........+....... ........+... .....+.++.++
T Consensus 253 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~----------------------~~~~~~~~l~~l 309 (352)
T 2jii_A 253 SLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKF-VDKPGPFVGPCG----------------------HWIRPSETLQKY 309 (352)
T ss_dssp HHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHH-HHSCCCEECTTS----------------------CEECCCHHHHHH
T ss_pred HHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhc-cCChhhhhhhcc----------------------ccCCCcHHHHHH
Confidence 999999999999999986532322222221111 111111111000 001134668999
Q ss_pred HhhcCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 042634 393 GVTCSSELPRERMNMEEVAAQLLSFRNKLV 422 (427)
Q Consensus 393 ~~~cl~~dP~~Rpt~~ev~~~L~~~~~~~~ 422 (427)
+.+||+.||++|||++|+++.|+++.++..
T Consensus 310 i~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 310 LKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp HHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 999999999999999999999999987753
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=277.22 Aligned_cols=205 Identities=19% Similarity=0.243 Sum_probs=160.0
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
+.|++++..+..+.. .+...++||||+ +++|.+++.... ..+++..++.++.|++.||+||| +.||+||
T Consensus 61 l~~~~~i~~~~~~~~----~~~~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~ 129 (296)
T 4hgt_A 61 MQGGVGIPTIRWCGA----EGDYNVMVMELL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIH---SKNFIHR 129 (296)
T ss_dssp HTTSTTCCCEEEEEE----ETTEEEEEEECC-CCBHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECS
T ss_pred hcCCCCCCeeeeecC----CCCceEEEEEcc-CCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecC
Confidence 456776666655422 245679999999 999999986432 45899999999999999999999 8999999
Q ss_pred cccCCceee---CCCCceEecccccccccCC-------------cCCCccccccccccCCCCcCccccchhHHHHHHHHH
Q 042634 259 DLKPSNVLL---DGELTAHVGDFGLAKFLPE-------------ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETF 322 (427)
Q Consensus 259 Dlkp~NIll---~~~~~~kL~DFG~a~~~~~-------------~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell 322 (427)
||||+||++ +.++.+||+|||+|+.... ...+|..|+|||++.+..++.++|||||||++|||+
T Consensus 130 Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 209 (296)
T 4hgt_A 130 DVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFN 209 (296)
T ss_dssp CCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred CCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHh
Confidence 999999999 7889999999999986543 226889999999999999999999999999999999
Q ss_pred hCCCCCCcccCCCc--cHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCC
Q 042634 323 TGKRPTNEMFTGNL--TLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSEL 400 (427)
Q Consensus 323 ~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~d 400 (427)
+|+.||........ .+........+..... ....++.++.+++.+||+.|
T Consensus 210 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~~ 261 (296)
T 4hgt_A 210 LGSLPWQGLKAATKRQKYERISEKKMSTPIEV----------------------------LCKGYPSEFATYLNFCRSLR 261 (296)
T ss_dssp HSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH----------------------------HTTTSCHHHHHHHHHHHTSC
T ss_pred cCCCCCcccchhhhhhhhhhhhcccccchhhh----------------------------hhccCCHHHHHHHHHHHhcC
Confidence 99999986432211 1111111111110000 01123567899999999999
Q ss_pred CCCCCCHHHHHHHHHHHHHHHH
Q 042634 401 PRERMNMEEVAAQLLSFRNKLV 422 (427)
Q Consensus 401 P~~Rpt~~ev~~~L~~~~~~~~ 422 (427)
|++|||++|+++.|+++.++..
T Consensus 262 p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 262 FDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp TTCCCCHHHHHHHHHHHHHHHT
T ss_pred CCCCCCHHHHHHHHHHHHHHhC
Confidence 9999999999999999988753
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-36 Score=283.93 Aligned_cols=201 Identities=22% Similarity=0.394 Sum_probs=160.9
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchh------------hhhccCHHHHHHHHHHHHHHHHHH
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNRE------------ALKNLNLLQRLSIAVDVASALDYL 247 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~~~~~i~~~L~~L 247 (427)
+||||+++++.+.. ....++||||+++|+|.+++..... ....+++..++.++.|++.||+||
T Consensus 99 ~hp~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L 173 (334)
T 2pvf_A 99 KHKNIINLLGACTQ-----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL 173 (334)
T ss_dssp CCTTBCCEEEEECS-----SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHH
T ss_pred cCCCEeeEEEEEcc-----CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHH
Confidence 79999999998644 5678999999999999999875431 113488999999999999999999
Q ss_pred hhcCCCCeeeccccCCceeeCCCCceEecccccccccCCc--------CCCccccccccccCCCCcCccccchhHHHHHH
Q 042634 248 HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA--------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLL 319 (427)
Q Consensus 248 H~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ 319 (427)
| +.||+||||||+||+++.++.+||+|||+++..... ..++..|+|||++.+..++.++|||||||++|
T Consensus 174 H---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 250 (334)
T 2pvf_A 174 A---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMW 250 (334)
T ss_dssp H---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHH
T ss_pred H---hCCeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHH
Confidence 9 899999999999999999999999999999865432 25667899999998888999999999999999
Q ss_pred HHHh-CCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCC
Q 042634 320 ETFT-GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSS 398 (427)
Q Consensus 320 ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~ 398 (427)
||++ |..||.+... ..+...+...... ..+..++.++.+++.+||+
T Consensus 251 ellt~g~~p~~~~~~--~~~~~~~~~~~~~-------------------------------~~~~~~~~~l~~li~~~l~ 297 (334)
T 2pvf_A 251 EIFTLGGSPYPGIPV--EELFKLLKEGHRM-------------------------------DKPANCTNELYMMMRDCWH 297 (334)
T ss_dssp HHHTTSCCSSTTCCH--HHHHHHHHHTCCC-------------------------------CCCTTCCHHHHHHHHHHTC
T ss_pred HHHhCCCCCcCcCCH--HHHHHHHhcCCCC-------------------------------CCCccCCHHHHHHHHHHcc
Confidence 9999 9999975311 1111111111000 0112345678999999999
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHH
Q 042634 399 ELPRERMNMEEVAAQLLSFRNKL 421 (427)
Q Consensus 399 ~dP~~Rpt~~ev~~~L~~~~~~~ 421 (427)
.||++|||++|+++.|+++....
T Consensus 298 ~dp~~Rps~~ell~~L~~l~~~~ 320 (334)
T 2pvf_A 298 AVPSQRPTFKQLVEDLDRILTLT 320 (334)
T ss_dssp SSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CChhhCcCHHHHHHHHHHHHhcc
Confidence 99999999999999999997653
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=279.48 Aligned_cols=199 Identities=24% Similarity=0.395 Sum_probs=161.9
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+++++|.+++..... ..+++..++.++.|++.||+||| +.||+||
T Consensus 66 l~h~~i~~~~~~~~~-----~~~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~ 135 (288)
T 3kfa_A 66 IKHPNLVQLLGVCTR-----EPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLE---KKNFIHR 135 (288)
T ss_dssp CCCTTBCCEEEEECS-----SSSEEEEEECCTTEEHHHHHHHCCT--TTSCHHHHHHHHHHHHHHHHHHH---HHTCCCS
T ss_pred CCCCCEeeEEEEEcc-----CCCEEEEEEcCCCCcHHHHHHhccc--CCccHhHHHHHHHHHHHHHHHHH---HCCccCC
Confidence 469999999998543 5678999999999999999865432 45899999999999999999999 8899999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC-------CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCCc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT-------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~-------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~~ 330 (427)
||||+||+++.++.+||+|||.++...... .++..|+|||++.+..++.++||||+||++|+|++ |..||..
T Consensus 136 dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~ 215 (288)
T 3kfa_A 136 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 215 (288)
T ss_dssp CCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCCcceEEEcCCCCEEEccCccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999998765433 45667999999998899999999999999999999 9999975
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
... ......+...... ..+..++.++.+++.+||+.||++|||++|+
T Consensus 216 ~~~--~~~~~~~~~~~~~-------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~ 262 (288)
T 3kfa_A 216 IDL--SQVYELLEKDYRM-------------------------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEI 262 (288)
T ss_dssp CCG--GGHHHHHHTTCCC-------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCH--HHHHHHHhccCCC-------------------------------CCCCCCCHHHHHHHHHHhCCChhhCcCHHHH
Confidence 321 1121111111000 0122345678999999999999999999999
Q ss_pred HHHHHHHHHH
Q 042634 411 AAQLLSFRNK 420 (427)
Q Consensus 411 ~~~L~~~~~~ 420 (427)
++.|+.+.++
T Consensus 263 ~~~l~~~~~~ 272 (288)
T 3kfa_A 263 HQAFETMFQE 272 (288)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHh
Confidence 9999998765
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-36 Score=280.41 Aligned_cols=215 Identities=22% Similarity=0.280 Sum_probs=154.4
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||++ |+|.+++.... ..+++..++.++.|++.||+||| +.||+||
T Consensus 76 l~hp~iv~~~~~~~~-----~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~ 143 (311)
T 3niz_A 76 LHHPNIVSLIDVIHS-----ERCLTLVFEFME-KDLKKVLDENK---TGLQDSQIKIYLYQLLRGVAHCH---QHRILHR 143 (311)
T ss_dssp CCCTTBCCEEEEECC-----SSCEEEEEECCS-EEHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred cCCCCEeeeeeEEcc-----CCEEEEEEcCCC-CCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccC
Confidence 469999999998543 567899999996 58888776543 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCC-CCcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
||||+||+++.++.+||+|||+|+..... ..+|..|+|||++.+ ..++.++||||+||++|||++|+.||.+.
T Consensus 144 Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 223 (311)
T 3niz_A 144 DLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGV 223 (311)
T ss_dssp CCCGGGEEECTTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCchHhEEECCCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999999875422 267899999999876 56899999999999999999999999865
Q ss_pred cCCCccHHHHHHHhcc---cchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 042634 332 FTGNLTLHNFVKEALP---ERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME 408 (427)
Q Consensus 332 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ 408 (427)
.... .+......... ..+....+...... ... .......+ ....+.++.++.+++.+||+.||++|||++
T Consensus 224 ~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~---~~~-~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 296 (311)
T 3niz_A 224 TDDD-QLPKIFSILGTPNPREWPQVQELPLWKQ---RTF-QVFEKKPW--SSIIPGFCQEGIDLLSNMLCFDPNKRISAR 296 (311)
T ss_dssp STTT-HHHHHHHHHCCCCTTTSGGGTTSHHHHS---CCC-CCCCCCCH--HHHSTTCCHHHHHHHHHHSCSCTTTSCCHH
T ss_pred ChHH-HHHHHHHHHCCCChHHhhhhhccchhhh---ccc-ccccCCcH--HHhCcccCHHHHHHHHHHcCCChhHCCCHH
Confidence 3322 22222221111 11111000000000 000 00000000 001122345789999999999999999999
Q ss_pred HHHH
Q 042634 409 EVAA 412 (427)
Q Consensus 409 ev~~ 412 (427)
|+++
T Consensus 297 ell~ 300 (311)
T 3niz_A 297 DAMN 300 (311)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 9986
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-36 Score=281.28 Aligned_cols=205 Identities=18% Similarity=0.242 Sum_probs=155.8
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+++++|.+++.........+++..++.++.|++.||+||| +.||+||
T Consensus 89 l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~ 160 (310)
T 2wqm_A 89 LNHPNVIKYYASFIE-----DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHR 160 (310)
T ss_dssp CCCTTBCCEEEEEEE-----TTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCC
T ss_pred CCCCCEeeEEEEEEc-----CCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCC
Confidence 469999999998654 45789999999999999998754433356899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+||+++.++.+||+|||+++..... ..++..|+|||++.+..++.++|||||||++|||++|..||.+..
T Consensus 161 dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 240 (310)
T 2wqm_A 161 DIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 240 (310)
T ss_dssp CCCGGGEEECTTSCEEECCC------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred CCcHHHEEEcCCCCEEEEeccceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 99999999999999999999999865432 267889999999999999999999999999999999999997532
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
.....+...+.. .... ......++.++.+++.+||+.||++|||++||++
T Consensus 241 ~~~~~~~~~~~~---~~~~---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 241 MNLYSLCKKIEQ---CDYP---------------------------PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp CCHHHHHHHHHT---TCSC---------------------------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhHHHHHHHhhc---ccCC---------------------------CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 211111111110 0000 0011224556899999999999999999999999
Q ss_pred HHHHHHHHH
Q 042634 413 QLLSFRNKL 421 (427)
Q Consensus 413 ~L~~~~~~~ 421 (427)
.|+++....
T Consensus 291 ~l~~l~~~~ 299 (310)
T 2wqm_A 291 VAKRMHACT 299 (310)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHhh
Confidence 999998764
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=275.67 Aligned_cols=199 Identities=24% Similarity=0.420 Sum_probs=160.7
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+. ....++||||+++++|.+++..... ..+++..+..++.|++.||+||| +.||+||
T Consensus 65 l~h~~i~~~~~~~~------~~~~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~ 133 (279)
T 1qpc_A 65 LQHQRLVRLYAVVT------QEPIYIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIE---ERNYIHR 133 (279)
T ss_dssp CCCTTBCCEEEEEC------SSSCEEEEECCTTCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHH---HTTEECS
T ss_pred CCCcCcceEEEEEc------CCCcEEEEecCCCCCHHHHHhcCCC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecc
Confidence 46999999998753 2457899999999999999976532 46899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC-------CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCCc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT-------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~-------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~~ 330 (427)
||||+||+++.++.+||+|||.++...... .++..|+|||++.+..++.++|||||||++|||++ |+.||.+
T Consensus 134 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 213 (279)
T 1qpc_A 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213 (279)
T ss_dssp CCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred CCCHhhEEEcCCCCEEECCCcccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999998764322 45678999999988889999999999999999999 9999975
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
... ......+..... ...+..++.++.+++.+||+.||++|||++|+
T Consensus 214 ~~~--~~~~~~~~~~~~-------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 260 (279)
T 1qpc_A 214 MTN--PEVIQNLERGYR-------------------------------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYL 260 (279)
T ss_dssp CCH--HHHHHHHHTTCC-------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred cCH--HHHHHHHhcccC-------------------------------CCCcccccHHHHHHHHHHhccChhhCCCHHHH
Confidence 311 111111111000 00112345678999999999999999999999
Q ss_pred HHHHHHHHHHH
Q 042634 411 AAQLLSFRNKL 421 (427)
Q Consensus 411 ~~~L~~~~~~~ 421 (427)
++.|+++....
T Consensus 261 ~~~l~~~~~~~ 271 (279)
T 1qpc_A 261 RSVLEDFFTAT 271 (279)
T ss_dssp HHHHHHHHHHC
T ss_pred HHHHHHHHHhc
Confidence 99999997654
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=287.17 Aligned_cols=188 Identities=19% Similarity=0.218 Sum_probs=153.9
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+++|+|.+++... ..+++..++.++.||+.||+||| +.||+||
T Consensus 98 l~hp~iv~~~~~~~~-----~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHr 165 (350)
T 1rdq_E 98 VNFPFLVKLEFSFKD-----NSNLYMVMEYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLH---SLDLIYR 165 (350)
T ss_dssp CCCTTBCCEEEEEEC-----SSEEEEEEECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred CCCCCCCeEEEEEEc-----CCEEEEEEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccc
Confidence 479999999988543 56789999999999999998654 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC---CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT---NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGN 335 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~---~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~~~ 335 (427)
||||+|||++.++.+||+|||+|+...... .||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 166 Dlkp~NIll~~~g~~kL~DFg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--- 242 (350)
T 1rdq_E 166 DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ--- 242 (350)
T ss_dssp CCSGGGEEECTTSCEEECCCTTCEECSSCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---
T ss_pred cCccceEEECCCCCEEEcccccceeccCCcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC---
Confidence 999999999999999999999998765433 78999999999999999999999999999999999999997531
Q ss_pred ccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCC-----HHHH
Q 042634 336 LTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMN-----MEEV 410 (427)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt-----~~ev 410 (427)
..+.......... . .+...+.++.+++.+||+.||++||+ ++||
T Consensus 243 --~~~~~~~i~~~~~----~-------------------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei 291 (350)
T 1rdq_E 243 --PIQIYEKIVSGKV----R-------------------------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDI 291 (350)
T ss_dssp --HHHHHHHHHHCCC----C-------------------------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHH
T ss_pred --HHHHHHHHHcCCC----C-------------------------CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHH
Confidence 1111111110000 0 11123456889999999999999998 8888
Q ss_pred HH
Q 042634 411 AA 412 (427)
Q Consensus 411 ~~ 412 (427)
++
T Consensus 292 ~~ 293 (350)
T 1rdq_E 292 KN 293 (350)
T ss_dssp HT
T ss_pred Hh
Confidence 65
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=284.63 Aligned_cols=210 Identities=27% Similarity=0.397 Sum_probs=163.8
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++++... +....++||||+++|+|.+++... .+++..++.++.|++.||+||| +.||+||
T Consensus 90 l~h~~iv~~~~~~~~~---~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~ 158 (318)
T 3lxp_A 90 LYHEHIIKYKGCCEDA---GAASLQLVMEYVPLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYLH---AQHYIHR 158 (318)
T ss_dssp CCCTTBCCEEEEEEET---TTTEEEEEECCCTTCBHHHHGGGS-----CCCHHHHHHHHHHHHHHHHHHH---HTTEECS
T ss_pred CCCcchhhEEEEEecC---CCceEEEEEecccCCcHHHHHhhC-----CCCHHHHHHHHHHHHHHHHHHH---hCCccCC
Confidence 4699999999986542 235678999999999999999654 3899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc---------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA---------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTN 329 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~---------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~ 329 (427)
||||+||+++.++.+||+|||.++..... ..++..|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 159 Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~ 238 (318)
T 3lxp_A 159 DLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQ 238 (318)
T ss_dssp CCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred CCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCccc
Confidence 99999999999999999999999876442 256778999999998899999999999999999999999986
Q ss_pred cccCCCccHHHHHHHhcc------cchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCC
Q 042634 330 EMFTGNLTLHNFVKEALP------ERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRE 403 (427)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~ 403 (427)
..... .... .... ..+.+.++. ......+..++.++.+++.+||+.||++
T Consensus 239 ~~~~~---~~~~--~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~l~~li~~~l~~dP~~ 294 (318)
T 3lxp_A 239 SPPTK---FLEL--IGIAQGQMTVLRLTELLER-------------------GERLPRPDKCPAEVYHLMKNCWETEASF 294 (318)
T ss_dssp SHHHH---HHHH--HCSCCHHHHHHHHHHHHHT-------------------TCCCCCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred ccchh---hhhh--hcccccchhHHHHHHHHhc-------------------ccCCCCCccccHHHHHHHHHHcCCCccc
Confidence 42110 0000 0000 000000000 0001122345677999999999999999
Q ss_pred CCCHHHHHHHHHHHHHHHHh
Q 042634 404 RMNMEEVAAQLLSFRNKLVK 423 (427)
Q Consensus 404 Rpt~~ev~~~L~~~~~~~~~ 423 (427)
|||++|+++.|+.+.+++..
T Consensus 295 Rps~~ell~~L~~l~~~~~~ 314 (318)
T 3lxp_A 295 RPTFENLIPILKTVHEKYQG 314 (318)
T ss_dssp SCCHHHHHHHHHHHHHHHHC
T ss_pred CcCHHHHHHHHHHHHHhhcc
Confidence 99999999999999988753
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=284.34 Aligned_cols=196 Identities=22% Similarity=0.334 Sum_probs=153.4
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+++|+|.+++.... ..+++..++.++.|++.||+||| ++||+||
T Consensus 69 l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~ 137 (289)
T 4fvq_A 69 LSHKHLVLNYGVCVC-----GDENILVQEFVKFGSLDTYLKKNK---NCINILWKLEVAKQLAAAMHFLE---ENTLIHG 137 (289)
T ss_dssp SCCTTBCCEEEEECC-----TTCCEEEEECCTTCBHHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHH---HTTCCCC
T ss_pred CCCCCEeEEEEEEEe-----CCCCEEEEECCCCCCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHh---hCCeECC
Confidence 469999999998644 556799999999999999997543 34899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCc--------eEecccccccccCCcC--CCccccccccccCC-CCcCccccchhHHHHHHHHHhCCCC
Q 042634 259 DLKPSNVLLDGELT--------AHVGDFGLAKFLPEAT--NNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETFTGKRP 327 (427)
Q Consensus 259 Dlkp~NIll~~~~~--------~kL~DFG~a~~~~~~~--~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell~g~~p 327 (427)
||||+||+++.++. +||+|||.++...... .++..|+|||++.+ ..++.++|||||||++|||++|..|
T Consensus 138 Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~ 217 (289)
T 4fvq_A 138 NVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217 (289)
T ss_dssp CCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred CcCcceEEEecCCcccccccceeeeccCcccccccCccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCC
Confidence 99999999988876 9999999997664433 67888999999987 6789999999999999999996554
Q ss_pred CCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCH
Q 042634 328 TNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM 407 (427)
Q Consensus 328 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~ 407 (427)
+...... ......... ... .+...+.++.+++.+||+.||++|||+
T Consensus 218 ~~~~~~~-~~~~~~~~~--~~~-------------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~ 263 (289)
T 4fvq_A 218 PLSALDS-QRKLQFYED--RHQ-------------------------------LPAPKAAELANLINNCMDYEPDHRPSF 263 (289)
T ss_dssp TTTTSCH-HHHHHHHHT--TCC-------------------------------CCCCSSCTTHHHHHHHSCSSGGGSCCH
T ss_pred Cccccch-HHHHHHhhc--cCC-------------------------------CCCCCCHHHHHHHHHHcCCChhHCcCH
Confidence 4321111 001010000 000 000112347889999999999999999
Q ss_pred HHHHHHHHHHHH
Q 042634 408 EEVAAQLLSFRN 419 (427)
Q Consensus 408 ~ev~~~L~~~~~ 419 (427)
+|+++.|+++..
T Consensus 264 ~~ll~~l~~l~~ 275 (289)
T 4fvq_A 264 RAIIRDLNSLFT 275 (289)
T ss_dssp HHHHHHHHTCC-
T ss_pred HHHHHHHHHhcC
Confidence 999999998754
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=309.06 Aligned_cols=197 Identities=24% Similarity=0.369 Sum_probs=160.3
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||++++++.. ...++|||||++|+|.+++... ..+++..++.++.||+.||+||| +.||+||
T Consensus 427 l~hpnIv~l~~~~~~------~~~~lv~E~~~~g~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHr 493 (635)
T 4fl3_A 427 LDNPYIVRMIGICEA------ESWMLVMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLE---ESNFVHR 493 (635)
T ss_dssp CCCTTBCCEEEEEES------SSEEEEEECCTTEEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred CCCCCEeeEEEEEec------CCEEEEEEccCCCCHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeCC
Confidence 579999999998632 3578999999999999999654 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC---------CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT---------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPT 328 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~---------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf 328 (427)
||||+|||++.++.+||+|||+|+...... .++..|+|||++.+..++.++|||||||++|||++ |+.||
T Consensus 494 DLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf 573 (635)
T 4fl3_A 494 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 573 (635)
T ss_dssp CCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred CCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999998764322 45678999999999999999999999999999998 99999
Q ss_pred CcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 042634 329 NEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME 408 (427)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ 408 (427)
.+... ..+...+..... ...+..++.++.++|.+||+.||++|||++
T Consensus 574 ~~~~~--~~~~~~i~~~~~-------------------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ 620 (635)
T 4fl3_A 574 RGMKG--SEVTAMLEKGER-------------------------------MGCPAGCPREMYDLMNLCWTYDVENRPGFA 620 (635)
T ss_dssp TTCCH--HHHHHHHHTTCC-------------------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred CCCCH--HHHHHHHHcCCC-------------------------------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHH
Confidence 76421 111111111100 002233567799999999999999999999
Q ss_pred HHHHHHHHHHHHH
Q 042634 409 EVAAQLLSFRNKL 421 (427)
Q Consensus 409 ev~~~L~~~~~~~ 421 (427)
+|++.|+++..++
T Consensus 621 ~l~~~L~~~~~~l 633 (635)
T 4fl3_A 621 AVELRLRNYYYDV 633 (635)
T ss_dssp HHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHh
Confidence 9999999987765
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=277.69 Aligned_cols=192 Identities=21% Similarity=0.284 Sum_probs=151.0
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+... .....++||||+++++|.+++.. ..+++..++.++.|++.||+||| +.||+||
T Consensus 93 l~h~~iv~~~~~~~~~---~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~ 161 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDP---NEDHLYMVFELVNQGPVMEVPTL-----KPLSEDQARFYFQDLIKGIEYLH---YQKIIHR 161 (298)
T ss_dssp CCCTTBCCEEEEEECS---SSSEEEEEEECCTTCBSCCSSCS-----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred CCCCCCCeEEEEEEcC---CCCEEEEEEecCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecc
Confidence 4699999999986431 24568999999999999987654 34899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCCCC---cCccccchhHHHHHHHHHhCCCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMGSE---VSTSGDVYSFGILLLETFTGKRPTN 329 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~~~---~~~~~DiwS~G~vl~ell~g~~pf~ 329 (427)
||||+||+++.++.+||+|||+++..... ..||+.|+|||++.+.. ++.++|||||||++|||++|+.||.
T Consensus 162 Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 241 (298)
T 2zv2_A 162 DIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241 (298)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCHHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 99999999999999999999999876432 37899999999998765 4788999999999999999999997
Q ss_pred cccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 042634 330 EMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEE 409 (427)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~e 409 (427)
... ............. ... ....++.++.+++.+||+.||++|||++|
T Consensus 242 ~~~-----~~~~~~~~~~~~~-~~~--------------------------~~~~~~~~l~~li~~~l~~dp~~R~s~~e 289 (298)
T 2zv2_A 242 DER-----IMCLHSKIKSQAL-EFP--------------------------DQPDIAEDLKDLITRMLDKNPESRIVVPE 289 (298)
T ss_dssp CSS-----HHHHHHHHHHCCC-CCC--------------------------SSSCCCHHHHHHHHHHTCSCTTTSCCHHH
T ss_pred Ccc-----HHHHHHHHhcccC-CCC--------------------------CccccCHHHHHHHHHHhhcChhhCCCHHH
Confidence 531 1111111000000 000 01123456899999999999999999999
Q ss_pred HHHH
Q 042634 410 VAAQ 413 (427)
Q Consensus 410 v~~~ 413 (427)
++++
T Consensus 290 ~l~h 293 (298)
T 2zv2_A 290 IKLH 293 (298)
T ss_dssp HTTC
T ss_pred HhcC
Confidence 9753
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-36 Score=285.41 Aligned_cols=193 Identities=20% Similarity=0.292 Sum_probs=147.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+++|+|.+++... ..+++.++..++.|++.||+||| +.||+||
T Consensus 105 l~h~niv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~ 172 (349)
T 2w4o_A 105 LSHPNIIKLKEIFET-----PTEISLVLELVTGGELFDRIVEK----GYYSERDAADAVKQILEAVAYLH---ENGIVHR 172 (349)
T ss_dssp CCCTTBCCEEEEEEC-----SSEEEEEECCCCSCBHHHHHTTC----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCC
T ss_pred CCCCCCcceeeeEec-----CCeEEEEEEeCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEec
Confidence 469999999998643 56789999999999999998765 34899999999999999999999 8999999
Q ss_pred cccCCceeeCC---CCceEecccccccccCCc-----CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCc
Q 042634 259 DLKPSNVLLDG---ELTAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~---~~~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~ 330 (427)
||||+||+++. ++.+||+|||+++..... ..||+.|+|||++.+..++.++|||||||++|||++|..||..
T Consensus 173 Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 252 (349)
T 2w4o_A 173 DLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYD 252 (349)
T ss_dssp CCCGGGEEESSSSTTCCEEECCCC----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CCCcccEEEecCCCCCCEEEccCccccccCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence 99999999975 889999999999876433 2688999999999999999999999999999999999999975
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
.......+........ ....+ .....+.++.+++.+||+.||++|||++|+
T Consensus 253 ~~~~~~~~~~i~~~~~-----~~~~~------------------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~ 303 (349)
T 2w4o_A 253 ERGDQFMFRRILNCEY-----YFISP------------------------WWDEVSLNAKDLVRKLIVLDPKKRLTTFQA 303 (349)
T ss_dssp TTCHHHHHHHHHTTCC-----CCCTT------------------------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred CcccHHHHHHHHhCCC-----ccCCc------------------------hhhhCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 3221111111100000 00000 112235568899999999999999999999
Q ss_pred HH
Q 042634 411 AA 412 (427)
Q Consensus 411 ~~ 412 (427)
++
T Consensus 304 l~ 305 (349)
T 2w4o_A 304 LQ 305 (349)
T ss_dssp HH
T ss_pred hc
Confidence 86
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-36 Score=285.10 Aligned_cols=196 Identities=21% Similarity=0.276 Sum_probs=138.1
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeecc
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCD 259 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrD 259 (427)
+||||+++++++.. ....++||||+++|+|.+++... ..+++..+..++.|++.||+||| +.||+|||
T Consensus 64 ~h~niv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~D 131 (325)
T 3kn6_A 64 GHPNIVKLHEVFHD-----QLHTFLVMELLNGGELFERIKKK----KHFSETEASYIMRKLVSAVSHMH---DVGVVHRD 131 (325)
T ss_dssp TCTTBCCEEEEEEC-----SSEEEEEECCCCSCBHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCC
T ss_pred CCCCeeEEEEEEEc-----CCEEEEEEEccCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCCeecC
Confidence 59999999998543 56789999999999999998754 45999999999999999999999 89999999
Q ss_pred ccCCceeeCCCC---ceEecccccccccCCc------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCc
Q 042634 260 LKPSNVLLDGEL---TAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNE 330 (427)
Q Consensus 260 lkp~NIll~~~~---~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~ 330 (427)
|||+||+++.++ .+||+|||+++..... ..+|..|+|||++.+..++.++||||+||++|||++|+.||..
T Consensus 132 lkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 211 (325)
T 3kn6_A 132 LKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQS 211 (325)
T ss_dssp CCGGGEEEEC----CEEEECCCTTCEECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-
T ss_pred CCHHHEEEecCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence 999999997665 8999999999865432 2678899999999999999999999999999999999999976
Q ss_pred ccCCC--ccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 042634 331 MFTGN--LTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME 408 (427)
Q Consensus 331 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ 408 (427)
..... ....+......... .. ........++.++.+++.+||+.||++|||++
T Consensus 212 ~~~~~~~~~~~~~~~~i~~~~--------~~-----------------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ 266 (325)
T 3kn6_A 212 HDRSLTCTSAVEIMKKIKKGD--------FS-----------------FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMS 266 (325)
T ss_dssp ------CCCHHHHHHHHTTTC--------CC-----------------CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTT
T ss_pred CccccccccHHHHHHHHHcCC--------CC-----------------CCcccccCCCHHHHHHHHHHCCCChhHCCCHH
Confidence 42211 11111111111100 00 00001233567789999999999999999999
Q ss_pred HHHH
Q 042634 409 EVAA 412 (427)
Q Consensus 409 ev~~ 412 (427)
|+++
T Consensus 267 ell~ 270 (325)
T 3kn6_A 267 GLRY 270 (325)
T ss_dssp TSTT
T ss_pred HHhc
Confidence 9874
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=283.66 Aligned_cols=209 Identities=29% Similarity=0.438 Sum_probs=158.9
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+... +....++||||+++|+|.+++.... ..+++..++.++.|++.||+||| +.||+||
T Consensus 80 l~h~~i~~~~~~~~~~---~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~ 150 (302)
T 4e5w_A 80 LYHENIVKYKGICTED---GGNGIKLIMEFLPSGSLKEYLPKNK---NKINLKQQLKYAVQICKGMDYLG---SRQYVHR 150 (302)
T ss_dssp CCCTTBCCEEEEEEC------CCEEEEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHH---HTTEECS
T ss_pred CCCCCeeeeeeEEecC---CCceEEEEEEeCCCCcHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHhh---cCCcccC
Confidence 4699999999986541 2356789999999999999985443 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc---------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA---------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTN 329 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~---------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~ 329 (427)
||||+||+++.++.+||+|||.++..... ..+|..|+|||++.+..++.++||||+||++|||++|..|+.
T Consensus 151 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 230 (302)
T 4e5w_A 151 DLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS 230 (302)
T ss_dssp CCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred CCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCc
Confidence 99999999999999999999999865432 257778999999999999999999999999999999999865
Q ss_pred cccCCCccHHHHHHHhcccc----hhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCC
Q 042634 330 EMFTGNLTLHNFVKEALPER----LAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERM 405 (427)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rp 405 (427)
.. .........+.. ....... .....+...+..++.++.+++.+||+.||++||
T Consensus 231 ~~------~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 288 (302)
T 4e5w_A 231 SP------MALFLKMIGPTHGQMTVTRLVNT----------------LKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRT 288 (302)
T ss_dssp SH------HHHHHHHHCSCCGGGHHHHHHHH----------------HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSC
T ss_pred ch------hhHHhhccCCcccccCHHHHHHH----------------HhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCC
Confidence 32 111111100000 0000000 000001112234567799999999999999999
Q ss_pred CHHHHHHHHHHHH
Q 042634 406 NMEEVAAQLLSFR 418 (427)
Q Consensus 406 t~~ev~~~L~~~~ 418 (427)
|++|+++.|+++.
T Consensus 289 s~~~ll~~L~~ll 301 (302)
T 4e5w_A 289 SFQNLIEGFEALL 301 (302)
T ss_dssp CHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHh
Confidence 9999999999875
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=287.80 Aligned_cols=230 Identities=18% Similarity=0.227 Sum_probs=166.9
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++++... +....++||||+++|+|.+++...... ..+++..++.++.|++.||+||| +.||+||
T Consensus 64 l~hpnIv~~~~~~~~~---~~~~~~lv~e~~~~g~L~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~ 136 (396)
T 4eut_A 64 LNHKNIVKLFAIEEET---TTRHKVLIMEFCPCGSLYTVLEEPSNA-YGLPESEFLIVLRDVVGGMNHLR---ENGIVHR 136 (396)
T ss_dssp CCCTTBCCEEEEEECT---TTCCEEEEECCCTTEEHHHHTTSGGGT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred cCCCCCCeEEEeeccC---CCCeeEEEEecCCCCCHHHHHHhhhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCEEEC
Confidence 4699999999876432 234679999999999999999865422 33899999999999999999999 8999999
Q ss_pred cccCCceee----CCCCceEecccccccccCCc-----CCCccccccccccCC--------CCcCccccchhHHHHHHHH
Q 042634 259 DLKPSNVLL----DGELTAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMG--------SEVSTSGDVYSFGILLLET 321 (427)
Q Consensus 259 Dlkp~NIll----~~~~~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~--------~~~~~~~DiwS~G~vl~el 321 (427)
||||+||++ +.++.+||+|||+|+..... ..||..|+|||++.+ ..++.++|||||||++|||
T Consensus 137 Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el 216 (396)
T 4eut_A 137 NIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHA 216 (396)
T ss_dssp CCCGGGEEEEECTTSCEEEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHH
T ss_pred CcCHHHEEEeecCCCceeEEEecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHH
Confidence 999999999 77888999999999876443 268899999999865 5678899999999999999
Q ss_pred HhCCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCC
Q 042634 322 FTGKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELP 401 (427)
Q Consensus 322 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP 401 (427)
++|+.||.......... +.+.....+.....+........ ... .+....+ .........+..+.+++++||+.||
T Consensus 217 ~tg~~Pf~~~~~~~~~~-~~~~~~~~~~p~~~~~~~~~~~~--~~~-~~~~~~~-~~~~l~~~~~~~l~~ll~~~L~~dP 291 (396)
T 4eut_A 217 ATGSLPFRPFEGPRRNK-EVMYKIITGKPSGAISGVQKAEN--GPI-DWSGDMP-VSCSLSRGLQVLLTPVLANILEADQ 291 (396)
T ss_dssp HHSSCSEECTTCTTTCH-HHHHHHHHSCCTTCCEEEECSTT--CCE-EEESSCC-TTCSSCHHHHHHHHHHHHHHSCCCT
T ss_pred HHCCCCCCCCCcccchH-HHHHHHhcCCCcccchhheeccC--CCc-ccCccCC-cccccchHHHhhchHHHHHhhccCh
Confidence 99999997643322222 22221111111111100000000 000 0000000 1112346678889999999999999
Q ss_pred CCCCCHHHHHHHHHHHHHH
Q 042634 402 RERMNMEEVAAQLLSFRNK 420 (427)
Q Consensus 402 ~~Rpt~~ev~~~L~~~~~~ 420 (427)
++|||++|+++.++++.++
T Consensus 292 ~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 292 EKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp TTSCCHHHHHHHHHHHHTC
T ss_pred hhhccHHHHHHHHHHHhhc
Confidence 9999999999999887653
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=286.46 Aligned_cols=194 Identities=18% Similarity=0.262 Sum_probs=154.8
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+++|+|.+++.... ..+++..+..++.||+.||+||| +.||+||
T Consensus 105 l~hpnIv~~~~~~~~-----~~~~~lv~E~~~gg~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~givHr 173 (387)
T 1kob_A 105 LHHPKLINLHDAFED-----KYEMVLILEFLSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMH---EHSIVHL 173 (387)
T ss_dssp CCSTTBCCEEEEEEC-----SSEEEEEEECCCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred CCCcCCCeEEEEEEe-----CCEEEEEEEcCCCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeec
Confidence 579999999998543 567899999999999999987543 35899999999999999999999 8999999
Q ss_pred cccCCceeeCC--CCceEecccccccccCCcC-----CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 259 DLKPSNVLLDG--ELTAHVGDFGLAKFLPEAT-----NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 259 Dlkp~NIll~~--~~~~kL~DFG~a~~~~~~~-----~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
||||+|||++. ++.+||+|||+|+...... .||..|+|||++.+..++.++|||||||++|||++|..||.+.
T Consensus 174 Dlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 253 (387)
T 1kob_A 174 DIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE 253 (387)
T ss_dssp CCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred ccchHHeEEecCCCCceEEEecccceecCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCC
Confidence 99999999974 5789999999998765432 7899999999999999999999999999999999999999753
Q ss_pred cCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 042634 332 FTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVA 411 (427)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~ 411 (427)
.. ............. .+ .......+.++.+++.+||+.||++|||++|++
T Consensus 254 ~~-----~~~~~~i~~~~~~--~~-----------------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell 303 (387)
T 1kob_A 254 DD-----LETLQNVKRCDWE--FD-----------------------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDAL 303 (387)
T ss_dssp SH-----HHHHHHHHHCCCC--CC-----------------------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred CH-----HHHHHHHHhCCCC--CC-----------------------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 11 1111110000000 00 001122356689999999999999999999998
Q ss_pred HH
Q 042634 412 AQ 413 (427)
Q Consensus 412 ~~ 413 (427)
+.
T Consensus 304 ~h 305 (387)
T 1kob_A 304 EH 305 (387)
T ss_dssp TS
T ss_pred hC
Confidence 74
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-36 Score=278.30 Aligned_cols=197 Identities=24% Similarity=0.365 Sum_probs=160.5
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+. ....++||||+++++|.+++... ..+++..+..++.|++.||+||| +.||+||
T Consensus 75 l~h~~i~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~ 141 (291)
T 1xbb_A 75 LDNPYIVRMIGICE------AESWMLVMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLE---ESNFVHR 141 (291)
T ss_dssp CCCTTBCCEEEEEE------SSSEEEEEECCTTEEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHH---HTTEECS
T ss_pred CCCCCEEEEEEEEC------CCCcEEEEEeCCCCCHHHHHHhC----cCCCHHHHHHHHHHHHHHHHHHH---hCCeEcC
Confidence 46999999999862 35678999999999999998754 34899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC---------CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT---------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPT 328 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~---------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf 328 (427)
||||+||+++.++.+||+|||+++...... .++..|+|||++.+..++.++|||||||++|||++ |+.||
T Consensus 142 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~ 221 (291)
T 1xbb_A 142 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 221 (291)
T ss_dssp CCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred CCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCC
Confidence 999999999999999999999998764322 45678999999988889999999999999999999 99999
Q ss_pred CcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 042634 329 NEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME 408 (427)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ 408 (427)
..... ......+...... ..+..++.++.+++.+||+.||++|||+.
T Consensus 222 ~~~~~--~~~~~~~~~~~~~-------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 268 (291)
T 1xbb_A 222 RGMKG--SEVTAMLEKGERM-------------------------------GCPAGCPREMYDLMNLCWTYDVENRPGFA 268 (291)
T ss_dssp TTCCH--HHHHHHHHTTCCC-------------------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred CCCCH--HHHHHHHHcCCCC-------------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHH
Confidence 75321 1111111110000 01223456789999999999999999999
Q ss_pred HHHHHHHHHHHHH
Q 042634 409 EVAAQLLSFRNKL 421 (427)
Q Consensus 409 ev~~~L~~~~~~~ 421 (427)
|+++.|+++....
T Consensus 269 ~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 269 AVELRLRNYYYDV 281 (291)
T ss_dssp HHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHH
Confidence 9999999997664
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=286.12 Aligned_cols=193 Identities=21% Similarity=0.230 Sum_probs=154.2
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+++|+|.+++.... ..+++..++.++.||+.||+||| +.||+||
T Consensus 143 l~hpnIv~~~~~~~~-----~~~~~lv~E~~~~~~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~ 211 (373)
T 2x4f_A 143 LDHANLIQLYDAFES-----KNDIVLVMEYVDGGELFDRIIDES---YNLTELDTILFMKQICEGIRHMH---QMYILHL 211 (373)
T ss_dssp CCCTTBCCEEEEEEC-----SSEEEEEEECCTTCEEHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred CCCCCCCeEEEEEEE-----CCEEEEEEeCCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccc
Confidence 579999999998644 567899999999999998886443 45899999999999999999999 8999999
Q ss_pred cccCCceee--CCCCceEecccccccccCCcC-----CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 259 DLKPSNVLL--DGELTAHVGDFGLAKFLPEAT-----NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 259 Dlkp~NIll--~~~~~~kL~DFG~a~~~~~~~-----~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
||||+|||+ +.++.+||+|||+++...... .||+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus 212 Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 291 (373)
T 2x4f_A 212 DLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGD 291 (373)
T ss_dssp CCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred cCCHHHEEEecCCCCcEEEEeCCCceecCCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999 667899999999998764432 6899999999999899999999999999999999999999753
Q ss_pred cCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 042634 332 FTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVA 411 (427)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~ 411 (427)
.. ...+.......... .. ......+.++.+++.+||+.||++|||++|++
T Consensus 292 ~~-~~~~~~i~~~~~~~-----~~------------------------~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l 341 (373)
T 2x4f_A 292 ND-AETLNNILACRWDL-----ED------------------------EEFQDISEEAKEFISKLLIKEKSWRISASEAL 341 (373)
T ss_dssp SH-HHHHHHHHHTCCCS-----CS------------------------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred CH-HHHHHHHHhccCCC-----Ch------------------------hhhccCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 21 11111111110000 00 01122356689999999999999999999998
Q ss_pred H
Q 042634 412 A 412 (427)
Q Consensus 412 ~ 412 (427)
+
T Consensus 342 ~ 342 (373)
T 2x4f_A 342 K 342 (373)
T ss_dssp H
T ss_pred c
Confidence 7
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-36 Score=285.59 Aligned_cols=188 Identities=20% Similarity=0.235 Sum_probs=151.5
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
.+||+|+++++.+. .....++||||+++|+|.+++... ..+++..++.++.||+.||+||| +.||+||
T Consensus 78 ~~hp~iv~l~~~~~-----~~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH---~~givHr 145 (353)
T 2i0e_A 78 GKPPFLTQLHSCFQ-----TMDRLYFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYR 145 (353)
T ss_dssp TCCTTBCCEEEEEE-----CSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCC
T ss_pred CCCCEEeeEEEEEE-----cCCEEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEec
Confidence 37999999998853 356789999999999999998654 45999999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC------cCCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE------ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+|||++.++.+||+|||+|+.... ...||+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 146 Dlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 225 (353)
T 2i0e_A 146 DLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 225 (353)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCCHHHEEEcCCCcEEEEeCCcccccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC
Confidence 9999999999999999999999986422 2278999999999999999999999999999999999999997531
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCC-----H
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMN-----M 407 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt-----~ 407 (427)
. ............ . .+...+.++.+++.+||+.||++||+ +
T Consensus 226 --~---~~~~~~i~~~~~------------------------~-----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~ 271 (353)
T 2i0e_A 226 --E---DELFQSIMEHNV------------------------A-----YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGE 271 (353)
T ss_dssp --H---HHHHHHHHHCCC------------------------C-----CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHH
T ss_pred --H---HHHHHHHHhCCC------------------------C-----CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCH
Confidence 1 111111110000 0 11123456889999999999999996 4
Q ss_pred HHHHH
Q 042634 408 EEVAA 412 (427)
Q Consensus 408 ~ev~~ 412 (427)
+|+++
T Consensus 272 ~~i~~ 276 (353)
T 2i0e_A 272 RDIKE 276 (353)
T ss_dssp HHHHT
T ss_pred HHHhc
Confidence 66654
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=284.32 Aligned_cols=201 Identities=26% Similarity=0.381 Sum_probs=160.4
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchh------------hhhccCHHHHHHHHHHHHHHHHHH
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNRE------------ALKNLNLLQRLSIAVDVASALDYL 247 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~~~~~i~~~L~~L 247 (427)
+||||+++++.+.. ....++||||+++|+|.+++..... ....+++..++.++.|++.||+||
T Consensus 84 ~hp~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L 158 (327)
T 1fvr_A 84 HHPNIINLLGACEH-----RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 158 (327)
T ss_dssp CCTTBCCEEEEEEE-----TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHH
T ss_pred CCCchhhhceeeee-----CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHH
Confidence 79999999998644 5678999999999999999876431 113589999999999999999999
Q ss_pred hhcCCCCeeeccccCCceeeCCCCceEecccccccccCCc-----CCCccccccccccCCCCcCccccchhHHHHHHHHH
Q 042634 248 HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETF 322 (427)
Q Consensus 248 H~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell 322 (427)
| +.||+||||||+||+++.++.+||+|||+++..... ..++..|+|||++.+..++.++|||||||++|||+
T Consensus 159 H---~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell 235 (327)
T 1fvr_A 159 S---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 235 (327)
T ss_dssp H---HTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHH
T ss_pred H---hCCccCCCCccceEEEcCCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHH
Confidence 9 899999999999999999999999999999754322 25677899999998888999999999999999999
Q ss_pred h-CCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCC
Q 042634 323 T-GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELP 401 (427)
Q Consensus 323 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP 401 (427)
+ |+.||.+.. ....... .... .. ...+..++.++.+++.+||+.||
T Consensus 236 t~g~~pf~~~~-----~~~~~~~-~~~~----~~-----------------------~~~~~~~~~~l~~li~~~l~~dp 282 (327)
T 1fvr_A 236 SLGGTPYCGMT-----CAELYEK-LPQG----YR-----------------------LEKPLNCDDEVYDLMRQCWREKP 282 (327)
T ss_dssp TTSCCTTTTCC-----HHHHHHH-GGGT----CC-----------------------CCCCTTBCHHHHHHHHHHTCSSG
T ss_pred cCCCCCCCCCc-----HHHHHHH-hhcC----CC-----------------------CCCCCCCCHHHHHHHHHHccCCh
Confidence 8 999997531 1111111 1000 00 00112245668999999999999
Q ss_pred CCCCCHHHHHHHHHHHHHHH
Q 042634 402 RERMNMEEVAAQLLSFRNKL 421 (427)
Q Consensus 402 ~~Rpt~~ev~~~L~~~~~~~ 421 (427)
++|||++|+++.|+++.++.
T Consensus 283 ~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 283 YERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp GGSCCHHHHHHHHHHHHHSS
T ss_pred hhCcCHHHHHHHHHHHHHhh
Confidence 99999999999999987653
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=275.38 Aligned_cols=204 Identities=19% Similarity=0.254 Sum_probs=158.5
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
+.|++++..+..+.. .+...++||||+ +++|.+++.... ..+++..+..++.|++.||+||| ++||+||
T Consensus 61 l~~~~~i~~~~~~~~----~~~~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~ 129 (296)
T 3uzp_A 61 MQGGVGIPTIRWCGA----EGDYNVMVMELL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIH---SKNFIHR 129 (296)
T ss_dssp HTTSTTCCCEEEEEE----ETTEEEEEEECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHH---HTTEECS
T ss_pred hhcCCCCCccccccC----CCCceEEEEEec-CCCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeC
Confidence 456666665554422 245679999999 999999986432 45999999999999999999999 8999999
Q ss_pred cccCCceee---CCCCceEecccccccccCCc-------------CCCccccccccccCCCCcCccccchhHHHHHHHHH
Q 042634 259 DLKPSNVLL---DGELTAHVGDFGLAKFLPEA-------------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETF 322 (427)
Q Consensus 259 Dlkp~NIll---~~~~~~kL~DFG~a~~~~~~-------------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell 322 (427)
||||+||++ +.++.+||+|||.++..... ..|+..|+|||++.+..++.++|||||||++|||+
T Consensus 130 dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 209 (296)
T 3uzp_A 130 DVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFN 209 (296)
T ss_dssp CCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred CCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHH
Confidence 999999999 47889999999999865432 26888999999999999999999999999999999
Q ss_pred hCCCCCCcccCCC--ccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCC
Q 042634 323 TGKRPTNEMFTGN--LTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSEL 400 (427)
Q Consensus 323 ~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~d 400 (427)
+|+.||....... ..+.............. ....++.++.+++.+||+.|
T Consensus 210 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~d 261 (296)
T 3uzp_A 210 LGSLPWQGLKAATKRQKYERISEKKMSTPIEV----------------------------LCKGYPSEFATYLNFCRSLR 261 (296)
T ss_dssp HSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH----------------------------HTTTSCHHHHHHHHHHHTSC
T ss_pred hCCCCCCCcCchhhhhhhhhhcccccCCchHH----------------------------HHhhCCHHHHHHHHHHHhcC
Confidence 9999998643221 11211111111110000 11223567899999999999
Q ss_pred CCCCCCHHHHHHHHHHHHHHH
Q 042634 401 PRERMNMEEVAAQLLSFRNKL 421 (427)
Q Consensus 401 P~~Rpt~~ev~~~L~~~~~~~ 421 (427)
|++|||++|+++.|+++..+.
T Consensus 262 p~~Rps~~~l~~~l~~~~~~~ 282 (296)
T 3uzp_A 262 FDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp TTCCCCHHHHHHHHHHHHHHT
T ss_pred cCcCCCHHHHHHHHHHHHHhc
Confidence 999999999999999998764
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-36 Score=286.19 Aligned_cols=196 Identities=21% Similarity=0.258 Sum_probs=152.9
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
.+||||+++++.+. +....++||||+++|+|.+++... ..+++..+..++.||+.||+||| +.||+||
T Consensus 73 ~~hp~iv~~~~~~~-----~~~~~~lv~E~~~gg~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH---~~givHr 140 (342)
T 2qr7_A 73 GQHPNIITLKDVYD-----DGKYVYVVTELMKGGELLDKILRQ----KFFSEREASAVLFTITKTVEYLH---AQGVVHR 140 (342)
T ss_dssp TTSTTBCCEEEEEE-----CSSEEEEEECCCCSCBHHHHHHTC----TTCCHHHHHHHHHHHHHHHHHHH---HTTEECS
T ss_pred cCCCCcCeEEEEEE-----cCCEEEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcEec
Confidence 47999999999854 366789999999999999988755 35899999999999999999999 8999999
Q ss_pred cccCCceeeCCC----CceEecccccccccCCc------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCC
Q 042634 259 DLKPSNVLLDGE----LTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPT 328 (427)
Q Consensus 259 Dlkp~NIll~~~----~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf 328 (427)
||||+|||+..+ +.+||+|||+++..... ..+|+.|+|||++.+..++.++||||+||++|||++|..||
T Consensus 141 Dlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf 220 (342)
T 2qr7_A 141 DLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPF 220 (342)
T ss_dssp CCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSS
T ss_pred cCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCC
Confidence 999999998432 35999999999865432 26789999999998888999999999999999999999999
Q ss_pred CcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 042634 329 NEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME 408 (427)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ 408 (427)
..... ....+........... ... ..+...+.++.+++.+||+.||++|||++
T Consensus 221 ~~~~~--~~~~~~~~~i~~~~~~-~~~------------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~ 273 (342)
T 2qr7_A 221 ANGPD--DTPEEILARIGSGKFS-LSG------------------------GYWNSVSDTAKDLVSKMLHVDPHQRLTAA 273 (342)
T ss_dssp CSSTT--SCHHHHHHHHHHCCCC-CCS------------------------TTTTTSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred CCCCc--CCHHHHHHHHccCCcc-cCc------------------------cccccCCHHHHHHHHHHCCCChhHCcCHH
Confidence 75321 1122221111111000 000 01122355688999999999999999999
Q ss_pred HHHHH
Q 042634 409 EVAAQ 413 (427)
Q Consensus 409 ev~~~ 413 (427)
|++++
T Consensus 274 ~il~h 278 (342)
T 2qr7_A 274 LVLRH 278 (342)
T ss_dssp HHTTS
T ss_pred HHhcC
Confidence 99864
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=289.06 Aligned_cols=220 Identities=17% Similarity=0.214 Sum_probs=153.9
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||++++++.. ....++|||||++|+|.+++..... ..+++..++.++.||+.||+||| +.||+||
T Consensus 83 l~h~niv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHr 152 (389)
T 3gni_B 83 FNHPNIVPYRATFIA-----DNELWVVTSFMAYGSAKDLICTHFM--DGMNELAIAYILQGVLKALDYIH---HMGYVHR 152 (389)
T ss_dssp CCCTTBCCEEEEEEE-----TTEEEEEEECCTTCBHHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred CCCCCCCcEeEEEEE-----CCEEEEEEEccCCCCHHHHHhhhcc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeecC
Confidence 579999999998654 5678999999999999999865422 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC-------------cCCCccccccccccCC--CCcCccccchhHHHHHHHHHh
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE-------------ATNNFFNFQIAEYGMG--SEVSTSGDVYSFGILLLETFT 323 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~-------------~~~~~~~y~aPE~~~~--~~~~~~~DiwS~G~vl~ell~ 323 (427)
||||+|||++.++.+||+|||.+..... ...||..|+|||++.+ ..++.++|||||||++|||++
T Consensus 153 Dlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~ 232 (389)
T 3gni_B 153 SVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELAN 232 (389)
T ss_dssp CCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHH
Confidence 9999999999999999999998864321 1267888999999987 678999999999999999999
Q ss_pred CCCCCCcccCCCccHHHHHHHhcccchhcccCcccccc-------------cc--cc--chhhhccccccccccchHHHH
Q 042634 324 GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVE-------------RE--EG--ETSKANAHKQFTRSFSVKECL 386 (427)
Q Consensus 324 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~--~~--~~~~~~~~~~~~~~~~~~~~~ 386 (427)
|+.||.+...... +........+ ...+...... .. .. ................+...+
T Consensus 233 g~~pf~~~~~~~~-~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 307 (389)
T 3gni_B 233 GHVPFKDMPATQM-LLEKLNGTVP----CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFS 307 (389)
T ss_dssp SSCTTTTCCSTTH-HHHC------------------------------------------------------------CC
T ss_pred CCCCCCCCCHHHH-HHHHhcCCCC----ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccC
Confidence 9999976432221 1111111111 0000000000 00 00 000000000001111234456
Q ss_pred HHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 042634 387 VSVLGIGVTCSSELPRERMNMEEVAAQ 413 (427)
Q Consensus 387 ~~~~~l~~~cl~~dP~~Rpt~~ev~~~ 413 (427)
.++.+++.+||+.||++|||++|++++
T Consensus 308 ~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 308 PHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred HHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 779999999999999999999999864
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=292.93 Aligned_cols=189 Identities=23% Similarity=0.401 Sum_probs=154.4
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++++.. ....++||||+++|+|.+++... ..+++..++.++.||+.||+||| +.||+||
T Consensus 73 l~HpnIv~l~~~~~~-----~~~~~lv~E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~givHr 140 (476)
T 2y94_A 73 FRHPHIIKLYQVIST-----PSDIFMVMEYVSGGELFDYICKN----GRLDEKESRRLFQQILSGVDYCH---RHMVVHR 140 (476)
T ss_dssp CCCTTBCCEEEEEEC-----SSEEEEEEECCSSEEHHHHTTSS----SSCCHHHHHHHHHHHHHHHHHHH---TTTEECS
T ss_pred CCCCCCCcEEEEEEE-----CCEEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcc
Confidence 579999999998544 56789999999999999999765 45999999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc-----CCCccccccccccCCCCc-CccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMGSEV-STSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~~~~-~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+||+++.++.+||+|||+++..... ..||+.|+|||++.+..+ +.++||||+||++|||++|+.||.+..
T Consensus 141 DLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~ 220 (476)
T 2y94_A 141 DLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH 220 (476)
T ss_dssp CCSGGGEEECTTCCEEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccHHHEEEecCCCeEEEeccchhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC
Confidence 99999999999999999999999876443 278999999999988776 789999999999999999999997531
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
. ........ +.... .+...+.++.+++.+||+.||++|||++|+++
T Consensus 221 ~-----~~~~~~i~--------~~~~~---------------------~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 221 V-----PTLFKKIC--------DGIFY---------------------TPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp S-----HHHHHHHH--------TTCCC---------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred H-----HHHHHHHh--------cCCcC---------------------CCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 1 11111110 00000 11123456889999999999999999999987
Q ss_pred H
Q 042634 413 Q 413 (427)
Q Consensus 413 ~ 413 (427)
+
T Consensus 267 h 267 (476)
T 2y94_A 267 H 267 (476)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=275.34 Aligned_cols=219 Identities=19% Similarity=0.213 Sum_probs=152.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. +...++||||++ |++.+++.... ..+++..++.++.|++.||+||| +.||+||
T Consensus 58 l~h~~iv~~~~~~~~-----~~~~~lv~e~~~-~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~ 125 (292)
T 3o0g_A 58 LKHKNIVRLHDVLHS-----DKKLTLVFEFCD-QDLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCH---SRNVLHR 125 (292)
T ss_dssp CCCTTBCCEEEEEEE-----TTEEEEEEECCS-EEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred CCCCCEeeEEeEEEe-----CCEEEEEEecCC-CCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeecC
Confidence 469999999998644 567899999996 46665554322 45999999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCCCC-cCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMGSE-VSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~~~-~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
||||+||+++.++.+||+|||+|+..... ..+|..|+|||++.+.. ++.++||||+||++|||++|..||...
T Consensus 126 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~ 205 (292)
T 3o0g_A 126 DLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 205 (292)
T ss_dssp CCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCC
T ss_pred CCCHHHEEEcCCCCEEEeecccceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCC
Confidence 99999999999999999999999865422 26788999999998765 799999999999999999988886433
Q ss_pred cCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 042634 332 FTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVA 411 (427)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~ 411 (427)
......+........... ............ ......... ...........+.++.+++.+||+.||++|||++|++
T Consensus 206 ~~~~~~~~~i~~~~~~~~-~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 281 (292)
T 3o0g_A 206 NDVDDQLKRIFRLLGTPT-EEQWPSMTKLPD-YKPYPMYPA--TTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281 (292)
T ss_dssp SSHHHHHHHHHHHHCCCC-TTTCTTGGGSTT-CCCCCCCCT--TCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred CCHHHHHHHHHHHhCCCC-hhhhhhhccccc-ccccccccC--CcchhhcccccChHHHHHHHHHhccChhhCCCHHHHh
Confidence 222222222222211110 000000000000 000000000 0000001123456788999999999999999999998
Q ss_pred HH
Q 042634 412 AQ 413 (427)
Q Consensus 412 ~~ 413 (427)
++
T Consensus 282 ~h 283 (292)
T 3o0g_A 282 QH 283 (292)
T ss_dssp TS
T ss_pred cC
Confidence 63
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=288.36 Aligned_cols=187 Identities=24% Similarity=0.225 Sum_probs=150.9
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+++|+|.+++... ..+++..++.++.||+.||+||| ++||+||
T Consensus 96 ~~hp~Iv~l~~~~~~-----~~~~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH---~~givHr 163 (373)
T 2r5t_A 96 VKHPFLVGLHFSFQT-----ADKLYFVLDYINGGELFYHLQRE----RCFLEPRARFYAAEIASALGYLH---SLNIVYR 163 (373)
T ss_dssp CCCTTBCCEEEEEEC-----SSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCC
T ss_pred CCCCCCCCEEEEEEe-----CCEEEEEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCceec
Confidence 679999999988543 56889999999999999988653 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC------cCCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE------ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+|||++.++.+||+|||+|+.... ...||+.|+|||++.+..++.++|||||||++|||++|..||.+..
T Consensus 164 Dlkp~NIll~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 243 (373)
T 2r5t_A 164 DLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 243 (373)
T ss_dssp CCCGGGEEECTTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB
T ss_pred CCCHHHEEECCCCCEEEeeCccccccccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 9999999999999999999999986322 2278999999999999999999999999999999999999997531
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVA 411 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~ 411 (427)
..+......... .. .+...+.++.+++.+||+.||++||++.+.+
T Consensus 244 -----~~~~~~~i~~~~--------~~---------------------~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 244 -----TAEMYDNILNKP--------LQ---------------------LKPNITNSARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp -----HHHHHHHHHHSC--------CC---------------------CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred -----HHHHHHHHHhcc--------cC---------------------CCCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence 111111111000 00 0112345688999999999999999986433
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=279.89 Aligned_cols=186 Identities=23% Similarity=0.203 Sum_probs=149.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
.+||||+++++.+.. +...++||||+ +++|.+++.... ..+++..++.++.|++.||+||| +.||+||
T Consensus 114 ~~h~~iv~l~~~~~~-----~~~~~lv~e~~-~~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~ 181 (311)
T 3p1a_A 114 GQHPCCVRLEQAWEE-----GGILYLQTELC-GPSLQQHCEAWG---ASLPEAQVWGYLRDTLLALAHLH---SQGLVHL 181 (311)
T ss_dssp CCCTTBCCEEEEEEE-----TTEEEEEEECC-CCBHHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred cCCCcEEEEEEEEEe-----CCEEEEEEecc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCEecC
Confidence 479999999998654 56789999999 789988876542 45999999999999999999999 8899999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc-----CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFT 333 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~ 333 (427)
||||+|||++.++.+||+|||+++..... ..||+.|+|||++.+ .++.++|||||||++|||++|..||...
T Consensus 182 Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~-- 258 (311)
T 3p1a_A 182 DVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG-- 258 (311)
T ss_dssp CCSGGGEEECGGGCEEECCCTTCEECC------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH--
T ss_pred CCCHHHEEECCCCCEEEccceeeeecccCCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc--
Confidence 99999999999999999999999876443 268999999999876 7899999999999999999997776432
Q ss_pred CCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 334 GNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
..+... ...... ...+..++.++.+++.+||+.||++|||++|+++
T Consensus 259 --~~~~~~------------~~~~~~-------------------~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 259 --EGWQQL------------RQGYLP-------------------PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp --HHHHHH------------TTTCCC-------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --cHHHHH------------hccCCC-------------------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 011110 000000 0011224567899999999999999999999986
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=285.56 Aligned_cols=211 Identities=24% Similarity=0.358 Sum_probs=160.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. .+....++||||+++++|.+++.... ..+++..++.++.|++.||+||| +.||+||
T Consensus 81 l~h~~i~~~~~~~~~---~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~ 151 (327)
T 3lxl_A 81 LHSDFIVKYRGVSYG---PGRQSLRLVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGMEYLG---SRRCVHR 151 (327)
T ss_dssp CCCTTBCCEEEEEEC---SSSCEEEEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHH---HTTEECS
T ss_pred cCCCceeEEEEEEec---CCCceEEEEEeecCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH---hCCccCC
Confidence 479999999987543 22456789999999999999987543 35899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc---------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA---------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTN 329 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~---------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~ 329 (427)
||||+||+++.++.+||+|||.++..... ..++..|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 152 Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~ 231 (327)
T 3lxl_A 152 DLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSC 231 (327)
T ss_dssp CCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred CCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCc
Confidence 99999999999999999999999865432 256778999999998889999999999999999999999986
Q ss_pred cccCCCccHHHHHHHhc----ccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCC
Q 042634 330 EMFTGNLTLHNFVKEAL----PERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERM 405 (427)
Q Consensus 330 ~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rp 405 (427)
.... ....... ........+.. ........+..++.++.+++.+||+.||++||
T Consensus 232 ~~~~------~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp 289 (327)
T 3lxl_A 232 SPSA------EFLRMMGCERDVPALSRLLELL----------------EEGQRLPAPPACPAEVHELMKLCWAPSPQDRP 289 (327)
T ss_dssp SHHH------HHHHHCC----CCHHHHHHHHH----------------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred cccc------hhhhhcccccccccHHHHHHHh----------------hcccCCCCCCcccHHHHHHHHHHcCCChhhCc
Confidence 4211 0000000 00000000000 00000112234567799999999999999999
Q ss_pred CHHHHHHHHHHHHHH
Q 042634 406 NMEEVAAQLLSFRNK 420 (427)
Q Consensus 406 t~~ev~~~L~~~~~~ 420 (427)
|++|+++.|+.+...
T Consensus 290 s~~ell~~L~~~~~~ 304 (327)
T 3lxl_A 290 SFSALGPQLDMLWSG 304 (327)
T ss_dssp CHHHHHHHHHHC---
T ss_pred CHHHHHHHHHHHHhh
Confidence 999999999998654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-36 Score=281.50 Aligned_cols=224 Identities=21% Similarity=0.268 Sum_probs=153.7
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchh--hhhccCHHHHHHHHHHHHHHHHHHhhcCCCCee
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNRE--ALKNLNLLQRLSIAVDVASALDYLHHYCETPIV 256 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~iv 256 (427)
++||||+++++.+.. ....++||||++ |+|.+++..... ....+++..+..++.|++.||+||| +.||+
T Consensus 60 l~hp~iv~~~~~~~~-----~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~iv 130 (317)
T 2pmi_A 60 LKHENIVRLYDVIHT-----ENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKIL 130 (317)
T ss_dssp CCBTTBCCEEEEECC-----TTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred cCCCCcceEEEEEEE-----CCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCee
Confidence 469999999998543 567899999996 699888864321 1134889999999999999999999 89999
Q ss_pred eccccCCceeeCCCCceEecccccccccCC------cCCCccccccccccCC-CCcCccccchhHHHHHHHHHhCCCCCC
Q 042634 257 HCDLKPSNVLLDGELTAHVGDFGLAKFLPE------ATNNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETFTGKRPTN 329 (427)
Q Consensus 257 HrDlkp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell~g~~pf~ 329 (427)
||||||+||+++.++.+||+|||+++.... ...+|..|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 131 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 210 (317)
T 2pmi_A 131 HRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFP 210 (317)
T ss_dssp CCCCCGGGEEECTTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred eCCCChHHeEEcCCCCEEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999999987542 2367899999999876 468999999999999999999999997
Q ss_pred cccCCCccHHHHHHHhcc--cchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCH
Q 042634 330 EMFTGNLTLHNFVKEALP--ERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM 407 (427)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~ 407 (427)
+.... ..+......... ......+........ ......................+.++.+++.+||+.||++|||+
T Consensus 211 ~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 288 (317)
T 2pmi_A 211 GTNDE-EQLKLIFDIMGTPNESLWPSVTKLPKYNP-NIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSA 288 (317)
T ss_dssp CSSHH-HHHHHHHHHHCSCCTTTCGGGGGCTTCCT-TCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred CCChH-HHHHHHHHHhCCCChhHhhhhhhhhhccc-ccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCH
Confidence 54211 111111111110 000000000000000 00000000000000000111234578999999999999999999
Q ss_pred HHHHHH
Q 042634 408 EEVAAQ 413 (427)
Q Consensus 408 ~ev~~~ 413 (427)
+|+++.
T Consensus 289 ~e~l~h 294 (317)
T 2pmi_A 289 KQALHH 294 (317)
T ss_dssp HHHTTS
T ss_pred HHHhCC
Confidence 999763
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=280.79 Aligned_cols=206 Identities=18% Similarity=0.238 Sum_probs=160.5
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+... .......++||||+++|+|.+++.........+++..++.++.|++.||+||| +.||+||
T Consensus 83 l~h~~iv~~~~~~~~~-~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~ 158 (317)
T 2buj_A 83 FNHPNILRLVAYCLRE-RGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHR 158 (317)
T ss_dssp CCCTTBCCCCEEEEEE-ETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred cCCCCeeeEEEEEEec-cCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccC
Confidence 4799999999986531 11234678999999999999998764333356999999999999999999999 8899999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc---------------CCCccccccccccCCCC---cCccccchhHHHHHHH
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA---------------TNNFFNFQIAEYGMGSE---VSTSGDVYSFGILLLE 320 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~---------------~~~~~~y~aPE~~~~~~---~~~~~DiwS~G~vl~e 320 (427)
||||+||+++.++.+||+|||.++..... ..|+..|+|||++.+.. ++.++|||||||++||
T Consensus 159 dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~e 238 (317)
T 2buj_A 159 DLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYA 238 (317)
T ss_dssp CCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHH
Confidence 99999999999999999999998765321 14688999999987654 6899999999999999
Q ss_pred HHhCCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCC
Q 042634 321 TFTGKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSEL 400 (427)
Q Consensus 321 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~d 400 (427)
|++|+.||.................... .....++.++.+++.+||+.|
T Consensus 239 l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~l~~li~~~l~~d 287 (317)
T 2buj_A 239 MMFGEGPYDMVFQKGDSVALAVQNQLSI-------------------------------PQSPRHSSALWQLLNSMMTVD 287 (317)
T ss_dssp HHHSSCTTHHHHHTTSCHHHHHHCC--C-------------------------------CCCTTSCHHHHHHHHHHTCSS
T ss_pred HHhCCCChhhhhcccchhhHHhhccCCC-------------------------------CccccCCHHHHHHHHHHhhcC
Confidence 9999999965322222221111110000 011223456899999999999
Q ss_pred CCCCCCHHHHHHHHHHHHH
Q 042634 401 PRERMNMEEVAAQLLSFRN 419 (427)
Q Consensus 401 P~~Rpt~~ev~~~L~~~~~ 419 (427)
|++|||++|+++.|+.+..
T Consensus 288 p~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 288 PHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp GGGSCCHHHHHHHHHHTCC
T ss_pred hhhCCCHHHHHHHhhhcCC
Confidence 9999999999999998754
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-36 Score=294.41 Aligned_cols=188 Identities=21% Similarity=0.261 Sum_probs=153.5
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCC-CCeee
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCE-TPIVH 257 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~-~~ivH 257 (427)
++||||+++++.+.. ....++||||+++|+|.+++... ..+++..++.++.|++.||+||| + .||+|
T Consensus 205 l~h~~iv~l~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH---~~~giiH 272 (446)
T 4ejn_A 205 SRHPFLTALKYSFQT-----HDRLCFVMEYANGGELFFHLSRE----RVFSEDRARFYGAEIVSALDYLH---SEKNVVY 272 (446)
T ss_dssp CSCTTSCCEEEEEEE-----TTEEEEEECCCSSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHH---HHTCCCC
T ss_pred CCCCeEeeEEEEEee-----CCEEEEEEeeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHh---hcCCEEE
Confidence 579999999998654 56789999999999999988654 45899999999999999999999 6 89999
Q ss_pred ccccCCceeeCCCCceEecccccccccCC------cCCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 258 CDLKPSNVLLDGELTAHVGDFGLAKFLPE------ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 258 rDlkp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
|||||+|||++.++.+||+|||+|+.... ...||+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus 273 rDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 352 (446)
T 4ejn_A 273 RDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 352 (446)
T ss_dssp CCCCGGGEEECSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCCCHHHEEECCCCCEEEccCCCceeccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCC
Confidence 99999999999999999999999986432 237899999999999999999999999999999999999999753
Q ss_pred cCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCC-----C
Q 042634 332 FTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERM-----N 406 (427)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rp-----t 406 (427)
.. ............ . .+...+.++.+++.+||+.||++|| |
T Consensus 353 ~~-----~~~~~~i~~~~~------------------------~-----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t 398 (446)
T 4ejn_A 353 DH-----EKLFELILMEEI------------------------R-----FPRTLGPEAKSLLSGLLKKDPKQRLGGGSED 398 (446)
T ss_dssp SH-----HHHHHHHHHCCC------------------------C-----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTT
T ss_pred CH-----HHHHHHHHhCCC------------------------C-----CCccCCHHHHHHHHHHcccCHHHhCCCCCCC
Confidence 11 111111100000 0 1112345688999999999999999 9
Q ss_pred HHHHHH
Q 042634 407 MEEVAA 412 (427)
Q Consensus 407 ~~ev~~ 412 (427)
++|+++
T Consensus 399 ~~ell~ 404 (446)
T 4ejn_A 399 AKEIMQ 404 (446)
T ss_dssp HHHHHT
T ss_pred HHHHHh
Confidence 999986
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=290.42 Aligned_cols=224 Identities=17% Similarity=0.179 Sum_probs=151.2
Q ss_pred cccccchhhhccccccCC-CCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 042634 179 IRHRNLVKIITSCASVDF-QGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVH 257 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivH 257 (427)
++||||+++++++..... ......++||||+++ ++.+.+.. .+++..+..++.|++.||+||| +.||+|
T Consensus 118 l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH---~~~iiH 187 (464)
T 3ttj_A 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLH---SAGIIH 187 (464)
T ss_dssp CCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHH---HTTCCC
T ss_pred CCCCCCCcEEEEEccCCccccCCeEEEEEeCCCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHH---HCCccc
Confidence 579999999998754321 233457999999954 56665542 3889999999999999999999 889999
Q ss_pred ccccCCceeeCCCCceEecccccccccCCc-----CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 258 CDLKPSNVLLDGELTAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 258 rDlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
|||||+|||++.++.+||+|||+|+..... ..||+.|+|||++.+..++.++||||+||++|||++|+.||.+..
T Consensus 188 rDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~ 267 (464)
T 3ttj_A 188 RDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 267 (464)
T ss_dssp CCCCGGGEEECTTSCEEECCCCCC-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCCChHhEEEeCCCCEEEEEEEeeeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999999876543 378999999999999999999999999999999999999997632
Q ss_pred CCCccHHHHHHHhccc--chhcccCcccccccc------ccchhhhcccccc-ccccchHHHHHHHHHHHhhcCCCCCCC
Q 042634 333 TGNLTLHNFVKEALPE--RLAEIVDPVLLVERE------EGETSKANAHKQF-TRSFSVKECLVSVLGIGVTCSSELPRE 403 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~------~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~cl~~dP~~ 403 (427)
. ...+...+.....+ .....+.+....... ............+ .........+.++.+++.+||+.||++
T Consensus 268 ~-~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~ 346 (464)
T 3ttj_A 268 Y-IDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 346 (464)
T ss_dssp H-HHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTT
T ss_pred H-HHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhh
Confidence 1 11122221111110 000000000000000 0000000000000 011122334678999999999999999
Q ss_pred CCCHHHHHHH
Q 042634 404 RMNMEEVAAQ 413 (427)
Q Consensus 404 Rpt~~ev~~~ 413 (427)
|||++|++++
T Consensus 347 R~ta~e~L~H 356 (464)
T 3ttj_A 347 RISVDDALQH 356 (464)
T ss_dssp SCCHHHHHTS
T ss_pred CCCHHHHhcC
Confidence 9999999874
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=275.58 Aligned_cols=202 Identities=22% Similarity=0.360 Sum_probs=159.2
Q ss_pred cccccchhhhccccccCC-----------CCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHH
Q 042634 179 IRHRNLVKIITSCASVDF-----------QGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYL 247 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~-----------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~L 247 (427)
++||||+++++.+....+ ......++||||+++|+|.+++..... ..+++..++.++.|++.||.||
T Consensus 61 l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~l 138 (284)
T 2a19_B 61 LDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG--EKLDKVLALELFEQITKGVDYI 138 (284)
T ss_dssp CCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGG--SCCCHHHHHHHHHHHHHHHHHH
T ss_pred CCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccC--CCCCHHHHHHHHHHHHHHHHHH
Confidence 479999999987644222 113447899999999999999975432 4689999999999999999999
Q ss_pred hhcCCCCeeeccccCCceeeCCCCceEecccccccccCCc-----CCCccccccccccCCCCcCccccchhHHHHHHHHH
Q 042634 248 HHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETF 322 (427)
Q Consensus 248 H~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell 322 (427)
| +.||+||||||+||+++.++.+||+|||+++..... ..++..|+|||++.+..++.++|||||||++|||+
T Consensus 139 H---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 215 (284)
T 2a19_B 139 H---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215 (284)
T ss_dssp H---HTTEECSCCSGGGEEEEETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHH
T ss_pred H---hCCeeeccCCHHHEEEcCCCCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHH
Confidence 9 899999999999999999999999999999876443 26888999999999999999999999999999999
Q ss_pred hCCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCC
Q 042634 323 TGKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPR 402 (427)
Q Consensus 323 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~ 402 (427)
+|..||... .......... . .+...+.++.+++.+||+.||+
T Consensus 216 ~~~~~~~~~-------~~~~~~~~~~----~---------------------------~~~~~~~~~~~li~~~l~~dp~ 257 (284)
T 2a19_B 216 HVCDTAFET-------SKFFTDLRDG----I---------------------------ISDIFDKKEKTLLQKLLSKKPE 257 (284)
T ss_dssp SCCSSHHHH-------HHHHHHHHTT----C---------------------------CCTTSCHHHHHHHHHHTCSSGG
T ss_pred hcCCcchhH-------HHHHHHhhcc----c---------------------------ccccCCHHHHHHHHHHccCChh
Confidence 999886431 0111100000 0 0011234578999999999999
Q ss_pred CCCCHHHHHHHHHHHHHHHHh
Q 042634 403 ERMNMEEVAAQLLSFRNKLVK 423 (427)
Q Consensus 403 ~Rpt~~ev~~~L~~~~~~~~~ 423 (427)
+|||+.|+++.|..+++....
T Consensus 258 ~Rps~~e~l~~l~~~~~~~~~ 278 (284)
T 2a19_B 258 DRPNTSEILRTLTVWKKSPEK 278 (284)
T ss_dssp GSCCHHHHHHHHHHHTC----
T ss_pred hCcCHHHHHHHHHHHhhCCCc
Confidence 999999999999999766544
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=283.85 Aligned_cols=195 Identities=21% Similarity=0.248 Sum_probs=146.0
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++++.. ....++||||+++|+|.+++... ..+++..++.++.|++.||+||| ++||+||
T Consensus 73 l~hpniv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~ 140 (361)
T 3uc3_A 73 LRHPNIVRFKEVILT-----PTHLAIIMEYASGGELYERICNA----GRFSEDEARFFFQQLLSGVSYCH---SMQICHR 140 (361)
T ss_dssp CCCTTBCCEEEEEEC-----SSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCSC
T ss_pred CCCCCCCcEEEEEee-----CCEEEEEEEeCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccC
Confidence 579999999998643 56789999999999999988643 45999999999999999999999 8999999
Q ss_pred cccCCceeeCCCCc--eEecccccccccCC-----cCCCccccccccccCCCCcCcc-ccchhHHHHHHHHHhCCCCCCc
Q 042634 259 DLKPSNVLLDGELT--AHVGDFGLAKFLPE-----ATNNFFNFQIAEYGMGSEVSTS-GDVYSFGILLLETFTGKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~~~~--~kL~DFG~a~~~~~-----~~~~~~~y~aPE~~~~~~~~~~-~DiwS~G~vl~ell~g~~pf~~ 330 (427)
||||+||+++.++. +||+|||+|+.... ...||+.|+|||++.+..++.+ +||||+||++|||++|+.||.+
T Consensus 141 Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 220 (361)
T 3uc3_A 141 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFED 220 (361)
T ss_dssp CCCGGGEEECSSSSCCEEECCCCCC---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC-
T ss_pred CCCHHHEEEcCCCCceEEEeecCccccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCC
Confidence 99999999987765 99999999985322 2378999999999988887655 8999999999999999999976
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
.... ..+............ ... .....+.++.+++.+||+.||++|||++|+
T Consensus 221 ~~~~-~~~~~~~~~~~~~~~--------~~~-------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~el 272 (361)
T 3uc3_A 221 PEEP-RDYRKTIQRILSVKY--------SIP-------------------DDIRISPECCHLISRIFVADPATRISIPEI 272 (361)
T ss_dssp ---C-CCHHHHHHHHHTTCC--------CCC-------------------TTSCCCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred CccH-HHHHHHHHHHhcCCC--------CCC-------------------CcCCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 4222 222222222111100 000 001124568899999999999999999999
Q ss_pred HHH
Q 042634 411 AAQ 413 (427)
Q Consensus 411 ~~~ 413 (427)
+++
T Consensus 273 l~h 275 (361)
T 3uc3_A 273 KTH 275 (361)
T ss_dssp HTS
T ss_pred HhC
Confidence 875
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-36 Score=301.99 Aligned_cols=196 Identities=29% Similarity=0.459 Sum_probs=159.7
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++++.. ...++||||+++|+|.+++..... ..+++.+++.++.||+.||+||| ++||+||
T Consensus 319 l~hpniv~~~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHr 387 (535)
T 2h8h_A 319 LRHEKLVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 387 (535)
T ss_dssp CCCTTBCCEEEEECS------SSCEEEECCCTTEEHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred CCCCCEeeEEEEEee------ccceEeeehhcCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCC
Confidence 579999999988533 457999999999999999975432 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC-------cCCCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCCc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE-------ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~-------~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~~ 330 (427)
||||+|||++.++.+||+|||+++.... ...++..|+|||++....++.++|||||||++|||++ |+.||.+
T Consensus 388 Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~ 467 (535)
T 2h8h_A 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 467 (535)
T ss_dssp CCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTT
T ss_pred CCCHhhEEEcCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999987643 2256678999999998899999999999999999999 9999975
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
.... .+...+..... ...+..++.++.++|.+||+.||++|||++||
T Consensus 468 ~~~~--~~~~~i~~~~~-------------------------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l 514 (535)
T 2h8h_A 468 MVNR--EVLDQVERGYR-------------------------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYL 514 (535)
T ss_dssp CCHH--HHHHHHHTTCC-------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCHH--HHHHHHHcCCC-------------------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 4211 11111111000 00123456778999999999999999999999
Q ss_pred HHHHHHHH
Q 042634 411 AAQLLSFR 418 (427)
Q Consensus 411 ~~~L~~~~ 418 (427)
++.|+.+.
T Consensus 515 ~~~L~~~~ 522 (535)
T 2h8h_A 515 QAFLEDYF 522 (535)
T ss_dssp HHHHHTSS
T ss_pred HHHHHHHh
Confidence 99998874
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=280.17 Aligned_cols=183 Identities=20% Similarity=0.309 Sum_probs=152.4
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCC-CcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNG-SLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVH 257 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivH 257 (427)
++||||+++++++.. ....++||||+.+| +|.+++... ..+++..+..++.|++.||+||| +.||+|
T Consensus 86 l~h~~Iv~~~~~~~~-----~~~~~lv~e~~~~g~~l~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH 153 (335)
T 3dls_A 86 VEHANIIKVLDIFEN-----QGFFQLVMEKHGSGLDLFAFIDRH----PRLDEPLASYIFRQLVSAVGYLR---LKDIIH 153 (335)
T ss_dssp CCCTTBCCEEEEEEC-----SSEEEEEEECCTTSCBHHHHHHTC----CCCCHHHHHHHHHHHHHHHHHHH---HTTEEC
T ss_pred CCCCCEeeEEEEEee-----CCEEEEEEEeCCCCccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEE
Confidence 469999999998543 56789999999777 999988765 35899999999999999999999 899999
Q ss_pred ccccCCceeeCCCCceEecccccccccCCcC-----CCccccccccccCCCCc-CccccchhHHHHHHHHHhCCCCCCcc
Q 042634 258 CDLKPSNVLLDGELTAHVGDFGLAKFLPEAT-----NNFFNFQIAEYGMGSEV-STSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 258 rDlkp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~y~aPE~~~~~~~-~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
|||||+||+++.++.+||+|||+++...... .||+.|+|||++.+..+ +.++|||||||++|||++|+.||...
T Consensus 154 ~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 233 (335)
T 3dls_A 154 RDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCEL 233 (335)
T ss_dssp SCCSGGGEEECTTSCEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSG
T ss_pred eccCHHHEEEcCCCcEEEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhH
Confidence 9999999999999999999999998765433 68999999999988877 88999999999999999999999652
Q ss_pred cCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 042634 332 FTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVA 411 (427)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~ 411 (427)
.. ....... .+..++.++.+++.+||+.||++|||++|++
T Consensus 234 ~~-------------------~~~~~~~---------------------~~~~~~~~l~~li~~~L~~dP~~Rps~~ell 273 (335)
T 3dls_A 234 EE-------------------TVEAAIH---------------------PPYLVSKELMSLVSGLLQPVPERRTTLEKLV 273 (335)
T ss_dssp GG-------------------GTTTCCC---------------------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HH-------------------HHhhccC---------------------CCcccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 11 0000000 0111345689999999999999999999998
Q ss_pred HH
Q 042634 412 AQ 413 (427)
Q Consensus 412 ~~ 413 (427)
+.
T Consensus 274 ~h 275 (335)
T 3dls_A 274 TD 275 (335)
T ss_dssp HC
T ss_pred cC
Confidence 75
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-36 Score=289.93 Aligned_cols=192 Identities=18% Similarity=0.226 Sum_probs=152.3
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||++++.+.. ....++|||||++|+|.+++.. ..+++..++.++.||+.||+||| +.||+||
T Consensus 126 l~hp~Iv~l~~~~~~-----~~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH---~~givHr 192 (410)
T 3v8s_A 126 ANSPWVVQLFYAFQD-----DRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIH---SMGFIHR 192 (410)
T ss_dssp CCCTTBCCEEEEEEC-----SSEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred CCCCCCCeEEEEEEE-----CCEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEec
Confidence 579999999998543 5678999999999999998854 34899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc-------CCCccccccccccCCCC----cCccccchhHHHHHHHHHhCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA-------TNNFFNFQIAEYGMGSE----VSTSGDVYSFGILLLETFTGKRP 327 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-------~~~~~~y~aPE~~~~~~----~~~~~DiwS~G~vl~ell~g~~p 327 (427)
||||+|||++.++.+||+|||+|+..... ..||+.|+|||++.+.. ++.++|||||||++|||++|+.|
T Consensus 193 DLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~P 272 (410)
T 3v8s_A 193 DVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272 (410)
T ss_dssp CCSGGGEEECTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCT
T ss_pred cCCHHHeeECCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCC
Confidence 99999999999999999999999865432 37999999999998765 88999999999999999999999
Q ss_pred CCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCC--CC
Q 042634 328 TNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRE--RM 405 (427)
Q Consensus 328 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~--Rp 405 (427)
|.+.. ............. ...-+ .....+.++.+++.+||+.+|++ ||
T Consensus 273 f~~~~-----~~~~~~~i~~~~~-~~~~p------------------------~~~~~s~~~~~li~~lL~~~~~rlgR~ 322 (410)
T 3v8s_A 273 FYADS-----LVGTYSKIMNHKN-SLTFP------------------------DDNDISKEAKNLICAFLTDREVRLGRN 322 (410)
T ss_dssp TCCSS-----HHHHHHHHHTHHH-HCCCC------------------------TTCCCCHHHHHHHHHHSSCGGGCTTSS
T ss_pred CCCCC-----hhhHHHHHHhccc-cccCC------------------------CcccccHHHHHHHHHHccChhhhCCCC
Confidence 97531 1111111110000 00000 00113456889999999999998 99
Q ss_pred CHHHHHHH
Q 042634 406 NMEEVAAQ 413 (427)
Q Consensus 406 t~~ev~~~ 413 (427)
+++||+++
T Consensus 323 ~~~ei~~H 330 (410)
T 3v8s_A 323 GVEEIKRH 330 (410)
T ss_dssp CHHHHHTS
T ss_pred CHHHHhcC
Confidence 99999864
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-36 Score=281.72 Aligned_cols=199 Identities=21% Similarity=0.352 Sum_probs=158.4
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhh------hhccCHHHHHHHHHHHHHHHHHHhhcCC
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREA------LKNLNLLQRLSIAVDVASALDYLHHYCE 252 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~------~~~l~~~~~~~~~~~i~~~L~~LH~~~~ 252 (427)
++||||+++++.+.. ....++||||+++|+|.+++...... ...+++..++.++.|++.||+||| +
T Consensus 85 l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~ 156 (322)
T 1p4o_A 85 FNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---A 156 (322)
T ss_dssp CCCTTBCCEEEEECS-----SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---H
T ss_pred cCCCCEeeeEEEEcc-----CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---H
Confidence 479999999998543 56789999999999999998754321 134688999999999999999999 8
Q ss_pred CCeeeccccCCceeeCCCCceEecccccccccCCc--------CCCccccccccccCCCCcCccccchhHHHHHHHHHh-
Q 042634 253 TPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA--------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT- 323 (427)
Q Consensus 253 ~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~- 323 (427)
+||+||||||+||+++.++.+||+|||+++..... ..++..|+|||++.+..++.++|||||||++|||++
T Consensus 157 ~~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~ 236 (322)
T 1p4o_A 157 NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATL 236 (322)
T ss_dssp TTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHT
T ss_pred CCCccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhc
Confidence 89999999999999999999999999999865332 145678999999998899999999999999999999
Q ss_pred CCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCC
Q 042634 324 GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRE 403 (427)
Q Consensus 324 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~ 403 (427)
|..||..... .+........... ..+..++..+.+++.+||+.||++
T Consensus 237 g~~p~~~~~~-----~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dp~~ 283 (322)
T 1p4o_A 237 AEQPYQGLSN-----EQVLRFVMEGGLL----------------------------DKPDNCPDMLFELMRMCWQYNPKM 283 (322)
T ss_dssp SCCTTTTSCH-----HHHHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred CCCccccCCH-----HHHHHHHHcCCcC----------------------------CCCCCCCHHHHHHHHHHcCCCccc
Confidence 8999875311 1111111000000 011234566899999999999999
Q ss_pred CCCHHHHHHHHHHHH
Q 042634 404 RMNMEEVAAQLLSFR 418 (427)
Q Consensus 404 Rpt~~ev~~~L~~~~ 418 (427)
|||++|+++.|+++.
T Consensus 284 Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 284 RPSFLEIISSIKEEM 298 (322)
T ss_dssp SCCHHHHHHHHGGGS
T ss_pred CcCHHHHHHHHHHhh
Confidence 999999999998874
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-35 Score=286.33 Aligned_cols=193 Identities=25% Similarity=0.325 Sum_probs=148.3
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+. ....++||||+++|+|.+++... ..+++..++.++.|++.||+||| +.||+||
T Consensus 197 l~hpniv~l~~~~~------~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHr 263 (419)
T 3i6u_A 197 LNHPCIIKIKNFFD------AEDYYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLH---ENGIIHR 263 (419)
T ss_dssp CCCTTBCCCCEEEE------SSEEEEEEECCTTCBGGGGTSSS----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred CCCCCEeeEEEEEe------cCceEEEEEcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccc
Confidence 57999999998753 23478999999999999998765 45899999999999999999999 8899999
Q ss_pred cccCCceeeCCC---CceEecccccccccCCcC-----CCccccccccccCC---CCcCccccchhHHHHHHHHHhCCCC
Q 042634 259 DLKPSNVLLDGE---LTAHVGDFGLAKFLPEAT-----NNFFNFQIAEYGMG---SEVSTSGDVYSFGILLLETFTGKRP 327 (427)
Q Consensus 259 Dlkp~NIll~~~---~~~kL~DFG~a~~~~~~~-----~~~~~y~aPE~~~~---~~~~~~~DiwS~G~vl~ell~g~~p 327 (427)
||||+|||++.+ ..+||+|||+|+...... .||+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 264 Dlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~p 343 (419)
T 3i6u_A 264 DLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343 (419)
T ss_dssp CCCGGGEEESSSSSSCCEEECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCS
T ss_pred CCChHhEEEecCCCcceEEEeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCC
Confidence 999999999654 469999999998765432 68899999999864 5688999999999999999999999
Q ss_pred CCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCH
Q 042634 328 TNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM 407 (427)
Q Consensus 328 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~ 407 (427)
|...... ..+...+.......... .....+.++.+++.+||+.||++|||+
T Consensus 344 f~~~~~~-~~~~~~i~~~~~~~~~~----------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~ 394 (419)
T 3i6u_A 344 FSEHRTQ-VSLKDQITSGKYNFIPE----------------------------VWAEVSEKALDLVKKLLVVDPKARFTT 394 (419)
T ss_dssp SCCCSSS-CCHHHHHHTTCCCCCHH----------------------------HHTTSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred CCCCcch-HHHHHHHhcCCCCCCch----------------------------hhcccCHHHHHHHHHHccCChhHCcCH
Confidence 9754222 22222222111000000 112245678999999999999999999
Q ss_pred HHHHHH
Q 042634 408 EEVAAQ 413 (427)
Q Consensus 408 ~ev~~~ 413 (427)
+|++++
T Consensus 395 ~e~l~h 400 (419)
T 3i6u_A 395 EEALRH 400 (419)
T ss_dssp HHHHHS
T ss_pred HHHhCC
Confidence 999873
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=272.84 Aligned_cols=189 Identities=20% Similarity=0.274 Sum_probs=152.6
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+++|+|.+++... ..+++..+..++.|++.||+||| +.||+||
T Consensus 66 l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~ 133 (279)
T 3fdn_A 66 LRHPNILRLYGYFHD-----ATRVYLILEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCH---SKRVIHR 133 (279)
T ss_dssp CCCTTBCCEEEEEEC-----SSEEEEEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH---TTTCEEC
T ss_pred CCCCCCcchhheEec-----CCEEEEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCEecc
Confidence 469999999998543 56789999999999999988654 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc----CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA----TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTG 334 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~~ 334 (427)
||||+||+++.++.+||+|||++...... ..++..|+|||.+.+..++.++||||+|+++|||++|+.||....
T Consensus 134 dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-- 211 (279)
T 3fdn_A 134 DIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-- 211 (279)
T ss_dssp CCCGGGEEECTTSCEEECSCCEESCC--------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS--
T ss_pred cCChHhEEEcCCCCEEEEeccccccCCcccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc--
Confidence 99999999999999999999998765433 378899999999999999999999999999999999999997531
Q ss_pred CccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 042634 335 NLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAAQ 413 (427)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~ 413 (427)
........... .. ..+...+..+.+++.+||+.||++|||++|++++
T Consensus 212 ---~~~~~~~~~~~------~~-----------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 212 ---YQETYKRISRV------EF-----------------------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp ---HHHHHHHHHHT------CC-----------------------CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred ---HHHHHHHHHhC------CC-----------------------CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 11111110000 00 0111234568899999999999999999999975
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-35 Score=270.45 Aligned_cols=192 Identities=21% Similarity=0.319 Sum_probs=153.9
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+++++|.+++... ..+++..+..++.|++.||+||| +.||+||
T Consensus 62 l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~ 129 (276)
T 2yex_A 62 LNHENVVKFYGHRRE-----GNIQYLFLEYCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLH---GIGITHR 129 (276)
T ss_dssp CCCTTBCCEEEEEEE-----TTEEEEEEECCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHH---HTTEECS
T ss_pred cCCCCceeeeeEEEc-----CCEEEEEEEecCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHH---hCCeecc
Confidence 479999999998544 56789999999999999999754 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC--------cCCCccccccccccCCCCc-CccccchhHHHHHHHHHhCCCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE--------ATNNFFNFQIAEYGMGSEV-STSGDVYSFGILLLETFTGKRPTN 329 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~--------~~~~~~~y~aPE~~~~~~~-~~~~DiwS~G~vl~ell~g~~pf~ 329 (427)
||||+||+++.++.+||+|||.+..... ...++..|+|||++.+..+ +.++|||||||++|||++|+.||.
T Consensus 130 dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 209 (276)
T 2yex_A 130 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209 (276)
T ss_dssp CCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCS
T ss_pred CCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999976432 2368889999999988775 789999999999999999999997
Q ss_pred cccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 042634 330 EMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEE 409 (427)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~e 409 (427)
........+..+..... ... .....+..+.+++.+||+.||++|||++|
T Consensus 210 ~~~~~~~~~~~~~~~~~------~~~-------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 258 (276)
T 2yex_A 210 QPSDSCQEYSDWKEKKT------YLN-------------------------PWKKIDSAPLALLHKILVENPSARITIPD 258 (276)
T ss_dssp CSCTTSHHHHHHHTTCT------TST-------------------------TGGGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CCchHHHHHHHhhhccc------ccC-------------------------chhhcCHHHHHHHHHHCCCCchhCCCHHH
Confidence 64332222211111000 000 11123456889999999999999999999
Q ss_pred HHHH
Q 042634 410 VAAQ 413 (427)
Q Consensus 410 v~~~ 413 (427)
+++.
T Consensus 259 il~~ 262 (276)
T 2yex_A 259 IKKD 262 (276)
T ss_dssp HTTC
T ss_pred HhcC
Confidence 9763
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-36 Score=282.32 Aligned_cols=210 Identities=25% Similarity=0.433 Sum_probs=161.7
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+... +....++||||+++++|.+++.... ..+++..++.++.|++.||+||| +.||+||
T Consensus 99 l~h~~iv~~~~~~~~~---~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~ 169 (326)
T 2w1i_A 99 LQHDNIVKYKGVCYSA---GRRNLKLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLG---TKRYIHR 169 (326)
T ss_dssp CCCTTBCCEEEEECC-------CCEEEECCCTTCBHHHHHHHST---TSSCHHHHHHHHHHHHHHHHHHH---HTTEECS
T ss_pred CCCCCeeeEEEEEEec---CCCceEEEEECCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH---hCCEecc
Confidence 4699999999875431 2346789999999999999987543 35899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc---------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA---------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTN 329 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~---------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~ 329 (427)
||||+||+++.++.+||+|||+++..... ..++..|+|||.+.+..++.++|||||||++|||++|..||.
T Consensus 170 dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~ 249 (326)
T 2w1i_A 170 DLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK 249 (326)
T ss_dssp CCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGG
T ss_pred CCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCC
Confidence 99999999999999999999999876432 245667999999988889999999999999999999999876
Q ss_pred cccCCCccHHHHHHHhccc--------chhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCC
Q 042634 330 EMFTGNLTLHNFVKEALPE--------RLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELP 401 (427)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP 401 (427)
... ..+....... .+.+.+.. ..+...+..++.++.+++.+||+.||
T Consensus 250 ~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~l~~li~~cl~~dP 304 (326)
T 2w1i_A 250 SPP------AEFMRMIGNDKQGQMIVFHLIELLKN-------------------NGRLPRPDGCPDEIYMIMTECWNNNV 304 (326)
T ss_dssp SHH------HHHHHHHCTTCCTHHHHHHHHHHHHT-------------------TCCCCCCTTCCHHHHHHHHHHSCSSG
T ss_pred CCH------HHHHHhhccccchhhhHHHHHHHhhc-------------------CCCCCCCCcccHHHHHHHHHHcCCCh
Confidence 420 0110000000 00000000 00001223456779999999999999
Q ss_pred CCCCCHHHHHHHHHHHHHHHH
Q 042634 402 RERMNMEEVAAQLLSFRNKLV 422 (427)
Q Consensus 402 ~~Rpt~~ev~~~L~~~~~~~~ 422 (427)
++|||++|+++.|+++++++.
T Consensus 305 ~~Rps~~el~~~L~~l~~~l~ 325 (326)
T 2w1i_A 305 NQRPSFRDLALRVDQIRDQMA 325 (326)
T ss_dssp GGSCCHHHHHHHHHHHHHHHH
T ss_pred hhCcCHHHHHHHHHHHHHHhc
Confidence 999999999999999998864
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=283.88 Aligned_cols=201 Identities=20% Similarity=0.341 Sum_probs=148.6
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.... ..+...++||||+++++|.+++... ..+++..++.++.|++.||+||| +.||+||
T Consensus 69 l~hp~iv~~~~~~~~~~-~~~~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~ 140 (311)
T 3ork_A 69 LNHPAIVAVYDTGEAET-PAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSH---QNGIIHR 140 (311)
T ss_dssp CCCTTBCCEEEEEEEEE-TTEEEEEEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCC
T ss_pred CCCCCcceEEEeeeccC-CCCcccEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcC
Confidence 47999999998865421 1112348999999999999998644 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc---------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA---------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTN 329 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~---------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~ 329 (427)
||||+||+++.++.+||+|||+++..... ..||..|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 141 dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~ 220 (311)
T 3ork_A 141 DVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT 220 (311)
T ss_dssp CCCGGGEEEETTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999865432 257899999999999999999999999999999999999997
Q ss_pred cccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 042634 330 EMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEE 409 (427)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~e 409 (427)
+.... .......... ... .......++.++.+++.+||+.||++||++.+
T Consensus 221 ~~~~~-----~~~~~~~~~~---~~~----------------------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~ 270 (311)
T 3ork_A 221 GDSPV-----SVAYQHVRED---PIP----------------------PSARHEGLSADLDAVVLKALAKNPENRYQTAA 270 (311)
T ss_dssp CSSHH-----HHHHHHHHCC---CCC----------------------HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHH
T ss_pred CCChH-----HHHHHHhcCC---CCC----------------------cccccCCCCHHHHHHHHHHHhcCHhhChhhHH
Confidence 53211 1111100000 000 00001124566899999999999999996665
Q ss_pred -HHHHHHHH
Q 042634 410 -VAAQLLSF 417 (427)
Q Consensus 410 -v~~~L~~~ 417 (427)
+...+.++
T Consensus 271 ~l~~~l~~~ 279 (311)
T 3ork_A 271 EMRADLVRV 279 (311)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 44555544
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=274.29 Aligned_cols=218 Identities=19% Similarity=0.240 Sum_probs=151.9
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||++ ++|.+++.... ..+++..++.++.|++.||+||| ++||+||
T Consensus 57 l~h~~iv~~~~~~~~-----~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~ 124 (288)
T 1ob3_A 57 LKHSNIVKLYDVIHT-----KKRLVLVFEHLD-QDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCH---DRRVLHR 124 (288)
T ss_dssp CCCTTBCCEEEEEEC-----SSCEEEEEECCS-EEHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred cCCCCEeeeeeEEcc-----CCeEEEEEEecC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH---HCCeecC
Confidence 469999999998543 567899999996 58888886543 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC------cCCCccccccccccCC-CCcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE------ATNNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
||||+||+++.++.+||+|||+++.... ...+|..|+|||++.+ ..++.++||||+||++|||++|+.||.+.
T Consensus 125 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 204 (288)
T 1ob3_A 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204 (288)
T ss_dssp CCCGGGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCCHHHEEEcCCCCEEEeECccccccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999986542 2267899999999876 45899999999999999999999999764
Q ss_pred cCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 042634 332 FTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVA 411 (427)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~ 411 (427)
... ..+........................ ... .....+..........+.++.+++.+||+.||++|||++|++
T Consensus 205 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 279 (288)
T 1ob3_A 205 SEA-DQLMRIFRILGTPNSKNWPNVTELPKY--DPN--FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279 (288)
T ss_dssp SHH-HHHHHHHHHHCCCCTTTSTTGGGSTTC--CTT--CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred CHH-HHHHHHHHHHCCCChhhchhhhccccc--ccc--cccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 211 111111111111000000000000000 000 000000000001122456688999999999999999999998
Q ss_pred HH
Q 042634 412 AQ 413 (427)
Q Consensus 412 ~~ 413 (427)
++
T Consensus 280 ~h 281 (288)
T 1ob3_A 280 EH 281 (288)
T ss_dssp TS
T ss_pred cC
Confidence 63
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-35 Score=292.03 Aligned_cols=138 Identities=22% Similarity=0.359 Sum_probs=119.2
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||++++++....+......++||||+ +|+|.+++... ..+++..++.++.||+.||+||| +.||+||
T Consensus 109 l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHr 180 (458)
T 3rp9_A 109 LNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTP----VYLTELHIKTLLYNLLVGVKYVH---SAGILHR 180 (458)
T ss_dssp CCCTTBCCEEEECCCSCTTTCCCEEEEECCC-SEEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCC
T ss_pred CCCCCCCceEEEEecCCcccCceEEEEEecc-ccchhhhcccC----CCCCHHHHHHHHHHHHHHHHHHH---hCCcCCC
Confidence 4799999999998665555556789999998 68999888654 45999999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC---------------------------------cCCCcccccccccc-CCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE---------------------------------ATNNFFNFQIAEYG-MGSE 304 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~---------------------------------~~~~~~~y~aPE~~-~~~~ 304 (427)
||||+|||++.++.+||+|||+|+.... ...||+.|+|||++ ....
T Consensus 181 DlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~ 260 (458)
T 3rp9_A 181 DLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQEN 260 (458)
T ss_dssp CCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCC
T ss_pred CCChhhEEECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCC
Confidence 9999999999999999999999987532 12568899999976 4567
Q ss_pred cCccccchhHHHHHHHHHhC
Q 042634 305 VSTSGDVYSFGILLLETFTG 324 (427)
Q Consensus 305 ~~~~~DiwS~G~vl~ell~g 324 (427)
++.++|||||||++|||++|
T Consensus 261 ~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 261 YTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CCTHHHHHHHHHHHHHHHTT
T ss_pred CCcHhHHHHHHHHHHHHHHh
Confidence 99999999999999999993
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=280.51 Aligned_cols=188 Identities=21% Similarity=0.244 Sum_probs=149.6
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+++|+|.+++... ..+++..+..++.||+.||+||| +.||+||
T Consensus 78 l~hp~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~ 145 (327)
T 3a62_A 78 VKHPFIVDLIYAFQT-----GGKLYLILEYLSGGELFMQLERE----GIFMEDTACFYLAEISMALGHLH---QKGIIYR 145 (327)
T ss_dssp CCCTTBCCEEEEEEC-----SSCEEEEEECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCC
T ss_pred CCCCCccceeEEEEc-----CCEEEEEEeCCCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHH---hCCEEcc
Confidence 469999999988543 56789999999999999988643 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC------cCCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE------ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+||+++.++.+||+|||+++.... ...||..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 146 Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 225 (327)
T 3a62_A 146 DLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN 225 (327)
T ss_dssp CCCTTTEEECTTSCEEECCCSCC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cCCHHHeEECCCCcEEEEeCCcccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC
Confidence 9999999999999999999999976432 2368999999999999999999999999999999999999997531
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCC-----CH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERM-----NM 407 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rp-----t~ 407 (427)
. ........... .. .+...+.++.+++.+||+.||++|| |+
T Consensus 226 ~-----~~~~~~i~~~~----~~-------------------------~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~ 271 (327)
T 3a62_A 226 R-----KKTIDKILKCK----LN-------------------------LPPYLTQEARDLLKKLLKRNAASRLGAGPGDA 271 (327)
T ss_dssp H-----HHHHHHHHHTC----CC-------------------------CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTH
T ss_pred H-----HHHHHHHHhCC----CC-------------------------CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCH
Confidence 1 11111110000 00 1112345688999999999999999 77
Q ss_pred HHHHH
Q 042634 408 EEVAA 412 (427)
Q Consensus 408 ~ev~~ 412 (427)
+|+++
T Consensus 272 ~e~l~ 276 (327)
T 3a62_A 272 GEVQA 276 (327)
T ss_dssp HHHHH
T ss_pred HHHHc
Confidence 78765
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-36 Score=277.78 Aligned_cols=194 Identities=21% Similarity=0.276 Sum_probs=144.9
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCC-Ceee
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCET-PIVH 257 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~-~ivH 257 (427)
.+||||+++++.+.. ....++||||++ |+|.+++.........+++..++.++.|++.||+||| ++ ||+|
T Consensus 63 ~~h~~iv~~~~~~~~-----~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H 133 (290)
T 3fme_A 63 VDCPFTVTFYGALFR-----EGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIH 133 (290)
T ss_dssp CCCTTBCCEEEEEEC-----SSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCC
T ss_pred CCCCeEEEEeeeeec-----cCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeec
Confidence 579999999998643 567899999995 6888877654333356999999999999999999999 76 9999
Q ss_pred ccccCCceeeCCCCceEecccccccccCCc-----CCCcccccccccc----CCCCcCccccchhHHHHHHHHHhCCCCC
Q 042634 258 CDLKPSNVLLDGELTAHVGDFGLAKFLPEA-----TNNFFNFQIAEYG----MGSEVSTSGDVYSFGILLLETFTGKRPT 328 (427)
Q Consensus 258 rDlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~----~~~~~~~~~DiwS~G~vl~ell~g~~pf 328 (427)
|||||+||+++.++.+||+|||.++..... ..++..|+|||++ .+..++.++||||+||++|||++|+.||
T Consensus 134 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 213 (290)
T 3fme_A 134 RDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPY 213 (290)
T ss_dssp CCCSGGGCEECTTCCEEBCCC---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSS
T ss_pred CCCCHHHEEECCCCCEEEeecCCcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCc
Confidence 999999999999999999999999865433 2788999999996 5567899999999999999999999999
Q ss_pred CcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 042634 329 NEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME 408 (427)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ 408 (427)
.........+........+. .....++.++.+++.+||+.||++|||++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~ 262 (290)
T 3fme_A 214 DSWGTPFQQLKQVVEEPSPQ-------------------------------LPADKFSAEFVDFTSQCLKKNSKERPTYP 262 (290)
T ss_dssp CCCSCHHHHHHHHHHSCCCC-------------------------------CCTTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred cccCchHHHHHHHhccCCCC-------------------------------cccccCCHHHHHHHHHHhhcChhhCcCHH
Confidence 75321111111111110000 01122355689999999999999999999
Q ss_pred HHHH
Q 042634 409 EVAA 412 (427)
Q Consensus 409 ev~~ 412 (427)
|+++
T Consensus 263 e~l~ 266 (290)
T 3fme_A 263 ELMQ 266 (290)
T ss_dssp HHTT
T ss_pred HHHh
Confidence 9987
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=274.93 Aligned_cols=190 Identities=16% Similarity=0.258 Sum_probs=151.5
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeecc
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCD 259 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrD 259 (427)
+||||+++++.+.. ....++||||+++++|.+++.........+++..++.++.|++.||+||| ++||+|||
T Consensus 69 ~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~D 140 (289)
T 1x8b_A 69 QHSHVVRYFSAWAE-----DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMD 140 (289)
T ss_dssp SCTTBCCEEEEEEE-----TTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSC
T ss_pred CCCCeeeeeeeeec-----CCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecC
Confidence 79999999998644 56789999999999999999765443356899999999999999999999 89999999
Q ss_pred ccCCceeeCC-------------------CCceEecccccccccCCcC--CCccccccccccCCC-CcCccccchhHHHH
Q 042634 260 LKPSNVLLDG-------------------ELTAHVGDFGLAKFLPEAT--NNFFNFQIAEYGMGS-EVSTSGDVYSFGIL 317 (427)
Q Consensus 260 lkp~NIll~~-------------------~~~~kL~DFG~a~~~~~~~--~~~~~y~aPE~~~~~-~~~~~~DiwS~G~v 317 (427)
|||+||+++. ...+||+|||.++...... .++..|+|||++.+. .++.++|||||||+
T Consensus 141 ikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~i 220 (289)
T 1x8b_A 141 IKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALT 220 (289)
T ss_dssp CSGGGEEEC--------------------CCCEEECCCTTCEETTCSCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHH
T ss_pred CCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCccccCCCccccChhHhcCCCCCCchhhHHHHHHH
Confidence 9999999984 4479999999998765433 789999999999775 56789999999999
Q ss_pred HHHHHhCCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcC
Q 042634 318 LLETFTGKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCS 397 (427)
Q Consensus 318 l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl 397 (427)
+|||++|.+++... ...........+ . .+..++.++.+++.+||
T Consensus 221 l~~l~~~~~~~~~~----~~~~~~~~~~~~----~----------------------------~~~~~~~~~~~li~~~l 264 (289)
T 1x8b_A 221 VVCAAGAEPLPRNG----DQWHEIRQGRLP----R----------------------------IPQVLSQEFTELLKVMI 264 (289)
T ss_dssp HHHHTTCCCCCSSS----HHHHHHHTTCCC----C----------------------------CSSCCCHHHHHHHHHHT
T ss_pred HHHHhcCCCCCcch----hHHHHHHcCCCC----C----------------------------CCcccCHHHHHHHHHHh
Confidence 99999999876432 111111000000 0 11123456899999999
Q ss_pred CCCCCCCCCHHHHHHH
Q 042634 398 SELPRERMNMEEVAAQ 413 (427)
Q Consensus 398 ~~dP~~Rpt~~ev~~~ 413 (427)
+.||++|||++|++++
T Consensus 265 ~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 265 HPDPERRPSAMALVKH 280 (289)
T ss_dssp CSSGGGSCCHHHHHTC
T ss_pred CCCcccCCCHHHHhhC
Confidence 9999999999999863
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-35 Score=271.36 Aligned_cols=195 Identities=25% Similarity=0.362 Sum_probs=152.0
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCC--ee
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETP--IV 256 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~--iv 256 (427)
++||||+++++.+... ..+....++||||+++|+|.+++... ..+++..++.++.|++.||+||| +.| |+
T Consensus 82 l~h~~iv~~~~~~~~~-~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~ 153 (290)
T 1t4h_A 82 LQHPNIVRFYDSWEST-VKGKKCIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLH---TRTPPII 153 (290)
T ss_dssp CCCTTBCCEEEEEEEE-SSSCEEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCC
T ss_pred CCCCCeeeeeeeeccc-cCCCceEEEEEEecCCCCHHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHH---cCCCCEE
Confidence 4699999999876442 22345679999999999999998653 45899999999999999999999 788 99
Q ss_pred eccccCCceeeC-CCCceEecccccccccCCcC----CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 257 HCDLKPSNVLLD-GELTAHVGDFGLAKFLPEAT----NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 257 HrDlkp~NIll~-~~~~~kL~DFG~a~~~~~~~----~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
||||||+||+++ .++.+||+|||++....... .++..|+|||++. ..++.++||||+||++|+|++|+.||...
T Consensus 154 H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 232 (290)
T 1t4h_A 154 HRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSEC 232 (290)
T ss_dssp CSCCCGGGEEESSTTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ECCCCHHHEEEECCCCCEEEeeCCCcccccccccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCc
Confidence 999999999997 78999999999997654432 6889999999876 45899999999999999999999999753
Q ss_pred cCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 042634 332 FTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVA 411 (427)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~ 411 (427)
... ........... .+. ..+...+.++.+++.+||+.||++|||++|++
T Consensus 233 ~~~----~~~~~~~~~~~-----~~~----------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell 281 (290)
T 1t4h_A 233 QNA----AQIYRRVTSGV-----KPA----------------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 281 (290)
T ss_dssp SSH----HHHHHHHTTTC-----CCG----------------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred CcH----HHHHHHHhccC-----Ccc----------------------ccCCCCCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 211 11111111000 000 01111234689999999999999999999998
Q ss_pred HH
Q 042634 412 AQ 413 (427)
Q Consensus 412 ~~ 413 (427)
++
T Consensus 282 ~h 283 (290)
T 1t4h_A 282 NH 283 (290)
T ss_dssp TS
T ss_pred hC
Confidence 63
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=287.57 Aligned_cols=195 Identities=17% Similarity=0.195 Sum_probs=153.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++|||||++|+|.+++.... ..+++..++.++.|++.||+||| +.||+||
T Consensus 131 ~~hp~Iv~l~~~~~~-----~~~~~lV~Ey~~gg~L~~~l~~~~---~~l~e~~~~~~~~qi~~aL~~LH---~~giiHr 199 (437)
T 4aw2_A 131 GDSKWITTLHYAFQD-----DNNLYLVMDYYVGGDLLTLLSKFE---DRLPEEMARFYLAEMVIAIDSVH---QLHYVHR 199 (437)
T ss_dssp SCTTTBCCEEEEEEC-----SSEEEEEECCCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred CCCCCEEEEEEEEee-----CCEEEEEEecCCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeEec
Confidence 579999999998544 567899999999999999997632 45999999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc-------CCCccccccccccC-----CCCcCccccchhHHHHHHHHHhCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA-------TNNFFNFQIAEYGM-----GSEVSTSGDVYSFGILLLETFTGKR 326 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-------~~~~~~y~aPE~~~-----~~~~~~~~DiwS~G~vl~ell~g~~ 326 (427)
||||+|||++.++.+||+|||+|+..... ..||+.|+|||++. ...++.++|||||||++|||++|+.
T Consensus 200 DLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~ 279 (437)
T 4aw2_A 200 DIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGET 279 (437)
T ss_dssp CCSGGGEEECTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSC
T ss_pred ccCHHHeeEcCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCC
Confidence 99999999999999999999999765332 37899999999987 5678999999999999999999999
Q ss_pred CCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCC--C
Q 042634 327 PTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRE--R 404 (427)
Q Consensus 327 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~--R 404 (427)
||.+... .+.......... ... +.. .....+.++.+++++|+..+|++ |
T Consensus 280 Pf~~~~~-----~~~~~~i~~~~~-~~~---------------------~p~--~~~~~s~~~~dLi~~lL~~~~~r~~r 330 (437)
T 4aw2_A 280 PFYAESL-----VETYGKIMNHKE-RFQ---------------------FPT--QVTDVSENAKDLIRRLICSREHRLGQ 330 (437)
T ss_dssp TTCCSSH-----HHHHHHHHTHHH-HCC---------------------CCS--SCCCSCHHHHHHHHTTSSCGGGCTTT
T ss_pred CCCCCCh-----hHHHHhhhhccc-ccc---------------------CCc--ccccCCHHHHHHHHHHhcccccccCC
Confidence 9975311 111111110000 000 000 00113456889999999999988 9
Q ss_pred CCHHHHHHH
Q 042634 405 MNMEEVAAQ 413 (427)
Q Consensus 405 pt~~ev~~~ 413 (427)
|+++|++++
T Consensus 331 ~~~~eil~H 339 (437)
T 4aw2_A 331 NGIEDFKKH 339 (437)
T ss_dssp TTTHHHHTS
T ss_pred CCHHHHhCC
Confidence 999998763
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=286.70 Aligned_cols=200 Identities=17% Similarity=0.142 Sum_probs=149.1
Q ss_pred cccccchhhhccccccC--CC------------CCC-----ccceeeeeecCCCcccccccchhh---hhccCHHHHHHH
Q 042634 179 IRHRNLVKIITSCASVD--FQ------------GND-----SEALVYEFMVNGSLEEWLHPNREA---LKNLNLLQRLSI 236 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~--~~------------~~~-----~~~lv~e~~~~g~L~~~l~~~~~~---~~~l~~~~~~~~ 236 (427)
++|||||++++.+.... +. ++. ..++||||+ +|+|.+++...... ...+++..++.+
T Consensus 133 l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i 211 (377)
T 3byv_A 133 IKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQL 211 (377)
T ss_dssp CCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHH
T ss_pred cCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHH
Confidence 47999999996543210 11 111 368999999 78999998754210 123455888899
Q ss_pred HHHHHHHHHHHhhcCCCCeeeccccCCceeeCCCCceEecccccccccCCc---CCCccccccccccCCC----------
Q 042634 237 AVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA---TNNFFNFQIAEYGMGS---------- 303 (427)
Q Consensus 237 ~~~i~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~~y~aPE~~~~~---------- 303 (427)
+.||+.||+||| +.||+||||||+|||++.++.+||+|||+|+..... ..| ..|+|||++.+.
T Consensus 212 ~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~ 287 (377)
T 3byv_A 212 TLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRR 287 (377)
T ss_dssp HHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCE
T ss_pred HHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEechhheecCCcccCCCC-cCccChhhhccccccccccccc
Confidence 999999999999 899999999999999999999999999999875432 266 899999999887
Q ss_pred -CcCccccchhHHHHHHHHHhCCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccch
Q 042634 304 -EVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSV 382 (427)
Q Consensus 304 -~~~~~~DiwS~G~vl~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 382 (427)
.++.++|||||||++|||++|+.||........ ...+... .
T Consensus 288 ~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~-------------~~~~~~~-------------------------~ 329 (377)
T 3byv_A 288 TLMTFSFDAWALGLVIYWIWCADLPITKDAALGG-------------SEWIFRS-------------------------C 329 (377)
T ss_dssp EECCHHHHHHHHHHHHHHHHHSSCCC------CC-------------SGGGGSS-------------------------C
T ss_pred ccCChhhhHHHHHHHHHHHHHCCCCCcccccccc-------------hhhhhhh-------------------------c
Confidence 899999999999999999999999965321110 0000000 0
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCCCHHHHHH--HHHHHHHHH
Q 042634 383 KECLVSVLGIGVTCSSELPRERMNMEEVAA--QLLSFRNKL 421 (427)
Q Consensus 383 ~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~--~L~~~~~~~ 421 (427)
..++.++.+++.+||+.||++|||+.|+++ -++.+.+.+
T Consensus 330 ~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~ 370 (377)
T 3byv_A 330 KNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTEL 370 (377)
T ss_dssp CCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHHHHH
T ss_pred cCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHHHHH
Confidence 113456889999999999999999999996 455555444
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=287.65 Aligned_cols=140 Identities=24% Similarity=0.424 Sum_probs=121.7
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeecc
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCD 259 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrD 259 (427)
.||||+++++++.. .+....++|||||+ |+|.+++.. ..+++..+..++.|++.||+||| +.||+|||
T Consensus 67 ~h~niv~l~~~~~~---~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrD 134 (388)
T 3oz6_A 67 GHENIVNLLNVLRA---DNDRDVYLVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLH---SGGLLHRD 134 (388)
T ss_dssp TCTTBCCEEEEEEC---TTSSCEEEEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCC
T ss_pred CCCCCCeeeeEEec---CCCCEEEEEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCC
Confidence 59999999998643 22346899999995 688888854 34889999999999999999999 89999999
Q ss_pred ccCCceeeCCCCceEecccccccccCC---------------------------cCCCccccccccccCC-CCcCccccc
Q 042634 260 LKPSNVLLDGELTAHVGDFGLAKFLPE---------------------------ATNNFFNFQIAEYGMG-SEVSTSGDV 311 (427)
Q Consensus 260 lkp~NIll~~~~~~kL~DFG~a~~~~~---------------------------~~~~~~~y~aPE~~~~-~~~~~~~Di 311 (427)
|||+|||++.++.+||+|||+|+.... ...||+.|+|||++.+ ..++.++||
T Consensus 135 lkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di 214 (388)
T 3oz6_A 135 MKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDM 214 (388)
T ss_dssp CCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHH
T ss_pred CCHHHeEEcCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhH
Confidence 999999999999999999999986532 1268899999999987 678999999
Q ss_pred hhHHHHHHHHHhCCCCCCcc
Q 042634 312 YSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 312 wS~G~vl~ell~g~~pf~~~ 331 (427)
||+||++|||++|+.||.+.
T Consensus 215 wSlG~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 215 WSLGCILGEILCGKPIFPGS 234 (388)
T ss_dssp HHHHHHHHHHHHSSCSCCCS
T ss_pred HHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999764
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=282.80 Aligned_cols=195 Identities=14% Similarity=0.098 Sum_probs=157.0
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchh-hhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNRE-ALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
.|+|++++++.+.. ....++|||||++|+|.+++..... ....+++..++.++.||+.||+||| +.||+||
T Consensus 125 ~~~~iv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHr 196 (365)
T 3e7e_A 125 MQHMFMKFYSAHLF-----QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHG 196 (365)
T ss_dssp GGGGBCCEEEEEEC-----SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECC
T ss_pred hhhhhhhhheeeec-----CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecC
Confidence 48999999988544 5678999999999999999964321 1245999999999999999999999 8999999
Q ss_pred cccCCceeeCC-----------CCceEecccccccccC--------CcCCCccccccccccCCCCcCccccchhHHHHHH
Q 042634 259 DLKPSNVLLDG-----------ELTAHVGDFGLAKFLP--------EATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLL 319 (427)
Q Consensus 259 Dlkp~NIll~~-----------~~~~kL~DFG~a~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ 319 (427)
||||+|||++. ++.+||+|||+|+... ....||..|+|||++.+..++.++|||||||++|
T Consensus 197 DiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 276 (365)
T 3e7e_A 197 DIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVY 276 (365)
T ss_dssp CCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHH
T ss_pred CCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHH
Confidence 99999999988 8999999999997543 1237899999999999999999999999999999
Q ss_pred HHHhCCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCC
Q 042634 320 ETFTGKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSE 399 (427)
Q Consensus 320 ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~ 399 (427)
||++|+.||.....+... ....... . ...+.+.+++.+|++.
T Consensus 277 elltg~~pf~~~~~~~~~------------~~~~~~~----------------------~----~~~~~~~~~~~~~l~~ 318 (365)
T 3e7e_A 277 CMLFGTYMKVKNEGGECK------------PEGLFRR----------------------L----PHLDMWNEFFHVMLNI 318 (365)
T ss_dssp HHHHSSCCCEEEETTEEE------------ECSCCTT----------------------C----SSHHHHHHHHHHHHCC
T ss_pred HHHhCCCccccCCCCcee------------echhccc----------------------c----CcHHHHHHHHHHHcCC
Confidence 999999998653221100 0000000 0 0134567899999999
Q ss_pred CCCCC-CCHHHHHHHHHHHHHH
Q 042634 400 LPRER-MNMEEVAAQLLSFRNK 420 (427)
Q Consensus 400 dP~~R-pt~~ev~~~L~~~~~~ 420 (427)
+|.+| |+++++.+.|+++.++
T Consensus 319 ~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 319 PDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp CCTTCCCCHHHHHHHHHHHHHH
T ss_pred CCCCcchHHHHHHHHHHHHHHH
Confidence 99999 6889999999888654
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=290.38 Aligned_cols=180 Identities=11% Similarity=-0.011 Sum_probs=136.9
Q ss_pred ccceeeeeecCCCcccccccchhhhhccCHHHH------HHHHHHHHHHHHHHhhcCCCCeeeccccCCceeeCCCCceE
Q 042634 201 SEALVYEFMVNGSLEEWLHPNREALKNLNLLQR------LSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAH 274 (427)
Q Consensus 201 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~------~~~~~~i~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~k 274 (427)
..++|||||+ |+|.+++.... ..+++..+ ..++.||+.||+||| ++||+||||||+|||++.++.+|
T Consensus 162 ~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~k 234 (371)
T 3q60_A 162 NYLLLMPAAS-VDLELLFSTLD---FVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLM 234 (371)
T ss_dssp EEEEEECCCS-EEHHHHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTEEETTCSGGGEEECTTSCEE
T ss_pred eEEEEecCCC-CCHHHHHHHhc---cccchhhhhhhhhHHHHHHHHHHHHHHHH---HCCCccCcCCHHHEEECCCCCEE
Confidence 4799999997 89999997643 23455555 788899999999999 89999999999999999999999
Q ss_pred ecccccccccCCcC---CCccccccccccCC--CCcCccccchhHHHHHHHHHhCCCCCCcccCCCccHHHHHHHhcccc
Q 042634 275 VGDFGLAKFLPEAT---NNFFNFQIAEYGMG--SEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEALPER 349 (427)
Q Consensus 275 L~DFG~a~~~~~~~---~~~~~y~aPE~~~~--~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 349 (427)
|+|||+|+...... .+++.|+|||++.+ ..++.++|||||||++|||++|+.||..........
T Consensus 235 L~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~----------- 303 (371)
T 3q60_A 235 LGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGS----------- 303 (371)
T ss_dssp ECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTC-----------
T ss_pred EEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccc-----------
Confidence 99999998775433 66789999999987 679999999999999999999999998642221100
Q ss_pred hhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 350 LAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
........... ... .......++.++.+++.+||+.||++|||++|+++
T Consensus 304 ~~~~~~~~~~~-------------~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 304 WKRPSLRVPGT-------------DSL-AFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CCBCCTTSCCC-------------CSC-CCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred hhhhhhhhccc-------------ccc-chhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000000 000 00011234567899999999999999999999975
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-35 Score=271.78 Aligned_cols=194 Identities=22% Similarity=0.288 Sum_probs=149.6
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+++|+|.+++.........+++..++.++.|++.||+||| +.||+||
T Consensus 77 l~hp~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~ 148 (285)
T 3is5_A 77 LDHPNIIKIFEVFED-----YHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHK 148 (285)
T ss_dssp CCCTTBCCEEEEEEC-----SSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCC
T ss_pred CCCchHHhHHHheec-----CCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEEC
Confidence 479999999998543 56789999999999999998765444466999999999999999999999 8999999
Q ss_pred cccCCceee---CCCCceEecccccccccCCc-----CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCc
Q 042634 259 DLKPSNVLL---DGELTAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll---~~~~~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~ 330 (427)
||||+||++ +.++.+||+|||+++..... ..++..|+|||++. ..++.++||||+||++|||++|+.||.+
T Consensus 149 dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~ 227 (285)
T 3is5_A 149 DLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTG 227 (285)
T ss_dssp CCSGGGEEESSSSTTCCEEECCCCCCCC----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCHHHEEEecCCCCCCEEEEeeecceecCCcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCC
Confidence 999999999 45678999999999865432 27889999999975 5689999999999999999999999975
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
.. ........... ...... .....+.++.+++.+||+.||++|||++|+
T Consensus 228 ~~-----~~~~~~~~~~~------~~~~~~--------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~ 276 (285)
T 3is5_A 228 TS-----LEEVQQKATYK------EPNYAV--------------------ECRPLTPQAVDLLKQMLTKDPERRPSAAQV 276 (285)
T ss_dssp SS-----HHHHHHHHHHC------CCCCCC----------------------CCCCHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred CC-----HHHHHhhhccC------Cccccc--------------------ccCcCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 32 11111110000 000000 000123567899999999999999999999
Q ss_pred HH
Q 042634 411 AA 412 (427)
Q Consensus 411 ~~ 412 (427)
++
T Consensus 277 l~ 278 (285)
T 3is5_A 277 LH 278 (285)
T ss_dssp HT
T ss_pred hc
Confidence 86
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=279.47 Aligned_cols=218 Identities=19% Similarity=0.222 Sum_probs=151.2
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||++ |+|.+++.... ..+++..++.++.|++.||+||| +.||+||
T Consensus 57 l~h~~iv~~~~~~~~-----~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~ 124 (324)
T 3mtl_A 57 LKHANIVTLHDIIHT-----EKSLTLVFEYLD-KDLKQYLDDCG---NIINMHNVKLFLFQLLRGLAYCH---RQKVLHR 124 (324)
T ss_dssp CCCTTBCCEEEEEEC-----SSCEEEEEECCS-EEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHH---HTTEEES
T ss_pred cCCCCCCeeeeEEee-----CCEEEEEecccc-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCccCC
Confidence 469999999998543 567899999995 68888876543 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCC-CCcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
||||+||+++.++.+||+|||+++..... ..+|..|+|||++.+ ..++.++||||+||++|||++|+.||.+.
T Consensus 125 Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 204 (324)
T 3mtl_A 125 DLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGS 204 (324)
T ss_dssp SCCGGGEEECTTCCEEECSSSEEECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CcCHHHEEECCCCCEEEccCcccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999999865432 267899999999876 56899999999999999999999999764
Q ss_pred cCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 042634 332 FTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVA 411 (427)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~ 411 (427)
... .....+......................... ................+.++.+++.+||+.||++|||++|++
T Consensus 205 ~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 280 (324)
T 3mtl_A 205 TVE--EQLHFIFRILGTPTEETWPGILSNEEFKTYN--YPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAM 280 (324)
T ss_dssp SHH--HHHHHHHHHHCCCCTTTSTTGGGCHHHHHTC--CCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred CHH--HHHHHHHHHhCCCChHhchhhhcchhhcccc--cccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHh
Confidence 211 1111111111111111111110000000000 000000000001122456688999999999999999999998
Q ss_pred H
Q 042634 412 A 412 (427)
Q Consensus 412 ~ 412 (427)
+
T Consensus 281 ~ 281 (324)
T 3mtl_A 281 K 281 (324)
T ss_dssp T
T ss_pred c
Confidence 6
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=277.11 Aligned_cols=198 Identities=26% Similarity=0.380 Sum_probs=157.3
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ...++||||+++++|.+++.... ..+++..+..++.|++.||+||| +.||+||
T Consensus 78 l~h~~i~~~~~~~~~------~~~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~ 145 (291)
T 1u46_A 78 LDHRNLIRLYGVVLT------PPMKMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLE---SKRFIHR 145 (291)
T ss_dssp CCCTTBCCEEEEECS------SSCEEEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHH---HTTEECS
T ss_pred CCCCCcccEEEEEcc------CCceeeEecccCCCHHHHHHhcc---CCcCHHHHHHHHHHHHHHHHHHH---hCCcccC
Confidence 469999999998643 23789999999999999986543 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC---------CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT---------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPT 328 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~---------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf 328 (427)
||||+||+++.++.+||+|||+++...... .++..|+|||++.+..++.++|||||||++|||++ |+.||
T Consensus 146 dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~ 225 (291)
T 1u46_A 146 DLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW 225 (291)
T ss_dssp CCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence 999999999999999999999998764322 56678999999988889999999999999999999 99999
Q ss_pred CcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 042634 329 NEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME 408 (427)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ 408 (427)
..... .+......... . ....+..++.++.+++.+||+.||++|||++
T Consensus 226 ~~~~~-----~~~~~~~~~~~----~-----------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 273 (291)
T 1u46_A 226 IGLNG-----SQILHKIDKEG----E-----------------------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFV 273 (291)
T ss_dssp TTCCH-----HHHHHHHHTSC----C-----------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred ccCCH-----HHHHHHHHccC----C-----------------------CCCCCcCcCHHHHHHHHHHccCCcccCcCHH
Confidence 75321 11111110000 0 0001123456789999999999999999999
Q ss_pred HHHHHHHHHHHH
Q 042634 409 EVAAQLLSFRNK 420 (427)
Q Consensus 409 ev~~~L~~~~~~ 420 (427)
|+++.|+++...
T Consensus 274 ~l~~~l~~~~~~ 285 (291)
T 1u46_A 274 ALRDFLLEAQPT 285 (291)
T ss_dssp HHHHHHHHHC--
T ss_pred HHHHHHHHhCcc
Confidence 999999988543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=296.06 Aligned_cols=195 Identities=22% Similarity=0.288 Sum_probs=155.9
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+++|+|.+++..... ..+++..++.++.||+.||+||| +.||+||
T Consensus 241 l~hp~Iv~l~~~~~~-----~~~l~lVmEy~~gg~L~~~l~~~~~--~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHr 310 (576)
T 2acx_A 241 VNSRFVVSLAYAYET-----KDALCLVLTLMNGGDLKFHIYHMGQ--AGFPEARAVFYAAEICCGLEDLH---RERIVYR 310 (576)
T ss_dssp CCCTTBCCEEEEEEC-----SSEEEEEECCCCSCBHHHHHHSSSS--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred cCCCCEeeEEEEEee-----CCEEEEEEEcCCCCcHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHH---HCCEecc
Confidence 579999999988543 5678999999999999998865432 34899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc-----CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFT 333 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~ 333 (427)
||||+|||++.++.+||+|||+|+..... ..||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 311 DLKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~ 390 (576)
T 2acx_A 311 DLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKK 390 (576)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCEECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSS
T ss_pred CCchheEEEeCCCCeEEEecccceecccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCccccc
Confidence 99999999999999999999999876443 3789999999999999999999999999999999999999976422
Q ss_pred CCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCC-----CHH
Q 042634 334 GNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERM-----NME 408 (427)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rp-----t~~ 408 (427)
.. ............. . . .+...+.++.+++.+||+.||++|| |++
T Consensus 391 ~~-~~~~i~~~i~~~~--~----------------------~-----~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~ 440 (576)
T 2acx_A 391 KI-KREEVERLVKEVP--E----------------------E-----YSERFSPQARSLCSQLLCKDPAERLGCRGGSAR 440 (576)
T ss_dssp CC-CHHHHHHHHHHCC--C----------------------C-----CCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHH
T ss_pred ch-hHHHHHHHhhccc--c----------------------c-----CCccCCHHHHHHHHHhccCCHHHcCCCCCCCHH
Confidence 11 1111111100000 0 0 1112345689999999999999999 788
Q ss_pred HHHHH
Q 042634 409 EVAAQ 413 (427)
Q Consensus 409 ev~~~ 413 (427)
||+++
T Consensus 441 eil~H 445 (576)
T 2acx_A 441 EVKEH 445 (576)
T ss_dssp HHHTS
T ss_pred HHHhC
Confidence 88753
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-35 Score=276.62 Aligned_cols=195 Identities=16% Similarity=0.185 Sum_probs=153.2
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
.+||||+++++.+.. ....++||||+++|+|.+++..... ..+++..++.++.|++.||+||| +.||+||
T Consensus 86 ~~~~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~ql~~~L~~LH---~~givH~ 155 (327)
T 3lm5_A 86 KSCPRVINLHEVYEN-----TSEIILILEYAAGGEIFSLCLPELA--EMVSENDVIRLIKQILEGVYYLH---QNNIVHL 155 (327)
T ss_dssp TTCTTBCCEEEEEEC-----SSEEEEEEECCTTEEGGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECS
T ss_pred cCCCCEEEEEEEEEe-----CCeEEEEEEecCCCcHHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHH---HCCeecC
Confidence 368999999998543 5678999999999999999865432 45899999999999999999999 8999999
Q ss_pred cccCCceeeCC---CCceEecccccccccCCcC-----CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCc
Q 042634 259 DLKPSNVLLDG---ELTAHVGDFGLAKFLPEAT-----NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~---~~~~kL~DFG~a~~~~~~~-----~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~ 330 (427)
||||+||+++. ++.+||+|||+++...... .|++.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 156 Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 235 (327)
T 3lm5_A 156 DLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVG 235 (327)
T ss_dssp CCCGGGEEESCBTTBCCEEECCGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCChHHEEEecCCCCCcEEEeeCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999987 7899999999998765432 789999999999999999999999999999999999999975
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
.... .....+....... . ......++..+.+++.+||+.||++|||++|+
T Consensus 236 ~~~~--~~~~~i~~~~~~~----~------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~l 285 (327)
T 3lm5_A 236 EDNQ--ETYLNISQVNVDY----S------------------------EETFSSVSQLATDFIQSLLVKNPEKRPTAEIC 285 (327)
T ss_dssp SSHH--HHHHHHHHTCCCC----C------------------------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred CCch--HHHHHHHhccccc----C------------------------chhhcccCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 3211 1100011100000 0 00112245668899999999999999999999
Q ss_pred HHH
Q 042634 411 AAQ 413 (427)
Q Consensus 411 ~~~ 413 (427)
++.
T Consensus 286 l~h 288 (327)
T 3lm5_A 286 LSH 288 (327)
T ss_dssp TTC
T ss_pred hCC
Confidence 763
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=277.27 Aligned_cols=208 Identities=23% Similarity=0.266 Sum_probs=150.5
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
.+||||+++++.+.. ....++||||+++|+|.+++... ..+++..+..++.|++.||+||| +.||+||
T Consensus 68 ~~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~ 135 (316)
T 2ac3_A 68 QGHRNVLELIEFFEE-----EDRFYLVFEKMRGGSILSHIHKR----RHFNELEASVVVQDVASALDFLH---NKGIAHR 135 (316)
T ss_dssp CCCTTBCCEEEEEEE-----TTEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCC
T ss_pred cCCCCeeeEEEEEee-----CCEEEEEEEcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---hCCceeC
Confidence 479999999998644 56789999999999999998654 45899999999999999999999 8899999
Q ss_pred cccCCceeeCCCCc---eEecccccccccCCc-------------CCCccccccccccCC-----CCcCccccchhHHHH
Q 042634 259 DLKPSNVLLDGELT---AHVGDFGLAKFLPEA-------------TNNFFNFQIAEYGMG-----SEVSTSGDVYSFGIL 317 (427)
Q Consensus 259 Dlkp~NIll~~~~~---~kL~DFG~a~~~~~~-------------~~~~~~y~aPE~~~~-----~~~~~~~DiwS~G~v 317 (427)
||||+||+++.++. +||+|||+++..... ..||..|+|||++.. ..++.++|||||||+
T Consensus 136 dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~i 215 (316)
T 2ac3_A 136 DLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVI 215 (316)
T ss_dssp CCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHH
T ss_pred CCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHH
Confidence 99999999988765 999999999765321 158899999999875 557899999999999
Q ss_pred HHHHHhCCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcC
Q 042634 318 LLETFTGKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCS 397 (427)
Q Consensus 318 l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl 397 (427)
+|||++|+.||.........+... ...+.....+........ ...+.......+.++.+++.+||
T Consensus 216 l~~l~~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~~~~i~~~~-------------~~~~~~~~~~~~~~~~~li~~~L 280 (316)
T 2ac3_A 216 LYILLSGYPPFVGRCGSDCGWDRG--EACPACQNMLFESIQEGK-------------YEFPDKDWAHISCAAKDLISKLL 280 (316)
T ss_dssp HHHHHHSSCSCCCCCCSCSCC------CCHHHHHHHHHHHHHCC-------------CCCCHHHHTTSCHHHHHHHHHHS
T ss_pred HHHHHHCCCCCccccccccccccc--ccchhHHHHHHHHHhccC-------------cccCchhcccCCHHHHHHHHHHh
Confidence 999999999998653322111100 000000000000000000 00000001124567899999999
Q ss_pred CCCCCCCCCHHHHHHH
Q 042634 398 SELPRERMNMEEVAAQ 413 (427)
Q Consensus 398 ~~dP~~Rpt~~ev~~~ 413 (427)
+.||++|||++|++++
T Consensus 281 ~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 281 VRDAKQRLSAAQVLQH 296 (316)
T ss_dssp CSSTTTSCCHHHHHHS
T ss_pred hCChhhCCCHHHHhcC
Confidence 9999999999999874
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=278.47 Aligned_cols=174 Identities=20% Similarity=0.280 Sum_probs=137.8
Q ss_pred ccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccccCCceeeCCCCceEeccccc
Q 042634 201 SEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGL 280 (427)
Q Consensus 201 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~ 280 (427)
..++|||||++|+|.+++...... ...++..++.++.|++.||+||| +.||+||||||+||+++.++.+||+|||+
T Consensus 135 ~~~lv~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 210 (332)
T 3qd2_B 135 YLYIQMQLCRKENLKDWMNRRCSL-EDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGL 210 (332)
T ss_dssp EEEEEEECCCSSCHHHHHHTCCSG-GGSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEEecCCCCHHHHHhcccCc-cchhhHHHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCc
Confidence 378999999999999998765322 34567789999999999999999 89999999999999999999999999999
Q ss_pred ccccCCc------------------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccCCCccHHHHH
Q 042634 281 AKFLPEA------------------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFV 342 (427)
Q Consensus 281 a~~~~~~------------------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~~~~~~~~~~ 342 (427)
++..... ..||+.|+|||++.+..++.++|||||||++|||++|..|+... ....
T Consensus 211 a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-------~~~~ 283 (332)
T 3qd2_B 211 VTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-------VRII 283 (332)
T ss_dssp CEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-------HHHH
T ss_pred ccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-------HHHH
Confidence 9876543 25889999999999999999999999999999999987764321 0000
Q ss_pred HHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 042634 343 KEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAAQ 413 (427)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~ 413 (427)
...... .........+.++.+++.+||+.||++|||++|++++
T Consensus 284 ~~~~~~----------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 284 TDVRNL----------------------------KFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHTT----------------------------CCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHhhcc----------------------------CCCcccccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 000000 0000223445667899999999999999999999863
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=271.92 Aligned_cols=189 Identities=21% Similarity=0.291 Sum_probs=135.0
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+++++|.+++.... ..+++..++.++.|++.||+||| +.||+||
T Consensus 68 l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~ 136 (278)
T 3cok_A 68 LKHPSILELYNYFED-----SNYVYLVLEMCHNGEMNRYLKNRV---KPFSENEARHFMHQIITGMLYLH---SHGILHR 136 (278)
T ss_dssp BCCTTBCCEEEEEEC-----SSEEEEEEECCTTEEHHHHHHTCS---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECS
T ss_pred CCCCCeEeEEEEEcc-----CCeEEEEEecCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecC
Confidence 469999999998543 567899999999999999987543 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+||+++.++.+||+|||.+...... ..++..|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 137 dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 216 (278)
T 3cok_A 137 DLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDT 216 (278)
T ss_dssp SCCGGGEEECTTCCEEECCCTTCEECC----------------------------CTHHHHHHHHHHHHHHSSCSSCCCS
T ss_pred CCCHHHEEEcCCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChh
Confidence 99999999999999999999999875432 267889999999999899999999999999999999999997532
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
... ... ....... ..+...+.++.+++.+||+.||++|||++|+++
T Consensus 217 ~~~-----~~~--------~~~~~~~---------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 217 VKN-----TLN--------KVVLADY---------------------EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CC------------------CCSSCC---------------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHH-----HHH--------HHhhccc---------------------CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 111 000 0000000 011123456889999999999999999999986
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=283.12 Aligned_cols=191 Identities=22% Similarity=0.315 Sum_probs=150.8
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+. |++.+++.... ..+++..+..++.|++.||+||| +.||+||
T Consensus 111 l~hpniv~~~~~~~~-----~~~~~lv~e~~~-g~l~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~ 178 (348)
T 1u5q_A 111 LRHPNTIQYRGCYLR-----EHTAWLVMEYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLH---SHNMIHR 178 (348)
T ss_dssp CCCTTBCCEEEEEEE-----TTEEEEEEECCS-EEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCC
T ss_pred CCCCCEeeEEEEEEE-----CCeEEEEEecCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeC
Confidence 579999999998654 567899999995 78877775332 46899999999999999999999 8899999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc--CCCccccccccccC---CCCcCccccchhHHHHHHHHHhCCCCCCcccC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA--TNNFFNFQIAEYGM---GSEVSTSGDVYSFGILLLETFTGKRPTNEMFT 333 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~--~~~~~~y~aPE~~~---~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~ 333 (427)
||||+||+++.++.+||+|||+++..... ..||+.|+|||++. ...++.++|||||||++|||++|+.||.....
T Consensus 179 Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 258 (348)
T 1u5q_A 179 DVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 258 (348)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCBSSSSBCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred CCCHHHEEECCCCCEEEeeccCceecCCCCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 99999999999999999999999876543 37899999999984 56789999999999999999999999975311
Q ss_pred CCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 042634 334 GNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAAQ 413 (427)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~ 413 (427)
........... .+. .....++..+.+++.+||+.||++|||++|+++.
T Consensus 259 -----~~~~~~~~~~~-----~~~----------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 259 -----MSALYHIAQNE-----SPA----------------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp -----HHHHHHHHHSC-----CCC----------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred -----HHHHHHHHhcC-----CCC----------------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11111100000 000 0111234568899999999999999999999864
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-35 Score=293.91 Aligned_cols=196 Identities=20% Similarity=0.270 Sum_probs=155.2
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+++|+|.+++.........+++..++.++.||+.||+||| +.||+||
T Consensus 242 l~hp~Iv~l~~~~~~-----~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHr 313 (543)
T 3c4z_A 242 VHSRFIVSLAYAFET-----KTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYR 313 (543)
T ss_dssp CCCTTBCCEEEEEEC-----SSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred cCCCCEeeEEEEEee-----CCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCccc
Confidence 579999999988543 56789999999999999988654332346999999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+|||++.++.+||+|||+++..... ..||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 314 DLKP~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~ 393 (543)
T 3c4z_A 314 DLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG 393 (543)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTT
T ss_pred CCChHHEEEeCCCCEEEeecceeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCc
Confidence 99999999999999999999999875432 278999999999999999999999999999999999999997642
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCH-----
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM----- 407 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~----- 407 (427)
.. ............... ..+...+.++.+++.+||+.||++||++
T Consensus 394 ~~-~~~~~~~~~i~~~~~-----------------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a 443 (543)
T 3c4z_A 394 EK-VENKELKQRVLEQAV-----------------------------TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSC 443 (543)
T ss_dssp CC-CCHHHHHHHHHHCCC-----------------------------CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBS
T ss_pred cc-hhHHHHHHHHhhccc-----------------------------CCCcccCHHHHHHHHHhccCCHhHCCCCcccCH
Confidence 21 111121111111000 0112234568899999999999999975
Q ss_pred HHHHH
Q 042634 408 EEVAA 412 (427)
Q Consensus 408 ~ev~~ 412 (427)
+||++
T Consensus 444 ~ei~~ 448 (543)
T 3c4z_A 444 DGLRT 448 (543)
T ss_dssp HHHHT
T ss_pred HHHHc
Confidence 55553
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-35 Score=300.91 Aligned_cols=197 Identities=22% Similarity=0.369 Sum_probs=159.3
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+. ....++||||+++|+|.+++.... ..+++..++.++.|++.||+||| +.||+||
T Consensus 448 l~HpnIv~l~~~~~------~~~~~lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~givHr 515 (656)
T 2j0j_A 448 FDHPHIVKLIGVIT------ENPVWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQLSTALAYLE---SKRFVHR 515 (656)
T ss_dssp CCCTTBCCEEEEEC------SSSCEEEEECCTTCBHHHHHHHTT---TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred CCCCCCCeEEEEEe------cCceEEEEEcCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccc
Confidence 57999999999853 245799999999999999986543 35899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC-------CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCCc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT-------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~-------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~~ 330 (427)
||||+|||++.++.+||+|||+|+...... .++..|+|||++.+..++.++|||||||++|||++ |..||.+
T Consensus 516 Dikp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~ 595 (656)
T 2j0j_A 516 DIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 595 (656)
T ss_dssp CCSGGGEEEEETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ccchHhEEEeCCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCC
Confidence 999999999999999999999998764432 45678999999988899999999999999999997 9999975
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
.... .....+..... ...+..++..+.+++.+||+.||++|||+.|+
T Consensus 596 ~~~~--~~~~~i~~~~~-------------------------------~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el 642 (656)
T 2j0j_A 596 VKNN--DVIGRIENGER-------------------------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 642 (656)
T ss_dssp CCHH--HHHHHHHHTCC-------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCHH--HHHHHHHcCCC-------------------------------CCCCccccHHHHHHHHHHcCCChhHCcCHHHH
Confidence 3211 11111111000 00122345678999999999999999999999
Q ss_pred HHHHHHHHHH
Q 042634 411 AAQLLSFRNK 420 (427)
Q Consensus 411 ~~~L~~~~~~ 420 (427)
++.|+++.++
T Consensus 643 ~~~L~~il~~ 652 (656)
T 2j0j_A 643 KAQLSTILEE 652 (656)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 9999999765
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-35 Score=274.28 Aligned_cols=198 Identities=20% Similarity=0.234 Sum_probs=151.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+++++|.+++... ..+++..++.++.|++.||+||| +.||+||
T Consensus 91 l~hp~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~ 158 (309)
T 2h34_A 91 LQEPHVVPIHDFGEI-----DGQLYVDMRLINGVDLAAMLRRQ----GPLAPPRAVAIVRQIGSALDAAH---AAGATHR 158 (309)
T ss_dssp CCCTTBCCEEEEEEE-----TTEEEEEEECCCCEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred cCCCCeeEEEEEEee-----CCeEEEEEEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCcCCcC
Confidence 579999999998644 56789999999999999998653 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc-------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA-------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
||||+||+++.++.+||+|||+++..... ..++..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 159 dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 238 (309)
T 2h34_A 159 DVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGD 238 (309)
T ss_dssp CCCGGGEEECTTSCEEECSCCC----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSC
T ss_pred CCChHHEEEcCCCCEEEecCccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCc
Confidence 99999999999999999999999865432 26788999999999999999999999999999999999999753
Q ss_pred cCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCC-CHHHH
Q 042634 332 FTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERM-NMEEV 410 (427)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rp-t~~ev 410 (427)
... .+...+....+. . ...+..++.++.+++.+||+.||++|| |++|+
T Consensus 239 ~~~--~~~~~~~~~~~~-~----------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l 287 (309)
T 2h34_A 239 QLS--VMGAHINQAIPR-P----------------------------STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDL 287 (309)
T ss_dssp HHH--HHHHHHHSCCCC-G----------------------------GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHH
T ss_pred hHH--HHHHHhccCCCC-c----------------------------cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHH
Confidence 110 111111110000 0 001122455688999999999999999 99999
Q ss_pred HHHHHHHHH
Q 042634 411 AAQLLSFRN 419 (427)
Q Consensus 411 ~~~L~~~~~ 419 (427)
++.|+++..
T Consensus 288 ~~~l~~~l~ 296 (309)
T 2h34_A 288 SAAAHAALA 296 (309)
T ss_dssp HHHHHHTCC
T ss_pred HHHHHHHHH
Confidence 999998743
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=274.12 Aligned_cols=193 Identities=19% Similarity=0.255 Sum_probs=154.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+++++|.+++... ..+++..+..++.|++.||+||| +.||+||
T Consensus 72 l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~ 139 (321)
T 2a2a_A 72 VLHHNVITLHDVYEN-----RTDVVLILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLH---TKKIAHF 139 (321)
T ss_dssp CCCTTBCCEEEEEEC-----SSEEEEEECCCCSCBHHHHHHTC----SCEEHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred CCCCCcceEEEEEec-----CCEEEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecC
Confidence 469999999998543 56789999999999999998754 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCC----ceEecccccccccCCc-----CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCC
Q 042634 259 DLKPSNVLLDGEL----TAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTN 329 (427)
Q Consensus 259 Dlkp~NIll~~~~----~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~ 329 (427)
||||+||+++.++ .+||+|||+++..... ..||..|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 140 dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 219 (321)
T 2a2a_A 140 DLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 219 (321)
T ss_dssp CCSGGGEEESCTTSSSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSC
T ss_pred CCChHHEEEecCCCCcCCEEEccCccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCC
Confidence 9999999999887 7999999999876443 268899999999999999999999999999999999999997
Q ss_pred cccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 042634 330 EMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEE 409 (427)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~e 409 (427)
+... ............ ..+ .......+..+.+++.+||+.||++|||++|
T Consensus 220 ~~~~-----~~~~~~i~~~~~--~~~-----------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e 269 (321)
T 2a2a_A 220 GDTK-----QETLANITSVSY--DFD-----------------------EEFFSHTSELAKDFIRKLLVKETRKRLTIQE 269 (321)
T ss_dssp CSSH-----HHHHHHHHTTCC--CCC-----------------------HHHHTTCCHHHHHHHHTTSCSSTTTSCCHHH
T ss_pred CCCH-----HHHHHHHHhccc--ccC-----------------------hhhhcccCHHHHHHHHHHcCCChhhCcCHHH
Confidence 5311 111111000000 000 0011223456899999999999999999999
Q ss_pred HHHH
Q 042634 410 VAAQ 413 (427)
Q Consensus 410 v~~~ 413 (427)
++++
T Consensus 270 ~l~h 273 (321)
T 2a2a_A 270 ALRH 273 (321)
T ss_dssp HHHS
T ss_pred HhcC
Confidence 9863
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=275.41 Aligned_cols=197 Identities=23% Similarity=0.272 Sum_probs=154.0
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCC----
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETP---- 254 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~---- 254 (427)
++||||+++++.+... .+...++||||+++++|.+++.........+++..++.++.|++.||+||| +.|
T Consensus 62 l~h~~i~~~~~~~~~~---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~ 135 (279)
T 2w5a_A 62 LKHPNIVRYYDRIIDR---TNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGH 135 (279)
T ss_dssp CCCTTBCCEEEEEEEG---GGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC----
T ss_pred cCCCCCCeEEEEEecC---CCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCC
Confidence 4699999999875331 245679999999999999999765433345999999999999999999999 667
Q ss_pred -eeeccccCCceeeCCCCceEecccccccccCCcC------CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCC
Q 042634 255 -IVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEAT------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRP 327 (427)
Q Consensus 255 -ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~p 327 (427)
|+||||||+||+++.++.+||+|||.++...... .++..|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 136 ~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 215 (279)
T 2w5a_A 136 TVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215 (279)
T ss_dssp --CCCCCSGGGEEECSSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCS
T ss_pred eeEEeccchhhEEEcCCCCEEEecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCC
Confidence 9999999999999999999999999998765432 678899999999998999999999999999999999999
Q ss_pred CCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCH
Q 042634 328 TNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM 407 (427)
Q Consensus 328 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~ 407 (427)
|..... ..+...+...... . .+..++.++.+++.+||+.||++|||+
T Consensus 216 ~~~~~~--~~~~~~i~~~~~~---~----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~ 262 (279)
T 2w5a_A 216 FTAFSQ--KELAGKIREGKFR---R----------------------------IPYRYSDELNEIITRMLNLKDYHRPSV 262 (279)
T ss_dssp SCCSSH--HHHHHHHHHTCCC---C----------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CcccCH--HHHHHHHhhcccc---c----------------------------CCcccCHHHHHHHHHHcCCCcccCCCH
Confidence 975421 1111111110000 0 112245668999999999999999999
Q ss_pred HHHHHHH
Q 042634 408 EEVAAQL 414 (427)
Q Consensus 408 ~ev~~~L 414 (427)
+|+++.+
T Consensus 263 ~~ll~~~ 269 (279)
T 2w5a_A 263 EEILENP 269 (279)
T ss_dssp HHHHTST
T ss_pred HHHHhCh
Confidence 9999765
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-35 Score=277.22 Aligned_cols=221 Identities=20% Similarity=0.209 Sum_probs=155.1
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeecc
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCD 259 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrD 259 (427)
.||||+++++.+... .....++||||+++++|.+++. .+++..++.++.|++.||+||| +.||+|||
T Consensus 89 ~~~~i~~~~~~~~~~---~~~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~D 155 (330)
T 3nsz_A 89 GGPNIITLADIVKDP---VSRTPALVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCH---SMGIMHRD 155 (330)
T ss_dssp TSTTBCCEEEEEECT---TTCCEEEEEECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHH---HTTEECCC
T ss_pred CCCCEEEeeeeeccC---CCCceEEEEeccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHH---hCCeeeCC
Confidence 599999999986431 2456799999999999988873 3788999999999999999999 89999999
Q ss_pred ccCCceeeCCCC-ceEecccccccccCCc-----CCCccccccccccCC-CCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 260 LKPSNVLLDGEL-TAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 260 lkp~NIll~~~~-~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
|||+|||++.++ .+||+|||+|+..... ..++..|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus 156 ikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~ 235 (330)
T 3nsz_A 156 VKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 235 (330)
T ss_dssp CSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred CCHHHEEEcCCCCEEEEEeCCCceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 999999999776 8999999999865432 268889999999887 678999999999999999999999996532
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccc-cc---hhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREE-GE---TSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME 408 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~---~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ 408 (427)
.....+.............+.++......... .. .........+.........+.++.+++.+||+.||++|||++
T Consensus 236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~ 315 (330)
T 3nsz_A 236 DNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR 315 (330)
T ss_dssp SHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHH
T ss_pred chHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHH
Confidence 22222222222111111111111000000000 00 000000001111112233567789999999999999999999
Q ss_pred HHHHH
Q 042634 409 EVAAQ 413 (427)
Q Consensus 409 ev~~~ 413 (427)
|++++
T Consensus 316 e~l~h 320 (330)
T 3nsz_A 316 EAMEH 320 (330)
T ss_dssp HHHTS
T ss_pred HHhcC
Confidence 99863
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-35 Score=280.06 Aligned_cols=221 Identities=18% Similarity=0.218 Sum_probs=155.4
Q ss_pred cccccchhhhccccccC-CCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 042634 179 IRHRNLVKIITSCASVD-FQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVH 257 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~-~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivH 257 (427)
++||||+++++++.... .......++||||+ +++|.+++.. ..+++..+..++.|++.||+||| +.||+|
T Consensus 81 l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH---~~~ivH 151 (367)
T 1cm8_A 81 MRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIH---AAGIIH 151 (367)
T ss_dssp CCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEEC
T ss_pred CCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccc
Confidence 46999999999865421 11224569999999 8899998864 34899999999999999999999 899999
Q ss_pred ccccCCceeeCCCCceEecccccccccCCc---CCCccccccccccCC-CCcCccccchhHHHHHHHHHhCCCCCCcccC
Q 042634 258 CDLKPSNVLLDGELTAHVGDFGLAKFLPEA---TNNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETFTGKRPTNEMFT 333 (427)
Q Consensus 258 rDlkp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~ 333 (427)
|||||+||+++.++.+||+|||+|+..... ..+|..|+|||++.+ ..++.++||||+||++|||++|+.||.+...
T Consensus 152 ~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 231 (367)
T 1cm8_A 152 RDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH 231 (367)
T ss_dssp CCCCGGGEEECTTCCEEECCCTTCEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cCcCHHHEEEcCCCCEEEEeeecccccccccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999999999999999999999876543 378899999999877 6799999999999999999999999975321
Q ss_pred CCccHHHHHHHhcc--cchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 042634 334 GNLTLHNFVKEALP--ERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVA 411 (427)
Q Consensus 334 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~ 411 (427)
. ..+......... ......+........... ........+.. .....+..+.+++.+||+.||++|||++|++
T Consensus 232 ~-~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~--~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l 306 (367)
T 1cm8_A 232 L-DQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKG--LPELEKKDFAS--ILTNASPLAVNLLEKMLVLDAEQRVTAGEAL 306 (367)
T ss_dssp H-HHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHH--SCCCCCCCGGG--TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred H-HHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHh--CCCCCCCCHHH--HCCCCCHHHHHHHHHHccCChhHCCCHHHHh
Confidence 1 111111111111 111110100000000000 00000000000 1123456789999999999999999999998
Q ss_pred HH
Q 042634 412 AQ 413 (427)
Q Consensus 412 ~~ 413 (427)
++
T Consensus 307 ~h 308 (367)
T 1cm8_A 307 AH 308 (367)
T ss_dssp HS
T ss_pred cC
Confidence 73
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=277.87 Aligned_cols=226 Identities=18% Similarity=0.206 Sum_probs=151.6
Q ss_pred cccccchhhhccccccCC---CCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 042634 179 IRHRNLVKIITSCASVDF---QGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPI 255 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~---~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~i 255 (427)
++||||+++++.+..... ......++||||++ |+|.+.+.... ..+++..++.++.|++.||+||| +.||
T Consensus 73 l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH---~~~i 145 (351)
T 3mi9_A 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE-HDLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYYIH---RNKI 145 (351)
T ss_dssp CCCTTBCCEEEEEEEC--------CEEEEEEECCS-EEHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred ccCCCcccHhheeeccccccccCCceEEEEEeccC-CCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHH---HCCe
Confidence 469999999998755321 11346799999995 57777765443 45899999999999999999999 8999
Q ss_pred eeccccCCceeeCCCCceEecccccccccCC----------cCCCccccccccccCC-CCcCccccchhHHHHHHHHHhC
Q 042634 256 VHCDLKPSNVLLDGELTAHVGDFGLAKFLPE----------ATNNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETFTG 324 (427)
Q Consensus 256 vHrDlkp~NIll~~~~~~kL~DFG~a~~~~~----------~~~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell~g 324 (427)
+||||||+||+++.++.+||+|||+|+.... ...+|+.|+|||++.+ ..++.++|||||||++|||++|
T Consensus 146 vH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g 225 (351)
T 3mi9_A 146 LHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 225 (351)
T ss_dssp ECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHS
T ss_pred eCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhC
Confidence 9999999999999999999999999986531 1267889999999876 5589999999999999999999
Q ss_pred CCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCC
Q 042634 325 KRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRER 404 (427)
Q Consensus 325 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~R 404 (427)
+.||.+... ......+.........+.................................+..+.+++.+||+.||++|
T Consensus 226 ~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 303 (351)
T 3mi9_A 226 SPIMQGNTE--QHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQR 303 (351)
T ss_dssp SCSCCCSSH--HHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGS
T ss_pred CCCCCCCCh--HHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhC
Confidence 999976321 111111111110000000000000000000000000000000000111124568899999999999999
Q ss_pred CCHHHHHHH
Q 042634 405 MNMEEVAAQ 413 (427)
Q Consensus 405 pt~~ev~~~ 413 (427)
||++|++++
T Consensus 304 ~t~~e~l~h 312 (351)
T 3mi9_A 304 IDSDDALNH 312 (351)
T ss_dssp CCHHHHHTS
T ss_pred CCHHHHhCC
Confidence 999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-35 Score=284.77 Aligned_cols=193 Identities=18% Similarity=0.186 Sum_probs=150.7
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
.+||||+++++.+.. ....++||||+++|+|.+++.... ..+++..++.++.||+.||+||| +.||+||
T Consensus 118 ~~hp~Iv~l~~~~~~-----~~~~~lVmE~~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~LH---~~giiHr 186 (412)
T 2vd5_A 118 GDRRWITQLHFAFQD-----ENYLYLVMEYYVGGDLLTLLSKFG---ERIPAEMARFYLAEIVMAIDSVH---RLGYVHR 186 (412)
T ss_dssp SCTTTBCCEEEEEEC-----SSEEEEEECCCCSCBHHHHHHHHS---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred cCCCCeeeEEEEEee-----CCEEEEEEcCCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeec
Confidence 479999999988543 567899999999999999996532 35899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc-------CCCccccccccccC-------CCCcCccccchhHHHHHHHHHhC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA-------TNNFFNFQIAEYGM-------GSEVSTSGDVYSFGILLLETFTG 324 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-------~~~~~~y~aPE~~~-------~~~~~~~~DiwS~G~vl~ell~g 324 (427)
||||+|||++.++.+||+|||+|+..... ..||+.|+|||++. ...++.++|||||||++|||++|
T Consensus 187 DLKp~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG 266 (412)
T 2vd5_A 187 DIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYG 266 (412)
T ss_dssp CCSGGGEEECTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHS
T ss_pred ccCHHHeeecCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhC
Confidence 99999999999999999999999876432 27899999999987 45789999999999999999999
Q ss_pred CCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCC
Q 042634 325 KRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRER 404 (427)
Q Consensus 325 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~R 404 (427)
+.||..... .+......... ....-+ ......+.++.+++.+||. +|++|
T Consensus 267 ~~Pf~~~~~-----~~~~~~i~~~~-~~~~~p-----------------------~~~~~~s~~~~dli~~lL~-~p~~R 316 (412)
T 2vd5_A 267 QTPFYADST-----AETYGKIVHYK-EHLSLP-----------------------LVDEGVPEEARDFIQRLLC-PPETR 316 (412)
T ss_dssp SCTTCCSSH-----HHHHHHHHTHH-HHCCCC---------------------------CCCHHHHHHHHTTSS-CGGGC
T ss_pred CCCCCCCCH-----HHHHHHHHhcc-cCcCCC-----------------------ccccCCCHHHHHHHHHHcC-Chhhc
Confidence 999975311 11111110000 000000 0112245678999999999 99998
Q ss_pred ---CCHHHHHH
Q 042634 405 ---MNMEEVAA 412 (427)
Q Consensus 405 ---pt~~ev~~ 412 (427)
|+++|+++
T Consensus 317 lgr~~~~ei~~ 327 (412)
T 2vd5_A 317 LGRGGAGDFRT 327 (412)
T ss_dssp TTTTTHHHHHT
T ss_pred CCCCCHHHHhc
Confidence 68999865
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-35 Score=278.29 Aligned_cols=199 Identities=21% Similarity=0.253 Sum_probs=151.6
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+++++|.+++.... ..+++..+..++.|++.||+||| +.||+||
T Consensus 86 l~h~~iv~~~~~~~~-----~~~~~iv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~ 154 (319)
T 2y4i_B 86 TRHENVVLFMGACMS-----PPHLAIITSLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGYLH---AKGILHK 154 (319)
T ss_dssp CCCTTBCCCCEEEEC-----SSCEEEECBCCCSEEHHHHTTSSC---CCCCSHHHHHHHHHHHHHHHHHH---HTTCCCC
T ss_pred CCCCCEeEEEEEEec-----CCceEEEeecccCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccc
Confidence 469999999998654 456899999999999999997653 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC-----------cCCCccccccccccCC---------CCcCccccchhHHHHH
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE-----------ATNNFFNFQIAEYGMG---------SEVSTSGDVYSFGILL 318 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~-----------~~~~~~~y~aPE~~~~---------~~~~~~~DiwS~G~vl 318 (427)
||||+||+++ ++.+||+|||+++.... ...|+..|+|||++.. ..++.++|||||||++
T Consensus 155 dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il 233 (319)
T 2y4i_B 155 DLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIW 233 (319)
T ss_dssp CCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHH
T ss_pred CCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHH
Confidence 9999999998 67999999999875421 1257889999999864 4578999999999999
Q ss_pred HHHHhCCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCC
Q 042634 319 LETFTGKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSS 398 (427)
Q Consensus 319 ~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~ 398 (427)
|||++|+.||...... .....+...... .. ....++.++.+++.+||+
T Consensus 234 ~el~~g~~p~~~~~~~--~~~~~~~~~~~~--------~~----------------------~~~~~~~~l~~li~~~l~ 281 (319)
T 2y4i_B 234 YELHAREWPFKTQPAE--AIIWQMGTGMKP--------NL----------------------SQIGMGKEISDILLFCWA 281 (319)
T ss_dssp HHHHHSSCSSSSCCHH--HHHHHHHTTCCC--------CC----------------------CCSSCCTTHHHHHHHHHC
T ss_pred HHHHhCCCCCCCCCHH--HHHHHhccCCCC--------CC----------------------CcCCCCHHHHHHHHHHhc
Confidence 9999999999753211 111111110000 00 001123458899999999
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHH
Q 042634 399 ELPRERMNMEEVAAQLLSFRNKL 421 (427)
Q Consensus 399 ~dP~~Rpt~~ev~~~L~~~~~~~ 421 (427)
.||++|||++|+++.|+++.++.
T Consensus 282 ~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 282 FEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp SSTTTSCCHHHHHHHHTTC----
T ss_pred CChhhCcCHHHHHHHHHHHHHhh
Confidence 99999999999999999987653
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-35 Score=277.57 Aligned_cols=197 Identities=20% Similarity=0.179 Sum_probs=149.8
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchh-----------------------------------
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNRE----------------------------------- 223 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~----------------------------------- 223 (427)
++||||+++++++.. ....++||||+++|+|.+++.....
T Consensus 85 l~hpniv~~~~~~~~-----~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (345)
T 3hko_A 85 LHHPNIARLYEVYED-----EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRE 159 (345)
T ss_dssp CCCTTBCCEEEEEEC-----SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEE
T ss_pred CCCCCcceeehhhcc-----CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccc
Confidence 469999999998643 5678999999999999998852100
Q ss_pred -hhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccccCCceeeCCCC--ceEecccccccccCC----------cCCC
Q 042634 224 -ALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGEL--TAHVGDFGLAKFLPE----------ATNN 290 (427)
Q Consensus 224 -~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~--~~kL~DFG~a~~~~~----------~~~~ 290 (427)
....+++..++.++.|++.||+||| +.||+||||||+||+++.++ .+||+|||+++.... ...|
T Consensus 160 ~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g 236 (345)
T 3hko_A 160 SLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAG 236 (345)
T ss_dssp ECCHHHHHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CC
T ss_pred cccccccHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCC
Confidence 0123567889999999999999999 88999999999999998766 899999999986422 2368
Q ss_pred ccccccccccCC--CCcCccccchhHHHHHHHHHhCCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchh
Q 042634 291 FFNFQIAEYGMG--SEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETS 368 (427)
Q Consensus 291 ~~~y~aPE~~~~--~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (427)
|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.... ............. ..
T Consensus 237 t~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~-----~~------------- 297 (345)
T 3hko_A 237 TPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDA-DTISQVLNKKLCF-----EN------------- 297 (345)
T ss_dssp CGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCCCT-----TS-------------
T ss_pred CccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChH-HHHHHHHhccccc-----CC-------------
Confidence 899999999875 67899999999999999999999999753211 1111111110000 00
Q ss_pred hhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 042634 369 KANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAAQ 413 (427)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~ 413 (427)
......+.++.+++.+||+.||++|||+.|+++.
T Consensus 298 -----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 298 -----------PNYNVLSPLARDLLSNLLNRNVDERFDAMRALQH 331 (345)
T ss_dssp -----------GGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHS
T ss_pred -----------cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0111234568899999999999999999999874
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=282.38 Aligned_cols=228 Identities=18% Similarity=0.221 Sum_probs=156.9
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCC-Ceee
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCET-PIVH 257 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~-~ivH 257 (427)
..||||+++++.+.... ......++||||+ ++++.+++..... ..+++..++.++.||+.||+||| ++ ||+|
T Consensus 98 ~~~~~iv~~~~~~~~~~-~~~~~~~lv~e~~-~~~l~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH---~~~givH 170 (397)
T 1wak_A 98 PNREMVVQLLDDFKISG-VNGTHICMVFEVL-GHHLLKWIIKSNY--QGLPLPCVKKIIQQVLQGLDYLH---TKCRIIH 170 (397)
T ss_dssp GGGGGBCCEEEEEEEEE-TTEEEEEEEECCC-CCBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHH---HTTCEEC
T ss_pred CCcceeeeeecceeecC-CCCceEEEEEecc-CccHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHH---HhCCEec
Confidence 34899999999865321 1345789999999 6777766654322 45899999999999999999999 77 9999
Q ss_pred ccccCCceeeCCCC-------------------------------------------------ceEecccccccccCCc-
Q 042634 258 CDLKPSNVLLDGEL-------------------------------------------------TAHVGDFGLAKFLPEA- 287 (427)
Q Consensus 258 rDlkp~NIll~~~~-------------------------------------------------~~kL~DFG~a~~~~~~- 287 (427)
|||||+|||++.++ .+||+|||.|+.....
T Consensus 171 rDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~ 250 (397)
T 1wak_A 171 TDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF 250 (397)
T ss_dssp CCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS
T ss_pred CCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC
Confidence 99999999998775 7999999999876543
Q ss_pred --CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccCCCccHH-----HHHHHh--cccchhc--ccC-
Q 042634 288 --TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLH-----NFVKEA--LPERLAE--IVD- 355 (427)
Q Consensus 288 --~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~~~~~~~-----~~~~~~--~~~~~~~--~~~- 355 (427)
..||..|+|||++.+..++.++|||||||++|||++|+.||........... ...... .+..... ...
T Consensus 251 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 330 (397)
T 1wak_A 251 TEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSK 330 (397)
T ss_dssp CSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGG
T ss_pred ccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccc
Confidence 3789999999999999999999999999999999999999986533322111 111100 1100000 000
Q ss_pred ccccccccccc----hhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 042634 356 PVLLVEREEGE----TSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAAQ 413 (427)
Q Consensus 356 ~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~ 413 (427)
........... ...............+...+..+.+++.+||+.||++|||++|++++
T Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 331 EFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp GTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 00000000000 00000000000112346678889999999999999999999999863
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-35 Score=282.76 Aligned_cols=189 Identities=24% Similarity=0.361 Sum_probs=145.2
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeecc
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCD 259 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrD 259 (427)
.||||+++++++.. ....++||| +.+++|.+++... ..+++..+..++.||+.||+||| +.||+|||
T Consensus 114 ~~~~iv~~~~~~~~-----~~~~~lv~E-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrD 180 (390)
T 2zmd_A 114 HSDKIIRLYDYEIT-----DQYIYMVME-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSD 180 (390)
T ss_dssp TCTTBCCEEEEEEC-----SSEEEEEEE-CCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHH---TTTCCCCC
T ss_pred CCCeEEEEEEEEec-----CCEEEEEEe-cCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecC
Confidence 37999999987544 456899999 5589999998754 35888999999999999999999 89999999
Q ss_pred ccCCceeeCCCCceEecccccccccCC--------cCCCccccccccccCC-----------CCcCccccchhHHHHHHH
Q 042634 260 LKPSNVLLDGELTAHVGDFGLAKFLPE--------ATNNFFNFQIAEYGMG-----------SEVSTSGDVYSFGILLLE 320 (427)
Q Consensus 260 lkp~NIll~~~~~~kL~DFG~a~~~~~--------~~~~~~~y~aPE~~~~-----------~~~~~~~DiwS~G~vl~e 320 (427)
|||+|||++ ++.+||+|||+|+.... ...||+.|+|||++.+ ..++.++|||||||++||
T Consensus 181 lkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~e 259 (390)
T 2zmd_A 181 LKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 259 (390)
T ss_dssp CCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHH
T ss_pred CCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHH
Confidence 999999995 57899999999987543 2368999999999865 368999999999999999
Q ss_pred HHhCCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCC
Q 042634 321 TFTGKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSEL 400 (427)
Q Consensus 321 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~d 400 (427)
|++|+.||...... . ..... ++++..... .+...+.++.+++.+||+.|
T Consensus 260 ll~G~~Pf~~~~~~---~-~~~~~--------~~~~~~~~~-------------------~~~~~~~~~~~li~~~L~~d 308 (390)
T 2zmd_A 260 MTYGKTPFQQIINQ---I-SKLHA--------IIDPNHEIE-------------------FPDIPEKDLQDVLKCCLKRD 308 (390)
T ss_dssp HHHSSCTTTTCCCH---H-HHHHH--------HHCTTSCCC-------------------CCCCSCHHHHHHHHHHTCSS
T ss_pred HHHCCCcchhhhHH---H-HHHHH--------HhCccccCC-------------------CCccchHHHHHHHHHHcccC
Confidence 99999999753211 1 11111 111100000 00111346889999999999
Q ss_pred CCCCCCHHHHHHH
Q 042634 401 PRERMNMEEVAAQ 413 (427)
Q Consensus 401 P~~Rpt~~ev~~~ 413 (427)
|++|||++|+++.
T Consensus 309 P~~Rps~~ell~h 321 (390)
T 2zmd_A 309 PKQRISIPELLAH 321 (390)
T ss_dssp TTTSCCHHHHHTS
T ss_pred hhhCCCHHHHhhC
Confidence 9999999999864
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=288.48 Aligned_cols=143 Identities=24% Similarity=0.349 Sum_probs=125.6
Q ss_pred ccccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 042634 178 FIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVH 257 (427)
Q Consensus 178 ll~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivH 257 (427)
...|+||+++++.+.. ....++||||+ +++|.+++..... ..+++..++.++.||+.||+||| +.||+|
T Consensus 155 ~~~~~~iv~~~~~~~~-----~~~~~lv~e~~-~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH 223 (429)
T 3kvw_A 155 KDNTMNVIHMLENFTF-----RNHICMTFELL-SMNLYELIKKNKF--QGFSLPLVRKFAHSILQCLDALH---KNRIIH 223 (429)
T ss_dssp TTSCSCBCCEEEEEEE-----TTEEEEEECCC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHH---HHTEEC
T ss_pred ccCCcCEEEEEeeccc-----CCeEEEEEecc-CCCHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeec
Confidence 3578999999998644 46789999999 5799998865432 45899999999999999999999 889999
Q ss_pred ccccCCceeeCCCCc--eEecccccccccCCcC---CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 258 CDLKPSNVLLDGELT--AHVGDFGLAKFLPEAT---NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 258 rDlkp~NIll~~~~~--~kL~DFG~a~~~~~~~---~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
|||||+|||++.++. +||+|||+|+...... .+|+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus 224 rDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 224 CDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp SCCSGGGEEESSTTSCCEEECCCTTCEETTCCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCCCHHHeEEccCCCcceEEeecccceecCCcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 999999999999887 9999999998654433 7889999999999999999999999999999999999999764
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=278.53 Aligned_cols=201 Identities=26% Similarity=0.391 Sum_probs=158.0
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchh---hhhccCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNRE---ALKNLNLLQRLSIAVDVASALDYLHHYCETPI 255 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~i 255 (427)
++||||+++++.+.. ....++||||+++|+|.+++..... ....+++..++.++.|++.||+||| +.||
T Consensus 90 l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i 161 (327)
T 2yfx_A 90 FNHQNIVRCIGVSLQ-----SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHF 161 (327)
T ss_dssp CCCTTBCCEEEEECS-----SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTC
T ss_pred CCCCCCCeEEEEEcC-----CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCe
Confidence 479999999998544 4567999999999999999865421 1134889999999999999999999 8999
Q ss_pred eeccccCCceeeCC---CCceEecccccccccCC--------cCCCccccccccccCCCCcCccccchhHHHHHHHHHh-
Q 042634 256 VHCDLKPSNVLLDG---ELTAHVGDFGLAKFLPE--------ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT- 323 (427)
Q Consensus 256 vHrDlkp~NIll~~---~~~~kL~DFG~a~~~~~--------~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~- 323 (427)
+||||||+||+++. +..+||+|||+++.... ...++..|+|||++.+..++.++|||||||++|||++
T Consensus 162 ~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~ 241 (327)
T 2yfx_A 162 IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL 241 (327)
T ss_dssp CCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred ecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcC
Confidence 99999999999984 45699999999975422 1256788999999988899999999999999999998
Q ss_pred CCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCC
Q 042634 324 GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRE 403 (427)
Q Consensus 324 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~ 403 (427)
|..||.... .......+...... ..+..++..+.+++.+||+.||++
T Consensus 242 g~~p~~~~~--~~~~~~~~~~~~~~-------------------------------~~~~~~~~~l~~li~~~l~~dp~~ 288 (327)
T 2yfx_A 242 GYMPYPSKS--NQEVLEFVTSGGRM-------------------------------DPPKNCPGPVYRIMTQCWQHQPED 288 (327)
T ss_dssp SCCSSTTCC--HHHHHHHHHTTCCC-------------------------------CCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred CCCCCCCcC--HHHHHHHHhcCCCC-------------------------------CCCCCCCHHHHHHHHHHhcCChhh
Confidence 999987531 11111111110000 011224567899999999999999
Q ss_pred CCCHHHHHHHHHHHHHH
Q 042634 404 RMNMEEVAAQLLSFRNK 420 (427)
Q Consensus 404 Rpt~~ev~~~L~~~~~~ 420 (427)
|||++|+++.|+.+...
T Consensus 289 Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 289 RPNFAIILERIEYCTQD 305 (327)
T ss_dssp SCCHHHHHHHHHHHHHC
T ss_pred CcCHHHHHHHHHHHhcC
Confidence 99999999999988653
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=269.12 Aligned_cols=193 Identities=19% Similarity=0.242 Sum_probs=152.7
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+++++|.+++... ..+++..+..++.|++.||+||| +.||+||
T Consensus 62 l~h~~i~~~~~~~~~-----~~~~~~v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~ 129 (284)
T 3kk8_A 62 LQHPNIVRLHDSIQE-----ESFHYLVFDLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCH---SNGIVHR 129 (284)
T ss_dssp CCCTTBCCEEEEEEC-----SSEEEEEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECS
T ss_pred cCCCCcCeEEEEEEc-----CCEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcCcC
Confidence 469999999998543 56779999999999998887644 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCc---eEecccccccccCCc-----CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCc
Q 042634 259 DLKPSNVLLDGELT---AHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~~~~---~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~ 330 (427)
||||+||+++.++. +||+|||.+...... ..++..|+|||++.+..++.++||||+||++|+|++|+.||..
T Consensus 130 dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 209 (284)
T 3kk8_A 130 NLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 209 (284)
T ss_dssp CCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCHHHEEEecCCCCCcEEEeeceeeEEcccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCC
Confidence 99999999976654 999999999766443 2788999999999999999999999999999999999999965
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
... ......+...... ... .....++.++.+++.+||+.||++|||++|+
T Consensus 210 ~~~--~~~~~~~~~~~~~----~~~------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~ 259 (284)
T 3kk8_A 210 EDQ--HRLYAQIKAGAYD----YPS------------------------PEWDTVTPEAKSLIDSMLTVNPKKRITADQA 259 (284)
T ss_dssp SSH--HHHHHHHHHTCCC----CCT------------------------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred Cch--hHHHHHHHhcccc----CCc------------------------hhhcccCHHHHHHHHHHcccChhhCCCHHHH
Confidence 311 1111111110000 000 0111234568899999999999999999999
Q ss_pred HHH
Q 042634 411 AAQ 413 (427)
Q Consensus 411 ~~~ 413 (427)
+++
T Consensus 260 l~h 262 (284)
T 3kk8_A 260 LKV 262 (284)
T ss_dssp TTS
T ss_pred hcC
Confidence 874
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=268.54 Aligned_cols=192 Identities=19% Similarity=0.228 Sum_probs=151.7
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+++++|.+++... ..+++..+..++.|++.||+||| +.||+||
T Consensus 63 l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~ 130 (277)
T 3f3z_A 63 LDHPNIIRLYETFED-----NTDIYLVMELCTGGELFERVVHK----RVFRESDAARIMKDVLSAVAYCH---KLNVAHR 130 (277)
T ss_dssp CCCTTBCCEEEEEEC-----SSEEEEEEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred CCCCCEeeEEEEEec-----CCeEEEEEeccCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCccCC
Confidence 479999999998543 56789999999999999988654 45899999999999999999999 8999999
Q ss_pred cccCCceee---CCCCceEecccccccccCCc-----CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCc
Q 042634 259 DLKPSNVLL---DGELTAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll---~~~~~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~ 330 (427)
||||+||++ +.++.+||+|||.+...... ..+|+.|+|||++.+. ++.++||||+||++|||++|+.||..
T Consensus 131 dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (277)
T 3f3z_A 131 DLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSA 209 (277)
T ss_dssp CCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCHHHEEEecCCCCCcEEEEecccceeccCccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCC
Confidence 999999999 78899999999999865432 3788999999998654 89999999999999999999999975
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
... ......+...... . +......++.++.+++.+||+.||++|||+.|+
T Consensus 210 ~~~--~~~~~~~~~~~~~-----------~-----------------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~ 259 (277)
T 3f3z_A 210 PTD--SEVMLKIREGTFT-----------F-----------------PEKDWLNVSPQAESLIRRLLTKSPKQRITSLQA 259 (277)
T ss_dssp SSH--HHHHHHHHHCCCC-----------C-----------------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred CCH--HHHHHHHHhCCCC-----------C-----------------CchhhhcCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 321 1111111110000 0 000011245678999999999999999999999
Q ss_pred HHH
Q 042634 411 AAQ 413 (427)
Q Consensus 411 ~~~ 413 (427)
+++
T Consensus 260 l~h 262 (277)
T 3f3z_A 260 LEH 262 (277)
T ss_dssp TTS
T ss_pred hcC
Confidence 863
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=269.14 Aligned_cols=189 Identities=20% Similarity=0.287 Sum_probs=153.6
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+++|+|.+++... ..+++..+..++.|++.||+||| +.||+||
T Consensus 71 l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~ 138 (284)
T 2vgo_A 71 LRHPNILRMYNYFHD-----RKRIYLMLEFAPRGELYKELQKH----GRFDEQRSATFMEELADALHYCH---ERKVIHR 138 (284)
T ss_dssp CCCTTBCCEEEEEEC-----SSEEEEEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH---TTTEECC
T ss_pred CCCCCEeeEEEEEEc-----CCEEEEEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCceec
Confidence 469999999998543 56789999999999999988654 35899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc----CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA----TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTG 334 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~~ 334 (427)
||||+||+++.++.+||+|||.+...... ..++..|+|||++.+..++.++|||||||++|||++|..||.....
T Consensus 139 dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~- 217 (284)
T 2vgo_A 139 DIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH- 217 (284)
T ss_dssp CCSGGGEEECTTCCEEECCCTTCEECSSSCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-
T ss_pred CCCHHHEEEcCCCCEEEecccccccCcccccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH-
Confidence 99999999999999999999999765432 3788999999999999999999999999999999999999975311
Q ss_pred CccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 042634 335 NLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAAQ 413 (427)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~ 413 (427)
.......... + . . .+...+.++.+++.+||+.||++|||++|++++
T Consensus 218 ----~~~~~~~~~~------~--~----------------~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 218 ----TETHRRIVNV------D--L----------------K-----FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp ----HHHHHHHHTT------C--C----------------C-----CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred ----hHHHHHHhcc------c--c----------------C-----CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 1111110000 0 0 0 111234568899999999999999999999874
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-35 Score=275.12 Aligned_cols=215 Identities=19% Similarity=0.280 Sum_probs=151.3
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+++++|.+++... ..+++..+..++.|++.||+||| +.||+||
T Consensus 59 l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~ 126 (311)
T 4agu_A 59 LKHPNLVNLLEVFRR-----KRRLHLVFEYCDHTVLHELDRYQ----RGVPEHLVKSITWQTLQAVNFCH---KHNCIHR 126 (311)
T ss_dssp CCCTTBCCEEEEEEE-----TTEEEEEEECCSEEHHHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred CCCCCccchhheeec-----CCeEEEEEEeCCCchHHHHHhhh----cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCC
Confidence 469999999998644 56789999999999998887654 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCC-CCcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
||||+||+++.++.+||+|||.++..... ..++..|+|||++.+ ..++.++||||+||++|||++|+.||.+.
T Consensus 127 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 206 (311)
T 4agu_A 127 DVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGK 206 (311)
T ss_dssp CCSGGGEEECTTSCEEECCCTTCEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCChhhEEEcCCCCEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999999876432 278889999999876 66899999999999999999999999764
Q ss_pred cCCCccHHHHHHHhcc---cchhcccC-c-cccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCC
Q 042634 332 FTGNLTLHNFVKEALP---ERLAEIVD-P-VLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMN 406 (427)
Q Consensus 332 ~~~~~~~~~~~~~~~~---~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt 406 (427)
.... ....+..... +....... . ............. ... .......+.++.+++.+||+.||++|||
T Consensus 207 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rpt 278 (311)
T 4agu_A 207 SDVD--QLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDM----EPL--ELKFPNISYPALGLLKGCLHMDPTERLT 278 (311)
T ss_dssp SHHH--HHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSC----CCH--HHHCTTCCHHHHHHHHHHCCSSTTTSCC
T ss_pred CHHH--HHHHHHHHhcccccccccccccccccccCcCCCcccc----chh--hhhcccccHHHHHHHHHHccCChhhcCC
Confidence 2211 1111111110 00000000 0 0000000000000 000 0001234566899999999999999999
Q ss_pred HHHHHHH
Q 042634 407 MEEVAAQ 413 (427)
Q Consensus 407 ~~ev~~~ 413 (427)
++|++++
T Consensus 279 ~~ell~h 285 (311)
T 4agu_A 279 CEQLLHH 285 (311)
T ss_dssp HHHHHTS
T ss_pred HHHHhcC
Confidence 9999853
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-35 Score=281.61 Aligned_cols=223 Identities=19% Similarity=0.195 Sum_probs=154.8
Q ss_pred cccccchhhhccccccCC---------------------------------CCCCccceeeeeecCCCcccccccchhhh
Q 042634 179 IRHRNLVKIITSCASVDF---------------------------------QGNDSEALVYEFMVNGSLEEWLHPNREAL 225 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~---------------------------------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~ 225 (427)
++||||+++++++..... ..+...++||||++ |+|.+.+.......
T Consensus 57 l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~ 135 (383)
T 3eb0_A 57 LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSG 135 (383)
T ss_dssp CCCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTT
T ss_pred cCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcC
Confidence 579999999988643211 22345789999996 68887776543333
Q ss_pred hccCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccccCCceeeC-CCCceEecccccccccCCc-----CCCccccccccc
Q 042634 226 KNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLD-GELTAHVGDFGLAKFLPEA-----TNNFFNFQIAEY 299 (427)
Q Consensus 226 ~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrDlkp~NIll~-~~~~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~ 299 (427)
..+++..++.++.|++.||+||| +.||+||||||+||+++ .++.+||+|||+|+..... ..+|..|+|||+
T Consensus 136 ~~l~~~~~~~i~~qi~~aL~~LH---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~ 212 (383)
T 3eb0_A 136 RSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPEL 212 (383)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHH---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHH
Confidence 56999999999999999999999 89999999999999997 6889999999999865432 267889999999
Q ss_pred cCCC-CcCccccchhHHHHHHHHHhCCCCCCcccCCCccHHHHHHHhcccchhccc--Cccccccccccchhhhcccccc
Q 042634 300 GMGS-EVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEALPERLAEIV--DPVLLVEREEGETSKANAHKQF 376 (427)
Q Consensus 300 ~~~~-~~~~~~DiwS~G~vl~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 376 (427)
+.+. .++.++||||+||++|||++|+.||.+... ...+...+.....+....+. ++..... ..+ ......+
T Consensus 213 ~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~~~~i~~~~g~p~~~~~~~~~~~~~~~--~~~---~~~~~~~ 286 (383)
T 3eb0_A 213 MLGATEYTPSIDLWSIGCVFGELILGKPLFSGETS-IDQLVRIIQIMGTPTKEQMIRMNPHYTEV--RFP---TLKAKDW 286 (383)
T ss_dssp HTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCHHHHHHHCTTC--C--CCC---CCCCCCH
T ss_pred hcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCCHHHHHHhCcccccc--cCC---ccCcccH
Confidence 8775 489999999999999999999999976321 11222222221111111000 0000000 000 0000000
Q ss_pred ccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 377 TRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 377 ~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
....+..++.++.+++.+||+.||++|||+.|+++
T Consensus 287 -~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 287 -RKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMA 321 (383)
T ss_dssp -HHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -HhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00112234567899999999999999999999985
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=282.32 Aligned_cols=224 Identities=19% Similarity=0.189 Sum_probs=152.6
Q ss_pred cccccchhhhccccccCC-CCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 042634 179 IRHRNLVKIITSCASVDF-QGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVH 257 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivH 257 (427)
++||||+++++++..... .+....++||||+++ ++.+.+.........+++..++.++.|++.||+||| +.||+|
T Consensus 89 l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH 164 (394)
T 4e7w_A 89 VKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICH 164 (394)
T ss_dssp CCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEEC
T ss_pred CCCCCcceEEEEEEecCCCCCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccC
Confidence 579999999998754321 223346899999965 444443322222356899999999999999999999 899999
Q ss_pred ccccCCceeeC-CCCceEecccccccccCCc-----CCCccccccccccCCC-CcCccccchhHHHHHHHHHhCCCCCCc
Q 042634 258 CDLKPSNVLLD-GELTAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMGS-EVSTSGDVYSFGILLLETFTGKRPTNE 330 (427)
Q Consensus 258 rDlkp~NIll~-~~~~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~~-~~~~~~DiwS~G~vl~ell~g~~pf~~ 330 (427)
|||||+|||++ .++.+||+|||+|+..... ..+|+.|+|||++.+. .++.++||||+||++|||++|+.||.+
T Consensus 165 rDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 244 (394)
T 4e7w_A 165 RDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPG 244 (394)
T ss_dssp SCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCCHHHEEEcCCCCcEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999998 7899999999999875332 2778899999998764 589999999999999999999999976
Q ss_pred ccCCCccHHHHHHHhcccchhcc--cCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEI--VDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME 408 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ 408 (427)
... ...+...+.....+....+ .++..... ... ......+.. ......+.++.+++.+||+.||++|||+.
T Consensus 245 ~~~-~~~l~~i~~~~g~p~~~~~~~~~~~~~~~--~~~---~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 317 (394)
T 4e7w_A 245 ESG-IDQLVEIIKVLGTPSREQIKTMNPNYMEH--KFP---QIRPHPFSK-VFRPRTPPDAIDLISRLLEYTPSARLTAI 317 (394)
T ss_dssp SSH-HHHHHHHHHHHCCCCHHHHHHHCGGGSSS--CCC---CCCCCCHHH-HSCTTCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred CCH-HHHHHHHHHHhCCCCHHHHHhhChhhhhh--ccc---cccCCcHHH-hccccCCHHHHHHHHHHhCCChhhCCCHH
Confidence 421 1122222221111110000 00000000 000 000000000 01122456789999999999999999999
Q ss_pred HHHHH
Q 042634 409 EVAAQ 413 (427)
Q Consensus 409 ev~~~ 413 (427)
|++++
T Consensus 318 e~l~h 322 (394)
T 4e7w_A 318 EALCH 322 (394)
T ss_dssp HHHTS
T ss_pred HHhcC
Confidence 99864
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=274.98 Aligned_cols=200 Identities=21% Similarity=0.237 Sum_probs=142.5
Q ss_pred ccccchhhhccccccC---CCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCC--
Q 042634 180 RHRNLVKIITSCASVD---FQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETP-- 254 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~---~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~-- 254 (427)
+||||+++++.+.... .......++||||+ +|+|.+++..... ...+++..++.++.|++.||+||| +.|
T Consensus 84 ~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~-~g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ 158 (337)
T 3ll6_A 84 GHPNIVQFCSAASIGKEESDTGQAEFLLLTELC-KGQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMH---RQKPP 158 (337)
T ss_dssp TSTTBCCEEEEEEECTTTSTTSSEEEEEEEECC-SEEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHH---TSSSC
T ss_pred cCCChhhccccccccccccccCCceEEEEEEec-CCCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH---hCCCC
Confidence 5999999998863211 13344578999999 5899888864321 145999999999999999999999 888
Q ss_pred eeeccccCCceeeCCCCceEecccccccccCCc------------------CCCcccccccccc---CCCCcCccccchh
Q 042634 255 IVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA------------------TNNFFNFQIAEYG---MGSEVSTSGDVYS 313 (427)
Q Consensus 255 ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~------------------~~~~~~y~aPE~~---~~~~~~~~~DiwS 313 (427)
|+||||||+||+++.++.+||+|||+++..... ..++..|+|||++ .+..++.++||||
T Consensus 159 ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~s 238 (337)
T 3ll6_A 159 IIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWA 238 (337)
T ss_dssp CBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHH
T ss_pred EEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHH
Confidence 999999999999999999999999999876432 2478899999998 5667899999999
Q ss_pred HHHHHHHHHhCCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHH
Q 042634 314 FGILLLETFTGKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIG 393 (427)
Q Consensus 314 ~G~vl~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 393 (427)
|||++|||++|+.||...... .......... ....++..+.+++
T Consensus 239 lG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~-------------------------------~~~~~~~~~~~li 282 (337)
T 3ll6_A 239 LGCILYLLCFRQHPFEDGAKL-----RIVNGKYSIP-------------------------------PHDTQYTVFHSLI 282 (337)
T ss_dssp HHHHHHHHHHSSCCC-----------------CCCC-------------------------------TTCCSSGGGHHHH
T ss_pred HHHHHHHHHhCCCCCcchhHH-----HhhcCcccCC-------------------------------cccccchHHHHHH
Confidence 999999999999999653111 0000000000 0011123467899
Q ss_pred hhcCCCCCCCCCCHHHHHHHHHHHHHH
Q 042634 394 VTCSSELPRERMNMEEVAAQLLSFRNK 420 (427)
Q Consensus 394 ~~cl~~dP~~Rpt~~ev~~~L~~~~~~ 420 (427)
.+||+.||++|||++|+++.|+++...
T Consensus 283 ~~~l~~~p~~Rps~~e~l~~l~~~~~~ 309 (337)
T 3ll6_A 283 RAMLQVNPEERLSIAEVVHQLQEIAAA 309 (337)
T ss_dssp HHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 999999999999999999999999765
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=283.75 Aligned_cols=143 Identities=21% Similarity=0.305 Sum_probs=121.9
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+....+......++||||+ +|+|.+++... ..+++..++.++.||+.||+||| +.||+||
T Consensus 82 l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~----~~l~~~~~~~i~~qil~aL~~LH---~~givHr 153 (432)
T 3n9x_A 82 LKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTP----IFLTEEHIKTILYNLLLGENFIH---ESGIIHR 153 (432)
T ss_dssp CCCTTBCCEEEECCCSCTTTCCCEEEEEECC-SEEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred cCCCCcceEEEEEecCCCCcCCeEEEEEecC-CcCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCCCCC
Confidence 4699999999987664444446789999999 56999988654 45999999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC----------------------------cCCCcccccccccc-CCCCcCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE----------------------------ATNNFFNFQIAEYG-MGSEVSTSG 309 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~----------------------------~~~~~~~y~aPE~~-~~~~~~~~~ 309 (427)
||||+|||++.++.+||+|||+|+.... ...||+.|+|||++ ....++.++
T Consensus 154 Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~ 233 (432)
T 3n9x_A 154 DLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSI 233 (432)
T ss_dssp CCCGGGEEECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHH
T ss_pred CCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCccc
Confidence 9999999999999999999999987532 22678999999986 556799999
Q ss_pred cchhHHHHHHHHHhCCCCCC
Q 042634 310 DVYSFGILLLETFTGKRPTN 329 (427)
Q Consensus 310 DiwS~G~vl~ell~g~~pf~ 329 (427)
||||+||++|||++|..||.
T Consensus 234 DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 234 DIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp HHHHHHHHHHHHHTTCTTTC
T ss_pred ccchHHHHHHHHHhcccccc
Confidence 99999999999998665554
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=299.67 Aligned_cols=188 Identities=20% Similarity=0.238 Sum_probs=152.6
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
.+||+|+++++.+ ......++||||+++|+|.+++... ..+++..++.++.||+.||+||| +.||+||
T Consensus 399 ~~~~~i~~l~~~~-----~~~~~~~lV~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH---~~gIiHr 466 (674)
T 3pfq_A 399 GKPPFLTQLHSCF-----QTMDRLYFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYR 466 (674)
T ss_dssp TCCTTBCCEEEEC-----BCSSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH---HTSEECC
T ss_pred cCCCeEEEEEEEE-----EeCCEEEEEEeCcCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEec
Confidence 4799999999884 3466789999999999999998754 45999999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC------cCCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE------ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+|||++.++.+||+|||+|+.... ...||+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 467 DLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~ 546 (674)
T 3pfq_A 467 DLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 546 (674)
T ss_dssp CCCSTTEEECSSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCChhhEEEcCCCcEEEeecceeeccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC
Confidence 9999999999999999999999986322 2278999999999999999999999999999999999999997531
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCH-----
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM----- 407 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~----- 407 (427)
. .+......... .. .+...+.++.+++.+||+.||++||++
T Consensus 547 ~-----~~~~~~i~~~~--------~~---------------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~ 592 (674)
T 3pfq_A 547 E-----DELFQSIMEHN--------VA---------------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGE 592 (674)
T ss_dssp H-----HHHHHHHHSSC--------CC---------------------CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHH
T ss_pred H-----HHHHHHHHhCC--------CC---------------------CCccCCHHHHHHHHHHccCCHHHCCCCCCCcH
Confidence 1 11111111100 00 112234568999999999999999998
Q ss_pred HHHHH
Q 042634 408 EEVAA 412 (427)
Q Consensus 408 ~ev~~ 412 (427)
+||++
T Consensus 593 ~ei~~ 597 (674)
T 3pfq_A 593 RDIKE 597 (674)
T ss_dssp HHHHS
T ss_pred HHHhc
Confidence 66654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-35 Score=278.32 Aligned_cols=188 Identities=23% Similarity=0.356 Sum_probs=144.3
Q ss_pred cccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccc
Q 042634 181 HRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDL 260 (427)
Q Consensus 181 Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrDl 260 (427)
||||+++++++.. ....++|||+ .+++|.+++... ..+++.++..++.|++.||+||| +.||+||||
T Consensus 68 ~~~iv~~~~~~~~-----~~~~~lv~e~-~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDi 134 (343)
T 3dbq_A 68 SDKIIRLYDYEIT-----DQYIYMVMEC-GNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDL 134 (343)
T ss_dssp CTTBCCEEEEEEC-----SSEEEEEECC-CSEEHHHHHHHS----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCC
T ss_pred CCceEEEeeeEee-----CCEEEEEEeC-CCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCC
Confidence 3999999998543 5678999995 588999998754 45899999999999999999999 899999999
Q ss_pred cCCceeeCCCCceEecccccccccCCc--------CCCccccccccccCC-----------CCcCccccchhHHHHHHHH
Q 042634 261 KPSNVLLDGELTAHVGDFGLAKFLPEA--------TNNFFNFQIAEYGMG-----------SEVSTSGDVYSFGILLLET 321 (427)
Q Consensus 261 kp~NIll~~~~~~kL~DFG~a~~~~~~--------~~~~~~y~aPE~~~~-----------~~~~~~~DiwS~G~vl~el 321 (427)
||+|||++ ++.+||+|||+|+..... ..||+.|+|||++.+ ..++.++|||||||++|||
T Consensus 135 kp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~el 213 (343)
T 3dbq_A 135 KPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM 213 (343)
T ss_dssp CGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHH
T ss_pred CcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHH
Confidence 99999997 578999999999875332 268999999999864 6789999999999999999
Q ss_pred HhCCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCC
Q 042634 322 FTGKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELP 401 (427)
Q Consensus 322 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP 401 (427)
++|+.||...... ... .... +++..... .+...+.++.+++.+||+.||
T Consensus 214 l~g~~pf~~~~~~---~~~-~~~~--------~~~~~~~~-------------------~~~~~~~~l~~li~~~L~~dp 262 (343)
T 3dbq_A 214 TYGKTPFQQIINQ---ISK-LHAI--------IDPNHEIE-------------------FPDIPEKDLQDVLKCCLKRDP 262 (343)
T ss_dssp HHSSCTTTTCCSH---HHH-HHHH--------HCTTSCCC-------------------CCCCSCHHHHHHHHHHTCSST
T ss_pred HhCCCcchhhhhH---HHH-HHHH--------hcCCcccC-------------------CcccCCHHHHHHHHHHcCCCh
Confidence 9999999753211 111 1111 11000000 011123467899999999999
Q ss_pred CCCCCHHHHHHH
Q 042634 402 RERMNMEEVAAQ 413 (427)
Q Consensus 402 ~~Rpt~~ev~~~ 413 (427)
++|||++|++++
T Consensus 263 ~~Rpt~~e~l~h 274 (343)
T 3dbq_A 263 KQRISIPELLAH 274 (343)
T ss_dssp TTSCCHHHHHTS
T ss_pred hHCCCHHHHHhC
Confidence 999999999865
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=278.39 Aligned_cols=193 Identities=20% Similarity=0.257 Sum_probs=151.5
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeecc
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCD 259 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrD 259 (427)
+||||+++++.+.. ....++||||+++|+|.+++... ..+++..++.++.|++.||+||| +.||+|||
T Consensus 117 ~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~D 184 (355)
T 1vzo_A 117 QSPFLVTLHYAFQT-----ETKLHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLH---KLGIIYRD 184 (355)
T ss_dssp TCTTBCCEEEEEEE-----TTEEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCC
T ss_pred CCCceeEEEEEEee-----CceEEEEeecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCC
Confidence 69999999988544 56789999999999999998654 45899999999999999999999 88999999
Q ss_pred ccCCceeeCCCCceEecccccccccCCc-------CCCccccccccccCC--CCcCccccchhHHHHHHHHHhCCCCCCc
Q 042634 260 LKPSNVLLDGELTAHVGDFGLAKFLPEA-------TNNFFNFQIAEYGMG--SEVSTSGDVYSFGILLLETFTGKRPTNE 330 (427)
Q Consensus 260 lkp~NIll~~~~~~kL~DFG~a~~~~~~-------~~~~~~y~aPE~~~~--~~~~~~~DiwS~G~vl~ell~g~~pf~~ 330 (427)
|||+|||++.++.+||+|||+++..... ..||..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 185 lkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~ 264 (355)
T 1vzo_A 185 IKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTV 264 (355)
T ss_dssp CCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSC
T ss_pred CCHHHEEECCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCcc
Confidence 9999999999999999999999865322 268999999999986 3478999999999999999999999975
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCC-----
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERM----- 405 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rp----- 405 (427)
..... ............. ...+..++..+.+++.+||+.||++||
T Consensus 265 ~~~~~-~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~ 314 (355)
T 1vzo_A 265 DGEKN-SQAEISRRILKSE-----------------------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPR 314 (355)
T ss_dssp TTSCC-CHHHHHHHHHHCC-----------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTT
T ss_pred CCccc-hHHHHHHHHhccC-----------------------------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCC
Confidence 32221 1222111111000 001122345688999999999999999
Q ss_pred CHHHHHHHH
Q 042634 406 NMEEVAAQL 414 (427)
Q Consensus 406 t~~ev~~~L 414 (427)
|++|+++..
T Consensus 315 s~~ell~h~ 323 (355)
T 1vzo_A 315 DADEIKEHL 323 (355)
T ss_dssp THHHHHTSG
T ss_pred CHHHHHcCc
Confidence 999998753
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=286.24 Aligned_cols=191 Identities=21% Similarity=0.256 Sum_probs=151.7
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++++.. ....++|||||.+|+|.+++... ..+++..+..++.|++.||+||| +.||+||
T Consensus 78 l~hpniv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~ 145 (486)
T 3mwu_A 78 LDHPNIMKLFEILED-----SSSFYIVGELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMH---KHNIVHR 145 (486)
T ss_dssp CCCTTBCCEEEEEEC-----SSEEEEEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred CCCCCcCeEEEEEEc-----CCEEEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEec
Confidence 479999999998543 56789999999999999888654 45899999999999999999999 8999999
Q ss_pred cccCCceeeC---CCCceEecccccccccCCc-----CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCc
Q 042634 259 DLKPSNVLLD---GELTAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~---~~~~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~ 330 (427)
||||+|||++ .++.+||+|||+|+..... ..||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+
T Consensus 146 Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~ 224 (486)
T 3mwu_A 146 DLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYG 224 (486)
T ss_dssp CCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCchHHEEEecCCCCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999995 4568999999999866433 278999999999876 589999999999999999999999975
Q ss_pred ccCCCccHHHHHHHh-cccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 042634 331 MFTGNLTLHNFVKEA-LPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEE 409 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~e 409 (427)
... ..+...+... .... .......+.++.+++.+||+.||++|||+.|
T Consensus 225 ~~~--~~~~~~i~~~~~~~~-----------------------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~ 273 (486)
T 3mwu_A 225 KNE--YDILKRVETGKYAFD-----------------------------LPQWRTISDDAKDLIRKMLTFHPSLRITATQ 273 (486)
T ss_dssp SSH--HHHHHHHHHTCCCSC-----------------------------SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred CCH--HHHHHHHHhCCCCCC-----------------------------CcccCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 311 1111111110 0000 0011223556889999999999999999999
Q ss_pred HHHH
Q 042634 410 VAAQ 413 (427)
Q Consensus 410 v~~~ 413 (427)
++++
T Consensus 274 ~l~h 277 (486)
T 3mwu_A 274 CLEH 277 (486)
T ss_dssp HHHC
T ss_pred HhcC
Confidence 9874
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=284.78 Aligned_cols=189 Identities=19% Similarity=0.276 Sum_probs=150.1
Q ss_pred CCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccccCCceee---CCCCceEe
Q 042634 199 NDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLL---DGELTAHV 275 (427)
Q Consensus 199 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrDlkp~NIll---~~~~~~kL 275 (427)
....++||||+ +++|.+++.... ..+++..++.++.||+.||+||| +.||+||||||+|||+ +.++.+||
T Consensus 75 ~~~~~lvme~~-g~sL~~ll~~~~---~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL 147 (483)
T 3sv0_A 75 GDYNVLVMDLL-GPSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYI 147 (483)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEE
T ss_pred CCEEEEEEECC-CCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEE
Confidence 45679999999 999999986432 45999999999999999999999 8999999999999999 58899999
Q ss_pred cccccccccCC-------------cCCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccCCCccHHHHH
Q 042634 276 GDFGLAKFLPE-------------ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFV 342 (427)
Q Consensus 276 ~DFG~a~~~~~-------------~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~~~~~~~~~~ 342 (427)
+|||+|+.... ...||..|+|||++.+..++.++|||||||++|||++|+.||.+..... ..+..
T Consensus 148 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~--~~~~~ 225 (483)
T 3sv0_A 148 IDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT--KKQKY 225 (483)
T ss_dssp CCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS--HHHHH
T ss_pred EeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchh--HHHHH
Confidence 99999986543 2368889999999999999999999999999999999999998653221 11111
Q ss_pred HHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHHHH
Q 042634 343 KEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAAQLLSFRNK 420 (427)
Q Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~~~~~ 420 (427)
...........+.. ....++.++.+++.+||+.||++||++++|++.|+++...
T Consensus 226 ~~i~~~~~~~~~~~------------------------l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~ 279 (483)
T 3sv0_A 226 EKISEKKVATSIEA------------------------LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR 279 (483)
T ss_dssp HHHHHHHHHSCHHH------------------------HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHhhccccccHHH------------------------HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence 11111100000000 1122456799999999999999999999999999998764
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=278.85 Aligned_cols=223 Identities=16% Similarity=0.192 Sum_probs=143.1
Q ss_pred cccccchhhhcccccc-CCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 042634 179 IRHRNLVKIITSCASV-DFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVH 257 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~-~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivH 257 (427)
++||||+++++.+... .+......++|+||+ +++|.+++.. ..+++..+..++.||+.||+||| +.||+|
T Consensus 85 l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~givH 155 (367)
T 2fst_X 85 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIH---SADIIH 155 (367)
T ss_dssp CCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCC
T ss_pred CCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeee
Confidence 4699999999986542 122235679999999 8899998864 34899999999999999999999 899999
Q ss_pred ccccCCceeeCCCCceEecccccccccCCc---CCCccccccccccCC-CCcCccccchhHHHHHHHHHhCCCCCCcccC
Q 042634 258 CDLKPSNVLLDGELTAHVGDFGLAKFLPEA---TNNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETFTGKRPTNEMFT 333 (427)
Q Consensus 258 rDlkp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~ 333 (427)
|||||+||+++.++.+||+|||+|+..... ..+|..|+|||++.+ ..++.++||||+||++|||++|+.||.+...
T Consensus 156 ~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 235 (367)
T 2fst_X 156 RDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 235 (367)
T ss_dssp CCCCGGGEEECTTCCEEECC---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred CCCCHhhEEECCCCCEEEeeccccccccccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999999999999999999999876443 378899999999887 6789999999999999999999999976321
Q ss_pred CCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 042634 334 GNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAAQ 413 (427)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~ 413 (427)
...+.........+ ..+.+...... ........................+..+.+++.+||+.||++|||++|++++
T Consensus 236 -~~~l~~i~~~~g~p-~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 236 -IDQLKLILRLVGTP-GAELLKKISSE-SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp -HHHHHHHHHHHCSC-CHHHHTTCCCH-HHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -HHHHHHHHHHhCCC-CHHHHHHhhhH-HHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 11111111111111 00111100000 0000000000000000000011235668999999999999999999999864
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=277.07 Aligned_cols=219 Identities=19% Similarity=0.198 Sum_probs=155.4
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+...........++||||+. |+|.+++.. ..+++..+..++.|++.||+||| +.||+||
T Consensus 82 l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~ 152 (364)
T 3qyz_A 82 FRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIH---SANVLHR 152 (364)
T ss_dssp CCCTTBCCCCEEECCSSTTTCCCEEEEEECCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred cCCCCCccceeEEecCCccccceEEEEEcccC-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecC
Confidence 46999999999876654455567899999995 689888854 34899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc---------CCCccccccccccCC-CCcCccccchhHHHHHHHHHhCCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA---------TNNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETFTGKRPT 328 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~---------~~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell~g~~pf 328 (427)
||||+||+++.++.+||+|||.++..... ..||+.|+|||++.+ ..++.++||||+||++|||++|+.||
T Consensus 153 Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf 232 (364)
T 3qyz_A 153 DLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 232 (364)
T ss_dssp CCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSS
T ss_pred CCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCC
Confidence 99999999999999999999999866432 278899999998654 45899999999999999999999999
Q ss_pred CcccCCCccHHHHHHHhccc---chhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCC
Q 042634 329 NEMFTGNLTLHNFVKEALPE---RLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERM 405 (427)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rp 405 (427)
.+.... ..+.........+ .+....+..... ....................+.++.+++.+||+.||++||
T Consensus 233 ~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 306 (364)
T 3qyz_A 233 PGKHYL-DQLNHILGILGSPSQEDLNCIINLKARN-----YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI 306 (364)
T ss_dssp CCSSGG-GHHHHHHHHHCSCCHHHHHTCCCHHHHH-----HHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSC
T ss_pred CCCChH-HHHHHHHHHhCCCCHHHHHHhhhhhHHH-----HHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCC
Confidence 764211 1122222111111 011111000000 0000000000000001122356789999999999999999
Q ss_pred CHHHHHH
Q 042634 406 NMEEVAA 412 (427)
Q Consensus 406 t~~ev~~ 412 (427)
|++|+++
T Consensus 307 t~~e~l~ 313 (364)
T 3qyz_A 307 EVEQALA 313 (364)
T ss_dssp CHHHHHT
T ss_pred CHHHHhc
Confidence 9999986
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=288.61 Aligned_cols=191 Identities=23% Similarity=0.283 Sum_probs=153.0
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++++.. ....++||||+.+|+|.+++... ..+++..+..++.|++.||+||| ++||+||
T Consensus 83 l~hpniv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~ 150 (484)
T 3nyv_A 83 LDHPNIMKLYEFFED-----KGYFYLVGEVYTGGELFDEIISR----KRFSEVDAARIIRQVLSGITYMH---KNKIVHR 150 (484)
T ss_dssp CCCTTBCCEEEEEEC-----SSEEEEEECCCCSCBHHHHHHTC----SCCBHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred CCCCCCCcEEEEEEe-----CCEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeC
Confidence 479999999998543 56789999999999999988655 45899999999999999999999 8999999
Q ss_pred cccCCceee---CCCCceEecccccccccCCcC-----CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCc
Q 042634 259 DLKPSNVLL---DGELTAHVGDFGLAKFLPEAT-----NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll---~~~~~~kL~DFG~a~~~~~~~-----~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~ 330 (427)
||||+|||+ +.++.+||+|||+|+...... .||+.|+|||++.+ .++.++||||+||++|+|++|..||.+
T Consensus 151 Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~ 229 (484)
T 3nyv_A 151 DLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNG 229 (484)
T ss_dssp CCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCHHHEEEecCCCCCcEEEEeeeeeEEcccccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCC
Confidence 999999999 567899999999998765433 78999999999876 689999999999999999999999975
Q ss_pred ccCCCccHHHHHHHh-cccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 042634 331 MFTGNLTLHNFVKEA-LPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEE 409 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~e 409 (427)
... ......+... .... .......+.++.+++.+||+.||++|||++|
T Consensus 230 ~~~--~~~~~~i~~~~~~~~-----------------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e 278 (484)
T 3nyv_A 230 ANE--YDILKKVEKGKYTFE-----------------------------LPQWKKVSESAKDLIRKMLTYVPSMRISARD 278 (484)
T ss_dssp SSH--HHHHHHHHHCCCCCC-----------------------------SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCH--HHHHHHHHcCCCCCC-----------------------------CcccccCCHHHHHHHHHHCCCChhHCcCHHH
Confidence 311 1111111110 0000 0011224566889999999999999999999
Q ss_pred HHHH
Q 042634 410 VAAQ 413 (427)
Q Consensus 410 v~~~ 413 (427)
++++
T Consensus 279 ~l~h 282 (484)
T 3nyv_A 279 ALDH 282 (484)
T ss_dssp HHTS
T ss_pred HhhC
Confidence 9863
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=275.67 Aligned_cols=192 Identities=22% Similarity=0.322 Sum_probs=151.6
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeecc
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCD 259 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrD 259 (427)
+||||+++++.+.. ....++||||+++++|.+++... ..+++..+..++.||+.||+||| +.||+|||
T Consensus 158 ~hp~iv~~~~~~~~-----~~~~~lv~e~~~g~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~D 225 (365)
T 2y7j_A 158 GHPHIITLIDSYES-----SSFMFLVFDLMRKGELFDYLTEK----VALSEKETRSIMRSLLEAVSFLH---ANNIVHRD 225 (365)
T ss_dssp TCTTBCCEEEEEEB-----SSEEEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSC
T ss_pred CCCCEeEEEEEEee-----CCEEEEEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCC
Confidence 79999999988543 56789999999999999998643 45899999999999999999999 89999999
Q ss_pred ccCCceeeCCCCceEecccccccccCCc-----CCCccccccccccCC------CCcCccccchhHHHHHHHHHhCCCCC
Q 042634 260 LKPSNVLLDGELTAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMG------SEVSTSGDVYSFGILLLETFTGKRPT 328 (427)
Q Consensus 260 lkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~------~~~~~~~DiwS~G~vl~ell~g~~pf 328 (427)
|||+||+++.++.+||+|||++...... ..||+.|+|||++.+ ..++.++|||||||++|||++|+.||
T Consensus 226 lkp~NIl~~~~~~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf 305 (365)
T 2y7j_A 226 LKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPF 305 (365)
T ss_dssp CSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred CCHHHEEECCCCCEEEEecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCC
Confidence 9999999999999999999999876433 278999999999853 35889999999999999999999999
Q ss_pred CcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 042634 329 NEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME 408 (427)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ 408 (427)
.... .......+...... ... .....++.++.+++.+||+.||++|||++
T Consensus 306 ~~~~--~~~~~~~i~~~~~~----~~~------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ 355 (365)
T 2y7j_A 306 WHRR--QILMLRMIMEGQYQ----FSS------------------------PEWDDRSSTVKDLISRLLQVDPEARLTAE 355 (365)
T ss_dssp CCSS--HHHHHHHHHHTCCC----CCH------------------------HHHSSSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred CCCC--HHHHHHHHHhCCCC----CCC------------------------cccccCCHHHHHHHHHHcCCChhHCcCHH
Confidence 6531 11111111110000 000 00112345689999999999999999999
Q ss_pred HHHHH
Q 042634 409 EVAAQ 413 (427)
Q Consensus 409 ev~~~ 413 (427)
|+++.
T Consensus 356 ell~h 360 (365)
T 2y7j_A 356 QALQH 360 (365)
T ss_dssp HHHHS
T ss_pred HHhcC
Confidence 99863
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-34 Score=268.93 Aligned_cols=220 Identities=19% Similarity=0.226 Sum_probs=156.9
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeecc
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCD 259 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrD 259 (427)
.||||+++++.+...........++||||+. |+|.+++..... ..+++..+..++.|++.||+||| +.||+|||
T Consensus 72 ~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~d 145 (326)
T 1blx_A 72 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLH---SHRVVHRD 145 (326)
T ss_dssp CCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCC
T ss_pred CCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHH---HCCceecc
Confidence 7999999999875332334567899999996 799998865432 34899999999999999999999 89999999
Q ss_pred ccCCceeeCCCCceEecccccccccCCc-----CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccCC
Q 042634 260 LKPSNVLLDGELTAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTG 334 (427)
Q Consensus 260 lkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~~ 334 (427)
|||+||+++.++.+||+|||.++..... ..++..|+|||++.+..++.++|||||||++|||++|+.||.+....
T Consensus 146 lkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 225 (326)
T 1blx_A 146 LKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV 225 (326)
T ss_dssp CCGGGEEECTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred CCHHHeEEcCCCCEEEecCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH
Confidence 9999999999999999999999876432 37788999999999999999999999999999999999999753211
Q ss_pred CccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 335 NLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
..+................. ...... .................++..+.+++.+||+.||++|||++|+++
T Consensus 226 -~~~~~i~~~~~~~~~~~~~~-~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 226 -DQLGKILDVIGLPGEEDWPR-DVALPR-----QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp -HHHHHHHHHHCCCCGGGSCT-TCSSCG-----GGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -HHHHHHHHHcCCCCcccCcc-ccccch-----hhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 11111111111000000000 000000 000000000000011234567889999999999999999999985
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=278.03 Aligned_cols=221 Identities=19% Similarity=0.234 Sum_probs=154.6
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCC-Ceee
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCET-PIVH 257 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~-~ivH 257 (427)
++||||+++++.+.. +...++||||+++++|.+++... ..+++..+..++.|++.||+||| +. ||+|
T Consensus 88 l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H 155 (360)
T 3eqc_A 88 CNSPYIVGFYGAFYS-----DGEISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLR---EKHKIMH 155 (360)
T ss_dssp CCCTTBCCEEEEEEE-----TTEEEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH---HHHCCCC
T ss_pred CCCCCEEEEeEEEEE-----CCEEEEEEECCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HhCCEEc
Confidence 469999999998654 56789999999999999998654 35899999999999999999999 64 9999
Q ss_pred ccccCCceeeCCCCceEecccccccccC----CcCCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccC
Q 042634 258 CDLKPSNVLLDGELTAHVGDFGLAKFLP----EATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFT 333 (427)
Q Consensus 258 rDlkp~NIll~~~~~~kL~DFG~a~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~ 333 (427)
|||||+||+++.++.+||+|||+++... ....|+..|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 156 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 235 (360)
T 3eqc_A 156 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 235 (360)
T ss_dssp SCCSGGGEEECTTCCEEECCCCCCHHHHHHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCH
T ss_pred CCccHHHEEECCCCCEEEEECCCCcccccccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999999999999999999997542 233789999999999999999999999999999999999999975321
Q ss_pred CCccHHHHHHHhcc-------cchh---cccCccccccccccc--hhhhccccccccccchHHHHHHHHHHHhhcCCCCC
Q 042634 334 GNLTLHNFVKEALP-------ERLA---EIVDPVLLVEREEGE--TSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELP 401 (427)
Q Consensus 334 ~~~~~~~~~~~~~~-------~~~~---~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP 401 (427)
.. .......... .... ............... ..................++.++.+++.+||+.||
T Consensus 236 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 313 (360)
T 3eqc_A 236 KE--LELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNP 313 (360)
T ss_dssp HH--HHHHHC------------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSST
T ss_pred HH--HHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcCh
Confidence 11 1111000000 0000 000000000000000 00000000001111222345679999999999999
Q ss_pred CCCCCHHHHHHH
Q 042634 402 RERMNMEEVAAQ 413 (427)
Q Consensus 402 ~~Rpt~~ev~~~ 413 (427)
++|||++|++++
T Consensus 314 ~~Rpt~~ell~h 325 (360)
T 3eqc_A 314 AERADLKQLMVH 325 (360)
T ss_dssp TTSCCHHHHHTS
T ss_pred hhCCCHHHHhhC
Confidence 999999999874
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=271.26 Aligned_cols=192 Identities=25% Similarity=0.303 Sum_probs=151.3
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ...++||||+++++|.+++... ..+++..++.++.|++.||+||| +.||+||
T Consensus 72 l~h~~i~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~ 138 (322)
T 2ycf_A 72 LNHPCIIKIKNFFDA------EDYYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLH---ENGIIHR 138 (322)
T ss_dssp CCCTTBCCEEEEEES------SSEEEEEECCTTEETHHHHSTT----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred CCCCCCceEeeEEcC------CceEEEEecCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecc
Confidence 479999999987532 3479999999999999988754 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCC---ceEecccccccccCCcC-----CCccccccccccC---CCCcCccccchhHHHHHHHHHhCCCC
Q 042634 259 DLKPSNVLLDGEL---TAHVGDFGLAKFLPEAT-----NNFFNFQIAEYGM---GSEVSTSGDVYSFGILLLETFTGKRP 327 (427)
Q Consensus 259 Dlkp~NIll~~~~---~~kL~DFG~a~~~~~~~-----~~~~~y~aPE~~~---~~~~~~~~DiwS~G~vl~ell~g~~p 327 (427)
||||+||+++.++ .+||+|||+++...... .|+..|+|||++. ...++.++|||||||++|||++|..|
T Consensus 139 dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 218 (322)
T 2ycf_A 139 DLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218 (322)
T ss_dssp CCSGGGEEESSSSSSCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCS
T ss_pred CCCHHHEEEecCCCCCeEEEccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999998765 49999999998765432 6889999999973 56789999999999999999999999
Q ss_pred CCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCH
Q 042634 328 TNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM 407 (427)
Q Consensus 328 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~ 407 (427)
|....... .+...+......... .....++.++.+++.+||+.||++|||+
T Consensus 219 f~~~~~~~-~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~li~~~l~~dP~~Rps~ 269 (322)
T 2ycf_A 219 FSEHRTQV-SLKDQITSGKYNFIP----------------------------EVWAEVSEKALDLVKKLLVVDPKARFTT 269 (322)
T ss_dssp SCSTTCSS-CHHHHHHHTCCCCCH----------------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred CcccchHH-HHHHHHHhCccccCc----------------------------hhhhhcCHHHHHHHHHHcccCHhhCCCH
Confidence 97542221 222222111100000 0112235678999999999999999999
Q ss_pred HHHHH
Q 042634 408 EEVAA 412 (427)
Q Consensus 408 ~ev~~ 412 (427)
+|+++
T Consensus 270 ~~~l~ 274 (322)
T 2ycf_A 270 EEALR 274 (322)
T ss_dssp HHHHT
T ss_pred HHHhh
Confidence 99985
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-34 Score=265.54 Aligned_cols=193 Identities=19% Similarity=0.263 Sum_probs=152.7
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+++++|.+++... ..+++..+..++.|++.||+||| +.||+||
T Consensus 65 l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~ 132 (283)
T 3bhy_A 65 IRHPNIITLHDIFEN-----KTDVVLILELVSGGELFDFLAEK----ESLTEDEATQFLKQILDGVHYLH---SKRIAHF 132 (283)
T ss_dssp CCCTTBCCEEEEEEC-----SSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECS
T ss_pred CCCCCeeehhheecC-----CCeEEEEEeecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCccCC
Confidence 469999999998543 56789999999999999998643 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCC----ceEecccccccccCCc-----CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCC
Q 042634 259 DLKPSNVLLDGEL----TAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTN 329 (427)
Q Consensus 259 Dlkp~NIll~~~~----~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~ 329 (427)
||||+||+++.++ .+||+|||.++..... ..++..|+|||++.+..++.++||||||+++|||++|..||.
T Consensus 133 dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 212 (283)
T 3bhy_A 133 DLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 212 (283)
T ss_dssp CCSGGGEEESCSSSSSCCEEECCCTTCEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred CCChHHEEEecCCCCCCceEEEecccceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCC
Confidence 9999999998876 8999999999876432 268889999999999999999999999999999999999997
Q ss_pred cccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 042634 330 EMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEE 409 (427)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~e 409 (427)
.... ........... .. . ........+..+.+++.+||+.||++|||++|
T Consensus 213 ~~~~-----~~~~~~~~~~~----~~--~-------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ 262 (283)
T 3bhy_A 213 GETK-----QETLTNISAVN----YD--F-------------------DEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQ 262 (283)
T ss_dssp CSSH-----HHHHHHHHTTC----CC--C-------------------CHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred Ccch-----HHHHHHhHhcc----cC--C-------------------cchhcccCCHHHHHHHHHHccCCHhHCcCHHH
Confidence 5311 11111100000 00 0 00011223556899999999999999999999
Q ss_pred HHHH
Q 042634 410 VAAQ 413 (427)
Q Consensus 410 v~~~ 413 (427)
++++
T Consensus 263 ~l~h 266 (283)
T 3bhy_A 263 SLEH 266 (283)
T ss_dssp HHHC
T ss_pred HHhC
Confidence 9973
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-34 Score=274.32 Aligned_cols=210 Identities=20% Similarity=0.258 Sum_probs=154.4
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccc------cccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCC
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEW------LHPNREALKNLNLLQRLSIAVDVASALDYLHHYCE 252 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~ 252 (427)
++||||+++++.+.. ....++||||+++|+|.++ +..... ..+++..++.++.|++.||+||| +
T Consensus 100 l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~ 169 (348)
T 2pml_X 100 IKNEYCLTCEGIITN-----YDEVYIIYEYMENDSILKFDEYFFVLDKNYT--CFIPIQVIKCIIKSVLNSFSYIH---N 169 (348)
T ss_dssp CCCTTBCCCSEEEES-----SSEEEEEEECCTTCBSSEESSSEESSCSSSC--CCCCHHHHHHHHHHHHHHHHHHH---H
T ss_pred CCCCCcceEEEEEee-----CCeEEEEEeccCCCcHHHHHHHhhhhhhccc--cCCCHHHHHHHHHHHHHHHHHHh---c
Confidence 469999999998644 5678999999999999999 554212 56999999999999999999999 7
Q ss_pred -CCeeeccccCCceeeCCCCceEecccccccccCC----cCCCccccccccccCCC-CcCc-cccchhHHHHHHHHHhCC
Q 042634 253 -TPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPE----ATNNFFNFQIAEYGMGS-EVST-SGDVYSFGILLLETFTGK 325 (427)
Q Consensus 253 -~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~y~aPE~~~~~-~~~~-~~DiwS~G~vl~ell~g~ 325 (427)
.||+||||||+||+++.++.+||+|||.++.... ...++..|+|||++.+. .++. ++|||||||++|||++|+
T Consensus 170 ~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~ 249 (348)
T 2pml_X 170 EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249 (348)
T ss_dssp TSCEECCCCCGGGEEECTTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSS
T ss_pred cCCEeecCCChHhEEEcCCCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999999987543 23788999999999887 6666 999999999999999999
Q ss_pred CCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCC
Q 042634 326 RPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERM 405 (427)
Q Consensus 326 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rp 405 (427)
.||....... .....+..... ............ ............++.++.+++.+||+.||++||
T Consensus 250 ~pf~~~~~~~-~~~~~i~~~~~-~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 315 (348)
T 2pml_X 250 VPFSLKISLV-ELFNNIRTKNI-EYPLDRNHFLYP------------LTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERI 315 (348)
T ss_dssp CSSCCSSCSH-HHHHHHTSCCC-CCCCSSSSSTTT------------TCC--------CCCHHHHHHHHHHCCSSGGGSC
T ss_pred CCCCCCCcHH-HHHHHHhccCc-CCccchhhhhcc------------ccccccccchhhcCHHHHHHHHHHccCChhhCC
Confidence 9997542211 11111111000 000000000000 000000011133456789999999999999999
Q ss_pred CHHHHHH
Q 042634 406 NMEEVAA 412 (427)
Q Consensus 406 t~~ev~~ 412 (427)
|++|+++
T Consensus 316 s~~e~l~ 322 (348)
T 2pml_X 316 TSEDALK 322 (348)
T ss_dssp CHHHHHT
T ss_pred CHHHHhc
Confidence 9999986
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=274.55 Aligned_cols=217 Identities=18% Similarity=0.191 Sum_probs=148.2
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. +...++||||++ |+|.+++... ..+++..++.++.|++.||+||| +.||+||
T Consensus 90 l~h~~iv~~~~~~~~-----~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~ 156 (329)
T 3gbz_A 90 LQHRNIIELKSVIHH-----NHRLHLIFEYAE-NDLKKYMDKN----PDVSMRVIKSFLYQLINGVNFCH---SRRCLHR 156 (329)
T ss_dssp CCCTTBCCEEEEEEE-----TTEEEEEEECCS-EEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred cCCCCcceEEEEEec-----CCEEEEEEecCC-CCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCEECC
Confidence 469999999998644 567899999996 6999988655 34899999999999999999999 8999999
Q ss_pred cccCCceee-----CCCCceEecccccccccCCc------CCCccccccccccCCC-CcCccccchhHHHHHHHHHhCCC
Q 042634 259 DLKPSNVLL-----DGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMGS-EVSTSGDVYSFGILLLETFTGKR 326 (427)
Q Consensus 259 Dlkp~NIll-----~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~~-~~~~~~DiwS~G~vl~ell~g~~ 326 (427)
||||+|||+ +.++.+||+|||+|+..... ..+|..|+|||++.+. .++.++|||||||++|||++|+.
T Consensus 157 Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 236 (329)
T 3gbz_A 157 DLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTP 236 (329)
T ss_dssp CCCGGGEEEEC-----CCEEEECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred CCCHHHEEEecCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 999999999 45566999999999865422 2678899999999874 48999999999999999999999
Q ss_pred CCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCC
Q 042634 327 PTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMN 406 (427)
Q Consensus 327 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt 406 (427)
||...... ..+........... ............+... .................+.++.+++.+||+.||++|||
T Consensus 237 pf~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 312 (329)
T 3gbz_A 237 LFPGDSEI-DQLFKIFEVLGLPD-DTTWPGVTALPDWKQS--FPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRIS 312 (329)
T ss_dssp SSCCSSHH-HHHHHHHHHHCCCC-TTTSTTGGGSTTCCTT--CCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCC
T ss_pred CcCCCCHH-HHHHHHHHHhCCCc-hhhhhhhhhhhhhhhh--hhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCC
Confidence 99753211 11111111111000 0000000000000000 00000000000011224567899999999999999999
Q ss_pred HHHHHH
Q 042634 407 MEEVAA 412 (427)
Q Consensus 407 ~~ev~~ 412 (427)
++|+++
T Consensus 313 ~~e~l~ 318 (329)
T 3gbz_A 313 AKNALE 318 (329)
T ss_dssp HHHHHT
T ss_pred HHHHhC
Confidence 999986
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-34 Score=268.36 Aligned_cols=193 Identities=25% Similarity=0.273 Sum_probs=154.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+++++|.+++... ..+++..+..++.|++.||+||| +.||+||
T Consensus 63 l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~ 130 (304)
T 2jam_A 63 IKHENIVTLEDIYES-----TTHYYLVMQLVSGGELFDRILER----GVYTEKDASLVIQQVLSAVKYLH---ENGIVHR 130 (304)
T ss_dssp CCCTTBCCEEEEEEC-----SSEEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCC
T ss_pred CCCCCeeehhhhccc-----CCEEEEEEEcCCCccHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccc
Confidence 469999999998543 56789999999999999988643 45899999999999999999999 8999999
Q ss_pred cccCCceee---CCCCceEecccccccccCCcC----CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 259 DLKPSNVLL---DGELTAHVGDFGLAKFLPEAT----NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 259 Dlkp~NIll---~~~~~~kL~DFG~a~~~~~~~----~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
||||+||++ +.++.+||+|||.++...... .++..|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 131 dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 210 (304)
T 2jam_A 131 DLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEE 210 (304)
T ss_dssp SCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred CCCHHHEEEecCCCCCCEEEccCCcceecCCCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 999999999 788999999999998765433 5888999999999999999999999999999999999999753
Q ss_pred cCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 042634 332 FTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVA 411 (427)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~ 411 (427)
.. ......+...... .. .......+.++.+++.+||+.||++|||++|++
T Consensus 211 ~~--~~~~~~i~~~~~~----~~------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l 260 (304)
T 2jam_A 211 TE--SKLFEKIKEGYYE----FE------------------------SPFWDDISESAKDFICHLLEKDPNERYTCEKAL 260 (304)
T ss_dssp CH--HHHHHHHHHCCCC----CC------------------------TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHH
T ss_pred CH--HHHHHHHHcCCCC----CC------------------------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 11 1111111110000 00 001122356689999999999999999999998
Q ss_pred HH
Q 042634 412 AQ 413 (427)
Q Consensus 412 ~~ 413 (427)
+.
T Consensus 261 ~h 262 (304)
T 2jam_A 261 SH 262 (304)
T ss_dssp TS
T ss_pred cC
Confidence 63
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=275.33 Aligned_cols=189 Identities=22% Similarity=0.228 Sum_probs=153.2
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. +...++||||+++++|.+++... ..+++.+++.++.|++.||+||| +.||+||
T Consensus 98 l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~ 165 (335)
T 2owb_A 98 LAHQHVVGFHGFFED-----NDFVFVVLELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLH---RNRVIHR 165 (335)
T ss_dssp CCCTTBCCEEEEEEC-----SSEEEEEECCCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECS
T ss_pred CCCCCCCeEEEEEec-----CCeEEEEEecCCCCCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCCEec
Confidence 579999999998543 56789999999999999987643 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+||+++.++.+||+|||+++..... ..++..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 166 dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 245 (335)
T 2owb_A 166 DLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC 245 (335)
T ss_dssp CCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred CCCchhEEEcCCCCEEEeeccCceecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC
Confidence 99999999999999999999999865422 268889999999999999999999999999999999999997531
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
. ........... .. .+..++.++.+++.+||+.||++|||++|+++
T Consensus 246 ~-----~~~~~~~~~~~----~~-------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 246 L-----KETYLRIKKNE----YS-------------------------IPKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp H-----HHHHHHHHHTC----CC-------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred H-----HHHHHHHhcCC----CC-------------------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 11111100000 00 11123456789999999999999999999986
Q ss_pred H
Q 042634 413 Q 413 (427)
Q Consensus 413 ~ 413 (427)
.
T Consensus 292 ~ 292 (335)
T 2owb_A 292 D 292 (335)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-34 Score=274.17 Aligned_cols=224 Identities=17% Similarity=0.173 Sum_probs=148.3
Q ss_pred cccccchhhhccccccC-CCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 042634 179 IRHRNLVKIITSCASVD-FQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVH 257 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~-~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivH 257 (427)
++||||+++++++.... +......++||||++ |+|.+++. ..+++..+..++.|++.||+||| +.||+|
T Consensus 81 l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH---~~~ivH 150 (371)
T 2xrw_A 81 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQ------MELDHERMSYLLYQMLCGIKHLH---SAGIIH 150 (371)
T ss_dssp CCCTTBCCEEEEECSCCSTTTCCEEEEEEECCS-EEHHHHHH------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCC
T ss_pred cCCCCccceEEeeccccccccccceEEEEEcCC-CCHHHHHh------hccCHHHHHHHHHHHHHHHHHHH---HCCeec
Confidence 57999999999865422 122346799999995 57877764 23889999999999999999999 899999
Q ss_pred ccccCCceeeCCCCceEecccccccccCCc-----CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 258 CDLKPSNVLLDGELTAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 258 rDlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
|||||+||+++.++.+||+|||+|+..... ..||..|+|||++.+..++.++||||+||++|||++|+.||.+..
T Consensus 151 ~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 230 (371)
T 2xrw_A 151 RDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 230 (371)
T ss_dssp SCCCGGGEEECTTSCEEECCCCC----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccCCHHHEEEcCCCCEEEEEeecccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999999876443 378899999999999999999999999999999999999997632
Q ss_pred CCCccHHHHHHHhcc--cchhcccCccccccccccc------hhhh-ccccccccccchHHHHHHHHHHHhhcCCCCCCC
Q 042634 333 TGNLTLHNFVKEALP--ERLAEIVDPVLLVEREEGE------TSKA-NAHKQFTRSFSVKECLVSVLGIGVTCSSELPRE 403 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~------~~~~-~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~ 403 (427)
.. ..+......... +.....+.+.......... .... ...............+.++.+++.+||+.||++
T Consensus 231 ~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~ 309 (371)
T 2xrw_A 231 HI-DQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASK 309 (371)
T ss_dssp HH-HHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGG
T ss_pred HH-HHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhh
Confidence 11 111111110000 0000000000000000000 0000 000000011123445778999999999999999
Q ss_pred CCCHHHHHHH
Q 042634 404 RMNMEEVAAQ 413 (427)
Q Consensus 404 Rpt~~ev~~~ 413 (427)
|||++|++++
T Consensus 310 R~t~~e~l~h 319 (371)
T 2xrw_A 310 RISVDEALQH 319 (371)
T ss_dssp SCCHHHHHHS
T ss_pred CCCHHHHhCC
Confidence 9999999874
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=266.12 Aligned_cols=189 Identities=23% Similarity=0.389 Sum_probs=146.9
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+++++|.+++... ..+++..+..++.|++.||+||| +.||+||
T Consensus 68 l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~ 135 (276)
T 2h6d_A 68 FRHPHIIKLYQVIST-----PTDFFMVMEYVSGGELFDYICKH----GRVEEMEARRLFQQILSAVDYCH---RHMVVHR 135 (276)
T ss_dssp CCCTTBCCEEEEEEC-----SSEEEEEEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHH---HHCSSCC
T ss_pred CCCCCEeEEEEEEec-----CCeEEEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCCccC
Confidence 469999999998543 56789999999999999998654 35899999999999999999999 8899999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc-----CCCccccccccccCCCCc-CccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMGSEV-STSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~~~~-~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+||+++.++.+||+|||.+...... ..++..|+|||.+.+..+ +.++||||||+++|||++|+.||....
T Consensus 136 dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 215 (276)
T 2h6d_A 136 DLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH 215 (276)
T ss_dssp CCCGGGEEECTTSCEEECCCCGGGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CCChhhEEECCCCCEEEeecccccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence 99999999999999999999999876543 267889999999988765 689999999999999999999996531
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
. ....+.+..... ..+..++.++.+++.+||+.||++|||++|+++
T Consensus 216 ~--~~~~~~~~~~~~--------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 216 V--PTLFKKIRGGVF--------------------------------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp H--HHHHHHHHHCCC--------------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred H--HHHHHHhhcCcc--------------------------------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 1 111111111000 011123456889999999999999999999987
Q ss_pred H
Q 042634 413 Q 413 (427)
Q Consensus 413 ~ 413 (427)
.
T Consensus 262 h 262 (276)
T 2h6d_A 262 H 262 (276)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=286.21 Aligned_cols=192 Identities=21% Similarity=0.252 Sum_probs=151.3
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++++.. ....++|||||++|+|.+++... ..+++..+..++.||+.||+||| +.||+||
T Consensus 93 l~hpniv~~~~~~~~-----~~~~~lv~e~~~~g~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~ 160 (494)
T 3lij_A 93 LDHPNIMKLYDFFED-----KRNYYLVMECYKGGELFDEIIHR----MKFNEVDAAVIIKQVLSGVTYLH---KHNIVHR 160 (494)
T ss_dssp CCCTTBCCEEEEEEC-----SSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECS
T ss_pred CCCCCCCeEEEEEEe-----CCEEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCceec
Confidence 579999999998643 56789999999999999888644 45899999999999999999999 8999999
Q ss_pred cccCCceeeCC---CCceEecccccccccCCc-----CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCc
Q 042634 259 DLKPSNVLLDG---ELTAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~---~~~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~ 330 (427)
||||+|||++. ++.+||+|||+|+..... ..||+.|+|||++. ..++.++||||+||++|+|++|..||.+
T Consensus 161 Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~ 239 (494)
T 3lij_A 161 DLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGG 239 (494)
T ss_dssp CCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCChhhEEEeCCCCCCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999976 456999999999876433 26899999999976 5699999999999999999999999975
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
... ..+...+...... ... ......+.++.+++.+||+.||++|||++|+
T Consensus 240 ~~~--~~~~~~i~~~~~~----~~~------------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~ 289 (494)
T 3lij_A 240 QTD--QEILRKVEKGKYT----FDS------------------------PEWKNVSEGAKDLIKQMLQFDSQRRISAQQA 289 (494)
T ss_dssp SSH--HHHHHHHHHTCCC----CCS------------------------GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred CCH--HHHHHHHHhCCCC----CCc------------------------hhcccCCHHHHHHHHHHCCCChhhCccHHHH
Confidence 321 1111111110000 000 0112234568899999999999999999999
Q ss_pred HHH
Q 042634 411 AAQ 413 (427)
Q Consensus 411 ~~~ 413 (427)
+++
T Consensus 290 l~h 292 (494)
T 3lij_A 290 LEH 292 (494)
T ss_dssp HTC
T ss_pred hcC
Confidence 864
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=282.31 Aligned_cols=223 Identities=20% Similarity=0.196 Sum_probs=152.8
Q ss_pred cccccchhhhccccccCC-CCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 042634 179 IRHRNLVKIITSCASVDF-QGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVH 257 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivH 257 (427)
++|||||++++++..... .+....++||||++ +++.+.+.........+++..++.++.||+.||+||| +.||+|
T Consensus 104 l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH 179 (420)
T 1j1b_A 104 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICH 179 (420)
T ss_dssp CCCTTBCCEEEEEEEEETTTTEEEEEEEEECCC-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEEC
T ss_pred cCCCCccceeeEEeccCCCCcceeEEeehhccc-ccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccc
Confidence 579999999888644221 11233678999996 4666665543333356999999999999999999999 899999
Q ss_pred ccccCCceeeCCC-CceEecccccccccCCc-----CCCccccccccccCCC-CcCccccchhHHHHHHHHHhCCCCCCc
Q 042634 258 CDLKPSNVLLDGE-LTAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMGS-EVSTSGDVYSFGILLLETFTGKRPTNE 330 (427)
Q Consensus 258 rDlkp~NIll~~~-~~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~~-~~~~~~DiwS~G~vl~ell~g~~pf~~ 330 (427)
|||||+|||++.+ +.+||+|||+|+..... ..+|..|+|||++.+. .++.++|||||||++|||++|+.||.+
T Consensus 180 rDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~ 259 (420)
T 1j1b_A 180 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 259 (420)
T ss_dssp SCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCCChhhEEEeCCCCeEEeccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 9999999999965 67899999999875432 2788999999998764 789999999999999999999999976
Q ss_pred ccCCCccHHHHHHHhccc---chhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCH
Q 042634 331 MFTGNLTLHNFVKEALPE---RLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM 407 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~ 407 (427)
... ...+.+.+.....+ .+... ++..... ... ......+.. ......+.++.+++.+||+.||++|||+
T Consensus 260 ~~~-~~~l~~i~~~lg~p~~~~~~~~-~~~~~~~--~~p---~~~~~~~~~-~~~~~~~~~~~~Li~~~L~~dP~~R~t~ 331 (420)
T 1j1b_A 260 DSG-VDQLVEIIKVLGTPTREQIREM-NPNYTEF--KFP---QIKAHPWTK-VFRPRTPPEAIALCSRLLEYTPTARLTP 331 (420)
T ss_dssp SSH-HHHHHHHHHHHCSCCHHHHHHH-CSCCCCC--CCC---CCCCCCHHH-HSCTTSCHHHHHHHHHHSCSSGGGSCCH
T ss_pred CCH-HHHHHHHHHHhCCCCHHHHHhh-Chhhhhh--ccC---ccCCCCHHH-hcCCCCCHHHHHHHHHhccCChhHCCCH
Confidence 321 11222222221111 11111 0000000 000 000000000 0112235678999999999999999999
Q ss_pred HHHHHH
Q 042634 408 EEVAAQ 413 (427)
Q Consensus 408 ~ev~~~ 413 (427)
.|++++
T Consensus 332 ~e~l~h 337 (420)
T 1j1b_A 332 LEACAH 337 (420)
T ss_dssp HHHHTS
T ss_pred HHHhCC
Confidence 999863
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=269.30 Aligned_cols=189 Identities=22% Similarity=0.220 Sum_probs=153.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+++++|.+++... ..+++..++.++.|++.||+||| +.||+||
T Consensus 72 l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~ 139 (294)
T 2rku_A 72 LAHQHVVGFHGFFED-----NDFVFVVLELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLH---RNRVIHR 139 (294)
T ss_dssp CCCTTBCCEEEEEEC-----SSEEEEEEECCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred CCCCCEeeeeeeecc-----CCEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccc
Confidence 479999999998543 56789999999999999987543 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+||+++.++.+||+|||.++..... ..++..|+|||++.+..++.++||||+|+++|||++|+.||....
T Consensus 140 dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 219 (294)
T 2rku_A 140 DLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC 219 (294)
T ss_dssp CCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred CCChHhEEEcCCCCEEEEeccCceecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999999865422 268889999999999899999999999999999999999997532
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
. .+........ .. ..+...+..+.+++.+||+.||++|||++|+++
T Consensus 220 ~-----~~~~~~~~~~--------~~---------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 220 L-----KETYLRIKKN--------EY---------------------SIPKHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp H-----HHHHHHHHTT--------CC---------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred H-----HHHHHHHhhc--------cC---------------------CCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 1 1111110000 00 011123456889999999999999999999987
Q ss_pred H
Q 042634 413 Q 413 (427)
Q Consensus 413 ~ 413 (427)
.
T Consensus 266 ~ 266 (294)
T 2rku_A 266 D 266 (294)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-34 Score=271.40 Aligned_cols=222 Identities=17% Similarity=0.193 Sum_probs=157.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
..|++++++++.+.. ....++||||+ +++|.+++..... ..+++..+..++.|++.||+||| ++||+||
T Consensus 74 ~~~~~i~~~~~~~~~-----~~~~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~ 142 (339)
T 1z57_A 74 NSTFRCVQMLEWFEH-----HGHICIVFELL-GLSTYDFIKENGF--LPFRLDHIRKMAYQICKSVNFLH---SNKLTHT 142 (339)
T ss_dssp TCTTCBCCEEEEEEE-----TTEEEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred CCceeeEeeeccccc-----CCcEEEEEcCC-CCCHHHHHHhcCC--CCCcHHHHHHHHHHHHHHHHHHH---HCCCcCC
Confidence 456678888887543 56789999999 9999998865432 35889999999999999999999 8999999
Q ss_pred cccCCceeeCC-------------------CCceEecccccccccCCc---CCCccccccccccCCCCcCccccchhHHH
Q 042634 259 DLKPSNVLLDG-------------------ELTAHVGDFGLAKFLPEA---TNNFFNFQIAEYGMGSEVSTSGDVYSFGI 316 (427)
Q Consensus 259 Dlkp~NIll~~-------------------~~~~kL~DFG~a~~~~~~---~~~~~~y~aPE~~~~~~~~~~~DiwS~G~ 316 (427)
||||+||+++. ++.+||+|||.++..... ..||..|+|||++.+..++.++|||||||
T Consensus 143 Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 222 (339)
T 1z57_A 143 DLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGC 222 (339)
T ss_dssp CCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHH
T ss_pred CCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHH
Confidence 99999999987 668999999999876543 37899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCcccCCCccHHHHHHHh---cccchhcccCc-cccccccccch--------hhhccccccccccchHH
Q 042634 317 LLLETFTGKRPTNEMFTGNLTLHNFVKEA---LPERLAEIVDP-VLLVEREEGET--------SKANAHKQFTRSFSVKE 384 (427)
Q Consensus 317 vl~ell~g~~pf~~~~~~~~~~~~~~~~~---~~~~~~~~~~~-~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~ 384 (427)
++|||++|..||..... ......+... .+..+...... .........+. .................
T Consensus 223 il~el~~g~~pf~~~~~--~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (339)
T 1z57_A 223 ILIEYYLGFTVFPTHDS--KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDV 300 (339)
T ss_dssp HHHHHHHSSCSCCCSCH--HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSH
T ss_pred HHHHHHhCCCCCCCCCh--HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchh
Confidence 99999999999975321 1111111111 11111110000 00000000000 00000000011122345
Q ss_pred HHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 042634 385 CLVSVLGIGVTCSSELPRERMNMEEVAAQ 413 (427)
Q Consensus 385 ~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~ 413 (427)
+++++.+++.+||+.||++|||++|++++
T Consensus 301 ~~~~l~~li~~~L~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 301 EHERLFDLIQKMLEYDPAKRITLREALKH 329 (339)
T ss_dssp HHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred hHHHHHHHHHHHhCcCcccccCHHHHhcC
Confidence 67889999999999999999999999864
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=270.41 Aligned_cols=194 Identities=21% Similarity=0.267 Sum_probs=151.0
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+++++|.+++..... ...+++..+..++.|++.||+||| +.||+||
T Consensus 76 l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~ 146 (295)
T 2clq_A 76 LKHKNIVQYLGSFSE-----NGFIKIFMEQVPGGSLSALLRSKWG-PLKDNEQTIGFYTKQILEGLKYLH---DNQIVHR 146 (295)
T ss_dssp CCCTTBCCEEEEEEE-----TTEEEEEEECCSEEEHHHHHHHTTC-CCTTCHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred CCCCCEeeEeeEEEe-----CCcEEEEEEeCCCCCHHHHHHhhcc-CCCccHHHHHHHHHHHHHHHHHHH---hCCEEcc
Confidence 479999999998644 5578999999999999999865421 134678889999999999999999 8999999
Q ss_pred cccCCceeeCC-CCceEecccccccccCC------cCCCccccccccccCCCC--cCccccchhHHHHHHHHHhCCCCCC
Q 042634 259 DLKPSNVLLDG-ELTAHVGDFGLAKFLPE------ATNNFFNFQIAEYGMGSE--VSTSGDVYSFGILLLETFTGKRPTN 329 (427)
Q Consensus 259 Dlkp~NIll~~-~~~~kL~DFG~a~~~~~------~~~~~~~y~aPE~~~~~~--~~~~~DiwS~G~vl~ell~g~~pf~ 329 (427)
||||+||+++. ++.+||+|||.++.... ...++..|+|||++.+.. ++.++|||||||++|||++|+.||.
T Consensus 147 dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 226 (295)
T 2clq_A 147 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFY 226 (295)
T ss_dssp CCSGGGEEEETTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTG
T ss_pred CCChhhEEEECCCCCEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCcc
Confidence 99999999987 89999999999987543 236888999999987643 7899999999999999999999997
Q ss_pred cccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 042634 330 EMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEE 409 (427)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~e 409 (427)
................... ..+..++.++.+++.+||+.||++|||++|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ 275 (295)
T 2clq_A 227 ELGEPQAAMFKVGMFKVHP-------------------------------EIPESMSAEAKAFILKCFEPDPDKRACAND 275 (295)
T ss_dssp GGSSHHHHHHHHHHHCCCC-------------------------------CCCTTSCHHHHHHHHHTTCSSTTTSCCHHH
T ss_pred CCCchhHHHHhhccccccc-------------------------------cccccCCHHHHHHHHHHccCChhhCCCHHH
Confidence 5321111000000000000 011224566889999999999999999999
Q ss_pred HHH
Q 042634 410 VAA 412 (427)
Q Consensus 410 v~~ 412 (427)
+++
T Consensus 276 ll~ 278 (295)
T 2clq_A 276 LLV 278 (295)
T ss_dssp HHT
T ss_pred Hhc
Confidence 986
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-34 Score=274.83 Aligned_cols=143 Identities=24% Similarity=0.321 Sum_probs=121.7
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeecc
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCD 259 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrD 259 (427)
.|++++++++.+.. ....++||||+ +|+|.+++..... ..+++..++.++.|++.||.|||+. ..||+|||
T Consensus 114 ~~~~iv~~~~~~~~-----~~~~~lv~e~~-~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrD 184 (382)
T 2vx3_A 114 MKYYIVHLKRHFMF-----RNHLCLVFEML-SYNLYDLLRNTNF--RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCD 184 (382)
T ss_dssp GGGGBCCEEEEEEE-----TTEEEEEEECC-CCBHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCC
T ss_pred cceeEEEeeeeecc-----CCceEEEEecC-CCCHHHHHhhcCc--CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCC
Confidence 35568888777543 46789999999 5699998865432 4589999999999999999999942 46999999
Q ss_pred ccCCceeeC--CCCceEecccccccccCCc---CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 260 LKPSNVLLD--GELTAHVGDFGLAKFLPEA---TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 260 lkp~NIll~--~~~~~kL~DFG~a~~~~~~---~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
|||+|||++ .++.+||+|||+|+..... ..+|+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus 185 lkp~NIll~~~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 185 LKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp CSGGGEEESSTTSCCEEECCCTTCEETTCCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCcccEEEecCCCCcEEEEeccCceecccccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999994 4778999999999876543 37889999999999999999999999999999999999999864
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-34 Score=266.59 Aligned_cols=190 Identities=22% Similarity=0.298 Sum_probs=154.2
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+++++|.+++.. ..+++..+..++.|++.||+||| +.||+||
T Consensus 77 l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~ 143 (303)
T 3a7i_A 77 CDSPYVTKYYGSYLK-----DTKLWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLH---SEKKIHR 143 (303)
T ss_dssp CCCTTBCCEEEEEEE-----TTEEEEEEECCTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred CCCCCEeEEEEEEec-----CCeEEEEEEeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCccC
Confidence 479999999998654 4578999999999999999864 34899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+||+++.++.+||+|||.+...... ..++..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 144 dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 223 (303)
T 3a7i_A 144 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH 223 (303)
T ss_dssp CCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CCChheEEECCCCCEEEeecccceecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC
Confidence 99999999999999999999999765432 268889999999999999999999999999999999999997531
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
. ......+....+.. .+..++.++.+++.+||+.||++|||++|+++
T Consensus 224 ~--~~~~~~~~~~~~~~-------------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 270 (303)
T 3a7i_A 224 P--MKVLFLIPKNNPPT-------------------------------LEGNYSKPLKEFVEACLNKEPSFRPTAKELLK 270 (303)
T ss_dssp H--HHHHHHHHHSCCCC-------------------------------CCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred H--HHHHHHhhcCCCCC-------------------------------CccccCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 1 11111111100000 11123456899999999999999999999987
Q ss_pred HH
Q 042634 413 QL 414 (427)
Q Consensus 413 ~L 414 (427)
..
T Consensus 271 ~~ 272 (303)
T 3a7i_A 271 HK 272 (303)
T ss_dssp CH
T ss_pred Ch
Confidence 53
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=278.64 Aligned_cols=215 Identities=19% Similarity=0.191 Sum_probs=150.5
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+...........++||||+. |+|.+++.... ..+++..+..++.|++.||+||| +.||+||
T Consensus 86 l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~ 158 (362)
T 3pg1_A 86 FHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR---IVISPQHIQYFMYHILLGLHVLH---EAGVVHR 158 (362)
T ss_dssp CCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCC
T ss_pred CCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH---HCcCEec
Confidence 46999999999875543344456799999996 78888876543 45899999999999999999999 8899999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc-----CCCccccccccccCC-CCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+||+++.++.+||+|||.++..... ..++..|+|||++.+ ..++.++||||+||++|||++|+.||.+..
T Consensus 159 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 238 (362)
T 3pg1_A 159 DLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST 238 (362)
T ss_dssp CCCGGGEEECTTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CCChHHEEEcCCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999999854332 267889999999877 678999999999999999999999997532
Q ss_pred CCCccHHHHHHHhcccchhc-----------ccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCC
Q 042634 333 TGNLTLHNFVKEALPERLAE-----------IVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELP 401 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP 401 (427)
. ...+.........+.... ............ .........+..+.+++.+||+.||
T Consensus 239 ~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~li~~~L~~dP 305 (362)
T 3pg1_A 239 F-YNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPAR------------AWTAVVPTADPVALDLIAKMLEFNP 305 (362)
T ss_dssp H-HHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCC------------CHHHHSTTSCHHHHHHHHHHTCSSG
T ss_pred H-HHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChh------------hHHhhCCCCCHHHHHHHHHHhcCCh
Confidence 1 111111111111111110 000000000000 0000112235668999999999999
Q ss_pred CCCCCHHHHHHH
Q 042634 402 RERMNMEEVAAQ 413 (427)
Q Consensus 402 ~~Rpt~~ev~~~ 413 (427)
++|||++|++++
T Consensus 306 ~~Rpt~~ell~h 317 (362)
T 3pg1_A 306 QRRISTEQALRH 317 (362)
T ss_dssp GGSCCHHHHHTS
T ss_pred hhCCCHHHHHcC
Confidence 999999999863
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-34 Score=274.79 Aligned_cols=203 Identities=18% Similarity=0.216 Sum_probs=137.0
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
..||||+++++.+.... .++...++||||+++|+|.+++..... ..+++.+++.++.|++.||+||| +.||+||
T Consensus 79 ~~h~~i~~~~~~~~~~~-~~~~~~~lv~e~~~gg~L~~~l~~~~~--~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~ 152 (336)
T 3fhr_A 79 SGGPHIVCILDVYENMH-HGKRCLLIIMECMEGGELFSRIQERGD--QAFTEREAAEIMRDIGTAIQFLH---SHNIAHR 152 (336)
T ss_dssp TTSTTBCCEEEEEEEEE-TTEEEEEEEEECCTTEEHHHHHHTC-C--CCCBHHHHHHHHHHHHHHHHHHH---HTTEECS
T ss_pred cCCCChHHHHHHHhhcc-CCCceEEEEEeccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecC
Confidence 57999999999865421 223457899999999999999976532 45999999999999999999999 8899999
Q ss_pred cccCCceeeCC---CCceEecccccccccCCc----CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 259 DLKPSNVLLDG---ELTAHVGDFGLAKFLPEA----TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 259 Dlkp~NIll~~---~~~~kL~DFG~a~~~~~~----~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
||||+||+++. ++.+||+|||+++..... ..+|+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 153 dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (336)
T 3fhr_A 153 DVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSN 232 (336)
T ss_dssp CCSGGGEEESCSSTTCCEEECCCTTCEEC----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred CCCHHHEEEEecCCCceEEEeccccceeccccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 99999999976 456999999999866433 26788999999998889999999999999999999999999754
Q ss_pred cCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 042634 332 FTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVA 411 (427)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~ 411 (427)
...... ...... +...... .+......++.++.+++.+||+.||++|||++|++
T Consensus 233 ~~~~~~--~~~~~~-------~~~~~~~-----------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 286 (336)
T 3fhr_A 233 TGQAIS--PGMKRR-------IRLGQYG-----------------FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFM 286 (336)
T ss_dssp ---------------------------C-----------------CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred cchhhh--hhHHHh-------hhccccc-----------------cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 221110 000000 0000000 00001123456789999999999999999999998
Q ss_pred HH
Q 042634 412 AQ 413 (427)
Q Consensus 412 ~~ 413 (427)
+.
T Consensus 287 ~h 288 (336)
T 3fhr_A 287 NH 288 (336)
T ss_dssp HS
T ss_pred cC
Confidence 73
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-34 Score=269.03 Aligned_cols=192 Identities=21% Similarity=0.255 Sum_probs=153.7
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+++++|.+++.... ..+++..+..++.|++.||.||| +.||+||
T Consensus 81 l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~ 149 (314)
T 3com_A 81 CDSPHVVKYYGSYFK-----NTDLWIVMEYCGAGSVSDIIRLRN---KTLTEDEIATILQSTLKGLEYLH---FMRKIHR 149 (314)
T ss_dssp CCCTTBCCEEEEEEE-----TTEEEEEEECCTTEEHHHHHHHHT---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred CCCCCCccEEEEEEe-----CCEEEEEeecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---hCCCcCC
Confidence 479999999998644 457899999999999999986322 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+||+++.++.+||+|||.+...... ..++..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 150 dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 229 (314)
T 3com_A 150 DIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH 229 (314)
T ss_dssp CCSGGGEEECTTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CcCHHHEEECCCCCEEEeecccchhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999999765432 268889999999999999999999999999999999999997531
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
.. ..........+.. . ..+...+..+.+++.+||+.||++|||++|+++
T Consensus 230 ~~--~~~~~~~~~~~~~--------~---------------------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 230 PM--RAIFMIPTNPPPT--------F---------------------RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp HH--HHHHHHHHSCCCC--------C---------------------SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred hH--HHHHHHhcCCCcc--------c---------------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 10 0000000000000 0 011223556899999999999999999999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-34 Score=271.40 Aligned_cols=217 Identities=19% Similarity=0.192 Sum_probs=153.3
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+++ +|.+++.... ..+++..+..++.|++.||+||| +.||+||
T Consensus 69 l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~ 136 (346)
T 1ua2_A 69 LSHPNIIGLLDAFGH-----KSNISLVFDFMET-DLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLH---QHWILHR 136 (346)
T ss_dssp CCCTTBCCEEEEECC-----TTCCEEEEECCSE-EHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHH---HTTCCCC
T ss_pred CCCCCCCeEEEEEee-----CCceEEEEEcCCC-CHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHH---HCCEECC
Confidence 469999999998543 5678999999964 8888876543 45889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCCC-CcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMGS-EVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~~-~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
||||+||+++.++.+||+|||+++..... ..+|..|+|||++.+. .++.++|||||||++|||++|.+||.+.
T Consensus 137 Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~ 216 (346)
T 1ua2_A 137 DLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD 216 (346)
T ss_dssp CCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCCHHHEEEcCCCCEEEEecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 99999999999999999999999876432 2688899999998764 5899999999999999999999998753
Q ss_pred cCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 042634 332 FTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVA 411 (427)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~ 411 (427)
.. ...+................+.....+. ... ..............++.++.+++.+||+.||++|||++|++
T Consensus 217 ~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~--~~~---~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 290 (346)
T 1ua2_A 217 SD-LDQLTRIFETLGTPTEEQWPDMCSLPDY--VTF---KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 290 (346)
T ss_dssp SH-HHHHHHHHHHHCCCCTTTSSSTTSSTTC--CCC---CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHH
T ss_pred CH-HHHHHHHHHHcCCCChhhhhhhccCccc--ccc---cccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHh
Confidence 21 1112222221111100000000000000 000 00000000000122456789999999999999999999998
Q ss_pred HH
Q 042634 412 AQ 413 (427)
Q Consensus 412 ~~ 413 (427)
++
T Consensus 291 ~h 292 (346)
T 1ua2_A 291 KM 292 (346)
T ss_dssp TS
T ss_pred cC
Confidence 64
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-34 Score=269.81 Aligned_cols=203 Identities=23% Similarity=0.277 Sum_probs=151.7
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchh----hhhccCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNRE----ALKNLNLLQRLSIAVDVASALDYLHHYCETP 254 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~----~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ 254 (427)
++||||+++++.+.. ....++||||+++++|.+++..... ....+++..+..++.|++.||+||| +.|
T Consensus 70 l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ 141 (303)
T 2vwi_A 70 CHHPNIVSYYTSFVV-----KDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNG 141 (303)
T ss_dssp CCCTTBCCEEEEEES-----SSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred cCCCCEeeEEEEEee-----cCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCC
Confidence 469999999998644 4578999999999999998864211 1145899999999999999999999 899
Q ss_pred eeeccccCCceeeCCCCceEecccccccccCCc-----------CCCccccccccccCC-CCcCccccchhHHHHHHHHH
Q 042634 255 IVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA-----------TNNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETF 322 (427)
Q Consensus 255 ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~-----------~~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell 322 (427)
|+||||||+||+++.++.+||+|||.++..... ..++..|+|||++.+ ..++.++|||||||++|||+
T Consensus 142 i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~ 221 (303)
T 2vwi_A 142 QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELA 221 (303)
T ss_dssp CCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHH
T ss_pred CCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHH
Confidence 999999999999999999999999999765321 267889999999866 56899999999999999999
Q ss_pred hCCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCC
Q 042634 323 TGKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPR 402 (427)
Q Consensus 323 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~ 402 (427)
+|+.||....... .........+........ .......++.++.+++.+||+.||+
T Consensus 222 ~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~li~~~l~~dp~ 277 (303)
T 2vwi_A 222 TGAAPYHKYPPMK--VLMLTLQNDPPSLETGVQ----------------------DKEMLKKYGKSFRKMISLCLQKDPE 277 (303)
T ss_dssp HSSCTTTTSCGGG--HHHHHHTSSCCCTTC---------------------------CCCCCCCHHHHHHHHHHCCSSGG
T ss_pred hCCCCCccCchhh--HHHHHhccCCCccccccc----------------------cchhhhhhhHHHHHHHHHHccCChh
Confidence 9999997642211 111111111110000000 0001112345688999999999999
Q ss_pred CCCCHHHHHHH
Q 042634 403 ERMNMEEVAAQ 413 (427)
Q Consensus 403 ~Rpt~~ev~~~ 413 (427)
+|||++|+++.
T Consensus 278 ~Rps~~~ll~h 288 (303)
T 2vwi_A 278 KRPTAAELLRH 288 (303)
T ss_dssp GSCCHHHHHTS
T ss_pred hCcCHHHHhhC
Confidence 99999999873
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-34 Score=274.46 Aligned_cols=224 Identities=18% Similarity=0.163 Sum_probs=154.7
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+....+......++||||+. |+|.+++.. ..+++..+..++.|++.||+||| +.||+||
T Consensus 66 l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~ 136 (353)
T 2b9h_A 66 FKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLH---GSNVIHR 136 (353)
T ss_dssp CCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECS
T ss_pred CcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHH---HCCeecC
Confidence 46999999999876655555677899999995 688888754 34899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc----------------CCCccccccccccCC-CCcCccccchhHHHHHHHH
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA----------------TNNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLET 321 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~----------------~~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~el 321 (427)
||||+||+++.++.+||+|||+++..... ..||..|+|||++.+ ..++.++|||||||++|||
T Consensus 137 Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l 216 (353)
T 2b9h_A 137 DLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216 (353)
T ss_dssp CCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHH
T ss_pred CCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHH
Confidence 99999999999999999999999865421 257889999998754 6789999999999999999
Q ss_pred HhCCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCC
Q 042634 322 FTGKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELP 401 (427)
Q Consensus 322 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP 401 (427)
++|+.||.+..... .+.........+.......... .........................++.++.+++.+||+.||
T Consensus 217 ~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 294 (353)
T 2b9h_A 217 FLRRPIFPGRDYRH-QLLLIFGIIGTPHSDNDLRCIE-SPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDP 294 (353)
T ss_dssp HHSSCSCCCSSHHH-HHHHHHHHHCCCCSTTTTTTCC-CHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSG
T ss_pred HhCCCCCCCCCcHH-HHHHHHHHhCCCchhccccccc-cchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCc
Confidence 99999997642111 1111111111100000000000 000000000000000000000112345678999999999999
Q ss_pred CCCCCHHHHHHH
Q 042634 402 RERMNMEEVAAQ 413 (427)
Q Consensus 402 ~~Rpt~~ev~~~ 413 (427)
++|||++|++++
T Consensus 295 ~~Rpt~~ell~h 306 (353)
T 2b9h_A 295 AKRITAKEALEH 306 (353)
T ss_dssp GGSCCHHHHHTS
T ss_pred ccCCCHHHHhcC
Confidence 999999999863
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-34 Score=278.39 Aligned_cols=146 Identities=19% Similarity=0.340 Sum_probs=118.4
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhh-----hhccCHHHHHHHHHHHHHHHHHHhhcCCC
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREA-----LKNLNLLQRLSIAVDVASALDYLHHYCET 253 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-----~~~l~~~~~~~~~~~i~~~L~~LH~~~~~ 253 (427)
++||||+++++++.. ......++||||+ .|+|.+++...... ...+++..++.++.||+.||+||| +.
T Consensus 75 l~hpniv~~~~~~~~---~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~ 147 (405)
T 3rgf_A 75 LKHPNVISLQKVFLS---HADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---AN 147 (405)
T ss_dssp CCCTTBCCCCEEEEE---TTTTEEEEEEECC-SEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HT
T ss_pred cCCCCeeeEeeEEec---CCCCeEEEEEeCC-CCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hC
Confidence 469999999998643 2245789999999 46888877543211 124899999999999999999999 89
Q ss_pred CeeeccccCCceee----CCCCceEecccccccccCCc---------CCCccccccccccCCC-CcCccccchhHHHHHH
Q 042634 254 PIVHCDLKPSNVLL----DGELTAHVGDFGLAKFLPEA---------TNNFFNFQIAEYGMGS-EVSTSGDVYSFGILLL 319 (427)
Q Consensus 254 ~ivHrDlkp~NIll----~~~~~~kL~DFG~a~~~~~~---------~~~~~~y~aPE~~~~~-~~~~~~DiwS~G~vl~ 319 (427)
||+||||||+|||+ +.++.+||+|||+|+..... ..||+.|+|||++.+. .++.++|||||||++|
T Consensus 148 ~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ 227 (405)
T 3rgf_A 148 WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFA 227 (405)
T ss_dssp TCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHH
T ss_pred CEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHH
Confidence 99999999999999 67789999999999865432 2678999999999874 5899999999999999
Q ss_pred HHHhCCCCCCcc
Q 042634 320 ETFTGKRPTNEM 331 (427)
Q Consensus 320 ell~g~~pf~~~ 331 (427)
||++|+.||...
T Consensus 228 ell~g~~pf~~~ 239 (405)
T 3rgf_A 228 ELLTSEPIFHCR 239 (405)
T ss_dssp HHHHSSCTTCCC
T ss_pred HHHhCCCCCCCc
Confidence 999999999754
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-34 Score=285.91 Aligned_cols=192 Identities=21% Similarity=0.253 Sum_probs=152.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++++.. ....++|||||++|+|.+++... ..+++..+..++.||+.||+||| +.||+||
T Consensus 103 l~hpniv~~~~~~~~-----~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~ 170 (504)
T 3q5i_A 103 LDHPNIIKLFDVFED-----KKYFYLVTEFYEGGELFEQIINR----HKFDECDAANIMKQILSGICYLH---KHNIVHR 170 (504)
T ss_dssp CCCTTBCCEEEEEEC-----SSEEEEEEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECS
T ss_pred CCCCCCCeEEEEEEc-----CCEEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeC
Confidence 479999999998543 56789999999999999988654 45999999999999999999999 8999999
Q ss_pred cccCCceeeCCCC---ceEecccccccccCCc-----CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCc
Q 042634 259 DLKPSNVLLDGEL---TAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~~~---~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~ 330 (427)
||||+||+++.++ .+||+|||+|+..... ..||+.|+|||++. ..++.++||||+||++|+|++|..||.+
T Consensus 171 Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~ 249 (504)
T 3q5i_A 171 DIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGG 249 (504)
T ss_dssp CCSGGGEEESSTTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCcHHHEEEecCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999998765 6999999999876543 37899999999986 4689999999999999999999999975
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
... ..+...+..... .. ........+.++.+++.+||+.||.+|||++|+
T Consensus 250 ~~~--~~~~~~i~~~~~-----------~~-----------------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~ 299 (504)
T 3q5i_A 250 QND--QDIIKKVEKGKY-----------YF-----------------DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEA 299 (504)
T ss_dssp SSH--HHHHHHHHHCCC-----------CC-----------------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred CCH--HHHHHHHHcCCC-----------CC-----------------CccccCCCCHHHHHHHHHHcCCChhHCCCHHHH
Confidence 311 111111111000 00 000112235668999999999999999999999
Q ss_pred HHH
Q 042634 411 AAQ 413 (427)
Q Consensus 411 ~~~ 413 (427)
+++
T Consensus 300 l~h 302 (504)
T 3q5i_A 300 LNS 302 (504)
T ss_dssp HTS
T ss_pred hcC
Confidence 864
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=275.67 Aligned_cols=218 Identities=20% Similarity=0.262 Sum_probs=151.7
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++++.. ....++||||+++++|.++.... ..+++..+..++.|++.||+||| +.||+||
T Consensus 81 l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~ 148 (331)
T 4aaa_A 81 LRHENLVNLLEVCKK-----KKRWYLVFEFVDHTILDDLELFP----NGLDYQVVQKYLFQIINGIGFCH---SHNIIHR 148 (331)
T ss_dssp CCCTTBCCEEEEEEE-----TTEEEEEEECCSEEHHHHHHHST----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCC
T ss_pred CCCCCEeeEEEEeec-----CCEEEEEEecCCcchHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHH---HCCEEcc
Confidence 469999999998654 56789999999998888876543 34899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC------cCCCccccccccccCCC-CcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE------ATNNFFNFQIAEYGMGS-EVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~~y~aPE~~~~~-~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
||||+||+++.++.+||+|||.++.... ...++..|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 149 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 228 (331)
T 4aaa_A 149 DIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGD 228 (331)
T ss_dssp CCCGGGEEECTTSCEEECCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CcChheEEEcCCCcEEEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999976543 23788899999998875 7899999999999999999999999764
Q ss_pred cCCCccHHHHHHHh--cccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 042634 332 FTGNLTLHNFVKEA--LPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEE 409 (427)
Q Consensus 332 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~e 409 (427)
.... .+....... ..+.........-.......... . ...........++.++.+++.+||+.||++|||++|
T Consensus 229 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~-~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e 303 (331)
T 4aaa_A 229 SDID-QLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEI---K-EREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAE 303 (331)
T ss_dssp SHHH-HHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCC---S-SCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGG
T ss_pred CcHH-HHHHHHHHhCCCChhhhhHhhhccccccccCccc---c-ccchhhhcccchhHHHHHHHHHHhccCcccCCCHHH
Confidence 2211 111111110 00000000000000000000000 0 000000011234677999999999999999999999
Q ss_pred HHHH
Q 042634 410 VAAQ 413 (427)
Q Consensus 410 v~~~ 413 (427)
++++
T Consensus 304 ll~h 307 (331)
T 4aaa_A 304 LLHH 307 (331)
T ss_dssp GGGS
T ss_pred HhcC
Confidence 9874
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=274.80 Aligned_cols=228 Identities=19% Similarity=0.194 Sum_probs=152.8
Q ss_pred cccccchhhhccccccCCC--CCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCee
Q 042634 179 IRHRNLVKIITSCASVDFQ--GNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIV 256 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~--~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~iv 256 (427)
++||||+++++++...... .....++||||+++ +|...+.........+++..+..++.|++.||.|||.. +.||+
T Consensus 76 l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~iv 153 (360)
T 3e3p_A 76 LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVC 153 (360)
T ss_dssp HCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCB
T ss_pred cCCCCcccHHHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCC-CCCee
Confidence 4799999999987553221 12236899999964 55544433222225688999999999999999999943 57999
Q ss_pred eccccCCceeeCC-CCceEecccccccccCCcC-----CCccccccccccCCCC-cCccccchhHHHHHHHHHhCCCCCC
Q 042634 257 HCDLKPSNVLLDG-ELTAHVGDFGLAKFLPEAT-----NNFFNFQIAEYGMGSE-VSTSGDVYSFGILLLETFTGKRPTN 329 (427)
Q Consensus 257 HrDlkp~NIll~~-~~~~kL~DFG~a~~~~~~~-----~~~~~y~aPE~~~~~~-~~~~~DiwS~G~vl~ell~g~~pf~ 329 (427)
||||||+|||++. ++.+||+|||+|+...... .+|..|+|||++.+.. ++.++|||||||++|||++|+.||.
T Consensus 154 H~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~ 233 (360)
T 3e3p_A 154 HRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFR 233 (360)
T ss_dssp CSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcC
Confidence 9999999999986 8999999999998764432 6788999999987654 8999999999999999999999997
Q ss_pred cccCCCccHHHHHHHhccc--chhcccCcccc-ccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCC
Q 042634 330 EMFTGNLTLHNFVKEALPE--RLAEIVDPVLL-VEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMN 406 (427)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt 406 (427)
+... ...+.......... ......++... ......... .....+ ......++.++.+++.+||+.||++|||
T Consensus 234 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rpt 308 (360)
T 3e3p_A 234 GDNS-AGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGI--PWSNVF--SDHSLKDAKEAYDLLSALLQYLPEERMK 308 (360)
T ss_dssp CSSH-HHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCC--CHHHHT--TTCCCTTHHHHHHHHHHHTCSSGGGSCC
T ss_pred CCCh-HHHHHHHHHHcCCCCHHHHHhcccchhhccccccccC--Cccccc--chhhccccHHHHHHHHHHhccCccccCC
Confidence 6321 11122222211111 00000110000 000000000 000000 0011224677999999999999999999
Q ss_pred HHHHHHH
Q 042634 407 MEEVAAQ 413 (427)
Q Consensus 407 ~~ev~~~ 413 (427)
+.|++++
T Consensus 309 ~~e~l~h 315 (360)
T 3e3p_A 309 PYEALCH 315 (360)
T ss_dssp HHHHTTS
T ss_pred HHHHhcC
Confidence 9999863
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=272.37 Aligned_cols=197 Identities=20% Similarity=0.240 Sum_probs=148.4
Q ss_pred ccccchhhhccccccCCC-CCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 180 RHRNLVKIITSCASVDFQ-GNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
+||||+++++.+...... .....++||||+++|+|.+++..... ..+++..+..++.|++.||+||| +.||+||
T Consensus 79 ~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~ 153 (326)
T 2x7f_A 79 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG--NTLKEEWIAYICREILRGLSHLH---QHKVIHR 153 (326)
T ss_dssp CSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHH---HTTCCCC
T ss_pred CCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccc
Confidence 799999999987553221 13567999999999999999875432 46899999999999999999999 8899999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccC-----CCCcCccccchhHHHHHHHHHhCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGM-----GSEVSTSGDVYSFGILLLETFTGKRP 327 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~-----~~~~~~~~DiwS~G~vl~ell~g~~p 327 (427)
||||+||+++.++.+||+|||++...... ..++..|+|||++. +..++.++|||||||++|||++|..|
T Consensus 154 dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 233 (326)
T 2x7f_A 154 DIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233 (326)
T ss_dssp CCSGGGEEECTTCCEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCT
T ss_pred CCcHHHEEEcCCCCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999865432 26889999999987 56689999999999999999999999
Q ss_pred CCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCH
Q 042634 328 TNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM 407 (427)
Q Consensus 328 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~ 407 (427)
|..... . .............. ....++..+.+++.+||+.||++|||+
T Consensus 234 ~~~~~~----~-~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~ 281 (326)
T 2x7f_A 234 LCDMHP----M-RALFLIPRNPAPRL---------------------------KSKKWSKKFQSFIESCLVKNHSQRPAT 281 (326)
T ss_dssp TTTSCH----H-HHHHHHHHSCCCCC---------------------------SCSCSCHHHHHHHHHHCCSSGGGSCCH
T ss_pred CCCCcH----H-HHHHHhhcCccccC---------------------------CccccCHHHHHHHHHHhccChhhCCCH
Confidence 965321 0 10000000000000 111234568899999999999999999
Q ss_pred HHHHHH
Q 042634 408 EEVAAQ 413 (427)
Q Consensus 408 ~ev~~~ 413 (427)
+|+++.
T Consensus 282 ~~ll~h 287 (326)
T 2x7f_A 282 EQLMKH 287 (326)
T ss_dssp HHHHTS
T ss_pred HHHhhC
Confidence 999873
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-34 Score=274.33 Aligned_cols=228 Identities=17% Similarity=0.227 Sum_probs=155.0
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCC-Ceee
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCET-PIVH 257 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~-~ivH 257 (427)
..||||+++++.+.... .+....++||||+ +++|.+++..... ..+++..+..++.||+.||+||| ++ ||+|
T Consensus 83 ~~~~~i~~~~~~~~~~~-~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH 155 (373)
T 1q8y_A 83 MGANHILKLLDHFNHKG-PNGVHVVMVFEVL-GENLLALIKKYEH--RGIPLIYVKQISKQLLLGLDYMH---RRCGIIH 155 (373)
T ss_dssp HHHTTBCCCCEEEEEEE-TTEEEEEEEECCC-CEEHHHHHHHTTT--SCCCHHHHHHHHHHHHHHHHHHH---HTTCEEC
T ss_pred cccchHHHHHHHhhccC-CCCceEEEEEecC-CCCHHHHHHHhhc--cCCcHHHHHHHHHHHHHHHHHHH---hcCCEEe
Confidence 45999999999865421 1223678999999 9999999865432 45899999999999999999999 77 9999
Q ss_pred ccccCCceeeC------CCCceEecccccccccCCc---CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCC
Q 042634 258 CDLKPSNVLLD------GELTAHVGDFGLAKFLPEA---TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPT 328 (427)
Q Consensus 258 rDlkp~NIll~------~~~~~kL~DFG~a~~~~~~---~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf 328 (427)
|||||+|||++ ..+.+||+|||+|+..... ..+|..|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 156 ~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf 235 (373)
T 1q8y_A 156 TDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF 235 (373)
T ss_dssp SCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC
T ss_pred cCCChHHeEEeccCCCcCcceEEEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCC
Confidence 99999999994 4458999999999876543 37899999999999999999999999999999999999999
Q ss_pred CcccCCCc-----cHHHHHHHh--cccchh-------cccCccccccccccchhhhccccccccccchHHHHHHHHHHHh
Q 042634 329 NEMFTGNL-----TLHNFVKEA--LPERLA-------EIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGV 394 (427)
Q Consensus 329 ~~~~~~~~-----~~~~~~~~~--~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 394 (427)
........ .+....... .+..+. ...+..-.......................+..++.++.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 315 (373)
T 1q8y_A 236 EPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 315 (373)
T ss_dssp ---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHG
T ss_pred CCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHH
Confidence 86432111 111111111 010000 0000000000000000000000000111234667889999999
Q ss_pred hcCCCCCCCCCCHHHHHHH
Q 042634 395 TCSSELPRERMNMEEVAAQ 413 (427)
Q Consensus 395 ~cl~~dP~~Rpt~~ev~~~ 413 (427)
+||+.||++|||++|++++
T Consensus 316 ~~L~~dP~~Rpt~~ell~h 334 (373)
T 1q8y_A 316 PMLQLDPRKRADAGGLVNH 334 (373)
T ss_dssp GGGCSSTTTCBCHHHHHTC
T ss_pred HHhccCccccCCHHHHhhC
Confidence 9999999999999999863
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=263.71 Aligned_cols=191 Identities=21% Similarity=0.285 Sum_probs=151.8
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeecc
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCD 259 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrD 259 (427)
.||||+++++.+.. +...++||||+++++|.+++... ..+++..+..++.|++.||+||| +.||+|||
T Consensus 82 ~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~d 149 (298)
T 1phk_A 82 GHPNIIQLKDTYET-----NTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALH---KLNIVHRD 149 (298)
T ss_dssp TCTTBCCEEEEEEC-----SSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSC
T ss_pred CCCCEeeeeeeecc-----CCeEEEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCC
Confidence 59999999998543 56789999999999999998653 45899999999999999999999 89999999
Q ss_pred ccCCceeeCCCCceEecccccccccCCc-----CCCccccccccccC------CCCcCccccchhHHHHHHHHHhCCCCC
Q 042634 260 LKPSNVLLDGELTAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGM------GSEVSTSGDVYSFGILLLETFTGKRPT 328 (427)
Q Consensus 260 lkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~------~~~~~~~~DiwS~G~vl~ell~g~~pf 328 (427)
|||+||+++.++.+||+|||.+...... ..++..|+|||++. ...++.++|||||||++|||++|+.||
T Consensus 150 l~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~ 229 (298)
T 1phk_A 150 LKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229 (298)
T ss_dssp CSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred CCcceEEEcCCCcEEEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCC
Confidence 9999999999999999999999875433 26888999999985 456889999999999999999999999
Q ss_pred CcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 042634 329 NEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME 408 (427)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ 408 (427)
..... ......+...... .. ......++.++.+++.+||+.||++|||++
T Consensus 230 ~~~~~--~~~~~~~~~~~~~----~~------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 279 (298)
T 1phk_A 230 WHRKQ--MLMLRMIMSGNYQ----FG------------------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAE 279 (298)
T ss_dssp CCSSH--HHHHHHHHHTCCC----CC------------------------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred cCccH--HHHHHHHhcCCcc----cC------------------------cccccccCHHHHHHHHHHccCCcccCCCHH
Confidence 65311 1111111110000 00 001123456789999999999999999999
Q ss_pred HHHH
Q 042634 409 EVAA 412 (427)
Q Consensus 409 ev~~ 412 (427)
|+++
T Consensus 280 ~ll~ 283 (298)
T 1phk_A 280 EALA 283 (298)
T ss_dssp HHTT
T ss_pred HHHh
Confidence 9985
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-34 Score=267.57 Aligned_cols=192 Identities=19% Similarity=0.235 Sum_probs=149.2
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+++++|.+++.... ..+++..+..++.|++.||+||| +.||+||
T Consensus 73 l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~ 141 (302)
T 2j7t_A 73 CDHPYIVKLLGAYYH-----DGKLWIMIEFCPGGAVDAIMLELD---RGLTEPQIQVVCRQMLEALNFLH---SKRIIHR 141 (302)
T ss_dssp CCCTTBCCEEEEEEC-----C-CEEEEEECCTTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCC
T ss_pred CCCCCEeeeeeeeee-----CCeEEEEEEeCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHh---cCCcccC
Confidence 479999999998644 467899999999999998876432 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEeccccccccc------CCcCCCcccccccccc-----CCCCcCccccchhHHHHHHHHHhCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFL------PEATNNFFNFQIAEYG-----MGSEVSTSGDVYSFGILLLETFTGKRP 327 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~------~~~~~~~~~y~aPE~~-----~~~~~~~~~DiwS~G~vl~ell~g~~p 327 (427)
||||+||+++.++.+||+|||++... .....++..|+|||++ .+..++.++|||||||++|||++|..|
T Consensus 142 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 221 (302)
T 2j7t_A 142 DLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221 (302)
T ss_dssp CCSGGGEEECTTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCT
T ss_pred CCCHHHEEECCCCCEEEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCC
Confidence 99999999999999999999997643 1233788999999998 466789999999999999999999999
Q ss_pred CCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCH
Q 042634 328 TNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM 407 (427)
Q Consensus 328 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~ 407 (427)
|..... .............. ...+..++.++.+++.+||+.||++|||+
T Consensus 222 ~~~~~~-----~~~~~~~~~~~~~~--------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 270 (302)
T 2j7t_A 222 HHELNP-----MRVLLKIAKSDPPT--------------------------LLTPSKWSVEFRDFLKIALDKNPETRPSA 270 (302)
T ss_dssp TTTSCH-----HHHHHHHHHSCCCC--------------------------CSSGGGSCHHHHHHHHHHSCSCTTTSCCH
T ss_pred CccCCH-----HHHHHHHhccCCcc--------------------------cCCccccCHHHHHHHHHHcccChhhCCCH
Confidence 975321 11111100000000 00122345668999999999999999999
Q ss_pred HHHHH
Q 042634 408 EEVAA 412 (427)
Q Consensus 408 ~ev~~ 412 (427)
+|+++
T Consensus 271 ~~ll~ 275 (302)
T 2j7t_A 271 AQLLE 275 (302)
T ss_dssp HHHTT
T ss_pred HHHhc
Confidence 99986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-34 Score=279.56 Aligned_cols=196 Identities=20% Similarity=0.309 Sum_probs=143.8
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhc---cCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKN---LNLLQRLSIAVDVASALDYLHHYCETPI 255 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~---l~~~~~~~~~~~i~~~L~~LH~~~~~~i 255 (427)
.+|||||++++.+. .....++||||| +|+|.+++......... .++..++.++.||+.||+||| +.||
T Consensus 66 ~~HpnIv~~~~~~~-----~~~~~~lv~E~~-~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~i 136 (434)
T 2rio_A 66 DDHPNVIRYYCSET-----TDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKI 136 (434)
T ss_dssp TTSTTBCCEEEEEE-----CSSEEEEEECCC-SEEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTE
T ss_pred cCCCCcCeEEEEEe-----cCCeEEEEEecC-CCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCc
Confidence 47999999998743 356789999999 57999998765321111 133346789999999999999 8999
Q ss_pred eeccccCCceeeCCC-------------CceEecccccccccCCc----------CCCccccccccccCC-------CCc
Q 042634 256 VHCDLKPSNVLLDGE-------------LTAHVGDFGLAKFLPEA----------TNNFFNFQIAEYGMG-------SEV 305 (427)
Q Consensus 256 vHrDlkp~NIll~~~-------------~~~kL~DFG~a~~~~~~----------~~~~~~y~aPE~~~~-------~~~ 305 (427)
+||||||+|||++.+ +.+||+|||+|+..... ..||+.|+|||++.+ ..+
T Consensus 137 vHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 216 (434)
T 2rio_A 137 IHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRL 216 (434)
T ss_dssp ECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCC
T ss_pred cccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCc
Confidence 999999999999654 48999999999876432 268899999999876 568
Q ss_pred CccccchhHHHHHHHHHh-CCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHH
Q 042634 306 STSGDVYSFGILLLETFT-GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKE 384 (427)
Q Consensus 306 ~~~~DiwS~G~vl~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (427)
+.++|||||||++|||++ |+.||....... .......... .. ........
T Consensus 217 ~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---~~i~~~~~~~--~~------------------------~~~~~~~~ 267 (434)
T 2rio_A 217 TRSIDIFSMGCVFYYILSKGKHPFGDKYSRE---SNIIRGIFSL--DE------------------------MKCLHDRS 267 (434)
T ss_dssp CTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH---HHHHHTCCCC--CC------------------------CTTCCCHH
T ss_pred chhhhhHhHHHHHHHHHhCCCCCCCCchhhH---HHHhcCCCCc--cc------------------------cccccccc
Confidence 999999999999999999 999996532111 1111110000 00 00112345
Q ss_pred HHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 385 CLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 385 ~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
.+.++.+++.+||+.||++|||+.||++
T Consensus 268 ~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 268 LIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred chHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 6788999999999999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=263.55 Aligned_cols=192 Identities=22% Similarity=0.330 Sum_probs=147.8
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ......++||||++++ +.+++..... ..+++..+..++.|++.||+||| ++||+||
T Consensus 63 l~h~~i~~~~~~~~~---~~~~~~~lv~e~~~~~-l~~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~ 133 (305)
T 2wtk_C 63 LRHKNVIQLVDVLYN---EEKQKMYMVMEYCVCG-MQEMLDSVPE--KRFPVCQAHGYFCQLIDGLEYLH---SQGIVHK 133 (305)
T ss_dssp CCCTTBCCEEEEEEC---C---CEEEEEECCSEE-HHHHHHHSTT--CSCCHHHHHHHHHHHHHHHHHHH---HTTEECS
T ss_pred cCCCCeeEEEEEEEc---CCCCeEEEEehhccCC-HHHHHHhCcc--cccCHHHHHHHHHHHHHHHHHHH---HCCeeec
Confidence 469999999998532 2245689999999766 6666654322 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC--------cCCCccccccccccCCCC--cCccccchhHHHHHHHHHhCCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE--------ATNNFFNFQIAEYGMGSE--VSTSGDVYSFGILLLETFTGKRPT 328 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~--------~~~~~~~y~aPE~~~~~~--~~~~~DiwS~G~vl~ell~g~~pf 328 (427)
||||+||+++.++.+||+|||.+..... ...++..|+|||++.+.. ++.++|||||||++|||++|+.||
T Consensus 134 dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 213 (305)
T 2wtk_C 134 DIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPF 213 (305)
T ss_dssp CCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSC
T ss_pred CCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999987542 226889999999987644 478999999999999999999999
Q ss_pred CcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 042634 329 NEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME 408 (427)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ 408 (427)
.... ............. ..+..++.++.+++.+||+.||++|||++
T Consensus 214 ~~~~-----~~~~~~~i~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 259 (305)
T 2wtk_C 214 EGDN-----IYKLFENIGKGSY-----------------------------AIPGDCGPPLSDLLKGMLEYEPAKRFSIR 259 (305)
T ss_dssp CCSS-----HHHHHHHHHHCCC-----------------------------CCCSSSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred CCch-----HHHHHHHHhcCCC-----------------------------CCCCccCHHHHHHHHHHccCChhhCCCHH
Confidence 7531 1111111000000 01112355688999999999999999999
Q ss_pred HHHHH
Q 042634 409 EVAAQ 413 (427)
Q Consensus 409 ev~~~ 413 (427)
|++++
T Consensus 260 ~ll~~ 264 (305)
T 2wtk_C 260 QIRQH 264 (305)
T ss_dssp HHHHS
T ss_pred HHhcC
Confidence 99874
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=272.89 Aligned_cols=220 Identities=15% Similarity=0.150 Sum_probs=149.1
Q ss_pred cccccchhhhccccccCCC-CCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 042634 179 IRHRNLVKIITSCASVDFQ-GNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVH 257 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivH 257 (427)
++||||+++++++...... .....++||||+. ++|.+++.. .+++..+..++.|++.||+||| +.||+|
T Consensus 98 l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~aL~~LH---~~~ivH 167 (371)
T 4exu_A 98 MQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGM------EFSEEKIQYLVYQMLKGLKYIH---SAGVVH 167 (371)
T ss_dssp CCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTTS------CCCHHHHHHHHHHHHHHHHHHH---HTTCCC
T ss_pred cCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHhhc------CCCHHHHHHHHHHHHHHHHHHH---HCCCcC
Confidence 5699999999986542211 1123489999995 788877743 3899999999999999999999 889999
Q ss_pred ccccCCceeeCCCCceEecccccccccCCc---CCCccccccccccCC-CCcCccccchhHHHHHHHHHhCCCCCCcccC
Q 042634 258 CDLKPSNVLLDGELTAHVGDFGLAKFLPEA---TNNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETFTGKRPTNEMFT 333 (427)
Q Consensus 258 rDlkp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~ 333 (427)
|||||+||+++.++.+||+|||+++..... ..+|..|+|||++.+ ..++.++|||||||++|||++|+.||.+...
T Consensus 168 ~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 247 (371)
T 4exu_A 168 RDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY 247 (371)
T ss_dssp SCCCGGGEEECTTCCEEECSTTCC--------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred CCcCHHHeEECCCCCEEEEecCcccccccCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 999999999999999999999999876543 377899999999887 6789999999999999999999999975321
Q ss_pred CCccHHHHHHHhcc--cchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 042634 334 GNLTLHNFVKEALP--ERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVA 411 (427)
Q Consensus 334 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~ 411 (427)
. ..+......... ......+...... ....................++.++.+++.+||+.||++|||++|++
T Consensus 248 ~-~~~~~i~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 322 (371)
T 4exu_A 248 L-DQLTQILKVTGVPGTEFVQKLNDKAAK----SYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQAL 322 (371)
T ss_dssp H-HHHHHHHHHHCCCCHHHHTTCSCHHHH----HHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred H-HHHHHHHHHhCCCcHHHHHHhhhhhhh----hhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHh
Confidence 1 111111111111 0111101000000 00000000000000001122456789999999999999999999998
Q ss_pred HH
Q 042634 412 AQ 413 (427)
Q Consensus 412 ~~ 413 (427)
++
T Consensus 323 ~h 324 (371)
T 4exu_A 323 TH 324 (371)
T ss_dssp TS
T ss_pred cC
Confidence 64
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=5.6e-33 Score=265.99 Aligned_cols=219 Identities=19% Similarity=0.198 Sum_probs=150.8
Q ss_pred cccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccc
Q 042634 181 HRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDL 260 (427)
Q Consensus 181 Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrDl 260 (427)
|++++.+++.+.. ....++||||+ ++++.+++..... ..+++..++.++.||+.||+||| +.||+||||
T Consensus 81 ~~~~~~~~~~~~~-----~~~~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dl 149 (355)
T 2eu9_A 81 KFLCVLMSDWFNF-----HGHMCIAFELL-GKNTFEFLKENNF--QPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDL 149 (355)
T ss_dssp CSCBCCEEEEEEE-----TTEEEEEEECC-CCBHHHHHHHTTT--CCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCC
T ss_pred ceeEEEeeeeeee-----CCeEEEEEecc-CCChHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCC
Confidence 3446776666433 45789999999 7777777754322 45899999999999999999999 899999999
Q ss_pred cCCceee-------------------CCCCceEecccccccccCCc---CCCccccccccccCCCCcCccccchhHHHHH
Q 042634 261 KPSNVLL-------------------DGELTAHVGDFGLAKFLPEA---TNNFFNFQIAEYGMGSEVSTSGDVYSFGILL 318 (427)
Q Consensus 261 kp~NIll-------------------~~~~~~kL~DFG~a~~~~~~---~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl 318 (427)
||+|||+ +.++.+||+|||+++..... ..||..|+|||++.+..++.++|||||||++
T Consensus 150 kp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 229 (355)
T 2eu9_A 150 KPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCIL 229 (355)
T ss_dssp CGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHH
T ss_pred CHHHEEEecccccccccccccccccccCCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHH
Confidence 9999999 56789999999999875443 3789999999999999999999999999999
Q ss_pred HHHHhCCCCCCcccCCCccHHHHHHHh---cccchhccc-Cccccccccccc--------hhhhccccccccccchHHHH
Q 042634 319 LETFTGKRPTNEMFTGNLTLHNFVKEA---LPERLAEIV-DPVLLVEREEGE--------TSKANAHKQFTRSFSVKECL 386 (427)
Q Consensus 319 ~ell~g~~pf~~~~~~~~~~~~~~~~~---~~~~~~~~~-~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~ 386 (427)
|||++|+.||...... .....+... .+..+.... ...........+ ...................+
T Consensus 230 ~el~~g~~pf~~~~~~--~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (355)
T 2eu9_A 230 FEYYRGFTLFQTHENR--EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEH 307 (355)
T ss_dssp HHHHHSSCSCCCSSHH--HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHH
T ss_pred HHHHhCCCCCCCCCHH--HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhH
Confidence 9999999999753211 111111111 111111000 000000000000 00000000001111233456
Q ss_pred HHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 387 VSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 387 ~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
.++.+++.+||+.||++|||++|+++
T Consensus 308 ~~l~~li~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 308 VQLFDLMRRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 78999999999999999999999985
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2e-33 Score=276.08 Aligned_cols=190 Identities=20% Similarity=0.245 Sum_probs=141.8
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeecc
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCD 259 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrD 259 (427)
+|||||++++.+.. ....++||||| +|+|.+++.... ..+++..+..++.||+.||+||| +.||+|||
T Consensus 76 ~HpnIv~l~~~~~~-----~~~~~lv~E~~-~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrD 143 (432)
T 3p23_A 76 EHPNVIRYFCTEKD-----RQFQYIAIELC-AATLQEYVEQKD---FAHLGLEPITLLQQTTSGLAHLH---SLNIVHRD 143 (432)
T ss_dssp CCTTBCCEEEEEEE-----TTEEEEEEECC-SEEHHHHHHSSS---CCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCC
T ss_pred CCCCcCeEEEEEec-----CCEEEEEEECC-CCCHHHHHHhcC---CCccchhHHHHHHHHHHHHHHHH---HCcCEeCC
Confidence 79999999987543 56789999999 569999987553 23455567889999999999999 89999999
Q ss_pred ccCCceeeCC-----CCceEecccccccccCCc---------CCCccccccccccC---CCCcCccccchhHHHHHHHHH
Q 042634 260 LKPSNVLLDG-----ELTAHVGDFGLAKFLPEA---------TNNFFNFQIAEYGM---GSEVSTSGDVYSFGILLLETF 322 (427)
Q Consensus 260 lkp~NIll~~-----~~~~kL~DFG~a~~~~~~---------~~~~~~y~aPE~~~---~~~~~~~~DiwS~G~vl~ell 322 (427)
|||+|||++. ...+||+|||+|+..... ..||+.|+|||++. ...++.++|||||||++|||+
T Consensus 144 lKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ell 223 (432)
T 3p23_A 144 LKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVI 223 (432)
T ss_dssp CSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHH
T ss_pred CCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHH
Confidence 9999999943 346889999999876432 26899999999997 456788999999999999999
Q ss_pred h-CCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCC
Q 042634 323 T-GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELP 401 (427)
Q Consensus 323 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP 401 (427)
+ |..||..... .............. .......+..+.+++.+||+.||
T Consensus 224 t~g~~pf~~~~~------~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~li~~~L~~dP 272 (432)
T 3p23_A 224 SEGSHPFGKSLQ------RQANILLGACSLDC-------------------------LHPEKHEDVIARELIEKMIAMDP 272 (432)
T ss_dssp TTSCBTTBSTTT------HHHHHHTTCCCCTT-------------------------SCTTCHHHHHHHHHHHHHSCSSG
T ss_pred cCCCCCcchhhH------HHHHHHhccCCccc-------------------------cCccccccHHHHHHHHHHHhCCH
Confidence 9 9999854211 00000000000000 00112345567899999999999
Q ss_pred CCCCCHHHHHH
Q 042634 402 RERMNMEEVAA 412 (427)
Q Consensus 402 ~~Rpt~~ev~~ 412 (427)
++|||++||++
T Consensus 273 ~~Rps~~evl~ 283 (432)
T 3p23_A 273 QKRPSAKHVLK 283 (432)
T ss_dssp GGSCCHHHHHT
T ss_pred hhCCCHHHHHh
Confidence 99999999984
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=7.4e-33 Score=265.38 Aligned_cols=220 Identities=15% Similarity=0.169 Sum_probs=150.6
Q ss_pred cccccchhhhccccccCC-CCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 042634 179 IRHRNLVKIITSCASVDF-QGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVH 257 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivH 257 (427)
++||||+++++.+..... ......++||||+. ++|.+++.. .+++..+..++.|++.||+||| ++||+|
T Consensus 80 l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~LH---~~~ivH 149 (353)
T 3coi_A 80 MQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGL------KFSEEKIQYLVYQMLKGLKYIH---SAGVVH 149 (353)
T ss_dssp CCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTTS------CCCHHHHHHHHHHHHHHHHHHH---HTTCCC
T ss_pred cCCCCcccHhheEecccccccceeEEEEecccc-CCHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---HCCccc
Confidence 469999999998654211 11123589999995 788888753 3899999999999999999999 899999
Q ss_pred ccccCCceeeCCCCceEecccccccccCCc---CCCccccccccccCC-CCcCccccchhHHHHHHHHHhCCCCCCcccC
Q 042634 258 CDLKPSNVLLDGELTAHVGDFGLAKFLPEA---TNNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETFTGKRPTNEMFT 333 (427)
Q Consensus 258 rDlkp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~ 333 (427)
|||||+||+++.++.+||+|||+++..... ..+|..|+|||++.+ ..++.++|||||||++|||++|+.||.+...
T Consensus 150 ~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 229 (353)
T 3coi_A 150 RDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY 229 (353)
T ss_dssp SSCCGGGEEECTTCCEEECSTTCTTC--------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH
T ss_pred CCCCHHHEeECCCCcEEEeecccccCCCCCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999999999999999999999876443 267899999999887 6789999999999999999999999975321
Q ss_pred CCccHHHHHHHhc-c-cchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 042634 334 GNLTLHNFVKEAL-P-ERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVA 411 (427)
Q Consensus 334 ~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~ 411 (427)
. ..+........ + ......+...... ....................++.++.+++.+||+.||++|||++|++
T Consensus 230 ~-~~~~~i~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l 304 (353)
T 3coi_A 230 L-DQLTQILKVTGVPGTEFVQKLNDKAAK----SYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQAL 304 (353)
T ss_dssp H-HHHHHHHHHHCBCCHHHHTTCSCHHHH----HHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred H-HHHHHHHHHhCCCCHHHHHHHhhHHHH----HHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 1 11111111111 0 0010000000000 00000000000000001123466789999999999999999999998
Q ss_pred HH
Q 042634 412 AQ 413 (427)
Q Consensus 412 ~~ 413 (427)
++
T Consensus 305 ~h 306 (353)
T 3coi_A 305 TH 306 (353)
T ss_dssp TS
T ss_pred cC
Confidence 63
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=1.6e-33 Score=266.25 Aligned_cols=182 Identities=19% Similarity=0.243 Sum_probs=149.0
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecC-CCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVN-GSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
.||||+++++.+.. ....++|||++.+ ++|.+++... ..+++..++.++.|++.||+||| +.||+||
T Consensus 106 ~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~ 173 (320)
T 3a99_A 106 GFSGVIRLLDWFER-----PDSFVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCH---NCGVLHR 173 (320)
T ss_dssp SSCSBCCEEEEEEC-----SSEEEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred CCCCceEEEEEEec-----CCcEEEEEEcCCCCccHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcEeC
Confidence 57999999998543 5678999999976 8999988653 45899999999999999999999 8999999
Q ss_pred cccCCceeeC-CCCceEecccccccccCCc----CCCccccccccccCCCCc-CccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLD-GELTAHVGDFGLAKFLPEA----TNNFFNFQIAEYGMGSEV-STSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~-~~~~~kL~DFG~a~~~~~~----~~~~~~y~aPE~~~~~~~-~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+||+++ .++.+||+|||+++..... ..||..|+|||++.+..+ +.++|||||||++|||++|+.||....
T Consensus 174 Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 253 (320)
T 3a99_A 174 DIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 253 (320)
T ss_dssp CCSGGGEEEETTTTEEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH
T ss_pred CCCHHHEEEeCCCCCEEEeeCccccccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh
Confidence 9999999998 7889999999999876543 268899999999877665 788999999999999999999996420
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
....... . .+..++.++.+++.+||+.||++|||++|+++
T Consensus 254 -------~~~~~~~------~---------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 254 -------EIIRGQV------F---------------------------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp -------HHHHCCC------C---------------------------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------hhhcccc------c---------------------------ccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1100000 0 01113456889999999999999999999986
Q ss_pred H
Q 042634 413 Q 413 (427)
Q Consensus 413 ~ 413 (427)
.
T Consensus 294 h 294 (320)
T 3a99_A 294 H 294 (320)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=8.3e-34 Score=269.05 Aligned_cols=198 Identities=21% Similarity=0.207 Sum_probs=134.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchh-hhhccCHHHHHHHHHHHHHHHHHHhhcCCC-Cee
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNRE-ALKNLNLLQRLSIAVDVASALDYLHHYCET-PIV 256 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~-~iv 256 (427)
++||||+++++.+.. ....++||||++ |+|.+++..... ....+++..+..++.|++.||.||| +. ||+
T Consensus 78 ~~h~niv~~~~~~~~-----~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~iv 148 (327)
T 3aln_A 78 SDCPYIVQFYGALFR-----EGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKII 148 (327)
T ss_dssp CCCTTBCCEEEEEEC-----SSEEEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCC
T ss_pred CCCCcEeeeeeEEEe-----CCceEEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEe
Confidence 579999999998644 457899999996 577777653211 1245889999999999999999999 77 999
Q ss_pred eccccCCceeeCCCCceEecccccccccCCcC-----CCcccccccccc----CCCCcCccccchhHHHHHHHHHhCCCC
Q 042634 257 HCDLKPSNVLLDGELTAHVGDFGLAKFLPEAT-----NNFFNFQIAEYG----MGSEVSTSGDVYSFGILLLETFTGKRP 327 (427)
Q Consensus 257 HrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~y~aPE~~----~~~~~~~~~DiwS~G~vl~ell~g~~p 327 (427)
||||||+||+++.++.+||+|||+++...... .|+..|+|||++ .+..++.++|||||||++|||++|+.|
T Consensus 149 H~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 228 (327)
T 3aln_A 149 HRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228 (327)
T ss_dssp CSCCCGGGEEEETTTEEEECCCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCC
T ss_pred ECCCCHHHEEEcCCCCEEEccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCC
Confidence 99999999999999999999999998764332 688899999998 456789999999999999999999999
Q ss_pred CCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCH
Q 042634 328 TNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM 407 (427)
Q Consensus 328 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~ 407 (427)
|........ .+......... .........++.++.+++.+||+.||++|||+
T Consensus 229 f~~~~~~~~------------~~~~~~~~~~~----------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 280 (327)
T 3aln_A 229 YPKWNSVFD------------QLTQVVKGDPP----------------QLSNSEEREFSPSFINFVNLCLTKDESKRPKY 280 (327)
T ss_dssp SSCC-------------------CCCCCSCCC----------------CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCCcchHHH------------HHHHHhcCCCC----------------CCCCcccccCCHHHHHHHHHHhhCChhhCcCH
Confidence 975311100 00011100000 00000111235568999999999999999999
Q ss_pred HHHHHH
Q 042634 408 EEVAAQ 413 (427)
Q Consensus 408 ~ev~~~ 413 (427)
+|+++.
T Consensus 281 ~ell~h 286 (327)
T 3aln_A 281 KELLKH 286 (327)
T ss_dssp HHHTTS
T ss_pred HHHHhC
Confidence 999874
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.8e-33 Score=262.14 Aligned_cols=188 Identities=23% Similarity=0.342 Sum_probs=143.7
Q ss_pred cccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccc
Q 042634 181 HRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDL 260 (427)
Q Consensus 181 Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrDl 260 (427)
||||+++++.+.. ....++||| +.+++|.+++... ..+++..++.++.|++.||+||| +.||+||||
T Consensus 87 ~~~iv~~~~~~~~-----~~~~~lv~e-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dl 153 (313)
T 3cek_A 87 SDKIIRLYDYEIT-----DQYIYMVME-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDL 153 (313)
T ss_dssp CTTBCCEEEEEEC-----SSEEEEEEC-CCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCC
T ss_pred CCceEEEEEEeec-----CCEEEEEEe-cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCC
Confidence 6999999998544 457899999 5589999998754 45899999999999999999999 889999999
Q ss_pred cCCceeeCCCCceEecccccccccCCc--------CCCccccccccccCC-----------CCcCccccchhHHHHHHHH
Q 042634 261 KPSNVLLDGELTAHVGDFGLAKFLPEA--------TNNFFNFQIAEYGMG-----------SEVSTSGDVYSFGILLLET 321 (427)
Q Consensus 261 kp~NIll~~~~~~kL~DFG~a~~~~~~--------~~~~~~y~aPE~~~~-----------~~~~~~~DiwS~G~vl~el 321 (427)
||+||++++ +.+||+|||+++..... ..|+..|+|||++.+ ..++.++|||||||++|||
T Consensus 154 kp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el 232 (313)
T 3cek_A 154 KPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM 232 (313)
T ss_dssp CGGGEEEET-TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHH
T ss_pred CcccEEEEC-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHH
Confidence 999999965 89999999999875432 268899999999875 4688999999999999999
Q ss_pred HhCCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCC
Q 042634 322 FTGKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELP 401 (427)
Q Consensus 322 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP 401 (427)
++|+.||....... .. .... .++..... .+..++.++.+++.+||+.||
T Consensus 233 ~~g~~pf~~~~~~~---~~-~~~~--------~~~~~~~~-------------------~~~~~~~~l~~li~~~l~~dp 281 (313)
T 3cek_A 233 TYGKTPFQQIINQI---SK-LHAI--------IDPNHEIE-------------------FPDIPEKDLQDVLKCCLKRDP 281 (313)
T ss_dssp HHSSCTTTTCCSHH---HH-HHHH--------HCTTSCCC-------------------CCCCSCHHHHHHHHHHTCSST
T ss_pred HhCCCchhhHHHHH---HH-HHHH--------HhcccccC-------------------CcccchHHHHHHHHHHccCCc
Confidence 99999997532111 11 1111 11000000 011124568899999999999
Q ss_pred CCCCCHHHHHHH
Q 042634 402 RERMNMEEVAAQ 413 (427)
Q Consensus 402 ~~Rpt~~ev~~~ 413 (427)
++|||++|+++.
T Consensus 282 ~~Rps~~ell~h 293 (313)
T 3cek_A 282 KQRISIPELLAH 293 (313)
T ss_dssp TTSCCHHHHHTS
T ss_pred ccCcCHHHHhcC
Confidence 999999999874
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.9e-33 Score=257.78 Aligned_cols=192 Identities=22% Similarity=0.276 Sum_probs=149.7
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+.. ....++||||+++++|.+++... ..+++..+..++.|++.||+||| +.||+||
T Consensus 78 l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~ 145 (287)
T 2wei_A 78 LDHPNIMKLFEILED-----SSSFYIVGELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMH---KHNIVHR 145 (287)
T ss_dssp CCCTTBCCEEEEEEC-----SSEEEEEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred ccCCCccEEEEEEeC-----CCeEEEEEEccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecc
Confidence 479999999998543 56789999999999998887643 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCC---CceEecccccccccCCcC-----CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCc
Q 042634 259 DLKPSNVLLDGE---LTAHVGDFGLAKFLPEAT-----NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~~---~~~kL~DFG~a~~~~~~~-----~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~ 330 (427)
||||+||+++.+ +.+||+|||.++...... .++..|+|||++.+ .++.++|||||||++|+|++|+.||..
T Consensus 146 dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~ 224 (287)
T 2wei_A 146 DLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYG 224 (287)
T ss_dssp CCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCChhhEEEecCCCcccEEEeccCcceeecCCCccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCC
Confidence 999999999654 479999999998765433 46778999999875 489999999999999999999999975
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
... ......+... .... + ......++.++.+++.+||+.||++|||++|+
T Consensus 225 ~~~--~~~~~~~~~~---~~~~--~-----------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el 274 (287)
T 2wei_A 225 KNE--YDILKRVETG---KYAF--D-----------------------LPQWRTISDDAKDLIRKMLTFHPSLRITATQC 274 (287)
T ss_dssp SSH--HHHHHHHHHC---CCCC--C-----------------------SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCH--HHHHHHHHcC---CCCC--C-----------------------chhhhhcCHHHHHHHHHHcccChhhCcCHHHH
Confidence 311 1111111110 0000 0 00112235568999999999999999999999
Q ss_pred HHH
Q 042634 411 AAQ 413 (427)
Q Consensus 411 ~~~ 413 (427)
++.
T Consensus 275 l~h 277 (287)
T 2wei_A 275 LEH 277 (287)
T ss_dssp HHS
T ss_pred hcC
Confidence 874
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-33 Score=261.87 Aligned_cols=197 Identities=21% Similarity=0.295 Sum_probs=145.1
Q ss_pred cccccchhhhccccccC--------CCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhc
Q 042634 179 IRHRNLVKIITSCASVD--------FQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHY 250 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~--------~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~ 250 (427)
++||||+++++.+.... .......++||||+++|+|.+++.... ..+++..++.++.|++.||+|||
T Consensus 59 l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH-- 133 (303)
T 1zy4_A 59 LNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN---LNQQRDEYWRLFRQILEALSYIH-- 133 (303)
T ss_dssp CCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSC---GGGCHHHHHHHHHHHHHHHHHHH--
T ss_pred cCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccc---cccchHHHHHHHHHHHHHHHHHH--
Confidence 46999999998764311 122456799999999999999997543 45788999999999999999999
Q ss_pred CCCCeeeccccCCceeeCCCCceEecccccccccCC--------------------cCCCccccccccccCCC-CcCccc
Q 042634 251 CETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPE--------------------ATNNFFNFQIAEYGMGS-EVSTSG 309 (427)
Q Consensus 251 ~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~--------------------~~~~~~~y~aPE~~~~~-~~~~~~ 309 (427)
+.||+||||||+||+++.++.+||+|||.++.... ...++..|+|||++.+. .++.++
T Consensus 134 -~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~ 212 (303)
T 1zy4_A 134 -SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKI 212 (303)
T ss_dssp -HTTCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHH
T ss_pred -hCCeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchh
Confidence 88999999999999999999999999999986532 12578899999998764 689999
Q ss_pred cchhHHHHHHHHHhCCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHH
Q 042634 310 DVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSV 389 (427)
Q Consensus 310 DiwS~G~vl~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (427)
|||||||++|||++ ||..... ........ ... ... + +...+..++..+
T Consensus 213 Di~slG~il~~l~~---p~~~~~~----~~~~~~~~-----~~~-~~~------------------~-~~~~~~~~~~~~ 260 (303)
T 1zy4_A 213 DMYSLGIIFFEMIY---PFSTGME----RVNILKKL-----RSV-SIE------------------F-PPDFDDNKMKVE 260 (303)
T ss_dssp HHHHHHHHHHHHHS---CCSSHHH----HHHHHHHH-----HST-TCC------------------C-CTTCCTTTSHHH
T ss_pred hHHHHHHHHHHHHh---ccCCchh----HHHHHHhc-----ccc-ccc------------------c-CccccccchHHH
Confidence 99999999999998 5542110 00111110 000 000 0 000122345568
Q ss_pred HHHHhhcCCCCCCCCCCHHHHHHH
Q 042634 390 LGIGVTCSSELPRERMNMEEVAAQ 413 (427)
Q Consensus 390 ~~l~~~cl~~dP~~Rpt~~ev~~~ 413 (427)
.+++.+||+.||++|||++|++++
T Consensus 261 ~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 261 KKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHhcCcccCcCHHHHhCC
Confidence 899999999999999999999863
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-33 Score=265.07 Aligned_cols=193 Identities=22% Similarity=0.258 Sum_probs=140.4
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCC-Ceee
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCET-PIVH 257 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~-~ivH 257 (427)
.+||||+++++.+.. ....++||||+ ++.+..+.... ...+++..+..++.|++.||+||| +. ||+|
T Consensus 81 ~~h~~i~~~~~~~~~-----~~~~~lv~e~~-~~~~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H 148 (318)
T 2dyl_A 81 HDCPYIVQCFGTFIT-----NTDVFIAMELM-GTCAEKLKKRM---QGPIPERILGKMTVAIVKALYYLK---EKHGVIH 148 (318)
T ss_dssp TTCTTBCCEEEEEEC-----SSEEEEEECCC-SEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCC
T ss_pred cCCCceeeEEEEEec-----CCcEEEEEecc-CCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEe
Confidence 579999999998644 56789999999 55554444321 145899999999999999999999 64 9999
Q ss_pred ccccCCceeeCCCCceEecccccccccCCc-----CCCccccccccccC-----CCCcCccccchhHHHHHHHHHhCCCC
Q 042634 258 CDLKPSNVLLDGELTAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGM-----GSEVSTSGDVYSFGILLLETFTGKRP 327 (427)
Q Consensus 258 rDlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~-----~~~~~~~~DiwS~G~vl~ell~g~~p 327 (427)
|||||+||+++.++.+||+|||+++..... ..++..|+|||++. ...++.++|||||||++|||++|+.|
T Consensus 149 ~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 228 (318)
T 2dyl_A 149 RDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228 (318)
T ss_dssp CCCCGGGEEECTTSCEEECCCTTC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCT
T ss_pred CCCCHHHEEECCCCCEEEEECCCchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCC
Confidence 999999999999999999999999765432 26888999999984 45688999999999999999999999
Q ss_pred CCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCH
Q 042634 328 TNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM 407 (427)
Q Consensus 328 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~ 407 (427)
|.........+...... .+... . ....++.++.+++.+||+.||++|||+
T Consensus 229 f~~~~~~~~~~~~~~~~-~~~~~----~-------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~ 278 (318)
T 2dyl_A 229 YKNCKTDFEVLTKVLQE-EPPLL----P-------------------------GHMGFSGDFQSFVKDCLTKDHRKRPKY 278 (318)
T ss_dssp TTTCCSHHHHHHHHHHS-CCCCC----C-------------------------SSSCCCHHHHHHHHHHTCSCTTTSCCH
T ss_pred CCCCCccHHHHHHHhcc-CCCCC----C-------------------------ccCCCCHHHHHHHHHHccCChhHCcCH
Confidence 97532211111111110 00000 0 001134568899999999999999999
Q ss_pred HHHHHH
Q 042634 408 EEVAAQ 413 (427)
Q Consensus 408 ~ev~~~ 413 (427)
+|++++
T Consensus 279 ~~ll~h 284 (318)
T 2dyl_A 279 NKLLEH 284 (318)
T ss_dssp HHHTTS
T ss_pred HHHhhC
Confidence 999874
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.7e-33 Score=261.02 Aligned_cols=182 Identities=20% Similarity=0.291 Sum_probs=146.8
Q ss_pred ccccchhhhccccccCCCCCCccceeeee-ecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEF-MVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
+||||+++++.+.. ....++|||| +.+++|.+++... ..+++..++.++.|++.||+||| +.||+||
T Consensus 96 ~h~~i~~~~~~~~~-----~~~~~~v~e~~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~ 163 (312)
T 2iwi_A 96 GHPGVIRLLDWFET-----QEGFMLVLERPLPAQDLFDYITEK----GPLGEGPSRCFFGQVVAAIQHCH---SRGVVHR 163 (312)
T ss_dssp CCSSBCCEEEEC----------CEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHH---HHTEECC
T ss_pred CCCCeeeEEEEEec-----CCeEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeec
Confidence 79999999998543 5678999999 7889999998653 45899999999999999999999 8899999
Q ss_pred cccCCceeeC-CCCceEecccccccccCCcC----CCccccccccccCCCCc-CccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLD-GELTAHVGDFGLAKFLPEAT----NNFFNFQIAEYGMGSEV-STSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~-~~~~~kL~DFG~a~~~~~~~----~~~~~y~aPE~~~~~~~-~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+||+++ .++.+||+|||.++...... .++..|+|||++.+..+ +.++|||||||++|||++|+.||...
T Consensus 164 dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~- 242 (312)
T 2iwi_A 164 DIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD- 242 (312)
T ss_dssp CCSGGGEEEETTTTEEEECCCSSCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-
T ss_pred CCChhhEEEeCCCCeEEEEEcchhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh-
Confidence 9999999998 88999999999998765432 68889999999877666 45899999999999999999999642
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
........ . .+..++.++.+++.+||+.||++|||++|+++
T Consensus 243 ------~~~~~~~~--------~-------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 243 ------QEILEAEL--------H-------------------------FPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp ------HHHHHTCC--------C-------------------------CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ------HHHhhhcc--------C-------------------------CcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01100000 0 11123456889999999999999999999987
Q ss_pred H
Q 042634 413 Q 413 (427)
Q Consensus 413 ~ 413 (427)
+
T Consensus 284 ~ 284 (312)
T 2iwi_A 284 D 284 (312)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.8e-33 Score=262.55 Aligned_cols=215 Identities=19% Similarity=0.276 Sum_probs=150.2
Q ss_pred cccccchhhhccccccC---------CCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhh
Q 042634 179 IRHRNLVKIITSCASVD---------FQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHH 249 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~---------~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~ 249 (427)
++||||+++++.+.... +......++||||++ |+|.+++.. ..+++..++.++.|++.||+|||
T Consensus 65 l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH- 137 (320)
T 2i6l_A 65 LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIH- 137 (320)
T ss_dssp CCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHH-
T ss_pred cCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHH-
Confidence 46999999998753211 123456799999996 699998864 34889999999999999999999
Q ss_pred cCCCCeeeccccCCceeeC-CCCceEecccccccccCCc---------CCCccccccccccCC-CCcCccccchhHHHHH
Q 042634 250 YCETPIVHCDLKPSNVLLD-GELTAHVGDFGLAKFLPEA---------TNNFFNFQIAEYGMG-SEVSTSGDVYSFGILL 318 (427)
Q Consensus 250 ~~~~~ivHrDlkp~NIll~-~~~~~kL~DFG~a~~~~~~---------~~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl 318 (427)
+.||+||||||+||+++ .++.+||+|||.++..... ..++..|+|||.+.+ ..++.++|||||||++
T Consensus 138 --~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il 215 (320)
T 2i6l_A 138 --SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIF 215 (320)
T ss_dssp --HTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHH
T ss_pred --hCCEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHH
Confidence 89999999999999997 5679999999999875421 155788999998865 6789999999999999
Q ss_pred HHHHhCCCCCCcccCCCccHHHHHHHhcccc----hhcccC---ccccccccccchhhhccccccccccchHHHHHHHHH
Q 042634 319 LETFTGKRPTNEMFTGNLTLHNFVKEALPER----LAEIVD---PVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLG 391 (427)
Q Consensus 319 ~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 391 (427)
|||++|+.||.+... ......+....+.. ..+... ....... .............++.++.+
T Consensus 216 ~el~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~ 284 (320)
T 2i6l_A 216 AEMLTGKTLFAGAHE--LEQMQLILESIPVVHEEDRQELLSVIPVYIRNDM---------TEPHKPLTQLLPGISREAVD 284 (320)
T ss_dssp HHHHHSSCSSCCSSH--HHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHT---------TSCCCCHHHHSTTCCHHHHH
T ss_pred HHHHhCCCCCCCCCH--HHHHHHHHHhcCCCchhhhhhhhhcCcccccccc---------cCCCCChhHhcchhhHHHHH
Confidence 999999999976421 11111111111100 000000 0000000 00000000011234667899
Q ss_pred HHhhcCCCCCCCCCCHHHHHHH
Q 042634 392 IGVTCSSELPRERMNMEEVAAQ 413 (427)
Q Consensus 392 l~~~cl~~dP~~Rpt~~ev~~~ 413 (427)
++.+||+.||++|||++|++++
T Consensus 285 li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 285 FLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHcCCCccccCCHHHHhCC
Confidence 9999999999999999999863
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=272.28 Aligned_cols=225 Identities=22% Similarity=0.203 Sum_probs=156.3
Q ss_pred cccccchhhhccccccC-CCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 042634 179 IRHRNLVKIITSCASVD-FQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVH 257 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~-~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivH 257 (427)
++||||+++++++.... +..+...++||||+++|+|.+++...... ..+++..++.++.|++.||+||| +.||+|
T Consensus 69 L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~-~~lse~~i~~I~~QLl~aL~yLH---s~gIVH 144 (676)
T 3qa8_A 69 LNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENC-CGLKEGPIRTLLSDISSALRYLH---ENRIIH 144 (676)
T ss_dssp CCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCT-TCCCSSHHHHHHHHHHHHHHHHH---HTTBCC
T ss_pred CCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccC-CCCCHHHHHHHHHHHHHHHHHHH---HCCCcc
Confidence 46999999998865422 23356789999999999999998764321 35889999999999999999999 899999
Q ss_pred ccccCCceeeCCCCc---eEecccccccccCCcC-----CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCC
Q 042634 258 CDLKPSNVLLDGELT---AHVGDFGLAKFLPEAT-----NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTN 329 (427)
Q Consensus 258 rDlkp~NIll~~~~~---~kL~DFG~a~~~~~~~-----~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~ 329 (427)
|||||+||+++.++. +||+|||.++...... .|+..|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 145 rDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~ 224 (676)
T 3qa8_A 145 RDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFL 224 (676)
T ss_dssp CCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCCHHHeEeecCCCceeEEEcccccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 999999999986654 9999999998765432 78899999999999999999999999999999999999997
Q ss_pred cccCCCccHHHHHHHhcccchhc-ccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 042634 330 EMFTGNLTLHNFVKEALPERLAE-IVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME 408 (427)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ 408 (427)
+... ...+........... .......... . .. .....+.......+..+.+++.+||++||++|||++
T Consensus 225 ~~~~----~~~~~~~i~~~~~~~~~~~~~l~g~~---~---~~-~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~ 293 (676)
T 3qa8_A 225 PNWQ----PVQWHGKVREKSNEHIVVYDDLTGAV---K---FS-SVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDP 293 (676)
T ss_dssp SSCH----HHHSSTTCC------CCSCCCCSSSC---C---CC-SSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCT
T ss_pred cccc----hhhhhhhhhcccchhhhhhhhhcccc---c---cc-cccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHH
Confidence 5311 000000000000000 0000000000 0 00 000011112334677899999999999999999998
Q ss_pred HH-----HHHHHHHH
Q 042634 409 EV-----AAQLLSFR 418 (427)
Q Consensus 409 ev-----~~~L~~~~ 418 (427)
|+ .+.++.+.
T Consensus 294 elL~hp~F~~l~~iL 308 (676)
T 3qa8_A 294 QNPNVGCFQALDSIL 308 (676)
T ss_dssp TCCCCTTHHHHHHHH
T ss_pred HHhcCHHHHHHHHHH
Confidence 84 45554443
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.4e-32 Score=280.02 Aligned_cols=192 Identities=23% Similarity=0.307 Sum_probs=150.2
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++++......+....++||||+++++|.+++.. .+++.+++.++.||+.||+||| ++||+||
T Consensus 136 l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH---~~giiHr 206 (681)
T 2pzi_A 136 VVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLH---SIGLVYN 206 (681)
T ss_dssp CCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred cCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHH---HCCCeec
Confidence 579999999998765332222236999999999999987754 4899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc--CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccCCCc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA--TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNL 336 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~--~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~~~~ 336 (427)
||||+|||++.+ .+||+|||+++..... ..||+.|+|||++.+.. +.++|||||||++|||++|..||.+......
T Consensus 207 Dlkp~NIll~~~-~~kl~DFG~a~~~~~~~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~ 284 (681)
T 2pzi_A 207 DLKPENIMLTEE-QLKLIDLGAVSRINSFGYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL 284 (681)
T ss_dssp CCSGGGEEECSS-CEEECCCTTCEETTCCSCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC
T ss_pred ccChHHeEEeCC-cEEEEecccchhcccCCccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc
Confidence 999999999886 8999999999876543 37899999999987654 8999999999999999999988764211100
Q ss_pred cHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCC-CHHHHHHHHH
Q 042634 337 TLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERM-NMEEVAAQLL 415 (427)
Q Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rp-t~~ev~~~L~ 415 (427)
+ . .......+..+.+++.+||+.||++|| +++++...|.
T Consensus 285 ----------~-------~-----------------------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 285 ----------P-------E-----------------------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp ----------C-------T-----------------------TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred ----------c-------c-----------------------cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence 0 0 001222446788999999999999999 5777888887
Q ss_pred HHHHHH
Q 042634 416 SFRNKL 421 (427)
Q Consensus 416 ~~~~~~ 421 (427)
.+..+.
T Consensus 325 ~~~~~~ 330 (681)
T 2pzi_A 325 GVLREV 330 (681)
T ss_dssp HHHHHH
T ss_pred HHHHHh
Confidence 775543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=251.21 Aligned_cols=187 Identities=20% Similarity=0.296 Sum_probs=140.2
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
.+||||+++++.+... ..+....++||||+++|+|.+++..... ..+++..++.++.|++.||+||| +.||+||
T Consensus 68 ~~h~~i~~~~~~~~~~-~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~ 141 (299)
T 3m2w_A 68 SQCPHIVRIVDVYENL-YAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLH---SINIAHR 141 (299)
T ss_dssp TTSTTBCCEEEEEEEE-ETTEEEEEEEECCCCSCBHHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred ccCCCchhHHhhhhhh-cCCCceEEEEEeecCCCcHHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccC
Confidence 5799999999986542 2234567999999999999999976432 45899999999999999999999 8999999
Q ss_pred cccCCceeeCC---CCceEecccccccccCCcCCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccCCC
Q 042634 259 DLKPSNVLLDG---ELTAHVGDFGLAKFLPEATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGN 335 (427)
Q Consensus 259 Dlkp~NIll~~---~~~~kL~DFG~a~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~~~ 335 (427)
||||+||+++. ++.+||+|||+|+... +..++.++||||+||++|||++|+.||.......
T Consensus 142 dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~----------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~ 205 (299)
T 3m2w_A 142 DVKPENLLYTSKRPNAILKLTDFGFAKETT----------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 205 (299)
T ss_dssp CCSGGGEEESSSSTTCCEEECCCTTCEECT----------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-----
T ss_pred CCCHHHEEEecCCCCCcEEEeccccccccc----------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchh
Confidence 99999999988 7899999999986542 3567889999999999999999999997532110
Q ss_pred ccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 042634 336 LTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAAQ 413 (427)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~ 413 (427)
. .......+. .... ..+......++.++.+++.+||+.||++|||++|++++
T Consensus 206 ~----------~~~~~~~~~---~~~~-------------~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 206 I----------SPGMKTRIR---MGQY-------------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp ------------CCSCCSSC---TTCC-------------SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred h----------hHHHHHHHh---hccc-------------cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0 000000000 0000 00000112346778999999999999999999999874
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=261.21 Aligned_cols=177 Identities=16% Similarity=0.140 Sum_probs=135.8
Q ss_pred ccceeeeeecCCCcccccccc---hhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccccCCceeeCCCCceEecc
Q 042634 201 SEALVYEFMVNGSLEEWLHPN---REALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGD 277 (427)
Q Consensus 201 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~D 277 (427)
..+++|+++ +++|.++++.. ......+++..++.++.|++.||+||| ++||+||||||+|||++.++.+||+|
T Consensus 179 ~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~iiHrDiKp~NILl~~~~~~kL~D 254 (413)
T 3dzo_A 179 SRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTG 254 (413)
T ss_dssp SEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECC
T ss_pred ceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcccceEEEecCCeEEEEe
Confidence 346677765 78999888421 111245888999999999999999999 89999999999999999999999999
Q ss_pred cccccccCCc---CCCcccccccccc----------CCCCcCccccchhHHHHHHHHHhCCCCCCcccCCCccHHHHHHH
Q 042634 278 FGLAKFLPEA---TNNFFNFQIAEYG----------MGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKE 344 (427)
Q Consensus 278 FG~a~~~~~~---~~~~~~y~aPE~~----------~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~~~~~~~~~~~~ 344 (427)
||+++..... ..| +.|+|||++ ....++.++|||||||++|||++|+.||........
T Consensus 255 FG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~-------- 325 (413)
T 3dzo_A 255 FEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGG-------- 325 (413)
T ss_dssp GGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSC--------
T ss_pred ccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhh--------
Confidence 9999876543 366 899999999 556689999999999999999999999975321100
Q ss_pred hcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH--HHHHHHH
Q 042634 345 ALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAAQ--LLSFRNK 420 (427)
Q Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~--L~~~~~~ 420 (427)
...+... ...++.++.+++.+||+.||++|||+.|+++. ++++.+.
T Consensus 326 -----~~~~~~~-------------------------~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~~~ 373 (413)
T 3dzo_A 326 -----SEWIFRS-------------------------CKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTE 373 (413)
T ss_dssp -----SGGGGSS-------------------------CCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHH
T ss_pred -----HHHHHhh-------------------------cccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHHHH
Confidence 0000000 00124568999999999999999999998764 4444443
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-30 Score=242.65 Aligned_cols=179 Identities=11% Similarity=0.071 Sum_probs=136.6
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++++.. +...++||||+++++|.++++.. ....++..++.|++.||+||| ++||+||
T Consensus 88 l~hp~iv~~~~~~~~-----~~~~~lv~e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH---~~givH~ 153 (286)
T 3uqc_A 88 IDKPGVARVLDVVHT-----RAGGLVVAEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAH---RAGVALS 153 (286)
T ss_dssp CCCTTBCCEEEEEEE-----TTEEEEEEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHH---HTTCCCC
T ss_pred CCCCCcceeeEEEEE-----CCcEEEEEEecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHH---HCCCccC
Confidence 579999999998644 56789999999999999998543 355678899999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcCCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccCCCccH
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTL 338 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~~~~~~ 338 (427)
||||+|||++.++.+||+++|. ++ .++.++|||||||++|||++|+.||.+........
T Consensus 154 Dikp~NIll~~~g~~kl~~~~~--------------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~ 212 (286)
T 3uqc_A 154 IDHPSRVRVSIDGDVVLAYPAT--------------MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA 212 (286)
T ss_dssp CCSGGGEEEETTSCEEECSCCC--------------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE
T ss_pred CCCcccEEEcCCCCEEEEeccc--------------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH
Confidence 9999999999999999996653 33 37899999999999999999999998642211000
Q ss_pred HHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHHHHHH
Q 042634 339 HNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAAQLLSFR 418 (427)
Q Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L~~~~ 418 (427)
.....+..... ........++.++.+++.+||+.||++| |++|+++.|+++.
T Consensus 213 ----------~~~~~~~~~~~-----------------~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~ 264 (286)
T 3uqc_A 213 ----------PAERDTAGQPI-----------------EPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT 264 (286)
T ss_dssp ----------ECCBCTTSCBC-----------------CHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred ----------HHHHHhccCCC-----------------ChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence 00000000000 0000112345678999999999999999 9999999999986
Q ss_pred HH
Q 042634 419 NK 420 (427)
Q Consensus 419 ~~ 420 (427)
..
T Consensus 265 ~~ 266 (286)
T 3uqc_A 265 AV 266 (286)
T ss_dssp C-
T ss_pred cc
Confidence 43
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-30 Score=247.90 Aligned_cols=193 Identities=16% Similarity=0.117 Sum_probs=143.0
Q ss_pred ccccchhhhcccccc--------CCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcC
Q 042634 180 RHRNLVKIITSCASV--------DFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYC 251 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~--------~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~ 251 (427)
.||||+++++.+... ++.+....++|||||++|++.+.+.+ ..+++..++.++.||+.||+|||+
T Consensus 107 ~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~~aL~~lH~-- 179 (336)
T 2vuw_A 107 YPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTASLAVAEA-- 179 (336)
T ss_dssp CCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHHHHHHHHHH--
T ss_pred CcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHH--
Confidence 389999988876541 12235678999999999987776643 348999999999999999999993
Q ss_pred CCCeeeccccCCceeeCCCC--------------------ceEecccccccccCCcC-CCccccccccccCCCCcCcccc
Q 042634 252 ETPIVHCDLKPSNVLLDGEL--------------------TAHVGDFGLAKFLPEAT-NNFFNFQIAEYGMGSEVSTSGD 310 (427)
Q Consensus 252 ~~~ivHrDlkp~NIll~~~~--------------------~~kL~DFG~a~~~~~~~-~~~~~y~aPE~~~~~~~~~~~D 310 (427)
+.||+||||||+|||++.++ .+||+|||+|+...... .||+.|+|||++.+.. +.++|
T Consensus 180 ~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~~~~gt~~y~aPE~~~g~~-~~~~D 258 (336)
T 2vuw_A 180 SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDG-DYQFD 258 (336)
T ss_dssp HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETTEEECCCCTTCSGGGCCCS-SHHHH
T ss_pred hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCCcEEEeecccChhhhcCCC-cccee
Confidence 37899999999999998876 89999999999765443 7899999999998776 89999
Q ss_pred chhHHHH-HHHHHhCCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHH
Q 042634 311 VYSFGIL-LLETFTGKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSV 389 (427)
Q Consensus 311 iwS~G~v-l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (427)
|||+|++ .+++++|..||.... +....... +..... .. ...........+.++
T Consensus 259 iwsl~~~~~~~~~~g~~p~~~~~-----~~~~~~~~----~~~~~~---~~--------------~~~~~~~~~~~s~~~ 312 (336)
T 2vuw_A 259 IYRLMKKENNNRWGEYHPYSNVL-----WLHYLTDK----MLKQMT---FK--------------TKCNTPAMKQIKRKI 312 (336)
T ss_dssp HHHHHHHHHTTCTTSCCTHHHHH-----HHHHHHHH----HHHTCC---CS--------------SCCCSHHHHHHHHHH
T ss_pred hhhhhCCCCcccccccCCCcchh-----hhhHHHHh----hhhhhc---cC--------------cccchhhhhhcCHHH
Confidence 9998777 777888999985310 00000000 000000 00 000011345678899
Q ss_pred HHHHhhcCCCCCCCCCCHHHHH
Q 042634 390 LGIGVTCSSELPRERMNMEEVA 411 (427)
Q Consensus 390 ~~l~~~cl~~dP~~Rpt~~ev~ 411 (427)
.+++.+||+.| |++|++
T Consensus 313 ~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 313 QEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHhccC-----CHHHHH
Confidence 99999999976 999988
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=252.01 Aligned_cols=178 Identities=35% Similarity=0.622 Sum_probs=142.2
Q ss_pred eeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccC
Q 042634 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNL 81 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~ 81 (427)
|+|++|+++|.+|..+..+++|++|+|++|++++.+|.+++.+++|++|+|++|.++|.+|..++.+++|++|++++|++
T Consensus 471 L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l 550 (768)
T 3rgz_A 471 LILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLF 550 (768)
T ss_dssp EECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEE
T ss_pred EEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCcc
Confidence 67777888777787788888888888888888777787888888888888888888888888888888888888888888
Q ss_pred cccCCCCccc----------------------------------------------------------------------
Q 042634 82 TGTTPTEVIG---------------------------------------------------------------------- 91 (427)
Q Consensus 82 ~~~~p~~~~~---------------------------------------------------------------------- 91 (427)
+|.+|..+..
T Consensus 551 ~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~ 630 (768)
T 3rgz_A 551 NGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDN 630 (768)
T ss_dssp ESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSS
T ss_pred CCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhc
Confidence 7777754432
Q ss_pred cccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCCCCcccccCCcee
Q 042634 92 LSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENL 171 (427)
Q Consensus 92 l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~~l~~l~~L~~L 171 (427)
+.+| +.|+|++|+++|.+|.+++++++|+.|+|++|+++|.+|..++++++|+.|++++|+++|.+|..+..++.|+.|
T Consensus 631 l~~L-~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L 709 (768)
T 3rgz_A 631 NGSM-MFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEI 709 (768)
T ss_dssp SBCC-CEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEE
T ss_pred cccc-cEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEE
Confidence 2345 468888888888888888888888888888888888888888888888888888888888888888888888888
Q ss_pred eccCCcccc
Q 042634 172 DLSRNNFIR 180 (427)
Q Consensus 172 ~L~~N~ll~ 180 (427)
++++|++..
T Consensus 710 ~ls~N~l~g 718 (768)
T 3rgz_A 710 DLSNNNLSG 718 (768)
T ss_dssp ECCSSEEEE
T ss_pred ECcCCcccc
Confidence 888887754
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-27 Score=223.97 Aligned_cols=178 Identities=28% Similarity=0.497 Sum_probs=169.3
Q ss_pred CeeecCCcccc--cCCccccCCCCCCEeeeec-ccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEcc
Q 042634 1 AFTLVGNQFTG--RIPGSIGDLHKLQRLTLEM-NKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLS 77 (427)
Q Consensus 1 ~l~l~~n~l~~--~~p~~~~~l~~L~~L~l~~-n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~ 77 (427)
+|+|++|.++| .+|..++.+++|++|+|++ |.+++.+|..|+++++|++|+|++|.+++.+|..+..+++|++|+++
T Consensus 54 ~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls 133 (313)
T 1ogq_A 54 NLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFS 133 (313)
T ss_dssp EEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECC
T ss_pred EEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCC
Confidence 37999999999 8999999999999999995 99999999999999999999999999999999999999999999999
Q ss_pred CccCcccCCCCccccccccceeeccCCcCcCCCCCCCcCCC-CCCeEECcCCcccccCCccccccccccceeeeeeeccc
Q 042634 78 NNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILK-NLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRG 156 (427)
Q Consensus 78 ~N~~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~-~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~ 156 (427)
+|.+++.+|..+..+++| ++|++++|++++.+|..++.++ +|+.|++++|++++.+|..++.+. |+.|++++|.+++
T Consensus 134 ~N~l~~~~p~~~~~l~~L-~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~ 211 (313)
T 1ogq_A 134 YNALSGTLPPSISSLPNL-VGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEG 211 (313)
T ss_dssp SSEEESCCCGGGGGCTTC-CEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEE
T ss_pred CCccCCcCChHHhcCCCC-CeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccC
Confidence 999999999999999999 6899999999999999999998 999999999999999999999987 9999999999999
Q ss_pred cCCCCcccccCCceeeccCCcccc
Q 042634 157 NIPSSLSSLRGIENLDLSRNNFIR 180 (427)
Q Consensus 157 ~~p~~l~~l~~L~~L~L~~N~ll~ 180 (427)
.+|..+..+++|+.|++++|.+..
T Consensus 212 ~~~~~~~~l~~L~~L~L~~N~l~~ 235 (313)
T 1ogq_A 212 DASVLFGSDKNTQKIHLAKNSLAF 235 (313)
T ss_dssp CCGGGCCTTSCCSEEECCSSEECC
T ss_pred cCCHHHhcCCCCCEEECCCCceee
Confidence 999999999999999999998864
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.94 E-value=5.2e-27 Score=220.85 Aligned_cols=195 Identities=25% Similarity=0.416 Sum_probs=168.6
Q ss_pred CeeecC-CcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCc
Q 042634 1 AFTLVG-NQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNN 79 (427)
Q Consensus 1 ~l~l~~-n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 79 (427)
+|+|++ |.+++.+|..++.+++|++|+|++|++++.+|..|+++++|++|+|++|.+++.+|..+..+++|++|++++|
T Consensus 80 ~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 159 (313)
T 1ogq_A 80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159 (313)
T ss_dssp EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred eeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCC
Confidence 378995 9999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCcccCCCCccccc-cccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccC
Q 042634 80 NLTGTTPTEVIGLS-SLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNI 158 (427)
Q Consensus 80 ~~~~~~p~~~~~l~-~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~ 158 (427)
++++.+|..+..+. +| ++|++++|++++.+|..+..++ |+.|++++|.+++.+|..++.+++|+.|++++|.+++.+
T Consensus 160 ~l~~~~p~~l~~l~~~L-~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 237 (313)
T 1ogq_A 160 RISGAIPDSYGSFSKLF-TSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDL 237 (313)
T ss_dssp CCEEECCGGGGCCCTTC-CEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBG
T ss_pred cccCcCCHHHhhhhhcC-cEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeec
Confidence 99999999999988 77 6899999999999999999987 999999999999888889999999999999999998766
Q ss_pred CCCcccccCCceeeccCCccc-ccccchhhhccccccCCCC
Q 042634 159 PSSLSSLRGIENLDLSRNNFI-RHRNLVKIITSCASVDFQG 198 (427)
Q Consensus 159 p~~l~~l~~L~~L~L~~N~ll-~Hpniv~~~~~~~~~~~~~ 198 (427)
|. +..+++|+.|++++|.+. ..|..+.-+.....++..+
T Consensus 238 ~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~ 277 (313)
T 1ogq_A 238 GK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSF 277 (313)
T ss_dssp GG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCS
T ss_pred Cc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcC
Confidence 55 778889999999999886 4444433333333333333
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-26 Score=242.86 Aligned_cols=177 Identities=38% Similarity=0.570 Sum_probs=113.8
Q ss_pred eeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccC
Q 042634 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNL 81 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~ 81 (427)
|+|++|.++|.+|..++.+++|+.|+|++|++++.+|..++++++|++|+|++|+++|.+|.+++.+++|++|++++|++
T Consensus 447 L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 526 (768)
T 3rgz_A 447 LKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSF 526 (768)
T ss_dssp EECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCC
T ss_pred EECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcc
Confidence 45555555555566666666666666666666655666666666666666666666666666666666666666666666
Q ss_pred cccCCCCccccccccceeeccCCcCcCCCCCCC-----------------------------------------------
Q 042634 82 TGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNF----------------------------------------------- 114 (427)
Q Consensus 82 ~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~----------------------------------------------- 114 (427)
+|.+|..+..+++| +.|++++|+++|.+|..+
T Consensus 527 ~~~~p~~l~~l~~L-~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 605 (768)
T 3rgz_A 527 SGNIPAELGDCRSL-IWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLN 605 (768)
T ss_dssp EEECCGGGGGCTTC-CEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGG
T ss_pred cCcCCHHHcCCCCC-CEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhh
Confidence 66666666666666 456666666665555432
Q ss_pred -----------------------cCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCCCCcccccCCcee
Q 042634 115 -----------------------GILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENL 171 (427)
Q Consensus 115 -----------------------~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~~l~~l~~L~~L 171 (427)
+.+++|+.||+++|+++|.+|.+++++++|+.|++++|.++|.+|..++.+++|+.|
T Consensus 606 ~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~L 685 (768)
T 3rgz_A 606 RLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNIL 685 (768)
T ss_dssp GGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEE
T ss_pred ccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEE
Confidence 234556666777777777777777777777777777777777777777777777777
Q ss_pred eccCCccc
Q 042634 172 DLSRNNFI 179 (427)
Q Consensus 172 ~L~~N~ll 179 (427)
++++|++.
T Consensus 686 dLs~N~l~ 693 (768)
T 3rgz_A 686 DLSSNKLD 693 (768)
T ss_dssp ECCSSCCE
T ss_pred ECCCCccc
Confidence 77777665
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.4e-28 Score=246.17 Aligned_cols=133 Identities=19% Similarity=0.132 Sum_probs=98.4
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
..|+||+++++++ .++...||||||++|++|.+++... .++++. .|+.||+.||+|+| ++|||||
T Consensus 299 ~~~~~i~~~~~~~-----ed~~~~yLVMEyv~G~~L~d~i~~~----~~l~~~---~I~~QIl~AL~ylH---~~GIIHR 363 (569)
T 4azs_A 299 PAGFDAPAVLAHG-----ENAQSGWLVMEKLPGRLLSDMLAAG----EEIDRE---KILGSLLRSLAALE---KQGFWHD 363 (569)
T ss_dssp CTTCCCCCEEEEE-----ECSSEEEEEEECCCSEEHHHHHHTT----CCCCHH---HHHHHHHHHHHHHH---HTTCEES
T ss_pred CCCCCeeEEEEEE-----EECCEEEEEEecCCCCcHHHHHHhC----CCCCHH---HHHHHHHHHHHHHH---HCCceec
Confidence 4799999999984 4477899999999999999999765 346654 58999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC------CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRP 327 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~p 327 (427)
||||+|||++.++.+||+|||+|+...... .||+.|+|||++.+ .+..++|+||+|++++++.++..+
T Consensus 364 DIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 364 DVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp CCCGGGEEECTTSCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred cCchHhEEECCCCCEEEeecccCeeCCCCCccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 999999999999999999999998765432 68899999999875 467789999999998887665444
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.93 E-value=7e-26 Score=214.44 Aligned_cols=174 Identities=24% Similarity=0.325 Sum_probs=143.7
Q ss_pred CeeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCcc
Q 042634 1 AFTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNN 80 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~ 80 (427)
+|+|++|+++ .+|+.++.+++|++|+|++|.++ .+|..++++++|++|+|++|.++ .+|..++.+++|++|++++|+
T Consensus 85 ~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~ 161 (328)
T 4fcg_A 85 ALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACP 161 (328)
T ss_dssp EEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEET
T ss_pred EEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCC
Confidence 3788888888 77888888888888888888888 78888888888888888888888 888888888888888888888
Q ss_pred CcccCCCCccc---------cccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeee
Q 042634 81 LTGTTPTEVIG---------LSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNG 151 (427)
Q Consensus 81 ~~~~~p~~~~~---------l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~ 151 (427)
+.+.+|..+.. +++| ++|+|++|.++ .+|..++.+++|+.|++++|+++ .+|..++.+++|+.|++++
T Consensus 162 ~~~~~p~~~~~~~~~~~~~~l~~L-~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L~Ls~ 238 (328)
T 4fcg_A 162 ELTELPEPLASTDASGEHQGLVNL-QSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRG 238 (328)
T ss_dssp TCCCCCSCSEEEC-CCCEEESTTC-CEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC-CCCGGGGGCTTCCEEECTT
T ss_pred CccccChhHhhccchhhhccCCCC-CEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC-cCchhhccCCCCCEEECcC
Confidence 88888877654 7777 57888888887 78888888888888888888888 4777788888888888888
Q ss_pred eeccccCCCCcccccCCceeeccCCcccc
Q 042634 152 NFFRGNIPSSLSSLRGIENLDLSRNNFIR 180 (427)
Q Consensus 152 n~l~~~~p~~l~~l~~L~~L~L~~N~ll~ 180 (427)
|.+.+.+|..+..+++|+.|++++|.+..
T Consensus 239 n~~~~~~p~~~~~l~~L~~L~L~~n~~~~ 267 (328)
T 4fcg_A 239 CTALRNYPPIFGGRAPLKRLILKDCSNLL 267 (328)
T ss_dssp CTTCCBCCCCTTCCCCCCEEECTTCTTCC
T ss_pred CcchhhhHHHhcCCCCCCEEECCCCCchh
Confidence 88888888888888888888888876643
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.1e-25 Score=209.97 Aligned_cols=175 Identities=22% Similarity=0.309 Sum_probs=165.5
Q ss_pred CeeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccC---------CCCC
Q 042634 1 AFTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGK---------CQNL 71 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~---------l~~L 71 (427)
+|+|++|.++ .+|..++.+++|++|+|++|+++ .+|..++++++|++|++++|++.+.+|..++. +++|
T Consensus 108 ~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L 185 (328)
T 4fcg_A 108 HMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNL 185 (328)
T ss_dssp EEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTC
T ss_pred EEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhccCCCC
Confidence 4899999999 89999999999999999999999 89999999999999999999999899998875 9999
Q ss_pred CeEEccCccCcccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeee
Q 042634 72 ILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNG 151 (427)
Q Consensus 72 ~~l~l~~N~~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~ 151 (427)
++|++++|+++ .+|..+.++++| ++|+|++|+++ .+|..++.+++|+.|++++|.+.+.+|..++.+++|+.|++++
T Consensus 186 ~~L~L~~n~l~-~lp~~l~~l~~L-~~L~L~~N~l~-~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~ 262 (328)
T 4fcg_A 186 QSLRLEWTGIR-SLPASIANLQNL-KSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKD 262 (328)
T ss_dssp CEEEEEEECCC-CCCGGGGGCTTC-CEEEEESSCCC-CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTT
T ss_pred CEEECcCCCcC-cchHhhcCCCCC-CEEEccCCCCC-cCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCC
Confidence 99999999999 889899999999 68999999998 5888899999999999999999999999999999999999999
Q ss_pred eeccccCCCCcccccCCceeeccCCcccc
Q 042634 152 NFFRGNIPSSLSSLRGIENLDLSRNNFIR 180 (427)
Q Consensus 152 n~l~~~~p~~l~~l~~L~~L~L~~N~ll~ 180 (427)
|.+.+.+|..+..+++|+.|++++|++..
T Consensus 263 n~~~~~~p~~~~~l~~L~~L~L~~n~~~~ 291 (328)
T 4fcg_A 263 CSNLLTLPLDIHRLTQLEKLDLRGCVNLS 291 (328)
T ss_dssp CTTCCBCCTTGGGCTTCCEEECTTCTTCC
T ss_pred CCchhhcchhhhcCCCCCEEeCCCCCchh
Confidence 99999999999999999999999988755
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4e-25 Score=205.10 Aligned_cols=181 Identities=24% Similarity=0.252 Sum_probs=156.0
Q ss_pred CeeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeecccc-CcccCCcCccCCCCCCeEEccCc
Q 042634 1 AFTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENM-LEGSIPSSLGKCQNLILLDLSNN 79 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~-l~~~~p~~~~~l~~L~~l~l~~N 79 (427)
+|+|++|.+++..+..+..+++|++|+|++|.+++..|..|+++++|++|++++|. +++..|..+..+++|++|++++|
T Consensus 36 ~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n 115 (285)
T 1ozn_A 36 RIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRC 115 (285)
T ss_dssp EEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTS
T ss_pred EEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCC
Confidence 37899999997777789999999999999999997668889999999999999997 77444778889999999999999
Q ss_pred cCcccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCC
Q 042634 80 NLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIP 159 (427)
Q Consensus 80 ~~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p 159 (427)
.+++..|..+.++++| ++|++++|++++..+..++.+++|+.|++++|++++..+..+..+++|+.|++++|.+++..|
T Consensus 116 ~l~~~~~~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 194 (285)
T 1ozn_A 116 GLQELGPGLFRGLAAL-QYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHP 194 (285)
T ss_dssp CCCCCCTTTTTTCTTC-CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred cCCEECHhHhhCCcCC-CEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCH
Confidence 9998778888889999 679999999986666678899999999999999986555578889999999999999998888
Q ss_pred CCcccccCCceeeccCCcccccc
Q 042634 160 SSLSSLRGIENLDLSRNNFIRHR 182 (427)
Q Consensus 160 ~~l~~l~~L~~L~L~~N~ll~Hp 182 (427)
..+..+++|+.|++++|.+..-+
T Consensus 195 ~~~~~l~~L~~L~l~~n~l~~~~ 217 (285)
T 1ozn_A 195 HAFRDLGRLMTLYLFANNLSALP 217 (285)
T ss_dssp TTTTTCTTCCEEECCSSCCSCCC
T ss_pred hHccCcccccEeeCCCCcCCcCC
Confidence 88999999999999998886543
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.2e-24 Score=200.17 Aligned_cols=176 Identities=22% Similarity=0.216 Sum_probs=153.3
Q ss_pred eeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCcc-
Q 042634 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNN- 80 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~- 80 (427)
++.+++.++ .+|..+ .++|+.|+|++|.+++..+..|+.+++|++|++++|.+++..|..+..+++|++|++++|.
T Consensus 16 ~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~ 92 (285)
T 1ozn_A 16 TSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92 (285)
T ss_dssp EECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTT
T ss_pred EEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCC
Confidence 678888898 667654 5799999999999996555679999999999999999997778889999999999999997
Q ss_pred CcccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCCC
Q 042634 81 LTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPS 160 (427)
Q Consensus 81 ~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~ 160 (427)
++...|..+.++++| ++|++++|.+++..|..+.++++|+.|++++|++++..+..++.+++|+.|++++|.+++..+.
T Consensus 93 l~~~~~~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 171 (285)
T 1ozn_A 93 LRSVDPATFHGLGRL-HTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPER 171 (285)
T ss_dssp CCCCCTTTTTTCTTC-CEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTT
T ss_pred ccccCHHHhcCCcCC-CEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHH
Confidence 776668888999999 6899999999987788899999999999999999965556788999999999999999987777
Q ss_pred CcccccCCceeeccCCccccc
Q 042634 161 SLSSLRGIENLDLSRNNFIRH 181 (427)
Q Consensus 161 ~l~~l~~L~~L~L~~N~ll~H 181 (427)
.+..+++|+.|++++|.+..-
T Consensus 172 ~~~~l~~L~~L~l~~n~l~~~ 192 (285)
T 1ozn_A 172 AFRGLHSLDRLLLHQNRVAHV 192 (285)
T ss_dssp TTTTCTTCCEEECCSSCCCEE
T ss_pred HhcCccccCEEECCCCccccc
Confidence 799999999999999987553
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.1e-25 Score=229.78 Aligned_cols=144 Identities=19% Similarity=0.269 Sum_probs=95.1
Q ss_pred cceeecCcchhccccCCEeeeccccCccc-----------------CCcCcc--CCCCCCeEEccCccCcccCCCCcccc
Q 042634 32 KFWGEIPSSIGNLTLLITLNFAENMLEGS-----------------IPSSLG--KCQNLILLDLSNNNLTGTTPTEVIGL 92 (427)
Q Consensus 32 ~~~~~~p~~~~~l~~L~~L~l~~n~l~~~-----------------~p~~~~--~l~~L~~l~l~~N~~~~~~p~~~~~l 92 (427)
+++| +|.+|+++++|++|+|++|.++|. +|..++ ++++|++|++++|.+.+.+|..++++
T Consensus 194 ~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l 272 (636)
T 4eco_A 194 NITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKAL 272 (636)
T ss_dssp EEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTC
T ss_pred CCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcC
Confidence 4444 677777777777777777777764 777777 77777777777777777777777777
Q ss_pred ccccceeeccCCc-CcC-CCCCCCcCC------CCCCeEECcCCcccccCCc--cccccccccceeeeeeeccccCCCCc
Q 042634 93 SSLSIYLDLSQNQ-LNG-PLPSNFGIL------KNLGAIDISENKLSGQIPS--SIGSCIRLEQLVMNGNFFRGNIPSSL 162 (427)
Q Consensus 93 ~~l~~~L~l~~n~-~~~-~~p~~~~~l------~~L~~l~l~~n~~~~~~p~--~~~~~~~l~~l~l~~n~l~~~~p~~l 162 (427)
++| ++|++++|+ ++| .+|..++.+ ++|+.|++++|+++ .+|. .++.+++|+.|++++|.++|.+| .+
T Consensus 273 ~~L-~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~ 349 (636)
T 4eco_A 273 PEM-QLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AF 349 (636)
T ss_dssp SSC-CEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CC
T ss_pred CCC-CEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hh
Confidence 777 567777776 666 566655554 66666666666666 5665 56666666666666666665555 55
Q ss_pred ccccCCceeeccCCccc
Q 042634 163 SSLRGIENLDLSRNNFI 179 (427)
Q Consensus 163 ~~l~~L~~L~L~~N~ll 179 (427)
..+++|+.|++++|.+.
T Consensus 350 ~~l~~L~~L~L~~N~l~ 366 (636)
T 4eco_A 350 GSEIKLASLNLAYNQIT 366 (636)
T ss_dssp EEEEEESEEECCSSEEE
T ss_pred CCCCCCCEEECCCCccc
Confidence 55555555555555543
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.92 E-value=3.5e-24 Score=194.97 Aligned_cols=176 Identities=21% Similarity=0.229 Sum_probs=158.8
Q ss_pred eeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccC
Q 042634 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNL 81 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~ 81 (427)
+++++|.++ .+|..+. ++|+.|+|++|.+++..|..|+++++|++|+|++|.+++..|..+..+++|++|++++|++
T Consensus 19 l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 95 (251)
T 3m19_A 19 VDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQL 95 (251)
T ss_dssp EECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCC
T ss_pred EecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcc
Confidence 789999999 7787766 6999999999999977777899999999999999999977777799999999999999999
Q ss_pred cccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCCCC
Q 042634 82 TGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSS 161 (427)
Q Consensus 82 ~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~~ 161 (427)
++..+..+.++++| ++|+|++|++++..+..+..+++|+.|++++|++++..|..++.+++|+.|++++|.+++..+..
T Consensus 96 ~~~~~~~~~~l~~L-~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 174 (251)
T 3m19_A 96 ASLPLGVFDHLTQL-DKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGA 174 (251)
T ss_dssp CCCCTTTTTTCTTC-CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTT
T ss_pred cccChhHhcccCCC-CEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHH
Confidence 97777888999999 68999999999666667899999999999999999655558999999999999999999888888
Q ss_pred cccccCCceeeccCCccccc
Q 042634 162 LSSLRGIENLDLSRNNFIRH 181 (427)
Q Consensus 162 l~~l~~L~~L~L~~N~ll~H 181 (427)
+..+++|+.+++++|.+...
T Consensus 175 ~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 175 FDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp TTTCTTCCEEECCSCCBCTT
T ss_pred HhCCCCCCEEEeeCCceeCC
Confidence 99999999999999998554
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.91 E-value=9.4e-24 Score=194.30 Aligned_cols=176 Identities=23% Similarity=0.295 Sum_probs=142.5
Q ss_pred eeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcC-ccCCCCCCeEEccCcc
Q 042634 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSS-LGKCQNLILLDLSNNN 80 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~-~~~l~~L~~l~l~~N~ 80 (427)
+++++|+++ .+|..+. ++|+.|+|++|++++..+..|+++++|++|+|++|.++ .+|.. +..+++|++|++++|+
T Consensus 21 l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~i~~~~~~~l~~L~~L~l~~n~ 96 (270)
T 2o6q_A 21 VDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNK 96 (270)
T ss_dssp EECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCS-CCCTTTTSSCTTCCEEECCSSC
T ss_pred EEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccC-eeChhhhcCCCCCCEEECCCCc
Confidence 688888888 5776554 67899999999988544457888999999999999988 55554 5778889999999999
Q ss_pred CcccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCCC
Q 042634 81 LTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPS 160 (427)
Q Consensus 81 ~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~ 160 (427)
+++..+..+.++.+| ++|++++|++++..|..++.+++|+.|++++|.+++..+..++.+++|+.|++++|.+++..+.
T Consensus 97 l~~~~~~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 175 (270)
T 2o6q_A 97 LQALPIGVFDQLVNL-AELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEG 175 (270)
T ss_dssp CCCCCTTTTTTCSSC-CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred CCcCCHhHcccccCC-CEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChh
Confidence 986666777888888 6799999999877677788899999999999988854445578888999999999988887777
Q ss_pred CcccccCCceeeccCCcccccc
Q 042634 161 SLSSLRGIENLDLSRNNFIRHR 182 (427)
Q Consensus 161 ~l~~l~~L~~L~L~~N~ll~Hp 182 (427)
.+..+++|+.|++++|.+..-+
T Consensus 176 ~~~~l~~L~~L~L~~N~l~~~~ 197 (270)
T 2o6q_A 176 AFDKLTELKTLKLDNNQLKRVP 197 (270)
T ss_dssp TTTTCTTCCEEECCSSCCSCCC
T ss_pred HhccCCCcCEEECCCCcCCcCC
Confidence 7888888999999888876543
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.8e-23 Score=194.27 Aligned_cols=175 Identities=23% Similarity=0.242 Sum_probs=150.6
Q ss_pred eeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccC
Q 042634 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNL 81 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~ 81 (427)
+++++|+++ .+|..+. ++|+.|+|++|++++..|..|.++++|++|+|++|.++ .+|.. +.+++|++|++++|++
T Consensus 15 l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~-~~l~~L~~L~Ls~N~l 89 (290)
T 1p9a_G 15 VNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVD-GTLPVLGTLDLSHNQL 89 (290)
T ss_dssp EECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEECC-SCCTTCCEEECCSSCC
T ss_pred EECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccC-cccCC-CCCCcCCEEECCCCcC
Confidence 688999999 6787664 68999999999999777788999999999999999999 55544 7889999999999999
Q ss_pred cccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCCCC
Q 042634 82 TGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSS 161 (427)
Q Consensus 82 ~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~~ 161 (427)
+ .+|..+.++++| ++|++++|++++..|..|..+++|+.|++++|++++..+..+..+++|+.|++++|++++..+..
T Consensus 90 ~-~l~~~~~~l~~L-~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~ 167 (290)
T 1p9a_G 90 Q-SLPLLGQTLPAL-TVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGL 167 (290)
T ss_dssp S-SCCCCTTTCTTC-CEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTT
T ss_pred C-cCchhhccCCCC-CEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHH
Confidence 8 788888889999 68999999998666688999999999999999999655566788999999999999999766667
Q ss_pred cccccCCceeeccCCccccccc
Q 042634 162 LSSLRGIENLDLSRNNFIRHRN 183 (427)
Q Consensus 162 l~~l~~L~~L~L~~N~ll~Hpn 183 (427)
+..+++|+.|++++|.+..-|.
T Consensus 168 ~~~l~~L~~L~L~~N~l~~ip~ 189 (290)
T 1p9a_G 168 LNGLENLDTLLLQENSLYTIPK 189 (290)
T ss_dssp TTTCTTCCEEECCSSCCCCCCT
T ss_pred hcCcCCCCEEECCCCcCCccCh
Confidence 7889999999999998875443
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.3e-24 Score=228.70 Aligned_cols=139 Identities=21% Similarity=0.274 Sum_probs=93.7
Q ss_pred cCcchhccccCCEeeeccccCcc-----------------cCCcCcc--CCCCCCeEEccCccCcccCCCCccccccccc
Q 042634 37 IPSSIGNLTLLITLNFAENMLEG-----------------SIPSSLG--KCQNLILLDLSNNNLTGTTPTEVIGLSSLSI 97 (427)
Q Consensus 37 ~p~~~~~l~~L~~L~l~~n~l~~-----------------~~p~~~~--~l~~L~~l~l~~N~~~~~~p~~~~~l~~l~~ 97 (427)
+|.+|+++++|++|+|++|.++| .+|..++ .+++|++|+|++|.+.+.+|..+.++++| +
T Consensus 440 IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L-~ 518 (876)
T 4ecn_A 440 ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPEL-Q 518 (876)
T ss_dssp ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSC-C
T ss_pred hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCC-C
Confidence 67777777777777777777776 2777776 77777777777777777777777777777 5
Q ss_pred eeeccCCc-CcC-CCCCCCcCCC-------CCCeEECcCCcccccCCc--cccccccccceeeeeeeccccCCCCccccc
Q 042634 98 YLDLSQNQ-LNG-PLPSNFGILK-------NLGAIDISENKLSGQIPS--SIGSCIRLEQLVMNGNFFRGNIPSSLSSLR 166 (427)
Q Consensus 98 ~L~l~~n~-~~~-~~p~~~~~l~-------~L~~l~l~~n~~~~~~p~--~~~~~~~l~~l~l~~n~l~~~~p~~l~~l~ 166 (427)
.|+|++|+ ++| .+|..++.++ +|+.|++++|.++ .+|. .++++++|+.|++++|.++ .+| .+..++
T Consensus 519 ~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~ 595 (876)
T 4ecn_A 519 SLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNV 595 (876)
T ss_dssp EEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTS
T ss_pred EEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCC
Confidence 67777776 666 5665544443 6666666666666 5666 5666666666666666665 445 555555
Q ss_pred CCceeeccCCccc
Q 042634 167 GIENLDLSRNNFI 179 (427)
Q Consensus 167 ~L~~L~L~~N~ll 179 (427)
+|+.|++++|.+.
T Consensus 596 ~L~~L~Ls~N~l~ 608 (876)
T 4ecn_A 596 KLTDLKLDYNQIE 608 (876)
T ss_dssp EESEEECCSSCCS
T ss_pred cceEEECcCCccc
Confidence 5666666555554
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.90 E-value=2.2e-24 Score=222.12 Aligned_cols=174 Identities=22% Similarity=0.370 Sum_probs=163.2
Q ss_pred CCcccccCCccccCCCCCCEeeeecccceee-----------------cCcchh--ccccCCEeeeccccCcccCCcCcc
Q 042634 6 GNQFTGRIPGSIGDLHKLQRLTLEMNKFWGE-----------------IPSSIG--NLTLLITLNFAENMLEGSIPSSLG 66 (427)
Q Consensus 6 ~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~-----------------~p~~~~--~l~~L~~L~l~~n~l~~~~p~~~~ 66 (427)
+|+++| +|.+++++++|++|+|++|.++|. +|.+++ ++++|++|+|++|.+.|.+|..++
T Consensus 192 ~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~ 270 (636)
T 4eco_A 192 SNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLK 270 (636)
T ss_dssp SCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTT
T ss_pred cCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHh
Confidence 789998 999999999999999999999975 999999 999999999999999999999999
Q ss_pred CCCCCCeEEccCcc-Ccc-cCCCCcccc------ccccceeeccCCcCcCCCCC--CCcCCCCCCeEECcCCcccccCCc
Q 042634 67 KCQNLILLDLSNNN-LTG-TTPTEVIGL------SSLSIYLDLSQNQLNGPLPS--NFGILKNLGAIDISENKLSGQIPS 136 (427)
Q Consensus 67 ~l~~L~~l~l~~N~-~~~-~~p~~~~~l------~~l~~~L~l~~n~~~~~~p~--~~~~l~~L~~l~l~~n~~~~~~p~ 136 (427)
++++|++|++++|+ ++| .+|..++.+ ++| ++|++++|+++ .+|. .++++++|+.|++++|+++|.+|
T Consensus 271 ~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L-~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip- 347 (636)
T 4eco_A 271 ALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKI-QIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP- 347 (636)
T ss_dssp TCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTC-CEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-
T ss_pred cCCCCCEEECcCCCCCccccchHHHHhhhccccCCCC-CEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-
Confidence 99999999999999 998 899888876 888 68999999999 8999 99999999999999999999999
Q ss_pred cccccccccceeeeeeeccccCCCCcccccC-CceeeccCCcccccccc
Q 042634 137 SIGSCIRLEQLVMNGNFFRGNIPSSLSSLRG-IENLDLSRNNFIRHRNL 184 (427)
Q Consensus 137 ~~~~~~~l~~l~l~~n~l~~~~p~~l~~l~~-L~~L~L~~N~ll~Hpni 184 (427)
.++.+++|+.|++++|.++ .+|..+..+++ |+.|++++|.+..-|..
T Consensus 348 ~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~~lp~~ 395 (636)
T 4eco_A 348 AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLKYIPNI 395 (636)
T ss_dssp CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCSSCCSC
T ss_pred hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCcccchh
Confidence 9999999999999999999 78899999999 99999999998765543
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.7e-23 Score=196.17 Aligned_cols=175 Identities=28% Similarity=0.295 Sum_probs=81.2
Q ss_pred eeecCCccc--ccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCC-cCccCCCCCCeEEccC
Q 042634 2 FTLVGNQFT--GRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIP-SSLGKCQNLILLDLSN 78 (427)
Q Consensus 2 l~l~~n~l~--~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p-~~~~~l~~L~~l~l~~ 78 (427)
|+|++|.++ +..|..+..+++|++|+|++|.++ .+|..+..+++|++|++++|.+++..+ ..+..+++|++|++++
T Consensus 57 L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~ 135 (306)
T 2z66_A 57 LSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISH 135 (306)
T ss_dssp EECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTT
T ss_pred EECCCCccCcccCcccccccccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCC
Confidence 455555554 222344444555555555555554 344444445555555555555442211 2344444455555555
Q ss_pred ccCcccCCCCccccccccceeeccCCcCcC-CCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeecccc
Q 042634 79 NNLTGTTPTEVIGLSSLSIYLDLSQNQLNG-PLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGN 157 (427)
Q Consensus 79 N~~~~~~p~~~~~l~~l~~~L~l~~n~~~~-~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~ 157 (427)
|.+++..|..+.++++| ++|++++|.+++ .+|..+..+++|+.|++++|++++..|..+..+++|+.|++++|.+++.
T Consensus 136 n~l~~~~~~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 214 (306)
T 2z66_A 136 THTRVAFNGIFNGLSSL-EVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSL 214 (306)
T ss_dssp SCCEECSTTTTTTCTTC-CEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBC
T ss_pred CcCCccchhhcccCcCC-CEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCcc
Confidence 55444444444444444 344444444443 2444444444444444444444443344444444444444444444443
Q ss_pred CCCCcccccCCceeeccCCcc
Q 042634 158 IPSSLSSLRGIENLDLSRNNF 178 (427)
Q Consensus 158 ~p~~l~~l~~L~~L~L~~N~l 178 (427)
.+..+..+++|+.|++++|.+
T Consensus 215 ~~~~~~~l~~L~~L~L~~N~l 235 (306)
T 2z66_A 215 DTFPYKCLNSLQVLDYSLNHI 235 (306)
T ss_dssp CSGGGTTCTTCCEEECTTSCC
T ss_pred ChhhccCcccCCEeECCCCCC
Confidence 333444444444444444444
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.90 E-value=6.1e-23 Score=190.74 Aligned_cols=173 Identities=23% Similarity=0.260 Sum_probs=150.8
Q ss_pred CeeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCcc
Q 042634 1 AFTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNN 80 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~ 80 (427)
+|+|++|.+++..|..+..+++|+.|+|++|.++ .+|.. +.+++|++|+|++|.++ .+|..+..+++|++|++++|+
T Consensus 35 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~-~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~ 111 (290)
T 1p9a_G 35 ILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNR 111 (290)
T ss_dssp EEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEECC-SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSC
T ss_pred EEEcCCCcCCccCHHHhhcCCCCCEEECCCCccC-cccCC-CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCc
Confidence 3789999999888888999999999999999998 46553 88999999999999999 899999999999999999999
Q ss_pred CcccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCCC
Q 042634 81 LTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPS 160 (427)
Q Consensus 81 ~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~ 160 (427)
+++..|..|.++.+| ++|+|++|++++..+..+..+++|+.|++++|++++..+..+..+++|+.|++++|.++ .+|.
T Consensus 112 l~~l~~~~~~~l~~L-~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~ 189 (290)
T 1p9a_G 112 LTSLPLGALRGLGEL-QELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPK 189 (290)
T ss_dssp CCCCCSSTTTTCTTC-CEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCT
T ss_pred CcccCHHHHcCCCCC-CEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccCh
Confidence 997777888999999 67999999998766677889999999999999999533345678999999999999999 4678
Q ss_pred CcccccCCceeeccCCcc
Q 042634 161 SLSSLRGIENLDLSRNNF 178 (427)
Q Consensus 161 ~l~~l~~L~~L~L~~N~l 178 (427)
.+..+..|+.+++++|.+
T Consensus 190 ~~~~~~~L~~l~L~~Np~ 207 (290)
T 1p9a_G 190 GFFGSHLLPFAFLHGNPW 207 (290)
T ss_dssp TTTTTCCCSEEECCSCCB
T ss_pred hhcccccCCeEEeCCCCc
Confidence 888888899999988876
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.90 E-value=6.3e-23 Score=188.96 Aligned_cols=174 Identities=25% Similarity=0.267 Sum_probs=152.6
Q ss_pred eeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccC
Q 042634 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNL 81 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~ 81 (427)
|++++|.++ .++ .+..+++|++|+|++|.+++ + +.++.+++|++|+|++|.+++..|..+..+++|++|++++|++
T Consensus 46 L~l~~~~i~-~~~-~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 121 (272)
T 3rfs_A 46 IIANNSDIK-SVQ-GIQYLPNVRYLALGGNKLHD-I-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQL 121 (272)
T ss_dssp EECTTSCCC-CCT-TGGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCC
T ss_pred eeeCCCCcc-ccc-ccccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcC
Confidence 688899988 434 58999999999999999985 4 4799999999999999999965556688999999999999999
Q ss_pred cccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCCCC
Q 042634 82 TGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSS 161 (427)
Q Consensus 82 ~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~~ 161 (427)
++..+..+.++++| ++|++++|++++..+..++.+++|+.|++++|++++..|..++.+++|+.|++++|.+++..+..
T Consensus 122 ~~~~~~~~~~l~~L-~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 200 (272)
T 3rfs_A 122 QSLPDGVFDKLTNL-TYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGV 200 (272)
T ss_dssp CCCCTTTTTTCTTC-CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTT
T ss_pred CccCHHHhccCCCC-CEEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHH
Confidence 97777778899999 68999999999766677899999999999999999766667889999999999999999888878
Q ss_pred cccccCCceeeccCCcccc
Q 042634 162 LSSLRGIENLDLSRNNFIR 180 (427)
Q Consensus 162 l~~l~~L~~L~L~~N~ll~ 180 (427)
+..+++|+.|++++|.+..
T Consensus 201 ~~~l~~L~~L~l~~N~~~~ 219 (272)
T 3rfs_A 201 FDRLTSLQYIWLHDNPWDC 219 (272)
T ss_dssp TTTCTTCCEEECCSSCBCC
T ss_pred HhCCcCCCEEEccCCCccc
Confidence 8999999999999998754
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.90 E-value=1e-22 Score=187.28 Aligned_cols=177 Identities=24% Similarity=0.299 Sum_probs=157.1
Q ss_pred CeeecCCcccccCCccccCCCCCCEeeeecccceeecCc-chhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCc
Q 042634 1 AFTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPS-SIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNN 79 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~-~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 79 (427)
+|+|++|++++..+..|..+++|++|+|++|+++ .+|. .|.++++|++|++++|.+++..+..+..+++|++|++++|
T Consensus 41 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 119 (270)
T 2o6q_A 41 KLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRN 119 (270)
T ss_dssp EEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCS-CCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSS
T ss_pred EEECcCCCCCeeCHHHhcCCCCCCEEECCCCccC-eeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCC
Confidence 3799999999776678999999999999999998 5665 4689999999999999999544456789999999999999
Q ss_pred cCcccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCC
Q 042634 80 NLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIP 159 (427)
Q Consensus 80 ~~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p 159 (427)
.+++..+..+.++++| ++|+|++|.+++..+..+..+++|+.|++++|++++..+..+..+++|+.|++++|.+++..+
T Consensus 120 ~l~~~~~~~~~~l~~L-~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 198 (270)
T 2o6q_A 120 QLKSLPPRVFDSLTKL-TYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPE 198 (270)
T ss_dssp CCCCCCTTTTTTCTTC-CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred ccCeeCHHHhCcCcCC-CEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCH
Confidence 9998888888999999 689999999996555668999999999999999996555678999999999999999998777
Q ss_pred CCcccccCCceeeccCCccc
Q 042634 160 SSLSSLRGIENLDLSRNNFI 179 (427)
Q Consensus 160 ~~l~~l~~L~~L~L~~N~ll 179 (427)
..+..+++|+.|++++|.+.
T Consensus 199 ~~~~~l~~L~~L~l~~N~~~ 218 (270)
T 2o6q_A 199 GAFDSLEKLKMLQLQENPWD 218 (270)
T ss_dssp TTTTTCTTCCEEECCSSCBC
T ss_pred HHhccccCCCEEEecCCCee
Confidence 77899999999999999864
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=5.2e-23 Score=189.90 Aligned_cols=180 Identities=20% Similarity=0.175 Sum_probs=143.0
Q ss_pred CeeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCcc
Q 042634 1 AFTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNN 80 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~ 80 (427)
+|+|++|++++..+..+..+++|++|+|++|++++..+..++++++|++|+|++|.+++..|..+..+++|++|++++|.
T Consensus 32 ~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 111 (276)
T 2z62_A 32 NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN 111 (276)
T ss_dssp EEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSC
T ss_pred EEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCC
Confidence 37888888887766688888889999998888886555678888889999999888886666778888889999999888
Q ss_pred CcccCCCCccccccccceeeccCCcCcC-CCCCCCcCCCCCCeEECcCCcccccCCcccccccccc----ceeeeeeecc
Q 042634 81 LTGTTPTEVIGLSSLSIYLDLSQNQLNG-PLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLE----QLVMNGNFFR 155 (427)
Q Consensus 81 ~~~~~p~~~~~l~~l~~~L~l~~n~~~~-~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~----~l~l~~n~l~ 155 (427)
+++..+..+..+++| ++|++++|.+++ .+|..++.+++|+.|++++|++++..+..+..+.+++ .|++++|.++
T Consensus 112 l~~~~~~~~~~l~~L-~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~ 190 (276)
T 2z62_A 112 LASLENFPIGHLKTL-KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 190 (276)
T ss_dssp CCCSTTCCCTTCTTC-CEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCC
T ss_pred ccccCchhcccCCCC-CEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCccc
Confidence 887766678888888 678888888875 3688888888899999998888876666777777777 7788888888
Q ss_pred ccCCCCcccccCCceeeccCCcccccc
Q 042634 156 GNIPSSLSSLRGIENLDLSRNNFIRHR 182 (427)
Q Consensus 156 ~~~p~~l~~l~~L~~L~L~~N~ll~Hp 182 (427)
+..+..+.. .+|+.|++++|.+..-|
T Consensus 191 ~~~~~~~~~-~~L~~L~L~~n~l~~~~ 216 (276)
T 2z62_A 191 FIQPGAFKE-IRLKELALDTNQLKSVP 216 (276)
T ss_dssp EECTTSSCS-CCEEEEECCSSCCSCCC
T ss_pred ccCccccCC-CcccEEECCCCceeecC
Confidence 655544443 47888888888775443
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.89 E-value=5.1e-23 Score=192.87 Aligned_cols=180 Identities=23% Similarity=0.283 Sum_probs=161.9
Q ss_pred CeeecCCcccccCCccccCCCCCCEeeeeccccee--ecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccC
Q 042634 1 AFTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWG--EIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSN 78 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~--~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 78 (427)
+|+|++|+++...+..+..+++|+.|+|++|.++. ..|..+..+++|++|+|++|.++ .+|..+..+++|++|++++
T Consensus 32 ~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~ 110 (306)
T 2z66_A 32 RLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQH 110 (306)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTT
T ss_pred EEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCCccc-cChhhcCCCCCCCEEECCC
Confidence 37999999994433457999999999999999983 34778889999999999999999 7898999999999999999
Q ss_pred ccCcccCC-CCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccc-cCCccccccccccceeeeeeeccc
Q 042634 79 NNLTGTTP-TEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSG-QIPSSIGSCIRLEQLVMNGNFFRG 156 (427)
Q Consensus 79 N~~~~~~p-~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~-~~p~~~~~~~~l~~l~l~~n~l~~ 156 (427)
|++++..+ ..+..+++| ++|++++|.+++..|..+..+++|+.|++++|.+++ .+|..+..+++|+.|++++|.+++
T Consensus 111 n~l~~~~~~~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~ 189 (306)
T 2z66_A 111 SNLKQMSEFSVFLSLRNL-IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ 189 (306)
T ss_dssp SEEESSTTTTTTTTCTTC-CEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCE
T ss_pred CcccccccchhhhhccCC-CEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCC
Confidence 99996665 578889999 689999999998889999999999999999999986 589999999999999999999999
Q ss_pred cCCCCcccccCCceeeccCCcccccc
Q 042634 157 NIPSSLSSLRGIENLDLSRNNFIRHR 182 (427)
Q Consensus 157 ~~p~~l~~l~~L~~L~L~~N~ll~Hp 182 (427)
..|..+..+++|+.|++++|.+...+
T Consensus 190 ~~~~~~~~l~~L~~L~L~~N~l~~~~ 215 (306)
T 2z66_A 190 LSPTAFNSLSSLQVLNMSHNNFFSLD 215 (306)
T ss_dssp ECTTTTTTCTTCCEEECTTSCCSBCC
T ss_pred cCHHHhcCCCCCCEEECCCCccCccC
Confidence 88999999999999999999986654
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=6.7e-23 Score=202.77 Aligned_cols=60 Identities=23% Similarity=0.262 Sum_probs=32.8
Q ss_pred CCCeEECcCCcccccCCccccccccccceeeeeeeccccCCCCcccccCCceeeccCCcc
Q 042634 119 NLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178 (427)
Q Consensus 119 ~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l 178 (427)
+|+.|++++|.+++.+|..++.+++|+.|++++|.+++..|..+..+++|+.|++++|.+
T Consensus 276 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l 335 (455)
T 3v47_A 276 GVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFL 335 (455)
T ss_dssp CCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred CceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCcc
Confidence 344444555555544555555555555555555555555555555555555555555554
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.2e-23 Score=197.80 Aligned_cols=159 Identities=21% Similarity=0.204 Sum_probs=69.9
Q ss_pred CCCCCCEeeeecccceeecCcch--hccccCCEeeeccccCcccCCcCccCC-----CCCCeEEccCccCcccCCCCccc
Q 042634 19 DLHKLQRLTLEMNKFWGEIPSSI--GNLTLLITLNFAENMLEGSIPSSLGKC-----QNLILLDLSNNNLTGTTPTEVIG 91 (427)
Q Consensus 19 ~l~~L~~L~l~~n~~~~~~p~~~--~~l~~L~~L~l~~n~l~~~~p~~~~~l-----~~L~~l~l~~N~~~~~~p~~~~~ 91 (427)
++++|++|+|++|++++.+|..+ +.+++|++|+|++|++++. |..++.+ ++|++|++++|++++..|..+.+
T Consensus 93 ~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~ 171 (312)
T 1wwl_A 93 GISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRV 171 (312)
T ss_dssp TTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCC
T ss_pred CcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhcc
Confidence 44445555555555444444443 4444455555555554432 4444443 44455555555544444444444
Q ss_pred cccccceeeccCCcCcCC--CCCCC--cCCCCCCeEECcCCcccc--cCCc-cccccccccceeeeeeeccccCC-CCcc
Q 042634 92 LSSLSIYLDLSQNQLNGP--LPSNF--GILKNLGAIDISENKLSG--QIPS-SIGSCIRLEQLVMNGNFFRGNIP-SSLS 163 (427)
Q Consensus 92 l~~l~~~L~l~~n~~~~~--~p~~~--~~l~~L~~l~l~~n~~~~--~~p~-~~~~~~~l~~l~l~~n~l~~~~p-~~l~ 163 (427)
+++| ++|++++|++.+. +|..+ +.+++|+.|++++|++++ .++. .+..+++|+.|++++|.+++..| ..+.
T Consensus 172 l~~L-~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 250 (312)
T 1wwl_A 172 FPAL-STLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCD 250 (312)
T ss_dssp CSSC-CEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCC
T ss_pred CCCC-CEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhh
Confidence 4444 3445554444332 12222 444444444444444441 1111 12234444444444444444332 2233
Q ss_pred cccCCceeeccCCccc
Q 042634 164 SLRGIENLDLSRNNFI 179 (427)
Q Consensus 164 ~l~~L~~L~L~~N~ll 179 (427)
.+++|+.|++++|.+.
T Consensus 251 ~l~~L~~L~Ls~N~l~ 266 (312)
T 1wwl_A 251 WPSQLNSLNLSFTGLK 266 (312)
T ss_dssp CCTTCCEEECTTSCCS
T ss_pred hcCCCCEEECCCCccC
Confidence 3444444444444443
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.4e-22 Score=200.38 Aligned_cols=176 Identities=23% Similarity=0.259 Sum_probs=128.6
Q ss_pred CeeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCcc
Q 042634 1 AFTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNN 80 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~ 80 (427)
+|+|++|++++..|..|.++++|+.|+|++|++++..|..|+++++|++|+|++|.+++..+..+..+++|++|++++|+
T Consensus 79 ~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~ 158 (452)
T 3zyi_A 79 YLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNP 158 (452)
T ss_dssp EEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCC
T ss_pred EEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECCCCC
Confidence 47999999998888999999999999999999997777889999999999999999994444558889999999999999
Q ss_pred CcccCCCCccccccccceeeccCCcCcCCCC-CCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCC
Q 042634 81 LTGTTPTEVIGLSSLSIYLDLSQNQLNGPLP-SNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIP 159 (427)
Q Consensus 81 ~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p-~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p 159 (427)
+++..+..+.++++| +.|++++|...+.+| ..+.++++|+.|++++|+++ .+| .+..+++|+.|++++|.+++..|
T Consensus 159 l~~~~~~~~~~l~~L-~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~ 235 (452)
T 3zyi_A 159 IESIPSYAFNRVPSL-MRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRP 235 (452)
T ss_dssp CCEECTTTTTTCTTC-CEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCS-SCC-CCTTCTTCCEEECTTSCCSEECG
T ss_pred cceeCHhHHhcCCcc-cEEeCCCCCCccccChhhccCCCCCCEEECCCCccc-ccc-cccccccccEEECcCCcCcccCc
Confidence 986666667777777 467777643333443 34666666666666666665 333 35555666666666666665555
Q ss_pred CCcccccCCceeeccCCccc
Q 042634 160 SSLSSLRGIENLDLSRNNFI 179 (427)
Q Consensus 160 ~~l~~l~~L~~L~L~~N~ll 179 (427)
..+..+++|+.|++++|.+.
T Consensus 236 ~~~~~l~~L~~L~L~~n~l~ 255 (452)
T 3zyi_A 236 GSFHGLSSLKKLWVMNSQVS 255 (452)
T ss_dssp GGGTTCTTCCEEECTTSCCC
T ss_pred ccccCccCCCEEEeCCCcCc
Confidence 55566666666666655553
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.89 E-value=2.5e-22 Score=190.48 Aligned_cols=175 Identities=23% Similarity=0.281 Sum_probs=121.8
Q ss_pred CeeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCcc
Q 042634 1 AFTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNN 80 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~ 80 (427)
+|+|++|.+++..|..+.++++|++|+|++|++++..|..|+++++|++|++++|.++ .+|..+. ++|++|++++|+
T Consensus 58 ~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l~~n~ 134 (332)
T 2ft3_A 58 LLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRIHDNR 134 (332)
T ss_dssp EEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC--TTCCEEECCSSC
T ss_pred EEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc--ccCCEEECCCCc
Confidence 3788999999777778999999999999999998766888999999999999999988 8887765 778888888888
Q ss_pred CcccCCCCccccccccceeeccCCcCc--CCCCCCCcCC--------------------CCCCeEECcCCcccccCCccc
Q 042634 81 LTGTTPTEVIGLSSLSIYLDLSQNQLN--GPLPSNFGIL--------------------KNLGAIDISENKLSGQIPSSI 138 (427)
Q Consensus 81 ~~~~~p~~~~~l~~l~~~L~l~~n~~~--~~~p~~~~~l--------------------~~L~~l~l~~n~~~~~~p~~~ 138 (427)
+++..+..+.++++| +.|++++|.++ +..|..+..+ ++|+.|++++|.+++..|..+
T Consensus 135 i~~~~~~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~~~l~L~~L~l~~n~l~~l~~~~~~~L~~L~l~~n~i~~~~~~~l 213 (332)
T 2ft3_A 135 IRKVPKGVFSGLRNM-NCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETLNELHLDHNKIQAIELEDL 213 (332)
T ss_dssp CCCCCSGGGSSCSSC-CEEECCSCCCBGGGSCTTSSCSCCCSCCBCCSSBCSSCCSSSCSSCSCCBCCSSCCCCCCTTSS
T ss_pred cCccCHhHhCCCccC-CEEECCCCccccCCCCcccccCCccCEEECcCCCCCccCccccCCCCEEECCCCcCCccCHHHh
Confidence 886555567778887 56888888874 3555655555 234444444444443333445
Q ss_pred cccccccceeeeeeeccccCCCCcccccCCceeeccCCccc
Q 042634 139 GSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNFI 179 (427)
Q Consensus 139 ~~~~~l~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~ll 179 (427)
..+++|+.|++++|.+++..+..+..+++|+.|++++|.+.
T Consensus 214 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 254 (332)
T 2ft3_A 214 LRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS 254 (332)
T ss_dssp TTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC
T ss_pred cCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe
Confidence 55555555555555555544445555555555555555544
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.5e-22 Score=184.10 Aligned_cols=156 Identities=24% Similarity=0.252 Sum_probs=141.5
Q ss_pred CeeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCcc
Q 042634 1 AFTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNN 80 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~ 80 (427)
.|+|++|++++..|..+..+++|++|+|++|++++..|..|.++++|++|+|++|.+++..|..+..+++|++|++++|+
T Consensus 39 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~ 118 (251)
T 3m19_A 39 KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQ 118 (251)
T ss_dssp EEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCc
Confidence 37999999998888899999999999999999997666779999999999999999995555678999999999999999
Q ss_pred CcccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeecccc
Q 042634 81 LTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGN 157 (427)
Q Consensus 81 ~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~ 157 (427)
+++..+..+.++.+| ++|+|++|++++..+..++.+++|+.|++++|++++..|..+..+++|+.|++++|.+++.
T Consensus 119 l~~~~~~~~~~l~~L-~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 119 LKSLPSGVFDRLTKL-KELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CCCCCTTTTTTCTTC-CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CCCcChhHhccCCcc-cEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 997777778899999 6899999999966666899999999999999999976667899999999999999999865
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.7e-23 Score=220.10 Aligned_cols=175 Identities=21% Similarity=0.313 Sum_probs=157.6
Q ss_pred cCCcccccCCccccCCCCCCEeeeeccccee-----------------ecCcchh--ccccCCEeeeccccCcccCCcCc
Q 042634 5 VGNQFTGRIPGSIGDLHKLQRLTLEMNKFWG-----------------EIPSSIG--NLTLLITLNFAENMLEGSIPSSL 65 (427)
Q Consensus 5 ~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~-----------------~~p~~~~--~l~~L~~L~l~~n~l~~~~p~~~ 65 (427)
.+|+|+| +|..+++|++|+.|+|++|+++| .+|.+++ ++++|++|+|++|.+.|.+|..+
T Consensus 433 ~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l 511 (876)
T 4ecn_A 433 LTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFL 511 (876)
T ss_dssp CSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGG
T ss_pred ccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHH
Confidence 4589998 89999999999999999999997 3999988 99999999999999999999999
Q ss_pred cCCCCCCeEEccCcc-Ccc-cCCCCccccc-------cccceeeccCCcCcCCCCC--CCcCCCCCCeEECcCCcccccC
Q 042634 66 GKCQNLILLDLSNNN-LTG-TTPTEVIGLS-------SLSIYLDLSQNQLNGPLPS--NFGILKNLGAIDISENKLSGQI 134 (427)
Q Consensus 66 ~~l~~L~~l~l~~N~-~~~-~~p~~~~~l~-------~l~~~L~l~~n~~~~~~p~--~~~~l~~L~~l~l~~n~~~~~~ 134 (427)
+++++|++|++++|+ ++| .+|..++.+. +| +.|+|++|+++ .+|. .++++++|+.|++++|+++ .+
T Consensus 512 ~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L-~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~l 588 (876)
T 4ecn_A 512 YDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKI-QIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HL 588 (876)
T ss_dssp GGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTC-CEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BC
T ss_pred hCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCc-cEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cc
Confidence 999999999999998 988 7888777665 88 68999999998 8998 8999999999999999999 89
Q ss_pred CccccccccccceeeeeeeccccCCCCcccccC-CceeeccCCcccccccch
Q 042634 135 PSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRG-IENLDLSRNNFIRHRNLV 185 (427)
Q Consensus 135 p~~~~~~~~l~~l~l~~n~l~~~~p~~l~~l~~-L~~L~L~~N~ll~Hpniv 185 (427)
| .++.+++|+.|++++|.++ .+|..+..+++ |+.|++++|.+..-|...
T Consensus 589 p-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~~lp~~~ 638 (876)
T 4ecn_A 589 E-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKYIPNIF 638 (876)
T ss_dssp C-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCCSCCSCC
T ss_pred h-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCCcCchhh
Confidence 9 8999999999999999999 78888999998 999999999987655443
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.5e-22 Score=200.27 Aligned_cols=113 Identities=22% Similarity=0.195 Sum_probs=92.4
Q ss_pred CCCCeEEccCccCcccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCcccccccccccee
Q 042634 69 QNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLV 148 (427)
Q Consensus 69 ~~L~~l~l~~N~~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~ 148 (427)
++|++|++++|.+++.+|..+..+++| ++|++++|++++..|..++.+++|+.|++++|++++..|..++++++|+.|+
T Consensus 275 ~~L~~L~l~~n~l~~~~~~~~~~l~~L-~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 353 (455)
T 3v47_A 275 SGVKTCDLSKSKIFALLKSVFSHFTDL-EQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLD 353 (455)
T ss_dssp SCCCEEECCSSCCCEECTTTTTTCTTC-CEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEE
T ss_pred cCceEEEecCccccccchhhcccCCCC-CEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEE
Confidence 356667777777777778888888888 6788888888877788888888888888888888877777888888888888
Q ss_pred eeeeeccccCCCCcccccCCceeeccCCcccccc
Q 042634 149 MNGNFFRGNIPSSLSSLRGIENLDLSRNNFIRHR 182 (427)
Q Consensus 149 l~~n~l~~~~p~~l~~l~~L~~L~L~~N~ll~Hp 182 (427)
+++|.+++..|..+..+++|+.|++++|++..-|
T Consensus 354 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 387 (455)
T 3v47_A 354 LSYNHIRALGDQSFLGLPNLKELALDTNQLKSVP 387 (455)
T ss_dssp CCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCCCcccccChhhccccccccEEECCCCccccCC
Confidence 8888888887888888888888888888876543
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=9.5e-23 Score=188.17 Aligned_cols=178 Identities=21% Similarity=0.239 Sum_probs=157.4
Q ss_pred CeeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCcc
Q 042634 1 AFTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNN 80 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~ 80 (427)
+|+|++|++++..+..+..+++|++|+|++|.+++..|..++++++|++|++++|.+++..+..++.+++|++|++++|.
T Consensus 56 ~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 135 (276)
T 2z62_A 56 VLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNL 135 (276)
T ss_dssp EEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSC
T ss_pred EEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCc
Confidence 47999999998777889999999999999999997777889999999999999999996555579999999999999999
Q ss_pred Cccc-CCCCccccccccceeeccCCcCcCCCCCCCcCCCCCC----eEECcCCcccccCCccccccccccceeeeeeecc
Q 042634 81 LTGT-TPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLG----AIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFR 155 (427)
Q Consensus 81 ~~~~-~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~----~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~ 155 (427)
+++. +|..+.++++| +.|++++|++++..+..+..+++|+ .|++++|++++ +|.......+|+.|++++|.++
T Consensus 136 l~~~~l~~~~~~l~~L-~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~-~~~~~~~~~~L~~L~L~~n~l~ 213 (276)
T 2z62_A 136 IQSFKLPEYFSNLTNL-EHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLKELALDTNQLK 213 (276)
T ss_dssp CCCCCCCGGGGGCTTC-CEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCE-ECTTSSCSCCEEEEECCSSCCS
T ss_pred cceecCchhhccCCCC-CEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccc-cCccccCCCcccEEECCCCcee
Confidence 9863 68899999999 6899999999977778888888877 89999999995 5555555568999999999999
Q ss_pred ccCCCCcccccCCceeeccCCcccc
Q 042634 156 GNIPSSLSSLRGIENLDLSRNNFIR 180 (427)
Q Consensus 156 ~~~p~~l~~l~~L~~L~L~~N~ll~ 180 (427)
+..+..+..+++|+.+++++|.+..
T Consensus 214 ~~~~~~~~~l~~L~~L~l~~N~~~c 238 (276)
T 2z62_A 214 SVPDGIFDRLTSLQKIWLHTNPWDC 238 (276)
T ss_dssp CCCTTTTTTCCSCCEEECCSSCBCC
T ss_pred ecCHhHhcccccccEEEccCCcccc
Confidence 8766778999999999999999864
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=9.9e-23 Score=208.92 Aligned_cols=179 Identities=23% Similarity=0.212 Sum_probs=126.2
Q ss_pred eeecCCccccc--CCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCC-cCccCCCCCCeEEccC
Q 042634 2 FTLVGNQFTGR--IPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIP-SSLGKCQNLILLDLSN 78 (427)
Q Consensus 2 l~l~~n~l~~~--~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p-~~~~~l~~L~~l~l~~ 78 (427)
|+|++|.+++. +|..+..+++|+.|+|++|.++ .+|..++.+++|+.|++++|.+++..| ..+..+++|++|++++
T Consensus 355 L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~ 433 (606)
T 3vq2_A 355 LDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISY 433 (606)
T ss_dssp EECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEE-EECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTT
T ss_pred EECcCCccCCCcchhhhhccCCcccEeECCCCccc-cchhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcC
Confidence 56677777655 3666777777777777777776 466667777777777777777775555 4666777777777777
Q ss_pred ccCcccCCCCccccccccceeeccCCcCcC-CCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeecccc
Q 042634 79 NNLTGTTPTEVIGLSSLSIYLDLSQNQLNG-PLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGN 157 (427)
Q Consensus 79 N~~~~~~p~~~~~l~~l~~~L~l~~n~~~~-~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~ 157 (427)
|.+++..|..+.++++| +.|++++|++++ .+|..++.+++|+.|++++|++++..|..++++++|+.|++++|.+++.
T Consensus 434 n~l~~~~~~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 512 (606)
T 3vq2_A 434 TNTKIDFDGIFLGLTSL-NTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFL 512 (606)
T ss_dssp SCCEECCTTTTTTCTTC-CEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCE
T ss_pred CCCCccchhhhcCCCCC-CEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCc
Confidence 77776677777777777 567777777765 3667777777777777777777766667777777777777777777776
Q ss_pred CCCCcccccCCceeeccCCcccccc
Q 042634 158 IPSSLSSLRGIENLDLSRNNFIRHR 182 (427)
Q Consensus 158 ~p~~l~~l~~L~~L~L~~N~ll~Hp 182 (427)
.|..+..+++|+.|++++|++..-|
T Consensus 513 ~~~~~~~l~~L~~L~l~~N~l~~~p 537 (606)
T 3vq2_A 513 DSSHYNQLYSLSTLDCSFNRIETSK 537 (606)
T ss_dssp EGGGTTTCTTCCEEECTTSCCCCEE
T ss_pred CHHHccCCCcCCEEECCCCcCcccC
Confidence 6777777777777777777665433
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.3e-22 Score=183.24 Aligned_cols=178 Identities=16% Similarity=0.180 Sum_probs=151.4
Q ss_pred CeeecCCcccccCCccccCCCCCCEeeeeccc-ceeecCcchhccccCCEeeecc-ccCcccCCcCccCCCCCCeEEccC
Q 042634 1 AFTLVGNQFTGRIPGSIGDLHKLQRLTLEMNK-FWGEIPSSIGNLTLLITLNFAE-NMLEGSIPSSLGKCQNLILLDLSN 78 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~-~~~~~p~~~~~l~~L~~L~l~~-n~l~~~~p~~~~~l~~L~~l~l~~ 78 (427)
+|+|++|++++..+..+.++++|+.|+|++|. +++..+..|+++++|++|++++ |.+++..|..+..+++|++|++++
T Consensus 35 ~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~ 114 (239)
T 2xwt_C 35 TLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFN 114 (239)
T ss_dssp EEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEE
T ss_pred EEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCC
Confidence 37999999997777789999999999999997 8744445799999999999998 999955556788999999999999
Q ss_pred ccCcccCCCCccccccccc---eeeccCC-cCcCCCCCCCcCCCCCC-eEECcCCcccccCCccccccccccceeeeeee
Q 042634 79 NNLTGTTPTEVIGLSSLSI---YLDLSQN-QLNGPLPSNFGILKNLG-AIDISENKLSGQIPSSIGSCIRLEQLVMNGNF 153 (427)
Q Consensus 79 N~~~~~~p~~~~~l~~l~~---~L~l~~n-~~~~~~p~~~~~l~~L~-~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~ 153 (427)
|++++ +|. +..+.+| + .|++++| .+++..+..|..+++|+ .|++++|+++ .+|......++|+.|++++|.
T Consensus 115 n~l~~-lp~-~~~l~~L-~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~n~ 190 (239)
T 2xwt_C 115 TGLKM-FPD-LTKVYST-DIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNK 190 (239)
T ss_dssp ECCCS-CCC-CTTCCBC-CSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECTTCT
T ss_pred CCCcc-ccc-ccccccc-ccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcCCCC
Confidence 99985 666 7788888 5 7999999 89866667799999999 9999999999 777765555899999999995
Q ss_pred -ccccCCCCcccc-cCCceeeccCCcccccc
Q 042634 154 -FRGNIPSSLSSL-RGIENLDLSRNNFIRHR 182 (427)
Q Consensus 154 -l~~~~p~~l~~l-~~L~~L~L~~N~ll~Hp 182 (427)
+++..+..+..+ ++|+.|++++|.+..-|
T Consensus 191 ~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~ 221 (239)
T 2xwt_C 191 YLTVIDKDAFGGVYSGPSLLDVSQTSVTALP 221 (239)
T ss_dssp TCCEECTTTTTTCSBCCSEEECTTCCCCCCC
T ss_pred CcccCCHHHhhccccCCcEEECCCCccccCC
Confidence 987777888999 99999999999876544
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.4e-22 Score=201.71 Aligned_cols=177 Identities=21% Similarity=0.195 Sum_probs=155.8
Q ss_pred CeeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCc-CccCCCCCCeEEccCc
Q 042634 1 AFTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS-SLGKCQNLILLDLSNN 79 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~-~~~~l~~L~~l~l~~N 79 (427)
+|||++|++++..|..|.++++|++|+|++|.+++..|..|+++++|++|+|++|.++ .+|. .+..+++|++|++++|
T Consensus 36 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~Ls~n 114 (477)
T 2id5_A 36 LLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISEN 114 (477)
T ss_dssp EEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC-SCCTTSSTTCTTCCEEECTTS
T ss_pred EEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCC-ccCcccccCCCCCCEEECCCC
Confidence 3799999999888889999999999999999999777889999999999999999999 5554 5788999999999999
Q ss_pred cCcccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCC
Q 042634 80 NLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIP 159 (427)
Q Consensus 80 ~~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p 159 (427)
++++..|..+.++.+| +.|++++|.+++..|..+.++++|+.|++++|++++..+..+.++++|+.|++++|.+.+..+
T Consensus 115 ~i~~~~~~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~ 193 (477)
T 2id5_A 115 KIVILLDYMFQDLYNL-KSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRD 193 (477)
T ss_dssp CCCEECTTTTTTCTTC-CEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECT
T ss_pred ccccCChhHccccccC-CEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeCh
Confidence 9998888889999999 679999999998888899999999999999999985444568889999999999999998877
Q ss_pred CCcccccCCceeeccCCccc
Q 042634 160 SSLSSLRGIENLDLSRNNFI 179 (427)
Q Consensus 160 ~~l~~l~~L~~L~L~~N~ll 179 (427)
..+..+++|+.|++++|...
T Consensus 194 ~~~~~l~~L~~L~l~~~~~~ 213 (477)
T 2id5_A 194 YSFKRLYRLKVLEISHWPYL 213 (477)
T ss_dssp TCSCSCTTCCEEEEECCTTC
T ss_pred hhcccCcccceeeCCCCccc
Confidence 78888888888888876553
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=6.1e-22 Score=187.56 Aligned_cols=175 Identities=24% Similarity=0.318 Sum_probs=118.2
Q ss_pred CeeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCcc
Q 042634 1 AFTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNN 80 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~ 80 (427)
+|+|++|++++..+..+.++++|++|+|++|++++..|..|+++++|++|++++|.++ .+|..+. ++|++|++++|+
T Consensus 56 ~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l~~n~ 132 (330)
T 1xku_A 56 LLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENE 132 (330)
T ss_dssp EEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEECCSSC
T ss_pred EEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhc--ccccEEECCCCc
Confidence 3789999999776678999999999999999999766888999999999999999998 7787664 567777777777
Q ss_pred CcccCCCCccccccccceeeccCCcCc--CCCCCCCcCCCCCCeEECcCCccc---------------------ccCCcc
Q 042634 81 LTGTTPTEVIGLSSLSIYLDLSQNQLN--GPLPSNFGILKNLGAIDISENKLS---------------------GQIPSS 137 (427)
Q Consensus 81 ~~~~~p~~~~~l~~l~~~L~l~~n~~~--~~~p~~~~~l~~L~~l~l~~n~~~---------------------~~~p~~ 137 (427)
+++..+..+.++.+| +.|++++|+++ +..+..+..+++|+.|++++|.++ +..|..
T Consensus 133 l~~~~~~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~l~~~~~~~L~~L~l~~n~l~~~~~~~ 211 (330)
T 1xku_A 133 ITKVRKSVFNGLNQM-IVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVDAAS 211 (330)
T ss_dssp CCBBCHHHHTTCTTC-CEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSSCCTTCSEEECTTSCCCEECTGG
T ss_pred ccccCHhHhcCCccc-cEEECCCCcCCccCcChhhccCCCCcCEEECCCCccccCCccccccCCEEECCCCcCCccCHHH
Confidence 775555556666666 45666666664 244555555555555555555544 333444
Q ss_pred ccccccccceeeeeeeccccCCCCcccccCCceeeccCCccc
Q 042634 138 IGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNFI 179 (427)
Q Consensus 138 ~~~~~~l~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~ll 179 (427)
+..+++|+.|++++|.+++..+..+..+++|+.|++++|.+.
T Consensus 212 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 253 (330)
T 1xku_A 212 LKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV 253 (330)
T ss_dssp GTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS
T ss_pred hcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc
Confidence 555555555555555555444444555555555555555544
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=3.7e-22 Score=196.72 Aligned_cols=176 Identities=23% Similarity=0.244 Sum_probs=133.7
Q ss_pred CeeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCcc
Q 042634 1 AFTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNN 80 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~ 80 (427)
+|+|++|++++..+..|.++++|+.|+|++|++++..|..|.++++|++|+|++|++++..+..+..+++|++|++++|+
T Consensus 68 ~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~ 147 (440)
T 3zyj_A 68 LLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNP 147 (440)
T ss_dssp EEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCC
T ss_pred EEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCc
Confidence 37899999998888899999999999999999986666789999999999999999994444468889999999999999
Q ss_pred CcccCCCCccccccccceeeccCCcCcCCCC-CCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCC
Q 042634 81 LTGTTPTEVIGLSSLSIYLDLSQNQLNGPLP-SNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIP 159 (427)
Q Consensus 81 ~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p-~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p 159 (427)
+++..+..+.++++| +.|++++|...+.++ ..|.++++|+.|++++|.++ .+| .+..+++|+.|++++|.+++..|
T Consensus 148 i~~~~~~~~~~l~~L-~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~ 224 (440)
T 3zyj_A 148 IESIPSYAFNRIPSL-RRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRP 224 (440)
T ss_dssp CCEECTTTTTTCTTC-CEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECT
T ss_pred ccccCHHHhhhCccc-CEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccCh
Confidence 987776677777777 567777744333444 35677777777777777776 455 35666667777777777766666
Q ss_pred CCcccccCCceeeccCCccc
Q 042634 160 SSLSSLRGIENLDLSRNNFI 179 (427)
Q Consensus 160 ~~l~~l~~L~~L~L~~N~ll 179 (427)
..+..+++|+.|++++|.+.
T Consensus 225 ~~~~~l~~L~~L~L~~n~l~ 244 (440)
T 3zyj_A 225 GSFQGLMHLQKLWMIQSQIQ 244 (440)
T ss_dssp TTTTTCTTCCEEECTTCCCC
T ss_pred hhhccCccCCEEECCCCcee
Confidence 66666666666666666653
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.88 E-value=3.6e-23 Score=194.54 Aligned_cols=178 Identities=21% Similarity=0.208 Sum_probs=151.3
Q ss_pred CeeecCCcccccCCccc--cCCCCCCEeeeecccceeecCcchhcc-----ccCCEeeeccccCcccCCcCccCCCCCCe
Q 042634 1 AFTLVGNQFTGRIPGSI--GDLHKLQRLTLEMNKFWGEIPSSIGNL-----TLLITLNFAENMLEGSIPSSLGKCQNLIL 73 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~--~~l~~L~~L~l~~n~~~~~~p~~~~~l-----~~L~~L~l~~n~l~~~~p~~~~~l~~L~~ 73 (427)
+|+|++|+++|.+|..+ ..+++|++|+|++|++++. |..++.+ ++|++|+|++|.+++..|..++.+++|++
T Consensus 99 ~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 177 (312)
T 1wwl_A 99 ELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALST 177 (312)
T ss_dssp EEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCE
T ss_pred EEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCE
Confidence 48999999999999987 8999999999999999965 8889988 99999999999999777789999999999
Q ss_pred EEccCccCcccC--CCCc--cccccccceeeccCCcCcC--CCC-CCCcCCCCCCeEECcCCcccccCC-cccccccccc
Q 042634 74 LDLSNNNLTGTT--PTEV--IGLSSLSIYLDLSQNQLNG--PLP-SNFGILKNLGAIDISENKLSGQIP-SSIGSCIRLE 145 (427)
Q Consensus 74 l~l~~N~~~~~~--p~~~--~~l~~l~~~L~l~~n~~~~--~~p-~~~~~l~~L~~l~l~~n~~~~~~p-~~~~~~~~l~ 145 (427)
|++++|++.+.+ |..+ ..+++| ++|+|++|++++ .++ ..+..+++|+.|++++|++++.+| ..+..+++|+
T Consensus 178 L~Ls~N~l~~~~~~~~~~~~~~l~~L-~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~ 256 (312)
T 1wwl_A 178 LDLSDNPELGERGLISALCPLKFPTL-QVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLN 256 (312)
T ss_dssp EECCSCTTCHHHHHHHHSCTTSCTTC-CEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCC
T ss_pred EECCCCCcCcchHHHHHHHhccCCCC-CEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCC
Confidence 999999987652 3333 778888 689999999973 222 334678999999999999998775 4566789999
Q ss_pred ceeeeeeeccccCCCCcccccCCceeeccCCccccccc
Q 042634 146 QLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNFIRHRN 183 (427)
Q Consensus 146 ~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~ll~Hpn 183 (427)
.|++++|.++ .+|..+. ++|+.|++++|++..-|.
T Consensus 257 ~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~p~ 291 (312)
T 1wwl_A 257 SLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRNPS 291 (312)
T ss_dssp EEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSCCC
T ss_pred EEECCCCccC-hhhhhcc--CCceEEECCCCCCCCChh
Confidence 9999999999 6777776 889999999999877655
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.88 E-value=2.9e-22 Score=198.19 Aligned_cols=179 Identities=22% Similarity=0.243 Sum_probs=154.8
Q ss_pred CeeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccC-c
Q 042634 1 AFTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSN-N 79 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~-N 79 (427)
+|+|++|++++..|..|.++++|++|+|++|++++..+..|+++++|++|+|++|.+++..+..+..+++|++|++++ |
T Consensus 103 ~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~ 182 (452)
T 3zyi_A 103 VLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELK 182 (452)
T ss_dssp EEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCT
T ss_pred EEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCC
Confidence 479999999988889999999999999999999954445689999999999999999955455788999999999999 4
Q ss_pred cCcccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCC
Q 042634 80 NLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIP 159 (427)
Q Consensus 80 ~~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p 159 (427)
.+....+..+.++.+| ++|+|++|.++ .+| .+..+++|+.|++++|++++..|..|.++++|+.|++++|.+++..+
T Consensus 183 ~l~~i~~~~~~~l~~L-~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 259 (452)
T 3zyi_A 183 KLEYISEGAFEGLFNL-KYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIER 259 (452)
T ss_dssp TCCEECTTTTTTCTTC-CEEECTTSCCS-SCC-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECT
T ss_pred CccccChhhccCCCCC-CEEECCCCccc-ccc-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECH
Confidence 5554444568889999 68999999998 455 58889999999999999998888899999999999999999999888
Q ss_pred CCcccccCCceeeccCCcccccc
Q 042634 160 SSLSSLRGIENLDLSRNNFIRHR 182 (427)
Q Consensus 160 ~~l~~l~~L~~L~L~~N~ll~Hp 182 (427)
..+..+++|+.|++++|++..-+
T Consensus 260 ~~~~~l~~L~~L~L~~N~l~~~~ 282 (452)
T 3zyi_A 260 NAFDGLASLVELNLAHNNLSSLP 282 (452)
T ss_dssp TTTTTCTTCCEEECCSSCCSCCC
T ss_pred HHhcCCCCCCEEECCCCcCCccC
Confidence 89999999999999999886544
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.88 E-value=3.4e-22 Score=204.44 Aligned_cols=104 Identities=28% Similarity=0.310 Sum_probs=66.0
Q ss_pred eeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcC-ccCCCCCCeEEccCcc
Q 042634 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSS-LGKCQNLILLDLSNNN 80 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~-~~~l~~L~~l~l~~N~ 80 (427)
|+|++|.+++..|..|+.+++|++|+|++|.+++..|..|+++++|++|+|++|.++ .+|+. ++.+++|++|++++|.
T Consensus 80 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~Ls~N~ 158 (597)
T 3oja_B 80 LNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNN 158 (597)
T ss_dssp EECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSC
T ss_pred EECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCC-CCCHHHhccCCCCCEEEeeCCc
Confidence 566666666655556666666666666666666544445666666666666666666 44443 4666666666666666
Q ss_pred CcccCCCCccccccccceeeccCCcCc
Q 042634 81 LTGTTPTEVIGLSSLSIYLDLSQNQLN 107 (427)
Q Consensus 81 ~~~~~p~~~~~l~~l~~~L~l~~n~~~ 107 (427)
+++..|..+.++++| ..|++++|.++
T Consensus 159 l~~~~~~~~~~l~~L-~~L~L~~N~l~ 184 (597)
T 3oja_B 159 LERIEDDTFQATTSL-QNLQLSSNRLT 184 (597)
T ss_dssp CCBCCTTTTTTCTTC-CEEECTTSCCS
T ss_pred CCCCChhhhhcCCcC-cEEECcCCCCC
Confidence 666666666666666 45666666655
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=5.6e-22 Score=195.43 Aligned_cols=179 Identities=25% Similarity=0.287 Sum_probs=153.4
Q ss_pred CeeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCc-
Q 042634 1 AFTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNN- 79 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N- 79 (427)
+|+|++|++++..+..|.++++|+.|+|++|++++..+..|..+++|++|+|++|.+++..+..+..+++|++|++++|
T Consensus 92 ~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~ 171 (440)
T 3zyj_A 92 ILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELK 171 (440)
T ss_dssp EEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCT
T ss_pred EEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCC
Confidence 4789999999777788999999999999999998433447899999999999999999555557889999999999995
Q ss_pred cCcccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCC
Q 042634 80 NLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIP 159 (427)
Q Consensus 80 ~~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p 159 (427)
.+....+..+.++.+| ++|+|++|.++ .+| .+..+++|+.|++++|++++..|..|.++++|+.|++++|.+++..+
T Consensus 172 ~l~~i~~~~~~~l~~L-~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 248 (440)
T 3zyj_A 172 RLSYISEGAFEGLSNL-RYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIER 248 (440)
T ss_dssp TCCEECTTTTTTCSSC-CEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECT
T ss_pred CcceeCcchhhccccc-CeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEECh
Confidence 4444444568889999 68999999998 666 47889999999999999998888899999999999999999999888
Q ss_pred CCcccccCCceeeccCCcccccc
Q 042634 160 SSLSSLRGIENLDLSRNNFIRHR 182 (427)
Q Consensus 160 ~~l~~l~~L~~L~L~~N~ll~Hp 182 (427)
..+..+++|+.|++++|++..-+
T Consensus 249 ~~~~~l~~L~~L~L~~N~l~~~~ 271 (440)
T 3zyj_A 249 NAFDNLQSLVEINLAHNNLTLLP 271 (440)
T ss_dssp TSSTTCTTCCEEECTTSCCCCCC
T ss_pred hhhcCCCCCCEEECCCCCCCccC
Confidence 89999999999999999886543
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.87 E-value=3.3e-22 Score=184.19 Aligned_cols=169 Identities=25% Similarity=0.268 Sum_probs=147.6
Q ss_pred CeeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCcc
Q 042634 1 AFTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNN 80 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~ 80 (427)
+|+|++|.+++ + +.+..+++|++|+|++|.+++..|..++++++|++|++++|.+++..|..++.+++|++|++++|+
T Consensus 67 ~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 144 (272)
T 3rfs_A 67 YLALGGNKLHD-I-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQ 144 (272)
T ss_dssp EEECTTSCCCC-C-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEECCCCCCCC-c-hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCc
Confidence 47999999996 3 579999999999999999996555668999999999999999996655668999999999999999
Q ss_pred CcccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCCC
Q 042634 81 LTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPS 160 (427)
Q Consensus 81 ~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~ 160 (427)
+++..+..+..+++| +.|++++|++++..+..++.+++|+.|++++|++++..|..++.+++|+.|++++|.+.+.
T Consensus 145 l~~~~~~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~--- 220 (272)
T 3rfs_A 145 LQSLPKGVFDKLTNL-TELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT--- 220 (272)
T ss_dssp CCCCCTTTTTTCTTC-CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC---
T ss_pred cCccCHHHhccCccC-CEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc---
Confidence 997777778899999 6899999999977777789999999999999999987777789999999999999998865
Q ss_pred CcccccCCceeeccCCccc
Q 042634 161 SLSSLRGIENLDLSRNNFI 179 (427)
Q Consensus 161 ~l~~l~~L~~L~L~~N~ll 179 (427)
+++++.+++..|.+.
T Consensus 221 ----~~~l~~l~~~~n~~~ 235 (272)
T 3rfs_A 221 ----CPGIRYLSEWINKHS 235 (272)
T ss_dssp ----TTTTHHHHHHHHHTG
T ss_pred ----CcHHHHHHHHHHhCC
Confidence 345777777766654
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.87 E-value=1.7e-22 Score=201.31 Aligned_cols=168 Identities=20% Similarity=0.248 Sum_probs=113.9
Q ss_pred CeeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCcc
Q 042634 1 AFTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNN 80 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~ 80 (427)
+|+|++|.+++..|..|+.+++|++|+|++|.+++..| ++.+++|++|+|++|.++ .+|.. ++|++|++++|.
T Consensus 38 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~-~l~~~----~~L~~L~L~~N~ 110 (487)
T 3oja_A 38 ELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-ELLVG----PSIETLHAANNN 110 (487)
T ss_dssp EEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEE-EEEEC----TTCCEEECCSSC
T ss_pred EEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCC-CCCCC----CCcCEEECcCCc
Confidence 48999999998878899999999999999999996554 999999999999999998 44422 566666666666
Q ss_pred CcccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCcccc-ccccccceeeeeeeccccCC
Q 042634 81 LTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIG-SCIRLEQLVMNGNFFRGNIP 159 (427)
Q Consensus 81 ~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~-~~~~l~~l~l~~n~l~~~~p 159 (427)
+++..+.. +++| ..|+|++|.+++..|..++.+++|+.|++++|.+++.+|..++ .+++|+.|++++|.+++..+
T Consensus 111 l~~~~~~~---l~~L-~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~ 186 (487)
T 3oja_A 111 ISRVSCSR---GQGK-KNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKG 186 (487)
T ss_dssp CCCEEECC---CSSC-EEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEEC
T ss_pred CCCCCccc---cCCC-CEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccccc
Confidence 66544432 3445 4566666666655555666666666666666666655555554 45666666666666655421
Q ss_pred CCcccccCCceeeccCCccccc
Q 042634 160 SSLSSLRGIENLDLSRNNFIRH 181 (427)
Q Consensus 160 ~~l~~l~~L~~L~L~~N~ll~H 181 (427)
...+++|+.|++++|.+..-
T Consensus 187 --~~~l~~L~~L~Ls~N~l~~~ 206 (487)
T 3oja_A 187 --QVVFAKLKTLDLSSNKLAFM 206 (487)
T ss_dssp --CCCCTTCCEEECCSSCCCEE
T ss_pred --cccCCCCCEEECCCCCCCCC
Confidence 22355566666666655443
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.87 E-value=4.7e-22 Score=203.41 Aligned_cols=130 Identities=16% Similarity=0.153 Sum_probs=117.5
Q ss_pred eeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccC
Q 042634 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNL 81 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~ 81 (427)
|++++|.+++..+..+..+++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..|..++.+++|++|++++|.+
T Consensus 56 l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 135 (597)
T 3oja_B 56 VTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDL 135 (597)
T ss_dssp EEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCC
Confidence 68999999966556688999999999999999977777999999999999999999977677789999999999999999
Q ss_pred cccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccc
Q 042634 82 TGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSG 132 (427)
Q Consensus 82 ~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~ 132 (427)
++.++..|.++++| ++|+|++|.+++..|..++.+++|+.|++++|.+++
T Consensus 136 ~~l~~~~~~~l~~L-~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 185 (597)
T 3oja_B 136 SSLPRGIFHNTPKL-TTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH 185 (597)
T ss_dssp CCCCTTTTTTCTTC-CEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSB
T ss_pred CCCCHHHhccCCCC-CEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCC
Confidence 96666667899999 689999999998888899999999999999999885
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=1.1e-21 Score=174.63 Aligned_cols=152 Identities=20% Similarity=0.240 Sum_probs=108.9
Q ss_pred eeecCCcccccCCccccCCCCCCEeeeecccceeecCc-chhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCcc
Q 042634 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPS-SIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNN 80 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~-~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~ 80 (427)
+++++|.++ .+|..+. ..++.|+|++|++++..|. .|+.+++|++|+|++|.+++..|..+..+++|++|++++|+
T Consensus 16 l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~ 92 (220)
T 2v70_A 16 VDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNR 92 (220)
T ss_dssp EECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred eEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCc
Confidence 577777777 4666553 3457777777777754343 46777777888887777775555567777777777777777
Q ss_pred CcccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeecccc
Q 042634 81 LTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGN 157 (427)
Q Consensus 81 ~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~ 157 (427)
+++..|..+.++.+| ++|+|++|++++..|..+..+++|+.|+|++|++++..|..|..+++|+.|++++|.++..
T Consensus 93 l~~~~~~~~~~l~~L-~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 168 (220)
T 2v70_A 93 LENVQHKMFKGLESL-KTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCN 168 (220)
T ss_dssp CCCCCGGGGTTCSSC-CEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECS
T ss_pred cCccCHhHhcCCcCC-CEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCC
Confidence 776666667777777 5677777777766677777777777777777777766677777777777777777777643
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=3.6e-22 Score=187.49 Aligned_cols=177 Identities=20% Similarity=0.156 Sum_probs=149.8
Q ss_pred CeeecCCcccccCCccc--cCCCCCCEeeeecccceeecC----cchhccccCCEeeeccccCcccCCcCccCCCCCCeE
Q 042634 1 AFTLVGNQFTGRIPGSI--GDLHKLQRLTLEMNKFWGEIP----SSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILL 74 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~--~~l~~L~~L~l~~n~~~~~~p----~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l 74 (427)
+|+|++|.+++.+|..+ ..+++|+.|+|++|.+++..| ..+..+++|++|+|++|.+++..|..++.+++|++|
T Consensus 95 ~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L 174 (310)
T 4glp_A 95 ELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSL 174 (310)
T ss_dssp EEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEE
T ss_pred EEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEE
Confidence 47999999999999988 999999999999999997555 345679999999999999997777889999999999
Q ss_pred EccCccCccc--C--CCCccccccccceeeccCCcCcCCCCC----CCcCCCCCCeEECcCCcccccCCcccccc---cc
Q 042634 75 DLSNNNLTGT--T--PTEVIGLSSLSIYLDLSQNQLNGPLPS----NFGILKNLGAIDISENKLSGQIPSSIGSC---IR 143 (427)
Q Consensus 75 ~l~~N~~~~~--~--p~~~~~l~~l~~~L~l~~n~~~~~~p~----~~~~l~~L~~l~l~~n~~~~~~p~~~~~~---~~ 143 (427)
++++|++.+. + +..+..+++| ++|+|++|+++ .+|. .++.+++|+.|++++|++++.+|..++.+ ++
T Consensus 175 ~Ls~N~l~~~~~~~~~~~~~~l~~L-~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~ 252 (310)
T 4glp_A 175 DLSDNPGLGERGLMAALCPHKFPAI-QNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSA 252 (310)
T ss_dssp ECCSCTTCHHHHHHTTSCTTSSCCC-CSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTT
T ss_pred ECCCCCCccchhhhHHHhhhcCCCC-CEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCc
Confidence 9999998752 2 2334678888 67999999997 4444 25788999999999999998779888887 69
Q ss_pred ccceeeeeeeccccCCCCcccccCCceeeccCCcccccc
Q 042634 144 LEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNFIRHR 182 (427)
Q Consensus 144 l~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~ll~Hp 182 (427)
|+.|++++|.++ .+|..+. ++|+.|++++|++..-|
T Consensus 253 L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~~ 288 (310)
T 4glp_A 253 LNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRAP 288 (310)
T ss_dssp CCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSCC
T ss_pred CCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCCc
Confidence 999999999999 5677764 79999999999987544
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.1e-21 Score=201.17 Aligned_cols=179 Identities=23% Similarity=0.255 Sum_probs=152.7
Q ss_pred CeeecCCcccccCCcc-ccCCCCCCEeeeecccceeec--CcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEcc
Q 042634 1 AFTLVGNQFTGRIPGS-IGDLHKLQRLTLEMNKFWGEI--PSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLS 77 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~-~~~l~~L~~L~l~~n~~~~~~--p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~ 77 (427)
+|++++|.+++.+|.. +..+++|++|++++|.+++.. |..++.+++|++|++++|.+++..|..+..+++|++|+++
T Consensus 329 ~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 408 (606)
T 3t6q_A 329 HLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLA 408 (606)
T ss_dssp EEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECT
T ss_pred EEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECC
Confidence 3788999998877765 888999999999999998655 6788999999999999999997778888899999999999
Q ss_pred CccCcccCCCC-ccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCccccc---CCccccccccccceeeeeee
Q 042634 78 NNNLTGTTPTE-VIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQ---IPSSIGSCIRLEQLVMNGNF 153 (427)
Q Consensus 78 ~N~~~~~~p~~-~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~---~p~~~~~~~~l~~l~l~~n~ 153 (427)
+|++++..|.. +..+++| +.|++++|.+++..|..++.+++|+.|++++|++++. .+..+..+++|+.|++++|.
T Consensus 409 ~n~l~~~~~~~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~ 487 (606)
T 3t6q_A 409 FTRLKVKDAQSPFQNLHLL-KVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCD 487 (606)
T ss_dssp TCCEECCTTCCTTTTCTTC-CEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSC
T ss_pred CCcCCCcccchhhhCcccC-CEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCc
Confidence 99998776644 7888888 6799999999888888899999999999999988862 33568889999999999999
Q ss_pred ccccCCCCcccccCCceeeccCCcccc
Q 042634 154 FRGNIPSSLSSLRGIENLDLSRNNFIR 180 (427)
Q Consensus 154 l~~~~p~~l~~l~~L~~L~L~~N~ll~ 180 (427)
+++..|..+..+++|+.|++++|++..
T Consensus 488 l~~~~~~~~~~l~~L~~L~Ls~N~l~~ 514 (606)
T 3t6q_A 488 LSSIDQHAFTSLKMMNHVDLSHNRLTS 514 (606)
T ss_dssp CCEECTTTTTTCTTCCEEECCSSCCCG
T ss_pred cCccChhhhccccCCCEEECCCCccCc
Confidence 998888888999999999999988754
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.87 E-value=1.8e-21 Score=173.33 Aligned_cols=150 Identities=22% Similarity=0.271 Sum_probs=101.0
Q ss_pred eeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccC
Q 042634 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNL 81 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~ 81 (427)
+++++|.++ .+|..+. ++|+.|+|++|++++..|..|..+++|++|+|++|++++..|..+..+++|++|+|++|++
T Consensus 16 v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l 92 (220)
T 2v9t_B 16 VDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKI 92 (220)
T ss_dssp EECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCC
T ss_pred EEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcC
Confidence 566777777 5566544 5677777777777754444677777777777777777755566777777777777777777
Q ss_pred cccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeecc
Q 042634 82 TGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFR 155 (427)
Q Consensus 82 ~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~ 155 (427)
++..+..|.++.+| ++|+|++|++++..|..|..+++|+.|+|++|++++..+..+..+++|+.|++++|.+.
T Consensus 93 ~~l~~~~f~~l~~L-~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 93 TELPKSLFEGLFSL-QLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp CCCCTTTTTTCTTC-CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred CccCHhHccCCCCC-CEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence 74444455666666 46777777776666666777777777777777776544445666666666666666665
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.86 E-value=1.8e-21 Score=184.47 Aligned_cols=176 Identities=22% Similarity=0.324 Sum_probs=145.3
Q ss_pred CeeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCcc
Q 042634 1 AFTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNN 80 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~ 80 (427)
+|+|++|++++..|..++.+++|++|+|++|+++ .+|..+. ++|++|++++|.+++..+..+..+++|++|++++|.
T Consensus 82 ~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~ 158 (332)
T 2ft3_A 82 ALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNP 158 (332)
T ss_dssp EEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCC
T ss_pred EEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCc
Confidence 3789999999888889999999999999999998 7887665 788888888888884333457778888888888888
Q ss_pred Cc--ccCCCCcccc--------------------ccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccc
Q 042634 81 LT--GTTPTEVIGL--------------------SSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSI 138 (427)
Q Consensus 81 ~~--~~~p~~~~~l--------------------~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~ 138 (427)
++ +..|..+..+ .+| ++|++++|.+++..|..+..+++|+.|++++|++++..|..+
T Consensus 159 l~~~~~~~~~~~~l~L~~L~l~~n~l~~l~~~~~~~L-~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~ 237 (332)
T 2ft3_A 159 LENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETL-NELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSL 237 (332)
T ss_dssp CBGGGSCTTSSCSCCCSCCBCCSSBCSSCCSSSCSSC-SCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGG
T ss_pred cccCCCCcccccCCccCEEECcCCCCCccCccccCCC-CEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHh
Confidence 85 2444444433 355 468888888887777889999999999999999997777789
Q ss_pred cccccccceeeeeeeccccCCCCcccccCCceeeccCCccccc
Q 042634 139 GSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNFIRH 181 (427)
Q Consensus 139 ~~~~~l~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~ll~H 181 (427)
+.+++|+.|++++|.++ .+|..+..+++|+.|++++|.+..-
T Consensus 238 ~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~ 279 (332)
T 2ft3_A 238 SFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKV 279 (332)
T ss_dssp GGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBC
T ss_pred hCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCcc
Confidence 99999999999999999 6788899999999999999988653
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.86 E-value=2e-21 Score=188.44 Aligned_cols=104 Identities=28% Similarity=0.310 Sum_probs=62.0
Q ss_pred eeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcC-ccCCCCCCeEEccCcc
Q 042634 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSS-LGKCQNLILLDLSNNN 80 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~-~~~l~~L~~l~l~~N~ 80 (427)
|+|++|.+++..|..+..+++|++|+|++|.+++..|..|+++++|++|+|++|.++ .+|.. +..+++|++|++++|.
T Consensus 74 L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~ 152 (390)
T 3o6n_A 74 LNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNN 152 (390)
T ss_dssp EECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSC
T ss_pred EECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccC-cCCHHHhcCCCCCcEEECCCCc
Confidence 566666666555556666666666666666666444445566666666666666666 45544 3556666666666666
Q ss_pred CcccCCCCccccccccceeeccCCcCc
Q 042634 81 LTGTTPTEVIGLSSLSIYLDLSQNQLN 107 (427)
Q Consensus 81 ~~~~~p~~~~~l~~l~~~L~l~~n~~~ 107 (427)
+++..|..+.++++| ++|++++|+++
T Consensus 153 l~~~~~~~~~~l~~L-~~L~l~~n~l~ 178 (390)
T 3o6n_A 153 LERIEDDTFQATTSL-QNLQLSSNRLT 178 (390)
T ss_dssp CCBCCTTTTSSCTTC-CEEECCSSCCS
T ss_pred cCccChhhccCCCCC-CEEECCCCcCC
Confidence 665555555556665 45666666554
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.86 E-value=8e-22 Score=174.05 Aligned_cols=167 Identities=23% Similarity=0.209 Sum_probs=126.5
Q ss_pred eeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccC
Q 042634 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNL 81 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~ 81 (427)
++.+++.++ .+|..+ .++|++|+|++|++++..+..++++++|++|++++|++++..+..+..+++|++|++++|++
T Consensus 12 v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l 88 (208)
T 2o6s_A 12 VECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQL 88 (208)
T ss_dssp EECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcC
Confidence 567778887 566554 45888888888888854444578888888888888888844334467888888888888888
Q ss_pred cccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCCCC
Q 042634 82 TGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSS 161 (427)
Q Consensus 82 ~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~~ 161 (427)
++..+..+.++.+| ++|++++|++++..+..+..+++|+.|++++|++++..+..+..+++|+.|++++|.+.+.
T Consensus 89 ~~~~~~~~~~l~~L-~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~---- 163 (208)
T 2o6s_A 89 QSLPNGVFDKLTQL-KELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT---- 163 (208)
T ss_dssp CCCCTTTTTTCTTC-CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCC----
T ss_pred CccCHhHhcCccCC-CEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecC----
Confidence 86666667788888 6788888888865556678888888888888888865555678888888888888877653
Q ss_pred cccccCCceeeccCCccc
Q 042634 162 LSSLRGIENLDLSRNNFI 179 (427)
Q Consensus 162 l~~l~~L~~L~L~~N~ll 179 (427)
++.++.|+++.|++.
T Consensus 164 ---~~~l~~L~~~~n~~~ 178 (208)
T 2o6s_A 164 ---CPGIRYLSEWINKHS 178 (208)
T ss_dssp ---TTTTHHHHHHHHHCT
T ss_pred ---CCCHHHHHHHHHhCC
Confidence 345667766666654
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=1.2e-21 Score=194.99 Aligned_cols=178 Identities=21% Similarity=0.192 Sum_probs=108.0
Q ss_pred CeeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCcc
Q 042634 1 AFTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNN 80 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~ 80 (427)
+|+|++|.+++..|..|..+++|+.|+|++|++++..+..++++++|+.|+|++|.+++..+..+..+++|++|++++|.
T Consensus 132 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~ 211 (477)
T 2id5_A 132 SLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWP 211 (477)
T ss_dssp EEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCT
T ss_pred EEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCc
Confidence 36788888887777788888888888888888874333457778888888888888876555567777766666666665
Q ss_pred CcccCCCCc------------------------cccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCc
Q 042634 81 LTGTTPTEV------------------------IGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPS 136 (427)
Q Consensus 81 ~~~~~p~~~------------------------~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~ 136 (427)
+.+.+|... .++++| +.|+|++|++++..+..+..+++|+.|++++|++++..|.
T Consensus 212 ~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L-~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 290 (477)
T 2id5_A 212 YLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYL-RFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPY 290 (477)
T ss_dssp TCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTC-CEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTT
T ss_pred cccccCcccccCccccEEECcCCcccccCHHHhcCcccc-CeeECCCCcCCccChhhccccccCCEEECCCCccceECHH
Confidence 555555443 444444 3455555555444444445555555555555555544444
Q ss_pred cccccccccceeeeeeeccccCCCCcccccCCceeeccCCccc
Q 042634 137 SIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNFI 179 (427)
Q Consensus 137 ~~~~~~~l~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~ll 179 (427)
.+.++++|+.|++++|.+++..+..+..+++|+.|++++|.+.
T Consensus 291 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 333 (477)
T 2id5_A 291 AFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333 (477)
T ss_dssp TBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEE
T ss_pred HhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCcc
Confidence 5555555555555555555443344445555555555555543
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=7e-22 Score=202.59 Aligned_cols=176 Identities=20% Similarity=0.134 Sum_probs=136.0
Q ss_pred CeeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCcc
Q 042634 1 AFTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNN 80 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~ 80 (427)
+|+|++|++++..|..|.++++|++|+|++|++++..|..|+++++|++|+|++|.+++..|..++++++|++|++++|.
T Consensus 36 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~ 115 (606)
T 3vq2_A 36 NIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETK 115 (606)
T ss_dssp EEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSC
T ss_pred EEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCc
Confidence 36788888887777778888888888888888886666778888888888888888886667778888888888888888
Q ss_pred CcccCCCCccccccccceeeccCCcCcC-CCCCCCcCCCCCCeEECcCCcccccCCcccccccccc----ceeeeeeecc
Q 042634 81 LTGTTPTEVIGLSSLSIYLDLSQNQLNG-PLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLE----QLVMNGNFFR 155 (427)
Q Consensus 81 ~~~~~p~~~~~l~~l~~~L~l~~n~~~~-~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~----~l~l~~n~l~ 155 (427)
+++..|..++++.+| ++|++++|.+++ .+|..++++++|+.|++++|++++..|..++.+.+|+ .|++++|.++
T Consensus 116 l~~~~~~~~~~l~~L-~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~ 194 (606)
T 3vq2_A 116 LASLESFPIGQLITL-KKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID 194 (606)
T ss_dssp CCCSSSSCCTTCTTC-CEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCCCC
T ss_pred cccccccccCCCCCC-CEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCCcc
Confidence 876666778888888 578888888875 5688888888888888888888877777777777665 5888888887
Q ss_pred ccCCCCcccccCCceeeccCCcc
Q 042634 156 GNIPSSLSSLRGIENLDLSRNNF 178 (427)
Q Consensus 156 ~~~p~~l~~l~~L~~L~L~~N~l 178 (427)
+..+..+... +|+.|++++|.+
T Consensus 195 ~~~~~~~~~~-~L~~L~L~~n~~ 216 (606)
T 3vq2_A 195 FIQDQAFQGI-KLHELTLRGNFN 216 (606)
T ss_dssp EECTTTTTTC-EEEEEEEESCCS
T ss_pred eeCcccccCc-eeeeeeccCCcc
Confidence 6555544444 788888887765
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=6.2e-22 Score=202.99 Aligned_cols=179 Identities=21% Similarity=0.190 Sum_probs=163.7
Q ss_pred CeeecCCcccccC--CccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcC-ccCCCCCCeEEcc
Q 042634 1 AFTLVGNQFTGRI--PGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSS-LGKCQNLILLDLS 77 (427)
Q Consensus 1 ~l~l~~n~l~~~~--p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~-~~~l~~L~~l~l~ 77 (427)
+|+|++|.+++.. |..+..+++|+.|++++|.+++..|..++.+++|+.|++++|.+++..|+. +..+++|++|+++
T Consensus 354 ~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~ 433 (606)
T 3t6q_A 354 ELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLS 433 (606)
T ss_dssp EEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECT
T ss_pred EEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECC
Confidence 4799999999776 788999999999999999999888889999999999999999999776655 8899999999999
Q ss_pred CccCcccCCCCccccccccceeeccCCcCcC---CCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeec
Q 042634 78 NNNLTGTTPTEVIGLSSLSIYLDLSQNQLNG---PLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFF 154 (427)
Q Consensus 78 ~N~~~~~~p~~~~~l~~l~~~L~l~~n~~~~---~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l 154 (427)
+|.+++..|..+.++++| ++|++++|++++ ..+..+..+++|+.|++++|++++..|..++.+++|+.|++++|.+
T Consensus 434 ~n~l~~~~~~~~~~l~~L-~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l 512 (606)
T 3t6q_A 434 HSLLDISSEQLFDGLPAL-QHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRL 512 (606)
T ss_dssp TCCCBTTCTTTTTTCTTC-CEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred CCccCCcCHHHHhCCCCC-CEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCcc
Confidence 999998899999999999 689999999986 3346799999999999999999988899999999999999999999
Q ss_pred cccCCCCcccccCCceeeccCCccccc
Q 042634 155 RGNIPSSLSSLRGIENLDLSRNNFIRH 181 (427)
Q Consensus 155 ~~~~p~~l~~l~~L~~L~L~~N~ll~H 181 (427)
++..|..+..++.| .|++++|++..-
T Consensus 513 ~~~~~~~l~~l~~L-~L~L~~N~l~~~ 538 (606)
T 3t6q_A 513 TSSSIEALSHLKGI-YLNLASNHISII 538 (606)
T ss_dssp CGGGGGGGTTCCSC-EEECCSSCCCCC
T ss_pred CcCChhHhCccccc-EEECcCCccccc
Confidence 99999999999999 999999998754
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=1.9e-22 Score=193.00 Aligned_cols=176 Identities=22% Similarity=0.228 Sum_probs=144.7
Q ss_pred eeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccC
Q 042634 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNL 81 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~ 81 (427)
.|+++|+++ .+|..+. ++|+.|+|++|++++..+..++++++|++|++++|.+++..|..+..+++|++|++++|++
T Consensus 36 c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l 112 (353)
T 2z80_A 36 CKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYL 112 (353)
T ss_dssp EECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred eeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcC
Confidence 477888888 6787655 4899999999999854445789999999999999999976677788999999999999999
Q ss_pred cccCCCCccccccccceeeccCCcCcCCCCC--CCcCCCCCCeEECcCC-cccccCCccccccccccceeeeeeeccccC
Q 042634 82 TGTTPTEVIGLSSLSIYLDLSQNQLNGPLPS--NFGILKNLGAIDISEN-KLSGQIPSSIGSCIRLEQLVMNGNFFRGNI 158 (427)
Q Consensus 82 ~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~--~~~~l~~L~~l~l~~n-~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~ 158 (427)
++..+..+.++++| ++|++++|+++ .+|. .+..+++|+.|++++| .+++..|..++++++|+.|++++|.+++..
T Consensus 113 ~~~~~~~~~~l~~L-~~L~L~~n~l~-~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 190 (353)
T 2z80_A 113 SNLSSSWFKPLSSL-TFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYE 190 (353)
T ss_dssp SSCCHHHHTTCTTC-SEEECTTCCCS-SSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEEC
T ss_pred CcCCHhHhCCCccC-CEEECCCCCCc-ccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccC
Confidence 85554557888888 67999999997 5555 7888999999999998 466555678888999999999999999888
Q ss_pred CCCcccccCCceeeccCCcccccc
Q 042634 159 PSSLSSLRGIENLDLSRNNFIRHR 182 (427)
Q Consensus 159 p~~l~~l~~L~~L~L~~N~ll~Hp 182 (427)
|..+..+++|+.|++++|.+...+
T Consensus 191 ~~~l~~l~~L~~L~l~~n~l~~~~ 214 (353)
T 2z80_A 191 PKSLKSIQNVSHLILHMKQHILLL 214 (353)
T ss_dssp TTTTTTCSEEEEEEEECSCSTTHH
T ss_pred HHHHhccccCCeecCCCCccccch
Confidence 888988999999999888875433
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.86 E-value=2e-21 Score=188.44 Aligned_cols=131 Identities=16% Similarity=0.150 Sum_probs=115.0
Q ss_pred CeeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCcc
Q 042634 1 AFTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNN 80 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~ 80 (427)
+|++++|.++...+..+..+++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..|..++.+++|++|++++|.
T Consensus 49 ~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 128 (390)
T 3o6n_A 49 IVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERND 128 (390)
T ss_dssp EEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCc
Confidence 37899999995544557899999999999999996666789999999999999999997667779999999999999999
Q ss_pred CcccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccc
Q 042634 81 LTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSG 132 (427)
Q Consensus 81 ~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~ 132 (427)
++...+..+.++++| ++|++++|.+++..|..++.+++|+.|++++|++++
T Consensus 129 l~~l~~~~~~~l~~L-~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 179 (390)
T 3o6n_A 129 LSSLPRGIFHNTPKL-TTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH 179 (390)
T ss_dssp CCCCCTTTTTTCTTC-CEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSB
T ss_pred cCcCCHHHhcCCCCC-cEEECCCCccCccChhhccCCCCCCEEECCCCcCCc
Confidence 995444556889999 689999999998778889999999999999999884
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=7.3e-22 Score=185.41 Aligned_cols=173 Identities=19% Similarity=0.183 Sum_probs=147.6
Q ss_pred CeeecCCcccccCC----ccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCccc--CC--cCccCCCCCC
Q 042634 1 AFTLVGNQFTGRIP----GSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGS--IP--SSLGKCQNLI 72 (427)
Q Consensus 1 ~l~l~~n~l~~~~p----~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~--~p--~~~~~l~~L~ 72 (427)
+|+|++|.+++..| ..+..+++|++|+|++|++++..|..++.+++|++|+|++|++.+. +| ..+..+++|+
T Consensus 121 ~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~ 200 (310)
T 4glp_A 121 SLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQ 200 (310)
T ss_dssp SCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCC
T ss_pred EEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCC
Confidence 47999999998766 4567899999999999999977778899999999999999998753 33 3347899999
Q ss_pred eEEccCccCcccCCC----CccccccccceeeccCCcCcCCCCCCCcCC---CCCCeEECcCCcccccCCcccccccccc
Q 042634 73 LLDLSNNNLTGTTPT----EVIGLSSLSIYLDLSQNQLNGPLPSNFGIL---KNLGAIDISENKLSGQIPSSIGSCIRLE 145 (427)
Q Consensus 73 ~l~l~~N~~~~~~p~----~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l---~~L~~l~l~~n~~~~~~p~~~~~~~~l~ 145 (427)
+|++++|+++ .+|. .+.++.+| ++|+|++|++++..|..+..+ ++|+.|++++|+++ .+|..+. ++|+
T Consensus 201 ~L~Ls~N~l~-~l~~~~~~l~~~l~~L-~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~ 275 (310)
T 4glp_A 201 NLALRNTGME-TPTGVCAALAAAGVQP-HSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLR 275 (310)
T ss_dssp SCBCCSSCCC-CHHHHHHHHHHHTCCC-SSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCS
T ss_pred EEECCCCCCC-chHHHHHHHHhcCCCC-CEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCC
Confidence 9999999997 3333 24677889 679999999998889888887 69999999999999 7899885 7999
Q ss_pred ceeeeeeeccccCCCCcccccCCceeeccCCcccc
Q 042634 146 QLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNFIR 180 (427)
Q Consensus 146 ~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~ll~ 180 (427)
.|++++|.+++. |. +..+++|+.|++++|.+.+
T Consensus 276 ~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 276 VLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp CEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred EEECCCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence 999999999974 33 6788999999999998754
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=7.6e-22 Score=198.60 Aligned_cols=175 Identities=22% Similarity=0.326 Sum_probs=124.5
Q ss_pred eeecCCcccccCCccc-----cCCCCCCEeeeecccceeecC-cch-------------------------hccccCCEe
Q 042634 2 FTLVGNQFTGRIPGSI-----GDLHKLQRLTLEMNKFWGEIP-SSI-------------------------GNLTLLITL 50 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~-----~~l~~L~~L~l~~n~~~~~~p-~~~-------------------------~~l~~L~~L 50 (427)
|+|++|+++|.+|..+ +.+++|+.+++++|.+ .+| ..+ +.+++|++|
T Consensus 252 L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~~L 329 (520)
T 2z7x_B 252 FSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHL 329 (520)
T ss_dssp EEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEE
T ss_pred EEeecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCccccccchhhCCcccEE
Confidence 6788888888888877 6676666666666666 344 111 566777778
Q ss_pred eeccccCcccCCcCccCCCCCCeEEccCccCcc--cCCCCccccccccceeeccCCcCcCCCCCC-CcCCCCCCeEECcC
Q 042634 51 NFAENMLEGSIPSSLGKCQNLILLDLSNNNLTG--TTPTEVIGLSSLSIYLDLSQNQLNGPLPSN-FGILKNLGAIDISE 127 (427)
Q Consensus 51 ~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~~~--~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~-~~~l~~L~~l~l~~ 127 (427)
++++|.+++.+|..++.+++|++|++++|++++ .+|..+.++++| ++|++++|++++.+|.. +..+++|+.|++++
T Consensus 330 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L-~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~ 408 (520)
T 2z7x_B 330 DFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSL-QQLDISQNSVSYDEKKGDCSWTKSLLSLNMSS 408 (520)
T ss_dssp ECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTC-CEEECCSSCCBCCGGGCSCCCCTTCCEEECCS
T ss_pred EeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCC-CEEECCCCcCCcccccchhccCccCCEEECcC
Confidence 888888777677777777778888888887775 445566777777 56778888777656643 67777777777777
Q ss_pred CcccccCCccccccccccceeeeeeeccccCCCCcccccCCceeeccCCcccccc
Q 042634 128 NKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNFIRHR 182 (427)
Q Consensus 128 n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~ll~Hp 182 (427)
|++++.+|..+. ++|+.|++++|.++ .+|..+..+++|+.|++++|++..-|
T Consensus 409 N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~ 460 (520)
T 2z7x_B 409 NILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVP 460 (520)
T ss_dssp SCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCC
T ss_pred CCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccC
Confidence 777766666554 57777777777777 56666667777777777777766444
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=1.2e-21 Score=199.17 Aligned_cols=173 Identities=22% Similarity=0.257 Sum_probs=80.5
Q ss_pred eeecCCcccccCCccccCCCCCCEeeeecccceeec--CcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCc
Q 042634 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEI--PSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNN 79 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~--p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 79 (427)
|++++|.+++.++. ..+++|+.|++++|++++.. |..+.++++|++|++++|.++ .+|+.+..+++|++|++++|
T Consensus 330 L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~-~~~~~~~~l~~L~~L~l~~n 406 (570)
T 2z63_A 330 LTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHS 406 (570)
T ss_dssp EEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTS
T ss_pred EeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCccc-cccccccccCCCCEEEccCC
Confidence 34455554444333 44445555555555444321 344444455555555555444 23333444444555555554
Q ss_pred cCcccCC-CCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCccc-ccCCccccccccccceeeeeeecccc
Q 042634 80 NLTGTTP-TEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLS-GQIPSSIGSCIRLEQLVMNGNFFRGN 157 (427)
Q Consensus 80 ~~~~~~p-~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~-~~~p~~~~~~~~l~~l~l~~n~l~~~ 157 (427)
.+++..| ..+.++++| ++|++++|.+++..|..+..+++|+.|++++|+++ +.+|..++.+++|+.|++++|.+++.
T Consensus 407 ~l~~~~~~~~~~~l~~L-~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~ 485 (570)
T 2z63_A 407 NLKQMSEFSVFLSLRNL-IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQL 485 (570)
T ss_dssp EEESCTTSCTTTTCTTC-CEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEE
T ss_pred ccccccchhhhhcCCCC-CEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccC
Confidence 4444333 234444444 34444444444444444444444444544444444 33444444444444444444444444
Q ss_pred CCCCcccccCCceeeccCCcc
Q 042634 158 IPSSLSSLRGIENLDLSRNNF 178 (427)
Q Consensus 158 ~p~~l~~l~~L~~L~L~~N~l 178 (427)
.|..+..+++|+.|++++|++
T Consensus 486 ~~~~~~~l~~L~~L~l~~n~l 506 (570)
T 2z63_A 486 SPTAFNSLSSLQVLNMASNQL 506 (570)
T ss_dssp CTTTTTTCTTCCEEECCSSCC
T ss_pred ChhhhhcccCCCEEeCCCCcC
Confidence 444444444444444444444
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=2.7e-21 Score=205.51 Aligned_cols=177 Identities=23% Similarity=0.213 Sum_probs=156.1
Q ss_pred CeeecCCcccccCCccccCCCCCCEeeeecccceeec-CcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCc
Q 042634 1 AFTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEI-PSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNN 79 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~-p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 79 (427)
+|||++|.+++..|..|.++++|++|+|++|.+.+.+ |..|+++++|++|+|++|.+++..|..++++++|++|++++|
T Consensus 28 ~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n 107 (844)
T 3j0a_A 28 RLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFC 107 (844)
T ss_dssp EEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTC
T ss_pred EEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCC
Confidence 4799999999888999999999999999999766677 678999999999999999999888999999999999999999
Q ss_pred cCcccCCCC--ccccccccceeeccCCcCcCCCC-CCCcCCCCCCeEECcCCcccccCCcccccc--ccccceeeeeeec
Q 042634 80 NLTGTTPTE--VIGLSSLSIYLDLSQNQLNGPLP-SNFGILKNLGAIDISENKLSGQIPSSIGSC--IRLEQLVMNGNFF 154 (427)
Q Consensus 80 ~~~~~~p~~--~~~l~~l~~~L~l~~n~~~~~~p-~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~--~~l~~l~l~~n~l 154 (427)
.+++.+|.. +.++++| ++|+|++|.+++..+ ..++++++|+.|++++|.+++..|..++.+ ++|+.|++++|.+
T Consensus 108 ~l~~~~~~~~~~~~L~~L-~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l 186 (844)
T 3j0a_A 108 GLSDAVLKDGYFRNLKAL-TRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSL 186 (844)
T ss_dssp CCSSCCSTTCCCSSCSSC-CEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBS
T ss_pred CCCcccccCccccccCCC-CEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCCcc
Confidence 999877654 8889999 689999999987655 578999999999999999998888888887 8999999999999
Q ss_pred cccCCCCcccccC------CceeeccCCcc
Q 042634 155 RGNIPSSLSSLRG------IENLDLSRNNF 178 (427)
Q Consensus 155 ~~~~p~~l~~l~~------L~~L~L~~N~l 178 (427)
.+..|..+..+.+ |+.|++++|.+
T Consensus 187 ~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l 216 (844)
T 3j0a_A 187 YSRVSVDWGKCMNPFRNMVLEILDVSGNGW 216 (844)
T ss_dssp CCCCCCCCCSSSCTTTTCCBSEEBCSSCCS
T ss_pred ccccccchhhcCCccccCceeEEecCCCcC
Confidence 9888887776665 89999998865
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=5.8e-21 Score=180.85 Aligned_cols=173 Identities=23% Similarity=0.303 Sum_probs=148.3
Q ss_pred CeeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcc--cCCcCccCCCCCCeEEccC
Q 042634 1 AFTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEG--SIPSSLGKCQNLILLDLSN 78 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~--~~p~~~~~l~~L~~l~l~~ 78 (427)
+|+|++|+++ .+|..+. ++|+.|++++|.+++..+..++++++|+.|++++|.++. ..|..+..+++|++|++++
T Consensus 104 ~L~Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~ 180 (330)
T 1xku_A 104 RLYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIAD 180 (330)
T ss_dssp EEECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCS
T ss_pred EEECCCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCC
Confidence 4789999999 6777665 799999999999986555678999999999999999963 6777889999999999999
Q ss_pred ccCcccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccC
Q 042634 79 NNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNI 158 (427)
Q Consensus 79 N~~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~ 158 (427)
|.++ .+|..+. ++| +.|++++|++++..|..+..+++|+.|++++|++++..+..++.+++|+.|++++|.++ .+
T Consensus 181 n~l~-~l~~~~~--~~L-~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~l 255 (330)
T 1xku_A 181 TNIT-TIPQGLP--PSL-TELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KV 255 (330)
T ss_dssp SCCC-SCCSSCC--TTC-SEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SC
T ss_pred Cccc-cCCcccc--ccC-CEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cC
Confidence 9998 5665543 677 67999999998877889999999999999999999777778999999999999999998 57
Q ss_pred CCCcccccCCceeeccCCccccc
Q 042634 159 PSSLSSLRGIENLDLSRNNFIRH 181 (427)
Q Consensus 159 p~~l~~l~~L~~L~L~~N~ll~H 181 (427)
|..+..+++|+.|++++|.+..-
T Consensus 256 p~~l~~l~~L~~L~l~~N~i~~~ 278 (330)
T 1xku_A 256 PGGLADHKYIQVVYLHNNNISAI 278 (330)
T ss_dssp CTTTTTCSSCCEEECCSSCCCCC
T ss_pred ChhhccCCCcCEEECCCCcCCcc
Confidence 88899999999999999988654
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.85 E-value=1.7e-21 Score=186.92 Aligned_cols=173 Identities=23% Similarity=0.197 Sum_probs=148.2
Q ss_pred eeecCCcccccCCccccCCCCCCEeeeecccceeecCcchh-ccccCCEeeeccccCcccCCcCccCCCCCCeEEccCcc
Q 042634 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIG-NLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNN 80 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~-~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~ 80 (427)
+++++|+|+ .+|..+. ..++.|+|++|++++..+..+. ++++|++|+|++|++++..|..+..+++|++|+|++|+
T Consensus 23 l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~ 99 (361)
T 2xot_A 23 LSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNH 99 (361)
T ss_dssp EECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred EEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCc
Confidence 688999999 6787664 4689999999999965556676 99999999999999996666779999999999999999
Q ss_pred CcccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccc----cccccccceeeeeeeccc
Q 042634 81 LTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSI----GSCIRLEQLVMNGNFFRG 156 (427)
Q Consensus 81 ~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~----~~~~~l~~l~l~~n~l~~ 156 (427)
+++..+..|.++.+| +.|+|++|++++..|..|..+++|+.|+|++|+++ .+|..+ ..+++|+.|++++|.+++
T Consensus 100 l~~~~~~~~~~l~~L-~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 177 (361)
T 2xot_A 100 LHTLDEFLFSDLQAL-EVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKK 177 (361)
T ss_dssp CCEECTTTTTTCTTC-CEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC-SCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred CCcCCHHHhCCCcCC-CEEECCCCcccEECHHHhCCcccCCEEECCCCcCC-eeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence 998777789999999 68999999999878899999999999999999999 577654 579999999999999997
Q ss_pred cCCCCcccccC--CceeeccCCccc
Q 042634 157 NIPSSLSSLRG--IENLDLSRNNFI 179 (427)
Q Consensus 157 ~~p~~l~~l~~--L~~L~L~~N~ll 179 (427)
..+..+..++. ++.|++++|.+.
T Consensus 178 l~~~~~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 178 LPLTDLQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp CCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred cCHHHhhhccHhhcceEEecCCCcc
Confidence 65566777776 478999999874
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=2.3e-21 Score=195.16 Aligned_cols=102 Identities=26% Similarity=0.215 Sum_probs=69.4
Q ss_pred eeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccC
Q 042634 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNL 81 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~ 81 (427)
|+|++|.+++..|..|.++++|++|+|++|++++..|..|+++++|++|+|++|+++ .+|.. .+++|++|++++|++
T Consensus 26 L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L~~N~l 102 (520)
T 2z7x_B 26 LNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDLSFNAF 102 (520)
T ss_dssp EECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEECCSSCC
T ss_pred EECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEeccCCcc
Confidence 567777777655566777777777777777777655667777777777777777777 56655 667777777777777
Q ss_pred cc-cCCCCccccccccceeeccCCcCc
Q 042634 82 TG-TTPTEVIGLSSLSIYLDLSQNQLN 107 (427)
Q Consensus 82 ~~-~~p~~~~~l~~l~~~L~l~~n~~~ 107 (427)
++ .+|..++++.+| ++|++++|.++
T Consensus 103 ~~~~~p~~~~~l~~L-~~L~L~~n~l~ 128 (520)
T 2z7x_B 103 DALPICKEFGNMSQL-KFLGLSTTHLE 128 (520)
T ss_dssp SSCCCCGGGGGCTTC-CEEEEEESSCC
T ss_pred ccccchhhhccCCcc-eEEEecCcccc
Confidence 65 356666666666 45666666553
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.85 E-value=2e-21 Score=197.39 Aligned_cols=174 Identities=21% Similarity=0.282 Sum_probs=95.4
Q ss_pred CeeecCCcccccCCccc-----cCCCC--------------------------CCEeeeecccceeecCcchhccccCCE
Q 042634 1 AFTLVGNQFTGRIPGSI-----GDLHK--------------------------LQRLTLEMNKFWGEIPSSIGNLTLLIT 49 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~-----~~l~~--------------------------L~~L~l~~n~~~~~~p~~~~~l~~L~~ 49 (427)
+|++++|.++|.+|..+ ..+++ |+.|++++|.+. .++ ..+.+++|++
T Consensus 280 ~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~-~~~-~~~~l~~L~~ 357 (562)
T 3a79_B 280 YLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFI-HMV-CPPSPSSFTF 357 (562)
T ss_dssp EEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCC-CCC-CCSSCCCCCE
T ss_pred EEEEeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCcc-ccc-CccCCCCceE
Confidence 36888888888888776 33332 333333333332 111 0145556666
Q ss_pred eeeccccCcccCCcCccCCCCCCeEEccCccCccc--CCCCccccccccceeeccCCcCcCCCCC-CCcCCCCCCeEECc
Q 042634 50 LNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGT--TPTEVIGLSSLSIYLDLSQNQLNGPLPS-NFGILKNLGAIDIS 126 (427)
Q Consensus 50 L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~~~~--~p~~~~~l~~l~~~L~l~~n~~~~~~p~-~~~~l~~L~~l~l~ 126 (427)
|++++|.+++.+|..++.+++|++|++++|++++. +|..+.++++| ++|++++|++++.+|. .+..+++|+.|+++
T Consensus 358 L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L-~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~ 436 (562)
T 3a79_B 358 LNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSL-ETLDVSLNSLNSHAYDRTCAWAESILVLNLS 436 (562)
T ss_dssp EECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTC-CEEECTTSCCBSCCSSCCCCCCTTCCEEECC
T ss_pred EECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCC-CEEECCCCcCCCccChhhhcCcccCCEEECC
Confidence 66666666655555566666666666666666532 22345555555 4566666666553443 35555666666666
Q ss_pred CCcccccCCccccccccccceeeeeeeccccCCCCcccccCCceeeccCCcccc
Q 042634 127 ENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNFIR 180 (427)
Q Consensus 127 ~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~ll~ 180 (427)
+|++++.+|..+. ++|+.|++++|.++ .+|..+..+++|+.|++++|++..
T Consensus 437 ~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~ 487 (562)
T 3a79_B 437 SNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKS 487 (562)
T ss_dssp SSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCC
T ss_pred CCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCC
Confidence 6666555554443 45566666666655 345444455666666666665543
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=5e-22 Score=201.27 Aligned_cols=170 Identities=25% Similarity=0.252 Sum_probs=98.0
Q ss_pred eecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccCc
Q 042634 3 TLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLT 82 (427)
Q Consensus 3 ~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~~ 82 (427)
|.++|.++ .+|..+. ++|++|+|++|++++..|..|+++++|++|+|++|++++..|..++.+++|++|++++|+++
T Consensus 11 ~~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~ 87 (549)
T 2z81_A 11 DGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLS 87 (549)
T ss_dssp ECTTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCC
T ss_pred ECCCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccC
Confidence 45556666 4555443 56666666666666544555666666666666666666555555666666666666666666
Q ss_pred ccCCCCccccccccceeeccCCcCcC-CCCCCCcCCCCCCeEECcCCcccccCC-ccccccccccceeeeeeeccccCCC
Q 042634 83 GTTPTEVIGLSSLSIYLDLSQNQLNG-PLPSNFGILKNLGAIDISENKLSGQIP-SSIGSCIRLEQLVMNGNFFRGNIPS 160 (427)
Q Consensus 83 ~~~p~~~~~l~~l~~~L~l~~n~~~~-~~p~~~~~l~~L~~l~l~~n~~~~~~p-~~~~~~~~l~~l~l~~n~l~~~~p~ 160 (427)
+..|..+.++.+| ++|++++|++++ ..|..++++++|+.|++++|.+.+.+| ..++++++|+.|++++|.+++..|.
T Consensus 88 ~~~~~~~~~l~~L-~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 166 (549)
T 2z81_A 88 SLSSSWFGPLSSL-KYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQ 166 (549)
T ss_dssp SCCHHHHTTCTTC-CEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTT
T ss_pred ccCHHHhccCCCC-cEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChh
Confidence 5555555666666 456666666654 345556666666666666665333444 3556666666666666666655555
Q ss_pred CcccccCCceeeccCC
Q 042634 161 SLSSLRGIENLDLSRN 176 (427)
Q Consensus 161 ~l~~l~~L~~L~L~~N 176 (427)
.+..+++|+.|+++.|
T Consensus 167 ~l~~l~~L~~L~l~~n 182 (549)
T 2z81_A 167 SLKSIRDIHHLTLHLS 182 (549)
T ss_dssp TTTTCSEEEEEEEECS
T ss_pred hhhccccCceEecccC
Confidence 5554444444444333
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.85 E-value=7.8e-21 Score=170.31 Aligned_cols=147 Identities=23% Similarity=0.271 Sum_probs=68.3
Q ss_pred eecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCC-cCccCCCCCCeEEccCccC
Q 042634 3 TLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIP-SSLGKCQNLILLDLSNNNL 81 (427)
Q Consensus 3 ~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p-~~~~~l~~L~~l~l~~N~~ 81 (427)
+.+++.++ .+|..+. ++|++|+|++|++++..|..|+++++|++|+|++|+++ .+| ..+..+++|++|+|++|++
T Consensus 25 ~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~-~i~~~~~~~l~~L~~L~Ls~N~l 100 (229)
T 3e6j_A 25 DCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQL 100 (229)
T ss_dssp ECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCC
T ss_pred EccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCC-CcChhhcccCCCcCEEECCCCcC
Confidence 44444444 4444332 45555555555555433444555555555555555554 333 2234455555555555555
Q ss_pred cccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeecc
Q 042634 82 TGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFR 155 (427)
Q Consensus 82 ~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~ 155 (427)
++..+..+..+.+| ++|+|++|+++ .+|..+..+++|+.|++++|++++..+..+..+++|+.|++++|.++
T Consensus 101 ~~l~~~~~~~l~~L-~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 172 (229)
T 3e6j_A 101 TVLPSAVFDRLVHL-KELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWD 172 (229)
T ss_dssp CCCCTTTTTTCTTC-CEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBC
T ss_pred CccChhHhCcchhh-CeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCcc
Confidence 43333334444444 34444444444 44444444444444444444444322233444444444444444443
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=3.8e-21 Score=183.87 Aligned_cols=179 Identities=20% Similarity=0.194 Sum_probs=156.8
Q ss_pred CeeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcC-ccCCCCCCeEEccCc
Q 042634 1 AFTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSS-LGKCQNLILLDLSNN 79 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~-~~~l~~L~~l~l~~N 79 (427)
+|+|++|++++..+..+..+++|+.|+|++|++++..|..|+++++|++|+|++|.++ .+|.. +..+++|++|++++|
T Consensus 56 ~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~n 134 (353)
T 2z80_A 56 SLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGN 134 (353)
T ss_dssp EEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCS-SCCHHHHTTCTTCSEEECTTC
T ss_pred EEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCC-cCCHhHhCCCccCCEEECCCC
Confidence 4899999999776678999999999999999999777788999999999999999999 66665 899999999999999
Q ss_pred cCcccCC-CCccccccccceeeccCCc-CcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeecccc
Q 042634 80 NLTGTTP-TEVIGLSSLSIYLDLSQNQ-LNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGN 157 (427)
Q Consensus 80 ~~~~~~p-~~~~~l~~l~~~L~l~~n~-~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~ 157 (427)
++++..+ ..+.++++| ++|++++|. +++..|..++.+++|+.|++++|.+++..|..++.+++|+.|++++|.++..
T Consensus 135 ~l~~l~~~~~~~~l~~L-~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~ 213 (353)
T 2z80_A 135 PYKTLGETSLFSHLTKL-QILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILL 213 (353)
T ss_dssp CCSSSCSSCSCTTCTTC-CEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTH
T ss_pred CCcccCchhhhccCCCC-cEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccc
Confidence 9994444 378889999 689999995 6655678899999999999999999988899999999999999999999754
Q ss_pred CCCCcccccCCceeeccCCccccc
Q 042634 158 IPSSLSSLRGIENLDLSRNNFIRH 181 (427)
Q Consensus 158 ~p~~l~~l~~L~~L~L~~N~ll~H 181 (427)
.+..+..+++|+.|++++|.+...
T Consensus 214 ~~~~~~~~~~L~~L~L~~n~l~~~ 237 (353)
T 2z80_A 214 LEIFVDVTSSVECLELRDTDLDTF 237 (353)
T ss_dssp HHHHHHHTTTEEEEEEESCBCTTC
T ss_pred hhhhhhhcccccEEECCCCccccc
Confidence 434455689999999999987653
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.85 E-value=7.5e-21 Score=169.29 Aligned_cols=158 Identities=20% Similarity=0.203 Sum_probs=141.4
Q ss_pred CCEeeeecccceeecCcchhccccCCEeeeccccCcccCCc-CccCCCCCCeEEccCccCcccCCCCccccccccceeec
Q 042634 23 LQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS-SLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDL 101 (427)
Q Consensus 23 L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~-~~~~l~~L~~l~l~~N~~~~~~p~~~~~l~~l~~~L~l 101 (427)
-+.+++++|.++ .+|..+. ..++.|+|++|.+++..|. .+..+++|++|++++|++++..+..+.++.+| ++|+|
T Consensus 13 ~~~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L-~~L~L 88 (220)
T 2v70_A 13 GTTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGV-NEILL 88 (220)
T ss_dssp TTEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTC-CEEEC
T ss_pred CCEeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCC-CEEEC
Confidence 468999999998 6998774 4568999999999965454 48899999999999999998888889999999 68999
Q ss_pred cCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCCCCcccccCCceeeccCCccccc
Q 042634 102 SQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNFIRH 181 (427)
Q Consensus 102 ~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~ll~H 181 (427)
++|++++..|..|..+++|+.|+|++|++++..|..+..+++|+.|++++|.+++..|..+..+++|+.|++++|.+.-.
T Consensus 89 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 168 (220)
T 2v70_A 89 TSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCN 168 (220)
T ss_dssp CSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECS
T ss_pred CCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCC
Confidence 99999977778899999999999999999988899999999999999999999998899999999999999999998644
Q ss_pred ccc
Q 042634 182 RNL 184 (427)
Q Consensus 182 pni 184 (427)
-.+
T Consensus 169 c~l 171 (220)
T 2v70_A 169 CYL 171 (220)
T ss_dssp GGG
T ss_pred Cch
Confidence 333
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.85 E-value=1.8e-20 Score=166.79 Aligned_cols=155 Identities=23% Similarity=0.291 Sum_probs=140.2
Q ss_pred CCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccCcccCCCCccccccccceeecc
Q 042634 23 LQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLS 102 (427)
Q Consensus 23 L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~~~l~~l~~~L~l~ 102 (427)
-+.+++++|.++ .+|..+. ++|+.|+|++|.+++..|..+..+++|++|+|++|++++..|..|.++.+| ++|+|+
T Consensus 13 ~~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L-~~L~Ls 88 (220)
T 2v9t_B 13 NNIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSL-NSLVLY 88 (220)
T ss_dssp TTEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSC-CEEECC
T ss_pred CCEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCC-CEEECC
Confidence 378999999998 7998775 799999999999996656689999999999999999998889999999999 689999
Q ss_pred CCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCCCCcccccCCceeeccCCccccc
Q 042634 103 QNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNFIRH 181 (427)
Q Consensus 103 ~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~ll~H 181 (427)
+|+++...+..|..+++|+.|+|++|++++..|..|..+++|+.|++++|.+++..+..+..+++|+.+++++|.+.-.
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 167 (220)
T 2v9t_B 89 GNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFICD 167 (220)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred CCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCCC
Confidence 9999955455689999999999999999987788999999999999999999988888899999999999999988543
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=3.5e-21 Score=195.03 Aligned_cols=179 Identities=20% Similarity=0.171 Sum_probs=159.3
Q ss_pred CeeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCcc
Q 042634 1 AFTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNN 80 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~ 80 (427)
+|||++|++++..|..+.++++|++|+|++|++++..|..|+++++|++|+|++|.+++..|..++.+++|++|++++|.
T Consensus 30 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~ 109 (549)
T 2z81_A 30 SLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNP 109 (549)
T ss_dssp EEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCC
T ss_pred EEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCc
Confidence 48999999998888999999999999999999998777899999999999999999996555569999999999999999
Q ss_pred Ccc-cCCCCccccccccceeeccCCcCcCCCC-CCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccC
Q 042634 81 LTG-TTPTEVIGLSSLSIYLDLSQNQLNGPLP-SNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNI 158 (427)
Q Consensus 81 ~~~-~~p~~~~~l~~l~~~L~l~~n~~~~~~p-~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~ 158 (427)
+++ ..|..+.++.+| ++|++++|.+.+.+| ..++++++|+.|++++|.+++.+|..++.+++|+.|+++.|.+....
T Consensus 110 l~~~~~~~~~~~l~~L-~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~ 188 (549)
T 2z81_A 110 YQTLGVTSLFPNLTNL-QTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLL 188 (549)
T ss_dssp CSSSCSSCSCTTCTTC-CEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTTHH
T ss_pred ccccchhhhhhccCCc-cEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCcccccc
Confidence 986 456788999999 689999999656666 68999999999999999999999999999999999999999987433
Q ss_pred CCCcccccCCceeeccCCcccc
Q 042634 159 PSSLSSLRGIENLDLSRNNFIR 180 (427)
Q Consensus 159 p~~l~~l~~L~~L~L~~N~ll~ 180 (427)
...+..+++|+.|++++|.+..
T Consensus 189 ~~~~~~l~~L~~L~L~~n~l~~ 210 (549)
T 2z81_A 189 EIFADILSSVRYLELRDTNLAR 210 (549)
T ss_dssp HHHHHSTTTBSEEEEESCBCTT
T ss_pred hhhHhhcccccEEEccCCcccc
Confidence 2233568999999999998865
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.84 E-value=5.8e-21 Score=194.05 Aligned_cols=103 Identities=24% Similarity=0.192 Sum_probs=76.4
Q ss_pred eeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccC
Q 042634 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNL 81 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~ 81 (427)
|+|++|.+++..|..|.++++|++|+|++|++++..|..|+++++|++|+|++|.++ .+|.. .+++|++|++++|++
T Consensus 57 L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~Ls~N~l 133 (562)
T 3a79_B 57 LSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDLSFNDF 133 (562)
T ss_dssp EECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEECCSSCC
T ss_pred EECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEECCCCCc
Confidence 677788887666667788888888888888887666677777888888888888877 67766 677788888888887
Q ss_pred cc-cCCCCccccccccceeeccCCcCcC
Q 042634 82 TG-TTPTEVIGLSSLSIYLDLSQNQLNG 108 (427)
Q Consensus 82 ~~-~~p~~~~~l~~l~~~L~l~~n~~~~ 108 (427)
++ .+|..+.++.+| ++|++++|++++
T Consensus 134 ~~l~~p~~~~~l~~L-~~L~L~~n~l~~ 160 (562)
T 3a79_B 134 DVLPVCKEFGNLTKL-TFLGLSAAKFRQ 160 (562)
T ss_dssp SBCCCCGGGGGCTTC-CEEEEECSBCCT
T ss_pred cccCchHhhcccCcc-cEEecCCCcccc
Confidence 75 335677777777 567777777653
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=5.3e-21 Score=198.76 Aligned_cols=170 Identities=22% Similarity=0.288 Sum_probs=144.9
Q ss_pred CeeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCc-CccCCCCCCeEEccCc
Q 042634 1 AFTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS-SLGKCQNLILLDLSNN 79 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~-~~~~l~~L~~l~l~~N 79 (427)
+|+|++|.+++..|..|.++++|++|+|++|.+++..|..|+++++|++|+|++|.++ .+|+ .++.+++|++|++++|
T Consensus 29 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n 107 (680)
T 1ziw_A 29 VLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS-QLSDKTFAFCTNLTELHLMSN 107 (680)
T ss_dssp EEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCC-CCCTTTTTTCTTCSEEECCSS
T ss_pred EEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccC-ccChhhhccCCCCCEEECCCC
Confidence 4789999999776678999999999999999999777888999999999999999999 6665 6899999999999999
Q ss_pred cCcccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCcccc--ccccccceeeeeeecccc
Q 042634 80 NLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIG--SCIRLEQLVMNGNFFRGN 157 (427)
Q Consensus 80 ~~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~--~~~~l~~l~l~~n~l~~~ 157 (427)
++++..|..+.++.+| ++|++++|.+++..|..++++++|+.|++++|.+++..|..++ .+++|+.|++++|.+++.
T Consensus 108 ~l~~~~~~~~~~l~~L-~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~ 186 (680)
T 1ziw_A 108 SIQKIKNNPFVKQKNL-ITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEF 186 (680)
T ss_dssp CCCCCCSCTTTTCTTC-CEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCCCB
T ss_pred ccCccChhHccccCCC-CEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCccccc
Confidence 9987777889999999 6899999999988888999999999999999999976666554 568999999999999988
Q ss_pred CCCCcccccCCceee
Q 042634 158 IPSSLSSLRGIENLD 172 (427)
Q Consensus 158 ~p~~l~~l~~L~~L~ 172 (427)
.|..+..+.+|+.++
T Consensus 187 ~~~~~~~l~~L~~L~ 201 (680)
T 1ziw_A 187 SPGCFHAIGRLFGLF 201 (680)
T ss_dssp CTTGGGGSSEECEEE
T ss_pred Chhhhhhhhhhhhhh
Confidence 887776654443333
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.84 E-value=8.2e-21 Score=167.53 Aligned_cols=158 Identities=26% Similarity=0.226 Sum_probs=108.2
Q ss_pred eeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccC
Q 042634 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNL 81 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~ 81 (427)
|+|++|++++..+..+..+++|++|+|++|++++..+..|+.+++|++|+|++|.+++..+..+..+++|++|++++|++
T Consensus 33 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l 112 (208)
T 2o6s_A 33 LDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQL 112 (208)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcC
Confidence 67777777755555567777777777777777743334467777777777777777733333466777777777777777
Q ss_pred cccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCCCC
Q 042634 82 TGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSS 161 (427)
Q Consensus 82 ~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~~ 161 (427)
++..+..+..+++| +.|++++|++++..+..+..+++|+.|++++|.+.+ .+++|+.|+++.|.++|.+|.+
T Consensus 113 ~~~~~~~~~~l~~L-~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~ 184 (208)
T 2o6s_A 113 QSLPDGVFDKLTQL-KDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNS 184 (208)
T ss_dssp CCCCTTTTTTCTTC-CEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBCT
T ss_pred cccCHhHhccCCcC-CEEECCCCccceeCHHHhccCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCceeecc
Confidence 76555556677777 567777777775545556777777777777776653 4556777777777777777776
Q ss_pred cccccC
Q 042634 162 LSSLRG 167 (427)
Q Consensus 162 l~~l~~ 167 (427)
++.+..
T Consensus 185 ~~~l~~ 190 (208)
T 2o6s_A 185 AGSVAP 190 (208)
T ss_dssp TSSBCT
T ss_pred CccccC
Confidence 665543
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=2.9e-20 Score=193.15 Aligned_cols=178 Identities=21% Similarity=0.224 Sum_probs=134.2
Q ss_pred eeecCCcccccCCccccCCCCCCEeeeecccceeecC-cchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCcc
Q 042634 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIP-SSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNN 80 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p-~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~ 80 (427)
|+|++|++++..|..+..+++|+.|+|++|.+++.+| ..+.++++|++|++++|.+++..|..+..+++|++|++++|.
T Consensus 386 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~ 465 (680)
T 1ziw_A 386 LNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVA 465 (680)
T ss_dssp EECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSC
T ss_pred EECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhcccc
Confidence 6778888887778888888888888888888887776 577888888888888888886666677777788888888877
Q ss_pred Cc--ccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccC----C----ccccccccccceeee
Q 042634 81 LT--GTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQI----P----SSIGSCIRLEQLVMN 150 (427)
Q Consensus 81 ~~--~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~----p----~~~~~~~~l~~l~l~ 150 (427)
++ +.+|..+.++.+| +.|++++|++++..|..+..+++|+.|++++|++++.. | ..+.++++|+.|+++
T Consensus 466 l~~~~~~p~~~~~l~~L-~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~ 544 (680)
T 1ziw_A 466 LKNVDSSPSPFQPLRNL-TILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLE 544 (680)
T ss_dssp CBCTTCSSCTTTTCTTC-CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECC
T ss_pred ccccccCCcccccCCCC-CEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECC
Confidence 76 5667777777777 56888888887666666777888888888888777421 1 236677778888888
Q ss_pred eeeccccCCCCcccccCCceeeccCCcccc
Q 042634 151 GNFFRGNIPSSLSSLRGIENLDLSRNNFIR 180 (427)
Q Consensus 151 ~n~l~~~~p~~l~~l~~L~~L~L~~N~ll~ 180 (427)
+|.++...+..+..+++|+.|++++|++..
T Consensus 545 ~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~ 574 (680)
T 1ziw_A 545 SNGFDEIPVEVFKDLFELKIIDLGLNNLNT 574 (680)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred CCCCCCCCHHHcccccCcceeECCCCCCCc
Confidence 887775444567777788888887777654
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.84 E-value=2.6e-21 Score=192.80 Aligned_cols=170 Identities=19% Similarity=0.155 Sum_probs=140.4
Q ss_pred CeeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCcc
Q 042634 1 AFTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNN 80 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~ 80 (427)
+|+|++|.+++.+| +..+++|++|+|++|.+++ +|. .++|++|++++|.+++..+. .+++|++|++++|.
T Consensus 62 ~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~~----~~~L~~L~L~~N~l~~~~~~---~l~~L~~L~L~~N~ 131 (487)
T 3oja_A 62 LLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQE-LLV----GPSIETLHAANNNISRVSCS---RGQGKKNIYLANNK 131 (487)
T ss_dssp EEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEE-EEE----CTTCCEEECCSSCCCCEEEC---CCSSCEEEECCSSC
T ss_pred EEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCC-CCC----CCCcCEEECcCCcCCCCCcc---ccCCCCEEECCCCC
Confidence 48999999997765 9999999999999999984 554 38899999999999955443 35789999999999
Q ss_pred CcccCCCCccccccccceeeccCCcCcCCCCCCCc-CCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCC
Q 042634 81 LTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFG-ILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIP 159 (427)
Q Consensus 81 ~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~-~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p 159 (427)
+++..|..+.++++| ..|+|++|.+++..|..+. .+++|+.|+|++|.+++. |. +..+++|+.|++++|.+++. |
T Consensus 132 l~~~~~~~~~~l~~L-~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~~-~ 207 (487)
T 3oja_A 132 ITMLRDLDEGCRSRV-QYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFM-G 207 (487)
T ss_dssp CCSGGGBCGGGGSSE-EEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEE-C
T ss_pred CCCCCchhhcCCCCC-CEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccc-cc-cccCCCCCEEECCCCCCCCC-C
Confidence 998888888888888 6799999999887787776 789999999999999864 33 33588999999999999875 4
Q ss_pred CCcccccCCceeeccCCcccccccc
Q 042634 160 SSLSSLRGIENLDLSRNNFIRHRNL 184 (427)
Q Consensus 160 ~~l~~l~~L~~L~L~~N~ll~Hpni 184 (427)
..+..+++|+.|++++|.+..-|..
T Consensus 208 ~~~~~l~~L~~L~Ls~N~l~~lp~~ 232 (487)
T 3oja_A 208 PEFQSAAGVTWISLRNNKLVLIEKA 232 (487)
T ss_dssp GGGGGGTTCSEEECTTSCCCEECTT
T ss_pred HhHcCCCCccEEEecCCcCcccchh
Confidence 5588889999999999988764443
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.84 E-value=3.5e-21 Score=181.36 Aligned_cols=169 Identities=20% Similarity=0.248 Sum_probs=122.2
Q ss_pred CeeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCcc
Q 042634 1 AFTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNN 80 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~ 80 (427)
+|+|++|.+++..|..+..+++|+.|+|++|.+++.. + ++.+++|++|++++|.++ .+| ..++|++|++++|+
T Consensus 38 ~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~-~-~~~l~~L~~L~Ls~n~l~-~l~----~~~~L~~L~l~~n~ 110 (317)
T 3o53_A 38 ELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETL-D-LESLSTLRTLDLNNNYVQ-ELL----VGPSIETLHAANNN 110 (317)
T ss_dssp EEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEE-E-ETTCTTCCEEECCSSEEE-EEE----ECTTCCEEECCSSC
T ss_pred EEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcch-h-hhhcCCCCEEECcCCccc-ccc----CCCCcCEEECCCCc
Confidence 4799999999877788999999999999999998644 3 999999999999999998 444 23677777777777
Q ss_pred CcccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCcccc-ccccccceeeeeeeccccCC
Q 042634 81 LTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIG-SCIRLEQLVMNGNFFRGNIP 159 (427)
Q Consensus 81 ~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~-~~~~l~~l~l~~n~l~~~~p 159 (427)
+++..+.. +++| ++|++++|++++..|..++.+++|+.|++++|.+++..|..+. .+++|+.|++++|.+++. +
T Consensus 111 l~~~~~~~---~~~L-~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~ 185 (317)
T 3o53_A 111 ISRVSCSR---GQGK-KNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-K 185 (317)
T ss_dssp CSEEEECC---CSSC-EEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-E
T ss_pred cCCcCccc---cCCC-CEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-c
Confidence 77555443 3455 5677777777765566677777777777777777765555553 567777777777777654 2
Q ss_pred CCcccccCCceeeccCCcccccc
Q 042634 160 SSLSSLRGIENLDLSRNNFIRHR 182 (427)
Q Consensus 160 ~~l~~l~~L~~L~L~~N~ll~Hp 182 (427)
....+++|+.|++++|.+..-|
T Consensus 186 -~~~~l~~L~~L~Ls~N~l~~l~ 207 (317)
T 3o53_A 186 -GQVVFAKLKTLDLSSNKLAFMG 207 (317)
T ss_dssp -CCCCCTTCCEEECCSSCCCEEC
T ss_pred -cccccccCCEEECCCCcCCcch
Confidence 2234667777777777665443
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.84 E-value=8.1e-21 Score=193.14 Aligned_cols=173 Identities=21% Similarity=0.191 Sum_probs=139.7
Q ss_pred eeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccC
Q 042634 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNL 81 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~ 81 (427)
|||++|++++..+..|.++++|++|+|++|++++..|..|+++++|++|+|++|.+++..|..++.+++|++|++++|++
T Consensus 33 L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 112 (570)
T 2z63_A 33 LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNL 112 (570)
T ss_dssp EECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCC
T ss_pred EEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccccccccccc
Confidence 78888888877777888888888888888888865566788888888888888888866667788888888888888888
Q ss_pred cccCCCCccccccccceeeccCCcCcC-CCCCCCcCCCCCCeEECcCCcccccCCccccccccc----cceeeeeeeccc
Q 042634 82 TGTTPTEVIGLSSLSIYLDLSQNQLNG-PLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRL----EQLVMNGNFFRG 156 (427)
Q Consensus 82 ~~~~p~~~~~l~~l~~~L~l~~n~~~~-~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l----~~l~l~~n~l~~ 156 (427)
++..+..++++.+| ++|++++|.+++ .+|..++++++|+.|++++|++++..|..++.+.+| ..+++++|.+++
T Consensus 113 ~~l~~~~~~~l~~L-~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~l~~ 191 (570)
T 2z63_A 113 ASLENFPIGHLKTL-KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF 191 (570)
T ss_dssp CCSTTCSCTTCTTC-CEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCE
T ss_pred ccCCCccccccccc-cEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCCCcee
Confidence 86555567888888 678888888876 478888888888888888888887667778888887 778888888887
Q ss_pred cCCCCcccccCCceeeccCC
Q 042634 157 NIPSSLSSLRGIENLDLSRN 176 (427)
Q Consensus 157 ~~p~~l~~l~~L~~L~L~~N 176 (427)
..|..+..+ +|+.+++++|
T Consensus 192 ~~~~~~~~~-~L~~L~l~~n 210 (570)
T 2z63_A 192 IQPGAFKEI-RLHKLTLRNN 210 (570)
T ss_dssp ECTTTTTTC-EEEEEEEESC
T ss_pred cCHHHhccC-cceeEecccc
Confidence 777666655 6788877766
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.83 E-value=1e-20 Score=177.30 Aligned_cols=167 Identities=25% Similarity=0.374 Sum_probs=142.5
Q ss_pred CeeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCcc
Q 042634 1 AFTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNN 80 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~ 80 (427)
+|++++|.++ .+| .+..+++|+.|+|++|.++ .+|. ++.+++|++|+|++|.++ .+| .+..+++|++|++++|+
T Consensus 45 ~L~l~~~~i~-~l~-~~~~l~~L~~L~L~~n~i~-~~~~-~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~l~~n~ 118 (308)
T 1h6u_A 45 TLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQIT-DLAP-LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQ 118 (308)
T ss_dssp EEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCC-CCGG-GTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEEECTTSC
T ss_pred EEEeeCCCcc-Cch-hhhccCCCCEEEccCCcCC-CChh-HccCCCCCEEEccCCcCC-Cch-hhcCCCCCCEEECCCCC
Confidence 3789999998 456 6899999999999999998 5666 999999999999999999 555 78899999999999999
Q ss_pred CcccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCCC
Q 042634 81 LTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPS 160 (427)
Q Consensus 81 ~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~ 160 (427)
+++ +|. +..+++| ++|++++|++++ ++. ++.+++|+.|++++|++++ ++. +..+++|+.|++++|.+++..+
T Consensus 119 l~~-~~~-l~~l~~L-~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~- 190 (308)
T 1h6u_A 119 ITD-VTP-LAGLSNL-QVLYLDLNQITN-ISP-LAGLTNLQYLSIGNAQVSD-LTP-LANLSKLTTLKADDNKISDISP- 190 (308)
T ss_dssp CCC-CGG-GTTCTTC-CEEECCSSCCCC-CGG-GGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG-
T ss_pred CCC-chh-hcCCCCC-CEEECCCCccCc-Ccc-ccCCCCccEEEccCCcCCC-Chh-hcCCCCCCEEECCCCccCcChh-
Confidence 985 443 7888999 689999999985 443 8899999999999999984 555 8899999999999999987543
Q ss_pred CcccccCCceeeccCCcccccc
Q 042634 161 SLSSLRGIENLDLSRNNFIRHR 182 (427)
Q Consensus 161 ~l~~l~~L~~L~L~~N~ll~Hp 182 (427)
+..+++|+.|++++|.+..-+
T Consensus 191 -l~~l~~L~~L~L~~N~l~~~~ 211 (308)
T 1h6u_A 191 -LASLPNLIEVHLKNNQISDVS 211 (308)
T ss_dssp -GGGCTTCCEEECTTSCCCBCG
T ss_pred -hcCCCCCCEEEccCCccCccc
Confidence 888999999999999887655
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.83 E-value=1.6e-20 Score=169.47 Aligned_cols=169 Identities=18% Similarity=0.175 Sum_probs=144.8
Q ss_pred CeeecCCc-ccccCCccccCCCCCCEeeeec-ccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCC---eEE
Q 042634 1 AFTLVGNQ-FTGRIPGSIGDLHKLQRLTLEM-NKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLI---LLD 75 (427)
Q Consensus 1 ~l~l~~n~-l~~~~p~~~~~l~~L~~L~l~~-n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~---~l~ 75 (427)
+|+|++|+ +++..+..|..+++|++|+|++ |++++..|..|.++++|++|++++|.++ .+|. +..+++|+ +|+
T Consensus 59 ~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~-~lp~-~~~l~~L~~L~~L~ 136 (239)
T 2xwt_C 59 RIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPD-LTKVYSTDIFFILE 136 (239)
T ss_dssp EEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCC-SCCC-CTTCCBCCSEEEEE
T ss_pred EEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCc-cccc-cccccccccccEEE
Confidence 47999997 8866667899999999999998 9999555568999999999999999999 5887 88899998 999
Q ss_pred ccCc-cCcccCCCCccccccccc-eeeccCCcCcCCCCCCCcCCCCCCeEECcCCc-ccccCCcccccc-ccccceeeee
Q 042634 76 LSNN-NLTGTTPTEVIGLSSLSI-YLDLSQNQLNGPLPSNFGILKNLGAIDISENK-LSGQIPSSIGSC-IRLEQLVMNG 151 (427)
Q Consensus 76 l~~N-~~~~~~p~~~~~l~~l~~-~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~-~~~~~p~~~~~~-~~l~~l~l~~ 151 (427)
+++| .+++..+..+.++.+| + .|++++|.++ .+|......++|+.|++++|+ +++..+..+..+ ++|+.|++++
T Consensus 137 l~~N~~l~~i~~~~~~~l~~L-~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~ 214 (239)
T 2xwt_C 137 ITDNPYMTSIPVNAFQGLCNE-TLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQ 214 (239)
T ss_dssp EESCTTCCEECTTTTTTTBSS-EEEEECCSCCCC-EECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTT
T ss_pred CCCCcchhhcCcccccchhcc-eeEEEcCCCCCc-ccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCC
Confidence 9999 9997777779999999 6 7999999998 677665555899999999995 986556678899 9999999999
Q ss_pred eeccccCCCCcccccCCceeeccCC
Q 042634 152 NFFRGNIPSSLSSLRGIENLDLSRN 176 (427)
Q Consensus 152 n~l~~~~p~~l~~l~~L~~L~L~~N 176 (427)
|.+++. |.. .+++|+.|+++++
T Consensus 215 N~l~~l-~~~--~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 215 TSVTAL-PSK--GLEHLKELIARNT 236 (239)
T ss_dssp CCCCCC-CCT--TCTTCSEEECTTC
T ss_pred CccccC-Chh--HhccCceeeccCc
Confidence 999965 443 5778888887764
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.83 E-value=4.4e-20 Score=165.36 Aligned_cols=154 Identities=22% Similarity=0.231 Sum_probs=139.6
Q ss_pred CCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccCcccCCCCccccccccceeecc
Q 042634 23 LQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLS 102 (427)
Q Consensus 23 L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~~~l~~l~~~L~l~ 102 (427)
.+.++.+++.++ .+|..+. ++|++|+|++|.+++..|..+..+++|++|+|++|+++...+..+.++++| +.|+|+
T Consensus 21 ~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L-~~L~Ls 96 (229)
T 3e6j_A 21 GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQL-TVLDLG 96 (229)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC-CEEECC
T ss_pred CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCc-CEEECC
Confidence 578999999998 8998775 999999999999997778889999999999999999986666778899999 689999
Q ss_pred CCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCCCCcccccCCceeeccCCccccc
Q 042634 103 QNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNFIRH 181 (427)
Q Consensus 103 ~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~ll~H 181 (427)
+|++++..+..+..+++|+.|++++|+++ .+|..+..+++|+.|++++|.+++..+..+..+++|+.|++++|.+.-.
T Consensus 97 ~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 174 (229)
T 3e6j_A 97 TNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCE 174 (229)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTT
T ss_pred CCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCC
Confidence 99999766677899999999999999999 8999999999999999999999987777899999999999999987543
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.83 E-value=2.5e-20 Score=174.68 Aligned_cols=148 Identities=23% Similarity=0.346 Sum_probs=66.4
Q ss_pred CCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccCcccCCCCccccccccce
Q 042634 19 DLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIY 98 (427)
Q Consensus 19 ~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~~~l~~l~~~ 98 (427)
.+++|+.|++++|.++ .+| .+..+++|++|+|++|.++ .+|+ +..+++|++|++++|++++ ++ .+..+.+| +.
T Consensus 39 ~l~~L~~L~l~~~~i~-~l~-~~~~l~~L~~L~L~~n~i~-~~~~-~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L-~~ 111 (308)
T 1h6u_A 39 DLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQIT-DLAP-LKNLTKITELELSGNPLKN-VS-AIAGLQSI-KT 111 (308)
T ss_dssp HHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCC-CCGG-GTTCCSCCEEECCSCCCSC-CG-GGTTCTTC-CE
T ss_pred HcCCcCEEEeeCCCcc-Cch-hhhccCCCCEEEccCCcCC-CChh-HccCCCCCEEEccCCcCCC-ch-hhcCCCCC-CE
Confidence 3444444555444444 333 3444444555555555444 3333 4444445555555554442 22 34444444 34
Q ss_pred eeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCCCCcccccCCceeeccCCcc
Q 042634 99 LDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178 (427)
Q Consensus 99 L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l 178 (427)
|++++|++++ +|. +..+++|+.|++++|++++ ++. ++.+++|+.|++++|.+++..+ +..+++|+.|++++|.+
T Consensus 112 L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l 185 (308)
T 1h6u_A 112 LDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITN-ISP-LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKI 185 (308)
T ss_dssp EECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCC-CGG-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred EECCCCCCCC-chh-hcCCCCCCEEECCCCccCc-Ccc-ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCcc
Confidence 4555554442 222 4444445555555544442 222 4444444445555444443221 44444444444444444
Q ss_pred c
Q 042634 179 I 179 (427)
Q Consensus 179 l 179 (427)
.
T Consensus 186 ~ 186 (308)
T 1h6u_A 186 S 186 (308)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.83 E-value=2.3e-20 Score=163.21 Aligned_cols=155 Identities=16% Similarity=0.215 Sum_probs=127.7
Q ss_pred cccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccCcccCCCCccccccc
Q 042634 16 SIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSL 95 (427)
Q Consensus 16 ~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~~~l~~l 95 (427)
....+++|+.|++++|.++ .+| .+..+++|++|++++|.++ .+ +.+..+++|++|++++|++++..|..+..+++|
T Consensus 39 ~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~-~~-~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L 114 (197)
T 4ezg_A 39 TEAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT-NY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSL 114 (197)
T ss_dssp BHHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS-CC-GGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTC
T ss_pred ChhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC-cc-hhhhcCCCCCEEEeECCccCcccChhhcCCCCC
Confidence 3467788999999999998 677 6888999999999999665 43 478888999999999999987778888888888
Q ss_pred cceeeccCCcCcCCCCCCCcCCCCCCeEECcCCc-ccccCCccccccccccceeeeeeeccccCCCCcccccCCceeecc
Q 042634 96 SIYLDLSQNQLNGPLPSNFGILKNLGAIDISENK-LSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLS 174 (427)
Q Consensus 96 ~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~-~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~ 174 (427)
++|++++|++++..|..++.+++|+.|++++|+ ++ .+| .+..+++|+.|++++|.+++. + .+..+++|+.|+++
T Consensus 115 -~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~-~-~l~~l~~L~~L~l~ 189 (197)
T 4ezg_A 115 -TLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHDY-R-GIEDFPKLNQLYAF 189 (197)
T ss_dssp -CEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCCC-T-TGGGCSSCCEEEEC
T ss_pred -CEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcCh-H-HhccCCCCCEEEee
Confidence 679999999987778888889999999999998 55 666 688889999999999998863 3 78888899999998
Q ss_pred CCccc
Q 042634 175 RNNFI 179 (427)
Q Consensus 175 ~N~ll 179 (427)
+|++.
T Consensus 190 ~N~i~ 194 (197)
T 4ezg_A 190 SQTIG 194 (197)
T ss_dssp BC---
T ss_pred CcccC
Confidence 88763
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=3.2e-20 Score=190.90 Aligned_cols=157 Identities=20% Similarity=0.229 Sum_probs=92.5
Q ss_pred CcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccCcccCC
Q 042634 7 NQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTP 86 (427)
Q Consensus 7 n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p 86 (427)
.+|+ .+|..+- +++++|||++|+|++..|.+|+++++|++|+|++|++++..|.+|.++++|++|+|++|++++..+
T Consensus 41 ~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~ 117 (635)
T 4g8a_A 41 LNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLAL 117 (635)
T ss_dssp SCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECG
T ss_pred CCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCH
Confidence 3445 4454332 256666666666664333456666666666666666663334456666666666666666665555
Q ss_pred CCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccc-cCCccccccccccceeeeeeeccccCCCCcccc
Q 042634 87 TEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSG-QIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSL 165 (427)
Q Consensus 87 ~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~-~~p~~~~~~~~l~~l~l~~n~l~~~~p~~l~~l 165 (427)
..|.++.+| ++|+|++|++++..+..|+++++|+.|++++|.+++ .+|..++.+++|+.|++++|.+++..+..+..+
T Consensus 118 ~~f~~L~~L-~~L~Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L 196 (635)
T 4g8a_A 118 GAFSGLSSL-QKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVL 196 (635)
T ss_dssp GGGTTCTTC-CEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHH
T ss_pred HHhcCCCCC-CEEECCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccch
Confidence 556666666 456666666664444556666666666666666653 345556666666666666666666555555444
Q ss_pred cC
Q 042634 166 RG 167 (427)
Q Consensus 166 ~~ 167 (427)
.+
T Consensus 197 ~~ 198 (635)
T 4g8a_A 197 HQ 198 (635)
T ss_dssp HT
T ss_pred hh
Confidence 43
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.82 E-value=4.7e-20 Score=195.99 Aligned_cols=174 Identities=23% Similarity=0.246 Sum_probs=157.4
Q ss_pred eeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccC-CcCccCCCCCCeEEccCcc
Q 042634 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSI-PSSLGKCQNLILLDLSNNN 80 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~-p~~~~~l~~L~~l~l~~N~ 80 (427)
.|.++++++ .+|. -.++|+.|+|++|.+++..|..|+++++|++|+|++|.+.+.+ |..+.++++|++|+|++|.
T Consensus 9 ~dcs~~~L~-~vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~ 84 (844)
T 3j0a_A 9 AFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSK 84 (844)
T ss_dssp EEESCCCSS-CCCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCC
T ss_pred EEccCCCCC-CCCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCc
Confidence 578899999 6676 5689999999999999888899999999999999999777777 6789999999999999999
Q ss_pred CcccCCCCccccccccceeeccCCcCcCCCCCC--CcCCCCCCeEECcCCcccccCC-ccccccccccceeeeeeecccc
Q 042634 81 LTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSN--FGILKNLGAIDISENKLSGQIP-SSIGSCIRLEQLVMNGNFFRGN 157 (427)
Q Consensus 81 ~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~--~~~l~~L~~l~l~~n~~~~~~p-~~~~~~~~l~~l~l~~n~l~~~ 157 (427)
+++..|..+.++.+| ++|+|++|.+++.+|.. ++++++|+.|++++|.+++..| ..++++++|+.|++++|.+++.
T Consensus 85 l~~~~p~~~~~l~~L-~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~ 163 (844)
T 3j0a_A 85 IYFLHPDAFQGLFHL-FELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLV 163 (844)
T ss_dssp CCEECTTSSCSCSSC-CCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCC
T ss_pred CcccCHhHccCCccc-CEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCee
Confidence 999999999999999 68999999999877765 9999999999999999997655 5799999999999999999998
Q ss_pred CCCCcccc--cCCceeeccCCcccc
Q 042634 158 IPSSLSSL--RGIENLDLSRNNFIR 180 (427)
Q Consensus 158 ~p~~l~~l--~~L~~L~L~~N~ll~ 180 (427)
.+..+..+ ++|+.|+++.|.+..
T Consensus 164 ~~~~l~~l~~~~L~~L~L~~n~l~~ 188 (844)
T 3j0a_A 164 CEHELEPLQGKTLSFFSLAANSLYS 188 (844)
T ss_dssp CSGGGHHHHHCSSCCCEECCSBSCC
T ss_pred CHHHcccccCCccceEECCCCcccc
Confidence 88999888 899999999987643
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.82 E-value=2.8e-20 Score=172.92 Aligned_cols=166 Identities=22% Similarity=0.342 Sum_probs=136.9
Q ss_pred CeeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCcc
Q 042634 1 AFTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNN 80 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~ 80 (427)
+|++++|.++ .+| .+..+++|+.|+|++|++++ +++ ++++++|++|++++|.++ .+| .+..+++|++|++++|+
T Consensus 50 ~L~l~~~~i~-~~~-~~~~l~~L~~L~L~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~-~~~-~l~~l~~L~~L~L~~n~ 123 (291)
T 1h6t_A 50 QIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTD-IKP-LANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNG 123 (291)
T ss_dssp EEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEECTTSC
T ss_pred EEEccCCCcc-cCh-hHhcCCCCCEEEccCCccCC-Ccc-cccCCCCCEEECCCCcCC-CCh-hhccCCCCCEEECCCCc
Confidence 3788899988 444 48889999999999999984 555 899999999999999998 455 48889999999999999
Q ss_pred CcccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCCC
Q 042634 81 LTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPS 160 (427)
Q Consensus 81 ~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~ 160 (427)
+++ + ..+..+++| +.|++++|++++ + ..++.+++|+.|++++|++++ ++. +..+++|+.|++++|.+++. +
T Consensus 124 i~~-~-~~l~~l~~L-~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~N~l~~-~~~-l~~l~~L~~L~L~~N~i~~l-~- 194 (291)
T 1h6t_A 124 ISD-I-NGLVHLPQL-ESLYLGNNKITD-I-TVLSRLTKLDTLSLEDNQISD-IVP-LAGLTKLQNLYLSKNHISDL-R- 194 (291)
T ss_dssp CCC-C-GGGGGCTTC-CEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCBC-G-
T ss_pred CCC-C-hhhcCCCCC-CEEEccCCcCCc-c-hhhccCCCCCEEEccCCcccc-chh-hcCCCccCEEECCCCcCCCC-h-
Confidence 985 3 357788888 679999999985 3 678889999999999999985 444 88899999999999999864 3
Q ss_pred CcccccCCceeeccCCccccc
Q 042634 161 SLSSLRGIENLDLSRNNFIRH 181 (427)
Q Consensus 161 ~l~~l~~L~~L~L~~N~ll~H 181 (427)
.+..+++|+.|++++|.+...
T Consensus 195 ~l~~l~~L~~L~l~~n~i~~~ 215 (291)
T 1h6t_A 195 ALAGLKNLDVLELFSQECLNK 215 (291)
T ss_dssp GGTTCTTCSEEEEEEEEEECC
T ss_pred hhccCCCCCEEECcCCcccCC
Confidence 488889999999998887553
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=2.2e-20 Score=192.05 Aligned_cols=174 Identities=21% Similarity=0.184 Sum_probs=144.2
Q ss_pred CeeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCcc
Q 042634 1 AFTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNN 80 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~ 80 (427)
+|||++|+|++..|..|.++++|++|+|++|+|++..|..|++|++|++|+|++|++++..|..|.++++|++|++++|+
T Consensus 56 ~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~ 135 (635)
T 4g8a_A 56 NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN 135 (635)
T ss_dssp EEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSC
T ss_pred EEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCc
Confidence 48999999997777889999999999999999996555679999999999999999994444568999999999999999
Q ss_pred CcccCCCCccccccccceeeccCCcCcC-CCCCCCcCCCCCCeEECcCCcccccCCcccccccccc----ceeeeeeecc
Q 042634 81 LTGTTPTEVIGLSSLSIYLDLSQNQLNG-PLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLE----QLVMNGNFFR 155 (427)
Q Consensus 81 ~~~~~p~~~~~l~~l~~~L~l~~n~~~~-~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~----~l~l~~n~l~ 155 (427)
+++..+..++++++| ++|+|++|.+++ .+|..++.+++|+.|++++|++++..|..+..+.++. .++++.|.++
T Consensus 136 l~~l~~~~~~~L~~L-~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~ 214 (635)
T 4g8a_A 136 LASLENFPIGHLKTL-KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 214 (635)
T ss_dssp CCCSTTCCCTTCTTC-CEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCC
T ss_pred CCCCChhhhhcCccc-CeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCccc
Confidence 997777789999999 689999999975 5688999999999999999999988888888776655 4677788887
Q ss_pred ccCCCCcccccCCceeeccCC
Q 042634 156 GNIPSSLSSLRGIENLDLSRN 176 (427)
Q Consensus 156 ~~~p~~l~~l~~L~~L~L~~N 176 (427)
...+..+.. ..+..+++..|
T Consensus 215 ~i~~~~~~~-~~~~~l~l~~n 234 (635)
T 4g8a_A 215 FIQPGAFKE-IRLHKLTLRNN 234 (635)
T ss_dssp EECTTTTTT-CEEEEEEEESC
T ss_pred ccCcccccc-hhhhhhhhhcc
Confidence 654443332 23344444443
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.82 E-value=2e-20 Score=163.56 Aligned_cols=148 Identities=21% Similarity=0.213 Sum_probs=128.7
Q ss_pred CeeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCcc
Q 042634 1 AFTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNN 80 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~ 80 (427)
+|++++|+++ .+| .+..+++|+.|++++|.++ . ++.++.+++|++|++++|.+++..|..++.+++|++|++++|+
T Consensus 48 ~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~-~-~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~ 123 (197)
T 4ezg_A 48 YITLANINVT-DLT-GIEYAHNIKDLTINNIHAT-N-YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSA 123 (197)
T ss_dssp EEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS-C-CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSB
T ss_pred EEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC-c-chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCc
Confidence 3789999999 667 7999999999999999776 3 4579999999999999999998889999999999999999999
Q ss_pred CcccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccc
Q 042634 81 LTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRG 156 (427)
Q Consensus 81 ~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~ 156 (427)
+++..|..+..+++| ++|++++|++.+.+| .+..+++|+.|++++|++++ ++ .+..+++|+.|++++|.+.+
T Consensus 124 i~~~~~~~l~~l~~L-~~L~L~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 124 HDDSILTKINTLPKV-NSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp CBGGGHHHHTTCSSC-CEEECCSCTBCCCCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC----
T ss_pred cCcHhHHHHhhCCCC-CEEEccCCCCccccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCcccCC
Confidence 998888889999999 689999998334676 78999999999999999984 66 88899999999999999864
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=1.6e-21 Score=196.11 Aligned_cols=129 Identities=16% Similarity=0.196 Sum_probs=109.4
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||++....+.. ....++||||+++++|.+++.. +..++.|+++||+||| ++||+||
T Consensus 396 l~h~nIv~~~~~~~~-----~~~~~lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH---~~gIiHr 455 (540)
T 3en9_A 396 VKDFGIPAPYIFDVD-----LDNKRIMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLH---KNDVIHN 455 (540)
T ss_dssp GGGGTCCCCCEEEEE-----TTTTEEEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHH---HTTEECT
T ss_pred cCCCCcCceEEEEEe-----CCccEEEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHH---HCcCccC
Confidence 579999944333222 3456999999999999999864 4579999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc-------------CCCccccccccccCC--CCcCccccchhHHHHHHHHHh
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA-------------TNNFFNFQIAEYGMG--SEVSTSGDVYSFGILLLETFT 323 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-------------~~~~~~y~aPE~~~~--~~~~~~~DiwS~G~vl~ell~ 323 (427)
||||+|||++. .+||+|||+|+..... ..||+.|+|||++.. ..|+..+|+||..+-..+-+.
T Consensus 456 DiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~ 533 (540)
T 3en9_A 456 DLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVE 533 (540)
T ss_dssp TCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHH
T ss_pred CCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHH
Confidence 99999999999 9999999999987552 268899999999987 668889999999999988888
Q ss_pred CCCCCC
Q 042634 324 GKRPTN 329 (427)
Q Consensus 324 g~~pf~ 329 (427)
++.+|.
T Consensus 534 ~r~rY~ 539 (540)
T 3en9_A 534 RRARYV 539 (540)
T ss_dssp TCSCCC
T ss_pred hccccC
Confidence 887764
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.81 E-value=2.2e-20 Score=175.80 Aligned_cols=168 Identities=20% Similarity=0.180 Sum_probs=140.3
Q ss_pred CeeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCcc
Q 042634 1 AFTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNN 80 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~ 80 (427)
+|+|++|++++..| +..+++|++|+|++|+++ .+|. +++|+.|++++|++++..+. .+++|++|++++|+
T Consensus 62 ~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~-~l~~----~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~N~ 131 (317)
T 3o53_A 62 LLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-ELLV----GPSIETLHAANNNISRVSCS---RGQGKKNIYLANNK 131 (317)
T ss_dssp EEECTTSCCEEEEE--ETTCTTCCEEECCSSEEE-EEEE----CTTCCEEECCSSCCSEEEEC---CCSSCEEEECCSSC
T ss_pred EEECCCCcCCcchh--hhhcCCCCEEECcCCccc-cccC----CCCcCEEECCCCccCCcCcc---ccCCCCEEECCCCC
Confidence 47999999997654 999999999999999998 4553 48999999999999954433 36789999999999
Q ss_pred CcccCCCCccccccccceeeccCCcCcCCCCCCC-cCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCC
Q 042634 81 LTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNF-GILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIP 159 (427)
Q Consensus 81 ~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~-~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p 159 (427)
+++..|..+..+++| ++|++++|.+++..|..+ ..+++|+.|++++|.+++ +|.. ..+++|+.|++++|.+++. |
T Consensus 132 l~~~~~~~~~~l~~L-~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~-~~l~~L~~L~Ls~N~l~~l-~ 207 (317)
T 3o53_A 132 ITMLRDLDEGCRSRV-QYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQ-VVFAKLKTLDLSSNKLAFM-G 207 (317)
T ss_dssp CCSGGGBCTGGGSSE-EEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCE-EECC-CCCTTCCEEECCSSCCCEE-C
T ss_pred CCCccchhhhccCCC-CEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcc-cccc-cccccCCEEECCCCcCCcc-h
Confidence 998878888889999 689999999987666666 478999999999999985 4443 3589999999999999964 5
Q ss_pred CCcccccCCceeeccCCcccccc
Q 042634 160 SSLSSLRGIENLDLSRNNFIRHR 182 (427)
Q Consensus 160 ~~l~~l~~L~~L~L~~N~ll~Hp 182 (427)
..+..+++|+.|++++|.+..-|
T Consensus 208 ~~~~~l~~L~~L~L~~N~l~~l~ 230 (317)
T 3o53_A 208 PEFQSAAGVTWISLRNNKLVLIE 230 (317)
T ss_dssp GGGGGGTTCSEEECTTSCCCEEC
T ss_pred hhhcccCcccEEECcCCcccchh
Confidence 56889999999999999886533
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.81 E-value=3.6e-20 Score=169.51 Aligned_cols=165 Identities=23% Similarity=0.277 Sum_probs=141.4
Q ss_pred eeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccC
Q 042634 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNL 81 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~ 81 (427)
+++++|.+++. + .+..+++|+.|++++|.++ .+| .++.+++|++|+|++|+++ .+|+ +..+++|++|++++|++
T Consensus 24 l~l~~~~i~~~-~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~-~~~~-l~~l~~L~~L~L~~N~l 97 (263)
T 1xeu_A 24 QNLGKQSVTDL-V-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRL 97 (263)
T ss_dssp HHHTCSCTTSE-E-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCC-CCGG-GTTCSSCCEEECCSSCC
T ss_pred HHhcCCCcccc-c-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccC-CChh-hccCCCCCEEECCCCcc
Confidence 46788898844 4 6889999999999999998 687 7999999999999999999 5665 99999999999999999
Q ss_pred cccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCCCC
Q 042634 82 TGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSS 161 (427)
Q Consensus 82 ~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~~ 161 (427)
++ +|... . .+| +.|++++|++++ ++ .++.+++|+.|++++|++++ +| .++.+++|+.|++++|.+++. ..
T Consensus 98 ~~-l~~~~-~-~~L-~~L~L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~-~~-~l~~l~~L~~L~L~~N~i~~~--~~ 167 (263)
T 1xeu_A 98 KN-LNGIP-S-ACL-SRLFLDNNELRD-TD-SLIHLKNLEILSIRNNKLKS-IV-MLGFLSKLEVLDLHGNEITNT--GG 167 (263)
T ss_dssp SC-CTTCC-C-SSC-CEEECCSSCCSB-SG-GGTTCTTCCEEECTTSCCCB-CG-GGGGCTTCCEEECTTSCCCBC--TT
T ss_pred CC-cCccc-c-Ccc-cEEEccCCccCC-Ch-hhcCcccccEEECCCCcCCC-Ch-HHccCCCCCEEECCCCcCcch--HH
Confidence 85 44432 2 778 689999999985 44 68999999999999999995 55 788999999999999999976 67
Q ss_pred cccccCCceeeccCCcccccc
Q 042634 162 LSSLRGIENLDLSRNNFIRHR 182 (427)
Q Consensus 162 l~~l~~L~~L~L~~N~ll~Hp 182 (427)
+..+++|+.|++++|.+...|
T Consensus 168 l~~l~~L~~L~l~~N~~~~~~ 188 (263)
T 1xeu_A 168 LTRLKKVNWIDLTGQKCVNEP 188 (263)
T ss_dssp STTCCCCCEEEEEEEEEECCC
T ss_pred hccCCCCCEEeCCCCcccCCc
Confidence 889999999999999876543
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.81 E-value=1.1e-19 Score=184.79 Aligned_cols=166 Identities=22% Similarity=0.344 Sum_probs=145.7
Q ss_pred CeeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCcc
Q 042634 1 AFTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNN 80 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~ 80 (427)
.|+|++|.++ .+| .+..+++|+.|+|++|++++ +|+ ++.+++|+.|+|++|.++ .+| .+..+++|++|+|++|.
T Consensus 47 ~L~l~~n~i~-~l~-~l~~l~~L~~L~Ls~N~l~~-~~~-l~~l~~L~~L~Ls~N~l~-~l~-~l~~l~~L~~L~Ls~N~ 120 (605)
T 1m9s_A 47 QIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTD-IKP-LTNLKNLGWLFLDENKIK-DLS-SLKDLKKLKSLSLEHNG 120 (605)
T ss_dssp CCBCTTCCCC-CCT-TGGGCTTCCEEECTTSCCCC-CGG-GGGCTTCCEEECCSSCCC-CCT-TSTTCTTCCEEECTTSC
T ss_pred EEECcCCCCC-CCh-HHccCCCCCEEEeeCCCCCC-Chh-hccCCCCCEEECcCCCCC-CCh-hhccCCCCCEEEecCCC
Confidence 4789999998 455 58999999999999999985 555 999999999999999999 555 79999999999999999
Q ss_pred CcccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCCC
Q 042634 81 LTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPS 160 (427)
Q Consensus 81 ~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~ 160 (427)
+++ + ..+..+++| +.|+|++|++++. ..++.+++|+.|+|++|++++..| +..+++|+.|++++|.+++. .
T Consensus 121 l~~-l-~~l~~l~~L-~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l--~ 191 (605)
T 1m9s_A 121 ISD-I-NGLVHLPQL-ESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL--R 191 (605)
T ss_dssp CCC-C-GGGGGCTTC-SEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC--G
T ss_pred CCC-C-ccccCCCcc-CEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCC--h
Confidence 985 4 358889999 6899999999854 788999999999999999996555 89999999999999999974 4
Q ss_pred CcccccCCceeeccCCccccc
Q 042634 161 SLSSLRGIENLDLSRNNFIRH 181 (427)
Q Consensus 161 ~l~~l~~L~~L~L~~N~ll~H 181 (427)
.+..+++|+.|++++|.+...
T Consensus 192 ~l~~l~~L~~L~L~~N~l~~~ 212 (605)
T 1m9s_A 192 ALAGLKNLDVLELFSQECLNK 212 (605)
T ss_dssp GGTTCTTCSEEECCSEEEECC
T ss_pred HHccCCCCCEEEccCCcCcCC
Confidence 688999999999999988553
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.81 E-value=7.4e-20 Score=175.41 Aligned_cols=154 Identities=22% Similarity=0.173 Sum_probs=132.9
Q ss_pred CeeecCCcccccCCcccc-CCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCc
Q 042634 1 AFTLVGNQFTGRIPGSIG-DLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNN 79 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~~-~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 79 (427)
+|+|++|+|++..+..+. .+++|+.|+|++|++++..|..|.++++|++|+|++|++++..+..+..+++|++|+|++|
T Consensus 43 ~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N 122 (361)
T 2xot_A 43 LLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNN 122 (361)
T ss_dssp EEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCC
Confidence 389999999987777787 9999999999999999666678999999999999999999655567999999999999999
Q ss_pred cCcccCCCCccccccccceeeccCCcCcCCCCCC-C---cCCCCCCeEECcCCcccccCCcccccccc--ccceeeeeee
Q 042634 80 NLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSN-F---GILKNLGAIDISENKLSGQIPSSIGSCIR--LEQLVMNGNF 153 (427)
Q Consensus 80 ~~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~-~---~~l~~L~~l~l~~n~~~~~~p~~~~~~~~--l~~l~l~~n~ 153 (427)
++++..|..+.++.+| +.|+|++|+++ .+|.. + ..+++|+.|+|++|++++..+..+..++. ++.|++++|.
T Consensus 123 ~i~~~~~~~~~~l~~L-~~L~L~~N~l~-~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~ 200 (361)
T 2xot_A 123 HIVVVDRNAFEDMAQL-QKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNP 200 (361)
T ss_dssp CCCEECTTTTTTCTTC-CEEECCSSCCC-SCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSC
T ss_pred cccEECHHHhCCcccC-CEEECCCCcCC-eeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCC
Confidence 9998889999999999 68999999998 46655 4 67999999999999999533356777776 4889999998
Q ss_pred ccc
Q 042634 154 FRG 156 (427)
Q Consensus 154 l~~ 156 (427)
+..
T Consensus 201 ~~C 203 (361)
T 2xot_A 201 LEC 203 (361)
T ss_dssp EEC
T ss_pred ccC
Confidence 863
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.80 E-value=4e-19 Score=178.91 Aligned_cols=153 Identities=27% Similarity=0.355 Sum_probs=76.8
Q ss_pred eeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccC
Q 042634 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNL 81 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~ 81 (427)
|+|++|+|++ +|..+. ++|+.|+|++|+++ .+| +.+++|++|+|++|.+++ +|. +.. +|++|++++|++
T Consensus 64 L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l 132 (571)
T 3cvr_A 64 LQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQL 132 (571)
T ss_dssp EECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCC
T ss_pred EEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcC
Confidence 5666666664 555442 55666666666665 455 335555555555555553 554 433 455555555555
Q ss_pred cccCCCCccccccccceeeccCCcCcC-------------------CCCCCCcCCCCCCeEECcCCcccccCCccccccc
Q 042634 82 TGTTPTEVIGLSSLSIYLDLSQNQLNG-------------------PLPSNFGILKNLGAIDISENKLSGQIPSSIGSCI 142 (427)
Q Consensus 82 ~~~~p~~~~~l~~l~~~L~l~~n~~~~-------------------~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~ 142 (427)
++ +|. .+++| +.|+|++|.+++ .+|. ++ ++|+.|+|++|+|+ .+|. +..
T Consensus 133 ~~-lp~---~l~~L-~~L~Ls~N~l~~lp~~l~~L~~L~Ls~N~L~~lp~-l~--~~L~~L~Ls~N~L~-~lp~-~~~-- 200 (571)
T 3cvr_A 133 TM-LPE---LPALL-EYINADNNQLTMLPELPTSLEVLSVRNNQLTFLPE-LP--ESLEALDVSTNLLE-SLPA-VPV-- 200 (571)
T ss_dssp SC-CCC---CCTTC-CEEECCSSCCSCCCCCCTTCCEEECCSSCCSCCCC-CC--TTCCEEECCSSCCS-SCCC-CC---
T ss_pred CC-CCC---cCccc-cEEeCCCCccCcCCCcCCCcCEEECCCCCCCCcch-hh--CCCCEEECcCCCCC-chhh-HHH--
Confidence 53 333 23344 344444444442 1444 33 45555555555555 4444 333
Q ss_pred cc-------cceeeeeeeccccCCCCcccccCCceeeccCCcc
Q 042634 143 RL-------EQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178 (427)
Q Consensus 143 ~l-------~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l 178 (427)
+| +.|++++|.++. +|..+..+++|+.|++++|.+
T Consensus 201 ~L~~~~~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~L~~N~l 242 (571)
T 3cvr_A 201 RNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPL 242 (571)
T ss_dssp -------CCEEEECCSSCCCC-CCGGGGGSCTTEEEECCSSSC
T ss_pred hhhcccccceEEecCCCccee-cCHHHhcCCCCCEEEeeCCcC
Confidence 44 555555555552 445455555555555555555
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.80 E-value=3.2e-19 Score=179.67 Aligned_cols=144 Identities=27% Similarity=0.349 Sum_probs=114.9
Q ss_pred eeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccC
Q 042634 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNL 81 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~ 81 (427)
|+|++|+|++ +|. +.. +|+.|+|++|++++ +|. .+++|+.|+|++|.++ .+|. .+++|++|++++|++
T Consensus 105 L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~L 172 (571)
T 3cvr_A 105 LDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLT-MLPE---LPTSLEVLSVRNNQL 172 (571)
T ss_dssp EECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCC
T ss_pred EEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccC-cCCC---cCCCcCEEECCCCCC
Confidence 5677777775 566 554 77777777777774 666 5778888888888888 4776 567899999999999
Q ss_pred cccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCC-------CeEECcCCcccccCCccccccccccceeeeeeec
Q 042634 82 TGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNL-------GAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFF 154 (427)
Q Consensus 82 ~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L-------~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l 154 (427)
++ +|. +. .+| +.|+|++|.++ .+|. +.. +| +.|+|++|+++ .+|..++.+++|+.|++++|.+
T Consensus 173 ~~-lp~-l~--~~L-~~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l 242 (571)
T 3cvr_A 173 TF-LPE-LP--ESL-EALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPL 242 (571)
T ss_dssp SC-CCC-CC--TTC-CEEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSC
T ss_pred CC-cch-hh--CCC-CEEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcC
Confidence 85 666 54 778 68999999998 7888 655 77 99999999999 7999999999999999999999
Q ss_pred cccCCCCcccccC
Q 042634 155 RGNIPSSLSSLRG 167 (427)
Q Consensus 155 ~~~~p~~l~~l~~ 167 (427)
++.+|..+..+..
T Consensus 243 ~~~~p~~l~~l~~ 255 (571)
T 3cvr_A 243 SSRIRESLSQQTA 255 (571)
T ss_dssp CHHHHHHHHHHHH
T ss_pred CCcCHHHHHHhhc
Confidence 9998888777654
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.80 E-value=2.6e-19 Score=155.86 Aligned_cols=130 Identities=23% Similarity=0.363 Sum_probs=103.8
Q ss_pred eeecCCcccccCCccccCCCCCCEeeeecccceeecCc-chhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCcc
Q 042634 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPS-SIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNN 80 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~-~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~ 80 (427)
+++++|+++ .+|..+.. +|+.|+|++|++++..|. .++.+++|++|+|++|.+++..|..+..+++|++|++++|+
T Consensus 13 l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 89 (192)
T 1w8a_A 13 VDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENK 89 (192)
T ss_dssp EECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCC
T ss_pred EEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCc
Confidence 678888886 67776654 888888888888743333 37888888888888888887777888888888888888888
Q ss_pred CcccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCC
Q 042634 81 LTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIP 135 (427)
Q Consensus 81 ~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p 135 (427)
+++..|..+.++++| ++|+|++|++++..|..+..+++|+.|++++|.+++..+
T Consensus 90 l~~~~~~~~~~l~~L-~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 90 IKEISNKMFLGLHQL-KTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp CCEECSSSSTTCTTC-CEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred CCccCHHHhcCCCCC-CEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 887777778888888 578888888887778888888888888888888876543
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.79 E-value=3.1e-19 Score=170.01 Aligned_cols=170 Identities=24% Similarity=0.367 Sum_probs=141.5
Q ss_pred CeeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCcc
Q 042634 1 AFTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNN 80 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~ 80 (427)
+|++++|.+++. +. +..+++|+.|++++|.++ .++. +..+++|+.|++++|.++ .++. +..+++|++|++++|.
T Consensus 159 ~L~l~~~~~~~~-~~-~~~l~~L~~L~l~~n~l~-~~~~-~~~l~~L~~L~l~~n~l~-~~~~-~~~~~~L~~L~l~~n~ 232 (347)
T 4fmz_A 159 YLTVTESKVKDV-TP-IANLTDLYSLSLNYNQIE-DISP-LASLTSLHYFTAYVNQIT-DITP-VANMTRLNSLKIGNNK 232 (347)
T ss_dssp EEECCSSCCCCC-GG-GGGCTTCSEEECTTSCCC-CCGG-GGGCTTCCEEECCSSCCC-CCGG-GGGCTTCCEEECCSSC
T ss_pred EEEecCCCcCCc-hh-hccCCCCCEEEccCCccc-cccc-ccCCCccceeecccCCCC-CCch-hhcCCcCCEEEccCCc
Confidence 378899998854 33 889999999999999998 4655 889999999999999998 4444 8888999999999999
Q ss_pred CcccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCCC
Q 042634 81 LTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPS 160 (427)
Q Consensus 81 ~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~ 160 (427)
+++..+ +..+++| ++|++++|.+++ + ..+..+++|+.|++++|++++ + ..+..+++|+.|++++|.+++..|.
T Consensus 233 l~~~~~--~~~l~~L-~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~L~~n~l~~~~~~ 305 (347)
T 4fmz_A 233 ITDLSP--LANLSQL-TWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISD-I-SVLNNLSQLNSLFLNNNQLGNEDME 305 (347)
T ss_dssp CCCCGG--GTTCTTC-CEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCGGGHH
T ss_pred cCCCcc--hhcCCCC-CEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCC-C-hhhcCCCCCCEEECcCCcCCCcChh
Confidence 985443 7788888 679999999974 3 568889999999999999884 4 4578899999999999999888888
Q ss_pred CcccccCCceeeccCCccccccc
Q 042634 161 SLSSLRGIENLDLSRNNFIRHRN 183 (427)
Q Consensus 161 ~l~~l~~L~~L~L~~N~ll~Hpn 183 (427)
.+..+++|+.|++++|.+..-+.
T Consensus 306 ~l~~l~~L~~L~L~~n~l~~~~~ 328 (347)
T 4fmz_A 306 VIGGLTNLTTLFLSQNHITDIRP 328 (347)
T ss_dssp HHHTCTTCSEEECCSSSCCCCGG
T ss_pred HhhccccCCEEEccCCccccccC
Confidence 88889999999999998866544
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.78 E-value=7.6e-20 Score=190.45 Aligned_cols=153 Identities=25% Similarity=0.274 Sum_probs=126.6
Q ss_pred cCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccCccc
Q 042634 5 VGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGT 84 (427)
Q Consensus 5 ~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~~~~ 84 (427)
+.|.+. .+|..+..+++|+.|+|++|.++ .+|..+.++++|++|+|++|.|+ .+|..++.+++|++|+|++|+|+ .
T Consensus 209 ~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~ 284 (727)
T 4b8c_D 209 IENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-S 284 (727)
T ss_dssp --------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-S
T ss_pred ccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-c
Confidence 334444 45788999999999999999998 89999999999999999999999 99999999999999999999999 8
Q ss_pred CCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCcccccccc-ccceeeeeeeccccCCCCcc
Q 042634 85 TPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIR-LEQLVMNGNFFRGNIPSSLS 163 (427)
Q Consensus 85 ~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~-l~~l~l~~n~l~~~~p~~l~ 163 (427)
+|..++++.+| .+|+|++|.++ .+|..|+.|++|+.|+|++|.+++.+|..++.+.. +..+++++|.+++.+|..+.
T Consensus 285 lp~~~~~l~~L-~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~l~ 362 (727)
T 4b8c_D 285 LPAELGSCFQL-KYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHERR 362 (727)
T ss_dssp CCSSGGGGTTC-SEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC--
T ss_pred cChhhcCCCCC-CEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccccc
Confidence 89999999999 68999999997 89999999999999999999999988988876533 23578999999998887543
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.78 E-value=2.2e-18 Score=170.22 Aligned_cols=160 Identities=22% Similarity=0.227 Sum_probs=91.4
Q ss_pred eeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccC
Q 042634 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNL 81 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~ 81 (427)
|+|++|.+++. | +++.+++|++|+|++|++++ +| ++.+++|++|++++|.+++ +| ++.+++|++|++++|++
T Consensus 47 L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~-~~--~~~l~~L~~L~L~~N~l 118 (457)
T 3bz5_A 47 LDCHNSSITDM-T-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNCDTNKL 118 (457)
T ss_dssp EECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSC-CC--CTTCTTCCEEECCSSCC
T ss_pred EEccCCCcccC-h-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCce-ee--cCCCCcCCEEECCCCcC
Confidence 67777777753 4 57777777777777777764 44 6677777777777777773 33 66667777777777777
Q ss_pred cccCCCCccccccccceeeccCCcCcCCCCC--------------------CCcCCCCCCeEECcCCcccccCCcccccc
Q 042634 82 TGTTPTEVIGLSSLSIYLDLSQNQLNGPLPS--------------------NFGILKNLGAIDISENKLSGQIPSSIGSC 141 (427)
Q Consensus 82 ~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~--------------------~~~~l~~L~~l~l~~n~~~~~~p~~~~~~ 141 (427)
++ +| +..+++| ++|++++|++++ ++- .++.+++|+.|++++|++++ +| ++.+
T Consensus 119 ~~-l~--~~~l~~L-~~L~l~~N~l~~-l~l~~l~~L~~L~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~-l~--l~~l 190 (457)
T 3bz5_A 119 TK-LD--VSQNPLL-TYLNCARNTLTE-IDVSHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKITE-LD--VSQN 190 (457)
T ss_dssp SC-CC--CTTCTTC-CEEECTTSCCSC-CCCTTCTTCCEEECTTCSCCCCCCCTTCTTCCEEECCSSCCCC-CC--CTTC
T ss_pred Ce-ec--CCCCCcC-CEEECCCCccce-eccccCCcCCEEECCCCCcccccccccCCcCCEEECCCCccce-ec--cccC
Confidence 64 33 5556666 456666666654 220 23334444444444444442 33 4444
Q ss_pred ccccceeeeeeeccccCCCCcccccCCceeeccCCcccc
Q 042634 142 IRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNFIR 180 (427)
Q Consensus 142 ~~l~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~ll~ 180 (427)
++|+.|++++|.+++. .+..+++|+.|++++|++..
T Consensus 191 ~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~ 226 (457)
T 3bz5_A 191 KLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE 226 (457)
T ss_dssp TTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC
T ss_pred CCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc
Confidence 4444444444444432 24444555555555555443
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.78 E-value=7.3e-19 Score=174.41 Aligned_cols=167 Identities=29% Similarity=0.421 Sum_probs=137.7
Q ss_pred CeeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCcc
Q 042634 1 AFTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNN 80 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~ 80 (427)
+|++++|.+++..| ++.+++|+.|++++|+++ .++ .+..+++|+.|++++|.+++. ++ +..+++|++|++++|.
T Consensus 203 ~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~-~~~-~l~~l~~L~~L~l~~n~l~~~-~~-~~~l~~L~~L~l~~n~ 276 (466)
T 1o6v_A 203 SLIATNNQISDITP--LGILTNLDELSLNGNQLK-DIG-TLASLTNLTDLDLANNQISNL-AP-LSGLTKLTELKLGANQ 276 (466)
T ss_dssp EEECCSSCCCCCGG--GGGCTTCCEEECCSSCCC-CCG-GGGGCTTCSEEECCSSCCCCC-GG-GTTCTTCSEEECCSSC
T ss_pred EEEecCCccccccc--ccccCCCCEEECCCCCcc-cch-hhhcCCCCCEEECCCCccccc-hh-hhcCCCCCEEECCCCc
Confidence 37899999996644 788999999999999998 454 588999999999999999844 43 8889999999999999
Q ss_pred CcccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCCC
Q 042634 81 LTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPS 160 (427)
Q Consensus 81 ~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~ 160 (427)
+++..+ +..+++| +.|++++|++++..| ++.+++|+.|++++|++++..| ++.+++|+.|++++|.+++. .
T Consensus 277 l~~~~~--~~~l~~L-~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~ 347 (466)
T 1o6v_A 277 ISNISP--LAGLTAL-TNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--S 347 (466)
T ss_dssp CCCCGG--GTTCTTC-SEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--G
T ss_pred cCcccc--ccCCCcc-CeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCc--h
Confidence 986544 7788888 679999999985433 7889999999999999986544 78889999999999998875 4
Q ss_pred CcccccCCceeeccCCcccccc
Q 042634 161 SLSSLRGIENLDLSRNNFIRHR 182 (427)
Q Consensus 161 ~l~~l~~L~~L~L~~N~ll~Hp 182 (427)
.+..+++|+.|++++|.+...+
T Consensus 348 ~l~~l~~L~~L~l~~n~l~~~~ 369 (466)
T 1o6v_A 348 SLANLTNINWLSAGHNQISDLT 369 (466)
T ss_dssp GGTTCTTCCEEECCSSCCCBCG
T ss_pred hhccCCCCCEEeCCCCccCccc
Confidence 6888899999999998886544
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.78 E-value=1.1e-18 Score=166.12 Aligned_cols=166 Identities=25% Similarity=0.349 Sum_probs=142.2
Q ss_pred CeeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCcc
Q 042634 1 AFTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNN 80 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~ 80 (427)
+|++++|..... ++.+..+++|++|++++|.++ .++. ++.+++|+.|++++|.++ .++. +..+++|++|++++|.
T Consensus 136 ~L~l~~n~~~~~-~~~~~~l~~L~~L~l~~~~~~-~~~~-~~~l~~L~~L~l~~n~l~-~~~~-~~~l~~L~~L~l~~n~ 210 (347)
T 4fmz_A 136 SLNLGANHNLSD-LSPLSNMTGLNYLTVTESKVK-DVTP-IANLTDLYSLSLNYNQIE-DISP-LASLTSLHYFTAYVNQ 210 (347)
T ss_dssp EEECTTCTTCCC-CGGGTTCTTCCEEECCSSCCC-CCGG-GGGCTTCSEEECTTSCCC-CCGG-GGGCTTCCEEECCSSC
T ss_pred EEECCCCCCccc-ccchhhCCCCcEEEecCCCcC-Cchh-hccCCCCCEEEccCCccc-cccc-ccCCCccceeecccCC
Confidence 378999977645 445999999999999999998 4555 999999999999999999 5665 8889999999999999
Q ss_pred CcccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCCC
Q 042634 81 LTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPS 160 (427)
Q Consensus 81 ~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~ 160 (427)
+++..+ +..+++| +.|++++|.+++ ++. +..+++|+.|++++|.+++ + ..+..+++|+.|++++|.+++. .
T Consensus 211 l~~~~~--~~~~~~L-~~L~l~~n~l~~-~~~-~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~~--~ 281 (347)
T 4fmz_A 211 ITDITP--VANMTRL-NSLKIGNNKITD-LSP-LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISDI--S 281 (347)
T ss_dssp CCCCGG--GGGCTTC-CEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCCC--G
T ss_pred CCCCch--hhcCCcC-CEEEccCCccCC-Ccc-hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCCC--h
Confidence 985554 7888899 689999999984 444 8899999999999999984 4 5688999999999999999874 4
Q ss_pred CcccccCCceeeccCCcccc
Q 042634 161 SLSSLRGIENLDLSRNNFIR 180 (427)
Q Consensus 161 ~l~~l~~L~~L~L~~N~ll~ 180 (427)
.+..+++|+.|++++|.+..
T Consensus 282 ~~~~l~~L~~L~L~~n~l~~ 301 (347)
T 4fmz_A 282 VLNNLSQLNSLFLNNNQLGN 301 (347)
T ss_dssp GGGGCTTCSEEECCSSCCCG
T ss_pred hhcCCCCCCEEECcCCcCCC
Confidence 68889999999999998854
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=3.1e-21 Score=195.07 Aligned_cols=174 Identities=22% Similarity=0.267 Sum_probs=137.7
Q ss_pred eeecCCcccccCCccccCCCCCCEeeeeccc-------------ceeecCcchhccccCCEee-eccccCcccCCc----
Q 042634 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNK-------------FWGEIPSSIGNLTLLITLN-FAENMLEGSIPS---- 63 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~-------------~~~~~p~~~~~l~~L~~L~-l~~n~l~~~~p~---- 63 (427)
|+|++|+|+ .+|.+++.+++|+.|++++|. +.+.+|..++.+++|+.|+ ++.|.+. .++.
T Consensus 354 L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~-~L~~l~l~ 431 (567)
T 1dce_A 354 CELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD-DLRSKFLL 431 (567)
T ss_dssp CCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH-HHHHHHHH
T ss_pred ccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc-hhhhhhhh
Confidence 577778777 678888888888888876664 4555666777777777777 4544333 2211
Q ss_pred --CccCC--CCCCeEEccCccCcccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCcccc
Q 042634 64 --SLGKC--QNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIG 139 (427)
Q Consensus 64 --~~~~l--~~L~~l~l~~N~~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~ 139 (427)
.+..+ ..|++|++++|.+++ +|. +.++.+| +.|+|++|.++ .+|..++.+++|+.|+|++|++++ +| .++
T Consensus 432 ~n~i~~l~~~~L~~L~Ls~n~l~~-lp~-~~~l~~L-~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~ 505 (567)
T 1dce_A 432 ENSVLKMEYADVRVLHLAHKDLTV-LCH-LEQLLLV-THLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVA 505 (567)
T ss_dssp HHHHHHHHHTTCSEEECTTSCCSS-CCC-GGGGTTC-CEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGT
T ss_pred cccccccCccCceEEEecCCCCCC-CcC-ccccccC-cEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccC
Confidence 11111 258899999999985 676 8999999 68999999998 899999999999999999999995 78 899
Q ss_pred ccccccceeeeeeeccccC-CCCcccccCCceeeccCCccccccc
Q 042634 140 SCIRLEQLVMNGNFFRGNI-PSSLSSLRGIENLDLSRNNFIRHRN 183 (427)
Q Consensus 140 ~~~~l~~l~l~~n~l~~~~-p~~l~~l~~L~~L~L~~N~ll~Hpn 183 (427)
.+++|+.|++++|.+++.. |..+..+++|+.|++++|.+..-|.
T Consensus 506 ~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 550 (567)
T 1dce_A 506 NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG 550 (567)
T ss_dssp TCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred CCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence 9999999999999999876 8999999999999999999876654
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.77 E-value=1.2e-18 Score=172.91 Aligned_cols=167 Identities=27% Similarity=0.350 Sum_probs=142.3
Q ss_pred CeeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCcc
Q 042634 1 AFTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNN 80 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~ 80 (427)
+|++++|.+++. +.+..+++|+.|++++|.+++.. + ++.+++|+.|++++|.++ .++ .+..+++|++|++++|.
T Consensus 181 ~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~-~-~~~l~~L~~L~l~~n~l~-~~~-~l~~l~~L~~L~l~~n~ 254 (466)
T 1o6v_A 181 RLDISSNKVSDI--SVLAKLTNLESLIATNNQISDIT-P-LGILTNLDELSLNGNQLK-DIG-TLASLTNLTDLDLANNQ 254 (466)
T ss_dssp EEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG-G-GGGCTTCCEEECCSSCCC-CCG-GGGGCTTCSEEECCSSC
T ss_pred EEECcCCcCCCC--hhhccCCCCCEEEecCCcccccc-c-ccccCCCCEEECCCCCcc-cch-hhhcCCCCCEEECCCCc
Confidence 378999999843 45899999999999999998543 3 888999999999999999 554 68889999999999999
Q ss_pred CcccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCCC
Q 042634 81 LTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPS 160 (427)
Q Consensus 81 ~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~ 160 (427)
+++..| +..+++| +.|++++|.+++. |. +..+++|+.|++++|++++ ++. ++.+++|+.|++++|.+++..|
T Consensus 255 l~~~~~--~~~l~~L-~~L~l~~n~l~~~-~~-~~~l~~L~~L~L~~n~l~~-~~~-~~~l~~L~~L~L~~n~l~~~~~- 326 (466)
T 1o6v_A 255 ISNLAP--LSGLTKL-TELKLGANQISNI-SP-LAGLTALTNLELNENQLED-ISP-ISNLKNLTYLTLYFNNISDISP- 326 (466)
T ss_dssp CCCCGG--GTTCTTC-SEEECCSSCCCCC-GG-GTTCTTCSEEECCSSCCSC-CGG-GGGCTTCSEEECCSSCCSCCGG-
T ss_pred cccchh--hhcCCCC-CEEECCCCccCcc-cc-ccCCCccCeEEcCCCcccC-chh-hcCCCCCCEEECcCCcCCCchh-
Confidence 986655 7888899 6899999999854 43 8899999999999999995 443 8899999999999999998765
Q ss_pred CcccccCCceeeccCCcccccc
Q 042634 161 SLSSLRGIENLDLSRNNFIRHR 182 (427)
Q Consensus 161 ~l~~l~~L~~L~L~~N~ll~Hp 182 (427)
+..+++|+.|++++|.+..-+
T Consensus 327 -~~~l~~L~~L~l~~n~l~~~~ 347 (466)
T 1o6v_A 327 -VSSLTKLQRLFFYNNKVSDVS 347 (466)
T ss_dssp -GGGCTTCCEEECCSSCCCCCG
T ss_pred -hccCccCCEeECCCCccCCch
Confidence 788999999999999886654
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.77 E-value=4.1e-18 Score=168.27 Aligned_cols=160 Identities=23% Similarity=0.267 Sum_probs=109.5
Q ss_pred eeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccC
Q 042634 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNL 81 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~ 81 (427)
|+|++|++++. | ++.+++|++|+|++|++++ +| ++++++|++|++++|.+++ +| ++.+++|++|++++|++
T Consensus 69 L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~-~~--~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l 139 (457)
T 3bz5_A 69 LICTSNNITTL-D--LSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTL 139 (457)
T ss_dssp EECCSSCCSCC-C--CTTCTTCSEEECCSSCCSC-CC--CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCC
T ss_pred EEccCCcCCeE-c--cccCCCCCEEECcCCCCce-ee--cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCcc
Confidence 55666666642 3 5566666666666666653 32 5555666666666665552 33 55555555555555555
Q ss_pred cc---------------------cCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccc
Q 042634 82 TG---------------------TTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGS 140 (427)
Q Consensus 82 ~~---------------------~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~ 140 (427)
++ .+ .+..+++| +.|++++|++++ +| ++.+++|+.|++++|++++ + .++.
T Consensus 140 ~~l~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L-~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~-~--~l~~ 210 (457)
T 3bz5_A 140 TEIDVSHNTQLTELDCHLNKKITKL--DVTPQTQL-TTLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITK-L--DLNQ 210 (457)
T ss_dssp SCCCCTTCTTCCEEECTTCSCCCCC--CCTTCTTC-CEEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSC-C--CCTT
T ss_pred ceeccccCCcCCEEECCCCCccccc--ccccCCcC-CEEECCCCccce-ec--cccCCCCCEEECcCCcCCe-e--cccc
Confidence 43 33 24556677 578888888875 55 8888999999999999985 4 4888
Q ss_pred cccccceeeeeeeccccCCCCcccccCCceeeccCCcccccc
Q 042634 141 CIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNFIRHR 182 (427)
Q Consensus 141 ~~~l~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~ll~Hp 182 (427)
+++|+.|++++|.+++ +| +..+++|+.|++++|++...|
T Consensus 211 l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~ 249 (457)
T 3bz5_A 211 NIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELD 249 (457)
T ss_dssp CTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCC
T ss_pred CCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcC
Confidence 8999999999999987 45 778888999999998876543
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.77 E-value=1.9e-20 Score=177.60 Aligned_cols=174 Identities=17% Similarity=0.208 Sum_probs=143.3
Q ss_pred eeecCCcccccCCccccCCCCCCEeeeecccceee-cCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCc-
Q 042634 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGE-IPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNN- 79 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~-~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N- 79 (427)
|++++|.+++..|. +..+++|+.|+|++|.+++. +|..+..+++|++|+|++|.+++..|..++.+++|++|++++|
T Consensus 75 L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~ 153 (336)
T 2ast_B 75 FRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCS 153 (336)
T ss_dssp EECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCB
T ss_pred EEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCC
Confidence 67888888866554 67889999999999988765 7788888999999999999998888888888999999999999
Q ss_pred cCccc-CCCCccccccccceeeccCC-cCcCC-CCCCCcCCC-CCCeEECcCC--ccc-ccCCccccccccccceeeeee
Q 042634 80 NLTGT-TPTEVIGLSSLSIYLDLSQN-QLNGP-LPSNFGILK-NLGAIDISEN--KLS-GQIPSSIGSCIRLEQLVMNGN 152 (427)
Q Consensus 80 ~~~~~-~p~~~~~l~~l~~~L~l~~n-~~~~~-~p~~~~~l~-~L~~l~l~~n--~~~-~~~p~~~~~~~~l~~l~l~~n 152 (427)
.+++. ++..+.++++| ++|++++| .+++. ++..+..++ +|+.|++++| .++ +.+|..+..+++|+.|++++|
T Consensus 154 ~l~~~~l~~~~~~~~~L-~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~ 232 (336)
T 2ast_B 154 GFSEFALQTLLSSCSRL-DELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDS 232 (336)
T ss_dssp SCCHHHHHHHHHHCTTC-CEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTC
T ss_pred CCCHHHHHHHHhcCCCC-CEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCC
Confidence 67653 66667788888 67999999 88753 567788888 9999999998 454 456777888899999999999
Q ss_pred e-ccccCCCCcccccCCceeeccCCc
Q 042634 153 F-FRGNIPSSLSSLRGIENLDLSRNN 177 (427)
Q Consensus 153 ~-l~~~~p~~l~~l~~L~~L~L~~N~ 177 (427)
. +++..+..+..+++|+.|++++|.
T Consensus 233 ~~l~~~~~~~l~~l~~L~~L~l~~~~ 258 (336)
T 2ast_B 233 VMLKNDCFQEFFQLNYLQHLSLSRCY 258 (336)
T ss_dssp TTCCGGGGGGGGGCTTCCEEECTTCT
T ss_pred CcCCHHHHHHHhCCCCCCEeeCCCCC
Confidence 8 776777788888999999998886
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.77 E-value=1.4e-18 Score=151.23 Aligned_cols=130 Identities=25% Similarity=0.321 Sum_probs=102.5
Q ss_pred CEeeeecccceeecCcchhccccCCEeeeccccCcccCCc-CccCCCCCCeEEccCccCcccCCCCccccccccceeecc
Q 042634 24 QRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS-SLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLS 102 (427)
Q Consensus 24 ~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~-~~~~l~~L~~l~l~~N~~~~~~p~~~~~l~~l~~~L~l~ 102 (427)
+.+++++|.++ .+|..+.. +|+.|++++|.+++..|. .+..+++|++|++++|++++..|..+.++.+| ++|+|+
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L-~~L~Ls 86 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI-QELQLG 86 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTC-CEEECC
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccC-CEEECC
Confidence 67888888886 78876644 788888888888844333 37788888888888888887778888888888 578888
Q ss_pred CCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeecccc
Q 042634 103 QNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGN 157 (427)
Q Consensus 103 ~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~ 157 (427)
+|++++..|..+..+++|+.|+|++|++++.+|..+..+++|+.|++++|.+++.
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 141 (192)
T 1w8a_A 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred CCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCc
Confidence 8888877777788888888888888888877788888888888888888887754
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.77 E-value=1.5e-18 Score=161.22 Aligned_cols=144 Identities=26% Similarity=0.331 Sum_probs=127.2
Q ss_pred CeeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCcc
Q 042634 1 AFTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNN 80 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~ 80 (427)
+|+|++|++++. ++ +..+++|+.|+|++|++++ +|. ++.+++|++|++++|.++ .+ +.+..+++|++|++++|+
T Consensus 72 ~L~L~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~L~~n~i~-~~-~~l~~l~~L~~L~l~~n~ 145 (291)
T 1h6t_A 72 KLFLNGNKLTDI-KP-LANLKNLGWLFLDENKVKD-LSS-LKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNK 145 (291)
T ss_dssp EEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCC-GGG-GTTCTTCCEEECTTSCCC-CC-GGGGGCTTCCEEECCSSC
T ss_pred EEEccCCccCCC-cc-cccCCCCCEEECCCCcCCC-Chh-hccCCCCCEEECCCCcCC-CC-hhhcCCCCCCEEEccCCc
Confidence 479999999965 44 9999999999999999984 554 999999999999999999 55 478899999999999999
Q ss_pred CcccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeecccc
Q 042634 81 LTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGN 157 (427)
Q Consensus 81 ~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~ 157 (427)
+++. ..+..+++| +.|++++|++++..| +..+++|+.|++++|.+++ +| .+..+++|+.|++++|.++..
T Consensus 146 l~~~--~~l~~l~~L-~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~l~~n~i~~~ 215 (291)
T 1h6t_A 146 ITDI--TVLSRLTKL-DTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECLNK 215 (291)
T ss_dssp CCCC--GGGGGCTTC-SEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEEEEEECC
T ss_pred CCcc--hhhccCCCC-CEEEccCCccccchh--hcCCCccCEEECCCCcCCC-Ch-hhccCCCCCEEECcCCcccCC
Confidence 9854 568889999 689999999986444 9999999999999999994 65 489999999999999999864
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.76 E-value=2.3e-20 Score=177.06 Aligned_cols=175 Identities=20% Similarity=0.235 Sum_probs=152.2
Q ss_pred CeeecCCccccc-CCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccc-cCcc-cCCcCccCCCCCCeEEcc
Q 042634 1 AFTLVGNQFTGR-IPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAEN-MLEG-SIPSSLGKCQNLILLDLS 77 (427)
Q Consensus 1 ~l~l~~n~l~~~-~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n-~l~~-~~p~~~~~l~~L~~l~l~ 77 (427)
+|+|++|.+++. +|..+..+++|+.|+|++|.+++..|..++.+++|++|++++| .+++ .+|..+..+++|++|+++
T Consensus 97 ~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~ 176 (336)
T 2ast_B 97 HMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLS 176 (336)
T ss_dssp EEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECC
T ss_pred EEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCC
Confidence 479999999876 8889999999999999999999888999999999999999999 7886 377778899999999999
Q ss_pred Cc-cCccc-CCCCccccc-cccceeeccCC--cCc-CCCCCCCcCCCCCCeEECcCCc-ccccCCccccccccccceeee
Q 042634 78 NN-NLTGT-TPTEVIGLS-SLSIYLDLSQN--QLN-GPLPSNFGILKNLGAIDISENK-LSGQIPSSIGSCIRLEQLVMN 150 (427)
Q Consensus 78 ~N-~~~~~-~p~~~~~l~-~l~~~L~l~~n--~~~-~~~p~~~~~l~~L~~l~l~~n~-~~~~~p~~~~~~~~l~~l~l~ 150 (427)
+| .+++. ++..+..++ +| ++|++++| .++ +.+|..+..+++|+.|++++|. +++..+..++++++|+.|+++
T Consensus 177 ~~~~l~~~~~~~~~~~l~~~L-~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~ 255 (336)
T 2ast_B 177 WCFDFTEKHVQVAVAHVSETI-TQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLS 255 (336)
T ss_dssp CCTTCCHHHHHHHHHHSCTTC-CEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECT
T ss_pred CCCCcChHHHHHHHHhcccCC-CEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCC
Confidence 99 99864 567788889 99 68999999 555 4677788899999999999999 777888899999999999999
Q ss_pred eee-ccccCCCCcccccCCceeeccCC
Q 042634 151 GNF-FRGNIPSSLSSLRGIENLDLSRN 176 (427)
Q Consensus 151 ~n~-l~~~~p~~l~~l~~L~~L~L~~N 176 (427)
+|. +.......+..+++|+.|++++|
T Consensus 256 ~~~~~~~~~~~~l~~~~~L~~L~l~~~ 282 (336)
T 2ast_B 256 RCYDIIPETLLELGEIPTLKTLQVFGI 282 (336)
T ss_dssp TCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred CCCCCCHHHHHHHhcCCCCCEEeccCc
Confidence 995 33222235788999999999988
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.76 E-value=1.9e-18 Score=164.94 Aligned_cols=179 Identities=18% Similarity=0.158 Sum_probs=129.2
Q ss_pred eeecCCcccccCCccccCCCCCCEeeeecccceeecCc-chhccccCCE-eeeccccCcccCCcCccCCCCCCeEEccCc
Q 042634 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPS-SIGNLTLLIT-LNFAENMLEGSIPSSLGKCQNLILLDLSNN 79 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~-~~~~l~~L~~-L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 79 (427)
|+|++|+|+...+..|.+|++|++|+|++|++.+.+|. .|.+++++.. +++++|++++..|..+..+++|++|++++|
T Consensus 35 L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n 114 (350)
T 4ay9_X 35 LRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNT 114 (350)
T ss_dssp EEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEE
T ss_pred EEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhcccccccccccc
Confidence 67888888844345678888888888888887656664 4677777654 556677888555566777888888888888
Q ss_pred cCcccCCCCccccccccceeeccC-CcCcCCCCCCCcCCC-CCCeEECcCCcccccCCccccccccccceeeee-eeccc
Q 042634 80 NLTGTTPTEVIGLSSLSIYLDLSQ-NQLNGPLPSNFGILK-NLGAIDISENKLSGQIPSSIGSCIRLEQLVMNG-NFFRG 156 (427)
Q Consensus 80 ~~~~~~p~~~~~l~~l~~~L~l~~-n~~~~~~p~~~~~l~-~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~-n~l~~ 156 (427)
++++..+..+....++ ..|++.+ |.+....+..+..+. .++.|++++|+++ .+|..+....+|+.+++++ |.++.
T Consensus 115 ~l~~~~~~~~~~~~~l-~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~-~i~~~~f~~~~L~~l~l~~~n~l~~ 192 (350)
T 4ay9_X 115 GIKHLPDVHKIHSLQK-VLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEE 192 (350)
T ss_dssp CCSSCCCCTTCCBSSC-EEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-EECTTSSTTEEEEEEECTTCTTCCC
T ss_pred ccccCCchhhcccchh-hhhhhccccccccccccchhhcchhhhhhcccccccc-CCChhhccccchhHHhhccCCcccC
Confidence 8876655555555555 4566654 455533334566664 6888999999998 6787777778899999975 66665
Q ss_pred cCCCCcccccCCceeeccCCcccccc
Q 042634 157 NIPSSLSSLRGIENLDLSRNNFIRHR 182 (427)
Q Consensus 157 ~~p~~l~~l~~L~~L~L~~N~ll~Hp 182 (427)
..+..|..+++|+.|++++|++..-|
T Consensus 193 i~~~~f~~l~~L~~LdLs~N~l~~lp 218 (350)
T 4ay9_X 193 LPNDVFHGASGPVILDISRTRIHSLP 218 (350)
T ss_dssp CCTTTTTTEECCSEEECTTSCCCCCC
T ss_pred CCHHHhccCcccchhhcCCCCcCccC
Confidence 54467899999999999999886554
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.76 E-value=4.8e-19 Score=174.78 Aligned_cols=167 Identities=22% Similarity=0.246 Sum_probs=100.9
Q ss_pred CeeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccC-------------CEeeeccccCcccCCcCccC
Q 042634 1 AFTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLL-------------ITLNFAENMLEGSIPSSLGK 67 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L-------------~~L~l~~n~l~~~~p~~~~~ 67 (427)
+|++++|.+ |.+|+++++|++|++|++++|.++|.+|.+++++++| +.|++++|.++ .+|..
T Consensus 15 ~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~-~lp~~--- 89 (454)
T 1jl5_A 15 EPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPEL--- 89 (454)
T ss_dssp --------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCS-CCCSC---
T ss_pred hhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccc-cCCCC---
Confidence 468899999 6999999999999999999999999999988887654 67777777766 44432
Q ss_pred CCCCCeEEccCccCcccCCCCccc----------------c-ccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcc
Q 042634 68 CQNLILLDLSNNNLTGTTPTEVIG----------------L-SSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKL 130 (427)
Q Consensus 68 l~~L~~l~l~~N~~~~~~p~~~~~----------------l-~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~ 130 (427)
.++|++|++++|.+++ +|..+.+ + .+| ++|++++|++++ +| .++++++|+.|++++|++
T Consensus 90 ~~~L~~L~l~~n~l~~-lp~~~~~L~~L~l~~n~l~~l~~~~~~L-~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l 165 (454)
T 1jl5_A 90 PPHLESLVASCNSLTE-LPELPQSLKSLLVDNNNLKALSDLPPLL-EYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSL 165 (454)
T ss_dssp CTTCSEEECCSSCCSS-CCCCCTTCCEEECCSSCCSCCCSCCTTC-CEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCC
T ss_pred cCCCCEEEccCCcCCc-cccccCCCcEEECCCCccCcccCCCCCC-CEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcC
Confidence 2445555555555553 3332111 1 345 567777777774 66 577788888888888877
Q ss_pred cccCCccccccccccceeeeeeeccccCCCCcccccCCceeeccCCcccccc
Q 042634 131 SGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNFIRHR 182 (427)
Q Consensus 131 ~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~ll~Hp 182 (427)
++ +|..+ .+|+.|++++|.+++ +| .+..+++|+.|++++|.+..-|
T Consensus 166 ~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~l~ 211 (454)
T 1jl5_A 166 KK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKKLP 211 (454)
T ss_dssp SC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSSCC
T ss_pred cc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCcCC
Confidence 74 66544 367777777777776 45 5777888888888887775544
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.76 E-value=2.2e-18 Score=157.59 Aligned_cols=143 Identities=21% Similarity=0.319 Sum_probs=126.7
Q ss_pred CeeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCcc
Q 042634 1 AFTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNN 80 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~ 80 (427)
+|++++|+++ .+| .+..+++|+.|+|++|+++ .+|+ ++++++|+.|+|++|+++ .+|.... ++|++|++++|+
T Consensus 45 ~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~-~~~~-l~~l~~L~~L~L~~N~l~-~l~~~~~--~~L~~L~L~~N~ 117 (263)
T 1xeu_A 45 NFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLK-NLNGIPS--ACLSRLFLDNNE 117 (263)
T ss_dssp EEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCC-CCGG-GTTCSSCCEEECCSSCCS-CCTTCCC--SSCCEEECCSSC
T ss_pred EEECcCCCcc-cch-HHhhCCCCCEEECCCCccC-CChh-hccCCCCCEEECCCCccC-CcCcccc--CcccEEEccCCc
Confidence 3799999999 567 7999999999999999999 5666 999999999999999999 6775444 899999999999
Q ss_pred CcccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeecccc
Q 042634 81 LTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGN 157 (427)
Q Consensus 81 ~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~ 157 (427)
+++ ++ .+..+++| +.|++++|++++ +| .++.+++|+.|++++|++++. ..+..+++|+.|++++|.+++.
T Consensus 118 l~~-~~-~l~~l~~L-~~L~Ls~N~i~~-~~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 118 LRD-TD-SLIHLKNL-EILSIRNNKLKS-IV-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp CSB-SG-GGTTCTTC-CEEECTTSCCCB-CG-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred cCC-Ch-hhcCcccc-cEEECCCCcCCC-Ch-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence 995 44 58889999 689999999985 44 789999999999999999964 7789999999999999999865
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.76 E-value=4e-18 Score=148.31 Aligned_cols=127 Identities=23% Similarity=0.300 Sum_probs=63.2
Q ss_pred CEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccCcccCCCCccccccccceeeccC
Q 042634 24 QRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQ 103 (427)
Q Consensus 24 ~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~~~l~~l~~~L~l~~ 103 (427)
+.+++++|.++ .+|..+. ++|+.|+|++|.++ .+|..+..+++|++|++++|++++..+..|.++.+| ++|+|++
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L-~~L~Ls~ 87 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQL-LTLILSY 87 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTC-CEEECCS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCC-CEEECCC
Confidence 34455555554 4444332 34555555555555 445445555555555555555554444445555555 3455555
Q ss_pred CcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeecc
Q 042634 104 NQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFR 155 (427)
Q Consensus 104 n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~ 155 (427)
|++++..|..|..+++|+.|+|++|++++..+..+..+++|+.|++++|.+.
T Consensus 88 N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 88 NRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp SCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred CccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 5555444444555555555555555555322224455555555555555554
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.76 E-value=2.2e-18 Score=146.48 Aligned_cols=137 Identities=23% Similarity=0.208 Sum_probs=118.9
Q ss_pred cCCCCCCEeeeecccce-eecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccCcccCCCCcccccccc
Q 042634 18 GDLHKLQRLTLEMNKFW-GEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLS 96 (427)
Q Consensus 18 ~~l~~L~~L~l~~n~~~-~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~~~l~~l~ 96 (427)
...++|+.|+|++|.++ +.+|..+..+++|++|++++|.++ .+ ..+..+++|++|++++|++++.+|..+..+++|
T Consensus 21 ~~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~-~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L- 97 (168)
T 2ell_A 21 RTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNL- 97 (168)
T ss_dssp SCTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCC-CC-SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTC-
T ss_pred CCcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCC-Ch-hhhccCCCCCEEECcCCcCchHHHHHHhhCCCC-
Confidence 34478999999999998 789998999999999999999999 44 789999999999999999997788877779999
Q ss_pred ceeeccCCcCcCCCC--CCCcCCCCCCeEECcCCcccccCCc----cccccccccceeeeeeeccccCCC
Q 042634 97 IYLDLSQNQLNGPLP--SNFGILKNLGAIDISENKLSGQIPS----SIGSCIRLEQLVMNGNFFRGNIPS 160 (427)
Q Consensus 97 ~~L~l~~n~~~~~~p--~~~~~l~~L~~l~l~~n~~~~~~p~----~~~~~~~l~~l~l~~n~l~~~~p~ 160 (427)
+.|++++|.+++ +| ..+..+++|+.|++++|.+++ +|. .+..+++|+.|++++|.+.. +|.
T Consensus 98 ~~L~Ls~N~l~~-~~~~~~l~~l~~L~~L~l~~N~l~~-~~~~~~~~~~~l~~L~~L~l~~n~~~~-~~~ 164 (168)
T 2ell_A 98 THLNLSGNKLKD-ISTLEPLKKLECLKSLDLFNCEVTN-LNDYRESVFKLLPQLTYLDGYDREDQE-APD 164 (168)
T ss_dssp CEEECBSSSCCS-SGGGGGGSSCSCCCEEECCSSGGGT-STTHHHHHHTTCSSCCEETTEETTSCB-CCS
T ss_pred CEEeccCCccCc-chhHHHHhcCCCCCEEEeeCCcCcc-hHHHHHHHHHhCccCcEecCCCCChhh-ccc
Confidence 689999999984 44 788999999999999999995 554 78889999999999998874 344
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.75 E-value=1.4e-20 Score=182.09 Aligned_cols=179 Identities=18% Similarity=0.224 Sum_probs=148.6
Q ss_pred CeeecCC---cccccCCccc-------cCCCCCCEeeeeccccee----ecCcchhccccCCEeeeccccCcccCCcCcc
Q 042634 1 AFTLVGN---QFTGRIPGSI-------GDLHKLQRLTLEMNKFWG----EIPSSIGNLTLLITLNFAENMLEGSIPSSLG 66 (427)
Q Consensus 1 ~l~l~~n---~l~~~~p~~~-------~~l~~L~~L~l~~n~~~~----~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~ 66 (427)
+|+|++| ++++.+|..+ ..+++|++|+|++|.+++ .+|..+..+++|++|+|++|.+++..+..+.
T Consensus 64 ~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~ 143 (386)
T 2ca6_A 64 IAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIA 143 (386)
T ss_dssp EEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHH
T ss_pred EEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHH
Confidence 3788884 6777888776 789999999999999986 4888999999999999999999855444444
Q ss_pred C----C---------CCCCeEEccCccCc-ccCC---CCccccccccceeeccCCcCc--C---CCCCCCcCCCCCCeEE
Q 042634 67 K----C---------QNLILLDLSNNNLT-GTTP---TEVIGLSSLSIYLDLSQNQLN--G---PLPSNFGILKNLGAID 124 (427)
Q Consensus 67 ~----l---------~~L~~l~l~~N~~~-~~~p---~~~~~l~~l~~~L~l~~n~~~--~---~~p~~~~~l~~L~~l~ 124 (427)
. + ++|++|++++|+++ +.+| ..+..+++| +.|++++|.++ | ..|..+..+++|+.|+
T Consensus 144 ~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L-~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~ 222 (386)
T 2ca6_A 144 RALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLL-HTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLD 222 (386)
T ss_dssp HHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTC-CEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEE
T ss_pred HHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCCc-CEEECcCCCCCHhHHHHHHHHHhhcCCCccEEE
Confidence 3 3 89999999999997 4555 356678888 68999999997 2 3455889999999999
Q ss_pred CcCCccc----ccCCccccccccccceeeeeeecccc----CCCCc--ccccCCceeeccCCcccc
Q 042634 125 ISENKLS----GQIPSSIGSCIRLEQLVMNGNFFRGN----IPSSL--SSLRGIENLDLSRNNFIR 180 (427)
Q Consensus 125 l~~n~~~----~~~p~~~~~~~~l~~l~l~~n~l~~~----~p~~l--~~l~~L~~L~L~~N~ll~ 180 (427)
|++|.++ +.+|..+..+++|+.|++++|.+++. ++..+ +.+++|+.|++++|.+..
T Consensus 223 Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~ 288 (386)
T 2ca6_A 223 LQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIEL 288 (386)
T ss_dssp CCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBH
T ss_pred CcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCH
Confidence 9999996 57888999999999999999999876 45555 348999999999999865
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.75 E-value=3.7e-20 Score=179.22 Aligned_cols=179 Identities=21% Similarity=0.286 Sum_probs=149.3
Q ss_pred CeeecCCcccccCC----ccccCCCCCCEeeeecc---cceeecCcch-------hccccCCEeeeccccCcc----cCC
Q 042634 1 AFTLVGNQFTGRIP----GSIGDLHKLQRLTLEMN---KFWGEIPSSI-------GNLTLLITLNFAENMLEG----SIP 62 (427)
Q Consensus 1 ~l~l~~n~l~~~~p----~~~~~l~~L~~L~l~~n---~~~~~~p~~~-------~~l~~L~~L~l~~n~l~~----~~p 62 (427)
+|+|++|++++..+ ..+..+++|+.|+|++| ++++.+|..+ ..+++|++|+|++|.+++ .+|
T Consensus 36 ~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~ 115 (386)
T 2ca6_A 36 EIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLI 115 (386)
T ss_dssp EEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHH
T ss_pred EEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCHHHHHHHH
Confidence 48999999997744 44779999999999995 5556667665 689999999999999997 488
Q ss_pred cCccCCCCCCeEEccCccCcccCCCCcc----cc---------ccccceeeccCCcCc-CCCC---CCCcCCCCCCeEEC
Q 042634 63 SSLGKCQNLILLDLSNNNLTGTTPTEVI----GL---------SSLSIYLDLSQNQLN-GPLP---SNFGILKNLGAIDI 125 (427)
Q Consensus 63 ~~~~~l~~L~~l~l~~N~~~~~~p~~~~----~l---------~~l~~~L~l~~n~~~-~~~p---~~~~~l~~L~~l~l 125 (427)
..+..+++|++|+|++|.++...+..+. .+ ++| ++|+|++|+++ +.+| ..+..+++|+.|++
T Consensus 116 ~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L-~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L 194 (386)
T 2ca6_A 116 DFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPL-RSIICGRNRLENGSMKEWAKTFQSHRLLHTVKM 194 (386)
T ss_dssp HHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCC-CEEECCSSCCTGGGHHHHHHHHHHCTTCCEEEC
T ss_pred HHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCC-cEEECCCCCCCcHHHHHHHHHHHhCCCcCEEEC
Confidence 8899999999999999999754444333 33 788 68999999997 4555 46778999999999
Q ss_pred cCCccc--c---cCCccccccccccceeeeeeecc----ccCCCCcccccCCceeeccCCcccc
Q 042634 126 SENKLS--G---QIPSSIGSCIRLEQLVMNGNFFR----GNIPSSLSSLRGIENLDLSRNNFIR 180 (427)
Q Consensus 126 ~~n~~~--~---~~p~~~~~~~~l~~l~l~~n~l~----~~~p~~l~~l~~L~~L~L~~N~ll~ 180 (427)
++|+++ | .+|..+..+++|+.|++++|.++ +.+|..+..+++|+.|++++|.+..
T Consensus 195 ~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~ 258 (386)
T 2ca6_A 195 VQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSA 258 (386)
T ss_dssp CSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCH
T ss_pred cCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCch
Confidence 999998 3 35558899999999999999996 5678888999999999999998754
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.75 E-value=1.2e-18 Score=148.05 Aligned_cols=134 Identities=25% Similarity=0.289 Sum_probs=118.0
Q ss_pred CeeecCCccc-ccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCc
Q 042634 1 AFTLVGNQFT-GRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNN 79 (427)
Q Consensus 1 ~l~l~~n~l~-~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 79 (427)
+|+|++|+++ +.+|..+..+++|+.|+|++|.+++ + ..++.+++|++|++++|.+++.+|..+..+++|++|++++|
T Consensus 28 ~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 105 (168)
T 2ell_A 28 ELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS-V-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGN 105 (168)
T ss_dssp EEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCC-C-SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSS
T ss_pred EEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCC-h-hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCC
Confidence 4799999998 8899999999999999999999985 5 77999999999999999999768888888999999999999
Q ss_pred cCcccCC-CCccccccccceeeccCCcCcCCCC---CCCcCCCCCCeEECcCCcccccCCccc
Q 042634 80 NLTGTTP-TEVIGLSSLSIYLDLSQNQLNGPLP---SNFGILKNLGAIDISENKLSGQIPSSI 138 (427)
Q Consensus 80 ~~~~~~p-~~~~~l~~l~~~L~l~~n~~~~~~p---~~~~~l~~L~~l~l~~n~~~~~~p~~~ 138 (427)
++++..+ ..+..+++| +.|++++|++++..+ ..+..+++|+.|++++|.+. ++|.+-
T Consensus 106 ~l~~~~~~~~l~~l~~L-~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~~~ 166 (168)
T 2ell_A 106 KLKDISTLEPLKKLECL-KSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-EAPDSD 166 (168)
T ss_dssp SCCSSGGGGGGSSCSCC-CEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-BCCSSS
T ss_pred ccCcchhHHHHhcCCCC-CEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-hccccc
Confidence 9985432 678899999 689999999985443 38899999999999999988 677653
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.74 E-value=8.3e-18 Score=171.05 Aligned_cols=148 Identities=26% Similarity=0.318 Sum_probs=129.9
Q ss_pred CeeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCcc
Q 042634 1 AFTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNN 80 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~ 80 (427)
.|+|++|+|++. |+ +..+++|+.|+|++|.++ .+| .++.+++|+.|+|++|.++ .+ +.+..+++|+.|+|++|.
T Consensus 69 ~L~Ls~N~l~~~-~~-l~~l~~L~~L~Ls~N~l~-~l~-~l~~l~~L~~L~Ls~N~l~-~l-~~l~~l~~L~~L~Ls~N~ 142 (605)
T 1m9s_A 69 KLFLNGNKLTDI-KP-LTNLKNLGWLFLDENKIK-DLS-SLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNK 142 (605)
T ss_dssp EEECTTSCCCCC-GG-GGGCTTCCEEECCSSCCC-CCT-TSTTCTTCCEEECTTSCCC-CC-GGGGGCTTCSEEECCSSC
T ss_pred EEEeeCCCCCCC-hh-hccCCCCCEEECcCCCCC-CCh-hhccCCCCCEEEecCCCCC-CC-ccccCCCccCEEECCCCc
Confidence 389999999965 44 999999999999999998 455 7999999999999999999 55 468999999999999999
Q ss_pred CcccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCCC
Q 042634 81 LTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPS 160 (427)
Q Consensus 81 ~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~ 160 (427)
+++. ..+..+++| +.|+|++|++++..| +..+++|+.|+|++|++++ + ..+..+++|+.|++++|.+.+....
T Consensus 143 l~~l--~~l~~l~~L-~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~-l-~~l~~l~~L~~L~L~~N~l~~~p~~ 215 (605)
T 1m9s_A 143 ITDI--TVLSRLTKL-DTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-L-RALAGLKNLDVLELFSQECLNKPIN 215 (605)
T ss_dssp CCCC--GGGGSCTTC-SEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-C-GGGTTCTTCSEEECCSEEEECCCCC
T ss_pred cCCc--hhhcccCCC-CEEECcCCcCCCchh--hccCCCCCEEECcCCCCCC-C-hHHccCCCCCEEEccCCcCcCCccc
Confidence 9965 568899999 689999999996555 9999999999999999995 5 4689999999999999999875433
Q ss_pred C
Q 042634 161 S 161 (427)
Q Consensus 161 ~ 161 (427)
.
T Consensus 216 ~ 216 (605)
T 1m9s_A 216 H 216 (605)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.74 E-value=9.7e-20 Score=174.69 Aligned_cols=178 Identities=20% Similarity=0.244 Sum_probs=134.0
Q ss_pred eeecCCcccccCCccccCCCCCCEeeeecccceeecC----cchhccc-cCCEeeeccccCcccCCcCccCC-----CCC
Q 042634 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIP----SSIGNLT-LLITLNFAENMLEGSIPSSLGKC-----QNL 71 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p----~~~~~l~-~L~~L~l~~n~l~~~~p~~~~~l-----~~L 71 (427)
++|+.|+++|.+|..+...++|+.|+|++|.+++..+ ..+..++ +|++|+|++|.+++..+..++.+ ++|
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L 82 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence 5788899998888877777779999999999885444 5677788 89999999999987767777775 889
Q ss_pred CeEEccCccCcccCCCCcccc-----ccccceeeccCCcCcCCCCCCCc----C-CCCCCeEECcCCcccccCCc----c
Q 042634 72 ILLDLSNNNLTGTTPTEVIGL-----SSLSIYLDLSQNQLNGPLPSNFG----I-LKNLGAIDISENKLSGQIPS----S 137 (427)
Q Consensus 72 ~~l~l~~N~~~~~~p~~~~~l-----~~l~~~L~l~~n~~~~~~p~~~~----~-l~~L~~l~l~~n~~~~~~p~----~ 137 (427)
++|++++|.+++..+..+... .+| ++|+|++|++++..+..+. . .++|+.|++++|.+++..+. .
T Consensus 83 ~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L-~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 83 TSLNLSGNFLSYKSSDELVKTLAAIPFTI-TVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CEEECCSSCGGGSCHHHHHHHHHTSCTTC-CEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred cEEECcCCcCChHHHHHHHHHHHhCCCCc-cEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 999999999987666644433 677 6799999998765544433 3 36889999999988854333 3
Q ss_pred ccccc-cccceeeeeeeccccCCCCccc----c-cCCceeeccCCcccc
Q 042634 138 IGSCI-RLEQLVMNGNFFRGNIPSSLSS----L-RGIENLDLSRNNFIR 180 (427)
Q Consensus 138 ~~~~~-~l~~l~l~~n~l~~~~p~~l~~----l-~~L~~L~L~~N~ll~ 180 (427)
+..+. +|+.|++++|.+++..+..+.. + ++|+.|++++|.+..
T Consensus 162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~ 210 (362)
T 3goz_A 162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGL 210 (362)
T ss_dssp HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGG
T ss_pred HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCCh
Confidence 44454 8888999999888766554443 3 588889998888754
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.74 E-value=2.9e-19 Score=186.06 Aligned_cols=167 Identities=25% Similarity=0.272 Sum_probs=121.4
Q ss_pred CeeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCcc
Q 042634 1 AFTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNN 80 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~ 80 (427)
.|+|++|.++ .+|..+..+++|++|+|++|.|+ .+|..|++|++|++|+|++|.|+ .+|..++.+++|++|+|++|.
T Consensus 228 ~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~ 304 (727)
T 4b8c_D 228 ALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNM 304 (727)
T ss_dssp EEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSC
T ss_pred EEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCC
Confidence 3899999999 88999999999999999999999 89999999999999999999999 999999999999999999999
Q ss_pred CcccCCCCccccccccceeeccCCcCcCCCCCCCcCCCC-CCeEECcCCcccccCCccccccccccceeeeee-------
Q 042634 81 LTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKN-LGAIDISENKLSGQIPSSIGSCIRLEQLVMNGN------- 152 (427)
Q Consensus 81 ~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~-L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n------- 152 (427)
|+ .+|..+..+.+| ..|+|++|++++.+|..+..+.. +..++|++|.++|.+|..+. .|+++.|
T Consensus 305 l~-~lp~~~~~l~~L-~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~l~------~l~l~~n~~~~~~~ 376 (727)
T 4b8c_D 305 VT-TLPWEFGNLCNL-QFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHERR------FIEINTDGEPQREY 376 (727)
T ss_dssp CC-CCCSSTTSCTTC-CCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC----------------------
T ss_pred CC-ccChhhhcCCCc-cEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccccc------eeEeeccccccccc
Confidence 98 888889999999 68999999999988888766532 23478999999999887654 3455555
Q ss_pred -eccccCCCCcccccCCceeeccCCcc
Q 042634 153 -FFRGNIPSSLSSLRGIENLDLSRNNF 178 (427)
Q Consensus 153 -~l~~~~p~~l~~l~~L~~L~L~~N~l 178 (427)
.+.+..+..+..+..+....++.|.+
T Consensus 377 ~~l~~~~~~~~~~l~~~~~~~ls~Nil 403 (727)
T 4b8c_D 377 DSLQQSTEHLATDLAKRTFTVLSYNTL 403 (727)
T ss_dssp -------------------------CC
T ss_pred CCccccccchhhcccccceeeeecccc
Confidence 33333333344444444444444443
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.73 E-value=1.3e-19 Score=173.91 Aligned_cols=180 Identities=17% Similarity=0.205 Sum_probs=143.7
Q ss_pred CeeecCCcccccCC----ccccCCC-CCCEeeeecccceeecCcchhcc-----ccCCEeeeccccCcccCCcCccC---
Q 042634 1 AFTLVGNQFTGRIP----GSIGDLH-KLQRLTLEMNKFWGEIPSSIGNL-----TLLITLNFAENMLEGSIPSSLGK--- 67 (427)
Q Consensus 1 ~l~l~~n~l~~~~p----~~~~~l~-~L~~L~l~~n~~~~~~p~~~~~l-----~~L~~L~l~~n~l~~~~p~~~~~--- 67 (427)
+|||++|.+++..+ ..+..++ +|+.|+|++|.+++..+..+..+ ++|++|+|++|.+++..+..++.
T Consensus 26 ~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~ 105 (362)
T 3goz_A 26 SLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLA 105 (362)
T ss_dssp EEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHH
T ss_pred EEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHHHHHHH
Confidence 48999999997766 7788999 99999999999997767788886 99999999999999766665444
Q ss_pred -C-CCCCeEEccCccCcccCCCCccc-----cccccceeeccCCcCcCCC----CCCCcCCC-CCCeEECcCCcccccCC
Q 042634 68 -C-QNLILLDLSNNNLTGTTPTEVIG-----LSSLSIYLDLSQNQLNGPL----PSNFGILK-NLGAIDISENKLSGQIP 135 (427)
Q Consensus 68 -l-~~L~~l~l~~N~~~~~~p~~~~~-----l~~l~~~L~l~~n~~~~~~----p~~~~~l~-~L~~l~l~~n~~~~~~p 135 (427)
+ ++|++|++++|.+++..+..+.. ..+| ++|+|++|.++... +..+..++ +|+.|++++|++++..+
T Consensus 106 ~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L-~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~ 184 (362)
T 3goz_A 106 AIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASI-TSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNC 184 (362)
T ss_dssp TSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTC-CEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCH
T ss_pred hCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCce-eEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhH
Confidence 3 89999999999998766655433 2577 68999999998533 33445565 99999999999997766
Q ss_pred ccccc----c-ccccceeeeeeecccc----CCCCccc-ccCCceeeccCCccccc
Q 042634 136 SSIGS----C-IRLEQLVMNGNFFRGN----IPSSLSS-LRGIENLDLSRNNFIRH 181 (427)
Q Consensus 136 ~~~~~----~-~~l~~l~l~~n~l~~~----~p~~l~~-l~~L~~L~L~~N~ll~H 181 (427)
..++. + ++|+.|++++|.+++. ++..+.. .++|+.|++++|.+..-
T Consensus 185 ~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~ 240 (362)
T 3goz_A 185 AELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGP 240 (362)
T ss_dssp HHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCC
T ss_pred HHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcH
Confidence 65554 4 6999999999999873 3444544 35899999999987543
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.73 E-value=1.7e-17 Score=142.24 Aligned_cols=126 Identities=25% Similarity=0.261 Sum_probs=60.2
Q ss_pred eeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccC
Q 042634 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNL 81 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~ 81 (427)
+++++|+++ .+|..+ .++|+.|+|++|++++..+..++.+++|++|++++|.+++..+..+..+++|++|++++|++
T Consensus 12 l~~~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~l 88 (177)
T 2o6r_A 12 IRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKL 88 (177)
T ss_dssp EECCSSCCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EEecCCCCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCCCc
Confidence 345555555 334322 24555555555555532223345555555555555555522222344555555555555555
Q ss_pred cccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCccc
Q 042634 82 TGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLS 131 (427)
Q Consensus 82 ~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~ 131 (427)
++..+..+..+.+| +.|++++|++++..+..+..+++|+.|++++|.++
T Consensus 89 ~~~~~~~~~~l~~L-~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 137 (177)
T 2o6r_A 89 QSLPNGVFDKLTQL-KELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 137 (177)
T ss_dssp CCCCTTTTTTCTTC-CEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred cccCHHHhhCCccc-CEEECcCCcceEeCHHHhcCCcccCEEEecCCCee
Confidence 54444444445555 34555555554322233344555555555555544
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.73 E-value=1.6e-17 Score=144.59 Aligned_cols=125 Identities=25% Similarity=0.325 Sum_probs=91.2
Q ss_pred eeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccC
Q 042634 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNL 81 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~ 81 (427)
+++++|+++ .+|..+. ++|+.|+|++|+++ .+|..|.++++|++|+|++|.+++..|..|..+++|++|+|++|++
T Consensus 15 l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l 90 (193)
T 2wfh_A 15 VRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL 90 (193)
T ss_dssp EECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCcc
Confidence 567777777 5666543 57777777777776 6777777777777777777777755455677777777777777777
Q ss_pred cccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCccc
Q 042634 82 TGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLS 131 (427)
Q Consensus 82 ~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~ 131 (427)
++..|..|.++++| +.|+|++|+++...+..|..+++|+.|++++|.+.
T Consensus 91 ~~i~~~~f~~l~~L-~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 91 RCIPPRTFDGLKSL-RLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp CBCCTTTTTTCTTC-CEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred CEeCHHHhCCCCCC-CEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 76666677777777 56777777777544456777777777777777776
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.73 E-value=4e-17 Score=161.02 Aligned_cols=158 Identities=27% Similarity=0.374 Sum_probs=99.9
Q ss_pred eeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccC
Q 042634 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNL 81 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~ 81 (427)
|+|++|.+++ +|.. +++|+.|++++|+++ .+|.. .++|++|++++|.++ .+| +++.+++|++|++++|++
T Consensus 96 L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~-~l~~~---~~~L~~L~L~~n~l~-~lp-~~~~l~~L~~L~l~~N~l 165 (454)
T 1jl5_A 96 LVASCNSLTE-LPEL---PQSLKSLLVDNNNLK-ALSDL---PPLLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSL 165 (454)
T ss_dssp EECCSSCCSS-CCCC---CTTCCEEECCSSCCS-CCCSC---CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCC
T ss_pred EEccCCcCCc-cccc---cCCCcEEECCCCccC-cccCC---CCCCCEEECcCCCCC-CCc-ccCCCCCCCEEECCCCcC
Confidence 4555555554 4432 245555555555555 23321 156777777777777 466 577777777777777777
Q ss_pred cccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCCCC
Q 042634 82 TGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSS 161 (427)
Q Consensus 82 ~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~~ 161 (427)
++ +|..+ .+| ++|++++|++++ +| .++++++|+.|++++|++++ +|... .+|+.|++++|.++ .+| .
T Consensus 166 ~~-lp~~~---~~L-~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~---~~L~~L~l~~n~l~-~lp-~ 232 (454)
T 1jl5_A 166 KK-LPDLP---PSL-EFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP---LSLESIVAGNNILE-ELP-E 232 (454)
T ss_dssp SC-CCCCC---TTC-CEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC---TTCCEEECCSSCCS-SCC-C
T ss_pred cc-cCCCc---ccc-cEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc---CcccEEECcCCcCC-ccc-c
Confidence 74 55433 355 567777777764 55 57777777777777777774 55433 36677777777776 455 3
Q ss_pred cccccCCceeeccCCcccccc
Q 042634 162 LSSLRGIENLDLSRNNFIRHR 182 (427)
Q Consensus 162 l~~l~~L~~L~L~~N~ll~Hp 182 (427)
+..+++|+.|++++|++..-|
T Consensus 233 ~~~l~~L~~L~l~~N~l~~l~ 253 (454)
T 1jl5_A 233 LQNLPFLTTIYADNNLLKTLP 253 (454)
T ss_dssp CTTCTTCCEEECCSSCCSSCC
T ss_pred cCCCCCCCEEECCCCcCCccc
Confidence 667777777777777665433
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.73 E-value=2e-18 Score=143.71 Aligned_cols=128 Identities=20% Similarity=0.192 Sum_probs=95.6
Q ss_pred CCCCCEeeeecccce-eecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccCcccCCCCccccccccce
Q 042634 20 LHKLQRLTLEMNKFW-GEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIY 98 (427)
Q Consensus 20 l~~L~~L~l~~n~~~-~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~~~l~~l~~~ 98 (427)
.++|+.|++++|.++ +.+|..++.+++|++|++++|.+++ + ..++.+++|++|++++|.+++.+|..+..+++| ++
T Consensus 16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L-~~ 92 (149)
T 2je0_A 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS-I-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNL-TH 92 (149)
T ss_dssp GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCC-C-TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTC-CE
T ss_pred CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCC-c-hhhhcCCCCCEEECCCCcccchHHHHhhhCCCC-CE
Confidence 357888888888887 6778777888888888888888884 4 677788888888888888886677766667777 56
Q ss_pred eeccCCcCcCC-CCCCCcCCCCCCeEECcCCcccccCC---ccccccccccceeee
Q 042634 99 LDLSQNQLNGP-LPSNFGILKNLGAIDISENKLSGQIP---SSIGSCIRLEQLVMN 150 (427)
Q Consensus 99 L~l~~n~~~~~-~p~~~~~l~~L~~l~l~~n~~~~~~p---~~~~~~~~l~~l~l~ 150 (427)
|++++|++++. .+..++.+++|+.|++++|++++..+ ..++.+++|+.|+++
T Consensus 93 L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 93 LNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp EECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred EECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 88888887742 33677778888888888888775433 356777777777665
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=5e-19 Score=178.92 Aligned_cols=158 Identities=20% Similarity=0.211 Sum_probs=131.8
Q ss_pred ccccCCccccCCCCCCEee-eecccceeecCc------chhcc--ccCCEeeeccccCcccCCcCccCCCCCCeEEccCc
Q 042634 9 FTGRIPGSIGDLHKLQRLT-LEMNKFWGEIPS------SIGNL--TLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNN 79 (427)
Q Consensus 9 l~~~~p~~~~~l~~L~~L~-l~~n~~~~~~p~------~~~~l--~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 79 (427)
+.|.+|..++.|++|+.|+ ++.|.+. .++. .+..+ ..|+.|+|++|.++ .+|. ++.+++|++|+|++|
T Consensus 397 ~~~~~~~~l~~l~~L~~L~~l~~n~~~-~L~~l~l~~n~i~~l~~~~L~~L~Ls~n~l~-~lp~-~~~l~~L~~L~Ls~N 473 (567)
T 1dce_A 397 PLLYEKETLQYFSTLKAVDPMRAAYLD-DLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHN 473 (567)
T ss_dssp TGGGHHHHHHHHHHHHHHCGGGHHHHH-HHHHHHHHHHHHHHHHHTTCSEEECTTSCCS-SCCC-GGGGTTCCEEECCSS
T ss_pred cccCCHHHHHHHHhcccCcchhhcccc-hhhhhhhhcccccccCccCceEEEecCCCCC-CCcC-ccccccCcEeecCcc
Confidence 6778888899999999999 6777654 3432 22222 36899999999999 6886 999999999999999
Q ss_pred cCcccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccC-CccccccccccceeeeeeeccccC
Q 042634 80 NLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQI-PSSIGSCIRLEQLVMNGNFFRGNI 158 (427)
Q Consensus 80 ~~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~-p~~~~~~~~l~~l~l~~n~l~~~~ 158 (427)
.++ .+|..++++++| +.|+|++|++++ +| .++.+++|+.|+|++|++++.+ |..++.+++|+.|++++|.+++.+
T Consensus 474 ~l~-~lp~~~~~l~~L-~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 549 (567)
T 1dce_A 474 RLR-ALPPALAALRCL-EVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEE 549 (567)
T ss_dssp CCC-CCCGGGGGCTTC-CEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSS
T ss_pred ccc-ccchhhhcCCCC-CEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCc
Confidence 999 889999999999 689999999985 77 8999999999999999999766 999999999999999999999865
Q ss_pred CCC---cccccCCceeec
Q 042634 159 PSS---LSSLRGIENLDL 173 (427)
Q Consensus 159 p~~---l~~l~~L~~L~L 173 (427)
|.. +..+++|+.|++
T Consensus 550 ~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 550 GIQERLAEMLPSVSSILT 567 (567)
T ss_dssp SCTTHHHHHCTTCSEEEC
T ss_pred cHHHHHHHHCcccCccCC
Confidence 532 234778887753
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.72 E-value=8.8e-17 Score=163.79 Aligned_cols=69 Identities=25% Similarity=0.299 Sum_probs=36.0
Q ss_pred eeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccC
Q 042634 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNL 81 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~ 81 (427)
|+|++|+|+ .+|. .+++|++|+|++|+++ .+|. .+++|++|+|++|.++ .+|. .+++|++|++++|++
T Consensus 66 L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~l~~---~l~~L~~L~L~~N~l 133 (622)
T 3g06_A 66 LVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLT-HLPA---LPSGLCKLWIFGNQL 133 (622)
T ss_dssp EEECSCCCS-CCCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCC-CCCC---CCTTCCEEECCSSCC
T ss_pred EEecCCCCC-CCCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCC-CCCC---CCCCcCEEECCCCCC
Confidence 566666666 4454 4556666666666665 4554 4455555555555555 3443 233344444444444
Q ss_pred c
Q 042634 82 T 82 (427)
Q Consensus 82 ~ 82 (427)
+
T Consensus 134 ~ 134 (622)
T 3g06_A 134 T 134 (622)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.72 E-value=6.3e-17 Score=164.85 Aligned_cols=74 Identities=27% Similarity=0.329 Sum_probs=48.9
Q ss_pred ceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCCCCcccccCCceeeccCC
Q 042634 97 IYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRN 176 (427)
Q Consensus 97 ~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N 176 (427)
+.|++++|++++ +| ..+++|+.|++++|+++ .+|. .+++|+.|++++|.++ .+|..+..+++|+.|++++|
T Consensus 224 ~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N 294 (622)
T 3g06_A 224 KELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGN 294 (622)
T ss_dssp CEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSC
T ss_pred CEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCC
Confidence 345555555552 44 33456666666666666 4555 4566777777777777 56777778888888888888
Q ss_pred ccc
Q 042634 177 NFI 179 (427)
Q Consensus 177 ~ll 179 (427)
.+.
T Consensus 295 ~l~ 297 (622)
T 3g06_A 295 PLS 297 (622)
T ss_dssp CCC
T ss_pred CCC
Confidence 764
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.70 E-value=7.9e-17 Score=138.07 Aligned_cols=131 Identities=18% Similarity=0.211 Sum_probs=96.9
Q ss_pred CCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccCcccCCCCccccccccceeecc
Q 042634 23 LQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLS 102 (427)
Q Consensus 23 L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~~~l~~l~~~L~l~ 102 (427)
.+.+++++|+++ .+|..+ .++|+.|++++|.+++..+..+..+++|++|++++|++++..+..+.++.+| ++|+++
T Consensus 9 ~~~l~~~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L-~~L~l~ 84 (177)
T 2o6r_A 9 GTEIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKL-TILYLH 84 (177)
T ss_dssp TTEEECCSSCCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTC-CEEECC
T ss_pred CCEEEecCCCCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCcc-CEEECC
Confidence 567888888887 677554 3688888888888884444456778888888888888886666667777787 568888
Q ss_pred CCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeecccc
Q 042634 103 QNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGN 157 (427)
Q Consensus 103 ~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~ 157 (427)
+|++++..+..+..+++|+.|++++|++++..+..+..+++|+.|++++|.+++.
T Consensus 85 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 139 (177)
T 2o6r_A 85 ENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 139 (177)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred CCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeecc
Confidence 8888765556677888888888888888743333456777888888888877654
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.70 E-value=1.3e-17 Score=138.67 Aligned_cols=129 Identities=19% Similarity=0.163 Sum_probs=115.4
Q ss_pred ccccCCEeeeccccCc-ccCCcCccCCCCCCeEEccCccCcccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCC
Q 042634 43 NLTLLITLNFAENMLE-GSIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLG 121 (427)
Q Consensus 43 ~l~~L~~L~l~~n~l~-~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~ 121 (427)
..++|+.|++++|.++ +.+|..+..+++|++|++++|.+++. ..+..+++| ++|++++|.+++.+|..++.+++|+
T Consensus 15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L-~~L~Ls~n~i~~~~~~~~~~l~~L~ 91 (149)
T 2je0_A 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKL-KKLELSDNRVSGGLEVLAEKCPNLT 91 (149)
T ss_dssp CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTC-CEEECCSSCCCSCTHHHHHHCTTCC
T ss_pred CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCC-CEEECCCCcccchHHHHhhhCCCCC
Confidence 3578999999999999 89999999999999999999999965 678889999 6899999999977888888999999
Q ss_pred eEECcCCccccc-CCccccccccccceeeeeeeccccCC---CCcccccCCceeecc
Q 042634 122 AIDISENKLSGQ-IPSSIGSCIRLEQLVMNGNFFRGNIP---SSLSSLRGIENLDLS 174 (427)
Q Consensus 122 ~l~l~~n~~~~~-~p~~~~~~~~l~~l~l~~n~l~~~~p---~~l~~l~~L~~L~L~ 174 (427)
.|++++|++++. .|..++.+++|+.|++++|.+++..+ ..+..+++|+.|+++
T Consensus 92 ~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 92 HLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp EEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred EEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 999999999962 34889999999999999999998655 468889999999876
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.69 E-value=3.2e-17 Score=140.47 Aligned_cols=135 Identities=19% Similarity=0.162 Sum_probs=112.1
Q ss_pred ccccCCCCCCEeeeecccceeecCcchhccc-cCCEeeeccccCcccCCcCccCCCCCCeEEccCccCcccCCCCccccc
Q 042634 15 GSIGDLHKLQRLTLEMNKFWGEIPSSIGNLT-LLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLS 93 (427)
Q Consensus 15 ~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~-~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~~~l~ 93 (427)
+.+.++.+|+.|+|++|+++ .+|. +..+. +|++|++++|.+++ + +.+..+++|++|++++|++++..|..+..++
T Consensus 13 ~~~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~-~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 88 (176)
T 1a9n_A 13 AQYTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRK-L-DGFPLLRRLKTLLVNNNRICRIGEGLDQALP 88 (176)
T ss_dssp CEEECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCE-E-CCCCCCSSCCEEECCSSCCCEECSCHHHHCT
T ss_pred HhcCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCc-c-cccccCCCCCEEECCCCcccccCcchhhcCC
Confidence 45678899999999999998 5765 66665 99999999999994 4 6888999999999999999965555558888
Q ss_pred cccceeeccCCcCcCCCCC--CCcCCCCCCeEECcCCcccccCCcc----ccccccccceeeeeeeccc
Q 042634 94 SLSIYLDLSQNQLNGPLPS--NFGILKNLGAIDISENKLSGQIPSS----IGSCIRLEQLVMNGNFFRG 156 (427)
Q Consensus 94 ~l~~~L~l~~n~~~~~~p~--~~~~l~~L~~l~l~~n~~~~~~p~~----~~~~~~l~~l~l~~n~l~~ 156 (427)
+| ++|++++|+++ .+|. .+..+++|+.|++++|.++ .+|.. ++.+++|+.|+++.|....
T Consensus 89 ~L-~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~~ 154 (176)
T 1a9n_A 89 DL-TELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLKE 154 (176)
T ss_dssp TC-CEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred CC-CEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHHH
Confidence 88 67999999995 6776 7888999999999999998 67774 7888888888888887653
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.69 E-value=2e-19 Score=157.35 Aligned_cols=147 Identities=24% Similarity=0.323 Sum_probs=72.7
Q ss_pred CCCCCCEeeeecccceeecCc------chhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccCcccCCCCcccc
Q 042634 19 DLHKLQRLTLEMNKFWGEIPS------SIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGL 92 (427)
Q Consensus 19 ~l~~L~~L~l~~n~~~~~~p~------~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~~~l 92 (427)
....++.++++.|.++|.+|. .++.+++|++|++++|.++ .+| .+..+++|++|++++|.++ .+|..+..+
T Consensus 16 ~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~-~l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~ 92 (198)
T 1ds9_A 16 ERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVA 92 (198)
T ss_dssp HTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEES-CCC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHH
T ss_pred hcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCc-ccc-ccccCCCCCEEECCCCCcc-cccchhhcC
Confidence 334444455555555444444 4555555555555555555 244 4455555555555555554 344444444
Q ss_pred ccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCC--ccccccccccceeeeeeeccccCCCC---------
Q 042634 93 SSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIP--SSIGSCIRLEQLVMNGNFFRGNIPSS--------- 161 (427)
Q Consensus 93 ~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p--~~~~~~~~l~~l~l~~n~l~~~~p~~--------- 161 (427)
++| +.|++++|++++ +| .++.+++|+.|++++|++++ +| ..+..+++|+.|++++|.+++..|..
T Consensus 93 ~~L-~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~-~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~ 168 (198)
T 1ds9_A 93 DTL-EELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITN-WGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIE 168 (198)
T ss_dssp HHC-SEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCC-HHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHH
T ss_pred CcC-CEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCc-hhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHH
Confidence 444 345555555542 33 34455555555555555552 22 24455555555555555555443332
Q ss_pred -cccccCCceee
Q 042634 162 -LSSLRGIENLD 172 (427)
Q Consensus 162 -l~~l~~L~~L~ 172 (427)
+..+++|+.|+
T Consensus 169 ~~~~l~~L~~Ld 180 (198)
T 1ds9_A 169 VVKRLPNLKKLD 180 (198)
T ss_dssp HHHHCSSCSEEC
T ss_pred HHHhCCCcEEEC
Confidence 44555555554
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.65 E-value=8.4e-19 Score=153.38 Aligned_cols=145 Identities=20% Similarity=0.246 Sum_probs=125.6
Q ss_pred eeecCCcccccCCc------cccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEE
Q 042634 2 FTLVGNQFTGRIPG------SIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLD 75 (427)
Q Consensus 2 l~l~~n~l~~~~p~------~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~ 75 (427)
+++++|.++|.+|. .+..+++|++|+|++|.+++ +| .++++++|++|++++|.++ .+|..+..+++|++|+
T Consensus 23 l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~ 99 (198)
T 1ds9_A 23 TEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELW 99 (198)
T ss_dssp TTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEE
T ss_pred cchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEE
Confidence 57888999999887 89999999999999999984 88 8999999999999999999 8998888889999999
Q ss_pred ccCccCcccCCCCccccccccceeeccCCcCcCCCC--CCCcCCCCCCeEECcCCcccccCCcc----------cccccc
Q 042634 76 LSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLP--SNFGILKNLGAIDISENKLSGQIPSS----------IGSCIR 143 (427)
Q Consensus 76 l~~N~~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p--~~~~~l~~L~~l~l~~n~~~~~~p~~----------~~~~~~ 143 (427)
+++|++++ +| .+..+++| +.|++++|++++ +| ..+..+++|+.|++++|.+++.+|.. +..+++
T Consensus 100 L~~N~l~~-l~-~~~~l~~L-~~L~l~~N~i~~-~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~ 175 (198)
T 1ds9_A 100 ISYNQIAS-LS-GIEKLVNL-RVLYMSNNKITN-WGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPN 175 (198)
T ss_dssp EEEEECCC-HH-HHHHHHHS-SEEEESEEECCC-HHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSS
T ss_pred CcCCcCCc-CC-ccccCCCC-CEEECCCCcCCc-hhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCC
Confidence 99999985 55 57888899 689999999974 44 47889999999999999998776653 788899
Q ss_pred ccceeeeeeecc
Q 042634 144 LEQLVMNGNFFR 155 (427)
Q Consensus 144 l~~l~l~~n~l~ 155 (427)
|+.|+ +|.++
T Consensus 176 L~~Ld--~~~i~ 185 (198)
T 1ds9_A 176 LKKLD--GMPVD 185 (198)
T ss_dssp CSEEC--CGGGT
T ss_pred cEEEC--CcccC
Confidence 99876 66665
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.65 E-value=3.2e-16 Score=149.37 Aligned_cols=170 Identities=18% Similarity=0.176 Sum_probs=133.6
Q ss_pred CeeecCCcccccCCc-cccCCCCCCE-eeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccC
Q 042634 1 AFTLVGNQFTGRIPG-SIGDLHKLQR-LTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSN 78 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~-~~~~l~~L~~-L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~ 78 (427)
+|+|++|++.+.+|. .|.++++|+. ++++.|++++..|..|..+++|++|++++|.+++..+..+....++..|++++
T Consensus 58 ~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~ 137 (350)
T 4ay9_X 58 KIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQD 137 (350)
T ss_dssp EEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEES
T ss_pred EEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhcc
Confidence 489999999877774 5788998775 66778999965577899999999999999999954445566777889999965
Q ss_pred -ccCcccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcC-CcccccCCc-cccccccccceeeeeeecc
Q 042634 79 -NNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISE-NKLSGQIPS-SIGSCIRLEQLVMNGNFFR 155 (427)
Q Consensus 79 -N~~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~-n~~~~~~p~-~~~~~~~l~~l~l~~n~l~ 155 (427)
|++....+..+..+....+.|+|++|+++ .+|..+....+|+.|++++ |.++ .+|. .|.++++|+.|++++|+++
T Consensus 138 ~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~-~i~~~~f~~~~L~~l~l~~~n~l~-~i~~~~f~~l~~L~~LdLs~N~l~ 215 (350)
T 4ay9_X 138 NINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIH 215 (350)
T ss_dssp CTTCCEECTTSSTTSBSSCEEEECCSSCCC-EECTTSSTTEEEEEEECTTCTTCC-CCCTTTTTTEECCSEEECTTSCCC
T ss_pred ccccccccccchhhcchhhhhhcccccccc-CCChhhccccchhHHhhccCCccc-CCCHHHhccCcccchhhcCCCCcC
Confidence 67775555667777654367999999998 6777766778899999985 6666 6775 6789999999999999999
Q ss_pred ccCCCCcccccCCceee
Q 042634 156 GNIPSSLSSLRGIENLD 172 (427)
Q Consensus 156 ~~~p~~l~~l~~L~~L~ 172 (427)
...+..+.+++.|+.++
T Consensus 216 ~lp~~~~~~L~~L~~l~ 232 (350)
T 4ay9_X 216 SLPSYGLENLKKLRARS 232 (350)
T ss_dssp CCCSSSCTTCCEEECTT
T ss_pred ccChhhhccchHhhhcc
Confidence 76555556555555443
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.63 E-value=2.5e-18 Score=170.17 Aligned_cols=176 Identities=16% Similarity=0.081 Sum_probs=93.0
Q ss_pred eeecCCcccccCCccccC-----CCCCCEeeeecccceee----cCcchhccccCCEeeeccccCcccC-----CcCccC
Q 042634 2 FTLVGNQFTGRIPGSIGD-----LHKLQRLTLEMNKFWGE----IPSSIGNLTLLITLNFAENMLEGSI-----PSSLGK 67 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~-----l~~L~~L~l~~n~~~~~----~p~~~~~l~~L~~L~l~~n~l~~~~-----p~~~~~ 67 (427)
|+|++|.+++..+..+.. +++|+.|+|++|.+++. +|..+..+++|+.|++++|.+++.. +..+..
T Consensus 175 L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~ 254 (461)
T 1z7x_W 175 LTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHP 254 (461)
T ss_dssp EECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTST
T ss_pred EECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcC
Confidence 566666666544433332 45666666666666532 4555666666666666666666321 111223
Q ss_pred CCCCCeEEccCccCccc----CCCCccccccccceeeccCCcCcCCCCCCCcC-----CCCCCeEECcCCccccc----C
Q 042634 68 CQNLILLDLSNNNLTGT----TPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGI-----LKNLGAIDISENKLSGQ----I 134 (427)
Q Consensus 68 l~~L~~l~l~~N~~~~~----~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~-----l~~L~~l~l~~n~~~~~----~ 134 (427)
+++|++|++++|.++.. ++..+..+++| ++|++++|.+++..+..+.. .++|+.|++++|.+++. +
T Consensus 255 ~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L-~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l 333 (461)
T 1z7x_W 255 SSRLRTLWIWECGITAKGCGDLCRVLRAKESL-KELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHF 333 (461)
T ss_dssp TCCCCEEECTTSCCCHHHHHHHHHHHHHCTTC-CEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred CCCceEEECcCCCCCHHHHHHHHHHHhhCCCc-ceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHH
Confidence 55666666666666543 44445555566 45666666664322222221 24566666666655543 3
Q ss_pred CccccccccccceeeeeeeccccCCCCccc-----ccCCceeeccCCcc
Q 042634 135 PSSIGSCIRLEQLVMNGNFFRGNIPSSLSS-----LRGIENLDLSRNNF 178 (427)
Q Consensus 135 p~~~~~~~~l~~l~l~~n~l~~~~p~~l~~-----l~~L~~L~L~~N~l 178 (427)
|..+..+++|+.|++++|.+++..+..+.. .++|+.|++++|.+
T Consensus 334 ~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i 382 (461)
T 1z7x_W 334 SSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDV 382 (461)
T ss_dssp HHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCC
T ss_pred HHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCC
Confidence 344445556666666666555443333321 34555556555554
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.61 E-value=1.1e-16 Score=147.76 Aligned_cols=92 Identities=20% Similarity=0.131 Sum_probs=74.2
Q ss_pred CccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccccCCceeeCCCCceEecccc
Q 042634 200 DSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFG 279 (427)
Q Consensus 200 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG 279 (427)
...++||||+++|+|.+ +... ....++.|++.||+||| +.||+||||||+|||++ ++.+||+|||
T Consensus 173 ~~~~lvmE~~~g~~L~~-l~~~----------~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~-~~~vkl~DFG 237 (282)
T 1zar_A 173 EGNAVLMELIDAKELYR-VRVE----------NPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS-EEGIWIIDFP 237 (282)
T ss_dssp ETTEEEEECCCCEEGGG-CCCS----------CHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE-TTEEEECCCT
T ss_pred cceEEEEEecCCCcHHH-cchh----------hHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE-CCcEEEEECC
Confidence 45699999999999988 4321 23469999999999999 89999999999999999 9999999999
Q ss_pred cccccCCcCCCccccccccccCC----------CCcCccccchh
Q 042634 280 LAKFLPEATNNFFNFQIAEYGMG----------SEVSTSGDVYS 313 (427)
Q Consensus 280 ~a~~~~~~~~~~~~y~aPE~~~~----------~~~~~~~DiwS 313 (427)
+|+.. ..++|||++.. ..+..++|+|+
T Consensus 238 ~a~~~-------~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 238 QSVEV-------GEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp TCEET-------TSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred CCeEC-------CCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 99753 34788988743 33455566654
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.60 E-value=1.4e-17 Score=164.82 Aligned_cols=177 Identities=18% Similarity=0.165 Sum_probs=98.9
Q ss_pred eeecCCcccccCCcccc-CCC----CCCEeeeeccccee----ecCcchhccccCCEeeeccccCcccCCcCccC-----
Q 042634 2 FTLVGNQFTGRIPGSIG-DLH----KLQRLTLEMNKFWG----EIPSSIGNLTLLITLNFAENMLEGSIPSSLGK----- 67 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~-~l~----~L~~L~l~~n~~~~----~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~----- 67 (427)
|+|++|.+++..+..+. .+. +|++|+|++|.++. .+|..+..+++|++|+|++|.+++..+..+..
T Consensus 61 L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~ 140 (461)
T 1z7x_W 61 LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDP 140 (461)
T ss_dssp EECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTST
T ss_pred EeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcC
Confidence 56777777654443332 344 57777777777662 45666677777777777777766443333222
Q ss_pred CCCCCeEEccCccCcccC----CCCccccccccceeeccCCcCcCCCCCCCc-----CCCCCCeEECcCCccccc----C
Q 042634 68 CQNLILLDLSNNNLTGTT----PTEVIGLSSLSIYLDLSQNQLNGPLPSNFG-----ILKNLGAIDISENKLSGQ----I 134 (427)
Q Consensus 68 l~~L~~l~l~~N~~~~~~----p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~-----~l~~L~~l~l~~n~~~~~----~ 134 (427)
.++|++|++++|.+++.. +..+..+++| ++|++++|.++...+..+. .+++|+.|++++|.+++. +
T Consensus 141 ~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L-~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l 219 (461)
T 1z7x_W 141 QCRLEKLQLEYCSLSAASCEPLASVLRAKPDF-KELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDL 219 (461)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHHHHCTTC-CEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHH
T ss_pred CCcceEEECCCCCCCHHHHHHHHHHHhhCCCC-CEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHH
Confidence 345777777777666432 3344445666 4566666666533222222 244666666666666642 3
Q ss_pred CccccccccccceeeeeeeccccCC-----CCcccccCCceeeccCCccc
Q 042634 135 PSSIGSCIRLEQLVMNGNFFRGNIP-----SSLSSLRGIENLDLSRNNFI 179 (427)
Q Consensus 135 p~~~~~~~~l~~l~l~~n~l~~~~p-----~~l~~l~~L~~L~L~~N~ll 179 (427)
+..+..+++|+.|++++|.+++... ..+..+++|+.|++++|.+.
T Consensus 220 ~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~ 269 (461)
T 1z7x_W 220 CGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGIT 269 (461)
T ss_dssp HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCC
T ss_pred HHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCC
Confidence 5555566666666666666554321 11123556666666666543
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.60 E-value=6.5e-16 Score=132.24 Aligned_cols=143 Identities=16% Similarity=0.133 Sum_probs=117.7
Q ss_pred eecccceeecCcchhccccCCEeeeccccCcccCCcCccCCC-CCCeEEccCccCcccCCCCccccccccceeeccCCcC
Q 042634 28 LEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQ-NLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQL 106 (427)
Q Consensus 28 l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~-~L~~l~l~~N~~~~~~p~~~~~l~~l~~~L~l~~n~~ 106 (427)
++.+.+. . ...+..+++|+.|++++|.++ .+|. +..+. +|++|++++|.+++. ..+..+++| ++|++++|++
T Consensus 4 lt~~~i~-~-~~~~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L-~~L~Ls~N~l 76 (176)
T 1a9n_A 4 LTAELIE-Q-AAQYTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRL-KTLLVNNNRI 76 (176)
T ss_dssp CCHHHHH-T-SCEEECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSC-CEEECCSSCC
T ss_pred ccHHHHH-H-HHhcCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCC-CEEECCCCcc
Confidence 3444444 2 234778999999999999999 7764 55655 999999999999965 578889999 6899999999
Q ss_pred cCCCCCCCcCCCCCCeEECcCCcccccCCc--cccccccccceeeeeeeccccCCCC----cccccCCceeeccCCccc
Q 042634 107 NGPLPSNFGILKNLGAIDISENKLSGQIPS--SIGSCIRLEQLVMNGNFFRGNIPSS----LSSLRGIENLDLSRNNFI 179 (427)
Q Consensus 107 ~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~--~~~~~~~l~~l~l~~n~l~~~~p~~----l~~l~~L~~L~L~~N~ll 179 (427)
++..|..++.+++|+.|++++|+++ .+|. .++.+++|+.|++++|.++. +|.. +..+++|+.++++.|...
T Consensus 77 ~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 77 CRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETTEECCHH
T ss_pred cccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCCC-cHhHHHHHHHHCCccceeCCCcCCHH
Confidence 8543344599999999999999997 6787 88999999999999999985 5664 889999999999887753
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.60 E-value=2.7e-15 Score=127.61 Aligned_cols=107 Identities=25% Similarity=0.243 Sum_probs=89.5
Q ss_pred CCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccCcccCCCCccccccccceeec
Q 042634 22 KLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDL 101 (427)
Q Consensus 22 ~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~~~l~~l~~~L~l 101 (427)
..+.|++++|.++ .+|..+. ++|++|+|++|.+++..|..+..+++|++|+|++|++++..+..|.++++| ++|+|
T Consensus 10 ~~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L-~~L~L 85 (170)
T 3g39_A 10 SGTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQL-TQLSL 85 (170)
T ss_dssp ETTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTC-CEEEC
T ss_pred CCCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCC-CEEEC
Confidence 3578899999988 6887763 888999999999996667778889999999999999987666677888888 67999
Q ss_pred cCCcCcCCCCCCCcCCCCCCeEECcCCcccc
Q 042634 102 SQNQLNGPLPSNFGILKNLGAIDISENKLSG 132 (427)
Q Consensus 102 ~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~ 132 (427)
++|++++..+..+..+++|+.|+|++|+++.
T Consensus 86 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 116 (170)
T 3g39_A 86 NDNQLKSIPRGAFDNLKSLTHIWLLNNPWDC 116 (170)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCBCT
T ss_pred CCCccCEeCHHHhcCCCCCCEEEeCCCCCCC
Confidence 9999986556678999999999999999884
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.59 E-value=3.4e-15 Score=127.44 Aligned_cols=104 Identities=24% Similarity=0.240 Sum_probs=72.5
Q ss_pred CEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccCcccCCCCccccccccceeeccC
Q 042634 24 QRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQ 103 (427)
Q Consensus 24 ~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~~~l~~l~~~L~l~~ 103 (427)
+.+++++|.++ .+|..+. ++|++|+|++|++++..|..+..+++|++|+|++|+|++..+..|.++.+| +.|+|++
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L-~~L~L~~ 90 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQL-TQLDLND 90 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTC-CEEECCS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchh-hEEECCC
Confidence 67777777775 6776664 677777777777775556667777777777777777775554555667777 5677777
Q ss_pred CcCcCCCCCCCcCCCCCCeEECcCCccc
Q 042634 104 NQLNGPLPSNFGILKNLGAIDISENKLS 131 (427)
Q Consensus 104 n~~~~~~p~~~~~l~~L~~l~l~~n~~~ 131 (427)
|++++..+..+..+++|+.|+|++|++.
T Consensus 91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 91 NHLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred CccceeCHHHhccccCCCEEEeCCCCcc
Confidence 7776443444777777777777777776
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.59 E-value=4.5e-15 Score=126.23 Aligned_cols=108 Identities=22% Similarity=0.266 Sum_probs=84.9
Q ss_pred cCCEeeeccccCcccCCcCccCCCCCCeEEccCccCcccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEEC
Q 042634 46 LLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDI 125 (427)
Q Consensus 46 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l 125 (427)
..+.|++++|.++ .+|..+. ++|++|++++|++++..|..+.++.+| ++|+|++|++++..+..|..+++|+.|+|
T Consensus 10 ~~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L-~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L 85 (170)
T 3g39_A 10 SGTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQL-TRLDLDNNQLTVLPAGVFDKLTQLTQLSL 85 (170)
T ss_dssp ETTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTC-SEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccC-CEEECCCCCcCccChhhccCCCCCCEEEC
Confidence 4578888888888 7887664 778888888888887777778888888 57888888888655566788888888888
Q ss_pred cCCcccccCCccccccccccceeeeeeecccc
Q 042634 126 SENKLSGQIPSSIGSCIRLEQLVMNGNFFRGN 157 (427)
Q Consensus 126 ~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~ 157 (427)
++|++++..|..+..+++|+.|++++|.++..
T Consensus 86 ~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 117 (170)
T 3g39_A 86 NDNQLKSIPRGAFDNLKSLTHIWLLNNPWDCA 117 (170)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCBCTT
T ss_pred CCCccCEeCHHHhcCCCCCCEEEeCCCCCCCC
Confidence 88888854445678888888888888888753
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.59 E-value=4e-15 Score=126.98 Aligned_cols=102 Identities=27% Similarity=0.331 Sum_probs=91.0
Q ss_pred CeeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcC-ccCCCCCCeEEccCc
Q 042634 1 AFTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSS-LGKCQNLILLDLSNN 79 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~-~~~l~~L~~l~l~~N 79 (427)
.+++++|+++ .+|..+. ++|+.|+|++|++++..|..|+++++|++|+|++|+|+ .+|+. +..+++|++|+|++|
T Consensus 16 ~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 16 LVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSS
T ss_pred EEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCC-ccChhHhCCcchhhEEECCCC
Confidence 3789999998 7888775 89999999999999766888999999999999999999 56655 689999999999999
Q ss_pred cCcccCCCCccccccccceeeccCCcCc
Q 042634 80 NLTGTTPTEVIGLSSLSIYLDLSQNQLN 107 (427)
Q Consensus 80 ~~~~~~p~~~~~l~~l~~~L~l~~n~~~ 107 (427)
++++..+..+..+++| +.|+|++|++.
T Consensus 92 ~l~~l~~~~~~~l~~L-~~L~L~~N~~~ 118 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSL-THIYLYNNPWD 118 (174)
T ss_dssp CCCCCCTTTTTTCTTC-SEEECCSSCBC
T ss_pred ccceeCHHHhccccCC-CEEEeCCCCcc
Confidence 9996666668999999 68999999997
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.49 E-value=7.9e-14 Score=132.57 Aligned_cols=101 Identities=24% Similarity=0.197 Sum_probs=53.2
Q ss_pred eeecCC-cccccCCccccCCCCCCEeeeec-ccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCc
Q 042634 2 FTLVGN-QFTGRIPGSIGDLHKLQRLTLEM-NKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNN 79 (427)
Q Consensus 2 l~l~~n-~l~~~~p~~~~~l~~L~~L~l~~-n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 79 (427)
++++++ +|+ .+|. +..+++|+.|+|++ |++++..|..|++|++|+.|+|++|+|++..|..|.++++|++|+|++|
T Consensus 13 v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 90 (347)
T 2ifg_A 13 LRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90 (347)
T ss_dssp EECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred EEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence 455555 555 3455 56666666666654 6665433345566666666666666666544445555666666666666
Q ss_pred cCcccCCCCccccccccceeeccCCcC
Q 042634 80 NLTGTTPTEVIGLSSLSIYLDLSQNQL 106 (427)
Q Consensus 80 ~~~~~~p~~~~~l~~l~~~L~l~~n~~ 106 (427)
+|++.++..+..+. | +.|+|.+|++
T Consensus 91 ~l~~~~~~~~~~~~-L-~~l~l~~N~~ 115 (347)
T 2ifg_A 91 ALESLSWKTVQGLS-L-QELVLSGNPL 115 (347)
T ss_dssp CCSCCCSTTTCSCC-C-CEEECCSSCC
T ss_pred ccceeCHHHcccCC-c-eEEEeeCCCc
Confidence 66533333332222 3 3444444444
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.45 E-value=3.7e-13 Score=127.03 Aligned_cols=155 Identities=14% Similarity=0.131 Sum_probs=98.9
Q ss_pred CCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccC----cccCCCCc------
Q 042634 20 LHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNL----TGTTPTEV------ 89 (427)
Q Consensus 20 l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~----~~~~p~~~------ 89 (427)
+++|+.|+|+. +++..-+..|.+|++|+.|++++|.++...+.+|.++.++.++.+..+.. ...-...|
T Consensus 100 ~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L 178 (329)
T 3sb4_A 100 KQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPL 178 (329)
T ss_dssp CTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCC
T ss_pred cCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccccccccccccc
Confidence 89999999988 77733335688999999999999988733334465555555555444211 00000000
Q ss_pred --------------------------------------------cccccccceeeccCCcCcCCCCCCCcCCCCCCeEEC
Q 042634 90 --------------------------------------------IGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDI 125 (427)
Q Consensus 90 --------------------------------------------~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l 125 (427)
..+.+| +.++|++|+++...+..|.+|++|+.+++
T Consensus 179 ~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L-~~l~L~~n~i~~I~~~aF~~~~~L~~l~l 257 (329)
T 3sb4_A 179 ETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNL-VSLDISKTNATTIPDFTFAQKKYLLKIKL 257 (329)
T ss_dssp EEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTC-CEEECTTBCCCEECTTTTTTCTTCCEEEC
T ss_pred ceeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCC-eEEECCCCCcceecHhhhhCCCCCCEEEC
Confidence 014566 56777777776444456777777888877
Q ss_pred cCCcccccCCcccccccccc-ceeeeeeeccccCCCCcccccCCceeeccCCcc
Q 042634 126 SENKLSGQIPSSIGSCIRLE-QLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178 (427)
Q Consensus 126 ~~n~~~~~~p~~~~~~~~l~-~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l 178 (427)
++| ++..-+.+|.+|.+|+ .+.+.+ .++...+.+|.++++|+.++++.|.+
T Consensus 258 ~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i 309 (329)
T 3sb4_A 258 PHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKI 309 (329)
T ss_dssp CTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCC
T ss_pred Ccc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCcc
Confidence 777 5533344677777777 777777 56655567777777777777766554
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.41 E-value=3.9e-13 Score=127.74 Aligned_cols=105 Identities=19% Similarity=0.092 Sum_probs=90.7
Q ss_pred CEeeeecc-cceeecCcchhccccCCEeeecc-ccCcccCCcCccCCCCCCeEEccCccCcccCCCCccccccccceeec
Q 042634 24 QRLTLEMN-KFWGEIPSSIGNLTLLITLNFAE-NMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDL 101 (427)
Q Consensus 24 ~~L~l~~n-~~~~~~p~~~~~l~~L~~L~l~~-n~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~~~l~~l~~~L~l 101 (427)
..++++++ .++ .+|. |+.+++|+.|+|++ |.|++..|..|+.+++|++|+|++|+|++..|..|.++++| +.|+|
T Consensus 11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L-~~L~l 87 (347)
T 2ifg_A 11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL-SRLNL 87 (347)
T ss_dssp SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCC-CEEEC
T ss_pred CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCC-CEEeC
Confidence 45788988 898 6999 99999999999996 99996655789999999999999999999998889999999 68999
Q ss_pred cCCcCcCCCCCCCcCCCCCCeEECcCCcccc
Q 042634 102 SQNQLNGPLPSNFGILKNLGAIDISENKLSG 132 (427)
Q Consensus 102 ~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~ 132 (427)
++|+|++..+..+..++ |+.|+|.+|.+..
T Consensus 88 ~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 88 SFNALESLSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp CSSCCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred CCCccceeCHHHcccCC-ceEEEeeCCCccC
Confidence 99999854445566555 9999999999873
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.34 E-value=5.9e-12 Score=118.69 Aligned_cols=152 Identities=17% Similarity=0.254 Sum_probs=114.8
Q ss_pred CCCCCEeeeecccce--e-----------------ecC-cchhc--------cccCCEeeeccccCcccCCcCccCCCCC
Q 042634 20 LHKLQRLTLEMNKFW--G-----------------EIP-SSIGN--------LTLLITLNFAENMLEGSIPSSLGKCQNL 71 (427)
Q Consensus 20 l~~L~~L~l~~n~~~--~-----------------~~p-~~~~~--------l~~L~~L~l~~n~l~~~~p~~~~~l~~L 71 (427)
+++|+.|||++|++. . .+| ..|.+ |++|+.|+|++ .++..-+.+|.+|++|
T Consensus 48 l~~L~~LdLs~n~i~~~~~~~~~~~~~~~~~~~~~~I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L 126 (329)
T 3sb4_A 48 FPSLKVLDISNAEIKMYSGKAGTYPNGKFYIYMANFVPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNL 126 (329)
T ss_dssp CTTCCEEEEEEEEECCEEESSSSSGGGCCEEECTTEECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTC
T ss_pred hccCeEEecCcceeEEecCccccccccccccccccccCHHHhcccccccccccCCCcEEECCc-cccchhHHHhhcCccc
Confidence 788999999999987 1 233 35667 99999999999 8883334568899999
Q ss_pred CeEEccCccCcccCCCCccccccccceeeccCCcC----cCCCCCCC---------------------------------
Q 042634 72 ILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQL----NGPLPSNF--------------------------------- 114 (427)
Q Consensus 72 ~~l~l~~N~~~~~~p~~~~~l~~l~~~L~l~~n~~----~~~~p~~~--------------------------------- 114 (427)
++|++++|.++...+..|.++.++ ..+.+..+.. ...-...|
T Consensus 127 ~~l~l~~n~i~~i~~~aF~~~~~l-~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~ 205 (329)
T 3sb4_A 127 KICQIRKKTAPNLLPEALADSVTA-IFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKAGLQPRDIN 205 (329)
T ss_dssp CEEEBCCSSCCEECTTSSCTTTCE-EEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTCCHHHHHHHTTCCGGGCS
T ss_pred ceEEcCCCCccccchhhhcCCCce-EEecCcchhhhhccccccccccccccccceeEEecCCCcHHHHHhhcccCccccc
Confidence 999999999987777788887766 4455444211 00000000
Q ss_pred -----------------cCCCCCCeEECcCCcccccCCc-cccccccccceeeeeeeccccCCCCcccccCCc-eeeccC
Q 042634 115 -----------------GILKNLGAIDISENKLSGQIPS-SIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIE-NLDLSR 175 (427)
Q Consensus 115 -----------------~~l~~L~~l~l~~n~~~~~~p~-~~~~~~~l~~l~l~~n~l~~~~p~~l~~l~~L~-~L~L~~ 175 (427)
..+++|+.+++++|.++ .||. +|.+|.+|+.+++.+| ++...+.+|.++.+|+ .+.+..
T Consensus 206 ~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~-~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~ 283 (329)
T 3sb4_A 206 FLTIEGKLDNADFKLIRDYMPNLVSLDISKTNAT-TIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA 283 (329)
T ss_dssp EEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCC-EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT
T ss_pred eEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcc-eecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc
Confidence 13789999999999999 4554 7899999999999998 7777778899999999 998875
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.32 E-value=1.3e-14 Score=139.05 Aligned_cols=160 Identities=17% Similarity=0.132 Sum_probs=109.6
Q ss_pred CCCCCEeeeecccceeecCcchhcc-----ccCCEeeeccccCcccCCcCcc-CCCCCCeEEccCccCcccCCCCcc---
Q 042634 20 LHKLQRLTLEMNKFWGEIPSSIGNL-----TLLITLNFAENMLEGSIPSSLG-KCQNLILLDLSNNNLTGTTPTEVI--- 90 (427)
Q Consensus 20 l~~L~~L~l~~n~~~~~~p~~~~~l-----~~L~~L~l~~n~l~~~~p~~~~-~l~~L~~l~l~~N~~~~~~p~~~~--- 90 (427)
+++|+.|+|++|.++..-...+..+ ++|+.|+|++|.++......+. .+++|++|+|++|.++......+.
T Consensus 71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L 150 (372)
T 3un9_A 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL 150 (372)
T ss_dssp HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence 4578888888888875434444443 6888888888888754333333 356788888888888644333332
Q ss_pred --ccccccceeeccCCcCcC----CCCCCCcCCCCCCeEECcCCccccc----CCccccccccccceeeeeeecccc---
Q 042634 91 --GLSSLSIYLDLSQNQLNG----PLPSNFGILKNLGAIDISENKLSGQ----IPSSIGSCIRLEQLVMNGNFFRGN--- 157 (427)
Q Consensus 91 --~l~~l~~~L~l~~n~~~~----~~p~~~~~l~~L~~l~l~~n~~~~~----~p~~~~~~~~l~~l~l~~n~l~~~--- 157 (427)
...+| ++|+|++|.++. .++..+..+++|+.|+|++|.++.. ++..+..+++|+.|++++|.++..
T Consensus 151 ~~~~~~L-~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~ 229 (372)
T 3un9_A 151 LHDQCQI-TTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAAL 229 (372)
T ss_dssp HSTTCCC-CEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHH
T ss_pred HhcCCcc-ceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHH
Confidence 24566 578888888863 2344456778888999999888742 345566777888999999888753
Q ss_pred -CCCCcccccCCceeeccCCcccc
Q 042634 158 -IPSSLSSLRGIENLDLSRNNFIR 180 (427)
Q Consensus 158 -~p~~l~~l~~L~~L~L~~N~ll~ 180 (427)
++..+...++|+.|++++|.+..
T Consensus 230 ~l~~~L~~~~~L~~L~Ls~N~i~~ 253 (372)
T 3un9_A 230 ALARAAREHPSLELLHLYFNELSS 253 (372)
T ss_dssp HHHHHHHHCSSCCEEECTTSSCCH
T ss_pred HHHHHHHhCCCCCEEeccCCCCCH
Confidence 23344556788999999888643
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.30 E-value=1.9e-14 Score=137.91 Aligned_cols=161 Identities=19% Similarity=0.149 Sum_probs=118.2
Q ss_pred CeeecCCcccccCCccccCC-----CCCCEeeeecccceeecCcch-hccccCCEeeeccccCcccCCcCc-----cCCC
Q 042634 1 AFTLVGNQFTGRIPGSIGDL-----HKLQRLTLEMNKFWGEIPSSI-GNLTLLITLNFAENMLEGSIPSSL-----GKCQ 69 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~~~l-----~~L~~L~l~~n~~~~~~p~~~-~~l~~L~~L~l~~n~l~~~~p~~~-----~~l~ 69 (427)
+|+|++|.++..-...+... ++|+.|+|++|.++..-...+ ..+++|+.|+|++|.++......+ ...+
T Consensus 76 ~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~ 155 (372)
T 3un9_A 76 QLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQC 155 (372)
T ss_dssp EEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTC
T ss_pred EEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCC
Confidence 37899999986544444333 699999999999974433333 457889999999999985444444 2457
Q ss_pred CCCeEEccCccCccc----CCCCccccccccceeeccCCcCcC----CCCCCCcCCCCCCeEECcCCccccc----CCcc
Q 042634 70 NLILLDLSNNNLTGT----TPTEVIGLSSLSIYLDLSQNQLNG----PLPSNFGILKNLGAIDISENKLSGQ----IPSS 137 (427)
Q Consensus 70 ~L~~l~l~~N~~~~~----~p~~~~~l~~l~~~L~l~~n~~~~----~~p~~~~~l~~L~~l~l~~n~~~~~----~p~~ 137 (427)
+|++|+|++|.++.. ++..+...++| ++|+|++|.++. .++..+..+++|+.|+|++|.++.. ++..
T Consensus 156 ~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L-~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~ 234 (372)
T 3un9_A 156 QITTLRLSNNPLTAAGVAVLMEGLAGNTSV-THLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARA 234 (372)
T ss_dssp CCCEEECCSSCCHHHHHHHHHHHHHTCSSC-CEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHH
T ss_pred ccceeeCCCCCCChHHHHHHHHHHhcCCCc-CEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHH
Confidence 899999999999742 33344667788 689999999974 2355667788999999999999853 3344
Q ss_pred ccccccccceeeeeeeccccCCCCc
Q 042634 138 IGSCIRLEQLVMNGNFFRGNIPSSL 162 (427)
Q Consensus 138 ~~~~~~l~~l~l~~n~l~~~~p~~l 162 (427)
+..+++|+.|++++|.++......+
T Consensus 235 L~~~~~L~~L~Ls~N~i~~~g~~~L 259 (372)
T 3un9_A 235 AREHPSLELLHLYFNELSSEGRQVL 259 (372)
T ss_dssp HHHCSSCCEEECTTSSCCHHHHHHH
T ss_pred HHhCCCCCEEeccCCCCCHHHHHHH
Confidence 5567899999999999886543333
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.29 E-value=1.8e-12 Score=117.80 Aligned_cols=77 Identities=26% Similarity=0.258 Sum_probs=58.6
Q ss_pred ccceeeeeecC-CCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccccCCceeeCCCCceEecccc
Q 042634 201 SEALVYEFMVN-GSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFG 279 (427)
Q Consensus 201 ~~~lv~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG 279 (427)
..++||||+.+ |.+...+.... ...++..+..++.|++.||.|||. +.||+||||||+|||++. .+||+|||
T Consensus 142 ~~~lVmE~~g~~g~~~~~L~~~~---~~~~~~~~~~i~~qi~~~l~~lH~--~~givHrDlkp~NILl~~--~~~liDFG 214 (258)
T 1zth_A 142 KNVLLMEFIGEDELPAPTLVELG---RELKELDVEGIFNDVVENVKRLYQ--EAELVHADLSEYNIMYID--KVYFIDMG 214 (258)
T ss_dssp TTEEEEECCEETTEECCBHHHHG---GGGGGSCHHHHHHHHHHHHHHHHH--TSCEECSSCSTTSEEESS--SEEECCCT
T ss_pred CCEEEEEecCCCCCccccHHHHh---hccChHHHHHHHHHHHHHHHHHHH--HCCEEeCCCCHHHEEEcC--cEEEEECc
Confidence 46899999942 43322222111 113345678899999999999995 579999999999999998 89999999
Q ss_pred ccccc
Q 042634 280 LAKFL 284 (427)
Q Consensus 280 ~a~~~ 284 (427)
+|...
T Consensus 215 ~a~~~ 219 (258)
T 1zth_A 215 QAVTL 219 (258)
T ss_dssp TCEET
T ss_pred ccccC
Confidence 99765
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.28 E-value=3e-13 Score=137.91 Aligned_cols=151 Identities=13% Similarity=0.118 Sum_probs=82.6
Q ss_pred eeecCCc-ccc-cCCccccCCCCCCEeeeecccceee----cCcchhccccCCEeeeccccCc----ccCCcCccCCCCC
Q 042634 2 FTLVGNQ-FTG-RIPGSIGDLHKLQRLTLEMNKFWGE----IPSSIGNLTLLITLNFAENMLE----GSIPSSLGKCQNL 71 (427)
Q Consensus 2 l~l~~n~-l~~-~~p~~~~~l~~L~~L~l~~n~~~~~----~p~~~~~l~~L~~L~l~~n~l~----~~~p~~~~~l~~L 71 (427)
|+|++|. ++. .++..+..+++|++|+|++|.+++. ++..+.++++|++|++++|.++ +.++..+..+++|
T Consensus 143 L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L 222 (592)
T 3ogk_B 143 LKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSL 222 (592)
T ss_dssp EEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTC
T ss_pred EECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCC
Confidence 5666665 211 1222234667777777777776644 3334456677777777777775 3445555667777
Q ss_pred CeEEccCccCcccCCCCccccccccceeeccCCcCc---CCCCCCCcCCCCCCeEECcCCcccccCCcccccccccccee
Q 042634 72 ILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLN---GPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLV 148 (427)
Q Consensus 72 ~~l~l~~N~~~~~~p~~~~~l~~l~~~L~l~~n~~~---~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~ 148 (427)
++|++++|.+.+ +|..+.++++| +.|+++.+... +..+..+..+++|+.|+++++... .+|..+..+++|+.|+
T Consensus 223 ~~L~L~~~~~~~-l~~~~~~~~~L-~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~L~~L~ 299 (592)
T 3ogk_B 223 VSVKVGDFEILE-LVGFFKAAANL-EEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQIRKLD 299 (592)
T ss_dssp CEEECSSCBGGG-GHHHHHHCTTC-CEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGGGCCEEE
T ss_pred cEEeccCccHHH-HHHHHhhhhHH-HhhcccccccccchHHHHHHhhccccccccCccccchh-HHHHHHhhcCCCcEEe
Confidence 777777777763 44555566666 45666542221 222334444455555555544322 3444444455555555
Q ss_pred eeeeecc
Q 042634 149 MNGNFFR 155 (427)
Q Consensus 149 l~~n~l~ 155 (427)
+++|.++
T Consensus 300 Ls~~~l~ 306 (592)
T 3ogk_B 300 LLYALLE 306 (592)
T ss_dssp ETTCCCC
T ss_pred cCCCcCC
Confidence 5555443
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.24 E-value=1.1e-12 Score=133.71 Aligned_cols=131 Identities=11% Similarity=0.124 Sum_probs=88.2
Q ss_pred CCCCCCEeeeecccceeecCcchhcc--ccCCEeeecccc-Ccc-cCCcCccCCCCCCeEEccCccCccc----CCCCcc
Q 042634 19 DLHKLQRLTLEMNKFWGEIPSSIGNL--TLLITLNFAENM-LEG-SIPSSLGKCQNLILLDLSNNNLTGT----TPTEVI 90 (427)
Q Consensus 19 ~l~~L~~L~l~~n~~~~~~p~~~~~l--~~L~~L~l~~n~-l~~-~~p~~~~~l~~L~~l~l~~N~~~~~----~p~~~~ 90 (427)
.+++|+.|+|++|.+++..+..++.+ ++|++|+|++|. ++. .++..+..+++|++|++++|.+++. ++....
T Consensus 110 ~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~ 189 (592)
T 3ogk_B 110 NLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQ 189 (592)
T ss_dssp HCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHH
T ss_pred hCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHh
Confidence 67788888888888776666667664 348888888776 221 2333344677888888888887655 222344
Q ss_pred ccccccceeeccCCcCc----CCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeee
Q 042634 91 GLSSLSIYLDLSQNQLN----GPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNG 151 (427)
Q Consensus 91 ~l~~l~~~L~l~~n~~~----~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~ 151 (427)
++++| +.|++++|.++ +.++..+.++++|+.|++++|.+.+ +|..+..+++|+.|+++.
T Consensus 190 ~~~~L-~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~ 252 (592)
T 3ogk_B 190 HNTSL-EVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGS 252 (592)
T ss_dssp HCCCC-CEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECB
T ss_pred cCCCc-cEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccc
Confidence 56677 56888888876 2344445677888888888887774 666666677777777664
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.09 E-value=2.8e-11 Score=114.89 Aligned_cols=93 Identities=13% Similarity=0.111 Sum_probs=68.6
Q ss_pred ccccchhhhccccccC-CCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 180 RHRNLVKIITSCASVD-FQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~-~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
.|+|+++++....... .-.....++||||++|+.|.++.... ....++.|++.+|.||| ..|||||
T Consensus 163 E~~nL~rL~~~gv~vp~p~~~~~~~LVME~i~G~~L~~l~~~~----------~~~~l~~qll~~l~~lH---~~gIVHr 229 (397)
T 4gyi_A 163 EFAFMKALYEEGFPVPEPIAQSRHTIVMSLVDALPMRQVSSVP----------DPASLYADLIALILRLA---KHGLIHG 229 (397)
T ss_dssp HHHHHHHHHHTTCSCCCEEEEETTEEEEECCSCEEGGGCCCCS----------CHHHHHHHHHHHHHHHH---HTTEECS
T ss_pred HHHHHHHHHhcCCCCCeeeeccCceEEEEecCCccHhhhcccH----------HHHHHHHHHHHHHHHHH---HCCCcCC
Confidence 4788888876532211 00112347999999988887664321 23568899999999999 8999999
Q ss_pred cccCCceeeCCCC----------ceEecccccccccC
Q 042634 259 DLKPSNVLLDGEL----------TAHVGDFGLAKFLP 285 (427)
Q Consensus 259 Dlkp~NIll~~~~----------~~kL~DFG~a~~~~ 285 (427)
||||.|||+++++ .+.|+||+.+....
T Consensus 230 DLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 230 DFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp CCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred CCCHHHEEEeCCCCcccccccccceEEEEeCCcccCC
Confidence 9999999997766 48899999887543
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.08 E-value=5.4e-12 Score=128.59 Aligned_cols=128 Identities=16% Similarity=0.199 Sum_probs=61.6
Q ss_pred CCCCCCEeeeecccceeecCcchh-ccccCCEeeeccc-cCccc-CCcCccCCCCCCeEEccCccCcccCCCCcc----c
Q 042634 19 DLHKLQRLTLEMNKFWGEIPSSIG-NLTLLITLNFAEN-MLEGS-IPSSLGKCQNLILLDLSNNNLTGTTPTEVI----G 91 (427)
Q Consensus 19 ~l~~L~~L~l~~n~~~~~~p~~~~-~l~~L~~L~l~~n-~l~~~-~p~~~~~l~~L~~l~l~~N~~~~~~p~~~~----~ 91 (427)
.+++|+.|+|++|.+++..+..+. .+++|++|+|++| .++.. ++..+..+++|++|++++|.+++..+.++. .
T Consensus 103 ~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~ 182 (594)
T 2p1m_B 103 SYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDT 182 (594)
T ss_dssp HCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTT
T ss_pred hCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhc
Confidence 455666666666666554444454 4566666666665 34321 333333556666666666665543333222 3
Q ss_pred cccccceeeccCCc--CcC-CCCCCCcCCCCCCeEECcCC-cccccCCcccccccccccee
Q 042634 92 LSSLSIYLDLSQNQ--LNG-PLPSNFGILKNLGAIDISEN-KLSGQIPSSIGSCIRLEQLV 148 (427)
Q Consensus 92 l~~l~~~L~l~~n~--~~~-~~p~~~~~l~~L~~l~l~~n-~~~~~~p~~~~~~~~l~~l~ 148 (427)
+++| +.|++++|. ++. .++.-+.++++|+.|++++| .+. .+|..+..+++|+.|+
T Consensus 183 ~~~L-~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~-~l~~~~~~~~~L~~L~ 241 (594)
T 2p1m_B 183 YTSL-VSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLE-KLATLLQRAPQLEELG 241 (594)
T ss_dssp CCCC-CEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHH-HHHHHHHHCTTCSEEE
T ss_pred CCcC-cEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHH-HHHHHHhcCCcceEcc
Confidence 3455 456666554 110 01111233455666666555 222 2344444444444444
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.04 E-value=2.3e-12 Score=131.39 Aligned_cols=173 Identities=16% Similarity=0.095 Sum_probs=99.7
Q ss_pred eeecCCcccccCC-ccccCCCCCCEeeeeccccee-ecCcchhccccCCEeee---------ccccCcccCCcCcc-CCC
Q 042634 2 FTLVGNQFTGRIP-GSIGDLHKLQRLTLEMNKFWG-EIPSSIGNLTLLITLNF---------AENMLEGSIPSSLG-KCQ 69 (427)
Q Consensus 2 l~l~~n~l~~~~p-~~~~~l~~L~~L~l~~n~~~~-~~p~~~~~l~~L~~L~l---------~~n~l~~~~p~~~~-~l~ 69 (427)
|+|++|.+++... ..+..+++|+.|++++| ++. .++.....+++|+.|++ +.|.+++.....+. .++
T Consensus 294 L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~ 372 (594)
T 2p1m_B 294 LNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCP 372 (594)
T ss_dssp EECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCT
T ss_pred EEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhch
Confidence 5566666554322 22445666666666665 321 12222234666666666 23444433222332 366
Q ss_pred CCCeEEccCccCcccCCCCcc-ccccccceeecc--C----CcCcCCCC------CCCcCCCCCCeEECcCCcccccCCc
Q 042634 70 NLILLDLSNNNLTGTTPTEVI-GLSSLSIYLDLS--Q----NQLNGPLP------SNFGILKNLGAIDISENKLSGQIPS 136 (427)
Q Consensus 70 ~L~~l~l~~N~~~~~~p~~~~-~l~~l~~~L~l~--~----n~~~~~~p------~~~~~l~~L~~l~l~~n~~~~~~p~ 136 (427)
+|++|+++.|.+++..+..+. .+++| +.|+++ + |.++ ..| ..+..+++|+.|++++ .+++..+.
T Consensus 373 ~L~~L~~~~~~l~~~~~~~l~~~~~~L-~~L~L~~~~~~~~~~l~-~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~ 449 (594)
T 2p1m_B 373 KLESVLYFCRQMTNAALITIARNRPNM-TRFRLCIIEPKAPDYLT-LEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFE 449 (594)
T ss_dssp TCCEEEEEESCCCHHHHHHHHHHCTTC-CEEEEEESSTTCCCTTT-CCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHH
T ss_pred hHHHHHHhcCCcCHHHHHHHHhhCCCc-ceeEeecccCCCccccc-CCchhhHHHHHHhhCCCccEEeecC-cccHHHHH
Confidence 777777777777654444333 36666 567777 3 4444 222 1255677788888866 55554455
Q ss_pred cccc-cccccceeeeeeeccccCCCCc-ccccCCceeeccCCcc
Q 042634 137 SIGS-CIRLEQLVMNGNFFRGNIPSSL-SSLRGIENLDLSRNNF 178 (427)
Q Consensus 137 ~~~~-~~~l~~l~l~~n~l~~~~p~~l-~~l~~L~~L~L~~N~l 178 (427)
.++. +++|+.|++++|.+++..+..+ ..+++|+.|++++|.+
T Consensus 450 ~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~ 493 (594)
T 2p1m_B 450 YIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPF 493 (594)
T ss_dssp HHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSC
T ss_pred HHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCC
Confidence 5555 7778888888888765544444 5577888888888776
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.00 E-value=2.8e-09 Score=102.97 Aligned_cols=160 Identities=13% Similarity=0.118 Sum_probs=90.3
Q ss_pred cccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccCcccCCC
Q 042634 8 QFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPT 87 (427)
Q Consensus 8 ~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~ 87 (427)
.++..-+..|.++++|+.++|+.|+++ .+|...-.+++|+.+.|.+| ++..-..+|.++++|+.+++..| ++..-..
T Consensus 167 ~l~~I~~~aF~~c~~L~~l~l~~n~l~-~I~~~aF~~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~ 243 (401)
T 4fdw_A 167 TLEQLKEDIFYYCYNLKKADLSKTKIT-KLPASTFVYAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQE 243 (401)
T ss_dssp TCCEECSSTTTTCTTCCEEECTTSCCS-EECTTTTTTCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTT
T ss_pred CccEehHHHhhCcccCCeeecCCCcce-EechhhEeecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccc
Confidence 455344467888888888888888887 56654333678888888754 55233345777777888877764 3323333
Q ss_pred CccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCccc-----ccCCccccccccccceeeeeeeccccCCCCc
Q 042634 88 EVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLS-----GQIPSSIGSCIRLEQLVMNGNFFRGNIPSSL 162 (427)
Q Consensus 88 ~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~-----~~~p~~~~~~~~l~~l~l~~n~l~~~~p~~l 162 (427)
+|.+ .+| ..+.+ .|.++..-+..|.+|++|+.+++.+|.+. ..-+.+|.+|.+|+.+.+.+ .++.....+|
T Consensus 244 aF~~-~~L-~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~~I~~~aF 319 (401)
T 4fdw_A 244 AFRE-SGI-TTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIRILGQGLL 319 (401)
T ss_dssp TTTT-CCC-SEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCCEECTTTT
T ss_pred cccc-CCc-cEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCC-ceEEEhhhhh
Confidence 4444 444 34555 23343233455556666666666555443 12233455555555555552 2443444455
Q ss_pred ccccCCceeecc
Q 042634 163 SSLRGIENLDLS 174 (427)
Q Consensus 163 ~~l~~L~~L~L~ 174 (427)
.++++|+.+.+.
T Consensus 320 ~~c~~L~~l~lp 331 (401)
T 4fdw_A 320 GGNRKVTQLTIP 331 (401)
T ss_dssp TTCCSCCEEEEC
T ss_pred cCCCCccEEEEC
Confidence 555555555543
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=98.97 E-value=3.4e-09 Score=102.36 Aligned_cols=164 Identities=10% Similarity=0.107 Sum_probs=122.7
Q ss_pred eecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccCc
Q 042634 3 TLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLT 82 (427)
Q Consensus 3 ~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~~ 82 (427)
+|.+| ++..-+..|.+ .+|+.+.|.. .++..-+..|.+|++|+.++|++|.++ .+|......++|+.+.+.+| ++
T Consensus 141 ~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~-~I~~~aF~~~~L~~l~lp~~-l~ 215 (401)
T 4fdw_A 141 VLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKIT-KLPASTFVYAGIEEVLLPVT-LK 215 (401)
T ss_dssp ECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCS-EECTTTTTTCCCSEEECCTT-CC
T ss_pred EeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeeecCCCcce-EechhhEeecccCEEEeCCc-hh
Confidence 44444 55333455666 4799999985 676344467999999999999999999 78877666889999999855 76
Q ss_pred ccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeecc-----cc
Q 042634 83 GTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFR-----GN 157 (427)
Q Consensus 83 ~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~-----~~ 157 (427)
..-..+|.++.+| +.+.+..| ++..-...|.+ .+|+.+.+.+ .++..-+.+|.+|.+|+.+.+.+|.+. ..
T Consensus 216 ~I~~~aF~~~~~L-~~l~l~~~-l~~I~~~aF~~-~~L~~i~lp~-~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I 291 (401)
T 4fdw_A 216 EIGSQAFLKTSQL-KTIEIPEN-VSTIGQEAFRE-SGITTVKLPN-GVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMI 291 (401)
T ss_dssp EECTTTTTTCTTC-CCEECCTT-CCEECTTTTTT-CCCSEEEEET-TCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEE
T ss_pred eehhhHhhCCCCC-CEEecCCC-ccCcccccccc-CCccEEEeCC-CccEEChhHhhCCCCCCEEEeCCccccCCcccEE
Confidence 5666788889999 57988875 44344456666 7899999954 455344568889999999999988775 44
Q ss_pred CCCCcccccCCceeeccC
Q 042634 158 IPSSLSSLRGIENLDLSR 175 (427)
Q Consensus 158 ~p~~l~~l~~L~~L~L~~ 175 (427)
.+..|..+++|+.+.+..
T Consensus 292 ~~~aF~~c~~L~~l~l~~ 309 (401)
T 4fdw_A 292 HPYCLEGCPKLARFEIPE 309 (401)
T ss_dssp CTTTTTTCTTCCEECCCT
T ss_pred CHHHhhCCccCCeEEeCC
Confidence 567888999999998863
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.84 E-value=7.3e-10 Score=105.23 Aligned_cols=160 Identities=14% Similarity=0.164 Sum_probs=111.6
Q ss_pred cccCCCCCCEeeeecccc---------eeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccCcccCC
Q 042634 16 SIGDLHKLQRLTLEMNKF---------WGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTP 86 (427)
Q Consensus 16 ~~~~l~~L~~L~l~~n~~---------~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p 86 (427)
.+..+++|+.|.+..+.. .+.++..+..+++|+.|+|++|.-. .+|+ + .+++|++|++..|.++....
T Consensus 134 s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l~~~~l 210 (362)
T 2ra8_A 134 NKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGLPDSVV 210 (362)
T ss_dssp THHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-BCCS-C-BCTTCSEEEEECSBCCHHHH
T ss_pred hhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-eecc-c-cCCCCcEEEEecCCCChHHH
Confidence 356788999999976533 1235556678899999999988422 4554 4 38899999999988864333
Q ss_pred CCcc--ccccccceeeccC--CcCcCC-----CCCCC--cCCCCCCeEECcCCcccccCCcccc---ccccccceeeeee
Q 042634 87 TEVI--GLSSLSIYLDLSQ--NQLNGP-----LPSNF--GILKNLGAIDISENKLSGQIPSSIG---SCIRLEQLVMNGN 152 (427)
Q Consensus 87 ~~~~--~l~~l~~~L~l~~--n~~~~~-----~p~~~--~~l~~L~~l~l~~n~~~~~~p~~~~---~~~~l~~l~l~~n 152 (427)
..+. .+++| +.|+|+. |...+. +...+ ..+++|+.|+|.+|.+++..+..+. .+++|+.|+++.|
T Consensus 211 ~~l~~~~lp~L-~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n 289 (362)
T 2ra8_A 211 EDILGSDLPNL-EKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAG 289 (362)
T ss_dssp HHHHHSBCTTC-CEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSS
T ss_pred HHHHHccCCCC-cEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCC
Confidence 3333 57788 5688753 332211 11122 3578999999999998865444443 5889999999999
Q ss_pred ecccc----CCCCcccccCCceeeccCCccc
Q 042634 153 FFRGN----IPSSLSSLRGIENLDLSRNNFI 179 (427)
Q Consensus 153 ~l~~~----~p~~l~~l~~L~~L~L~~N~ll 179 (427)
.+++. ++..+..+++|+.|+++.|.+.
T Consensus 290 ~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~ 320 (362)
T 2ra8_A 290 VLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320 (362)
T ss_dssp CCBHHHHHHHHTTHHHHTTCSEEECCSBBCC
T ss_pred CCChHHHHHHHhhcccCCcceEEECCCCcCC
Confidence 99864 3455567899999999988764
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.80 E-value=2.3e-10 Score=103.41 Aligned_cols=40 Identities=38% Similarity=0.539 Sum_probs=20.5
Q ss_pred ccccCCEeeeccccCcc--cCCcCccCCCCCCeEEccCccCc
Q 042634 43 NLTLLITLNFAENMLEG--SIPSSLGKCQNLILLDLSNNNLT 82 (427)
Q Consensus 43 ~l~~L~~L~l~~n~l~~--~~p~~~~~l~~L~~l~l~~N~~~ 82 (427)
++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|+
T Consensus 168 ~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~ 209 (267)
T 3rw6_A 168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK 209 (267)
T ss_dssp HCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCC
T ss_pred hCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccC
Confidence 34555555555555554 33344445555555555555554
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.73 E-value=1.3e-09 Score=103.54 Aligned_cols=159 Identities=18% Similarity=0.199 Sum_probs=109.1
Q ss_pred CCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCcc--CCCCCCeEEccC--ccCcccC---
Q 042634 13 IPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLG--KCQNLILLDLSN--NNLTGTT--- 85 (427)
Q Consensus 13 ~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~--~l~~L~~l~l~~--N~~~~~~--- 85 (427)
++..+..+++|+.|+|++|.-. .+|. + .+++|+.|+|+.|.++......++ .+++|++|+|+. |...+..
T Consensus 164 L~~ll~~~P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~ 240 (362)
T 2ra8_A 164 LSPVLDAMPLLNNLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMN 240 (362)
T ss_dssp CHHHHHTCTTCCEEEEECCBTC-BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGG
T ss_pred HHHHHhcCCCCcEEEEeCCCCc-eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHH
Confidence 5566788899999999988422 3555 4 389999999999988755444454 789999999864 3322221
Q ss_pred --CCCc--cccccccceeeccCCcCcCCCCCCC---cCCCCCCeEECcCCccccc----CCccccccccccceeeeeeec
Q 042634 86 --PTEV--IGLSSLSIYLDLSQNQLNGPLPSNF---GILKNLGAIDISENKLSGQ----IPSSIGSCIRLEQLVMNGNFF 154 (427)
Q Consensus 86 --p~~~--~~l~~l~~~L~l~~n~~~~~~p~~~---~~l~~L~~l~l~~n~~~~~----~p~~~~~~~~l~~l~l~~n~l 154 (427)
...+ ..+++| +.|+|.+|.++...+..+ ..+++|+.|+|+.|.+++. ++..+..+++|+.|+++.|.+
T Consensus 241 ~l~~~l~~~~~p~L-r~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i 319 (362)
T 2ra8_A 241 VFRPLFSKDRFPNL-KWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYL 319 (362)
T ss_dssp GTGGGSCTTTCTTC-CEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBC
T ss_pred HHHHHHhcCCCCCc-CEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcC
Confidence 1112 246788 689999999864332222 3578999999999999864 445556789999999999998
Q ss_pred cccCCCCccc-ccCCceeeccCCc
Q 042634 155 RGNIPSSLSS-LRGIENLDLSRNN 177 (427)
Q Consensus 155 ~~~~p~~l~~-l~~L~~L~L~~N~ 177 (427)
+...-..+.. + ...++++.+.
T Consensus 320 ~d~~~~~l~~al--g~~~~~~~~~ 341 (362)
T 2ra8_A 320 SDEMKKELQKSL--PMKIDVSDSQ 341 (362)
T ss_dssp CHHHHHHHHHHC--CSEEECCSBC
T ss_pred CHHHHHHHHHHc--CCEEEecCCc
Confidence 7543333332 2 2456666554
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.72 E-value=2.7e-09 Score=96.34 Aligned_cols=83 Identities=24% Similarity=0.280 Sum_probs=63.1
Q ss_pred eeecCCc---ccccCCccccCCCCCCEeeeeccccee--ecCcchhccccCCEeeeccccCcccCCcCccCCC--CCCeE
Q 042634 2 FTLVGNQ---FTGRIPGSIGDLHKLQRLTLEMNKFWG--EIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQ--NLILL 74 (427)
Q Consensus 2 l~l~~n~---l~~~~p~~~~~l~~L~~L~l~~n~~~~--~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~--~L~~l 74 (427)
++++.|. +.+.++....++++|+.|+|++|+|++ .+|..++.+++|+.|+|++|++++. ..+..++ +|++|
T Consensus 148 l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L 225 (267)
T 3rw6_A 148 IDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEEL 225 (267)
T ss_dssp CCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEE
T ss_pred ccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceE
Confidence 3456663 333333333678999999999999997 5567788999999999999999953 3455555 88899
Q ss_pred EccCccCcccCC
Q 042634 75 DLSNNNLTGTTP 86 (427)
Q Consensus 75 ~l~~N~~~~~~p 86 (427)
+|++|.+++.+|
T Consensus 226 ~L~~Npl~~~~~ 237 (267)
T 3rw6_A 226 WLDGNSLCDTFR 237 (267)
T ss_dssp ECTTSTTGGGCS
T ss_pred EccCCcCccccC
Confidence 999999887666
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.54 E-value=5.1e-09 Score=89.83 Aligned_cols=118 Identities=12% Similarity=0.077 Sum_probs=58.9
Q ss_pred ccCCCCCCEeeeecc-cceee----cCcchhccccCCEeeeccccCccc----CCcCccCCCCCCeEEccCccCcccCCC
Q 042634 17 IGDLHKLQRLTLEMN-KFWGE----IPSSIGNLTLLITLNFAENMLEGS----IPSSLGKCQNLILLDLSNNNLTGTTPT 87 (427)
Q Consensus 17 ~~~l~~L~~L~l~~n-~~~~~----~p~~~~~l~~L~~L~l~~n~l~~~----~p~~~~~l~~L~~l~l~~N~~~~~~p~ 87 (427)
+...++|+.|+|++| .+... +...+...++|++|+|++|.++.. +...+...++|++|+|++|.++..-..
T Consensus 32 l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~ 111 (185)
T 1io0_A 32 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGIL 111 (185)
T ss_dssp HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHH
T ss_pred HhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHH
Confidence 444555666666665 55421 223334445566666666655521 222233334555555555555421100
Q ss_pred CccccccccceeeccCCcCcCCCCCCCcCCCCCCeEEC--cCCccccc----CCccccccccccceeeeeeecc
Q 042634 88 EVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDI--SENKLSGQ----IPSSIGSCIRLEQLVMNGNFFR 155 (427)
Q Consensus 88 ~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l--~~n~~~~~----~p~~~~~~~~l~~l~l~~n~l~ 155 (427)
.+...+...+.|+.|+| ++|.++.. +...+...++|+.|++++|.+.
T Consensus 112 ---------------------~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 112 ---------------------ALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp ---------------------HHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred ---------------------HHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 12334444556777777 56666543 2233444566777777777664
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.45 E-value=1.1e-08 Score=87.73 Aligned_cols=122 Identities=11% Similarity=0.109 Sum_probs=83.5
Q ss_pred cCcchhccccCCEeeeccc-cCccc----CCcCccCCCCCCeEEccCccCcccCCCCccccccccceeeccCCcCcCCCC
Q 042634 37 IPSSIGNLTLLITLNFAEN-MLEGS----IPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLP 111 (427)
Q Consensus 37 ~p~~~~~l~~L~~L~l~~n-~l~~~----~p~~~~~l~~L~~l~l~~N~~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p 111 (427)
+...+...++|+.|+|++| .++.. +...+...++|++|+|++|.+...-.. .+.
T Consensus 28 l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~---------------------~l~ 86 (185)
T 1io0_A 28 LKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAF---------------------ALA 86 (185)
T ss_dssp HHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHH---------------------HHH
T ss_pred HHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHH---------------------HHH
Confidence 3345566788888888888 77632 344455567788888888877521111 111
Q ss_pred CCCcCCCCCCeEECcCCccccc----CCccccccccccceee--eeeeccccC----CCCcccccCCceeeccCCccc
Q 042634 112 SNFGILKNLGAIDISENKLSGQ----IPSSIGSCIRLEQLVM--NGNFFRGNI----PSSLSSLRGIENLDLSRNNFI 179 (427)
Q Consensus 112 ~~~~~l~~L~~l~l~~n~~~~~----~p~~~~~~~~l~~l~l--~~n~l~~~~----p~~l~~l~~L~~L~L~~N~ll 179 (427)
..+...+.|+.|+|++|.++.. +...+...++|+.|++ +.|.+.... ...+...++|+.|+++.|.+.
T Consensus 87 ~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 87 EMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 2233456788899999988753 4556777889999999 889997653 334455689999999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.25 E-value=1.7e-07 Score=86.91 Aligned_cols=123 Identities=18% Similarity=0.139 Sum_probs=82.4
Q ss_pred ccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcC-----------------------------
Q 042634 201 SEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYC----------------------------- 251 (427)
Q Consensus 201 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~----------------------------- 251 (427)
..++|||+++|.++.+... ..++..++..++.+++..+..||...
T Consensus 90 ~~~~vm~~i~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (304)
T 3sg8_A 90 MSFAGFTKIKGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSR 163 (304)
T ss_dssp CSCEEEECCCCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTT
T ss_pred cceEEEcccCCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcc
Confidence 4578999999888754321 33677778888888888888888510
Q ss_pred --------------------------CCCeeeccccCCceeeCC--CCceEecccccccccCCcC--CCcccc---cccc
Q 042634 252 --------------------------ETPIVHCDLKPSNVLLDG--ELTAHVGDFGLAKFLPEAT--NNFFNF---QIAE 298 (427)
Q Consensus 252 --------------------------~~~ivHrDlkp~NIll~~--~~~~kL~DFG~a~~~~~~~--~~~~~y---~aPE 298 (427)
...++|+|++|.||+++. ...+.|+||+.+....... .....+ ..|+
T Consensus 164 ~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~ 243 (304)
T 3sg8_A 164 ELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGME 243 (304)
T ss_dssp TSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHH
T ss_pred cCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHH
Confidence 135899999999999988 5678999999987643211 000000 1121
Q ss_pred ccC------CC--------CcCccccchhHHHHHHHHHhCCCCCC
Q 042634 299 YGM------GS--------EVSTSGDVYSFGILLLETFTGKRPTN 329 (427)
Q Consensus 299 ~~~------~~--------~~~~~~DiwS~G~vl~ell~g~~pf~ 329 (427)
... +. ......+.|++|.++|.+.+|..+|.
T Consensus 244 ~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 244 FVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 110 00 01122588999999999999998763
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.22 E-value=3.5e-07 Score=82.74 Aligned_cols=75 Identities=17% Similarity=0.074 Sum_probs=57.2
Q ss_pred CCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcC---------------------------
Q 042634 199 NDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYC--------------------------- 251 (427)
Q Consensus 199 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~--------------------------- 251 (427)
....++||||++|.+|.+.+.. ......++.++++++..||...
T Consensus 82 ~~~~~lv~e~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (263)
T 3tm0_A 82 DGWSNLLMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLAD 152 (263)
T ss_dssp TTEEEEEEECCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSC
T ss_pred CCceEEEEEecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccc
Confidence 3467899999999888765321 1123468889999999999610
Q ss_pred -----------------------------CCCeeeccccCCceeeCCCCceEeccccccc
Q 042634 252 -----------------------------ETPIVHCDLKPSNVLLDGELTAHVGDFGLAK 282 (427)
Q Consensus 252 -----------------------------~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~ 282 (427)
...++|+|++|.||+++.+..+.|+||+.+.
T Consensus 153 ~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 153 VDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1458999999999999877667899999774
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.17 E-value=2.8e-06 Score=80.62 Aligned_cols=78 Identities=19% Similarity=0.215 Sum_probs=61.8
Q ss_pred ccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcC-----------------------------
Q 042634 201 SEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYC----------------------------- 251 (427)
Q Consensus 201 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~----------------------------- 251 (427)
..++||||++|..+.+... ..++..++..++.++++.|..||...
T Consensus 115 ~~~~vme~v~G~~l~~~~~------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (359)
T 3dxp_A 115 RAFYIMEFVSGRVLWDQSL------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKL 188 (359)
T ss_dssp SCEEEEECCCCBCCCCTTC------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHH
T ss_pred CeEEEEEecCCeecCCCcc------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHh
Confidence 4689999999888754221 23677888899999999999999620
Q ss_pred --------------------------CCCeeeccccCCceeeCCCC--ceEeccccccccc
Q 042634 252 --------------------------ETPIVHCDLKPSNVLLDGEL--TAHVGDFGLAKFL 284 (427)
Q Consensus 252 --------------------------~~~ivHrDlkp~NIll~~~~--~~kL~DFG~a~~~ 284 (427)
...++|+|+++.||+++.++ .+.|+||+.+...
T Consensus 189 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 189 SETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred cCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 25799999999999998765 3689999988753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.09 E-value=1.5e-06 Score=78.24 Aligned_cols=72 Identities=17% Similarity=0.109 Sum_probs=53.0
Q ss_pred CccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcC----------------------------
Q 042634 200 DSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYC---------------------------- 251 (427)
Q Consensus 200 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~---------------------------- 251 (427)
...++||||++|.++. ... .+ ...++.++++.+..||...
T Consensus 88 ~~~~~v~e~i~G~~l~--~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (264)
T 1nd4_A 88 GRDWLLLGEVPGQDLL--SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQ 155 (264)
T ss_dssp SCEEEEEECCSSEETT--TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCT
T ss_pred CCCEEEEEecCCcccC--cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccc
Confidence 4579999999998884 211 11 1256778888888888421
Q ss_pred ---------------------------CCCeeeccccCCceeeCCCCceEecccccccc
Q 042634 252 ---------------------------ETPIVHCDLKPSNVLLDGELTAHVGDFGLAKF 283 (427)
Q Consensus 252 ---------------------------~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 283 (427)
..+++|+|++|.||+++.+..++|+|||.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 156 DDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp TSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11399999999999998877778999998753
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=97.83 E-value=0.00014 Score=69.85 Aligned_cols=152 Identities=15% Similarity=0.095 Sum_probs=110.7
Q ss_pred ccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccCcccCCCCcccccc
Q 042634 15 GSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSS 94 (427)
Q Consensus 15 ~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~~~l~~ 94 (427)
.......+|+.+.+..+ ++..-...+.++..|+.+.+..+... .....+..+.+|+.+....+.+. ...+.++.+
T Consensus 224 ~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~ 298 (394)
T 4fs7_A 224 DFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSS 298 (394)
T ss_dssp TTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTT
T ss_pred hhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeec---ccccccccc
Confidence 34455578888888754 44233456888999999999888665 55667888888998888776543 235667778
Q ss_pred ccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCCCCcccccCCceeecc
Q 042634 95 LSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLS 174 (427)
Q Consensus 95 l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~ 174 (427)
| ..+.+.++ ++..-...|.+|++|+.+++.++ ++..-..+|.+|.+|+.+.+..| ++.....+|.++.+|+.+++.
T Consensus 299 L-~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp 374 (394)
T 4fs7_A 299 L-TEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELP 374 (394)
T ss_dssp C-CEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEE
T ss_pred c-cccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEEC
Confidence 8 56777655 54344567889999999999765 55233457889999999999877 665666788999999998875
Q ss_pred C
Q 042634 175 R 175 (427)
Q Consensus 175 ~ 175 (427)
.
T Consensus 375 ~ 375 (394)
T 4fs7_A 375 K 375 (394)
T ss_dssp G
T ss_pred C
Confidence 4
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=97.83 E-value=0.00015 Score=69.53 Aligned_cols=153 Identities=11% Similarity=0.082 Sum_probs=111.3
Q ss_pred CccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccCcccCCCCccccc
Q 042634 14 PGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLS 93 (427)
Q Consensus 14 p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~~~l~ 93 (427)
...+.+...|+.+.+..+... +.......+.|+.+.+.++. +..-...+..+++|+.+.+..+... .....+..+.
T Consensus 201 ~~~F~~~~~L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~~-~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~ 276 (394)
T 4fs7_A 201 DYCFAECILLENMEFPNSLYY--LGDFALSKTGVKNIIIPDSF-TELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCS 276 (394)
T ss_dssp TTTTTTCTTCCBCCCCTTCCE--ECTTTTTTCCCCEEEECTTC-CEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCT
T ss_pred chhhccccccceeecCCCceE--eehhhcccCCCceEEECCCc-eecccccccccccceeEEcCCCcce-eecccccccc
Confidence 456788889999998876554 45556667889999887554 4133456788899999999888665 5556677777
Q ss_pred cccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCCCCcccccCCceeec
Q 042634 94 SLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDL 173 (427)
Q Consensus 94 ~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~~l~~l~~L~~L~L 173 (427)
.+ ..+....+.+ ....+..+.+|+.+.+.++ ++..-..+|.+|.+|+.+++.++ ++.....+|.++++|+.+.+
T Consensus 277 ~l-~~~~~~~~~i---~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~l 350 (394)
T 4fs7_A 277 GL-KKVIYGSVIV---PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINF 350 (394)
T ss_dssp TC-CEEEECSSEE---CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECC
T ss_pred cc-ceeccCceee---ccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEE
Confidence 77 4565555443 2356888999999999876 45233457889999999999755 66555678899999999987
Q ss_pred cCC
Q 042634 174 SRN 176 (427)
Q Consensus 174 ~~N 176 (427)
..+
T Consensus 351 p~~ 353 (394)
T 4fs7_A 351 PLS 353 (394)
T ss_dssp CTT
T ss_pred Ccc
Confidence 643
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=97.71 E-value=0.00036 Score=66.37 Aligned_cols=149 Identities=8% Similarity=0.054 Sum_probs=73.0
Q ss_pred CCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccCcccCCCCccccccccce
Q 042634 19 DLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIY 98 (427)
Q Consensus 19 ~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~~~l~~l~~~ 98 (427)
....+..+.+..+... .....+..+..|+.+.+..+. +..-..++..+++|+.+.+..+ ++..-..++.++.++ ..
T Consensus 192 ~~~~~~~~~~~~~~~~-i~~~~f~~~~~l~~i~~~~~~-~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l-~~ 267 (379)
T 4h09_A 192 AAKTGTEFTIPSTVKT-VTAYGFSYGKNLKKITITSGV-TTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTAL-KT 267 (379)
T ss_dssp TTCCCSEEECCTTCCE-ECTTTTTTCSSCSEEECCTTC-CEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTC-CE
T ss_pred ccccccccccccceeE-Eeecccccccccceeeeccce-eEEccccccCCccceEEEcCCC-ccEeCccccceeehh-cc
Confidence 3344444444332222 333445555566666554442 2133344555566666666544 332333445555555 34
Q ss_pred eeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCCCCcccccCCceeec
Q 042634 99 LDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDL 173 (427)
Q Consensus 99 L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~~l~~l~~L~~L~L 173 (427)
+.+..+ +...-...|.+|++|+.+.+.++.++..-..+|.+|.+|+.+.+.++ ++.....+|.++++|+.+.+
T Consensus 268 i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~i 340 (379)
T 4h09_A 268 LNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISY 340 (379)
T ss_dssp EEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCC
T ss_pred cccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEE
Confidence 544332 22122345566666666666665555222335566666666666543 33333455666666665554
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=97.67 E-value=0.00017 Score=69.14 Aligned_cols=145 Identities=17% Similarity=0.297 Sum_probs=94.8
Q ss_pred CCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccCcccCCCCccccccccceeec
Q 042634 22 KLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDL 101 (427)
Q Consensus 22 ~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~~~l~~l~~~L~l 101 (427)
.+..+.+. +.++..-...|.+++.|+.+.+.++..+ .-..++.++++|+.+.+. +.++......|.++.+| +.+.+
T Consensus 243 ~~~~~~ip-~~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L-~~i~l 318 (394)
T 4gt6_A 243 EDPAFKIP-NGVARIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISL-KSIDI 318 (394)
T ss_dssp CCSEEECC-TTEEEECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTC-CEEEC
T ss_pred ccceEEcC-CcceEcccceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCc-CEEEe
Confidence 44445443 3444233456888888998888776654 445667888889988886 44554555678888888 56888
Q ss_pred cCCcCcCCCCCCCcCCCCCCeEECcCCcccccCC-ccccccccccceeeeeeeccccCCCCcccccCCceeeccCC
Q 042634 102 SQNQLNGPLPSNFGILKNLGAIDISENKLSGQIP-SSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRN 176 (427)
Q Consensus 102 ~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p-~~~~~~~~l~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N 176 (427)
..+ ++..-...|.+|.+|+.+.+..+ ++ .|. .+|.+|.+|+.+.+.++.... ..+...++|+.+.+..|
T Consensus 319 p~~-v~~I~~~aF~~C~~L~~i~ip~s-v~-~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~ 388 (394)
T 4gt6_A 319 PEG-ITQILDDAFAGCEQLERIAIPSS-VT-KIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPG 388 (394)
T ss_dssp CTT-CCEECTTTTTTCTTCCEEEECTT-CC-BCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC--------
T ss_pred CCc-ccEehHhHhhCCCCCCEEEECcc-cC-EEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCC
Confidence 654 44344577889999999999765 55 454 478889999999998876542 34556677777766544
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.67 E-value=1.4e-05 Score=66.99 Aligned_cols=84 Identities=13% Similarity=0.139 Sum_probs=59.9
Q ss_pred CCCCEeeeecccceeecCcchhccccCCEeeecccc-CcccCCcCccCC----CCCCeEEccCcc-CcccCCCCcccccc
Q 042634 21 HKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENM-LEGSIPSSLGKC----QNLILLDLSNNN-LTGTTPTEVIGLSS 94 (427)
Q Consensus 21 ~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~-l~~~~p~~~~~l----~~L~~l~l~~N~-~~~~~p~~~~~l~~ 94 (427)
-+|+.|||+++.++..--..+.++++|+.|+|++|. ++..-=..++.+ ++|++|++++|. ++..--..+..+++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 478999999988874434567888999999999985 664433445554 369999999975 65332234567778
Q ss_pred ccceeeccCCc
Q 042634 95 LSIYLDLSQNQ 105 (427)
Q Consensus 95 l~~~L~l~~n~ 105 (427)
| +.|+|++++
T Consensus 141 L-~~L~L~~c~ 150 (176)
T 3e4g_A 141 L-KYLFLSDLP 150 (176)
T ss_dssp C-CEEEEESCT
T ss_pred C-CEEECCCCC
Confidence 8 678888876
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00033 Score=67.09 Aligned_cols=157 Identities=13% Similarity=0.234 Sum_probs=108.9
Q ss_pred CccccCCCCCCEeeeecccceeecCcchh--------------ccccCCEeeeccccCcccCCcCccCCCCCCeEEccCc
Q 042634 14 PGSIGDLHKLQRLTLEMNKFWGEIPSSIG--------------NLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNN 79 (427)
Q Consensus 14 p~~~~~l~~L~~L~l~~n~~~~~~p~~~~--------------~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 79 (427)
...+.+..+|+......+... .+...+. ....+..+.+.++ ++..-..+|.++++|+.+.+..+
T Consensus 198 ~~af~~c~~l~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~~-v~~i~~~aF~~c~~L~~i~lp~~ 275 (394)
T 4gt6_A 198 TNAFSECFALSTITSDSESYP-AIDNVLYEKSANGDYALIRYPSQREDPAFKIPNG-VARIETHAFDSCAYLASVKMPDS 275 (394)
T ss_dssp TTTTTTCTTCCEEEECCSSSC-BSSSCEEEECTTSCEEEEECCTTCCCSEEECCTT-EEEECTTTTTTCSSCCEEECCTT
T ss_pred cchhhhccccceecccccccc-cccceeecccccccccccccccccccceEEcCCc-ceEcccceeeecccccEEecccc
Confidence 456788888888887766554 3332221 2233444444333 33233456888999999999877
Q ss_pred cCcccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCC
Q 042634 80 NLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIP 159 (427)
Q Consensus 80 ~~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p 159 (427)
..+ .-..+|.++.+| +.+.+. +.++..-...|.+|.+|+.+++..+ ++..-..+|.+|.+|+.+.+.++ ++....
T Consensus 276 ~~~-I~~~aF~~c~~L-~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~ 350 (394)
T 4gt6_A 276 VVS-IGTGAFMNCPAL-QDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPE 350 (394)
T ss_dssp CCE-ECTTTTTTCTTC-CEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCG
T ss_pred cce-ecCccccccccc-ccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhH
Confidence 654 555678888888 568775 4455344578999999999999876 45233458889999999999765 555556
Q ss_pred CCcccccCCceeeccCCc
Q 042634 160 SSLSSLRGIENLDLSRNN 177 (427)
Q Consensus 160 ~~l~~l~~L~~L~L~~N~ 177 (427)
.+|.++++|+.+++.++.
T Consensus 351 ~aF~~C~~L~~i~~~~~~ 368 (394)
T 4gt6_A 351 SAFSNCTALNNIEYSGSR 368 (394)
T ss_dssp GGGTTCTTCCEEEESSCH
T ss_pred hHhhCCCCCCEEEECCce
Confidence 789999999999988754
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00057 Score=64.98 Aligned_cols=107 Identities=12% Similarity=0.143 Sum_probs=46.2
Q ss_pred cCccCCCCCCeEEccCccCcccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccc
Q 042634 63 SSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCI 142 (427)
Q Consensus 63 ~~~~~l~~L~~l~l~~N~~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~ 142 (427)
..+..+++|+.+.+..+ ++......+.++..| ..+.+..+ ++..-...|.++.+|+.+.+..+ +...-..+|.+|.
T Consensus 211 ~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L-~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~ 286 (379)
T 4h09_A 211 YGFSYGKNLKKITITSG-VTTLGDGAFYGMKAL-DEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCS 286 (379)
T ss_dssp TTTTTCSSCSEEECCTT-CCEECTTTTTTCSSC-CEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCT
T ss_pred cccccccccceeeeccc-eeEEccccccCCccc-eEEEcCCC-ccEeCccccceeehhcccccccc-ceecccccccccc
Confidence 33444445555554433 221223334444444 33444333 22122334445555555555433 2211122444555
Q ss_pred cccceeeeeeeccccCCCCcccccCCceeec
Q 042634 143 RLEQLVMNGNFFRGNIPSSLSSLRGIENLDL 173 (427)
Q Consensus 143 ~l~~l~l~~n~l~~~~p~~l~~l~~L~~L~L 173 (427)
+|+.+.+.++.++.....+|.++.+|+.+.+
T Consensus 287 ~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~l 317 (379)
T 4h09_A 287 NLTKVVMDNSAIETLEPRVFMDCVKLSSVTL 317 (379)
T ss_dssp TCCEEEECCTTCCEECTTTTTTCTTCCEEEC
T ss_pred ccccccccccccceehhhhhcCCCCCCEEEc
Confidence 5555555555444443444555555555544
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.57 E-value=1.3e-05 Score=67.11 Aligned_cols=94 Identities=9% Similarity=0.076 Sum_probs=66.0
Q ss_pred cCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCcc-CcccCCCCcccc----ccccceeeccCCc-CcCCC
Q 042634 37 IPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNN-LTGTTPTEVIGL----SSLSIYLDLSQNQ-LNGPL 110 (427)
Q Consensus 37 ~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~-~~~~~p~~~~~l----~~l~~~L~l~~n~-~~~~~ 110 (427)
+|.....--+|+.||++++.++..--..+.++++|++|+|++|. ++..-=..+..+ ++| ++|+|++|. ++..-
T Consensus 53 LP~~~~~~~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L-~~L~Ls~C~~ITD~G 131 (176)
T 3e4g_A 53 LPTGPLDKYKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSM-LEMEIISCGNVTDKG 131 (176)
T ss_dssp SCCCSTTCCCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHC-CEEEEESCTTCCHHH
T ss_pred CCcccCCCceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCC-CEEEcCCCCcCCHHH
Confidence 45433333479999999999986555668899999999999996 552211223332 357 689999986 76432
Q ss_pred CCCCcCCCCCCeEECcCCc-cc
Q 042634 111 PSNFGILKNLGAIDISENK-LS 131 (427)
Q Consensus 111 p~~~~~l~~L~~l~l~~n~-~~ 131 (427)
=..+.++++|+.|+++++. ++
T Consensus 132 l~~L~~~~~L~~L~L~~c~~It 153 (176)
T 3e4g_A 132 IIALHHFRNLKYLFLSDLPGVK 153 (176)
T ss_dssp HHHGGGCTTCCEEEEESCTTCC
T ss_pred HHHHhcCCCCCEEECCCCCCCC
Confidence 2456789999999999874 44
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.07 E-value=0.001 Score=52.82 Aligned_cols=15 Identities=20% Similarity=0.251 Sum_probs=6.3
Q ss_pred CCCCCCeEECcCCcc
Q 042634 116 ILKNLGAIDISENKL 130 (427)
Q Consensus 116 ~l~~L~~l~l~~n~~ 130 (427)
.+++|+.|+|++|.+
T Consensus 53 ~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 53 ALPALRTAHLGANPW 67 (130)
T ss_dssp GCTTCCEEECCSSCC
T ss_pred hccccCEEEecCCCe
Confidence 333444444444433
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.03 E-value=0.00068 Score=53.88 Aligned_cols=54 Identities=17% Similarity=0.179 Sum_probs=25.0
Q ss_pred Eeeeecccce-eecCcchhccccCCEeeeccccCcccCCcC-ccCCCCCCeEEccCccC
Q 042634 25 RLTLEMNKFW-GEIPSSIGNLTLLITLNFAENMLEGSIPSS-LGKCQNLILLDLSNNNL 81 (427)
Q Consensus 25 ~L~l~~n~~~-~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~-~~~l~~L~~l~l~~N~~ 81 (427)
.++-+++.++ ..+|..+ -++|+.|+|++|+|+ .+|.. |..+++|++|+|++|.+
T Consensus 12 ~v~Cs~~~L~~~~vP~~l--p~~l~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAF--PVDTTELVLTGNNLT-ALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp EEECCSSCCCTTTSCSCC--CTTCSEEECTTSCCS-SCCTTTGGGCTTCCEEECCSSCC
T ss_pred EEEeCCCCCccccCCCCC--CcCCCEEECCCCcCC-ccChhhhhhccccCEEEecCCCe
Confidence 4455555543 1344332 123555555555555 34332 34455555555555544
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=96.96 E-value=0.00074 Score=62.26 Aligned_cols=32 Identities=28% Similarity=0.452 Sum_probs=26.0
Q ss_pred CCCeeeccccCCceeeCC---CCc-eEecccccccc
Q 042634 252 ETPIVHCDLKPSNVLLDG---ELT-AHVGDFGLAKF 283 (427)
Q Consensus 252 ~~~ivHrDlkp~NIll~~---~~~-~kL~DFG~a~~ 283 (427)
...++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 189 ~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 189 TPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp CCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred CCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 346799999999999987 344 58999998754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.92 E-value=0.0019 Score=55.49 Aligned_cols=99 Identities=14% Similarity=0.101 Sum_probs=62.9
Q ss_pred CcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccccCCceeeCCCCceEecccccccccCCcCCCcc
Q 042634 213 SLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFF 292 (427)
Q Consensus 213 ~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~ 292 (427)
+|.+.|+... .++++.+++.++.|.+.+|.-.-. .+.-..+=+.|..|++..+|.+-..+ +.+. ....
T Consensus 34 SL~eIL~~~~---~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------~~~~ 101 (229)
T 2yle_A 34 SLEEILRLYN---QPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------AGEP 101 (229)
T ss_dssp EHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred cHHHHHHHcC---CCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc------cccc
Confidence 6777776544 679999999999999999877621 11111233456888898888887764 2211 1233
Q ss_pred ccccccccCCCCcCccccchhHHHHHHHHHhC
Q 042634 293 NFQIAEYGMGSEVSTSGDVYSFGILLLETFTG 324 (427)
Q Consensus 293 ~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g 324 (427)
.+.|||... ...+.+.=|||+|+++|..+--
T Consensus 102 ~~~~pe~~~-~~~te~~~IysLG~tLY~ALDy 132 (229)
T 2yle_A 102 PPVAGKLGY-SQCMETEVIESLGIIIYKALDY 132 (229)
T ss_dssp -----CCSS-SSSCHHHHHHHHHHHHHHHHTT
T ss_pred CCCChhhcc-ccchHHHHHHHHHHHHHHHhhc
Confidence 466888763 3446778899999999998863
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.56 E-value=0.00024 Score=60.54 Aligned_cols=63 Identities=16% Similarity=0.173 Sum_probs=30.1
Q ss_pred CCCCCEeeeecc-ccee----ecCcchhccccCCEeeeccccCcccCCcCcc----CCCCCCeEEccCccCc
Q 042634 20 LHKLQRLTLEMN-KFWG----EIPSSIGNLTLLITLNFAENMLEGSIPSSLG----KCQNLILLDLSNNNLT 82 (427)
Q Consensus 20 l~~L~~L~l~~n-~~~~----~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~----~l~~L~~l~l~~N~~~ 82 (427)
-+.|+.|+|++| .+.. .+-..+..=+.|+.|+|++|.++..--..+. .=++|++|+|++|.|.
T Consensus 40 n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig 111 (197)
T 1pgv_A 40 DTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 111 (197)
T ss_dssp CSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred CCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCC
Confidence 345666666653 4431 1223344445566666666666532222222 2234555555555554
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=96.35 E-value=0.0017 Score=58.38 Aligned_cols=29 Identities=21% Similarity=0.286 Sum_probs=25.8
Q ss_pred eeeccccCCceeeCCCCceEecccccccc
Q 042634 255 IVHCDLKPSNVLLDGELTAHVGDFGLAKF 283 (427)
Q Consensus 255 ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 283 (427)
++|+|+.+.||+++.++.+-|+||+.+..
T Consensus 195 l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 195 VTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp EECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred EEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 79999999999999887778999998753
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.35 E-value=0.00047 Score=58.73 Aligned_cols=81 Identities=12% Similarity=0.126 Sum_probs=56.3
Q ss_pred CeeecCC-ccccc----CCccccCCCCCCEeeeecccceeecCc----chhccccCCEeeeccccCcccC----CcCccC
Q 042634 1 AFTLVGN-QFTGR----IPGSIGDLHKLQRLTLEMNKFWGEIPS----SIGNLTLLITLNFAENMLEGSI----PSSLGK 67 (427)
Q Consensus 1 ~l~l~~n-~l~~~----~p~~~~~l~~L~~L~l~~n~~~~~~p~----~~~~l~~L~~L~l~~n~l~~~~----p~~~~~ 67 (427)
+|+|++| ++... +-..+..=+.|+.|+|++|.+...--. .+..=+.|+.|+|++|.|+..- -..+..
T Consensus 45 ~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~ 124 (197)
T 1pgv_A 45 EVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLV 124 (197)
T ss_dssp EEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTT
T ss_pred EEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHHHHHHhh
Confidence 3788885 77532 335567778999999999999743323 3445578999999999999532 223334
Q ss_pred CCCCCeEEccCccC
Q 042634 68 CQNLILLDLSNNNL 81 (427)
Q Consensus 68 l~~L~~l~l~~N~~ 81 (427)
=+.|++|+|++|..
T Consensus 125 N~tL~~L~L~n~~~ 138 (197)
T 1pgv_A 125 TQSIVEFKADNQRQ 138 (197)
T ss_dssp TCCCSEEECCCCSS
T ss_pred CCceeEEECCCCcC
Confidence 45688888886533
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=96.33 E-value=0.0065 Score=57.03 Aligned_cols=32 Identities=22% Similarity=0.256 Sum_probs=27.1
Q ss_pred CCCeeeccccCCceeeCCCCceEecccccccc
Q 042634 252 ETPIVHCDLKPSNVLLDGELTAHVGDFGLAKF 283 (427)
Q Consensus 252 ~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 283 (427)
...++|+|+.+.||+++++..+.|+||+.+..
T Consensus 221 ~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 221 EPVLLWGDARVGNVLYRDFQPVAVLDWEMVAL 252 (357)
T ss_dssp CCEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred CceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence 45789999999999999655679999998854
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=95.39 E-value=0.017 Score=53.62 Aligned_cols=31 Identities=23% Similarity=0.239 Sum_probs=28.2
Q ss_pred CCCeeeccccCCceeeCCCCceEeccccccc
Q 042634 252 ETPIVHCDLKPSNVLLDGELTAHVGDFGLAK 282 (427)
Q Consensus 252 ~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~ 282 (427)
..+++|+|+++.||+++.++.+.|+||+.+.
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 5789999999999999888899999999774
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=94.35 E-value=0.04 Score=52.94 Aligned_cols=72 Identities=14% Similarity=0.093 Sum_probs=48.1
Q ss_pred CCCeeeccccCCceeeCCCCceEecccccccccCCcC-C------CccccccccccCCCC---cCccccchhHHHHHHHH
Q 042634 252 ETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEAT-N------NFFNFQIAEYGMGSE---VSTSGDVYSFGILLLET 321 (427)
Q Consensus 252 ~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~-~------~~~~y~aPE~~~~~~---~~~~~DiwS~G~vl~el 321 (427)
...++|+|++|.|||++.++ ++++||+.+....... . -...|++|+...... -....++.+....+|+.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 78899999999999998776 9999999987654321 1 113466666543211 12234455777777777
Q ss_pred HhC
Q 042634 322 FTG 324 (427)
Q Consensus 322 l~g 324 (427)
+.+
T Consensus 310 y~~ 312 (420)
T 2pyw_A 310 FNK 312 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 665
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=93.54 E-value=0.15 Score=46.38 Aligned_cols=30 Identities=23% Similarity=0.315 Sum_probs=25.1
Q ss_pred CCeeeccccCCceeeCCCCceEecccccccc
Q 042634 253 TPIVHCDLKPSNVLLDGELTAHVGDFGLAKF 283 (427)
Q Consensus 253 ~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 283 (427)
..++|+|+.+.||+ ..++.+.++||..+..
T Consensus 173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 173 LAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred ceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 45899999999999 5566789999988754
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=92.04 E-value=0.18 Score=46.51 Aligned_cols=32 Identities=34% Similarity=0.352 Sum_probs=28.0
Q ss_pred CCCeeeccccCCceeeCCC----CceEecccccccc
Q 042634 252 ETPIVHCDLKPSNVLLDGE----LTAHVGDFGLAKF 283 (427)
Q Consensus 252 ~~~ivHrDlkp~NIll~~~----~~~kL~DFG~a~~ 283 (427)
...++|+|+.+.||+++.+ ..+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 5689999999999999874 6889999998864
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=91.12 E-value=0.064 Score=49.26 Aligned_cols=31 Identities=29% Similarity=0.384 Sum_probs=26.9
Q ss_pred CCCeeeccccCCceeeCCCCceEeccccccc
Q 042634 252 ETPIVHCDLKPSNVLLDGELTAHVGDFGLAK 282 (427)
Q Consensus 252 ~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~ 282 (427)
..+++|+|+++.||+++.+..+.++||+.+.
T Consensus 186 ~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 186 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 4679999999999999987667899998775
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=91.07 E-value=0.22 Score=45.75 Aligned_cols=30 Identities=20% Similarity=0.197 Sum_probs=26.1
Q ss_pred CCCeeeccccCCceeeCCCCceEecccccccc
Q 042634 252 ETPIVHCDLKPSNVLLDGELTAHVGDFGLAKF 283 (427)
Q Consensus 252 ~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 283 (427)
...++|+|+++.||+++ + .+.++||+.+..
T Consensus 194 ~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 194 TVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred CeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 56789999999999999 4 899999988754
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=87.46 E-value=0.52 Score=44.77 Aligned_cols=29 Identities=24% Similarity=0.416 Sum_probs=24.2
Q ss_pred eeeccccCCceee------CCCCceEecccccccc
Q 042634 255 IVHCDLKPSNVLL------DGELTAHVGDFGLAKF 283 (427)
Q Consensus 255 ivHrDlkp~NIll------~~~~~~kL~DFG~a~~ 283 (427)
++|+|+.+.|||+ +++..++++||-.|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5699999999999 4567899999987753
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=86.53 E-value=0.61 Score=45.20 Aligned_cols=17 Identities=35% Similarity=0.653 Sum_probs=15.1
Q ss_pred CCCeeeccccCCceeeC
Q 042634 252 ETPIVHCDLKPSNVLLD 268 (427)
Q Consensus 252 ~~~ivHrDlkp~NIll~ 268 (427)
...++|+|+.+.|||++
T Consensus 289 ~~v~cHnDl~~gNIL~~ 305 (458)
T 2qg7_A 289 PIVLCHCDLLSSNIINT 305 (458)
T ss_dssp CEEEECSCCCGGGEEEC
T ss_pred CeeEEecCCCCCcEEee
Confidence 34689999999999998
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=86.52 E-value=0.75 Score=43.46 Aligned_cols=31 Identities=19% Similarity=0.334 Sum_probs=26.8
Q ss_pred CCCeeeccccCCceeeCCCCceEecccccccc
Q 042634 252 ETPIVHCDLKPSNVLLDGELTAHVGDFGLAKF 283 (427)
Q Consensus 252 ~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 283 (427)
...++|+|+.+.||+++.+ .++++||..+..
T Consensus 226 ~~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~ 256 (397)
T 2olc_A 226 AETLIHGDLHTGSIFASEH-ETKVIDPEFAFY 256 (397)
T ss_dssp CCEEECSCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred CCceeeCCCCcCcEEEeCC-CeEEEeCccccc
Confidence 5789999999999999876 489999987764
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=86.47 E-value=0.28 Score=45.52 Aligned_cols=32 Identities=22% Similarity=0.346 Sum_probs=28.1
Q ss_pred CCCeeeccccCCceeeCCCCceEecccccccc
Q 042634 252 ETPIVHCDLKPSNVLLDGELTAHVGDFGLAKF 283 (427)
Q Consensus 252 ~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 283 (427)
...++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 45799999999999999888899999987754
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=85.39 E-value=0.34 Score=45.39 Aligned_cols=30 Identities=20% Similarity=0.309 Sum_probs=25.0
Q ss_pred CCCeeeccccCCceeeCCCCceEeccccccc
Q 042634 252 ETPIVHCDLKPSNVLLDGELTAHVGDFGLAK 282 (427)
Q Consensus 252 ~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~ 282 (427)
...++|+|+++.|||++.+. +.++||..|.
T Consensus 211 ~~~l~HgDl~~~Nil~~~~~-~~lID~e~a~ 240 (369)
T 3c5i_A 211 TIVFCHNDLQENNIINTNKC-LRLIDFEYSG 240 (369)
T ss_dssp CEEEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred CeEEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence 45789999999999998655 8999998775
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=84.20 E-value=0.51 Score=45.32 Aligned_cols=31 Identities=29% Similarity=0.356 Sum_probs=24.8
Q ss_pred CCCeeeccccCCceeeCCC----------------------------CceEeccccccc
Q 042634 252 ETPIVHCDLKPSNVLLDGE----------------------------LTAHVGDFGLAK 282 (427)
Q Consensus 252 ~~~ivHrDlkp~NIll~~~----------------------------~~~kL~DFG~a~ 282 (427)
...++|+|+.+.|||++.+ ..+.++||..|.
T Consensus 248 ~~v~~H~Dl~~gNiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lIDfEya~ 306 (429)
T 1nw1_A 248 PVTFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYAS 306 (429)
T ss_dssp CEEEECSCCCGGGEEEEC------------------------------CCEECCCTTCE
T ss_pred CeEEEeCCCCCCeEEeeCCccccccccccccccccccccccccccCCCeEEEEecccCC
Confidence 3568999999999999875 678899998775
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 427 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-37 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-33 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-32 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-31 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-30 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-30 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-30 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-28 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-28 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-28 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-27 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-27 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-27 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-27 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-27 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-26 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-26 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-26 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 7e-26 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-25 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-25 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-25 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-25 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-25 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-24 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-24 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-23 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-23 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-23 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-23 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-23 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-23 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 7e-23 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-22 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 8e-22 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-21 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-21 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-21 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-21 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-21 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-21 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-21 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 9e-20 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-19 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-18 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-18 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-18 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-17 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-17 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-17 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-17 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 8e-17 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-16 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-16 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-16 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-14 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 0.003 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 0.003 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 9e-16 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-15 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-15 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-15 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-14 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-14 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-13 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-13 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-12 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-11 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-10 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-09 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-07 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-10 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-08 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-08 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-04 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-04 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 0.002 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 9e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 7e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.002 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 8e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-04 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 3e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 0.002 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 0.002 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (342), Expect = 1e-37
Identities = 52/256 (20%), Positives = 93/256 (36%), Gaps = 51/256 (19%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
RH N++ + + A+V ++ SL LH +++ + IA
Sbjct: 61 TRHVNILLFM------GYSTAPQLAIVTQWCEGSSLYHHLHIIE---TKFEMIKLIDIAR 111
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNN-------- 290
A +DYLH I+H DLK +N+ L +LT +GDFGLA + +
Sbjct: 112 QTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSG 168
Query: 291 ---FFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEALP 347
+ ++ + S DVY+FGI+L E TG+ P + + + + + L
Sbjct: 169 SILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLS 228
Query: 348 ERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM 407
L+++ C ++ + C + ER
Sbjct: 229 PDLSKVRS----------------------------NCPKAMKRLMAECLKKKRDERPLF 260
Query: 408 EEVAAQLLSFRNKLVK 423
++ A + L K
Sbjct: 261 PQILASIELLARSLPK 276
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (311), Expect = 2e-33
Identities = 44/188 (23%), Positives = 71/188 (37%), Gaps = 13/188 (6%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
++H N+V+ + N + +V E+ G L + + + L+ L +
Sbjct: 60 LKHPNIVRYYDRIID---RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 116
Query: 239 DVASALDYLH--HYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQI 296
+ AL H ++H DLKP+NV LDG+ +GDFGLA+ L T+ F
Sbjct: 117 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVG 176
Query: 297 A------EYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEALPERL 350
E + D++S G LL E P L ++E R+
Sbjct: 177 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF--SQKELAGKIREGKFRRI 234
Query: 351 AEIVDPVL 358
L
Sbjct: 235 PYRYSDEL 242
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 3e-32
Identities = 43/247 (17%), Positives = 80/247 (32%), Gaps = 27/247 (10%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+V + + ++ E M GSL++ L + +++
Sbjct: 61 CNSPYIVGFYGAF-----YSDGEISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSI 111
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNN----FFNF 294
V L YL I+H D+KPSN+L++ + DFG++ L ++ N ++
Sbjct: 112 AVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSY 169
Query: 295 QIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEALPERLAEIV 354
E G+ S D++S G+ L+E G+ P L L F + +
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL-MFGCQVEGDAAETPP 228
Query: 355 DPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSEL-----------PRE 403
P + S E P E
Sbjct: 229 RPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAE 288
Query: 404 RMNMEEV 410
R +++++
Sbjct: 289 RADLKQL 295
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 2e-31
Identities = 46/259 (17%), Positives = 83/259 (32%), Gaps = 43/259 (16%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+RH N++ I + + D LV ++ +GSL ++L+ + + + +A+
Sbjct: 54 LRHENILGFIAAD-NKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLAL 107
Query: 239 DVASALDYLHHYC-----ETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFN 293
AS L +LH + I H DLK N+L+ T + D GLA AT+
Sbjct: 108 STASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDI 167
Query: 294 ----------------FQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLT 337
+ E D+Y+ G++ E L
Sbjct: 168 APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227
Query: 338 LHNFVKE--ALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVT 395
++ V ++ E + + L + E L + I
Sbjct: 228 YYDLVPSDPSVEEMRKVVCEQKL--------------RPNIPNRWQSCEALRVMAKIMRE 273
Query: 396 CSSELPRERMNMEEVAAQL 414
C R+ + L
Sbjct: 274 CWYANGAARLTALRIKKTL 292
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 2e-30
Identities = 46/185 (24%), Positives = 74/185 (40%), Gaps = 12/185 (6%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
++H N+V+ S S +G LV E M +G+L+ +L K + + S
Sbjct: 65 LQHPNIVRFYDSWES-TVKGKKCIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCR 119
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGEL-TAHVGDFGLAKFLPEATNNFF----N 293
+ L +LH PI+H DLK N+ + G + +GD GLA +
Sbjct: 120 QILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPE 178
Query: 294 FQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEALPERLAEI 353
F E + S DVY+FG+ +LE T + P +E P ++
Sbjct: 179 FMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV 237
Query: 354 VDPVL 358
P +
Sbjct: 238 AIPEV 242
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 3e-30
Identities = 54/244 (22%), Positives = 82/244 (33%), Gaps = 44/244 (18%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+RH NLV+++ + +V E+M GSL ++L L L ++
Sbjct: 57 LRHSNLVQLLGVI----VEEKGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSL 110
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFF---NFQ 295
DV A++YL VH DL NVL+ + A V DFGL K + +
Sbjct: 111 DVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT 167
Query: 296 IAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEALPERLAEIVD 355
E + ST DV+SFGILL E ++ R + K +
Sbjct: 168 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPP 227
Query: 356 PVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAAQLL 415
V V +K C R + ++ QL
Sbjct: 228 AVYEV---------------------MKNCW-----------HLDAAMRPSFLQLREQLE 255
Query: 416 SFRN 419
+
Sbjct: 256 HIKT 259
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 4e-30
Identities = 46/246 (18%), Positives = 88/246 (35%), Gaps = 50/246 (20%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
++H+ LV++ + ++ E+M NGSL ++L L + + L +A
Sbjct: 65 LQHQRLVRLY------AVVTQEPIYIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAA 116
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNF------- 291
+A + ++ +H DL+ +N+L+ L+ + DFGLA+ + +
Sbjct: 117 QIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP 173
Query: 292 FNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEALPERLA 351
+ E + DV+SFGILL E T R T + N + R
Sbjct: 174 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD 233
Query: 352 EIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVA 411
+ + + ++ C E P +R + +
Sbjct: 234 NCPEELYQL---------------------MRLCW-----------KERPEDRPTFDYLR 261
Query: 412 AQLLSF 417
+ L F
Sbjct: 262 SVLEDF 267
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (277), Expect = 2e-28
Identities = 53/243 (21%), Positives = 85/243 (34%), Gaps = 50/243 (20%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+RH LV++ + +V E+M GSL ++L K L L Q + +A
Sbjct: 69 LRHEKLVQLY------AVVSEEPIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAA 120
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNF------- 291
+AS + Y+ VH DL+ +N+L+ L V DFGLA+ + +
Sbjct: 121 QIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP 177
Query: 292 FNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEALPERLA 351
+ E + + DV+SFGILL E T R L +
Sbjct: 178 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPP 237
Query: 352 EIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVA 411
E + + + + +C + P ER E +
Sbjct: 238 ECPESLHDL---------------------MCQCW-----------RKEPEERPTFEYLQ 265
Query: 412 AQL 414
A L
Sbjct: 266 AFL 268
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 4e-28
Identities = 40/208 (19%), Positives = 66/208 (31%), Gaps = 35/208 (16%)
Query: 178 FIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKN---------- 227
H N+V ++ +C + L++E+ G L +L RE
Sbjct: 97 LGSHENIVNLLGAC-----TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 151
Query: 228 ---------LNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDF 278
L L A VA +++L VH DL NVL+ + DF
Sbjct: 152 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDF 208
Query: 279 GLAKFLPEATNNFFNFQIA--------EYGMGSEVSTSGDVYSFGILLLETFTGKRPTNE 330
GLA+ + +N E + DV+S+GILL E F+
Sbjct: 209 GLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268
Query: 331 MFTGNLTLHNFVKEALPERLAEIVDPVL 358
+ + ++ +
Sbjct: 269 GIPVDANFYKLIQNGFKMDQPFYATEEI 296
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 6e-28
Identities = 45/257 (17%), Positives = 85/257 (33%), Gaps = 55/257 (21%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+ + +V++I C + LV E G L ++L R + + + +
Sbjct: 66 LDNPYIVRLIGVCQAEAL------MLVMEMAGGGPLHKFLVGKR---EEIPVSNVAELLH 116
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIA- 297
V+ + YL VH DL NVLL A + DFGL+K L + +
Sbjct: 117 QVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 298 --------EYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNEMFTGNLTLHNFVKEALPE 348
E + S+ DV+S+G+ + E + G++P +M + F+++
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM--KGPEVMAFIEQGKRM 231
Query: 349 RLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME 408
P L + +C +R +
Sbjct: 232 ECPPECPPEL---------------YAL-----MSDCW-----------IYKWEDRPDFL 260
Query: 409 EVAAQLLSFRNKLVKNI 425
V ++ + L +
Sbjct: 261 TVEQRMRACYYSLASKV 277
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (269), Expect = 3e-27
Identities = 34/160 (21%), Positives = 61/160 (38%), Gaps = 22/160 (13%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
H N+VK++ + ++ ++ EF G+++ + + L Q +
Sbjct: 66 CDHPNIVKLLDAFYY-----ENNLWILIEFCAGGAVDAVMLELE---RPLTESQIQVVCK 117
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQ--- 295
AL+YLH + I+H DLK N+L + + DFG++ +F
Sbjct: 118 QTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTP 174
Query: 296 --------IAEYGMGSEVSTSGDVYSFGILLLETFTGKRP 327
+ E DV+S GI L+E + P
Sbjct: 175 YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 214
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 108 bits (270), Expect = 3e-27
Identities = 51/258 (19%), Positives = 100/258 (38%), Gaps = 60/258 (23%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
H N++ + + ++ EFM NGSL+ +L N ++Q + +
Sbjct: 84 FDHPNVIHLEGVV-----TKSTPVMIITEFMENGSLDSFLRQND---GQFTVIQLVGMLR 135
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIA- 297
+A+ + YL VH DL N+L++ L V DFGL++FL + T++
Sbjct: 136 GIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALG 192
Query: 298 ----------EYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNEMFTGNLTLHNFVKEAL 346
E + +++ DV+S+GI++ E + G+RP +M ++
Sbjct: 193 GKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV---------- 242
Query: 347 PERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMN 406
NA +Q R +C ++ + + C + R
Sbjct: 243 -----------------------INAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPK 279
Query: 407 MEEVAAQLLSFRNKLVKN 424
++ L +K+++N
Sbjct: 280 FGQIVNTL----DKMIRN 293
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (267), Expect = 4e-27
Identities = 36/195 (18%), Positives = 71/195 (36%), Gaps = 21/195 (10%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+RH N++++ L+ E+ G++ L + + +
Sbjct: 63 LRHPNILRLYGYF-----HDATRVYLILEYAPLGTVYRELQKLS----KFDEQRTATYIT 113
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIA- 297
++A+AL Y H ++H D+KP N+LL + DFG + P + +
Sbjct: 114 ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDY 170
Query: 298 ---EYGMGSEVSTSGDVYSFGILLLETFTGKRP-----TNEMFTGNLTLHNFVKEALPER 349
E G D++S G+L E GK P E + + + + E
Sbjct: 171 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG 230
Query: 350 LAEIVDPVLLVEREE 364
+++ +L +
Sbjct: 231 ARDLISRLLKHNPSQ 245
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 107 bits (267), Expect = 6e-27
Identities = 51/264 (19%), Positives = 91/264 (34%), Gaps = 68/264 (25%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLH------------------- 219
+ N+VK++ CA L++E+M G L E+L
Sbjct: 73 FDNPNIVKLLGVCAV-----GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 127
Query: 220 -PNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDF 278
+ L+ ++L IA VA+ + YL VH DL N L+ + + DF
Sbjct: 128 RVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADF 184
Query: 279 GLAKFLPEATNNF--------FNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNE 330
GL++ + A + E + +T DV+++G++L E F+
Sbjct: 185 GLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP-- 242
Query: 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVL 390
+ A E + + D +L E C + +
Sbjct: 243 ----------YYGMAHEEVIYYVRDGNILACPEN--------------------CPLELY 272
Query: 391 GIGVTCSSELPRERMNMEEVAAQL 414
+ C S+LP +R + + L
Sbjct: 273 NLMRLCWSKLPADRPSFCSIHRIL 296
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 107 bits (268), Expect = 7e-27
Identities = 36/185 (19%), Positives = 66/185 (35%), Gaps = 18/185 (9%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+RH N ++ + LV E+ + + + K L ++ ++
Sbjct: 72 LRHPNTIQYRGCY-----LREHTAWLVMEYCLGSASDLLEVHK----KPLQEVEIAAVTH 122
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA-----TNNFFN 293
L YLH + ++H D+K N+LL +GDFG A + A T +
Sbjct: 123 GALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMA 179
Query: 294 FQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEALPERLAEI 353
++ + DV+S GI +E K P M + L++ + P +
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQNESPALQSGH 238
Query: 354 VDPVL 358
Sbjct: 239 WSEYF 243
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (264), Expect = 2e-26
Identities = 43/255 (16%), Positives = 83/255 (32%), Gaps = 52/255 (20%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
H N++ ++ C + S +V +M +G L ++ N + + +
Sbjct: 85 FSHPNVLSLLGIC----LRSEGSPLVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGL 137
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIA- 297
VA + VH DL N +LD + T V DFGLA+ + + + + +
Sbjct: 138 QVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 194
Query: 298 ---------EYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEALPE 348
E + +T DV+SFG+LL E T P ++
Sbjct: 195 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL 254
Query: 349 RLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME 408
+ DP+ V + +C R +
Sbjct: 255 QPEYCPDPLYEV---------------------MLKCW-----------HPKAEMRPSFS 282
Query: 409 EVAAQLLSFRNKLVK 423
E+ +++ + + +
Sbjct: 283 ELVSRISAIFSTFIG 297
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (260), Expect = 3e-26
Identities = 49/244 (20%), Positives = 86/244 (35%), Gaps = 50/244 (20%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+ H LV++ C ++ E+M NG L +L R Q L +
Sbjct: 56 LSHEKLVQLYGVCTK-----QRPIFIITEYMANGCLLNYLREMR---HRFQTQQLLEMCK 107
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIA- 297
DV A++YL +H DL N L++ + V DFGL++++ +
Sbjct: 108 DVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP 164
Query: 298 ------EYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEALPERLA 351
E M S+ S+ D+++FG+L+ E ++ + E FT N + + L
Sbjct: 165 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT-NSETAEHIAQGLRLYRP 223
Query: 352 EIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVA 411
+ V I +C E ER + +
Sbjct: 224 HLASE-------------------------------KVYTIMYSCWHEKADERPTFKILL 252
Query: 412 AQLL 415
+ +L
Sbjct: 253 SNIL 256
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 3e-26
Identities = 44/259 (16%), Positives = 77/259 (29%), Gaps = 61/259 (23%)
Query: 178 FIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNR--------------E 223
H N+V ++ +C ++ E+ G L +L R +
Sbjct: 83 LGNHMNIVNLLGAC-----TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137
Query: 224 ALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKF 283
L+L LS + VA + +L +H DL N+LL + DFGLA+
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARD 194
Query: 284 LPEATNNFFNFQIA--------EYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGN 335
+ +N E + DV+S+GI L E F+ +
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254
Query: 336 LTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVT 395
+ +KE E + +K C
Sbjct: 255 SKFYKMIKEGFRMLSPEHAPAEM---------------YDI-----MKTCW--------- 285
Query: 396 CSSELPRERMNMEEVAAQL 414
P +R +++ +
Sbjct: 286 --DADPLKRPTFKQIVQLI 302
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 7e-26
Identities = 48/243 (19%), Positives = 80/243 (32%), Gaps = 50/243 (20%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+ H LV++ C LV+EFM +G L ++L R L + +
Sbjct: 57 LSHPKLVQLYGVC-----LEQAPICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCL 108
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIA- 297
DV + + E ++H DL N L+ V DFG+ +F+ +
Sbjct: 109 DVCEGM---AYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP 165
Query: 298 ------EYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEALPERLA 351
E S S+ DV+SFG+L+ E F+ + E + + + +
Sbjct: 166 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG------F 219
Query: 352 EIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVA 411
+ P + V I C E P +R +
Sbjct: 220 RLYKP--------------------------RLASTHVYQIMNHCWKERPEDRPAFSRLL 253
Query: 412 AQL 414
QL
Sbjct: 254 RQL 256
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 103 bits (257), Expect = 1e-25
Identities = 50/249 (20%), Positives = 91/249 (36%), Gaps = 49/249 (19%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
I+H NLV+++ C ++ EFM G+L ++L + ++ + L +A
Sbjct: 70 IKHPNLVQLLGVC-----TREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMAT 122
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNN-------F 291
++SA++YL +H DL N L+ V DFGL++ + T
Sbjct: 123 QISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 179
Query: 292 FNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEALPERLA 351
+ E ++ S DV++FG+LL E T ++
Sbjct: 180 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS-------------PYPGIDLSQVY 226
Query: 352 EIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVA 411
E+++ +ER EG C V + C P +R + E+
Sbjct: 227 ELLEKDYRMERPEG-------------------CPEKVYELMRACWQWNPSDRPSFAEIH 267
Query: 412 AQLLSFRNK 420
+ +
Sbjct: 268 QAFETMFQE 276
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 104 bits (260), Expect = 2e-25
Identities = 37/156 (23%), Positives = 62/156 (39%), Gaps = 18/156 (11%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+RH LV + + F+ ++ ++YEFM G L E + ++ + +
Sbjct: 80 LRHPTLVNLHDA-----FEDDNEMVMIYEFMSGGELFEKVADEH---NKMSEDEAVEYMR 131
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHV--GDFGLAKFLPEATNNFFNFQI 296
V L ++H VH DLKP N++ + + + DFGL L +
Sbjct: 132 QVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGT 188
Query: 297 A-----EYGMGSEVSTSGDVYSFGILLLETFTGKRP 327
A E G V D++S G+L +G P
Sbjct: 189 AEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 224
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 4e-25
Identities = 47/248 (18%), Positives = 82/248 (33%), Gaps = 54/248 (21%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+ + +V++I +S LV E G L ++L NR ++ + +
Sbjct: 65 LDNPYIVRMI------GICEAESWMLVMEMAELGPLNKYLQQNR----HVKDKNIIELVH 114
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNF------- 291
V+ + YL + VH DL NVLL + A + DFGL+K L N +
Sbjct: 115 QVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 171
Query: 292 --FNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEALPER 349
+ E + S+ DV+SFG+L+ E F+ + G+ K
Sbjct: 172 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC 231
Query: 350 LAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEE 409
A + + + C + R
Sbjct: 232 PAGCPREMYDL---------------------MNLCW-----------TYDVENRPGFAA 259
Query: 410 VAAQLLSF 417
V +L ++
Sbjct: 260 VELRLRNY 267
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 6e-25
Identities = 34/176 (19%), Positives = 63/176 (35%), Gaps = 20/176 (11%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
++ N+V + S D +V E++ GSL + + Q ++
Sbjct: 74 NKNPNIVNYLDSY-----LVGDELWVVMEYLAGGSLTDVVTETCMDEG-----QIAAVCR 123
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIA- 297
+ AL++LH ++H D+K N+LL + + + DFG + +
Sbjct: 124 ECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTP 180
Query: 298 -----EYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEALPE 348
E D++S GI+ +E G+ P L+ PE
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE-NPLRALYLIATNGTPE 235
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (251), Expect = 7e-25
Identities = 38/190 (20%), Positives = 67/190 (35%), Gaps = 21/190 (11%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+ H N+VK + + + L E+ G L + + P+ +
Sbjct: 60 LNHENVVKFYGHR-----REGNIQYLFLEYCSGGELFDRIEPD----IGMPEPDAQRFFH 110
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIA- 297
+ + + YLH I H D+KP N+LLD + DFGLA ++
Sbjct: 111 QLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG 167
Query: 298 -------EYGMGSEVST-SGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEALPER 349
E E DV+S GI+L G+ P ++ ++ ++
Sbjct: 168 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN 227
Query: 350 LAEIVDPVLL 359
+ +D L
Sbjct: 228 PWKKIDSAPL 237
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 1e-24
Identities = 46/253 (18%), Positives = 82/253 (32%), Gaps = 59/253 (23%)
Query: 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPN------------REALKN 227
H N++ ++ +C + L E+ +G+L ++L +
Sbjct: 69 HHPNIINLLGAC-----EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 123
Query: 228 LNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA 287
L+ Q L A DVA + + + +H DL N+L+ A + DFGL++
Sbjct: 124 LSSQQLLHFAADVARGM---DYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY 180
Query: 288 TNNF-----FNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFV 342
+ E S +T+ DV+S+G+LL E + T
Sbjct: 181 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 240
Query: 343 KEALPERLAEIVDPVL-LVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELP 401
+ E+ D V L+ + C E P
Sbjct: 241 QGYRLEKPLNCDDEVYDLMRQ---------------------------------CWREKP 267
Query: 402 RERMNMEEVAAQL 414
ER + ++ L
Sbjct: 268 YERPSFAQILVSL 280
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 2e-24
Identities = 35/157 (22%), Positives = 62/157 (39%), Gaps = 20/157 (12%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+ H VK+ + FQ ++ + NG L +++ + +
Sbjct: 65 LDHPFFVKLYFT-----FQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTA 115
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIA- 297
++ SAL+YLH I+H DLKP N+LL+ ++ + DFG AK L +
Sbjct: 116 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 172
Query: 298 -------EYGMGSEVSTSGDVYSFGILLLETFTGKRP 327
E S D+++ G ++ + G P
Sbjct: 173 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 209
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.5 bits (242), Expect = 1e-23
Identities = 52/246 (21%), Positives = 83/246 (33%), Gaps = 52/246 (21%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+ HRNL+++ +V E GSL + L ++ + L AV
Sbjct: 68 LDHRNLIRLYGVVL------TPPMKMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAV 118
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIA- 297
VA + YL +H DL N+LL +GDFGL + LP+ +++ +
Sbjct: 119 QVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 175
Query: 298 --------EYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEALPER 349
E S + D + FG+ L E FT + G+ LH KE
Sbjct: 176 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE--- 232
Query: 350 LAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEE 409
R ++C + + V C + P +R
Sbjct: 233 ----------------------------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVA 264
Query: 410 VAAQLL 415
+ LL
Sbjct: 265 LRDFLL 270
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.9 bits (243), Expect = 2e-23
Identities = 40/249 (16%), Positives = 81/249 (32%), Gaps = 52/249 (20%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+ + ++ +++ C + L+ + M G L +++ ++ N+ L+ V
Sbjct: 68 VDNPHVCRLLGICL------TSTVQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCV 118
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNF------- 291
+A ++YL +VH DL NVL+ + DFGLAK L +
Sbjct: 119 QIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 175
Query: 292 -FNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEALPERL 350
+ E + + DV+S+G+ + E T + +
Sbjct: 176 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-------------ASEI 222
Query: 351 AEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410
+ I++ + + C + V I V C R E+
Sbjct: 223 SSILEKGERLPQPP-------------------ICTIDVYMIMVKCWMIDADSRPKFREL 263
Query: 411 AAQLLSFRN 419
+
Sbjct: 264 IIEFSKMAR 272
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.4 bits (239), Expect = 3e-23
Identities = 38/245 (15%), Positives = 87/245 (35%), Gaps = 52/245 (21%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
H N++++ + ++ E+M NG+L+++ RE ++LQ + +
Sbjct: 66 FSHHNIIRLEGVISK-----YKPMMIITEYMENGALDKF---LREKDGEFSVLQLVGMLR 117
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIA- 297
+A+ + + VH DL N+L++ L V DFGL++ L + +
Sbjct: 118 GIAAGM---KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGK 174
Query: 298 --------EYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEALPER 349
E + +++ DV+SFGI++ E T +
Sbjct: 175 IPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-------------NHE 221
Query: 350 LAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEE 409
+ + ++ + +C ++ + + C + R +
Sbjct: 222 VMKAINDGFRLPTPM-------------------DCPSAIYQLMMQCWQQERARRPKFAD 262
Query: 410 VAAQL 414
+ + L
Sbjct: 263 IVSIL 267
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.4 bits (242), Expect = 3e-23
Identities = 37/156 (23%), Positives = 68/156 (43%), Gaps = 18/156 (11%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
RHRN++ + S F+ + +++EF+ + E ++ + LN + +S
Sbjct: 58 ARHRNILHLHES-----FESMEELVMIFEFISGLDIFERINTSA---FELNEREIVSYVH 109
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHV--GDFGLAKFLPEATNNF----- 291
V AL +LH I H D++P N++ ++ + +FG A+ L N
Sbjct: 110 QVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTA 166
Query: 292 FNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRP 327
+ E VST+ D++S G L+ +G P
Sbjct: 167 PEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.0 bits (238), Expect = 4e-23
Identities = 41/243 (16%), Positives = 79/243 (32%), Gaps = 51/243 (20%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
H ++VK+I + ++ E G L +L + +L+L + A
Sbjct: 65 FDHPHIVKLI------GVITENPVWIIMELCTLGELRSFLQVRK---YSLDLASLILYAY 115
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNF------- 291
+++AL YL VH D+ NVL+ +GDFGL++++ ++T
Sbjct: 116 QLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 172
Query: 292 FNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEALPERLA 351
+ E +++ DV+ FG+ + E + N +
Sbjct: 173 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP 232
Query: 352 EIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVA 411
+ + + +C + P R E+
Sbjct: 233 NCPPTLYSL---------------------MTKCW-----------AYDPSRRPRFTELK 260
Query: 412 AQL 414
AQL
Sbjct: 261 AQL 263
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 97.1 bits (241), Expect = 6e-23
Identities = 33/156 (21%), Positives = 61/156 (39%), Gaps = 18/156 (11%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+ H L+ + + F+ L+ EF+ G L + + ++ + ++
Sbjct: 83 LHHPKLINLHDA-----FEDKYEMVLILEFLSGGELFDRIAAED---YKMSEAEVINYMR 134
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHV--GDFGLAKFLPEATNNFFNFQI 296
L ++H E IVH D+KP N++ + + + V DFGLA L
Sbjct: 135 QACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTAT 191
Query: 297 AEYG-----MGSEVSTSGDVYSFGILLLETFTGKRP 327
AE+ V D+++ G+L +G P
Sbjct: 192 AEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 227
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 97.1 bits (241), Expect = 7e-23
Identities = 39/221 (17%), Positives = 79/221 (35%), Gaps = 25/221 (11%)
Query: 169 ENLDLSRNNFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNL 228
E + LS + +V + + F D + + + M G L L +
Sbjct: 54 ERIMLSLVSTGDCPFIVCMSYA-----FHTPDKLSFILDLMNGGDLHYHLSQHG----VF 104
Query: 229 NLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEAT 288
+ A ++ L+++H+ +V+ DLKP+N+LLD + D GLA +
Sbjct: 105 SEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 161
Query: 289 NNFFN-----FQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRP--------TNEMFTGN 335
+ G +S D +S G +L + G P +E+
Sbjct: 162 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT 221
Query: 336 LTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQF 376
LT+ + ++ L +++ +L + ++
Sbjct: 222 LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEV 262
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.9 bits (235), Expect = 2e-22
Identities = 42/250 (16%), Positives = 85/250 (34%), Gaps = 54/250 (21%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKN------LNLLQ 232
++V+++ ++ E M G L+ +L R A+ N +L +
Sbjct: 80 FNCHHVVRLLGVV-----SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134
Query: 233 RLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFF 292
+ +A ++A + YL+ VH DL N ++ + T +GDFG+ + + E
Sbjct: 135 MIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 191
Query: 293 NFQIA--------EYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKE 344
+ E +T DV+SFG++L E T + + L ++
Sbjct: 192 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG 251
Query: 345 ALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRER 404
L ++ C + + C P+ R
Sbjct: 252 GLLDK--------------------------------PDNCPDMLFELMRMCWQYNPKMR 279
Query: 405 MNMEEVAAQL 414
+ E+ + +
Sbjct: 280 PSFLEIISSI 289
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 92.5 bits (229), Expect = 8e-22
Identities = 41/204 (20%), Positives = 77/204 (37%), Gaps = 26/204 (12%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+ H +V + + + G +V E++ +L + +H + + + +
Sbjct: 64 LNHPAIVAVYDTGEAETPAGPLP-YIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIA 118
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIA- 297
D AL++ + I+H D+KP+N+++ V DFG+A+ + ++ N+
Sbjct: 119 DACQALNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 175
Query: 298 --------EYGMGSEVSTSGDVYSFGILLLETFTGKRP---------TNEMFTGNLTLHN 340
E G V DVYS G +L E TG+ P + + +
Sbjct: 176 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS 235
Query: 341 FVKEALPERLAEIVDPVLLVEREE 364
E L L +V L E
Sbjct: 236 ARHEGLSADLDAVVLKALAKNPEN 259
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.3 bits (228), Expect = 1e-21
Identities = 45/255 (17%), Positives = 78/255 (30%), Gaps = 58/255 (22%)
Query: 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLH------------PNREALKN 227
H N+V ++ +C + ++ EF G+L +L P
Sbjct: 75 HHLNVVNLLGAC----TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130
Query: 228 LNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA 287
L L + + VA +++L +H DL N+LL + + DFGLA+ + +
Sbjct: 131 LTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 187
Query: 288 TNNFFNFQIA--------EYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLH 339
+ E + DV+SFG+LL E F+ +
Sbjct: 188 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247
Query: 340 NFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSE 399
+KE R + P + + C
Sbjct: 248 RRLKEGTRMRAPDYTTP-------------------------------EMYQTMLDCWHG 276
Query: 400 LPRERMNMEEVAAQL 414
P +R E+ L
Sbjct: 277 EPSQRPTFSELVEHL 291
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 91.7 bits (227), Expect = 1e-21
Identities = 36/186 (19%), Positives = 71/186 (38%), Gaps = 23/186 (12%)
Query: 158 IPSSLSSLRGIENLDLSRNNFIRHRNLVKIITSCASV-----DFQGNDSEALVYEFMVNG 212
I + E + R ++ ++++ ++ ++ ++ N LV++ M G
Sbjct: 36 IDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKG 95
Query: 213 SLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELT 272
L ++L L+ + I + + LH + IVH DLKP N+LLD ++
Sbjct: 96 ELFDYLTEK----VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMN 148
Query: 273 AHVGDFGLAKFLPEATNN-----FFNFQIAEYGMGSEV------STSGDVYSFGILLLET 321
+ DFG + L ++ E S D++S G+++
Sbjct: 149 IKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTL 208
Query: 322 FTGKRP 327
G P
Sbjct: 209 LAGSPP 214
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.8 bits (227), Expect = 2e-21
Identities = 42/255 (16%), Positives = 85/255 (33%), Gaps = 60/255 (23%)
Query: 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNR------------EALKN 227
+H+N++ ++ +C + ++ E+ G+L E+L R +
Sbjct: 77 KHKNIINLLGACTQ-----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 228 LNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA 287
L+ +S A VA ++YL +H DL NVL+ + + DFGLA+ +
Sbjct: 132 LSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188
Query: 288 TNNFFNFQI--------AEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLH 339
E + DV+SFG+LL E FT
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 248
Query: 340 NFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSE 399
+ ++ + + + ++ +++C
Sbjct: 249 LLKEGHRMDKPSNCTNELYMM---------------------MRDCW-----------HA 276
Query: 400 LPRERMNMEEVAAQL 414
+P +R +++ L
Sbjct: 277 VPSQRPTFKQLVEDL 291
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.2 bits (228), Expect = 2e-21
Identities = 45/251 (17%), Positives = 82/251 (32%), Gaps = 34/251 (13%)
Query: 173 LSRNNFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQ 232
L H N+V++ C LV+E + +
Sbjct: 61 LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE---PGVPTET 117
Query: 233 RLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNF- 291
+ + LD+LH + +VH DLKP N+L+ + DFGLA+
Sbjct: 118 IKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS 174
Query: 292 ----FNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVK--EA 345
++ E + S +T D++S G + E F K F G+ + K +
Sbjct: 175 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL----FRGSSDVDQLGKILDV 230
Query: 346 LPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFS------VKECLVSVLGIGVTCSSE 399
+ E + + R+ + A ++F + +CL
Sbjct: 231 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFN---------- 280
Query: 400 LPRERMNMEEV 410
P +R++
Sbjct: 281 -PAKRISAYSA 290
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.5 bits (229), Expect = 2e-21
Identities = 37/157 (23%), Positives = 65/157 (41%), Gaps = 12/157 (7%)
Query: 179 IRHRNLVKIITSCASVDFQGNDS-EALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIA 237
+ H N+V++ S + ++ LV +++ H +R + L ++
Sbjct: 70 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK-QTLPVIYVKLYM 128
Query: 238 VDVASALDYLHHYCETPIVHCDLKPSNVLLDGE-LTAHVGDFGLAKFLPEATNNFFNFQI 296
+ +L Y+H + I H D+KP N+LLD + + DFG AK L N
Sbjct: 129 YQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 185
Query: 297 AEYGMGSEV------STSGDVYSFGILLLETFTGKRP 327
Y + ++S DV+S G +L E G+
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.1 bits (228), Expect = 2e-21
Identities = 31/157 (19%), Positives = 57/157 (36%), Gaps = 14/157 (8%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+ ++V+I+ ++ + G +V E + G L + + + + I
Sbjct: 62 SQCPHIVRIVDVYENL-YAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMK 118
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLD---GELTAHVGDFGLAKFLPEATNNFFNFQ 295
+ A+ YLH I H D+KP N+L + DFG AK +
Sbjct: 119 SIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY 175
Query: 296 IAEYG-----MGSEVSTSGDVYSFGILLLETFTGKRP 327
Y + S D++S G+++ G P
Sbjct: 176 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 212
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.9 bits (225), Expect = 5e-21
Identities = 43/197 (21%), Positives = 78/197 (39%), Gaps = 23/197 (11%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
H L + + Q ++ V E++ G L + + +L + A
Sbjct: 60 WEHPFLTHMFCTF-----QTKENLFFVMEYLNGGDLMYHIQSCHK----FDLSRATFYAA 110
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNF------F 292
++ L +LH IV+ DLK N+LLD + + DFG+ K
Sbjct: 111 EIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTP 167
Query: 293 NFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRP-----TNEMFTGNLTLHNFVKEALP 347
++ E +G + + S D +SFG+LL E G+ P E+F + F L
Sbjct: 168 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLE 227
Query: 348 ERLAEIVDPVLLVEREE 364
+ +++ + + E E+
Sbjct: 228 KEAKDLLVKLFVREPEK 244
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 87.1 bits (215), Expect = 9e-20
Identities = 35/152 (23%), Positives = 62/152 (40%), Gaps = 15/152 (9%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+ H ++++ + Q ++ +++ G L L ++ A
Sbjct: 61 VTHPFIIRMWGTF-----QDAQQIFMIMDYIEGGELFSLLRKSQ----RFPNPVAKFYAA 111
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNF---FNFQ 295
+V L + I++ DLKP N+LLD + DFG AK++P+ T ++
Sbjct: 112 EVCL---ALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYI 168
Query: 296 IAEYGMGSEVSTSGDVYSFGILLLETFTGKRP 327
E + S D +SFGIL+ E G P
Sbjct: 169 APEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 200
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.7 bits (211), Expect = 3e-19
Identities = 42/247 (17%), Positives = 90/247 (36%), Gaps = 25/247 (10%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEA---LVYEFMVNGSLEEWLHPNREALKNLNLLQRLS 235
++H N+V +I C + N + LV++F + + L L +
Sbjct: 66 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV----LVKFTLSEIKR 121
Query: 236 IAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQ 295
+ + L+ L++ I+H D+K +NVL+ + + DFGLA+ A N+ N
Sbjct: 122 VMQML---LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 178
Query: 296 IAEYG-----------MGSEVSTSGDVYSFGILLLETFTGKRP-TNEMFTGNLTLHNFVK 343
+ D++ G ++ E +T L L + +
Sbjct: 179 TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 238
Query: 344 EALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRE 403
++ + VD L E+ E + K +++ + ++ P +
Sbjct: 239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLID---KLLVLDPAQ 295
Query: 404 RMNMEEV 410
R++ ++
Sbjct: 296 RIDSDDA 302
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 83.9 bits (207), Expect = 1e-18
Identities = 26/154 (16%), Positives = 46/154 (29%), Gaps = 14/154 (9%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
I+H N+V + ++ L+ + + G L + + +
Sbjct: 64 IKHPNIVALDDI-----YESGGHLYLIMQLVSGGELFDRIVEK----GFYTERDASRLIF 114
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIAE 298
V A+ YLH LD + + DFGL+K +
Sbjct: 115 QVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPG 174
Query: 299 YG-----MGSEVSTSGDVYSFGILLLETFTGKRP 327
Y S + D +S G++ G P
Sbjct: 175 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 208
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.0 bits (204), Expect = 3e-18
Identities = 36/159 (22%), Positives = 61/159 (38%), Gaps = 19/159 (11%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
RH N++ I + + LV M L + L L+
Sbjct: 63 FRHENIIGINDIIRAPTIEQMKDVYLVTHLM-GADLYKLLKTQH-----LSNDHICYFLY 116
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNN-------- 290
+ L Y+H ++H DLKPSN+LL+ + DFGLA+ ++
Sbjct: 117 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 173
Query: 291 -FFNFQIAEYGMGSEVST-SGDVYSFGILLLETFTGKRP 327
++ E + S+ T S D++S G +L E + +
Sbjct: 174 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 212
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.4 bits (200), Expect = 7e-18
Identities = 40/246 (16%), Positives = 80/246 (32%), Gaps = 39/246 (15%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+ H N++ ++ + + +LV++FM + L + +
Sbjct: 57 LSHPNIIGLLDAF-----GHKSNISLVFDFMETDLEVIIKDNSL----VLTPSHIKAYML 107
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIAE 298
L+YLH + I+H DLKP+N+LLD + DFGLAK + + +
Sbjct: 108 MTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTR 164
Query: 299 YGMGSEV-------STSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEALPERLA 351
+ E+ D+++ G +L E ++ ++L
Sbjct: 165 WYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPF-------------LPGDSDLDQLT 211
Query: 352 EIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSEL-------PRER 404
I + + E+ + +SF G + P R
Sbjct: 212 RIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCAR 271
Query: 405 MNMEEV 410
+ +
Sbjct: 272 ITATQA 277
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.9 bits (196), Expect = 2e-17
Identities = 33/156 (21%), Positives = 68/156 (43%), Gaps = 18/156 (11%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+ H N+VK++ D +++ + ++ L++++ AL + L S
Sbjct: 58 LNHPNIVKLL------DVIHTENKLYLVFEFLHQDLKKFMD--ASALTGIPLPLIKSYLF 109
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIAE 298
+ L + H + ++H DLKP N+L++ E + DFGLA+ + + +
Sbjct: 110 QLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTL 166
Query: 299 YGMGSEV-------STSGDVYSFGILLLETFTGKRP 327
+ E+ ST+ D++S G + E T +
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRAL 202
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 79.5 bits (195), Expect = 3e-17
Identities = 37/245 (15%), Positives = 81/245 (33%), Gaps = 36/245 (14%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
++H N+VK+ + LV+E + + L+ ++
Sbjct: 57 LKHSNIVKLYDVIHT-----KKRLVLVFEHLDQDLKKLLDVCEGG-------LESVTAKS 104
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIAE 298
+ L+ + + + ++H DLKP N+L++ E + DFGLA+ + + +
Sbjct: 105 FLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTL 164
Query: 299 YGMGSEV-------STSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEALPERLA 351
+ +V ST+ D++S G + E G + + + F P
Sbjct: 165 WYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKN 224
Query: 352 EIVDPVLLVEREEGETSKANAHKQFTRSFS------VKECLVSVLGIGVTCSSELPRERM 405
L + + F + + + L P +R+
Sbjct: 225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLD-----------PNQRI 273
Query: 406 NMEEV 410
++
Sbjct: 274 TAKQA 278
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.2 bits (194), Expect = 4e-17
Identities = 33/156 (21%), Positives = 62/156 (39%), Gaps = 19/156 (12%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
++H+N+V++ + LV+EF + + N +L+ S
Sbjct: 58 LKHKNIVRLHDV-----LHSDKKLTLVFEFCDQDLKKYFDSCN----GDLDPEIVKSFLF 108
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQIAE 298
+ L + H ++H DLKP N+L++ + +FGLA+ + +
Sbjct: 109 QLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTL 165
Query: 299 YGMGSEV-------STSGDVYSFGILLLETFTGKRP 327
+ +V STS D++S G + E RP
Sbjct: 166 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 79.8 bits (196), Expect = 4e-17
Identities = 26/156 (16%), Positives = 58/156 (37%), Gaps = 6/156 (3%)
Query: 175 RNNFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRL 234
+ + + +++ + V + + + ++ + + + +
Sbjct: 85 IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHAR 144
Query: 235 SIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFF-- 292
A + +YLH +++ DLKP N+L+D + V DFG AK + T
Sbjct: 145 FYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGT 201
Query: 293 -NFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRP 327
E + + + D ++ G+L+ E G P
Sbjct: 202 PEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.8 bits (191), Expect = 8e-17
Identities = 33/176 (18%), Positives = 54/176 (30%), Gaps = 20/176 (11%)
Query: 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVD 239
+++++ DS L+ E R L S
Sbjct: 67 GFSGVIRLLDWFER-----PDSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQ 118
Query: 240 VASALDYLHHYCETPIVHCDLKPSNVLLDGE-LTAHVGDFGLAKFLPEATNNFF----NF 294
V A+ + ++H D+K N+L+D + DFG L + F +
Sbjct: 119 VLEAVRHC---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVY 175
Query: 295 QIAEYGMGSEV-STSGDVYSFGILLLETFTGKRP---TNEMFTGNLTLHNFVKEAL 346
E+ S V+S GILL + G P E+ G + V
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSEC 231
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 78.3 bits (192), Expect = 1e-16
Identities = 45/245 (18%), Positives = 77/245 (31%), Gaps = 24/245 (9%)
Query: 177 NFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSI 236
N N++ + + + ALV+E + N ++ + L
Sbjct: 85 NLRGGPNIITLADIV---KDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFY 134
Query: 237 AVDVASALDYLHHYCETPIVHCDLKPSNVLLDGE-LTAHVGDFGLAKFLPEATNNFFNFQ 295
++ ALDY H I+H D+KP NV++D E + D+GLA+F
Sbjct: 135 MYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 191
Query: 296 IAEYGMGSE------VSTSGDVYSFGILLLETFTGKRPTNEMFTGNLTLHNFVKEALPER 349
+ S D++S G +L K P L K E
Sbjct: 192 SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED 251
Query: 350 LAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSEL----PRERM 405
L + +D + ++ F E V + +L + R+
Sbjct: 252 LYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL 311
Query: 406 NMEEV 410
E
Sbjct: 312 TAREA 316
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 77.2 bits (189), Expect = 2e-16
Identities = 34/174 (19%), Positives = 60/174 (34%), Gaps = 27/174 (15%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
++ + I C D +V E + + + +R+ +L L +A
Sbjct: 59 MQGGVGIPTIRWC----GAEGDYNVMVMELLGPSLEDLFNFCSRK----FSLKTVLLLAD 110
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVL---LDGELTAHVGDFGLAKFLPEATNNFFNFQ 295
+ S ++Y+H +H D+KP N L ++ DFGLAK +A +
Sbjct: 111 QMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPY 167
Query: 296 IA-------------EYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGNL 336
+G E S D+ S G +L+ G P +
Sbjct: 168 RENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK 221
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 77.0 bits (188), Expect = 5e-16
Identities = 41/190 (21%), Positives = 65/190 (34%), Gaps = 31/190 (16%)
Query: 6 GNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSL 65
NQ + P I L L+L N+ ++ +LT L L+ A N + P L
Sbjct: 206 NNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--L 259
Query: 66 GKCQNLILLDLSNNNLTGTTPTEVIGLSSLSI-------------------YLDLSQNQL 106
L L L N ++ +P + + YL L N +
Sbjct: 260 SGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNI 319
Query: 107 NGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLR 166
+ P L L + + NK+S SS+ + + L N P L++L
Sbjct: 320 SDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLT 373
Query: 167 GIENLDLSRN 176
I L L+
Sbjct: 374 RITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 72.0 bits (175), Expect = 2e-14
Identities = 39/169 (23%), Positives = 63/169 (37%), Gaps = 31/169 (18%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIP- 62
L GNQ G++ L L L L N+ P + LT L L N + P
Sbjct: 226 LNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPL 281
Query: 63 -------------------SSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQ 103
S + +NL L L NN++ +P L+ L L +
Sbjct: 282 AGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVS--SLTKLQ-RLFFAN 338
Query: 104 NQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGN 152
N+++ S+ L N+ + N++S P + + R+ QL +N
Sbjct: 339 NKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 37.3 bits (85), Expect = 0.003
Identities = 16/68 (23%), Positives = 27/68 (39%), Gaps = 4/68 (5%)
Query: 19 DLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSN 78
L + + L + + +L + TL ++ SI + NL ++ SN
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSN 75
Query: 79 NNLTGTTP 86
N LT TP
Sbjct: 76 NQLTDITP 83
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 37.3 bits (85), Expect = 0.003
Identities = 18/86 (20%), Positives = 32/86 (37%), Gaps = 7/86 (8%)
Query: 69 QNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISEN 128
+ L N+T T L ++ L + + L NL I+ S N
Sbjct: 22 AEKMKTVLGKTNVTDTVSQT--DLDQVT-TLQADRLGIKSI--DGVEYLNNLTQINFSNN 76
Query: 129 KLSGQIPSSIGSCIRLEQLVMNGNFF 154
+L+ P + + +L ++MN N
Sbjct: 77 QLTDITP--LKNLTKLVDILMNNNQI 100
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.2 bits (184), Expect = 9e-16
Identities = 29/158 (18%), Positives = 58/158 (36%), Gaps = 21/158 (13%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
I+H N++ + ++ L+ E + G L ++L ++L +
Sbjct: 70 IQHPNVITLHEV-----YENKTDVILILELVAGGELFDFLAEK----ESLTEEEATEFLK 120
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGE----LTAHVGDFGLAKFLPEATNNFFNF 294
+ + + ++ I H DLKP N++L + DFGLA + F
Sbjct: 121 QILNGV---YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF 177
Query: 295 QIAEYG-----MGSEVSTSGDVYSFGILLLETFTGKRP 327
E+ + D++S G++ +G P
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.1 bits (181), Expect = 2e-15
Identities = 33/158 (20%), Positives = 53/158 (33%), Gaps = 20/158 (12%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
IR + + FQ L+ +++ G L L + +
Sbjct: 85 IRQSPFLVTLHYA----FQTETKLHLILDYINGGELFTHLSQR-------ERFTEHEVQI 133
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQI-- 296
V + L H + I++ D+K N+LLD + DFGL+K
Sbjct: 134 YVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGT 193
Query: 297 -------AEYGMGSEVSTSGDVYSFGILLLETFTGKRP 327
G S + D +S G+L+ E TG P
Sbjct: 194 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.4 bits (182), Expect = 3e-15
Identities = 31/155 (20%), Positives = 55/155 (35%), Gaps = 18/155 (11%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
RH L + + Q +D V E+ G L L R +
Sbjct: 62 TRHPFLTALKYAF-----QTHDRLCFVMEYANGGELFFHLSRER----VFTEERARFYGA 112
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFN----- 293
++ SAL + +V+ D+K N++LD + + DFGL K
Sbjct: 113 EIVSAL---EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP 169
Query: 294 -FQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRP 327
+ E ++ + D + G+++ E G+ P
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 73.3 bits (179), Expect = 3e-15
Identities = 27/217 (12%), Positives = 60/217 (27%), Gaps = 42/217 (19%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
+ + + Q LV + + + R+ ++ A
Sbjct: 57 LAGCTGIPNVYYF----GQEGLHNVLVIDLLGPSLEDLLDLCGRK----FSVKTVAMAAK 108
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVG-----DFGLAKFLPEATNNFFN 293
+ + + +H +V+ D+KP N L+ + + DFG+ KF +
Sbjct: 109 QMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHI 165
Query: 294 FQIA-------------EYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGN-LTLH 339
+G E S D+ + G + + G P + +
Sbjct: 166 PYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY 225
Query: 340 NFVKEA------------LPERLAEIVDPVLLVEREE 364
+ E PE + + + +
Sbjct: 226 ERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDA 262
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.5 bits (177), Expect = 1e-14
Identities = 33/154 (21%), Positives = 66/154 (42%), Gaps = 14/154 (9%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSE-ALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIA 237
+RH N++ ++ + + ++ LV FM G+ L + + L + +
Sbjct: 74 MRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKH----EKLGEDRIQFLV 127
Query: 238 VDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFN---F 294
+ L Y+H I+H DLKP N+ ++ + + DFGLA+ + +
Sbjct: 128 YQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWY 184
Query: 295 QIAEYGMGSE-VSTSGDVYSFGILLLETFTGKRP 327
+ E + + + D++S G ++ E TGK
Sbjct: 185 RAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 218
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 71.2 bits (173), Expect = 2e-14
Identities = 45/189 (23%), Positives = 74/189 (39%), Gaps = 7/189 (3%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS 63
L N+ T G +L L L L NK P + L L L ++N L+ +P
Sbjct: 38 LQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPE 96
Query: 64 SLGKCQNLILLDLSNNNLTGTTPTEVIGLSS-LSIYLDLSQNQLNGPLPSNFGILKNLGA 122
+ K L + N +T + GL+ + + L + + +G F +K L
Sbjct: 97 KMPKTLQ--ELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSY 154
Query: 123 IDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNFIRHR 182
I I++ ++ IP + L +L ++GN +SL L + L LS N+
Sbjct: 155 IRIADTNIT-TIPQGLPP--SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVD 211
Query: 183 NLVKIITSC 191
N T
Sbjct: 212 NGSLANTPH 220
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.5 bits (169), Expect = 1e-13
Identities = 26/153 (16%), Positives = 59/153 (38%), Gaps = 12/153 (7%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAV 238
++H N++ ++ ++ + ++ L + + L +
Sbjct: 74 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-----LTDDHVQFLIY 128
Query: 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFFNFQI-- 296
+ L Y+H I+H DLKPSN+ ++ + + DFGLA+ + + +
Sbjct: 129 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYR 185
Query: 297 --AEYGMGSEVSTSGDVYSFGILLLETFTGKRP 327
+ + D++S G ++ E TG+
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.4 bits (166), Expect = 3e-13
Identities = 29/155 (18%), Positives = 58/155 (37%), Gaps = 16/155 (10%)
Query: 179 IRHRNLVKIITSCASVDFQGNDSE-ALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIA 237
+ H+N++ ++ + LV E M + + +
Sbjct: 73 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE-------RMSYLL 125
Query: 238 VDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEATNNFF----- 292
+ + +LH I+H DLKPSN+++ + T + DFGLA+ +
Sbjct: 126 YQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 182
Query: 293 NFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRP 327
++ E +G + D++S G ++ E K
Sbjct: 183 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKIL 217
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 66.6 bits (161), Expect = 1e-12
Identities = 37/172 (21%), Positives = 71/172 (41%), Gaps = 15/172 (8%)
Query: 165 LRGIENLDLSRNNFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREA 224
L+ + + D ++ + + +++K++ + +G + +V F V G L E
Sbjct: 63 LQRVNDADNTKEDSMGANHILKLLDHF---NHKGPNGVHVVMVFEVLGENLLALIKKYEH 119
Query: 225 LKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLD----GELTAHVGDFGL 280
+ + L+ I+ + LDY+H C I+H D+KP NVL++ E + L
Sbjct: 120 -RGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADL 176
Query: 281 AKFLPEATNNFFNFQIAEYG-----MGSEVSTSGDVYSFGILLLETFTGKRP 327
+ + Q EY +G+ D++S L+ E TG
Sbjct: 177 GNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFL 228
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.8 bits (148), Expect = 3e-11
Identities = 35/166 (21%), Positives = 57/166 (34%), Gaps = 2/166 (1%)
Query: 14 PGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLIL 73
P + L +L L L+ P L L L +N L+ + NL
Sbjct: 98 PATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTH 157
Query: 74 LDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQ 133
L L N ++ GL SL L QN++ P F L L + + N LS
Sbjct: 158 LFLHGNRISSVPERAFRGLHSLDRL-LLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSAL 216
Query: 134 IPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNFI 179
++ L+ L +N N + + + ++ S +
Sbjct: 217 PTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVP 261
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.9 bits (138), Expect = 5e-10
Identities = 28/137 (20%), Positives = 45/137 (32%), Gaps = 2/137 (1%)
Query: 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSI 61
L N + DL L L L N+ + L L L +N +
Sbjct: 134 LYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVH 193
Query: 62 PSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLG 121
P + L+ L L NNL+ + L +L YL L+ N + L
Sbjct: 194 PHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQ-YLRLNDNPWVCD-CRARPLWAWLQ 251
Query: 122 AIDISENKLSGQIPSSI 138
S +++ +P +
Sbjct: 252 KFRGSSSEVPCSLPQRL 268
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.7 bits (135), Expect = 1e-09
Identities = 30/129 (23%), Positives = 47/129 (36%), Gaps = 5/129 (3%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS 63
L GN+ + + LH L RL L N+ P + +L L+TL N L
Sbjct: 160 LHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTE 219
Query: 64 SLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAI 123
+L + L L L++N L + S +++ LP L
Sbjct: 220 ALAPLRALQYLRLNDNPWVCDCR--ARPLWAWLQKFRGSSSEVPCSLPQR---LAGRDLK 274
Query: 124 DISENKLSG 132
++ N L G
Sbjct: 275 RLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.8 bits (117), Expect = 2e-07
Identities = 34/167 (20%), Positives = 54/167 (32%), Gaps = 2/167 (1%)
Query: 13 IPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLI 72
+P I QR+ L N+ +S L L N+L ++ L
Sbjct: 26 VPVGIPAA--SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 73 LLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSG 132
LDLS+N + L L + L P F L L + + +N L
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143
Query: 133 QIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNFI 179
+ L L ++GN + L ++ L L +N
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA 190
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 59.4 bits (142), Expect = 2e-10
Identities = 18/59 (30%), Positives = 27/59 (45%), Gaps = 1/59 (1%)
Query: 28 LEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTP 86
L N+ +G +P + L L +LN + N L G IP G Q + +NN +P
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 55.9 bits (133), Expect = 3e-09
Identities = 17/64 (26%), Positives = 29/64 (45%), Gaps = 4/64 (6%)
Query: 51 NFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQL--NG 108
+ N + G++P L + + L L++S NNL G P + L + N+
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFD-VSAYANNKCLCGS 307
Query: 109 PLPS 112
PLP+
Sbjct: 308 PLPA 311
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 55.5 bits (132), Expect = 4e-09
Identities = 20/66 (30%), Positives = 29/66 (43%), Gaps = 1/66 (1%)
Query: 94 SLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNF 153
LDL N++ G LP LK L ++++S N L G+IP G+ R + N
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNK 302
Query: 154 FRGNIP 159
P
Sbjct: 303 CLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 54.0 bits (128), Expect = 1e-08
Identities = 39/199 (19%), Positives = 65/199 (32%), Gaps = 23/199 (11%)
Query: 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSI 61
+ +G IP + + L L N G +P SI +L L+ + F N + G+I
Sbjct: 106 LYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAI 165
Query: 62 PSSLGKCQNLILLDLSNNN----------------------LTGTTPTEVIGLSSLSIYL 99
P S G L + N V+ S +
Sbjct: 166 PDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQK 225
Query: 100 DLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIP 159
G+ KNL +D+ N++ G +P + L L ++ N G IP
Sbjct: 226 IHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP 285
Query: 160 SSLSSLRGIENLDLSRNNF 178
+L+ + + N
Sbjct: 286 -QGGNLQRFDVSAYANNKC 303
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 53.2 bits (126), Expect = 2e-08
Identities = 20/65 (30%), Positives = 25/65 (38%), Gaps = 3/65 (4%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS 63
L N+ G +P + L L L + N GEIP GNL +A N P
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP- 308
Query: 64 SLGKC 68
L C
Sbjct: 309 -LPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 40.5 bits (93), Expect = 2e-04
Identities = 36/147 (24%), Positives = 55/147 (37%), Gaps = 2/147 (1%)
Query: 39 SSIGNLTLLITLNFAENMLEG--SIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLS 96
+ + L+ + L IPSSL L L + N I +
Sbjct: 44 DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103
Query: 97 IYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRG 156
YL ++ ++G +P +K L +D S N LSG +P SI S L + +GN G
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163
Query: 157 NIPSSLSSLRGIENLDLSRNNFIRHRN 183
IP S S + N + +
Sbjct: 164 AIPDSYGSFSKLFTSMTISRNRLTGKI 190
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 40.5 bits (93), Expect = 2e-04
Identities = 52/225 (23%), Positives = 85/225 (37%), Gaps = 51/225 (22%)
Query: 4 LVGNQFTGR--IPGSIGDLHKLQRLTLEMN-KFWGEIPSSIGNLTLLITLNFAENMLEGS 60
L G IP S+ +L L L + G IP +I LT L L + G+
Sbjct: 57 LSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGA 116
Query: 61 IPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNL 120
IP L + + L+ LD S N L+GT P + L +L N+++G +P ++G L
Sbjct: 117 IPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGI-TFDGNRISGAIPDSYGSFSKL 175
Query: 121 GA-IDISENKLSGQIPSSIGSCIRLEQLV------------------------------- 148
+ IS N+L+G+IP + + +
Sbjct: 176 FTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAF 235
Query: 149 ---------------MNGNFFRGNIPSSLSSLRGIENLDLSRNNF 178
+ N G +P L+ L+ + +L++S NN
Sbjct: 236 DLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNL 280
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 37.4 bits (85), Expect = 0.002
Identities = 41/140 (29%), Positives = 62/140 (44%), Gaps = 4/140 (2%)
Query: 16 SIGDLHKLQRLTLEMNKFWG--EIPSSIGNLTLLITLNFAENM-LEGSIPSSLGKCQNLI 72
+ +++ L L IPSS+ NL L L L G IP ++ K L
Sbjct: 45 TDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLH 104
Query: 73 LLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSG 132
L +++ N++G P + + +L D S N L+G LP + L NL I N++SG
Sbjct: 105 YLYITHTNVSGAIPDFLSQIKTLVTL-DFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163
Query: 133 QIPSSIGSCIRLEQLVMNGN 152
IP S GS +L +
Sbjct: 164 AIPDSYGSFSKLFTSMTISR 183
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 52.5 bits (125), Expect = 1e-08
Identities = 25/154 (16%), Positives = 46/154 (29%), Gaps = 21/154 (13%)
Query: 166 RGIENLDLSRNNFIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREAL 225
R +L S RN + + + Y + N L E +
Sbjct: 46 RDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKV------YAWEGNAVLMELIDAKEL-- 97
Query: 226 KNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAK--- 282
+ + + + + +H IVH DL NVL+ E + DF +
Sbjct: 98 YRVRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVG 153
Query: 283 ------FLPEATNNFFNFQIAEYGMGSEVSTSGD 310
L N + Y +++++ D
Sbjct: 154 EEGWREILERDVRNIITYFSRTYRTEKDINSAID 187
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 45.5 bits (107), Expect = 9e-07
Identities = 24/117 (20%), Positives = 46/117 (39%), Gaps = 5/117 (4%)
Query: 74 LDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQ 133
L L++ +LT + L ++ +LDLS N+L P+ L+ L + S+N
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVT-HLDLSHNRLRALPPA-LAALRCLEVLQASDNA-LEN 57
Query: 134 IPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNFIRHRNLVKIITS 190
+ E L+ N + L S + L+L N+ + + + +
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAE 114
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.8 bits (100), Expect = 7e-06
Identities = 27/120 (22%), Positives = 43/120 (35%), Gaps = 9/120 (7%)
Query: 49 TLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNG 108
L+ A L ++ L + + LDLS+N L P L++L L +
Sbjct: 2 VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP----ALAALRCLEVLQASDNAL 55
Query: 109 PLPSNFGILKNLGAIDISENKL-SGQIPSSIGSCIRLEQLVMNGNFFRG--NIPSSLSSL 165
L L + + N+L + SC RL L + GN I L+ +
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 36.2 bits (83), Expect = 0.002
Identities = 21/81 (25%), Positives = 33/81 (40%), Gaps = 4/81 (4%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEG-SIP 62
L N+ P ++ L L+ L+ + E + NL L L N L+ +
Sbjct: 27 LSHNRLRALPP-ALAALRCLE--VLQASDNALENVDGVANLPRLQELLLCNNRLQQSAAI 83
Query: 63 SSLGKCQNLILLDLSNNNLTG 83
L C L+LL+L N+L
Sbjct: 84 QPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.7 bits (109), Expect = 3e-06
Identities = 26/100 (26%), Positives = 34/100 (34%), Gaps = 13/100 (13%)
Query: 51 NFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPL 110
+ N I S +L L++SNN L L L S N L +
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLIELPA----LPPRLE-RLIASFNHLAE-V 319
Query: 111 PSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMN 150
P LK L + N L + P S +E L MN
Sbjct: 320 PELPQNLKQL---HVEYNPLR-EFPDIPES---VEDLRMN 352
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 45.2 bits (105), Expect = 8e-06
Identities = 21/91 (23%), Positives = 31/91 (34%), Gaps = 9/91 (9%)
Query: 7 NQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLG 66
N + I L+ L + NK E+P+ L L + N L +P
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKL-IELPALPPRLE---RLIASFNHLA-EVPELP- 323
Query: 67 KCQNLILLDLSNNNLTGTTPTEVIGLSSLSI 97
QNL L + N L P + L +
Sbjct: 324 --QNLKQLHVEYNPLR-EFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.4 bits (103), Expect = 2e-05
Identities = 17/90 (18%), Positives = 38/90 (42%), Gaps = 8/90 (8%)
Query: 101 LSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPS 160
N + + S + +L +++S NKL ++P+ RLE+L+ + N +P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHL-AEVPE 321
Query: 161 SLSSLRGIENLDLSRNNFIRHRNLVKIITS 190
+L+ L + N ++ + +
Sbjct: 322 LPQNLK---QLHVEYNPLREFPDIPESVED 348
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (106), Expect = 7e-06
Identities = 11/78 (14%), Positives = 27/78 (34%), Gaps = 4/78 (5%)
Query: 70 NLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNG----PLPSNFGILKNLGAIDI 125
++ LD+ L+ E++ L + L L + S + L +++
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 126 SENKLSGQIPSSIGSCIR 143
N+L + ++
Sbjct: 63 RSNELGDVGVHCVLQGLQ 80
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 4e-05
Identities = 16/78 (20%), Positives = 30/78 (38%), Gaps = 9/78 (11%)
Query: 98 YLDLSQNQLNG----PLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIR-----LEQLV 148
L L+ ++ L + +L +D+S N L + +R LEQLV
Sbjct: 373 VLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLV 432
Query: 149 MNGNFFRGNIPSSLSSLR 166
+ ++ + L +L
Sbjct: 433 LYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 5e-05
Identities = 17/84 (20%), Positives = 31/84 (36%), Gaps = 8/84 (9%)
Query: 43 NLTLLITLNFAENMLEG----SIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGL----SS 94
++L L A+ + S+ ++L +L LDLSNN L +++
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 95 LSIYLDLSQNQLNGPLPSNFGILK 118
L L L + + L+
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (94), Expect = 2e-04
Identities = 14/87 (16%), Positives = 26/87 (29%), Gaps = 22/87 (25%)
Query: 94 SLSI-YLDLSQNQLN-GPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNG 151
SL I LD+ +L+ +L+ + + + L+ I
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDI------------- 47
Query: 152 NFFRGNIPSSLSSLRGIENLDLSRNNF 178
S+L + L+L N
Sbjct: 48 -------SSALRVNPALAELNLRSNEL 67
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 3e-04
Identities = 18/92 (19%), Positives = 30/92 (32%), Gaps = 9/92 (9%)
Query: 23 LQRLTLEMNKFWGE-IPSSIGNLTLLITLNFAENMLEG----SIPSSLGKCQNLILLDLS 77
+Q L ++ + + L + + L I S+L L L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 78 NNNLTGTTPTEVI-GLSSLSI---YLDLSQNQ 105
+N L V+ GL + S L L
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (90), Expect = 6e-04
Identities = 12/81 (14%), Positives = 24/81 (29%), Gaps = 9/81 (11%)
Query: 21 HKLQRLTLEMNKFWGE----IPSSIGNLTLLITLNFAENMLEGSIPSSLGK-----CQNL 71
L+ L L + +++ L L+ + N L + L + L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 72 ILLDLSNNNLTGTTPTEVIGL 92
L L + + + L
Sbjct: 429 EQLVLYDIYWSEEMEDRLQAL 449
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.9 bits (102), Expect = 2e-05
Identities = 30/205 (14%), Positives = 58/205 (28%), Gaps = 49/205 (23%)
Query: 40 SIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYL 99
+ + + +N + L ++P L K + +L LS N L + ++ + L+ L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLT-QL 60
Query: 100 DLSQNQ---------------------------------------------LNGPLPSNF 114
+L + + L
Sbjct: 61 NLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGAL 120
Query: 115 GILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLS 174
L L + + N+L P + +LE+L + N L+ L ++ L L
Sbjct: 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQ 180
Query: 175 RNNFIRHRNLVKIITSCASVDFQGN 199
N+ GN
Sbjct: 181 ENSLYTIPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.8 bits (99), Expect = 4e-05
Identities = 30/176 (17%), Positives = 55/176 (31%), Gaps = 5/176 (2%)
Query: 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS 63
L N ++ +L +L L+ + G L +L TL+ + N L+
Sbjct: 38 LSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV--DGTLPVLGTLDLSHNQLQSLPLL 95
Query: 64 SLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAI 123
+L N + P + L L N+L P L +
Sbjct: 96 GQTLPALTVLDVSFNRLTS--LPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKL 153
Query: 124 DISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNFI 179
++ N L+ + L+ L++ N IP + L N ++
Sbjct: 154 SLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.1 bits (98), Expect = 3e-05
Identities = 22/127 (17%), Positives = 43/127 (33%), Gaps = 6/127 (4%)
Query: 12 RIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNL 71
++ + + + L++ + + + LN +M ++ L
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPEL 67
Query: 72 ILLDLSNNNLTGTTPTEVI--GLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENK 129
+ L+LSNN L I +L L+LS N+L + L + + N
Sbjct: 68 LSLNLSNNRLYRLDDMSSIVQKAPNLK-ILNLSGNELKSERELDKIKGLKLEELWLDGNS 126
Query: 130 LSGQIPS 136
LS
Sbjct: 127 LSDTFRD 133
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.9 bits (94), Expect = 2e-04
Identities = 16/131 (12%), Positives = 40/131 (30%), Gaps = 26/131 (19%)
Query: 24 QRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTG 83
Q L L ++ + + ++ + ++ + + +DLSN+ +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQGVIA-FRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIEV 60
Query: 84 TTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIR 143
+T L L + + +LS I +++
Sbjct: 61 ST------------------------LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSN 96
Query: 144 LEQLVMNGNFF 154
L +L ++G
Sbjct: 97 LVRLNLSGCSG 107
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.9 bits (89), Expect = 6e-04
Identities = 20/76 (26%), Positives = 34/76 (44%), Gaps = 6/76 (7%)
Query: 30 MNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEV 89
+ + + NL+ L TL +N + P L NLI + L NN ++ +P +
Sbjct: 158 IGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--L 213
Query: 90 IGLSSLSIYLDLSQNQ 105
S+L + L+ NQ
Sbjct: 214 ANTSNLF-IVTLT-NQ 227
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 37.1 bits (84), Expect = 0.002
Identities = 15/104 (14%), Positives = 32/104 (30%), Gaps = 26/104 (25%)
Query: 6 GNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLIT---------------- 49
N+ LH+L+ L L N+ +P S +L L +
Sbjct: 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAW 146
Query: 50 -------LNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTP 86
+ PS + +++ + DL ++ ++
Sbjct: 147 FAEWLRKKSLNGGAARCGAPSKV---RDVQIKDLPHSEFKCSSE 187
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 36.7 bits (83), Expect = 0.002
Identities = 35/158 (22%), Positives = 65/158 (41%), Gaps = 6/158 (3%)
Query: 23 LQRLTLEMNKFWGEIPSSI-GNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNL 81
L L N+ + G L L+ L N L G P++ ++ L L N +
Sbjct: 31 TTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKI 90
Query: 82 TGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSC 141
+ +GL L L+L NQ++ +P +F L +L +++++ N + + +
Sbjct: 91 KEISNKMFLGLHQL-KTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAE 149
Query: 142 IRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNFI 179
+ +NG R PS + R ++ DL + F
Sbjct: 150 WLR-KKSLNGGAARCGAPSKV---RDVQIKDLPHSEFK 183
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 427 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.97 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.92 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.92 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.89 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.87 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.84 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.83 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.81 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.8 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.74 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.73 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.72 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.71 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.68 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.67 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.67 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.67 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.66 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.64 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.63 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.61 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.6 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.59 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.58 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.53 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.5 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.48 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.44 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.43 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.41 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.3 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.13 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.03 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.02 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 98.95 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.75 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.59 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.53 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.39 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.51 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.46 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.64 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.46 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 96.06 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 95.32 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 92.92 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 87.49 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 84.82 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-47 Score=349.41 Aligned_cols=203 Identities=26% Similarity=0.381 Sum_probs=161.6
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||++++++.. ...++|||||++|+|.+++.... ..+++..++.++.|||+||+||| ++|||||
T Consensus 61 l~HpnIv~~~~~~~~------~~~~lv~Ey~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHr 128 (276)
T d1uwha_ 61 TRHVNILLFMGYSTA------PQLAIVTQWCEGSSLYHHLHIIE---TKFEMIKLIDIARQTAQGMDYLH---AKSIIHR 128 (276)
T ss_dssp CCCTTBCCEEEEECS------SSCEEEEECCCEEEHHHHHHTSC---CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred CCCCCEeeeeEEEec------cEEEEEEecCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHh---cCCEecc
Confidence 579999999987532 45799999999999999986543 45999999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc--------CCCccccccccccCC---CCcCccccchhHHHHHHHHHhCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA--------TNNFFNFQIAEYGMG---SEVSTSGDVYSFGILLLETFTGKRP 327 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~--------~~~~~~y~aPE~~~~---~~~~~~~DiwS~G~vl~ell~g~~p 327 (427)
||||+|||++.++.+||+|||+|+..... ..||+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 129 DlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~P 208 (276)
T d1uwha_ 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208 (276)
T ss_dssp CCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred ccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCC
Confidence 99999999999999999999999875432 278999999999864 3579999999999999999999999
Q ss_pred CCcccCCCccHHHHHHHhc-ccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCC
Q 042634 328 TNEMFTGNLTLHNFVKEAL-PERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMN 406 (427)
Q Consensus 328 f~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt 406 (427)
|.+.... ..+...+.... ++.... .+..+++++.+++.+||+.||++|||
T Consensus 209 f~~~~~~-~~~~~~~~~~~~~p~~~~----------------------------~~~~~~~~l~~li~~cl~~dp~~RPt 259 (276)
T d1uwha_ 209 YSNINNR-DQIIFMVGRGYLSPDLSK----------------------------VRSNCPKAMKRLMAECLKKKRDERPL 259 (276)
T ss_dssp TTTCCCH-HHHHHHHHHTSCCCCGGG----------------------------SCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred CCCCChH-HHHHHHHhcCCCCCcchh----------------------------ccccchHHHHHHHHHHcCCCHhHCcC
Confidence 9764221 11112222111 111100 22345677999999999999999999
Q ss_pred HHHHHHHHHHHHHHHH
Q 042634 407 MEEVAAQLLSFRNKLV 422 (427)
Q Consensus 407 ~~ev~~~L~~~~~~~~ 422 (427)
|+||++.|+.+++.++
T Consensus 260 ~~~il~~Le~l~~~~P 275 (276)
T d1uwha_ 260 FPQILASIELLARSLP 275 (276)
T ss_dssp HHHHHHHHHHHHHTCC
T ss_pred HHHHHHHHHHHHHcCC
Confidence 9999999999987654
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=336.78 Aligned_cols=198 Identities=26% Similarity=0.430 Sum_probs=154.3
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||++++++.. +...++|||||++|+|.+++.... ..+++..++.++.|||.||+||| +++|+||
T Consensus 57 l~HpnIv~~~g~~~~-----~~~~~lv~E~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qia~gl~~lH---~~~iiHr 125 (263)
T d1sm2a_ 57 LSHPKLVQLYGVCLE-----QAPICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLE---EACVIHR 125 (263)
T ss_dssp CCCTTBCCEEEEECS-----SSSCEEEEECCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCT
T ss_pred cCCCCcccccceecc-----CCceEEEEEecCCCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHhhh---ccceeec
Confidence 579999999999754 467899999999999999986543 45889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc-------CCCccccccccccCCCCcCccccchhHHHHHHHHHhC-CCCCCc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA-------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTG-KRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g-~~pf~~ 330 (427)
||||+|||+++++.+||+|||+|+..... ..||..|+|||++.+..++.++|||||||++|||+++ .+||..
T Consensus 126 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~ 205 (263)
T d1sm2a_ 126 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 205 (263)
T ss_dssp TCSGGGEEECGGGCEEECSCC------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred ccchhheeecCCCCeEecccchheeccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCC
Confidence 99999999999999999999999876432 2678899999999999999999999999999999995 555543
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
. ....+.+.+...... ..+..++.++.+++.+||+.||++||||+||
T Consensus 206 ~--~~~~~~~~i~~~~~~-------------------------------~~p~~~~~~l~~li~~cl~~~p~~Rps~~~i 252 (263)
T d1sm2a_ 206 R--SNSEVVEDISTGFRL-------------------------------YKPRLASTHVYQIMNHCWKERPEDRPAFSRL 252 (263)
T ss_dssp C--CHHHHHHHHHHTCCC-------------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred C--CHHHHHHHHHhcCCC-------------------------------CCccccCHHHHHHHHHHccCCHhHCcCHHHH
Confidence 2 111111111111100 0123345678999999999999999999999
Q ss_pred HHHHHHHHHH
Q 042634 411 AAQLLSFRNK 420 (427)
Q Consensus 411 ~~~L~~~~~~ 420 (427)
+++|+++.+.
T Consensus 253 l~~L~~i~es 262 (263)
T d1sm2a_ 253 LRQLAEIAES 262 (263)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHhC
Confidence 9999998764
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.3e-45 Score=340.93 Aligned_cols=197 Identities=23% Similarity=0.426 Sum_probs=155.0
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||++++++.. +...++|||||++|+|.+++.... ..+++.+++.++.|||+||+||| ++||+||
T Consensus 84 l~HpnIv~l~g~~~~-----~~~~~iv~Ey~~~g~L~~~~~~~~---~~l~~~~~~~i~~qia~gl~yLH---~~~iiHr 152 (299)
T d1jpaa_ 84 FDHPNVIHLEGVVTK-----STPVMIITEFMENGSLDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLA---DMNYVHR 152 (299)
T ss_dssp CCCTTBCCEEEEECS-----SSSCEEEEECCTTEEHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred CCCCCCccEEEEEee-----CCEEEEEEEecCCCcceeeecccc---CCCCHHHHHHHHHHHHHHHHHHh---hCCCccC
Confidence 579999999998644 567899999999999999886543 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC-----------CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT-----------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKR 326 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~-----------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~ 326 (427)
||||+|||++.++++||+|||+|+...... .+|+.|+|||++.+..++.++|||||||++|||++ |+.
T Consensus 153 DlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~ 232 (299)
T d1jpaa_ 153 DLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER 232 (299)
T ss_dssp CCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred ccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCC
Confidence 999999999999999999999998764321 46788999999999999999999999999999998 899
Q ss_pred CCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCC
Q 042634 327 PTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMN 406 (427)
Q Consensus 327 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt 406 (427)
||.+... ..+...+..... ...+.+++.++.+++.+||+.||++|||
T Consensus 233 Pf~~~~~--~~~~~~i~~~~~-------------------------------~~~~~~~~~~l~~li~~cl~~~P~~RPs 279 (299)
T d1jpaa_ 233 PYWDMTN--QDVINAIEQDYR-------------------------------LPPPMDCPSALHQLMLDCWQKDRNHRPK 279 (299)
T ss_dssp TTTTCCH--HHHHHHHHTTCC-------------------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCC
T ss_pred CCCCCCH--HHHHHHHHcCCC-------------------------------CCCCccchHHHHHHHHHHcCCCHhHCcC
Confidence 9975421 111111111100 0022335677899999999999999999
Q ss_pred HHHHHHHHHHHHH
Q 042634 407 MEEVAAQLLSFRN 419 (427)
Q Consensus 407 ~~ev~~~L~~~~~ 419 (427)
|+||++.|+++.+
T Consensus 280 ~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 280 FGQIVNTLDKMIR 292 (299)
T ss_dssp HHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhc
Confidence 9999999998865
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-45 Score=336.96 Aligned_cols=201 Identities=23% Similarity=0.354 Sum_probs=165.2
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||++++++.. +..++|||||++|+|.+++.... ..+++.++..++.||+.||+||| ++||+||
T Consensus 66 l~HpnIv~l~g~~~~------~~~~lvmE~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHr 133 (285)
T d1u59a_ 66 LDNPYIVRLIGVCQA------EALMLVMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLE---EKNFVHR 133 (285)
T ss_dssp CCCTTBCCEEEEEES------SSEEEEEECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred CCCCCEeeEeeeecc------CeEEEEEEeCCCCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHHHH---hCCeecC
Confidence 579999999998643 35789999999999999876543 45999999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc---------CCCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA---------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPT 328 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~---------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf 328 (427)
||||+|||++.++.+||+|||+|+..... ..||+.|+|||++.+..++.++|||||||++|||++ |+.||
T Consensus 134 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf 213 (285)
T d1u59a_ 134 DLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY 213 (285)
T ss_dssp CCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred cCchhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCC
Confidence 99999999999999999999999876432 257889999999999999999999999999999998 99999
Q ss_pred CcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 042634 329 NEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME 408 (427)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ 408 (427)
.+... ..+...+..... ...++.++.++.+++.+||+.||++||||.
T Consensus 214 ~~~~~--~~~~~~i~~~~~-------------------------------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~ 260 (285)
T d1u59a_ 214 KKMKG--PEVMAFIEQGKR-------------------------------MECPPECPPELYALMSDCWIYKWEDRPDFL 260 (285)
T ss_dssp TTCCT--HHHHHHHHTTCC-------------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHH
T ss_pred CCCCH--HHHHHHHHcCCC-------------------------------CCCCCcCCHHHHHHHHHHcCCCHhHCcCHH
Confidence 76421 112222111100 012234567799999999999999999999
Q ss_pred HHHHHHHHHHHHHHhh
Q 042634 409 EVAAQLLSFRNKLVKN 424 (427)
Q Consensus 409 ev~~~L~~~~~~~~~~ 424 (427)
+|++.|+.....+...
T Consensus 261 ~i~~~L~~~~~~~~~~ 276 (285)
T d1u59a_ 261 TVEQRMRACYYSLASK 276 (285)
T ss_dssp HHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhhhc
Confidence 9999999887766554
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-45 Score=334.01 Aligned_cols=191 Identities=21% Similarity=0.298 Sum_probs=155.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||++++++.. +...++|||||++|+|.+++... ..+++.+++.++.||+.||+||| ++||+||
T Consensus 60 l~HpnIv~~~~~~~~-----~~~~~ivmEy~~gg~L~~~l~~~----~~l~e~~~~~i~~qi~~al~ylH---~~~IiHr 127 (271)
T d1nvra_ 60 LNHENVVKFYGHRRE-----GNIQYLFLEYCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLH---GIGITHR 127 (271)
T ss_dssp CCCTTBCCEEEEEEE-----TTEEEEEEECCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHH---HTTEECS
T ss_pred CCCCCEeeEeeeecc-----CceeEEEEeccCCCcHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HcCCccC
Confidence 579999999998654 56789999999999999999765 45999999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC--------cCCCccccccccccCCCCc-CccccchhHHHHHHHHHhCCCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE--------ATNNFFNFQIAEYGMGSEV-STSGDVYSFGILLLETFTGKRPTN 329 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~--------~~~~~~~y~aPE~~~~~~~-~~~~DiwS~G~vl~ell~g~~pf~ 329 (427)
||||+|||+++++.+||+|||+|+.... ...||+.|+|||++.+..+ +.++||||+||++|||++|+.||.
T Consensus 128 DiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~ 207 (271)
T d1nvra_ 128 DIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 207 (271)
T ss_dssp CCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCS
T ss_pred cccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCC
Confidence 9999999999999999999999987532 2379999999999988876 678999999999999999999997
Q ss_pred cccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 042634 330 EMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEE 409 (427)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~e 409 (427)
........+.......... ......+.++.+++.+||+.||++|||++|
T Consensus 208 ~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~e 256 (271)
T d1nvra_ 208 QPSDSCQEYSDWKEKKTYL-------------------------------NPWKKIDSAPLALLHKILVENPSARITIPD 256 (271)
T ss_dssp SSSTTSHHHHHHHTTCTTS-------------------------------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CCChHHHHHHHHhcCCCCC-------------------------------CccccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 6433222211111000000 011223456789999999999999999999
Q ss_pred HHH
Q 042634 410 VAA 412 (427)
Q Consensus 410 v~~ 412 (427)
+++
T Consensus 257 il~ 259 (271)
T d1nvra_ 257 IKK 259 (271)
T ss_dssp HTT
T ss_pred Hhc
Confidence 975
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-45 Score=333.07 Aligned_cols=198 Identities=24% Similarity=0.406 Sum_probs=159.0
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||++++++.. +..++|||||++|+|.+++..... ..+++..++.++.||++||+||| +++|+||
T Consensus 65 l~HpnIv~~~g~~~~------~~~~iv~Ey~~~g~L~~~~~~~~~--~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHr 133 (272)
T d1qpca_ 65 LQHQRLVRLYAVVTQ------EPIYIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIE---ERNYIHR 133 (272)
T ss_dssp CCCTTBCCEEEEECS------SSCEEEEECCTTCBHHHHTTSHHH--HTCCHHHHHHHHHHHHHHHHHHH---HTTEECS
T ss_pred CCCCCEeEEEeeecc------CCeEEEEEeCCCCcHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccC
Confidence 579999999997543 456899999999999998876543 45999999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc-------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA-------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
||||+|||+++++.+||+|||+|+..... ..||+.|+|||++.+..++.++|||||||++|||+||..|+...
T Consensus 134 DiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~ 213 (272)
T d1qpca_ 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213 (272)
T ss_dssp CCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred ccchhheeeecccceeeccccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999999876543 26788999999999899999999999999999999966554332
Q ss_pred cCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 042634 332 FTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVA 411 (427)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~ 411 (427)
.. ...+.+.+..... ...+..+++++.+++.+||+.||++||||+||+
T Consensus 214 ~~-~~~~~~~i~~~~~-------------------------------~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~ 261 (272)
T d1qpca_ 214 MT-NPEVIQNLERGYR-------------------------------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLR 261 (272)
T ss_dssp CC-HHHHHHHHHTTCC-------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CC-HHHHHHHHHhcCC-------------------------------CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence 11 1111111111000 001233566789999999999999999999999
Q ss_pred HHHHHHHH
Q 042634 412 AQLLSFRN 419 (427)
Q Consensus 412 ~~L~~~~~ 419 (427)
+.|+.+-.
T Consensus 262 ~~L~~~ft 269 (272)
T d1qpca_ 262 SVLEDFFT 269 (272)
T ss_dssp HHHHHHHH
T ss_pred HHhhhhhh
Confidence 99998753
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-45 Score=331.30 Aligned_cols=189 Identities=20% Similarity=0.282 Sum_probs=156.9
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||++++++.. +...++|||||++|+|.+++... ..+++..++.++.||+.||+||| ++||+||
T Consensus 63 l~hpnIv~~~~~~~~-----~~~~~ivmEy~~~g~L~~~l~~~----~~l~e~~~~~i~~qi~~al~~lH---~~~ivHr 130 (263)
T d2j4za1 63 LRHPNILRLYGYFHD-----ATRVYLILEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCH---SKRVIHR 130 (263)
T ss_dssp CCCTTBCCEEEEEEC-----SSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCC
T ss_pred cCCCCCCeEEEEEEE-----CCEEEEEEeecCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeee
Confidence 579999999998543 66789999999999999998654 45999999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC----CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT----NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTG 334 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~----~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~~ 334 (427)
||||+|||++.++.+||+|||+|+...... .||+.|+|||++.+..++.++|||||||++|||++|+.||.+..
T Consensus 131 DiKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-- 208 (263)
T d2j4za1 131 DIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-- 208 (263)
T ss_dssp CCCGGGEEECTTSCEEECCCCSCSCCCCCCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS--
T ss_pred eeccccceecCCCCEeecccceeeecCCCcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC--
Confidence 999999999999999999999998765443 78999999999999999999999999999999999999997531
Q ss_pred CccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 042634 335 NLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAAQ 413 (427)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~ 413 (427)
..+.......... ..+..+++++.+++.+||+.||++|||++|++++
T Consensus 209 ---~~~~~~~i~~~~~-----------------------------~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 209 ---YQETYKRISRVEF-----------------------------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp ---HHHHHHHHHTTCC-----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ---HHHHHHHHHcCCC-----------------------------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 1111111110000 0112245668899999999999999999999863
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=332.42 Aligned_cols=197 Identities=24% Similarity=0.367 Sum_probs=161.5
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||+++++|.. +..++|||||++|+|.+++... ..+++..++.++.||+.||+||| ++||+||
T Consensus 65 l~HpnIv~~~g~~~~------~~~~lvmE~~~~g~L~~~l~~~----~~l~~~~~~~i~~qi~~gl~ylH---~~~iiHr 131 (277)
T d1xbba_ 65 LDNPYIVRMIGICEA------ESWMLVMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLE---ESNFVHR 131 (277)
T ss_dssp CCCTTBCCEEEEEES------SSEEEEEECCTTEEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHH---HTTEECS
T ss_pred CCCCCCceEEEEecc------CCEEEEEEcCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHhhHH---hCCcccC
Confidence 579999999998632 3568999999999999998754 45999999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc---------CCCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA---------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPT 328 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~---------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf 328 (427)
||||+|||++.++.+||+|||+|+..... ..||+.|+|||++.+..++.++|||||||++|||++ |+.||
T Consensus 132 DlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf 211 (277)
T d1xbba_ 132 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 211 (277)
T ss_dssp CCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred CCcchhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCC
Confidence 99999999999999999999999875432 268889999999999999999999999999999998 89999
Q ss_pred CcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 042634 329 NEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME 408 (427)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ 408 (427)
.+... ..+...+....+ ...+..++.++.+++.+||+.||++||||+
T Consensus 212 ~~~~~--~~~~~~i~~~~~-------------------------------~~~p~~~~~~~~~li~~cl~~dp~~RPs~~ 258 (277)
T d1xbba_ 212 RGMKG--SEVTAMLEKGER-------------------------------MGCPAGCPREMYDLMNLCWTYDVENRPGFA 258 (277)
T ss_dssp TTCCH--HHHHHHHHTTCC-------------------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred CCCCH--HHHHHHHHcCCC-------------------------------CCCCcccCHHHHHHHHHHcCCCHhHCcCHH
Confidence 76321 111111111100 002234567789999999999999999999
Q ss_pred HHHHHHHHHHHHH
Q 042634 409 EVAAQLLSFRNKL 421 (427)
Q Consensus 409 ev~~~L~~~~~~~ 421 (427)
||++.|+.+-.+.
T Consensus 259 ~i~~~L~~~~~~~ 271 (277)
T d1xbba_ 259 AVELRLRNYYYDV 271 (277)
T ss_dssp HHHHHHHHHHHHH
T ss_pred HHHHHhhCHHhhc
Confidence 9999998875443
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-45 Score=340.98 Aligned_cols=197 Identities=24% Similarity=0.348 Sum_probs=159.7
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchh-------------------hhhccCHHHHHHHHHH
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNRE-------------------ALKNLNLLQRLSIAVD 239 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------------~~~~l~~~~~~~~~~~ 239 (427)
.+|||||++++++.. ....++|||||++|+|.++++.... ....+++..++.++.|
T Consensus 98 ~~HpnIv~l~~~~~~-----~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q 172 (325)
T d1rjba_ 98 GSHENIVNLLGACTL-----SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQ 172 (325)
T ss_dssp CCCTTBCCEEEEECS-----SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHH
T ss_pred cCCCcEeEEEEEEee-----CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHH
Confidence 479999999998654 5678999999999999999865431 1235899999999999
Q ss_pred HHHHHHHHhhcCCCCeeeccccCCceeeCCCCceEecccccccccCCcC--------CCccccccccccCCCCcCccccc
Q 042634 240 VASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEAT--------NNFFNFQIAEYGMGSEVSTSGDV 311 (427)
Q Consensus 240 i~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~--------~~~~~y~aPE~~~~~~~~~~~Di 311 (427)
|+.||+||| ++|||||||||+||+++.++.+||+|||+|+...... .||+.|+|||++.+..++.++||
T Consensus 173 i~~gl~yLH---~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Di 249 (325)
T d1rjba_ 173 VAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDV 249 (325)
T ss_dssp HHHHHHHHH---HTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHH
T ss_pred HHHHHHHHH---hCCeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceec
Confidence 999999999 8999999999999999999999999999998754332 46889999999999999999999
Q ss_pred hhHHHHHHHHHh-CCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHH
Q 042634 312 YSFGILLLETFT-GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVL 390 (427)
Q Consensus 312 wS~G~vl~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (427)
|||||++|||++ |+.||.+.... ..+.+.+...... ..+..+++++.
T Consensus 250 wS~Gvil~emlt~g~~Pf~~~~~~-~~~~~~~~~~~~~-------------------------------~~p~~~~~~l~ 297 (325)
T d1rjba_ 250 WSYGILLWEIFSLGVNPYPGIPVD-ANFYKLIQNGFKM-------------------------------DQPFYATEEIY 297 (325)
T ss_dssp HHHHHHHHHHTTTSCCSSTTCCCS-HHHHHHHHTTCCC-------------------------------CCCTTCCHHHH
T ss_pred cchhHHHHHHHhCCCCCCCCCCHH-HHHHHHHhcCCCC-------------------------------CCCCcCCHHHH
Confidence 999999999998 89999764221 1222222221110 02233566799
Q ss_pred HHHhhcCCCCCCCCCCHHHHHHHHH
Q 042634 391 GIGVTCSSELPRERMNMEEVAAQLL 415 (427)
Q Consensus 391 ~l~~~cl~~dP~~Rpt~~ev~~~L~ 415 (427)
+++.+||+.||++||||+||+++|.
T Consensus 298 ~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 298 IIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHHHHHh
Confidence 9999999999999999999999985
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-44 Score=334.57 Aligned_cols=198 Identities=23% Similarity=0.362 Sum_probs=160.6
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||++++++.. +...++|||||++|+|.+++..... ..+++..++.++.||+.||+||| ++||+||
T Consensus 70 l~HpnIv~~~~~~~~-----~~~~~iv~E~~~~g~l~~~l~~~~~--~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHr 139 (287)
T d1opja_ 70 IKHPNLVQLLGVCTR-----EPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLE---KKNFIHR 139 (287)
T ss_dssp CCCTTBCCEEEEECS-----SSSCEEEEECCTTCBHHHHHHHSCT--TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred CCCCCEecCCccEee-----CCeeEEEeecccCcchHHHhhhccc--cchHHHHHHHHHHHHHHHHHHHH---HCCcccC
Confidence 579999999998654 5678999999999999999865432 46899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC-------CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT-------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~-------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
||||+|||+++++.+||+|||+|+...... .|+..|+|||++.+..++.++|||||||++|||++|..||...
T Consensus 140 DlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~ 219 (287)
T d1opja_ 140 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 219 (287)
T ss_dssp CCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred ccccCeEEECCCCcEEEccccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCc
Confidence 999999999999999999999999765433 4678899999999999999999999999999999977766432
Q ss_pred cCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 042634 332 FTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVA 411 (427)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~ 411 (427)
.. ...+.+.+...... ..+..++.++.+++.+||+.||++||||+||+
T Consensus 220 ~~-~~~~~~~i~~~~~~-------------------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~ 267 (287)
T d1opja_ 220 ID-LSQVYELLEKDYRM-------------------------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIH 267 (287)
T ss_dssp CC-HHHHHHHHHTTCCC-------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ch-HHHHHHHHhcCCCC-------------------------------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence 11 11111111111100 01233556789999999999999999999999
Q ss_pred HHHHHHH
Q 042634 412 AQLLSFR 418 (427)
Q Consensus 412 ~~L~~~~ 418 (427)
+.|+.+.
T Consensus 268 ~~L~~~~ 274 (287)
T d1opja_ 268 QAFETMF 274 (287)
T ss_dssp HHHHHTT
T ss_pred HHHHHHH
Confidence 9998874
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-45 Score=333.83 Aligned_cols=198 Identities=22% Similarity=0.280 Sum_probs=148.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcC--CCCee
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYC--ETPIV 256 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~--~~~iv 256 (427)
++|||||++++++.. ..+...++|||||++|+|.+++.+.......+++..++.++.|++.||+|||+.. ..+|+
T Consensus 60 l~HpnIv~~~~~~~~---~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~Ii 136 (269)
T d2java1 60 LKHPNIVRYYDRIID---RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVL 136 (269)
T ss_dssp CCCTTBCCEEEEEEC-------CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC------
T ss_pred CCCCCEeeEEEEEEe---CCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEE
Confidence 579999999998643 1234678999999999999999765544467999999999999999999999431 13499
Q ss_pred eccccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCc
Q 042634 257 HCDLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNE 330 (427)
Q Consensus 257 HrDlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~ 330 (427)
||||||+|||++.++.+||+|||+|+..... ..||+.|+|||++.+..++.++|||||||++|||++|+.||.+
T Consensus 137 HrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~ 216 (269)
T d2java1 137 HRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA 216 (269)
T ss_dssp ---CCGGGEEECTTSCEEECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred eCcCchhhcCcCCCCcEEEeeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCC
Confidence 9999999999999999999999999876432 2789999999999999999999999999999999999999975
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
... ..+...+.. ..... .+..+++++.+++.+||+.||++|||++|+
T Consensus 217 ~~~--~~~~~~i~~---~~~~~----------------------------~~~~~s~~l~~li~~~L~~dp~~Rps~~el 263 (269)
T d2java1 217 FSQ--KELAGKIRE---GKFRR----------------------------IPYRYSDELNEIITRMLNLKDYHRPSVEEI 263 (269)
T ss_dssp SSH--HHHHHHHHH---TCCCC----------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCH--HHHHHHHHc---CCCCC----------------------------CCcccCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 311 111111111 00000 112245578999999999999999999999
Q ss_pred HH
Q 042634 411 AA 412 (427)
Q Consensus 411 ~~ 412 (427)
++
T Consensus 264 l~ 265 (269)
T d2java1 264 LE 265 (269)
T ss_dssp HT
T ss_pred Hh
Confidence 75
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-44 Score=332.38 Aligned_cols=190 Identities=19% Similarity=0.260 Sum_probs=154.9
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||++++++.. ....++|||||++|+|.+++.. ..+++.+++.++.||+.||+||| ++||+||
T Consensus 74 l~HpnIv~~~~~~~~-----~~~~~ivmEy~~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH---~~~iiHr 140 (293)
T d1yhwa1 74 NKNPNIVNYLDSYLV-----GDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLH---SNQVIHR 140 (293)
T ss_dssp CCCTTBCCEEEEEEE-----TTEEEEEEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred CCCCCEeeEeEEEEE-----CCEEEEEEEecCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHH---HCCCccc
Confidence 579999999998654 5678999999999999987753 34999999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+|||++.++.+||+|||+|+..... ..||+.|+|||++.+..++.++||||+||++|||++|+.||.+..
T Consensus 141 DiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~ 220 (293)
T d1yhwa1 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (293)
T ss_dssp CCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CCcHHHeEECCCCcEeeccchhheeeccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC
Confidence 99999999999999999999999876432 279999999999999999999999999999999999999997531
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
.. ..+........+. ...+..++.++.+++.+||+.||++|||++|+++
T Consensus 221 ~~-~~~~~~~~~~~~~------------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 221 PL-RALYLIATNGTPE------------------------------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp HH-HHHHHHHHHCSCC------------------------------CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HH-HHHHHHHhCCCCC------------------------------CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11 0111111110000 0012234567899999999999999999999975
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-44 Score=325.40 Aligned_cols=194 Identities=26% Similarity=0.367 Sum_probs=152.2
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCC--ee
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETP--IV 256 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~--iv 256 (427)
++|||||++++++... ..++...++|||||++|+|.+++.+. ..+++..++.++.||+.||+||| +++ |+
T Consensus 65 l~HpnIv~~~~~~~~~-~~~~~~~~ivmE~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~gl~yLH---~~~~~Ii 136 (270)
T d1t4ha_ 65 LQHPNIVRFYDSWEST-VKGKKCIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLH---TRTPPII 136 (270)
T ss_dssp CCCTTBCCEEEEEEEE-SSSCEEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCC
T ss_pred CCCCCeeeEEEEEeec-cccCCEEEEEEeCCCCCcHHHHHhcc----ccccHHHHHHHHHHHHHHHHHHH---HCCCCEE
Confidence 5799999999986542 22345679999999999999998654 45999999999999999999999 777 99
Q ss_pred eccccCCceeeC-CCCceEecccccccccCCcC----CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 257 HCDLKPSNVLLD-GELTAHVGDFGLAKFLPEAT----NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 257 HrDlkp~NIll~-~~~~~kL~DFG~a~~~~~~~----~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
||||||+|||++ .++.+||+|||+|+...... .||+.|+|||++.+ +++.++|||||||++|||++|+.||.+.
T Consensus 137 HrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~ 215 (270)
T d1t4ha_ 137 HRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC 215 (270)
T ss_dssp CSCCCGGGEEESSTTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred eCCcChhhceeeCCCCCEEEeecCcceeccCCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCc
Confidence 999999999996 57899999999998754432 79999999999865 5999999999999999999999999753
Q ss_pred cCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 042634 332 FTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVA 411 (427)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~ 411 (427)
.. ........... ..+. ..+..++.++.+++.+||+.||++|||++|++
T Consensus 216 ~~----~~~~~~~i~~~-----~~~~----------------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell 264 (270)
T d1t4ha_ 216 QN----AAQIYRRVTSG-----VKPA----------------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 264 (270)
T ss_dssp SS----HHHHHHHHTTT-----CCCG----------------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred cc----HHHHHHHHHcC-----CCCc----------------------ccCccCCHHHHHHHHHHccCCHhHCcCHHHHh
Confidence 21 11111111100 0000 01111334588999999999999999999997
Q ss_pred H
Q 042634 412 A 412 (427)
Q Consensus 412 ~ 412 (427)
+
T Consensus 265 ~ 265 (270)
T d1t4ha_ 265 N 265 (270)
T ss_dssp T
T ss_pred C
Confidence 6
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-44 Score=330.21 Aligned_cols=198 Identities=20% Similarity=0.375 Sum_probs=155.6
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||++++++.. ....++|||||.+|++.+++.... ..+++.+++.++.||+.||+||| +++|+||
T Consensus 66 l~H~nIv~~~g~~~~-----~~~~~~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHr 134 (283)
T d1mqba_ 66 FSHHNIIRLEGVISK-----YKPMMIITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLA---NMNYVHR 134 (283)
T ss_dssp CCCTTBCCEEEEECS-----SSSEEEEEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred cCCCCEeeeeEEEec-----CCceEEEEEecccCcchhhhhccc---ccccHHHHHHHHHHHHHhhhhcc---ccccccC
Confidence 579999999998654 467899999999999988775443 46999999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc---------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA---------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTN 329 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~---------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~ 329 (427)
||||+|||++.++.+||+|||+|+..... ..||..|+|||++.+..++.++|||||||++|||++|..|+.
T Consensus 135 DlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~ 214 (283)
T d1mqba_ 135 DLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY 214 (283)
T ss_dssp CCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred ccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCcc
Confidence 99999999999999999999999875432 257889999999999999999999999999999999766654
Q ss_pred cccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 042634 330 EMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEE 409 (427)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~e 409 (427)
.... ...+...+..... ...+..++.++.+++.+||+.||++||||+|
T Consensus 215 ~~~~-~~~~~~~i~~~~~-------------------------------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~e 262 (283)
T d1mqba_ 215 WELS-NHEVMKAINDGFR-------------------------------LPTPMDCPSAIYQLMMQCWQQERARRPKFAD 262 (283)
T ss_dssp TTCC-HHHHHHHHHTTCC-------------------------------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred ccCC-HHHHHHHHhccCC-------------------------------CCCchhhHHHHHHHHHHHCcCCHhHCcCHHH
Confidence 3211 1111111111100 0022335667899999999999999999999
Q ss_pred HHHHHHHHHH
Q 042634 410 VAAQLLSFRN 419 (427)
Q Consensus 410 v~~~L~~~~~ 419 (427)
|++.|+++.+
T Consensus 263 il~~L~~l~~ 272 (283)
T d1mqba_ 263 IVSILDKLIR 272 (283)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHhh
Confidence 9999998865
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-43 Score=329.26 Aligned_cols=203 Identities=22% Similarity=0.330 Sum_probs=155.6
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchh------------hhhccCHHHHHHHHHHHHHHHHH
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNRE------------ALKNLNLLQRLSIAVDVASALDY 246 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~~~~~i~~~L~~ 246 (427)
.+|+|||.+++.+.. .+...++|||||++|+|.++++.... ....+++.+++.++.||+.||+|
T Consensus 74 ~~h~~iv~~~~~~~~----~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~y 149 (299)
T d1ywna1 74 GHHLNVVNLLGACTK----PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEF 149 (299)
T ss_dssp CCCTTBCCEEEEECS----TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHH
T ss_pred cCCCeEEEeeeeecc----CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHH
Confidence 469999999887533 34567999999999999999865432 12358999999999999999999
Q ss_pred HhhcCCCCeeeccccCCceeeCCCCceEecccccccccCCc--------CCCccccccccccCCCCcCccccchhHHHHH
Q 042634 247 LHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA--------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILL 318 (427)
Q Consensus 247 LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl 318 (427)
|| ++||+||||||+|||++.++.+||+|||+|+..... ..||+.|+|||++.+..++.++|||||||++
T Consensus 150 lH---~~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil 226 (299)
T d1ywna1 150 LA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 226 (299)
T ss_dssp HH---HTTCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred HH---hCCCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHH
Confidence 99 899999999999999999999999999999865332 2688999999999999999999999999999
Q ss_pred HHHHhC-CCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcC
Q 042634 319 LETFTG-KRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCS 397 (427)
Q Consensus 319 ~ell~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl 397 (427)
|||++| .+||.+... ...+...+....... .+..++.++.+++.+||
T Consensus 227 ~ellt~~~~p~~~~~~-~~~~~~~~~~~~~~~-------------------------------~~~~~~~~l~~li~~cl 274 (299)
T d1ywna1 227 WEIFSLGASPYPGVKI-DEEFCRRLKEGTRMR-------------------------------APDYTTPEMYQTMLDCW 274 (299)
T ss_dssp HHHHTTSCCSSTTCCC-SHHHHHHHHHTCCCC-------------------------------CCTTCCHHHHHHHHHHT
T ss_pred HHHHhCCCCCCCCCCH-HHHHHHHHhcCCCCC-------------------------------CCccCCHHHHHHHHHHc
Confidence 999986 557765322 222222222211110 12234566899999999
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHH
Q 042634 398 SELPRERMNMEEVAAQLLSFRNK 420 (427)
Q Consensus 398 ~~dP~~Rpt~~ev~~~L~~~~~~ 420 (427)
+.||++||||+||+++|+++.+.
T Consensus 275 ~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 275 HGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp CSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCChhHCcCHHHHHHHHHHHHhC
Confidence 99999999999999999998654
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-44 Score=327.93 Aligned_cols=192 Identities=21% Similarity=0.267 Sum_probs=154.6
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||++++++.. ....++|||||++|+|.+++.+.. ..+++.+++.++.||+.||+||| ++||+||
T Consensus 66 l~HpnIv~l~~~~~~-----~~~~~lvmEy~~~g~L~~~~~~~~---~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHr 134 (288)
T d2jfla1 66 CDHPNIVKLLDAFYY-----ENNLWILIEFCAGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLH---DNKIIHR 134 (288)
T ss_dssp CCCTTBCCEEEEEEE-----TTEEEEEEECCTTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred CCCCCCCeEEEEEee-----CCeEEEEEecCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCEEEe
Confidence 579999999998654 567899999999999999875432 45999999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCC------cCCCccccccccccC-----CCCcCccccchhHHHHHHHHHhCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPE------ATNNFFNFQIAEYGM-----GSEVSTSGDVYSFGILLLETFTGKRP 327 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~------~~~~~~~y~aPE~~~-----~~~~~~~~DiwS~G~vl~ell~g~~p 327 (427)
||||+|||++.++.+||+|||+|+.... ...||+.|+|||++. ...|+.++|||||||++|||++|+.|
T Consensus 135 DiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~P 214 (288)
T d2jfla1 135 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 214 (288)
T ss_dssp CCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCT
T ss_pred ecChhheeECCCCCEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCC
Confidence 9999999999999999999999986532 348999999999984 45689999999999999999999999
Q ss_pred CCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCH
Q 042634 328 TNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM 407 (427)
Q Consensus 328 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~ 407 (427)
|.+..... .+...... .++. ...+..++.++.+++.+||+.||++|||+
T Consensus 215 f~~~~~~~-~~~~i~~~-~~~~-----------------------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~ 263 (288)
T d2jfla1 215 HHELNPMR-VLLKIAKS-EPPT-----------------------------LAQPSRWSSNFKDFLKKCLEKNVDARWTT 263 (288)
T ss_dssp TTTSCGGG-HHHHHHHS-CCCC-----------------------------CSSGGGSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred CCCCCHHH-HHHHHHcC-CCCC-----------------------------CCccccCCHHHHHHHHHHccCChhHCcCH
Confidence 97642111 11111111 0000 00123345678999999999999999999
Q ss_pred HHHHH
Q 042634 408 EEVAA 412 (427)
Q Consensus 408 ~ev~~ 412 (427)
+|+++
T Consensus 264 ~ell~ 268 (288)
T d2jfla1 264 SQLLQ 268 (288)
T ss_dssp HHHTT
T ss_pred HHHhc
Confidence 99986
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-44 Score=335.87 Aligned_cols=141 Identities=25% Similarity=0.354 Sum_probs=126.9
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCC-CCeee
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCE-TPIVH 257 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~-~~ivH 257 (427)
++|||||++++++.. ....++|||||++|+|.+++.+. ..+++..++.++.|++.||+||| + +||+|
T Consensus 61 l~HpnIv~l~~~~~~-----~~~~~iVmEy~~gg~L~~~l~~~----~~l~~~~~~~~~~qil~aL~yLH---~~~~IiH 128 (322)
T d1s9ja_ 61 CNSPYIVGFYGAFYS-----DGEISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLR---EKHKIMH 128 (322)
T ss_dssp CCCTTBCCEEEEEEC-----SSEEEEEEECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH---HHHCCCC
T ss_pred CCCCCCCcEEEEEEE-----CCEEEEEEEcCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHH---HhCCEEc
Confidence 469999999998644 56789999999999999999654 45999999999999999999999 5 48999
Q ss_pred ccccCCceeeCCCCceEecccccccccCC----cCCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 258 CDLKPSNVLLDGELTAHVGDFGLAKFLPE----ATNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 258 rDlkp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
|||||+|||++.++.+||+|||+|+.... ...||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.
T Consensus 129 RDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~ 206 (322)
T d1s9ja_ 129 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 206 (322)
T ss_dssp SCCSGGGEEECTTCCEEECCCCCCHHHHHHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred cccCHHHeeECCCCCEEEeeCCCccccCCCccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 99999999999999999999999986532 338999999999999999999999999999999999999999764
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-43 Score=319.98 Aligned_cols=195 Identities=25% Similarity=0.441 Sum_probs=160.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||++++++.. +...++||||+++|+|.+++.... ..+++..+.+++.|+++||+||| +.||+||
T Consensus 56 l~HpnIv~~~g~~~~-----~~~~~iv~Ey~~~g~l~~~~~~~~---~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~ 124 (258)
T d1k2pa_ 56 LSHEKLVQLYGVCTK-----QRPIFIITEYMANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLE---SKQFLHR 124 (258)
T ss_dssp CCCTTBCCEEEEECC-----SSSEEEEEECCTTEEHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHH---HTTBCCS
T ss_pred cCCCceeeEEEEEee-----CCceEEEEEccCCCcHHHhhhccc---cCCcHHHHHHHHHHHHHHHHHHh---hcCcccc
Confidence 579999999998654 567899999999999999876544 45889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc-------CCCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCCc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA-------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~~ 330 (427)
||||+||++++++.+||+|||+|+..... ..+|..|+|||++.+..++.++|||||||++|||++ |+.||.+
T Consensus 125 dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~ 204 (258)
T d1k2pa_ 125 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER 204 (258)
T ss_dssp CCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cccceeEEEcCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCC
Confidence 99999999999999999999999865433 267888999999999999999999999999999998 8999976
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
... ..+...+..... ...+..++.++.+++.+||+.||++||||+||
T Consensus 205 ~~~--~~~~~~i~~~~~-------------------------------~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei 251 (258)
T d1k2pa_ 205 FTN--SETAEHIAQGLR-------------------------------LYRPHLASEKVYTIMYSCWHEKADERPTFKIL 251 (258)
T ss_dssp SCH--HHHHHHHHTTCC-------------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHH
T ss_pred CCH--HHHHHHHHhCCC-------------------------------CCCcccccHHHHHHHHHHccCCHhHCcCHHHH
Confidence 421 111111111100 00223345678999999999999999999999
Q ss_pred HHHHHHH
Q 042634 411 AAQLLSF 417 (427)
Q Consensus 411 ~~~L~~~ 417 (427)
+++|.++
T Consensus 252 l~~L~di 258 (258)
T d1k2pa_ 252 LSNILDV 258 (258)
T ss_dssp HHHHHCC
T ss_pred HHHhhCC
Confidence 9998653
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-43 Score=323.26 Aligned_cols=197 Identities=21% Similarity=0.357 Sum_probs=154.3
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||++++++.. ...++|||||++|+|.+++.... ..+++..++.++.||++||+||| +++|+||
T Consensus 65 l~HpnIv~l~~~~~~------~~~~iv~E~~~~g~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHr 132 (273)
T d1mp8a_ 65 FDHPHIVKLIGVITE------NPVWIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLE---SKRFVHR 132 (273)
T ss_dssp CCCTTBCCEEEEECS------SSCEEEEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred CCCCCEeeEEEEEec------CeEEEEEEeccCCcHHhhhhccC---CCCCHHHHHHHHHHHHHHhhhhc---ccCeecc
Confidence 579999999998632 46799999999999998875443 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc-------CCCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCCc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA-------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~~ 330 (427)
||||+||+++.++.+||+|||+|+..... ..||+.|+|||++.+..++.++|||||||++|||++ |.+||.+
T Consensus 133 DlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~ 212 (273)
T d1mp8a_ 133 DIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 212 (273)
T ss_dssp CCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ccchhheeecCCCcEEEccchhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCC
Confidence 99999999999999999999999875432 267889999999999999999999999999999998 8999876
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
... ..+...+...... ..+..++.++.+++.+||+.||++||||+||
T Consensus 213 ~~~--~~~~~~i~~~~~~-------------------------------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei 259 (273)
T d1mp8a_ 213 VKN--NDVIGRIENGERL-------------------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 259 (273)
T ss_dssp CCG--GGHHHHHHTTCCC-------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCH--HHHHHHHHcCCCC-------------------------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHH
Confidence 422 1122211111000 0223456779999999999999999999999
Q ss_pred HHHHHHHHHH
Q 042634 411 AAQLLSFRNK 420 (427)
Q Consensus 411 ~~~L~~~~~~ 420 (427)
++.|+++.++
T Consensus 260 ~~~L~~i~~~ 269 (273)
T d1mp8a_ 260 KAQLSTILEE 269 (273)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 9999998765
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-43 Score=326.56 Aligned_cols=189 Identities=20% Similarity=0.283 Sum_probs=154.3
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||++++++.. +...++|||||++|+|.+++... ..+++..++.++.|++.||+||| +.||+||
T Consensus 65 l~HpnIv~l~~~~~~-----~~~~~ivmEy~~gg~L~~~~~~~----~~l~e~~~~~~~~qi~~al~ylH---~~~iiHr 132 (288)
T d1uu3a_ 65 LDHPFFVKLYFTFQD-----DEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLH---GKGIIHR 132 (288)
T ss_dssp CCSTTBCCEEEEEEC-----SSEEEEEECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECS
T ss_pred cCCCCeeEEEEEEEE-----CCEEEEEEEccCCCCHHHhhhcc----CCCCHHHHHHHHHHHHHHHHhhc---cccEEcC
Confidence 579999999998543 56789999999999999988654 45999999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc--------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA--------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~ 330 (427)
||||+|||+++++.+||+|||+|+..... ..||+.|+|||++.+..++.++||||+||++|||++|+.||.+
T Consensus 133 DiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 212 (288)
T d1uu3a_ 133 DLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 212 (288)
T ss_dssp CCSGGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCCccccccCCCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCC
Confidence 99999999999999999999999876422 2699999999999999999999999999999999999999975
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
.. ............. + .+...+.++.+++.+||+.||++|||++|+
T Consensus 213 ~~-----~~~~~~~i~~~~~----~-------------------------~p~~~s~~~~~li~~~L~~dP~~R~t~~e~ 258 (288)
T d1uu3a_ 213 GN-----EYLIFQKIIKLEY----D-------------------------FPEKFFPKARDLVEKLLVLDATKRLGCEEM 258 (288)
T ss_dssp SS-----HHHHHHHHHTTCC----C-------------------------CCTTCCHHHHHHHHTTSCSSGGGSTTSGGG
T ss_pred cC-----HHHHHHHHHcCCC----C-------------------------CCccCCHHHHHHHHHHccCCHhHCcCHHHH
Confidence 31 1111111110000 0 111234568899999999999999999997
Q ss_pred HHH
Q 042634 411 AAQ 413 (427)
Q Consensus 411 ~~~ 413 (427)
++.
T Consensus 259 ~~~ 261 (288)
T d1uu3a_ 259 EGY 261 (288)
T ss_dssp TCH
T ss_pred cCC
Confidence 654
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-43 Score=317.49 Aligned_cols=199 Identities=27% Similarity=0.365 Sum_probs=156.3
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||++++++.. .+...++||||+++|+|.+++..... ..+++..++.++.||+.||+||| +.+|+||
T Consensus 57 l~HpnIv~~~g~~~~----~~~~~~lv~ey~~~g~L~~~l~~~~~--~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~ 127 (262)
T d1byga_ 57 LRHSNLVQLLGVIVE----EKGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHR 127 (262)
T ss_dssp CCCTTBCCEEEEECC----C--CCEEEECCCTTEEHHHHHHHHHH--HHCCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred CCCCCEeeEEEEEEe----cCCcEEEEEeccCCCCHHHHHHhcCC--CCCCHHHHHHHHHHHHhhccccc---cCceecc
Confidence 579999999998643 23457999999999999999975432 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC---CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCCcccCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT---NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTNEMFTG 334 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~---~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~~~~~~ 334 (427)
||||+||+++.++.+||+|||+++...... .++..|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 128 dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~-- 205 (262)
T d1byga_ 128 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-- 205 (262)
T ss_dssp CCSGGGEEECTTSCEEECCCCC------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC--
T ss_pred ccchHhheecCCCCEeecccccceecCCCCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCC--
Confidence 999999999999999999999999764433 67889999999999999999999999999999998 788876531
Q ss_pred CccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHHH
Q 042634 335 NLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAAQL 414 (427)
Q Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~L 414 (427)
...+...+...... ..+..++.++.+++.+||+.||++||||.|++++|
T Consensus 206 ~~~~~~~i~~~~~~-------------------------------~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L 254 (262)
T d1byga_ 206 LKDVVPRVEKGYKM-------------------------------DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQL 254 (262)
T ss_dssp GGGHHHHHTTTCCC-------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHcCCCC-------------------------------CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHH
Confidence 11222221111000 01223456789999999999999999999999999
Q ss_pred HHHHH
Q 042634 415 LSFRN 419 (427)
Q Consensus 415 ~~~~~ 419 (427)
++++.
T Consensus 255 ~~i~~ 259 (262)
T d1byga_ 255 EHIKT 259 (262)
T ss_dssp HHHHH
T ss_pred HHHHh
Confidence 99875
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-42 Score=323.76 Aligned_cols=193 Identities=22% Similarity=0.242 Sum_probs=146.4
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||++++++.. +...++|||||++|+|.+++... ..+++.++..++.||+.||+||| ++||+||
T Consensus 64 l~HpnIv~l~~~~~~-----~~~~~lvmE~~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~al~ylH---~~~iiHr 131 (307)
T d1a06a_ 64 IKHPNIVALDDIYES-----GGHLYLIMQLVSGGELFDRIVEK----GFYTERDASRLIFQVLDAVKYLH---DLGIVHR 131 (307)
T ss_dssp CCCTTBCCEEEEEEC-----SSEEEEEECCCCSCBHHHHHHTC----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred CCCCCCCcEEEEEEE-----CCEEEEEEeccCCCcHHHhhhcc----cCCCHHHHHHHHHHHHHHHHhhh---hceeeeE
Confidence 579999999998543 66789999999999999999764 45999999999999999999999 8999999
Q ss_pred cccCCceeeC---CCCceEecccccccccCCcC-----CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCc
Q 042634 259 DLKPSNVLLD---GELTAHVGDFGLAKFLPEAT-----NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~---~~~~~kL~DFG~a~~~~~~~-----~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~ 330 (427)
||||+||++. .++.+||+|||+|+...... .||+.|+|||++.+..++.++||||+||++|||++|+.||.+
T Consensus 132 DiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 211 (307)
T d1a06a_ 132 DLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD 211 (307)
T ss_dssp CCCGGGEEESSSSTTCCEEECCC------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred EecccceeecccCCCceEEEeccceeEEccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCC
Confidence 9999999994 57899999999998764432 799999999999999999999999999999999999999975
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
... ......+...... . ........+.++.+++.+||+.||++|||++|+
T Consensus 212 ~~~--~~~~~~i~~~~~~-----------~-----------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ei 261 (307)
T d1a06a_ 212 END--AKLFEQILKAEYE-----------F-----------------DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQA 261 (307)
T ss_dssp SSH--HHHHHHHHTTCCC-----------C-----------------CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred CCH--HHHHHHHhccCCC-----------C-----------------CCccccCCCHHHHHHHHHHccCCHhHCcCHHHH
Confidence 311 1111111110000 0 000112345668999999999999999999999
Q ss_pred HHH
Q 042634 411 AAQ 413 (427)
Q Consensus 411 ~~~ 413 (427)
+++
T Consensus 262 l~h 264 (307)
T d1a06a_ 262 LQH 264 (307)
T ss_dssp HHS
T ss_pred hcC
Confidence 874
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.2e-43 Score=327.35 Aligned_cols=190 Identities=20% Similarity=0.267 Sum_probs=152.6
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||++++++.. ....++|||||.+|++..++... ..+++.+++.++.||+.||+||| ++||+||
T Consensus 72 l~HpnIv~~~~~~~~-----~~~~~iv~E~~~~g~l~~~~~~~----~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHr 139 (309)
T d1u5ra_ 72 LRHPNTIQYRGCYLR-----EHTAWLVMEYCLGSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLH---SHNMIHR 139 (309)
T ss_dssp CCCTTBCCEEEEEEE-----TTEEEEEEECCSEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCC
T ss_pred CCCCCEeeEEEEEEE-----CCEEEEEEEecCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHH---hCCEecc
Confidence 579999999998654 56789999999999987665433 45999999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC--CCccccccccccCC---CCcCccccchhHHHHHHHHHhCCCCCCcccC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT--NNFFNFQIAEYGMG---SEVSTSGDVYSFGILLLETFTGKRPTNEMFT 333 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~--~~~~~y~aPE~~~~---~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~ 333 (427)
||||+|||++.++.+||+|||+|+...... .||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+...
T Consensus 140 DiKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~ 219 (309)
T d1u5ra_ 140 DVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219 (309)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCBSSSSBCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred CCCcceEEECCCCCEEEeecccccccCCCCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH
Confidence 999999999999999999999999765433 89999999999864 4589999999999999999999999975311
Q ss_pred CCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 334 GNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
.+........... ...+..+++++.+++.+||+.||++|||++|+++
T Consensus 220 -----~~~~~~i~~~~~~---------------------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 220 -----MSALYHIAQNESP---------------------------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp -----HHHHHHHHHSCCC---------------------------CCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -----HHHHHHHHhCCCC---------------------------CCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 1111111100000 0011223567899999999999999999999975
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-43 Score=321.94 Aligned_cols=197 Identities=28% Similarity=0.427 Sum_probs=155.4
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||++++.+.. +..++|||||++|+|..++..... ..+++.+++.++.||+.||+||| +.||+||
T Consensus 69 l~h~nIv~~~g~~~~------~~~~lv~Ey~~~g~l~~~~~~~~~--~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~ 137 (285)
T d1fmka3 69 LRHEKLVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 137 (285)
T ss_dssp CCCTTBCCEEEEECS------SSCEEEECCCTTCBHHHHHSHHHH--TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred cccCCEeEEEEEEec------CCeEEEEEecCCCchhhhhhhccc--ccchHHHHHHHHHHHHHHHHHHh---hhheecc
Confidence 689999999998632 357899999999999988875433 45999999999999999999999 8899999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc-------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA-------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
||||+|||++.++.+||+|||+|+..... ..+|..|+|||++....++.++|||||||++|||++|..||...
T Consensus 138 DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~ 217 (285)
T d1fmka3 138 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 217 (285)
T ss_dssp CCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred cccceEEEECCCCcEEEcccchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCC
Confidence 99999999999999999999999865432 26788999999999999999999999999999999976665432
Q ss_pred cCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 042634 332 FTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVA 411 (427)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~ 411 (427)
.. ...+...+..... ...+..+++++.+++.+||+.||++||||+||+
T Consensus 218 ~~-~~~~~~~i~~~~~-------------------------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~ 265 (285)
T d1fmka3 218 MV-NREVLDQVERGYR-------------------------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQ 265 (285)
T ss_dssp CC-HHHHHHHHHTTCC-------------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CC-HHHHHHHHHhcCC-------------------------------CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHH
Confidence 11 1111111111100 002233566789999999999999999999999
Q ss_pred HHHHHHH
Q 042634 412 AQLLSFR 418 (427)
Q Consensus 412 ~~L~~~~ 418 (427)
+.|+.+.
T Consensus 266 ~~L~~~~ 272 (285)
T d1fmka3 266 AFLEDYF 272 (285)
T ss_dssp HHHHTTT
T ss_pred HHHhhhh
Confidence 9888754
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-42 Score=317.40 Aligned_cols=223 Identities=20% Similarity=0.230 Sum_probs=163.5
Q ss_pred ccccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhc-----CC
Q 042634 178 FIRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHY-----CE 252 (427)
Q Consensus 178 ll~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~-----~~ 252 (427)
.++|||||++++++.... ......++|||||++|+|.+++++. .+++..++.++.|+|.||+|+|+. ..
T Consensus 53 ~~~HpnIv~~~~~~~~~~-~~~~~~~lv~Ey~~~g~L~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~ 126 (303)
T d1vjya_ 53 MLRHENILGFIAADNKDN-GTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGK 126 (303)
T ss_dssp TCCCTTBCCEEEEEEEEC-SSSEEEEEEEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB
T ss_pred hCCCCcCcceEEEEEeCC-CcceEEEEEEecccCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccC
Confidence 367999999999976532 1223578999999999999999643 489999999999999999999942 13
Q ss_pred CCeeeccccCCceeeCCCCceEecccccccccCCc----------CCCccccccccccCCCC------cCccccchhHHH
Q 042634 253 TPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA----------TNNFFNFQIAEYGMGSE------VSTSGDVYSFGI 316 (427)
Q Consensus 253 ~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~----------~~~~~~y~aPE~~~~~~------~~~~~DiwS~G~ 316 (427)
+||+||||||+|||++.++.+||+|||+++..... ..||+.|+|||++.+.. ++.++|||||||
T Consensus 127 ~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gv 206 (303)
T d1vjya_ 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGL 206 (303)
T ss_dssp CEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHH
T ss_pred CCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHH
Confidence 69999999999999999999999999999865322 26899999999987643 678999999999
Q ss_pred HHHHHHhCCCCCCcccCCCccHHHHHHHhcc-cchh-cccCccccccccccchhhhccccccccccchHHHHHHHHHHHh
Q 042634 317 LLLETFTGKRPTNEMFTGNLTLHNFVKEALP-ERLA-EIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGV 394 (427)
Q Consensus 317 vl~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 394 (427)
++|||++|..||................... .... ...+... .+.........+++..+.+++.
T Consensus 207 vl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~p~~~~~~~~~~~~~~l~~li~ 272 (303)
T d1vjya_ 207 VFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKL--------------RPNIPNRWQSCEALRVMAKIMR 272 (303)
T ss_dssp HHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCC--------------CCCCCGGGGGCHHHHHHHHHHH
T ss_pred HHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhcccc--------------CCCCCcccCChHHHHHHHHHHH
Confidence 9999999998875432221111000000000 0000 0000000 0011111234456778999999
Q ss_pred hcCCCCCCCCCCHHHHHHHHHHHHHH
Q 042634 395 TCSSELPRERMNMEEVAAQLLSFRNK 420 (427)
Q Consensus 395 ~cl~~dP~~Rpt~~ev~~~L~~~~~~ 420 (427)
+||+.||++||||.||++.|+++.++
T Consensus 273 ~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 273 ECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp TTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 99999999999999999999999876
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-42 Score=322.41 Aligned_cols=201 Identities=21% Similarity=0.367 Sum_probs=161.4
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||++++++... +...++|||||++|+|.+++.... ..+++..++.++.|++.||.|+| +.+|+||
T Consensus 85 l~HpnIv~~~g~~~~~----~~~~~lv~E~~~~g~l~~~~~~~~---~~~~~~~~~~i~~qia~gL~~lH---~~~iiHr 154 (311)
T d1r0pa_ 85 FSHPNVLSLLGICLRS----EGSPLVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLA---SKKFVHR 154 (311)
T ss_dssp CCCTTBCCCCEEEEET----TTEEEEEEECCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred CCCCCEeEEeEEEEec----CCceEEEEEEeecCchhhhhcccc---ccchHHHHHHHHHHHHHhhhhhc---ccCcccC
Confidence 5799999999986442 346789999999999999887553 45778899999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc----------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA----------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPT 328 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~----------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf 328 (427)
||||+|||+++++.+||+|||+++..... ..||..|+|||.+....++.++|||||||++|||++|..||
T Consensus 155 DLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~ 234 (311)
T d1r0pa_ 155 DLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 234 (311)
T ss_dssp CCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred CccHHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCC
Confidence 99999999999999999999999875432 25788999999999999999999999999999999988887
Q ss_pred CcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 042634 329 NEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME 408 (427)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ 408 (427)
....... .+...+..... ...+..++.++.+++.+||+.||++||||.
T Consensus 235 ~~~~~~~-~~~~~i~~g~~-------------------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ 282 (311)
T d1r0pa_ 235 YPDVNTF-DITVYLLQGRR-------------------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFS 282 (311)
T ss_dssp CC-------CHHHHHTTCC-------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCCCHH-HHHHHHHcCCC-------------------------------CCCcccCcHHHHHHHHHHcCCCHhHCcCHH
Confidence 6432211 11111111100 001233456789999999999999999999
Q ss_pred HHHHHHHHHHHHH
Q 042634 409 EVAAQLLSFRNKL 421 (427)
Q Consensus 409 ev~~~L~~~~~~~ 421 (427)
||+++|+++.+++
T Consensus 283 ei~~~L~~i~~~~ 295 (311)
T d1r0pa_ 283 ELVSRISAIFSTF 295 (311)
T ss_dssp HHHHHHHHHHHTC
T ss_pred HHHHHHHHHHHhh
Confidence 9999999998754
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-42 Score=323.84 Aligned_cols=197 Identities=21% Similarity=0.364 Sum_probs=161.4
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||+++++|.. ...++++||+.+|+|.+++.... ..+++..++.++.|||.||+||| ++||+||
T Consensus 68 l~HpnIv~l~g~~~~------~~~~~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHr 135 (317)
T d1xkka_ 68 VDNPHVCRLLGICLT------STVQLITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHR 135 (317)
T ss_dssp CCCTTBCCEEEEEES------SSEEEEEECCTTCBHHHHHHHTS---SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred CCCCCEeeEEEEEec------CCeeEEEEeccCCcccccccccc---cCCCHHHHHHHHHHHHHHHHHHH---HcCcccC
Confidence 579999999998754 35688999999999998876543 56999999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC--------CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT--------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPTN 329 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~--------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf~ 329 (427)
||||+|||++.++.+||+|||+|+...... .||+.|+|||++.+..++.++|||||||++|||+| |..||.
T Consensus 136 DlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~ 215 (317)
T d1xkka_ 136 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 215 (317)
T ss_dssp CCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cchhhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCC
Confidence 999999999999999999999998764322 57889999999999999999999999999999998 788887
Q ss_pred cccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 042634 330 EMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEE 409 (427)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~e 409 (427)
+.. ...+...+...... ..+..++.++.+++.+||+.||++||||.|
T Consensus 216 ~~~--~~~~~~~i~~~~~~-------------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~e 262 (317)
T d1xkka_ 216 GIP--ASEISSILEKGERL-------------------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRE 262 (317)
T ss_dssp TSC--GGGHHHHHHHTCCC-------------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCC--HHHHHHHHHcCCCC-------------------------------CCCcccCHHHHHHHHHhCCCChhhCcCHHH
Confidence 542 12222222221110 022335667899999999999999999999
Q ss_pred HHHHHHHHHHH
Q 042634 410 VAAQLLSFRNK 420 (427)
Q Consensus 410 v~~~L~~~~~~ 420 (427)
|++.|+.+.+.
T Consensus 263 il~~l~~~~~~ 273 (317)
T d1xkka_ 263 LIIEFSKMARD 273 (317)
T ss_dssp HHHHHHHHHHS
T ss_pred HHHHHHHHHhC
Confidence 99999988653
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=7.2e-42 Score=323.51 Aligned_cols=194 Identities=21% Similarity=0.298 Sum_probs=156.0
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||++++++.. ....++|||||++|+|.+++.... ..+++..++.++.||+.||+||| ++||+||
T Consensus 80 l~HpnIv~~~~~~~~-----~~~~~ivmE~~~gg~L~~~l~~~~---~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHr 148 (350)
T d1koaa2 80 LRHPTLVNLHDAFED-----DNEMVMIYEFMSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMH---ENNYVHL 148 (350)
T ss_dssp TCCTTBCCEEEEEEE-----TTEEEEEECCCCSCBHHHHHTCTT---SCBCHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred CCCCCCCcEEEEEEE-----CCEEEEEEEcCCCCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHH---hcCCeee
Confidence 579999999998544 568899999999999999986543 45999999999999999999999 8999999
Q ss_pred cccCCceeeC--CCCceEecccccccccCCcC-----CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 259 DLKPSNVLLD--GELTAHVGDFGLAKFLPEAT-----NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 259 Dlkp~NIll~--~~~~~kL~DFG~a~~~~~~~-----~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
||||+|||++ .++.+||+|||+|+...... .||+.|+|||++.+..++.++||||+||++|||++|+.||.+.
T Consensus 149 DiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 228 (350)
T d1koaa2 149 DLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE 228 (350)
T ss_dssp CCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eechhHeeeccCCCCeEEEeecchheecccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC
Confidence 9999999995 45789999999998775543 7899999999999999999999999999999999999999753
Q ss_pred cCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 042634 332 FTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVA 411 (427)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~ 411 (427)
. . .+........... .. ......+++++.+++.+||+.||++|||++|++
T Consensus 229 ~--~---~~~~~~i~~~~~~--~~-----------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil 278 (350)
T d1koaa2 229 N--D---DETLRNVKSCDWN--MD-----------------------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQAL 278 (350)
T ss_dssp S--H---HHHHHHHHHTCCC--SC-----------------------CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred C--H---HHHHHHHHhCCCC--CC-----------------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 1 1 1111111100000 00 001122345689999999999999999999998
Q ss_pred HH
Q 042634 412 AQ 413 (427)
Q Consensus 412 ~~ 413 (427)
++
T Consensus 279 ~h 280 (350)
T d1koaa2 279 EH 280 (350)
T ss_dssp HS
T ss_pred cC
Confidence 74
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.1e-41 Score=322.59 Aligned_cols=194 Identities=20% Similarity=0.267 Sum_probs=156.2
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||++++++. .+...++|||||++|+|.+++.... ..+++.+++.++.||+.||+||| ++||+||
T Consensus 83 l~HpnIv~~~~~~~-----~~~~~~ivmE~~~gg~L~~~~~~~~---~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHR 151 (352)
T d1koba_ 83 LHHPKLINLHDAFE-----DKYEMVLILEFLSGGELFDRIAAED---YKMSEAEVINYMRQACEGLKHMH---EHSIVHL 151 (352)
T ss_dssp CCSTTBCCEEEEEE-----CSSEEEEEEECCCCCBHHHHTTCTT---CCBCHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred CCCCCCCcEEEEEE-----ECCEEEEEEEcCCCChHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeec
Confidence 57999999999854 3678899999999999998876543 45999999999999999999999 8999999
Q ss_pred cccCCceeeC--CCCceEecccccccccCCcC-----CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 259 DLKPSNVLLD--GELTAHVGDFGLAKFLPEAT-----NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 259 Dlkp~NIll~--~~~~~kL~DFG~a~~~~~~~-----~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
||||+|||++ .++.+||+|||+|+...... .||+.|+|||++.+..++.++||||+||++|||++|+.||.+.
T Consensus 152 DiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 231 (352)
T d1koba_ 152 DIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE 231 (352)
T ss_dssp CCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred ccccccccccccCCCeEEEeecccceecCCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 9999999997 57899999999999876543 7899999999999999999999999999999999999999753
Q ss_pred cCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 042634 332 FTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVA 411 (427)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~ 411 (427)
.. ......+...... . +.......+.++.+++.+||+.||++|||++|++
T Consensus 232 ~~--~~~~~~i~~~~~~-~---------------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil 281 (352)
T d1koba_ 232 DD--LETLQNVKRCDWE-F---------------------------DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDAL 281 (352)
T ss_dssp SH--HHHHHHHHHCCCC-C---------------------------CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred CH--HHHHHHHHhCCCC-C---------------------------CcccccCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 11 1111111110000 0 0001122455689999999999999999999998
Q ss_pred HH
Q 042634 412 AQ 413 (427)
Q Consensus 412 ~~ 413 (427)
++
T Consensus 282 ~H 283 (352)
T d1koba_ 282 EH 283 (352)
T ss_dssp TS
T ss_pred cC
Confidence 63
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-42 Score=318.31 Aligned_cols=200 Identities=24% Similarity=0.398 Sum_probs=162.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchh------------hhhccCHHHHHHHHHHHHHHHHH
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNRE------------ALKNLNLLQRLSIAVDVASALDY 246 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~~~~~i~~~L~~ 246 (427)
.+|||||++++++.. +...++|||||++|+|.+++..... ....+++.+++.++.||+.||+|
T Consensus 76 ~~HpnIv~~~~~~~~-----~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~y 150 (299)
T d1fgka_ 76 GKHKNIINLLGACTQ-----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY 150 (299)
T ss_dssp CCCTTBCCEEEEECS-----SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHH
T ss_pred cCCCeEEeccccccc-----CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHH
Confidence 479999999999754 5678999999999999999865431 12458999999999999999999
Q ss_pred HhhcCCCCeeeccccCCceeeCCCCceEecccccccccCCc--------CCCccccccccccCCCCcCccccchhHHHHH
Q 042634 247 LHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA--------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILL 318 (427)
Q Consensus 247 LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl 318 (427)
|| +.+||||||||+|||++.++.+||+|||+++..... ..+++.|+|||++.+..|+.++||||||||+
T Consensus 151 lH---~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl 227 (299)
T d1fgka_ 151 LA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLL 227 (299)
T ss_dssp HH---HTTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred hh---hCCEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHH
Confidence 99 899999999999999999999999999999876432 2678899999999999999999999999999
Q ss_pred HHHHh-CCCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcC
Q 042634 319 LETFT-GKRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCS 397 (427)
Q Consensus 319 ~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl 397 (427)
|||++ |.+||.+... ..+.+.+...... ..+..++.++.+++.+||
T Consensus 228 ~ell~~g~~p~~~~~~--~~~~~~i~~~~~~-------------------------------~~p~~~~~~l~~li~~cl 274 (299)
T d1fgka_ 228 WEIFTLGGSPYPGVPV--EELFKLLKEGHRM-------------------------------DKPSNCTNELYMMMRDCW 274 (299)
T ss_dssp HHHHTTSCCSSTTCCH--HHHHHHHHTTCCC-------------------------------CCCSSCCHHHHHHHHHHT
T ss_pred HHhccCCCCCCCCCCH--HHHHHHHHcCCCC-------------------------------CCCccchHHHHHHHHHHc
Confidence 99998 7888865321 1111111111100 011224556899999999
Q ss_pred CCCCCCCCCHHHHHHHHHHHHH
Q 042634 398 SELPRERMNMEEVAAQLLSFRN 419 (427)
Q Consensus 398 ~~dP~~Rpt~~ev~~~L~~~~~ 419 (427)
+.||++||||+||++.|+++..
T Consensus 275 ~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 275 HAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp CSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCHhHCcCHHHHHHHHHHHhh
Confidence 9999999999999999998854
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-42 Score=322.56 Aligned_cols=203 Identities=19% Similarity=0.232 Sum_probs=157.3
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
.+|||||++++++... ...+...|+|||||+||+|.+++..... ..+++.+++.++.||+.||+||| +.||+||
T Consensus 62 ~~hpnIv~l~~~~~~~-~~~~~~~~ivmEy~~gg~L~~~i~~~~~--~~l~e~~~~~i~~qi~~al~ylH---~~~iiHR 135 (335)
T d2ozaa1 62 SQCPHIVRIVDVYENL-YAGRKCLLIVMECLDGGELFSRIQDRGD--QAFTEREASEIMKSIGEAIQYLH---SINIAHR 135 (335)
T ss_dssp TTSTTBCCEEEEEEEE-ETTEEEEEEEEECCCSEEHHHHHHSCSC--CCEEHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred cCCCCCCeEEEEEeec-ccCCCEEEEEEECCCCCcHHHHHHhcCC--CCcCHHHHHHHHHHHHHHHHHHH---HcCCccc
Confidence 5799999999986442 1224568999999999999999975432 46999999999999999999999 8999999
Q ss_pred cccCCceeeCC---CCceEecccccccccCCcC-----CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCc
Q 042634 259 DLKPSNVLLDG---ELTAHVGDFGLAKFLPEAT-----NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNE 330 (427)
Q Consensus 259 Dlkp~NIll~~---~~~~kL~DFG~a~~~~~~~-----~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~ 330 (427)
||||+|||++. .+.+||+|||+|+...... .||+.|+|||++.+..|+.++||||+||++|||++|+.||.+
T Consensus 136 DiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~ 215 (335)
T d2ozaa1 136 DVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS 215 (335)
T ss_dssp CCSGGGEEESCSSTTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEE
T ss_pred cccccccccccccccccccccccceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCC
Confidence 99999999975 5679999999998764432 799999999999999999999999999999999999999975
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHH
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEV 410 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev 410 (427)
...... ... +... +..... -.+......+++++.+++.+||+.||++|||++|+
T Consensus 216 ~~~~~~-~~~-~~~~-------i~~~~~-----------------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ei 269 (335)
T d2ozaa1 216 NHGLAI-SPG-MKTR-------IRMGQY-----------------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 269 (335)
T ss_dssp TTCC----------C-------CCSCSS-----------------SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred CCHHHH-HHH-HHHH-------HhcCCC-----------------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 321110 000 0000 000000 00011223456789999999999999999999999
Q ss_pred HHH
Q 042634 411 AAQ 413 (427)
Q Consensus 411 ~~~ 413 (427)
+++
T Consensus 270 l~h 272 (335)
T d2ozaa1 270 MNH 272 (335)
T ss_dssp HHS
T ss_pred HcC
Confidence 873
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-42 Score=316.90 Aligned_cols=195 Identities=26% Similarity=0.377 Sum_probs=157.3
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||++++++.. ...++|||||++|++.+++.... ..+++..++.++.|||.||+||| ++||+||
T Consensus 68 l~H~nIv~~~g~~~~------~~~~lv~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHr 135 (273)
T d1u46a_ 68 LDHRNLIRLYGVVLT------PPMKMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLE---SKRFIHR 135 (273)
T ss_dssp CCCTTBCCEEEEECS------SSCEEEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHH---HTTEECS
T ss_pred CCCCCEEEEEEEEee------cchheeeeeecCcchhhhhhccc---CCCCHHHHHHHHHHHHHHHHHhh---hCCEeee
Confidence 579999999998643 35689999999999998876543 45999999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC---------CCccccccccccCCCCcCccccchhHHHHHHHHHh-CCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT---------NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFT-GKRPT 328 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~---------~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~-g~~pf 328 (427)
||||+||+++.++.+||+|||+++...... .++..|+|||++.+..++.++|||||||++|||++ |+.||
T Consensus 136 Dikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf 215 (273)
T d1u46a_ 136 DLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW 215 (273)
T ss_dssp CCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred eecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCC
Confidence 999999999999999999999999764432 56778999999999999999999999999999998 89999
Q ss_pred CcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 042634 329 NEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME 408 (427)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ 408 (427)
.+.. ..+.......... +...+..++.++.+++.+||+.||++||||.
T Consensus 216 ~~~~-----~~~~~~~i~~~~~---------------------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ 263 (273)
T d1u46a_ 216 IGLN-----GSQILHKIDKEGE---------------------------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFV 263 (273)
T ss_dssp TTCC-----HHHHHHHHHTSCC---------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCcC-----HHHHHHHHHhCCC---------------------------CCCCcccccHHHHHHHHHHcCCChhHCcCHH
Confidence 7531 1111111110000 0001223456789999999999999999999
Q ss_pred HHHHHHHHH
Q 042634 409 EVAAQLLSF 417 (427)
Q Consensus 409 ev~~~L~~~ 417 (427)
||.+.|++.
T Consensus 264 ei~~~L~~~ 272 (273)
T d1u46a_ 264 ALRDFLLEA 272 (273)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHhc
Confidence 999888764
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-42 Score=322.22 Aligned_cols=199 Identities=25% Similarity=0.418 Sum_probs=159.0
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccch--------------------hhhhccCHHHHHHHHH
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNR--------------------EALKNLNLLQRLSIAV 238 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------------------~~~~~l~~~~~~~~~~ 238 (427)
++||||+++++.+.. ....+++|||+++|+|.+++.... .....+++..++.++.
T Consensus 73 l~h~niv~~~~~~~~-----~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~ 147 (301)
T d1lufa_ 73 FDNPNIVKLLGVCAV-----GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIAR 147 (301)
T ss_dssp CCCTTBCCEEEEECS-----SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHH
T ss_pred cCCCCcccceeeecc-----CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHH
Confidence 579999999998654 567899999999999999885321 1123488999999999
Q ss_pred HHHHHHHHHhhcCCCCeeeccccCCceeeCCCCceEecccccccccCCc--------CCCccccccccccCCCCcCcccc
Q 042634 239 DVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA--------TNNFFNFQIAEYGMGSEVSTSGD 310 (427)
Q Consensus 239 ~i~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~D 310 (427)
|++.||+||| +.+||||||||+|||++.++.+||+|||+|+..... ..+++.|+|||++.+..++.++|
T Consensus 148 qi~~gl~ylH---~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksD 224 (301)
T d1lufa_ 148 QVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESD 224 (301)
T ss_dssp HHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHH
T ss_pred HHHHHhhhcc---cCCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhh
Confidence 9999999999 899999999999999999999999999999865332 26778899999999999999999
Q ss_pred chhHHHHHHHHHhCC-CCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHH
Q 042634 311 VYSFGILLLETFTGK-RPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSV 389 (427)
Q Consensus 311 iwS~G~vl~ell~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 389 (427)
||||||++|||++|. +||.+.. ...+...+..... ...+..++.++
T Consensus 225 VwS~Gvvl~ell~~~~~p~~~~~--~~e~~~~v~~~~~-------------------------------~~~p~~~~~~~ 271 (301)
T d1lufa_ 225 VWAYGVVLWEIFSYGLQPYYGMA--HEEVIYYVRDGNI-------------------------------LACPENCPLEL 271 (301)
T ss_dssp HHHHHHHHHHHHTTTCCTTTTSC--HHHHHHHHHTTCC-------------------------------CCCCTTCCHHH
T ss_pred hccchhhHHHHHccCCCCCCCCC--HHHHHHHHHcCCC-------------------------------CCCCccchHHH
Confidence 999999999999985 5676431 1111111111100 00123345678
Q ss_pred HHHHhhcCCCCCCCCCCHHHHHHHHHHHH
Q 042634 390 LGIGVTCSSELPRERMNMEEVAAQLLSFR 418 (427)
Q Consensus 390 ~~l~~~cl~~dP~~Rpt~~ev~~~L~~~~ 418 (427)
.+++.+||+.||++||||.||++.|++++
T Consensus 272 ~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 272 YNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 99999999999999999999999999875
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-42 Score=322.82 Aligned_cols=202 Identities=25% Similarity=0.345 Sum_probs=161.9
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccch------------hhhhccCHHHHHHHHHHHHHHHHH
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNR------------EALKNLNLLQRLSIAVDVASALDY 246 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~~~~~i~~~L~~ 246 (427)
.+|||||++++++.. +...++||||+++|+|.++++... .....+++..+..++.||+.||+|
T Consensus 68 ~~HpnIv~~~~~~~~-----~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~ 142 (309)
T d1fvra_ 68 GHHPNIINLLGACEH-----RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDY 142 (309)
T ss_dssp CCCTTBCCEEEEEEE-----TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHH
T ss_pred cCCCCEeeEEEEEec-----CCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHh
Confidence 369999999999754 567899999999999999987542 112468999999999999999999
Q ss_pred HhhcCCCCeeeccccCCceeeCCCCceEecccccccccCCc-----CCCccccccccccCCCCcCccccchhHHHHHHHH
Q 042634 247 LHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLET 321 (427)
Q Consensus 247 LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~el 321 (427)
+| +++|+||||||+|||++.++.+||+|||+|+..... ..||..|+|||.+.+..++.++|||||||++|||
T Consensus 143 lH---~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~el 219 (309)
T d1fvra_ 143 LS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 219 (309)
T ss_dssp HH---HTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHH
T ss_pred hh---cCCccccccccceEEEcCCCceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHH
Confidence 99 899999999999999999999999999999865432 2688899999999999999999999999999999
Q ss_pred HhCCC-CCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCC
Q 042634 322 FTGKR-PTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSEL 400 (427)
Q Consensus 322 l~g~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~d 400 (427)
++|.. ||.+. ...+........ . +...+..++.++.+++.+||+.|
T Consensus 220 l~~~~~p~~~~-----~~~~~~~~i~~~-----~-----------------------~~~~~~~~~~~~~~li~~cl~~d 266 (309)
T d1fvra_ 220 VSLGGTPYCGM-----TCAELYEKLPQG-----Y-----------------------RLEKPLNCDDEVYDLMRQCWREK 266 (309)
T ss_dssp HTTSCCTTTTC-----CHHHHHHHGGGT-----C-----------------------CCCCCTTBCHHHHHHHHHHTCSS
T ss_pred HhcCCCCCCCC-----CHHHHHHHHHhc-----C-----------------------CCCCCccCCHHHHHHHHHHcCCC
Confidence 99764 66542 111111111100 0 00022335667999999999999
Q ss_pred CCCCCCHHHHHHHHHHHHHHH
Q 042634 401 PRERMNMEEVAAQLLSFRNKL 421 (427)
Q Consensus 401 P~~Rpt~~ev~~~L~~~~~~~ 421 (427)
|++||||+||++.|+++.++.
T Consensus 267 P~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 267 PYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp GGGSCCHHHHHHHHHHHHHSS
T ss_pred hhHCcCHHHHHHHHHHHHhcC
Confidence 999999999999999987653
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-41 Score=319.16 Aligned_cols=189 Identities=20% Similarity=0.257 Sum_probs=154.8
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||++++++.. ....++|||||++|+|.+++... ..+++..++.++.||+.||+||| ++||+||
T Consensus 62 l~hp~Iv~l~~~~~~-----~~~~~iv~ey~~gg~L~~~~~~~----~~~~e~~~~~~~~qil~al~ylH---~~~iiHR 129 (337)
T d1o6la_ 62 TRHPFLTALKYAFQT-----HDRLCFVMEYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLH---SRDVVYR 129 (337)
T ss_dssp CCCTTBCCEEEEEEC-----SSEEEEEEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCC
T ss_pred CCCCCEEEEEeeecc-----ccccccceeccCCCchhhhhhcc----cCCcHHHHHHHHHHHhhhhhhhh---hcCcccc
Confidence 579999999998544 67889999999999999988754 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+|||++.++.+||+|||+|+..... ..||+.|+|||++.+..|+.++||||+||++|||++|+.||.+..
T Consensus 130 DlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~ 209 (337)
T d1o6la_ 130 DIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209 (337)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccCHHHeEecCCCCEEEeecccccccccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC
Confidence 99999999999999999999999875432 278999999999999999999999999999999999999997632
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCC-----H
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMN-----M 407 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt-----~ 407 (427)
. .+.......... . .+..++.++.+++.+||+.||++||+ +
T Consensus 210 ~-----~~~~~~i~~~~~------------------------~-----~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~ 255 (337)
T d1o6la_ 210 H-----ERLFELILMEEI------------------------R-----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDA 255 (337)
T ss_dssp H-----HHHHHHHHHCCC------------------------C-----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTH
T ss_pred H-----HHHHHHHhcCCC------------------------C-----CCccCCHHHHHHHHhhccCCchhhcccccccH
Confidence 1 111111110000 0 11223456789999999999999995 7
Q ss_pred HHHHHH
Q 042634 408 EEVAAQ 413 (427)
Q Consensus 408 ~ev~~~ 413 (427)
+|++++
T Consensus 256 ~eil~H 261 (337)
T d1o6la_ 256 KEVMEH 261 (337)
T ss_dssp HHHHTS
T ss_pred HHHHcC
Confidence 888763
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.1e-41 Score=324.06 Aligned_cols=191 Identities=19% Similarity=0.209 Sum_probs=154.6
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||++++++.. ....++|||||++|+|.+++... ..+++..++.++.||+.||+||| ++||+||
T Consensus 64 ~~hpnIv~l~~~~~~-----~~~~~ivmE~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~ylH---~~~iiHr 131 (364)
T d1omwa3 64 GDCPFIVCMSYAFHT-----PDKLSFILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMH---NRFVVYR 131 (364)
T ss_dssp SCCTTBCCEEEEEEC-----SSEEEEEECCCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred CCCCcEEEEEEEEEE-----CCEEEEEEEecCCCcHHHHHHhc----ccccHHHHHHHHHHHHHHHHHHH---HCCccce
Confidence 469999999998543 56789999999999999998654 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC----CCccccccccccCC-CCcCccccchhHHHHHHHHHhCCCCCCcccC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT----NNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETFTGKRPTNEMFT 333 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~----~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~ 333 (427)
||||+|||++.++.+||+|||+|+...... .||+.|+|||++.. ..|+.++||||+||++|||++|+.||.+...
T Consensus 132 DlKP~NILl~~~g~iKl~DFGla~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~ 211 (364)
T d1omwa3 132 DLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 211 (364)
T ss_dssp CCSGGGEEECSSSCEEECCCTTCEECSSSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS
T ss_pred eeccceeEEcCCCcEEEeeeceeeecCCCcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCH
Confidence 999999999999999999999998765433 79999999999875 5689999999999999999999999976422
Q ss_pred CCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCC-----HH
Q 042634 334 GNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMN-----ME 408 (427)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt-----~~ 408 (427)
. .............. ..+..++.++.+++.+||+.||++||| ++
T Consensus 212 ~--~~~~~~~~~~~~~~-----------------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~ 260 (364)
T d1omwa3 212 K--DKHEIDRMTLTMAV-----------------------------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQ 260 (364)
T ss_dssp S--CHHHHHHHSSSCCC-----------------------------CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHH
T ss_pred H--HHHHHHHhcccCCC-----------------------------CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHH
Confidence 2 12222111111000 011123456899999999999999999 68
Q ss_pred HHHH
Q 042634 409 EVAA 412 (427)
Q Consensus 409 ev~~ 412 (427)
|+++
T Consensus 261 eil~ 264 (364)
T d1omwa3 261 EVKE 264 (364)
T ss_dssp HHHT
T ss_pred HHHc
Confidence 8875
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-41 Score=313.53 Aligned_cols=192 Identities=18% Similarity=0.244 Sum_probs=154.7
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||++++++.. ....++|||||++|+|.+++... ..+++..++.++.|++.||+||| +.||+||
T Consensus 70 l~HpnIv~~~~~~~~-----~~~~~iv~E~~~gg~L~~~i~~~----~~l~~~~~~~~~~qi~~al~yLH---~~~ivHr 137 (293)
T d1jksa_ 70 IQHPNVITLHEVYEN-----KTDVILILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLH---SLQIAHF 137 (293)
T ss_dssp CCCTTBCCEEEEEEC-----SSEEEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred CCCCCCCcEEEEEEE-----CCEEEEEEEcCCCccccchhccc----cccchhHHHHHHHHHHHHHHhhh---hcceeec
Confidence 579999999998544 67889999999999999998654 45999999999999999999999 8999999
Q ss_pred cccCCceeeCCCC----ceEecccccccccCCc-----CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCC
Q 042634 259 DLKPSNVLLDGEL----TAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTN 329 (427)
Q Consensus 259 Dlkp~NIll~~~~----~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~ 329 (427)
||||+||+++.++ .+||+|||+|+..... ..+|+.|+|||++.+..++.++||||+||++|||++|+.||.
T Consensus 138 DiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~ 217 (293)
T d1jksa_ 138 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 217 (293)
T ss_dssp CCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccccceEEEecCCCcccceEecchhhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCC
Confidence 9999999998776 5999999999876443 278899999999999999999999999999999999999997
Q ss_pred cccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHH
Q 042634 330 EMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEE 409 (427)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~e 409 (427)
+... .+......... ... ....+..++.++.+++.+||+.||++|||++|
T Consensus 218 ~~~~-----~~~~~~i~~~~--------~~~-----------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e 267 (293)
T d1jksa_ 218 GDTK-----QETLANVSAVN--------YEF-----------------EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQD 267 (293)
T ss_dssp CSSH-----HHHHHHHHTTC--------CCC-----------------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHH
T ss_pred CCCH-----HHHHHHHHhcC--------CCC-----------------CchhcCCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 5311 11111110000 000 00011234567889999999999999999999
Q ss_pred HHH
Q 042634 410 VAA 412 (427)
Q Consensus 410 v~~ 412 (427)
+++
T Consensus 268 il~ 270 (293)
T d1jksa_ 268 SLQ 270 (293)
T ss_dssp HHH
T ss_pred Hhc
Confidence 986
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-41 Score=316.61 Aligned_cols=202 Identities=23% Similarity=0.347 Sum_probs=162.0
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchh--------------hhhccCHHHHHHHHHHHHHHH
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNRE--------------ALKNLNLLQRLSIAVDVASAL 244 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------------~~~~l~~~~~~~~~~~i~~~L 244 (427)
.+|||||++++.+.. ....++|||||++|+|.++++.... ....+++..++.++.||+.||
T Consensus 84 ~~HpnIv~~~g~~~~-----~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl 158 (311)
T d1t46a_ 84 GNHMNIVNLLGACTI-----GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGM 158 (311)
T ss_dssp CCCTTBCCEEEEECS-----SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHH
T ss_pred cCCCCEEEEEEEEee-----CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHH
Confidence 379999999999754 5678999999999999999864321 123588999999999999999
Q ss_pred HHHhhcCCCCeeeccccCCceeeCCCCceEecccccccccCCcC--------CCccccccccccCCCCcCccccchhHHH
Q 042634 245 DYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEAT--------NNFFNFQIAEYGMGSEVSTSGDVYSFGI 316 (427)
Q Consensus 245 ~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~--------~~~~~y~aPE~~~~~~~~~~~DiwS~G~ 316 (427)
+||| +++||||||||+||+++.++.+|++|||.++...... .||+.|+|||++.+..++.++|||||||
T Consensus 159 ~~LH---~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~ 235 (311)
T d1t46a_ 159 AFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 235 (311)
T ss_dssp HHHH---HTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred HHHH---hCCeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHH
Confidence 9999 8999999999999999999999999999999765432 6788999999999999999999999999
Q ss_pred HHHHHHhC-CCCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhh
Q 042634 317 LLLETFTG-KRPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVT 395 (427)
Q Consensus 317 vl~ell~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 395 (427)
++|||+++ .+||... .....+.+.+....+.. .+..++.++.+++.+
T Consensus 236 ~l~ellt~g~p~~~~~-~~~~~~~~~i~~~~~~~-------------------------------~~~~~~~~l~~Li~~ 283 (311)
T d1t46a_ 236 FLWELFSLGSSPYPGM-PVDSKFYKMIKEGFRML-------------------------------SPEHAPAEMYDIMKT 283 (311)
T ss_dssp HHHHHHTTTCCSSTTC-CSSHHHHHHHHHTCCCC-------------------------------CCTTSCHHHHHHHHH
T ss_pred HHHHHHhCCCCCCCCC-CHHHHHHHHHhcCCCCC-------------------------------CcccccHHHHHHHHH
Confidence 99999995 5545432 22222333333222110 122245678999999
Q ss_pred cCCCCCCCCCCHHHHHHHHHHHHHH
Q 042634 396 CSSELPRERMNMEEVAAQLLSFRNK 420 (427)
Q Consensus 396 cl~~dP~~Rpt~~ev~~~L~~~~~~ 420 (427)
||+.||++||||+||++.|+++..+
T Consensus 284 cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 284 CWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HcCCChhHCcCHHHHHHHHHHhhcc
Confidence 9999999999999999999987554
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.4e-41 Score=314.76 Aligned_cols=189 Identities=23% Similarity=0.313 Sum_probs=155.3
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||++++++.. ....++|||||++|+|..++... ..+++..++.++.||+.||+||| ++||+||
T Consensus 61 l~HpnIv~~~~~~~~-----~~~~~ivmE~~~gg~l~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH---~~~iiHr 128 (316)
T d1fota_ 61 VTHPFIIRMWGTFQD-----AQQIFMIMDYIEGGELFSLLRKS----QRFPNPVAKFYAAEVCLALEYLH---SKDIIYR 128 (316)
T ss_dssp CCBTTBCCEEEEEEC-----SSEEEEEECCCCSCBHHHHHHHT----SSCCHHHHHHHHHHHHHHHHHHH---TTTEECC
T ss_pred ccCcChhheeeeEee-----CCeeeeEeeecCCcccccccccc----ccccccHHHHHHHHHHHhhhhhc---cCcEEcc
Confidence 579999999998543 67889999999999999888655 45888999999999999999999 9999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC---CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT---NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGN 335 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~---~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~~~ 335 (427)
||||+|||++.++.+||+|||+|+...... .||+.|+|||++.+..|+.++||||+||++|||++|+.||.+..
T Consensus 129 DiKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~--- 205 (316)
T d1fota_ 129 DLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN--- 205 (316)
T ss_dssp CCCGGGEEECTTSCEEECCCSSCEECSSCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS---
T ss_pred ccCchheeEcCCCCEEEecCccceEeccccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC---
Confidence 999999999999999999999999875443 79999999999999999999999999999999999999997531
Q ss_pred ccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCC-----CHHHH
Q 042634 336 LTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERM-----NMEEV 410 (427)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rp-----t~~ev 410 (427)
..+.......... ..+...+.++.+++.+||+.||.+|+ |++|+
T Consensus 206 --~~~~~~~i~~~~~-----------------------------~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~i 254 (316)
T d1fota_ 206 --TMKTYEKILNAEL-----------------------------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDV 254 (316)
T ss_dssp --HHHHHHHHHHCCC-----------------------------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHH
T ss_pred --HHHHHHHHHcCCC-----------------------------CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHH
Confidence 1111111110000 01122345688999999999999996 89999
Q ss_pred HHH
Q 042634 411 AAQ 413 (427)
Q Consensus 411 ~~~ 413 (427)
+++
T Consensus 255 l~H 257 (316)
T d1fota_ 255 KNH 257 (316)
T ss_dssp HTS
T ss_pred HcC
Confidence 764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.6e-41 Score=312.22 Aligned_cols=203 Identities=21% Similarity=0.353 Sum_probs=156.0
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||++++++...+ ......++|||||++|+|.+++... ..+++.+++.++.||+.||+||| ++||+||
T Consensus 64 ~~hpniv~~~~~~~~~~-~~~~~~~lvmE~~~g~~L~~~~~~~----~~l~~~~~~~i~~qi~~al~~lH---~~~iiHr 135 (277)
T d1o6ya_ 64 LNHPAIVAVYDTGEAET-PAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSH---QNGIIHR 135 (277)
T ss_dssp CCCTTBCCEEEEEEEEC-SSSEEEEEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred cCCCCCCcccceeeecc-CCCceEEEEEECCCCCEehhhhccc----CCCCHHHHHHHHHHHHHHHHHHH---hCCccCc
Confidence 67999999999865422 1123478999999999999887654 45999999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc---------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA---------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTN 329 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~---------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~ 329 (427)
||||+|||++.++..|++|||.++..... ..||+.|+|||++.+..+++++||||+||++|||++|+.||.
T Consensus 136 DiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~ 215 (277)
T d1o6ya_ 136 DVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT 215 (277)
T ss_dssp CCSGGGEEEETTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccCcccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCC
Confidence 99999999999999999999998765322 268999999999999999999999999999999999999997
Q ss_pred cccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCC-CHH
Q 042634 330 EMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERM-NME 408 (427)
Q Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rp-t~~ 408 (427)
+... .+.......... .. ........++++.+++.+||+.||++|| |++
T Consensus 216 ~~~~-----~~~~~~~~~~~~---~~----------------------~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~ 265 (277)
T d1o6ya_ 216 GDSP-----VSVAYQHVREDP---IP----------------------PSARHEGLSADLDAVVLKALAKNPENRYQTAA 265 (277)
T ss_dssp CSSH-----HHHHHHHHHCCC---CC----------------------GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHH
T ss_pred CcCH-----HHHHHHHHhcCC---CC----------------------CchhccCCCHHHHHHHHHHccCCHhHCHhHHH
Confidence 5311 111111110000 00 0001122456689999999999999999 899
Q ss_pred HHHHHHHHHHH
Q 042634 409 EVAAQLLSFRN 419 (427)
Q Consensus 409 ev~~~L~~~~~ 419 (427)
|+++.|.++++
T Consensus 266 ~l~~~l~r~~n 276 (277)
T d1o6ya_ 266 EMRADLVRVHN 276 (277)
T ss_dssp HHHHHHHHHHC
T ss_pred HHHHHHHHHhC
Confidence 99999998753
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-41 Score=317.17 Aligned_cols=188 Identities=22% Similarity=0.311 Sum_probs=154.4
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||++++++.. +...++|||||++|+|.+++... ..+++.+++.++.||+.||+||| ++||+||
T Consensus 60 ~~hp~Iv~~~~~~~~-----~~~~yivmEy~~~g~L~~~i~~~----~~~~e~~~~~~~~qi~~al~ylH---~~~iiHr 127 (320)
T d1xjda_ 60 WEHPFLTHMFCTFQT-----KENLFFVMEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLH---SKGIVYR 127 (320)
T ss_dssp TTCTTBCCEEEEEEC-----SSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCC
T ss_pred CCCCcEEEEEEEEcc-----CCceeEEEeecCCCcHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeec
Confidence 689999999998544 66799999999999999999754 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+|||+++++.+||+|||+|+..... ..||+.|+|||++.+..++.++||||+||++|||++|+.||.+..
T Consensus 128 Dikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~ 207 (320)
T d1xjda_ 128 DLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 207 (320)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCcccceeecCCCceeccccchhhhcccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999999865332 278999999999999999999999999999999999999997531
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHH-HHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME-EVA 411 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~-ev~ 411 (427)
..+......... . ..+..++.++.+++.+||+.||++|||+. |++
T Consensus 208 -----~~~~~~~i~~~~------~-----------------------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~ 253 (320)
T d1xjda_ 208 -----EEELFHSIRMDN------P-----------------------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 253 (320)
T ss_dssp -----HHHHHHHHHHCC------C-----------------------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred -----HHHHHHHHHcCC------C-----------------------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence 111111110000 0 01122355689999999999999999995 675
Q ss_pred H
Q 042634 412 A 412 (427)
Q Consensus 412 ~ 412 (427)
+
T Consensus 254 ~ 254 (320)
T d1xjda_ 254 Q 254 (320)
T ss_dssp G
T ss_pred h
Confidence 3
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.1e-40 Score=305.48 Aligned_cols=192 Identities=21% Similarity=0.290 Sum_probs=154.0
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeecc
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCD 259 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrD 259 (427)
.|||||++++.+. ++...++|||||++|+|.++++.. ..+++.+++.++.||+.||+||| ++||+|||
T Consensus 68 ~hpnIv~~~~~~~-----~~~~~~ivmE~~~~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~~lH---~~~ivHrD 135 (277)
T d1phka_ 68 GHPNIIQLKDTYE-----TNTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALH---KLNIVHRD 135 (277)
T ss_dssp TCTTBCCEEEEEE-----CSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSC
T ss_pred CCCCeEEEEeecc-----cCcceEEEEEcCCCchHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HcCCcccc
Confidence 4999999999854 367889999999999999999654 46999999999999999999999 89999999
Q ss_pred ccCCceeeCCCCceEecccccccccCCc-----CCCccccccccccCC------CCcCccccchhHHHHHHHHHhCCCCC
Q 042634 260 LKPSNVLLDGELTAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMG------SEVSTSGDVYSFGILLLETFTGKRPT 328 (427)
Q Consensus 260 lkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~------~~~~~~~DiwS~G~vl~ell~g~~pf 328 (427)
|||+|||++.++.+||+|||+|+..... ..||..|+|||++.+ ..++.++||||+||++|||++|+.||
T Consensus 136 lkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf 215 (277)
T d1phka_ 136 LKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 215 (277)
T ss_dssp CSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred cccceEEEcCCCCeEEccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCC
Confidence 9999999999999999999999876543 278899999999853 34688999999999999999999999
Q ss_pred CcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 042634 329 NEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME 408 (427)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ 408 (427)
.+... ....+.+.. .... . +......+++++.+++.+||+.||++|||++
T Consensus 216 ~~~~~--~~~~~~i~~---~~~~-~------------------------~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~ 265 (277)
T d1phka_ 216 WHRKQ--MLMLRMIMS---GNYQ-F------------------------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAE 265 (277)
T ss_dssp CCSSH--HHHHHHHHH---TCCC-C------------------------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred CCCCH--HHHHHHHHh---CCCC-C------------------------CCcccccCCHHHHHHHHHHccCChhHCcCHH
Confidence 75321 111111111 0000 0 0001223456789999999999999999999
Q ss_pred HHHHH
Q 042634 409 EVAAQ 413 (427)
Q Consensus 409 ev~~~ 413 (427)
||+++
T Consensus 266 eil~h 270 (277)
T d1phka_ 266 EALAH 270 (277)
T ss_dssp HHTTS
T ss_pred HHHcC
Confidence 99764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.2e-41 Score=316.41 Aligned_cols=188 Identities=19% Similarity=0.212 Sum_probs=154.7
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||++++++.. ....++||||+.+|+|.+++... ..+++..++.++.||+.||+||| +.|||||
T Consensus 98 l~hpnIv~~~~~~~~-----~~~~~~v~e~~~~g~l~~~l~~~----~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHR 165 (350)
T d1rdqe_ 98 VNFPFLVKLEFSFKD-----NSNLYMVMEYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLH---SLDLIYR 165 (350)
T ss_dssp CCCTTBCCEEEEEEC-----SSEEEEEEECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred cCCCcEeeccccccc-----ccccccccccccccchhhhHhhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCEecC
Confidence 579999999998543 56789999999999999988654 45999999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC---CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT---NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFTGN 335 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~---~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~~~ 335 (427)
||||+|||++.++.+||+|||+|+...... .||+.|+|||++.+..++.++||||+||++|||++|+.||.+..
T Consensus 166 DIKP~NILl~~~g~ikL~DFG~a~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~--- 242 (350)
T d1rdqe_ 166 DLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ--- 242 (350)
T ss_dssp CCSGGGEEECTTSCEEECCCTTCEECSSCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---
T ss_pred cCCHHHcccCCCCCEEeeeceeeeecccccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC---
Confidence 999999999999999999999999875443 78999999999999999999999999999999999999997531
Q ss_pred ccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCC-----CHHHH
Q 042634 336 LTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERM-----NMEEV 410 (427)
Q Consensus 336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rp-----t~~ev 410 (427)
............. ..+..++.++.+++.+||+.||.+|+ |++|+
T Consensus 243 --~~~~~~~i~~~~~-----------------------------~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~el 291 (350)
T d1rdqe_ 243 --PIQIYEKIVSGKV-----------------------------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDI 291 (350)
T ss_dssp --HHHHHHHHHHCCC-----------------------------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHH
T ss_pred --HHHHHHHHhcCCC-----------------------------CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHH
Confidence 1111111110000 01122345688999999999999994 89998
Q ss_pred HH
Q 042634 411 AA 412 (427)
Q Consensus 411 ~~ 412 (427)
++
T Consensus 292 l~ 293 (350)
T d1rdqe_ 292 KN 293 (350)
T ss_dssp HT
T ss_pred Hc
Confidence 76
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-40 Score=307.33 Aligned_cols=217 Identities=18% Similarity=0.155 Sum_probs=154.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||++++++.. +...++|||||.++++..+.... ..+++..++.+++||+.||+||| ++||+||
T Consensus 57 l~hpnIv~~~~~~~~-----~~~~~ivmE~~~~~~~~~~~~~~----~~l~~~~~~~~~~qil~aL~~lH---~~~iiHr 124 (299)
T d1ua2a_ 57 LSHPNIIGLLDAFGH-----KSNISLVFDFMETDLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLH---QHWILHR 124 (299)
T ss_dssp CCCTTBCCEEEEECC-----TTCCEEEEECCSEEHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHH---HTTCCCC
T ss_pred CCCCCEeEEEeeecc-----CCceeehhhhhcchHHhhhhhcc----cCCCHHHHHHHHHHHHHHHHHhh---ccceecc
Confidence 469999999998544 66789999999888777666544 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCC-CCcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
||||+|||++.++.+||+|||.|+..... ..||+.|+|||++.. ..++.++||||+||++|||++|..||.+.
T Consensus 125 DiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~ 204 (299)
T d1ua2a_ 125 DLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD 204 (299)
T ss_dssp CCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCCcceEEecCCCccccccCccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCC
Confidence 99999999999999999999999876442 268999999999865 45799999999999999999999999753
Q ss_pred cCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 042634 332 FTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVA 411 (427)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~ 411 (427)
.. ...+.........+......+....... .. . .......+. ......++++.+++.+||+.||++|||++|++
T Consensus 205 ~~-~~~l~~i~~~~~~~~~~~~~~~~~~~~~-~~-~-~~~~~~~~~--~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L 278 (299)
T d1ua2a_ 205 SD-LDQLTRIFETLGTPTEEQWPDMCSLPDY-VT-F-KSFPGIPLH--HIFSAAGDDLLDLIQGLFLFNPCARITATQAL 278 (299)
T ss_dssp SH-HHHHHHHHHHHCCCCTTTSSSTTSSTTC-CC-C-CCCCCCCHH--HHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHH
T ss_pred CH-HHHHHHHHHhcCCCChhhccchhccchh-hh-h-ccCCCCChH--HhcccCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 21 1111122111111111111000000000 00 0 000000000 00112346789999999999999999999998
Q ss_pred HH
Q 042634 412 AQ 413 (427)
Q Consensus 412 ~~ 413 (427)
++
T Consensus 279 ~H 280 (299)
T d1ua2a_ 279 KM 280 (299)
T ss_dssp TS
T ss_pred CC
Confidence 63
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-40 Score=306.56 Aligned_cols=222 Identities=18% Similarity=0.203 Sum_probs=157.8
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
.+|||||++++++...........+++|||+.++++........ ..+++..++.++.|++.||+||| ++||+||
T Consensus 67 ~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~---~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHr 140 (305)
T d1blxa_ 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLH---SHRVVHR 140 (305)
T ss_dssp TCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCC
T ss_pred cCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhccC---CCCCHHHHHHHHHHHHHHHHHHH---hCCEEec
Confidence 36999999999876554455567899999998776654433222 45899999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc-----CCCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcccC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMFT 333 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~~ 333 (427)
||||+|||++.++.+||+|||+++..... ..||+.|+|||++.+.+|+.++||||+||++|||++|+.||.+...
T Consensus 141 DiKp~NILi~~~~~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~ 220 (305)
T d1blxa_ 141 DLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 220 (305)
T ss_dssp CCCGGGEEECTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred CCCccEEEEcCCCCeeecchhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH
Confidence 99999999999999999999999875432 3899999999999999999999999999999999999999975421
Q ss_pred CCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHHH
Q 042634 334 GNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAAQ 413 (427)
Q Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~~ 413 (427)
...+.........+.... .............. ...... .......++.+.+++.+||+.||++|||++|++++
T Consensus 221 -~~~~~~i~~~~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~--~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 221 -VDQLGKILDVIGLPGEED-WPRDVALPRQAFHS---KSAQPI--EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp -HHHHHHHHHHHCCCCGGG-SCTTCSSCGGGSCC---CCCCCG--GGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -HHHHHHHHHhhCCCchhc-ccccccchhhhhcc---ccccch--hhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 111222222111111000 00000000000000 000000 00112234568899999999999999999999764
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-41 Score=311.86 Aligned_cols=200 Identities=21% Similarity=0.332 Sum_probs=160.0
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhh------hccCHHHHHHHHHHHHHHHHHHhhcCC
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREAL------KNLNLLQRLSIAVDVASALDYLHHYCE 252 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~------~~l~~~~~~~~~~~i~~~L~~LH~~~~ 252 (427)
++|||||++++.+.. ....++|||||++|+|.+++....... ..+++..+..++.|+|+||.||| +
T Consensus 80 l~h~nIv~~~~~~~~-----~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~ 151 (308)
T d1p4oa_ 80 FNCHHVVRLLGVVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---A 151 (308)
T ss_dssp CCCTTBCCEEEEECS-----SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---H
T ss_pred cCCCCEeeeeeEEec-----CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---h
Confidence 579999999998654 567899999999999999986543211 23688999999999999999999 8
Q ss_pred CCeeeccccCCceeeCCCCceEecccccccccCCc--------CCCccccccccccCCCCcCccccchhHHHHHHHHHhC
Q 042634 253 TPIVHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA--------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTG 324 (427)
Q Consensus 253 ~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~--------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g 324 (427)
++|+||||||+|||+++++++||+|||+|+..... ..+|+.|+|||.+.+..++.++|||||||++|||++|
T Consensus 152 ~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~ 231 (308)
T d1p4oa_ 152 NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATL 231 (308)
T ss_dssp TTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHT
T ss_pred CCeeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhC
Confidence 89999999999999999999999999999866432 2578899999999999999999999999999999998
Q ss_pred C-CCCCcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCC
Q 042634 325 K-RPTNEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRE 403 (427)
Q Consensus 325 ~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~ 403 (427)
. .||.+.. ..+.......+.. ...+..++.++.+++.+||+.||++
T Consensus 232 ~~~p~~~~~-----~~~~~~~i~~~~~----------------------------~~~p~~~~~~l~~li~~cl~~~P~~ 278 (308)
T d1p4oa_ 232 AEQPYQGLS-----NEQVLRFVMEGGL----------------------------LDKPDNCPDMLFELMRMCWQYNPKM 278 (308)
T ss_dssp SCCTTTTSC-----HHHHHHHHHTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred CCCCCCCCC-----HHHHHHHHHhCCC----------------------------CCCcccchHHHHHHHHHHcCCChhH
Confidence 5 6665431 1111111111000 0022335567999999999999999
Q ss_pred CCCHHHHHHHHHHHHH
Q 042634 404 RMNMEEVAAQLLSFRN 419 (427)
Q Consensus 404 Rpt~~ev~~~L~~~~~ 419 (427)
||||+||++.|++..+
T Consensus 279 RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 279 RPSFLEIISSIKEEME 294 (308)
T ss_dssp SCCHHHHHHHHGGGSC
T ss_pred CcCHHHHHHHHHHhcC
Confidence 9999999999987644
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-40 Score=308.85 Aligned_cols=194 Identities=22% Similarity=0.311 Sum_probs=155.4
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||++++++.. ....|+|||||++|+|.+++.... ..+++.+++.++.||+.||+||| +.||+||
T Consensus 58 l~HpnIv~~~~~~~~-----~~~~~lvmE~~~gg~L~~~i~~~~---~~l~e~~~~~i~~qi~~al~yLH---~~~iiHr 126 (321)
T d1tkia_ 58 ARHRNILHLHESFES-----MEELVMIFEFISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLH---SHNIGHF 126 (321)
T ss_dssp SCCTTBCCEEEEEEE-----TTEEEEEECCCCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred CCCCCCCeEEEEEEE-----CCEEEEEEecCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---HcCCCcc
Confidence 579999999998543 667899999999999999997653 35899999999999999999999 8999999
Q ss_pred cccCCceeeCCC--CceEecccccccccCCcC-----CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 259 DLKPSNVLLDGE--LTAHVGDFGLAKFLPEAT-----NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 259 Dlkp~NIll~~~--~~~kL~DFG~a~~~~~~~-----~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
||||+|||++.+ ..+||+|||+++...... .+++.|+|||...+..++.++||||+||++|||++|..||.+.
T Consensus 127 DlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~ 206 (321)
T d1tkia_ 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE 206 (321)
T ss_dssp CCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred cccccceeecCCCceEEEEcccchhhccccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCC
Confidence 999999999754 589999999998775443 6888999999999999999999999999999999999999753
Q ss_pred cCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 042634 332 FTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVA 411 (427)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~ 411 (427)
.. .+......... ... +......++.++.+++.+||+.||++|||++|++
T Consensus 207 ~~-----~~~~~~i~~~~--------~~~-----------------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil 256 (321)
T d1tkia_ 207 TN-----QQIIENIMNAE--------YTF-----------------DEEAFKEISIEAMDFVDRLLVKERKSRMTASEAL 256 (321)
T ss_dssp SH-----HHHHHHHHHTC--------CCC-----------------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred CH-----HHHHHHHHhCC--------CCC-----------------ChhhccCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 21 11111110000 000 0001112355689999999999999999999998
Q ss_pred HH
Q 042634 412 AQ 413 (427)
Q Consensus 412 ~~ 413 (427)
++
T Consensus 257 ~h 258 (321)
T d1tkia_ 257 QH 258 (321)
T ss_dssp HS
T ss_pred cC
Confidence 73
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-40 Score=299.66 Aligned_cols=182 Identities=19% Similarity=0.227 Sum_probs=147.4
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecC-CCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVN-GSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
.|||||++++++.. ....++||||+.+ +++.+++... ..+++.+++.++.||+.||+||| ++||+||
T Consensus 67 ~h~nIv~~~~~~~~-----~~~~~lv~e~~~~~~~l~~~~~~~----~~l~e~~~~~~~~qi~~al~~lH---~~~iiHr 134 (273)
T d1xwsa_ 67 GFSGVIRLLDWFER-----PDSFVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCH---NCGVLHR 134 (273)
T ss_dssp SSCSBCCEEEEEEC-----SSEEEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECS
T ss_pred CCCCccEEEEEEee-----CCeEEEEEEeccCcchHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCCccc
Confidence 49999999998543 5678999999976 5777776543 45999999999999999999999 8999999
Q ss_pred cccCCceeeCCC-CceEecccccccccCCc----CCCccccccccccCCCCc-CccccchhHHHHHHHHHhCCCCCCccc
Q 042634 259 DLKPSNVLLDGE-LTAHVGDFGLAKFLPEA----TNNFFNFQIAEYGMGSEV-STSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 259 Dlkp~NIll~~~-~~~kL~DFG~a~~~~~~----~~~~~~y~aPE~~~~~~~-~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
||||+|||++.+ +.+||+|||+|+..... ..||+.|+|||++.+..+ +.++||||+||++|||++|+.||....
T Consensus 135 DiKp~NIll~~~~~~vkl~DFG~a~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~ 214 (273)
T d1xwsa_ 135 DIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 214 (273)
T ss_dssp CCSGGGEEEETTTTEEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH
T ss_pred cCcccceEEecCCCeEEECccccceecccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch
Confidence 999999999854 79999999999876443 378999999999987765 678999999999999999999997520
Q ss_pred CCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
+....... .+...+.++.+++.+||+.||++|||++|+++
T Consensus 215 -------~i~~~~~~---------------------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 215 -------EIIRGQVF---------------------------------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp -------HHHHCCCC---------------------------------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------HHhhcccC---------------------------------CCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 11110000 01113456889999999999999999999986
Q ss_pred H
Q 042634 413 Q 413 (427)
Q Consensus 413 ~ 413 (427)
+
T Consensus 255 h 255 (273)
T d1xwsa_ 255 H 255 (273)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-39 Score=297.81 Aligned_cols=219 Identities=20% Similarity=0.242 Sum_probs=151.9
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||++++.+.. +...++||||+.+ ++.+++..... ..+++..++.++.|++.||+||| +.|||||
T Consensus 58 l~Hp~Iv~~~~~~~~-----~~~~~iv~e~~~~-~~~~~~~~~~~--~~l~e~~~~~~~~qil~~L~yLH---~~~IiHr 126 (298)
T d1gz8a_ 58 LNHPNIVKLLDVIHT-----ENKLYLVFEFLHQ-DLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCH---SHRVLHR 126 (298)
T ss_dssp CCCTTBCCEEEEEEE-----TTEEEEEEECCSE-EHHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred CCCCcEEEecccccc-----ccceeEEEeecCC-chhhhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhh---cCCEEcc
Confidence 579999999998654 5678999999955 44444432221 56999999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC------CCccccccccccCCCC-cCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT------NNFFNFQIAEYGMGSE-VSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~------~~~~~y~aPE~~~~~~-~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
||||+|||++.++.+||+|||.|+...... .||+.|+|||.+.... ++.++||||+||++|||++|+.||.+.
T Consensus 127 DiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~ 206 (298)
T d1gz8a_ 127 DLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206 (298)
T ss_dssp CCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccCchheeecccCcceeccCCcceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCC
Confidence 999999999999999999999998764322 7899999999887765 488999999999999999999999753
Q ss_pred cCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 042634 332 FTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVA 411 (427)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~ 411 (427)
.. ...+.........+. ........ ................+. ......+.++.+++.+||+.||++|||++|++
T Consensus 207 ~~-~~~~~~i~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell 281 (298)
T d1gz8a_ 207 SE-IDQLFRIFRTLGTPD-EVVWPGVT-SMPDYKPSFPKWARQDFS--KVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 281 (298)
T ss_dssp SH-HHHHHHHHHHHCCCC-TTTSTTGG-GSTTCCTTSCCCCCCCHH--HHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred CH-HHHHHHHHHhcCCCc-hhhccccc-cccccccccccccccchh--hhccCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 21 111222221111110 00000000 000000000000000000 00112346789999999999999999999998
Q ss_pred HH
Q 042634 412 AQ 413 (427)
Q Consensus 412 ~~ 413 (427)
++
T Consensus 282 ~H 283 (298)
T d1gz8a_ 282 AH 283 (298)
T ss_dssp TS
T ss_pred CC
Confidence 75
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.2e-38 Score=290.04 Aligned_cols=217 Identities=18% Similarity=0.214 Sum_probs=152.8
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||++++.+.. +...+++|||+.++.+..+.... ..+++..+..++.||+.||+||| +.|||||
T Consensus 57 l~hpnIv~~~~~~~~-----~~~~~i~~e~~~~~~~~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHr 124 (286)
T d1ob3a_ 57 LKHSNIVKLYDVIHT-----KKRLVLVFEHLDQDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCH---DRRVLHR 124 (286)
T ss_dssp CCCTTBCCEEEEEEC-----SSCEEEEEECCSEEHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred CCCCcEEeeeeeccc-----CCceeEEEEeehhhhHHHHHhhc----CCcchhhhHHHHHHHHHHHHHhc---cCcEEec
Confidence 479999999988543 67789999999777666665544 45999999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc------CCCccccccccccCCC-CcCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA------TNNFFNFQIAEYGMGS-EVSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~~y~aPE~~~~~-~~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
||||+|||++.++.+||+|||.|...... ..+++.|+|||.+.+. .++.++||||+||++|||++|+.||.+.
T Consensus 125 DiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~ 204 (286)
T d1ob3a_ 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204 (286)
T ss_dssp CCCGGGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCCCceeeEcCCCCEEecccccceecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCC
Confidence 99999999999999999999999875432 2688899999998764 5699999999999999999999999754
Q ss_pred cCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 042634 332 FTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVA 411 (427)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~ 411 (427)
.. ...+.+..............+....... ...................+.++.+++++||+.||++|||++|++
T Consensus 205 ~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell 279 (286)
T d1ob3a_ 205 SE-ADQLMRIFRILGTPNSKNWPNVTELPKY----DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279 (286)
T ss_dssp SH-HHHHHHHHHHHCCCCTTTSTTGGGSTTC----CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred CH-HHHHHHHHHhhCCCChhhccchhhhhhc----ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 21 1112222222111111111000000000 000000000000111122345688999999999999999999998
Q ss_pred H
Q 042634 412 A 412 (427)
Q Consensus 412 ~ 412 (427)
+
T Consensus 280 ~ 280 (286)
T d1ob3a_ 280 E 280 (286)
T ss_dssp T
T ss_pred c
Confidence 5
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-38 Score=293.48 Aligned_cols=223 Identities=17% Similarity=0.210 Sum_probs=151.3
Q ss_pred cccccchhhhccccccC---CCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 042634 179 IRHRNLVKIITSCASVD---FQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPI 255 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~---~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~i 255 (427)
++|||++++++.+.... ...+...++||||+.++.+..+.... ..+++..++.++.|++.||+||| +.||
T Consensus 66 l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~----~~~~~~~~~~i~~qil~~l~~lH---~~~i 138 (318)
T d3blha1 66 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIH---RNKI 138 (318)
T ss_dssp CCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTCTT----CCCCHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred hcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhhcc----cccccHHHHHHHHHHHHHHHHhc---cCCE
Confidence 57999999998864422 12245679999999777766554433 45889999999999999999999 8999
Q ss_pred eeccccCCceeeCCCCceEecccccccccCCc----------CCCccccccccccCCC-CcCccccchhHHHHHHHHHhC
Q 042634 256 VHCDLKPSNVLLDGELTAHVGDFGLAKFLPEA----------TNNFFNFQIAEYGMGS-EVSTSGDVYSFGILLLETFTG 324 (427)
Q Consensus 256 vHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~----------~~~~~~y~aPE~~~~~-~~~~~~DiwS~G~vl~ell~g 324 (427)
+||||||+|||++.++.+||+|||+|+..... ..||+.|+|||++.+. .+++++||||+||++|||++|
T Consensus 139 vHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g 218 (318)
T d3blha1 139 LHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 218 (318)
T ss_dssp ECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHS
T ss_pred EecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhC
Confidence 99999999999999999999999999765321 2689999999998765 689999999999999999999
Q ss_pred CCCCCcccCCCccHHHHHHHhc---ccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCC
Q 042634 325 KRPTNEMFTGNLTLHNFVKEAL---PERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELP 401 (427)
Q Consensus 325 ~~pf~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP 401 (427)
+.||.+.. .......+.... +.......+...... ...............+........+.+++.+||+.||
T Consensus 219 ~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP 293 (318)
T d3blha1 219 SPIMQGNT--EQHQLALISQLCGSITPEVWPNVDNYELYE---KLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDP 293 (318)
T ss_dssp SCSCCCSS--HHHHHHHHHHHHCCCCTTTSTTCCCC----------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSST
T ss_pred CCCCCCCC--HHHHHHHHHHhcCCCChhhccccchhhhhh---hhcccccccccchhhhccccCCHHHHHHHHHHCcCCh
Confidence 99997532 111111111111 111111111000000 0000000000011111122234567899999999999
Q ss_pred CCCCCHHHHHHH
Q 042634 402 RERMNMEEVAAQ 413 (427)
Q Consensus 402 ~~Rpt~~ev~~~ 413 (427)
++|||++|++++
T Consensus 294 ~~R~sa~elL~H 305 (318)
T d3blha1 294 AQRIDSDDALNH 305 (318)
T ss_dssp TTSCCHHHHHHS
T ss_pred hHCcCHHHHHcC
Confidence 999999999864
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-37 Score=295.27 Aligned_cols=223 Identities=20% Similarity=0.180 Sum_probs=151.7
Q ss_pred cccccchhhhccccccCC-CCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 042634 179 IRHRNLVKIITSCASVDF-QGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVH 257 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivH 257 (427)
++|||||++++++..... .+....++|||||+++ +.+.+.........+++.+++.++.||+.||+||| ++||+|
T Consensus 70 l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiH 145 (350)
T d1q5ka_ 70 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICH 145 (350)
T ss_dssp CCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEEC
T ss_pred cCCCCCCcEEEEEEecCccCCceEEEEEEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcc
Confidence 579999999998754321 2334568999999655 44444332222356999999999999999999999 999999
Q ss_pred ccccCCceeeCCCC-ceEecccccccccCCc-----CCCccccccccccCC-CCcCccccchhHHHHHHHHHhCCCCCCc
Q 042634 258 CDLKPSNVLLDGEL-TAHVGDFGLAKFLPEA-----TNNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETFTGKRPTNE 330 (427)
Q Consensus 258 rDlkp~NIll~~~~-~~kL~DFG~a~~~~~~-----~~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell~g~~pf~~ 330 (427)
|||||+|||++.++ .+||+|||+|+..... ..|+..|+|||.+.+ ..++.++||||+||++|||++|+.||..
T Consensus 146 rDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~ 225 (350)
T d1q5ka_ 146 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 225 (350)
T ss_dssp CCCCGGGEEECTTTCCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred cCCCcceEEEecCCCceeEecccchhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCC
Confidence 99999999999775 8999999999876433 278899999998775 5689999999999999999999999975
Q ss_pred ccCCCccHHHHHHHhccc---chhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCH
Q 042634 331 MFTGNLTLHNFVKEALPE---RLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNM 407 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~ 407 (427)
... ...+.......... .+............ .......+. .......+.++.+++.+||+.||++|||+
T Consensus 226 ~~~-~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~------~~~~~~~~~-~~~~~~~s~~~~dLl~~mL~~dP~~R~ta 297 (350)
T d1q5ka_ 226 DSG-VDQLVEIIKVLGTPTREQIREMNPNYTEFKF------PQIKAHPWT-KVFRPRTPPEAIALCSRLLEYTPTARLTP 297 (350)
T ss_dssp SSH-HHHHHHHHHHHCCCCHHHHHHHCC---CCCC------CCCCCCCGG-GTSCTTSCHHHHHHHHHHSCSSGGGSCCH
T ss_pred CCH-HHHHHHHHHHhCCChHHhhhhhccchhhccc------cccccCchh-hhcccCCCHHHHHHHHHHccCChhHCcCH
Confidence 321 11121211111110 01110000000000 000000000 00112235568999999999999999999
Q ss_pred HHHHHH
Q 042634 408 EEVAAQ 413 (427)
Q Consensus 408 ~ev~~~ 413 (427)
+|++++
T Consensus 298 ~e~L~H 303 (350)
T d1q5ka_ 298 LEACAH 303 (350)
T ss_dssp HHHHTS
T ss_pred HHHhcC
Confidence 999864
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.1e-37 Score=291.69 Aligned_cols=220 Identities=20% Similarity=0.194 Sum_probs=152.1
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeecc
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCD 259 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrD 259 (427)
.||||+++++.+.. ......++|||||.+++|..+. +.+++..++.++.||+.||+||| ++||+|||
T Consensus 88 ~hpnIv~~~~~~~~---~~~~~~~~v~e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrD 154 (328)
T d3bqca1 88 GGPNIITLADIVKD---PVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCH---SMGIMHRD 154 (328)
T ss_dssp TSTTBCCEEEEEEC---TTTCSEEEEEECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCC
T ss_pred CCCCCcEEEEEEEe---cCCCceeEEEeecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHh---hccccccc
Confidence 59999999988543 2245689999999999997764 34899999999999999999999 89999999
Q ss_pred ccCCceeeCCCC-ceEecccccccccCCcC-----CCccccccccccCCC-CcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 260 LKPSNVLLDGEL-TAHVGDFGLAKFLPEAT-----NNFFNFQIAEYGMGS-EVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 260 lkp~NIll~~~~-~~kL~DFG~a~~~~~~~-----~~~~~y~aPE~~~~~-~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
|||+|||++.++ .+||+|||+|+...... .+|..|+|||.+.+. .++.++||||+||++||+++|+.||....
T Consensus 155 iKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~ 234 (328)
T d3bqca1 155 VKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 234 (328)
T ss_dssp CSGGGEEEETTTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred ccccceEEcCCCCeeeecccccceeccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCc
Confidence 999999998654 69999999998765432 688999999998775 47999999999999999999999997542
Q ss_pred CCCccHHHHHHHhcccchhccc---Cccccccccc-cchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 042634 333 TGNLTLHNFVKEALPERLAEIV---DPVLLVEREE-GETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME 408 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ 408 (427)
...............+...... +......... .....................+.++.+++++||+.||++|||++
T Consensus 235 ~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~ 314 (328)
T d3bqca1 235 DNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR 314 (328)
T ss_dssp SHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred hhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHH
Confidence 2211111111111000000000 0000000000 00000000001111112233456789999999999999999999
Q ss_pred HHHH
Q 042634 409 EVAA 412 (427)
Q Consensus 409 ev~~ 412 (427)
|+++
T Consensus 315 e~L~ 318 (328)
T d3bqca1 315 EAME 318 (328)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 9986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.4e-37 Score=287.41 Aligned_cols=202 Identities=19% Similarity=0.250 Sum_probs=151.0
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|+++|..+..+.. .+...++||||+ ++++...+.... ..+++..+..++.|++.||+||| ++||+||
T Consensus 59 l~~~~~i~~~~~~~~----~~~~~~ivme~~-~~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHr 127 (299)
T d1ckia_ 59 MQGGVGIPTIRWCGA----EGDYNVMVMELL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIH---SKNFIHR 127 (299)
T ss_dssp STTSTTCCCEEEEEE----ETTEEEEEEECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHH---HTTEECS
T ss_pred ccCCCcccEEEEEEe----cCCEEEEEEEEc-CCchhhhhhhcc---CCCcHHHHHHHHHHHHHHHHHHH---HCCeeec
Confidence 446665555544322 256788999999 677766654332 46999999999999999999999 8999999
Q ss_pred cccCCceeeC---CCCceEecccccccccCCc-------------CCCccccccccccCCCCcCccccchhHHHHHHHHH
Q 042634 259 DLKPSNVLLD---GELTAHVGDFGLAKFLPEA-------------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETF 322 (427)
Q Consensus 259 Dlkp~NIll~---~~~~~kL~DFG~a~~~~~~-------------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell 322 (427)
||||+|||++ .+..+||+|||+|+..... ..||+.|+|||++.+..++.++|||||||++|||+
T Consensus 128 DiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~ 207 (299)
T d1ckia_ 128 DVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFN 207 (299)
T ss_dssp CCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHH
T ss_pred cCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHH
Confidence 9999999975 4567999999999875421 26899999999999999999999999999999999
Q ss_pred hCCCCCCcccCCCccH--HHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCC
Q 042634 323 TGKRPTNEMFTGNLTL--HNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSEL 400 (427)
Q Consensus 323 ~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~d 400 (427)
+|+.||.......... ........+..... ....++.++.+++.+||+.|
T Consensus 208 tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~p~~~~~li~~cl~~~ 259 (299)
T d1ckia_ 208 LGSLPWQGLKAATKRQKYERISEKKMSTPIEV----------------------------LCKGYPSEFATYLNFCRSLR 259 (299)
T ss_dssp HSSCTTCCCC-------HHHHHHHHHHSCHHH----------------------------HTTTSCHHHHHHHHHHHHSC
T ss_pred hCCCcccccchHHHHHHHHHhhcccCCCChhH----------------------------hccCCCHHHHHHHHHHccCC
Confidence 9999997643222111 11111111100000 11235677899999999999
Q ss_pred CCCCCCHHHHHHHHHHHHH
Q 042634 401 PRERMNMEEVAAQLLSFRN 419 (427)
Q Consensus 401 P~~Rpt~~ev~~~L~~~~~ 419 (427)
|++|||++++.+.|+.+..
T Consensus 260 p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 260 FDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp TTCCCCHHHHHHHHHHHHH
T ss_pred hhHCcCHHHHHHHHHHHHH
Confidence 9999999999999888754
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-37 Score=294.84 Aligned_cols=223 Identities=17% Similarity=0.210 Sum_probs=152.0
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++||||+++++.+....+......+++ +|+.+|+|.+++.. ..+++..++.++.|++.||+||| ++||+||
T Consensus 63 l~hp~iv~~~~~~~~~~~~~~~~~~l~-~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH---~~~iiHR 133 (345)
T d1pmea_ 63 FRHENIIGINDIIRAPTIEQMKDVYLV-THLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIH---SANVLHR 133 (345)
T ss_dssp CCCTTBCCCCEEECCSSTTTCCCEEEE-EECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred cCCCCCCcEEEEEeeccccccceEEEE-EeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCcCC
Confidence 579999999998766544444444555 55669999999854 34999999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCc---------CCCccccccccccCC-CCcCccccchhHHHHHHHHHhCCCCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEA---------TNNFFNFQIAEYGMG-SEVSTSGDVYSFGILLLETFTGKRPT 328 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~---------~~~~~~y~aPE~~~~-~~~~~~~DiwS~G~vl~ell~g~~pf 328 (427)
||||+|||++.++.+||+|||+|+..... ..||+.|+|||++.. ..++.++||||+||++|||++|+.||
T Consensus 134 DIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf 213 (345)
T d1pmea_ 134 DLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 213 (345)
T ss_dssp CCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSC
T ss_pred CCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCC
Confidence 99999999999999999999999865332 268899999999855 56789999999999999999999999
Q ss_pred CcccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHH
Q 042634 329 NEMFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNME 408 (427)
Q Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ 408 (427)
......+ ............... ........... .....................+.++.+++.+||+.||++|||++
T Consensus 214 ~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~ 290 (345)
T d1pmea_ 214 PGKHYLD-QLNHILGILGSPSQE-DLNCIINLKAR-NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVE 290 (345)
T ss_dssp CCSSHHH-HHHHHHHHHCSCCHH-HHHTCCCHHHH-HHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred CCCCHHH-HHHHHhhhccCCChh-hhhhhhhhhhh-cccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHH
Confidence 7542111 111111111111000 00000000000 00000000000000000112235688999999999999999999
Q ss_pred HHHHH
Q 042634 409 EVAAQ 413 (427)
Q Consensus 409 ev~~~ 413 (427)
|++++
T Consensus 291 e~L~h 295 (345)
T d1pmea_ 291 QALAH 295 (345)
T ss_dssp HHHTS
T ss_pred HHhcC
Confidence 99874
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-37 Score=292.80 Aligned_cols=221 Identities=18% Similarity=0.209 Sum_probs=154.8
Q ss_pred cccccchhhhccccccCC-CCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 042634 179 IRHRNLVKIITSCASVDF-QGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVH 257 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivH 257 (427)
++|||||++++++..... ......++||||| +.+|..+.+. ..+++..++.++.||+.||+||| ++||+|
T Consensus 74 l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~~IiH 144 (346)
T d1cm8a_ 74 MRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIH---AAGIIH 144 (346)
T ss_dssp CCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEEC
T ss_pred cCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHH---hCCCcc
Confidence 579999999998755332 2344579999999 6677776543 45999999999999999999999 899999
Q ss_pred ccccCCceeeCCCCceEecccccccccCCcC---CCccccccccccCCC-CcCccccchhHHHHHHHHHhCCCCCCcccC
Q 042634 258 CDLKPSNVLLDGELTAHVGDFGLAKFLPEAT---NNFFNFQIAEYGMGS-EVSTSGDVYSFGILLLETFTGKRPTNEMFT 333 (427)
Q Consensus 258 rDlkp~NIll~~~~~~kL~DFG~a~~~~~~~---~~~~~y~aPE~~~~~-~~~~~~DiwS~G~vl~ell~g~~pf~~~~~ 333 (427)
|||||+|||++.++.+|++|||.|+...... .+|+.|+|||++.+. .++.++||||+||++|||++|+.||.+...
T Consensus 145 rDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~ 224 (346)
T d1cm8a_ 145 RDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH 224 (346)
T ss_dssp CCCCGGGEEECTTCCEEECCCTTCEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cccCcchhhcccccccccccccceeccCCccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCCh
Confidence 9999999999999999999999999876543 789999999998764 568999999999999999999999976421
Q ss_pred CCccHHHHHHHhcc--cchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 042634 334 GNLTLHNFVKEALP--ERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVA 411 (427)
Q Consensus 334 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~ 411 (427)
...+......... .................. ........+. ......+..+.+++.+||+.||++|||++|++
T Consensus 225 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~--~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL 299 (346)
T d1cm8a_ 225 -LDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKG--LPELEKKDFA--SILTNASPLAVNLLEKMLVLDAEQRVTAGEAL 299 (346)
T ss_dssp -HHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHH--SCCCCCCCGG--GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred -HHHHHHHHhccCCCcHHHHhhhcchhhhhhhcc--CCcccccchH--HhccCCCHHHHHHHHHHCcCChhHCcCHHHHh
Confidence 1111111111111 100000000000000000 0000000000 01122345678999999999999999999998
Q ss_pred HH
Q 042634 412 AQ 413 (427)
Q Consensus 412 ~~ 413 (427)
++
T Consensus 300 ~H 301 (346)
T d1cm8a_ 300 AH 301 (346)
T ss_dssp HS
T ss_pred cC
Confidence 75
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.2e-36 Score=279.69 Aligned_cols=202 Identities=16% Similarity=0.176 Sum_probs=157.4
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeecc
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCD 259 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrD 259 (427)
+|+|++.+++.... +...++||||+ +++|.+++.... ..+++.++..++.|++.||+||| +.||+|||
T Consensus 59 ~~~~i~~~~~~~~~-----~~~~~~vme~~-~~~l~~~~~~~~---~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrD 126 (293)
T d1csna_ 59 GCTGIPNVYYFGQE-----GLHNVLVIDLL-GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIH---EKSLVYRD 126 (293)
T ss_dssp TCTTCCCEEEEEEE-----TTEEEEEEECC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHH---TTTEECCC
T ss_pred CCCCCCEEEEEeec-----CCccEEEEEec-CCCHHHHHHhhc---cchhhHHHHHHHHHHHHHHHHHH---HCCceecc
Confidence 45888888776433 56789999999 899998876543 45899999999999999999999 99999999
Q ss_pred ccCCceeeCC-----CCceEecccccccccCCc-------------CCCccccccccccCCCCcCccccchhHHHHHHHH
Q 042634 260 LKPSNVLLDG-----ELTAHVGDFGLAKFLPEA-------------TNNFFNFQIAEYGMGSEVSTSGDVYSFGILLLET 321 (427)
Q Consensus 260 lkp~NIll~~-----~~~~kL~DFG~a~~~~~~-------------~~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~el 321 (427)
|||+|||++. ++.+||+|||+|+..... ..||+.|+|||++.+..++.++|||||||++|||
T Consensus 127 iKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~el 206 (293)
T d1csna_ 127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYF 206 (293)
T ss_dssp CCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred CCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHH
Confidence 9999999974 578999999999875321 2689999999999999999999999999999999
Q ss_pred HhCCCCCCcccCCCcc-HHHHHHH-hcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCC
Q 042634 322 FTGKRPTNEMFTGNLT-LHNFVKE-ALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSE 399 (427)
Q Consensus 322 l~g~~pf~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~ 399 (427)
++|+.||.+....... ....+.. .......+ ....+++++.+++..||+.
T Consensus 207 ltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~----------------------------l~~~~p~~l~~ii~~~~~~ 258 (293)
T d1csna_ 207 LRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE----------------------------LCAGFPEEFYKYMHYARNL 258 (293)
T ss_dssp HHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH----------------------------HTTTSCHHHHHHHHHHHHC
T ss_pred HhCCCcCCCccchhHHHHHHHHHhccCCCChHH----------------------------hcCCCCHHHHHHHHHHhcC
Confidence 9999999864322211 1111110 00000000 1122456789999999999
Q ss_pred CCCCCCCHHHHHHHHHHHHHHH
Q 042634 400 LPRERMNMEEVAAQLLSFRNKL 421 (427)
Q Consensus 400 dP~~Rpt~~ev~~~L~~~~~~~ 421 (427)
+|++||+++.+.+.|+++.++.
T Consensus 259 ~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 259 AFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp CTTCCCCHHHHHHHHHHHHHHT
T ss_pred CcccCcCHHHHHHHHHHHHHHc
Confidence 9999999999999988886653
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-37 Score=285.34 Aligned_cols=191 Identities=19% Similarity=0.243 Sum_probs=151.2
Q ss_pred ccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeecc
Q 042634 180 RHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCD 259 (427)
Q Consensus 180 ~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrD 259 (427)
+||||+++++.+.. ....+++|||+.+|+|.+++... ..+++..++.++.|++.||+|+| +.||+|||
T Consensus 87 h~pnIv~~~~~~~~-----~~~~~~v~e~~~~~~L~~~i~~~----~~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrD 154 (322)
T d1vzoa_ 87 QSPFLVTLHYAFQT-----ETKLHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLH---KLGIIYRD 154 (322)
T ss_dssp TCTTBCCEEEEEEE-----TTEEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCC
T ss_pred CCCeEEEeeeeecc-----CCceeeeeecccccHHHHHHHhc----ccccHHHHHHHHHHHHHHHHHhh---cCCEEecc
Confidence 45899999988544 56789999999999999998655 45788999999999999999999 89999999
Q ss_pred ccCCceeeCCCCceEecccccccccCCc-------CCCccccccccccCCC--CcCccccchhHHHHHHHHHhCCCCCCc
Q 042634 260 LKPSNVLLDGELTAHVGDFGLAKFLPEA-------TNNFFNFQIAEYGMGS--EVSTSGDVYSFGILLLETFTGKRPTNE 330 (427)
Q Consensus 260 lkp~NIll~~~~~~kL~DFG~a~~~~~~-------~~~~~~y~aPE~~~~~--~~~~~~DiwS~G~vl~ell~g~~pf~~ 330 (427)
|||+|||++.++.+||+|||+|+..... ..|++.|+|||.+.+. .++.++||||+||++|||++|+.||.+
T Consensus 155 iKp~Nill~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~ 234 (322)
T d1vzoa_ 155 IKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTV 234 (322)
T ss_dssp CCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSC
T ss_pred CCccceeecCCCCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999865432 2688899999998764 468899999999999999999999986
Q ss_pred ccCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCC-----
Q 042634 331 MFTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERM----- 405 (427)
Q Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rp----- 405 (427)
..... .............. ..+..++.++.+++.+||++||++||
T Consensus 235 ~~~~~-~~~~i~~~~~~~~~-----------------------------~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~ 284 (322)
T d1vzoa_ 235 DGEKN-SQAEISRRILKSEP-----------------------------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPR 284 (322)
T ss_dssp TTSCC-CHHHHHHHHHHCCC-----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTT
T ss_pred CCHHH-HHHHHHHhcccCCC-----------------------------CCcccCCHHHHHHHHHHcccCHHHcCCCCcc
Confidence 53222 22222222111100 01223466789999999999999999
Q ss_pred CHHHHHH
Q 042634 406 NMEEVAA 412 (427)
Q Consensus 406 t~~ev~~ 412 (427)
|++|+++
T Consensus 285 t~~eil~ 291 (322)
T d1vzoa_ 285 DADEIKE 291 (322)
T ss_dssp THHHHHT
T ss_pred cHHHHHc
Confidence 4788875
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-36 Score=279.78 Aligned_cols=219 Identities=19% Similarity=0.189 Sum_probs=155.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||||++++.+.. ....++|+|++.++++..++... ..+++..++.++.|++.||+||| ++||+||
T Consensus 58 l~h~niv~~~~~~~~-----~~~~~iv~~~~~~~~l~~~~~~~----~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHr 125 (292)
T d1unla_ 58 LKHKNIVRLHDVLHS-----DKKLTLVFEFCDQDLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCH---SRNVLHR 125 (292)
T ss_dssp CCCTTBCCEEEEEEC-----SSEEEEEEECCSEEHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred cCcCCEEeecccccc-----ccceeEEeeeccccccccccccc----cccchhHHHHHHHHHHHHHHHhh---cCCEeee
Confidence 579999999998644 56789999999999888877654 45889999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC------CCccccccccccCCCC-cCccccchhHHHHHHHHHhCCCCCCcc
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT------NNFFNFQIAEYGMGSE-VSTSGDVYSFGILLLETFTGKRPTNEM 331 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~------~~~~~y~aPE~~~~~~-~~~~~DiwS~G~vl~ell~g~~pf~~~ 331 (427)
||||+|||++.++.+||+|||.|+...... .++..|+|||++.... ++.++||||+||++|||++|+.||...
T Consensus 126 DiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~ 205 (292)
T d1unla_ 126 DLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 205 (292)
T ss_dssp CCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCC
T ss_pred cccCcccccccCCceeeeecchhhcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCC
Confidence 999999999999999999999998765432 5677899999987765 699999999999999999999997543
Q ss_pred cCCCccHHHHHHHhcccchhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHH
Q 042634 332 FTGNLTLHNFVKEALPERLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVA 411 (427)
Q Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~ 411 (427)
......+........+.. ............. ........ ...........+..+.+++++||+.||++||||+|++
T Consensus 206 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~--~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L 281 (292)
T d1unla_ 206 NDVDDQLKRIFRLLGTPT-EEQWPSMTKLPDY-KPYPMYPA--TTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281 (292)
T ss_dssp SSHHHHHHHHHHHHCCCC-TTTCTTGGGSTTC-CCCCCCCT--TCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred CCHHHHHHHHHhhcCCCC-hhhhhhhhhcccc-cccccccc--cchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 222222222222111111 0000000000000 00000000 0000111122345688999999999999999999997
Q ss_pred HH
Q 042634 412 AQ 413 (427)
Q Consensus 412 ~~ 413 (427)
++
T Consensus 282 ~H 283 (292)
T d1unla_ 282 QH 283 (292)
T ss_dssp TS
T ss_pred cC
Confidence 63
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-36 Score=283.86 Aligned_cols=223 Identities=16% Similarity=0.136 Sum_probs=150.7
Q ss_pred cccccchhhhccccccCC-CCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 042634 179 IRHRNLVKIITSCASVDF-QGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVH 257 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivH 257 (427)
++|||||++++++..... ......|+|||||.++.+ +.+. ..+++..++.+++||+.||+||| +.||+|
T Consensus 73 l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~-~~~~------~~~~~~~i~~~~~qil~gl~~LH---~~giiH 142 (355)
T d2b1pa1 73 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC-QVIQ------MELDHERMSYLLYQMLCGIKHLH---SAGIIH 142 (355)
T ss_dssp CCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHH-HHHT------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCC
T ss_pred cCCCCeeEEEEEEecccccccCceeEEEEeccchHHH-Hhhh------cCCCHHHHHHHHHHHHHHHHHhh---hccccc
Confidence 579999999998754332 345678999999965544 4443 34889999999999999999999 899999
Q ss_pred ccccCCceeeCCCCceEecccccccccCCcC-----CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCCccc
Q 042634 258 CDLKPSNVLLDGELTAHVGDFGLAKFLPEAT-----NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTNEMF 332 (427)
Q Consensus 258 rDlkp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~~~~ 332 (427)
|||||+|||++.++.+|++|||.++...... .+|+.|+|||++.+..+++++||||+||++|||++|+.||.+..
T Consensus 143 rDlKP~Nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~ 222 (355)
T d2b1pa1 143 RDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_dssp SCCCGGGEEECTTCCEEECCCCC---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccCCccccccccccceeeechhhhhccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCC
Confidence 9999999999999999999999988765433 78899999999999999999999999999999999999997531
Q ss_pred CCCccHHHHHHHhcc---c-------chhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCC
Q 042634 333 TGNLTLHNFVKEALP---E-------RLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPR 402 (427)
Q Consensus 333 ~~~~~~~~~~~~~~~---~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~ 402 (427)
. ............. . ......+....... ......................+.++.+++++|++.||+
T Consensus 223 ~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~ 300 (355)
T d2b1pa1 223 Y-IDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAG-LTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPA 300 (355)
T ss_dssp H-HHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCC-CCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTT
T ss_pred H-HHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccc-cccccccccccccccccccccCCHHHHHHHHHHCcCChh
Confidence 1 1111111111111 0 00000000000000 000000000111111223455678899999999999999
Q ss_pred CCCCHHHHHHH
Q 042634 403 ERMNMEEVAAQ 413 (427)
Q Consensus 403 ~Rpt~~ev~~~ 413 (427)
+||||+|++++
T Consensus 301 ~R~ta~elL~H 311 (355)
T d2b1pa1 301 KRISVDDALQH 311 (355)
T ss_dssp TSCCHHHHHTS
T ss_pred HCcCHHHHhcC
Confidence 99999999854
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-36 Score=286.18 Aligned_cols=222 Identities=14% Similarity=0.159 Sum_probs=150.0
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
++|||+|++++++...........+++|+|+.+|+|.+++... .+++..++.++.||+.||+||| ++||+||
T Consensus 74 l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~~-----~l~e~~~~~i~~qil~aL~~LH---~~giiHr 145 (348)
T d2gfsa1 74 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-----KLTDDHVQFLIYQILRGLKYIH---SADIIHR 145 (348)
T ss_dssp CCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHH---HTTCCCC
T ss_pred cCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhcccc-----cccHHHHHHHHHHHHHHHHHHH---hCCCccc
Confidence 5799999999987553332334456677788899999998643 4999999999999999999999 8999999
Q ss_pred cccCCceeeCCCCceEecccccccccCCcC---CCccccccccccCCCC-cCccccchhHHHHHHHHHhCCCCCCcccCC
Q 042634 259 DLKPSNVLLDGELTAHVGDFGLAKFLPEAT---NNFFNFQIAEYGMGSE-VSTSGDVYSFGILLLETFTGKRPTNEMFTG 334 (427)
Q Consensus 259 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~---~~~~~y~aPE~~~~~~-~~~~~DiwS~G~vl~ell~g~~pf~~~~~~ 334 (427)
||||+|||++.++.+|++|||.|....... .|+..|+|||...+.. ++.++||||+||++|||++|+.||.+....
T Consensus 146 DiKp~NILi~~~~~~kl~dfg~a~~~~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~ 225 (348)
T d2gfsa1 146 DLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 225 (348)
T ss_dssp CCCGGGEEECTTCCEEECCC----CCTGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccCCccccccccccccccccchhcccCcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHH
Confidence 999999999999999999999998765433 7888999999877754 689999999999999999999999753111
Q ss_pred CccHHHHHHHhccc--chhcccCccccccccccchhhhccccccccccchHHHHHHHHHHHhhcCCCCCCCCCCHHHHHH
Q 042634 335 NLTLHNFVKEALPE--RLAEIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVTCSSELPRERMNMEEVAA 412 (427)
Q Consensus 335 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dP~~Rpt~~ev~~ 412 (427)
............. ............ .....................+.++.+++.+||+.||++|||++|+++
T Consensus 226 -~~~~~i~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 226 -DQLKLILRLVGTPGAELLKKISSESAR----NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp -HHHHHHHHHHCCCCHHHHTTCCCHHHH----HHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -HHHHHHHHhcCCCChHHhhhccchhhh----hhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 1111111111110 000000000000 000000000000000001123456889999999999999999999986
Q ss_pred H
Q 042634 413 Q 413 (427)
Q Consensus 413 ~ 413 (427)
+
T Consensus 301 H 301 (348)
T d2gfsa1 301 H 301 (348)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.97 E-value=5e-32 Score=258.25 Aligned_cols=229 Identities=17% Similarity=0.181 Sum_probs=146.1
Q ss_pred cccccchhhhccccccCCCCCCccceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 042634 179 IRHRNLVKIITSCASVDFQGNDSEALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHC 258 (427)
Q Consensus 179 l~Hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHr 258 (427)
..|+||+++++++... +....+.+++++..+........ ......+++..++.++.||+.||+|||+ ..||+||
T Consensus 77 ~~~~~iv~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHr 150 (362)
T d1q8ya_ 77 MGANHILKLLDHFNHK---GPNGVHVVMVFEVLGENLLALIK-KYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHT 150 (362)
T ss_dssp HHHTTBCCCCEEEEEE---ETTEEEEEEEECCCCEEHHHHHH-HTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECS
T ss_pred cCcCceEEEEEEeeec---cccceeeeeeecccccccccccc-cccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccc
Confidence 4689999999875432 13345666666655443222211 1112568899999999999999999994 4899999
Q ss_pred cccCCceeeCCCC------ceEecccccccccCCcC---CCccccccccccCCCCcCccccchhHHHHHHHHHhCCCCCC
Q 042634 259 DLKPSNVLLDGEL------TAHVGDFGLAKFLPEAT---NNFFNFQIAEYGMGSEVSTSGDVYSFGILLLETFTGKRPTN 329 (427)
Q Consensus 259 Dlkp~NIll~~~~------~~kL~DFG~a~~~~~~~---~~~~~y~aPE~~~~~~~~~~~DiwS~G~vl~ell~g~~pf~ 329 (427)
||||+|||++.++ .+|++|||.|+...... .||+.|+|||++....++.++||||+||+++||++|+.||.
T Consensus 151 DlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~ 230 (362)
T d1q8ya_ 151 DIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 230 (362)
T ss_dssp CCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-
T ss_pred cCChhHeeeeccCcccccceeeEeecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCC
Confidence 9999999997654 49999999998654433 78999999999999999999999999999999999999997
Q ss_pred cccCCCc-----cHHHHHHHhc--ccchh-------cccCccccccccccchhhhccccccccccchHHHHHHHHHHHhh
Q 042634 330 EMFTGNL-----TLHNFVKEAL--PERLA-------EIVDPVLLVEREEGETSKANAHKQFTRSFSVKECLVSVLGIGVT 395 (427)
Q Consensus 330 ~~~~~~~-----~~~~~~~~~~--~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 395 (427)
....... .+...+.... +.... ...+..............................+.++.+++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~ 310 (362)
T d1q8ya_ 231 PDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP 310 (362)
T ss_dssp --------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGG
T ss_pred CCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHH
Confidence 5422111 0111111100 00000 00000000000000000000000001122345677889999999
Q ss_pred cCCCCCCCCCCHHHHHHH
Q 042634 396 CSSELPRERMNMEEVAAQ 413 (427)
Q Consensus 396 cl~~dP~~Rpt~~ev~~~ 413 (427)
|+++||++|||++|++++
T Consensus 311 mL~~dP~~Rpta~e~L~H 328 (362)
T d1q8ya_ 311 MLQLDPRKRADAGGLVNH 328 (362)
T ss_dssp GGCSSTTTCBCHHHHHTC
T ss_pred HCCCChhHCcCHHHHhcC
Confidence 999999999999999863
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.92 E-value=1.9e-25 Score=207.98 Aligned_cols=178 Identities=31% Similarity=0.553 Sum_probs=132.9
Q ss_pred CeeecCCcccc--cCCccccCCCCCCEeeeec-ccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEcc
Q 042634 1 AFTLVGNQFTG--RIPGSIGDLHKLQRLTLEM-NKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLS 77 (427)
Q Consensus 1 ~l~l~~n~l~~--~~p~~~~~l~~L~~L~l~~-n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~ 77 (427)
+|||++|.++| .+|+++++|++|++|+|++ |+++|.+|++|++|++|++|+|++|++.+..|..+..+.+|++++++
T Consensus 54 ~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~ 133 (313)
T d1ogqa_ 54 NLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFS 133 (313)
T ss_dssp EEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECC
T ss_pred EEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccc
Confidence 37899999987 5789999999999999986 88988899999999999999999999987777777778888888888
Q ss_pred CccCcccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCC-CeEECcCCcccccCC---------------------
Q 042634 78 NNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNL-GAIDISENKLSGQIP--------------------- 135 (427)
Q Consensus 78 ~N~~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L-~~l~l~~n~~~~~~p--------------------- 135 (427)
+|.+.+.+|..+.+++.+ +.+++++|.++|.+|..+..+..+ +.+++++|+++|..|
T Consensus 134 ~N~~~~~~p~~l~~l~~L-~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~ 212 (313)
T d1ogqa_ 134 YNALSGTLPPSISSLPNL-VGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGD 212 (313)
T ss_dssp SSEEESCCCGGGGGCTTC-CEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEEC
T ss_pred cccccccCchhhccCccc-ceeeccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 888877777777777777 567777777777777666555543 445555554443222
Q ss_pred -------------------------ccccccccccceeeeeeeccccCCCCcccccCCceeeccCCccc
Q 042634 136 -------------------------SSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNFI 179 (427)
Q Consensus 136 -------------------------~~~~~~~~l~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~ll 179 (427)
..++.+++++.|++++|+++|.+|..++.+++|+.|++++|++.
T Consensus 213 ~~~~~~~~~~l~~l~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~ 281 (313)
T d1ogqa_ 213 ASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC 281 (313)
T ss_dssp CGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEE
T ss_pred ccccccccccccccccccccccccccccccccccccccCccCeecccCChHHhCCCCCCEEECcCCccc
Confidence 23445556666777777777777777777777777777777665
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.92 E-value=1.6e-25 Score=208.36 Aligned_cols=178 Identities=28% Similarity=0.501 Sum_probs=152.9
Q ss_pred CeeecC-CcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCc
Q 042634 1 AFTLVG-NQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNN 79 (427)
Q Consensus 1 ~l~l~~-n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 79 (427)
+|||++ |+++|.+|++|++|++|++|+|++|++++..|..+..+.+|+.+++++|.+.+.+|..++.+++|+++++++|
T Consensus 80 ~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n 159 (313)
T d1ogqa_ 80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159 (313)
T ss_dssp EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred ccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeecccc
Confidence 479987 8999999999999999999999999999888888999999999999999999899999999999999999999
Q ss_pred cCcccCCCCccccccccceeeccCCcCcCCCCC----------------------------------------------C
Q 042634 80 NLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPS----------------------------------------------N 113 (427)
Q Consensus 80 ~~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~----------------------------------------------~ 113 (427)
.+++.+|..+..+..+...+++++|+++|..|. .
T Consensus 160 ~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~ 239 (313)
T d1ogqa_ 160 RISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK 239 (313)
T ss_dssp CCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999888887777666544555555555433222 3
Q ss_pred CcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCCCCcccccCCceeeccCCccc
Q 042634 114 FGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNFI 179 (427)
Q Consensus 114 ~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~ll 179 (427)
++.+++|+.|++++|+++|.+|.+|+++++|+.|++++|+++|.+|+ ++++++|+.+++++|+.+
T Consensus 240 ~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~~l 304 (313)
T d1ogqa_ 240 VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCL 304 (313)
T ss_dssp CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSSEE
T ss_pred cccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCccc
Confidence 45667899999999999999999999999999999999999999885 688999999999999753
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=3.2e-23 Score=188.04 Aligned_cols=174 Identities=23% Similarity=0.233 Sum_probs=122.5
Q ss_pred eeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccC
Q 042634 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNL 81 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~ 81 (427)
+|.+++.|+ .+|+.+. ++|++|+|++|++++..+..|.++++|++|+|++|+++ .+|. ++.+++|++|++++|++
T Consensus 15 v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~~-~~~l~~L~~L~Ls~N~l 89 (266)
T d1p9ag_ 15 VNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV-DGTLPVLGTLDLSHNQL 89 (266)
T ss_dssp EECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEEC-CSCCTTCCEEECCSSCC
T ss_pred EEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-cccc-ccccccccccccccccc
Confidence 466777777 5676553 46777788887777433356777777888888877777 5653 46677777888888777
Q ss_pred cccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCCCC
Q 042634 82 TGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSS 161 (427)
Q Consensus 82 ~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~~ 161 (427)
+ ..+..+.++++| +.|++++|.+....+..+..+.++..|++++|.+++..+..+..+++++.+++++|++++..+..
T Consensus 90 ~-~~~~~~~~l~~L-~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~ 167 (266)
T d1p9ag_ 90 Q-SLPLLGQTLPAL-TVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGL 167 (266)
T ss_dssp S-SCCCCTTTCTTC-CEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTT
T ss_pred c-cccccccccccc-ccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccc
Confidence 7 445566777777 56777777777655666777777777777777777444445666777777777777777766666
Q ss_pred cccccCCceeeccCCcccccc
Q 042634 162 LSSLRGIENLDLSRNNFIRHR 182 (427)
Q Consensus 162 l~~l~~L~~L~L~~N~ll~Hp 182 (427)
+..+++|+.|++++|++..-|
T Consensus 168 ~~~l~~L~~L~Ls~N~L~~lp 188 (266)
T d1p9ag_ 168 LNGLENLDTLLLQENSLYTIP 188 (266)
T ss_dssp TTTCTTCCEEECCSSCCCCCC
T ss_pred cccccccceeecccCCCcccC
Confidence 777777777777777765443
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.87 E-value=7.1e-22 Score=179.07 Aligned_cols=173 Identities=23% Similarity=0.252 Sum_probs=157.6
Q ss_pred CeeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCcc
Q 042634 1 AFTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNN 80 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~ 80 (427)
+|||++|+|++..+..|.++++|+.|+|++|+++ .+|. ++.+++|++|+|++|+++ ..|..+..+++|++|++++|.
T Consensus 35 ~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~~-~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~ 111 (266)
T d1p9ag_ 35 ILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV-DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNR 111 (266)
T ss_dssp EEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEEC-CSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSC
T ss_pred EEECcCCcCCCcCHHHhhcccccccccccccccc-cccc-cccccccccccccccccc-ccccccccccccccccccccc
Confidence 4899999999776678999999999999999998 6764 689999999999999999 778899999999999999999
Q ss_pred CcccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCCC
Q 042634 81 LTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPS 160 (427)
Q Consensus 81 ~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~ 160 (427)
+.+..+..+..+.++ .+|++++|.++...+..+..+++|+.+++++|++++..+..+..+++|+.|++++|.|+ .+|.
T Consensus 112 ~~~~~~~~~~~l~~l-~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~ 189 (266)
T d1p9ag_ 112 LTSLPLGALRGLGEL-QELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPK 189 (266)
T ss_dssp CCCCCSSTTTTCTTC-CEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCT
T ss_pred cceeecccccccccc-ccccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccCh
Confidence 998777888888898 68999999999766778889999999999999999766778899999999999999999 6888
Q ss_pred CcccccCCceeeccCCcc
Q 042634 161 SLSSLRGIENLDLSRNNF 178 (427)
Q Consensus 161 ~l~~l~~L~~L~L~~N~l 178 (427)
.+..+++|+.|++++|.+
T Consensus 190 ~~~~~~~L~~L~L~~Np~ 207 (266)
T d1p9ag_ 190 GFFGSHLLPFAFLHGNPW 207 (266)
T ss_dssp TTTTTCCCSEEECCSCCB
T ss_pred hHCCCCCCCEEEecCCCC
Confidence 888999999999999976
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.84 E-value=1.9e-20 Score=171.20 Aligned_cols=181 Identities=23% Similarity=0.241 Sum_probs=149.5
Q ss_pred CeeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeec-cccCcccCCcCccCCCCCCeEEccCc
Q 042634 1 AFTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFA-ENMLEGSIPSSLGKCQNLILLDLSNN 79 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~-~n~l~~~~p~~~~~l~~L~~l~l~~N 79 (427)
+|+|++|+|+...+..|.++++|++|++++|++....+..+.+++.+..++.+ .|.++...|..+.++++|++|++++|
T Consensus 36 ~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n 115 (284)
T d1ozna_ 36 RIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRC 115 (284)
T ss_dssp EEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTS
T ss_pred EEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEecCCc
Confidence 37889999985555678889999999999998886666667778888888765 56666444667888999999999999
Q ss_pred cCcccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCC
Q 042634 80 NLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIP 159 (427)
Q Consensus 80 ~~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p 159 (427)
.+....+..+....+| ..+++++|++++..+..|..+++|+.|++++|++++..|.++.++++|+.+++++|++++..|
T Consensus 116 ~~~~~~~~~~~~~~~L-~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~ 194 (284)
T d1ozna_ 116 GLQELGPGLFRGLAAL-QYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHP 194 (284)
T ss_dssp CCCCCCTTTTTTCTTC-CEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred ccccccccccchhccc-chhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccCh
Confidence 9986666777778888 679999999986666788889999999999999987667788899999999999999998888
Q ss_pred CCcccccCCceeeccCCcccccc
Q 042634 160 SSLSSLRGIENLDLSRNNFIRHR 182 (427)
Q Consensus 160 ~~l~~l~~L~~L~L~~N~ll~Hp 182 (427)
..|..+++++.|++++|.+..-+
T Consensus 195 ~~f~~l~~L~~L~l~~N~i~~~~ 217 (284)
T d1ozna_ 195 HAFRDLGRLMTLYLFANNLSALP 217 (284)
T ss_dssp TTTTTCTTCCEEECCSSCCSCCC
T ss_pred hHhhhhhhccccccccccccccc
Confidence 99999999999999999886543
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.83 E-value=1.3e-20 Score=161.91 Aligned_cols=169 Identities=24% Similarity=0.351 Sum_probs=138.0
Q ss_pred eeecCCcccccCCccccCCCCCCEeeeecccceeecC-cchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCcc
Q 042634 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIP-SSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNN 80 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p-~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~ 80 (427)
++.++|+|+ .+|..+. +++++|+|++|+|++.++ ..|+++++|+.|+|++|.+.+..+..+..+++|++|++++|+
T Consensus 13 v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~ 89 (192)
T d1w8aa_ 13 VDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENK 89 (192)
T ss_dssp EECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCC
T ss_pred EEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecccc
Confidence 688999999 7888764 689999999999986554 568999999999999999997777889999999999999999
Q ss_pred CcccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCCC
Q 042634 81 LTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPS 160 (427)
Q Consensus 81 ~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~ 160 (427)
+++..|..|.++++| ++|+|++|++++..|+.|..+++|++|+|++|.+... +....-...++.+.+..|.++...|.
T Consensus 90 l~~l~~~~F~~l~~L-~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~-~~~~~~~~~l~~~~l~~~~~~c~~p~ 167 (192)
T d1w8aa_ 90 IKEISNKMFLGLHQL-KTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN-CHLAWFAEWLRKKSLNGGAARCGAPS 167 (192)
T ss_dssp CCEECSSSSTTCTTC-CEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS-GGGHHHHHHHHHHCCSGGGCBBCSST
T ss_pred ccccCHHHHhCCCcc-cccccCCccccccCHHHhcCCcccccccccccccccc-cchHHHhhhhhhhcccCCCeEeCCCh
Confidence 998888889999999 6899999999977788899999999999999998843 22212223466677777777766665
Q ss_pred CcccccCCceeeccCCcc
Q 042634 161 SLSSLRGIENLDLSRNNF 178 (427)
Q Consensus 161 ~l~~l~~L~~L~L~~N~l 178 (427)
. ++.+..++++.|.+
T Consensus 168 ~---l~~~~l~~L~~n~l 182 (192)
T d1w8aa_ 168 K---VRDVQIKDLPHSEF 182 (192)
T ss_dssp T---TTTSBGGGSCTTTC
T ss_pred h---hcCCEeeecCHhhC
Confidence 4 45566677777665
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.81 E-value=5.5e-20 Score=168.11 Aligned_cols=178 Identities=21% Similarity=0.229 Sum_probs=159.3
Q ss_pred CeeecCCcccccCCccccCCCCCCEeeee-cccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCc
Q 042634 1 AFTLVGNQFTGRIPGSIGDLHKLQRLTLE-MNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNN 79 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~~~l~~L~~L~l~-~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N 79 (427)
+||+++|++.+..+..+..++.+..++.+ .|.++...|..+.++++|++|++++|.+.+..+..+..+++|+.+++++|
T Consensus 60 ~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N 139 (284)
T d1ozna_ 60 ILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDN 139 (284)
T ss_dssp EEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccc
Confidence 47999999998888888999999999876 56676444678999999999999999998555566778899999999999
Q ss_pred cCcccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCC
Q 042634 80 NLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIP 159 (427)
Q Consensus 80 ~~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p 159 (427)
.+++..+..+..+.++ +.|++++|++++..+..|.++++|+.+++++|++++..|..|.++++|+.|++++|.+.+..+
T Consensus 140 ~l~~i~~~~f~~~~~L-~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~ 218 (284)
T d1ozna_ 140 ALQALPDDTFRDLGNL-THLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPT 218 (284)
T ss_dssp CCCCCCTTTTTTCTTC-CEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCH
T ss_pred cccccChhHhccccch-hhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccc
Confidence 9997777788888999 689999999997778899999999999999999998889999999999999999999999888
Q ss_pred CCcccccCCceeeccCCccc
Q 042634 160 SSLSSLRGIENLDLSRNNFI 179 (427)
Q Consensus 160 ~~l~~l~~L~~L~L~~N~ll 179 (427)
..+..+++|+.+++++|.+.
T Consensus 219 ~~~~~~~~L~~L~l~~N~l~ 238 (284)
T d1ozna_ 219 EALAPLRALQYLRLNDNPWV 238 (284)
T ss_dssp HHHTTCTTCCEEECCSSCEE
T ss_pred cccccccccCEEEecCCCCC
Confidence 88999999999999999874
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.80 E-value=3.5e-19 Score=164.42 Aligned_cols=175 Identities=25% Similarity=0.324 Sum_probs=103.1
Q ss_pred CeeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCcc
Q 042634 1 AFTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNN 80 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~ 80 (427)
+|+|++|+|+...+..|.++++|+.|++++|.++...|..|.++++|++|++++|+++ .+|..+. ..|+.|+++.|.
T Consensus 35 ~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~-~l~~~~~--~~l~~L~~~~n~ 111 (305)
T d1xkua_ 35 LLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENE 111 (305)
T ss_dssp EEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEECCSSC
T ss_pred EEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCccC-cCccchh--hhhhhhhccccc
Confidence 3788888888444456888888888888888888555667888888888888888877 4443322 234444444443
Q ss_pred CcccCCC--------------------------Ccccccccc--------------------ceeeccCCcCcCCCCCCC
Q 042634 81 LTGTTPT--------------------------EVIGLSSLS--------------------IYLDLSQNQLNGPLPSNF 114 (427)
Q Consensus 81 ~~~~~p~--------------------------~~~~l~~l~--------------------~~L~l~~n~~~~~~p~~~ 114 (427)
+.+..+. .+.++.+|. +.|++++|..++..+..+
T Consensus 112 l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~l~~~~~~~L~~L~l~~n~~~~~~~~~~ 191 (305)
T d1xkua_ 112 ITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKVDAASL 191 (305)
T ss_dssp CCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCSSCCTTCSEEECTTSCCCEECTGGG
T ss_pred hhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccccCcccCCccCEEECCCCcCCCCChhHh
Confidence 3321110 112222231 234555555544445555
Q ss_pred cCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCCCCcccccCCceeeccCCccc
Q 042634 115 GILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNFI 179 (427)
Q Consensus 115 ~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~ll 179 (427)
..++.++.|++++|.+++..|..+.++++|+.|++++|.++. +|.++..+++|+.|++++|++.
T Consensus 192 ~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~-lp~~l~~l~~L~~L~Ls~N~i~ 255 (305)
T d1xkua_ 192 KGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNIS 255 (305)
T ss_dssp TTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSS-CCTTTTTCSSCCEEECCSSCCC
T ss_pred hccccccccccccccccccccccccccccceeeecccccccc-cccccccccCCCEEECCCCccC
Confidence 555566666666666665445555666666666666666653 4555666666666666665543
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=3.5e-18 Score=148.72 Aligned_cols=158 Identities=23% Similarity=0.355 Sum_probs=85.4
Q ss_pred eeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccC
Q 042634 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNL 81 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~ 81 (427)
|++++|.++. ++ .+..+++|+.|+|++|+++ .+++ ++.+++|++|++++|+++ .+| .+..+++|+.|++++|.+
T Consensus 51 L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~-~l~~-~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~~~~ 124 (210)
T d1h6ta2 51 IIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLT-DIKP-LANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGI 124 (210)
T ss_dssp EECTTSCCCC-CT-TGGGCTTCCEEECCSSCCC-CCGG-GTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCEEECTTSCC
T ss_pred EECcCCCCCC-ch-hHhhCCCCCEEeCCCcccc-Cccc-cccCcccccccccccccc-ccc-cccccccccccccccccc
Confidence 4555555552 22 2555666666666666665 2432 555666666666666665 444 355556666666666655
Q ss_pred cccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCCCC
Q 042634 82 TGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSS 161 (427)
Q Consensus 82 ~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~~ 161 (427)
. .++ .+..++.+ ..+++++|.+++ +..++.+++|+.+++++|++++ ++ .++++++|+.|++++|.++. ++ .
T Consensus 125 ~-~~~-~l~~l~~l-~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~-i~-~l~~l~~L~~L~Ls~N~i~~-l~-~ 195 (210)
T d1h6ta2 125 S-DIN-GLVHLPQL-ESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISD-IV-PLAGLTKLQNLYLSKNHISD-LR-A 195 (210)
T ss_dssp C-CCG-GGGGCTTC-CEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCB-CG-G
T ss_pred c-ccc-cccccccc-cccccccccccc--cccccccccccccccccccccc-cc-cccCCCCCCEEECCCCCCCC-Ch-h
Confidence 4 222 34455555 456666666542 2345555666666666666552 33 25556666666666666553 22 3
Q ss_pred cccccCCceeecc
Q 042634 162 LSSLRGIENLDLS 174 (427)
Q Consensus 162 l~~l~~L~~L~L~ 174 (427)
+..+++|+.|+++
T Consensus 196 l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 196 LAGLKNLDVLELF 208 (210)
T ss_dssp GTTCTTCSEEEEE
T ss_pred hcCCCCCCEEEcc
Confidence 5555666665554
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.74 E-value=6.4e-18 Score=145.73 Aligned_cols=165 Identities=25% Similarity=0.352 Sum_probs=129.5
Q ss_pred eecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccCc
Q 042634 3 TLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLT 82 (427)
Q Consensus 3 ~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~~ 82 (427)
+++.+.+++.++. ..+.+|+.|++++|.++ .++ .+..+++|++|++++|+++ .+++ ++++++|++|++++|.+.
T Consensus 24 ~l~~~~~~~~~~~--~~l~~l~~L~l~~~~i~-~l~-~l~~l~nL~~L~Ls~N~l~-~~~~-l~~l~~L~~L~l~~n~~~ 97 (199)
T d2omxa2 24 VLGKTNVTDTVSQ--TDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLT-DITP-LKNLTKLVDILMNNNQIA 97 (199)
T ss_dssp HTTCSSTTSEECH--HHHTTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCC-CCGG-GTTCTTCCEEECCSSCCC
T ss_pred HhCCCCCCCccCH--HHhcCCCEEECCCCCCC-Ccc-ccccCCCcCcCcccccccc-Cccc-ccCCcccccccccccccc
Confidence 3566777765443 46788999999999988 564 5888999999999999998 5554 888999999999999887
Q ss_pred ccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCCCCc
Q 042634 83 GTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSL 162 (427)
Q Consensus 83 ~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~~l 162 (427)
.++ .+.+++.| +.|++++|.+.. + ..+..+++|+.|++++|++. .+| .+..+++++.|++++|++++. ..+
T Consensus 98 -~~~-~l~~l~~L-~~L~l~~~~~~~-~-~~~~~l~~L~~L~l~~n~l~-~~~-~l~~~~~L~~L~l~~n~l~~l--~~l 168 (199)
T d2omxa2 98 -DIT-PLANLTNL-TGLTLFNNQITD-I-DPLKNLTNLNRLELSSNTIS-DIS-ALSGLTSLQQLNFSSNQVTDL--KPL 168 (199)
T ss_dssp -CCG-GGTTCTTC-SEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCC--GGG
T ss_pred -ccc-cccccccc-cccccccccccc-c-cccchhhhhHHhhhhhhhhc-ccc-cccccccccccccccccccCC--ccc
Confidence 444 37788888 679999888864 2 45778899999999999887 443 578889999999999998864 247
Q ss_pred ccccCCceeeccCCcccccc
Q 042634 163 SSLRGIENLDLSRNNFIRHR 182 (427)
Q Consensus 163 ~~l~~L~~L~L~~N~ll~Hp 182 (427)
..+++|+.|++++|++.+-+
T Consensus 169 ~~l~~L~~L~ls~N~i~~i~ 188 (199)
T d2omxa2 169 ANLTTLERLDISSNKVSDIS 188 (199)
T ss_dssp TTCTTCCEEECCSSCCCCCG
T ss_pred cCCCCCCEEECCCCCCCCCc
Confidence 88899999999998875533
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.73 E-value=3.7e-17 Score=150.59 Aligned_cols=173 Identities=22% Similarity=0.254 Sum_probs=126.7
Q ss_pred eecCCcccccCCccccCCCCCCEeeeecccceeecCc-chhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccC
Q 042634 3 TLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPS-SIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNL 81 (427)
Q Consensus 3 ~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~-~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~ 81 (427)
|=++++|+ .+|..+. ++|++|+|++|+++ .+|+ +|.++++|++|++++|.++...|..|..+++|++|++++|++
T Consensus 16 ~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~-~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l 91 (305)
T d1xkua_ 16 QCSDLGLE-KVPKDLP--PDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 91 (305)
T ss_dssp ECTTSCCC-SCCCSCC--TTCCEEECCSSCCC-CBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCC
T ss_pred EecCCCCC-ccCCCCC--CCCCEEECcCCcCC-CcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCcc
Confidence 44667788 7888764 68999999999998 5765 799999999999999999955577899999999999999999
Q ss_pred cccCCCCccccccccceeeccCCcCcC--------------------------CCCCCCcCCC-----------------
Q 042634 82 TGTTPTEVIGLSSLSIYLDLSQNQLNG--------------------------PLPSNFGILK----------------- 118 (427)
Q Consensus 82 ~~~~p~~~~~l~~l~~~L~l~~n~~~~--------------------------~~p~~~~~l~----------------- 118 (427)
+ .+|..+. ..+ ..|++..|.+.+ ..+..+..++
T Consensus 92 ~-~l~~~~~--~~l-~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~l~~ 167 (305)
T d1xkua_ 92 K-ELPEKMP--KTL-QELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQ 167 (305)
T ss_dssp S-BCCSSCC--TTC-CEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCS
T ss_pred C-cCccchh--hhh-hhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccccCc
Confidence 8 5655432 233 345555555531 1112233333
Q ss_pred ----CCCeEECcCCcccccCCccccccccccceeeeeeeccccCCCCcccccCCceeeccCCccccccc
Q 042634 119 ----NLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNFIRHRN 183 (427)
Q Consensus 119 ----~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~ll~Hpn 183 (427)
+|+.|++++|..++..+..+..++.++.|++++|.+++..+..+..+++|+.|++++|++...|.
T Consensus 168 ~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~lp~ 236 (305)
T d1xkua_ 168 GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPG 236 (305)
T ss_dssp SCCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCT
T ss_pred ccCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccccccc
Confidence 45555566665555566667777788888888888887777778888888888888887765543
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.72 E-value=2e-17 Score=141.75 Aligned_cols=130 Identities=25% Similarity=0.304 Sum_probs=96.6
Q ss_pred CCEeeeecccceeecCcchhccccCCEeeeccccCcccCC-cCccCCCCCCeEEccCccCcccCCCCccccccccceeec
Q 042634 23 LQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIP-SSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDL 101 (427)
Q Consensus 23 L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p-~~~~~l~~L~~l~l~~N~~~~~~p~~~~~l~~l~~~L~l 101 (427)
.+.++.++|+++ .+|..+. +++++|+|++|+|++.++ ..+..+++|++|++++|.+.+..+..+..+.+| ++|+|
T Consensus 10 ~~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L-~~L~L 85 (192)
T d1w8aa_ 10 GTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI-QELQL 85 (192)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTC-CEEEC
T ss_pred CCEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeecccccccccccccccccccc-ceeee
Confidence 356778888887 6777663 677888888888875454 346777888888888888877777777777777 56888
Q ss_pred cCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccc
Q 042634 102 SQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRG 156 (427)
Q Consensus 102 ~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~ 156 (427)
++|+++...|..|.++++|+.|+|++|+|++..|.+|..+++|+.+++++|.+..
T Consensus 86 s~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~ 140 (192)
T d1w8aa_ 86 GENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140 (192)
T ss_dssp CSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred ccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCccccccccccccccc
Confidence 8888876556677778888888888888876556667777778888887777764
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.71 E-value=1.8e-17 Score=142.84 Aligned_cols=156 Identities=25% Similarity=0.367 Sum_probs=132.3
Q ss_pred CeeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCcc
Q 042634 1 AFTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNN 80 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~ 80 (427)
+|++++|.++ .++ .+..+++|++|+|++|++++ +++ ++++++|++|++++|.+. .+| .+..+++|++|++++|.
T Consensus 44 ~L~l~~~~i~-~l~-~l~~l~nL~~L~Ls~N~l~~-~~~-l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l~~~~ 117 (199)
T d2omxa2 44 TLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTLFNNQ 117 (199)
T ss_dssp EEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEECCSSC
T ss_pred EEECCCCCCC-Ccc-ccccCCCcCcCccccccccC-ccc-ccCCcccccccccccccc-ccc-ccccccccccccccccc
Confidence 3789999998 454 58999999999999999984 554 999999999999999998 666 48899999999999999
Q ss_pred CcccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCCC
Q 042634 81 LTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPS 160 (427)
Q Consensus 81 ~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~ 160 (427)
+.... .+..+++| ..|++++|++. .+ +.+..+++|+.|++++|++++ ++ .++++++|+.|++++|++++ ++
T Consensus 118 ~~~~~--~~~~l~~L-~~L~l~~n~l~-~~-~~l~~~~~L~~L~l~~n~l~~-l~-~l~~l~~L~~L~ls~N~i~~-i~- 188 (199)
T d2omxa2 118 ITDID--PLKNLTNL-NRLELSSNTIS-DI-SALSGLTSLQQLNFSSNQVTD-LK-PLANLTTLERLDISSNKVSD-IS- 188 (199)
T ss_dssp CCCCG--GGTTCTTC-SEEECCSSCCC-CC-GGGTTCTTCSEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-CG-
T ss_pred ccccc--ccchhhhh-HHhhhhhhhhc-cc-ccccccccccccccccccccC-Cc-cccCCCCCCEEECCCCCCCC-Cc-
Confidence 97432 46788899 68999999997 44 468899999999999999984 44 48899999999999999986 33
Q ss_pred CcccccCCcee
Q 042634 161 SLSSLRGIENL 171 (427)
Q Consensus 161 ~l~~l~~L~~L 171 (427)
.+..+++|+.|
T Consensus 189 ~l~~L~~L~~L 199 (199)
T d2omxa2 189 VLAKLTNLESL 199 (199)
T ss_dssp GGGGCTTCSEE
T ss_pred cccCCCCCCcC
Confidence 57788888765
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.68 E-value=7.9e-17 Score=141.79 Aligned_cols=167 Identities=26% Similarity=0.375 Sum_probs=131.5
Q ss_pred CeeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCcc
Q 042634 1 AFTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNN 80 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~ 80 (427)
+|++.+|+++ .++ .+..|++|+.|++++|++++ +++ +..+++|+++++++|.++ .++ .+.++++|+++++++|.
T Consensus 45 ~L~l~~~~i~-~l~-~l~~l~~L~~L~ls~n~i~~-~~~-l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L~~l~l~~~~ 118 (227)
T d1h6ua2 45 TLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITD-LAP-LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQ 118 (227)
T ss_dssp EEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCCSCCEEECCSCCCS-CCG-GGTTCTTCCEEECTTSC
T ss_pred EEECCCCCCC-cch-hHhcCCCCcEeecCCceeec-ccc-cccccccccccccccccc-ccc-ccccccccccccccccc
Confidence 3688899998 554 58899999999999999984 443 889999999999999888 665 57889999999999998
Q ss_pred CcccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCCC
Q 042634 81 LTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPS 160 (427)
Q Consensus 81 ~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~ 160 (427)
..+..+ +.....+ ..+.++++.+.. ...+..+++|+.|++++|.+++ + ..++++++|+.|++++|++++. .
T Consensus 119 ~~~~~~--~~~~~~~-~~l~~~~~~~~~--~~~~~~~~~L~~L~l~~n~~~~-~-~~l~~l~~L~~L~Ls~n~l~~l--~ 189 (227)
T d1h6ua2 119 ITDVTP--LAGLSNL-QVLYLDLNQITN--ISPLAGLTNLQYLSIGNAQVSD-L-TPLANLSKLTTLKADDNKISDI--S 189 (227)
T ss_dssp CCCCGG--GTTCTTC-CEEECCSSCCCC--CGGGGGCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCCC--G
T ss_pred ccccch--hccccch-hhhhchhhhhch--hhhhcccccccccccccccccc-c-hhhcccccceecccCCCccCCC--h
Confidence 874432 3445555 568888888763 2347788899999999998873 3 3478899999999999999863 3
Q ss_pred CcccccCCceeeccCCcccccc
Q 042634 161 SLSSLRGIENLDLSRNNFIRHR 182 (427)
Q Consensus 161 ~l~~l~~L~~L~L~~N~ll~Hp 182 (427)
.+..+++|+.|++++|++..-+
T Consensus 190 ~l~~l~~L~~L~Ls~N~lt~i~ 211 (227)
T d1h6ua2 190 PLASLPNLIEVHLKNNQISDVS 211 (227)
T ss_dssp GGGGCTTCCEEECTTSCCCBCG
T ss_pred hhcCCCCCCEEECcCCcCCCCc
Confidence 4888999999999999876543
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.67 E-value=1.1e-16 Score=151.85 Aligned_cols=165 Identities=29% Similarity=0.438 Sum_probs=121.8
Q ss_pred eeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccC
Q 042634 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNL 81 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~ 81 (427)
+++++|.+++..| +...++|+.|++++|+++ .+| .+..+++|+.|++++|.++ .++ .++.+++|++|++++|++
T Consensus 202 l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~-~~~-~l~~l~~L~~L~l~~n~l~-~~~-~~~~~~~L~~L~l~~~~l 275 (384)
T d2omza2 202 LIATNNQISDITP--LGILTNLDELSLNGNQLK-DIG-TLASLTNLTDLDLANNQIS-NLA-PLSGLTKLTELKLGANQI 275 (384)
T ss_dssp EECCSSCCCCCGG--GGGCTTCCEEECCSSCCC-CCG-GGGGCTTCSEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCC
T ss_pred eeccCCccCCCCc--ccccCCCCEEECCCCCCC-Ccc-hhhcccccchhccccCccC-CCC-cccccccCCEeeccCccc
Confidence 6788888885533 466788999999999887 454 6888899999999999988 444 377788899999999988
Q ss_pred cccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCCCC
Q 042634 82 TGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSS 161 (427)
Q Consensus 82 ~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~~ 161 (427)
++..+ +.++..+ ..+.+..|.+++ ...+..+++++.|++++|++++ ++ .+..+++|+.|++++|.+++ ++ .
T Consensus 276 ~~~~~--~~~~~~l-~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~-l~-~l~~l~~L~~L~L~~n~l~~-l~-~ 346 (384)
T d2omza2 276 SNISP--LAGLTAL-TNLELNENQLED--ISPISNLKNLTYLTLYFNNISD-IS-PVSSLTKLQRLFFANNKVSD-VS-S 346 (384)
T ss_dssp CCCGG--GTTCTTC-SEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSC-CG-GGGGCTTCCEEECCSSCCCC-CG-G
T ss_pred CCCCc--ccccccc-cccccccccccc--ccccchhcccCeEECCCCCCCC-Cc-ccccCCCCCEEECCCCCCCC-Ch-h
Confidence 74432 4556666 567778887764 2346777778888888888774 33 36777788888888887775 23 5
Q ss_pred cccccCCceeeccCCccccc
Q 042634 162 LSSLRGIENLDLSRNNFIRH 181 (427)
Q Consensus 162 l~~l~~L~~L~L~~N~ll~H 181 (427)
+..+++|+.|++++|++.+-
T Consensus 347 l~~l~~L~~L~l~~N~l~~l 366 (384)
T d2omza2 347 LANLTNINWLSAGHNQISDL 366 (384)
T ss_dssp GGGCTTCCEEECCSSCCCBC
T ss_pred HcCCCCCCEEECCCCcCCCC
Confidence 77777888888887776543
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.67 E-value=6.4e-17 Score=127.83 Aligned_cols=76 Identities=25% Similarity=0.367 Sum_probs=47.9
Q ss_pred eeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccC
Q 042634 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNL 81 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~ 81 (427)
|||++|+++ .+| .+..+++|++|++++|+++ .+|+.++.+++|+.|++++|.++ .+| .++.+++|++|++++|++
T Consensus 3 L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~i 77 (124)
T d1dcea3 3 LHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRL 77 (124)
T ss_dssp EECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSCC
T ss_pred EEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCCcc
Confidence 566666666 444 3666666666666666665 56666666666666666666666 444 356666666666666666
Q ss_pred c
Q 042634 82 T 82 (427)
Q Consensus 82 ~ 82 (427)
+
T Consensus 78 ~ 78 (124)
T d1dcea3 78 Q 78 (124)
T ss_dssp C
T ss_pred C
Confidence 5
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.67 E-value=5.1e-17 Score=134.81 Aligned_cols=128 Identities=20% Similarity=0.156 Sum_probs=104.5
Q ss_pred cccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccCcccCCCCccccccc
Q 042634 16 SIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSL 95 (427)
Q Consensus 16 ~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~~~l~~l 95 (427)
.+.+..+|+.|+|++|+|+ .+|..+..+++|++|+|++|.++ .++ .+..+++|++|++++|+++...+..+..++++
T Consensus 13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L 89 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 89 (162)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCcccccccccc
Confidence 3678889999999999998 68877788999999999999999 775 58889999999999999985555555678888
Q ss_pred cceeeccCCcCcCCCC--CCCcCCCCCCeEECcCCcccccCCc----cccccccccceee
Q 042634 96 SIYLDLSQNQLNGPLP--SNFGILKNLGAIDISENKLSGQIPS----SIGSCIRLEQLVM 149 (427)
Q Consensus 96 ~~~L~l~~n~~~~~~p--~~~~~l~~L~~l~l~~n~~~~~~p~----~~~~~~~l~~l~l 149 (427)
+.|++++|+++ .++ ..+..+++|+.|++++|.++ ..|. .++.+++|+.||.
T Consensus 90 -~~L~L~~N~i~-~~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~LD~ 146 (162)
T d1a9na_ 90 -TELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDF 146 (162)
T ss_dssp -CEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETT
T ss_pred -ccceecccccc-ccccccccccccccchhhcCCCccc-cccchHHHHHHHCCCcCeeCC
Confidence 67999999987 444 36788899999999999887 5664 4677788877763
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.66 E-value=1.3e-16 Score=138.66 Aligned_cols=162 Identities=21% Similarity=0.310 Sum_probs=135.9
Q ss_pred ecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccCcc
Q 042634 4 LVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTG 83 (427)
Q Consensus 4 l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~~~ 83 (427)
++.+.+++.++. ..|.+|+.|++++|.++ .++ .+..+++|++|+|++|.++ .++ .++.+++|++|++++|+++
T Consensus 31 l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~L~~n~i~-~l~-~~~~l~~L~~L~l~~n~i~- 103 (210)
T d1h6ta2 31 LKKKSVTDAVTQ--NELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLT-DIK-PLANLKNLGWLFLDENKVK- 103 (210)
T ss_dssp TTCSCTTSEECH--HHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCC-CCG-GGTTCTTCCEEECCSSCCC-
T ss_pred hCcCccCCccCH--HHhcCccEEECcCCCCC-Cch-hHhhCCCCCEEeCCCcccc-Ccc-ccccCcccccccccccccc-
Confidence 456666666553 35779999999999998 454 4899999999999999999 566 4788999999999999998
Q ss_pred cCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCCCCcc
Q 042634 84 TTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLS 163 (427)
Q Consensus 84 ~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~~l~ 163 (427)
.+| .+.++++| +.|++++|.+. .+ ..+..++.++.+++++|.+++ +..++.+++|+.+++++|.+++.. .+.
T Consensus 104 ~l~-~l~~l~~L-~~L~l~~~~~~-~~-~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~--~l~ 175 (210)
T d1h6ta2 104 DLS-SLKDLKKL-KSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIV--PLA 175 (210)
T ss_dssp CGG-GGTTCTTC-CEEECTTSCCC-CC-GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCG--GGT
T ss_pred ccc-cccccccc-ccccccccccc-cc-ccccccccccccccccccccc--cccccccccccccccccccccccc--ccc
Confidence 455 47888999 68999999986 34 468889999999999999984 456788999999999999998642 488
Q ss_pred cccCCceeeccCCcccc
Q 042634 164 SLRGIENLDLSRNNFIR 180 (427)
Q Consensus 164 ~l~~L~~L~L~~N~ll~ 180 (427)
.+++|+.|++++|++..
T Consensus 176 ~l~~L~~L~Ls~N~i~~ 192 (210)
T d1h6ta2 176 GLTKLQNLYLSKNHISD 192 (210)
T ss_dssp TCTTCCEEECCSSCCCB
T ss_pred CCCCCCEEECCCCCCCC
Confidence 99999999999998754
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.64 E-value=3.2e-16 Score=123.77 Aligned_cols=101 Identities=24% Similarity=0.300 Sum_probs=83.5
Q ss_pred CEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccCcccCCCCccccccccceeeccC
Q 042634 24 QRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQ 103 (427)
Q Consensus 24 ~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~~~l~~l~~~L~l~~ 103 (427)
++|+|++|+++ .+| .++.+++|++|++++|+++ .+|+.++.+++|++|++++|+++ .+| .+..+++| +.|++++
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L-~~L~l~~ 74 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRL-QELLLCN 74 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSC-CEEECCS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-cccccccc-CeEECCC
Confidence 57999999998 666 4899999999999999998 88888999999999999999998 444 47778888 6788888
Q ss_pred CcCcCCCC--CCCcCCCCCCeEECcCCccc
Q 042634 104 NQLNGPLP--SNFGILKNLGAIDISENKLS 131 (427)
Q Consensus 104 n~~~~~~p--~~~~~l~~L~~l~l~~n~~~ 131 (427)
|+++. +| ..+..+++|+.|++++|+++
T Consensus 75 N~i~~-~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 75 NRLQQ-SAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp SCCCS-SSTTGGGGGCTTCCEEECTTSGGG
T ss_pred CccCC-CCCchhhcCCCCCCEEECCCCcCC
Confidence 88873 33 45777888888888888887
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.63 E-value=1.1e-15 Score=135.48 Aligned_cols=178 Identities=16% Similarity=0.168 Sum_probs=116.6
Q ss_pred eeecCCcccccCCccccCCCCCCEeeeecccceeecCc-chhccccCCEeeec-cccCcccCCcCccCCCCCCeEEccCc
Q 042634 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPS-SIGNLTLLITLNFA-ENMLEGSIPSSLGKCQNLILLDLSNN 79 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~-~~~~l~~L~~L~l~-~n~l~~~~p~~~~~l~~L~~l~l~~N 79 (427)
|||++|+++...+..|.++++|++|+|++|.+...+|. .|.+++.++.+++. .|.+....|..+.++++|++|++++|
T Consensus 34 L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~ 113 (242)
T d1xwdc1 34 LRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNT 113 (242)
T ss_dssp EEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESC
T ss_pred EECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccccccccccccccccccccccccchh
Confidence 67777777744344567777777777777777654543 56677777777765 35666555566777777777777777
Q ss_pred cCcccCCCC-ccccccccceeeccCCcCcCCCCCCCcCCC-CCCeEECcCCcccccCCccccccccccce-eeeeeeccc
Q 042634 80 NLTGTTPTE-VIGLSSLSIYLDLSQNQLNGPLPSNFGILK-NLGAIDISENKLSGQIPSSIGSCIRLEQL-VMNGNFFRG 156 (427)
Q Consensus 80 ~~~~~~p~~-~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~-~L~~l~l~~n~~~~~~p~~~~~~~~l~~l-~l~~n~l~~ 156 (427)
.+....+.. +..+..+ ..+..+++.+...-+..+..++ .++.|++++|+++ .++..+....++..+ .+++|.++.
T Consensus 114 ~l~~~~~~~~~~~l~~l-~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~-~i~~~~~~~~~l~~~~~l~~n~l~~ 191 (242)
T d1xwdc1 114 GIKHLPDVHKIHSLQKV-LLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNCAFNGTQLDELNLSDNNNLEE 191 (242)
T ss_dssp CCCSCCCCTTTCBSSCE-EEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC-EECTTTTTTCCEEEEECTTCTTCCC
T ss_pred hhccccccccccccccc-ccccccccccccccccccccccccceeeeccccccc-ccccccccchhhhcccccccccccc
Confidence 776333322 2233333 3345555566533345555554 6788889999888 566655555665544 567788886
Q ss_pred cCCCCcccccCCceeeccCCccccc
Q 042634 157 NIPSSLSSLRGIENLDLSRNNFIRH 181 (427)
Q Consensus 157 ~~p~~l~~l~~L~~L~L~~N~ll~H 181 (427)
..+..+..+++|+.|++++|++..-
T Consensus 192 l~~~~f~~l~~L~~L~Ls~N~l~~l 216 (242)
T d1xwdc1 192 LPNDVFHGASGPVILDISRTRIHSL 216 (242)
T ss_dssp CCTTTTTTSCCCSEEECTTSCCCCC
T ss_pred ccHHHhcCCCCCCEEECCCCcCCcc
Confidence 5455678899999999999887543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.61 E-value=2.8e-17 Score=140.65 Aligned_cols=99 Identities=19% Similarity=0.116 Sum_probs=72.0
Q ss_pred cceeeeeecCCCcccccccchhhhhccCHHHHHHHHHHHHHHHHHHhhcCCCCeeeccccCCceeeCCCCceEecccccc
Q 042634 202 EALVYEFMVNGSLEEWLHPNREALKNLNLLQRLSIAVDVASALDYLHHYCETPIVHCDLKPSNVLLDGELTAHVGDFGLA 281 (427)
Q Consensus 202 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~L~~LH~~~~~~ivHrDlkp~NIll~~~~~~kL~DFG~a 281 (427)
.+++|||++++.+.+ ++...+..++.|++.|++||| ..||+||||||+|||++++ .++|+|||.|
T Consensus 85 ~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~liDFG~a 149 (191)
T d1zara2 85 NAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWIIDFPQS 149 (191)
T ss_dssp TEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEECCCTTC
T ss_pred CEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEEEEECCCc
Confidence 479999997655433 334456779999999999999 8999999999999999865 4899999999
Q ss_pred cccCCcCCCcccccc----ccccCCCCcCccccchhHHH
Q 042634 282 KFLPEATNNFFNFQI----AEYGMGSEVSTSGDVYSFGI 316 (427)
Q Consensus 282 ~~~~~~~~~~~~y~a----PE~~~~~~~~~~~DiwS~G~ 316 (427)
+........+.-.+. .+. ..+.|+.++|+||..-
T Consensus 150 ~~~~~~~~~~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 150 VEVGEEGWREILERDVRNIITY-FSRTYRTEKDINSAID 187 (191)
T ss_dssp EETTSTTHHHHHHHHHHHHHHH-HHHHHCCCCCHHHHHH
T ss_pred ccCCCCCcHHHHHHHHHHHHHH-HcCCCCCcccHHHHHH
Confidence 876543322111111 111 2356788999999754
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.60 E-value=2.8e-15 Score=142.02 Aligned_cols=160 Identities=27% Similarity=0.421 Sum_probs=119.5
Q ss_pred eeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccC
Q 042634 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNL 81 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~ 81 (427)
|++++|+++. + +.+..+++|+.|++++|.+++ +++ ++.+++|++|++++|.++ .++ .+..++.++.++++.|.+
T Consensus 224 L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~-~~~-~~~~~~L~~L~l~~~~l~-~~~-~~~~~~~l~~l~~~~n~l 297 (384)
T d2omza2 224 LSLNGNQLKD-I-GTLASLTNLTDLDLANNQISN-LAP-LSGLTKLTELKLGANQIS-NIS-PLAGLTALTNLELNENQL 297 (384)
T ss_dssp EECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCC-CGG-GTTCTTCSEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCC
T ss_pred EECCCCCCCC-c-chhhcccccchhccccCccCC-CCc-ccccccCCEeeccCcccC-CCC-cccccccccccccccccc
Confidence 6788888873 3 457788888888888888874 443 778888888888888887 444 366777888888888888
Q ss_pred cccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCCCC
Q 042634 82 TGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSS 161 (427)
Q Consensus 82 ~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~~ 161 (427)
++ + ..+..+.++ ..|++++|++++ ++ .+..+++|+.|++++|+++ .+| .++++++|+.|++++|++++..|
T Consensus 298 ~~-~-~~~~~~~~l-~~L~ls~n~l~~-l~-~l~~l~~L~~L~L~~n~l~-~l~-~l~~l~~L~~L~l~~N~l~~l~~-- 368 (384)
T d2omza2 298 ED-I-SPISNLKNL-TYLTLYFNNISD-IS-PVSSLTKLQRLFFANNKVS-DVS-SLANLTNINWLSAGHNQISDLTP-- 368 (384)
T ss_dssp SC-C-GGGGGCTTC-SEEECCSSCCSC-CG-GGGGCTTCCEEECCSSCCC-CCG-GGGGCTTCCEEECCSSCCCBCGG--
T ss_pred cc-c-cccchhccc-CeEECCCCCCCC-Cc-ccccCCCCCEEECCCCCCC-CCh-hHcCCCCCCEEECCCCcCCCChh--
Confidence 74 3 236667777 578888888875 33 3777888888888888887 344 57888888888888888886543
Q ss_pred cccccCCceeeccCC
Q 042634 162 LSSLRGIENLDLSRN 176 (427)
Q Consensus 162 l~~l~~L~~L~L~~N 176 (427)
+.++++|+.|++++|
T Consensus 369 l~~l~~L~~L~L~~N 383 (384)
T d2omza2 369 LANLTRITQLGLNDQ 383 (384)
T ss_dssp GTTCTTCSEEECCCE
T ss_pred hccCCCCCEeeCCCC
Confidence 777888888888765
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.59 E-value=4.7e-16 Score=128.92 Aligned_cols=118 Identities=20% Similarity=0.203 Sum_probs=100.9
Q ss_pred CeeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcC-ccCCCCCCeEEccCc
Q 042634 1 AFTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSS-LGKCQNLILLDLSNN 79 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~-~~~l~~L~~l~l~~N 79 (427)
+|||++|+|+ .+|..+..+++|+.|+|++|+++ .++ .+..+++|++|++++|+++ .+|+. +..+++|++|++++|
T Consensus 22 ~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~-~l~~~~~~~l~~L~~L~L~~N 97 (162)
T d1a9na_ 22 ELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDLTELILTNN 97 (162)
T ss_dssp EEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCC-EECSCHHHHCTTCCEEECCSC
T ss_pred EEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhccccccc-CCCccccccccccccceeccc
Confidence 4899999999 67887889999999999999998 675 5999999999999999999 66665 567999999999999
Q ss_pred cCcccCC-CCccccccccceeeccCCcCcCCCCC----CCcCCCCCCeEE
Q 042634 80 NLTGTTP-TEVIGLSSLSIYLDLSQNQLNGPLPS----NFGILKNLGAID 124 (427)
Q Consensus 80 ~~~~~~p-~~~~~l~~l~~~L~l~~n~~~~~~p~----~~~~l~~L~~l~ 124 (427)
+++.... ..+..+++| ++|++++|+++ ..|. .+..+++|+.||
T Consensus 98 ~i~~~~~l~~l~~l~~L-~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 98 SLVELGDLDPLASLKSL-TYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp CCCCGGGGGGGGGCTTC-CEEECCSSGGG-GSTTHHHHHHHHCTTCSEET
T ss_pred ccccccccccccccccc-chhhcCCCccc-cccchHHHHHHHCCCcCeeC
Confidence 9984322 457888999 68999999997 5664 478899999987
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.58 E-value=1.9e-15 Score=132.77 Aligned_cols=165 Identities=21% Similarity=0.283 Sum_probs=135.5
Q ss_pred eecCCcccccCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccCc
Q 042634 3 TLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLT 82 (427)
Q Consensus 3 ~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~~ 82 (427)
+++.+.+++.+ .+.+|.+|+.|++++|.++ .++ .+..+++|++|++++|.++ .++ .+..+++|+++++++|.++
T Consensus 25 ~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~ls~n~i~-~~~-~l~~l~~l~~l~~~~n~~~ 98 (227)
T d1h6ua2 25 AAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQIT-DLA-PLKNLTKITELELSGNPLK 98 (227)
T ss_dssp HTTCSSTTSEE--CHHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCC-CCG-GGTTCCSCCEEECCSCCCS
T ss_pred HhCCCCcCCcC--CHHHcCCcCEEECCCCCCC-cch-hHhcCCCCcEeecCCceee-ccc-ccccccccccccccccccc
Confidence 45667777654 4467889999999999998 674 6999999999999999999 444 3889999999999999998
Q ss_pred ccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCCCCc
Q 042634 83 GTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSL 162 (427)
Q Consensus 83 ~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~~l 162 (427)
.++ .+.++.+| +.+.+++|...+. ..+...+.+..+.++++.+.. ...+..+++|+.|++++|.+++. ..+
T Consensus 99 -~i~-~l~~l~~L-~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~--~~~~~~~~~L~~L~l~~n~~~~~--~~l 169 (227)
T d1h6ua2 99 -NVS-AIAGLQSI-KTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITN--ISPLAGLTNLQYLSIGNAQVSDL--TPL 169 (227)
T ss_dssp -CCG-GGTTCTTC-CEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCC--CGGGGGCTTCCEEECCSSCCCCC--GGG
T ss_pred -ccc-cccccccc-ccccccccccccc--chhccccchhhhhchhhhhch--hhhhccccccccccccccccccc--hhh
Confidence 454 47788899 6899999998743 346678899999999998874 34578899999999999999854 348
Q ss_pred ccccCCceeeccCCcccccc
Q 042634 163 SSLRGIENLDLSRNNFIRHR 182 (427)
Q Consensus 163 ~~l~~L~~L~L~~N~ll~Hp 182 (427)
..+++|+.|++++|++..-+
T Consensus 170 ~~l~~L~~L~Ls~n~l~~l~ 189 (227)
T d1h6ua2 170 ANLSKLTTLKADDNKISDIS 189 (227)
T ss_dssp TTCTTCCEEECCSSCCCCCG
T ss_pred cccccceecccCCCccCCCh
Confidence 88999999999999876533
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.53 E-value=7.8e-17 Score=138.39 Aligned_cols=130 Identities=25% Similarity=0.332 Sum_probs=72.1
Q ss_pred ecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccCcccCCCCccccccccceeeccCCcCcCCCCCCCc
Q 042634 36 EIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFG 115 (427)
Q Consensus 36 ~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~ 115 (427)
.+|..++.+++|+.|+|++|+++ .++ .+..+++|++|++++|.++ .+|.....+.+| +.|++++|+++ .++ .+.
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L-~~L~l~~N~i~-~l~-~~~ 112 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTL-EELWISYNQIA-SLS-GIE 112 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHC-CEEECSEEECC-CHH-HHH
T ss_pred hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccc-ccccccccccc-ccc-ccc
Confidence 34455666666666666666665 444 3555666666666666665 444333334445 45666666665 232 355
Q ss_pred CCCCCCeEECcCCcccccCC--ccccccccccceeeeeeeccccCCCC----------cccccCCceee
Q 042634 116 ILKNLGAIDISENKLSGQIP--SSIGSCIRLEQLVMNGNFFRGNIPSS----------LSSLRGIENLD 172 (427)
Q Consensus 116 ~l~~L~~l~l~~n~~~~~~p--~~~~~~~~l~~l~l~~n~l~~~~p~~----------l~~l~~L~~L~ 172 (427)
.+++|+.|++++|+++ .++ ..+.++++|+.|++++|.+....+.. +..+++|+.||
T Consensus 113 ~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD 180 (198)
T d1m9la_ 113 KLVNLRVLYMSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp HHHHSSEEEESEEECC-CHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred ccccccccccccchhc-cccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence 5666666666666665 333 24556666666666666665443322 34566666665
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.50 E-value=1.9e-16 Score=135.98 Aligned_cols=130 Identities=19% Similarity=0.264 Sum_probs=102.4
Q ss_pred cCCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccCcccCCCCccc
Q 042634 12 RIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEVIG 91 (427)
Q Consensus 12 ~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~~~ 91 (427)
.+|..+..|++|+.|+|++|+++ .++ .++++++|++|+|++|.++ .+|.....+++|++|++++|+++. ++ .+..
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~-~~~~ 113 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEK 113 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HH-HHHH
T ss_pred hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-cc-cccc
Confidence 34567888999999999999998 675 5899999999999999998 787666666789999999999984 33 4677
Q ss_pred cccccceeeccCCcCcCCCC--CCCcCCCCCCeEECcCCcccccCCcc----------cccccccccee
Q 042634 92 LSSLSIYLDLSQNQLNGPLP--SNFGILKNLGAIDISENKLSGQIPSS----------IGSCIRLEQLV 148 (427)
Q Consensus 92 l~~l~~~L~l~~n~~~~~~p--~~~~~l~~L~~l~l~~n~~~~~~p~~----------~~~~~~l~~l~ 148 (427)
+++| +.|++++|+++ .++ ..+..+++|+.|++++|+++...+.. +..+++|+.||
T Consensus 114 l~~L-~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD 180 (198)
T d1m9la_ 114 LVNL-RVLYMSNNKIT-NWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp HHHS-SEEEESEEECC-CHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred cccc-cccccccchhc-cccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence 8888 67999999987 444 46788999999999999887544432 45677787765
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.48 E-value=4.1e-14 Score=125.21 Aligned_cols=172 Identities=18% Similarity=0.186 Sum_probs=133.5
Q ss_pred CeeecCCcccccCC-ccccCCCCCCEeeeec-ccceeecCcchhccccCCEeeeccccCcccCCc--CccCCCCCCeEEc
Q 042634 1 AFTLVGNQFTGRIP-GSIGDLHKLQRLTLEM-NKFWGEIPSSIGNLTLLITLNFAENMLEGSIPS--SLGKCQNLILLDL 76 (427)
Q Consensus 1 ~l~l~~n~l~~~~p-~~~~~l~~L~~L~l~~-n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~--~~~~l~~L~~l~l 76 (427)
+|+|++|.+...+| ..|.++++++.|+++. |++....+..|.++++|+.|++++|.++ ..|. .+..++.|..+..
T Consensus 57 ~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~-~~~~~~~~~~l~~l~~~~~ 135 (242)
T d1xwdc1 57 KIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQ 135 (242)
T ss_dssp EEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCC-SCCCCTTTCBSSCEEEEEE
T ss_pred hhhhccccccceeeccccccccccccccccccccccccccccccccccccccccchhhhc-ccccccccccccccccccc
Confidence 47999999987665 5688999999999875 7888667778999999999999999998 4443 2444566677777
Q ss_pred cCccCcccCCCCccccccccceeeccCCcCcCCCCCCCcCCCCCCeE-ECcCCcccccCCc-cccccccccceeeeeeec
Q 042634 77 SNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNFGILKNLGAI-DISENKLSGQIPS-SIGSCIRLEQLVMNGNFF 154 (427)
Q Consensus 77 ~~N~~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~~~l~~L~~l-~l~~n~~~~~~p~-~~~~~~~l~~l~l~~n~l 154 (427)
+++.+....+..+.++......|++++|+++ .++....+..++..+ ++++|+++ .+|. .|.++++|+.|++++|++
T Consensus 136 ~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~-~i~~~~~~~~~l~~~~~l~~n~l~-~l~~~~f~~l~~L~~L~Ls~N~l 213 (242)
T d1xwdc1 136 DNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNCAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRI 213 (242)
T ss_dssp SCTTCCEECTTSSTTSBSSCEEEECCSSCCC-EECTTTTTTCCEEEEECTTCTTCC-CCCTTTTTTSCCCSEEECTTSCC
T ss_pred cccccccccccccccccccceeeeccccccc-ccccccccchhhhccccccccccc-cccHHHhcCCCCCCEEECCCCcC
Confidence 8888886666777776644377999999998 566555566666555 57888998 6765 578899999999999999
Q ss_pred cccCCCCcccccCCceeeccC
Q 042634 155 RGNIPSSLSSLRGIENLDLSR 175 (427)
Q Consensus 155 ~~~~p~~l~~l~~L~~L~L~~ 175 (427)
+...+..+.+++.|+.+++.+
T Consensus 214 ~~l~~~~~~~l~~L~~l~~~~ 234 (242)
T d1xwdc1 214 HSLPSYGLENLKKLRARSTYN 234 (242)
T ss_dssp CCCCSSSCTTCCEEESSSEES
T ss_pred CccCHHHHcCCcccccCcCCC
Confidence 976556677777777766543
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.44 E-value=1.6e-13 Score=112.60 Aligned_cols=110 Identities=19% Similarity=0.097 Sum_probs=72.4
Q ss_pred cCCCCCCEeeeecccceeecCcchhccccCCEeeeccc-cCcccCC-cCccCCCCCCeEEccCccCcccCCCCccccccc
Q 042634 18 GDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAEN-MLEGSIP-SSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSL 95 (427)
Q Consensus 18 ~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n-~l~~~~p-~~~~~l~~L~~l~l~~N~~~~~~p~~~~~l~~l 95 (427)
+.....+.++.+++.++ .+|..+.++++|+.|++++| .++ .++ .+|.++++|+.|+|++|+|+...|.+|.++++|
T Consensus 5 C~c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L 82 (156)
T d2ifga3 5 CCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQ-HLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82 (156)
T ss_dssp SCCSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCC-EECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCC
T ss_pred CCcCCCCeEEecCCCCc-cCcccccCccccCeeecCCCcccc-ccCchhhccccccCcceeeccccCCcccccccccccc
Confidence 33445556777777766 56666777777777777654 366 444 446667777777777777776666667777777
Q ss_pred cceeeccCCcCcCCCCCCCcCCCCCCeEECcCCccc
Q 042634 96 SIYLDLSQNQLNGPLPSNFGILKNLGAIDISENKLS 131 (427)
Q Consensus 96 ~~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~ 131 (427)
++|+|++|+++ .+|..+....+|+.|+|++|.+.
T Consensus 83 -~~L~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 83 -SRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp -CEEECCSSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred -cceeccCCCCc-ccChhhhccccccccccCCCccc
Confidence 46777777776 55554444446778888888764
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.43 E-value=9.5e-13 Score=122.46 Aligned_cols=75 Identities=28% Similarity=0.404 Sum_probs=49.7
Q ss_pred CeeecCCcccccCCccccCCCCCCEeeeecccceeecCcchhcc-----------------ccCCEeeeccccCcccCCc
Q 042634 1 AFTLVGNQFTGRIPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNL-----------------TLLITLNFAENMLEGSIPS 63 (427)
Q Consensus 1 ~l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l-----------------~~L~~L~l~~n~l~~~~p~ 63 (427)
+|||++|.++ .+|+. +++|++|+|++|+|+ .+|..+++| +.|++|++++|.++ .+|.
T Consensus 42 ~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~~~L~~L~l~~n~l~~l~~lp~~L~~L~L~~n~l~-~lp~ 115 (353)
T d1jl5a_ 42 ELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLE-KLPE 115 (353)
T ss_dssp EEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCCTTCCEEECCSSCCSCCCSCCTTCCEEECCSSCCS-SCCC
T ss_pred EEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccchhhhhhhhhhhcccchhhhhccccccccccccccc-cccc
Confidence 3788999998 67753 468888999999988 788765432 12555666666655 5553
Q ss_pred CccCCCCCCeEEccCccCc
Q 042634 64 SLGKCQNLILLDLSNNNLT 82 (427)
Q Consensus 64 ~~~~l~~L~~l~l~~N~~~ 82 (427)
++.+++|++|++++|.++
T Consensus 116 -~~~l~~L~~L~l~~~~~~ 133 (353)
T d1jl5a_ 116 -LQNSSFLKIIDVDNNSLK 133 (353)
T ss_dssp -CTTCTTCCEEECCSSCCS
T ss_pred -hhhhccceeecccccccc
Confidence 455666666666666554
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.41 E-value=5e-13 Score=109.55 Aligned_cols=103 Identities=20% Similarity=0.112 Sum_probs=86.1
Q ss_pred eeecCCcccccCCccccCCCCCCEeeeecc-cceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCcc
Q 042634 2 FTLVGNQFTGRIPGSIGDLHKLQRLTLEMN-KFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNN 80 (427)
Q Consensus 2 l~l~~n~l~~~~p~~~~~l~~L~~L~l~~n-~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~ 80 (427)
++.++++++ .+|..+..+++|+.|++++| .++..-+..|.++++|+.|+|++|+|+...|.+|..+++|++|+|++|+
T Consensus 13 l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~ 91 (156)
T d2ifga3 13 LRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA 91 (156)
T ss_dssp EECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSC
T ss_pred EEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCC
Confidence 678889998 67888999999999999866 5884334579999999999999999995556779999999999999999
Q ss_pred CcccCCCCccccccccceeeccCCcCc
Q 042634 81 LTGTTPTEVIGLSSLSIYLDLSQNQLN 107 (427)
Q Consensus 81 ~~~~~p~~~~~l~~l~~~L~l~~n~~~ 107 (427)
++ .+|.......++ ..|+|++|++.
T Consensus 92 l~-~l~~~~~~~~~l-~~L~L~~Np~~ 116 (156)
T d2ifga3 92 LE-SLSWKTVQGLSL-QELVLSGNPLH 116 (156)
T ss_dssp CS-CCCSTTTCSCCC-CEEECCSSCCC
T ss_pred Cc-ccChhhhccccc-cccccCCCccc
Confidence 99 555544444567 67999999985
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.30 E-value=5.3e-14 Score=127.69 Aligned_cols=159 Identities=18% Similarity=0.209 Sum_probs=96.0
Q ss_pred ccCCCCCCEeeeecccceee-cCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCc-cCccc-CCCCccccc
Q 042634 17 IGDLHKLQRLTLEMNKFWGE-IPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNN-NLTGT-TPTEVIGLS 93 (427)
Q Consensus 17 ~~~l~~L~~L~l~~n~~~~~-~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N-~~~~~-~p~~~~~l~ 93 (427)
.....+|++|||+++.++.. ++.-+..+++|++|+|++|.+++..+..++.+++|++|+++++ .++.. +..-+.+++
T Consensus 42 ~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~ 121 (284)
T d2astb2 42 HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS 121 (284)
T ss_dssp CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCT
T ss_pred hccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHH
Confidence 44556788888887777633 3344567788888888888877777777777788888888774 44411 111234566
Q ss_pred cccceeeccCCc-CcC-CCCCCCcC-CCCCCeEECcCC--ccccc-CCccccccccccceeeeee-eccccCCCCccccc
Q 042634 94 SLSIYLDLSQNQ-LNG-PLPSNFGI-LKNLGAIDISEN--KLSGQ-IPSSIGSCIRLEQLVMNGN-FFRGNIPSSLSSLR 166 (427)
Q Consensus 94 ~l~~~L~l~~n~-~~~-~~p~~~~~-l~~L~~l~l~~n--~~~~~-~p~~~~~~~~l~~l~l~~n-~l~~~~p~~l~~l~ 166 (427)
+| ++|+++++. ++. .+...+.. ++.|+.|+++++ .++.. +...+.+|++|+.|++++| .+++.....+..++
T Consensus 122 ~L-~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~ 200 (284)
T d2astb2 122 RL-DELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLN 200 (284)
T ss_dssp TC-CEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCT
T ss_pred hc-cccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccC
Confidence 77 568887753 321 11112222 356777777754 23211 2223345677777777764 45555556666777
Q ss_pred CCceeeccCC
Q 042634 167 GIENLDLSRN 176 (427)
Q Consensus 167 ~L~~L~L~~N 176 (427)
+|+.|+++++
T Consensus 201 ~L~~L~L~~C 210 (284)
T d2astb2 201 YLQHLSLSRC 210 (284)
T ss_dssp TCCEEECTTC
T ss_pred cCCEEECCCC
Confidence 7777777764
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.13 E-value=2.5e-10 Score=105.60 Aligned_cols=141 Identities=26% Similarity=0.279 Sum_probs=107.3
Q ss_pred CCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccCcccCCCCccccccccceee
Q 042634 21 HKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLD 100 (427)
Q Consensus 21 ~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~p~~~~~l~~l~~~L~ 100 (427)
.+|+.|||++|.++ .+|+. +++|++|+|++|+|+ ++|..+ .+|+.|++++|+++ .++.. .+.| ++|+
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L-~~L~ 104 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLL-EYLG 104 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTC-CEEE
T ss_pred cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---cccc-cccc
Confidence 36999999999998 79964 578999999999999 999764 57999999999998 55432 1245 6899
Q ss_pred ccCCcCcCCCCCCCcCCCCCCeEECcCCcccccCCccccccccccceeeeeeeccccCCCCcccccCCceeeccCCcccc
Q 042634 101 LSQNQLNGPLPSNFGILKNLGAIDISENKLSGQIPSSIGSCIRLEQLVMNGNFFRGNIPSSLSSLRGIENLDLSRNNFIR 180 (427)
Q Consensus 101 l~~n~~~~~~p~~~~~l~~L~~l~l~~n~~~~~~p~~~~~~~~l~~l~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~ll~ 180 (427)
+++|++. .+|. ++.+++|+.|++++|.+. ..|..... +..+.+..+... ....+..++.++.+.++.|....
T Consensus 105 L~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~-~~~~~~~~---l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~~ 176 (353)
T d1jl5a_ 105 VSNNQLE-KLPE-LQNSSFLKIIDVDNNSLK-KLPDLPPS---LEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLKK 176 (353)
T ss_dssp CCSSCCS-SCCC-CTTCTTCCEEECCSSCCS-CCCCCCTT---CCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCSS
T ss_pred ccccccc-cccc-hhhhccceeecccccccc-cccccccc---ccchhhcccccc--ccccccccccceecccccccccc
Confidence 9999997 6775 688999999999999988 45555443 444555444443 34556778888888888877654
Q ss_pred cc
Q 042634 181 HR 182 (427)
Q Consensus 181 Hp 182 (427)
.+
T Consensus 177 ~~ 178 (353)
T d1jl5a_ 177 LP 178 (353)
T ss_dssp CC
T ss_pred cc
Confidence 33
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.03 E-value=3.1e-12 Score=119.10 Aligned_cols=164 Identities=18% Similarity=0.173 Sum_probs=114.1
Q ss_pred ccccCCCCCCEeeeecccceee----cCcchhccccCCEeeeccccCcccCCcC-------------ccCCCCCCeEEcc
Q 042634 15 GSIGDLHKLQRLTLEMNKFWGE----IPSSIGNLTLLITLNFAENMLEGSIPSS-------------LGKCQNLILLDLS 77 (427)
Q Consensus 15 ~~~~~l~~L~~L~l~~n~~~~~----~p~~~~~l~~L~~L~l~~n~l~~~~p~~-------------~~~l~~L~~l~l~ 77 (427)
..+...++|+.|+|++|.++.. +...+..+++|+.|++++|.++..-... ....++|+.++++
T Consensus 87 ~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~ 166 (344)
T d2ca6a1 87 QALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICG 166 (344)
T ss_dssp HHHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECC
T ss_pred HHHhhCCCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecc
Confidence 3356678899999999988742 3445567889999999999876321111 1345678999999
Q ss_pred CccCccc----CCCCccccccccceeeccCCcCcC-----CCCCCCcCCCCCCeEECcCCccccc----CCccccccccc
Q 042634 78 NNNLTGT----TPTEVIGLSSLSIYLDLSQNQLNG-----PLPSNFGILKNLGAIDISENKLSGQ----IPSSIGSCIRL 144 (427)
Q Consensus 78 ~N~~~~~----~p~~~~~l~~l~~~L~l~~n~~~~-----~~p~~~~~l~~L~~l~l~~n~~~~~----~p~~~~~~~~l 144 (427)
+|.++.. +...+.....+ ++|+|++|+++. .+...+..+++|+.|++++|.++.. +...+..+++|
T Consensus 167 ~n~i~~~~~~~l~~~l~~~~~L-~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L 245 (344)
T d2ca6a1 167 RNRLENGSMKEWAKTFQSHRLL-HTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNL 245 (344)
T ss_dssp SSCCTGGGHHHHHHHHHHCTTC-CEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTC
T ss_pred cccccccccccccchhhhhhhh-cccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccc
Confidence 9988622 22224455677 679999998863 1345577888999999999988632 34556788899
Q ss_pred cceeeeeeeccccCCCCc----cc--ccCCceeeccCCccc
Q 042634 145 EQLVMNGNFFRGNIPSSL----SS--LRGIENLDLSRNNFI 179 (427)
Q Consensus 145 ~~l~l~~n~l~~~~p~~l----~~--l~~L~~L~L~~N~ll 179 (427)
+.|++++|.+++.....+ .. ...++.|+++.|++.
T Consensus 246 ~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~ 286 (344)
T d2ca6a1 246 RELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIE 286 (344)
T ss_dssp CEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCB
T ss_pred hhhhhhcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCC
Confidence 999999998876432222 22 356889999998863
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.02 E-value=1.3e-11 Score=111.50 Aligned_cols=174 Identities=20% Similarity=0.200 Sum_probs=92.4
Q ss_pred eeecCCccccc-CCccccCCCCCCEeeeecccceeecCcchhccccCCEeeeccc-cCccc-CCcCccCCCCCCeEEccC
Q 042634 2 FTLVGNQFTGR-IPGSIGDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAEN-MLEGS-IPSSLGKCQNLILLDLSN 78 (427)
Q Consensus 2 l~l~~n~l~~~-~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n-~l~~~-~p~~~~~l~~L~~l~l~~ 78 (427)
|||+++.+++. ++..+..+++|++|+|++|.++...+..++.+++|++|+++++ .++.. +..-+..+++|++|++++
T Consensus 51 LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~ 130 (284)
T d2astb2 51 MDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSW 130 (284)
T ss_dssp EECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCC
T ss_pred EECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhcccccccc
Confidence 56666665533 2334556666666666666666555566666666666666663 44421 222234456666666666
Q ss_pred c-cCccc-CCCCccc-cccccceeeccCCc--CcC-CCCCCCcCCCCCCeEECcCC-cccccCCccccccccccceeeee
Q 042634 79 N-NLTGT-TPTEVIG-LSSLSIYLDLSQNQ--LNG-PLPSNFGILKNLGAIDISEN-KLSGQIPSSIGSCIRLEQLVMNG 151 (427)
Q Consensus 79 N-~~~~~-~p~~~~~-l~~l~~~L~l~~n~--~~~-~~p~~~~~l~~L~~l~l~~n-~~~~~~p~~~~~~~~l~~l~l~~ 151 (427)
+ .++.. ++..+.. .++| +.|+++++. ++. .+...+.++++|+.|++++| .+++..+..++++++|+.|++++
T Consensus 131 c~~~~~~~~~~~~~~~~~~L-~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~ 209 (284)
T d2astb2 131 CFDFTEKHVQVAVAHVSETI-TQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSR 209 (284)
T ss_dssp CTTCCHHHHHHHHHHSCTTC-CEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTT
T ss_pred ccccccccchhhhccccccc-chhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCC
Confidence 4 33211 1111222 2344 456666532 221 12222345666666666664 35555555666666666666666
Q ss_pred e-eccccCCCCcccccCCceeeccCC
Q 042634 152 N-FFRGNIPSSLSSLRGIENLDLSRN 176 (427)
Q Consensus 152 n-~l~~~~p~~l~~l~~L~~L~L~~N 176 (427)
+ .+++.....+..+++|+.|+++++
T Consensus 210 C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 210 CYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp CTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred CCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 3 455444445556666666666554
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=98.95 E-value=1.2e-11 Score=114.98 Aligned_cols=176 Identities=18% Similarity=0.202 Sum_probs=88.1
Q ss_pred eeecCCccccc----CCccccCCCCCCEeeeecccceee----------cCcchhccccCCEeeeccccCccc----CCc
Q 042634 2 FTLVGNQFTGR----IPGSIGDLHKLQRLTLEMNKFWGE----------IPSSIGNLTLLITLNFAENMLEGS----IPS 63 (427)
Q Consensus 2 l~l~~n~l~~~----~p~~~~~l~~L~~L~l~~n~~~~~----------~p~~~~~l~~L~~L~l~~n~l~~~----~p~ 63 (427)
|+|++|.++.. +-..+...++|+.|+++.+..... +...+..+++|+.|+|++|.++.. +..
T Consensus 36 L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~ 115 (344)
T d2ca6a1 36 IVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLID 115 (344)
T ss_dssp EECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTHHHHHH
T ss_pred EECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccccccccccchhh
Confidence 55666665432 223345556666666665443210 112233455666666666666532 222
Q ss_pred CccCCCCCCeEEccCccCcccCCCC-------------ccccccccceeeccCCcCcC----CCCCCCcCCCCCCeEECc
Q 042634 64 SLGKCQNLILLDLSNNNLTGTTPTE-------------VIGLSSLSIYLDLSQNQLNG----PLPSNFGILKNLGAIDIS 126 (427)
Q Consensus 64 ~~~~l~~L~~l~l~~N~~~~~~p~~-------------~~~l~~l~~~L~l~~n~~~~----~~p~~~~~l~~L~~l~l~ 126 (427)
.+...++|++|++++|.+...-... ......+ ..+++++|+++. .+...+..++.|+.|+++
T Consensus 116 ~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L-~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~ 194 (344)
T d2ca6a1 116 FLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPL-RSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMV 194 (344)
T ss_dssp HHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCC-CEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECC
T ss_pred hhcccccchheecccccccccccccccccccccccccccccCccc-ceeecccccccccccccccchhhhhhhhcccccc
Confidence 3334556666666666553110000 0122334 346666665541 122223445666677776
Q ss_pred CCccccc-----CCccccccccccceeeeeeecccc----CCCCcccccCCceeeccCCcc
Q 042634 127 ENKLSGQ-----IPSSIGSCIRLEQLVMNGNFFRGN----IPSSLSSLRGIENLDLSRNNF 178 (427)
Q Consensus 127 ~n~~~~~-----~p~~~~~~~~l~~l~l~~n~l~~~----~p~~l~~l~~L~~L~L~~N~l 178 (427)
+|.++.. +...+..+++|+.|++++|.++.. +...+..+++|+.|++++|.+
T Consensus 195 ~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i 255 (344)
T d2ca6a1 195 QNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLL 255 (344)
T ss_dssp SSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCC
T ss_pred cccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCcc
Confidence 6665521 223455566666677776666432 233445566666666666654
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.75 E-value=3.7e-10 Score=92.68 Aligned_cols=63 Identities=25% Similarity=0.214 Sum_probs=29.2
Q ss_pred cCCCCCCEeeeecccceeecCcchhccccCCEeeeccccCcccCC---cCccCCCCCCeEEccCccCc
Q 042634 18 GDLHKLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIP---SSLGKCQNLILLDLSNNNLT 82 (427)
Q Consensus 18 ~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p---~~~~~l~~L~~l~l~~N~~~ 82 (427)
..+..+..+++.+|... .++.....+++|++|+|++|+++ .++ ..+..+++|+.|++++|.++
T Consensus 39 ~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~-~l~~~~~~~~~l~~L~~L~Ls~N~i~ 104 (162)
T d1koha1 39 VAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLY-RLDDMSSIVQKAPNLKILNLSGNELK 104 (162)
T ss_dssp TTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCC-CCSGGGTHHHHSTTCCCCCCTTSCCC
T ss_pred hhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCcccc-CCchhHHHHhhCCcccccccccCccc
Confidence 33333444444433332 33333344555555555555555 222 22344555555555555555
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.59 E-value=8.6e-10 Score=105.61 Aligned_cols=160 Identities=21% Similarity=0.172 Sum_probs=68.1
Q ss_pred cCCCCCCEeeeecccceee-----cCcchhccccCCEeeeccccCccc----CCcCccCCCCCCeEEccCccCcccCCCC
Q 042634 18 GDLHKLQRLTLEMNKFWGE-----IPSSIGNLTLLITLNFAENMLEGS----IPSSLGKCQNLILLDLSNNNLTGTTPTE 88 (427)
Q Consensus 18 ~~l~~L~~L~l~~n~~~~~-----~p~~~~~l~~L~~L~l~~n~l~~~----~p~~~~~l~~L~~l~l~~N~~~~~~p~~ 88 (427)
.....++.++++.|.+... ++........++.|++++|.+... ....+...+.++.+++++|.++..-...
T Consensus 223 ~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~ 302 (460)
T d1z7xw1 223 ASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARL 302 (460)
T ss_dssp HHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHH
T ss_pred cccccccccchhhccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccch
Confidence 3445555555555544311 111222344555555555555421 1222334445555555555553211110
Q ss_pred c-----cccccccceeeccCCcCcCCC----CCCCcCCCCCCeEECcCCccccc----CCcccc-ccccccceeeeeeec
Q 042634 89 V-----IGLSSLSIYLDLSQNQLNGPL----PSNFGILKNLGAIDISENKLSGQ----IPSSIG-SCIRLEQLVMNGNFF 154 (427)
Q Consensus 89 ~-----~~l~~l~~~L~l~~n~~~~~~----p~~~~~l~~L~~l~l~~n~~~~~----~p~~~~-~~~~l~~l~l~~n~l 154 (427)
+ .....+ ..+++++|.++... ...+...++|++|+|++|+++.. ++..+. ..+.|+.|++++|.+
T Consensus 303 l~~~l~~~~~~L-~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i 381 (460)
T d1z7xw1 303 LCETLLEPGCQL-ESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDV 381 (460)
T ss_dssp HHHHHTSTTCCC-CEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCC
T ss_pred hhcccccccccc-ccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCC
Confidence 0 011233 34555555554221 11123334555555555555432 222222 233455555555555
Q ss_pred ccc----CCCCcccccCCceeeccCCcc
Q 042634 155 RGN----IPSSLSSLRGIENLDLSRNNF 178 (427)
Q Consensus 155 ~~~----~p~~l~~l~~L~~L~L~~N~l 178 (427)
+.. ++..+..+++|+.|++++|++
T Consensus 382 ~~~~~~~l~~~l~~~~~L~~L~Ls~N~i 409 (460)
T d1z7xw1 382 SDSSCSSLAATLLANHSLRELDLSNNCL 409 (460)
T ss_dssp CHHHHHHHHHHHHHCCCCCEEECCSSSC
T ss_pred ChHHHHHHHHHHhcCCCCCEEECCCCcC
Confidence 432 222333445555555555554
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.53 E-value=1.8e-09 Score=88.46 Aligned_cols=120 Identities=22% Similarity=0.137 Sum_probs=72.0
Q ss_pred CCCEeeeecccceeecCcchhccccCCEeeeccccCcccCCcCccCCCCCCeEEccCccCcccC--CCCcccccccccee
Q 042634 22 KLQRLTLEMNKFWGEIPSSIGNLTLLITLNFAENMLEGSIPSSLGKCQNLILLDLSNNNLTGTT--PTEVIGLSSLSIYL 99 (427)
Q Consensus 22 ~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~~~~l~~L~~l~l~~N~~~~~~--p~~~~~l~~l~~~L 99 (427)
..+.|+++++... +.+..+..+..++..+|... .++.....+++|++|++++|+++..- +..+..+++| +.|
T Consensus 23 ~~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L-~~L 96 (162)
T d1koha1 23 SQQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNL-KIL 96 (162)
T ss_dssp SSCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTC-CCC
T ss_pred hhCeeecccCCCC----chhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcc-ccc
Confidence 4556666654432 34666666666666666555 55555556788888888888887432 2335566777 567
Q ss_pred eccCCcCcCCCCC-CCcCCCCCCeEECcCCcccccCCcc-------cccccccccee
Q 042634 100 DLSQNQLNGPLPS-NFGILKNLGAIDISENKLSGQIPSS-------IGSCIRLEQLV 148 (427)
Q Consensus 100 ~l~~n~~~~~~p~-~~~~l~~L~~l~l~~n~~~~~~p~~-------~~~~~~l~~l~ 148 (427)
+|++|.++ .++. .+.....|+.|++++|+++...... +..+++|+.||
T Consensus 97 ~Ls~N~i~-~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 97 NLSGNELK-SERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp CCTTSCCC-CGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred ccccCccc-cchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence 77777776 3332 2333446777777777776433321 33456666554
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.39 E-value=1.4e-08 Score=96.83 Aligned_cols=109 Identities=21% Similarity=0.244 Sum_probs=48.5
Q ss_pred CCCEeeeecccceee-cCcchhccccCCEeeeccccCcc----cCCcCccCCCCCCeEEccCccCccc----CCCCccc-
Q 042634 22 KLQRLTLEMNKFWGE-IPSSIGNLTLLITLNFAENMLEG----SIPSSLGKCQNLILLDLSNNNLTGT----TPTEVIG- 91 (427)
Q Consensus 22 ~L~~L~l~~n~~~~~-~p~~~~~l~~L~~L~l~~n~l~~----~~p~~~~~l~~L~~l~l~~N~~~~~----~p~~~~~- 91 (427)
+|+.||++.|+++.. +..-+..++++++|+|++|.++. .++..+..+++|++|||++|+++.. +...+..
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 345555555555421 01223445555555555555541 2233344455555555555555311 1111111
Q ss_pred cccccceeeccCCcCcCC----CCCCCcCCCCCCeEECcCCccc
Q 042634 92 LSSLSIYLDLSQNQLNGP----LPSNFGILKNLGAIDISENKLS 131 (427)
Q Consensus 92 l~~l~~~L~l~~n~~~~~----~p~~~~~l~~L~~l~l~~n~~~ 131 (427)
..+| +.|+|++|+++.. ++..+..+++|+.|++++|.++
T Consensus 83 ~~~L-~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 83 SCKI-QKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG 125 (460)
T ss_dssp TCCC-CEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred CCCC-CEEECCCCCccccccccccchhhccccccccccccccch
Confidence 1234 3455555555421 2334455555666666665554
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.51 E-value=5.3e-06 Score=67.48 Aligned_cols=64 Identities=17% Similarity=0.225 Sum_probs=36.0
Q ss_pred CCCCCCEeeeecc-cceee----cCcchhccccCCEeeeccccCcccCCcC----ccCCCCCCeEEccCccCc
Q 042634 19 DLHKLQRLTLEMN-KFWGE----IPSSIGNLTLLITLNFAENMLEGSIPSS----LGKCQNLILLDLSNNNLT 82 (427)
Q Consensus 19 ~l~~L~~L~l~~n-~~~~~----~p~~~~~l~~L~~L~l~~n~l~~~~p~~----~~~l~~L~~l~l~~N~~~ 82 (427)
+.++|+.|+|+++ .++.. +-..+...+.|++|+|++|.++...... +...++|++|++++|.++
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~ 85 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 85 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcc
Confidence 3467777777753 34421 1223445566777777777776322222 333456666666666665
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.46 E-value=8.2e-06 Score=66.32 Aligned_cols=111 Identities=13% Similarity=0.091 Sum_probs=73.9
Q ss_pred ccccCCEeeeccc-cCccc----CCcCccCCCCCCeEEccCccCcccCCC----CccccccccceeeccCCcCcCC----
Q 042634 43 NLTLLITLNFAEN-MLEGS----IPSSLGKCQNLILLDLSNNNLTGTTPT----EVIGLSSLSIYLDLSQNQLNGP---- 109 (427)
Q Consensus 43 ~l~~L~~L~l~~n-~l~~~----~p~~~~~l~~L~~l~l~~N~~~~~~p~----~~~~l~~l~~~L~l~~n~~~~~---- 109 (427)
+.++|+.|+|+++ .++.. +-..+...++|++|++++|.++..-.. .+...+.+ ++|+|++|.++..
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L-~~L~L~~n~i~~~g~~~ 91 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSL-RVLNVESNFLTPELLAR 91 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSC-CEEECCSSBCCHHHHHH
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccc-cceeeehhhcchHHHHH
Confidence 4578999999874 56532 333566677899999999988632222 23345667 6799999988631
Q ss_pred CCCCCcCCCCCCeEECcCCcccc-------cCCccccccccccceeeeeeec
Q 042634 110 LPSNFGILKNLGAIDISENKLSG-------QIPSSIGSCIRLEQLVMNGNFF 154 (427)
Q Consensus 110 ~p~~~~~l~~L~~l~l~~n~~~~-------~~p~~~~~~~~l~~l~l~~n~l 154 (427)
+-..+...+.|+.|++++|++.. .+...+...++|+.|+++.+..
T Consensus 92 l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 92 LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 143 (167)
T ss_dssp HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCc
Confidence 22346667889999999887552 1233444567888888776644
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.64 E-value=8.5e-05 Score=59.93 Aligned_cols=66 Identities=11% Similarity=0.092 Sum_probs=42.1
Q ss_pred ccCCCCCCEeeeec-ccceee----cCcchhccccCCEeeeccccCccc----CCcCccCCCCCCeEEccCccCc
Q 042634 17 IGDLHKLQRLTLEM-NKFWGE----IPSSIGNLTLLITLNFAENMLEGS----IPSSLGKCQNLILLDLSNNNLT 82 (427)
Q Consensus 17 ~~~l~~L~~L~l~~-n~~~~~----~p~~~~~l~~L~~L~l~~n~l~~~----~p~~~~~l~~L~~l~l~~N~~~ 82 (427)
..+.++|+.|+|++ +.++.. +-..+...++|+.|++++|.++.. +-..+...++|+++++++|.++
T Consensus 13 ~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~ 87 (166)
T d1io0a_ 13 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 87 (166)
T ss_dssp HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred HhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhcccccc
Confidence 34567888888886 445421 223445677788888888887743 2223444567788888777775
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.46 E-value=8.4e-05 Score=59.96 Aligned_cols=116 Identities=12% Similarity=0.121 Sum_probs=61.6
Q ss_pred chhccccCCEeeecc-ccCccc----CCcCccCCCCCCeEEccCccCcccCCCCccccccccceeeccCCcCcCCCCCCC
Q 042634 40 SIGNLTLLITLNFAE-NMLEGS----IPSSLGKCQNLILLDLSNNNLTGTTPTEVIGLSSLSIYLDLSQNQLNGPLPSNF 114 (427)
Q Consensus 40 ~~~~l~~L~~L~l~~-n~l~~~----~p~~~~~l~~L~~l~l~~N~~~~~~p~~~~~l~~l~~~L~l~~n~~~~~~p~~~ 114 (427)
...+.++|+.|+|++ |.++.. +-..+...++|++|++++|.++..--..+. ..+
T Consensus 12 ~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~---------------------~~l 70 (166)
T d1io0a_ 12 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALA---------------------EML 70 (166)
T ss_dssp HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHH---------------------HHH
T ss_pred HHhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHH---------------------HHH
Confidence 345668899999987 556532 334455677888888888887632211111 112
Q ss_pred cCCCCCCeEECcCCccccc----CCccccccccccceee--eeeecccc----CCCCcccccCCceeeccCC
Q 042634 115 GILKNLGAIDISENKLSGQ----IPSSIGSCIRLEQLVM--NGNFFRGN----IPSSLSSLRGIENLDLSRN 176 (427)
Q Consensus 115 ~~l~~L~~l~l~~n~~~~~----~p~~~~~~~~l~~l~l--~~n~l~~~----~p~~l~~l~~L~~L~L~~N 176 (427)
...++++.+++++|.++.. +-..+...++|+.+++ +.|.+... +...+...++|+.|+++.+
T Consensus 71 ~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~ 142 (166)
T d1io0a_ 71 KVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFT 142 (166)
T ss_dssp HHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCS
T ss_pred hhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCC
Confidence 2234555566665555422 2233445555554333 34444321 2233445566677766544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=96.06 E-value=0.0015 Score=56.34 Aligned_cols=30 Identities=23% Similarity=0.256 Sum_probs=25.9
Q ss_pred CeeeccccCCceeeCCCCceEecccccccc
Q 042634 254 PIVHCDLKPSNVLLDGELTAHVGDFGLAKF 283 (427)
Q Consensus 254 ~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 283 (427)
.++|+|+.|.||++++++.+-|+||+.+..
T Consensus 184 ~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 184 VFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp EEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred EEEEeeccCcceeecCCceEEEeechhccc
Confidence 378999999999999877778999998753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=95.32 E-value=0.007 Score=51.53 Aligned_cols=29 Identities=17% Similarity=0.172 Sum_probs=25.7
Q ss_pred CeeeccccCCceeeCCCCceEeccccccc
Q 042634 254 PIVHCDLKPSNVLLDGELTAHVGDFGLAK 282 (427)
Q Consensus 254 ~ivHrDlkp~NIll~~~~~~kL~DFG~a~ 282 (427)
.++|+|+.|.|||++.+..+-|+||+.+.
T Consensus 176 ~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 176 VVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp EEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred eEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 47999999999999988778899999775
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=92.92 E-value=0.014 Score=51.47 Aligned_cols=31 Identities=29% Similarity=0.384 Sum_probs=28.2
Q ss_pred CCCeeeccccCCceeeCCCCceEeccccccc
Q 042634 252 ETPIVHCDLKPSNVLLDGELTAHVGDFGLAK 282 (427)
Q Consensus 252 ~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~ 282 (427)
..|++|+|+.+.||+++.+...-+.||+.|.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 5789999999999999998888899999874
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=87.49 E-value=0.22 Score=43.68 Aligned_cols=30 Identities=20% Similarity=0.172 Sum_probs=24.9
Q ss_pred CCCeeeccccCCceeeCCCCceEecccccccc
Q 042634 252 ETPIVHCDLKPSNVLLDGELTAHVGDFGLAKF 283 (427)
Q Consensus 252 ~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 283 (427)
..+++|+|+.+.|||++++ ..++||+-+..
T Consensus 191 p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 191 TVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred CceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 4689999999999999754 45899998864
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=84.82 E-value=0.2 Score=45.29 Aligned_cols=31 Identities=19% Similarity=0.305 Sum_probs=26.7
Q ss_pred CCCeeeccccCCceeeCCCCceEecccccccc
Q 042634 252 ETPIVHCDLKPSNVLLDGELTAHVGDFGLAKF 283 (427)
Q Consensus 252 ~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 283 (427)
...++|+|+.|.|||++++. ++|+||..|..
T Consensus 222 ~~~LiHGDl~~gNIlv~~~~-~~vID~E~a~~ 252 (392)
T d2pula1 222 AETLIHGDLHTGSIFASEHE-TKVIDPEFAFY 252 (392)
T ss_dssp CCEEECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred CcceeccCCcCCceeEcCCc-eEEechhhccc
Confidence 45799999999999998765 89999988764
|